PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Singh, S; Manda, SM; Sikder, D; Birrer, MJ; Rothermel, BA; Garry, DJ; Mammen, PPA				Singh, Sarvjeet; Manda, Shilpa M.; Sikder, Devanjan; Birrer, Michael J.; Rothermel, Beverly A.; Garry, Daniel J.; Mammen, Pradeep P. A.			Calcineurin Activates Cytoglobin Transcription in Hypoxic Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE MUTANT; HUMAN MYOGLOBIN PROMOTER; C-JUN; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; ANGIOTENSIN-II; IN-VITRO; OVEREXPRESSION PROTECTS; ADULT CARDIOMYOCYTES; REGULATORY ELEMENTS	Cardiac hypertrophy develops in response to a variety of cardiovascular stresses and results in activation of numerous signaling cascades and proteins. In the present study, we demonstrate that cytoglobin is a stress-responsive hemoprotein in the hypoxia-induced hypertrophic myocardium and it is transcriptionally regulated by calcineurin-dependent transcription factors. The cytoglobin transcript level is abundantly expressed in the adult heart and in response to hypoxia cytoglobin expression is markedly up-regulated within the hypoxia-induced hypertrophic heart. To define the molecular mechanism resulting in the induction of cytoglobin, we undertook a transcriptional analysis of the 5' upstream regulatory region of the cytoglobin gene. Evolutionarily conserved binding elements for transcription factors HIF-1, AP-1, and NFAT are located within the upstream region of the cytoglobin gene. Transcriptional assays demonstrated that calcineurin activity modulates cytoglobin transcription. Increased calcineurin activity enhances the ability of NFAT and AP-1 to bind to the putative cytoglobin promoter, especially under hypoxic conditions. In addition, inhibition of calcineurin, NFAT, and/or AP-1 activities decreases endogenous cytoglobin transcript and protein levels. Thus, the regulation of cytoglobin transcription by calcineurin-dependent transcription factors suggests that cytoglobin may have a functional role in calcium-dependent events accompanying cardiac remodeling.	[Singh, Sarvjeet; Manda, Shilpa M.; Sikder, Devanjan; Rothermel, Beverly A.; Garry, Daniel J.; Mammen, Pradeep P. A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Garry, Daniel J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Garry, Daniel J.; Mammen, Pradeep P. A.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Birrer, Michael J.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mammen, PPA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pradeep.mammen@utsouthwestern.edu	singh, sarvjeet/F-1569-2015		National Institutes of Health [HL-63788, HL-076440]; American Heart Association-Texas; Donald W. Reynolds Clinical Cardiovascular Research Center; GlaxoSmithKline Research Foundation; NATIONAL CANCER INSTITUTE [ZIASC000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102478, K08HL076440, R01HL063788, R01HL072016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Texas(American Heart Association); Donald W. Reynolds Clinical Cardiovascular Research Center; GlaxoSmithKline Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by National Institutes of Health Grants HL-63788 (to D.J.G.) and HL-076440 (to P.P.A.M.). This study was also supported by grants from the American Heart Association-Texas Affiliate to (P.P.A.M.), the Donald W. Reynolds Clinical Cardiovascular Research Center (to D.J.G. and P.P.A.M.), and the GlaxoSmithKline Research Foundation (to P.P.A.M.).	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; BASSELDUBY R, 1993, CIRC RES, V73, P360, DOI 10.1161/01.RES.73.2.360; BROWN PH, 1994, ONCOGENE, V9, P791; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen BK, 2007, MOL BIOL CELL, V18, P1118, DOI 10.1091/mbc.E06-09-0797; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Coronella-Wood J, 2004, J BIOL CHEM, V279, P33567, DOI 10.1074/jbc.M404013200; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Erin N, 2003, NEUROSCIENCE, V117, P541, DOI 10.1016/S0306-4522(02)00933-8; Erin N, 2003, NEUROSCIENCE, V117, P557, DOI 10.1016/S0306-4522(02)00934-X; Fan MY, 2001, CANCER RES, V61, P4450; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRAYSON J, 1995, MOL CELL BIOL, V15, P1870; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Guo XM, 2006, BBA-GENE STRUCT EXPR, V1759, P208, DOI 10.1016/j.bbaexp.2006.04.002; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Im SH, 2004, MOL CELLS, V18, P1; Ito H, 1996, J MOL CELL CARDIOL, V28, P1271, DOI 10.1006/jmcc.1996.0117; Jacob MH, 2006, LIFE SCI, V79, P2187, DOI 10.1016/j.lfs.2006.07.015; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Koulmann N, 2006, AM J RESP CRIT CARE, V174, P699, DOI 10.1164/rccm.200512-1976OC; Kudoh S, 1997, CIRC RES, V80, P139, DOI 10.1161/01.RES.80.1.139; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Mammen PPA, 2003, AM J PHYSIOL-HEART C, V285, pH2132, DOI 10.1152/ajpheart.00147.2003; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Mammen PPA, 2006, J HISTOCHEM CYTOCHEM, V54, P1349, DOI 10.1369/jhc.6A7008.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2001, CIRC RES, V88, P1220, DOI 10.1161/hh1201.093159; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Paasinen-Sohns A, 2000, J CELL BIOL, V151, P801, DOI 10.1083/jcb.151.4.801; PARSONS WJ, 1993, P NATL ACAD SCI USA, V90, P1726, DOI 10.1073/pnas.90.5.1726; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Taimor G, 2001, FASEB J, V15, P2518, DOI 10.1096/fj.01-0353fje; Taimor G, 2001, J MOL CELL CARDIOL, V33, P503, DOI 10.1006/jmcc.2000.1324; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang NP, 1999, CIRC RES, V85, P387, DOI 10.1161/01.RES.85.5.387; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Wenzel S, 2001, FASEB J, V15, P2291, DOI 10.1096/fj.00-0827fje; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yan Z, 2001, J BIOL CHEM, V276, P17361, DOI 10.1074/jbc.M101251200; Yousef Z, 2000, CARDIOVASC DRUG THER, V14, P243, DOI 10.1023/A:1007879205916	78	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10409	10421		10.1074/jbc.M809572200	http://dx.doi.org/10.1074/jbc.M809572200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19203999	hybrid, Green Published			2022-12-25	WOS:000265104600015
J	Bamming, D; Horvath, CM				Bamming, Darja; Horvath, Curt M.			Regulation of Signal Transduction by Enzymatically Inactive Antiviral RNA Helicase Proteins MDA5, RIG-I, and LGP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; INDUCIBLE GENE-I; INNATE IMMUNITY; ADAPTER PROTEIN; ATPASE ACTIVITY; RESPONSES; RECOGNITION; DOMAIN; ACID; BETA	Intracellular pattern recognition receptors MDA5, RIG-I, and LGP2 are essential components of the cellular response to virus infection and are homologous to the DEXH box subfamily of RNA helicases. However, the relevance of helicase activity in the regulation of interferon production remains elusive. To examine the importance of the helicase domain function for these signaling proteins, a series of mutations targeting conserved helicase sequence motifs were analyzed for enzymatic activity, RNA binding, interferon induction, and antiviral signaling. Results indicate that all targeted motifs are required for ATP hydrolysis, but a subset is involved in RNA binding. The enzymatically inactive mutants differed in their signaling ability. Notably, mutations to MDA5 motifs I, III, and VI and RIG-I motif III produced helicase proteins with constitutive antiviral activity, whereas mutations in RIG-I motif V retained ATP hydrolysis but failed to mediate signal transduction. These findings demonstrate that type I interferon production mediated by full-length MDA5 and RIG-I is independent of the helicase domain catalytic activity. In addition, neither enzymatic activity nor RNA binding was required for negative regulation of antiviral signaling by LGP2, supporting an RNA-independent interference mechanism.	[Bamming, Darja; Horvath, Curt M.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Horvath, Curt M.] Northwestern Univ, Dept Med, Evanston, IL 60208 USA; [Horvath, Curt M.] Evanston NW Healthcare, Dept Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; NorthShore University Health System	Horvath, CM (corresponding author), Pancoe ENH Pavil Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	National Institutes of Health [AI073919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073919 ( to C. M. H.).	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503	43	132	138	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9700	9712		10.1074/jbc.M807365200	http://dx.doi.org/10.1074/jbc.M807365200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211564	Green Published, hybrid			2022-12-25	WOS:000264892900010
J	Eliseev, RA; Malecki, J; Lester, T; Zhang, Y; Humphrey, J; Gunter, TE				Eliseev, Roman A.; Malecki, Jonathan; Lester, Tobias; Zhang, Yu; Humphrey, John; Gunter, Thomas E.			Cyclophilin D Interacts with Bcl2 and Exerts an Anti-apoptotic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PORE; MEMBRANE; CALCINEURIN; TRANSPORT; BAX; LOCALIZATION; SUPPRESSION; MECHANISM; PROTEIN	Cyclophilin D(CypD) is a mitochondrial immunophilin and a key positive regulator of the mitochondrial permeability transition (MPT). Several reports have shown that CypD is overexpressed in various tumors, where it has an anti-apoptotic effect. Because the MPT is a cell death-inducing phenomenon, we hypothesized that the anti-apoptotic effect of CypD is independent of the MPT but is due to its interaction with some key apoptosis regulator, such as Bcl2. Our data indicate that CypD indeed interacts with Bcl2 as confirmed with co-immunoprecipitation, pulldown, and mammalian two-hybrid assays. A cyclophilin D inhibitor, cyclosporine A, disrupts the CypD-Bcl2 interaction. CypD enhances the limiting effect of Bcl2 on the tBid-induced release of cytochrome c from mitochondria, which is not mediated via the MPT. Gain- and loss-of-function experiments confirm that CypD has a limiting effect on cytochrome c release from mitochondria and that such an effect of CypD is cyclosporine A- and Bcl2-dependent. On a cellular level, overexpression or knockdown of CypD respectively decreases or increases cytochrome c release from mitochondria and overall cell sensitivity to apoptosis progressing via the "intrinsic" pathway. Therefore, we here describe a novel function of CypD as a Bcl2 collaborator and an inhibitor of cytochrome c release from mitochondria independent of the MPT. This function of CypD may explain the anti-apoptotic effect of this protein observed in various cancer cells. The fact that some tumors overexpress CypD suggests that this may be an additional mechanism of suppression of apoptosis in cancer.	[Eliseev, Roman A.; Zhang, Yu; Humphrey, John] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Malecki, Jonathan; Lester, Tobias; Gunter, Thomas E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Eliseev, RA (corresponding author), 575 Elmwood Ave,Rm 1-8509, Rochester, NY 14642 USA.	Roman_Eliseev@urmc.rochester.edu			National Institutes of Health [RO1 ES10041]; Wilmot Foundation; Karen D'Amico Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilmot Foundation; Karen D'Amico Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES10041. This work was also supported by grants from the Wilmot Foundation and the Karen D'Amico Foundation.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAO Y, 1994, CANCER RES, V54, P2468; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brdiczka DG, 2006, BBA-MOL BASIS DIS, V1762, P148, DOI 10.1016/j.bbadis.2005.09.007; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; CROMPTON M, 1988, BIOCHEM J, V255, P357; Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587; Eliseev R, 2004, PROTEIN EXPRES PURIF, V35, P206, DOI 10.1016/j.pep.2004.01.015; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Forte M, 2006, CELL DEATH DIFFER, V13, P1287, DOI 10.1038/sj.cdd.4401957; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gunter TE, 2004, J NEUROCHEM, V88, P266, DOI 10.1046/j.1471-4159.2003.02122.x; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; JONG D, 1994, CANCER RES, V54, P256; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; Motoyama S, 1998, BIOCHEM BIOPH RES CO, V249, P628, DOI 10.1006/bbrc.1998.9205; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Weischer M, 2007, EXP DERMATOL, V16, P385, DOI 10.1111/j.1600-0625.2007.00555.x; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159	38	84	91	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9692	9699		10.1074/jbc.M808750200	http://dx.doi.org/10.1074/jbc.M808750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228691	hybrid, Green Published			2022-12-25	WOS:000264892900009
J	Iwata, A; Nagashima, Y; Matsumoto, L; Suzuki, T; Yamanaka, T; Date, H; Deoka, K; Nukina, N; Tsuji, S				Iwata, Atsushi; Nagashima, Yu; Matsumoto, Lumine; Suzuki, Takahiro; Yamanaka, Tomoyuki; Date, Hidetoshi; Deoka, Ken; Nukina, Nobuyuki; Tsuji, Shoji			Intranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN; AUTOPHAGIC DEGRADATION; CAG REPEAT; NP95; HUNTINGTIN; CELLS; LOCALIZATION; EXPRESSION; LIGASE; NEURODEGENERATION	Huntington disease and its related autosomal-dominant polyglutamine (pQ) neurodegenerative diseases are characterized by intraneuronal accumulation of protein aggregates. Studies on protein aggregates have revealed the importance of the ubiquitin-proteasome system as the front line of protein quality control (PQC) machinery against aberrant proteins. Recently, we have shown that the autophagy-lysosomal system is also involved in cytoplasmic aggregate degradation, but the nucleus lacked this activity. Consequently, the nucleus relies entirely on the ubiquitin-proteasome system for PQC. According to previous studies, nuclear aggregates possess a higher cellular toxicity than do their cytoplasmic counterparts, however degradation kinetics of nuclear aggregates have been poorly understood. Here we show that nuclear ubiquitin ligases San1p and UHRF-2 each enhance nuclear pQ aggregate degradation and rescued pQ-induced cytotoxicity in cultured cells and primary neurons. Moreover, UHRF-2 is associated with nuclear inclusion bodies in vitro and in vivo. Our data suggest that UHRF-2 is an essential molecule for nuclear pQ degradation as a component of nuclear PQC machinery in mammalian cells.	[Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, Tokyo 1138655, Japan; [Iwata, Atsushi; Nagashima, Yu; Matsumoto, Lumine; Date, Hidetoshi; Deoka, Ken; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Takahiro] Jichi Med Univ, Dept Hematol, Shimotsuke, Tochigi 3290498, Japan; [Yamanaka, Tomoyuki; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3500198, Japan	University of Tokyo; University of Tokyo; Jichi Medical University; RIKEN	Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013; Nukina, Nobuyuki/GPP-6265-2022	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314; Yamanaka, Tomoyuki/0000-0002-5378-4326	Japan Society for the Promotion of Science; Takeda science foundation (Osaka, Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Foundation for Life Science; Janssen Pharmaceutical K. K. (Tokyo, Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda science foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Foundation for Life Science; Janssen Pharmaceutical K. K. (Tokyo, Japan)	This work was supported by a grant-in aid from the Japan Society for the Promotion of Science and by research funding from the Takeda science foundation (Osaka, Japan), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Sankyo Foundation for Life Science, and Janssen Pharmaceutical K. K. (Tokyo, Japan).	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Muto M, 2006, RADIAT RES, V166, P723, DOI 10.1667/RR0459.1; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; ROSSI JM, 1989, J CELL BIOL, V108, P425, DOI 10.1083/jcb.108.2.425; Sakai A, 2003, BIOL PHARM BULL, V26, P347; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	36	68	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9796	9803		10.1074/jbc.M809739200	http://dx.doi.org/10.1074/jbc.M809739200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218238	Green Published, hybrid			2022-12-25	WOS:000264892900020
J	Pacheco, B; Malmstrom, A; Maccarana, M				Pacheco, Benny; Malmstrom, Anders; Maccarana, Marco			Two Dermatan Sulfate Epimerases Form Iduronic Acid Domains in Dermatan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE; CORE PROTEIN; BIOSYNTHESIS; IDENTIFICATION; BINDING; POLYSACCHARIDE; DESULFATION; SUBSTRATE; RESIDUES; EXT1	A second dermatan sulfate epimerase (DS-epi2) was identified as a homolog of the first epimerase (DS-epi1), which was previously described by our group. DS-epi2 is 1,222 amino acids long and has an similar to 700-amino acid N-terminal epimerase domain that is highly conserved between the two enzymes. In addition, the C-terminal portion is predicted to be an O-sulfotransferase domain. In this study we found that DS-epi2 has epimerase activity, which involves conversion of D-glucuronic acid to L-iduronic acid (EC 5.1.3.19), but no O-sulfotransferase activity was detected. In dermatan sulfate, iduronic acid residues are either clustered together in blocks or alternating with glucuronic acid, forming hybrid structures. By using a short interfering RNA approach, we found that DS-epi2 and DS-epi1 are both involved in the biosynthesis of the iduronic acid blocks in fibroblasts and that DS-epi2 can also synthesize the hybrid structures. Both iduronic acid-containing domains have been shown to bind to several growth factors, many of which have biological roles in brain development. DS-epi2 has been genetically linked to bipolar disorder, which suggests that the dermatan sulfate domains generated by a defective enzyme may be involved in the etiology of the disease.	[Pacheco, Benny; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Biomed Ctr D12, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Maccarana, M (corresponding author), Lund Univ, Biomed Ctr D12, Dept Expt Med Sci, Tornavagen 10, SE-22184 Lund, Sweden.	marco.maccarana@med.lu.se	maccarana, marco/AAB-4764-2021	Maccarana, Marco/0000-0003-3549-8921; Malmstrom, Anders/0000-0002-6691-146X	Swedish Science Research Council; Medical Faculty of Lund University; Albert Osterlund Foundation; Greta and Johan Kock Foundation; Polysackaridforskning AB; Tissue in Motion Medical Faculty Program	Swedish Science Research Council; Medical Faculty of Lund University; Albert Osterlund Foundation; Greta and Johan Kock Foundation; Polysackaridforskning AB; Tissue in Motion Medical Faculty Program	This work was supported by grants from the Swedish Science Research Council, the Medical Faculty of Lund University, the Albert Osterlund Foundation, the Greta and Johan Kock Foundation, Polysackaridforskning AB, and the Tissue in Motion Medical Faculty Program.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Goossens D, 2003, MOL PSYCHIATR, V8, P83, DOI 10.1038/sj.mp.4001190; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; KANTOR TG, 1957, J AM CHEM SOC, V79, P152, DOI 10.1021/ja01558a040; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MALMSTROM A, 1984, J BIOL CHEM, V259, P161; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MIDURA RJ, 1994, GLYCOBIOLOGY, V4, P333, DOI 10.1093/glycob/4.3.333; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Munoz E, 2006, BIOCHEMISTRY-US, V45, P5122, DOI 10.1021/bi052403n; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Seidler DG, 2002, J BIOL CHEM, V277, P42409, DOI 10.1074/jbc.M208442200; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Tufvesson E, 2002, EUR J BIOCHEM, V269, P3688, DOI 10.1046/j.1432-1033.2002.03058.x; WLAD H, 1994, J BIOL CHEM, V269, P24538	31	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9788	9795		10.1074/jbc.M809339200	http://dx.doi.org/10.1074/jbc.M809339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188366	Green Published, hybrid			2022-12-25	WOS:000264892900019
J	Wrighton, KH; Lin, X; Yu, PB; Feng, XH				Wrighton, Katharine H.; Lin, Xia; Yu, Paul B.; Feng, Xin-Hua			Transforming Growth Factor beta Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; SPECIFICITY; ACTIVATION; ALK5; LOOP	Transforming growth factor-beta (TGF beta) superfamily ligands control a diverse set of cellular processes by activating type I and type II serine-threonine receptor kinases. Canonical TGF beta signaling is mediated via the T beta RI/ALK5 type I receptor that phosphorylates Smad2 and Smad3 in their SXS motif to facilitate their activation and subsequent role in transcriptional regulation. Canonical bone morphogenic protein (BMP) signaling is mediated via the ALK1/2/3/6 type I receptors that phosphorylate Smad1, Smad5, and Smad8 in their SXS motif. However, studies in endothelial cells have shown that TGF beta can also lead to the phosphorylation of Smad1, dependent on ALK1 receptor activity. Here we present data showing that TGF beta can significantly induce Smad1 phosphorylation in several non-endothelial cell lineages. Additionally, by using chemical inhibitors specific for the TGF beta/activin/nodal (ALK4/5/7) and BMP (ALK1/2/3/6) type I receptors, we show that in some cell types TGF beta induces Smad1 phosphorylation independently of the BMP type I receptors. Thus, TGF beta-mediated Smad1 phosphorylation appears to occur via different receptor complexes in a cell type-specific manner.	[Wrighton, Katharine H.; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wrighton, Katharine H.; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Yu, Paul B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr,Dept Med, Boston, MA 02114 USA; [Yu, Paul B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol,Dept Med, Boston, MA 02114 USA	Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,Rm 137D, Houston, TX 77030 USA.	xfeng@bcm.edu	Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Wrighton, Katharine/0000-0001-7075-3399	National Institutes of Health [R01DK073932, R01CA108454, R01AR053591, P50HL083794]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083794, K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK073932 ( to X. L.) and R01CA108454, R01AR053591, and P50HL083794 ( X.- H. F.).	Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	20	107	114	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9755	9763		10.1074/jbc.M809223200	http://dx.doi.org/10.1074/jbc.M809223200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224917	Green Published, hybrid			2022-12-25	WOS:000264892900015
J	Morenilla-Palao, C; Pertusa, M; Meseguer, V; Cabedo, H; Viana, F				Morenilla-Palao, Cruz; Pertusa, Maria; Meseguer, Victor; Cabedo, Hugo; Viana, Felix			Lipid Raft Segregation Modulates TRPM8 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR; ION CHANNELS; EPITHELIAL-CELLS; MEMBRANE RAFTS; CHOLESTEROL; PROTEIN; THERMOSENSATION; EXPRESSION; SENSATION; TRANSDUCTION	Transient receptor potential channels are a family of cation channels involved in diverse cellular functions. Most of these channels are expressed in the nervous system and play a key role in sensory physiology. TRPM8 (transient receptor potential melastatine 8), a member of this family, is activated by cold, cooling substances such menthol and icilin and voltage. Although TRPM8 is a thermosensitive channel highly expressed in cold sensory neurons, the mechanisms underlying its temperature sensitivity are still poorly understood. Here we show that, in sensory neurons, TRPM8 channel is localized in cholesterol-rich specialized membrane domains known as lipid rafts. We also show that, in heterologous expression systems, lipid raft segregation of TRPM8 is favored by glycosylation at the Asn(934) residue of the polypeptide. In electrophysiological and imaging experiments, using cold and menthol as agonists, we also demonstrate that lipid raft association modulates TRPM8 channel activity. We found that menthol- and cold-mediated responses of TRPM8 are potentiated when the lipid raft association of the channel is prevented. In addition, lipid raft disruption shifts the threshold for TRPM8 activation to a warmer temperature. In view of these data, we suggest a role for lipid rafts in the activity and temperature sensitivity of TRPM8. We propose a model wherein different lipid membrane environments affect the cold sensing properties of TRPM8, modulating the response of cold thermoreceptors.	[Morenilla-Palao, Cruz; Pertusa, Maria; Meseguer, Victor; Cabedo, Hugo; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant 03550, Spain; [Cabedo, Hugo] Unidad Invest Hosp San Juan de Alicante, Alacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Morenilla-Palao, C (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Apartado 18, Alacant 03550, Spain.	cruz@umh.es	Cabedo, Hugo/F-9404-2016; Viana, Felix/U-8533-2017	Cabedo, Hugo/0000-0002-1322-6290; Viana, Felix/0000-0003-1439-949X; Morenilla-Palao, Cruz/0000-0002-8159-1206; Pertusa, Maria/0000-0003-3856-9019	Spanish Ministry of Education and Science [BFU2007-61855]; Generalitat Valenciana [GV/2007/113]; CONSOLIDER-INGENIO [CSD2007-00023]	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grant BFU2007-61855 (to F. V.), Generalitat Valenciana Grant GV/2007/113 ( to C. M.-P.), and CONSOLIDER-INGENIO 2010 CSD2007-00023.	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; BARD M, 1988, LIPIDS, V23, P534, DOI 10.1007/BF02535593; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bergdahl A, 2003, CIRC RES, V93, P839, DOI 10.1161/01.RES.0000100367.45446.A3; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Cabedo H, 2004, J BIOL CHEM, V279, P33623, DOI 10.1074/jbc.M401962200; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Christian AE, 1997, J LIPID RES, V38, P2264; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Ding XQ, 2008, BIOCHEMISTRY-US, V47, P3677, DOI 10.1021/bi7019645; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Graziani A, 2006, BIOCHEM J, V396, P147, DOI 10.1042/BJ20051246; Hensel H, 1981, Monogr Physiol Soc, V38, P1; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pottosin II, 2007, PFLUG ARCH EUR J PHY, V454, P235, DOI 10.1007/s00424-007-0208-4; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Simen AA, 2001, J NEUROSCI, V21, P7587, DOI 10.1523/JNEUROSCI.21-19-07587.2001; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Tsavaler L, 2001, CANCER RES, V61, P3760; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	51	86	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9215	9224		10.1074/jbc.M807228200	http://dx.doi.org/10.1074/jbc.M807228200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176480	Green Published, hybrid			2022-12-25	WOS:000264669100028
J	Hossain, MB; Ji, P; Anish, R; Jacobson, RH; Takada, S				Hossain, Mohammad B.; Ji, Ping; Anish, Ramakrishnan; Jacobson, Raymond H.; Takada, Shinako			Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIAL BIOGENESIS; THERMOGENIC COACTIVATOR PGC-1; DNA-BINDING; PARP-1; MODULATION; GENE; ACTIVATION; PROMOTERS; IDENTIFICATION; INITIATION	Nuclear respiratory factor 1 (NRF-1) is one of the key transcriptional activators for nuclear-coded genes involved in mitochondrial biogenesis and function as well as for many housekeeping genes. A transcriptional co-activator PGC-1 and its related family member PRC have previously been shown to interact with NRF-1 and co-activate NRF-1. We show here that NRF-1 can also directly interact with poly(ADP-ribose) polymerase 1 (PARP-1) and co-purify the PARP-1(.)DNA-PK(.)Ku80(.)Ku70(.)topoisomerase II beta-containing protein complex. Our in vitro binding experiments show that DNA-binding/dimerization domain of NRF-1 and the N-terminal half of PARP-1, which contains two Zinc fingers and the auto-modification domain, are responsible for the interaction, and that this interaction occurs with or without PARP-1 poly(ADP-ribosyl)ation (PARylation). DNA-bound NRF-1 can form a complex with PARP-1, suggesting that NRF-1 can recruit the PARP-1(.)DNA-PK(.)Ku80(.)Ku70(.)topoisomerase II beta-containing protein complex to the promoter. PARP-1 can also PARylate the DNA-binding domain of NRF-1 and negatively regulate NRF-1(.)PARP-1 interaction. Transient transfection and chromatin immunoprecipitation experiments suggest that PARP-1 plays a role during transcriptional activation by NRF-1. Our finding identifies a new aspect of transcriptional regulation used by NRF-1.	[Hossain, Mohammad B.; Ji, Ping; Anish, Ramakrishnan; Jacobson, Raymond H.; Takada, Shinako] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Genes & Dev Program, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Takada, S (corresponding author), Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	stakada@mdanderson.org		Thachangattuthodi, Anish/0000-0002-8029-5421	National Institutes of Health [AI057504, GM069769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057504 ( to S. T.) and GM069769 ( to R. J.). This work was also supported by the DNA core facility at the M. D. Anderson Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; GOMEZCUADRADO A, 1995, MOL CELL BIOL, V15, P6670; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; Herzig RP, 2000, J CELL SCI, V113, P4263; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; OGATA N, 1980, J BIOL CHEM, V255, P7610; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker A, 1999, INT J RADIAT BIOL, V75, P91, DOI 10.1080/095530099140843; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SLATTERY E, 1983, J BIOL CHEM, V258, P5955; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	37	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8612	8623		10.1074/jbc.M807198200	http://dx.doi.org/10.1074/jbc.M807198200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181665	Green Published, hybrid			2022-12-25	WOS:000264397800046
J	Muik, M; Fahrner, M; Derler, I; Schindl, R; Bergsmann, J; Frischauf, I; Groschner, K; Romanin, C				Muik, Martin; Fahrner, Marc; Derler, Isabella; Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Groschner, Klaus; Romanin, Christoph			A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; CRAC CHANNELS; CALCIUM-CHANNEL; EF-HAND; DEPLETION; ACTIVATION; SENSOR; OLIGOMERIZATION; INACTIVATION	In immune cells, generation of sustained Ca2+ levels is mediated by the Ca2+ release-activated Ca2+ (CRAC) current. Molecular key players in this process comprise the stromal interaction molecule 1 (STIM1) that functions as a Ca2+ sensor in the endoplasmic reticulum and ORAI1 located in the plasma membrane. Depletion of endoplasmic reticulum Ca2+ stores leads to STIM1 multimerization into discrete puncta, which co-cluster with ORAI1 to couple to and activate ORAI1 channels. The cytosolic C terminus of STIM1 is sufficient to activate ORAI1 currents independent of store depletion. Here we identified an ORAI1-activating small fragment (OASF, aminoacids 233-450/474) within STIM1 C terminus comprising the two coiled-coil domains and additional 50-74 amino acids that exhibited enhanced interaction with ORAI1, resulting in 3-fold increased Ca2+ currents. This OASF, similar to the complete STIM1 C terminus, displayed the ability to homomerize by a novel assembly domain that occurred subsequent to the coiled-coil domains. A smaller fragment (amino acids 233-420) generated by a further deletion of 30 amino acids substantially reduced the ability to homomerize concomitant to a loss of coupling to as well as activation of ORAI1. Extending OASF by 35 amino acids (233-485) did not alter homomerization but substantially decreased efficiency in coupling to and activation of ORAI1. Expressing OASF in rat basophilic leukemia (RBL) mast cells demonstrated its enhanced plasma membrane targeting associated with 2.5-fold larger CRAC currents in comparison with the complete STIM1 C terminus. In aggregate, we have identified two cytosolic key regions within STIM1 C terminus that control ORAI1/CRAC activation: a homomerization domain indispensable for coupling to ORAI1 and a modulatory domain that controls the extent of coupling to ORAI1.	[Muik, Martin; Fahrner, Marc; Derler, Isabella; Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/V-4205-2019; Groschner, Klaus/A-2550-2010; Frischauf, Irene/AAG-2007-2019; Derler, Isabella/B-7871-2019; Schindl, Rainer/E-3959-2013; Romanin, Christoph/D-5399-2009	Groschner, Klaus/0000-0002-8659-377X; Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Schindl, Rainer/0000-0003-0896-8887; Romanin, Christoph/0000-0003-3756-4136; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation [P18280, P18169, P21118];  [W1201]	Austrian Science Foundation(Austrian Science Fund (FWF)); 	This work was supported by the Austrian Science Foundation (FWF) Project P18280 (to K. G.) and Projects P18169 and P21118 as well as subproject 11 within W1201 (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	38	255	261	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8421	8426		10.1074/jbc.C800229200	http://dx.doi.org/10.1074/jbc.C800229200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189966	Green Published, hybrid			2022-12-25	WOS:000264397800026
J	Rechter, S; Scott, GM; Eickhoff, J; Zielke, K; Auerochs, S; Muller, R; Stamminger, T; Rawlinson, WD; Marschall, M				Rechter, Sabine; Scott, Gillian M.; Eickhoff, Jan; Zielke, Katrin; Auerochs, Sabrina; Mueller, Regina; Stamminger, Thomas; Rawlinson, William D.; Marschall, Manfred			Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; OPEN READING FRAME; TRANSACTIVATOR PROTEIN; CELL-CYCLE; INFECTED-CELLS; UNSPLICED RNA; POLYMERASE-II; P-TEFB; RETINOBLASTOMA PROTEIN; VIRAL PROTEIN	Replication of human cytomegalovirus (HCMV) is subject to regulation by cellular protein kinases. Recently, we and others reported that inhibition of cyclin-dependent protein kinases (CDKs) or the viral CDK ortholog pUL97 can induce intranuclear speckled aggregation of the viral mRNA export factor, pUL69. Here we provide the first evidence for a direct regulatory role of CDKs on pUL69 functionality. Although replication of all HCMV strains was dependent on CDK activity, we found strain-specific differences in the amount of CDK inhibitor-induced pUL69 aggregate formation. In all cases analyzed, the inhibitor-induced pUL69 aggregates were clearly localized within viral replication centers but not subnuclear splicing, pore complex, or aggresome structures. The CDK9 and cyclin T1 proteins colocalized with these pUL69 aggregates, whereas other CDKs behaved differently. Phosphorylation analyses in vivo and in vitro demonstrated pUL69 was strongly phosphorylated in HCMV-infected fibroblasts and that CDKs represent a novel class of pUL69-phosphorylating kinases. Moreover, the analysis of CDK inhibitors in a pUL69-dependent nuclear mRNA export assay provided evidence for functional impairment of pUL69 under suppression of CDK activity. Thus, our data underline the crucial importance of CDKs for HCMV replication, and indicate a direct impact of CDK9-cyclin T1 on the nuclear localization and activity of the viral regulator pUL69.	[Rechter, Sabine; Zielke, Katrin; Auerochs, Sabrina; Mueller, Regina; Stamminger, Thomas; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Eickhoff, Jan] GPC Biotech AG, D-82152 Martinsried, Germany; [Scott, Gillian M.; Rawlinson, William D.] Univ New S Wales, SOMS BABS, Randwick, NSW 2031, Australia; [Scott, Gillian M.; Rawlinson, William D.] Univ New S Wales, Div Virol, SEALS POWH, Randwick, NSW 2031, Australia	University of Erlangen Nuremberg; GPC Biotech; University of New South Wales Sydney; University of New South Wales Sydney	Marschall, M (corresponding author), Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	manfred.marschall@viro.med.uni-erlangen.de		Rawlinson, William/0000-0003-0988-7827; Stamminger, Thomas/0000-0001-9878-3119	AIDS Research and Reference Reagent Program; Division of AIDS; NIAID; National Institutes of Health [759rD100, GDGrXbaF4, GDGrP53]	AIDS Research and Reference Reagent Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Marco Thomas and Jens Milbradt (University of Erlangen-Nuremberg, Erlangen, Germany) for scientific discussions and Luigi Lania (University of Monte S. Angelo, Italy) for kindly providing pACTII-T1. The following reagents were obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: 759rD100, GDGrXbaF4, and GDGrP53 (originally provided by contributor Donald Coen).	Advani SJ, 2001, J VIROL, V75, P7904, DOI 10.1128/JVI.75.17.7904-7912.2001; ARLT H, 1994, J VIROL, V68, P4117, DOI 10.1128/JVI.68.7.4117-4125.1994; Bain M, 2007, REV MED VIROL, V17, P423, DOI 10.1002/rmv.551; BIRON KK, 1986, P NATL ACAD SCI USA, V83, P8769, DOI 10.1073/pnas.83.22.8769; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Dittmer D, 1997, J VIROL, V71, P1629, DOI 10.1128/JVI.71.2.1629-1634.1997; Farjot G, 2000, J VIROL, V74, P6068, DOI 10.1128/JVI.74.13.6068-6076.2000; Fortun J, 2003, J NEUROSCI, V23, P10672; Fortunato EA, 2000, TRENDS MICROBIOL, V8, P111, DOI 10.1016/S0966-842X(00)01699-1; FRALDI A, 2001, J CELL BIOCHEM, V36, pS247; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Hayashi ML, 2000, P NATL ACAD SCI USA, V97, P2692, DOI 10.1073/pnas.050587597; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herget T, 2006, NEW CONCEPTS OF ANTIVIRAL THERAPY, P351; Herget T, 2004, ANTIMICROB AGENTS CH, V48, P4154, DOI 10.1128/AAC.48.11.4154-4162.2004; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Lischka P, 2007, J GEN VIROL, V88, P405, DOI 10.1099/vir.0.82480-0; Lorz K, 2006, J VIROL, V80, P5423, DOI 10.1128/JVI.02585-05; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Michel D, 2004, BBA-PROTEINS PROTEOM, V1697, P169, DOI 10.1016/j.bbapap.2003.11.022; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Napolitano G, 2003, J CELL PHYSIOL, V197, P1, DOI 10.1002/jcp.10376; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; Sanchez V, 2003, J VIROL, V77, P13214, DOI 10.1128/JVI.77.24.13214-13224.2003; Sanchez V, 2006, J VIROL, V80, P5886, DOI 10.1128/JVI.02656-05; Schang LM, 2004, BBA-PROTEINS PROTEOM, V1697, P197, DOI 10.1016/j.bbapap.2003.11.024; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Schleiss M, 2008, ANTIVIR RES, V79, P49, DOI 10.1016/j.antiviral.2008.01.154; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Smith-Donald BA, 2008, J VIROL, V82, P4533, DOI 10.1128/JVI.02022-07; Smith-Donald BA, 2008, J VIROL, V82, P4527, DOI 10.1128/JVI.02021-07; SULLIVAN V, 1993, ANTIMICROB AGENTS CH, V37, P19, DOI 10.1128/AAC.37.1.19; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; Tamrakar S, 2005, J VIROL, V79, P15477, DOI 10.1128/JVI.79.24.15477-15493.2005; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Toth Z, 2006, NUCLEIC ACIDS RES, V34, P1237, DOI 10.1093/nar/gkl007; Winkler M, 2000, J VIROL, V74, P8053, DOI 10.1128/JVI.74.17.8053-8064.2000; WINKLER M, 1994, J VIROL, V68, P3943, DOI 10.1128/JVI.68.6.3943-3954.1994; Winkler M, 1996, J VIROL, V70, P8984, DOI 10.1128/JVI.70.12.8984-8987.1996; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	61	45	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8942	8950		10.1074/jbc.M805693200	http://dx.doi.org/10.1074/jbc.M805693200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179338	hybrid, Green Published			2022-12-25	WOS:000264397800077
J	Dierker, T; Dreier, R; Petersen, A; Bordych, C; Grobe, K				Dierker, Tabea; Dreier, Rita; Petersen, Arnd; Bordych, Christian; Grobe, Kay			Heparan Sulfate-modulated, Metalloprotease-mediated Sonic Hedgehog Release from Producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; CHOLESTEROL MODIFICATION; LIPID RAFTS; CELLULAR CHOLESTEROL; CRYSTAL-STRUCTURE; TOUT-VELU; ADAM17; PROTEINS; MOVEMENT; SURFACE	The ectodomains of numerous proteins are released from cells by matrix metalloproteases to yield soluble intercellular regulators. A disintegrin and metalloprotease (ADAM) family members have often been found to be the responsible "sheddases," ADAM17/tumor necrosis factor-alpha-converting enzyme being its best characterized member. In this work, we show that ShhNp (lipidated and membrane-tethered Sonic hedgehog) is released from Bosc23 cells by metalloprotease-mediated ectodomain shedding, resulting in a soluble and biologically active morphogen. ShhNp shedding is increased by ADAM17 coexpression and cholesterol depletion of cells with methyl-beta-cyclodextrin and is reduced by metalloprotease inhibitors as well as ADAM17 RNA interference. We also show that the amount of shed ShhNp is modulated by extracellular heparan sulfate (HS) and that ShhNp shedding depends on specific HS sulfations. Based on those data, we suggest new roles for metalloproteases, including but not restricted to ADAM17, and for HS-proteoglycans in Hedgehog signaling.	[Dierker, Tabea; Dreier, Rita; Bordych, Christian; Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Dierker, Tabea] Univ Munster, Dept Gen Zool & Genet, D-48149 Munster, Germany; [Petersen, Arnd] Res Ctr Borstel, Dept Clin Med, D-23845 Borstel, Germany	University of Munster; University of Munster; Forschungszentrum Borstel	Grobe, K (corresponding author), Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB492-B15, SFB492-B18]; Ev. Studienwerk Villigst e.V	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); Ev. Studienwerk Villigst e.V	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grant SFB492-B15 (to K. G.) and SFB492-B18 (to R. D.). The costs of publication of this article were defrayed in part by the payment of page charges.; Supported by Ev. Studienwerk Villigst e.V.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Day ES, 1999, BIOCHEMISTRY-US, V38, P14868, DOI 10.1021/bi9910068; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marshall LJ, 2003, J IMMUNOL, V171, P2057, DOI 10.4049/jimmunol.171.4.2057; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Walev I, 2000, J LEUKOCYTE BIOL, V68, P865; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	47	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8013	8022		10.1074/jbc.M806838200	http://dx.doi.org/10.1074/jbc.M806838200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19176481	Green Published, hybrid			2022-12-25	WOS:000264195600064
J	Angrilli, A; Spironelli, C; Elbert, T; Crow, TJ; Marano, G; Stegagno, L				Angrilli, Alessandro; Spironelli, Chiara; Elbert, Thomas; Crow, Timothy J.; Marano, Gianfranco; Stegagno, Luciano			Schizophrenia as Failure of Left Hemispheric Dominance for the Phonological Component of Language	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; CEREBRAL ASYMMETRY; PLANUM TEMPORALE; WORKING-MEMORY; HOMO-SAPIENS; EEG ACTIVITY; BROCAS AREA; LATERALIZATION; BRAIN; CORTEX	Background: T. J. Crow suggested that the genetic variance associated with the evolution in Homo sapiens of hemispheric dominance for language carries with it the hazard of the symptoms of schizophrenia. Individuals lacking the typical left hemisphere advantage for language, in particular for phonological components, would be at increased risk of the typical symptoms such as auditory hallucinations and delusions. Methodology/Principal Findings: Twelve schizophrenic patients treated with low levels of neuroleptics and twelve matched healthy controls participated in an event-related potential experiment. Subjects matched word-pairs in three tasks: rhyming/phonological, semantic judgment and word recognition. Slow evoked potentials were recorded from 26 scalp electrodes, and a laterality index was computed for anterior and posterior regions during the inter stimulus interval. During phonological processing individuals with schizophrenia failed to achieve the left hemispheric dominance consistently observed in healthy controls. The effect involved anterior (fronto-temporal) brain regions and was specific for the Phonological task; group differences were small or absent when subjects processed the same stimulus material in a Semantic task or during Word Recognition, i.e. during tasks that typically activate more widespread areas in both hemispheres. Conclusions/Significance: We show for the first time how the deficit of lateralization in the schizophrenic brain is specific for the phonological component of language. This loss of hemispheric dominance would explain typical symptoms, e. g. when an individual's own thoughts are perceived as an external intruding voice. The change can be interpreted as a consequence of "hemispheric indecision'', a failure to segregate phonological engrams in one hemisphere.	[Angrilli, Alessandro; Spironelli, Chiara; Stegagno, Luciano] Univ Padua, Dept Gen Psychol, Padua, Italy; [Angrilli, Alessandro] CNR, Inst Neurosci, Padua, Italy; [Elbert, Thomas] Univ Konstanz, Ctr Psychiat, D-7750 Constance, Germany; [Elbert, Thomas] Univ Konstanz, Dept Psychol, D-7750 Constance, Germany; [Crow, Timothy J.] Warneford Hosp, Dept Psychiat, SANE POWIC, Oxford, England; [Marano, Gianfranco] Ctr Eating Disorders, Rovigo, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Konstanz; University of Konstanz	Angrilli, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	alessandro.angrilli@unipd.it	Angrilli, Alessandro/I-5519-2012; Spironelli, Chiara/AAC-1701-2021; Elbert, Thomas/C-8556-2009; Spironelli, Chiara/D-1548-2014	Spironelli, Chiara/0000-0002-8547-2431; Elbert, Thomas/0000-0003-1332-4939; Spironelli, Chiara/0000-0002-8547-2431; Angrilli, Alessandro/0000-0002-5571-7637	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); University of Padova [CPDA047438]; DFG (Deutsche Forschungsgemeinschaft)	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); University of Padova; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by a grant (PRIN 2006110284_001) from the MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) and University of Padova project n. CPDA047438 to A.A. and from DFG (Deutsche Forschungsgemeinschaft) funds to T.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Angrilli A, 2003, NEUROIMAGE, V20, P657, DOI 10.1016/S1053-8119(03)00395-1; Angrilli A, 2000, CLIN NEUROPHYSIOL, V111, P706, DOI 10.1016/S1388-2457(99)00308-9; BAUER H, 1989, ELECTROEN CLIN NEURO, V72, P545, DOI 10.1016/0013-4694(89)90232-0; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BORTOLINI V, 1972, LESSICO FREQUENZA LI; Broca P, 1877, B ACADEMIE MED, V6, P508; Buxhoeveden DR, 2001, BRAIN BEHAV EVOLUT, V57, P349, DOI 10.1159/000047253; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Crow T. J., 2007, EVOLUTION NERVOUS SY, V4, P549; Crow TJ, 2007, NEUROL PSYCHIAT BR, V14, P87; Crow TJ, 2004, CURR OPIN PSYCHIATR, V17, P97, DOI 10.1097/00001504-200403000-00006; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; CROW TJ, 1995, EUR ARCH PSY CLIN N, V245, P61, DOI 10.1007/BF02190732; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; CROW TJ, 1989, ARCH GEN PSYCHIAT, V46, P1145; Cullen TJ, 2006, BRIT J PSYCHIAT, V188, P26, DOI 10.1192/bjp.bp.104.008169; DELISI LE, 1994, SCHIZOPHR RES, V12, P19, DOI 10.1016/0920-9964(94)90080-9; ESIRI MM, 2008, GREENFIELDS NEUROPAT; FLORHENRY P, 1983, CEREBRAL BASIS PSYCH; Gilissen E, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P187; GOLD JM, 1995, CURR OPIN NEUROBIOL, V5, P225, DOI 10.1016/0959-4388(95)80030-1; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heim S, 2004, EUR CHILD ADOLES PSY, V13, P125, DOI 10.1007/s00787-004-0361-7; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Kayser J, 1999, INT J PSYCHOPHYSIOL, V34, P249, DOI 10.1016/S0167-8760(99)00082-3; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; McCarley RW, 2002, ARCH GEN PSYCHIAT, V59, P321, DOI 10.1001/archpsyc.59.4.321; McDonald B, 2000, AM J PSYCHIAT, V157, P40, DOI 10.1176/ajp.157.1.40; Miller R, 2008, NEURODYNAMIC THEORY; Ngan ETC, 2003, NEUROIMAGE, V20, P889, DOI 10.1016/S1053-8119(03)00385-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Penolazzi B, 2006, NEUROREPORT, V17, P429, DOI 10.1097/01.wnr.0000203350.99256.7d; Penolazzi B, 2008, PSYCHOPHYSIOLOGY, V45, P1025, DOI 10.1111/j.1469-8986.2008.00709.x; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Petty RG, 1999, SCHIZOPHRENIA BULL, V25, P121, DOI 10.1093/oxfordjournals.schbul.a033360; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rockstroh B, 1998, NEUROREPORT, V9, P3819, DOI 10.1097/00001756-199812010-00010; Rockstroh B, 2001, BIOL PSYCHIAT, V49, P694, DOI 10.1016/S0006-3223(00)01023-4; Rockstroh B., 1989, SLOW CORTICAL POTENT; Ruchkin DS, 1997, NEUROPSYCHOLOGIA, V35, P195, DOI 10.1016/S0028-3932(96)00068-1; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sommer IEC, 2003, SCHIZOPHR RES, V60, P183, DOI 10.1016/S0920-9964(02)00300-6; Spironelli C, 2008, J PSYCHIATR NEUROSCI, V33, P235; Spironelli C, 2008, NEUROIMAGE, V40, P912, DOI 10.1016/j.neuroimage.2007.12.012; Spironelli C, 2008, BIOL PSYCHOL, V77, P123, DOI 10.1016/j.biopsycho.2007.09.009; Spironelli C, 2006, BEHAV BRAIN RES, V175, P296, DOI 10.1016/j.bbr.2006.08.038; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Williams NA, 2006, AM J MED GENET B, V141B, P623, DOI 10.1002/ajmg.b.30357	60	71	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4507	10.1371/journal.pone.0004507	http://dx.doi.org/10.1371/journal.pone.0004507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KG	19223971	Green Published, gold, Green Submitted			2022-12-25	WOS:000265485800011
J	de la Puerta, ML; Trinidad, AG; Rodriguez, MD; Bogetz, J; Crespo, MS; Mustelin, T; Alonso, A; Bayon, Y				Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Bogetz, Jori; Sanchez Crespo, Mariano; Mustelin, Tomas; Alonso, Andres; Bayon, Yolanda			Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH	PLOS ONE			English	Article								YopH is an exceptionally active tyrosine phosphatase that is essential for virulence of Yersinia pestis, the bacterium causing plague. YopH breaks down signal transduction mechanisms in immune cells and inhibits the immune response. Only a few substrates for YopH have been characterized so far, for instance p130Cas and Fyb, but in view of YopH potency and the great number of proteins involved in signalling pathways it is quite likely that more proteins are substrates of this phosphatase. In this respect, we show here YopH interaction with several proteins not shown before, such as Gab1, Gab2, p85, and Vav and analyse the domains of YopH involved in these interactions. Furthermore, we show that Gab1, Gab2 and Vav are not dephosphorylated by YopH, in contrast to Fyb, Lck, or p85, which are readily dephosphorylated by the phosphatase. These data suggests that YopH might exert its actions by interacting with adaptors involved in signal transduction pathways, what allows the phosphatase to reach and dephosphorylate its susbstrates.	[Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Sanchez Crespo, Mariano; Alonso, Andres; Bayon, Yolanda] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Bogetz, Jori; Mustelin, Tomas] Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, Program Inflammat, La Jolla, CA USA; [Bogetz, Jori; Mustelin, Tomas] Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	de la Puerta, ML (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	ybayon@ibgm.uva.es	BAyón, Yolanda/L-7635-2014; Bogetz, Jori F./U-2258-2019; Alonso, Andrés/L-7523-2014	BAyón, Yolanda/0000-0003-3089-5485; Alonso, Andrés/0000-0001-8674-9378; Mustelin, Tomas/0000-0001-5912-8840; Sanchez Crespo, Mariano/0000-0002-6149-154X	Junta de Castilla y Leon [VA002B05]; Plan Nacional de Biologia Fundamental [BFU2006-01203/BMC]; Red Tematica de Investigacion Cardiovascular; Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo	Junta de Castilla y Leon(Junta de Castilla y Leon); Plan Nacional de Biologia Fundamental; Red Tematica de Investigacion Cardiovascular; Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo(Spanish Government)	This work was supported by Junta de Castilla y Leon (VA002B05), Plan Nacional de Biologia Fundamental (Grant BFU2006-01203/BMC), and Red Tematica de Investigacion Cardiovascular. Y. B. is under contract within the Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 1999, BIOL CHEM, V380, P795, DOI 10.1515/BC.1999.099; Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; CHRISTIE A B, 1982, Ecology of Disease, V1, P111; Cleri D J, 1997, Semin Respir Infect, V12, P12; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; GREEN SP, 1995, J LEUKOCYTE BIOL, V57, P972, DOI 10.1002/jlb.57.6.972; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Hinnebusch BJ, 1997, J MOL MED, V75, P645, DOI 10.1007/s001090050148; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Ivanov MI, 2005, MOL MICROBIOL, V55, P1346, DOI 10.1111/j.1365-2958.2005.04477.x; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Titball RW, 1998, BRIT MED BULL, V54, P625, DOI 10.1093/oxfordjournals.bmb.a011715; Titball RW, 2001, VACCINE, V19, P4175, DOI 10.1016/S0264-410X(01)00163-3; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343	37	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4431	10.1371/journal.pone.0004431	http://dx.doi.org/10.1371/journal.pone.0004431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221593	Green Submitted, Green Published, gold			2022-12-25	WOS:000265485700003
J	Gadkari, RA; Varughese, D; Srinivasan, N				Gadkari, Rupali A.; Varughese, Deepthi; Srinivasan, N.			Recognition of Interaction Interface Residues in Low-Resolution Structures of Protein Assemblies Solely from the Positions of C alpha Atoms	PLOS ONE			English	Article								Background: The number of available structures of large multi-protein assemblies is quite small. Such structures provide phenomenal insights on the organization, mechanism of formation and functional properties of the assembly. Hence detailed analysis of such structures is highly rewarding. However, the common problem in such analyses is the low resolution of these structures. In the recent times a number of attempts that combine low resolution cryo-EM data with higher resolution structures determined using X-ray analysis or NMR or generated using comparative modeling have been reported. Even in such attempts the best result one arrives at is the very course idea about the assembly structure in terms of trace of the C alpha atoms which are modeled with modest accuracy. Methodology/Principal Findings: In this paper first we present an objective approach to identify potentially solvent exposed and buried residues solely from the position of C alpha atoms and amino acid sequence using residue type-dependent thresholds for accessible surface areas of C alpha. We extend the method further to recognize potential protein-protein interface residues. Conclusion/Significance: Our approach to identify buried and exposed residues solely from the positions of C alpha atoms resulted in an accuracy of 84%, sensitivity of 83-89% and specificity of 67-94% while recognition of interfacial residues corresponded to an accuracy of 94%, sensitivity of 70-96% and specificity of 58-94%. Interestingly, detailed analysis of cases of mismatch between recognition of interface residues from C alpha positions and all-atom models suggested that, recognition of interfacial residues using C alpha atoms only correspond better with intuitive notion of what is an interfacial residue. Our method should be useful in the objective analysis of structures of protein assemblies when positions of only C alpha positions are available as, for example, in the cases of integration of cryo-EM data and high resolution structures of the components of the assembly.	[Gadkari, Rupali A.; Varughese, Deepthi; Srinivasan, N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gadkari, RA (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	rupali@mbu.iisc.ernet.in; ns@mbu.iisc.ernet.in		VARUGHESE, DEEPTHI/0000-0001-8784-2427	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India under the Mathematical Biology programme	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India under the Mathematical Biology programme(Department of Science & Technology (India))	This research is supported by Department of Biotechnology, Government of India and also by Department of Science and Technology, Government of India under the Mathematical Biology programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carugo O, 2000, PROTEIN ENG, V13, P607, DOI 10.1093/protein/13.9.607; CHAN HS, 1990, P NATL ACAD SCI USA, V87, P6388, DOI 10.1073/pnas.87.16.6388; DeLano W.L., PYMOL MOL GRAPHICS S; Dror O, 2007, ACTA CRYSTALLOGR D, V63, P42, DOI 10.1107/S0907444906041059; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Fischer TB, 2006, J STRUCT BIOL, V153, P103, DOI 10.1016/j.jsb.2005.11.005; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Hubbard S. J., 1993, NACCESS; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kazmierkiewicz R, 2003, BIOPHYS CHEM, V100, P261, DOI 10.1016/S0301-4622(02)00285-5; Kitmitto Ashraf, 2006, V129, P315; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEVITT M, 1977, J MOL BIOL, V114, P181, DOI 10.1016/0022-2836(77)90207-8; Marrone TJ, 1997, ANNU REV PHARMACOL, V37, P71, DOI 10.1146/annurev.pharmtox.37.1.71; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Poupon A, 2004, CURR OPIN STRUC BIOL, V14, P233, DOI 10.1016/j.sbi.2004.03.010; RAMAKRISHNAN C, 1982, INT J PEPT PROT RES, V20, P218; Rekha N, 2005, PROTEINS, V58, P339, DOI 10.1002/prot.20319; ROSE GD, 1977, J MOL BIOL, V113, P153, DOI 10.1016/0022-2836(77)90046-8; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salwinski L, 2003, CURR OPIN STRUC BIOL, V13, P377, DOI 10.1016/S0959-440X(03)00070-8; Singh YH, 2006, BIOPHYS CHEM, V124, P145, DOI 10.1016/j.bpc.2006.06.013; SOMAN K, 1984, IDENTIFICATION SECON; Thompson MJ, 1996, PROTEINS, V25, P38, DOI 10.1002/(SICI)1097-0134(199605)25:1<38::AID-PROT4>3.3.CO;2-H; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang JY, 2005, PROTEINS, V61, P481, DOI 10.1002/prot.20620; Xu ZG, 2006, PROTEINS, V63, P961, DOI 10.1002/prot.20934; Yuan Z, 2006, J PROTEOME RES, V5, P1063, DOI 10.1021/pr050397b; Yuan Z, 2004, PROTEINS, V57, P558, DOI 10.1002/prot.20234; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4476	10.1371/journal.pone.0004476	http://dx.doi.org/10.1371/journal.pone.0004476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214247	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484300012
J	Wang, ZX; Chen, F; Zhai, RH; Zhang, LS; Su, L; Lin, XH; Thompson, T; Christiani, DC				Wang, Zhaoxi; Chen, Feng; Zhai, Rihong; Zhang, Lingsong; Su, Li; Lin, Xihong; Thompson, Taylor; Christiani, David C.			Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development	PLOS ONE			English	Article								Background: We conducted an exploratory study of genome-wide gene expression in whole blood and found that the expression of neutrophil elastase inhibitor (PI3, elafin) was down-regulated during the early phase of ARDS. Further analyses of plasma PI3 levels revealed a rapid decrease during early ARDS development. PI3 and secretory leukocyte proteinase inhibitor (SLPI) are important low-molecular-weight proteinase inhibitors produced locally at neutrophil infiltration site in the lung. In this study, we tested the hypothesis that an imbalance between neutrophil elastase (HNE) and its inhibitors in blood is related to the development of ARDS. Methodology/Principal Findings: PI3, SLPI, and HNE were measured in plasma samples collected from 148 ARDS patients and 63 critical ill patients at risk for ARDS (controls). Compared with the controls, the ARDS patients had higher HNE, but lower PI3, at the onset of ARDS, resulting in increased HNE/PI3 ratio (mean = 14.5; 95% CI, 10.9-19.4, P<0.0001), whereas plasma SLPI was not associated with the risk of ARDS development. Although the controls had elevated plasma PI3 and HNE, their HNE/PI3 ratio (mean = 6.5; 95% CI, 4.9-8.8) was not significantly different from the healthy individuals (mean = 3.9; 95% CI, 2.7-5.9). Before the onset (7-days period prior to ARDS diagnosis), we only observed significantly elevated HNE, but the HNE-PI3 balance remained normal. With the progress from prior to the onset of ARDS, the plasma level of PI3 declined, whereas HNE was maintained at a higher level, tilting the balance toward more HNE in the circulation as characterized by an increased HNE/PI3 ratio. In contrast, three days after ICU admission, there was a significant drop of HNE/PI3 ratio in the at-risk controls. Conclusions/Significance: Plasma profiles of PI3, HNE, and HNE/PI3 may be useful clinical biomarkers in monitoring the development of ARDS.	[Wang, Zhaoxi; Chen, Feng; Zhai, Rihong; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Lingsong; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Thompson, Taylor; Christiani, David C.] Massachusetts Gen Hosp, Pulmon & Critical Care Unit, Boston, MA 02114 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wang, ZX (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	mikewang@hsph.harvard.edu			National Institute of Health [HL60710, ES00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from National Institute of Health (HL60710, ES00002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; DONNELLY SC, 1995, AM J RESP CRIT CARE, V151, P1428, DOI 10.1164/ajrccm.151.5.7735596; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; Frutos-Vivar Fernando, 2004, Curr Opin Crit Care, V10, P1, DOI 10.1097/00075198-200402000-00001; FUJISHIMA S, 2007, BIOMED PHARMACOTHER; Gando S, 2004, INFLAMMATION, V28, P237, DOI 10.1023/B:IFLA.0000049049.81688.fe; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Hashimoto S, 2008, RESPIROLOGY, V13, P581, DOI 10.1111/j.1440-1843.2008.01283.x; Hoshi K, 2005, TOHOKU J EXP MED, V207, P143, DOI 10.1620/tjem.207.143; IDELL S, 1985, AM REV RESPIR DIS, V132, P1098; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kodama T, 2007, INTERNAL MED, V46, P699, DOI 10.2169/internalmedicine.46.6182; LEE CT, 1981, NEW ENGL J MED, V304, P192, DOI 10.1056/NEJM198101223040402; McClintock DE, 2007, AM J RESP CRIT CARE, V175, P256, DOI 10.1164/rccm.200607-947OC; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Mortelliti MP, 2002, AM FAM PHYSICIAN, V65, P1823; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Parsons PE, 2005, AM J PHYSIOL-LUNG C, V288, pL426, DOI 10.1152/ajplung.00302.2004; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Reid PT, 1999, FEBS LETT, V457, P33, DOI 10.1016/S0014-5793(99)01004-2; RICE WG, 1990, SCIENCE, V249, P178, DOI 10.1126/science.2371565; ROCKER GM, 1989, LANCET, V1, P120; Sallenave JM, 1999, EUR RESPIR J, V13, P1029, DOI 10.1183/09031936.99.13510299; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; TAKAHASHI H, 1988, J BIOL CHEM, V263, P2543; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; Zeiher BG, 2002, CRIT CARE MED, V30, pS281, DOI 10.1097/00003246-200205001-00018; Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38	37	39	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4380	10.1371/journal.pone.0004380	http://dx.doi.org/10.1371/journal.pone.0004380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197381	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483700005
J	Major, L; La Linn, M; Slade, RW; Schroder, WA; Hyatt, AD; Gardner, J; Cowley, J; Suhrbier, A				Major, Lee; La Linn, May; Slade, Robert W.; Schroder, Wayne A.; Hyatt, Alex D.; Gardner, Joy; Cowley, Jeff; Suhrbier, Andreas			Ticks Associated with Macquarie Island Penguins Carry Arboviruses from Four Genera	PLOS ONE			English	Article								Macquarie Island, a small subantarctic island, is home to rockhopper, royal and king penguins, which are often infested with the globally distributed seabird tick, Ixodes uriae. A flavivirus, an orbivirus, a phlebovirus, and a nairovirus were isolated from these ticks and partial sequences obtained. The flavivirus was nearly identical to Gadgets Gully virus, isolated some 30 year previously, illustrating the remarkable genetic stability of this virus. The nearest relative to the orbivirus (for which we propose the name Sandy Bay virus) was the Scottish Broadhaven virus, and provided only the second available sequences from the Great Island orbivirus serogroup. The phlebovirus (for which we propose the name Catch-me-cave virus) and the previously isolated Precarious Point virus were distinct but related, with both showing homology with the Finnish Uukuniemi virus. These penguin viruses provided the second and third available sequences for the Uukuniemi group of phleboviruses. The nairovirus (for which we propose the name Finch Creek virus) was shown to be related to the North American Tillamook virus, the Asian Hazara virus and Nairobi sheep disease virus. Macquarie Island penguins thus harbour arboviruses from at least four of the seven arbovirus-containing genera, with related viruses often found in the northern hemisphere.	[Major, Lee; La Linn, May; Schroder, Wayne A.; Gardner, Joy; Suhrbier, Andreas] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Slade, Robert W.] So Cross Univ, Lismore, NSW, Australia; [Hyatt, Alex D.] CSIRO, Australian Animal Hlth Lab, Geelong, Vic, Australia; [Cowley, Jeff] CSIRO, Livestock Indust, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Southern Cross University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Major, L (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	andreasS@qimr.edu.au	Cowley, Jeff A/H-7553-2013	Cowley, Jeff/0000-0003-0454-4825; Suhrbier, Andreas/0000-0001-8986-9025	Australian Antarctic Science Advisory Committee (Project 1334); Australian Centre for International and Tropical Health; Australian Antarctic Division, NH&MRC Australia	Australian Antarctic Science Advisory Committee (Project 1334); Australian Centre for International and Tropical Health; Australian Antarctic Division, NH&MRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Australian Antarctic Science Advisory Committee (Project 1334) and the Australian Centre for International and Tropical Health. Australian Antarctic Division, NH&MRC Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Briese T, 2005, J NEUROVIROL, V11, P469, DOI 10.1080/13550280500187617; CHASTEL C, 1983, REV EPIDEMIOL SANTE, V31, P445; Chastel C, 1995, B SOC PATHOL EXOT, V88, P81; CHASTEL C, 1986, PRESSE MED, V15, P441; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DOHERTY RL, 1975, AM J TROP MED HYG, V24, P521, DOI 10.4269/ajtmh.1975.24.521; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; ERASMUS BJ, 1975, AUST VET J, V51, P196, DOI 10.1111/j.1751-0813.1975.tb00054.x; FOULKE RS, 1981, J GEN VIROL, V53, P169, DOI 10.1099/0022-1317-53-1-169; Gauthier-Clerc M, 1998, COLON WATERBIRD, V21, P229, DOI 10.2307/1521910; GORMAN BM, 1984, AUST J EXP BIOL MED, V62, P101, DOI 10.1038/icb.1984.10; Gould EA, 2006, EMERG INFECT DIS, V12, P549, DOI 10.3201/eid1204.051010; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; HAWKES RA, 1985, MED J AUSTRALIA, V143, P555, DOI 10.5694/j.1326-5377.1985.tb119949.x; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; HUMPHERYSMITH I, 1991, EPIDEMIOL INFECT, V107, P435, DOI 10.1017/S0950268800049086; HYATT AD, 1994, MICRON, V25, P597, DOI 10.1016/0968-4328(94)90022-1; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001; LVOV DK, 1974, J HYG EPID MICROB IM, V18, P87; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; MARIN MS, 1995, VIROLOGY, V206, P1133, DOI 10.1006/viro.1995.1038; MORGAN IR, 1981, AUST VET J, V57, P333, DOI 10.1111/j.1751-0813.1981.tb05839.x; MORGAN IR, 1985, J WILDLIFE DIS, V21, P193, DOI 10.7589/0090-3558-21.3.193; MOSS SR, 1988, J GEN VIROL, V69, P2721, DOI 10.1099/0022-1317-69-11-2721; Nunn MA, 2006, PARASITOLOGY, V132, P233, DOI 10.1017/S0031182005008930; NUTTALL PA, 1984, ARCH VIROL, V79, P35, DOI 10.1007/BF01314301; Pearce DA, 2003, ANTARCT SCI, V15, P319, DOI 10.1017/S0954102003001330; Pijlman GP, 2006, EXPERT OPIN BIOL TH, V6, P135, DOI 10.1517/14712598.6.2.135; Potgieter AC, 2002, J GEN VIROL, V83, P2215, DOI 10.1099/0022-1317-83-9-2215; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Reed Kurt D, 2003, Clin Med Res, V1, P5; SAIKKU P, 1975, MED BIOL, V53, P317; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496; STGEORGE TD, 1985, AM J TROP MED HYG, V34, P406; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAAVIK T, 1975, MED BIOL, V53, P321; Tuttle AD, 2005, JAVMA-J AM VET MED A, V226, P2059, DOI 10.2460/javma.2005.226.2059; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; YUNKER CE, 1975, MED BIOL, V53, P302	44	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4375	10.1371/journal.pone.0004375	http://dx.doi.org/10.1371/journal.pone.0004375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194498	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483600008
J	Gottig, N; Garavaglia, BS; Garofalo, CG; Orellano, EG; Ottado, J				Gottig, Natalia; Garavaglia, Betiana S.; Garofalo, Cecilia G.; Orellano, Elena G.; Ottado, Jorgelina			A Filamentous Hemagglutinin-Like Protein of Xanthomonas axonopodis pv. citri, the Phytopathogen Responsible for Citrus Canker, Is Involved in Bacterial Virulence	PLOS ONE			English	Article								Xanthomonas axonopodis pv. citri, the phytopathogen responsible for citrus canker has a number of protein secretion systems and among them, at least one type V protein secretion system belonging to the two-partner secretion pathway. This system is mainly associated to the translocation of large proteins such as adhesins to the outer membrane of several pathogens. Xanthomonas axonopodis pv. citri possess a filamentous hemagglutinin-like protein in close vicinity to its putative transporter protein, XacFhaB and XacFhaC, respectively. Expression analysis indicated that XacFhaB was induced in planta during plant-pathogen interaction. By mutation analysis of XacFhaB and XacFhaC genes we determined that XacFhaB is involved in virulence both in epiphytic and wound inoculations, displaying more dispersed and fewer canker lesions. Unexpectedly, the XacFhaC mutant in the transporter protein produced an intermediate virulence phenotype resembling wild type infection, suggesting that XacFhaB could be secreted by another partner different from XacFhaC. Moreover, XacFhaB mutants showed a general lack of adhesion and were affected in leaf surface attachment and biofilm formation. In agreement with the in planta phenotype, adhesin lacking cells moved faster in swarming plates. Since no hyperflagellation phenotype was observed in this bacteria, the faster movement may be attributed to the lack of cell-to-cell aggregation. Moreover, XacFhaB mutants secreted more exopolysaccharide that in turn may facilitate its motility. Our results suggest that this hemagglutinin-like protein is required for tissue colonization being mainly involved in surface attachment and biofilm formation, and that plant tissue attachment and cell-to-cell aggregation are dependent on the coordinated action of adhesin molecules and exopolysaccharides.	[Gottig, Natalia; Garavaglia, Betiana S.; Garofalo, Cecilia G.; Orellano, Elena G.; Ottado, Jorgelina] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario,CONICET, RA-2000 Rosario, Argentina	National University of Rosario	Gottig, N (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario,CONICET, RA-2000 Rosario, Argentina.	ottado@ibr.gov.ar		Gottig, Natalia/0000-0002-8730-8248	ANPCyT [PICT2006-00678]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) [Fellows]	ANPCyT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by ANPCyT PICT2006-00678 to Jorgelina Ottado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NG, EGO and JO are staff members and BSG and CGG are Fellows of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Chatterjee S, 2008, MOL PLANT MICROBE IN, V21, P1309, DOI 10.1094/MPMI-21-10-1309; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Fall R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-31; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hinsa SM, 2006, MICROBIOL-SGM, V152, P1375, DOI 10.1099/mic.0.28696-0; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; JacobDubuisson F, 1997, J BACTERIOL, V179, P775, DOI 10.1128/jb.179.3.775-783.1997; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; KAMOUN S, 1990, APPL ENVIRON MICROB, V56, P3855, DOI 10.1128/AEM.56.12.3855-3860.1990; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Mehta A, 2003, CURR MICROBIOL, V47, P400, DOI 10.1007/s00284-003-4051-3; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Moreira LM, 2004, ANNU REV PHYTOPATHOL, V42, P163, DOI 10.1146/annurev.phyto.42.040803.140310; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murray TS, 2008, J BACTERIOL, V190, P2700, DOI 10.1128/JB.01620-07; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Sambrook J., 2002, MOL CLONING LAB MANU; Shen YW, 2001, MOL PLANT MICROBE IN, V14, P204, DOI 10.1094/MPMI.2001.14.2.204; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668	50	122	123	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4358	10.1371/journal.pone.0004358	http://dx.doi.org/10.1371/journal.pone.0004358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194503	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483500008
J	Gazzolo, D; Frigiola, A; Bashir, M; Iskander, I; Mufeed, H; Aboulgar, H; Venturini, P; Marras, M; Serra, G; Frulio, R; Michetti, F; Petraglia, F; Abella, R; Florio, P				Gazzolo, Diego; Frigiola, Alessandro; Bashir, Moataza; Iskander, Iman; Mufeed, Hala; Aboulgar, Hanna; Venturini, Pierluigi; Marras, Mauro; Serra, Giovanni; Frulio, Rosanna; Michetti, Fabrizio; Petraglia, Felice; Abella, Raul; Florio, Pasquale			Diagnostic Accuracy of S100B Urinary Testing at Birth in Full-Term Asphyxiated Newborns to Predict Neonatal Death	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; EARLY INDICATOR; INTRAVENTRICULAR HEMORRHAGE; EARLY IDENTIFICATION; PRETERM INFANTS; S-100 PROTEIN; BRAIN-DAMAGE; TOOL; ENCEPHALOPATHY; SERUM	Background: Neonatal death in full-term infants who suffer from perinatal asphyxia (PA) is a major subject of investigation, since few tools exist to predict patients at risk of ominous outcome. We studied the possibility that urine S100B measurement may identify which PA-affected infants are at risk of early postnatal death. Methodology/Principal Findings: In a cross-sectional study between January 1, 2001 and December 1, 2006 we measured S100B protein in urine collected from term infants (n = 132), 60 of whom suffered PA. According to their outcome at 7 days, infants with PA were subsequently classified either as asphyxiated infants complicated by hypoxic ischemic encephalopathy with no ominous outcome (HIE Group; n = 48), or as newborns who died within the first post-natal week (Ominous Outcome Group; n = 12). Routine laboratory variables, cerebral ultrasound, neurological patterns and urine concentrations of S100B protein were determined at first urination and after 24, 48 and 96 hours. The severity of illness in the first 24 hours after birth was measured using the Score for Neonatal Acute Physiology-Perinatal Extension (SNAP-PE). Urine S100B levels were higher from the first urination in the ominous outcome group than in healthy or HIE Groups (p < 0.001 for all), and progressively increased. Multiple logistic regression analysis showed a significant correlation between S100B concentrations and the occurrence of neonatal death. At a cut-off.1.0 mg/L S100B had a sensitivity/specificity of 100% for predicting neonatal death. Conclusions/Significance: Increased S100B protein urine levels in term newborns suffering PA seem to suggest a higher risk of neonatal death for these infants.	[Gazzolo, Diego; Venturini, Pierluigi; Marras, Mauro; Serra, Giovanni; Frulio, Rosanna] Univ Genoa, G Gaslini Childrens Hosp, Dept Obstet Pediat & Neurosci, Genoa, Italy; [Gazzolo, Diego] G Garibaldi Hosp, Dept Maternal Fetal & Neonatal Hlth, Catania, Italy; [Frigiola, Alessandro; Abella, Raul] S Donato Milanese Univ Hosp, Dept Cardiac Surg, Perinatal Res Lab, Milan, Italy; [Bashir, Moataza; Iskander, Iman; Mufeed, Hala; Aboulgar, Hanna] Cairo Univ, Dept Neonatol, Cairo, Egypt; [Michetti, Fabrizio] Catholic Univ, Inst Anat, Rome, Italy; [Petraglia, Felice; Florio, Pasquale] Univ Siena, Dept Pediat Obstet & Reproduct Med, I-53100 Siena, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Egyptian Knowledge Bank (EKB); Cairo University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena	Gazzolo, D (corresponding author), Univ Genoa, G Gaslini Childrens Hosp, Dept Obstet Pediat & Neurosci, Genoa, Italy.	dgazzolo@hotmail.com	Petraglia, Felice/D-4373-2019; Frigiola, Alessandro/ABG-7502-2020	Petraglia, Felice/0000-0002-8851-625X; Frigiola, Alessandro/0000-0003-2762-9258	Italian Ministry of University and Scientific Research; Let's improve prenatal life Foundation; Stella Cometa Foundations	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Let's improve prenatal life Foundation; Stella Cometa Foundations	This work was partially supported by grants (COFIN 2005) provided by the Italian Ministry of University and Scientific Research, and from the "Let's improve prenatal life" and Stella Cometa" Foundations. The funding sources had no role in the design or conduct of the study, in the collection, management, analysis, or interpretation of the data, or in the preparation, review and approval of the manuscript.	BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; Florio P, 2004, LANCET, V364, P270, DOI 10.1016/S0140-6736(04)16677-4; Florio P, 2006, PEDIATRICS, V118, pE747, DOI 10.1542/peds.2005-2875; FREEMAN JM, 1988, PEDIATRICS, V82, P240; Gazzolo D, 1998, CLIN CHEM, V44, P1058; Gazzolo D, 2005, PEDIATR RES, V58, P1170, DOI 10.1203/01.pdr.0000185131.22985.30; Gazzolo D, 2004, CLIN CHEM, V50, P941, DOI 10.1373/clinchem.2003.021048; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gazzolo D, 2002, PEDIATR RES, V51, P215, DOI 10.1203/00006450-200202000-00015; Gazzolo D, 2002, ACTA PAEDIATR, V91, P218, DOI 10.1080/080352502317285243; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Marinoni E, 2002, OBSTET GYNECOL, V99, P1093, DOI 10.1016/S0029-7844(02)01996-8; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; Michetti F, 2002, CLIN CHEM, V48, P2097; MICHETTI F, 1979, NEUROSCI LETT, V11, P171, DOI 10.1016/0304-3940(79)90122-8; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Prechtl HFR., 1982, PSYCHOBIOLOGY HUMAN, P21; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Stephan C, 2003, CLIN CHEM, V49, P433, DOI 10.1373/49.3.433; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZWEIG MH, 1993, CLIN CHEM, V39, P561; INT J GYNECOL OBSTET, V61, P309	34	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4298	10.1371/journal.pone.0004298	http://dx.doi.org/10.1371/journal.pone.0004298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183802	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483200001
J	Oomen, CA; Girardi, CEN; Cahyadi, R; Verbeek, EC; Krugers, H; Joels, M; Lucassen, PJ				Oomen, Charlotte A.; Girardi, Carlos E. N.; Cahyadi, Rudy; Verbeek, Eva C.; Krugers, Harm; Joels, Marian; Lucassen, Paul J.			Opposite Effects of Early Maternal Deprivation on Neurogenesis in Male versus Female Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ADULT HIPPOCAMPAL NEUROGENESIS; CORTICOTROPIN-RELEASING-FACTOR; CHRONIC PSYCHOSOCIAL STRESS; GONADAL HORMONE MODULATION; FIBRILLARY ACIDIC PROTEIN; PRENATAL RESTRAINT STRESS; GENERATED GRANULE CELLS; CA3 PYRAMIDAL NEURONS; LONG-LASTING CHANGES	Background: Major depression is more prevalent in women than in men. The underlying neurobiological mechanisms are not well understood, but recent data shows that hippocampal volume reductions in depressed women occur only when depression is preceded by an early life stressor. This underlines the potential importance of early life stress, at least in women, for the vulnerability to develop depression. Perinatal stress exposure in rodents affects critical periods of brain development that persistently alter structural, emotional and neuroendocrine parameters in adult offspring. Moreover, stress inhibits adult hippocampal neurogenesis, a form of structural plasticity that has been implicated a.o. in antidepressant action and is highly abundant early postnatally. We here tested the hypothesis that early life stress differentially affects hippocampal structural plasticity in female versus male offspring. Principal Findings: We show that 24 h of maternal deprivation (MD) at PND3 affects hippocampal structural plasticity at PND21 in a sex-dependent manner. Neurogenesis was significantly increased in male but decreased in female offspring after MD. Since no other structural changes were found in granule cell layer volume, newborn cell survival or proliferation rate, astrocyte number or gliogenesis, this indicates that MD elicits specific changes in subsets of differentiating cells and differentially affects immature neurons. The MD induced sex-specific effects on neurogenesis cannot be explained by differences in maternal care. Conclusions: Our data shows that early environment has a critical influence on establishing sex differences in neural plasticity and supports the concept that the setpoint for neurogenesis may be determined during perinatal life. It is tempting to speculate that a reduced level of neurogenesis, secondary to early stress exposure, may contribute to maladaptation of the HPA axis and possibly to the increased vulnerability of women to stress-related disorders.	[Oomen, Charlotte A.; Girardi, Carlos E. N.; Cahyadi, Rudy; Verbeek, Eva C.; Krugers, Harm; Joels, Marian; Lucassen, Paul J.] Univ Amsterdam, SILS Ctr Neurosci, Amsterdam, Netherlands	University of Amsterdam	Oomen, CA (corresponding author), Univ Amsterdam, SILS Ctr Neurosci, Amsterdam, Netherlands.	Lucassen@science.uva.nl	Girardi, Carlos E N/H-4567-2014; Lucassen, Paul/ABA-3113-2020; Oomen, Charlotte/K-5259-2014; Joëls, Marian/P-6415-2016; Girardi, Carlos Eduardo Neves/B-4254-2015	Girardi, Carlos E N/0000-0002-1739-6924; Lucassen, Paul/0000-0001-9708-9133; Girardi, Carlos Eduardo Neves/0000-0002-1739-6924; Joels, Marian/0000-0002-4826-6209	Netherlands Brain Foundation	Netherlands Brain Foundation	PJL is supported by the Netherlands Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Belanoff JK, 2002, BIOL PSYCHIAT, V52, P386, DOI 10.1016/S0006-3223(02)01432-4; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Bland RC, 1997, CAN J PSYCHIAT, V42, P367, DOI 10.1177/070674379704200403; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Conejo NM, 2005, J NEUROSCI RES, V79, P488, DOI 10.1002/jnr.20372; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Dallman MF, 2003, PHYSIOL BEHAV, V79, P3, DOI 10.1016/S0031-9384(03)00100-8; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Desbonnet L, 2008, INT J DEV NEUROSCI, V26, P259, DOI 10.1016/j.ijdevneu.2008.02.004; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; Falconer EM, 2003, BRAIN RES, V975, P22, DOI 10.1016/S0006-8993(03)02542-3; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Frye C A, 2000, Stress, V3, P185, DOI 10.3109/10253890009001122; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; GARCIASEGURA LM, 1988, BRAIN RES, V456, P357, DOI 10.1016/0006-8993(88)90239-9; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gould E, 1997, J NEUROSCI, V17, P2492; Greisen MH, 2005, J NEUROSCI RES, V79, P772, DOI 10.1002/jnr.20418; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HENRY C, 1994, J NEUROENDOCRINOL, V6, P341, DOI 10.1111/j.1365-2826.1994.tb00591.x; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; HOFER MA, 1994, DEV PSYCHOBIOL, V27, P503, DOI 10.1002/dev.420270804; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; JOELS M, 2007, FRONTIERS NEUROENDOC; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Koehl M, 2001, NEUROTOX RES, V3, P65, DOI 10.1007/BF03033231; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Kole MHP, 2004, HIPPOCAMPUS, V14, P742, DOI 10.1002/hipo.10212; Ladd CO, 1996, ENDOCRINOLOGY, V137, P1212, DOI 10.1210/en.137.4.1212; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LEVINE S, 1956, J PERS, V24, P475, DOI 10.1111/j.1467-6494.1956.tb01283.x; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Levine S., 1994, ANN NY ACAD SCI, V746, P282, DOI DOI 10.1111/J.1749-6632.1994.TB39245.X; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Llorente R, 2008, DEV NEUROBIOL, V68, P1334, DOI 10.1002/dneu.20666; LUCASSEN PJ, 2008, EUR J NEURO IN PRESS; LUCASSEN PJ, 2008, REGULATION HIPPOCAMP, P363; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mandyam CD, 2008, DEV NEUROBIOL, V68, P575, DOI 10.1002/dneu.20600; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; Miranda P, 1999, J NEUROSCI, V19, P3316; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Nacher J, 2004, NEUROSCI LETT, V370, P40, DOI 10.1016/j.neulet.2004.07.062; OOMEN CA, 2007, BRIEF TREATMEN UNPUB; Penke Z, 2001, EUR J NEUROSCI, V14, P747, DOI 10.1046/j.0953-816x.2001.01691.x; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Reus VI, 2001, EXPERT OPIN INV DRUG, V10, P1789, DOI 10.1517/13543784.10.10.1789; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmitz C, 2002, MOL PSYCHIATR, V7, P810, DOI 10.1038/sj.mp.4001118; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Spritzer MD, 2007, DEV NEUROBIOL, V67, P1321, DOI 10.1002/dneu.20457; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Sutanto W, 1996, DEV BRAIN RES, V92, P156, DOI 10.1016/0165-3806(95)00213-8; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tauber SC, 2008, BRAIN PATHOL, V18, P497, DOI 10.1111/j.1750-3639.2008.00149.x; Thomas RM, 2008, GENE EXPRESSION, V14, P183; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Ustun T B, 2000, J Gend Specif Med, V3, P54; Vallee M, 1997, J NEUROSCI, V17, P2626; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Weiss EL, 1999, AM J PSYCHIAT, V156, P816, DOI 10.1176/ajp.156.6.816; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Workel JO, 1997, DEV BRAIN RES, V103, P199, DOI 10.1016/S0165-3806(97)81796-8; Workel JO, 2001, J NEUROENDOCRINOL, V13, P569, DOI 10.1046/j.1365-2826.2001.00668.x; Young E A, 1998, J Gend Specif Med, V1, P21	124	145	147	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e3675	10.1371/journal.pone.0003675	http://dx.doi.org/10.1371/journal.pone.0003675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19180242	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483100002
J	Gross, HJ; Pahl, M; Si, A; Zhu, H; Tautz, J; Zhang, SW				Gross, Hans J.; Pahl, Mario; Si, Aung; Zhu, Hong; Tautz, Juergen; Zhang, Shaowu			Number-Based Visual Generalisation in the Honeybee	PLOS ONE			English	Article							NUMERICAL COMPETENCE; MEMORY; SENSE; BEES; REPRESENTATION; RECOGNITION; PERCEPTION; SYMMETRY	Although the numerical abilities of many vertebrate species have been investigated in the scientific literature, there are few convincing accounts of invertebrate numerical competence. Honeybees, Apis mellifera, by virtue of their other impressive cognitive feats, are a prime candidate for investigations of this nature. We therefore used the well-established delayed match-to-sample paradigm, to test the limits of honeybees' ability to match two visual patterns solely on the basis of the shared number of elements in the two patterns. Using a y-maze, we found that bees can not only differentiate between patterns containing two and three elements, but can also use this prior knowledge to differentiate three from four, without any additional training. However, bees trained on the two versus three task could not distinguish between higher numbers, such as four versus five, four versus six, or five versus six. Control experiments confirmed that the bees were not using cues such as the colour of the exact configuration of the visual elements, the combined area or edge length of the elements, or illusory contours formed by the elements. To our knowledge, this is the first report of number-based visual generalisation by an invertebrate.	[Gross, Hans J.] Univ Wurzburg, Bioctr, Chair Biochem, Wurzburg, Germany; [Pahl, Mario; Tautz, Juergen] Univ Wurzburg, Bioctr, BEEgrp, D-97070 Wurzburg, Germany; [Pahl, Mario; Si, Aung; Zhu, Hong; Zhang, Shaowu] Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Excellence Vision Sci, Canberra, ACT, Australia	University of Wurzburg; University of Wurzburg; Australian National University	Gross, HJ (corresponding author), Univ Wurzburg, Bioctr, Chair Biochem, Wurzburg, Germany.	tautz@biozentrum.uni-wuerzburg.de; swzhang@rsbs.anu.edu.au		Zhang, Shaowu/0000-0002-3551-5587; Si, Aung/0000-0001-8115-9176	ARC COE in Vision Sciences [CE0561903, DP-0450535]; Alexander von Humboldt Foundation; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; DAAD [doctoral student's scholarship]	ARC COE in Vision Sciences(Australian Research Council); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the ARC COE in Vision Sciences (CE0561903), ARC DP-0450535 to SWZ, MP, AS and HZ. The Alexander von Humboldt Foundation supported the research of SWZ in Germany. MP was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg, and a DAAD (German Academic Exchange Service) doctoral student's scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; DAVIS H, 1984, ANIM LEARN BEHAV, V12, P409, DOI 10.3758/BF03199987; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; FRANKS N, 2006, P ROY SOC LOND B BIO, P165; GALLISTEL CR, 2005, MATH COGNITION, P559; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HORRIDGE GA, 1992, PHILOS T R SOC B, V337, P59, DOI 10.1098/rstb.1992.0083; Horridge GA, 1996, J INSECT PHYSIOL, V42, P755, DOI 10.1016/0022-1910(96)00026-1; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; Kilian A, 2003, LEARN BEHAV, V31, P133; Koehler O., 1941, Naturwissenschaften Berlin, V29, P201; LEPPIK EE, 1953, AM NAT, V87, P229, DOI 10.1086/281778; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Pahl M, 2007, J EXP BIOL, V210, P3559, DOI 10.1242/jeb.005488; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Zhang SW, 1999, NEUROBIOL LEARN MEM, V72, P180, DOI 10.1006/nlme.1998.3901; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102; Zhang SW, 2004, J EXP BIOL, V207, P3289, DOI 10.1242/jeb.01155; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	37	130	131	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4263	10.1371/journal.pone.0004263	http://dx.doi.org/10.1371/journal.pone.0004263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JG	19173008	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483000002
J	Wolfenson, H; Lubelski, A; Regev, T; Klafter, J; Henis, YI; Geiger, B				Wolfenson, Haguy; Lubelski, Ariel; Regev, Tamar; Klafter, Joseph; Henis, Yoav I.; Geiger, Benjamin			A Role for the Juxtamembrane Cytoplasm in the Molecular Dynamics of Focal Adhesions	PLOS ONE			English	Article							MATRIX ADHESIONS; ALPHA-ACTININ; INTEGRIN; CONTACTS; PHOSPHORYLATION; MECHANOSENSORS; ASSOCIATION; DIFFUSION; BINDING; KINASE	Focal adhesions (FAs) are specialized membrane-associated multi-protein complexes that link the cell to the extracellular matrix and play crucial roles in cell-matrix sensing. Considerable information is available on the complex molecular composition of these sites, yet the regulation of FA dynamics is largely unknown. Based on a combination of FRAP studies in live cells, with in silico simulations and mathematical modeling, we show that the FA plaque proteins paxillin and vinculin exist in four dynamic states: an immobile FA-bound fraction, an FA-associated fraction undergoing exchange, a juxtamembrane fraction experiencing attenuated diffusion, and a fast-diffusing cytoplasmic pool. The juxtamembrane region surrounding FAs displays a gradient of FA plaque proteins with respect to both concentration and dynamics. Based on these findings, we propose a new model for the regulation of FA dynamics in which this juxtamembrane domain acts as an intermediary layer, enabling an efficient regulation of FA formation and reorganization.	[Wolfenson, Haguy; Regev, Tamar; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Lubelski, Ariel; Klafter, Joseph] Tel Aviv Univ, Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; [Klafter, Joseph] Univ Freiburg, FRIAS, D-7800 Freiburg, Germany; [Geiger, Benjamin] Weizmann Inst Sci, Dept Molecular Cell Biol, Rehovot, Israel	Tel Aviv University; Tel Aviv University; University of Freiburg; Weizmann Institute of Science	Wolfenson, H (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	YoavHe@tauex.tau.ac.il; benny.geiger@weizmann.ac.il	Wolfenson, Haguy/AAC-7601-2020	Henis, Yoav/0000-0002-1408-3877; Regev, Tamar/0000-0003-0639-0890	National Institutes of Health [PN2 EY016586]; VW Foundation; German Israeli collaboration; Juvenile Diabetes Research Foundation; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VW Foundation(Volkswagen); German Israeli collaboration(German-Israeli Foundation for Scientific Research and Development); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Nanotechnology Center for Mechanics in Regenerative Medicine (PN2 EY016586); the VW Foundation; the German Israeli collaboration; the Juvenile Diabetes Research Foundation. None of these organizations have any impact in the study design.	Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; DUBAND JL, 1988, J CELL BIOL, V107, P1385, DOI 10.1083/jcb.107.4.1385; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Efron B., 1994, INTRO BOOTSTRAP; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; ELSON EL, 1979, J SUPRAMOL STR CELL, V12, P481, DOI 10.1002/jss.400120408; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Webb Donna J., 2004, V294, P3; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WEISS GH, 1994, ASPECTS APPL RANDOM, pR14; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WOJCIESZYN JW, 1981, P NATL ACAD SCI-BIOL, V78, P4407, DOI 10.1073/pnas.78.7.4407; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	45	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4304	10.1371/journal.pone.0004304	http://dx.doi.org/10.1371/journal.pone.0004304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172999	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483000013
J	Kang, J; Yu, HT				Kang, Jungseog; Yu, Hongtao			Kinase Signaling in the Spindle Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KINETOCHORE-MICROTUBULE INTERACTIONS; POLO-LIKE KINASE; MITOTIC CHECKPOINT; AURORA-B; CHROMOSOME ALIGNMENT; ASSEMBLY CHECKPOINT; CENP-E; ATTACHMENT STABILITY; INNER CENTROMERE; PROTEIN BUBR1	The spindle checkpoint is a cell cycle surveillance system that ensures the fidelity of chromosome segregation. In mitosis, it elicits the "wait anaphase" signal to inhibit the anaphase-promoting complex or cyclosome until all chromosomes achieve bipolar microtubule attachment and align at the metaphase plate. Because a single kinetochore unattached to microtubules activates the checkpoint, the wait anaphase signal is thought to be generated by this kinetochore and is then amplified and distributed throughout the cell to inhibit the anaphase-promoting complex/cyclosome. Several spindle checkpoint kinases participate in the generation and amplification of this signal. Recent studies have begun to reveal the activation mechanisms of these checkpoint kinases. Increasing evidence also indicates that the checkpoint kinases not only help to generate the wait anaphase signal but also actively correct kinetochore-microtubule attachment defects.	[Kang, Jungseog; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu		Yu, Hongtao/0000-0002-8861-049X				Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen RH, 2004, EMBO J, V23, P3113, DOI 10.1038/sj.emboj.7600308; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	59	32	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15359	15363		10.1074/jbc.R900005200	http://dx.doi.org/10.1074/jbc.R900005200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19228686	hybrid, Green Published			2022-12-25	WOS:000266501000003
J	Li, HQ; Randall, WR; Du, SJ				Li, Huiqing; Randall, William R.; Du, Shao-Jun			skNAC (skeletal Naca), a muscle-specific isoform of Naca (nascent polypeptide-associated complex alpha), is required for myofibril organization	FASEB JOURNAL			English	Article						thick filament; myofibrillogenesis; myosin; sarcomere	TRANSCRIPTION FACTOR; ZEBRAFISH EMBRYOS; SH3 DOMAIN; CARDIAC MYOFIBRILLOGENESIS; SELECTIVE REMOVAL; ELASTIC FILAMENTS; PROTEIN; GENE; EXPRESSION; SEQUENCE	Myofibrillogenesis, the precise assembly of sarcomeric proteins into the highly organized sarcomeres, is essential for muscle cell differentiation and function. Myofibrillogenesis requires proper folding and assembly of newly synthesized sarcomeric proteins. sknac (skeletal naca) is an alternatively spliced isoform of naca, which encodes the nascent polypeptide-associated complex alpha polypeptide that binds to newly synthesized polypeptides emerging from the ribosome. sknac is specifically expressed in skeletal and cardiac muscles. However, little is known about the function of skNAC in muscle development in vivo. To determine skNAC function, we have isolated and characterized the sknac gene from zebrafish. Zebrafish sknac cDNA differs from naca by containing an extra large exon that encodes 815 aa. Knockdown of sknac expression by antisense oligos resulted in zebrafish embryos with skeletal muscle defects. The sknac-knockdown embryos showed a paralyzed phenotype with little muscle contraction. In contrast, injection of a control oligo had no effect. Immunostaining and histological analyses revealed that sknac-knockdown embryos contained disorganized thick and thin filaments. Western blot analysis revealed that myosin protein levels were significantly reduced. Collectively, these results demonstrate that skNAC plays a vital role in myofibril assembly and function during muscle cell differentiation.-Li, H., Randall, W. R., Du, S.-J. skNAC (skeletal Naca), a muscle-specific isoform of Naca (nascent polypeptide-associated complex alpha), is required for myofibril organization in zebrafish embryo. FASEB J. 23, 1988-2000 (2009)	[Li, Huiqing; Du, Shao-Jun] Univ Maryland, Inst Biotechnol, Ctr Marine Biotechnol, Baltimore, MD 21202 USA; [Randall, William R.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21202 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Du, SJ (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Marine Biotechnol, 701 E Pratt St, Baltimore, MD 21202 USA.	dus@umbi.umd.edu		du, Jim/0000-0001-9227-4153	University of Maryland Biotechnology Institute; U.S.-Israel Binational Agricultural Research and Development (BARD) Fund [IS-3703-05]	University of Maryland Biotechnology Institute; U.S.-Israel Binational Agricultural Research and Development (BARD) Fund	We thank Becky Petre and Elena Bernick for editing. This research was supported by a University of Maryland Biotechnology Institute intercenter collaboration grant and by research grant IS-3703-05 from the U.S.-Israel Binational Agricultural Research and Development (BARD) Fund.	Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Du SJ, 2001, DEV DYNAM, V222, P655, DOI 10.1002/dvdy.1219; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; FUNATSU T, 1993, J CELL BIOL, V120, P711, DOI 10.1083/jcb.120.3.711; FUNATSU T, 1990, J CELL BIOL, V110, P53, DOI 10.1083/jcb.110.1.53; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; HANDEL SE, 1991, CELL TISSUE RES, V263, P419, DOI 10.1007/BF00327276; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; KOMIYAMA M, 1993, DEV DYNAM, V196, P291, DOI 10.1002/aja.1001960412; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Lopez S, 2005, J CELL SCI, V118, P1595, DOI 10.1242/jcs.02295; Moreau A, 1998, MOL CELL BIOL, V18, P1312, DOI 10.1128/MCB.18.3.1312; Munz B, 1999, J BIOL CHEM, V274, P13305, DOI 10.1074/jbc.274.19.13305; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Schoenauer R, 2005, J MOL BIOL, V349, P367, DOI 10.1016/j.jmb.2005.03.055; SHI XM, 1995, GENE, V165, P199, DOI 10.1016/0378-1119(95)00577-S; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; Wang QH, 2007, PROTEIN SCI, V16, P189, DOI 10.1110/ps.062496807; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WANG SM, 1988, J CELL BIOL, V107, P1075, DOI 10.1083/jcb.107.3.1075; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	39	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1988	2000		10.1096/fj.08-125542	http://dx.doi.org/10.1096/fj.08-125542			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19211926				2022-12-25	WOS:000266652400037
J	Bernard, A; Gao-Li, J; Franco, CA; Bouceba, T; Huet, A; Li, ZL				Bernard, Adrien; Gao-Li, Jacqueline; Franco, Claudio-Areias; Bouceba, Tahar; Huet, Alexis; Li, Zhenlin			Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; FACTOR PEDF; BINDING PROTEIN; NADPH OXIDASE; IDENTIFICATION; EXPRESSION; ISCHEMIA; VIRUS; MODEL; MECHANISMS	Pigment epithelium-derived factor (PEDF) is a multifunctional protein with neurotrophic, anti-oxidative, and anti-inflammatory properties. It is also one of the most potent endogenous inhibitors of angiogenesis, playing an important role in restricting tumor growth, invasion, and metastasis. Studies show that PEDF binds to cell surface proteins, but little is known about how it exerts its effects. Recently, research identified phospholipase A(2)/nutrin/patatin-like phospholipase domain-containing 2 as one PEDF receptor. To identify other receptors, we performed yeast two-hybrid screening using PEDF as bait and discovered that the non-integrin 37/67-kDa laminin receptor (LR) is another PEDF receptor. Co-immunoprecipitation, His tag pulldown, and surface plasmon resonance assays confirmed the interaction between PEDF and LR. Using the yeast two-hybrid method, we further restricted the LR-interacting domain on PEDF to a 34-amino acid (aa) peptide (aa 44-77) and the PEDF-interacting domain on LR to a 91-aa fragment (aa 120-210). A 25-mer peptide named P46 (aa 46-70), derived from 34-mer, interacts with LR in surface plasmon resonance assays and binds to endothelial cell (EC) membranes. This peptide induces EC apoptosis and inhibits EC migration, tube-like network formation in vitro, and retinal angiogenesis ex vivo, like PEDF. Our results suggest that LR is a real PEDF receptor that mediates PEDF angiogenesis inhibition.	[Bernard, Adrien; Gao-Li, Jacqueline; Franco, Claudio-Areias; Li, Zhenlin] Univ Paris 06, UR4, F-75252 Paris, France; [Bouceba, Tahar] Inst Federatif Rech 83, F-75252 Paris, France; [Huet, Alexis] Univ Paris 11, CNRS, IBBMC, Unite Mixte Rech 8619, F-91400 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Li, ZL (corresponding author), Univ Paris 06, UR4, BP256,7 Quai St Bernard, F-75005 Paris, France.	zhenlin.li@upmc.fr	Li, Zhenlin/E-3937-2016; Franco, Claudio A/B-1060-2013; Huet, Alexis/AAU-5958-2021; Franco, Claudio A/D-8117-2015	Franco, Claudio A/0000-0002-2861-3883; Huet, Alexis/0000-0001-6069-4460; Franco, Claudio A/0000-0002-2861-3883; LI, Zhenlin/0000-0002-3706-4505	Association pour la Recherche sur le Cancer [3587]; Naturalia et Biological; Retina France; Fondation de Recherche Medicale	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Naturalia et Biological; Retina France; Fondation de Recherche Medicale	This work was supported by funds from the Association pour la Recherche sur le Cancer (ARC, 3587, to Z.L.) and by fellowships from ARC and Naturalia et Biological (to A.B.), Retina France (to J.G.), and Fondation de Recherche Medicale (to C.A.F.).	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Ardini E, 2002, CANCER RES, V62, P1321; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Behling KC, 2002, MOL VIS, V8, P449; BERREIRO R, 2003, INVESTIG OPHTHALMOL, V44, P1282; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Donaldson Elaine A., 2000, Molecular Cell Biology Research Communications, V3, P53, DOI 10.1006/mcbr.2000.0191; Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821; Ek ETH, 2007, J ORTHOP RES, V25, P1671, DOI 10.1002/jor.20434; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gebarowska D, 2002, AM J PATHOL, V160, P307, DOI 10.1016/S0002-9440(10)64374-X; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Hutchings H, 2002, BIOCHEM BIOPH RES CO, V294, P764, DOI 10.1016/S0006-291X(02)00548-X; Kanda S, 2005, J CELL SCI, V118, P961, DOI 10.1242/jcs.01686; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KLEINMAN HK, 1988, P NATL ACAD SCI USA, V85, P1282, DOI 10.1073/pnas.85.4.1282; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; McKenna DJ, 2001, EXP EYE RES, V73, P81, DOI 10.1006/exer.2001.1013; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Schweitzer KM, 1997, LAB INVEST, V76, P25; Scott WN, 2000, BBA-PROTEIN STRUCT M, V1481, P25, DOI 10.1016/S0167-4838(00)00120-5; Selleri C, 2006, BLOOD, V108, P2476, DOI 10.1182/blood-2005-11-012625; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Stitt AW, 1998, AM J PATHOL, V152, P1359; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; TERRANOVA VP, 1986, J CELL PHYSIOL, V127, P473, DOI 10.1002/jcp.1041270318; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Thibaut S, 2009, J INVEST DERMATOL, V129, P449, DOI 10.1038/jid.2008.231; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Tombran-Tink J, 1996, Mol Vis, V2, P11; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; Yamagishi S, 2005, CELL TISSUE RES, V320, P437, DOI 10.1007/s00441-005-1094-8; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V296, P877, DOI 10.1016/S0006-291X(02)00940-3; Yamagishi SI, 2004, J MOL CELL CARDIOL, V37, P497, DOI 10.1016/j.yjmcc.2004.04.007; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	70	131	138	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10480	10490		10.1074/jbc.M809259200	http://dx.doi.org/10.1074/jbc.M809259200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224861	Green Published, hybrid			2022-12-25	WOS:000265104600022
J	Nishimoto-Morita, K; Shin, HW; Mitsuhashi, H; Kitamura, M; Zhang, Q; Johannes, L; Nakayama, K				Nishimoto-Morita, Kirika; Shin, Hye-Won; Mitsuhashi, Hiroko; Kitamura, Masashi; Zhang, Qian; Johannes, Ludger; Nakayama, Kazuhisa			Differential Effects of Depletion of ARL1 and ARFRP1 on Membrane Trafficking between the trans-Golgi Network and Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; EFFICIENT RETROGRADE TRANSPORT; NUCLEOTIDE EXCHANGE FACTOR; GRIP DOMAIN PROTEINS; PLASMA-MEMBRANE; SHIGA-TOXIN; EARLY/RECYCLING ENDOSOMES; CYTOPLASMIC DOMAIN; GTPASE ARL3P; LIVING CELLS	ARFRP1 and ARL1, which are both ARF-like small GTPases, are mammalian orthologs of yeast Arl3p and Arl1p, respectively. In yeast, Arl3p targeted to trans-Golgi network (TGN) membranes activates Arl1p, and the activated Arl1p in turn recruits a GRIP domain-containing protein; this complex regulates retrograde transport to the TGN and anterograde transport from the TGN. In the present study, using RNA interference-mediated knockdown of ARFRP1 and ARL1, we have examined whether the orthologs of Arl3p-Arl1p-GRIP story serve similar functions in mammalian cells. However, we have unexpectedly found differential roles of ARL1 and ARFRP1. Specifically, ARL1 and ARFRP1 regulate retrograde transport of Shiga toxin to the TGN and anterograde transport of VSVG from the TGN, respectively. Furthermore, we have obtained evidence suggesting that a SNARE complex containing Vti1a, syntaxin 6, and syntaxin 16 is involved in Shiga toxin transport downstream of ARL1.	[Nishimoto-Morita, Kirika; Shin, Hye-Won; Mitsuhashi, Hiroko; Kitamura, Masashi; Zhang, Qian; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Johannes, Ludger] Inst Curie, CNRS, UMR144, Traff & Signaling Lab, F-75248 Paris 05, France	Kyoto University; Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Johannes, Ludger/W-8593-2019; Johannes, Ludger/M-9778-2017; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Protein 3000 Project; Targeted Proteins Research Program; International Young Scientists Career Development Organization of Kyoto University; Uehara Memorial Foundation; NOVARTIS Foundation (Japan); Hayashi Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Protein 3000 Project; Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Young Scientists Career Development Organization of Kyoto University; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation (Japan)(Novartis); Hayashi Memorial Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for Promotion of Science, the Protein 3000 Project, the Targeted Proteins Research Program, the International Young Scientists Career Development Organization of Kyoto University, the Uehara Memorial Foundation, and the NOVARTIS Foundation (Japan) for the Promotion of Science, and the Hayashi Memorial Foundation for Female Natural Scientists.	Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Liu YW, 2006, J CELL SCI, V119, P3845, DOI 10.1242/jcs.03148; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Mueller AG, 2002, MOL CELL BIOL, V22, P1488, DOI 10.1128/MCB.22.5.1488-1494.2002; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Zahn C, 2008, J BIOL CHEM, V283, P27179, DOI 10.1074/jbc.M802108200; Zahn C, 2006, MOL MEMBR BIOL, V23, P475, DOI 10.1080/09687860600840100; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	40	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10583	10592		10.1074/jbc.M900847200	http://dx.doi.org/10.1074/jbc.M900847200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224922	Green Published, hybrid			2022-12-25	WOS:000265104600032
J	Ahuja, S; Crocker, E; Eilers, M; Hornak, V; Hirshfeld, A; Ziliox, M; Syrett, N; Reeves, PJ; Khorana, HG; Sheves, M; Smith, SO				Ahuja, Shivani; Crocker, Evan; Eilers, Markus; Hornak, Viktor; Hirshfeld, Amiram; Ziliox, Martine; Syrett, Natalie; Reeves, Philip J.; Khorana, H. Gobind; Sheves, Mordechai; Smith, Steven O.			Location of the Retinal Chromophore in the Activated State of Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE-SPINNING NMR; ASSISTED ROTATIONAL RESONANCE; PROTEIN-COUPLED RECEPTORS; HIGH-LEVEL EXPRESSION; MAMMALIAN-CELL LINES; METARHODOPSIN-II; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; TRANSMEMBRANE HELICES; BOVINE RHODOPSIN	Rhodopsin is a highly specialized G protein-coupled receptor (GPCR) that is activated by the rapid photochemical isomerization of its covalently bound 11-cis-retinal chromophore. Using two-dimensional solid-state NMR spectroscopy, we defined the position of the retinal in the active metarhodopsin II intermediate. Distance constraints were obtained between amino acids in the retinal binding site and specific C-13-labeled sites located on the beta-ionone ring, polyene chain, and Schiff base end of the retinal. We show that the retinal C20 methyl group rotates toward the second extracellular loop (EL2), which forms a cap on the retinal binding site in the inactive receptor. Despite the trajectory of the methyl group, we observed an increase in the C20-Gly(188) (EL2) distance consistent with an increase in separation between the retinal and EL2 upon activation. NMR distance constraints showed that the beta-ionone ring moves to a position between Met(207) and Phe(208) on transmembrane helix H5. Movement of the ring toward H5 was also reflected in increased separation between the C epsilon carbons of Lys(296) (H7) and Met(44) (H1) and between Gly(121) (H3) and the retinal C18 methyl group. Helix-helix interactions involving the H3-H5 and H4-H5 interfaces were also found to change in the formation of metarhodopsin II reflecting increased retinal-protein interactions in the region of Glu(122) (H3) and His(211) (H5). We discuss the location of the retinal in metarhodopsin II and its interaction with sequence motifs, which are highly conserved across the pharmaceutically important class A GPCR family, with respect to the mechanism of receptor activation.	[Eilers, Markus; Hornak, Viktor; Ziliox, Martine; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Ahuja, Shivani; Crocker, Evan] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Hirshfeld, Amiram; Sheves, Mordechai] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Reeves, Philip J.; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA 02139 USA; [Syrett, Natalie; Reeves, Philip J.] Univ Essex, Dept Biol Sci, Colchester C04 3SQ, Essex, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science; Massachusetts Institute of Technology (MIT); University of Essex	Smith, SO (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	steven.o.smith@sunysb.edu	Smith, Steven/HDM-9496-2022; Ahuja, Shivani/F-4537-2010		National Institutes of Health-National Science Foundation Instrumentation [S10 RR13889, DBI-9977553]; National Institutes of Health [GM-41412, EY-11716]; Israel Academy of Sciences and Humanities; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013889] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	National Institutes of Health-National Science Foundation Instrumentation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Academy of Sciences and Humanities; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health-National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and by National Institutes of Health Grants GM-41412 (to S. O. S.) and EY-11716 (to H. G. K.). This work was also supported by the Fund for Basic Research, administered by The Israel Academy of Sciences and Humanities (to M. S.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Beck M, 1998, FEBS LETT, V436, P304, DOI 10.1016/S0014-5793(98)01156-9; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; CHABRE M, 1979, PHOTOCHEM PHOTOBIOL, V30, P295, DOI 10.1111/j.1751-1097.1979.tb07150.x; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; Creemers AFL, 2002, P NATL ACAD SCI USA, V99, P9101, DOI 10.1073/pnas.112677599; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Crocker E, 2004, J BIOMOL NMR, V29, P11, DOI 10.1023/B:JNMR.0000019521.79321.3c; DULBECCO R, 1959, VIROLOGY, V8, P396, DOI 10.1016/0042-6822(59)90043-1; Eilers M, 1999, P NATL ACAD SCI USA, V96, P487, DOI 10.1073/pnas.96.2.487; Eilers M, 2002, METHOD ENZYMOL, V343, P212; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Getmanova E, 2004, BIOCHEMISTRY-US, V43, P1126, DOI 10.1021/bi030120u; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Han M, 1998, BIOCHEMISTRY-US, V37, P538, DOI 10.1021/bi972060w; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; HUBBARD R, 1952, J GEN PHYSIOL, V36, P269, DOI 10.1085/jgp.36.2.269; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; LUGTENBURG J, 1985, PURE APPL CHEM, V57, P753, DOI 10.1351/pac198557050753; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Marjamaki A, 1998, MOL PHARMACOL, V53, P370, DOI 10.1124/mol.53.3.370; MARR K, 1991, BIOCHEMISTRY-US, V30, P1254, DOI 10.1021/bi00219a013; MATSUMOTO H, 1978, VISION RES, V18, P607, DOI 10.1016/0042-6989(78)90212-2; Meng EC, 2001, TRENDS PHARMACOL SCI, V22, P587, DOI 10.1016/S0165-6147(00)01825-3; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Patel AB, 2005, J MOL BIOL, V347, P803, DOI 10.1016/j.jmb.2005.01.069; PATEL AB, 2004, THESIS STONY BROOK U; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Rohrig UF, 2002, BIOCHEMISTRY-US, V41, P10799, DOI 10.1021/bi026011h; Salgado GFJ, 2004, BIOCHEMISTRY-US, V43, P12819, DOI 10.1021/bi0491191; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schreiber M, 2006, ANGEW CHEM INT EDIT, V45, P4274, DOI 10.1002/anie.200600585; Shapiro DA, 2000, MOL PHARMACOL, V58, P877, DOI 10.1124/mol.58.5.877; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Spooner PJR, 2004, J MOL BIOL, V343, P719, DOI 10.1016/j.jmb.2004.08.049; Spooner PJR, 2002, BIOCHEMISTRY-US, V41, P7549, DOI 10.1021/bi020007o; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Strassburger JM, 1997, BIOPHYS J, V72, P2294, DOI 10.1016/S0006-3495(97)78874-X; Struts AV, 2007, J MOL BIOL, V372, P50, DOI 10.1016/j.jmb.2007.03.046; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; Yan ECY, 2002, BIOCHEMISTRY-US, V41, P3620, DOI 10.1021/bi0160011; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	75	78	79	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10190	10201		10.1074/jbc.M805725200	http://dx.doi.org/10.1074/jbc.M805725200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176531	Green Published, hybrid			2022-12-25	WOS:000264892900061
J	Bates, KT; Manning, PL; Hodgetts, D; Sellers, WI				Bates, Karl T.; Manning, Phillip L.; Hodgetts, David; Sellers, William I.			Estimating Mass Properties of Dinosaurs Using Laser Imaging and 3D Computer Modelling	PLOS ONE			English	Article							BODY-SIZE; INERTIAL PROPERTIES; FUNCTIONAL-ANATOMY; LIMB POSTURE; RANGE SIZE; TYRANNOSAURUS; MAMMALS; LOCOMOTION; RECONSTRUCTION; CONSERVATION	Body mass reconstructions of extinct vertebrates are most robust when complete to near-complete skeletons allow the reconstruction of either physical or digital models. Digital models are most efficient in terms of time and cost, and provide the facility to infinitely modify model properties non-destructively, such that sensitivity analyses can be conducted to quantify the effect of the many unknown parameters involved in reconstructions of extinct animals. In this study we use laser scanning (LiDAR) and computer modelling methods to create a range of 3D mass models of five specimens of non-avian dinosaur; two near-complete specimens of Tyrannosaurus rex, the most complete specimens of Acrocanthosaurus atokensis and Strutiomimum sedens, and a near-complete skeleton of a sub-adult Edmontosaurus annectens. LiDAR scanning allows a full mounted skeleton to be imaged resulting in a detailed 3D model in which each bone retains its spatial position and articulation. This provides a high resolution skeletal framework around which the body cavity and internal organs such as lungs and air sacs can be reconstructed. This has allowed calculation of body segment masses, centres of mass and moments or inertia for each animal. However, any soft tissue reconstruction of an extinct taxon inevitably represents a best estimate model with an unknown level of accuracy. We have therefore conducted an extensive sensitivity analysis in which the volumes of body segments and respiratory organs were varied in an attempt to constrain the likely maximum plausible range of mass parameters for each animal. Our results provide wide ranges in actual mass and inertial values, emphasizing the high level of uncertainty inevitable in such reconstructions. However, our sensitivity analysis consistently places the centre of mass well below and in front of hip joint in each animal, regardless of the chosen combination of body and respiratory structure volumes. These results emphasize that future biomechanical assessments of extinct taxa should be preceded by a detailed investigation of the plausible range of mass properties, in which sensitivity analyses are used to identify a suite of possible values to be tested as inputs in analytical models.	[Sellers, William I.] Univ Manchester, Adapt Organismal Biol Res Grp, Fac Life Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Manchester, Manchester Museum, Manchester M13 9PL, Lancs, England; [Manning, Phillip L.; Hodgetts, David] Univ Manchester, Sch Earth, Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Bates, KT (corresponding author), Univ Manchester, Adapt Organismal Biol Res Grp, Fac Life Sci, Jacksons Mill, Manchester, Lancs, England.	karl.bates@postgrad.manchester.ac.uk	Manning, Phillip/F-9966-2011; Hodgetts, David/A-5216-2011; Sellers, William Irvin/Q-3843-2019	Manning, Phillip/0000-0002-7161-6246; Sellers, William Irvin/0000-0002-2913-5406; Hodgetts, David/0000-0002-7437-7930	National Environmental Research Council [NER/S/A/2006/14101]	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Environmental Research Council doctoral grant to KTB (NER/S/A/2006/14101). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ARITA HT, 1990, CONSERV BIOL, V4, P181, DOI 10.1111/j.1523-1739.1990.tb00107.x; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; BATES KT, 2007, J VERTEBRATE PALEO S, V27, P45; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; BENTON MJ, 1989, PALAEOBIOLOGY SYNTHE, P147; BERGMANN C, 1847, VERHALTNISSE WARME 1; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Breithaupt Brent H., 2004, Ichnos, V11, P11, DOI 10.1080/10420940490442296; BROCHU CA, 2003, MEMOIR SOC VERTEBRAT, V7, P1, DOI DOI 10.2307/3889334; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; CLAESSENS LPA, 2004, J VERTEBR PALEONTOL, V24, P90; COLBERT EH, 1962, AM MUS NOVIT, P1; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Cope E.D., 1896, PRIMARY FACTORS ORGA, DOI DOI 10.5962/BHL.TITLE.2068; Crompton RH, 1996, AM J PHYS ANTHROPOL, V99, P547, DOI 10.1002/(SICI)1096-8644(199604)99:4<547::AID-AJPA3>3.0.CO;2-R; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Damuth J., 1990, BODY SIZE MAMMALIAN; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; GALTON PM, 1969, PELVIC MUSCULATURE D; Gaston KJ, 1996, CONSERV BIOL, V10, P638, DOI 10.1046/j.1523-1739.1996.10020638.x; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gaudin Timothy J., 2006, P1; GIERLINSKI G, 2005, P TRACK DIN OR DIXIE; GRAVES GR, 1991, P NATL ACAD SCI USA, V88, P2322, DOI 10.1073/pnas.88.6.2322; GREGORY WK, 1905, WEIGHT BRONTOSAURUS, V22, P572; Gunga HC, 2007, NATURWISSENSCHAFTEN, V94, P623, DOI 10.1007/s00114-007-0234-2; HALLAM A, 1975, NATURE, V258, P493, DOI 10.1038/258493a0; Hallam A., 1990, P249; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; HENDERSON DM, 2004, P ROYAL SOC LONDON S, V271, P57; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Isler K, 2006, J ANAT, V209, P201, DOI 10.1111/j.1469-7580.2006.00588.x; JABLONSKI DM, 1996, EVOLUTIONARY PALAEOB, P211; Kingsolver JG, 2004, EVOLUTION, V58, P1608; LABARBERA M, 1986, PATTERNS PROCESSES H, P69; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Perry SF, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P429; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; Romer A, 1956, OSTEOLOGY REPTILES; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; STANLEY SM, 1986, PALEOBIOLOGY, V12, P89, DOI 10.1017/S0094837300003006; STANLEY SM, 1990, DELAYED RECOVERY SPA, P410; STANLEY SM, EXTINCTION; Stevens JW, 2002, HEAT TRANSFER ENG, V23, P34, DOI 10.1080/01457630290090482; STEVENS KA, 2008, TYRANNOSAURUS REX TY, P435; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	71	91	92	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4532	10.1371/journal.pone.0004532	http://dx.doi.org/10.1371/journal.pone.0004532			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225569	Green Submitted, Green Published, gold			2022-12-25	WOS:000265486000009
J	Schwartz, M; Oren, YS; Bester, AC; Rahat, A; Sfez, R; Yitzchaik, S; de Villartay, JP; Kerem, B				Schwartz, Michal; Oren, Yifat S.; Bester, Assaf C.; Rahat, Ayelet; Sfez, Ruthy; Yitzchaik, Shlomo; de Villartay, Jean-Pierre; Kerem, Batsheva			Impaired Replication Stress Response in Cells from Immunodeficiency Patients Carrying Cernunnos/XLF Mutations	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-LIGASE-IV; COMMON FRAGILE SITES; END-JOINING GENES; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; GENOMIC INSTABILITY; HISTONE H2AX; CANCER RISK; REPAIR	Non-Homologous End Joining (NHEJ) is one of the two major pathways of DNA Double Strand Breaks (DSBs) repair. Mutations in human NHEJ genes can lead to immunodeficiency due to its role in V(D)J recombination in the immune system. In addition, most patients carrying mutations in NHEJ genes display developmental anomalies which are likely the result of a general defect in repair of endogenously induced DSBs such as those arising during normal DNA replication. Cernunnos/XLF is a recently identified NHEJ gene which is mutated in immunodeficiency with microcephaly patients. Here we aimed to investigate whether Cernunnos/XLF mutations disrupt the ability of patient cells to respond to replication stress conditions. Our results demonstrate that Cernunnos/XLF mutated cells and cells downregulated for Cernunnos/XLF have increased sensitivity to conditions which perturb DNA replication. In addition, under replication stress, these cells exhibit impaired DSB repair and increased accumulation of cells in G2/M. Moreover Cernunnos/XLF mutated and down regulated cells display greater chromosomal instability, particularly at fragile sites, under replication stress conditions. These results provide evidence for the role of Cernunnos/XLF in repair of DSBs and maintenance of genomic stability under replication stress conditions. This is the first study of a NHEJ syndrome showing association with impaired cellular response to replication stress conditions. These findings may be related to the clinical features in these patients which are not due to the V(D) J recombination defect. Additionally, in light of the emerging important role of replication stress in the early stages of cancer development, our findings may provide a mechanism for the role of NHEJ in preventing tumorigenesis.	[Schwartz, Michal; Oren, Yifat S.; Bester, Assaf C.; Rahat, Ayelet; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Sfez, Ruthy; Yitzchaik, Shlomo] Hebrew Univ Jerusalem, Dept Inorgan & Analytical Chem, IL-91905 Jerusalem, Israel; [de Villartay, Jean-Pierre] Inst Natl Sante & Rech Med, U768, Paris, France; [de Villartay, Jean-Pierre] Univ Paris 05, Fac Med Rene Descartes, Site Necker, IFR 94, Paris, France; [de Villartay, Jean-Pierre] Assistance Publ Hop Paris, Hop Necker Enfants Malades, Serv Immunol Hematol Pediat, Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Schwartz, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel.	kerem@cc.huji.ac.il	Bester, Assaf/ABG-1707-2021; de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463; Schwartz, Michal/0000-0001-5442-0201	Ministry of Science and Technology Israel; Deutsches Krebsforschungszetrum (DKFZ); Clore Israel Foundation [fellowship]	Ministry of Science and Technology Israel(Ministry of Science, Technology and Space (MOST), Israel); Deutsches Krebsforschungszetrum (DKFZ); Clore Israel Foundation	This research was supported by grants from the Ministry of Science and Technology Israel and the Deutsches Krebsforschungszetrum (DKFZ) to B.K.. M.S. is supported by a fellowship from the Clore Israel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bau DT, 2004, CANCER RES, V64, P5013, DOI 10.1158/0008-5472.CAN-04-0403; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Daboussi F, 2008, J CELL SCI, V121, P162, DOI 10.1242/jcs.010330; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fu YP, 2003, CANCER RES, V63, P2440; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; HOWLETT NG, 2005, HUM MOL GENET; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Knuutila S, 1998, AM J PATHOL, V152, P1107; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Liu YH, 2008, HUM MUTAT, V29, P381, DOI 10.1002/humu.20645; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Ozeri-Galai E, 2008, ONCOGENE, V27, P2109, DOI 10.1038/sj.onc.1210849; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4516	10.1371/journal.pone.0004516	http://dx.doi.org/10.1371/journal.pone.0004516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223975	gold, Green Submitted, Green Published			2022-12-25	WOS:000265485800016
J	Danielyan, L; Zellmer, S; Sickinger, S; Tolstonog, GV; Salvetter, J; Lourhmati, A; Reissig, DD; Gleiter, CH; Gebhardt, R; Buniatian, GH				Danielyan, Lusine; Zellmer, Sebastian; Sickinger, Stefan; Tolstonog, Genrich V.; Salvetter, Juergen; Lourhmati, Ali; Reissig, Dieter D.; Gleiter, Cristoph H.; Gebhardt, Rolf; Buniatian, Gayane Hrachia			Keratinocytes as Depository of Ammonium-Inducible Glutamine Synthetase: Age- and Anatomy-Dependent Distribution in Human and Rat Skin	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; HEPATIC STELLATE CELLS; SKELETAL-MUSCLE; TIGHT JUNCTIONS; PORTACAVAL ANASTOMOSIS; GENE-EXPRESSION; BRAIN-BARRIER; IN-VIVO; LIVER; METALLOTHIONEIN	In inner organs, glutamine contributes to proliferation, detoxification and establishment of a mechanical barrier, i.e., functions essential for skin, as well. However, the age-dependent and regional peculiarities of distribution of glutamine synthetase (GS), an enzyme responsible for generation of glutamine, and factors regulating its enzymatic activity in mammalian skin remain undisclosed. To explore this, GS localization was investigated using immunohistochemistry and double-labeling of young and adult human and rat skin sections as well as skin cells in culture. In human and rat skin GS was almost completely co-localized with astrocyte-specific proteins (e.g. GFAP). While GS staining was pronounced in all layers of the epidermis of young human skin, staining was reduced and more differentiated among different layers with age. In stratum basale and in stratum spinosum GS was co-localized with the adherens junction component beta-catenin. Inhibition of, glycogen synthase kinase 3 beta in cultured keratinocytes and HaCaT cells, however, did not support a direct role of beta-catenin in regulation of GS. Enzymatic and reverse transcriptase polymerase chain reaction studies revealed an unusual mode of regulation of this enzyme in keratinocytes, i.e., GS activity, but not expression, was enhanced about 8-10 fold when the cells were exposed to ammonium ions. Prominent posttranscriptional up-regulation of GS activity in keratinocytes by ammonium ions in conjunction with widespread distribution of GS immunoreactivity throughout the epidermis allows considering the skin as a large reservoir of latent GS. Such a depository of glutamine-generating enzyme seems essential for continuous	[Danielyan, Lusine; Lourhmati, Ali; Gleiter, Cristoph H.] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Zellmer, Sebastian; Sickinger, Stefan; Gebhardt, Rolf; Buniatian, Gayane Hrachia] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Tolstonog, Genrich V.] Heinrich Pette Inst Expt Virol & Immunol, Hamburg, Germany; [Salvetter, Juergen; Reissig, Dieter D.] Univ Leipzig, Inst Anat, Leipzig, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leipzig University; Heinrich Pette Institute; Leipzig University	Danielyan, L (corresponding author), Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany.	rgebhardt@medizin.uni-leipzig.de; buniatian@web.de		Danielyan, Lusine/0000-0003-4130-8477	Medical Faculties of the University of Tuebingen and Leipzig	Medical Faculties of the University of Tuebingen and Leipzig	This study was supported by the Medical Faculties of the University of Tuebingen and Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 1997, J TRAUMA, V42, P421, DOI 10.1097/00005373-199703000-00009; ABCOUWER SF, 1995, J SURG RES, V59, P59, DOI 10.1006/jsre.1995.1132; ARDAWI MSM, 1988, CLIN SCI, V74, P165, DOI 10.1042/cs0740165; AROLA L, 1981, ARCH INT PHYSIOL BIO, V89, P189, DOI 10.3109/13813458109069465; BAYREUTHER K, 1992, ANN NY ACAD SCI, V663, P167, DOI 10.1111/j.1749-6632.1992.tb38660.x; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bode JG, 1998, BIOCHEM J, V335, P697, DOI 10.1042/bj3350697; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGA VMM, 1995, CELL ADHES COMMUN, V3, P201, DOI 10.3109/15419069509081287; Buniatian G, 1996, EUR J CELL BIOL, V70, P23; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Buniatian GH, 2001, NEUROCHEM INT, V38, P373, DOI 10.1016/S0197-0186(00)00116-9; Burbaeva GS, 2005, NEUROCHEM RES, V30, P1443, DOI 10.1007/s11064-005-8654-x; BURCH HB, 1978, BIOCHEM BIOPH RES CO, V82, P498, DOI 10.1016/0006-291X(78)90902-6; Chakraborty T, 2007, LIFE SCI, V81, P489, DOI 10.1016/j.lfs.2007.06.023; Chatauret N, 2006, J HEPATOL, V44, P1083, DOI 10.1016/j.jhep.2005.11.048; Chwals WJ, 2004, MINI-REV MED CHEM, V4, P833, DOI 10.2174/1389557043403396; Conjard A, 2003, J BIOL CHEM, V278, P38159, DOI 10.1074/jbc.M302885200; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; Danielyan L, 2007, J INVEST DERMATOL, V127, P555, DOI 10.1038/sj.jid.5700575; DEJONG CHC, 1994, J HEPATOL, V21, P299, DOI 10.1016/S0168-8278(05)80305-8; Denes Z, 1985, Z Alternsforsch, V40, P159; Desjardins P, 1999, METAB BRAIN DIS, V14, P273, DOI 10.1023/A:1020741226752; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; Eizayaga F, 2006, WORLD J GASTROENTERO, V12, P1367, DOI 10.3748/wjg.v12.i9.1367; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Filipe J. A. C., 2002, Autonomic & Autacoid Pharmacology, V22, P155, DOI 10.1046/j.1474-8673.2002.00255.x; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Gebhardt R, 1998, CELL BIOL TOXICOL, V14, P55, DOI 10.1023/A:1007468521927; GEBHARDT R, 1994, ADV ENZYME REGUL, V34, P27, DOI 10.1016/0065-2571(94)90007-8; GEBHARDT R, 1986, CELL BIOL TOXICOL, V2, P9, DOI 10.1007/BF00117703; GEBHARDT R, 1994, HEPATOLOGY, V20, P684, DOI 10.1016/0270-9139(94)90105-8; GEBHARDT R, 1984, GLUTAMINE METABOLISM, P98; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GIRARD G, 1992, DIGEST DIS SCI, V37, P1121, DOI 10.1007/BF01300297; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Haberle J, 2006, J INHERIT METAB DIS, V29, P352, DOI 10.1007/s10545-006-0256-5; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; HAN EKH, 1993, J CELL BIOL, V122, P461, DOI 10.1083/jcb.122.2.461; HANSSON E, 1989, NEUROCHEM RES, V14, P585, DOI 10.1007/BF00964922; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hasan W, 2000, CELL TISSUE RES, V300, P97, DOI 10.1007/s004410050051; HOLASH JA, 1993, P NATL ACAD SCI USA, V90, P11069, DOI 10.1073/pnas.90.23.11069; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; JACKSON MJ, 1995, NEUROCHEM RES, V20, P201, DOI 10.1007/BF00970545; JAENICKE L, 1977, H-S Z PHYSIOL CHEM, V358, P883, DOI 10.1515/bchm2.1977.358.2.883; Jensen JM, 2005, EXP DERMATOL, V14, P609, DOI 10.1111/j.0906-6705.2005.00342.x; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Kruithof-de Julio M, 2005, J HEPATOL, V43, P126, DOI 10.1016/j.jhep.2005.01.036; KUBLER MD, 1993, J INVEST DERMATOL, V100, P785, DOI 10.1111/1523-1747.ep12476492; Labow BI, 1999, AM J PHYSIOL-ENDOC M, V276, pE1136, DOI 10.1152/ajpendo.1999.276.6.E1136; LEPRINCE G, 1995, NEUROCHEM RES, V20, P859, DOI 10.1007/BF00969698; LEVINTOW L, 1954, J NATL CANCER I, V15, P347; LEYDEN JJ, 1977, ARCH DERMATOL, V113, P1678, DOI 10.1001/archderm.113.12.1678; Li N, 2004, AM J PHYSIOL-GASTR L, V287, pG726, DOI 10.1152/ajpgi.00012.2004; LieVenema H, 1997, BIOCHEM J, V323, P611, DOI 10.1042/bj3230611; Malminen M, 2003, BRIT J DERMATOL, V149, P255, DOI 10.1046/j.1365-2133.2003.05438.x; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Michel M, 1996, J CELL SCI, V109, P1017; Mirlean N, 2006, ENVIRON POLLUT, V143, P335, DOI 10.1016/j.envpol.2005.11.022; NAGEL W, 1990, IMMUNOL LETT, V26, P291, DOI 10.1016/0165-2478(90)90162-J; Niemann C, 2006, BIOESSAYS, V28, P1, DOI 10.1002/bies.20352; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; Nose K, 2005, ANAL SCI, V21, P1471, DOI 10.2116/analsci.21.1471; OBANION MK, 1994, MOL BRAIN RES, V22, P57, DOI 10.1016/0169-328X(94)90032-9; Padden M, 2007, ACTA NEUROPATHOL, V113, P177, DOI 10.1007/s00401-006-0145-x; PATEL AJ, 1985, DEV BRAIN RES, V18, P175, DOI 10.1016/0165-3806(85)90262-7; Penkowa M, 2000, GLIA, V32, P247, DOI 10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T; Pinel C, 2006, NUTRITION, V22, P778, DOI 10.1016/j.nut.2006.05.005; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; PROZIALECK WC, 1993, LIFE SCI, V53, pPL337, DOI 10.1016/0024-3205(93)90567-M; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; REMESAR X, 1982, HORM METAB RES, V14, P419, DOI 10.1055/s-2007-1019033; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; SONI T, 1991, MOL CELL BIOCHEM, V102, P149; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Sullivan DM, 1997, GENE THER, V4, P1036, DOI 10.1038/sj.gt.3300505; Troy TC, 2007, MOL BIOTECHNOL, V36, P166, DOI 10.1007/s12033-007-0027-z; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Vastag M, 2005, PFLUG ARCH EUR J PHY, V449, P384, DOI 10.1007/s00424-004-1341-y; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Yoneda Kozo, 1992, Journal of Dermatology (Tokyo), V19, P761; ZELLMER S, 2001, EPITHELIAL CELL CULT, P179; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhen YX, 1999, ARCH DERMATOL RES, V291, P555, DOI 10.1007/s004030050453; Zhu QL, 2004, CELL TISSUE RES, V316, P243, DOI 10.1007/s00441-004-0864-z; ZIYLAN YZ, 1993, MOL CHEM NEUROPATHOL, V20, P203	94	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4416	10.1371/journal.pone.0004416	http://dx.doi.org/10.1371/journal.pone.0004416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204801	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484000007
J	Muller, IB; Wu, F; Bergmann, B; Knockel, J; Walter, RD; Gehring, H; Wrenger, C				Mueller, Ingrid B.; Wu, Fang; Bergmann, Baerbel; Knoeckel, Julia; Walter, Rolf D.; Gehring, Heinz; Wrenger, Carsten			Poisoning Pyridoxal 5-Phosphate-Dependent Enzymes: A New Strategy to Target the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article								The human malaria parasite Plasmodium falciparum is able to synthesize de novo pyridoxal 5-phosphate (PLP), a crucial cofactor, during erythrocytic schizogony. However, the parasite possesses additionally a pyridoxine/pyridoxal kinase (PdxK) to activate B6 vitamers salvaged from the host. We describe a strategy whereby synthetic pyridoxyl-amino acid adducts are channelled into the parasite. Trapped upon phosphorylation by the plasmodial PdxK, these compounds block PLP-dependent enzymes and thus impair the growth of P. falciparum. The novel compound PT3, a cyclic pyridoxyl-tryptophan methyl ester, inhibited the proliferation of Plasmodium very efficiently (IC50-value of 14 mu M) without harming human cells. The non-cyclic pyridoxyl-tryptophan methyl ester PT5 and the pyridoxyl-histidine methyl ester PHME were at least one order of magnitude less effective or completely ineffective in the case of the latter. Modeling in silico indicates that the phosphorylated forms of PT3 and PT5 fit well into the PLP-binding site of plasmodial ornithine decarboxylase (PfODC), the key enzyme of polyamine synthesis, consistent with the ability to abolish ODC activity in vitro. Furthermore, the antiplasmodial effect of PT3 is directly linked to the capability of Plasmodium to trap this pyridoxyl analog, as shown by an increased sensitivity of parasites overexpressing PfPdxK in their cytosol, as visualized by GFP fluorescence.	[Mueller, Ingrid B.; Bergmann, Baerbel; Knoeckel, Julia; Walter, Rolf D.; Wrenger, Carsten] Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany; [Wu, Fang; Gehring, Heinz] Univ Zurich, Dept Biochem, CH-8006 Zurich, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; University of Zurich	Muller, IB (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany.	ibmueller@bni-hamburg.de	Wu, Fang/B-1945-2008; Wrenger, Carsten/E-4110-2013	Wu, Fang/0000-0002-4194-2243; Wrenger, Carsten/0000-0001-5987-1749; Vivian, Julia/0000-0001-6688-7714	Deutsche Forschungsgemeinschaft [WA 395/15, WR 124/2]; COST Switzerland [C02.0017]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST Switzerland	This work was supported by Deutsche Forschungsgemeinschaft Grants WA 395/15 and WR 124/2 and by COST Switzerland (Action 922, Grant C02.0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Birkholtz L, 2003, PROTEINS, V50, P464, DOI 10.1002/prot.10274; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Crabb BS, 2004, METH MOL B, V270, P263; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Eschbach ML, 2006, BIOL CHEM, V387, P1583, DOI 10.1515/BC.2006.197; FONDA ML, 1982, AM J CLIN NUTR, V35, P1391, DOI 10.1093/ajcn/35.6.1391; FRIEDRICH W, 1988, VITAMINS, P1060; GAO GJ, 1994, J BIOL CHEM, V269, P7163; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; HELLER JS, 1975, BIOCHIM BIOPHYS ACTA, V403, P197, DOI 10.1016/0005-2744(75)90022-4; KHOMUTOV RM, 1971, BIOCHEM J, V124, P99, DOI 10.1042/bj1240099; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Muller IB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001815; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; Noda M, 2004, J BIOL CHEM, V279, P46143, DOI 10.1074/jbc.M404603200; PEGG AE, 1995, J CELL BIOCHEM, P132; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PLATZER EG, 1978, J PROTOZOOL, V25, P556, DOI 10.1111/j.1550-7408.1978.tb04186.x; POULIN R, 1992, J BIOL CHEM, V267, P150; Scott TC, 1997, MOL BIOCHEM PARASIT, V88, P1, DOI 10.1016/S0166-6851(97)00077-7; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Storici P, 2004, J BIOL CHEM, V279, P363, DOI 10.1074/jbc.M305884200; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WANG CC, 1995, ANNU REV PHARMACOL, V35, P93, DOI 10.1146/annurev.pa.35.040195.000521; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Wrenger C, 2001, J BIOL CHEM, V276, P29651, DOI 10.1074/jbc.M100578200; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Wu F, 2007, MOL CANCER THER, V6, P1831, DOI 10.1158/1535-7163.MCT-07-0045	38	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4406	10.1371/journal.pone.0004406	http://dx.doi.org/10.1371/journal.pone.0004406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197387	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483700013
J	Elahi, E; Suraweera, N; Volikos, E; Haines, J; Brown, N; Davidson, G; Churchman, M; Ilyas, M; Tomlinson, I; Silver, A				Elahi, Eiram; Suraweera, Nirosha; Volikos, Emmanouil; Haines, Jackie; Brown, Natalie; Davidson, Gerovie; Churchman, Mike; Ilyas, Mohammed; Tomlinson, Ian; Silver, Andrew			Five Quantitative Trait Loci Control Radiation-Induced Adenoma Multiplicity in Mom1R ApcMin/+ Mice	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; NADPH OXIDASES; SUSCEPTIBILITY; MOUSE; MODIFIER; CANCER; GENE; IDENTIFICATION; APC(MIN/+)	Ionising radiation is a carcinogen capable of inducing tumours, including colorectal cancer, in both humans and animals. By backcrossing a recombinant line of Apc(Min/+) mice to the inbred BALB/c mouse strain, which is unusually sensitive to radiation-induced tumour development, we obtained panels of 2Gy-irradiated and sham-irradiated N2 Apc(Min/+) mice for genotyping with a genome-wide panel of microsatellites at similar to 15 cM density and phenotyping by counting adenomas in the small intestine. Interval and composite interval mapping along with permutation testing identified five significant susceptibility quantitative trait loci (QTLs) responsible for radiation induced tumour multiplicity in the small intestine. These were defined as Mom (Modifier of Min) radiation-induced polyposis (Mrip1-5) on chromosome 2 (log of odds, LOD 2.8, p = 0.0003), two regions within chromosome 5 (LOD 5.2, p<0.00001, 6.2, p<0.00001) and two regions within chromosome 16 respectively (LOD 4.1, p = 4x10(-5), 4.8, p<0.00001). Suggestive QTLs were found for sham-irradiated mice on chromosomes 3, 6 and 13 (LOD 1.7, 1.5 and 2.0 respectively; p<0.005). Genes containing BALB/c specific non-synonymous polymorphisms were identified within Mrip regions and prediction programming used to locate potentially functional polymorphisms. Our study locates the QTL regions responsible for increased radiation-induced intestinal tumorigenesis in Apc(Min/+) mice and identifies candidate genes with predicted functional polymorphisms that are involved in spindle checkpoint and chromosomal stability (Bub1b, Casc5, and Bub1), DNA repair (Recc1 and Prkdc) or inflammation (Duox2, Itgb2l and Cxcl5). Our study demonstrates use of in silico analysis in candidate gene identification as a way of reducing large-scale backcross breeding programmes.	[Elahi, Eiram; Suraweera, Nirosha; Volikos, Emmanouil; Silver, Andrew] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Haines, Jackie; Brown, Natalie] HPA, Radiat Protect Div, Didcot, Oxon, England; [Davidson, Gerovie; Churchman, Mike] Univ Oxford, Radcliffe Infirmary, Canc Res UK, Genotyping Facil, Oxford OX1 2JD, England; [Ilyas, Mohammed] Queens Med Ctr, Sch Mol Med Sci, Div Pathol, Nottingham, England; [Tomlinson, Ian] Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London, England	University of London; Queen Mary University London; Health Protection Agency; Cancer Research UK; Radcliffe Infirmary; University of Oxford; University of Nottingham; Cancer Research UK	Elahi, E (corresponding author), Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England.	a.r.silver@qmul.ac.uk	Suraweera, Nirosha/E-5912-2012		Cancer Research UK	Cancer Research UK(Cancer Research UK)	Cancer Research UK funded this research. The Funder (Cancer Research UK) had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2007, GASTROENTEROLOGY, V132, P2448, DOI 10.1053/j.gastro.2007.03.027; Baier PK, 2005, ANTICANCER RES, V25, P3581; Basten C.J., 1994, P 5 WORLD C GEN APPL, P65; BASTEN CJ, 2004, QTL CARTOGRAPHER VER; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belknap JK, 2001, BEHAV GENET, V31, P5, DOI 10.1023/A:1010249607128; Bogue MA, 2007, NUCLEIC ACIDS RES, V35, pD643, DOI 10.1093/nar/gkl1049; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Degg NL, 2003, CANCER RES, V63, P2361; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Dimberg J, 2007, INT J ONCOL, V31, P97; Dragani TA, 2003, CANCER RES, V63, P3011; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Haines J, 2005, P NATL ACAD SCI USA, V102, P2868, DOI 10.1073/pnas.0500039102; Hashiguchi K, 2007, NUCLEIC ACIDS RES, V35, P2913, DOI 10.1093/nar/gkm115; Hojgaard A, 2006, IMMUNOLOGY, V119, P212, DOI 10.1111/j.1365-2567.2006.02426.x; JANSEN RC, 1994, GENETICS, V136, P1447; Katoh M, 2007, INT J ONCOL, V30, P247; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kwong LN, 2007, GENETICS, V176, P1237, DOI 10.1534/genetics.107.071217; LUONGO C, 1994, CANCER RES, V54, P5947; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; MacLaren Erik J, 2005, Alcohol Clin Exp Res, V29, P1568, DOI 10.1097/01.alc.0000179376.27331.ac; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Marshall KE, 2002, GENOME BIOL, V3; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; Mori N, 2000, J RADIAT RES, V41, P367, DOI 10.1269/jrr.41.367; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Silverman KA, 2002, GENOME RES, V12, P88, DOI 10.1101/gr.206002; SIPLEY JD, 1995, P NATL ACAD SCI USA, V92, P7515, DOI 10.1073/pnas.92.16.7515; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Turina M, 2008, ARCH SURG-CHICAGO, V143, P46, DOI 10.1001/archsurg.2007.7; *UNSCEAR, 2000, 55 SESS NEW YORK U S, V46; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; YU K, 2001, CANCER RES, V61, P1820; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4388	10.1371/journal.pone.0004388	http://dx.doi.org/10.1371/journal.pone.0004388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194513	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483600013
J	Popp, A; Urbach, A; Witte, OW; Frahm, C				Popp, Anke; Urbach, Anja; Witte, Otto W.; Frahm, Christiane			Adult and Embryonic GAD Transcripts Are Spatiotemporally Regulated during Postnatal Development in the Rat Brain	PLOS ONE			English	Article								Background: GABA (gamma-aminobutyric acid), the main inhibitory neurotransmitter in the brain, is synthesized by glutamic acid decarboxylase (GAD). GAD exists in two adult isoforms, GAD65 and GAD67. During embryonic brain development at least two additional transcripts exist, I-80 and I-86, which are distinguished by insertions of 80 or 86 bp into GAD67 mRNA, respectively. Though it was described that embryonic GAD67 transcripts are not detectable during adulthood there are evidences suggesting re-expression under certain pathological conditions in the adult brain. In the present study we systematically analyzed for the first time the spatiotemporal distribution of different GADs with emphasis on embryonic GAD67 mRNAs in the postnatal brain using highly sensitive methods. Methodology/Principal Findings: QPCR was used to precisely investigate the postnatal expression level of GAD related mRNAs in cortex, hippocampus, cerebellum, and olfactory bulb of rats from P1 throughout adulthood. Within the first three postnatal weeks the expression of both GAD65 and GAD67 mRNAs reached adult levels in hippocampus, cortex, and cerebellum. The olfactory bulb showed by far the highest expression of GAD65 as well as GAD67 transcripts. Embryonic GAD67 splice variants were still detectable at birth. They continuously declined to barely detectable levels during postnatal development in all investigated regions with exception of a comparatively high expression in the olfactory bulb. Radioactive in situ hybridizations confirmed the occurrence of embryonic GAD67 transcripts in the olfactory bulb and furthermore detected their localization mainly in the subventricular zone and the rostral migratory stream. Conclusions/Significance: Embryonic GAD67 transcripts can hardly be detected in the adult brain, except for specific regions associated with neurogenesis and high synaptic plasticity. Therefore a functional role in processes like proliferation, migration or synaptogenesis is suggested.	[Popp, Anke; Urbach, Anja; Witte, Otto W.; Frahm, Christiane] Univ Jena, Dept Neurol, Jena, Germany	Friedrich Schiller University of Jena	Popp, A (corresponding author), Univ Jena, Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Urbach, Anja/CAG-0282-2022; Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	BMBF [01GZ0306, 0311578]; Kompetenznetzwerk Schlaganfall, BMBF [01GI9905]	BMBF(Federal Ministry of Education & Research (BMBF)); Kompetenznetzwerk Schlaganfall, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (nos. 01GZ0306 and 0311578) and Kompetenznetzwerk Schlaganfall, BMBF (no. 01GI9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggensteiner M, 2003, DEV BRAIN RES, V142, P77, DOI 10.1016/S0165-3806(03)00033-6; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BEHAR T, 1994, DEV BRAIN RES, V77, P77, DOI 10.1016/0165-3806(94)90215-1; BEHAR T, 1993, DEV BRAIN RES, V72, P203, DOI 10.1016/0165-3806(93)90185-D; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Frahm C, 2001, DEV BRAIN RES, V132, P1, DOI 10.1016/S0165-3806(01)00288-7; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; GREIF KF, 1992, DEV BIOL, V153, P158, DOI 10.1016/0012-1606(92)90100-U; Guo YH, 1997, DEV BRAIN RES, V103, P127, DOI 10.1016/S0165-3806(97)81789-0; Gutierrez R, 2000, J NEUROPHYSIOL, V84, P3088, DOI 10.1152/jn.2000.84.6.3088; Gutierrez R, 2001, EUR J NEUROSCI, V13, P1371, DOI 10.1046/j.0953-816x.2001.01508.x; HOUSER CR, 1994, HIPPOCAMPUS, V4, P530, DOI 10.1002/hipo.450040503; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kobori H, 2001, HYPERTENSION, V37, P1329, DOI 10.1161/01.HYP.37.5.1329; Krizbai IA, 2000, NEUROREPORT, V11, P791, DOI 10.1097/00001756-200003200-00027; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Liu YWJ, 2007, CURR PHARM BIOTECHNO, V8, P187; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Szabo G, 2000, NEUROSCIENCE, V100, P287, DOI 10.1016/S0306-4522(00)00275-X; Varja P, 2002, J NEUROCHEM, V80, P605, DOI 10.1046/j.0022-3042.2001.00733.x; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	45	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4371	10.1371/journal.pone.0004371	http://dx.doi.org/10.1371/journal.pone.0004371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190758	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483300010
J	Hohn, C; Lee, SR; Pinchuk, LM; Petrie-Hanson, L				Hohn, Claudia; Lee, Sang-Ryul; Pinchuk, Lesya M.; Petrie-Hanson, Lora			Zebrafish Kidney Phagocytes Utilize Macropinocytosis and Ca2+-Dependent Endocytic Mechanisms	PLOS ONE			English	Article								Background: The innate immune response constitutes the first line of defense against invading pathogens and consists of a variety of immune defense mechanisms including active endocytosis by macrophages and granulocytes. Endocytosis can be used as a reliable measure of selective and non-selective mechanisms of antigen uptake in the early phase of an immune response. Numerous assays have been developed to measure this response in a variety of mammalian and fish species. The small size of the zebrafish has prevented the large-scale collection of monocytes/macrophages and granulocytes for these endocytic assays. Methodology/Principal Findings: Pooled zebrafish kidney hematopoietic tissues were used as a source of phagocytic cells for flow-cytometry based endocytic assays. FITC-Dextran, Lucifer Yellow and FITC-Edwardsiella ictaluri were used to evaluate selective and non-selective mechanisms of uptake in zebrafish phagocytes. Conclusions/Significance: Zebrafish kidney phagocytes characterized as monocytes/macrophages, neutrophils and lymphocytes utilize macropinocytosis and Ca2+-dependant endocytosis mechanisms of antigen uptake. These cells do not appear to utilize a mannose receptor. Heat-killed Edwardsiella ictaluri induces cytoskeletal interactions for internalization in zebrafish kidney monocytes/macrophages and granulocytes. The proposed method is easy to implement and should prove especially useful in immunological, toxicological and epidemiological research.	[Hohn, Claudia; Lee, Sang-Ryul; Pinchuk, Lesya M.; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Mississippi State University	Hohn, C (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu						AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; BARAKAT KK, 2005, RES J AGR BIOL SCI, V1, P195; BLAZER V S, 1991, Journal of Aquatic Animal Health, V3, P77, DOI 10.1577/1548-8667(1991)003&lt;0077:PMFANI&gt;2.3.CO;2; Boyd BL, 2004, VET IMMUNOL IMMUNOP, V102, P53, DOI 10.1016/j.vetimm.2004.06.009; Chaves-Pozo Elena, 2004, Biological Procedures Online, V6, P129, DOI 10.1251/bpo81; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DUNN PA, 1983, J IMMUNOL METHODS, V64, P71, DOI 10.1016/0022-1759(83)90385-X; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Esteban MA, 1998, CELL TISSUE RES, V293, P133, DOI 10.1007/s004410051105; Esteban MA, 2004, FISH SHELLFISH IMMUN, V16, P447, DOI 10.1016/j.fsi.2003.07.004; EWANOWICH CA, 1990, INFECT IMMUN, V58, P3187, DOI 10.1128/IAI.58.10.3187-3193.1990; GIVAN AL, 2001, FLOW CYTOMETRY 1 PRI, P154; HARDIE LJ, 1994, DEV COMP IMMUNOL, V18, P57, DOI 10.1016/0145-305X(94)90252-6; Harford AJ, 2006, FISH SHELLFISH IMMUN, V20, P562, DOI 10.1016/j.fsi.2005.07.005; Harford AJ, 2005, AQUAT TOXICOL, V75, P330, DOI 10.1016/j.aquatox.2005.09.005; HASUI M, 1989, J IMMUNOL METHODS, V117, P53, DOI 10.1016/0022-1759(89)90118-X; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hermann AC, 2004, J IMMUNOL METHODS, V292, P119, DOI 10.1016/j.jim.2004.06.016; Hohn C, 2007, ZEBRAFISH, V4, P117, DOI 10.1089/zeb.2006.0501; HOHN CM, 2008, THESIS MISSISSIPPI S; Inoue T, 2002, FISH SHELLFISH IMMUN, V13, P379, DOI 10.1006/fsim.2002.0413; Jensch BE, 2006, AQUACULTURE, V251, P509, DOI 10.1016/j.aquaculture.2005.05.042; KAHN S, 1995, J EXP MED, P182; Kamilya D, 2006, AQUACULTURE, V253, P130, DOI 10.1016/j.aquaculture.2005.07.038; Koduru S, 2006, DEV GENES EVOL, V216, P133, DOI 10.1007/s00427-005-0043-6; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Mendez E, 2001, ENDOCRINOLOGY, V142, P1090, DOI 10.1210/en.142.3.1090; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Neumann NF, 2001, DEV COMP IMMUNOL, V25, P807, DOI 10.1016/S0145-305X(01)00037-4; Nolan CM, 2006, DEV GENES EVOL, V216, P144, DOI 10.1007/s00427-005-0046-3; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; PETRIEHANSON L, BMC IMMUNOL IN PRESS; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rodriguez A, 2003, FISH SHELLFISH IMMUN, V14, P375, DOI 10.1006/fsim.2002.0446; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SANTOS JL, 1995, IMMUNOL LETT, V45, P1, DOI 10.1016/0165-2478(94)00180-Y; Sarder MRI, 2001, DEV COMP IMMUNOL, V25, P37, DOI 10.1016/S0145-305X(00)00040-9; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; SCHREIBER S, 1991, P NATL ACAD SCI USA, V88, P1616, DOI 10.1073/pnas.88.5.1616; Secombes C. J., 1992, Annual Review of Fish Diseases, V2, P53, DOI 10.1016/0959-8030(92)90056-4; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Skirpstunas RT, 2002, DIS AQUAT ORGAN, V51, P161, DOI 10.3354/dao051161; Steinkamp JA, 2000, CYTOMETRY, V39, P45, DOI 10.1002/(SICI)1097-0320(20000101)39:1<45::AID-CYTO7>3.0.CO;2-1; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; WATTS C, 1992, J CELL SCI, V103, P1; WEEKS BA, 1986, VET IMMUNOL IMMUNOP, V12, P313, DOI 10.1016/0165-2427(86)90135-2; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WHITEOWEN C, 1992, J CLIN MICROBIOL, V30, P2071, DOI 10.1128/JCM.30.8.2071-2076.1992; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1; YOSHIDA T, 1993, AQUACULTURE, V109, P207, DOI 10.1016/0044-8486(93)90163-S	70	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4314	10.1371/journal.pone.0004314	http://dx.doi.org/10.1371/journal.pone.0004314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183805	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483200004
J	Zangenehpour, S; Ghazanfar, AA; Lewkowicz, DJ; Zatorre, RJ				Zangenehpour, Shahin; Ghazanfar, Asif A.; Lewkowicz, David J.; Zatorre, Robert J.			Heterochrony and Cross-Species Intersensory Matching by Infant Vervet Monkeys	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; RHESUS-MONKEY; 1ST YEAR; MULTISENSORY INTEGRATION; BRAIN EVOLUTION; AUDITORY-CORTEX; ALARM CALLS; PERCEPTION; SPEECH; CUES	Background: Understanding the evolutionary origins of a phenotype requires understanding the relationship between ontogenetic and phylogenetic processes. Human infants have been shown to undergo a process of perceptual narrowing during their first year of life, whereby their intersensory ability to match the faces and voices of another species declines as they get older. We investigated the evolutionary origins of this behavioral phenotype by examining whether or not this developmental process occurs in non-human primates as well. Methodology/Principal Findings: We tested the ability of infant vervet monkeys (Cercopithecus aethiops), ranging in age from 23 to 65 weeks, to match the faces and voices of another non-human primate species (the rhesus monkey, Macaca mulatta). Even though the vervets had no prior exposure to rhesus monkey faces and vocalizations, our findings show that infant vervets can, in fact, recognize the correspondence between rhesus monkey faces and voices (but indicate that they do so by looking at the non-matching face for a greater proportion of overall looking time), and can do so well beyond the age of perceptual narrowing in human infants. Our results further suggest that the pattern of matching by vervet monkeys is influenced by the emotional saliency of the Face+Voice combination. That is, although they looked at the non-matching screen for Face+Voice combinations, they switched to looking at the matching screen when the Voice was replaced with a complex tone of equal duration. Furthermore, an analysis of pupillary responses revealed that their pupils showed greater dilation when looking at the matching natural face/voice combination versus the face/tone combination. Conclusions/Significance: Because the infant vervets in the current study exhibited cross-species intersensory matching far later in development than do human infants, our findings suggest either that intersensory perceptual narrowing does not occur in Old World monkeys or that it occurs later in development. We argue that these findings reflect the faster rate of neural development in monkeys relative to humans and the resulting differential interaction of this factor with the effects of early experience.	[Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada; [Ghazanfar, Asif A.] Princeton Univ, Neurosci Inst, Dept Psychol, Princeton, NJ 08544 USA; [Lewkowicz, David J.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA	McGill University; Princeton University; State University System of Florida; Florida Atlantic University	Zangenehpour, S (corresponding author), McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada.	shahin.zangenehpour@mcgill.ca		Lewkowicz, David/0000-0001-6685-3178	Canadian Institutes of Health Research (CIHR) [Fellowship]; W.G. Stairs Foundation; NICHD [R01 HD35849]; NSF [BCS-0751888, BCS-0547760]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035849] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); W.G. Stairs Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Canadian Institutes of Health Research (CIHR) Fellowship (to SZ), an operating grant from CIHR (to RJZ), a joint seed grant from W.G. Stairs Foundation (to SZ and RJZ), NICHD grant R01 HD35849 and NSF grant BCS-0751888 (to DJL), and an NSF BCS-0547760 CAREER award (to AAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2006, PRIMATES, V47, P350, DOI 10.1007/s10329-006-0182-z; Antinucci F., 1989, P67; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Bernstein LE, 2004, SPEECH COMMUN, V44, P5, DOI 10.1016/j.specom.2004.10.011; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; DEACON TW, 1990, AM ZOOL, V30, P629; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; GIBSON EJ, 1984, CHILD DEV, V55, P453, DOI 10.2307/1129956; Gibson K.R., 1991, BRAIN MATURATION COG, P29; Gottlieb G., 1992, INDIVIDUAL DEV EVOLU; Gould S. J., 1977, ONTOGENY PHYLOGENY; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; HAUSER MD, 1994, BRAIN LANG, V46, P232, DOI 10.1006/brln.1994.1014; HAUSER MD, 1993, ANIM BEHAV, V45, P423, DOI 10.1006/anbe.1993.1054; HAUSER MD, 1988, BEHAVIOUR, V105, P187, DOI 10.1163/156853988X00016; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Jordan KE, 2006, P NATL ACAD SCI USA, V103, P3486, DOI 10.1073/pnas.0508107103; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewkowicz DJ, 2008, BRAIN RES, V1242, P291, DOI 10.1016/j.brainres.2008.03.084; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Malkova L, 2006, EUR J NEUROSCI, V24, P3204, DOI 10.1111/j.1460-9568.2006.05175.x; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Petersen A. C., 1991, BRAIN MATURATION COG, P181; PETRINOVICH L, 1987, ANIM BEHAV, V35, P961, DOI 10.1016/S0003-3472(87)80153-7; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Schneirla T. C., 1949, PHILOS FUTURE, P243; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; TURKEWITZ G, 1982, DEV PSYCHOBIOL, V15, P357, DOI 10.1002/dev.420150408; Vatakis A, 2008, J VISION, V8, DOI 10.1167/8.9.14; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4302	10.1371/journal.pone.0004302	http://dx.doi.org/10.1371/journal.pone.0004302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JG	19172998	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483000011
J	Szargel, R; Rott, R; Eyal, A; Haskin, J; Shani, V; Balan, L; Wolosker, H; Engelender, S				Szargel, Raymonde; Rott, Ruth; Eyal, Allon; Haskin, Joseph; Shani, Vered; Balan, Livia; Wolosker, Herman; Engelender, Simone			Synphilin-1A Inhibits Seven in Absentia Homolog (SIAH) and Modulates alpha-Synuclein Monoubiquitylation and Inclusion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; UBIQUITIN-LIGASE; PROTEASOME IMPAIRMENT; MAMMALIAN HOMOLOGS; TUMOR SUPPRESSION; SINA GENE; WILD-TYPE; PROTEIN	Parkinson disease (PD) is characterized by the presence of ubiquitylated inclusions and the death of dopaminergic neurons. Seven in absentia homolog (SIAH) is a ubiquitin-ligase that ubiquitylates alpha-synuclein and synphilin-1 and is present in Lewy bodies of PD patients. Understanding the mechanisms that regulate the ubiquitylation of PD-related proteins might shed light on the events involved in the formation of Lewy bodies and death of neurons. We show in this study that the recently described synphilin-1 isoform, synphilin-1A, interacts in vitro and in vivo with the ubiquitin-protein isopeptide ligase SIAH and regulates its activity toward alpha-synuclein and synphilin-1. SIAH promotes limited ubiquitylation of synphilin-1A that does not lead to its degradation by the proteasome. SIAH also increases the formation of synphilin-1A inclusions in the presence of proteasome inhibitors, supporting the participation of ubiquitylated synphilin-1A in the formation of Lewy body-like inclusions. Synphilin-1A/SIAH inclusions recruit PD-related proteins, such as alpha-synuclein, synphilin-1, Parkin, PINK1, and UCH-L1. We found that synphilin-1A robustly increases the steady-state levels of SIAH by decreasing its auto-ubiquitylation and degradation. In addition, synphilin-1A blocks the ubiquitylation and degradation of the SIAH substrates synphilin-1 and deleted in colon cancer protein. Furthermore, synphilin-1A strongly decreases the monoubiquitylation of alpha-synuclein by SIAH and the formation of alpha-synuclein inclusions, supporting a role for monoubiquitylation in alpha-synuclein inclusion formation. Our results suggest a novel function for synphilin-1A as a regulator of SIAH activity and formation of Lewy body-like inclusions.	[Szargel, Raymonde; Rott, Ruth; Eyal, Allon; Haskin, Joseph; Shani, Vered; Engelender, Simone] Technion Israel Inst Technol, Dept Pharmacol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Balan, Livia; Wolosker, Herman] Technion Israel Inst Technol, Dept Biochem, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Engelender, S (corresponding author), Technion Israel Inst Technol, Dept Pharmacol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel.	simone@tx.technion.ac.il		Engelender, Simone/0000-0001-7401-6855; Wolosker, Herman/0000-0001-5508-9194	Israel Academy of Sciences; Ministry of Health/Ezvonot; The B. Rappaport Foundation; A.J. Berman Neurological Research Fund; Brauda Foundation; M. Rojek Memorial Fund for Lewy Body Research; Technion Research funds	Israel Academy of Sciences; Ministry of Health/Ezvonot; The B. Rappaport Foundation; A.J. Berman Neurological Research Fund; Brauda Foundation; M. Rojek Memorial Fund for Lewy Body Research; Technion Research funds	This work was supported by Israel Academy of Sciences, Ministry of Health/Ezvonot, The B. Rappaport Foundation, A.J. Berman Neurological Research Fund, Brauda Foundation Parkinson Disease Research Fund, M. Rojek Memorial Fund for Lewy Body Research, and the Technion Research funds (to S.E.).	Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Colapinto M, 2006, BIOCHEM BIOPH RES CO, V349, P1294, DOI 10.1016/j.bbrc.2006.08.163; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Eyal A, 2006, P NATL ACAD SCI USA, V103, P5917, DOI 10.1073/pnas.0509707103; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Park TJ, 2003, BIOCHEM BIOPH RES CO, V302, P671, DOI 10.1016/S0006-291X(03)00247-X; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Qian JJ, 2008, NEUROSCI LETT, V435, P142, DOI 10.1016/j.neulet.2008.02.021; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Wakabayashi K, 2002, ACTA NEUROPATHOL, V103, P209, DOI 10.1007/s004010100451; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26	50	30	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11706	11716		10.1074/jbc.M805990200	http://dx.doi.org/10.1074/jbc.M805990200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224863	Green Published, hybrid			2022-12-25	WOS:000265494500073
J	Kang, YH; Kang, MJ; Kim, JH; Lee, CH; Cho, IT; Hurwitz, J; Seo, YS				Kang, Young-Hoon; Kang, Min-Jung; Kim, Jeong-Hoon; Lee, Chul-Hwan; Cho, Il-Taeg; Hurwitz, Jerard; Seo, Yeon-Soo			The MPH1 Gene of Saccharomyces cerevisiae Functions in Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; DNA POLYMERASE-ALPHA; SINGLE-STRANDED-DNA; FLAP ENDONUCLEASE-1; HOMOLOGOUS RECOMBINATION; MUTATION AVOIDANCE; LAGGING-STRAND; YEAST DNA2; IN-VIVO; HELICASE	Saccharomyces cerevisiae MPH1 was first identified as a gene encoding a 3' to 5' DNA helicase, which when deleted leads to a mutator phenotype. In this study, we isolated MPH1 as a multicopy suppressor of the dna2K1080E helicase-negative lethal mutant. Purified Mph1 stimulated the endonuclease activities of both Fen1 and Dna2, which act faithfully in the processing of Okazaki fragments. This stimulation required neither ATP hydrolysis nor the helicase activity of Mph1. Multicopy expression of MPH1 also suppressed the temperature-sensitive growth defects in cells expressing dna2 Delta 405N, which lacks the N-terminal 405 amino acids of Dna2. However, Mph1 did not stimulate the endonuclease activity of the Dna2 Delta 405N mutant protein. The stimulation of Fen1 by Mph1 was limited to flap-structured substrates; Mph1 hardly stimulated the 5' to 3' exonuclease activity of Fen1. Mph1 binds to flap-structured substrate more efficiently than to nicked duplex structures, suggesting that the stimulatory effect of Mph1 is exerted through its binding to DNA substrates. In addition, we found that Mph1 reversed the inhibitory effects of replication protein A on Fen1 activity. Our biochemical and genetic data indicate that the in vivo suppression of Dna2 defects observed with both dna2K1080E and dna2 Delta 405N mutants occur via stimulation of Fen1 activity. These findings suggest that Mph1 plays an important, although not essential, role in processing of Okazaki fragments by facilitating the formation of ligatable nicks.	[Kang, Young-Hoon; Kang, Min-Jung; Kim, Jeong-Hoon; Lee, Chul-Hwan; Cho, Il-Taeg; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, DNA Replicat & Genome Instabil, Taejon 305701, South Korea; [Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Korea Advanced Institute of Science & Technology (KAIST); Memorial Sloan Kettering Cancer Center	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100	Ministry of Education, Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grants funded by the Ministry of Education, Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Brosh RM, 2001, EMBO J, V20, P5791; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BURGERS PMJ, 1988, NUCLEIC ACIDS RES, V16, P6297, DOI 10.1093/nar/16.14.6297; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hubscher U, 2001, MOL CELLS, V12, P149; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Maga G, 2000, J MOL BIOL, V295, P791, DOI 10.1006/jmbi.1999.3394; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; SCHELLER J, 2000, GENETICS, V11, P61; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; SHIODA M, 1982, P NATL ACAD SCI-BIOL, V79, P7209, DOI 10.1073/pnas.79.23.7209; Sommer D, 2008, NUCLEIC ACIDS RES, V36, P4699, DOI 10.1093/nar/gkn446; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	52	22	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10376	10386		10.1074/jbc.M808894200	http://dx.doi.org/10.1074/jbc.M808894200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19181670	Green Published, hybrid			2022-12-25	WOS:000265104600012
J	Ficko-Blean, E; Gregg, KJ; Adams, JJ; Hehemann, JH; Czjzek, M; Smith, SP; Boraston, AB				Ficko-Blean, Elizabeth; Gregg, Katie J.; Adams, Jarrett J.; Hehemann, Jan-Hendrik; Czjzek, Mirjam; Smith, Steven P.; Boraston, Alisdair B.			Portrait of an Enzyme, a Complete Structural Analysis of a Multimodular beta-N-Acetylglucosaminidase from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; VIBRIO-CHOLERAE NEURAMINIDASE; CARBOHYDRATE-BINDING MODULES; 84 GLYCOSIDE HYDROLASE; SMALL-ANGLE SCATTERING; MACROMOLECULAR STRUCTURES; HUMAN FIBRONECTIN; TOXIN; CRYSTALLIZATION; PATHOGENESIS	Common features of the extracellular carbohydrate-active virulence factors involved in host-pathogen interactions are their large sizes and modular complexities. This has made them recalcitrant to structural analysis, and therefore our understanding of the significance of modularity in these important proteins is lagging. Clostridium perfringens is a prevalent human pathogen that harbors a wide array of large, extracellular carbohydrate-active enzymes and is an excellent and relevant model system to approach this problem. Here we describe the complete structure of C. perfringens GH84C (NagJ), a 1001-amino acid multimodular homolog of the C. perfringens mu-toxin, which was determined using a combination of small angle x-ray scattering and x-ray crystallography. The resulting structure reveals unprecedented insight into how catalysis, carbohydrate-specific adherence, and the formation of molecular complexes with other enzymes via an ultra-tight protein-protein interaction are spatially coordinated in an enzyme involved in a host-pathogen interaction.	[Ficko-Blean, Elizabeth; Gregg, Katie J.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Adams, Jarrett J.; Smith, Steven P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Hehemann, Jan-Hendrik; Czjzek, Mirjam] Univ Paris 06, CNRS, Stn Biol Roscoff Marine Plants & Biomol, F-29682 Roscoff, France	University of Victoria; Queens University - Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Ficko-Blean, Elizabeth/N-1746-2013	Boraston, Alisdair/0000-0001-6417-0592; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Ficko-Blean, Elizabeth/0000-0002-3915-4715; Smith, Steven/0000-0003-2710-4400	Canadian Institutes of Health Research (CIHR); CNRS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by a Canadian Institutes of Health Research (CIHR) operating grant ( to A. B. B. and S. P. S.) and the CNRS ( to M. C.).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Adams JJ, 2008, P NATL ACAD SCI USA, V105, P12194, DOI 10.1073/pnas.0803154105; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bisig D, 1999, ACTA CRYSTALLOGR D, V55, P1069, DOI 10.1107/S090744499900284X; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bryant AE, 2005, J INFECT DIS, V192, P1014, DOI 10.1086/432729; CANARD B, 1994, MOL GEN GENET, V243, P215, DOI 10.1007/BF00280319; Chitayat S, 2008, J MOL BIOL, V381, P1202, DOI 10.1016/j.jmb.2008.06.050; Chitayat S, 2008, J MOL BIOL, V375, P20, DOI 10.1016/j.jmb.2007.10.031; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Figura N, 1997, J CLIN GASTROENTEROL, V25, pS149, DOI 10.1097/00004836-199700001-00025; Flores-Diaz M, 2005, J BIOL CHEM, V280, P26680, DOI 10.1074/jbc.M500278200; GALEN JE, 1992, INFECT IMMUN, V60, P406, DOI 10.1128/IAI.60.2.406-415.1992; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guinier A., 1955, SMALL ANGLE SCATTERI; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Hansen SMM, 2008, J NEUROCHEM, V106, P2030, DOI 10.1111/j.1471-4159.2008.05544.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hynes W, 2004, FRONT BIOSCI-LANDMRK, V9, P3399, DOI 10.2741/1491; Johnson S., 1997, CLOSTRIDIA MOL BIOL, P117, DOI DOI 10.1016/B978-012595020-6/50010-3; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; ROMAN A, 1993, J APPL CRYSTALLOGR, V26, P283; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Sheldon WL, 2006, BIOCHEM J, V399, P241, DOI 10.1042/BJ20060307; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Stevens DL, 2002, CLIN INFECT DIS, V35, pS93, DOI 10.1086/341928; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	57	34	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9876	9884		10.1074/jbc.M808954200	http://dx.doi.org/10.1074/jbc.M808954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193644	Green Published, hybrid			2022-12-25	WOS:000264892900029
J	Tuvim, MJ; Mospan, AR; Burns, KA; Chua, M; Mohler, PJ; Melicoff, E; Adachi, R; Ammar-Aouchiche, Z; Davis, CW; Dickey, BF				Tuvim, Michael J.; Mospan, Andrea Rossi; Burns, Kimberlie A.; Chua, Michael; Mohler, Peter J.; Melicoff, Ernestina; Adachi, Roberto; Ammar-Aouchiche, Zoulikha; Davis, C. William; Dickey, Burton F.			Synaptotagmin 2 Couples Mucin Granule Exocytosis to Ca2+ Signaling from Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY GOBLET CELLS; NEUROTRANSMITTER RELEASE; PC12 CELLS; VESICLE EXOCYTOSIS; INSULIN-SECRETION; OLIGOMERIC MUCINS; CLARA CELLS; ANKYRIN-B; MUCUS; IX	Synaptotagmin 2 (Syt2) functions as a low affinity, fast exocytic Ca2+ sensor in neurons, where it is activated by Ca2+ influx through voltage-gated channels. Targeted insertion of lacZ into the mouse syt2 locus reveals expression in mucin-secreting goblet cells of the airways. In these cells, rapid Ca2+ entry from the extracellular medium does not contribute significantly to stimulated secretion (Davis, C. W., and Dickey, B. F. (2008) Annu. Rev. Physiol. 70, 487-512). Nonetheless, Syt2(-/-) mice show a severe defect in acute agonist-stimulated airway mucin secretion, and Syt2(+/-) mice show a partial defect. In contrast to Munc13-2(-/-) mice (Zhu, Y., Ehre, C., Abdullah, L. H., Sheehan, J. K., Roy, M., Evans, C. M., Dickey, B. F., and Davis, C. W. ( 2008) J. Physiol. (Lond.) 586, 1977-1992), Syt2(-/-) mice show no spontaneous mucin accumulation, consistent with the inhibitory action of Syt2 at resting cytoplasmic Ca2+ in neurons. In human airway goblet cells, inositol trisphosphate receptors are found in rough endoplasmic reticulum that closely invests apical mucin granules, consistent with the known dependence of exocytic Ca2+ signaling on intracellular stores in these cells. Hence, Syt2 can serve as an exocytic sensor for diverse Ca2+ signaling systems, and its levels are limiting for stimulated secretory function in airway goblet cells.	[Tuvim, Michael J.; Melicoff, Ernestina; Adachi, Roberto; Ammar-Aouchiche, Zoulikha; Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Mospan, Andrea Rossi; Chua, Michael; Davis, C. William] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Mohler, Peter J.] Univ Iowa, Div Cardiol, Dept Internal Med, Iowa City, IA 52242 USA; [Burns, Kimberlie A.; Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill	Dickey, BF (corresponding author), MD Anderson Canc Ctr, Unit 1462, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bdickey@mdanderson.org		Tuvim, Michael/0000-0001-8126-7716; Adachi, Roberto/0000-0002-0146-0768; Dickey, Burton/0000-0002-4780-1847; Melicoff, Ernestina/0000-0001-5696-7112	National Institutes of Health [HL072984, HL094848, CA105352, CA016672, HL063756]; North American Cystic Fibrosis Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [U01CA105352, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094848, R01HL063756, R01HL072984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Cystic Fibrosis Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL072984, HL094848, CA105352, CA016672, and HL063756. This work was also supported by grants from the North American Cystic Fibrosis Foundation and American Heart Association.	Bahra P, 2004, BRIT J PHARMACOL, V143, P91, DOI 10.1038/sj.bjp.0705913; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Effros RM, 2005, J APPL PHYSIOL, V99, P1286, DOI 10.1152/japplphysiol.00362.2005; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Heidelberger R, 2007, NATURE, V450, P623, DOI 10.1038/450623a; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Li HG, 2008, GENESIS, V46, P300, DOI 10.1002/dvg.20396; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Perez-Vilar J, 2005, J HISTOCHEM CYTOCHEM, V53, P1305, DOI 10.1369/jhc.5B6713.2005; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Rossi AH, 2007, AM J PHYSIOL-LUNG C, V292, pL92, DOI 10.1152/ajplung.00081.2006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; WIDDICOMBE JG, 1989, EUR RESPIR J, V2, P107; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	47	43	43	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9781	9787		10.1074/jbc.M807849200	http://dx.doi.org/10.1074/jbc.M807849200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208631	Green Published, hybrid			2022-12-25	WOS:000264892900018
J	Li, SS; Shogren-Knaak, MA				Li, Shanshan; Shogren-Knaak, Michael A.			The Gcn5 Bromodomain of the SAGA Complex Facilitates Cooperative and Cross-tail Acetylation of Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL TAIL; HISTONE ACETYLTRANSFERASE; STRUCTURAL BASIS; CORE PARTICLE; RECOGNITION; COACTIVATORS; GRADIENT; PROMOTER; SIR2P; SAS2P	Bromodomains are acetyl lysine binding modules found in many complexes that regulate gene transcription. In budding yeast, the coactivator complex SAGA (Spt-Ada-Gcn5-acetyl-transferase) predominantly facilitates transcription of stress-activated genes and requires the bromodomain of the Gcn5 subunit for full activation of a number of these genes. This bromodomain has previously been shown to promote retention of the complex to H3 and H4 acetylated nucleosomes. Because the SAGA complex mediates histone H3 acetylation, we sought to determine to what extent the Gcn5 bromodomain directly modulates histone acetylation activity. Kinetic analysis of SAGA-mediated acetylation of nucleosomal substrates reveals that this bromodomain: 1) is required for the cooperative acetylation of nucleosomes, 2) enhances acetylation of an H3 histone tail when the other H3 tail within a nucleosome is already acetylated, and 3) augments the acetylation turnover of nucleosomes previously acetylated at lysine 16 of the histone H4 tails. These results indicate that the Gcn5 bromodomain promotes the establishment of nucleosome acetylation through multiple mechanisms and more generally show how chromatin recognition domains can modulate the enzymatic activity of chromatin modifying complexes.	[Li, Shanshan; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu	Georgieva, Elena/C-2588-2012; Li, Shanshan/F-5607-2013; Li, Shanshan/AAF-4758-2020	Li, Shanshan/0000-0002-0359-2369; Li, Shanshan/0000-0002-6424-2792	National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M. S. K.).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Boukaba A, 2004, J BIOL CHEM, V279, P7678, DOI 10.1074/jbc.M310849200; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Fry CJ, 2004, COLD SPRING HARB SYM, V69, P219, DOI 10.1101/sqb.2004.69.219; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	33	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9411	9417		10.1074/jbc.M809617200	http://dx.doi.org/10.1074/jbc.M809617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218239	Green Published, hybrid			2022-12-25	WOS:000264669100047
J	Pelzmann, A; Ferner, M; Gnida, M; Meyer-Klaucke, W; Maisel, T; Meyer, O				Pelzmann, Astrid; Ferner, Marion; Gnida, Manuel; Meyer-Klaucke, Wolfram; Maisel, Tobias; Meyer, Ortwin			The CoxD Protein of Oligotropha carboxidovorans Is a Predicted AAA plus ATPase Chaperone Involved in the Biogenesis of the CO Dehydrogenase [CuSMoO2] Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; IRON-MOLYBDENUM COFACTOR; RHODOBACTER-CAPSULATUS; MAGNESIUM CHELATASE; XANTHINE DEHYDROGENASE; PSEUDOMONAS-CARBOXYDOVORANS; MOLECULAR CHARACTERIZATION; MEGAPLASMID PHCG3; ESCHERICHIA-COLI; GENE-CLUSTER	CO dehydrogenase from the Gram-negative chemolithoautotrophic eubacterium Oligotropha carboxidovorans OM5 is a structurally characterized molybdenum-containing iron-sulfur flavoenzyme, which catalyzes the oxidation of CO (CO + H2O&RARR(3)CO(2) -> 2e(-) + 2H(+)). It accommodates in its active site a unique bimetallic [CuSMoO2] cluster, which is subject to post-translational maturation. Insertional mutagenesis of coxD has established its requirement for the assembly of the [CuSMoO2] cluster. Disruption of coxD led to a phenotype of the corresponding mutant OM5D::km with the following characteristics: (i) It was impaired in the utilization of CO, whereas the utilization of H-2 plus CO2 was not affected; (ii) Under appropriate induction conditions bacteria synthesized a fully assembled apo-CO dehydrogenase, which could not oxidize CO; (iii) Apo-CO dehydrogenase contained a [MoO3] site in place of the [CuSMoO2] cluster; and (iv) Employing sodium sulfide first and then the Cu(I)-(thiourea)(3) complex, the non-catalytic [MoO3] site could be reconstituted in vitro to a [CuSMoO2] cluster capable of oxidizing CO. Sequence information suggests that CoxD is a MoxR-like AAA + ATPase chaperone related to the hexameric, ring-shaped BchI component of Mg2+-chelatases. Recombinant CoxD, which appeared in Escherichia coli in inclusion bodies, occurs exclusively in cytoplasmic membranes of O. carboxidovorans grown in the presence of CO, and its occurrence coincided with GTPase activity upon sucrose density gradient centrifugation of cell extracts. The presumed function of CoxD is the partial unfolding of apo-CO dehydrogenase to assist in the stepwise introduction of sulfur and copper in the [MoO3] center of the enzyme.	[Pelzmann, Astrid; Ferner, Marion; Maisel, Tobias; Meyer, Ortwin] Univ Bayreuth, Chair Microbiol, D-95440 Bayreuth, Germany; [Gnida, Manuel; Meyer-Klaucke, Wolfram] Outstn Hamburg Deutsch Elekt Synchroton, European Mol Biol Lab, D-22603 Hamburg, Germany	University of Bayreuth; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Meyer, O (corresponding author), Univ Bayreuth, Chair Microbiol, Univ Str 30, D-95440 Bayreuth, Germany.	Ortwin.Meyer@uni-bayreuth.de	Meyer-Klaucke, Wolfram/G-1148-2010					ARPS PJ, 1987, J BACTERIOL, V169, P1061, DOI 10.1128/jb.169.3.1061-1070.1987; AULING G, 1988, SYST APPL MICROBIOL, V10, P264, DOI 10.1016/S0723-2020(88)80011-0; BEISENHERZ G, 1953, Z NATURFORSCH B, V8, P555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDENAS J, 1974, ANAL BIOCHEM, V60, P372, DOI 10.1016/0003-2697(74)90244-9; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Gremer L, 2000, J BIOL CHEM, V275, P1864, DOI 10.1074/jbc.275.3.1864; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; JOHNSON JL, 1990, ARCH BIOCHEM BIOPHYS, V283, P542, DOI 10.1016/0003-9861(90)90681-N; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; Luo MZ, 1999, PLANT MOL BIOL, V41, P721, DOI 10.1023/A:1006335317876; MEYER O, 1984, J BIOL CHEM, V259, P5612; MEYER O, 1993, SYST APPL MICROBIOL, V16, P390, DOI 10.1016/S0723-2020(11)80271-7; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; MEYER O, 1990, FEMS MICROBIOL LETT, V87, P253, DOI 10.1016/0378-1097(90)90463-Z; Meyer OO, 2005, BERGEYS MANUAL SYSTE, V2, P468; Meyer Ortwin, 1993, P433; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SANTIAGO B, 1997, J BACTERIOL, V197, P6053; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; SIMON R, 1983, BIOTECHNOLOGY, V1, P7784; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019	41	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9578	9586		10.1074/jbc.M805354200	http://dx.doi.org/10.1074/jbc.M805354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189964	Green Published, hybrid			2022-12-25	WOS:000264669100064
J	Terrenoire, C; Houslay, MD; Baillie, GS; Kass, RS				Terrenoire, Cecile; Houslay, Miles D.; Baillie, George S.; Kass, Robert S.			The Cardiac I-Ks Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-SPECIFIC PHOSPHODIESTERASE; SIGNALING SCAFFOLD PROTEINS; RAT VENTRICULAR MYOCYTES; LONG-QT SYNDROME; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTORS; ATRIAL-FIBRILLATION; PKA PHOSPHORYLATION; RYANODINE-RECEPTOR	The cardiac I-Ks potassium channel is a macromolecular complex consisting of alpha-(KCNQ1) and beta-subunits (KCNE1) and the A kinase-anchoring protein (AKAP) Yotiao (AKAP-9), which recruits protein kinase A) and protein phosphatase 1 to the channel. Here, we have tested the hypothesis that specific cAMP phosphodiesterase (PDE) isoforms of the PDE4D family that are expressed in the heart are also part of the I-Ks signaling complex and contribute to its regulation by cAMP. PDE4D isoforms co-immunoprecipitated with I-Ks channels in hearts of mice expressing the I-Ks channel. In myocytes isolated from these mice, I-Ks was increased by pharmacological PDE inhibition. PDE4D3, but not PDE4D5, co-immunoprecipitated with the I-Ks channel only in Chinese hamster ovary cells co-expressing AKAP-9, and PDE4D3, but not PDE4D5, co-immunoprecipitated with AKAP-9. Functional experiments in Chinese hamster ovary cells expressing AKAP-9 and either PDE4D3 or PDE4D5 isoforms revealed modulation of the I-Ks response to cAMP by PDE4D3 but not PDE4D5. We conclude that PDE4D3, like protein kinase A and protein phosphatase 1, is recruited to the I-Ks channel via AKAP-9 and contributes to its critical regulation by cAMP.	[Terrenoire, Cecile; Kass, Robert S.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Houslay, Miles D.; Baillie, George S.] Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Columbia University; University of Glasgow	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091	National Institutes of Health [5R01HL044365-16]; Medical Research Council [G0600765]; European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL044365-16 from the NHLBI (to R. S. K.). This work was also supported by Medical Research Council (U.K.) Grant G0600765 (to M. D. H. and G. S. B.), European Union Grant LSHB-CT-2006-037189 (M. D. H.), and Fondation Leducq Grant 06CVD02 (M. D. H. and G. S. B.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BETHKE T, 1992, BRIT J PHARMACOL, V107, P127, DOI 10.1111/j.1476-5381.1992.tb14474.x; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 1997, BIOCHEM J, V328, P539; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Kajimoto K, 1997, BRIT J PHARMACOL, V121, P1549, DOI 10.1038/sj.bjp.0701297; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; KASS RS, 1982, J PHYSIOL-LONDON, V322, P541, DOI 10.1113/jphysiol.1982.sp014054; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; REEVES ML, 1987, BIOCHEM J, V241, P535, DOI 10.1042/bj2410535; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Sampson KJ, 2008, J PHYSIOL-LONDON, V586, P627, DOI 10.1113/jphysiol.2007.141333; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858	53	99	106	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9140	9146		10.1074/jbc.M805366200	http://dx.doi.org/10.1074/jbc.M805366200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218243	Green Published, hybrid			2022-12-25	WOS:000264669100018
J	Luo, L; Luo, JZQ; Xiong, F; Abedi, M; Greer, D				Luo, LuGuang; Luo, John Z. Q.; Xiong, Fang; Abedi, Mehrdad; Greer, Deborah			Cytokines Inducing Bone Marrow SCA(+) Cells Migration into Pancreatic Islet and Conversion into Insulin-Positive Cells In Vivo	PLOS ONE			English	Article								We hypothesize that specific bone marrow lineages and cytokine treatment may facilitate bone marrow migration into islets, leading to a conversion into insulin producing cells in vivo. In this study we focused on identifying which bone marrow subpopulations and cytokine treatments play a role in bone marrow supporting islet function in vivo by evaluating whether bone marrow is capable of migrating into islets as well as converting into insulin positive cells. We approached this aim by utilizing several bone marrow lineages and cytokine-treated bone marrow from green fluorescent protein (GFP) positive bone marrow donors. Sorted lineages of Mac-1(+), Mac-1(-), Sca(+), Sca(-), Sca(-)/Mac-1(+) and Sca(+)/Mac-1(-) from GFP positive mice were transplanted to irradiated C57BL6 GFP negative mice. Bone marrow from transgenic human ubiquitin C promoter GFP (uGFP, with strong signal) C57BL6 mice was transplanted into GFP negative C57BL6 recipients. After eight weeks, migration of GFP positive donor' bone marrow to the recipient's pancreatic islets was evaluated as the percentage of positive GFP islets/total islets. The results show that the most effective migration comes from the Sca(+)/Mac(-) lineage and these cells, treated with cytokines for 48 hours, were found to have converted into insulin positive cells in pancreatic islets in vivo. This study suggests that bone marrow lineage positive cells and cytokine treatments are critical factors in determining whether bone marrow is able to migrate and form insulin producing cells in vivo. The mechanisms causing this facilitation as well as bone marrow converting to pancreatic beta cells still need to be investigated.			Luo, L (corresponding author), Roger Williams Gen Hosp, Ctr Stem Cell Biol, Providence, RI 02908 USA.	Lluo@rwmc.org	Abedi, Mehrdad/ABC-3565-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER; NCRR NIH HHS [2P20RR018757-06, P20 RR018757] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ai CW, 2007, STEM CELLS DEV, V16, P757, DOI 10.1089/scd.2007.0038; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Banerjee M, 2005, BIOCHEM BIOPH RES CO, V328, P318, DOI 10.1016/j.bbrc.2004.12.176; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Kang EM, 2005, EXP HEMATOL, V33, P699, DOI 10.1016/j.exphem.2005.03.008; Lavazais E, 2007, DIABETES METAB, V33, P68, DOI 10.1016/j.diabet.2006.11.002; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Naselli G, 2001, Int J Exp Diabetes Res, V1, P239; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Zanone MM, 2007, FASEB J, V21, P3308, DOI 10.1096/fj.06-7905com; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955	21	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4504	10.1371/journal.pone.0004504	http://dx.doi.org/10.1371/journal.pone.0004504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225560	gold, Green Published, Green Submitted			2022-12-25	WOS:000265486000002
J	Lee, DY; Shatseva, T; Jeyapalan, Z; Du, WW; Deng, ZQ; Yang, BB				Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Deng, Zhaoqun; Yang, Burton B.			A 3 '-Untranslated Region (3 ' UTR) Induces Organ Adhesion by Regulating miR-199a*Functions	PLOS ONE			English	Article								Mature microRNAs ( miRNAs) are single-stranded RNAs of 18-24 nucleotides that repress post-transcriptional gene expression. However, it is unknown whether the functions of mature miRNAs can be regulated. Here we report that expression of versican 3'UTR induces organ adhesion in transgenic mice by modulating miR-199a* activities. The study was initiated by the hypothesis that the non-coding 3'UTR plays a role in the regulation of miRNA function. Transgenic mice expressing a construct harboring the 3'UTR of versican exhibits the adhesion of organs. Computational analysis indicated that a large number of microRNAs could bind to this fragment potentially including miR-199a*. Expression of versican and fibronectin, two targets of miR-199a*, are up-regulated in transgenic mice, suggesting that the 3'UTR binds and modulates miR-199a* activities, freeing mRNAs of versican and fibronectin from being repressed by miR-199a*. Confirmation of the binding was performed by PCR using mature miR-199a* as a primer and the targeting was performed by luciferase assays. Enhanced adhesion by expression of the 3'UTR was confirmed by in vitro assays. Our results demonstrated that upon arrival in cytoplasm, miRNA activities can be modulated locally by the 3'UTR. Our assay may be developed as sophisticated approaches for studying the mutual regulation of miRNAs and mRNAs in vitro and in vivo. We anticipate that expression of the 3'UTR may be an approach in the development of gene therapy.	[Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Deng, Zhaoqun; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Deng, Zhaoqun; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Lee, DY (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			Heart and Stroke Foundation of Ontario [NA 6282, CI 5958]; National Sciences and Engineering Research Council of Canada [227937-01];  [Canada Graduate Scholarship]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); 	This work was supported by grants from Heart and Stroke Foundation of Ontario (NA 6282) and National Sciences and Engineering Research Council of Canada (227937-01) to BBY who is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario. DYL is the recipient of a Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ruvkun G, 2006, SCIENCE, V311, P36; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2007, J CELL PHYSIOL, V211, P213, DOI 10.1002/jcp.20921; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zheng PS, 2006, J BIOL CHEM, V281, P8175, DOI 10.1074/jbc.M509182200; Zheng PS, 2004, J CELL SCI, V117, P5887, DOI 10.1242/jcs.01516; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	66	92	93	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4527	10.1371/journal.pone.0004527	http://dx.doi.org/10.1371/journal.pone.0004527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223980	gold, Green Submitted, Green Published			2022-12-25	WOS:000265485800018
J	Yang, SZ; Wang, K; Gregory, B; Berrettini, W; Wang, LS; Hakonarson, H; Bucan, M				Yang, Shuzhang; Wang, Kai; Gregory, Brittany; Berrettini, Wade; Wang, Li-San; Hakonarson, Hakon; Bucan, Maja			Genomic Landscape of a Three-Generation Pedigree Segregating Affective Disorder	PLOS ONE			English	Article							COPY-NUMBER VARIATION; BIPOLAR AFFECTIVE-DISORDER; STRUCTURAL VARIATION; WIDE ASSOCIATION; GENE; AMISH; LOCI; RESOLUTION; MUTATIONS; VARIANTS	Bipolar disorder (BPD) is a common psychiatric illness with a complex mode of inheritance. Besides traditional linkage and association studies, which require large sample sizes, analysis of common and rare chromosomal copy number variants (CNVs) in extended families may provide novel insights into the genetic susceptibility of complex disorders. Using the Illumina HumanHap550 BeadChip with over 550,000 SNP markers, we genotyped 46 individuals in a three-generation Old Order Amish pedigree with 19 affected (16 BPD and three major depression) and 27 unaffected subjects. Using the PennCNV algorithm, we identified 50 CNV regions that ranged in size from 12 to 885 kb and encompassed at least 10 single nucleotide polymorphisms (SNPs). Of 19 well characterized CNV regions that were available for combined genotype-expression analysis 11 (58%) were associated with expression changes of genes within, partially within or near these CNV regions in fibroblasts or lymphoblastoid cell lines at a nominal P value <0.05. To further investigate the mode of inheritance of CNVs in the large pedigree, we analyzed a set of four CNVs, located at 6q27, 9q21.11, 12p13.31 and 15q11, all of which were enriched in subjects with affective disorders. We additionally show that these variants affect the expression of neuronal genes within or near the rearrangement. Our analysis suggests that family based studies of the combined effect of common and rare CNVs at many loci may represent a useful approach in the genetic analysis of disease susceptibility of mental disorders.	[Yang, Shuzhang; Wang, Kai; Gregory, Brittany; Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Berrettini, Wade] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Bucan, Maja] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Yang, SZ (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; bucan@pobox.upenn.edu			NIH [R01MH604687, R21 MH078179]; NARSAD Distinguished Investigator Award; Penn Genomics Frontiers Institute; Cotswold Foundation [Research Development Award]; Center for Applied Genomics from the Children's Hospital of Philadelphia [Institutional Development Award]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH078179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Distinguished Investigator Award(NARSAD); Penn Genomics Frontiers Institute; Cotswold Foundation; Center for Applied Genomics from the Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by NIH grants R01MH604687, R21 MH078179 and NARSAD Distinguished Investigator Award (M.B.), by Penn Genomics Frontiers Institute (LSW); by Research Development Award from the Cotswold Foundation (H.H.). The genotyping was funded by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; BUCAN M, 2008, GENOMIC LANDSC UNPUB; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DISKIN S, 2008, NUCL ACIDS IN PRESS; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EGELAND JA, 1983, AM J PSYCHIAT, V140, P56; FERREIRA MA, 2008, NAT GENET; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Francomano CA, 2003, AM J MED GENET C, V121C, P1, DOI 10.1002/ajmg.c.20001; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; HOSTETTER AM, 1983, AM J PSYCHIAT, V140, P62; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; IONITALAZA I, 2008, GENOMICS; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SERRETTI A, 2008, MOL PSYCHIAT; Shaw JA, 2005, J AM ACAD CHILD PSY, V44, P1104, DOI 10.1097/01.chi.0000177052.26476.e5; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; STEFANSSON H, 2008, NATURE; STONE JL, 2008, NATURE; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang S, 2007, GENES BRAIN BEHAV, V6, P77, DOI 10.1111/j.1601-183X.2006.00235.x; YANG S, 2008, MOL PSYCHIAT	47	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4474	10.1371/journal.pone.0004474	http://dx.doi.org/10.1371/journal.pone.0004474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214233	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484300011
J	Ciarrocchi, A; D'Angelo, R; Cordiglieri, C; Rispoli, A; Santi, S; Riccio, M; Carone, S; Mancia, AL; Paci, S; Cipollini, E; Ambrosetti, D; Melli, M				Ciarrocchi, Alessia; D'Angelo, Romina; Cordiglieri, Chiara; Rispoli, Ada; Santi, Spartaco; Riccio, Massimo; Carone, Simona; Mancia, Anna Laura; Paci, Simone; Cipollini, Elena; Ambrosetti, Davide; Melli, Marialuisa			Tollip Is a Mediator of Protein Sumoylation	PLOS ONE			English	Article								Tollip is an interactor of the interleukin-1 receptor involved in its activation. The endosomal turnover of ubiquitylated IL-1RI is also controlled by Tollip. Furthermore, together with Tom1, Tollip has a general role in endosomal protein traffic. This work shows that Tollip is involved in the sumoylation process. Using the yeast two-hybrid technique, we have isolated new Tollip partners including two sumoylation enzymes, SUMO-1 and the transcriptional repressor Daxx. The interactions were confirmed by GST-pull down experiments and immunoprecipitation of the co-expressed recombinants. More specifically, we show that the TIR domain of the cytoplasmic region of IL-1RI is a sumoylation target of Tollip. The sumoylated and unsumoylated RanGAP-1 protein also interacts with Tollip, suggesting a possible role in RanGAP-1 modification and nuclear-cytoplasmic protein translocation. In fact, Tollip is found in the nuclear bodies of SAOS-2/IL-1RI cells where it colocalizes with SUMO-1 and the Daxx repressor. We conclude that Tollip is involved in the control of both nuclear and cytoplasmic protein traffic, through two different and often contrasting processes: ubiquitylation and sumoylation.	[Ciarrocchi, Alessia; D'Angelo, Romina; Cordiglieri, Chiara; Rispoli, Ada; Carone, Simona; Mancia, Anna Laura; Paci, Simone; Cipollini, Elena; Ambrosetti, Davide; Melli, Marialuisa] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Santi, Spartaco; Riccio, Massimo] CNR, ITOI, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR)	Ciarrocchi, A (corresponding author), Arcispedale Santa Maria Nuova, Mol Biol Lab, Reggio Emilia, Italy.	marialuisa.melli@unibo.it	Ciarrocchi, Alessia/AAA-1130-2019; Cordiglieri, Chiara/AAX-1638-2021; Cordiglieri, Chiara/K-2041-2016; mancia, annalaura/F-9706-2013; Santi, Spartaco/Q-7587-2016	Ciarrocchi, Alessia/0000-0002-5541-2075; Cordiglieri, Chiara/0000-0002-2013-0043; Cordiglieri, Chiara/0000-0002-2013-0043; mancia, annalaura/0000-0001-8680-3530; Santi, Spartaco/0000-0001-9856-7053	Telethon [GGP030248]; Italian Ministry of Technology and Scientific Research; FIRB Neuroscienze [RBNE01WY7P]	Telethon(Fondazione Telethon); Italian Ministry of Technology and Scientific Research; FIRB Neuroscienze	This work was supported by Telethon grant GGP030248, partly by a grant from the Italian Ministry of Technology and Scientific Research and by a grant from FIRB Neuroscienze RBNE01WY7P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; DEDHAR S, 1989, EXP CELL RES, V183, P207, DOI 10.1016/0014-4827(89)90430-8; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; EDMONDS M, 1971, P NATL ACAD SCI USA, V6, P1336; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; RODAN SB, 1990, J IMMUNOL, V145, P1231; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; van den Akker E, 2005, J BIOL CHEM, V280, P38035, DOI 10.1074/jbc.M502938200; Yamakami M, 2004, BIOL PHARM BULL, V27, P564, DOI 10.1248/bpb.27.564; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	28	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4404	10.1371/journal.pone.0004404	http://dx.doi.org/10.1371/journal.pone.0004404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198660	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483900009
J	Esue, O; Tseng, Y; Wirtz, D				Esue, Osigwe; Tseng, Yiider; Wirtz, Denis			alpha-Actinin and Filamin Cooperatively Enhance the Stiffness of Actin Filament Networks	PLOS ONE			English	Article								Background: The close subcellular proximity of different actin filament crosslinking proteins suggests that these proteins may cooperate to organize F-actin structures to drive complex cellular functions during cell adhesion, motility and division. Here we hypothesize that alpha-actinin and filamin, two major F-actin crosslinking proteins that are both present in the lamella of adherent cells, display synergistic mechanical functions. Methodology/Principal Findings: Using quantitative rheology, we find that combining alpha-actinin and filamin is much more effective at producing elastic, solid-like actin filament networks than alpha-actinin and filamin separately. Moreover, F-actin networks assembled in the presence of alpha-actinin and filamin strain-harden more readily than networks in the presence of either a-actinin or filamin. Significance: These results suggest that cells combine auxiliary proteins with similar ability to crosslink filaments to generate stiff cytoskeletal structures, which are required for the production of internal propulsive forces for cell migration, and that these proteins do not have redundant mechanical functions.	[Esue, Osigwe; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Esue, Osigwe] Genentech Inc, Dept Early Stage Pharm Dev, San Francisco, CA USA; [Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	Johns Hopkins University; Roche Holding; Genentech; State University System of Florida; University of Florida	Esue, O (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Wirtz, Denis/A-3257-2010		NIH [GM084204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the NIH grant GM084204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH RJ, 1983, J CELL BIOL, V97, P217, DOI 10.1083/jcb.97.1.217; Critchley David R., 1993, P22; Doi M., 1989, THEORY POLYM DYNAMIC; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; GOLDMANN WH, 1993, FEBS LETT, V336, P408, DOI 10.1016/0014-5793(93)80847-N; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; LANGANGER G, 1984, J CELL BIOL, V99, P1324, DOI 10.1083/jcb.99.4.1324; LEBART MC, 1993, J BIOL CHEM, V268, P5642; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095; SHADIACK AM, 1991, J NEUROBIOL, V22, P617, DOI 10.1002/neu.480220607; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tilney LG, 2000, J CELL BIOL, V148, P87, DOI 10.1083/jcb.148.1.87; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2002, J BIOL CHEM, V277, P25609, DOI 10.1074/jbc.M202609200; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; ZEECE MG, 1979, BIOCHIM BIOPHYS ACTA, V581, P365, DOI 10.1016/0005-2795(79)90258-7	29	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4411	10.1371/journal.pone.0004411	http://dx.doi.org/10.1371/journal.pone.0004411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198659	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483900012
J	De Lisle, RC; Meldi, L; Roach, E; Flynn, M; Sewell, R				De Lisle, Robert C.; Meldi, Lauren; Roach, Eileen; Flynn, Maureen; Sewell, Racquel			Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse	PLOS ONE			English	Article								Background: Cystic fibrosis (CF) has many effects on the gastrointestinal tract and a common problem in this disease is poor nutrition. In the CF mouse there is an innate immune response with a large influx of mast cells into the muscularis externa of the small intestine and gastrointestinal dysmotility. The aim of this study was to evaluate the potential role of mast cells in gastrointestinal dysmotility using the CF mouse (Cftr(tm1UNC), Cftr knockout). Methodology: Wild type (WT) and CF mice were treated for 3 weeks with mast cell stabilizing drugs (ketotifen, cromolyn, doxantrazole) or were treated acutely with a mast cell activator (compound 48/80). Gastrointestinal transit was measured using gavage of a fluorescent tracer. Results: In CF mice gastric emptying at 20 min post-gavage did not differ from WT, but was significantly less than in WT at 90 min post-gavage. Gastric emptying was significantly increased in WT mice by doxantrazole, but none of the mast cell stabilizers had any significant effect on gastric emptying in CF mice. Mast cell activation significantly enhanced gastric emptying in WT mice but not in CF mice. Small intestinal transit was significantly less in CF mice as compared to WT. Of the mast cell stabilizers, only doxantrazole significantly affected small intestinal transit in WT mice and none had any effect in CF mice. Mast cell activation resulted in a small but significant increase in small intestinal transit in CF mice but not WT mice. Conclusions: The results indicate that mast cells are not involved in gastrointestinal dysmotility but their activation can stimulate small intestinal transit in cystic fibrosis.	[De Lisle, Robert C.; Meldi, Lauren; Roach, Eileen; Flynn, Maureen; Sewell, Racquel] Univ Kansas, Sch Med, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center	De Lisle, RC (corresponding author), Univ Kansas, Sch Med, Kansas City, KS USA.	rdelisle@kumc.edu			Cystic Fibrosis Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation to RCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALI A, 1983, BRIT MED J, V287, P1011, DOI 10.1136/bmj.287.6398.1011; Barbara G, 2006, NEUROGASTROENT MOTIL, V18, P6, DOI 10.1111/j.1365-2982.2005.00685.x; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Brown JF, 1998, BRIT J PHARMACOL, V123, P31, DOI 10.1038/sj.bjp.0701576; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Dalzell A M, 1990, Acta Univ Carol Med (Praha), V36, P159; DALZELL AM, 1990, ARCH DIS CHILD, V65, P585, DOI 10.1136/adc.65.6.585; De Lisle RC, 2001, AM J PHYSIOL-GASTR L, V281, pG899, DOI 10.1152/ajpgi.2001.281.4.G899; De Lisle RC, 2007, AM J PHYSIOL-GASTR L, V293, pG577, DOI 10.1152/ajpgi.00195.2007; De Lisle RC, 2007, AM J PHYSIOL-GASTR L, V293, pG104, DOI 10.1152/ajpgi.00548.2006; De Schepper HU, 2008, ALIMENT PHARM THER, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; ESCOBAR H, 1992, J PEDIATR GASTR NUTR, V14, P204, DOI 10.1097/00005176-199202000-00015; FARGEAS MJ, 1992, GASTROENTEROLOGY, V102, P157, DOI 10.1016/0016-5085(92)91795-6; Fridge JL, 2007, J PEDIATR GASTR NUTR, V44, P212, DOI 10.1097/MPG.0b013e31802c0ceb; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; GOLDHILL JM, 1995, J PHARMACOL EXP THER, V274, P72; Gregory PC, 1996, J PEDIATR GASTR NUTR, V23, P513, DOI 10.1097/00005176-199612000-00001; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Kalia N, 2000, J GASTROEN HEPATOL, V15, P133, DOI 10.1046/j.1440-1746.2000.02064.x; Knight PA, 2007, AM J PATHOL, V171, P1237, DOI 10.2353/ajpath.2007.061245; Lewindon PJ, 1998, J PAEDIATR CHILD H, V34, P79, DOI 10.1046/j.1440-1754.1998.00159.x; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MURPHY MS, 1992, DIGEST DIS SCI, V37, P187, DOI 10.1007/BF01308170; Norkina O, 2004, INFECT IMMUN, V72, P6040, DOI 10.1128/IAI.72.10.6040-6049.2004; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; SAND E, 2008, NEUROPHARMACOLOGY; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; SCOTT RB, 1993, DIGEST DIS SCI, V38, P396, DOI 10.1007/BF01316490; Scudamore CL, 1997, AM J PATHOL, V150, P1661; Serna H, 2006, J PHARMACOL EXP THER, V319, P1104, DOI 10.1124/jpet.106.104620; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Steiner DRS, 2003, J APPL PHYSIOL, V94, P325, DOI 10.1152/japplphysiol.00637.2002; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Van Nassauw L, 2007, AUTON NEUROSCI-BASIC, V133, P91, DOI 10.1016/j.autneu.2006.10.003; Wang XY, 2007, NEUROGASTROENT MOTIL, V19, P349, DOI 10.1111/j.1365-2982.2006.00894.x; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wood JD, 2007, J CLIN GASTROENTEROL, V41, pS7, DOI 10.1097/MCG.0b013e31802f1331	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4283	10.1371/journal.pone.0004283	http://dx.doi.org/10.1371/journal.pone.0004283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172182	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482900004
J	Shen, H; Kuo, CC; Chou, J; Delvolve, A; Jackson, SN; Post, J; Woods, AS; Hoffer, BJ; Wang, Y; Harvey, BK				Shen, Hui; Kuo, Chi-Chung; Chou, Jenny; Delvolve, Alice; Jackson, Shelley N.; Post, Jeremy; Woods, Amina S.; Hoffer, Barry J.; Wang, Yun; Harvey, Brandon K.			Astaxanthin reduces ischemic brain injury in adult rats	FASEB JOURNAL			English	Article						antioxidant; stroke; neuroprotection; apoptosis; glutamate	FOCAL CEREBRAL-ISCHEMIA; ALGA HAEMATOCOCCUS-PLUVIALIS; PENAEUS-MONODON FABRICIUS; NIVALIS BAUER WILLE; OXIDATIVE STRESS; RAINBOW-TROUT; DIETARY SUPPLEMENTATION; SYNTHETIC ASTAXANTHIN; ANTIOXIDANT ACTIVITY; ONCORHYNCHUS-MYKISS	Astaxanthin (ATX) is a dietary carotenoid of crustaceans and fish that contributes to their coloration. Dietary ATX is important for development and survival of salmonids and crustaceans and has been shown to reduce cardiac ischemic injury in rodents. The purpose of this study was to examine whether ATX can protect against ischemic injury in the mammalian brain. Adult rats were injected intracerebroventricularly with ATX or vehicle prior to a 60-min middle cerebral artery occlusion (MCAo). ATX was present in the infarction area at 70-75 min after onset of MCAo. Treatment with ATX, compared to vehicle, increased locomotor activity in stroke rats and reduced cerebral infarction at 2 d after MCAo. To evaluate the protective mechanisms of ATX against stroke, brain tissues were assayed for free radical damage, apoptosis, and excitoxicity. ATX antagonized ischemia-mediated loss of aconitase activity and reduced glutamate release, lipid peroxidation, translocation of cytochrome c, and TUNEL labeling in the ischemic cortex. ATX did not alter physiological parameters, such as body temperature, brain temperature, cerebral blood flow, blood gases, blood pressure, and pH. Collectively, our data suggest that ATX can reduce ischemia-related injury in brain tissue through the inhibition of oxidative stress, reduction of glutamate release, and antiapoptosis. ATX may be clinically useful for patients vulnerable or prone to ischemic events.-Shen, H., Kuo, C.-C., Chou, J., Delvolve, A., Jackson, S. N., Post, J., Woods, A. S., Hoffer, B. J., Wang, Y., Harvey, B. K. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 23, 1958-1968 (2009)	[Shen, Hui; Kuo, Chi-Chung; Chou, Jenny; Delvolve, Alice; Jackson, Shelley N.; Post, Jeremy; Woods, Amina S.; Hoffer, Barry J.; Wang, Yun; Harvey, Brandon K.] NIDA, NIH, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Harvey, BK (corresponding author), NIDA, NIH, Intramural Res Program, Ste 200,Rm 06A729,251 Bayview Blvd, Baltimore, MD 21224 USA.	bharvey@intra.nida.nih.gov	Harvey, Brandon Keith/AAY-4080-2021	Harvey, Brandon Keith/0000-0002-4036-1383	Intramural Research Program at the National Institute on Drug Abuse (USA); NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000461, ZIADA000443, Z01DA000461] Funding Source: NIH RePORTER	Intramural Research Program at the National Institute on Drug Abuse (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Intramural Research Program at the National Institute on Drug Abuse (USA). We thank Mr. Douglas Howard and Dr. Guann-Juh Chen for their technical assistance, Dr. Michael Tlusty for his photograph of the lobsters and his input on ATX in crustaceans, and Dr. Marc Halterman for his review and comments on the manuscript.	Amar EC, 2001, AQUAC RES, V32, P162, DOI 10.1046/j.1355-557x.2001.00051.x; Aoi W, 2003, ANTIOXID REDOX SIGN, V5, P139, DOI 10.1089/152308603321223630; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; Bell JG, 2000, J NUTR, V130, P1800, DOI 10.1093/jn/130.7.1800; Bertram JS, 2005, BBA-MOL BASIS DIS, V1740, P170, DOI 10.1016/j.bbadis.2005.01.003; CAMERA E, 2009, EXP DERMATOL    0918; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Chaumont D, 1995, J APPL PHYCOL, V7, P529, DOI 10.1007/BF00003939; Chen GJ, 2006, J NEUROSCI RES, V84, P1848, DOI 10.1002/jnr.21071; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chien YH, 2005, J EXP MAR BIOL ECOL, V318, P201, DOI 10.1016/j.jembe.2004.12.016; Chien YH, 2003, AQUACULTURE, V216, P177, DOI 10.1016/S0044-8486(02)00056-X; Clark WM, 2001, STROKE, V32, P1000, DOI 10.1161/01.STR.32.4.1000; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Flores M, 2007, AQUAC RES, V38, P740, DOI 10.1111/j.1365-2109.2007.01720.x; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gorton HL, 2003, PHOTOCHEM PHOTOBIOL, V77, P608, DOI 10.1562/0031-8655(2003)077<0608:URATSA>2.0.CO;2; Gorton HL, 2001, PHOTOCHEM PHOTOBIOL, V73, P611, DOI 10.1562/0031-8655(2001)073<0611:TLEACO>2.0.CO;2; Gross GJ, 2005, MOL CELL BIOCHEM, V272, P221, DOI 10.1007/s11010-005-7555-2; Gross GJ, 2004, LIFE SCI, V75, P215, DOI 10.1016/j.lfs.2003.12.006; Harvey BK, 2004, NEUROSCI LETT, V369, P138, DOI 10.1016/j.neulet.2004.07.086; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Hirvonen T, 2000, STROKE, V31, P2301, DOI 10.1161/01.STR.31.10.2301; Hsiao G, 2004, IN VIVO, V18, P351; Hurtado O, 2003, FASEB J, V17, P2082, DOI 10.1096/fj.02-1086fje; Hussein G, 2005, BIOL PHARM BULL, V28, P47, DOI 10.1248/bpb.28.47; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Jackson SN, 2007, J MASS SPECTROM, V42, P1093, DOI 10.1002/jms.1245; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Kobayashi M, 2000, APPL MICROBIOL BIOT, V54, P550, DOI 10.1007/s002530000416; Lee SJ, 2003, MOL CELLS, V16, P97; Leinonen JS, 2000, STROKE, V31, P33, DOI 10.1161/01.STR.31.1.33; Lin SZ, 1996, STROKE, V27, P747, DOI 10.1161/01.STR.27.4.747; Liu XB, 2007, BIOCHEM BIOPH RES CO, V357, P187, DOI 10.1016/j.bbrc.2007.03.120; Lockwood SF, 2005, CARDIOVASC DRUG REV, V23, P199; Lyons NM, 2002, J DERMATOL SCI, V30, P73, DOI 10.1016/S0923-1811(02)00063-4; Mackensen GB, 2001, J NEUROSCI, V21, P4582, DOI 10.1523/JNEUROSCI.21-13-04582.2001; Mailly F, 1999, J NEUROCHEM, V73, P1181, DOI 10.1046/j.1471-4159.1999.0731181.x; Merchie G, 1998, AQUAC RES, V29, P579, DOI 10.1111/j.1365-2109.1998.tb01171.x; MIKI W, 1991, PURE APPL CHEM, V63, P141, DOI 10.1351/pac199163010141; Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Nakano T, 1999, BBA-GEN SUBJECTS, V1426, P119, DOI 10.1016/S0304-4165(98)00145-7; NAKANO T, 1995, J AGR FOOD CHEM, V43, P1570, DOI 10.1021/jf00054a029; Namura S, 2001, STROKE, V32, P1906, DOI 10.1161/01.STR.32.8.1906; Page GI, 2005, COMP BIOCHEM PHYS B, V142, P398, DOI 10.1016/j.cbpb.2005.09.001; Pan CH, 2003, J EXP MAR BIOL ECOL, V297, P107, DOI 10.1016/j.jembe.2003.07.002; Pan CH, 2001, ZOOL STUD, V40, P371; Pangantihon-Kuhlmann MP, 1998, AQUAT LIVING RESOUR, V11, P403, DOI 10.1016/S0990-7440(99)80006-0; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Shen H, 2009, J NEUROSCI RES, V87, P545, DOI 10.1002/jnr.21865; Spiller Gene A., 2003, Journal of Medicinal Food, V6, P51, DOI 10.1089/109662003765184741; Steinbrenner J, 2003, PLANT MOL BIOL, V52, P343, DOI 10.1023/A:1023948929665; Tomac AC, 2002, P NATL ACAD SCI USA, V99, P9521, DOI 10.1073/pnas.152535899; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Vine AL, 2005, MOL CARCINOGEN, V43, P75, DOI 10.1002/mc.20080; Wang HYJ, 2008, INT J MASS SPECTROM, V278, P143, DOI 10.1016/j.ijms.2008.04.005; Wang Y, 2003, J NEUROSCI, V23, P7958; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Wu TH, 2006, J AGR FOOD CHEM, V54, P2418, DOI 10.1021/jf052651q; Zhang WR, 2000, NEUROL RES, V22, P517	63	100	113	0	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1958	1968		10.1096/fj.08-123281	http://dx.doi.org/10.1096/fj.08-123281			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19218497	Green Published			2022-12-25	WOS:000266652400034
J	Choudhury, R; Noakes, CJ; McKenzie, E; Kox, C; Lowe, M				Choudhury, Rawshan; Noakes, Christopher J.; McKenzie, Edward; Kox, Corinne; Lowe, Martin			Differential Clathrin Binding and Subcellular Localization of OCRL1 Splice Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN OCRL1; INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; TRANS-GOLGI NETWORK; LOWE-SYNDROME; ENDOCYTIC PATHWAY; RAC GTPASE; ENDOSOMES; TRAFFICKING; DEFICIENCY; ACTIVATION	Mutation of the inositol polyphosphate 5-phosphatase OCRL1 causes the X-linked disorder oculocerebrorenal syndrome of Lowe, characterized by defects in the brain, kidneys, and eyes. OCRL1 exists as two splice isoforms that differ by a single exon encoding 8 amino acids. The longer protein, termed isoform a, is the only form in brain, whereas both isoforms are present in all other tissues. The significance of OCRL1 splicing is currently unclear. Given its proximity to a clathrin-binding site, we hypothesized that splicing may alter the clathrin binding properties of OCRL1. Here we show that this is indeed the case. OCRL1 isoform a binds clathrin with higher affinity than isoform b and is significantly more enriched in clathrin-coated trafficking intermediates. We also identify a second clathrin-binding site in OCRL1 that contributes to clathrin binding of both isoforms. Association of OCRL1 with clathrin-coated intermediates requires membrane association through interaction with Rab GTPases but not binding to the clathrin adaptor AP2. Expression of OCRL1 isoform a lacking the 5-phosphatase domain impairs transferrin endocytosis, whereas an equivalent version of isoform b does not. Our results suggest that OCRL1 exists as two functional pools, one participating in clathrin-mediated trafficking events such as endocytosis and another that is much less or not involved in this process.	[Choudhury, Rawshan; Noakes, Christopher J.; McKenzie, Edward; Kox, Corinne; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lowe, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.lowe@manchester.ac.uk			Medical Research Council Senior Nonclinical Research Fellowship [G117/494]; Biotechnology and Biological Sciences Research Council Project [34/C17842]; MRC [G117/494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [C17842] Funding Source: researchfish; Medical Research Council [G117/494] Funding Source: researchfish	Medical Research Council Senior Nonclinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Senior Nonclinical Research Fellowship G117/494 and Biotechnology and Biological Sciences Research Council Project Grant 34/C17842 ( to M. L.).	Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2005, HUM MOL GENET, V14, P1441, DOI 10.1093/hmg/ddi153; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lichter-Konecki U, 2006, MOL GENET METAB, V89, P121, DOI 10.1016/j.ymgme.2006.04.005; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; McCrea HJ, 2008, BIOCHEM BIOPH RES CO, V369, P493, DOI 10.1016/j.bbrc.2008.02.067; Nussbaum R., 2001, METABOLIC MOL BASIS, V4, P6257; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Ungewickell A, 2004, P NATL ACAD SCI USA, V101, P13501, DOI 10.1073/pnas.0405664101; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Williams C, 2007, J CELL SCI, V120, P3941, DOI 10.1242/jcs.014423	29	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9965	9973		10.1074/jbc.M807442200	http://dx.doi.org/10.1074/jbc.M807442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211563	hybrid, Green Published			2022-12-25	WOS:000264892900039
J	Imamura, Y; Oda, A; Katahira, T; Bundo, K; Pike, KA; Ratcliffe, MJH; Kitamura, D				Imamura, Yasuhiro; Oda, Akihisa; Katahira, Takashi; Bundo, Kenji; Pike, Kelly A.; Ratcliffe, Michael J. H.; Kitamura, Daisuke			BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; JUN NH2-TERMINAL KINASE; ADAPTER PROTEIN BLNK; NON-ITAM TYROSINE; ANTIGEN-RECEPTOR; PHOSPHOLIPASE C-GAMMA-2; IG-ALPHA; LINKER PROTEIN; CUTTING EDGE; REQUIREMENT	Cross-linked B cell receptor (BCR) aggregates on the cell surface, then assembles into the "cap" where Ras is co-localized, and transduces various intracellular signals including Ras-ERK activation. BCR signals induce proliferation, differentiation, or apoptosis of B cells depending on their maturational stage. The adaptor protein BLNK binds various signaling proteins and Ig alpha, a signaling subunit of the BCR complex, and plays an important role in the BCR signal transduction. BLNK was shown to be required for activation of ERK, but not of Ras, after BCR cross-linking, raising a question how BLNK facilitates ERK activation. Here we demonstrate that BLNK binds the active form of H-Ras, and their binding is facilitated by BCR cross-linking. We have identified a 10-amino acid Ras-binding domain within BLNK that is necessary for restoration of BCR-mediated ERK activation in BLNK-deficient B cells and for anti-apoptotic signaling. The Ras-binding domain fused with a CD8 alpha-Ig alpha chimeric receptor could induce prolonged ERK phosphorylation, transcriptional activation of Elk1, as well as the capping of the receptor in BLNK-deficient B cells. These results indicate that BLNK recruits active H-Ras to the BCR complex, which is essential for sustained surface expression of BCR in the form of the cap and for the signal leading to functional ERK activation.	[Imamura, Yasuhiro; Oda, Akihisa; Katahira, Takashi; Bundo, Kenji; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, Chiba 2780022, Japan; [Pike, Kelly A.; Ratcliffe, Michael J. H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Pike, Kelly A.; Ratcliffe, Michael J. H.] Sunnybrook Hlth Sci Ctr, Discipline Mol & Cell Biol, Toronto, ON M5S 1A8, Canada	Tokyo University of Science; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, 2669 Yamazaki, Chiba 2780022, Japan.	kitamura@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Fonds de la Recherche en Sante du Quebec	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by Grants-in-Aid for Scientific Research ( B) from Ministry of Education, Culture, Sports, Science and Technology of Japan ( to D. K.).; Supported by a doctoral research award from the Fonds de la Recherche en Sante du Quebec.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Brezski RJ, 2007, J IMMUNOL, V179, P4464, DOI 10.4049/jimmunol.179.7.4464; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GRAZIADEI L, 1990, NATURE, V347, P396, DOI 10.1038/347396a0; HARWOOD AE, 1993, J IMMUNOL, V151, P4513; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Katahira T, 2006, INT IMMUNOL, V18, P545, DOI 10.1093/intimm/dxh395; Katsuta H, 1998, J IMMUNOL, V160, P1547; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LAZARUS AH, 1993, J EXP MED, V178, P1765, DOI 10.1084/jem.178.5.1765; Li WQ, 2000, GENE DEV, V14, P895; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Pike KA, 2005, J IMMUNOL, V174, P2012, DOI 10.4049/jimmunol.174.4.2012; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2006, J IMMUNOL, V176, P4690, DOI 10.4049/jimmunol.176.8.4690; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Yamamoto M, 2006, BLOOD, V108, P2703, DOI 10.1182/blood-2006-05-024968; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	57	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9804	9813		10.1074/jbc.M809051200	http://dx.doi.org/10.1074/jbc.M809051200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218240	Green Published, hybrid			2022-12-25	WOS:000264892900021
J	King, JB; West, MB; Cook, PF; Hanigan, MH				King, Jarrod B.; West, Matthew B.; Cook, Paul F.; Hanigan, Marie H.			A Novel, Species-specific Class of Uncompetitive Inhibitors of gamma-Glutamyl Transpeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; TRANSFERASE TRANSPEPTIDASE; ESCHERICHIA-COLI; B16 MELANOMA; ACTIVE-SITE; IN-VIVO; GLUTATHIONE; CELLS; MECHANISM; CYSTEINE	Expression of gamma-glutamyl transpeptidase (GGT) in tumors contributes to resistance to radiation and chemotherapy. GGT is inhibited by glutamine analogues that compete with the substrate for the gamma-glutamyl binding site. However, the glutamine analogues that have been evaluated in clinical trials are too toxic for use in humans. We have used high throughput screening to evaluate small molecules for their ability to inhibit GGT and have identified a novel class of inhibitors that are not glutamine analogues. These compounds are uncompetitive inhibitors, binding the gamma-glutamyl enzyme complex. OU749, the lead compound, has an intrinsic K-i of 17.6 mu M. It is a competitive inhibitor of the acceptor glycyl-glycine, which indicates that OU749 occupies the acceptor site while binding to the gamma-glutamyl substrate complex. OU749 is more than 150-fold less toxic than the GGT inhibitor acivicin toward dividing cells. Inhibition of GGT by OU749 is species-specific, inhibiting GGT isolated from human kidney with 7-10-fold greater potency than GGT isolated from rat or mouse kidney. OU749 does not inhibit GGT from pig cells. Human GGT expressed in mouse fibroblasts is inhibited by OU749 similarly to GGT from human cells, which indicates that the species specificity is determined by differences in the primary structure of the protein rather than species-specific, post-translational modifications. These studies have identified a novel class of inhibitors of GGT, providing the basis for further development of a new group of therapeutics that inhibit GGT by a mechanism distinct from the toxic glutamine analogues.	[King, Jarrod B.; West, Matthew B.; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman	Hanigan, MH (corresponding author), Biomed Res Ctr, Rm 264,975 NE 10th St, OK City, OK 73104 USA.	marie-hanigan@ouhsc.edu			National Institutes of Health [RO1CA57530]; Oklahoma Center for the Advancement of Science and Technology [HR03-044]; NATIONAL CANCER INSTITUTE [R01CA057530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA57530 from the NCI (to M. H. H.) and by Grant HR03-044 from the Oklahoma Center for the Advancement of Science and Technology (to M. H. H.). This work was also supported by the Grayce B. Kerr endowment to the University of Oklahoma to support the research of P. F. C.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; AHMAD S, 1987, J CELL PHYSIOL, V131, P240, DOI 10.1002/jcp.1041310214; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; Bai FJ, 2001, CHEM RES TOXICOL, V14, P863, DOI 10.1021/tx010011l; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Bose RN, 1997, J INORG BIOCHEM, V65, P199, DOI 10.1016/S0162-0134(96)00133-X; Carter BZ, 1997, J BIOL CHEM, V272, P12305, DOI 10.1074/jbc.272.19.12305; Cook P. F., 2007, ENZYME KINETICS MECH; FOLK JE, 1969, J BIOL CHEM, V244, P3707; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; Han LY, 2006, BIOORGAN MED CHEM, V14, P6043, DOI 10.1016/j.bmc.2006.05.008; HANIGAN MH, 1994, CANCER RES, V54, P5925; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hanigan MH, 2001, AM J PATHOL, V159, P1889, DOI 10.1016/S0002-9440(10)63035-0; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Henson SE, 1999, J IMMUNOL, V163, P1845; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P12471, DOI 10.1074/jbc.270.21.12471; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; KUMAGAI H, 1993, J MOL BIOL, V234, P1259, DOI 10.1006/jmbi.1993.1677; Lee CY, 2008, INT IMMUNOPHARMACOL, V8, P732, DOI 10.1016/j.intimp.2008.01.018; Lherbet C, 2004, BIOORG MED CHEM LETT, V14, P3451, DOI 10.1016/j.bmcl.2004.04.072; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; LYONS SD, 1990, J BIOL CHEM, V265, P11377; Mena S, 2007, CLIN CANCER RES, V13, P2658, DOI 10.1158/1078-0432.CCR-06-2642; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; ODWYER PJ, 1992, J NATL CANCER I, V84, P264, DOI 10.1093/jnci/84.4.264; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Ruoso P, 2004, CANCER CHEMOTH PHARM, V54, P49, DOI 10.1007/s00280-004-0776-3; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TAYLOR SA, 1991, J CLIN ONCOL, V9, P1476, DOI 10.1200/JCO.1991.9.8.1476; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; YAMASHITA K, 1986, J BIOCHEM-TOKYO, V99, P55, DOI 10.1093/oxfordjournals.jbchem.a135479	42	43	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9059	9065		10.1074/jbc.M809608200	http://dx.doi.org/10.1074/jbc.M809608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19203993	hybrid, Green Published			2022-12-25	WOS:000264669100008
J	Jang, M; Park, BC; Kang, S; Chi, SW; Cho, S; Chung, SJ; Lee, SC; Bae, KH; Park, SG				Jang, M.; Park, B. C.; Kang, S.; Chi, S-W; Cho, S.; Chung, S. J.; Lee, S. C.; Bae, K-H; Park, S. G.			Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene	ONCOGENE			English	Article						apoptosis; caspase; c-Myc; FBP-1; FUSE	CELL-DEATH; IDENTIFICATION; EXPRESSION; MITOCHONDRIAL; CLEAVAGE; BAX	Far upstream element-binding protein-1 (FBP-1) binds to an upstream element of the c-myc promoter and regulates the c-myc mRNA level. Earlier, FBP-1 was identified as a candidate substrate of caspase-7. Here, we report that FBP-1 is cleaved by executor caspases, both in vitro and during apoptosis. Cleavage occurs at the caspase consensus site (DQPD74) located within the classical bipartite nuclear localization signal sequence. In cells subjected to apoptotic stimuli, the caspase-mediated cleavage of FBP-1 leads to its decreased presence in the nucleus, concomitant with the marked downregulation of c-Myc and its various target proteins. By contrast, cells transfected with a non-cleavable mutant of FBP-1 (D74A) maintain higher levels of c-Myc and are protected from apoptosis. On the basis of these results, we suggest that the oncogenic potential of c-Myc is 'switched off' after apoptosis induction as a consequence of the caspase-mediated cleavage of FBP-1.	[Jang, M.; Park, B. C.; Kang, S.; Chi, S-W; Lee, S. C.; Bae, K-H; Park, S. G.] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305806, South Korea; [Cho, S.] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Chung, S. J.] Korea Res Inst Biosci & Biotechnol, BioNano Res Ctr, Taejon 305806, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Bae, KH (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305806, South Korea.	khbae@kribb.re.kr		Bae, Kwang-Hee/0000-0002-5868-2556; Kang, Sunghyun/0000-0003-1542-9750	KRIBB; Korea Science and Engineering Foundation [2008-01050]	KRIBB; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	We thank Drs Young Il Yeom, Seung Jun Kim and Do Hee Lee for their helpful advices. This study was supported by a grant sponsored by KRIBB (to K-H Bae) and Korea Science and Engineering Foundation (Basic Research Program no. 2008-01050) (to SG Park).	BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cao XF, 2008, J BIOL CHEM, V283, P14490, DOI 10.1074/jbc.M801107200; Chung HJ, 2005, MOL CELLS, V20, P157; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; He LS, 2000, NUCLEIC ACIDS RES, V28, P4558, DOI 10.1093/nar/28.22.4558; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Jang M, 2007, BIOCHEM BIOPH RES CO, V363, P388, DOI 10.1016/j.bbrc.2007.08.183; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Liu JB, 2007, CANCER CHEMOTH PHARM, V59, P217, DOI 10.1007/s00280-006-0260-3; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vindigni A, 2001, NUCLEIC ACIDS RES, V29, P1061, DOI 10.1093/nar/29.5.1061; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1	23	43	47	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1529	1536		10.1038/onc.2009.11	http://dx.doi.org/10.1038/onc.2009.11			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19219071				2022-12-25	WOS:000264537400005
J	Claessens, LPAM; O'Connor, PM; Unwin, DM				Claessens, Leon P. A. M.; O'Connor, Patrick M.; Unwin, David M.			Respiratory Evolution Facilitated the Origin of Pterosaur Flight and Aerial Gigantism	PLOS ONE			English	Article							POSTCRANIAL SKELETON; UNCINATE PROCESSES; PELVIC ASPIRATION; REPTILIAN LUNGS; PNEUMATICITY; DINOSAUR; VENTILATION; ANATOMY; FLOW	Pterosaurs, enigmatic extinct Mesozoic reptiles, were the first vertebrates to achieve true flapping flight. Various lines of evidence provide strong support for highly efficient wing design, control, and flight capabilities. However, little is known of the pulmonary system that powered flight in pterosaurs. We investigated the structure and function of the pterosaurian breathing apparatus through a broad scale comparative study of respiratory structure and function in living and extinct archosaurs, using computer-assisted tomographic (CT) scanning of pterosaur and bird skeletal remains, cineradiographic (X-ray film) studies of the skeletal breathing pump in extant birds and alligators, and study of skeletal structure in historic fossil specimens. In this report we present various lines of skeletal evidence that indicate that pterosaurs had a highly effective flow-through respiratory system, capable of sustaining powered flight, predating the appearance of an analogous breathing system in birds by approximately seventy million years. Convergent evolution of gigantism in several Cretaceous pterosaur lineages was made possible through body density reduction by expansion of the pulmonary air sac system throughout the trunk and the distal limb girdle skeleton, highlighting the importance of respiratory adaptations in pterosaur evolution, and the dramatic effect of the release of physical constraints on morphological diversification and evolutionary radiation.	Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [O'Connor, Patrick M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Unwin, David M.] Univ Leicester, Dept Museum Studies, Leicester LE1 7RH, Leics, England	College of the Holy Cross; University System of Ohio; Ohio University; University of Leicester	Claessens, LPAM (corresponding author), Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA.	lclaesse@holycross.edu	OConnor, Patrick M/I-9383-2012; Claessens, Leon P.A.M./F-5036-2012	OConnor, Patrick M/0000-0002-6762-3806; Claessens, Leon P.A.M./0000-0002-1873-6070	National Science Foundation [IBN 0206169]; Harvard University; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Deutsche Forschungsgemeinschaft; University of Leicester; Humboldt University, Berlin	National Science Foundation(National Science Foundation (NSF)); Harvard University; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Leicester; Humboldt University, Berlin	LC acknowledges funding from the National Science Foundation (IBN 0206169) and Harvard University for cineradiographic experiments. PO would like to thank the Ohio University College of Osteopathic Medicine and the Ohio University Office of Research and Sponsored Programs for support. DU thanks the Deutsche Forschungsgemeinschaft, the University of Leicester and the Humboldt University, Berlin for support.	AKESTER AR, 1973, J ZOOL, V170, P493; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bignon F, 1889, MEM SOC ZOOL FRANCE, V2, P260; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; BROILI F, 1927, SITZUNGSBER BAYER MN, P49; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; CLAESSENS LPA, J EXPT ZO A IN PRESS; CLAESSENS LPA, 2005, THESIS HARVARD U CAM; Claessens LPAM, 2004, P ROY SOC B-BIOL SCI, V271, P1461, DOI 10.1098/rspb.2004.2743; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Farmer CG, 2000, J EXP BIOL, V203, P1679; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hicks JW, 1999, RESP PHYSIOL, V117, P73, DOI 10.1016/S0034-5687(99)00060-2; Jones TD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P443; KUETHE DO, 1988, J EXP BIOL, V136, P1; LIEM KF, 1989, AM ZOOL, V29, P333; MARTILL DM, 1989, NATURE, V340, P138, DOI 10.1038/340138a0; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; OWEN R, 1859, MONOGRAPH FOSSIL REP, V1, P1; Owerkowicz T, 1999, SCIENCE, V284, P1661, DOI 10.1126/science.284.5420.1661; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; PADIAN K, 1983, PALEOBIOLOGY, V9, P218, DOI 10.1017/S009483730000765X; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; SHAROV AG, 1971, AKAD NAUK SSSR PALEO, V130, P104; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; WELLNHOFER P, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V215, P43; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1978, PTEROSAURIA; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Wilkinson MT, 2008, ZOOL J LINN SOC-LOND, V154, P27, DOI 10.1111/j.1096-3642.2008.00409.x; Wilkinson MT, 2006, P ROY SOC B-BIOL SCI, V273, P119, DOI 10.1098/rspb.2005.3278; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Zimmer K., 1935, Zoologica Stuttgart, V33, P1; [No title captured]	49	104	105	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4497	10.1371/journal.pone.0004497	http://dx.doi.org/10.1371/journal.pone.0004497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223979	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485800006
J	Diaz, JA; Murillo, MF; Jaramillo, NA				Diaz, Jairo A.; Murillo, Mauricio F.; Jaramillo, Natalia A.			Framework of Collagen Type I - Vasoactive Vessels Structuring Invariant Geometric Attractor in Cancer Tissues: Insight into Biological Magnetic Field	PLOS ONE			English	Article								In a previous research, we have described and documented self-assembly of geometric triangular chiral hexagon crystal-like complex organizations (GTCHC) in human pathological tissues. This article documents and gathers insights into the magnetic field in cancer tissues and also how it generates an invariant functional geometric attractor constituted for collider partners in their entangled environment. The need to identify this hierarquic attractor was born out of the concern to understand how the vascular net of these complexes are organized, and to determine if the spiral vascular subpatterns observed adjacent to GTCHC complexes and their assembly are interrelational. The study focuses on cancer tissues and all the macroscopic and microscopic material in which GTCHC complexes are identified, which have been overlooked so far, and are rigorously revised. This revision follows the same parameters that were established in the initial phase of the investigation, but with a new item: the visualization and documentation of external dorsal serous vascular bed areas in spatial correlation with the localization of GTCHC complexes inside the tumors. Following the standard of the electro-optical collision model, we were able to reproduce and replicate collider patterns, that is, pairs of left and right hand spin-spiraled subpatterns, associated with the orientation of the spinning process that can be an expansion or contraction disposition of light particles. Agreement between this model and tumor data is surprisingly close; electromagnetic spiral patterns generated were identical at the spiral vascular arrangement in connection with GTCHC complexes in malignant tumors. These findings suggest that the framework of collagen type 1 - vasoactive vessels that structure geometric attractors in cancer tissues with invariant morphology sets generate collider partners in their magnetic domain with opposite biological behavior. If these principles are incorporated into nanomaterial, biomedical devices, and engineered tissues, new therapeutic strategies could be developed for cancer treatment.	[Diaz, Jairo A.; Murillo, Mauricio F.; Jaramillo, Natalia A.] Univ Cooperat Colombia, Dept Pathol, Sch Med, Pathol Lab,Clin Corp, Villavicencio, Meta, Colombia	Universidad Cooperativa de Colombia	Diaz, JA (corresponding author), Univ Cooperat Colombia, Dept Pathol, Sch Med, Pathol Lab,Clin Corp, Villavicencio, Meta, Colombia.	jaditod@hotmail.com		Jaramillo Gomez, Natalia/0000-0002-0939-171X	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Corporation University Cooperative of Colombia, Villavicencio, Meta, Colombia	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Corporation University Cooperative of Colombia, Villavicencio, Meta, Colombia	This investigation was possible thanks to the logistical and economic support of the Medicine School, Pathology Department, Cooperative University of Colombia and the Clinical Corporation University Cooperative of Colombia. Villavicencio, Meta. Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kilani A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051912; Ambjorn J, 2006, CONTEMP PHYS, V47, P103, DOI 10.1080/00107510600603344; Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; DEKEERSMAECKER K, 2008, NOT PROTEIN ITS LOCA; DIAZ JA, 2007, GEOMETRIC TRIANGULAR; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; FRASER G, 2007, NEW PHYS 21 CENTURY; GIRTON TS, 1998, TISSUE ENG METHODS P, P67; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; Higashi T, 1996, BIOELECTROMAGNETICS, V17, P335, DOI 10.1002/(SICI)1521-186X(1996)17:4<335::AID-BEM10>3.0.CO;2-N; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Ingber DE, 1998, SCI AM, V278, P48, DOI 10.1038/scientificamerican0198-48; KARDILOV N, 2008, 3 DIMENSIONAL IMAGIN; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MUKAI K, 1980, AM J SURG PATHOL, V4, P273, DOI 10.1097/00000478-198006000-00008; NG LG, 2008, MIGRATORY DERMAL DEN; OKAZAKI M, 1988, PHYSIOL CHEM PHYS ME, V20, P3; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4506	10.1371/journal.pone.0004506	http://dx.doi.org/10.1371/journal.pone.0004506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223987	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485800010
J	Faucherre, A; Pujol-Marti, J; Kawakami, K; Lopez-Schier, H				Faucherre, Adele; Pujol-Marti, Jesus; Kawakami, Koichi; Lopez-Schier, Hernan			Afferent Neurons of the Zebrafish Lateral Line Are Strict Selectors of Hair-Cell Orientation	PLOS ONE			English	Article							MEDIATED ENHANCER TRAP; DIRECTIONAL SENSITIVITY; XENOPUS-LAEVIS; FISH; ORGAN; INNERVATION; NEUROMASTS; MUTATIONS; EFFERENT; SYSTEM	Hair cells in the inner ear display a characteristic polarization of their apical stereocilia across the plane of the sensory epithelium. This planar orientation allows coherent transduction of mechanical stimuli because the axis of morphological polarity of the stereocilia corresponds to the direction of excitability of the hair cells. Neuromasts of the lateral line in fishes and amphibians form two intermingled populations of hair cells oriented at 180 degrees relative to each other, however, creating a stimulus-polarity ambiguity. Therefore, it is unknown how these animals resolve the vectorial component of amechanical stimulus. Using genetic mosaics and live imaging in transgenic zebrafish to visualize hair cells and neurons at single-cell resolution, we show that lateral-line afferents can recognize the planar polarization of hair cells. Each neuron forms synapses with hair cells of identical orientation to divide the neuromast into functional planar-polarity compartments. We also show that afferent neurons are strict selectors of polarity that can re-establish synapses with identically oriented targets during hair-cell regeneration. Our results provide the anatomical bases for the physiological models of signal-polarity resolution by the lateral line.	[Faucherre, Adele; Pujol-Marti, Jesus; Lopez-Schier, Hernan] Ctr Regulacio Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain; [Kawakami, Koichi] Grad Univ Advanced Studies, Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Advanced Studies, Dept Genet, Mishima, Shizuoka, Japan	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Faucherre, A (corresponding author), Ctr Regulacio Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain.	hernan.lopez@crg.es	Kawakami, Koichi/AAF-1380-2019	Faucherre, Adele/0000-0002-6099-3898; Pujol-Marti, Jesus/0000-0001-9500-7106	CRG; Ministerio de Ciencia e Innovacion of Spain [SAF2006-04684]; Ramon y Cajal Investigator; National BioResource Project; Ministry of Education, Culture, Sports, Science and Technology of Japan; Obra Social Fundacio La Caixa [fellowship]	CRG; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal Investigator(Spanish Government); National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Obra Social Fundacio La Caixa(La Caixa Foundation)	This research was supported by start-up funds from the CRG and by a grant (SAF2006-04684) from the Ministerio de Ciencia e Innovacion of Spain, of which H.L. S. is a Ramon y Cajal Investigator. K.K. was funded by the National BioResource Project and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. J.P.-M. was supported by a fellowship from Obra Social Fundacio La Caixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleckmann H, 2007, FISH PHYSIOL, V25, P411, DOI 10.1016/S1546-5098(06)25010-6; Bricaud O, 2001, J COMP NEUROL, V434, P253, DOI 10.1002/cne.1175; Chagnaud BP, 2008, ZOOLOGY, V111, P204, DOI 10.1016/j.zool.2007.07.009; Chagnaud BP, 2007, J COMP PHYSIOL A, V193, P753, DOI 10.1007/s00359-007-0230-1; Coombs S, 1997, J COMP PHYSIOL A, V180, P401, DOI 10.1007/s003590050058; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; ECHTELER SM, 1992, P NATL ACAD SCI USA, V89, P6324, DOI 10.1073/pnas.89.14.6324; Fain G, 2003, SENSORY TRANSDUCTION; Fame RM, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-4; FLOCK A, 1962, J CELL BIOL, V15, P19, DOI 10.1083/jcb.15.1.19; FLOCK A, 1971, FISH PHYSIOL, V5, P241; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Gompel N, 2001, DEVELOPMENT, V128, P387; GORNER P, 1963, Z VERGL PHYSIOL, V47, P316, DOI 10.1007/BF00298039; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KROESE ABA, 1992, J NEUROPHYSIOL, V68, P2212, DOI 10.1152/jn.1992.68.6.2212; KROESE ABA, 1980, J EXP BIOL, V86, P63; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Ledent V, 2002, DEVELOPMENT, V129, P597; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; McHenry MJ, 2008, J COMP PHYSIOL A, V194, P795, DOI 10.1007/s00359-008-0350-2; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Mohr C, 1996, BRAIN BEHAV EVOLUT, V48, P55, DOI 10.1159/000113186; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; MUNZ H, 1985, J COMP PHYSIOL A, V157, P555, DOI 10.1007/BF01351350; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; ROUSE GW, 1991, P ROY SOC B-BIOL SCI, V246, P123, DOI 10.1098/rspb.1991.0133; Sapede D, 2005, P NATL ACAD SCI USA, V102, P1714, DOI 10.1073/pnas.0406382102; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; Sidi S, 2004, J NEUROSCI, V24, P4213, DOI 10.1523/JNEUROSCI.0223-04.2004; WERSALL J, 1965, COLD SPRING HARB SYM, V30, P115, DOI 10.1101/SQB.1965.030.01.015; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	46	96	96	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4477	10.1371/journal.pone.0004477	http://dx.doi.org/10.1371/journal.pone.0004477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223970	Green Submitted, gold, Green Published			2022-12-25	WOS:000265485800004
J	Essafi-Benkhadir, K; Grosso, S; Puissant, A; Robert, G; Essafi, M; Deckert, M; Chamorey, E; Dassonville, O; Milano, G; Auberger, P; Pages, G				Essafi-Benkhadir, Khadija; Grosso, Sebastien; Puissant, Alexandre; Robert, Guillaume; Essafi, Makram; Deckert, Marcel; Chamorey, Emmanuel; Dassonville, Olivier; Milano, Gerard; Auberger, Patrick; Pages, Gilles			Dual Role of Sp3 Transcription Factor as an Inducer of Apoptosis and a Marker of Tumour Aggressiveness	PLOS ONE			English	Article								Background: The ambiguous role of transcription factor Sp3 for tumour progression is still debated since it was described as a transcriptional repressor or activator. Here we tried to decipher the molecular mechanisms implicated in Sp3 accumulation observed in aggressive tumours. Methodology: We generated normal and tumour cell lines conditionally expressing Sp3. Cell growth was analyzed in vitro and after inoculation in nude mice. Apoptosis was assessed by pan- caspase activity assays, by counting fragmented nuclei and by determination of caspase 9 cleavage. Gene expression was determined by quantitative PCR. Cleavage by different caspases was performed after in vitro translation of the Sp3 cDNA in the presence of [S(35)] labelled methionine. Different tumour cell lines and head and neck tumour samples were tested for the presence of Sp3 by western blots. Correlation between Sp3 expression and overall survival has been statistically determined. Principal Findings: Conditional over-expression of Sp3 induces apoptosis and modifies expression of genes implicated in the regulation of cell cycle and pro and anti apoptotic genes. Sp3 over-expression strongly reduces the development of tumours in nude mice confirming its pro-apoptotic potential in vivo. However, cells can survive to apoptosis through selective Sp3 cleavage by caspase. Sp3 induction in established tumours resulted in transient regression then progression. Progression coincides with re-accumulation of the full length form of Sp3. Sp3 is over-expressed in tumour cell lines of different origins. The presence of high levels of the full-length form of Sp3 indicates a poor prognosis for overall survival of patients with head and neck tumours. Conclusions: Full length Sp3 accumulation highlights bypass of tumour cell apoptotic capacities and is indicative of head and neck tumours aggressiveness.	[Essafi-Benkhadir, Khadija; Pages, Gilles] Inst Pastuer Tunis, Unite Biochim Pathol Expt, Tunis, Tunisia; [Grosso, Sebastien; Puissant, Alexandre; Robert, Guillaume; Auberger, Patrick] Univ Nice Sophia Antipolis, Inst Dev Biol & Canc Res, Ctr Antoine Lacassagne, UMR CNRS 6543, F-06108 Nice, France; [Essafi, Makram; Deckert, Marcel] Univ Nice Sophia Antipolis, Fac Med, Equipe labellisee Ligue Natl contre Canc, Cell Death Different & Canc Team, F-06108 Nice, France; [Chamorey, Emmanuel] Univ Nice Sophia Antipolis, INSERM, U576, F-06108 Nice, France; [Dassonville, Olivier] Ctr Antoine Lacassagne, Stat Serv, Nice, France; [Milano, Gerard] Ctr Antoine Lacassagne, Oncopharmacol Unit, EA 3836, Nice, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Antoine Lacassagne	Essafi-Benkhadir, K (corresponding author), Inst Pastuer Tunis, Unite Biochim Pathol Expt, Tunis, Tunisia.	gpages@unice.fr	robert, guillaume/O-1935-2017; Deckert, Marcel/M-4998-2016; Puissant, Alexandre/AAF-3875-2021; AUBERGER, Patrick/G-1491-2013; Chamorey, Emmanuel/AGO-9982-2022; Essafi, Makram/V-8411-2019; Essafi-Benkhadir, Khadija/N-3727-2015; Pages, Gilles/N-7135-2017; Deckert, Marcel/T-3566-2019; PUISSANT, ALEXANDRE/O-9575-2016	robert, guillaume/0000-0002-6350-2222; Puissant, Alexandre/0000-0002-3997-9282; AUBERGER, Patrick/0000-0002-2481-8275; Deckert, Marcel/0000-0003-2094-559X; PUISSANT, ALEXANDRE/0000-0002-3997-9282; Milano, Gerard/0000-0003-2478-0040; Benkhadir-Essafi, Khadija/0000-0003-1371-1963	Centre National pour la Recherche Scientifique; University of Nice Sophia Antipolis; Ligue Nationale Contre le Cancer" Equipe Labellise; Association for International Cancer Research (AICR); National Institute of Cancer (INCA); French association for cancer research (ARC); Canceropale PACA	Centre National pour la Recherche Scientifique; University of Nice Sophia Antipolis; Ligue Nationale Contre le Cancer" Equipe Labellise; Association for International Cancer Research (AICR); National Institute of Cancer (INCA)(Institut National du Cancer (INCA) France); French association for cancer research (ARC); Canceropale PACA	This work was supported by the "Centre National pour la Recherche Scientifique", the University of Nice Sophia Antipolis, the "Ligue Nationale Contre le Cancer" Equipe Labellise, the Association for International Cancer Research (AICR), the National Institute of Cancer (INCA), the French association for cancer research (ARC) and the Canceropale PACA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Bertolotto C, 2000, J BIOL CHEM, V275, P12941, DOI 10.1074/jbc.275.17.12941; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chirakkal H, 2006, ONCOGENE, V25, P7192, DOI 10.1038/sj.onc.1209702; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; GEISER AG, 1993, GENE, V129, P223, DOI 10.1016/0378-1119(93)90272-5; HARROCH S, 1995, NUCLEIC ACIDS RES, V23, P3539, DOI 10.1093/nar/23.17.3539; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lou Z, 2005, CANCER RES, V65, P1007; Luciano F, 2002, LEUKEMIA, V16, P700, DOI 10.1038/sj.leu.2402401; Marchetti S, 2004, J CELL PHYSIOL, V199, P441, DOI 10.1002/jcp.10465; Maurer GD, 2007, CLIN CANCER RES, V13, P1123, DOI 10.1158/1078-0432.CCR-06-1668; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Nishiyama J, 2001, BIOCHEM J, V360, P49, DOI 10.1042/0264-6021:3600049; Onesto C, 2006, BRIT J CANCER, V94, P1516, DOI 10.1038/sj.bjc.6603108; Pages G, 2007, J CELL PHYSIOL, V213, P454, DOI 10.1002/jcp.21104; Pang HL, 1998, BIOCHEM J, V333, P209, DOI 10.1042/bj3330209; Ryu H, 2003, J NEUROSCI, V23, P3597; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Shi Q, 2001, CANCER RES, V61, P4143; Shi W, 1996, INT IMMUNOL, V8, P1205, DOI 10.1093/intimm/8.8.1205; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002	34	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4478	10.1371/journal.pone.0004478	http://dx.doi.org/10.1371/journal.pone.0004478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212434	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200017
J	Gupta, P; Ho, PC; Ha, SG; Lin, YW; Wei, LN				Gupta, Pawan; Ho, Ping-Chih; Ha, Sung Gil; Lin, Yi-Wei; Wei, Li-Na			HDAC3 as a Molecular Chaperone for Shuttling Phosphorylated TR2 to PML: A Novel Deacetylase Activity-Independent Function of HDAC3	PLOS ONE			English	Article								TR2 is an orphan nuclear receptor specifically expressed in early embryos (Wei and Hsu, 1994), and a transcription factor for transcriptional regulation of important genes in stem cells including the gate keeper Oct4 (Park et al. 2007). TR2 is known to function as an activator (Wei et al. 2000), or a repressor (Chinpaisal et al., 1998, Gupta et al. 2007). Due to the lack of specific ligands, mechanisms triggering its activator or repressor function have remained puzzling for decades. Recently, we found that all-trans retinoic acid (atRA) triggers the activation of extracellular-signal-regulated kinase 2 (ERK2), which phosphorylates TR2 and stimulates its partitioning to promyelocytic leukemia (PML) nuclear bodies, thereby converting the activator function of TR2 into repression (Gupta et al. 2008; Park et al. 2007). Recruitment of TR2 to PML is a crucial step in the conversion of TR2 from an activator to a repressor. However, it is unclear how phosphorylated TR2 is recruited to PML, an essential step in converting TR2 from an activator to a repressor. In the present study, we use both in vitro and in vivo systems to address the problem of recruiting TR2 to PML nuclear bodies. First, we identify histone deacetylase 3 (HDAC3) as an effector molecule. HDAC3 is known to interact with TR2 (Franco et al. 2001) and this interaction is enhanced by the atRA-stimulated phosphorylation of TR2 at Thr-210 (Gupta et al. 2008). Secondly, in this study, we also find that the carrier function of HDAC3 is independent of its deacetylase activity. Thirdly, we find another novel activity of atRA that stimulates nuclear enrichment of HDAC3 to form nuclear complex with PML, which is ERK2 independent. This is the first report identifying a deacetylase-independent function for HDAC3, which serves as a specific carrier molecule that targets a specifically phosphorylated protein to PML NBs. This is also the first study delineating how protein recruitment to PML nuclear bodies occurs, which can be stimulated by atRA in an ERK2-independent manner. These findings could provide new insights into the development of potential therapeutics and in understanding how orphan nuclear receptor activities can be regulated without ligands.	[Gupta, Pawan] Inst Microb Technol, Chandigarh, India; [Ho, Ping-Chih; Ha, Sung Gil; Lin, Yi-Wei; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Minnesota System; University of Minnesota Twin Cities	Gupta, P (corresponding author), Inst Microb Technol, Chandigarh, India.	weixx009@umn.edu		Gupta, Pawan/0000-0001-6692-7237	NIH [DK54733, DK60521, DA11190, DA 11806, K02-DA13926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060521, R01DK054733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, K02DA013926, P50DA011806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DK54733, DK60521, DA11190, DA 11806 and K02-DA13926 to LNW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Atsumi A, 2006, BIOCHEM BIOPH RES CO, V345, P1471, DOI 10.1016/j.bbrc.2006.05.047; Chinpaisal C, 1998, J BIOL CHEM, V273, P18077, DOI 10.1074/jbc.273.29.18077; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Glass CK, 2000, GENE DEV, V14, P121; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200; Gupta P, 2008, P NATL ACAD SCI USA, V105, P11424, DOI 10.1073/pnas.0710561105; Gupta P, 2007, NUCLEIC ACIDS RES, V35, P2269, DOI 10.1093/nar/gkl1147; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hildmann C, 2006, J BIOTECHNOL, V124, P258, DOI 10.1016/j.jbiotec.2006.01.030; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krusche CA, 2007, HUM REPROD, V22, P2956, DOI 10.1093/humrep/dem241; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li GJ, 2003, BIOCHEM BIOPH RES CO, V310, P384, DOI 10.1016/j.bbrc.2003.08.145; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Nakagawa M, 2007, ONCOL REP, V18, P769; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nicolas E, 2001, NUCLEIC ACIDS RES, V29, P3131, DOI 10.1093/nar/29.15.3131; Park SW, 2007, NAT STRUCT MOL BIOL, V14, P68, DOI 10.1038/nsmb1185; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WEI LN, 1994, DEV GROWTH DIFFER, V36, P187; Wei LN, 2000, J BIOL CHEM, V275, P11907, DOI 10.1074/jbc.275.16.11907; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Weichert W, 2008, NEOPLASIA, V10, P1021, DOI 10.1593/neo.08474; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	46	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4363	10.1371/journal.pone.0004363	http://dx.doi.org/10.1371/journal.pone.0004363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204783	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484000002
J	Kissen, R; Bones, AM				Kissen, Ralph; Bones, Atle M.			Nitrile-specifier Proteins Involved in Glucosinolate Hydrolysis in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APHID BREVICORYNE-BRASSICAE; MYROSINASE-BINDING PROTEIN; MUSTARD OIL BOMB; EPITHIOSPECIFIER PROTEIN; CABBAGE APHID; THIOGLUCOSIDE GLUCOHYDROLASE; FORM 1-CYANOEPITHIOALKANES; FUNCTIONAL GENOMICS; NATURAL VARIATION; TRICHOPLUSIA-NI	Glucosinolates are plant secondary metabolites present in Brassicaceae plants such as the model plant Arabidopsis thaliana. Intact glucosinolates are believed to be biologically inactive, whereas degradation products after hydrolysis have multiple roles in growth regulation and defense. The degradation of glucosinolates is catalyzed by thioglucosidases called myrosinases and leads by default to the formation of isothiocyanates. The interaction of a protein called epithiospecifier protein ( ESP) with myrosinase diverts the reaction toward the production of epithionitriles or nitriles depending on the glucosinolate structure. Here we report the identification of a new group of nitrile-specifier proteins (AtNSPs) in A. thaliana able to generate nitriles in conjunction with myrosinase and a more detailed characterization of one member (AtNSP2). Recombinant AtNSP2 expressed in Escherichia coli was used to test its impact on the outcome of glucosinolate hydrolysis using a gas chromatography mass spectrometry approach. AtNSP proteins share 30-45% sequence homology with A. thaliana ESP. Although AtESP and AtNSP proteins can switch myrosinase-catalyzed degradation of 2-propenyl-glucosinolate from isothiocyanate to nitrile, only AtESP generates the corresponding epithionitrile. Using the aromatic benzylglucosinolate, recombinant AtNSP2 is also able to direct product formation to the nitrile. Analysis of glucosinolate hydrolysis profiles of transgenic A. thaliana plants overexpressing AtNSP2 confirms its nitrile-specifier activity in planta. In silico expression analysis reveals distinctive expression patterns of AtNSPs, which supports a biological role for these proteins. In conclusion, we show that AtNSPs belonging to a new family of A. thaliana proteins structurally related to AtESP divert product formation from myrosinase-catalyzed glucosinolate hydrolysis and, thereby, likely affect the biological consequences of glucosinolate degradation. We discuss similarities and properties of AtNSPs and related proteins and the biological implications.	[Kissen, Ralph; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, NTNU, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, NTNU, NO-7491 Trondheim, Norway.	atle.bones@bio.ntnu.no	Bones, Atle M/C-6202-2014	Bones, Atle M/0000-0003-0544-7437	Norwegian Research Council [143250, 151991]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Norwegian Research Council Grants 143250 and 151991.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ANDERSSON D, 2004, 15 INT C AR RES BERL; Bellostas N, 2008, J NAT PROD, V71, P76, DOI 10.1021/np070438d; BENN M, 1977, PURE APPL CHEM, V49, P197, DOI 10.1351/pac197749020197; Bernardi R, 2000, FEBS LETT, V467, P296, DOI 10.1016/S0014-5793(00)01179-0; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Borek V, 2005, J AGR FOOD CHEM, V53, P8650, DOI 10.1021/jf051570r; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Burow M, 2007, PLANT MOL BIOL, V63, P49, DOI 10.1007/s11103-006-9071-5; Capella AN, 2001, PLANTA, V213, P691, DOI 10.1007/s004250100548; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAXENBICHLER ME, 1991, PHYTOCHEMISTRY, V30, P2623, DOI 10.1016/0031-9422(91)85112-D; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Foo HL, 2000, FEBS LETT, V468, P243, DOI 10.1016/S0014-5793(00)01176-5; Gardiner JB, 1999, J AGR FOOD CHEM, V47, P3837, DOI 10.1021/jf9812679; Geshi N, 1998, PLANTA, V204, P295, DOI 10.1007/s004250050259; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Husebye H, 2005, INSECT BIOCHEM MOLEC, V35, P1311, DOI 10.1016/j.ibmb.2005.07.004; Jander G, 2001, PLANT PHYSIOL, V126, P890, DOI 10.1104/pp.126.2.890; Jones AME, 2002, INSECT BIOCHEM MOLEC, V32, P275, DOI 10.1016/S0965-1748(01)00088-1; Jones AME, 2001, INSECT BIOCHEM MOLEC, V31, P1, DOI 10.1016/S0965-1748(00)00157-0; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kissen R, 2009, PHYTOCHEM REV, V8, P69, DOI 10.1007/s11101-008-9109-1; KJAER A, 1963, ACTA CHEM SCAND, V17, P2143; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; MACLEOD AJ, 1987, PHYTOCHEMISTRY, V26, P669, DOI 10.1016/S0031-9422(00)84763-9; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; PETROSKI RJ, 1985, PHYTOCHEMISTRY, V24, P213; PETROSKI RJ, 1982, PHYTOCHEMISTRY, V21, P1903, DOI 10.1016/0031-9422(82)83011-2; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Rohloff J, 2005, PHYTOCHEMISTRY, V66, P1941, DOI 10.1016/j.phytochem.2005.06.021; SPENCER GF, 1980, J SCI FOOD AGR, V31, P359, DOI 10.1002/jsfa.2740310406; Taipalensuu J, 1997, EUR J BIOCHEM, V250, P680, DOI 10.1111/j.1432-1033.1997.00680.x; THANGSTAD OP, 1991, PROTOPLASMA, V161, P85, DOI 10.1007/BF01322721; TOOKEY HL, 1973, CAN J BIOCHEM CELL B, V51, P1654, DOI 10.1139/o73-222; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Zabala MD, 2005, PHYTOCHEMISTRY, V66, P859, DOI 10.1016/j.phytochem.2005.02.026; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	62	101	107	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12057	12070		10.1074/jbc.M807500200	http://dx.doi.org/10.1074/jbc.M807500200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19224919	hybrid, Green Published			2022-12-25	WOS:000265494600038
J	Montero-Hadjadje, M; Elias, S; Chevalier, L; Benard, M; Tanguy, Y; Turquier, V; Galas, L; Yon, L; Malagon, MM; Driouich, A; Gasman, S; Anouar, Y				Montero-Hadjadje, Maite; Elias, Salah; Chevalier, Laurence; Benard, Magalie; Tanguy, Yannick; Turquier, Valerie; Galas, Ludovic; Yon, Laurent; Malagon, Maria M.; Driouich, Azeddine; Gasman, Stephane; Anouar, Youssef			Chromogranin A Promotes Peptide Hormone Sorting to Mobile Granules in Constitutively and Regulated Secreting Cells ROLE OF CONSERVED N- AND C-TERMINAL PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; TRANS-GOLGI NETWORK; SECRETOGRANIN-III; NEUROENDOCRINE CELLS; TARGETED ABLATION; CHROMAFFIN CELLS; STORAGE PROTEIN; ON/OFF SWITCH; BIOGENESIS; PITUITARY	Chromogranin A (CgA) has been proposed to play a major role in the formation of dense-core secretory granules (DCGs) in neuroendocrine cells. Here, we took advantage of unique features of the frog CgA (fCgA) to assess the role of this granin and its potential functional determinants in hormone sorting during DCG biogenesis. Expression of fCgA in the constitutively secreting COS-7 cells induced the formation of mobile vesicular structures, which contained cotransfected peptide hormones. The fCgA and the hormones coexpressed in the newly formed vesicles could be released in a regulated manner. The N- and C-terminal regions of fCgA, which exhibit remarkable sequence conservation with their mammalian counterparts were found to be essential for the formation of the mobile DCG-like structures in COS-7 cells. Expression of fCgA in the corticotrope AtT20 cells increased pro-opiomelanocortin levels in DCGs, whereas the expression of N- and C-terminal deletion mutants provoked retention of the hormone in the Golgi area. Furthermore, fCgA, but not its truncated forms, promoted pro-opiomelanocortin sorting to the regulated secretory pathway. These data demonstrate that CgA has the intrinsic capacity to induce the formation of mobile secretory granules and to promote the sorting and release of peptide hormones. The conserved terminal peptides are instrumental for these activities of CgA.	[Montero-Hadjadje, Maite; Elias, Salah; Tanguy, Yannick; Turquier, Valerie; Yon, Laurent; Anouar, Youssef] Univ Rouen, Equipe Associe Neuronal & Neuroendocrine Differen, INSERM, European Inst Peptide Res IFRMP 23,U413, F-76821 Mont St Aignan, France; [Chevalier, Laurence; Driouich, Azeddine] Univ Rouen, Format Rech Evolut CNRS 3090, IFRMP23, F-76821 Mont St Aignan, France; [Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14014, Spain; [Gasman, Stephane] Univ Strasbourg, Dept Neurotransmiss & Neuroendocrine Secret, Unite Proprede Rech 3212, CNRS,Inst Neurosci Cellulaires & Integrat, F-67084 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anouar, Y (corresponding author), Univ Rouen, Equipe Associe Neuronal & Neuroendocrine Differen, INSERM, European Inst Peptide Res IFRMP 23,U413, F-76821 Mont St Aignan, France.	youssef.anouar@univ-rouen.fr	Montero-Hadjadje, Maite/AAC-5692-2019; galas, ludovic/A-2500-2014; stéphane, gasman/Q-1145-2019; Malagon, Maria M/L-5386-2014; Anouar, Youssef/F-9683-2017; Gasman, Stephane/D-5113-2017; Yon, Laurent/E-1981-2016	Montero-Hadjadje, Maite/0000-0001-8859-893X; stéphane, gasman/0000-0001-8415-1276; Malagon, Maria M/0000-0002-2419-2727; Gasman, Stephane/0000-0001-8415-1276; Yon, Laurent/0000-0002-5420-5779; Elias, Salah/0000-0003-1005-438X	INSERM; Conseil Regional de Haute- Normandie; COMETE-3 Network [PHRC AOM-06179]; Ministere des Affaires Etrangeres; Ministerio de Educacion y Ciencia [HF2005-0053]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Haute- Normandie(Region Normandie); COMETE-3 Network; Ministere des Affaires Etrangeres; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by INSERM, the Conseil Regional de Haute- Normandie, the COMETE-3 Network (Grant PHRC AOM-06179), the Ministere des Affaires Etrangeres, and the Ministerio de Educacion y Ciencia (Grant HF2005-0053).	Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; CHANAT E, 1994, FEBS LETT, V351, P225, DOI 10.1016/0014-5793(94)00865-5; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Gorr SU, 1996, J BIOL CHEM, V271, P3575; Han L, 2008, MOL ENDOCRINOL, V22, P1935, DOI 10.1210/me.2008-0006; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; JEGOU S, 1983, GEN COMP ENDOCR, V51, P246, DOI 10.1016/0016-6480(83)90078-3; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Montero-Hadjadje M, 2002, CELL TISSUE RES, V310, P223, DOI 10.1007/s00441-002-0625-9; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; MOORE HPH, 1985, J CELL BIOL, V101, P1773, DOI 10.1083/jcb.101.5.1773; Morvan J, 2008, HISTOCHEM CELL BIOL, V129, P243, DOI 10.1007/s00418-008-0377-z; Natori S, 1996, P NATL ACAD SCI USA, V93, P4431, DOI 10.1073/pnas.93.9.4431; Peinado JR, 2006, ENDOCRINOLOGY, V147, P1408, DOI 10.1210/en.2005-0975; SEIDAH NG, 1987, FEBS LETT, V211, P144, DOI 10.1016/0014-5793(87)81425-4; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Turquier V, 1999, ENDOCRINOLOGY, V140, P4104, DOI 10.1210/en.140.9.4104; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; YOO SH, 1994, J BIOL CHEM, V269, P12001; Yoo SH, 2005, FEBS LETT, V579, P222, DOI 10.1016/j.febslet.2004.11.079; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8816, DOI 10.1021/bi00085a012; Yoo SH, 1996, J BIOL CHEM, V271, P1558; Yoo SH, 2000, J BIOL CHEM, V275, P15067, DOI 10.1074/jbc.M909391199	45	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12420	12431		10.1074/jbc.M805607200	http://dx.doi.org/10.1074/jbc.M805607200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19179339	Green Published, hybrid			2022-12-25	WOS:000265494600072
J	Bu, WY; Chou, AM; Lim, KB; Sudhaharan, T; Ahmed, S				Bu, Wenyu; Chou, Ai Mei; Lim, Kim Buay; Sudhaharan, Thankiah; Ahmed, Sohail			The Toca-1-N-WASP Complex Links Filopodial Formation to Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-WASP; MEMBRANE INVAGINATION; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; PLASMA-MEMBRANE; CDC42; DYNAMIN; PROTEIN; GROWTH; RHO	The transducer of Cdc42-dependent actin assembly (Toca-1)-N-WASP complex was isolated as an essential cofactor for Cdc42-driven actin polymerization in vitro. Toca-1 consists of an N-terminal F-BAR domain, followed by a Cdc42 binding site (HR1 domain) and an SH3 domain, (the N-WASP interacting site). N-WASP is an activator of actin nucleation through the Arp2/3 complex. The aim of the present study was to investigate the cellular function of the Toca-1-N-WASP complex. We report that Toca-1 induces filopodia and neurites as does N-WASP in N1E115 neuroblastoma cells. Toca-1 requires the F-BAR domain, Cdc42 binding site, and SH3 domain to induce filopodia. Toca-1 and N-WASP both require each other to induce filopodia. The expression of Toca-1 and N-WASP affects the distribution, size, and number of Rab5 positive membranes. Toca-1 interacts directly with N-WASP in filopodia and Rab5 membrane as seen by Forster resonance energy transfer. Thus the Toca-1-N-WASP complex localizes to and induces the formation of filopodia and endocytic vesicles. Last, three inhibitors of endocytosis, Dynamin-K44A, Eps15 Delta 95/295, and clathrin heavy chain RNA interference, block Toca-1-induced filopodial formation. Taken together, these data suggest that the Toca-1-N-WASP complex can link filopodial formation to endocytosis.	[Bu, Wenyu; Chou, Ai Mei; Lim, Kim Buay; Sudhaharan, Thankiah; Ahmed, Sohail] Inst Med Biol, Singapore 138665, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799				Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bray D., 2001, CELL MOVEMENT MOL MO; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Cotteret S, 2002, GENOME BIOL, V3; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kozma R, 1996, MOL CELL BIOL, V16, P5069; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sarner S, 2000, MOL CELL BIOL, V20, P158, DOI 10.1128/MCB.20.1.158-172.2000; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	51	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11622	11636		10.1074/jbc.M805940200	http://dx.doi.org/10.1074/jbc.M805940200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213734	Green Published, hybrid			2022-12-25	WOS:000265494500066
J	Claperon, C; Banegas-Font, I; Iturrioz, X; Rozenfeld, R; Maigret, B; Llorens-Cortes, C				Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Maigret, Bernard; Llorens-Cortes, Catherine			Identification of Threonine 348 as a Residue Involved in Aminopeptidase A Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RENIN-ANGIOTENSIN SYSTEM; EXOPEPTIDASE SPECIFICITY; ENZYMATIC-ACTIVITY; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; BP-1/6C3 ANTIGEN; BLOOD-PRESSURE; BRAIN NUCLEI; INHIBITORS	Aminopeptidase A (APA; EC 3.4.11.7) is a membrane-bound zinc metalloprotease cleaving in the brain the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the central control of blood pressure in hypertensive animals. We docked the specific APA inhibitor, glutamate phosphonate, in the three-dimensional model of the mouse APA ectodomain in the presence of Ca2+. In the S1 subsite of this model, the Ca2+ atom was coordinated with Asp-213, Asp-218, y and Glu-215 and three water molecules, one of which formed a hydrogen bond with the carboxylate side chain of the inhibitor. We report here that the carboxylate side chain of glutamate phosphonate also formed a hydrogen bond with the alcohol side chain of Thr-348. Mutagenic replacement of Thr-348 with an aspartate, tyrosine, or serine residue led to a modification of the hydrolysis velocity, with no change in the affinity of the recombinant enzymes for the substrate GluNA, either in the absence or presence of Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA, which was nevertheless restored by the addition of Ca2+. An analysis of three-dimensional models of the corresponding Thr-348 mutants revealed that the interaction between this residue and the inhibitor was abolished or disturbed, leading to a change in the position of the inhibitor in the active site. These findings demonstrate a key role of Thr-348 in substrate specificity of APA for N-terminal acidic amino acids by insuring the optimal positioning of the substrate during catalysis.	[Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] INSERM, U691, F-75231 Paris 05, France; [Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] Coll France, FR-75005 Paris, France; [Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] Univ Paris 06, FR-75006 Paris, France; [Maigret, Bernard] CNRS, UMR 7503, FR-54506 Vandoeuvre Les Nancy, France; [Maigret, Bernard] Lab Lorrain Rech Informat & Ses Applicat, FR-54506 Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Llorens-Cortes, C (corresponding author), INSERM, U691, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Iturrioz, Xavier/AAS-3555-2020; ITURRIOZ, Xavier/Q-4406-2017; Font, Inmaculada Banegas/H-4290-2011; Llorens-Cortes, Catherine/E-5839-2016; Llorens-Cortès, catherine/AAL-3893-2021	Iturrioz, Xavier/0000-0001-7143-8323; ITURRIOZ, Xavier/0000-0001-7143-8323; Llorens-Cortes, Catherine/0000-0002-7667-0401; Llorens-Cortès, catherine/0000-0002-7667-0401; Banegas Font, Inmaculada/0000-0002-1910-3726	Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique institutes	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique institutes(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a grant from the Fondation pour la Recherche Medicale, by the Institut National de la Sante et de la Recherche Medicale, and by the Centre National de la Recherche Scientifique institutes.	Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; CHAUVEL EN, 1994, J MED CHEM, V37, P2950, DOI 10.1021/jm00044a016; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; DANIELSEN EM, 1980, BIOCHEM J, V189, P591, DOI 10.1042/bj1890591; de Mota N, 2008, J NEUROCHEM, V106, P416, DOI 10.1111/j.1471-4159.2008.05402.x; Ferreira AJ, 2008, HYPERTENSION, V51, P1273, DOI 10.1161/HYPERTENSIONAHA.107.109561; Fournie-Zaluski MC, 2004, P NATL ACAD SCI USA, V101, P7775, DOI 10.1073/pnas.0402312101; GLENNER GG, 1962, NATURE, V194, P867, DOI 10.1038/194867a0; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; ITURRIOZ X, 2004, AMINOPEPTIDASE INHIB; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEJCZAK B, 1993, J ENZYM INHIB, V7, P97, DOI 10.3109/14756369309040752; LODJA Z, 1980, HISTOCHEMISTRY, V67, P267; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; NAGATSU I, 1970, BIOCHIM BIOPHYS ACTA, V198, P255, DOI 10.1016/0005-2744(70)90058-6; Reaux A, 2000, BIOCHEM SOC T, V28, P435, DOI 10.1042/0300-5127:0280435; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; Rozenfeld R, 2003, BIOCHEMISTRY-US, V42, P14785, DOI 10.1021/bi034358u; Rozenfeld R, 2002, J BIOL CHEM, V277, P29242, DOI 10.1074/jbc.M204406200; Schottel BL, 2008, CHEM SOC REV, V37, P68, DOI 10.1039/b614208g; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WILK S, 1993, ADV NEUROIMMUNOL, V3, P195, DOI 10.1016/S0960-5428(05)80021-X; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; Zini S, 1997, NEUROSCIENCE, V78, P1187, DOI 10.1016/S0306-4522(96)00660-4; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	35	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10618	10626		10.1074/jbc.M806783200	http://dx.doi.org/10.1074/jbc.M806783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228697	hybrid, Green Published			2022-12-25	WOS:000265104600036
J	Philominathan, STL; Koide, T; Hamada, K; Yasui, H; Seifert, S; Matsushita, O; Sakon, J				Philominathan, Sagaya Theresa Leena; Koide, Takaki; Hamada, Kentaro; Yasui, Hiroyuki; Seifert, Soenke; Matsushita, Osamu; Sakon, Joshua			Unidirectional Binding of Clostridial Collagenase to Triple Helical Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; PROTEIN INTERACTIONS; DUPUYTRENS-DISEASE; NMR-SPECTROSCOPY; DOMAIN; HISTOLYTICUM; ASSIGNMENTS; PEPTIDASE; AFFINITY; MODELS	Histotoxic clostridia produce collagenases responsible for extensive tissue destruction in gas gangrene. The C-terminal collagen-binding domain (CBD) of these enzymes is the minimal segment required to bind to collagen fibril. Collagen binding efficiency of CBD is more pronounced in the presence of Ca2+. We have shown that CBD can be functional to anchor growth factors in local tissue. A H-1-N-15 HSQC NMR titration study with three different tropocollagen analogues ((POG)(10))(3), ((GPOG)(7)PRG)(3), and (GPRG(POG)(7)C-carbamidomethyl)(3), mapped a saddle-like binding cleft on CBD. NMR titrations with three nitroxide spin-labeled analogues of collagenous peptide, (PROXYL-G(POG)(7)PRG)(3), (PROXYL-G(POG)(7))(3), and (GPRG(POG)(7)C-PROXYL)(3) (where PROXYL represents 2,2,5,5-tetramethyl-L-pyrrolidinyloxy), unambiguously demonstrated unidirectional binding of CBD to the tropocollagen analogues. Small angle x-rays cattering data revealed that CBD binds closer to a terminus for each of the five different tropocollagen analogues, which in conjunction with NMR titration studies, implies a binding mode where CBD binds to the C terminus of the triple helix.	[Philominathan, Sagaya Theresa Leena; Sakon, Joshua] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Koide, Takaki; Hamada, Kentaro] Waseda Univ, Dept Chem & Biochem, Sch Adv Sci & Engn, Tokyo 1698555, Japan; [Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto 6048414, Japan; [Seifert, Soenke] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Matsushita, Osamu] Kitasato Univ, Sch Med, Dept Microbiol & Parasitol, Kanagawa 2288555, Japan	University of Arkansas System; University of Arkansas Fayetteville; Waseda University; Kyoto Pharmaceutical University; United States Department of Energy (DOE); Argonne National Laboratory; Kitasato University	Philominathan, STL (corresponding author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.	pstleena@uark.edu	Sakon, Joshua/N-2289-2014; Yasui, Hiroyuki/AAW-7976-2020	Sakon, Joshua/0000-0002-8373-969X; Yasui, Hiroyuki/0000-0003-3317-3947	National Institutes of Health Center for Protein Structure and Function [NCRR COBRE 1 P20RR15569, INBRE P20RR16460.]; Japan Society for the Promotion of Science and Kagawa University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569, P20RR016460] Funding Source: NIH RePORTER	National Institutes of Health Center for Protein Structure and Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science and Kagawa University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by the National Institutes of Health Center for Protein Structure and Function Grants NCRR COBRE 1 P20RR15569 and INBRE P20RR16460. This work was also supported by the AR Biosciences Institute (ABI) and a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science and Kagawa University Project Research Fund 2005-2006.	Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; DeLano WL, 2002, PYMOL USERS MANUAL; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hajduk PJ, 1999, Q REV BIOPHYS, V32, P211, DOI 10.1017/S0033583500003528; Jain NU, 2001, PROTEIN SCI, V10, P2393, DOI 10.1110/ps.17401; Kelly JA, 2005, BIOCHEM J, V389, P569, DOI 10.1042/BJ20041722; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; KONIG S, 1992, BIOCHEMISTRY-US, V31, P8726; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Philominathan STL, 2008, BIOMOL NMR ASSIGN, V2, P127, DOI 10.1007/s12104-008-9102-z; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	30	24	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10868	10876		10.1074/jbc.M807684200	http://dx.doi.org/10.1074/jbc.M807684200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208618	Green Published, hybrid			2022-12-25	WOS:000265104600060
J	Adinolfi, E; Callegari, MG; Cirillo, M; Pinton, P; Giorgi, C; Cavagna, D; Rizzuto, R; Di Virgilio, F				Adinolfi, Elena; Callegari, Maria Giulia; Cirillo, Maria; Pinton, Paolo; Giorgi, Carlotta; Cavagna, Dario; Rizzuto, Rosario; Di Virgilio, Francesco			Expression of the P2X(7) Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP RECEPTOR; MACROPHAGE CULTURES; INTRACELLULAR CA2+; OXIDIZED ATP; P2 RECEPTORS; CELL-DEATH; CANCER; GROWTH; TRANSCRIPTION; DIFFERENTIATION	The P2X(7) receptor is known for the cytotoxic activity because of its ability to cause opening of non-selective pores in the plasma membrane and activate apoptotic caspases. A key factor of P2X(7)-dependent cytotoxicity is the massive intracellular Ca2+ increase triggered by its activation. Here we show that P2X(7) transfection increased the ability of the endoplasmic reticulum to accumulate, store, and release Ca2+. This caused a larger agonist-stimulated increase in cytosol and mitochondrial Ca2+ in P2X(7) transfectants than in mock transfected cells. P2X(7) transfectants survived and even proliferated in serum-free conditions and were resistant to apoptosis triggered by ceramide, staurosporin, or intracellular Zn2+ chelation. Finally, the nuclear factor of activated T cells complex 1 (NFATc1) was strongly activated in the P2X(7) transfectants. These observations support our previous finding that the P2X(7) receptor under tonic conditions of stimulation, i.e. those observed in response to basal ATP release, has an anti-apoptotic or even growth promoting rather than cytotoxic activity.	[Adinolfi, Elena; Callegari, Maria Giulia] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Cirillo, Maria; Pinton, Paolo; Giorgi, Carlotta; Cavagna, Dario; Rizzuto, Rosario; Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Adinolfi, E (corresponding author), Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, Via Borsari 46, I-44100 Ferrara, Italy.	elena.adinolfi@unife.it	Adinolfi, Elena/F-9169-2010; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	Adinolfi, Elena/0000-0001-8129-9929; Pinton, Paolo/0000-0001-7108-6508; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Rizzuto, Rosario/0000-0001-7044-5097; Giorgi, Carlotta/0000-0002-2494-7405	National Institutes of Health [1P01AG025532-01A1]; Italian Association for Cancer Research; Italian Space Agency; Italian Ministry of University and Scientific Research; Commission of European Communities 7th Framework Program [HEALTH-F2-2007-202231]; PRRIITT program of the Emilia Romagna Region; United Mitochondrial Disease Foundation; University of Ferrara; Telethon of Italy; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Commission of European Communities 7th Framework Program(European Commission); PRRIITT program of the Emilia Romagna Region; United Mitochondrial Disease Foundation; University of Ferrara; Telethon of Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01AG025532-01A1 (to R. R.). This work was also supported by grants from the Italian Association for Cancer Research (to F. D. V. and P. P.), Telethon of Italy (to F. D. V. and R. R.), the Italian Space Agency (to F. D. V. and R. R.), the Italian Ministry of University and Scientific Research (to F. D. V. and R. R.), the Commission of European Communities 7th Framework Program HEALTH-F2-2007-202231 (to F. D. V.), the PRRIITT program of the Emilia Romagna Region (to R. R and P. P.), the United Mitochondrial Disease Foundation (to P. P.), institutional funds from the University of Ferrara (to F. D. V., R. R., and P. P.), and the project young researchers of the University of Ferrara (to E. A.).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Chiozzi P, 1996, BIOCHEM BIOPH RES CO, V218, P176, DOI 10.1006/bbrc.1996.0031; CHOE CU, 2006, SCI STKE, pRE15; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Dumont FJ, 2000, CURR MED CHEM, V7, P731, DOI 10.2174/0929867003374723; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Fulgenzi A, 2008, INT J IMMUNOPATH PH, V21, P61, DOI 10.1177/039463200802100108; Gartland A, 2003, CALCIFIED TISSUE INT, V73, P361, DOI 10.1007/s00223-002-2098-y; Greig AVH, 2003, J INVEST DERMATOL, V121, P315, DOI 10.1046/j.1523-1747.2003.12379.x; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hillman KA, 2005, NEPHRON EXP NEPHROL, V101, pE24, DOI 10.1159/000086036; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lee M, 2006, MOL CELLS, V22, P1; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Slater M, 2005, HISTOPATHOLOGY, V47, P170, DOI 10.1111/j.1365-2559.2005.02155.x; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Viola JPB, 2005, BRAZ J MED BIOL RES, V38, P335, DOI 10.1590/S0100-879X2005000300003; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	49	85	85	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10120	10128		10.1074/jbc.M805805200	http://dx.doi.org/10.1074/jbc.M805805200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19204004	hybrid, Green Published			2022-12-25	WOS:000264892900054
J	Kang, Y; Lee, JH; Hoan, NN; Sohn, HM; Chang, IY; You, HJ				Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; Sohn, Hong-Moon; Chang, In-Youb; You, Ho Jin			Protein Phosphatase 5 Regulates the Function of 53BP1 after Neocarzinostatin-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; TETRATRICOPEPTIDE REPEAT DOMAIN; HISTONE H2AX; CHECKPOINT ACTIVATION; V(D)J RECOMBINATION; TUMOR-SUPPRESSOR; REPAIR; ATM; PROTEIN-PHOSPHATASE-5	53BP1 (p53-binding protein 1) is a conserved nuclear protein that is phosphorylated in response to DNA damage and rapidly recruited to the site of DNA double strand breaks, demonstrating its role in the early events to DNA damage and repair of damaged DNA. In this study, we used the yeast two-hybrid system to identify proteins that interact with 53BP1. Identification and characterization of 53BP1 protein interactions may help to further elucidate the function and regulation of 53BP1. We identified protein phosphatase 5 (PP5), a serine/threonine phosphatase that has been implicated in multiple cellular function, as a 53BP1-binding protein. This interaction further confirmed that 53BP1 interacts with PP5 in PP5-overexpressing U2OS cells, after radiomimetic agent neocarzinostatin (NCS) treatment. 53BP1 dephosphorylation at Ser-25 and Ser-1778 was accelerated in PP5-overexpressing U2OS cells following NCS treatment, and its dephosphorylation was correlated with reduced phospho-53BP1 foci formation. In contrast, the overexpression of PP5 had no effect on NCS-activated BRCA1-Ser1524 phosphorylation. Additionally, PP5 down-regulation inhibited the dephosphorylation of 53BP1 on Ser-1778 and the disappearance of phospho-53BP1 foci following NCS treatment. Moreover, non-homologous end-joining activity was reduced in PP5-overexpressing U2OS cells. These findings indicate that PP5 plays an important role in the regulation of 53BP1 phosphorylation and activity in vivo.	[Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; You, Ho Jin] Chosun Univ, Dept Pharmacol, Kwangju 501759, South Korea; [Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; You, Ho Jin] Chosun Univ, Dept Biomat, Kwangju 501759, South Korea; [Sohn, Hong-Moon] Chosun Univ, Dept Orthoped Surg, Kwangju 501759, South Korea; [Chang, In-Youb] Chosun Univ, Dept Anat, Kwangju 501759, South Korea	Chosun University; Chosun University; Chosun University; Chosun University	You, HJ (corresponding author), 2F Chosun Univ, DNA Repair Res Ctr, BioEngn BD, Sch Med, 375 Seosuk Dong, Kwangju 501759, South Korea.	hjyou@chosun.ac.kr		Chang, In-Youb/0000-0002-8911-7541; You, Ho Jin/0000-0002-0530-4017	Ministry of Science and Technology, the Korean Government [M1063901, M20706000032]	Ministry of Science and Technology, the Korean Government(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported in part by Grants M1063901 and M20706000032 from the Ministry of Science and Technology, the Korean Government.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 2006, GENES CELLS, V11, P935, DOI 10.1111/j.1365-2443.2006.00989.x; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi J, 2008, J RADIAT RES, V49, P93, DOI 10.1269/jrr.07130; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lee H, 2009, BIOCHEM BIOPH RES CO, V378, P32, DOI 10.1016/j.bbrc.2008.10.150; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Mochan TA, 2003, CANCER RES, V63, P8586; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nakamura A, 2006, METHOD ENZYMOL, V409, P236, DOI 10.1016/S0076-6879(05)09014-2; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward I, 2004, CURR TOP DEV BIOL, V63, P1, DOI 10.1016/S0070-2153(04)63001-8; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005	50	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9845	9853		10.1074/jbc.M809272200	http://dx.doi.org/10.1074/jbc.M809272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176521	Green Published, hybrid			2022-12-25	WOS:000264892900025
J	Kim, MS; Zeng, WZ; Yuan, JP; Shin, DM; Worley, PF; Muallem, S				Kim, Min Seuk; Zeng, Weizhong; Yuan, Joseph P.; Shin, Dong Min; Worley, Paul F.; Muallem, Shmuel			Native Store-operated Ca2+ Influx Requires the Channel Function of Orai1 and TRPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CALCIUM-CHANNELS; LIPID RAFTS; STIM1; ENTRY; RELEASE; ACTIVATION; SECRETION; PROTEINS; CURRENTS	With the discovery of STIM1 and Orai1 and gating of both TRPC and Orai1 channels by STIM1, a central question is the role of each of the channels in the native store-operated Ca2+ influx (SOCs). Here, we used a strategy of knockdown of Orai1 and of TRPC1 alone and in combination and rescue by small interfering RNA-protected mutants (sm) of smOrai1 and smTRPC1 to demonstrate that in human embryonic kidney (HEK) cells, rescue of SOCs required co-transfection of low levels of both smOrai1 and smTRPC1. The pore mutant Orai1(E106Q) failed to rescue the SOCs in the presence or absence of TRPC1 and, surprisingly, the pore mutant TRPC1(F562A) failed to rescue the SOCs in the presence or absence of Orai1. TRPC1 is gated by electrostatic interaction between TRPC1(D639D, D640D) with STIM1(K684K, K685K). Strikingly, the channel-dead TRPC1(D639K, D640K) that can be rescued only by the STIM1(K684E, K685E) mutant could restore SOCs only when expressed with Orai1 and STIM1( K684E, K685E). Accordingly, we found a mutual requirement of Orai1 and TRPC1 for their interaction with the native STIM1 in HEK cells. By contrast, SOC and the CRAC current in Jurkat cells were inhibited by knockdown of Orai1 but were not influenced by knockdown on TRPC1 or TRPC3. These findings define the molecular makeup of the native SOCs in HEK cells and the role of a STIM1-Orai1-TRPC1 complex in SOC activity.	[Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Shin, Dong Min] Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Oral Biol, Seoul 120752, South Korea; [Kim, Min Seuk; Zeng, Weizhong; Yuan, Joseph P.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Johns Hopkins University; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu		Shin, Dong Min/0000-0001-6042-0435	National Institutes of Health [DE12309, DK38938]; National Institute on Drug Abuse [DA00266, DA10309]; National Institute of Mental Health [MH068830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010309, P50DA000266, R01DA010309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant Grants DE12309 and DK38938 and by the National Institute on Drug Abuse ( Grants DA00266 and DA10309) and the National Institute of Mental Health ( Grant MH068830) ( to P. F. W.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Petersen OH, 2006, CELL CALCIUM, V40, P593, DOI 10.1016/j.ceca.2006.08.020; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	40	126	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9733	9741		10.1074/jbc.M808097200	http://dx.doi.org/10.1074/jbc.M808097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228695	Green Published, hybrid			2022-12-25	WOS:000264892900013
J	Kumaran, S; Yi, H; Krishnan, HB; Jez, JM				Kumaran, Sangaralingam; Yi, Hankuil; Krishnan, Hari B.; Jez, Joseph M.			Assembly of the Cysteine Synthase Complex and the Regulatory Role of Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; SULFUR ASSIMILATION; MOLECULAR-CLONING; REACTION-MECHANISM; THIOL LYASE; ACTIVE-SITE; BIOSYNTHESIS; PLANTS; GLUTATHIONE	Macromolecular assemblies play critical roles in regulating cellular functions. The cysteine synthase complex (CSC), which is formed by association of serine O-acetyltransferase (SAT) and O-acetylserine sulfhydrylase (OASS), acts as a sensor and modulator of thiol metabolism by responding to changes in nutrient conditions. Here we examine the oligomerization and energetics of formation of the soybean CSC. Biophysical examination of the CSC by size exclusion chromatography and sedimentation ultracentrifugation indicates that this assembly (complex M-r similar to 330,000) consists of a single SAT trimer (trimer M-r similar to 110,000) and three OASS dimers (dimer M-r similar to 70,000). Analysis of the SAT-OASS interaction by isothermal titration calorimetry reveals negative cooperativity with three distinct binding events during CSC formation with K-d values of 0.3, 7.5, and 78 nM. The three binding events are also observed using surface plasmon resonance with comparable affinities. The stability of the CSC derives from rapid association and extremely slow dissociation of OASS with SAT and requires the C terminus of SAT for the interaction. Steady-state kinetic analysis shows that CSC formation enhances SAT activity and releases SAT from substrate inhibition and feedback inhibition by cysteine, the final product of the biosynthesis pathway. Cysteine inhibits SAT and the CSC with K-i values of 2 and 70 mu M, respectively. These results suggest a new model for the architecture of this regulatory complex and additional control mechanisms for biochemically controlling plant cysteine biosynthesis. Based on previous work and our results, we suggest that OASS acts as an enzyme chaperone of SAT in the CSC.	[Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kumaran, Sangaralingam; Yi, Hankuil; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Krishnan, Hari B.] Univ Missouri, Dept Agron, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			United States Department of Agriculture [NRI-2005-02518]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture Grant NRI-2005-02518 (to J. M. J.).	Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; Chronis D, 2003, CROP SCI, V43, P1819, DOI 10.2135/cropsci2003.1819; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; Dominguez-Solis JR, 2008, P NATL ACAD SCI USA, V105, P16386, DOI 10.1073/pnas.0808204105; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Hell R, 2002, AMINO ACIDS, V22, P245, DOI 10.1007/s007260200012; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; HRAZDINA G, 1992, ANNU REV PLANT PHYS, V43, P241, DOI 10.1146/annurev.pp.43.060192.001325; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kocsy G, 2000, PLANTA, V210, P295, DOI 10.1007/PL00008137; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Kumaran Sangaralingam, 2008, P97, DOI 10.1007/978-3-540-76326-0_5; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; NIETOSOTELO J, 1986, PLANT PHYSIOL, V82, P1031, DOI 10.1104/pp.82.4.1031; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2007, PLANT CELL, V19, P625, DOI 10.1105/tpc.106.043125; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Zhu X, 1998, BIOSCI BIOTECH BIOCH, V62, P947, DOI 10.1271/bbb.62.947	43	61	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10268	10275		10.1074/jbc.M900154200	http://dx.doi.org/10.1074/jbc.M900154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213732	hybrid, Green Published			2022-12-25	WOS:000264892900068
J	Okrent, RA; Brooks, MD; Wildermuth, MC				Okrent, Rachel A.; Brooks, Matthew D.; Wildermuth, Mary C.			Arabidopsis GH3.12 (PBS3) Conjugates Amino Acids to 4-Substituted Benzoates and Is Inhibited by Salicylate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN TIR1; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; LITHOSPERMUM-ERYTHRORHIZON; ISOCHORISMATE SYNTHASE; DISEASE RESISTANCE; AUXIN RECEPTOR; CHORISMIC ACID; PLANTS; BIOSYNTHESIS	Salicylate ( SA, 2-hydroxybenzoate) is a phytohormone best known for its role as a critical mediator of local and systemic plant defense responses. In response to pathogens such as Pseudomonas syringae, SA is synthesized and activates widespread gene expression. In gh3.12/pbs3 mutants of Arabidopsis thaliana, induced total SA accumulation is significantly compromised as is SA-dependent gene expression and plant defense. AtGH3 subfamily I and II members have been shown to conjugate phytohormone acyl substrates to amino acids in vitro, with this role supported by in planta analyses. Here we sought to determine the in vitro biochemical activity and kinetic properties of GH3.12/avrPphB susceptible 3 (PBS3), a member of the uncharacterized AtGH3 subfamily III. Using a novel high throughput adenylation assay, we characterized the acyl substrate preference of PBS3. We found PBS3 favors 4-substituted benzoates such as 4-aminobenzoate and 4-hydroxybenzoate, with moderate activity on benzoate and no observed activity with 2-substituted benzoates. Similar to known GH3 enzymes, PBS3 catalyzes the conjugation of specific amino acids ( e. g. Glu) to its preferred acyl substrates. Kinetic analyses indicate 4-aminobenzoate and 4-hydroxybenzoate are preferred acyl substrates as PBS3 exhibits both higher affinities ( apparent K-m = 153 and 459 mu M, respectively) and higher catalytic efficiencies (k(cat)/K-m = 0.0179 and 0.0444 mu M-1 min(-1), respectively) with these acyl substrates compared with benzoate (apparent K-m = 867 mu M, k(cat)/K-m = 0.0046 mu M-1 min(-1)). Notably, SA specifically and reversibly inhibits PBS3 activity with an IC50 of 15 mu M. This suggests a general mechanism for the rapid, reversible regulation of GH3 activity and small molecule cross-talk. For PBS3, this may allow for coordination of flux through diverse chorismate-derived pathways.	[Okrent, Rachel A.; Brooks, Matthew D.; Wildermuth, Mary C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wildermuth, MC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	wildermuth@nature.berkeley.edu		Brooks, Matthew D./0000-0002-6081-6103; Okrent, Rachel/0000-0002-8053-3223	National Science Foundation Arabidopsis [MCB-0420267]	National Science Foundation Arabidopsis(National Science Foundation (NSF))	This work was supported by National Science Foundation Arabidopsis 2010 Grant MCB-0420267 ( to M. C. W.).	Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Beuerle T, 2002, ARCH BIOCHEM BIOPHYS, V400, P258, DOI 10.1016/S0003-9861(02)00026-7; BOURNE DJ, 1991, PHYTOCHEMISTRY, V30, P4041, DOI 10.1016/0031-9422(91)83462-T; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chen F, 2003, PLANT J, V36, P577, DOI 10.1046/j.1365-313X.2003.01902.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; FIGULY G, 1996, ENCYCLOPEDIA; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GAJEWSKI JJ, 1987, J AM CHEM SOC, V109, P1170, DOI 10.1021/ja00238a029; GIBSON F, 1964, BIOCHEM J, V90, P256, DOI 10.1042/bj0900256; GLASS NL, 1988, J BACTERIOL, V170, P2367, DOI 10.1128/jb.170.5.2367-2373.1988; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; GLEITZ J, 1991, PLANTA, V184, P362, DOI 10.1007/BF00195338; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Lee MW, 2008, PLANT J, V54, P452, DOI 10.1111/j.1365-313X.2008.03439.x; Lee MW, 2007, MOL PLANT MICROBE IN, V20, P1192, DOI 10.1094/MPMI-20-10-1192; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lu FC, 2004, ORG BIOMOL CHEM, V2, P2888, DOI 10.1039/b411428k; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; OBRIEN WE, 1976, ANAL BIOCHEM, V76, P423, DOI 10.1016/0003-2697(76)90337-7; Orsomando G, 2006, PLANT J, V46, P426, DOI 10.1111/j.1365-313X.2006.02685.x; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Quinlivan EP, 2006, ANAL BIOCHEM, V348, P163, DOI 10.1016/j.ab.2005.09.017; Rudolph F B, 1979, Methods Enzymol, V63, P138; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Song JT, 2006, MOL CELLS, V22, P233; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; STEFFAN H, 1988, VITIS, V27, P79; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; SUZUKI Y, 1988, PLANT CELL PHYSIOL, V29, P439; Swiezewska E, 2004, METHOD ENZYMOL, V378, P124; Tan JW, 2004, PHYTOCHEMISTRY, V65, P691, DOI 10.1016/j.phytochem.2003.12.009; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; TRENNHEUSER F, 1994, PHYTOCHEMISTRY, V37, P899, DOI 10.1016/S0031-9422(00)90380-7; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Warren RF, 1999, GENETICS, V152, P401; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Zhang GF, 2005, RAPID COMMUN MASS SP, V19, P963, DOI 10.1002/rcm.1878	59	108	111	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9742	9754		10.1074/jbc.M806662200	http://dx.doi.org/10.1074/jbc.M806662200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189963	Green Published, hybrid			2022-12-25	WOS:000264892900014
J	Ren, GP; Stephan, D; Xu, ZH; Zheng, Y; Tang, DM; Harrison, RS; Kurz, M; Jarrott, R; Shouldice, SR; Hiniker, A; Martin, JL; Heras, B; Bardwell, JCA				Ren, Guoping; Stephan, Daniel; Xu, Zhaohui; Zheng, Ying; Tang, Danming; Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Hiniker, Annie; Martin, Jennifer L.; Heras, Begona; Bardwell, James C. A.			Properties of the Thioredoxin Fold Superfamily Are Modulated by a Single Amino Acid Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTAL-STRUCTURE; IN-VIVO; DESTABILIZING DISULFIDE; DIRECTED EVOLUTION; CXXC-MOTIF; DSBA; BOND	The ubiquitous thioredoxin fold proteins catalyze oxidation, reduction, or disulfide exchange reactions depending on their redox properties. They also play vital roles in protein folding, redox control, and disease. Here, we have shown that a single residue strongly modifies both the redox properties of thioredoxin fold proteins and their ability to interact with substrates. This residue is adjacent in three-dimensional space to the characteristic CXXC active site motif of thioredoxin fold proteins but distant in sequence. This residue is just N-terminal to the conservative cis-proline. It is isoleucine 75 in the case of thioredoxin. Our findings support the conclusion that a very small percentage of the amino acid residues of thioredoxin-related proteins are capable of dictating the functions of these proteins.	[Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Martin, Jennifer L.; Heras, Begona] Univ Queensland, Special Res Ctr Funct & Appl Gen, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Martin, Jennifer L.; Heras, Begona] Univ Queensland, Special Res Ctr Funct & Appl Gen, Australian Res Council, Brisbane, Qld 4072, Australia; [Ren, Guoping; Stephan, Daniel; Hiniker, Annie; Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ren, Guoping; Stephan, Daniel; Zheng, Ying; Tang, Danming; Hiniker, Annie; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Hiniker, Annie] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Hiniker, Annie] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA	University of Queensland; University of Queensland; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Heras, B (corresponding author), Univ Queensland, Special Res Ctr Funct & Appl Gen, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	b.heras@imb.uq.edu.au	Xu, Zhi Ping/G-4987-2011; Ren, Guoping/D-8601-2012; Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Martin, Jennifer L./0000-0002-9225-8863	National Institutes of Health; Australian Research Council; University of Queensland Early Career Research Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); University of Queensland Early Career Research Award(University of Queensland)	This work was supported, in whole or in part, by a grant from the National Institutes of Health (to J.C. A.B.). This work was also supported by the Australian Research Council (to B.H. and J.L.M.) and a University of Queensland Early Career Research Award (to B.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Georgescu RE, 1998, BIOCHEMISTRY-US, V37, P10286, DOI 10.1021/bi9805083; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; HAHN J, 1986, SYST APPL MICROBIOL, V7, P178; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Hibbert EG, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-29; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Johannes TW, 2006, CURR OPIN MICROBIOL, V9, P261, DOI 10.1016/j.mib.2006.03.003; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; WOYCECHOWSKY K, 2008, BIOCHEMISTRY-US, V42, P5387; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	55	88	89	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10150	10159		10.1074/jbc.M809509200	http://dx.doi.org/10.1074/jbc.M809509200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19181668	Green Published, hybrid			2022-12-25	WOS:000264892900057
J	Sanabria, H; Swulius, MT; Kolodziej, SJ; Liu, J; Waxham, MN				Sanabria, Hugo; Swulius, Matthew T.; Kolodziej, Steven J.; Liu, Jun; Waxham, M. Neal			beta CaMKII Regulates Actin Assembly and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; 2-PHOTON CROSS-CORRELATION; DENDRITIC SPINES; CORRELATION SPECTROSCOPY; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; IN-VIVO; PLASTICITY; ORGANIZATION; MAINTENANCE	Ca2+-Calmodulin-dependent protein kinase II ( CaMKII) is an abundant synaptic protein that was recently shown to regulate the organization of actin filaments leading to structural modifications of synapses. CaMKII is a dodecameric complex with a special architecture that provides it with unique potential for organizing the actin cytoskeleton. We report using biochemical assays that the beta isoform of CaMKII binds to and bundles actin filaments, and the disposition of beta CaMKII within the actin bundles was revealed by cryoelectron tomography. In addition, beta CaMKII was found to inhibit actin polymerization, suggesting that it either serves as a capping protein or binds monomeric actin, reducing the amount of freely available monomers to nucleate polymer assembly. By means of fluorescent cross-correlation spectroscopy, we determined that beta CaMKII does indeed bind to monomeric actin, reaching saturation at a stoichiometry of 12: 1 actin monomers per beta CaMKII holoenzyme with a binding constant of 2.4 x 10(5) M-1. In cells, beta CaMKII has a dual functional role; it can sequester monomeric actin to reduce actin polymerization and can also bundle actin filaments. Together, these effects would impact both the dynamics of actin filament assembly and enhance the rigidity of the filaments once formed, significantly impacting the structure of synapses.	[Sanabria, Hugo; Swulius, Matthew T.; Kolodziej, Steven J.; Waxham, M. Neal] Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Liu, Jun] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Waxham, MN (corresponding author), Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, 6431 Fannin,Rm 7-254 MSB, Houston, TX 77030 USA.	m.n.waxham@uth.tmc.edu		Waxham, M. Neal/0000-0003-4801-1190; Sanabria, Hugo/0000-0001-7068-6827	NINDS [R01 NS26086]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026086, T32NS007467] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS26086 from NINDS ( to M. N. W.).	BEAN A, 2007, PROTEIN TRAFFICKING, P3; Caran N, 2001, J BIOL CHEM, V276, P42514, DOI 10.1074/jbc.M103013200; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Halpain S, 2003, NAT NEUROSCI, V6, P101, DOI 10.1038/nn0203-101; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Iyer V, 2006, J OPT SOC AM B, V23, P1420, DOI 10.1364/JOSAB.23.001420; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Kohl T, 2002, P NATL ACAD SCI USA, V99, P12161, DOI 10.1073/pnas.192433499; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KREIS T, 1999, GUIDEBOOK CYTOSKELET, P3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; OHTA Y, 1986, FEBS LETT, V208, P423, DOI 10.1016/0014-5793(86)81061-4; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanabria H, 2007, BIOPHYS J, V92, P313, DOI 10.1529/biophysj.106.090498; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Schwille P, 2001, CHEMPHYSCHEM, V2, P269, DOI 10.1002/1439-7641(20010518)2:5<269::AID-CPHC269>3.0.CO;2-Y; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007	38	54	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9770	9780		10.1074/jbc.M809518200	http://dx.doi.org/10.1074/jbc.M809518200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208632	Green Published, hybrid			2022-12-25	WOS:000264892900017
J	Vonck, J; Pisa, KY; Morgner, N; Brutschy, B; Muller, V				Vonck, Janet; Pisa, Kim Y.; Morgner, Nina; Brutschy, Bernhard; Mueller, Volker			Three-dimensional Structure of A(1)A(0) ATP Synthase from the Hyperthermophilic Archaeon Pyrococcus furiosus by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSARCINA-MAZEI GO1; A-TYPE; NA+-ATPASE; ROTOR RING; V-ATPASE; MOLECULAR ARCHITECTURE; METHANOPYRUS-KANDLERI; THERMUS-THERMOPHILUS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	The archaeal ATP synthase is a multisubunit complex that consists of a catalytic A(1) part and a transmembrane, ion translocation domain A(0). The A(1)A(0) complex from the hyperthermophile Pyrococcus furiosus was isolated. Mass analysis of the complex by laser-induced liquid bead ion desorption (LILBID) indicated a size of 730 +/- 10 kDa. A three-dimensional map was generated by electron microscopy from negatively stained images. The map at a resolution of 2.3 nm shows the A(1) and A(0) domain, connected by a central stalk and two peripheral stalks, one of which is connected to A(0), and both connected to A(1) via prominent knobs. X-ray structures of subunits from related proteins were fitted to the map. On the basis of the fitting and the LILBID analysis, a structural model is presented with the stoichiometry A(3)B(3)CDE(2)FH(2)ac(10).	[Vonck, Janet] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Pisa, Kim Y.; Mueller, Volker] Goethe Univ, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Morgner, Nina; Brutschy, Bernhard] Goethe Univ, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Vonck, J (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	janet.vonck@mpibp-frankfurt.mpg.de	Mueller, Volker/ABE-4305-2021; Morgner, Nina/O-7021-2018; Morgner, Nina/I-7975-2012	Mueller, Volker/0000-0001-7955-5508; Morgner, Nina/0000-0002-1872-490X; Vonck, Janet/0000-0001-5659-8863	Deutsche Forschungsgemeinschaft [SFB 472]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 472, to V. M. and Werner Kuhlbrandt).	Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Biukovic G, 2007, BIOCHEMISTRY-US, V46, P2070, DOI 10.1021/bi062123n; BODE C, 1968, Z KLIN CHEM KLIN BIO, V6, P418; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Coskun U, 2004, J BIOL CHEM, V279, P22759, DOI 10.1074/jbc.M313741200; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; CROSS RL, 1990, FEBS LETT, V259, P227, DOI 10.1016/0014-5793(90)80014-A; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Fritz M, 2008, FEBS J, V275, P1999, DOI 10.1111/j.1742-4658.2008.06354.x; Gayen S, 2007, BIOCHEMISTRY-US, V46, P11684, DOI 10.1021/bi701102n; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2001, BIOCHEMISTRY-US, V40, P1890, DOI 10.1021/bi002195t; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Lolkema JS, 2003, FEBS LETT, V543, P47, DOI 10.1016/S0014-5793(03)00398-3; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maeder DL, 1999, GENETICS, V152, P1299; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; Morgner N, 2008, INT J MASS SPECTROM, V277, P309, DOI 10.1016/j.ijms.2008.08.001; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Muller V, 1999, J BIOENERG BIOMEMBR, V31, P15, DOI 10.1023/A:1005451311009; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; Numoto N, 2004, ACTA CRYSTALLOGR D, V60, P810, DOI 10.1107/S0907444904003257; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; PUOPOLO K, 1991, J BIOL CHEM, V266, P24564; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1111/j.1574-6968.2001.tb10496.x; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Ubbink-Kok T, 2000, J MOL BIOL, V296, P311, DOI 10.1006/jmbi.1999.3459; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	69	59	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10110	10119		10.1074/jbc.M808498200	http://dx.doi.org/10.1074/jbc.M808498200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203996	Green Published, hybrid			2022-12-25	WOS:000264892900053
J	Beauchamp, E; Bulut, G; Abaan, O; Chen, K; Merchant, A; Matsui, W; Endo, Y; Rubin, JS; Toretsky, J; Uren, A				Beauchamp, Elspeth; Bulut, Gulay; Abaan, Ogan; Chen, Kevin; Merchant, Akil; Matsui, William; Endo, Yoshimi; Rubin, Jeffrey S.; Toretsky, Jeffrey; Ueren, Aykut			GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; HEDGEHOG SIGNALING PATHWAY; EWINGS-SARCOMA; PANCREATIC-CANCER; HUMAN HOMOLOG; IN-VITRO; GENE; MUTATIONS; ACTIVATION; EXPRESSION	Ewing sarcoma family of tumors (ESFT) is an undifferentiated neoplasm of the bone and soft tissue. ESFT is characterized by a specific chromosomal translocation occurring between chromosome 22 and (in most cases) chromosome 11, which generates an aberrant transcription factor, EWS-FLI1. The function of EWS-FLI1 is essential for the maintenance of ESFT cell survival and tumorigenesis. The Hedgehog pathway is activated in several cancers. Oncogenic potential of the Hedgehog pathway is mediated by increasing the activity of the GLI family of transcription factors. Recent evidence suggests that EWS-FLI1 increases expression of GLI1 by an unknown mechanism. Our data from chromatin immunoprecipitation and promoter reporter studies indicated GLI1 as a direct transcriptional target of EWS-FLI1. Expression of EWS-FLI1 in non-ESFT cells increased GLI1 expression and GLI-dependent transcription. We also detected high levels of GLI1 protein in ESFT cell lines. Pharmacological inhibition of GLI1 protein function decreased proliferation and soft agar colony formation of ESFT cells. Our results establish GLI1 as a direct transcriptional target of EWS-FLI1 and suggest a potential role for GLI1 in ESFT tumorigenesis.	[Beauchamp, Elspeth; Bulut, Gulay; Abaan, Ogan; Chen, Kevin; Toretsky, Jeffrey; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Merchant, Akil; Matsui, William] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Endo, Yoshimi; Rubin, Jeffrey S.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uren, A (corresponding author), 3970 Reservoir Rd NW,NRB,Rm E312, Washington, DC 20057 USA.	au26@georgetown.edu	BULUT, GULAY/J-3180-2012; Matsui, William H/C-3383-2009	Matsui, William/0000-0002-3088-0964	National Institutes of Health [CA88004, CA10841]; Children's Cancer Foundation of Baltimore, MD; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA133662, T32CA009686, R01CA088004, ZIABC011224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Foundation of Baltimore, MD; Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA88004 (to J.T.) and CA10841 (to A.U.). This work was also supported by a grant from the Children's Cancer Foundation of Baltimore, MD, and the Intramural Research Program of the NCI, National Institutes of Health.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Chansky HA, 2004, J ORTHOPAED RES, V22, P910, DOI 10.1016/j.orthres.2003.12.008; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Dahlen A, 2004, AM J PATHOL, V164, P1645, DOI 10.1016/S0002-9440(10)63723-6; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liu CZ, 1998, GENE, V209, P1, DOI 10.1016/S0378-1119(97)00668-9; MAO XH, 1994, J BIOL CHEM, V269, P18216; Nessling M, 2005, CANCER RES, V65, P439; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; OUCHIDA M, 1995, ONCOGENE, V11, P1049; Pietsch T, 1997, CANCER RES, V57, P2085; Reifenberger J, 1998, CANCER RES, V58, P1798; ROBERTS WM, 1989, CANCER RES, V49, P5407; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Sandberg AA, 2000, CANCER GENET CYTOGEN, V123, P1, DOI 10.1016/S0165-4608(00)00295-8; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Uren A, 2004, BIOCHEMISTRY-US, V43, P13579, DOI 10.1021/bi048776q; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	42	123	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9074	9082		10.1074/jbc.M806233200	http://dx.doi.org/10.1074/jbc.M806233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189974	Green Published, hybrid			2022-12-25	WOS:000264669100010
J	Ning, K; Miller, LC; Laidlaw, HA; Watterson, KR; Gallagher, J; Sutherland, C; Ashford, MLJ				Ning, Ke; Miller, Lisa C.; Laidlaw, Hilary A.; Watterson, Kenneth R.; Gallagher, Jennifer; Sutherland, Calum; Ashford, Michael L. J.			Leptin-dependent Phosphorylation of PTEN Mediates Actin Restructuring and Activation of ATP-sensitive K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR PHOSPHATASE; SIGNALING PATHWAYS; INSULIN; INHIBITION; TYROSINE; NEURONS; CELLS; EXPLOITATION; STIMULATION	Leptin activates multiple signaling pathways in cells, including the phosphatidylinositol 3-kinase pathway, indicating a degree of cross-talk with insulin signaling. The exact mechanisms by which leptin alters this signaling pathway and how it relates to functional outputs are unclear at present. A previous study has established that leptin inhibits the activity of the phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome 10), an important tumor suppressor and modifier of phosphoinositide signaling. In this study we demonstrate that leptin phosphorylates multiple sites on the C-terminal tail of PTEN in hypothalamic and pancreatic beta-cells, an action not replicated by insulin. Inhibitors of the protein kinases CK2 and glycogen synthase kinase 3 (GSK3) block leptin-mediated PTEN phosphorylation. PTEN phosphorylation mutants reveal the critical role these sites play in transmission of the leptin signal to F-actin depolymerization. CK2 and GSK3 inhibitors also prevent leptin-mediated F-actin depolymerization and consequent ATP-sensitive K+ channel opening. GSK3 kinase activity is inhibited by insulin but not leptin in hypothalamic cells. Both hormones increase N-terminal GSK3 serine phosphorylation, but in hypothalamic cells this action of leptin is transient. Leptin, not insulin, increases GSK3 tyrosine phosphorylation in both cell types. These results demonstrate a significant role for PTEN in leptin signal transmission and identify GSK3 as a potential important signaling node contributing to divergent outputs for these hormones.	[Ning, Ke; Miller, Lisa C.; Laidlaw, Hilary A.; Watterson, Kenneth R.; Gallagher, Jennifer; Sutherland, Calum; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	University of Dundee	Ashford, MLJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland.	m.l.j.ashford@dundee.ac.uk	Ning, Ke/E-7837-2010; Ning, Ke/B-4561-2009	Ashford, Michael/0000-0002-0861-7676; Ning, Ke/0000-0002-0771-1134; Sutherland, Calum/0000-0003-4398-7434	Wellcome Trust, Tenovus Scotland, [068692]; Biotechnology and Biological Sciences Research Council Studentship	Wellcome Trust, Tenovus Scotland,(Wellcome Trust); Biotechnology and Biological Sciences Research Council Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 068692 (to M.L.J.A.), Tenovus Scotland, and a Biotechnology and Biological Sciences Research Council Studentship (to L.C.M.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Downes CP, 2007, ADV ENZYME REGUL, V47, P184, DOI 10.1016/j.advenzreg.2006.12.018; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maroni P, 2005, CELL BIOL INT, V29, P542, DOI 10.1016/j.cellbi.2005.03.008; Maroni P, 2003, MOL CELL ENDOCRINOL, V201, P109, DOI 10.1016/S0303-7207(02)00427-6; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Mirshamsi S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-54; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Niswender KD, 2003, FRONT NEUROENDOCRIN, V24, P1, DOI 10.1016/S0091-3022(02)00105-X; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; WANG QM, 1994, J BIOL CHEM, V269, P14566; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	49	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9331	9340		10.1074/jbc.M806774200	http://dx.doi.org/10.1074/jbc.M806774200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208634	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000264669100039
J	Seelan, RS; Lakshmanan, J; Casanova, MF; Parthasarathy, RN				Seelan, Ratnam S.; Lakshmanan, Jaganathan; Casanova, Manuel F.; Parthasarathy, Ranga N.			Identification of myo-Inositol-3-phosphate Synthase Isoforms CHARACTERIZATION, EXPRESSION, AND PUTATIVE ROLE OF A 16-kDa gamma(c) ISOFORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOINOSITOL 1-PHOSPHATE SYNTHASE; OBSESSIVE-COMPULSIVE DISORDER; INTRON RETENTION; SACCHAROMYCES-CEREVISIAE; INOSITOL TREATMENT; MESSENGER-RNA; RAT TESTIS; L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHOLIPID BIOSYNTHESIS; 3-PHOSPHATE SYNTHASE	myo-Inositol is an important constituent of membrane phospholipids and is a precursor for the phosphoinositide signaling pathway. It is synthesized from glucose 6-phosphate by myoinositol-3-phosphate synthase (IP synthase), a homotrimer composed of a 68-kDa polypeptide in most mammalian tissues. It is a putative target for mood-stabilizing drugs such as lithium and valproate. Here, we show that the rat gene (Isyna1) encoding this enzyme generates a number of alternatively spliced transcripts in addition to the fully spliced form that encodes the 68-kDa subunit (the alpha isoform). Specifically, we identify a small 16-kDa subunit (the gamma(c) isoform) derived by an intron retention mechanism and provide evidence for its existence in rat tissues. The gamma(c) isoform is highly conserved in mammals, but it lacks the catalytic domain while retaining the NAD(+) binding domain. Both alpha and gamma(c) isoforms are predominantly expressed in many rat tissues and display apparent stoichiometry in purified enzyme preparations. An IP synthase polyclonal antibody not only detects the alpha and gamma(c) isoforms but also several other isoforms in pancreas, intestine, and testis suggesting that the holoenzyme is composed of unique subunits in various tissues. Interestingly, the alpha isoform is not expressed in the intestine. IP synthase activity assays using purified alpha and gamma(c) isoforms indicate that the latter negatively modulates alpha isoform activity, possibly by competing for NAD(+) molecules. Our findings have important ramifications for understanding the mood stabilization process and suggest that inositol biosynthesis is a highly regulated and dynamic process.	[Seelan, Ratnam S.; Lakshmanan, Jaganathan; Casanova, Manuel F.; Parthasarathy, Ranga N.] Univ Louisville, Dept Psychiat & Behav Sci, Louisville, KY 40202 USA; [Parthasarathy, Ranga N.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Mental Hlth Serv, Mol & Neurosci Lab, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Behav Sci Serv, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Res Serv, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Mental Hlth Serv, Bioinformat Lab, Louisville, KY 40206 USA	University of Louisville; University of Louisville; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Seelan, RS (corresponding author), Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, 501 S Preston St, Louisville, KY 40202 USA.	rsseel01@louisville.edu	Casanova, Manuel F/G-8861-2016	Casanova, Manuel F/0000-0002-3874-844X; Seelan, Ratnam/0000-0002-8925-1070	COBRE program of the National Center for Research Resources (NCRR) [5P20RR017702]; NIH [MH69991, R24MH068855]; Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069991, R24MH068855] Funding Source: NIH RePORTER	COBRE program of the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20RR017702 from the COBRE program of the National Center for Research Resources (NCRR), a component of NIH (to R. S. S.). This work was also supported by NIH Grant MH69991 (to M. F. C.) and by the Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C. (to R. N. P.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. Human brain tissues were provided by the Harvard Brain Tissue Resource Center, which is supported in part by NIH Grant R24MH068855.	Acevedo LD, 1997, J MASS SPECTROM, V32, P395, DOI 10.1002/(SICI)1096-9888(199704)32:4<395::AID-JMS487>3.0.CO;2-#; ADHIKARI J, 1988, INDIAN J BIOCHEM BIO, V25, P408; Agam G, 2002, BIPOLAR DISORD, V4, P15, DOI 10.1034/j.1399-5618.4.s1.2.x; Auffray C, 2006, EXP CELL RES, V312, P233, DOI 10.1016/j.yexcr.2005.10.014; BENJAMIN J, 1995, AM J PSYCHIAT, V152, P1084; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Berry GT, 2004, MOL GENET METAB, V82, P87, DOI 10.1016/j.ymgme.2004.02.002; Blanco E, 2006, NEUROSCIENCE, V140, P1245, DOI 10.1016/j.neuroscience.2006.03.031; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chen J, 2002, J APPL PHYSIOL, V92, P1480, DOI 10.1152/japplphysiol.00077.2001; COCKROFT DL, 1988, TERATOLOGY, V38, P281, DOI 10.1002/tera.1420380312; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; Einat H, 2001, J AFFECT DISORDERS, V62, P113, DOI 10.1016/S0165-0327(00)00355-4; EISENBER.F, 1967, J BIOL CHEM, V242, P1375; EISENBERG F, 1964, BIOCHEM BIOPH RES CO, V14, P419, DOI 10.1016/0006-291X(64)90079-8; EISENBERG F, 1987, METHOD ENZYMOL, V141, P127; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Fux M, 1996, AM J PSYCHIAT, V153, P1219; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Greene NDE, 1997, NAT MED, V3, P60, DOI 10.1038/nm0197-60; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Harvey BH, 2002, PROG NEURO-PSYCHOPH, V26, P21, DOI 10.1016/S0278-5846(01)00244-5; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; HASEGAWA R, 1981, P NATL ACAD SCI-BIOL, V78, P4863, DOI 10.1073/pnas.78.8.4863; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jensen ON, 1999, METH MOL B, V112, P513; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Ju SL, 2004, CLIN NEUROSCI RES, V4, P181, DOI 10.1016/j.cnr.2004.09.010; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; KINDL H, 1964, BIOCHEM Z, V339, P374; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LEVINE J, 1995, AM J PSYCHIAT, V152, P792; LOEWUS FA, 1962, BIOCHEM BIOPH RES CO, V7, P204, DOI 10.1016/0006-291X(62)90175-4; Macri MA, 2006, NEUROBIOL AGING, V27, P98, DOI 10.1016/j.neurobiolaging.2005.01.007; MAEDA T, 1980, J BIOL CHEM, V255, P8458; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; MALHOTRA OP, 1973, P NATL ACAD SCI USA, V70, P2077, DOI 10.1073/pnas.70.7.2077; Mansilla A, 2005, EMBO REP, V6, P1182, DOI 10.1038/sj.embor.7400539; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; NACCARATO WF, 1974, ARCH BIOCHEM BIOPHYS, V164, P194, DOI 10.1016/0003-9861(74)90022-8; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Parthasarathy Latha K., 2006, V39, P293; Rivera-Gonzalez R, 1998, J STEROID BIOCHEM, V64, P13, DOI 10.1016/S0960-0760(97)00142-8; Rumpel H, 2003, J MAGN RESON IMAGING, V17, P11, DOI 10.1002/jmri.10233; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Seelan RS, 2004, ARCH BIOCHEM BIOPHYS, V431, P95, DOI 10.1016/j.abb.2004.08.002; Shamir A, 2003, MOL BRAIN RES, V115, P104, DOI 10.1016/S0169-328X(03)00120-7; Shamir A, 2007, BIPOLAR DISORD, V9, P766, DOI 10.1111/j.1399-5618.2007.00440.x; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; Silver SM, 2006, J NEUROPATH EXP NEUR, V65, P37, DOI 10.1097/01.jnen.0000195938.02292.39; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; WHITING PH, 1979, BIOCHEM J, V179, P549, DOI 10.1042/bj1790549; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; WONG YHH, 1987, J NEUROCHEM, V48, P1434, DOI 10.1111/j.1471-4159.1987.tb05682.x; Xiao S, 2008, J NEUROSCI, V28, P1833, DOI 10.1523/JNEUROSCI.3222-07.2008; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	78	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9443	9457		10.1074/jbc.M900206200	http://dx.doi.org/10.1074/jbc.M900206200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19188364	Green Published, hybrid			2022-12-25	WOS:000264669100051
J	Suzuki, T; Sawaki, D; Aizawa, K; Munemasa, Y; Matsumura, T; Ishida, J; Nagai, R				Suzuki, Toru; Sawaki, Daigo; Aizawa, Kenichi; Munemasa, Yoshiko; Matsumura, Takayoshi; Ishida, Junichi; Nagai, Ryozo			Kruppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR KLF5/BTEB2; CYCLIN D1; FACTOR KLF5; EXPRESSION; CANCER; GENE; P21(WAF1/CIP1); PROGRESSION; REGULATOR	Kruppel-like factor 5 (KLF5), originally isolated as a regulator of phenotypic modulation of vascular smooth muscle cells, induces pathological cell growth and is expressed in the neointima. Although induction of KLF5 up-regulates growth factors like platelet derived growth factor-A chain, how KLF5 actually contributes to vascular remodeling, notably its direct effects on cell proliferation, had been poorly clarified. To investigate the effects of KLF5 on neointimal formation, we at first performed adenoviral overexpression of KLF5 to rats subjected to carotid balloon injury. Neointimal formation and proliferating cell nuclear antigen-positive rate were significantly increased at 14 days after injury in the KLF5-treated animals. At the cellular level, overexpression of KLF5 also resulted in markedly increased cell proliferation and cell cycle progression. As a molecular mechanism, we showed that KLF5 directly bound to the promoter and up-regulated gene expression of cyclin D1, as well as showing specific transactivation of cyclins and cyclin-dependent kinase inhibitors in cardiovascular cells. Conversely, knockdown of KLF5 by RNA interference specifically down-regulated cyclin D1 and impaired vascular smooth muscle cell proliferation. Furthermore, KLF5 attenuated cleavage of caspase-3 under conditions of apoptotic stimulation. Moreover, KLF5-administered animals exhibited a significant decrease in terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive cells in the medial layer, suggesting inhibition of apoptosis in the early phase after denudation. These findings collectively suggest that KLF5 plays a central role in cardiovascular pathologies through direct and specific stimulation of cell growth as well as inhibition of apoptosis.	[Suzuki, Toru; Sawaki, Daigo; Aizawa, Kenichi; Munemasa, Yoshiko; Matsumura, Takayoshi; Ishida, Junichi; Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp; nagai-tky@umin.ac.jp	SAWAKI, Daigo/T-6871-2018	SAWAKI, Daigo/0000-0003-1417-2033; Suzuki, Toru/0000-0002-8371-664X; , Junichi/0000-0001-9703-9419	Ministry of Education, Culture, Sports, Science, and Technology; New Energy Development Organization	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy Development Organization	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the New Energy Development Organization. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bennett MR, 2002, HEART, V87, P480, DOI 10.1136/heart.87.5.480; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hoshino Y, 2000, CIRCULATION, V102, P2528, DOI 10.1161/01.CIR.102.20.2528; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kang JH, 2006, DIABETOLOGIA, V49, P969, DOI 10.1007/s00125-006-0179-6; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Mayr M, 2001, EXP GERONTOL, V36, P969, DOI 10.1016/S0531-5565(01)00090-0; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Munemasa Y, 2008, MOL CELL BIOL, V28, P1171, DOI 10.1128/MCB.01396-07; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Ogata T, 2000, TRANSPLANTATION, V70, P1653, DOI 10.1097/00007890-200012150-00019; Perlman H, 1997, CIRCULATION, V95, P981; Sakamoto H, 2003, CARDIOLOGY, V100, P80, DOI 10.1159/000073043; Sata M, 2003, ARTERIOSCL THROM VAS, V23, P1548, DOI 10.1161/01.ATV.0000089327.48154.32; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sherr CJ, 2002, CELL CYCLE, V1, P36, DOI 10.4161/cc.1.1.106; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200	41	64	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9549	9557		10.1074/jbc.M806230200	http://dx.doi.org/10.1074/jbc.M806230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189969	Green Published, hybrid			2022-12-25	WOS:000264669100061
J	Tawaratsumida, K; Furuyashiki, M; Katsumoto, M; Fujimoto, Y; Fukase, K; Suda, Y; Hashimoto, M				Tawaratsumida, Kazuki; Furuyashiki, Maiko; Katsumoto, Mami; Fujimoto, Yukari; Fukase, Koichi; Suda, Yasuo; Hashimoto, Masahito			Characterization of N-terminal Structure of TLR2-activating Lipoprotein in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GINGIVAL FIBROBLASTS; LIPOTEICHOIC ACID LTA; CELL-WALL COMPONENTS; TOLL-LIKE RECEPTOR-2; MYCOPLASMA-SALIVARIUM; ENTEROCOCCUS-HIRAE; HOST RECOGNITION; CUTTING EDGE; ACTIVATION; PEPTIDOGLYCAN	Staphylococcus aureus is known to activate mammalian immune cells through Toll-like receptor 2 (TLR2). We recently demonstrated that a lipoprotein fraction obtained from S. aureus by Triton X-114 phase partitioning is a potent activator of TLR2. In this study, we separated TLR2-activating lipoproteins expressed in S. aureus and characterized an N-terminal structure. The lipoprotein fraction of S. aureus was prepared by glass bead disruption followed by Triton X-114 phase partitioning. The TLR2-activating molecules were mainly detected in the mass range of 30-35 kDa. Seven lipoproteins were identified by the mass spectra of their tryptic digests. Among them, three lipoproteins were separated by preparative SDS-PAGE and proved to activate TLR2. After digestion with trypsin in the presence of sodium deoxycholate, the N terminus of the lipopeptide was isolated from lipoprotein SAOUHSC_02699 by normal phase high pressure liquid chromatography and characterized as an S-(diacyloxypropyl) cystein-containing peptide using tandem mass spectra. The synthetic lipopeptide counterpart also stimulated the cells via TLR2. These results showed that the diacylated lipoprotein from S. aureus acts as a TLR2 ligand in mammalian cells.	[Tawaratsumida, Kazuki; Suda, Yasuo; Hashimoto, Masahito] Kagoshima Univ, Dept Nanostruct & Adv Mat, Kagoshima 8900065, Japan; [Furuyashiki, Maiko] Kagoshima Univ, Venture Business Lab, Kagoshima 8900065, Japan; [Katsumoto, Mami; Fujimoto, Yukari; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan	Kagoshima University; Kagoshima University; Osaka University	Hashimoto, M (corresponding author), Kagoshima Univ, Dept Nanostruct & Adv Mat, Korimoto 1-21-40, Kagoshima 8900065, Japan.	hassy@eng.kagoshima-u.ac.jp	Fujimoto, Yukari/M-7282-2014	Fujimoto, Yukari/0000-0001-5320-3192	Uehara Memorial Foundation	Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a research grant from The Uehara Memorial Foundation.	Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hashimoto M, 1997, J BIOCHEM-TOKYO, V121, P779; Hashimoto M, 2000, BIOCHEM BIOPH RES CO, V273, P164, DOI 10.1006/bbrc.2000.2921; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jensen ON, 1999, METH MOL B, V112, P513; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE HK, 2002, J IMMUNOL, V8, P4007; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Shibata K, 1997, FEMS IMMUNOL MED MIC, V19, P275, DOI 10.1016/S0928-8244(97)00093-X; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; SUDA Y, 1995, FEMS IMMUNOL MED MIC, V12, P97, DOI 10.1111/j.1574-695X.1995.tb00181.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; WALLIS RS, 1990, P NATL ACAD SCI USA, V87, P3348, DOI 10.1073/pnas.87.9.3348; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103	35	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9147	9152		10.1074/jbc.M900429200	http://dx.doi.org/10.1074/jbc.M900429200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218237	Green Published, hybrid			2022-12-25	WOS:000264669100019
J	Waggoner, SA; Johannes, GJ; Liebhaber, SA				Waggoner, Shelly A.; Johannes, Gregg J.; Liebhaber, Stephen A.			Depletion of the Poly(C)-binding Proteins alpha CP1 and alpha CP2 from K562 Cells Leads to p53-independent Induction of Cyclin-dependent Kinase Inhibitor (CDKN1A) and G(1) Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(RC) BINDING-PROTEIN; MESSENGER-RNA STABILITY; 5' UNTRANSLATED REGION; POLIOVIRUS RNA; POSTTRANSCRIPTIONAL REGULATION; 3'-UNTRANSLATED REGION; NONCODING REGION; NUCLEIC-ACID; CANCER CELLS; IDENTIFICATION	The alpha-globin poly(C)-binding proteins (alpha CPs) comprise an abundant and widely expressed set of K-homolog domain RNA-binding proteins. alpha CPs regulate the expression of a number of cellular and viral mRNAs at the levels of splicing, stability, and translation. Previous surveys have identified 160 mRNAs that are bound by alpha CP in the human hematopoietic cell line, K562. To explore the functions of these alpha CP/mRNA interactions, we identified mRNAs whose levels are altered in K562 cells acutely depleted of the two major alpha CP proteins, alpha CP1 and alpha CP2. Microarray analysis identified 27 mRNAs that are down-regulated and 14 mRNAs that are up-regulated in the alpha CP1/2-codepleted cells. This alpha CP1/2 co-depletion was also noted to inhibit cell proliferation and trigger a G(1) cell cycle arrest. Targeted analysis of genes involved in cell cycle control revealed a marked increase in p21(WAF) mRNA and protein. Analysis of mRNP complexes in K562 cells demonstrates in vivo association of p21WAF mRNA with alpha CP1 and alpha CP2. In vitro binding assays indicate that a 127-nucleotide region of the 3'-untranslated region of p21WAF interacts with both alpha CP1 and alpha CP2, and co-depletion of alpha CP1/2 results in a marked increase in p21WAF mRNA half-life. p21WAF induction and G1 arrest in the alpha CP1/2-co-depleted cells occur in the absence of p53 and are not observed in cells depleted of the individual alpha CP isoforms. The apparent redundancy in the actions of alpha CP1 and alpha CP2 upon p21WAF expression correlates with a parallel redundancy in their effects on cell cycle control. These data reveal a pivotal role for alpha CP1 and alpha CP2 in a p53-independent pathway of p21WAF control and cell cycle progression.	[Waggoner, Shelly A.; Liebhaber, Stephen A.] Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA; [Johannes, Gregg J.] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19102 USA	University of Pennsylvania; Drexel University	Liebhaber, SA (corresponding author), 415 Curie Blvd,560A CRB, Philadelphia, PA 19104 USA.	liebhabe@mail.med.upenn.edu			National Institutes of Health [PO1-CA72765, MERIT HL 65449, K01 DK-071137-04]; NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065449, R01HL065449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1-CA72765, MERIT HL 65449, and K01 DK-071137-04.	AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castano Z, 2008, INT J CANCER, V122, P1512, DOI 10.1002/ijc.23236; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; DelSal G, 1996, ONCOGENE, V12, P177; EL DW, 1993, CELL, V75, P817; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Funke B, 1996, NUCLEIC ACIDS RES, V24, P3821, DOI 10.1093/nar/24.19.3821; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gamarnik AV, 1997, RNA, V3, P882; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; HARPER JW, 1993, CELL, V75, P805; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Kim HS, 2005, MECH AGEING DEV, V126, P1255, DOI 10.1016/j.mad.2005.07.002; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Makeyev AV, 2000, GENOMICS, V67, P301, DOI 10.1006/geno.2000.6244; Murray KE, 2001, RNA, V7, P1126, DOI 10.1017/S1355838201010044; NEVINS JR, 1992, SCIENCE, V258, P424; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Paillard L, 2000, MECH DEVELOP, V93, P117, DOI 10.1016/S0925-4773(00)00279-3; Parsley TB, 1997, RNA, V3, P1124; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Spangberg K, 1999, J GEN VIROL, V80, P1371, DOI 10.1099/0022-1317-80-6-1371; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Tommerup N, 1996, GENOMICS, V32, P297, DOI 10.1006/geno.1996.0121; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; WENGONG W, 2000, MOL CELL BIOL, V20, P760; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	52	49	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9039	9049		10.1074/jbc.M806986200	http://dx.doi.org/10.1074/jbc.M806986200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211566	hybrid, Green Published			2022-12-25	WOS:000264669100006
J	Lauwers, A; Twyffels, L; Soin, R; Wauquier, C; Kruys, V; Gueydan, C				Lauwers, Aurelien; Twyffels, Laure; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril			Post-transcriptional Regulation of Genes Encoding Anti-microbial Peptides in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; AU-RICH ELEMENT; ACTIVATED PROTEIN-KINASE; P-BODY FORMATION; IMMUNE-RESPONSE; NUCLEOTIDE-SEQUENCE; TRISTETRAPROLIN; MELANOGASTER; DEGRADATION; PATHWAYS	Secretion of antimicrobial peptides (AMPep) is a central defense mechanism used by invertebrates to combat infections. In Drosophila the synthesis of these peptides is a highly regulated process allowing their rapid release in the hemolymph upon contact with pathogens and the arrest of their production after pathogen clearance. We observed that AMPep genes have either a transient or sustained expression profile in S2 Drosophila cells treated with peptidoglycan. Moreover, AMPep genes containing AU-rich elements (ARE) in their 3'-untranslated region (UTR) are subject to a post-transcriptional control affecting mRNA stability, thereby contributing to their transient expression profile. Cecropin A1 (CecA1) constitutes the prototype of this latter class of AMPeps. CecA1 mRNA bears in its 3'-UTR an ARE similar to class II AREs found in several short-lived mammalian mRNAs. In response to immune deficiency cascade signaling activated by Gram-negative peptidoglycans, CecA1 mRNA is transiently stabilized and subsequently submitted to deadenylation and decay mediated by the ARE present in its 3'-UTR. The functionality of CecA1 ARE relies on its ability to recruit TIS11 protein, which accelerates CecA1 mRNA deadenylation and decay. Moreover, we observed that CecA1 mRNA deadenylation is a biphasic process. Whereas early deadenylation is independent of TIS11, the later deadenylation phase depends on TIS11 and is mediated by CAF1 deadenylase. We also report that in contrast to tristetraprolin, its mammalian homolog, TIS11, is constitutively expressed in S2 cells and accumulates in cytoplasmic foci distinct from processing bodies, suggesting that the Drosophila ARE-mediated mRNA deadenylation and decay mechanism is markedly different in invertebrates and mammals.	[Lauwers, Aurelien; Twyffels, Laure; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril] Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles	Gueydan, C (corresponding author), Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	cgueydan@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403	 [GFP-DcP1];  [GFP-GW182]	; 	We thank Louis Delhaye for help with antibody production and Dr. E. Izaurralde for the GFP-DcP1 and GFP-GW182 constructs.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Celotto Alicia M, 2004, Methods Mol Biol, V257, P245, DOI 10.1385/1-59259-750-5:245; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P147; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levitin A, 2007, EUKARYOT CELL, V6, P658, DOI 10.1128/EC.00346-06; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; RYU JH, SCIENCE, V319, P777; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; VARNUM BC, 1989, ONCOGENE, V4, P119; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	42	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8973	8983		10.1074/jbc.M806778200	http://dx.doi.org/10.1074/jbc.M806778200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176529	Green Published, hybrid			2022-12-25	WOS:000264397800080
J	Potet, F; Chagot, B; Anghelescu, M; Viswanathan, PC; Stepanovic, SZ; Kupershmidt, S; Chazin, WJ; Balser, JR				Potet, Franck; Chagot, Benjamin; Anghelescu, Mircea; Viswanathan, Prakash C.; Stepanovic, Svetlana Z.; Kupershmidt, Sabina; Chazin, Walter J.; Balser, Jeffrey R.			Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT; INACTIVATION GATE; LIDOCAINE BLOCK; CALCIUM; MECHANISMS; MUTATION; SCN5A; FLECAINIDE	Sodium channels are fundamental signaling molecules in excitable cells, and are molecular targets for local anesthetic agents and intracellular free Ca2+ ([Ca2+](i)). Two regions of Na(V)1.5 have been identified previously as [Ca2+]i-sensitive modulators of channel inactivation. These include a C-terminal IQ motif that binds calmodulin (CaM) in different modes depending on Ca2+ levels, and an immediately adjacent C-terminal EF-hand domain that directly binds Ca2+. Here we show that a mutation of the IQ domain (A1924T; Brugada Syndrome) that reduces CaM binding stabilizes Na(V)1.5 inactivation, similarly and more extensively than even reducing [Ca2+](i). Because the DIII-DIV linker is an essential structure in Na(V)1.5 inactivation, we evaluated this domain for a potential CaM binding interaction. We identified a novel CaM binding site within the linker, validated its interaction with CaM by NMR spectroscopy, and revealed its micromolar affinity by isothermal titration calorimetry. Mutation of three consecutive hydrophobic residues (Phe(1520)-Ile(1521)-Phe(1522)) to alanines in this CaM-binding domain recapitulated the electrophysiology phenotype observed with mutation of the C-terminal IQ domain: NaV1.5 inactivation was stabilized; moreover, mutations of either CaM-binding domain abolish the well described stabilization of inactivation by lidocaine. The direct physical interaction of CaM with the C-terminal IQ domain and the DIII-DIV linker, combined with the similarity in phenotypes when CaM-binding sites in either domain are mutated, suggests these cytoplasmic structures could be functionally coupled through the action of CaM. These findings have bearing upon Na+ channel function in genetically altered channels and under pathophysiologic conditions where [Ca2+](i) impacts cardiac conduction.	[Kupershmidt, Sabina; Balser, Jeffrey R.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Kupershmidt, Sabina; Balser, Jeffrey R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Viswanathan, Prakash C.] Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Potet, F (corresponding author), 2213 Garland Ave,Langford P445 MRB 4, Nashville, TN 37232 USA.	franck.potet@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Kupershmidt, Sabina/AAO-5464-2021; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; Kupershmidt, Sabina/0000-0002-8119-2723; 	National Institutes of Health NIGMS [GM56307-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056307] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant GM56307-11. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balser JR, 1996, J CLIN INVEST, V98, P2874, DOI 10.1172/JCI119116; Baroudi G, 2000, FEBS LETT, V487, P224, DOI 10.1016/S0014-5793(00)02360-7; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELUCA A, 1991, N-S ARCH PHARMACOL, V344, P596; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kambouris NG, 2000, J CLIN INVEST, V105, P1133, DOI 10.1172/JCI9212; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; OPIE LH, 1990, ANNU REV MED, V41, P231; POGWIZD SM, 1987, CIRC RES, V61, P352, DOI 10.1161/01.RES.61.3.352; Rivolta I, 2002, PHYSIOL GENOMICS, V10, P191, DOI 10.1152/physiolgenomics.00039.2002; Robert E, 1999, AM J PHYSIOL-HEART C, V276, pH413, DOI 10.1152/ajpheart.1999.276.2.H413; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Stummann TC, 2005, EUR J PHARMACOL, V510, P197, DOI 10.1016/j.ejphar.2005.01.030; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Vedantham V, 1999, J GEN PHYSIOL, V113, P7, DOI 10.1085/jgp.113.1.7; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Viswanathan PC, 2001, CIRCULATION, V104, P1200, DOI 10.1161/hc3501.093797; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WILLIAMS EMV, 1989, AM J CARDIOL, V64, pJ5; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yogeeswari P, 2004, CURR DRUG TARGETS, V5, P589, DOI 10.2174/1389450043345227	40	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8846	8854		10.1074/jbc.M806871200	http://dx.doi.org/10.1074/jbc.M806871200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171938	Green Published, hybrid			2022-12-25	WOS:000264397800067
J	Susuki, S; Sato, T; Miyata, M; Momohara, M; Suico, MA; Shuto, T; Ando, Y; Kai, H				Susuki, Seiko; Sato, Takashi; Miyata, Masanori; Momohara, Mamiko; Suico, Mary Ann; Shuto, Tsuyoshi; Ando, Yukio; Kai, Hirofumi			The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; MOLECULAR CHAPERONES; SECRETORY PATHWAY; ER; PROTEINS; COMPLEX; EXPORT; RETROTRANSLOCATION; TRAFFICKING	Amyloid fibril formation of mutant transthyretin (TTR) that causes familial amyloid polyneuropathy occurs in the extracellular space. Thus, secretion of TTR variants contributes to the pathogenesis of amyloidosis. However, the molecular mechanisms underlying the endoplasmic reticulum (ER) exit or retention and subsequent degradation of TTR variants remain unclear. Here, we demonstrated that the nonsecreted TTR variants, such as D18G TTR and amyloidogenic TTRs with introduced monomeric mutation (M-TTRs), stably interact with the ER chaperone BiP in mammalian cells. These proteins were co-secreted with the secreted form of BiP in which the KDEL signal was removed, indicating that BiP partially contributes to the ER retention of nonsecreted TTR variants. More interestingly, the degradation efficiency of nonsecreted TTRs was increased when BiP was down-regulated by small interfering RNA. Thus, BiP protects the TTR variants from immediate degradation. Additionally, we showed that the stability of nonsecreted TTR variants is not disturbed in the coat complex II-deficient conditions, which are enough to inhibit the ER export of secreted TTR variants, including wild-type TTR. Therefore, the post-ER retrieval mechanism might not contribute to the ER-associated degradation of nonsecreted TTR variants. These findings suggest that the affinity to the ER-resident protein BiP regulates the fate of TTR variants in the ER.	[Susuki, Seiko; Sato, Takashi; Miyata, Masanori; Momohara, Mamiko; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Med, Global Ctr Excellence Cell Fate Regulat Res & Edu, Kumamoto 8620973, Japan; [Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Kumamoto 8600811, Japan	Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Med, Global Ctr Excellence Cell Fate Regulat Res & Edu, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Sato, Takashi/AHB-5258-2022	Sato, Takashi/0000-0003-4203-0999; Ando, Yukio/0000-0001-7115-9105	Amyloidosis Research Committee; Pathogenesis and Therapy of Hereditary Neuropathy Research Committee; Surveys and Research on Specific Disease; Ministry of Health and Welfare of Japan; Charitable Trust Clinical Pathology Research Foundation of Japan; Ministry of Education, Science, Sports and Culture (MEXT) of Japan; Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Amyloidosis Research Committee; Pathogenesis and Therapy of Hereditary Neuropathy Research Committee; Surveys and Research on Specific Disease; Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Charitable Trust Clinical Pathology Research Foundation of Japan; Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Amyloidosis Research Committee, the Pathogenesis and Therapy of Hereditary Neuropathy Research Committee, Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan, the Charitable Trust Clinical Pathology Research Foundation of Japan, and grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan and from the Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan.	Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hashimoto Y, 2008, BBA-MOL CELL RES, V1783, P153, DOI 10.1016/j.bbamcr.2007.08.011; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lass A, 2008, INT J BIOCHEM CELL B, V40, P2865, DOI 10.1016/j.biocel.2008.06.003; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Okiyoneda T, 2004, J PHARMACOL SCI, V95, P471, DOI 10.1254/jphs.SC0040081; Sato T, 2007, EMBO J, V26, P2501, DOI 10.1038/sj.emboj.7601685; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Sorgjerd K, 2006, J MOL BIOL, V356, P469, DOI 10.1016/j.jmb.2005.11.051; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082	34	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8312	8321		10.1074/jbc.M809354200	http://dx.doi.org/10.1074/jbc.M809354200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19188365	hybrid, Green Published			2022-12-25	WOS:000264397800015
J	Zuo, X; Morris, JS; Broaddus, R; Shureiqi, I				Zuo, X.; Morris, J. S.; Broaddus, R.; Shureiqi, I.			15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells	ONCOGENE			English	Article						15-lipoxygenase-1; colon cancer; NuRD; MTA1	HUMAN COLORECTAL-CARCINOMA; HISTONE DEACETYLASE INHIBITORS; DRUG-INDUCED APOPTOSIS; 15-LIPOXYGENASE-1 EXPRESSION; INDUCE APOPTOSIS; DOWN-REGULATION; PROTEIN-1 MTA1; BREAST-CANCER; IN-VIVO; DIFFERENTIATION	15-Lipoxygenase-1 (15-LOX-1) is transcriptionally silenced in cancer cells, and its transcription reactivation (for example, through histone deacetylase inhibitors (HDACIs)) restores apoptosis to cancer cells. However, the exact mechanism underlying 15-LOX-1 transcription reactivation in cancer cells is still undefined. Therefore, we evaluated the critical mechanisms required for 15-LOX-1 transcription reactivation in colon cancer cells. Specific HDAC1 and HDAC2 inhibition activated 15-LOX-1 transcription. 15-LOX-1 transcription was repressed through transcription repressor complex recruitment in the region of -120 to -391 of the 15-LOX-1 promoter. The nucleosome remodeling and histone deacetylase (NuRD) repression complex was recruited to this region. Depsipeptide significantly reduced the recruitment of NuRD key components (for example, metastasis-associated protein 1 (MTA1) and HDAC1) to the 15-LOX-1 promoter before 15-LOX-1 transcriptional activation. Knock down of NuRD key components (for example, MTA1 and HDAC1) by small interfering RNA (siRNA) activated 15-LOX-1 transcription, as measured by luciferase reporter assays in stably transfected SW480 cells with the 15-LOX-1 promoter construct of the -391, but not the -120 region. Relative to expression in normal tissue, MTA1 expression in colorectal cancer mucosa from colorectal cancer patients was negatively related to 15-LOX-1 expression. Thus, our results show that NuRD contributes to 15-LOX-1 transcription suppression in colon cancer cells and that HDACIs can inhibit NuRD recruitment to a promoter to activate gene transcription, as in the case of 15-LOX-1.	[Zuo, X.; Shureiqi, I.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Morris, J. S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; [Broaddus, R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Shureiqi, I.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shureiqi, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ishureiqi@mdanderson.org	Shureiqi, imad/T-6214-2019	Shureiqi, Imad/0000-0003-2019-938X; Zuo, Xiangsheng/0000-0002-8593-1132	National Cancer Institute, National Institutes of Health, Department of Health and Human Services R01 [R01 CA106577, R01 CA104278]; Caroline Wiess Law Endowment for Cancer Prevention; Jerry and Maury Rubenstein Foundation; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [R01CA106577, R01CA104278] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Caroline Wiess Law Endowment for Cancer Prevention; Jerry and Maury Rubenstein Foundation; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services R01 grants CA106577 and CA104278; the Caroline Wiess Law Endowment for Cancer Prevention; the Jerry and Maury Rubenstein Foundation and the National Colorectal Cancer Research Alliance. We thank Merck and Company Inc., Gloucester Pharmaceuticals and the National Cancer Institute for providing SAHA and depsipeptide. We also thank Ann M. Sutton, Department of Scientific Publications, the University of Texas M D Anderson Cancer Center, for editing the manuscript.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; BAER AN, 1991, BIOCHEM BIOPH RES CO, V180, P98, DOI 10.1016/S0006-291X(05)81260-4; Balasenthil S, 2006, HUM PATHOL, V37, P656, DOI 10.1016/j.humpath.2006.01.024; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Chen GG, 2003, INT J CANCER, V107, P837, DOI 10.1002/ijc.11447; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Deguchi A, 2005, CANCER RES, V65, P8442, DOI 10.1158/0008-5472.CAN-05-1109; Furumai R, 2002, CANCER RES, V62, P4916; Giannini R, 2005, ANTICANCER RES, V25, P4287; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; GLEASON MM, 1995, AM J PHYSIOL-CELL PH, V268, pC1301; Hennig R, 2007, NEOPLASIA, V9, P917, DOI 10.1593/neo.07565; Heslin MJ, 2005, ANN SURG, V241, P941, DOI 10.1097/01.sla.0000164177.95620.c1; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Hsi LC, 2004, CANCER RES, V64, P8778, DOI 10.1158/0008-5472.CAN-04-1867; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Kamitani H, 1998, J BIOL CHEM, V273, P21569, DOI 10.1074/jbc.273.34.21569; Kamitani H, 2001, CARCINOGENESIS, V22, P187, DOI 10.1093/carcin/22.1.187; Kamitani H, 2000, FEBS LETT, V467, P341, DOI 10.1016/S0014-5793(00)01155-8; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Merchant N, 2005, ANN SURG, V241, P946; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Shureiqi I, 2000, J NATL CANCER I, V92, P1136, DOI 10.1093/jnci/92.14.1136; Shureiqi I, 2000, CANCER RES, V60, P6846; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2005, CANCER RES, V65, P11486, DOI 10.1158/0008-5472.CAN-05-2180; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Shureiqi I, 2002, CANCER RES, V62, P1178; Shureiqi I, 2001, CANCER RES, V61, P4879; Shureiqi I, 2007, FASEB J, V21, P743, DOI 10.1096/fj.06-6830com; Takamitsu S., 2006, VIRCHOWS ARCH, V448, P422; TAKATA S, 1994, J CLIN INVEST, V93, P499, DOI 10.1172/JCI116999; Wu J, 2003, CARCINOGENESIS, V24, P243, DOI 10.1093/carcin/24.2.243; Wu Y, 2008, MOL THER, V16, P886, DOI 10.1038/mt.2008.44; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160; Zuo XS, 2008, FASEB J, V22, P1981, DOI 10.1096/fj.07-098301	50	20	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1496	1505		10.1038/onc.2008.494	http://dx.doi.org/10.1038/onc.2008.494			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19198625	Green Accepted			2022-12-25	WOS:000264537400002
J	Lucas, JE; Carvalho, CM; Chen, JLY; Chi, JT; West, M				Lucas, Joseph E.; Carvalho, Carlos M.; Chen, Julia Ling-Yu; Chi, Jen-Tsan; West, Mike			Cross-Study Projections of Genomic Biomarkers: An Evaluation in Cancer Genomics	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EXPRESSION; METASTASIS; MOLECULES; PREDICT; GENES; RNA; MAP	Human disease studies using DNA microarrays in both clinical/observational and experimental/controlled studies are having increasing impact on our understanding of the complexity of human diseases. A fundamental concept is the use of gene expression as a "common currency'' that links the results of in vitro controlled experiments to in vivo observational human studies. Many studies - in cancer and other diseases - have shown promise in using in vitro cell manipulations to improve understanding of in vivo biology, but experiments often simply fail to reflect the enormous phenotypic variation seen in human diseases. We address this with a framework and methods to dissect, enhance and extend the in vivo utility of in vitro derived gene expression signatures. From an experimentally defined gene expression signature we use statistical factor analysis to generate multiple quantitative factors in human cancer gene expression data. These factors retain their relationship to the original, one-dimensional in vitro signature but better describe the diversity of in vivo biology. In a breast cancer analysis, we show that factors can reflect fundamentally different biological processes linked to molecular and clinical features of human cancers, and that in combination they can improve prediction of clinical outcomes.	[Lucas, Joseph E.; Chen, Julia Ling-Yu; Chi, Jen-Tsan] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Carvalho, Carlos M.] Univ Chicago, Grad Sch Business, Chicago, IL 60637 USA; [West, Mike] Duke Univ, Dept Stat Sci, Durham, NC 27706 USA	Duke University; University of Chicago; Duke University	Lucas, JE (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	joe@stat.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X	National Science Foundation [DMS-0342172]; National Institutes of Health [NCI U54-CA-112952]; NATIONAL CANCER INSTITUTE [U54CA112952] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research partially supported by National Science Foundation (DMS-0342172) and National Institutes of Health (NCI U54-CA-112952). Any opinions, findings and conclusions or recommendations expressed in this work are those of the authors and do not necessarily reflect the views of the NSF or NIH.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; CARVALHO C, 2008, J AM STAT A IN PRESS; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Erman M, 2004, ANN ONCOL, V15, P1622, DOI 10.1093/annonc/mdh437; Han HJ, 2002, EXP NEPHROL, V10, P355, DOI 10.1159/000065300; HANS C, 2007, B INT SOC BAYESIAN A, V24, P8; Hans C, 2007, J AM STAT ASSOC, V102, P507, DOI 10.1198/016214507000000121; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; HUANG E, 2002, HORM RES, V58, P55; Huang ES, 2003, CELL CYCLE, V2, P415, DOI 10.4161/cc.2.5.492; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LUCAS JE, 2008, IN VITRO IN IN PRESS; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nevins JR, 2003, HUM MOL GENET, V12, pR153, DOI 10.1093/hmg/ddg287; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; SCHLAG P, 1980, J CANCER RES CLIN, V97, P63, DOI 10.1007/BF00411279; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Seo DM, 2007, ANN APPL STAT, V1, P152, DOI 10.1214/07-AOAS110; Simoncini T, 1999, J CLIN ENDOCR METAB, V84, P815, DOI 10.1210/jc.84.2.815; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SPANG R, 2001, SILICO BIOL, V2; STOCK JL, 1992, J CELL PHYSIOL, V150, P517, DOI 10.1002/jcp.1041500312; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; West M, 2003, BAYESIAN STATISTICS 7, P733	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4523	10.1371/journal.pone.0004523	http://dx.doi.org/10.1371/journal.pone.0004523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225561	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486000005
J	Collins, CA; Gnocchi, VF; White, RB; Boldrin, L; Perez-Ruiz, A; Relaix, F; Morgan, JE; Zammit, PS				Collins, Charlotte A.; Gnocchi, Viola F.; White, Robert B.; Boldrin, Luisa; Perez-Ruiz, Ana; Relaix, Frederic; Morgan, Jennifer E.; Zammit, Peter S.			Integrated Functions of Pax3 and Pax7 in the Regulation of Proliferation, Cell Size and Myogenic Differentiation	PLOS ONE			English	Article							MUSCLE SATELLITE CELL; STEM-CELL; CYCLE PROGRESSION; PROGENITOR CELLS; NEURAL-TUBE; PAX3-FKHR; ACTIVATION; EXPRESSION; HETEROGENEITY; DISTINCT	Pax3 and Pax7 are paired-box transcription factors with roles in developmental and adult regenerative myogenesis. Pax3 and Pax7 are expressed by postnatal satellite cells or their progeny but are down regulated during myogenic differentiation. We now show that constitutive expression of Pax3 or Pax7 in either satellite cells or C2C12 myoblasts results in an increased proliferative rate and decreased cell size. Conversely, expression of dominant-negative constructs leads to slowing of cell division, a dramatic increase in cell size and altered morphology. Similarly to the effects of Pax7, retroviral expression of Pax3 increases levels of Myf5 mRNA and MyoD protein, but does not result in sustained inhibition of myogenic differentiation. However, expression of Pax3 or Pax7 dominant-negative constructs inhibits expression of Myf5, MyoD and myogenin, and prevents differentiation from proceeding. In fibroblasts, expression of Pax3 or Pax7, or dominant-negative inhibition of these factors, reproduce the effects on cell size, morphology and proliferation seen in myoblasts. Our results show that in muscle progenitor cells, Pax3 and Pax7 function to maintain expression of myogenic regulatory factors, and promote population expansion, but are also required for myogenic differentiation to proceed.	[Collins, Charlotte A.; Boldrin, Luisa; Morgan, Jennifer E.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Gnocchi, Viola F.; White, Robert B.; Perez-Ruiz, Ana; Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Relaix, Frederic] Univ Paris 06, UPMC, Grp Myol, INSERM, UMR S 787, Fac Med Pitie Salpetriere, Mouse Mol Genet Grp, F-75252 Paris, France	University of London; University College London; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Collins, CA (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	peter.zammit@kcl.ac.uk	Zammit, peter/GXV-7746-2022; Pérez-Ruiz, Ana/I-2910-2015; White, Robert/H-6080-2014	Pérez-Ruiz, Ana/0000-0002-9901-057X; Relaix, Frederic/0000-0003-1270-1472; White, Robert/0000-0002-2854-0936; zammit, peter/0000-0001-9562-3072; Collins, Charlotte/0000-0002-8715-9035	Muscular Dystrophy Campaign [RA3/711, RA3/762]; Medical Research Council [G0700307, Joint Collaborative Career Development Award in Stem Cell Research]; The Wellcome Trust [085137, university award]; Fundacion Ramon Areces [post-doctoral fellowship]; INSERM Avenir program, UPMC, Institut de Myologie, AFM; EU 6th framework programme MYORES network of excellence [511978]; Association of International Cancer Research; MRC [G0700307, G0601943] Funding Source: UKRI; Medical Research Council [G0601943, G0601943B] Funding Source: researchfish	Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Wellcome Trust(Wellcome Trust); Fundacion Ramon Areces; INSERM Avenir program, UPMC, Institut de Myologie, AFM; EU 6th framework programme MYORES network of excellence; Association of International Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C.A.C. and L.B. were funded by the Muscular Dystrophy Campaign (RA3/711). V.F.G. received support from the Medical Research Council (grant number G0700307). R.B.W. was funded by the Muscular Dystrophy Campaign (RA3/762), and currently, by The Wellcome Trust (085137), while A.P.R. was funded by a Fundacion Ramon Areces post-doctoral fellowship. F.R. is funded by the INSERM Avenir program, UPMC, Institut de Myologie, AFM and is a member of the EU 6th framework programme MYORES network of excellence. J.E.M. was funded by an MRC Joint Collaborative Career Development Award in Stem Cell Research and is currently funded by a Wellcome Trust university award. The laboratory of P.S.Z. is also supported by the Association of International Cancer Research and the MYORES Network of Excellence contract 511978 from the European Commission 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Du SY, 2005, INT J CANCER, V115, P85, DOI 10.1002/ijc.20844; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Gang EJ, 2008, EXP CELL RES, V314, P1721, DOI 10.1016/j.yexcr.2008.02.016; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jun S, 1996, DEVELOPMENT, V122, P2639; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; SCHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574, DOI 10.1093/nar/22.22.4574; Scuoppo C, 2007, EXP CELL RES, V313, P2308, DOI 10.1016/j.yexcr.2007.02.037; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wiggan O, 2002, J CELL SCI, V115, P517; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	45	90	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4475	10.1371/journal.pone.0004475	http://dx.doi.org/10.1371/journal.pone.0004475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221588	Green Published, gold, Green Submitted			2022-12-25	WOS:000265485700007
J	Moralli, D; Monaco, ZL				Moralli, Daniela; Monaco, Zoia L.			Simultaneous Detection of FISH Signals and Bromo-Deoxyuridine Incorporation in Fixed Tissue Cultured Cells	PLOS ONE			English	Article								FISH (Fluorescence in situ hybridization) is a powerful technique that detects and localises specific DNA sequences on metaphase chromosomes, interphase nuclei or chromatin fibres. When coupled to BrdU (5-Bromo 2-deoxy-uridine) labeling of newly replicated DNA, the replication properties of different DNA sequences can be analysed. However, the technique for the detection of BrdU incorporation is time consuming, and relies on acidic pH buffer treatments, that prevent use of pH sensitive fluorochromes such as FITC (Fluoro-isothiocianate) during FISH. In this work, we describe a simplified protocol that allows the simultaneous detection of FISH signals and BrdU incorporation. Since the technique does not involve paraformaldehyde for cell fixation, or formamide for denaturation of the target DNA and in post-hybridisation washes, it represents a safer alternative to classical FISH techniques.			Moralli, D (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	zoia@well.ox.ac.uk	Monaco, Zoia L/C-5762-2011; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alazami AM, 2004, GENOMICS, V83, P844, DOI 10.1016/j.ygeno.2003.11.011; Barbosa ACC, 2000, CHROMOSOME RES, V8, P645; Boggs BA, 1997, METHODS, V13, P259, DOI 10.1006/meth.1997.0525; Chow JC, 2003, CELL MOL LIFE SCI, V60, P2586, DOI 10.1007/s00018-003-3121-9; D'Antoni S, 2004, GENE, V333, P111, DOI 10.1016/j.gene.2004.02.029; DESARIO A, 1991, CYTOTECHNOLOGY, V7, P55, DOI 10.1007/BF00135639; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Mejia JE, 2001, AM J HUM GENET, V69, P315, DOI 10.1086/321977; SHIRAISHI Y, 1990, CANCER GENET CYTOGEN, V50, P175, DOI 10.1016/0165-4608(90)90178-D; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002	11	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4483	10.1371/journal.pone.0004483	http://dx.doi.org/10.1371/journal.pone.0004483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221585	Green Published, gold, Green Submitted			2022-12-25	WOS:000265485700010
J	Scott, CP; VanWye, J; McDonald, MD; Crawford, DL				Scott, Cinda P.; VanWye, Jeff; McDonald, M. Danielle; Crawford, Douglas L.			Technical Analysis of cDNA Microarrays	PLOS ONE			English	Article							GENE-EXPRESSION	Background: There is extensive variation in gene expression among individuals within and between populations. Accurate measures of the variation in mRNA expression using microarrays can be confounded by technical variation, which includes variation in RNA isolation procedures, day of hybridization and methods used to amplify and dye label RNA for hybridization. Methodology/Principal Findings: In this manuscript we analyze the relationship between the amount of mRNA and the fluorescent signal from the microarray hybridizations demonstrating that for a wide-range of mRNA concentrations the fluorescent signal is a linear function of the amount of mRNA. Additionally, the separate isolation, labeling or hybridization of RNA does not add significant amounts of variation in microarray measures of gene expression. However, single or double rounds of amplification for labeling do have small but significant affects on 10% of genes, but this source of technical variation is easy to avoid. To examine both technical and stochastic biological variation, mRNA expression was measured from the same five individuals over a six-week time course. Conclusion: There were few, if any, meaningful differences in gene expression among time points. Thus, microarray measures using standard laboratory procedures can be precise and quantitative and are not subject to significant random biological noise.	[Scott, Cinda P.; VanWye, Jeff; McDonald, M. Danielle; Crawford, Douglas L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Fisheries, Miami, FL 33149 USA	University of Miami	Scott, CP (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dcrawford@rsmas.miami.edu		McDonald, M. Danielle/0000-0003-2074-1140; Crawford, Douglas/0000-0002-6239-4012	NSF/OCE [0221879, 0432368]; NIH/NHLBI [HL65470-01A2]; NSF-NIEHS [P50ES12736]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012736] Funding Source: NIH RePORTER	NSF/OCE(National Science Foundation (NSF)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NSF/OCE 0221879; NIH/NHLBI HL65470-01A2, and NSF-NIEHS P50ES12736 and NSF OCE-0432368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Beissbarth T, 2000, BIOINFORMATICS, V16, P1014; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Currie S, 1997, J EXP BIOL, V200, P607; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Dudoit S, 2003, BIOTECHNIQUES, P45; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Eberwine J, 1996, BIOTECHNIQUES, V20, P584; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gold D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-2; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2001, GENET RES, V77, P123; Koldkjaer P, 2004, J EXP BIOL, V207, P357, DOI 10.1242/jeb.00747; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Paschall JE, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-96; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; van Haaften RIM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-200; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yauk CL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh123; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4486	10.1371/journal.pone.0004486	http://dx.doi.org/10.1371/journal.pone.0004486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221589	Green Published, gold, Green Submitted			2022-12-25	WOS:000265485700011
J	Yang, CZ; Glover, JR				Yang, Chunzhong; Glover, John R.			The SmpB-tmRNA Tagging System Plays Important Roles in Streptomyces coelicolor Growth and Development	PLOS ONE			English	Article							TRANSFER-MESSENGER RNA; RARE LEUCINE CODON; TRANS-TRANSLATION; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; QUALITY-CONTROL; TTA CODONS; EXPRESSION; GENES; BLDA	The ssrA gene encodes tmRNA that, together with a specialized tmRNA-binding protein, SmpB, forms part of a ribonucleoprotein complex, provides a template for the resumption of translation elongation, subsequent termination and recycling of stalled ribosomes. In addition, the mRNA-like domain of tmRNA encodes a peptide that tags polypeptides derived from stalled ribosomes for degradation. Streptomyces are unique bacteria that undergo a developmental cycle culminating at sporulation that is at least partly controlled at the level of translation elongation by the abundance of a rare tRNA that decodes UUA codons found in a relatively small number of open reading frames prompting us to examine the role of tmRNA in S. coelicolor. Using a temperature sensitive replicon, we found that the ssrA gene could be disrupted only in cells with an extra-copy wild type gene but not in wild type cells or cells with an extra-copy mutant tmRNA (tmRNA(DD)) encoding a degradation-resistant tag. A cosmid-based gene replacement method that does not include a high temperature step enabled us to disrupt both the ssrA and smpB genes separately and at the same time suggesting that the tmRNA tagging system may be required for cell survival under high temperature. Indeed, mutant cells show growth and sporulation defects at high temperature and under optimal culture conditions. Interestingly, even though these defects can be completely restored by wild type genes, the Delta ssrA strain was only partially corrected by tmRNA(DD). In addition, wildtype tmRNA can restore the hygromycin-resistance to Delta ssrA cells while tmRNA(DD) failed to do so suggesting that degradation of aberrant peptides is important for antibiotic resistance. Overall, these results suggest that the tmRNA tagging system plays important roles during Streptomyces growth and sporulation under both normal and stress conditions.	[Yang, Chunzhong; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto	Yang, CZ (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	john.glover@utoronto.ca			Natural Science and Engineering Research Council of Canada [237865-00]; Cangene Corporation [237865-00]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cangene Corporation	The research was supported by a collaborative research and development grant (CRDPJ 237865-00) co-funded by the Natural Science and Engineering Research Council of Canada and Cangene Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, MOL MICROBIOL, V69, P1491, DOI 10.1111/j.1365-2958.2008.06381.x; Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; ANNE J, 1993, FEMS MICROBIOL LETT, V114, P121, DOI 10.1016/0378-1097(93)90507-X; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Binni C, 1997, TRENDS BIOTECHNOL, V15, P315, DOI 10.1016/S0167-7799(97)01062-7; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Braud S, 2006, ARCH MICROBIOL, V184, P343, DOI 10.1007/s00203-005-0051-y; Brawner M, 1991, Curr Opin Biotechnol, V2, P674, DOI 10.1016/0958-1669(91)90033-2; Chandra G, 2008, ANTON LEEUW INT J G, V94, P111, DOI 10.1007/s10482-008-9231-5; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x; de la Cruz J, 2001, RNA, V7, P1708; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Guthrie EP, 1998, MICROBIOL-SGM, V144, P727, DOI 10.1099/00221287-144-3-727; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Harlow E., 1999, USING ANTIBODIES LAB; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; Hopwood D A, 1985, Basic Life Sci, V30, P615; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kataoka M, 1999, FEBS LETT, V462, P425, DOI 10.1016/S0014-5793(99)01569-0; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; LESKIW BK, 1991, P NATL ACAD SCI USA, V88, P2461, DOI 10.1073/pnas.88.6.2461; LESKIW BK, 1991, MOL MICROBIOL, V5, P2861, DOI 10.1111/j.1365-2958.1991.tb01845.x; LESKIW BK, 1993, J BACTERIOL, V175, P1995, DOI 10.1128/JB.175.7.1995-2005.1993; Li WC, 2007, FEMS MICROBIOL LETT, V266, P20, DOI 10.1111/j.1574-6968.2006.00494.x; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Nguyen KT, 2003, J BACTERIOL, V185, P7291, DOI 10.1128/JB.185.24.7291-7296.2003; Ni SXY, 2003, PROTEIN EXPRES PURIF, V30, P62, DOI 10.1016/S1046-5928(03)00070-6; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Sambrook J, 2001, MOL CLONING LAB MANU; Spiers A, 2002, J BIOL CHEM, V277, P39443, DOI 10.1074/jbc.M202790200; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Takano E, 2003, MOL MICROBIOL, V50, P475, DOI 10.1046/j.1365-2958.2003.03728.x; Viala J, 2000, MOL MICROBIOL, V38, P602, DOI 10.1046/j.1365-2958.2000.02155.x; Viala J, 2003, MOL GENET GENOMICS, V268, P563, DOI 10.1007/s00438-002-0783-1; Wiegert T, 2001, J BACTERIOL, V183, P3885, DOI 10.1128/JB.183.13.3885-3889.2001; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Wower J, 2001, J NUTR, V131, p2978S, DOI 10.1093/jn/131.11.2978S; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	60	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4459	10.1371/journal.pone.0004459	http://dx.doi.org/10.1371/journal.pone.0004459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212432	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484200014
J	Grenier, J; Teillet, MA; Grifone, R; Kelly, RG; Duprez, D				Grenier, Julien; Teillet, Marie-Aimee; Grifone, Raphaelle; Kelly, Robert G.; Duprez, Delphine			Relationship between Neural Crest Cells and Cranial Mesoderm during Head Muscle Development	PLOS ONE			English	Article								Background: In vertebrates, the skeletal elements of the jaw, together with the connective tissues and tendons, originate from neural crest cells, while the associated muscles derive mainly from cranial mesoderm. Previous studies have shown that neural crest cells migrate in close association with cranial mesoderm and then circumscribe but do not penetrate the core of muscle precursor cells of the branchial arches at early stages of development, thus defining a sharp boundary between neural crest cells and mesodermal muscle progenitor cells. Tendons constitute one of the neural crest derivatives likely to interact with muscle formation. However, head tendon formation has not been studied, nor have tendon and muscle interactions in the head. Methodology/Principal Findings: Reinvestigation of the relationship between cranial neural crest cells and muscle precursor cells during development of the first branchial arch, using quail/chick chimeras and molecular markers revealed several novel features concerning the interface between neural crest cells and mesoderm. We observed that neural crest cells migrate into the cephalic mesoderm containing myogenic precursor cells, leading to the presence of neural crest cells inside the mesodermal core of the first branchial arch. We have also established that all the forming tendons associated with branchiomeric and eye muscles are of neural crest origin and express the Scleraxis marker in chick and mouse embryos. Moreover, analysis of Scleraxis expression in the absence of branchiomeric muscles in Tbx1(-/-) mutant mice, showed that muscles are not necessary for the initiation of tendon formation but are required for further tendon development. Conclusions/Significance: This results show that neural crest cells and muscle progenitor cells are more extensively mixed than previously believed during arch development. In addition, our results show that interactions between muscles and tendons during craniofacial development are similar to those observed in the limb, despite the distinct embryological origin of these cell types in the head.	[Grenier, Julien; Teillet, Marie-Aimee; Duprez, Delphine] Univ Paris 06, CNRS, UMR Biol Mol & Cellulaire Dev 7622, Paris, France; [Grifone, Raphaelle; Kelly, Robert G.] Univ Mediteranee, Dev Biol Inst Marseilles Luminy, CNRS, UMR 6216, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Grenier, J (corresponding author), Univ Paris 06, CNRS, UMR Biol Mol & Cellulaire Dev 7622, Paris, France.	delphine.duprez@upmc.fr	Duprez, Delphine/K-1856-2017; Kelly, Robert G/F-2523-2013	Duprez, Delphine/0000-0003-0248-7417; Kelly, Robert G/0000-0003-4357-0073; GRENIER, Julien/0000-0002-1897-1329	ANR; CNRS; University Paris 6; AFM; ARC; EU 6th PCRDT through the MYORES Network of excellence; Inserm Avenir Program	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 6; AFM(Association Francaise contre les Myopathies); ARC(Australian Research Council); EU 6th PCRDT through the MYORES Network of excellence; Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the ANR, CNRS, University Paris 6, AFM, ARC and the EU 6th PCRDT through the MYORES Network of excellence (D.D) and the Inserm Avenir Program and AFM (R.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bonnin MA, 2005, MECH DEVELOP, V122, P573, DOI 10.1016/j.mod.2004.11.005; Bothe I, 2007, DEV DYNAM, V236, P2397, DOI 10.1002/dvdy.21241; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brito JM, 2008, DEVELOPMENT, V135, P2311, DOI 10.1242/dev.019125; Brito JM, 2006, P NATL ACAD SCI USA, V103, P11607, DOI 10.1073/pnas.0604751103; Calloni GW, 2007, P NATL ACAD SCI USA, V104, P19879, DOI 10.1073/pnas.0708806104; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; COULY GF, 1992, DEVELOPMENT, V114, P1; COULY GF, 1993, DEVELOPMENT, V117, P409; Creuzet S, 2004, P NATL ACAD SCI USA, V101, P4843, DOI 10.1073/pnas.0400869101; Creuzet S, 2002, DEVELOPMENT, V129, P4301; Dastjerdi A, 2007, DEV DYNAM, V236, P353, DOI 10.1002/dvdy.21010; Dong FY, 2006, DEVELOPMENT, V133, P4891, DOI 10.1242/dev.02693; Duprez D, 1999, MECH DEVELOP, V89, P179, DOI 10.1016/S0925-4773(99)00206-3; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Grifone R, 2007, TRENDS GENET, V23, P365, DOI 10.1016/j.tig.2007.05.002; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Hacker A, 1998, DEVELOPMENT, V125, P3461; Hadchouel J, 2000, DEVELOPMENT, V127, P4455; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Haworth KE, 2007, DEV BIOL, V303, P244, DOI 10.1016/j.ydbio.2006.11.009; Hu D, 1999, DEVELOPMENT, V126, P4873; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kardon G, 1998, DEVELOPMENT, V125, P4019; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kulesa PM, 2008, DEV BIOL, V316, P275, DOI 10.1016/j.ydbio.2008.01.029; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Lee SH, 2004, DEV BIOL, V276, P207, DOI 10.1016/j.ydbio.2004.08.045; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MCCLEARN D, 1988, AM J ANAT, V183, P277, DOI 10.1002/aja.1001830402; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mootoosamy RC, 2002, DEVELOPMENT, V129, P573; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Noden DM, 1999, DEV DYNAM, V216, P96, DOI 10.1002/(SICI)1097-0177(199910)216:2<96::AID-DVDY2>3.3.CO;2-Y; NODEN DM, 1986, DEV BIOL, V116, P347, DOI 10.1016/0012-1606(86)90138-7; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Olsson L, 2001, DEV BIOL, V237, P354, DOI 10.1006/dbio.2001.0377; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Tozer S, 2007, DEVELOPMENT, V134, P2579, DOI 10.1242/DEV.02867; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Volohonsky G, 2007, DEVELOPMENT, V134, P347, DOI 10.1242/dev.02735; von Scheven G, 2006, GENE EXPR PATTERNS, V6, P383, DOI 10.1016/j.modgep.2005.09.008; von Scheven G, 2006, DEVELOPMENT, V133, P2731, DOI 10.1242/dev.02426; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	75	104	105	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4381	10.1371/journal.pone.0004381	http://dx.doi.org/10.1371/journal.pone.0004381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198652	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483900003
J	Reber, L; Vermeulen, L; Haegeman, G; Frossard, N				Reber, Laurent; Vermeulen, Linda; Haegeman, Guy; Frossard, Nelly			Ser276 Phosphorylation of NF-kappa B p65 by MSK1 Controls SCF Expression in Inflammation	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; PROTEIN KINASE-1 MSK1; STEM-CELL FACTOR; TRANSCRIPTIONAL ACTIVITY; CATALYTIC SUBUNIT; P50 ACETYLATION; DNA-BINDING; HISTONE H3; ACTIVATION; GLUCOCORTICOIDS	Transcription of the mast cell growth factor SCF (stem cell factor) is upregulated in inflammatory conditions, and this is dependent upon NF-kappa B, as well as the MAP kinases p38 and ERK activation. We show here that the MAPK downstream nuclear kinase MSK1 induces NF-kappa B p65 Ser276 phosphorylation upon IL-1 beta treatment, which was inhibited in cells transfected with a MSK1 kinase-dead (KD) mutant compared to the WT control. In addition, we show by ChIP experiments that MSK1 as well as MAPK inhibition abolishes binding of p65, of its coactivator CBP, and of MSK1 itself to the kB intronic enhancer site of the SCF gene. We show that interaction between NF-kappa B and CBP is prevented in cells transfected by a p65 S276C mutant. Finally, we demonstrate that both transfections of MSK1-KD and MSK1 siRNA - but not the WT MSK1 or control siRNA - downregulate the expression of SCF induced by IL-1 beta. Our study provides therefore a direct link between MSK1-mediated phosphorylation of Ser276 p65 of NF-kappa B, allowing its binding to the SCF intronic enhancer, and pathophysiological SCF expression in inflammation.	[Frossard, Nelly] Univ Strasbourg 1, Fac Pharm, EA3771, Illkirch Graffenstaden, France; [Vermeulen, Linda; Haegeman, Guy] Univ Ghent, Dept Mol Biol, LEGEST, Ghent, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University	Reber, L (corresponding author), Univ Strasbourg 1, Fac Pharm, EA3771, Illkirch Graffenstaden, France.	nelly.frossard@pharma.u-strasbg.fr	Reber, Laurent L/K-4148-2014; Frossard, Nelly/F-8301-2013	Reber, Laurent L/0000-0003-3384-6769; 	French Research Ministry (MENRT)	French Research Ministry (MENRT)(Ministry of Research, France)	LR is supported by a grant from the French Research Ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Da Silva CA, 2003, FASEB J, V17, P2334, DOI 10.1096/fj.03-0136fje; Da Silva CA, 2002, BRIT J PHARMACOL, V135, P1634, DOI 10.1038/sj.bjp.0704617; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Kassel O, 1998, MOL PHARMACOL, V54, P1073, DOI 10.1124/mol.54.6.1073; MOSIALOS G, 1991, MOL CELL BIOL, V11, P5867, DOI 10.1128/MCB.11.12.5867; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	28	113	125	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4393	10.1371/journal.pone.0004393	http://dx.doi.org/10.1371/journal.pone.0004393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197368	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483700008
J	Pang, YP; Singh, SK; Gao, Y; Lassiter, TL; Mishra, RK; Zhu, KY; Brimijoin, S				Pang, Yuan-Ping; Singh, Sanjay K.; Gao, Yang; Lassiter, T. Leon; Mishra, Rajesh K.; Zhu, Kun Yan; Brimijoin, Stephen			Selective and Irreversible Inhibitors of Aphid Acetylcholinesterases: Steps Toward Human-Safe Insecticides	PLOS ONE			English	Article								Aphids, among the most destructive insects to world agriculture, are mainly controlled by organophosphate insecticides that disable the catalytic serine residue of acetylcholinesterase (AChE). Because these agents also affect vertebrate AChEs, they are toxic to non-target species including humans and birds. We previously reported that a cysteine residue (Cys), found at the AChE active site in aphids and other insects but not mammals, might serve as a target for insect-selective pesticides. However, aphids have two different AChEs (termed AP and AO), and only AP-AChE carries the unique Cys. The absence of the active-site Cys in AO-AChE might raise concerns about the utility of targeting that residue. Herein we report the development of a methanethiosulfonate-containing small molecule that, at 6.0 mu M, irreversibly inhibits 99% of all AChE activity extracted from the greenbug aphid (Schizaphis graminum) without any measurable inhibition of the human AChE. Reactivation studies using beta-mercaptoethanol confirm that the irreversible inhibition resulted from the conjugation of the inhibitor to the unique Cys. These results suggest that AO-AChE does not contribute significantly to the overall AChE activity in aphids, thus offering new insight into the relative functional importance of the two insect AChEs. More importantly, by demonstrating that the Cystargeting inhibitor can abolish AChE activity in aphids, we can conclude that the unique Cys may be a viable target for species-selective agents to control aphids without causing human toxicity and resistance problems.	[Pang, Yuan-Ping; Singh, Sanjay K.; Gao, Yang; Lassiter, T. Leon; Mishra, Rajesh K.; Brimijoin, Stephen] Mayo Clin, Rochester, MN 55905 USA; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Mayo Clinic; Kansas State University	Pang, YP (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	pang@mayo.edu; brimijoi@mayo.edu		Zhu, Kun Yan/0000-0001-9372-8030	U.S. Army [W81XWH-04-2-0001, W81XWH-08-1-0154]; Minnesota Partnership for Medical Genomics and Biotechnology; University of Minnesota/Mayo/IBM Collaboration [Seed Grant]; Mayo Foundation for Medical Education and Research	U.S. Army(United States Department of DefenseUnited States Army); Minnesota Partnership for Medical Genomics and Biotechnology; University of Minnesota/Mayo/IBM Collaboration(University of Minnesota System); Mayo Foundation for Medical Education and Research	This work was supported by the U.S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001 and W81XWH-08-1-0154), the Minnesota Partnership for Medical Genomics and Biotechnology, the University of Minnesota/Mayo/IBM Collaboration Seed Grant Program, and the Mayo Foundation for Medical Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boyd AE, 2000, J BIOL CHEM, V275, P22401, DOI 10.1074/jbc.M000606200; BRESTKIN AP, 1985, INSECT BIOCHEM, V15, P309, DOI 10.1016/0020-1790(85)90019-8; BRIMIJOIN S, 1979, MOL PHARMACOL, V15, P641; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davey TW, 1998, AUST J CHEM, V51, P581, DOI 10.1071/C98001; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Fialka J. J., 2006, WALL STREET J, pA4; Frisch M J, 1999, GAUSSIAN 98 REVISION; Gao JR, 2002, PESTIC BIOCHEM PHYS, V73, P164, DOI 10.1016/S0048-3575(02)00105-0; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; Grayson EJ, 2005, J ORG CHEM, V70, P9740, DOI 10.1021/jo051374j; Hammond PI, 2003, J PHARMACOL EXP THER, V307, P190, DOI 10.1124/jpet.103.053405; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; KRONMAN C, 1992, GENE, V121, P295, DOI 10.1016/0378-1119(92)90134-B; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; LAZAR MD, 1999, ESA SECT S F3 GREENB, P39; Lewis G, 2007, PEST MANAG SCI, V63, P1047, DOI 10.1002/ps.1487; Malcolm CA, 1998, INSECT MOL BIOL, V7, P107, DOI 10.1046/j.1365-2583.1998.72055.x; Mamiya A, 1997, APPL ENTOMOL ZOOL, V32, P37, DOI 10.1303/aez.32.37; MANULIS S, 1981, PESTIC BIOCHEM PHYS, V15, P267, DOI 10.1016/0048-3575(81)90010-9; Mary A, 1998, BIOORGAN MED CHEM, V6, P1835, DOI 10.1016/S0968-0896(98)00133-3; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mohr W, 2003, SYNTHESIS-STUTTGART, P1279; MOORE TL, 1966, J ORG CHEM, V31, P3587, DOI 10.1021/jo01349a027; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; NOVOZHILOV KV, 1989, INSECT BIOCHEM, V19, P15, DOI 10.1016/0020-1790(89)90004-8; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pezzementi Leo, 2006, Invertebrate Neuroscience, V6, P47, DOI 10.1007/s10158-006-0017-z; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; RANDALL WR, 1994, BBA-GENE STRUCT EXPR, V1218, P453, DOI 10.1016/0167-4781(94)90204-6; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; ROSENBERRY TL, 1984, J BIOL CHEM, V259, P5643; SMISSAERT HR, 1976, PESTIC BIOCHEM PHYS, V6, P215, DOI 10.1016/0048-3575(76)90063-8; SMITH DJ, 1974, J BIOL CHEM, V249, P3317; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tomita T, 2000, INSECT BIOCHEM MOLEC, V30, P325, DOI 10.1016/S0965-1748(00)00006-0; Weber ME, 2005, J AM CHEM SOC, V127, P636, DOI 10.1021/ja044936+; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; ZAHAVI M, 1972, BIOCHIM BIOPHYS ACTA, V276, P577, DOI 10.1016/0005-2744(72)91024-8; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	56	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4349	10.1371/journal.pone.0004349	http://dx.doi.org/10.1371/journal.pone.0004349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194505	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483500005
J	Jose, MV; Govezensky, T; Garcia, JA; Bobadilla, JR				Jose, Marco V.; Govezensky, Tzipe; Garcia, Jose A.; Bobadilla, Juan R.			On the Evolution of the Standard Genetic Code: Vestiges of Critical Scale Invariance from the RNA World in Current Prokaryote Genomes	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DNA-SEQUENCES; CIRCULAR CODES; SYNTHETASES; PROTEIN; ORIGIN; PERIODICITIES; PRINCIPLE	Herein two genetic codes from which the primeval RNA code could have originated the standard genetic code (SGC) are derived. One of them, called extended RNA code type I, consists of all codons of the type RNY (purine-any base- pyrimidine) plus codons obtained by considering the RNA code but in the second (NYR type) and third (YRN type) reading frames. The extended RNA code type II, comprises all codons of the type RNY plus codons that arise from transversions of the RNA code in the first (YNY type) and third (RNR) nucleotide bases. In order to test if putative nucleotide sequences in the RNA World and in both extended RNA codes, share the same scaling and statistical properties to those encountered in current prokaryotes, we used the genomes of four Eubacteria and three Archaeas. For each prokaryote, we obtained their respective genomes obeying the RNA code or the extended RNA codes types I and II. In each case, we estimated the scaling properties of triplet sequences via a renormalization group approach, and we calculated the frequency distributions of distances for each codon. Remarkably, the scaling properties of the distance series of some codons from the RNA code and most codons from both extended RNA codes turned out to be identical or very close to the scaling properties of codons of the SGC. To test for the robustness of these results, we show, via computer simulation experiments, that random mutations of current genomes, at the rates of 10(-10) per site per year during three billions of years, were not enough for destroying the observed patterns. Therefore, we conclude that most current prokaryotes may still contain relics of the primeval RNA World and that both extended RNA codes may well represent two plausible evolutionary paths between the RNA code and the current SGC.	[Jose, Marco V.; Govezensky, Tzipe; Garcia, Jose A.; Bobadilla, Juan R.] Univ Nacl Autonoma Mexico, Theoret Biol Grp, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Garcia, Jose A.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	Universidad Nacional Autonoma de Mexico; University of Otago	Jose, MV (corresponding author), Univ Nacl Autonoma Mexico, Theoret Biol Grp, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	marcojose@biomedicas.unam.mx	José, Marco V./A-1075-2008; José, Marco/AFU-1547-2022; Athens, Josie/Q-7172-2018	José, Marco/0000-0001-8497-6681; Athens, Josie/0000-0002-9897-0683	PAPIIT [IN205307]; Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico(Universidad Nacional Autonoma de Mexico)	M.V.J. was financially supported by PAPIIT IN205307, and by the Multiproject: Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank helpful technical computer assistance by Jose M. Pascual.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; ARQUES DG, 1990, J THEOR BIOL, V143, P307, DOI 10.1016/S0022-5193(05)80032-3; Arques DG, 1996, J THEOR BIOL, V182, P45, DOI 10.1006/jtbi.1996.0142; Balter M, 2000, SCIENCE, V289, P1866, DOI 10.1126/science.289.5486.1866; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; CRICK FHC, 1957, P NATL ACAD SCI USA, V43, P416, DOI 10.1073/pnas.43.5.416; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Delarue M, 2007, RNA, V13, P161, DOI 10.1261/rna.257607; EIGEN M, 1985, P NATL ACAD SCI USA, V82, P2437, DOI 10.1073/pnas.82.8.2437; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P282, DOI 10.1007/BF01047470; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P217, DOI 10.1007/BF01047323; EIGEN M, 1989, SCIENCE, V244, P673, DOI 10.1126/science.2497522; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Frey G, 2003, J THEOR BIOL, V223, P413, DOI 10.1016/S0022-5193(03)00119-X; Garcia JA, 2005, REV MEX FIS, V51, P122; Garcia JA, 2004, PHYSICA A, V342, P288, DOI 10.1016/j.physa.2004.04.090; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Herzel H, 1997, PHYS REV E, V55, P800, DOI 10.1103/PhysRevE.55.800; HORNOS JEM, 1993, PHYS REV LETT, V71, P4401, DOI 10.1103/PhysRevLett.71.4401; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JOLIVET R, 2001, 1 EUR WORKSH EX, P173; Jose MV, 2007, B MATH BIOL, V69, P215, DOI 10.1007/s11538-006-9119-3; Jose MV, 2005, PHYSICA A, V351, P477, DOI 10.1016/j.physa.2004.11.060; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Jukes TH, 1996, J MOL EVOL, V42, P377; KENNETH DJ, 1995, ORIGINS LIFE EVOL B, V25, P515; Knight RD, 2000, CELL, V101, P569, DOI 10.1016/S0092-8674(00)80866-1; KONECNY J, 1995, J THEOR BIOL, V173, P263, DOI 10.1006/jtbi.1995.0061; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lopez-Villasenor I, 2004, BIOCHEM BIOPH RES CO, V325, P467, DOI 10.1016/j.bbrc.2004.10.053; Mandelbrot B.B, 1977, FRACTALS FORM CHANCE; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MAYNARDSMITH J, 1998, EVOLUTION GENETICS; Michel CJ, 2008, THEOR COMPUT SCI, V401, P17, DOI 10.1016/j.tcs.2008.02.049; Michel CJ, 2008, COMPUT MATH APPL, V55, P984, DOI 10.1016/j.camwa.2006.12.090; NAGEL GM, 1995, J MOL EVOL, V40, P487; NICHOLAS HB, 1995, J MOL EVOL, V40, P482; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Sanchez R, 2005, B MATH BIOL, V67, P1, DOI 10.1016/j.bulm.2004.05.005; SHEPHERD JCW, 1981, J MOL EVOL, V17, P94, DOI 10.1007/BF01732679; SHEPHERD JCW, 1981, P NATL ACAD SCI-BIOL, V78, P1596, DOI 10.1073/pnas.78.3.1596; SHEPHERD JCW, 1982, COLD SPRING HARB SYM, V47, P1099; SHEPHERD JCW, 1981, P NATL ACAD SCI USA, V47, P1588; Somette D, 2000, SPRINGER SERIES SYNE, P178; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Trevors JT, 1997, ANTON LEEUW INT J G, V71, P265, DOI 10.1023/A:1000123216769; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Trifonov EN, 1998, PHYSICA A, V249, P511, DOI 10.1016/S0378-4371(97)00510-4; West BJ, 1999, CHAOS SOLITON FRACT, V10, P1519, DOI 10.1016/S0960-0779(98)00149-0; WEST BJ, 1986, J APPL PHYSIOL, V60, P1089, DOI 10.1152/jappl.1986.60.3.1089; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE C, 1967, GENETIC CODE, pCH7; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WONG JTF, 1986, EUR J BIOCHEM, V159, P175, DOI 10.1111/j.1432-1033.1986.tb09849.x	68	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4340	10.1371/journal.pone.0004340	http://dx.doi.org/10.1371/journal.pone.0004340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183813	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483200012
J	Lin, YW; Cheng, CM; Leduc, PR; Chen, CC				Lin, Yi-Wen; Cheng, Chao-Min; Leduc, Philip R.; Chen, Chih-Cheng			Understanding Sensory Nerve Mechanotransduction through Localized Elastomeric Matrix Control	PLOS ONE			English	Article								Background: While neural systems are known to respond to chemical and electrical stimulation, the effect of mechanics on these highly sensitive cells is still not well understood. The ability to examine the effects of mechanics on these cells is limited by existing approaches, although their overall response is intimately tied to cell-matrix interactions. Here, we offer a novel method, which we used to investigate stretch-activated mechanotransduction on nerve terminals of sensory neurons through an elastomeric interface. Methodology/Principal Findings: To apply mechanical force on neurites, we cultured dorsal root ganglion neurons on an elastic substrate, polydimethylsiloxane (PDMS), coated with extracellular matrices (ECM). We then implemented a controlled indentation scheme using a glass pipette to mechanically stimulate individual neurites that were adjacent to the pipette. We used whole-cell patch clamping to record the stretch-activated action potentials on the soma of the single neurites to determine the mechanotransduction-based response. When we imposed specific mechanical force through the ECM, we noted a significant neuronal action potential response. Furthermore, because the mechanotransduction cascade is known to be directly affected by the cytoskeleton, we investigated the cell structure and its effects. When we disrupted microtubules and actin filaments with nocodozale or cytochalasin-D, respectively, the mechanically induced action potential was abrogated. In contrast, when using blockers of channels such as TRP, ASIC, and stretch-activated channels while mechanically stimulating the cells, we observed almost no change in action potential signalling when compared with mechanical activation of unmodified cells. Conclusions/Significance: These results suggest that sensory nerve terminals have a specific mechanosensitive response that is related to cell architecture.	[Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Cheng, Chao-Min; Leduc, Philip R.] Carnegie Mellon Univ, Dept Mech & Biomed Engn & Biol Sci, Pittsburgh, PA 15213 USA	Academia Sinica - Taiwan; Carnegie Mellon University	Lin, YW (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	prl@andrew.cmu.edu; chih@ibms.sinica.edu.tw	Lin, Yi-Wen/O-3541-2015; Chen, Chih-Cheng/AAT-1062-2021; Chen, Chih-Cheng/S-7015-2018; LeDuc, Philip/M-1103-2014	Lin, Yi-Wen/0000-0001-7204-8837; Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660; LeDuc, Philip/0000-0001-6397-2905	Institute of Biomedical Sciences, Academia Sinica [postdoctoral fellowship]; National Science Foundation-CAREER; National Academies Keck Foundation Futures Initiative; Pennsylvania Infrastructure Technology Alliance; Department of Energy-Genome to Life; Beckman Young Investigators Program; Taiwan [PhD Research Scholarship]; Carnegie Mellon University, USA [Dowd-ICES Scholarship]	Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); National Science Foundation-CAREER(National Science Foundation (NSF)); National Academies Keck Foundation Futures Initiative; Pennsylvania Infrastructure Technology Alliance; Department of Energy-Genome to Life(United States Department of Energy (DOE)); Beckman Young Investigators Program; Taiwan; Carnegie Mellon University, USA	This study was supported by a start-up fund from the Institute of Biomedical Sciences, Academia Sinica (to C.-C.C.) and postdoctoral fellowship from Academia Sinica (to Y.- W.L.). P.R.L. wishes to additionally thank National Science Foundation-CAREER, National Academies Keck Foundation Futures Initiative, Pennsylvania Infrastructure Technology Alliance, the Department of Energy-Genome to Life, and the Beckman Young Investigators Program for partial support. C.-M C. was supported in part by a PhD Research Scholarship from Taiwan and the Dowd-ICES Scholarship from Carnegie Mellon University, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Ditting T, 2003, BASIC RES CARDIOL, V98, P388, DOI 10.1007/s00395-003-0426-7; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Greve F, 2007, BIOMATERIALS, V28, P5246, DOI 10.1016/j.biomaterials.2007.08.010; HAJDUCZOK G, 1994, J CLIN INVEST, V94, P2392, DOI 10.1172/JCI117605; Hamill OP, 1996, PHARMACOL REV, V48, P231; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Heppelmann B, 2005, EXP BRAIN RES, V167, P114, DOI 10.1007/s00221-005-0040-z; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Lin YW, 2008, NEUROSCIENCE, V151, P544, DOI 10.1016/j.neuroscience.2007.10.020; Lin YW, 2003, J NEUROSCI, V23, P4173; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Piao L, 2006, J NEUROSCI RES, V83, P1373, DOI 10.1002/jnr.20810; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sanchez D, 2007, J NEUROSCI METH, V159, P26, DOI 10.1016/j.jneumeth.2006.06.018; Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Tseng TJ, 2007, EXP NEUROL, V204, P574, DOI 10.1016/j.expneurol.2006.12.018; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zagorodnyuk VP, 2003, J PHYSIOL-LONDON, V553, P575, DOI 10.1113/jphysiol.2003.051862	40	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4293	10.1371/journal.pone.0004293	http://dx.doi.org/10.1371/journal.pone.0004293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173000	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483000006
J	Park, EC; Glodowski, DR; Rongo, C				Park, Eun Chan; Glodowski, Doreen R.; Rongo, Christopher			The Ubiquitin Ligase RPM-1 and the p38 MAPK PMK-3 Regulate AMPA Receptor Trafficking	PLOS ONE			English	Article								Ubiquitination occurs at synapses, yet its role remains unclear. Previous studies demonstrated that the RPM-1 ubiquitin ligase organizes presynaptic boutons at neuromuscular junctions in C. elegans motorneurons. Here we find that RPM-1 has a novel postsynaptic role in interneurons, where it regulates the trafficking of the AMPA-type glutamate receptor GLR-1 from synapses into endosomes. Mutations in rpm-1 cause the aberrant accumulation of GLR-1 in neurites. Moreover, rpm-1 mutations enhance the endosomal accumulation of GLR-1 observed in mutants for lin-10, a Mint2 ortholog that promotes GLR-1 recycling from Syntaxin-13 containing endosomes. As in motorneurons, RPM-1 negatively regulates the pmk-3/p38 MAPK pathway in interneurons by repressing the protein levels of the MAPKKK DLK-1. This regulation of PMK-3 signaling is critical for RPM-1 function with respect to GLR-1 trafficking, as pmk-3 mutations suppress both lin-10 and rpm-1 mutations. Positive or negative changes in endocytosis mimic the effects of rpm-1 or pmk-3 mutations, respectively, on GLR-1 trafficking. Specifically, RAB-5(GDP), an inactive mutant of RAB-5 that reduces endocytosis, mimics the effect of pmk-3 mutations when introduced into wild-type animals, and occludes the effect of pmk-3 mutations when introduced into pmk-3 mutants. By contrast, RAB-5(GTP), which increases endocytosis, suppresses the effect of pmk-3 mutations, mimics the effect of rpm-1 mutations, and occludes the effect of rpm-1 mutations. Our findings indicate a novel specialized role for RPM-1 and PMK-3/p38 MAPK in regulating the endosomal trafficking of AMPARs at central synapses.	[Park, Eun Chan; Glodowski, Doreen R.; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Park, EC (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA.	rongo@waksman.rutgers.edu		Park, Eunchan/0000-0002-6147-4088	National Institutes of Health [R01 NS42023]; New Jersey Commission on Spinal Cord Research [07-2924-SCR-E-0]; American Heart Association [0755979T]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord Research; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The manuscript was funded by a grant from the National Institutes of Health (R01 NS42023), the New Jersey Commission on Spinal Cord Research (07-2924-SCR-E-0), and the American Heart Association (0755979T); these agencies had no other role in the research or the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jorgensen Erik M., 1995, Seminars in Developmental Biology, V6, P207, DOI 10.1016/S1044-5781(06)80030-7; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Le Guyader S, 2005, DEV BIOL, V277, P378, DOI 10.1016/j.ydbio.2004.09.029; LI GP, 1994, J BIOL CHEM, V269, P14631; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	60	42	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4284	10.1371/journal.pone.0004284	http://dx.doi.org/10.1371/journal.pone.0004284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172179	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482900005
J	Jakubowski, H; Perla-Kajan, J; Finnell, RH; Cabrera, RM; Wang, H; Gupta, S; Kruger, WD; Kraus, JP; Shih, DM				Jakubowski, Hieronim; Perla-Kajan, Joanna; Finnell, Richard H.; Cabrera, Robert M.; Wang, Hong; Gupta, Sapna; Kruger, Warren D.; Kraus, Jan P.; Shih, Diana M.			Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice	FASEB JOURNAL			English	Article						methionine; thiolactone; liver damage; atherothrombosis	CYSTATHIONINE-BETA-SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; PATHOLOGICAL CONSEQUENCES; POSSIBLE MECHANISM; MOLECULAR-BASIS; THIOLACTONE; HYPERHOMOCYSTEINEMIA; HUMANS; PLASMA; DEFICIENT	Genetic disorders of homocysteine (Hcy) or folate metabolism or high-methionine diets elevate plasma Hcy and its atherogenic metabolite Hcy- thiolactone. In humans, severe hyperhomocysteinemia due to genetic alterations in cystathionine beta-synthase (Cbs) or methylenetetrahydrofolate reductase (Mthfr) results in neurological abnormalities and premature death from vascular complications. In mouse models, dietary or genetic hyperhomocysteinemia results in liver or brain pathological changes and accelerates atherosclerosis. Hcy- thiolactone has the ability to form isopeptide bonds with protein lysine residues, which generates modified proteins (N-Hcy-protein) with autoimmunogenic and prothrombotic properties. Our aim was to determine how N-Hcy-protein levels are affected by genetic or nutritional disorders in Hcy or folate metabolism in mice. We found that plasma N-Hcy-protein was elevated 10-fold in mice fed a high-methionine diet compared with the animals fed a normal commercial diet. We also found that inactivation of Cbs, Mthfr, or the proton-coupled folate transporter (Pcft) gene resulted in a 10- to 30-fold increase in plasma or serum N- Hcy- protein levels. Liver N- Hcy- protein was elevated 3.4-fold in severely and 11-fold in extremely hyperhomocysteinemic Cbs-deficient mice, 3.6-fold in severely hyperhomocysteinemic Pcft mice, but was not elevated in mildly hyperhomocysteinemic Mthfr-deficient animals, suggesting that mice have a capacity to prevent accumulation of N-Hcy-protein in their organs. These findings provide evidence that N- Hcy- protein is an important metabolite associated with Hcy pathophysiology in the mouse.-Jakubowski, H., Perla-Kajan, J., Finnell, R. H., Cabrera, R. M., Wang, H., Gupta, S., Kruger, W. D., Kraus, J. P., and Shih, D. M. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 23, 1721-1727 (2009)	[Jakubowski, Hieronim; Perla-Kajan, Joanna] Univ Med & Dent New Jersey, New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol & Mol Genet, Newark, NJ 07101 USA; [Jakubowski, Hieronim; Perla-Kajan, Joanna] Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland; [Finnell, Richard H.; Cabrera, Robert M.] Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Texas Inst Genom Med, Houston, TX USA; [Wang, Hong] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; [Gupta, Sapna; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; [Kraus, Jan P.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Shih, Diana M.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Poznan University of Life Sciences; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jakubowski, H (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol & Mol Genet, 225 Warren St, Newark, NJ 07101 USA.	jakubows@umdnj.edu	Jakubowski, Hieronim/AAA-6834-2019; Jakubowski, Hieronim/A-2510-2017; kruger, warren/A-6407-2008; Kruger, Warren/Y-2541-2018; Perla-Kajan, Joanna/F-2965-2010; Finnell, Richard/D-8174-2018	Jakubowski, Hieronim/0000-0001-5845-4409; kruger, warren/0000-0002-4990-3695; Perla-Kajan, Joanna/0000-0002-0791-5057; Finnell, Richard/0000-0002-5962-8754	American Heart Association; Ministry of Science and Higher Education, Poland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077288, R01HL117654, R01HL067033, R01HL082774] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the American Heart Association and the Ministry of Science and Higher Education, Poland. We thank Rima Rozen (McGill University, Montreal, QC, Canada) for providing plasma and tissue samples from Mthfr-deficient mice. We also thank anonymous reviewers for their helpful comments.	Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; Ferretti G, 2004, J CELL BIOCHEM, V92, P351, DOI 10.1002/jcb.20069; Gu WJ, 2008, ADV THER, V25, P914, DOI 10.1007/s12325-008-0097-8; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2005, CLIN CHEM LAB MED, V43, P1011, DOI 10.1515/CCLM.2005.177; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; Jakubowski H, 2001, J NUTR, V131, p2983S, DOI 10.1093/jn/131.11.2983S; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2008, ANAL BIOCHEM, V380, P257, DOI 10.1016/j.ab.2008.05.049; Jakubowski H, 2007, CLIN CHEM LAB MED, V45, P1704, DOI 10.1515/CCLM.2007.338; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jakubowsky H., 2005, AMINOACYL TRNA SYNTH, P384; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; MUDD SH, 1985, AM J HUM GENET, V37, P1; MUDD SH, 2001, METABOLIC MOL BASES, V2, P2007; Perla-Kajan J, 2008, BIOMED PHARMACOTHER, V62, P473, DOI 10.1016/j.biopha.2008.04.001; Perna AF, 2006, KIDNEY INT, V69, P869, DOI 10.1038/sj.ki.5000070; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; Strauss KA, 2007, MOL GENET METAB, V91, P165, DOI 10.1016/j.ymgme.2007.02.012; Uji Y, 2002, CLIN CHEM, V48, P941; Undas A, 2005, THROMB HAEMOSTASIS, V93, P346, DOI 10.1160/TH04-08-0493; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Undas A, 2006, THROMB HAEMOSTASIS, V96, P342, DOI 10.1160/TH06-04-0228; Wang GP, 2002, ARTERIOSCL THROM VAS, V22, P1777, DOI 10.1161/01.ATV.0000035404.18281.37; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yang X, 2006, CLIN CHIM ACTA, V364, P230, DOI 10.1016/j.cccn.2005.07.007; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	43	87	88	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1721	1727		10.1096/fj.08-127548	http://dx.doi.org/10.1096/fj.08-127548			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19204075	Green Published			2022-12-25	WOS:000266652400012
J	Grininger, M; Staudt, H; Johansson, P; Wachtveitl, J; Oesterhelt, D				Grininger, Martin; Staudt, Heike; Johansson, Patrik; Wachtveitl, Josef; Oesterhelt, Dieter			Dodecin Is the Key Player in Flavin Homeostasis of Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOFLAVIN-BINDING; LOWER LIGAND; LUMICHROME; PROTEIN; DOMAIN; PHOTOLYASE; DYNAMICS	Flavins are employed to transform physical input into biological output signals. In this function, flavins catalyze a variety of light-induced reactions and redox processes. However, nature also provides flavoproteins with the ability to uncouple the mediation of signals. Such proteins are the riboflavin-binding proteins (RfBPs) with their function to store riboflavin for fast delivery of FMN and FAD. Here we present in vitro and in vivo data showing that the recently discovered archaeal dodecin is an RfBP, and we reveal that riboflavin storage is not restricted to eukaryotes. However, the function of the prokaryotic RfBP dodecin seems to be adapted to the requirement of a monocellular organism. While in eukaryotes RfBPs are involved in trafficking riboflavin, and dodecin is responsible for the flavin homeostasis of the cell. Although only 68 amino acids in length, dodecin is of high functional versatility in neutralizing riboflavin to protect the cellular environment from uncontrolled flavin reactivity. Besides the predominant ultrafast quenching of excited states, dodecin prevents light-induced riboflavin reactivity by the selective degradation of riboflavin to lumichrome. Coordinated with the high affinity for lumichrome, the directed degradation reaction is neutral to the cellular environment and provides an alternative pathway for suppressing uncontrolled riboflavin reactivity. Intriguingly, the different structural and functional properties of a homologous bacterial dodecin suggest that dodecin has different roles in different kingdoms of life.	[Grininger, Martin; Johansson, Patrik; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Staudt, Heike; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Grininger, M (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	grininge@biochem.mpg.de; oesterhe@biochem.mpg.de	Grininger, Martin/D-5329-2011; Wachtveitl, Josef/A-7590-2017	Wachtveitl, Josef/0000-0002-8496-8240; Grininger, Martin/0000-0002-7269-0667				Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Foraker AB, 2003, ADV DRUG DELIVER REV, V55, P1467, DOI 10.1016/j.addr.2003.07.005; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gray MJ, 2007, P NATL ACAD SCI USA, V104, P2921, DOI 10.1073/pnas.0609270104; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Heelis P. F., 1991, CHEM BIOCH FLAVOENZY, VI, P171; Hemmerich P, 1976, Fortschr Chem Org Naturst, V33, P451; Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006; Huber R, 2005, BIOCHEMISTRY-US, V44, P1800, DOI 10.1021/bi048318h; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; MacFarlane AW, 2001, BIOCHEMISTRY-US, V40, P15203, DOI 10.1021/bi0114224; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Marg BL, 2005, BIOCHEMISTRY-US, V44, P29, DOI 10.1021/bi0485169; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mataga N, 2000, J PHYS CHEM B, V104, P10667, DOI 10.1021/jp002145y; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Meissner B, 2007, J BIOL CHEM, V282, P33142, DOI 10.1074/jbc.M704951200; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; MOORE WM, 1963, J AM CHEM SOC, V85, P3367, DOI 10.1021/ja00904a013; Muller F, 1991, CHEM BIOCH FLAVOENZY, V1, P1; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCARANO G, 1994, ANAL CHIM ACTA, V296, P277, DOI 10.1016/0003-2670(94)80247-5; Sikorski M, 2001, J PHOTOCH PHOTOBIO B, V60, P114, DOI 10.1016/S1011-1344(01)00134-8; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tanaka F, 2007, J PHYS CHEM B, V111, P5694, DOI 10.1021/jp066450g; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; Twellmeyer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001064; UENO K, 1987, J BIOL CHEM, V262, P12780; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; WALKER WH, 1970, EUR J BIOCHEM, V13, P258, DOI 10.1111/j.1432-1033.1970.tb00926.x; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	38	33	36	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13068	13076		10.1074/jbc.M808063200	http://dx.doi.org/10.1074/jbc.M808063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19224924	hybrid, Green Published			2022-12-25	WOS:000265688300054
J	Chen, N; Chen, XQ; Huang, R; Zeng, H; Gong, J; Meng, WT; Lu, YP; Zhao, F; Wang, L; Zhou, Q				Chen, Ni; Chen, Xueqin; Huang, Rui; Zeng, Hao; Gong, Jing; Meng, Wentong; Lu, Yiping; Zhao, Fang; Wang, Lin; Zhou, Qiao			BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; FACTOR 1-ALPHA; FACTOR-I; CELLULAR PROLIFERATION; INDUCED APOPTOSIS; RNA INTERFERENCE; DOWN-REGULATION; UP-REGULATION; LUNG-CANCER; EXPRESSION	The transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays pivotal roles in physiology and pathophysiology. Constitutive or hypoxia-induced HIF-1 alpha overexpression is observed in many types of cancers including prostate adenocarcinoma, in which it is associated with resistance to apoptosis and therapeutic agents. BCL-xL, a hypoxia-responsive, anti-apoptotic protein of the Bcl-2 family, is also overexpressed in prostate carcinoma and many other cancers. Despite this connection, whether BCL-xL expression is directly regulated by HIF-1 alpha is not known. We used prostate cancer PC-3 cell with constitutive high HIF-1 alpha level as a model to address this important question. We first generated prostate cancer PC-3 cells in which HIF-1 alpha was stably knocked-down (HIF-KD) by using small interference RNA. BCL-xL was dramatically decreased in HIF-KD PC-3 cells, in parallel with sensitization to apoptosis with caspase-3 activation as well as decreased cell proliferation. We then demonstrated that HIF-1 alpha directly regulated BCL-xL transcription by binding to a hypoxia-responsive element in the BCL-xL promoter (-865 to -847) by reporter gene assay, chromatin immunoprecipitation, and electrophoretic mobility shift and supershift assays. HIF-1 alpha dependent BCL-xL overexpression may be an important mechanism by which HIF-1 alpha protects prostate cancer cells from apoptosis and leads to treatment resistance.	[Chen, Ni; Chen, Xueqin; Huang, Rui; Gong, Jing; Zhou, Qiao] Sichuan Univ, W China Med Sch, W China Hosp, Dept Pathol, Chengdu 610041, Peoples R China; [Chen, Ni; Chen, Xueqin; Huang, Rui; Zeng, Hao; Gong, Jing; Zhou, Qiao] Sichuan Univ, W China Med Sch, W China Hosp, Pathol Lab, Chengdu 610041, Peoples R China; [Zeng, Hao; Lu, Yiping] Sichuan Univ, W China Med Sch, W China Hosp, Dept Urol, Chengdu 610041, Peoples R China; [Meng, Wentong] Sichuan Univ, W China Med Sch, W China Hosp, Dept Lab Stem Cell Res,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Zhao, Fang] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; [Wang, Lin] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of Helsinki; University of Texas System; UTMD Anderson Cancer Center	Zhou, Q (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, Dept Pathol, Chengdu 610041, Peoples R China.	zhouqiao@mcwcums.com			Natural Science Foundation of China Grants NSFC [30570692, 30871383, 30800637]; Ministry of Education PhD Program Fund [20060610053]; Postdoctoral Fund of China [20060401022]; National Basic Research Program of China [2007CB947802]	Natural Science Foundation of China Grants NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education PhD Program Fund; Postdoctoral Fund of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China Grants NSFC 30570692, 30871383, and 30800637, Ministry of Education PhD Program Fund 20060610053, and Postdoctoral Fund 20060401022 of China. 1 Supported by National Basic Research Program of China Grant 2007CB947802.	Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Comerford KM, 2002, CANCER RES, V62, P3387; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gillespie DL, 2007, CLIN CANCER RES, V13, P2441, DOI 10.1158/1078-0432.CCR-06-2692; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hanze J, 2003, BIOCHEM BIOPH RES CO, V312, P571, DOI 10.1016/j.bbrc.2003.10.153; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kondo Y, 2005, J UROLOGY, V173, P1762, DOI 10.1097/01.ju.0000154343.35444.09; Lebedeva I, 2000, CANCER RES, V60, P6052; Liu XH, 2006, J CELL BIOCHEM, V97, P755, DOI 10.1002/jcb.20683; Liu YL, 2006, CANCER BIOL THER, V5, P1320, DOI 10.4161/cbt.5.10.3162; Margue CM, 2000, ONCOGENE, V19, P2921, DOI 10.1038/sj.onc.1203607; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Movsas B, 2002, UROLOGY, V60, P634, DOI 10.1016/S0090-4295(02)01858-7; Park SY, 2002, BIOCHEM BIOPH RES CO, V291, P150, DOI 10.1006/bbrc.2002.6421; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Rothermund Christy A, 2005, BMC Urol, V5, P5, DOI 10.1186/1471-2490-5-5; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Sowter HM, 2001, CANCER RES, V61, P6669; Sugars KL, 2001, NUCLEIC ACIDS RES, V29, P4530, DOI 10.1093/nar/29.22.4530; Vilenchik M, 2002, CANCER RES, V62, P2175; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Yoshida D, 2006, J NEURO-ONCOL, V78, P217, DOI 10.1007/s11060-005-9017-9; Yu EZ, 2004, LAB INVEST, V84, P553, DOI 10.1038/labinvest.3700071; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang QZ, 2004, INT J CANCER, V111, P849, DOI 10.1002/ijc.20334; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 1998, CANCER RES, V58, P5280; Zhong H, 1999, CANCER RES, V59, P5830	40	135	141	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10004	10012		10.1074/jbc.M805997200	http://dx.doi.org/10.1074/jbc.M805997200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211554	hybrid, Green Published			2022-12-25	WOS:000264892900043
J	Banci, L; Bertini, I; Cantini, F; Massagni, C; Migliardi, M; Rosato, A				Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Massagni, Chiara; Migliardi, Manuele; Rosato, Antonio			An NMR Study of the Interaction of the N-terminal Cytoplasmic Tail of the Wilson Disease Protein with Copper(I)-HAH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; METAL-BINDING DOMAIN; P-TYPE ATPASE; MENKES-DISEASE; INTERMOLECULAR INTERACTIONS; INTRACELLULAR TRAFFICKING; CATALYTIC-ACTIVITY; CANDIDATE GENE; CHAPERONE; ATP7A	ATP7B is a human P-1B-type ATPase that has a crucial role in maintaining copper(I) homeostasis. Mutations in the corresponding gene are the cause of Wilson disease. Among its various distinguishing features is a long (similar to 630 amino acids) N-terminal cytosolic tail containing six domains that are individually folded and capable of binding one copper(I) ion each. We expressed the entire tail as a single construct in Escherichia coli and investigated its interaction with its copper chaperone (i.e. HAH1) by solution NMR spectroscopy. We observed that all six of the metal-binding domains were metallated by Cu(I)-HAH1, with the first, the second, and the fourth domains forming an adduct with it. This behavior is different from that of the highly similar human ATPase ATP7A, in which only two domains form such an adduct. The distinct behaviors of the different domains were analyzed in terms of the energetics of Cu(I) transfer, hinting at a specific role of the interaction with copper(I)-HAH1 in the overall functional process.	[Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Massagni, Chiara; Migliardi, Manuele; Rosato, Antonio] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Rosato, Antonio] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Massagni, Chiara] FIORGEN Fdn, I-50019 Sesto Fiorentino, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Rosato, Antonio/D-8548-2011; Rosato, Antonio/M-3250-2019; Cantini, Francesca/O-1220-2015	Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; BANCI, LUCIA/0000-0003-0562-5774; Cantini, Francesca/0000-0003-0526-6732	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base) [RBLA032ZM7]; Ente Cassa di Risparmio di Firenze; European Commission [SPINE2-COMPLEXES-031220]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base project RBLA032ZM7), Ente Cassa di Risparmio di Firenze (Projects "Basi Molecolari di Patologie Umane Correlate a Disfunzioni della Catena Respiratoria" and "Relazione Varianti Proteiche Strutturali-malattie Genetiche"), and the European Commission (Project SPINE2-COMPLEXES-031220).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; Anastassopoulou I, 2004, BIOCHEMISTRY-US, V43, P13046, DOI 10.1021/bi0487591; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, J MOL BIOL, V352, P409, DOI 10.1016/j.jmb.2005.07.034; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2007, J BIOL CHEM, V282, P23140, DOI 10.1074/jbc.M700695200; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Bunce J, 2006, BBA-GEN SUBJECTS, V1760, P907, DOI 10.1016/j.bbagen.2006.02.005; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P478; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; Keller R., 2004, COMPUTER AIDED RESON, V1; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; van Dongen EMWM, 2004, BIOCHEM BIOPH RES CO, V323, P789, DOI 10.1016/j.bbrc.2004.08.160; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	53	78	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9354	9360		10.1074/jbc.M805981200	http://dx.doi.org/10.1074/jbc.M805981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181666	hybrid, Green Published			2022-12-25	WOS:000264669100041
J	Muftuoglu, M; de Souza-Pinto, NC; Dogan, A; Aamann, M; Stevnsner, T; Rybanska, I; Kirkali, G; Dizdaroglu, M; Bohr, VA				Muftuoglu, Meltem; de Souza-Pinto, Nadja C.; Dogan, Arin; Aamann, Maria; Stevnsner, Tinna; Rybanska, Ivana; Kirkali, Gueldal; Dizdaroglu, Miral; Bohr, Vilhelm A.			Cockayne Syndrome Group B Protein Stimulates Repair of Formamidopyrimidines by NEIL1 DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; GENE-PRODUCT; SUBSTRATE-SPECIFICITY; XERODERMA-PIGMENTOSUM; HELICASE DOMAIN; OXIDIZED BASES; DAMAGE; CSB	Cockayne syndrome (CS) is a premature aging condition characterized by sensitivity to UV radiation. However, this phenotype does not explain the progressive neurodegeneration in CS patients. It could be due to the hypersensitivity of CSB-deficient cells to oxidative stress. So far most studies on the role of CSB in repair of oxidatively induced DNA lesions have focused on 7,8-dihydro-8-oxoguanine. This study examines the role of CSB in the repair of formamidopyrimidines 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua) and 4,6-diamino-5-formamidopyrimidine (FapyAde), which are substrates for endonuclease VIII-like (NEIL1) DNA glycosylase. Results presented here show that csb(-/-) mice have a higher level of endogenous FapyAde and FapyGua in DNA from brain and kidney than wild type mice as well as higher levels of endogenous FapyAde in genomic DNA and mtDNA from liver. In addition, CSB stimulates NEIL1 incision activity in vitro, and CSB and NEIL1 co-immunoprecipitate and co-localize in HeLa cells. When CSB and NEIL1 are depleted from HeLa cells by short hairpin RNA knockdown, repair of induced FapyGua is strongly inhibited. These results suggest that CSB plays a role in repair of formamidopyrimidines, possibly by interacting with and stimulating NEIL1, and that accumulation of such modifications may have a causal role in the pathogenesis of CS.	[Muftuoglu, Meltem; de Souza-Pinto, Nadja C.; Dogan, Arin; Aamann, Maria; Rybanska, Ivana; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Stevnsner, Tinna] Aarhus Univ, Dept Mol Biol, Danish Aging Res Ctr, DK-8000 Aarhus, Denmark; [Stevnsner, Tinna] Aarhus Univ, Danish Ctr Mol Gerontol, DK-8000 Aarhus, Denmark; [Kirkali, Gueldal; Dizdaroglu, Miral] NIST, Chem Sci & Technol Lab, Gaithersburg, MD 20899 USA; [Dogan, Arin; Kirkali, Gueldal] Dokuz Eylul Univ, Fac Med, Dept Biochem, TR-35340 Izmir, Turkey; [Muftuoglu, Meltem] Univ Copenhagen, Ctr Healthy Ageing, DK-2200 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Aarhus University; Aarhus University; National Institute of Standards & Technology (NIST) - USA; Dokuz Eylul University; University of Copenhagen	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Muftuoglu, Meltem/AAG-5004-2019; Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto, Nadja C./C-3462-2013; Bohr, Vilhelm/AAP-5931-2020; Dogan, Arin/L-6443-2015	Muftuoglu, Meltem/0000-0001-5372-4780; Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja C./0000-0003-4206-964X; Dogan, Arin/0000-0002-5362-5501; Stevnsner, Tinna/0000-0003-1007-0427	National Institutes of Health; National Institute on Aging; National Institute of Standards and Technology; NATIONAL INSTITUTE ON AGING [Z01AG000722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Institute on Aging, and National Institute of Standards and Technology.	BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Christiansen M, 2003, NUCLEIC ACIDS RES, V31, P963, DOI 10.1093/nar/gkg164; de Souza-Pinto NC, 2002, INT REV NEUROBIOL, V53, P519; de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X; de Waard H, 2004, MOL CELL BIOL, V24, P7941, DOI 10.1128/MCB.24.18.7941-7948.2004; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DIZDAROGLU M, 1993, FEBS LETT, V315, P1, DOI 10.1016/0014-5793(93)81120-O; Dizdaroglu M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e12; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; Imam SZ, 2007, NUCLEIC ACIDS RES, V35, P4941, DOI 10.1093/nar/gkm386; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jaruga P, 2004, BIOCHEMISTRY-US, V43, P15909, DOI 10.1021/bi048162l; Jiang YL, 2005, J ORG CHEM, V70, P141, DOI 10.1021/jo048253o; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muftuoglu M, 2006, NUCLEIC ACIDS RES, V34, P295, DOI 10.1093/nar/gkj410; Muftuoglu M, 2002, GENE, V283, P27, DOI 10.1016/S0378-1119(01)00870-8; Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002; Osterod M, 2002, ONCOGENE, V21, P8232, DOI 10.1038/sj.onc.1206027; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Reddy P, 2004, PROTEIN EXPRES PURIF, V34, P126, DOI 10.1016/j.pep.2003.11.019; Roy LM, 2007, J BIOL CHEM, V282, P15790, DOI 10.1074/jbc.M610626200; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selzer RR, 2002, NUCLEIC ACIDS RES, V30, P782, DOI 10.1093/nar/30.3.782; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; STEENKEN S, 1989, CHEM REV, V89, P503, DOI 10.1021/cr00093a003; Stefanini M, 1996, HUM GENET, V97, P418; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; SUN B, 1995, J BIOL CHEM, V270, P19501, DOI 10.1074/jbc.270.33.19501; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; Trapp C, 2007, ONCOGENE, V26, P4044, DOI 10.1038/sj.onc.1210167; TROELSTRA C, 1990, MOL CELL BIOL, V10, P5806, DOI 10.1128/MCB.10.11.5806; Tuo J, 2001, J BIOL CHEM, V276, P45772, DOI 10.1074/jbc.M107888200; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	55	88	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9270	9279		10.1074/jbc.M807006200	http://dx.doi.org/10.1074/jbc.M807006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179336	hybrid, Green Published			2022-12-25	WOS:000264669100033
J	Sawallisch, C; Berhorster, K; Disanza, A; Mantoani, S; Kintscher, M; Stoenica, L; Dityatev, A; Sieber, S; Kindler, S; Morellini, F; Schweizer, M; Boeckers, TM; Korte, M; Scita, G; Kreienkamp, HJ				Sawallisch, Corinna; Berhoerster, Kerstin; Disanza, Andrea; Mantoani, Sara; Kintscher, Michael; Stoenica, Luminita; Dityatev, Alexander; Sieber, Sabrina; Kindler, Stefan; Morellini, Fabio; Schweizer, Michaela; Boeckers, Tobias M.; Korte, Martin; Scita, Giorgio; Kreienkamp, Hans-Juergen			The Insulin Receptor Substrate of 53 kDa (IRSp53) Limits Hippocampal Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTIC SHANK; SPINE MORPHOLOGY; MICE DEFICIENT; SMALL GTPASES; PROTEIN; CDC42; DOMAIN; FILOPODIA; COMPLEX	IRSp53 is an essential intermediate between the activation of Rac and Cdc42 GTPases and the formation of cellular protrusions; it affects cell shape by coupling membrane-deforming activity with the actin cytoskeleton. IRSp53 is highly expressed in neurons where it is also an abundant component of the postsynaptic density (PSD). Here we analyze the physiological function of this protein in the mouse brain by generating IRSp53-deficient mice. Neurons in the hippocampus of young and adult knock-out (KO) mice do not exhibit morphological abnormalities in vivo. Conversely, primary cultured neurons derived from IRSp53 KO mice display retarded dendritic development in vitro. On a molecular level, Eps8 cooperates with IRSp53 to enhance actin bundling and interacts with IRSp53 in developing neurons. However, postsynaptic Shank proteins which are expressed at high levels in mature neurons compete with Eps8 to block actin bundling. In electrophysiological experiments the removal of IRSp53 increases synaptic plasticity as measured by augmented long term potentiation and paired-pulse facilitation. A primarily postsynaptic role of IRSp53 is underscored by the decreased size of the PSDs, which display increased levels of N-methyl-D-aspartate receptor subunits in IRSp53 KO animals. Our data suggest that the incorporation of IRSp53 into the PSD enables the protein to limit the number of postsynaptic glutamate receptors and thereby affect synaptic plasticity rather than dendritic morphology. Consistent with altered synaptic plasticity, IRSp53-deficient mice exhibit cognitive deficits in the contextual fear-conditioning paradigm.	[Sawallisch, Corinna; Berhoerster, Kerstin; Sieber, Sabrina; Kindler, Stefan; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Stoenica, Luminita; Dityatev, Alexander] Univ Klinikum Hamburg Eppendorf, Inst Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Schweizer, Michaela] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Disanza, Andrea; Mantoani, Sara; Scita, Giorgio] Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Disanza, Andrea; Mantoani, Sara; Scita, Giorgio] Univ Milan, I-20139 Milan, Italy; [Kintscher, Michael; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Dityatev, Alexander] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Boeckers, Tobias M.] Univ Ulm, Inst Anat & Zellbiol, D-89081 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Braunschweig University of Technology; Istituto Italiano di Tecnologia - IIT; Ulm University	Kreienkamp, HJ (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	kreienkamp@uke.de	Scita, Giorgio/J-9670-2012; Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553; Disanza, Andrea/0000-0001-5101-2907; Scita, Giorgio/0000-0001-7984-1889; Kintscher, Michael/0000-0003-2355-1369	Deutsche Forschungsgemeinschaft [Kr1321, FOR885, Di 702/4-1, Di 702/4-2, Di 702/4-3, SFB497/B8]; Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale; Fondazione Italiana Ricerca sul Cancro	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale; Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Deutsche Forschungsgemeinschaft Kr1321 and FOR885 ( to H.-J.K.), Di 702/4-1,2,3 ( to A. Dityatev), and SFB497/B8 ( to T. M. B.), by Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale 2007 ( to G. S.), and by Fondazione Italiana Ricerca sul Cancro ( to A. Disanza).	Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Freitag S, 2003, BEHAV BRAIN RES, V145, P189, DOI 10.1016/S0166-4328(03)00109-8; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Soltau M, 2002, MOL CELL NEUROSCI, V21, P575, DOI 10.1006/mcne.2002.1201; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Thomas EA, 2001, NEUROSCI LETT, V309, P145, DOI 10.1016/S0304-3940(01)02064-X; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	38	62	62	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9225	9236		10.1074/jbc.M808425200	http://dx.doi.org/10.1074/jbc.M808425200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208628	Green Published, hybrid			2022-12-25	WOS:000264669100029
J	Walton, KL; Makanji, Y; Wilce, MC; Chan, KL; Robertson, DM; Harrison, CA				Walton, Kelly L.; Makanji, Yogeshwar; Wilce, Matthew C.; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.			A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor beta (TGF beta) Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMURATI-ENGELMANN-DISEASE; EXTRACELLULAR-MATRIX; ACTIVIN-A; BINDING-SITES; OVARIAN FAILURE; LATENT COMPLEX; BMP15 GENE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; FOLLICULAR-FLUID	The assembly and secretion of transforming growth factor beta superfamily ligands is dependent upon non-covalent interactions between their pro- and mature domains. Despite the importance of this interaction, little is known regarding the underlying regulatory mechanisms. In this study, the binding interface between the pro- and mature domains of the inhibin alpha-subunit was characterized using in vitro mutagenesis. Three hydrophobic residues near the N terminus of the prodomain (Leu(30), Phe(37), Leu(41)) were identified that, when mutated to alanine, disrupted heterodimer assembly and secretion. It is postulated that these residues mediate dimerization by interacting non-covalently with hydrophobic residues (Phe(271), Ile(280), Pro(283), Leu(338), and Val(340)) on the outer convex surface of the mature alpha-subunit. Homology modeling indicated that these mature residues are located at the interface between two beta-sheets of the alpha-subunit and that their side chains form a hydrophobic packing core. Mutation of these residues likely disturbs the conformation of this region, thereby disrupting non-covalent interactions with the prodomain. A similar hydrophobic interface was identified spanning the pro- and mature domains of the inhibin beta(A)-subunit. Mutation of key residues, including Ile(62), Leu(66), Phe(329), and Pro(341), across this interface was disruptive for the production of both inhibin A and activin A. In addition, mutation of Ile(62) and Leu(66) in the beta(A)-propeptide reduced its ability to bind, or inhibit the activity of, activin A. Conservation of the identified hydrophobic motifs in the pro- and mature domains of other transforming growth factor beta superfamily ligands suggests that we have identified a common biosynthetic pathway governing dimer assembly.	[Walton, Kelly L.; Makanji, Yogeshwar; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Makanji, Yogeshwar] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University; Monash University	Harrison, CA (corresponding author), Prince Henrys Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	Craig.Harrison@princehenrys.org	Walton, Kelly/ABF-7282-2020; Chan, Karen/E-4041-2015	Walton, Kelly/0000-0003-0627-2958; Harrison, Craig/0000-0003-1059-3682; Chan, Karen/0000-0001-9947-4713	National Health and Medical Research Council of Australia Project [388920, 494804, 241000]; Monash Postgraduate Scholarship	National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Monash Postgraduate Scholarship	This work was supported by National Health and Medical Research Council of Australia Project Grants 388920 (to K. L. W.) and 494804 (to C. A. H.) and Program Grant 241000 (to D. M. R.).; Supported by a Monash Postgraduate Scholarship.	Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Campos-Xavier AB, 2001, HUM GENET, V109, P653, DOI 10.1007/s00439-001-0644-8; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; del Re E, 2004, J BIOL CHEM, V279, P53126, DOI 10.1074/jbc.M408090200; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Farnworth PG, 2006, J ENDOCRINOL, V188, P451, DOI 10.1677/joe.1.06444; Farnworth PG, 2001, MOL CELL ENDOCRINOL, V180, P63, DOI 10.1016/S0303-7207(01)00499-3; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Maeda S, 2002, CALCIFIED TISSUE INT, V70, P54, DOI 10.1007/s002230010032; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Makanji Y, 2007, ENDOCRINOLOGY, V148, P2309, DOI 10.1210/en.2006-1612; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; ROBERTSON DM, 1986, MOL CELL ENDOCRINOL, V46, P29, DOI 10.1016/0303-7207(86)90066-3; Robertson DM, 2002, MOL CELL ENDOCRINOL, V191, P97, DOI 10.1016/S0303-7207(02)00060-6; RUSSELL DL, 1994, J REPROD FERTIL, V100, P115, DOI 10.1530/jrf.0.1000115; Saika S, 2001, GRAEF ARCH CLIN EXP, V239, P234, DOI 10.1007/s004170100275; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Sunada Yoshihide, 2006, Rinsho Shinkeigaku, V46, P942; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Wu SL, 2007, BONE, V40, P1630, DOI 10.1016/j.bone.2007.02.025; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	50	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9311	9320		10.1074/jbc.M808763200	http://dx.doi.org/10.1074/jbc.M808763200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193648	hybrid, Green Published			2022-12-25	WOS:000264669100037
J	Busso, CS; Iwakuma, T; Izumi, T				Busso, C. S.; Iwakuma, T.; Izumi, T.			Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway	ONCOGENE			English	Article						APE1; p53; MDM2; DNA repair; DNA damage; ubiquitination	BASE EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; ADENOMATOUS POLYPOSIS-COLI; ABASIC SITE REPAIR; EXTRACELLULAR CALCIUM; PROTEIN APE/REF-1; CELL-DEATH; IN-VIVO; P53; MDM2	APE1/Ref-1 is an essential DNA repair/gene regulatory protein in mammals of which intracellular level significantly affects cellular sensitivity to genotoxicants. The apurinic/apyrimidinic endonuclease 1 (APE1) functions are altered by phosphorylation and acetylation. We here report that APE1 is also modified by ubiquitination. APE1 ubiquitination occurred specifically at Lys residues near the N-terminus, and was markedly enhanced by mouse double minute 2 (MDM2), the major intracellular p53 inhibitor. Moreover, DNA-damaging reagents and nutlin-3, an inhibitor of MDM2-p53 interaction, increased APE1 ubiquitination in the presence of p53. Downmodulation of MDM2 increased APE1 level, suggesting that MDM2-mediated ubiquitination can be a signal for APE1 degradation. In addition, unlike the wild-type APE1, ubiquitin-APE1 fusion proteins were predominantly present in the cytoplasm. Therefore, monoubiquitination not only is a prerequisite for degradation, but may also alter the APE1 activities in cells. These results reveal a novel regulation of APE1 through ubiquitination.	[Izumi, T.] Louisiana State Univ, Stanley S Scott Canc Ctr, Dept Otolaryngol, Hlth Sci Ctr,CSRB, New Orleans, LA 70112 USA; [Iwakuma, T.] Louisiana State Univ, Stanley S Scott Canc Ctr, Dept Genet, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Izumi, T (corresponding author), Louisiana State Univ, Stanley S Scott Canc Ctr, Dept Otolaryngol, Hlth Sci Ctr,CSRB, 533 Bolivar St, New Orleans, LA 70112 USA.	tizumi@lsuhsc.edu			NCI [CA98664]; Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE [R01CA098664, R56CA098664] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank KA Kerlec, KM Lane, MWLake, MK Rogoszewicz and C Bulkin for their technical assistance, and Mr Lake for editorial help. We also thank Dr S Desai and Dr A Haas at LSUHSC, New Orleans for their critical discussion and experimental guidance. Dr Davis's excellent editorial help is much appreciated. This research was supported by NCI grant CA98664 (TI) and Louisiana Cancer Research Consortium funding.	ASOU H, 1991, BLOOD, V77, P2031; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Balusu R, 2007, BIOCHEMISTRY-US, V46, P13961, DOI 10.1021/bi701632e; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Fuchs S, 2003, J HYPERTENS, V21, P327, DOI 10.1097/00004872-200302000-00024; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Izumi T, 1996, BIOCHEMISTRY-US, V35, P14679, DOI 10.1021/bi961995u; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Kakolyris S, 1997, CANCER RES, V57, P1794; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koukourakis MI, 2001, INT J RADIAT ONCOL, V50, P27, DOI 10.1016/S0360-3016(00)01561-3; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; MCHAFFIE GS, 1995, BONE, V17, P11, DOI 10.1016/8756-3282(95)00131-V; Meira LB, 1997, NAT GENET, V17, P145, DOI 10.1038/ng1097-145; Meira LB, 2001, CANCER RES, V61, P5552; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; ONO Y, 1994, MUTAT RES, V315, P55, DOI 10.1016/0921-8777(94)90028-0; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; SAPORITO SM, 1989, J BACTERIOL, V171, P2542, DOI 10.1128/jb.171.5.2542-2546.1989; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shmueli A, 2004, MOL CELL, V13, P4, DOI 10.1016/S1097-2765(03)00529-X; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yacoub A, 1997, CANCER RES, V57, P5457; Yang HY, 2007, ONCOGENE, V26, P7355, DOI 10.1038/sj.onc.1210540; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; Zhao JF, 2008, J BIOL CHEM, V283, P9925, DOI 10.1074/jbc.M708345200; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	57	83	88	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1616	1625		10.1038/onc.2009.5	http://dx.doi.org/10.1038/onc.2009.5			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19219073	Green Accepted			2022-12-25	WOS:000264780500006
J	Seeger, FH; Chen, L; Spyridopoulos, I; Altschmied, J; Aicher, A; Haendeler, J				Seeger, Florian Hartmut; Chen, Linping; Spyridopoulos, Ioakim; Altschmied, Joachim; Aicher, Alexandra; Haendeler, Judith			Downregulation of ETS Rescues Diabetes-Induced Reduction of Endothelial Progenitor Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; VASCULAR COMPLICATIONS; ANGIOGENESIS; DIFFERENTIATION; NUMBER; INHIBITION; INCREASE; THERAPY	Background: Transplantation of vasculogenic progenitor cells (VPC) improves neovascularization after ischemia. However, patients with type 2 diabetes mellitus show a reduced VPC number and impaired functional activity. Previously, we demonstrated that p38 kinase inhibition prevents the negative effects of glucose on VPC number by increasing proliferation and differentiation towards the endothelial lineage in vitro. Moreover, the functional capacity of progenitor cells is reduced in a mouse model of metabolic syndrome including type 2 diabetes (Lepr(db)) in vivo. Findings: The aim of this study was to elucidate the underlying signalling mechanisms in vitro and in vivo. Therefore, we performed DNA-protein binding arrays in the bone marrow of mice with metabolic syndrome, in blood-derived progenitor cells of diabetic patients as well as in VPC ex vivo treated with high levels of glucose. The transcriptional activation of ETS transcription factors was increased in all samples analyzed. Downregulation of ETS1 expression by siRNA abrogated the reduction of VPC number induced by high-glucose treatment. In addition, we observed a concomitant suppression of the non-endothelial ETS-target genes matrix metalloproteinase 9 (MMP9) and CD115 upon short term lentiviral delivery of ETS-specific shRNAs. Long term inhibition of ETS expression by lentiviral infection increased the number of cells with the endothelial markers CD144 and CD105. Conclusion: These data demonstrate that diabetes leads to dysregulated activation of ETS, which blocks the functional activity of progenitor cells and their commitment towards the endothelial cell lineage.	[Seeger, Florian Hartmut; Chen, Linping; Spyridopoulos, Ioakim; Altschmied, Joachim; Aicher, Alexandra; Haendeler, Judith] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Haendeler, Judith] Univ Dusseldorf, IUF, D-4000 Dusseldorf, Germany	Goethe University Frankfurt; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Seeger, FH (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany.	juhae001@uni-duesseldorf.de	Aicher, Alexandra/GZK-8031-2022	Haendeler, Judith/0000-0001-8507-4540; Spyridopoulos, Ioakim/0000-0002-2750-2444; Aicher, Alexandra/0000-0002-8920-9577	University of Frankfurt; Deutsche Forschungsgemeinschaft [HA-2868/3-3, SFB728 B5]	University of Frankfurt; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a start-up grant of the University of Frankfurt to FHS and by grants from the Deutsche Forschungsgemeinschaft to JH (HA-2868/3-3 and SFB728 B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gadau S, 2006, DIABETOLOGIA, V49, P405, DOI 10.1007/s00125-005-0103-5; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Howard BV, 2002, CIRCULATION, V105, pE128; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lulli V, 2006, CELL DEATH DIFFER, V13, P1064, DOI 10.1038/sj.cdd.4401811; Marchetti V, 2006, DIABETES, V55, P2231, DOI 10.2337/db06-0369; Marziali G, 2002, BLOOD CELL MOL DIS, V29, P553, DOI 10.1006/bcmd.2002.0595; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; McLaughlin F, 1999, J CELL SCI, V112, P4695; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nakano T, 2000, J CELL PHYSIOL, V184, P255, DOI 10.1002/1097-4652(200008)184:2<255::AID-JCP14>3.0.CO;2-J; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shantsila E, 2008, J AM COLL CARDIOL, V51, P669, DOI 10.1016/j.jacc.2007.09.057; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030	37	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4529	10.1371/journal.pone.0004529	http://dx.doi.org/10.1371/journal.pone.0004529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225563	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486000007
J	Vassella, E; Oberle, M; Urwyler, S; Renggli, CK; Studer, E; Hemphill, A; Fragoso, C; Butikofer, P; Brun, R; Roditi, I				Vassella, Erik; Oberle, Michael; Urwyler, Simon; Renggli, Christina Kunz; Studer, Erwin; Hemphill, Andrew; Fragoso, Cristina; Butikofer, Peter; Brun, Reto; Roditi, Isabel			Major Surface Glycoproteins of Insect Forms of Trypanosoma brucei Are Not Essential for Cyclical Transmission by Tsetse	PLOS ONE			English	Article								Procyclic forms of Trypanosoma brucei reside in the midgut of tsetse flies where they are covered by several million copies of glycosylphosphatidylinositol-anchored proteins known as procyclins. It has been proposed that procyclins protect parasites against proteases and/or participate in tropism, directing them from the midgut to the salivary glands. There are four different procyclin genes, each subject to elaborate levels of regulation. To determine if procyclins are essential for survival and transmission of T. brucei, all four genes were deleted and parasite fitness was compared in vitro and in vivo. When co-cultured in vitro, the null mutant and wild type trypanosomes (tagged with cyan fluorescent protein) maintained a near-constant equilibrium. In contrast, when flies were infected with the same mixture, the null mutant was rapidly overgrown in the midgut, reflecting a reduction in fitness in vivo. Although the null mutant is patently defective in competition with procyclin-positive parasites, on its own it can complete the life cycle and generate infectious metacyclic forms. The procyclic form of T. brucei thus differs strikingly from the bloodstream form, which does not tolerate any perturbation of its variant surface glycoprotein coat, and from other parasites such as Plasmodium berghei, which requires the circumsporozoite protein for successful transmission to a new host.	[Vassella, Erik; Urwyler, Simon; Studer, Erwin; Fragoso, Cristina; Roditi, Isabel] Univ Bern, Inst Zellbiol, CH-3012 Bern, Switzerland; [Oberle, Michael; Renggli, Christina Kunz; Brun, Reto] Swiss Trop Inst, Basel, Switzerland; [Hemphill, Andrew] Univ Bern, Inst Parasitol, CH-3012 Bern, Switzerland; [Butikofer, Peter] Univ Bern, Inst Biochem Mol Med, CH-3012 Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Bern; University of Bern	Vassella, E (corresponding author), Univ Bern, Inst Pathol, Bern, Switzerland.	isabel.roditi@izb.unibe.ch		Hemphill, Andrew/0000-0002-0622-2128; Roditi, Isabel/0000-0003-2812-6513	Swiss National Science Foundation; Howard Hughes Medical Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Swiss National Science Foundation; Howard Hughes Medical Institute	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; BRUCE D, 1896, FURTHER REPORT TSETS; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 2003, MOL BIOCHEM PARASIT, V126, P287, DOI 10.1016/S0166-6851(02)00286-4; Chandra M, 2004, INSECT BIOCHEM MOLEC, V34, P1163, DOI 10.1016/j.ibmb.2004.07.004; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Furger A, 2001, FEBS LETT, V508, P90, DOI 10.1016/S0014-5793(01)03031-9; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; Gruszynski AE, 2006, MOL BIOCHEM PARASIT, V147, P211, DOI 10.1016/j.molbiopara.2006.02.013; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Haenni S, 2006, MOL BIOCHEM PARASIT, V150, P144, DOI 10.1016/j.molbiopara.2006.07.005; HAJDUK SL, 1984, J PROTOZOOL, V31, P41, DOI 10.1111/j.1550-7408.1984.tb04287.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Liniger M, 2004, MOL BIOCHEM PARASIT, V137, P247, DOI 10.1016/j.molbiopara.2004.06.006; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; RICHARDSON JP, 1988, MOL BIOCHEM PARASIT, V31, P203, DOI 10.1016/0166-6851(88)90150-8; Roditi I, 2002, TRENDS MICROBIOL, V10, P128, DOI 10.1016/S0966-842X(02)02309-0; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Schlaeppi AC, 2003, J BIOL CHEM, V278, P49980, DOI 10.1074/jbc.M309548200; SHARMA R, 2007, ASYMMETRIC CELL DIVI; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; TETLEY L, 1987, J CELL SCI, V87, P363; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2004, MOL BIOL CELL, V15, P3986, DOI 10.1091/mbc.E04-04-0341; Vassella E, 2001, J MOL BIOL, V312, P597, DOI 10.1006/jmbi.2001.5004; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2001, MOL MICROBIOL, V41, P33, DOI 10.1046/j.1365-2958.2001.02471.x; Welburn SC, 1997, MED VET ENTOMOL, V11, P286, DOI 10.1111/j.1365-2915.1997.tb00408.x; ZIEGELBAUER K, 1990, EUR J BIOCHEM, V192, P373, DOI 10.1111/j.1432-1033.1990.tb19237.x	40	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4493	10.1371/journal.pone.0004493	http://dx.doi.org/10.1371/journal.pone.0004493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223969	Green Published, gold			2022-12-25	WOS:000265485800005
J	Brenneis, M; Soppa, J				Brenneis, Mariam; Soppa, Joerg			Regulation of Translation in Haloarchaea: 5 '- and 3 '-UTRs Are Essential and Have to Functionally Interact In Vivo	PLOS ONE			English	Article								Recently a first genome-wide analysis of translational regulation using prokaryotic species had been performed which revealed that regulation of translational efficiency plays an important role in haloarchaea. In fact, the fractions of genes under differential growth phase-dependent translational control in the two species Halobacterium salinarum and Haloferax volcanii were as high as in eukaryotes. However, nothing is known about the mechanisms of translational regulation in archaea. Therefore, two genes exhibiting opposing directions of regulation were selected to unravel the importance of untranslated regions (UTRs) for differential translational control in vivo. Differential translational regulation in exponentially growing versus stationary phase cells was studied by comparing translational efficiencies using a reporter gene system. Translational regulation was not observed when 5'-UTRs or 3'-UTRs alone were fused to the reporter gene. However, their simultaneous presence was sufficient to transfer differential translational control from the native transcript to the reporter transcript. This was true for both directions of translational control. Translational regulation was completely abolished when stem loops in the 5'-UTR were changed by mutagenesis. An "UTR-swap'' experiment demonstrated that the direction of translational regulation is encoded in the 3'-UTR, not in the 5'-UTR. While much is known about 5'-UTR-dependent translational control in bacteria, the reported findings provide the first examples that both 5'- and 3'-UTRs are essential and sufficient to drive differential translational regulation in a prokaryote and therefore have to functionally interact in vivo. The current results indicate that 3'-UTR-dependent translational control had already evolved before capping and polyadenylation of transcripts were invented, which are essential for circularization of transcripts in eukaryotes.	[Brenneis, Mariam; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt	Brenneis, M (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (DFG) [SFB579]	German Research Council (DFG)(German Research Foundation (DFG))	The described work was supported by the German Research Council (DFG) throuth grant B6 in the framework of the special research program SFB579 "RNA ligand interactions". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Danner S, 1996, MOL MICROBIOL, V19, P1265, DOI 10.1111/j.1365-2958.1996.tb02471.x; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nicolai M, 2006, PLANT PHYSIOL, V141, P663, DOI 10.1104/pp.106.079418; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Patenge N, 1999, FEMS MICROBIOL LETT, V171, P27, DOI 10.1016/S0378-1097(98)00583-7; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; Rother M, 2001, BIOFACTORS, V14, P75, DOI 10.1002/biof.5520140111; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4484	10.1371/journal.pone.0004484	http://dx.doi.org/10.1371/journal.pone.0004484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214227	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484300014
J	Schmitt, I; Lumbsch, HT				Schmitt, Imke; Lumbsch, H. Thorsten			Ancient Horizontal Gene Transfer from Bacteria Enhances Biosynthetic Capabilities of Fungi	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; EVOLUTION; CLUSTER; CLONING; SYMBIONT; KETOSYNTHASE; PROBES; PKS	Background: Polyketides are natural products with a wide range of biological functions and pharmaceutical applications. Discovery and utilization of polyketides can be facilitated by understanding the evolutionary processes that gave rise to the biosynthetic machinery and the natural product potential of extant organisms. Gene duplication and subfunctionalization, as well as horizontal gene transfer are proposed mechanisms in the evolution of biosynthetic gene clusters. To explain the amount of homology in some polyketide synthases in unrelated organisms such as bacteria and fungi, interkingdom horizontal gene transfer has been evoked as the most likely evolutionary scenario. However, the origin of the genes and the direction of the transfer remained elusive. Methodology/Principal Findings: We used comparative phylogenetics to infer the ancestor of a group of polyketide synthase genes involved in antibiotic and mycotoxin production. We aligned keto synthase domain sequences of all available fungal 6-methylsalicylic acid (6-MSA)-type PKSs and their closest bacterial relatives. To assess the role of symbiotic fungi in the evolution of this gene we generated 24 6-MSA synthase sequence tags from lichen-forming fungi. Our results support an ancient horizontal gene transfer event from an actinobacterial source into ascomycete fungi, followed by gene duplication. Conclusions/Significance: Given that actinobacteria are unrivaled producers of biologically active compounds, such as antibiotics, it appears particularly promising to study biosynthetic genes of actinobacterial origin in fungi. The large number of 6-MSA-type PKS sequences found in lichen-forming fungi leads us hypothesize that the evolution of typical lichen compounds, such as orsellinic acid derivatives, was facilitated by the gain of this bacterial polyketide synthase.	[Schmitt, Imke] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Schmitt, Imke] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA; [Schmitt, Imke; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago)	Schmitt, I (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	schm2109@umn.edu			Deutsche Forschungsgemeinschaft (DFG) [Emmy Noether Fellowship]; Field Museum; Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Field Museum; Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago	This study was supported by an Emmy Noether Fellowship by the Deutsche Forschungsgemeinschaft (DFG) to IS, and a start up fund by the Field Museum to HTL. Sequences were generated in the Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; ARNOLD AE, 2008, SYSTEMATIC IN PRESS; BECK J, 1990, EUR J BIOCHEM, V192, P487, DOI 10.1111/j.1432-1033.1990.tb19252.x; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Buades C, 1996, J MOL EVOL, V42, P537, DOI 10.1007/BF02352283; CARDINALE M, 2008, FEMS MICROB IN PRESS; Cardinale M, 2006, FEMS MICROBIOL ECOL, V57, P484, DOI 10.1111/j.1574-6941.2006.00133.x; Castoe TA, 2007, GENE, V392, P47, DOI 10.1016/j.gene.2006.11.005; Chen J, 2000, CATENA, V39, P121, DOI 10.1016/S0341-8162(99)00085-5; DEMAIN AL, 2000, NATURAL FUNCTIONS SE, P1; Elix J. A., 1996, P154; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Gauslaa Y, 2001, OECOLOGIA, V126, P462, DOI 10.1007/s004420000541; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Grube M, 2003, MYCOL RES, V107, P1419, DOI 10.1017/S0953756203008724; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; Hawksworth DL, 1976, LICHENOLOGY PROGR PR, P139; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huneck S, 1996, IDENTIFICATION LICHE; HUNECK S, 2003, BIBL LICH, V85, P9; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Karolewiez A, 2005, SYST APPL MICROBIOL, V28, P588, DOI 10.1016/j.syapm.2005.03.008; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; KINRAIDE W T B, 1970, Lichenologist (London), V4, P234, DOI 10.1017/S0024282970000270; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kudo F, 2007, J ANTIBIOT, V60, P492, DOI 10.1038/ja.2007.63; LANGE OL, 1992, PFLANZENLEBEN UNTER; Lawrey JD, 2003, BRYOLOGIST, V106, P80, DOI 10.1639/0007-2745(2003)106[0080:LFIEAB]2.0.CO;2; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 1998, LICHENOLOGIST, V30, P357, DOI 10.1006/lich.1998.0147; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Miao V, 2001, TRENDS BIOTECHNOL, V19, P349, DOI 10.1016/S0167-7799(01)01700-0; Milinkovitch MC, 1998, MOL PHYLOGENET EVOL, V9, P348, DOI 10.1006/mpev.1998.0503; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Muggia L, 2008, MYCOL RES, V112, P277, DOI 10.1016/j.mycres.2007.08.020; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; PENALVA MA, 1990, P ROY SOC B-BIOL SCI, V241, P164, DOI 10.1098/rspb.1990.0081; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2004, J BACTERIOL, V186, P1280, DOI 10.1128/JB.186.5.1280-1286.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Sauer M, 2002, MYCOL RES, V106, P460, DOI 10.1017/S095375620200566X; Schmidt EW, 2008, NAT CHEM BIOL, V4, P466, DOI 10.1038/nchembio.101; Schmitt I, 2005, PHYTOCHEMISTRY, V66, P1241, DOI 10.1016/j.phytochem.2005.04.014; Schmitt I, 2008, ISME J, V2, P632, DOI 10.1038/ismej.2008.19; Schmitt I, 2008, MYCOL RES, V112, P289, DOI 10.1016/j.mycres.2007.08.023; Shao L, 2006, BIOCHEM BIOPH RES CO, V345, P133, DOI 10.1016/j.bbrc.2006.04.069; Shen B, 2000, TOP CURR CHEM, V209, P1; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Mark, 2005, MRBAYES 3 1 MANUAL, P1; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347; Zhang YQ, 2005, MYCOLOGY S, V22, P355	71	93	95	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4437	10.1371/journal.pone.0004437	http://dx.doi.org/10.1371/journal.pone.0004437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212443	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200004
J	Davies, EC; Green, CF; Taylor, S; Williamson, PR; Mottram, DR; Pirmohamed, M				Davies, Emma C.; Green, Christopher F.; Taylor, Stephen; Williamson, Paula R.; Mottram, David R.; Pirmohamed, Munir			Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes	PLOS ONE			English	Article							RISK-FACTORS; EVENTS; DEFINITIONS; ADMISSIONS; COSTS	Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. Patients admitted to twelve wards over a six-month period in 2005 were assessed for ADRs throughout their admission. Suspected ADRs were recorded and analysed for causality, severity and avoidability and whether they increased the length of stay. Multivariable analysis was undertaken to identify the risk factors for ADRs. The 5% significance level was used when assessing factors for inclusion in multivariable models. Out of the 3695 patient episodes assessed for ADRs, 545 (14.7%, 95% CI 13.6-15.9%) experienced one or more ADRs. Half of ADRs were definitely or possibly avoidable. The patients experiencing ADRs were more likely to be older, female, taking a larger number of medicines, and had a longer length of stay than those without ADRs. However, the only significant predictor of ADRs, from the multivariable analysis of a representative sample of patients, was the number of medicines taken by the patient with each additional medication multiplying the hazard of an ADR episode by 1.14 (95% CI 1.09, 1.20). ADRs directly increased length of stay in 147 (26.8%) patients. The drugs most frequently associated with ADRs were diuretics, opioid analgesics, and anticoagulants. In conclusion, approximately one in seven hospital in-patients experience an ADR, which is a significant cause of morbidity, increasing the length of stay of patients by an average of 0.25 days/patient admission episode. The overall burden of ADRs on hospitals is high, and effective intervention strategies are urgently needed to reduce this burden.	[Davies, Emma C.] Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England; [Davies, Emma C.; Mottram, David R.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England; [Green, Christopher F.] Countess Chester NHS Fdn Trust, Countess Chester Hlth Pk, Pharm Martindale House, Chester, Cheshire, England; [Taylor, Stephen; Williamson, Paula R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; [Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; Liverpool John Moores University; University of Liverpool; University of Liverpool	Davies, EC (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England.	munirp@liv.ac.uk	Pirmohamed, Munir/H-6004-2011; Williamson, Paula R/B-6425-2016	Pirmohamed, Munir/0000-0002-7534-7266; Williamson, Paula R/0000-0001-9802-6636	Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund; Liverpool John Moores University; Medical Research Council [G0800792] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund(Australian Research Council); Liverpool John Moores University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the study was provided by the Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund and Liverpool John Moores University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; *ASS BRIT PHARM IN, 2005, ABPI DAT SHEET COMP; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2005, BRIT NAT FORM; Brown H., 1999, APPL MIXED MODELS ME; Camargo AL, 2006, EUR J CLIN PHARMACOL, V62, P143, DOI 10.1007/s00228-005-0086-7; CARBONIN P, 1991, J AM GERIATR SOC, V39, P1093, DOI 10.1111/j.1532-5415.1991.tb02875.x; *CIPFA, 2002, HLTH SERV FIN DAT CO; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Davies EC, 2006, J CLIN PHARM THER, V31, P335, DOI 10.1111/j.1365-2710.2006.00744.x; Davies EC, 2007, CURR DRUG SAF, V2, P79, DOI 10.2174/157488607779315507; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; *DEP HLTH ENGL, 2008, DEP HLTH HEADL STAT; *DEP HLTH ENGL, 2008, AV DAIL NUMB AV OCC; Dormann H, 2004, ALIMENT PHARM THERAP, V19, P303, DOI 10.1111/j.1365-2036.2004.01854.x; Ducharme MM, 2007, INT J CLIN PRACT, V61, P157, DOI 10.1111/j.1742-1241.2006.01130.x; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; EVANS RS, 1994, ANN PHARMACOTHER, V28, P523, DOI 10.1177/106002809402800417; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; HOIGNE R, 1990, EUR J CLIN PHARMACOL, V39, P321, DOI 10.1007/BF00315403; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; HURWITZ N, 1969, BMJ-BRIT MED J, V1, P531, DOI 10.1136/bmj.1.5643.531; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; Kvasz M, 2000, MedGenMed, V2, pE3; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEACH S, 1986, AGE AGEING, V15, P241, DOI 10.1093/ageing/15.4.241; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *MED HEALTHC PROD, WHAT REP; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; OGILVIE RI, 1967, CAN MED ASSOC J, V97, P1450; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pirmohamed M, 2003, BRIT MED J, V327, P1179, DOI 10.1136/bmj.327.7425.1179; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Rawlins MDTJ, 1977, TXB ADVERSE DRUG REA; SEIDL LG, 1965, AM J PUBLIC HEALTH N, V55, P1170, DOI 10.2105/AJPH.55.8.1170; Simmons C, 1998, HOSP PHARM, V33, P1568; SMITH JW, 1966, ANN INTERN MED, V65, P629, DOI 10.7326/0003-4819-65-4-629; Suh DC, 2000, ANN PHARMACOTHER, V34, P1373, DOI 10.1345/aph.10094; van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016; VANKRAAIJ DJW, 1994, NETH J MED, V44, P166; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x; Wiffen P, 2002, BANDOLIER EXTRA, P1; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225	47	439	454	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4439	10.1371/journal.pone.0004439	http://dx.doi.org/10.1371/journal.pone.0004439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209224	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484100009
J	Schlessinger, A; Punta, M; Yachdav, G; Kajan, L; Rost, B				Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard			Improved Disorder Prediction by Combination of Orthogonal Approaches	PLOS ONE			English	Article								Disordered proteins are highly abundant in regulatory processes such as transcription and cell-signaling. Different methods have been developed to predict protein disorder often focusing on different types of disordered regions. Here, we present MD, a novel META-Disorder prediction method that molds various sources of information predominantly obtained from orthogonal prediction methods, to significantly improve in performance over its constituents. In sustained cross-validation, MD not only outperforms its origins, but it also compares favorably to other state-of-the-art prediction methods in a variety of tests that we applied. Availability: http://www.rostlab.org/services/md/	[Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, CUBIC, New York, NY 10027 USA; [Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Ctr Comput Biol & Bioinformat C2B2, New York, NY 10027 USA; [Schlessinger, Avner] Univ Calif San Francisco, Calif Inst Quant Biomed Res, Dept Biopharm Sci, San Francisco, CA 94143 USA; [Punta, Marco; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, NESG, New York, NY 10027 USA; [Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, NYCOMPS, New York, NY 10027 USA	Columbia University; Columbia University; University of California System; University of California San Francisco; Columbia University; Columbia University	Schlessinger, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, CUBIC, New York, NY 10027 USA.	as2067@columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676	National Library of Medicine (NLM) at the NIH [R01-LM07329]; NATIONAL LIBRARY OF MEDICINE [R01LM007329] Funding Source: NIH RePORTER	National Library of Medicine (NLM) at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the grant R01-LM07329 from the National Library of Medicine (NLM) at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boden M, 2006, BIOINFORMATICS, V22, P1809, DOI 10.1093/bioinformatics/btl198; BORDOLI L, 2006, ASSESSMENT DISORDER; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; CHENG J, 2005, ACCURATE PREDICTION, P213; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer David, 2007, V350, P49; Esnouf RM, 2006, ACTA CRYSTALLOGR D, V62, P1260, DOI 10.1107/S0907444906033580; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Gu J, 2006, PLOS COMPUT BIOL, V2, P769, DOI 10.1371/journal.pcbi.0020090; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Melamud E, 2003, PROTEINS, V53, P561, DOI 10.1002/prot.10533; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Moran O, 2007, BIOPHYS J, p274A; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Radivojac P, 2004, PROTEIN SCI, V13, P71, DOI 10.1110/ps.03128904; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero P, 1998, Pac Symp Biocomput, P437; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1995, PROTEIN SCI, V4, P521; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rost B., 2005, PROTEOMICS PROTOCOLS, P875, DOI DOI 10.1385/1-59259-890-0:875; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Snyder DA, 2005, J AM CHEM SOC, V127, P16505, DOI 10.1021/ja053564h; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; TSVETKOV P, 2007, PROTEINS; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yee AA, 2005, J AM CHEM SOC, V127, P16512, DOI 10.1021/ja053565+	78	142	142	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4433	10.1371/journal.pone.0004433	http://dx.doi.org/10.1371/journal.pone.0004433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209228	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484100005
J	Gingerich, PD; ul-Haq, M; von Koenigswald, W; Sanders, WJ; Smith, BH; Zalmout, IS				Gingerich, Philip D.; ul-Haq, Munir; von Koenigswald, Wighart; Sanders, William J.; Smith, B. Holly; Zalmout, Iyad S.			New Protocetid Whale from the Middle Eocene of Pakistan: Birth on Land, Precocial Development, and Sexual Dimorphism	PLOS ONE			English	Article							ARCHAEOCETE MAMMALIA; TOOTH DEVELOPMENT; LIFE-HISTORY; CETACEA; ORIGIN; DENTITION; EVOLUTION; TEETH; LOCOMOTION; FEET	Background: Protocetidae are middle Eocene (49-37 Ma) archaeocete predators ancestral to later whales. They are found in marine sedimentary rocks, but retain four legs and were not yet fully aquatic. Protocetids have been interpreted as amphibious, feeding in the sea but returning to land to rest. Methodology/Principal Findings: Two adult skeletons of a new 2.6 meter long protocetid, Maiacetus inuus, are described from the early middle Eocene Habib Rahi Formation of Pakistan. M. inuus differs from contemporary archaic whales in having a fused mandibular symphysis, distinctive astragalus bones in the ankle, and a less hind-limb dominated postcranial skeleton. One adult skeleton is female and bears the skull and partial skeleton of a single large near-term fetus. The fetal skeleton is positioned for head-first delivery, which typifies land mammals but not extant whales, evidence that birth took place on land. The fetal skeleton has permanent first molars well mineralized, which indicates precocial development at birth. Precocial development, with attendant size and mobility, were as critical for survival of a neonate at the land-sea interface in the Eocene as they are today. The second adult skeleton is the most complete known for a protocetid. The vertebral column, preserved in articulation, has 7 cervicals, 13 thoracics, 6 lumbars, 4 sacrals, and 21 caudals. All four limbs are preserved with hands and feet. This adult is 12% larger in linear dimensions than the female skeleton, on average, has canine teeth that are 20% larger, and is interpreted as male. Moderate sexual dimorphism indicates limited male-male competition during breeding, which in turn suggests little aggregation of food or shelter in the environment inhabited by protocetids. Conclusions/Significance: Discovery of a near-term fetus positioned for head-first delivery provides important evidence that early protocetid whales gave birth on land. This is consistent with skeletal morphology enabling Maiacetus to support its weight on land and corroborates previous ideas that protocetids were amphibious. Specimens this complete are virtual 'Rosetta stones' providing insight into functional capabilities and life history of extinct animals that cannot be gained any other way.	[Gingerich, Philip D.; Sanders, William J.; Zalmout, Iyad S.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Gingerich, Philip D.; Zalmout, Iyad S.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [ul-Haq, Munir] Geol Survey Pakistan, Quetta, Pakistan; [von Koenigswald, Wighart] Univ Bonn, Steinmann Inst Geol Mineral Palaontol, D-5300 Bonn, Germany; [Smith, B. Holly] Univ Michigan, Museum Anthropol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bonn; University of Michigan System; University of Michigan	Gingerich, PD (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	gingeric@umich.edu	Gingerich, Philip D/A-6903-2008; Smith, B. Holly/C-4984-2008	Gingerich, Philip D/0000-0002-1550-2674; Smith, B. Holly/0000-0001-5126-5445	Geological Survey of Pakistan, National Geographic Society [5537-95]; U. S. National Science Foundation [9714923, 0517773]; German Alexander von Humboldt Stiftung; University of Michigan	Geological Survey of Pakistan, National Geographic Society(National Geographic Society); U. S. National Science Foundation(National Science Foundation (NSF)); German Alexander von Humboldt Stiftung; University of Michigan(University of Michigan System)	Research was supported by the Geological Survey of Pakistan, National Geographic Society (5537-95), U. S. National Science Foundation (9714923, 0517773), German Alexander von Humboldt Stiftung, and University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf, 1988, GEOLOGISCHES JB B, V71, P1; BAIER W, 1958, TIERARZTLICHE GEBURS; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; BERKOVITZ BK, 1973, ARCH ORAL BIOL, V18, P465, DOI 10.1016/0003-9969(73)90066-6; Boisserie JR, 2005, P NATL ACAD SCI USA, V102, P1537, DOI 10.1073/pnas.0409518102; Boness DJ, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P278; BROWN WAB, 1991, J ZOOL, V224, P367, DOI 10.1111/j.1469-7998.1991.tb06031.x; Caldwell DK, 1985, HDB MARINE MAMMALS, V3, P33; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; DERRICKSON EM, 1992, FUNCT ECOL, V6, P57, DOI 10.2307/2389771; Dittrich L., 1960, Gegenbaurs Jahrbuch, V101, P1; Eltringham S. K., 1999, HIPPOS NATURAL HIST; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; FRANZEN J L, 1981, Senckenbergiana Lethaea, V61, P299; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip D., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P269; Gingerich Philp D., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P197; HALLMARTIN AJ, 1976, J ZOOL, V180, P263, DOI 10.1111/j.1469-7998.1976.tb04678.x; HAQ MU, 1999, GEOLOGICAL SURVEY PA, V705, P1; Harman MT, 1936, ANAT REC, V66, P97, DOI 10.1002/ar.1090660110; HELLGREN E C, 1984, Journal of Wildlife Diseases, V20, P354; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; KRAUS BS, 1969, TERATOLOGY, V2, P163, DOI 10.1002/tera.1420020212; KUBOTA K, 1961, FOLIA ANATOMICA JAPO, V37, P389; LANG EM, 1975, ZWERGFLUSSPFERD CHOE; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; LEMPPENAU U, 1964, THESIS L MAXIMILIANS; LUCKETT WP, 1982, FOLIA PRIMATOL, V37, P1; Madar SI, 2007, J PALEONTOL, V81, P176, DOI 10.1666/0022-3360(2007)81[176:TPSOEE]2.0.CO;2; Madar SI, 2002, J VERTEBR PALEONTOL, V22, P405, DOI 10.1671/0272-4634(2002)022[0405:AHROAN]2.0.CO;2; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MCKEAN CF, 1971, ARCH ORAL BIOL, V16, P639, DOI 10.1016/0003-9969(71)90067-7; MELLANBY M, 1929, MEDICAL RES COUNCIL, V140, P15; Nievelt A.F.H., 2005, PALEOBIOLOGY, V31, P324, DOI DOI 10.1666/0094-8373(2005)031[0324:TRONTR]2.0.CO;2; OKA SW, 1969, ARCH ORAL BIOL, V14, P639, DOI 10.1016/0003-9969(69)90187-3; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; SHIN HR, 1937, VIERTELJAHRSSCHRIFT, V82, P21; Slijper E. J., 1956, Hvalradets Skrifter, VNo. 41, P1; STOSS AO, 1944, TIERARZTLICHE GEBURS; TOMICH PQ, 1970, ANAT REC, V167, P107, DOI 10.1002/ar.1091670110; TONGE CH, 1973, J ANAT, V115, P1; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Weckerly FW, 1998, J MAMMAL, V79, P33, DOI 10.2307/1382840; WEINREB MM, 1964, AM J VET RES, V25, P891; Zalmout Iyad S., 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P79	52	78	81	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4366	10.1371/journal.pone.0004366	http://dx.doi.org/10.1371/journal.pone.0004366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194487	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483500010
J	Rodahl, LM; Haglund, K; Sem-Jacobsen, C; Wendler, F; Vincent, JP; Lindmo, K; Rusten, TE; Stenmark, H				Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Wendler, Franz; Vincent, Jean-Paul; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald			Disruption of Vps4 and JNK Function in Drosophila Causes Tumour Growth	PLOS ONE			English	Article							EPITHELIAL POLARITY; TRANSPORT; RECEPTOR; ATPASE; PROLIFERATION; TRANSDUCTION; TRAFFICKING; EXPRESSION; PHENOTYPE; COMPLEX	Several regulators of endocytic trafficking have recently been identified as tumour suppressors in Drosophila. These include components of the endosomal sorting complex required for transport (ESCRT) machinery. Disruption of subunits of ESCRT-I and -II leads to cell-autonomous endosomal accumulation of ubiquitinated receptors, loss of apicobasal polarity and epithelial integrity, and increased cell death. Here we report that disruption of the ATPase dVps4, the most downstream component of the ESCRT machinery, causes the same array of cellular phenotypes. We find that loss of epithelial integrity and increased apoptosis, but not loss of cell polarity, require the activation of JNK signalling. Abrogation of JNK signalling prevents apoptosis in dVps4 deficient cells. Indeed double deficiency in dVps4 and JNK signalling leads to the formation of neoplastic tumours. We conclude that dvps4 is a tumour suppressor in Drosophila and that JNK is central to the cell-autonomous phenotypes of ESCRT-deficient cells.	[Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald] Rikshosp Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Wendler, Franz; Vincent, Jean-Paul] MRC, Natl Inst Med Res, London, England	University of Oslo; University of Oslo; National Hospital Norway; MRC National Institute for Medical Research	Rodahl, LM (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	stenmark@ulrik.uio.no	Haglund, Kaisa/B-3927-2017; Stenmark, Harald/B-8868-2008	Haglund, Kaisa/0000-0002-7946-3299; Rusten, Tor Erik/0000-0002-9150-2676	International Human Frontier Science Program Organization [postdoctoral fellow]; Norwegian Cancer Society; Novo Nordisk Foundation; Hartmann Family Foundation; Research Council of Norway; MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: researchfish	International Human Frontier Science Program Organization(Human Frontier Science Program); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Hartmann Family Foundation; Research Council of Norway(Research Council of Norway); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KH is a postdoctoral fellow of the The International Human Frontier Science Program Organization. This work was also supported by the Norwegian Cancer Society, The Novo Nordisk Foundation, the Hartmann Family Foundation and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kwei KA, 2006, CANCER LETT, V231, P326, DOI 10.1016/j.canlet.2005.02.031; LE RC, 2005, DEV CELL, V9, P167; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Noselli S, 1999, CURR OPIN GENET DEV, V9, P466, DOI 10.1016/S0959-437X(99)80071-9; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; Sevrioukov EA, 2005, MOL BIOL CELL, V16, P2301, DOI 10.1091/mbc.E04-11-1013; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Weber U, 2000, DEVELOPMENT, V127, P3619; Yoshida S, 2001, J HUM GENET, V46, P182, DOI 10.1007/s100380170086; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	36	45	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4354	10.1371/journal.pone.0004354	http://dx.doi.org/10.1371/journal.pone.0004354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194501	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483500007
J	White, VA; Lewallen, S; Beare, NAV; Molyneux, ME; Taylor, TE				White, Valerie A.; Lewallen, Susan; Beare, Nicholas A. V.; Molyneux, Malcolm E.; Taylor, Terrie E.			Retinal Pathology of Pediatric Cerebral Malaria in Malawi	PLOS ONE			English	Article								Introduction: The causes of coma and death in cerebral malaria remain unknown. Malarial retinopathy has been identified as an important clinical sign in the diagnosis and prognosis of cerebral malaria. As part of a larger autopsy study to determine causes of death in children with coma presenting to hospital in Blantyre, Malawi, who were fully evaluated clinically prior to death, we examined the histopathology of eyes of patients who died and underwent autopsy. Methodology/Principal Findings: Children with coma were admitted to the pediatric research ward, classified according to clinical definitions as having cerebral malaria or another cause of coma, evaluated and treated. The eyes were examined by direct and indirect ophthalmoscopy. If a child died and permission was given, a standardized autopsy was carried out. The patient was then assigned an actual cause of death according to the autopsy findings. The eyes were examined pathologically for hemorrhages, cystoid macular edema, parasite sequestration and thrombi. They were stained immunohistochemically for fibrin and CD61 to identify the components of thrombi, beta-amyloid precursor protein to detect axonal damage, for fibrinogen to identify vascular leakage and for glial fibrillary acidic protein to detect gliosis. Sixty-four eyes from 64 patients were examined: 35 with cerebral malaria and 29 with comas of other causes. Cerebral malaria was distinguished by sequestration of parasitized erythrocytes, the presence and severity of retinal hemorrhages, the presence of cystoid macular edema, the occurrence and number of fibrin-platelet thrombi, the presence and amount of axonal damage and vascular leakage. Conclusions/Significance: We found significant differences in retinal histopathology between patients who died of cerebral malaria and those with other diagnoses. These histopathological findings offer insights into the etiology of malarial retinopathy and provide a pathological basis for recently described retinal capillary non-perfusion in children with malarial retinopathy. Because of the similarities between the retina and the brain it also suggests mechanisms that may contribute to coma and death in cerebral malaria.	Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [White, Valerie A.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Lewallen, Susan] British Columbia Ctr Epidemiol & Int Ophthalmol, Vancouver, BC, Canada; [Lewallen, Susan] Tumaini Univ, Kilimanjaro Christian Med Ctr, Kilimanjaro Ctr Community Ophthalmol, Moshi, Tanzania; [Beare, Nicholas A. V.] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programme, Coll Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Taylor, Terrie E.] Queen Elizabeth Cent Hosp, Blantyre Malaria Project, Blantyre, Malawi; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA	University of British Columbia; University of British Columbia; Kilimanjaro Christian Medical Centre; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	White, VA (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	val.white@vch.ca	Beare, Nicholas/AAG-4946-2019	Beare, Nicholas/0000-0001-8086-990X	Wellcome Trust [074125]; NIH [5R01AI034969-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The autopsy study is supported by Wellcome Trust grant #074125 to Dr M. Molyneux and by NIH grant #5R01AI034969-11 to Dr. T. Taylor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, SURV OPHTHALMOL, V51, P129, DOI 10.1016/j.survophthal.2005.12.003; Beare NA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1141, DOI 10.1001/archopht.122.8.1141; BEARE NA, JID IN PRESS; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; BOONPUCKNAVIG V, 1990, ARCH PATHOL LAB MED, V114, P1028; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Browning DJ, 2002, OPHTHALMOLOGY, V109, P2154, DOI 10.1016/S0161-6420(02)01217-4; Devonport H, 2006, EYE, V20, P255, DOI 10.1038/sj.eye.6701833; DUANE TD, 1980, OPHTHALMOLOGY, V87, P66; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Harding SP, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506776315781; KINCAID MC, 1982, BRIT J OPHTHALMOL, V66, P219, DOI 10.1136/bjo.66.4.219; KWON EE, 1994, J NEUROPATH EXP NEUR, V53, P625, DOI 10.1097/00005072-199411000-00010; Laure AK, 1998, ARCH OPHTHALMOL-CHIC, V116, P1119; Lewallen S, 1996, T ROY SOC TROP MED H, V90, P144, DOI 10.1016/S0035-9203(96)90116-9; Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8; LEWALLEN S, 1993, OPHTHALMOLOGY, V100, P857, DOI 10.1016/S0161-6420(93)31563-0; Lewallen S, 2000, ARCH OPHTHALMOL-CHIC, V118, P924; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; LOOAREESUWAN S, 1983, AM J TROP MED HYG, V32, P911, DOI 10.4269/ajtmh.1983.32.911; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Ong T, 2005, EYE, V19, P359, DOI 10.1038/sj.eye.6701491; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Reichard RR, 2004, OPHTHALMOLOGY, V111, P822, DOI 10.1016/j.ophtha.2003.07.016; Schemann JF, 2002, AM J TROP MED HYG, V67, P61, DOI 10.4269/ajtmh.2002.67.61; SPITZ S, 1946, Mil Surg, V99, P555; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tranos PG, 2004, SURV OPHTHALMOL, V49, P470, DOI 10.1016/j.survophthal.2004.06.002; White VA, 2001, T ROY SOC TROP MED H, V95, P618, DOI 10.1016/S0035-9203(01)90097-5	35	71	72	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4317	10.1371/journal.pone.0004317	http://dx.doi.org/10.1371/journal.pone.0004317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177166	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000265483100006
J	Colombo, G; Meli, M; Morra, G; Gabizon, R; Gasset, M				Colombo, Giorgio; Meli, Massimiliano; Morra, Giulia; Gabizon, Ruth; Gasset, Maria			Methionine Sulfoxides on Prion Protein Helix-3 Switch on the alpha-Fold Destabilization Required for Conversion	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ENERGY-DISTRIBUTION; OXIDATIVE STRESS; AMYLOID FIBRILS; STABILITY; DETERMINANTS; MODULATION; INSIGHTS; WATER	Background: The conversion of the cellular prion protein (PrPC) into the infectious form (PrPSc) is the key event in prion induced neurodegenerations. This process is believed to involve a multi-step conformational transition from an alpha-helical (PrPC) form to a beta-sheet-rich (PrPSc) state. In addition to the conformational difference, PrPSc exhibits as covalent signature the sulfoxidation of M213. To investigate whether such modification may play a role in the misfolding process we have studied the impact of methionine oxidation on the dynamics and energetics of the HuPrP(125-229) alpha-fold. Methodology/Principal Findings: Using molecular dynamics simulation, essential dynamics, correlated motions and signal propagation analysis, we have found that substitution of the sulfur atom of M213 by a sulfoxide group impacts on the stability of the native state increasing the flexibility of regions preceding the site of the modification and perturbing the network of stabilizing interactions. Together, these changes favor the population of alternative states which maybe essential in the productive pathway of the pathogenic conversion. These changes are also observed when the sulfoxidation is placed at M206 and at both, M206 and M213. Conclusions/Significance: Our results suggest that the sulfoxidation of Helix-3 methionines might be the switch for triggering the initial alpha-fold destabilization required for the productive pathogenic conversion.	[Colombo, Giorgio; Meli, Massimiliano; Morra, Giulia] CNR, Isto Chim Riconoscimento Mol, I-20133 Milan, Italy; [Gabizon, Ruth] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, Jerusalem, Israel; [Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Colombo, G (corresponding author), CNR, Isto Chim Riconoscimento Mol, I-20133 Milan, Italy.	g.colombo@icrm.cnr.it; mgasset@iqfr.csic.es	Colombo, Giorgio/A-2730-2012; Gasset, Maria/I-2050-2014; Gasset, Maria/K-4339-2012; Morra, Giulia/O-2311-2015; Meli, Massimiliano/AAY-8570-2020	Colombo, Giorgio/0000-0002-1318-668X; Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; Morra, Giulia/0000-0002-9681-7845; Meli, Massimiliano/0000-0003-3304-6104	EU [LSHB-CT-2006-037325, FOOD-CT-2004-506579]; Spanish MICINN [SAF2006-0418]; FIRB program [RNBE03PX33]	EU(European Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FIRB program(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants LSHB-CT-2006-037325 (GC) and FOOD-CT-2004-506579 (MG, RG) from the EU, SAF2006-0418 from the Spanish MICINN (MG), and RNBE03PX33 (GC) from the FIRB program. The authors have no financial interest in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Colacino S, 2006, PROTEINS, V62, P698, DOI 10.1002/prot.20804; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; DADO GP, 1993, J AM CHEM SOC, V115, P12609, DOI 10.1021/ja00079a060; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Geerke DP, 2004, J PHYS CHEM B, V108, P1436, DOI 10.1021/jp035034i; Griffiths SW, 2002, BIOCHEMISTRY-US, V41, P6245, DOI 10.1021/bi025599p; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuper J, 2007, J AM CHEM SOC, V129, P5786, DOI 10.1021/ja067036x; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LIU HY, 1995, J AM CHEM SOC, V117, P4363, DOI 10.1021/ja00120a018; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; LUO S, 2008, FASEB J IN PRESS; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MORRA G, 2008, MODELING SIGNA UNPUB; Morra G, 2008, PROTEINS, V72, P660, DOI 10.1002/prot.21963; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144; Requena JR, 2004, ARCH BIOCHEM BIOPHYS, V432, P188, DOI 10.1016/j.abb.2004.09.012; Roccatano D, 2005, BIOPOLYMERS, V78, P259, DOI 10.1002/bip.20290; Shiraishi N, 2005, BIOCHEM J, V387, P247, DOI 10.1042/BJ20041561; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Supattapone S, 2001, MOL CELL BIOL, V21, P2608, DOI 10.1128/MCB.21.7.2608-2616.2001; Tiana G, 2004, PROTEIN SCI, V13, P113, DOI 10.1110/ps.03223804; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; VANGUSTEREN WF, 2006, ENCY COMPUTATIONAL C, V2, P1211; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	54	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4296	10.1371/journal.pone.0004296	http://dx.doi.org/10.1371/journal.pone.0004296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172188	Green Submitted, gold, Green Published			2022-12-25	WOS:000265482900011
J	Marazziti, D; Di Pietro, C; Golini, E; Mandillo, S; Matteoni, R; Tocchini-Valentini, GP				Marazziti, Daniela; Di Pietro, Chiara; Golini, Elisabetta; Mandillo, Silvia; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.			Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor	FASEB JOURNAL			English	Article						parkin; PAEL-R; endoplasmic reticulum stress; proteasome; GRP78; protein	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; PAEL-R; GENE-EXPRESSION; AUTOPHAGY; SYSTEM; LC3; POLYGLUTAMINE; PROTEASOME; CELLS	The orphan G-protein-coupled receptor 37 (GPR37) is a substrate of parkin, and its insoluble aggregates accumulate in brain tissue samples of Parkinson's disease patients, including Lewy bodies and neurites. Parkin activates the clearance of the unfolded receptor, while the overexpression of GPR37, in the absence of parkin, can lead to unfolded protein-induced cell death. We found that overexpression of the human GPR37 receptor in HEK293 cells and consequent activation of an endoplasmic reticulum (ER) stress response had effects comparable to starvation, in inducing the cellular autophagic pathway. Treatment with specific modulators provided further evidence for the autophagic clearance of the overexpressed GPR37 protein, in detergent-soluble and -insoluble fractions, as confirmed by the conversion of the microtubule-associated protein 1, light chain 3 (LC3)-I marker to its LC3-II isoform. Furthermore, Gpr37-null mutant mice displayed consistent alterations of ER stress and autophagic pathway markers in brain tissue samples. These findings show that GPR37 overexpression per se can induce cellular autophagy, which may prevent the selective degeneration of GPR37-expressing neurons, as reported for Parkinson's and related neurodegenerative diseases.-Marazziti, D., Di Pietro, C., Golini, E., Mandillo, S., Matteoni, R., Tocchini-Valentini, G. P. Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor. FASEB J. 23, 1978-1987 (2009)	[Marazziti, Daniela; Di Pietro, Chiara; Golini, Elisabetta; Mandillo, Silvia; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.] CNR, Ist Biol Cellulare, I-00015 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR)	Tocchini-Valentini, GP (corresponding author), CNR, Ist Biol Cellulare, Campus A Buzzati Traverso,Via F Ramarini 32, I-00015 Rome, Italy.	gtocchini@ibc.cnr.it	Golini, Elisabetta/AAX-2849-2020; Daniela, Marazziti/AAC-1062-2022; Di Pietro, Chiara/AAA-7161-2021; Mandillo, Silvia/E-6503-2019; Mandillo, Silvia/AAW-1363-2020; , Elisabetta/D-9095-2015	Daniela, Marazziti/0000-0002-1582-9271; Mandillo, Silvia/0000-0002-4869-0974; MATTEONI, RAFAELE/0000-0002-0314-5948; , Elisabetta/0000-0002-9323-7124; DI PIETRO, CHIARA/0000-0002-2680-1821	Italian Ministry of Research	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	We are grateful to G. Di Segni for critical reading of the manuscript. We greatly thank Ryosuke Takahashi and Yuzuru Imai (RIKEN Brain Science Institute, Saitama, Japan) for the generous gift of the GPR37-specific antibody; V. Berno for help with the confocal microscopy; G. Di Franco, G. D' Erasmo, and A. Ventrera for excellent technical assistance; and A. Ferrara and T. Cuccurullo for secretarial work. This study was supported by Italian Ministry of Research grants (FIRB-G. Armenise Harvard Found. 2005, FIRB- Idee Progettuali 2005, PRIN-Cofin. 2007), and European Union Framework Programme 6 contracts (MUGEN, EURASNET, EUMODIC).	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018; Garcia-Echeverria C, 2002, MINI-REV MED CHEM, V2, P247, DOI 10.2174/1389557023406142; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Marazziti D., 2001, Current Genomics, V2, P253, DOI 10.2174/1389202013350850; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Pattarini R, 2008, NEUROSCIENCE, V155, P1174, DOI 10.1016/j.neuroscience.2008.06.064; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rezgaoui M, 2006, J CELL SCI, V119, P542, DOI 10.1242/jcs.02766; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang HY, 2007, NEUROTOXICOLOGY, V28, P979, DOI 10.1016/j.neuro.2007.02.013; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wang JY, 2008, NEUROCHEM INT, V52, P1037, DOI 10.1016/j.neuint.2007.10.017; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653	47	34	39	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1978	1987		10.1096/fj.08-121210	http://dx.doi.org/10.1096/fj.08-121210			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19218498				2022-12-25	WOS:000266652400036
J	Abbott, DW; Macauley, MS; Vocadlo, DJ; Boraston, AB				Abbott, D. Wade; Macauley, Matthew S.; Vocadlo, David J.; Boraston, Alisdair B.			Streptococcus pneumoniae Endohexosaminidase D, Structural and Mechanistic Insight into Substrate-assisted Catalysis in Family 85 Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; X-RAY-DIFFRACTION; HUMAN O-GLCNACASE; TRANSGLYCOSYLATION ACTIVITY; NAG-THIAZOLINE; ACTIVE-SITE; COMPLEX; OLIGOSACCHARIDES; GLUCOSAMINIDASE; IDENTIFICATION	Endo-beta-D-glucosaminidases from family 85 of glycoside hydrolases (GH85 endohexosaminidases) act to cleave the glycosidic linkage between the two N-acetylglucosamine units that make up the chitobiose core of N-glycans. Endohexosaminidase D (Endo-D), produced by Streptococcus pneumoniae, is believed to contribute to the virulence of this organism by playing a role in the deglycosylation of IgG antibodies. Endohexosaminidases have received significant attention for this reason and, moreover, because they are powerful tools for chemoenzymatic synthesis of proteins having defined glycoforms. Here we describe mechanistic and structural studies of the catalytic domain (SpGH85) of Endo-D that provide compelling support for GH85 enzymes using a catalytic mechanism involving substrate-assisted catalysis. Furthermore, the structure of SpGH85 in complex with the mechanism-based competitive inhibitor NAG-thiazoline (K-d = 28 mu M) provides a coherent rationale for previous mutagenesis studies of Endo-D and other related GH85 enzymes. We also find GH85, GH56, and GH18 enzymes have a similar configuration of catalytic residues. Notably, GH85 enzymes have an asparagine in place of the aspartate residue found in these other families of glycosidases. We propose that this residue, as the imidic acid tautomer, acts analogously to the key catalytic aspartate of GH56 and GH18 enzymes. This topographically conserved arrangement of the asparagine residue and a conserved glutamic acid, coupled with previous kinetic studies, suggests these enzymes may use an unusual proton shuttle to coordinate effective general acid and base catalysis to aid cleavage of the glycosidic bond. These results collectively provide a blueprint that may be used to facilitate protein engineering of these enzymes to improve their function as biocatalysts for synthesizing glycoproteins having defined glycoforms and also may serve as a guide for generating inhibitors of GH85 enzymes.	[Macauley, Matthew S.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Abbott, D. Wade; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	Simon Fraser University; University of Victoria	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Boraston, Alisdair/0000-0001-6417-0592; Macauley, Matthew/0000-0003-4579-1048; Abbott, Wade/0000-0003-4893-5799	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to A.B.B. and D. J.V.).	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Busca P, 1998, TETRAHEDRON LETT, V39, P8101, DOI 10.1016/S0040-4039(98)01838-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cunha AC, 1999, J CHEM EDUC, V76, P79, DOI 10.1021/ed076p79; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON MAL, 1995, BIOPHYS J, V69, P329, DOI 10.1016/S0006-3495(95)79905-2; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greig IR, 2008, J AM CHEM SOC, V130, P17620, DOI 10.1021/ja805640c; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hansch C, 1979, SUBSTITUENT CONSTANT; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Heidecke CD, 2008, CHEMBIOCHEM, V9, P2045, DOI 10.1002/cbic.200800214; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES CS, 1980, J BIOL CHEM, V255, P1861; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; KOIDE N, 1977, BIOCHEM BIOPH RES CO, V75, P838, DOI 10.1016/0006-291X(77)91458-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2008, BIOORGAN MED CHEM, V16, P4670, DOI 10.1016/j.bmc.2008.02.032; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rising TWDF, 2006, CARBOHYD RES, V341, P1574, DOI 10.1016/j.carres.2006.03.007; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROY R, 1991, CAN J CHEM, V69, P817, DOI 10.1139/v91-121; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1974, J BIOCHEM-TOKYO, V75, P931, DOI 10.1093/oxfordjournals.jbchem.a130467; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	69	76	83	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11676	11689		10.1074/jbc.M809663200	http://dx.doi.org/10.1074/jbc.M809663200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19181667	hybrid, Green Published			2022-12-25	WOS:000265494500070
J	Desmazieres, A; Charnay, P; Gilardi-Hebenstreit, P				Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale			Krox20 Controls the Transcription of Its Various Targets in the Developing Hindbrain According to Multiple Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; ZINC-FINGER GENE; RECEPTOR TYROSINE KINASE; CHICK-EMBRYO HINDBRAIN; HOST-CELL FACTOR; SEGMENTAL EXPRESSION; NERVOUS-SYSTEM; NAB PROTEINS; HOMEOTIC TRANSFORMATION; ACTIVATION DOMAIN	The zinc finger transcription factor Krox20 plays an essential role in the vertebrate hindbrain segmentation process. It positively or negatively controls a large variety of other regulatory genes, coordinating delimitation of segmental territories, specification of their identity, and maintenance of their integrity. We have investigated the molecular mechanisms of Krox20 transcriptional control by performing a detailed structure-function analysis of the protein in the developing chick hindbrain. This revealed an unsuspected diversity in the modes of action of a transcription factor in a single tissue, since regulation of each of the five tested target genes requires different parts of the protein and/or presumably different co-factors. The multiplicity of Krox20 functions might rely on this diversity. Investigation of known Krox20 co-factors was initiated in relation to this analysis. Nab was shown to act as a negative feedback modulator of the different Krox20 activating functions in the hindbrain. HCF-1 was found to bind to a Krox20 N-terminal region, which was shown to rely on multiple elements, including acidic domains, to convey Nab activation and Krox20 autoregulation.	[Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale] INSERM, U784, F-75230 Paris 05, France; [Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale] Ecole Normale Super, F-75230 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Charnay, P (corresponding author), INSERM, U784, 46 Rue Ulm, F-75230 Paris 05, France.	charnay@biologie.ens.fr		Desmazieres, Anne/0000-0001-6542-4566; Charnay, Patrick/0000-0002-3847-6042	Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies	Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT), Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies.	Barrow JR, 2000, DEVELOPMENT, V127, P933; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; BIRGBAUER E, 1995, DEVELOPMENT, V121, P935; BRONNERFRASER M, 1995, PERSPECT DEV NEUROBI, V3, P53; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Choe SK, 2004, DEV BIOL, V271, P350, DOI 10.1016/j.ydbio.2004.04.007; Chomette D, 2006, DEVELOPMENT, V133, P1253, DOI 10.1242/dev.02289; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; DAS G, 1995, NATURE, V374, P657, DOI 10.1038/374657a0; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Desmazieres A, 2008, J NEUROSCI, V28, P5891, DOI 10.1523/JNEUROSCI.5187-07.2008; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; Garcia-Dominguez M, 2006, EMBO J, V25, P2432, DOI 10.1038/sj.emboj.7601122; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; Ghislain J, 2003, DEVELOPMENT, V130, P941, DOI 10.1242/dev.00318; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; Gillian AL, 2004, J BIOL CHEM, V279, P9056, DOI 10.1074/jbc.M309308200; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Graham A, 1996, DEVELOPMENT, V122, P473; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; LaBoissiere S, 1997, MOL CELL BIOL, V17, P7108, DOI 10.1128/MCB.17.12.7108; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mahajan SS, 2002, J BIOL CHEM, V277, P44292, DOI 10.1074/jbc.M205440200; Manzanares M, 2002, EMBO J, V21, P365, DOI 10.1093/emboj/21.3.365; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; Mellitzer G, 2000, CURR OPIN NEUROBIOL, V10, P400, DOI 10.1016/S0959-4388(00)00095-7; Nonchev S, 1996, DEVELOPMENT, V122, P543; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Rossel M, 1999, DEVELOPMENT, V126, P5027; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SAJJADI FG, 1993, ONCOGENE, V8, P1807; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Seitanidou T, 1997, MECH DEVELOP, V65, P31, DOI 10.1016/S0925-4773(97)00051-8; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; Srinivasan R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-117; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Theil T, 1998, DEVELOPMENT, V125, P443; Trainor PA, 2002, DEVELOPMENT, V129, P433; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; Wingate RJT, 1996, DEVELOPMENT, V122, P2143; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	74	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10831	10840		10.1074/jbc.M808683200	http://dx.doi.org/10.1074/jbc.M808683200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218566	Green Published, hybrid			2022-12-25	WOS:000265104600057
J	Hishiki, A; Hashimoto, H; Hanafusa, T; Kamei, K; Ohashi, E; Shimizu, T; Ohmori, H; Sato, M				Hishiki, Asami; Hashimoto, Hiroshi; Hanafusa, Tomo; Kamei, Keijiro; Ohashi, Eiji; Shimizu, Toshiyuki; Ohmori, Haruo; Sato, Mamoru			Structural Basis for Novel Interactions between Human Translesion Synthesis Polymerases and Proliferating Cell Nuclear Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-BINDING DOMAINS; HUMAN PCNA; IN-VITRO; Y-FAMILY; REPLICATION MACHINERY; XERODERMA-PIGMENTOSUM; FLAP ENDONUCLEASE-1; DNA-SYNTHESIS; ERROR-FREE; POL-KAPPA	Translesion synthesis (TLS) is a DNA damage tolerance mechanism that allows continued DNA synthesis, even in the presence of damaged DNA templates. Mammals have multiple DNA polymerases specialized for TLS, including Pol eta, Pol iota, and Pol kappa. These enzymes show preferential bypass for different lesions. Proliferating cell nuclear antigen (PCNA), which functions as a sliding clamp for the replicative polymerase Pol delta, also interacts with the three TLS polymerases. Although many PCNA-binding proteins have a highly conserved sequence termed the PCNA-interacting protein box (PIP-box), Pol eta, Pol iota, and Pol kappa have a noncanonical PIP-box sequence. In response to DNA damage, Lys-164 of PCNA undergoes ubiquitination by the RAD6-RAD18 complex, and the ubiquitination is considered to facilitate TLS. Consistent with this, these three TLS polymerases have one or two ubiquitin binding domains and are recruited to replication forks via interactions with ubiquitinated PCNA involving the noncanonical PIP-box and ubiquitin binding domain. However, it is unclear how these TLS polymerases interact with PCNA. To address the structural basis for interactions between different TLS polymerases and PCNA, we determined crystal structures of PCNA bound to peptides containing the noncanonical PIP-box of these polymerases. We show that the three PIP-box peptides interact with PCNA in different ways, both from one another and from canonical PIP-box peptides. Especially, the PIP-box of Pol iota adopts a novel structure. Furthermore, these structures enable us to speculate how these TLS polymerases interact with Lys-164-monoubiquitinated PCNA. Our results will provide clues to understanding the mechanism of preferential recruitment of TLS polymerases to the stalled forks.	[Hishiki, Asami; Hashimoto, Hiroshi; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hanafusa, Tomo; Kamei, Keijiro; Ohashi, Eiji; Ohmori, Haruo] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Yokohama City University; Kyoto University	Hashimoto, H (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp; hohmori@virus1.virus.kyoto-u.ac.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society of the Promotion of Science [16770080, 18770091]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [16048226, 17048023, 19036025, 20052023, 18054026, 20051020, 16370077, 17013041]	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Young Scientists (B) from the Japan Society of the Promotion of Science 16770080 and 18770091 (to H. H.), Grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 16048226, 17048023, and 19036025 (to H. H.), 20052023 (to T. S.), 18054026 and 20051020 (to M. S.), and 16370077 and 17013041 (to H.O.), and the national projects on protein structural and functional analyses (Protein 3000 Project) and the Target Protein Research Programs from MEXT (to M. S., T. S., and H. H.).	Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P954, DOI 10.1107/S1744309108028522; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P819, DOI 10.1107/S174430910802277X; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2004, ADV PROTEIN CHEM, V69, P205; Vaisman A, 2003, DNA REPAIR, V2, P991, DOI 10.1016/S1568-7864(03)00094-6; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	48	112	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10552	10560		10.1074/jbc.M809745200	http://dx.doi.org/10.1074/jbc.M809745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208623	Green Published, hybrid			2022-12-25	WOS:000265104600029
J	Knauth, K; Cartwright, E; Freund, S; Bycroft, M; Buchberger, A				Knauth, Katja; Cartwright, Edward; Freund, Stefan; Bycroft, Mark; Buchberger, Alexander			VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; PRIMARY CILIUM-MAINTENANCE; RENAL-CELL CARCINOMA; FAMILIAL PHEOCHROMOCYTOMA; PROLYL HYDROXYLATION; GERMLINE MUTATIONS; UBIQUITIN LIGASES; REGULATE HIF; COMPLEX	pVHL (von Hippel-Lindau tumor suppressor protein) is the substrate recognition subunit of the CBCVHL ubiquitin ligase complex promoting the degradation of hypoxia-inducible factor subunits, HIF-1/2 alpha. Mutational inactivation of pVHL causes the hereditary von Hippel-Lindau tumor syndrome, which predisposes affected individuals to hemangioblastomas, renal cell carcinomas, and pheochromocytomas. Whereas the development of hemangioblastomas and renal cell carcinomas has been attributed to impaired HIF-1/2 alpha down-regulation by pVHL mutant proteins, the molecular defects underlying the development of pheochromocytomas are still unknown. Here, we present a detailed biochemical analysis of pVHL mutant proteins linked to type 2C (pheochromocytoma only) von Hippel-Lindau disease. Type 2C-associated mutations caused extensive structural perturbations of pVHL, as revealed by the reduced stability, increased proteolytic susceptibility, and dramatically altered NMR spectrum of recombinant, mutant pVHL-ElonginC-ElonginB complexes in vitro. In human cell lines, type 2C-linked mutations destabilized the CBCVHL ubiquitin ligase complex and resulted in reduced cellular pVHL levels. Together, our data reveal unexpectedly strong structural defects of type 2C-associated pVHL mutant proteins that are likely to affect both HIF-1/2 alpha-related and -unrelated pVHL functions in the pathogenesis of pheochromocytomas.	[Knauth, Katja; Buchberger, Alexander] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Cartwright, Edward; Freund, Stefan; Bycroft, Mark] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	Max Planck Society; University of Cambridge	Buchberger, A (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	buchberg@biochem.mpg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019; Bycroft, Mark/D-9446-2017	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bycroft, Mark/0000-0002-0673-2216	Deutsche Forschungsgemeinschaft Emmy Noether [Bu 951/1-3, Bu 951/1-4]; MRC [MC_U105459896] Funding Source: UKRI; Medical Research Council [MC_U105459896] Funding Source: researchfish	Deutsche Forschungsgemeinschaft Emmy Noether(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Emmy Noether Grants Bu 951/1-3 and Bu 951/1-4 (to A.B.).	Abbott MA, 2006, AM J MED GENET A, V140A, P685, DOI 10.1002/ajmg.a.31116; Bex C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm932; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brauch H, 2004, TOXICOL LETT, V151, P301, DOI 10.1016/j.toxlet.2003.12.074; Brauch H, 1999, JNCI-J NATL CANCER I, V91, P854, DOI 10.1093/jnci/91.10.854; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hes FJ, 2000, J MED GENET, V37, P939, DOI 10.1136/jmg.37.12.939; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2002, J BIOL CHEM, V277, P30388, DOI 10.1074/jbc.M203344200; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2005, CANCER CELL, V8, P91, DOI 10.1016/j.ccr.2005.07.012; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neumann Hartmut P. H., 1995, JAMA (Journal of the American Medical Association), V274, P1149, DOI 10.1001/jama.274.14.1149; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Thoma CR, 2007, CELL CYCLE, V6, P1809, DOI 10.4161/cc.6.15.4518; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weirich G, 2002, J CLIN ENDOCR METAB, V87, P5241, DOI 10.1210/jc.2002-020651; Xie L, 2005, J CELL BIOL, V168, P911, DOI 10.1083/jcb.200407079	55	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10514	10522		10.1074/jbc.M809056200	http://dx.doi.org/10.1074/jbc.M809056200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228690	Green Published, hybrid			2022-12-25	WOS:000265104600025
J	Wang, CK; Hu, SH; Martin, JL; Sjogren, T; Hajdu, J; Bohlin, L; Claeson, P; Goransson, U; Rosengren, KJ; Tang, J; Tan, NH; Craik, DJ				Wang, Conan K.; Hu, Shu-Hong; Martin, Jennifer L.; Sjogren, Tove; Hajdu, Janos; Bohlin, Lars; Claeson, Per; Goransson, Ulf; Rosengren, K. Johan; Tang, Jun; Tan, Ning-Hua; Craik, David J.			Combined X-ray and NMR Analysis of the Stability of the Cyclotide Cystine Knot Fold That Underpins Its Insecticidal Activity and Potential Use as a Drug Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-HIV ACTIVITY; SPIN COUPLING-CONSTANTS; KALATA B1; PLANT CYCLOTIDES; OLDENLANDIA-AFFINIS; SPATIAL STRUCTURE; CIRCULAR PROTEIN; CYCLIC PEPTIDE; MEMBRANE INTERACTION; STRUCTURAL MOTIF	Cyclotides are a family of plant defense proteins that are highly resistant to adverse chemical, thermal, and enzymatic treatment. Here, we present the first crystal structure of a cyclotide, varv F, from the European field pansy, Viola arvensis, determined at a resolution of 1.8 angstrom. The solution state NMR structure was also determined and, combined with measurements of biophysical parameters for several cyclotides, provided an insight into the structural features that account for the remarkable stability of the cyclotide family. The x-ray data confirm the cystine knot topology and the circular backbone, and delineate a conserved network of hydrogen bonds that contribute to the stability of the cyclotide fold. The structural role of a highly conserved Glu residue that has been shown to regulate cyclotide function was also determined, verifying its involvement in a stabilizing hydrogen bond network. We also demonstrate that varv F binds to dodecylphosphocholine micelles, defining the binding orientation and showing that its structure remains unchanged upon binding, further demonstrating that the cyclotide fold is rigid. This study provides a biological insight into the mechanism by which cyclotides maintain their native activity in the unfavorable environment of predator insect guts. It also provides a structural basis for explaining how a cluster of residues important for bioactivity may be involved in self-association interactions in membranes. As well as being important for their bioactivity, the structural rigidity of cyclotides makes them very suitable as a stable template for peptide-based drug design.	[Wang, Conan K.; Hu, Shu-Hong; Martin, Jennifer L.; Rosengren, K. Johan; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sjogren, Tove; Hajdu, Janos] Uppsala Univ, Dept Cellular & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Bohlin, Lars; Claeson, Per; Goransson, Ulf; Rosengren, K. Johan] Uppsala Univ, Dept Med Chem, Biomed Ctr, SE-75123 Uppsala, Sweden; [Tang, Jun; Tan, Ning-Hua] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	University of Queensland; Uppsala University; Uppsala University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS		d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Wang, Conan K/D-1481-2010; Rosengren, K. Johan/P-4450-2016; Martin, Jennifer L./A-6039-2010	Craik, David/0000-0003-0007-6796; Wang, Conan K/0000-0002-7973-7632; Rosengren, K. Johan/0000-0002-5007-8434; Martin, Jennifer L./0000-0002-9225-8863; Goransson, Ulf/0000-0002-5005-9612	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (to D.J.C.).	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Andersen NH, 1997, J AM CHEM SOC, V119, P8547, DOI 10.1021/ja963250h; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Barry DG, 2004, STRUCTURE, V12, P85, DOI 10.1016/j.str.2003.11.019; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen B, 2005, J BIOL CHEM, V280, P22395, DOI 10.1074/jbc.M501737200; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2007, MOL BIOSYST, V3, P257, DOI 10.1039/b616856f; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283; Goddard T. D., 2005, SPARKY 3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P174; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindholm P, 2002, MOL CANCER THER, V1, P365; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; LUZZATI D, 1953, ANN I PASTEUR PARIS, V85, P277; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MINOR W, 1993, XDISPLAYF; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Nair SS, 2006, BBA-PROTEINS PROTEOM, V1764, P1568, DOI 10.1016/j.bbapap.2006.07.009; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pauling L., 1960, NATURE CHEM BOND, V3rd; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RANCE M, 1983, BIOCHEM BIOPH RES CO, V27, P157; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Shenkarev ZO, 2008, J INORG BIOCHEM, V102, P1246, DOI 10.1016/j.jinorgbio.2008.01.018; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Shenkarev ZO, 2002, BIOPHYS J, V82, P762, DOI 10.1016/S0006-3495(02)75438-6; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Svangard E, 2003, PHYTOCHEMISTRY, V64, P135, DOI 10.1016/S0031-9422(03)00218-8; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	72	85	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10672	10683		10.1074/jbc.M900021200	http://dx.doi.org/10.1074/jbc.M900021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19211551	Green Published, hybrid			2022-12-25	WOS:000265104600041
J	Radhakrishnan, GK; Yu, Q; Harms, JS; Splitter, GA				Radhakrishnan, Girish K.; Yu, Qiqi; Harms, Jerome S.; Splitter, Gary A.			Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; VIRULENCE FACTOR; INNATE IMMUNITY; FAMILY; MOLECULE; IDENTIFICATION	Toll-like receptors (TLRs) play essential roles in the activation of innate immune responses against microbial infections. TLRs and downstream adaptor molecules contain a conserved cytoplasmic TIR domain. TIRAP is a TIR domain-containing adaptor protein that recruits the signaling adaptor MyD88 to a subset of TLRs. Many pathogenic microorganisms subvert TLR signaling pathways to suppress host immune responses to benefit their survival and persistence. Brucella encodes a TIR domain-containing protein (TcpB) that inhibits TLR2- and TLR4-mediated NF-kappa B activation. Sequence analysis indicated a moderate level of similarity between TcpB and the TLR adaptor molecule TIRAP. We found that TcpB could efficiently block TIRAP-induced NF-kappa B activation. Subsequent studies revealed that by analogy to TIRAP, TcpB interacts with phosphoinositides through its N-terminal domain and colocalizes with the plasma membrane and components of the cytoskeleton. Our findings suggest that TcpB targets the TIRAP-mediated pathway to subvert TLR signaling. In vivo mouse studies indicated that TcpB-deficient Brucella is defective in systemic spread at the early stages of infection.	[Radhakrishnan, Girish K.; Yu, Qiqi; Harms, Jerome S.; Splitter, Gary A.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Splitter, GA (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	Splitter@svm.vetmed.wisc.edu		Radhakrishnan, Girish/0000-0001-9088-0029	National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program [1U54-AI-057153]; National Institutes of Health [1R01AI073558]; Binational Agricultural Research and Development [US-3829-06 R]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073558, R21AI088038, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Agricultural Research and Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program Grant 1U54-AI-057153 and National Institutes of Health Grant 1R01AI073558. This work was also supported by Binational Agricultural Research and Development Grant US-3829-06 R.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bowie AG, 2007, CLIN EXP IMMUNOL, V147, P217, DOI 10.1111/j.1365-2249.2006.03301.x; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	31	118	124	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9892	9898		10.1074/jbc.M805458200	http://dx.doi.org/10.1074/jbc.M805458200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196716	hybrid, Green Published			2022-12-25	WOS:000264892900031
J	Sarnovsky, R; Rea, J; Makowski, M; Hertle, R; Kelly, C; Antignani, A; Pastrana, DV; FitzGerald, DJ				Sarnovsky, Robert; Rea, Jennifer; Makowski, Matt; Hertle, Ralf; Kelly, Colleen; Antignani, Antonella; Pastrana, Diana V.; FitzGerald, David J.			Proteolytic Cleavage of a C-terminal Prosequence, Leading to Autoprocessing at the N Terminus, Activates Leucine Aminopeptidase from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; IDENTIFICATION; RESISTANCE; ELASTASE; PROTEASE	At high bacterial cell density the gene expression program of Pseudomonas aeruginosa is regulated by quorum sensing. Among the gene products highly up-regulated by this system is an exoprotease, leucine aminopeptidase (PA-LAP), which is co-expressed with several known virulence factors and secreted as a proenzyme. We undertook a study of its activation by expressing the full-length proform of PA-LAP recombinantly in Escherichia coli (here termed, rLAP55) and characterizing individual steps in its conversion to an active enzyme. Activation is initiated with the proteolytic removal of a C-terminal prosequence. Removal of similar to 20 amino acids is accomplished by Pseudomonas elastase, which is also positively regulated by quorum sensing. Activation is also mediated by other proteases that cleave rLAP55 near its C terminus. The importance of the C terminus was confirmed by showing that C-terminal deletions of 1-24 amino acids produce a fully active enzyme. The removal of C-terminal prosequences either by proteolysis or deletion leads to an unusual autoprocessing event at the N terminus. Autoprocessing is apparently an intramolecular event, requires the active site of LAP, and results in the removal of 12 N-terminal amino acids. Furthermore, a detailed analysis of the C-terminal prosequence suggests that the proenzyme state is dependent on the presence of a basic side chain contributed by the last amino acid, lysine 536. Our data support a model whereby full-length PA-LAP is activated in a two-step process; proteolytic cleavage at the C terminus is followed by an intramolecular autocatalytic removal of a 12-amino acid propeptide at the N terminus.	[FitzGerald, David J.] NCI, Mol Biol Lab, CCR, Natl Inst Hlth,HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	FitzGerald, DJ (corresponding author), NCI, Mol Biol Lab, CCR, Natl Inst Hlth,HHS, 37 Convent Dr,Rm 5124, Bethesda, MD 20892 USA.	djpf@helix.nih.gov	Pastrana, Diana/ABD-6830-2020	Pastrana, Diana V./0000-0002-8084-5665	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC008757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, Intramural Research Program, NCI, Center for Cancer Research.	Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Endo H, 2002, J BIOL CHEM, V277, P26396, DOI 10.1074/jbc.M202244200; FUQUA WC, 1992, BIOTECHNIQUES, V12, P223; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; KRAMER MD, 1986, J IMMUNOL, V136, P4644; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Smith L, 2006, J MED MICROBIOL, V55, P1641, DOI 10.1099/jmm.0.46845-0; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; VASIL ML, 1990, INFECT IMMUN, V58, P4020, DOI 10.1128/IAI.58.12.4020-4029.1990; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wieland CW, 2002, INFECT IMMUN, V70, P1352, DOI 10.1128/IAI.70.3.1352-1358.2002; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982	22	14	14	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10243	10253		10.1074/jbc.M808686200	http://dx.doi.org/10.1074/jbc.M808686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213733	Green Published, hybrid			2022-12-25	WOS:000264892900066
J	Robert, I; Aussems, M; Keutgens, A; Zhang, X; Hennuy, B; Viatour, P; Vanstraelen, G; Merville, MP; Chapelle, JP; de Leval, L; Lambert, F; Dejardin, E; Gothot, A; Chariot, A				Robert, I.; Aussems, M.; Keutgens, A.; Zhang, X.; Hennuy, B.; Viatour, P.; Vanstraelen, G.; Merville, M-P; Chapelle, J-P; de Leval, L.; Lambert, F.; Dejardin, E.; Gothot, A.; Chariot, A.			Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappa B2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes	ONCOGENE			English	Article						NF-kappa B; MMP9; H3K4 HMT; p100	NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; REED-STERNBERG CELLS; SIGNALING PATHWAYS; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; MULTIPLE-MYELOMA; LYMPHOMA-CELLS; ACTIVE GENES; ALPHA-GENE	Constitutive nuclear factor (NF)-kappa Ba ctivation in haematological malignancies is caused in several cases by loss of function mutations within the coding sequence of NF-kappa B inhibitory molecules such as I kappa B alpha or p100. Hut-78, a truncated form of p100, constitutively generates p52 and contributes to the development of T-cell lymphomas but the molecular mechanism underlying this oncogenic potential remains unclear. We show here that MMP9 gene expression is induced through the alternative NF-kappa B-activating pathway in fibroblasts and also on Hut-78 or p52 overexpression in fibroblasts as well as in lymphoma cells. p52 is critical for Hut-78-mediated MMP9 gene induction as a Hut-78 mutant as well as other truncated NF-kappa B2 proteins that are not processed into p52 failed to induce the expression of this metalloproteinase. Conversely, MMP9 gene expression is impaired in p52-depleted HUT-78 cells. Interestingly, MLL1 and MLL2 H3K4 methyltransferase complexes are tethered by p52 on the MMP9 but not on the I kappa B alpha promoter, and the H3K4 trimethyltransferase activity recruited on the MMP9 promoter is impaired in p52-depleted HUT-78 cells. Moreover, MLL1 and MLL2 are associated with Hut-78 in a native chromatin-enriched extract. Thus, we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappa B-dependent gene induces its expression and potentially the invasive potential of lymphoma cells harbouring constitutive activity of the alternative NF-kappa B-activating pathway.	[Chariot, A.] Univ Liege, CHU Sart Tilman, Lab Chem Med,Interdisciplinary Cluster Appl Genop, Unit Signal Transduct,GIGA R,Tour GIGA, B-4000 Liege, Belgium; [Robert, I.; Aussems, M.; Keutgens, A.; Zhang, X.; Viatour, P.; Merville, M-P; Chapelle, J-P; Dejardin, E.; Chariot, A.] Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium; [Hennuy, B.] Univ Liege, CHU Sart Tilman, GIGA Transcript Facil, B-4000 Liege, Belgium; [Vanstraelen, G.; Gothot, A.] Univ Liege, CHU Sart Tilman, Dept Med Hematol, B-4000 Liege, Belgium; [de Leval, L.] Univ Liege, CHU Sart Tilman, Dept Pathol, B-4000 Liege, Belgium; [Lambert, F.] Univ Liege, CHU Sart Tilman, Lab Human Genet, B-4000 Liege, Belgium; [Dejardin, E.] Univ Liege, CHU Sart Tilman, Lab Virol & Immunol, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Chariot, A (corresponding author), Univ Liege, CHU Sart Tilman, Lab Chem Med,Interdisciplinary Cluster Appl Genop, Unit Signal Transduct,GIGA R,Tour GIGA, 2 B34, B-4000 Liege, Belgium.	Alain.chariot@ulg.ac.be	de Leval, Laurence/M-4889-2017; Dejardin, Emmanuel/AAE-9076-2021	de Leval, Laurence/0000-0003-3994-516X; Chariot, Alain/0000-0002-1691-4347	University of Liege (ULg); FNRS; TELEVIE; Belgian Federation against Cancer; Belgian State, Science Policy Office [IAP6/18]	University of Liege (ULg)(University of Liege); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Belgian Federation against Cancer; Belgian State, Science Policy Office(Belgian Federal Science Policy Office)	We are gratefulto F Fuks for helpful discussions, to M Pasparakis, Y St-Pierre and R Weil for the gifts of wild-type and NEMO-deficient mouse embryonic fibroblasts, the 164T2 cell line and the anti-NEMO antibody, respectively. We also thank Dr J-H Lee, Dr DG Skalnik and Dr C van Lint for the gift of expression plasmids. M- PM, LdeL and AC are Senior Research Associates whereas ED is Research Associate at the Belgian National fund for Research ('FNRS'). IR and XZ are 'TELEVIE' Research Assistants whereas MA and AK are 'FNRS' Research Assistants. This work was supported by grants from the University of Liege ( ULg), FNRS, TELEVIE, the Belgian Federation against Cancer, the IAP6/18 (funded by the Interuniversity Attraction Poles Programme, initiated by the Belgian State, Science Policy Office), the 'Centre Antireux and Fonds Leon Fredeericq (Faculty of Medicine, ULg).	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Aoudjit F, 1998, BLOOD, V91, P623, DOI 10.1182/blood.V91.2.623.623_623_629; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; CHANG CC, 1995, MOL CELL BIOL, V15, P5180; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, BIOCHEM BIOPH RES CO, V308, P744, DOI 10.1016/S0006-291X(03)01474-8; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Epinat JC, 2000, ONCOGENE, V19, P599, DOI 10.1038/sj.onc.1203376; FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keutgens A, 2006, BIOCHEM PHARMACOL, V72, P1069, DOI 10.1016/j.bcp.2006.06.011; Kim KE, 2000, ONCOGENE, V19, P1334, DOI 10.1038/sj.onc.1203432; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lalancette M, 2000, BLOOD, V95, P314, DOI 10.1182/blood.V95.1.314.001k32_314_319; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mori N, 2002, BLOOD, V99, P1341, DOI 10.1182/blood.V99.4.1341; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Sakata K, 2004, CANCER, V100, P356, DOI 10.1002/cncr.11905; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; THAKUR S, 1994, ONCOGENE, V9, P2335; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wang Z, 2008, J BIOL CHEM, V283, P10698, DOI 10.1074/jbc.M800806200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; ZHANG JD, 1994, ONCOGENE, V9, P1931	61	31	32	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1626	1638		10.1038/onc.2009.6	http://dx.doi.org/10.1038/onc.2009.6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19219072	Green Published			2022-12-25	WOS:000264780500007
J	Harita, Y; Kurihara, H; Kosako, H; Tezuka, T; Sekine, T; Igarashi, T; Ohsawa, I; Ohta, S; Hattori, S				Harita, Yutaka; Kurihara, Hidetake; Kosako, Hidetaka; Tezuka, Tohru; Sekine, Takashi; Igarashi, Takashi; Ohsawa, Ikuroh; Ohta, Shigeo; Hattori, Seisuke			Phosphorylation of Nephrin Triggers Ca2+ Signaling by Recruitment and Activation of Phospholipase C-gamma 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR SLIT DIAPHRAGM; II RECEPTOR BLOCKADE; MICE LACKING; NEPHROTIC SYNDROME; KIDNEY; PROTEINURIA; COMPONENT; DISEASE; KINASE; RATS	A specialized intercellular junction between podocytes, known as the slit diaphragm (SD), forms the essential structural framework for glomerular filtration in the kidney. In addition, mounting evidence demonstrates that the SD also plays a crucial role as a signaling platform in physiological and pathological states. Nephrin, the major component of the SD, is tyrosine-phosphorylated by a Src family tyrosine kinase, Fyn, in developing or injured podocytes, recruiting Nck to Nephrin via its Src homology 2 domain to regulate dynamic actin remodeling. Dysregulated Ca2+ homeostasis has also been implicated in podocyte damage, but the mechanism of how podocytes respond to injury is largely unknown. Here we have identified phospholipase C-gamma 1 (PLC-gamma 1) as a novel phospho-Nephrin-binding protein. When HEK293T cells expressing a chimeric protein consisting of CD8 and Nephrin cytoplasmic domain (CD) were treated with anti-CD8 and anti-mouse antibodies, clustering of Nephrin and phosphorylation of Nephrin-CD were induced. Upon this clustering, PLC-gamma 1 was bound to phosphorylated Nephrin Tyr-1204, which induced translocation of PLC-gamma 1 from cytoplasm to the CD8/Nephrin cluster on the plasma membrane. The recruitment of PLC-gamma 1 to Nephrin activated PLC-gamma 1, as detected by phosphorylation of PLC-gamma 1 Tyr-783 and increase in inositol 1,4,5-trisphosphate level. We also found that Nephrin Tyr-1204 phosphorylation triggers the Ca2+ response in a PLC-gamma 1-dependent fashion. Furthermore, PLC-gamma 1 is significantly phosphorylated in injured podocytes in vivo. Given the profound effect of PLC-gamma in diverse cellular functions, regulation of the Ca2+ signaling by Nephrin may be important in modulating the glomerular filtration barrier function.	[Harita, Yutaka; Hattori, Seisuke] Univ Tokyo, Div Cellular Prote BML, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Tezuka, Tohru] Univ Tokyo, Dept Oncol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Harita, Yutaka; Sekine, Takashi; Igarashi, Takashi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anaesthesia, Bunkyo Ku, Tokyo 1138421, Japan; [Ohsawa, Ikuroh; Ohta, Shigeo] Nippon Med Sch, Grad Sch Med, Inst Dev & Aging Sci, Dept Biochem & Cell Biol, Tokyo 1138602, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1088641, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Juntendo University; Nippon Medical School; Kitasato University	Hattori, S (corresponding author), Univ Tokyo, Div Cellular Prote BML, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hattoris@ims.u-tokyo.ac.jp						Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dowden J, 2006, CHEM BIOL, V13, P659, DOI 10.1016/j.chembiol.2006.05.005; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KURIHARA H, 1995, AM J PHYSIOL-RENAL, V268, pF514, DOI 10.1152/ajprenal.1995.268.3.F514; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; Litjens T, 2007, BIOCHEM J, V405, P269, DOI 10.1042/BJ20061762; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; REMUZZI A, 1993, J AM SOC NEPHROL, V4, P40; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tu CL, 2005, J INVEST DERMATOL, V124, P187, DOI 10.1111/j.0022-202X.2004.23544.x; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5	50	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8951	8962		10.1074/jbc.M806851200	http://dx.doi.org/10.1074/jbc.M806851200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179337	Green Published, hybrid			2022-12-25	WOS:000264397800078
J	Wang, LY; Tao, MF; Wendt-Pienkoski, E; Galm, U; Coughlin, JM; Shen, B				Wang, Liyan; Tao, Meifeng; Wendt-Pienkoski, Evelyn; Galm, Ute; Coughlin, Jane M.; Shen, Ben			Functional Characterization of tlmK Unveiling Unstable Carbinolamide Intermediates in the Tallysomycin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; ANTITUMOR ANTIBIOTICS; BLEOMYCIN FAMILY; PHASE-II; COMPLEX; BICYCLOMYCIN; BINDING; DERIVATIVES; CLEAVAGE; SEQUENCE	Tallysomycins (TLMs) belong to the bleomycin family of anticancer antibiotics. TLMs differ from bleomycins primarily by the presence of a 4-amino-4,6-dideoxy-L-talose sugar attached to C-41 as part of a glycosylcarbinolamide. We previously proposed, on the basis of bioinformatics analysis of the tlm biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158, that the tlmK gene is responsible for the attachment of this sugar moiety. We now report that inactivation of tlmK in S. hindustanus abolished TLM A and TLM B production, the resultant Delta tlmK mutant instead accumulated five new metabolites, and introduction of a functional copy of tlmK to the Delta tlmK mutant restored TLM A and TLM B production. Two major metabolites, TLM K-1 and TLM K-2, together with three minor metabolites, TLM K-3, TLM K-4, and TLM K-5, were isolated from the Delta tlmK mutant, and their structures were elucidated. These findings provide experimental evidence supporting the previous functional assignment of tlmK to encode a glycosyltransferase and unveil two carbinolamide pseudoaglycones as key intermediates in the TLM biosynthetic pathway. TlmK stabilizes the carbinolamide intermediates by glycosylating their hemiaminal hydroxyl groups, thereby protecting them from hydrolysis during TLM biosynthesis. In the absence of TlmK, the carbinolamide intermediates fragment to produce an amide TLM K-1 and aldehyde intermediates, which undergo further oxidative fragmentation to afford carboxylic acids TLM K-2, TLM K-3, TLM K-4, and TLM K-5.	[Wang, Liyan; Tao, Meifeng; Wendt-Pienkoski, Evelyn; Galm, Ute; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Coughlin, Jane M.; Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu			National Institutes of Health [CA94426]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94426.	BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; BOGER DL, 1995, J AM CHEM SOC, V117, P7338, DOI 10.1021/ja00133a007; Boger DL, 1999, ANGEW CHEM INT EDIT, V38, P448, DOI 10.1002/(SICI)1521-3773(19990215)38:4<448::AID-ANIE448>3.0.CO;2-W; Calafat AM, 1997, J AM CHEM SOC, V119, P3656, DOI 10.1021/ja963392b; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; DEBONO M, 1995, J MED CHEM, V38, P3271, DOI 10.1021/jm00017a012; DOWELL J, 2003, INT C ANT AG CHEM CH; FUJII A, 1974, J ANTIBIOT, V27, P73, DOI 10.7164/antibiotics.27.73; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Goodwin KD, 2008, P NATL ACAD SCI USA, V105, P5052, DOI 10.1073/pnas.0708143105; GREENAWAY FT, 1980, ORG MAGN RESONANCE, V13, P270, DOI 10.1002/mrc.1270130410; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; JAMES D, 2005, J CLIN PHARMACOL, V45, P227; KAKEYA H, 1995, J ANTIBIOT, V48, P733, DOI 10.7164/antibiotics.48.733; KAMIYA T, 1972, J ANTIBIOT, V25, P576, DOI 10.7164/antibiotics.25.576; KAWAGUCHI H, 1977, J ANTIBIOT, V30, P779, DOI 10.7164/antibiotics.30.779; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KONISHI M, 1977, J ANTIBIOT, V30, P789, DOI 10.7164/antibiotics.30.789; Leitheiser CJ, 2003, J AM CHEM SOC, V125, P8218, DOI 10.1021/ja021388w; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; MANSOURI K, 1991, MOL GEN GENET, V228, P459, DOI 10.1007/BF00260640; MIYAKI T, 1981, J ANTIBIOT, V34, P658, DOI 10.7164/antibiotics.34.658; MIYAMURA S, 1973, J ANTIBIOT, V26, P479, DOI 10.7164/antibiotics.26.479; MIYOSHI T, 1972, J ANTIBIOT, V25, P569, DOI 10.7164/antibiotics.25.569; NICAISE C, 1990, INVEST NEW DRUG, V8, P325; NICAISE C, 1990, CANCER CHEMOTH PHARM, V26, P221, DOI 10.1007/BF02897203; OKA S, 1980, RECENT RES CANCER, V74, P163; Sambrook J, 2001, MOL CLONING LAB MANU; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; SHIPLEY B, 1998, CHEM RES TOXICOL, V1, P25; SINGH SB, 1995, J ORG CHEM, V60, P7040, DOI 10.1021/jo00126a071; Smith AB, 2002, J AM CHEM SOC, V124, P11102, DOI 10.1021/ja020635t; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Tawara S, 2000, ANTIMICROB AGENTS CH, V44, P57, DOI 10.1128/AAC.44.1.57-62.2000; Troast DM, 2002, ORG LETT, V4, P991, DOI 10.1021/ol025558l; UMEZAWA H, 1981, J ANTIBIOT, V34, P1622, DOI 10.7164/antibiotics.34.1622; Zuber G, 1998, J AM CHEM SOC, V120, P9368, DOI 10.1021/ja981937r	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8256	8264		10.1074/jbc.M900640200	http://dx.doi.org/10.1074/jbc.M900640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189972	hybrid, Green Published			2022-12-25	WOS:000264397800009
J	Schuz, J; Waldemar, G; Olsen, JH; Johansen, C				Schuez, Joachim; Waldemar, Gunhild; Olsen, Jorgen H.; Johansen, Christoffer			Risks for Central Nervous System Diseases among Mobile Phone Subscribers: A Danish Retrospective Cohort Study	PLOS ONE			English	Article								The aim of this study was to investigate a possible link between cellular telephone use and risks for various diseases of the central nervous system (CNS). We conducted a large nationwide cohort study of 420 095 persons whose first cellular telephone subscription was between 1982 and 1995, who were followed through 2003 for hospital contacts for a diagnosis of a CNS disorder. Standardized hospitalization ratios (SHRs) were derived by dividing the number of hospital contacts in the cohort by the number expected in the Danish population. The SHRs were increased by 10-20% for migraine and vertigo. No associations were seen for amyotrophic lateral sclerosis, multiple sclerosis or epilepsy in women. SHRs decreased by 30-40% were observed for dementia (Alzheimer disease, vascular and other dementia), Parkinson disease and epilepsy among men. In analyses restricted to subscribers of 10 years or more, the SHRs remained similarly increased for migraine and vertigo and similarly decreased for Alzheimer disease and other dementia and epilepsy (in men); the other SHRs were close to unity. In conclusion, the excesses of migraine and vertigo observed in this first study on cellular telephones and CNS disease deserve further attention. An interplay of a healthy cohort effect and reversed causation bias due to prodromal symptoms impedes detection of a possible association with dementia and Parkinson disease. Identification of the factors that result in a healthy cohort might be of interest for elucidation of the etiology of these diseases.	[Schuez, Joachim; Olsen, Jorgen H.; Johansen, Christoffer] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Waldemar, Gunhild] Univ Copenhagen Hosp, Dept Neurol, Memory Disorder Res Grp, Copenhagen, Denmark	Danish Cancer Society; University of Copenhagen	Schuz, J (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.	joachim@cancer.dk	Johansen, Christoffer/AAG-7916-2020	Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662	The Danish Strategic Research Council [2064-04-0010]	The Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	The study received funding entirely from The Danish Strategic Research Council (2064-04-0010). The study sponsor had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ahlbom A, 2008, TOXICOLOGY, V246, P248, DOI 10.1016/j.tox.2008.02.004; BRESLOW NE, 1987, IARC SCI PUBL, V82; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Christensen HC, 2005, NEUROLOGY, V64, P1189, DOI 10.1212/01.WNL.0000156351.72313.D3; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Garcia AM, 2008, INT J EPIDEMIOL, V37, P329, DOI 10.1093/ije/dym295; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Hardell Lennart, 2006, World J Surg Oncol, V4, P74, DOI 10.1186/1477-7819-4-74; Hillert L, 2008, BIOELECTROMAGNETICS, V29, P185, DOI 10.1002/bem.20379; Hug K, 2006, SOZ PRAVENTIV MED, V51, P210, DOI 10.1007/s00038-006-5096-4; Johansen C, 2004, SCAND J WORK ENV HEA, V30, P1; Korczyn AD, 2007, J NEUROL SCI, V257, P2, DOI 10.1016/j.jns.2007.01.081; LAHKOLA A, 2008, INT J EPIDEMIOL 0802; Lahkola A, 2007, INT J CANCER, V120, P1769, DOI 10.1002/ijc.22503; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Lyngberg AC, 2005, AM J EPIDEMIOL, V161, P1066, DOI 10.1093/aje/kwi139; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; Rothman KJ, 2000, LANCET, V356, P1837, DOI 10.1016/S0140-6736(00)03244-X; *SCENIHR, 2008, POSS EFF EL FIELDS E; Schoemaker MJ, 2005, BRIT J CANCER, V93, P842, DOI 10.1038/sj.bjc.6602764; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Schuz J, 2006, BIOELECTROMAGNETICS, V27, P280, DOI 10.1002/bem.20212; Schuz J, 2005, BIOELECTROMAGNETICS, pS45, DOI 10.1002/bem.20129; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; Vrijheid M, 2006, OCCUP ENVIRON MED, V63, P237, DOI 10.1136/oem.2004.019281; Wilen J, 2003, BIOELECTROMAGNETICS, V24, P152, DOI 10.1002/bem.10101	32	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4389	10.1371/journal.pone.0004389	http://dx.doi.org/10.1371/journal.pone.0004389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194493	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483600014
J	van der Laan, S; de Kloet, ER; Meijer, OC				van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.			Timing Is Critical for Effective Glucocorticoid Receptor Mediated Repression of the cAMP-Induced CRH Gene	PLOS ONE			English	Article								Glucocorticoid negative feedback of the hypothalamus-pituitary-adrenal axis is mediated in part by direct repression of gene transcription in glucocorticoid receptor (GR) expressing cells. We have investigated the cross talk between the two main signaling pathways involved in activation and repression of corticotrophin releasing hormone (CRH) mRNA expression: cyclic AMP (cAMP) and GR. We report that in the At-T20 cell-line the glucocorticoid-mediated repression of the cAMP-induced human CRH proximal promoter activity depends on the relative timing of activation of both signaling pathways. Activation of the GR prior to or in conjunction with cAMP signaling results in an effective repression of the cAMP-induced transcription of the CRH gene. In contrast, activation of the GR 10 minutes after onset of cAMP treatment, results in a significant loss of GR-mediated repression. In addition, translocation of ligand-activated GR to the nucleus was found as early as 10 minutes after glucocorticoid treatment. Interestingly, while both signaling cascades counteract each other on the CRH proximal promoter, they synergize on a synthetic promoter containing 'positive' response elements. Since the order of activation of both signaling pathways may vary considerably in vivo, we conclude that a critical time-window exists for effective repression of the CRH gene by glucocorticoids.	[van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.] Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands; [van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Laan, S (corresponding author), Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands.	o.meijer@lacdr.leidenuniv.nl	meijer, onno c/D-8070-2018; de Kloet, Edo Ronald/H-3278-2011	meijer, onno c/0000-0002-8394-6859; de Kloet, Ron/0000-0001-9176-1830; VAN DER LAAN, Siem/0000-0001-8169-1963	ZON-MW Vidi [016.036.381]; Royal Dutch Academy of Arts and Sciences	ZON-MW Vidi(Netherlands Organization for Health Research and Development); Royal Dutch Academy of Arts and Sciences	The research described was funded by a ZON-MW Vidi grant (016.036.381) to OCM, and the Royal Dutch Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XN, 2008, BRAIN RES, V1223, P1, DOI 10.1016/j.brainres.2008.05.043; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Ginsberg AB, 2003, J NEUROENDOCRINOL, V15, P1075, DOI 10.1046/j.1365-2826.2003.01100.x; GuardiolaDiaz HM, 1996, MOL ENDOCRINOL, V10, P317, DOI 10.1210/me.10.3.317; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; King BR, 2007, FRONT BIOSCI, V12, P581, DOI 10.2741/2084; Kovacs KJ, 1996, J NEUROSCI, V16, P262; KRAUS J, 1995, DNA CELL BIOL, V14, P103, DOI 10.1089/dna.1995.14.103; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; Malkoski SP, 1999, MOL ENDOCRINOL, V13, P1629, DOI 10.1210/me.13.10.1629; Malkoski SP, 1997, MOL CELL ENDOCRINOL, V127, P189, DOI 10.1016/S0303-7207(96)04004-X; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; SHIPSTON MJ, 1992, ENDOCRINOLOGY, V130, P2213, DOI 10.1210/en.130.4.2213; SPENGLER D, 1992, MOL ENDOCRINOL, V6, P1931, DOI 10.1210/me.6.11.1931; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; van der Laan S, 2008, ENDOCRINOLOGY, V149, P725, DOI 10.1210/en.2007-1234; VAN LP, 1990, ENDOCRINOLOGY, V127, P1412, DOI 10.1210/endo-127-3-1412; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Winnay JN, 2006, ENDOCRINOLOGY, V147, P1322, DOI 10.1210/en.2005-0751; Wolfl S, 1999, MOL ENDOCRINOL, V13, P659, DOI 10.1210/me.13.5.659; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4327	10.1371/journal.pone.0004327	http://dx.doi.org/10.1371/journal.pone.0004327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177170	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483100010
J	Liraz, O; Rosenblum, K; Barkai, E				Liraz, Ori; Rosenblum, Kobi; Barkai, Edi			CAMKII Activation Is Not Required for Maintenance of Learning-Induced Enhancement of Neuronal Excitability	PLOS ONE			English	Article								Pyramidal neurons in the piriform cortex from olfactory-discrimination trained rats show enhanced intrinsic neuronal excitability that lasts for several days after learning. Such enhanced intrinsic excitability is mediated by long-term reduction in the post-burst after-hyperpolarization (AHP) which is generated by repetitive spike firing. AHP reduction is due to decreased conductance of a calcium-dependent potassium current, the sl(AHP). We have previously shown that learning-induced AHP reduction is maintained by persistent protein kinase C (PKC) and extracellular regulated kinase (ERK) activation. However, the molecular machinery underlying this long-lasting modulation of intrinsic excitability is yet to be fully described. Here we examine whether the CaMKII, which is known to be crucial in learning, memory and synaptic plasticity processes, is instrumental for the maintenance of learning-induced AHP reduction. KN93, that selectively blocks CaMKII autophosphorylation at Thr286, reduced the AHP in neurons from trained and control rat to the same extent. Consequently, the differences in AHP amplitude and neuronal adaptation between neurons from trained rats and controls remained. Accordingly, the level of activated CaMKII was similar in pirifrom cortex samples taken form trained and control rats. Our data show that although CaMKII modulates the amplitude of AHP of pyramidal neurons in the piriform cortex, its activation is not required for maintaining learning-induced enhancement of neuronal excitability.	[Liraz, Ori; Rosenblum, Kobi; Barkai, Edi] Univ Haifa, Fac Sci, Dept Neurobiol, IL-31999 Haifa, Israel; [Liraz, Ori; Rosenblum, Kobi; Barkai, Edi] Univ Haifa, Fac Sci, Dept Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Liraz, O (corresponding author), Univ Haifa, Fac Sci, Dept Neurobiol, IL-31999 Haifa, Israel.	ebarkai@research.haifa.ac.il			Israel Science Foundation; US-Israel Binational Foundation	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Foundation(US-Israel Binational Science Foundation)	Supported by grants from the Israel Science Foundation and the US-Israel Binational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brosh I, 2006, J NEUROPHYSIOL, V96, P1728, DOI 10.1152/jn.00376.2006; Cammarota M, 2002, CELL MOL NEUROBIOL, V22, P259, DOI 10.1023/A:1020763716886; Cohen-Matsliah SI, 2007, J NEUROSCI, V27, P12584, DOI 10.1523/JNEUROSCI.3728-07.2007; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Disterhoft JF, 2004, AGEING RES REV, V3, P383, DOI 10.1016/j.arr.2004.07.001; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Moyer JR, 1996, J NEUROSCI, V16, P5536; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Ohno M, 2006, EUR J NEUROSCI, V23, P2235, DOI 10.1111/j.1460-9568.2006.04746.x; Power JM, 2002, J NEUROSCI, V22, P7234; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 2001, J NEUROSCI, V21, P1385; Saar D, 1999, J NEUROSCI, V19, P8616; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; SANCHEZANDRES JV, 1991, J NEUROPHYSIOL, V65, P796, DOI 10.1152/jn.1991.65.4.796; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P450, DOI 10.1152/jn.1988.59.2.450; Seroussi Y, 2002, EUR J NEUROSCI, V16, P965, DOI 10.1046/j.1460-9568.2002.02155.x; Smolen P, 2008, AM J PHYSIOL-CELL PH, V294, pC503, DOI 10.1152/ajpcell.00447.2007; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Zelcer I, 2006, CEREB CORTEX, V16, P460, DOI 10.1093/cercor/bhi125; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4289	10.1371/journal.pone.0004289	http://dx.doi.org/10.1371/journal.pone.0004289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172997	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483000004
J	Mercer, RE; Wevrick, R				Mercer, Rebecca E.; Wevrick, Rachel			Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice	PLOS ONE			English	Article							ESTROUS-CYCLE; MOUSE; DEFICIENCY; HYPOGONADISM; TESTOSTERONE; PUBERTY; ABSENCE; NECDIN	Background: MAGEL2 is one of several genes typically inactivated in the developmental obesity disorder Prader-Willi syndrome (PWS). The physiological consequences of loss of MAGEL2, but without the concurrent loss of other PWS genes, are not well understood. Gene-targeted mutation of Magel2 in mice disrupts circadian rhythm and metabolism causing reduced total activity, reduced weight gain before weaning, and increased adiposity after weaning. Principal Findings: We now show that loss of Magel2 in mice causes reduced fertility in both males and females through extended breeding intervals and early reproductive decline and termination. Female Magel2-null mice display extended and irregular estrous cycles, while males show decreased testosterone levels, and reduced olfactory preference for female odors. Conclusions: Our results suggest that loss of MAGEL2 contributes to the reproductive deficits seen in people with PWS, and further highlights the role of normal circadian rhythm in the maintenance of fertility.	[Mercer, Rebecca E.; Wevrick, Rachel] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta	Mercer, RE (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	rachel.wevrick@ualberta.ca		Mercer, Rebecca/0000-0002-9264-7797; Wevrick, Rachel/0000-0002-3343-5794	Natural Sciences and Engineering Research Council of Canada; Canadian Diabetes Association [Doctoral Student Research Award]; CIHR	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Diabetes Association; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Diabetes Association. REM is funded by a Canadian Diabetes Association Doctoral Student Research Award, and a CIHR Strategic Training Grant in Maternal-Fetal Newborn Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Asnicar MA, 2002, ENDOCRINOLOGY, V143, P3994, DOI 10.1210/en.2002-220354; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ., 2005, REPROD FERT DEVELOP, V17, P126, DOI [10.1071/SRB05Abs297, DOI 10.1071/SRB05ABS297]; Brandau DT, 2008, AM J MED GENET A, V146A, P665, DOI 10.1002/ajmg.a.32194; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Crino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Eiholzer U, 2006, J CLIN ENDOCR METAB, V91, P892, DOI 10.1210/jc.2005-0902; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Guzman C, 2006, J PHYSIOL-LONDON, V572, P97, DOI 10.1113/jphysiol.2005.103903; HAMILTON CR, 1972, AM J MED, V52, P322, DOI 10.1016/0002-9343(72)90019-8; KATCHER ML, 1977, EUR J PEDIATR, V124, P257, DOI 10.1007/BF00441933; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; MILLER NL, 2008, HUM MOL GENET; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; Ren J, 2003, J NEUROSCI, V23, P1569; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; TAKANO H, 1987, ARCH HISTOL CYTOL, V50, P533, DOI 10.1679/aohc.50.533; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	33	62	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4291	10.1371/journal.pone.0004291	http://dx.doi.org/10.1371/journal.pone.0004291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172181	Green Submitted, Green Published, gold			2022-12-25	WOS:000265482900008
J	Pfisterer, C; Gruia, A; Fischer, S				Pfisterer, Christoph; Gruia, Andreea; Fischer, Stefan			The Mechanism of Photo-energy Storage in the Halorhodopsin Chloride Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRONOBACTERIUM-PHARAONIS; FTIR SPECTROSCOPY; BACTERIORHODOPSIN; TRANSPORT; DYNAMICS	The light-driven pump Halorhodopsin (hR) uses the energy stored in an initial meta-stable state (K), in which the bound retinal chromophore has been photoisomerized from all-trans to 13-cis, to drive the translocation of one chloride anion across the membrane. Thus far it was unclear whether retinal twisting or charge separation between the positive Schiff base of the retinal and the chloride anion is the primary mechanism of energy storage. Here, combined quantum mechanical/molecular mechanical (QM/MM) simulations show that the energy is predominantly stored by charge separation. However, a large variability in retinal twisting is observed, thus reconciling the contradictory hypotheses for storage. Surprisingly, the energy stored in the K-state amounts to only one-fifth of the photon energy. We explain why the protein cannot store more: even though this would accelerate chloride pumping, raising the K-state also reduces the relative energy barriers against unproductive decay, in particular via the premature cis to trans back-isomerization. Indeed, the protein has maximized its storage so that the back-isomerization barriers are just high enough (>= 18 kcal/mol) to keep the decay rate (1/100 ms) slower than the remaining photocycle (1/20 ms). This need to stabilize the captured photon-energy until it can be used in subsequent steps is inherent to light-driven proteins.	[Pfisterer, Christoph; Gruia, Andreea; Fischer, Stefan] Heidelberg Univ, IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Heidelberg Univ, IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany.	Stefan.Fischer@iwr.uni-heidelberg.de	Gruia, Andreea Karina/AAQ-8978-2020		Deutsche Forschungsgemeinschaft [SF63/7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SF63/7.	ALSHUTH T, 1985, FEBS LETT, V179, P55, DOI 10.1016/0014-5793(85)80190-3; Bondar AN, 2005, J PHYS CHEM B, V109, P14786, DOI 10.1021/jp0531255; Bondar AN, 2004, STRUCTURE, V12, P1281, DOI 10.1016/j.str.2004.04.016; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DER A, 1992, J PHOTOCH PHOTOBIO B, V15, P299, DOI 10.1016/1011-1344(92)85136-I; Dioumaev AK, 1997, PHOTOCHEM PHOTOBIOL, V66, P755, DOI 10.1111/j.1751-1097.1997.tb03220.x; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Gascon JA, 2004, BIOPHYS J, V87, P2931, DOI 10.1529/biophysj.104.048264; Gruia AD, 2005, STRUCTURE, V13, P617, DOI 10.1016/j.str.2005.01.021; Guijarro J, 2006, BIOCHEMISTRY-US, V45, P11578, DOI 10.1021/bi060753j; Herzfeld J, 2000, BBA-BIOENERGETICS, V1460, P95, DOI 10.1016/S0005-2728(00)00132-8; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Losi A, 2001, PHOTOCHEM PHOTOBIOL, V74, P495, DOI 10.1562/0031-8655(2001)074<0495:TOTESI>2.0.CO;2; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mukohata Y, 1999, J BIOCHEM-TOKYO, V125, P649, DOI 10.1093/oxfordjournals.jbchem.a022332; Muneyuki E, 2002, BIOPHYS J, V83, P1749, DOI 10.1016/S0006-3495(02)73941-6; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Oesterhelt D, 1995, ISR J CHEM, V35, P475; Paizs B, 1999, J PHYS CHEM B, V103, P5388, DOI 10.1021/jp982624l; ROTHSCHILD KJ, 1988, BIOCHEMISTRY-US, V27, P2420, DOI 10.1021/bi00407a026; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; Schwarzl SM, 2005, J COMPUT CHEM, V26, P1359, DOI 10.1002/jcc.20274; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Spudich JL, 2000, SCIENCE, V288, P1358, DOI 10.1126/science.288.5470.1358; VARO G, 1995, BIOCHEMISTRY-US, V34, P14500, DOI 10.1021/bi00044a028; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Zhou HY, 2002, CHEM PHYS, V277, P91, DOI 10.1016/S0301-0104(01)00695-4	32	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13562	13569		10.1074/jbc.M808787200	http://dx.doi.org/10.1074/jbc.M808787200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19211559	Green Published, hybrid			2022-12-25	WOS:000265877300033
J	Deshmane, SL; Mukerjee, R; Fan, SS; Del Valle, L; Michiels, C; Sweet, T; Rom, I; Khalili, K; Rappaport, J; Amini, S; Sawaya, BE				Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Michiels, Carine; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.			Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; VIRAL PROTEIN-R; FACTOR-KAPPA-B; TAT PROTEIN; GENE-TRANSCRIPTION; MODULATES TRANSCRIPTION; NEURONAL APOPTOSIS; HUMAN ASTROCYTES; CELL-LINES; STABILIZATION	The detection of biomarkers of oxidative stress in brain tissue and cerebrospinal fluid of patients with human immunodeficiency virus, type 1 (HIV)-associated dementia indicates the involvement of stress pathways in the neuropathogenesis of AIDS. Although the biological importance of oxidative stress on events involved in AIDS neuropathogenesis and the HIV-1 proteins responsible for oxidative stress remain to be elucidated, our results point to the activation of hypoxia-inducible factor 1 (HIF-1) upon HIV-1 infection and its elevation in brain cells of AIDS patients with dementia. HIF-1 is a transcription factor that is responsive to oxygen. Under hypoxic conditions, HIF-1 alpha becomes stable and translocates to the nucleus where it dimerizes with aryl hydrocarbon receptor nuclear translocator and modulates gene transcription. Activation of HIF-1 can also be mediated by the HIV-1 accessory protein Vpr. In addition, cellular components, including reactive oxygen species, contribute to the induction of HIF-1 alpha. Our results show that Vpr induces reactive oxygen species by increasing H2O2 production, which can contribute to HIF-1 alpha accumulation. Interestingly, increased levels of HIF-1 alpha stimulated HIV-1 gene transcription through HIF-1 association with HIV-1 long terminal repeat. These observations point to the existence of a positive feedback interplay between HIF-1 alpha and Vpr and that, by inducing oxidative stress via activation of HIF-1, Vpr can induce HIV-1 gene expression and dysregulate multiple host cellular pathways.	[Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Michiels, Carine] Univ Namur, Fac Univ Notre Dame Paix, Unite Rech Biol Cellulaire, B-5000 Namur, Belgium; [Sweet, Thersa; Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Namur; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Dept Neurol, Mol Virol Lab, 3400 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to B. E. S. and S. A.).	Aksenov MY, 2001, NEUROSCI LETT, V305, P5, DOI 10.1016/S0304-3940(01)01786-4; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Amini S, 2004, DNA CELL BIOL, V23, P249, DOI 10.1089/104454904773819833; Antal J, 2006, FOLIA MICROBIOL, V51, P406, DOI 10.1007/BF02931584; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Eldeen MB, 2006, J NEUROIMMUNOL, V176, P174, DOI 10.1016/j.jneuroim.2006.04.004; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; Foga IO, 1997, J ACQ IMMUN DEF SYND, V16, P223, DOI 10.1097/00042560-199712010-00001; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P1249, DOI 10.1016/j.intimp.2004.06.006; Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kimura H., 2005, Current Drug Targets - Inflammation and Allergy, V4, P489, DOI 10.2174/1568010054526287; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kurata SI, 1996, J BIOL CHEM, V271, P21798, DOI 10.1074/jbc.271.36.21798; LE BM, 2005, HISTOL HISTOPATHOL, V20, P205; Lungu GF, 2008, J NEUROVIROL, V14, P239, DOI 10.1080/13550280802093919; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Mukerjee R, 2007, J CELL BIOCHEM, V100, P1210, DOI 10.1002/jcb.21109; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Sacktor N, 2004, J NEUROIMMUNOL, V157, P176, DOI 10.1016/j.jneuroim.2004.08.037; Saunders M, 2005, APOPTOSIS, V10, P1419, DOI 10.1007/s10495-005-2467-x; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schweppe RE, 2006, J BIOL CHEM, V281, P20993, DOI 10.1074/jbc.M604208200; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Sweet T, 2003, J CELL BIOCHEM, V90, P884, DOI 10.1002/jcb.10701; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286; Valcour V, 2004, MITOCHONDRION, V4, P119, DOI 10.1016/j.mito.2004.05.009; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Viviani B, 2001, NEUROSCIENCE, V107, P51, DOI 10.1016/S0306-4522(01)00332-3; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	54	80	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11364	11373		10.1074/jbc.M809266200	http://dx.doi.org/10.1074/jbc.M809266200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19204000	Green Published, hybrid			2022-12-25	WOS:000265494500041
J	Atkinson, J; Guy, CP; Cadman, CJ; Moolenaar, GF; Goosen, N; McGlynn, P				Atkinson, John; Guy, Colin P.; Cadman, Chris J.; Moolenaar, Geri F.; Goosen, Nora; McGlynn, Peter			Stimulation of UvrD Helicase by UvrAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI UVRD; POLYMERASE-I; REPLICATION FORK; PHYSICAL INTERACTION; PROTEIN COMPLEX; DAMAGE RECOGNITION; PRIA HELICASE; MISMATCH	Helicases play critical roles in all aspects of nucleic acid metabolism by catalyzing the remodeling of DNA and RNA structures. UvrD is an abundant helicase in Escherichia coli with well characterized functions in mismatch and nucleotide excision repair and a possible role in displacement of proteins such as RecA from single-stranded DNA. The mismatch repair protein MutL is known to stimulate UvrD. Here we show that the nucleotide excision repair proteins UvrA and UvrB can together stimulate UvrD-catalyzed unwinding of a range of DNA substrates containing strand discontinuities, including forked DNA substrates. The stimulation is specific for UvrD, as UvrAB failed to stimulate Rep helicase, a UvrD homologue. Moreover, although UvrAB can promote limited strand displacement, stimulation of UvrD did not require the strand displacement function of UvrAB. We conclude that UvrAB, like MutL, modulate UvrD helicase activity. This stimulation likely plays a role in DNA strand and protein displacement by UvrD in nucleotide excision repair. Promotion of UvrD-catalyzed unwinding of nicked duplexes by UvrAB may also explain the need for UvrAB and UvrD in Okazaki fragment processing in cells lacking DNA polymerase I. More generally, these data support the idea that helicase activity is regulated in vivo, with helicases acting as part of multisubunit complexes rather than in isolation.	[Atkinson, John; Guy, Colin P.; Cadman, Chris J.; McGlynn, Peter] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Moolenaar, Geri F.; Goosen, Nora] Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Mol Genet Lab, NL-2300 RA Leiden, Netherlands	University of Aberdeen; Leiden University; Leiden University - Excl LUMC	McGlynn, P (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	p.mcglynn@abdn.ac.uk		McGlynn, Peter/0000-0001-8629-4713	Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; BBSRC [BB/C008316/1] Funding Source: UKRI; MRC [G0501626] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C008316/1] Funding Source: researchfish; Medical Research Council [G0501626] Funding Source: researchfish	Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to P. M.).	Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Goosen N, 2001, RES MICROBIOL, V152, P401, DOI 10.1016/S0923-2508(01)01211-6; Gordienko I, 1997, EMBO J, V16, P889, DOI 10.1093/emboj/16.4.889; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; HORIUCHI T, 1974, MOL GEN GENET, V128, P105, DOI 10.1007/BF02654484; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Janion C, 2001, ACTA BIOCHIM POL, V48, P599; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Malta E, 2006, J BIOL CHEM, V281, P2184, DOI 10.1074/jbc.M508901200; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Moolenaar GF, 2005, DNA REPAIR, V4, P699, DOI 10.1016/j.dnarep.2005.03.001; Moolenaar GF, 1997, MUTAT RES-DNA REPAIR, V385, P195, DOI 10.1016/S0921-8777(97)00042-6; Moolenaar GF, 2001, EMBO J, V20, P6140, DOI 10.1093/emboj/20.21.6140; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; MORIMYO M, 1976, MOL GEN GENET, V147, P243, DOI 10.1007/BF00582875; OH EY, 1989, J BIOL CHEM, V264, P1336; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; ORREN DK, 1992, J BIOL CHEM, V267, P780; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; PARSONS CA, 1990, J BIOL CHEM, V265, P9285; Payne BTI, 2006, NUCLEIC ACIDS RES, V34, P5194, DOI 10.1093/nar/gkl682; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; SHIZUYA H, 1972, J BACTERIOL, V112, P676, DOI 10.1128/JB.112.2.676-681.1972; SIEGEL EC, 1973, J BACTERIOL, V113, P161, DOI 10.1128/JB.113.1.161-166.1973; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skorvaga M, 2004, J BIOL CHEM, V279, P51574, DOI 10.1074/jbc.M409266200; Skorvaga M, 2002, J BIOL CHEM, V277, P1553, DOI 10.1074/jbc.M108847200; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; UYEMURA D, 1976, J BIOL CHEM, V251, P4085; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; VISSE R, 1992, J BIOL CHEM, V267, P6736; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713	71	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9612	9623		10.1074/jbc.M808030200	http://dx.doi.org/10.1074/jbc.M808030200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208629	Green Published, hybrid			2022-12-25	WOS:000264669100067
J	Burrows, JF; Kelvin, AA; McFarlane, C; Burden, RE; McGrattan, MJ; De la Vega, M; Govender, U; Quinn, DJ; Dib, K; Gadina, M; Scott, CJ; Johnston, JA				Burrows, James F.; Kelvin, Alyson A.; McFarlane, Cheryl; Burden, Roberta E.; McGrattan, Michael J.; De la Vega, Michelle; Govender, Ureshnie; Quinn, Derek J.; Dib, Karim; Gadina, Massimo; Scott, Christopher J.; Johnston, James A.			USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME; FAMILIAL CYLINDROMATOSIS; PARKINSONS-DISEASE; ALPHA-SUBUNIT; RHO GTPASES; A-FACTOR; UBIQUITIN; GENE; PATHWAY	The proto-oncogene Ras undergoes a series of post-translational modifications at its carboxyl-terminal CAAX motif that are essential for its proper membrane localization and function. One step in this process is the cleavage of the CAAX motif by the enzyme Ras-converting enzyme 1 (RCE1). Here we show that the deubiquitinating enzyme USP17 negatively regulates the activity of RCE1. We demonstrate that USP17 expression blocks Ras membrane localization and activation, thereby inhibiting phosphorylation of the downstream kinases MEK and ERK. Furthermore, we show that this effect is caused by the loss of RCE1 catalytic activity as a result of its deubiquitination by USP17. We also show that USP17 and RCE1 co-localize at the endoplasmic reticulum and that USP17 cannot block proliferation or Ras membrane localization in RCE1 null cells. These studies demonstrate that USP17 modulates Ras processing and activation, at least in part, by regulating RCE1 activity.	[Burrows, James F.; Kelvin, Alyson A.; McFarlane, Cheryl; McGrattan, Michael J.; De la Vega, Michelle; Govender, Ureshnie; Dib, Karim; Gadina, Massimo; Johnston, James A.] Queens Univ Belfast, Fac Med Hlth & Life Sci, Div Infect & Immunity, Ctr Canc Res & Cell Biol,Sch Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland; [Burrows, James F.; Burden, Roberta E.; Quinn, Derek J.; Scott, Christopher J.] Queens Univ Belfast, Fac Med Hlth & Life Sci, Sch Pharm, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Johnston, JA (corresponding author), Rm 226,Whitla Med Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	jim.johnston@qub.ac.uk	Gadina, Massimo/R-4195-2019		Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bowen S, 2005, J INVEST DERMATOL, V124, P919, DOI 10.1111/j.0022-202X.2005.23688.x; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Goalstone M, 1997, ENDOCRINOLOGY, V138, P5119, DOI 10.1210/en.138.12.5119; GRAY DA, 1995, ONCOGENE, V10, P2179; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar A, 1997, NEUROSCI LETT, V231, P143, DOI 10.1016/S0304-3940(97)00549-1; Kumar A, 1996, BIOCHEM BIOPH RES CO, V222, P445, DOI 10.1006/bbrc.1996.0764; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Migone TS, 2001, BLOOD, V98, P1935, DOI 10.1182/blood.V98.6.1935; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Pan JX, 2005, CANCER RES, V65, P9109, DOI 10.1158/0008-5472.CAN-05-2635; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang J, 2000, PARKINSONISM RELAT D, V6, P195, DOI 10.1016/S1353-8020(00)00015-8; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	51	64	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9587	9595		10.1074/jbc.M807216200	http://dx.doi.org/10.1074/jbc.M807216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19188362	Green Published, hybrid			2022-12-25	WOS:000264669100065
J	Gilman, B; Drullinger, LF; Kugel, JF; Goodrich, JA				Gilman, Benjamin; Drullinger, Linda F.; Kugel, Jennifer F.; Goodrich, James A.			TATA-binding Protein and Transcription Factor IIB Induce Transcript Slipping during Early Transcription by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR LATE PROMOTER; ABORTIVE INITIATION; DNA; ELONGATION; COMPLEXES; ESCAPE; ATP; CLEARANCE; STEPS; TFIIB	To better understand the mechanism of steps in early transcription by RNA polymerase II (pol II), we investigated the molecular determinants of transcript slipping within complexes assembled on promoters containing a pre-melted transcription bubble from -9 to +3. Transcript slippage occurs when an RNA transcript contains a repetitive sequence that allows the transcript to slip back and pair with the template strand of the DNA at a new register before transcription continues. We established the contributions of individual transcription factors, DNA elements, and RNA length to slipping on a heteroduplex template using a highly purified human pol II transcription system. We found that transcripts slip at a very defined point in the transcription reaction, after pol II completes phosphodiester bond synthesis at register +5. This point is set by the position of the polymerase active site on the DNA template, as opposed to the length of the transcript, as well as by a repetitive CUCU sequence that must occur from +2 to +5. Interestingly, slipping at this juncture is induced by TATA-binding protein and transcription factor IIB and requires a TATA box but not a transcription factor IIB recognition sequence. We propose a model in which transcribing complexes, upon completing phosphodiester bond synthesis at register +5, enter one of two branches in which they either complete productive synthesis of the transcript or undergo multiple rounds of transcript slipping.	[Gilman, Benjamin; Drullinger, Linda F.; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kugel, JF (corresponding author), Univ Colorado, Dept Chem & Biochem, 215 UCB, Boulder, CO 80309 USA.	jennifer.kugel@colorado.edu; james.goodrich@colorado.edu			National Science Foundation [MCB-0517296]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0517296 from the National Science Foundation.	Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JACOB GA, 1991, J BIOL CHEM, V266, P22537; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; Kugel JF, 2000, J BIOL CHEM, V275, P40483, DOI 10.1074/jbc.M006401200; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Pal M, 2002, MOL CELL BIOL, V22, P30, DOI 10.1128/MCB.22.1.30-40.2002; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Weaver JR, 2005, J BIOL CHEM, V280, P39860, DOI 10.1074/jbc.M509376200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	26	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9093	9098		10.1074/jbc.M900019200	http://dx.doi.org/10.1074/jbc.M900019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193635	hybrid, Green Published			2022-12-25	WOS:000264669100012
J	Jacobs, AT; Marnett, LJ				Jacobs, Aaron T.; Marnett, Lawrence J.			HSF1-mediated BAG3 Expression Attenuates Apoptosis in 4-Hydroxynonenal-treated Colon Cancer Cells via Stabilization of Anti-apoptotic Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PEROXIDATION END-PRODUCTS; LIPID-PEROXIDATION; OXIDATIVE STRESS; X-L; GENE-EXPRESSION; MICROARRAY DATA; MCL-1; ACTIVATION; DISEASE	4-Hydroxynonenal (HNE) is a pro-apoptotic electrophile generated during the spontaneous decomposition of oxidized lipids. We have previously shown that HNE activates the transcription factor, heat shock factor 1 (HSF1), and promotes cytoprotective heat shock gene expression and that silencing HSF1 sensitizes the colon cancer cell line RKO to HNE-induced apoptosis. Here we report a reduction in the anti-apoptotic proteins Bcl-X-L, Mcl-1, and Bcl-2 in HSF1-silenced RKO cells, and we examine the underlying mechanism. To investigate the regulation of the Bcl-2 family by HSF1, microarray analysis of gene expression was performed. We observed that the Hsp70 co-chaperone, BAG3 (Bcl-2-associated athanogene domain 3), is strongly induced by HNE in control but not in HSF1-silenced colon cancer cells. Silencing BAG3 expression with small interfering RNA caused a dramatic reduction in Bcl-XL, Mcl-1, and Bcl-2 protein levels in colon cancer cells and increased apoptosis, similar to the effect of silencing HSF1. Also, immunoprecipitation experiments indicate specific interactions between BAG3, Hsp70, and the Bcl-2 family member, Bcl-XL. Overall, our data reveal that BAG3 is HSF1-inducible and has a unique role facilitating cancer cell survival during pro-apoptotic stress by stabilizing the level of Bcl-2 family proteins.	[Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health [P01ES013125]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01ES013125 from NIEHS (Program Project Grant).	Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Antoku K, 2001, BIOCHEM BIOPH RES CO, V286, P1003, DOI 10.1006/bbrc.2001.5512; Arnold AA, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-20; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200; CAJONE F, 1992, CHEM-BIOL INTERACT, V84, P97, DOI 10.1016/0009-2797(92)90071-R; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Fleischer B, 2006, INT J ONCOL, V28, P25; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Liu W, 2000, J CELL SCI, V113, P635; Manion MK, 2006, CURR OPIN INVEST DR, V7, P1077; Montine KS, 1998, J NEUROPATH EXP NEUR, V57, P415, DOI 10.1097/00005072-199805000-00005; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Paradis V, 1997, HEPATOLOGY, V26, P135; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Romano MF, 2003, CANCER BIOL THER, V2, P508, DOI 10.4161/cbt.2.5.524; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w; Volkel W, 2005, FREE RADICAL BIO MED, V38, P1526, DOI 10.1016/j.freeradbiomed.2005.02.015; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang ZQ, 2007, J VASC RES, V44, P483, DOI 10.1159/000106466; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zhang W, 2001, FREE RADICAL BIO MED, V30, P699, DOI 10.1016/S0891-5849(01)00465-8; Zheng B, 2007, J IMMUNOL, V179, P7087, DOI 10.4049/jimmunol.179.10.7087	52	129	132	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9176	9183		10.1074/jbc.M808656200	http://dx.doi.org/10.1074/jbc.M808656200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179333	Green Published, hybrid			2022-12-25	WOS:000264669100023
J	Schwarzer, D; Stummeyer, K; Haselhorst, T; Freiberger, F; Rode, B; Grove, M; Scheper, T; von Itzstein, M; Muhlenhoff, M; Gerardy-Schahn, R				Schwarzer, David; Stummeyer, Katharina; Haselhorst, Thomas; Freiberger, Friedrich; Rode, Bastian; Grove, Melanie; Scheper, Thomas; von Itzstein, Mark; Muehlenhoff, Martina; Gerardy-Schahn, Rita			Proteolytic Release of the Intramolecular Chaperone Domain Confers Processivity to Endosialidase F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K1; TRICHODERMA-REESEI CELLOBIOHYDROLASE; POLYSIALIC ACID; CRYSTAL-STRUCTURE; ACTIVE-SITE; POLYSACCHARIDE CAPSULES; SERRATIA-MARCESCENS; AROMATIC RESIDUES; MOLECULAR-CLONING; FIBER PROTEINS	Endosialidases (endoNs), as identified so far, are tailspike proteins of bacteriophages that specifically bind and degrade the alpha 2,8-linked polysialic acid (polySia) capsules of their hosts. The crystal structure solved for the catalytic domain of endoN from coliphage K1F (endoNF) revealed a functional trimer. Folding of the catalytic trimer is mediated by an intramolecular C-terminal chaperone domain. Release of the chaperone from the folded protein confers kinetic stability to endoNF. In mutant c(S), the replacement of serine 911 by alanine prevents proteolysis and generates an enzyme that varies in activity from wild type. Using soluble polySia as substrate a 3-times higher activity was detected while evaluation with immobilized polySia revealed a 190-fold reduced activity. Importantly, activity of c(S) did not differ from wild type with tetrameric sialic acid, the minimal endoNF substrate. Furthermore, we show that the presence of the chaperone domain in c(S) destabilizes binding to polySia in a similar way as did selective disruption of a polySia binding site in the stalk domain. The improved catalytic efficiency toward soluble polySia observed in these mutants can be explained by higher dissociation and association probabilities, whereas inversely, an impaired processivity was found. The fact that endoNF is a processive enzyme introduces a new molecular basis to explain capsule degradation by bacteriophages, which until now has been regarded as a result of cooperative interaction of tailspike proteins. Moreover, knowing that release of the chaperone domain confers kinetic stability and processivity, conservation of the proteolytic process can be explained by its importance in phage evolution.	[Schwarzer, David; Stummeyer, Katharina; Freiberger, Friedrich; Grove, Melanie; Muehlenhoff, Martina; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Zellulare Chem, Zentrum Biochem, D-30625 Hannover, Germany; [Haselhorst, Thomas; von Itzstein, Mark] Griffith Univ, Inst Glyc, Griffith, Qld 4222, Australia; [Rode, Bastian; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany	Hannover Medical School; Griffith University; Leibniz University Hannover	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Zellulare Chem, Zentrum Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	von Itzstein, Mark/E-4823-2010; Scheper, Thomas/H-8143-2013; Schwarzer, David/C-1939-2012; Haselhorst, Thomas/A-5066-2015	Haselhorst, Thomas/0000-0002-3373-8680	Deutsche Forschungsgemeinschaft (DFG) [Ge801/7-1, 7-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) in the framework of DFG Research Unit 548 (Grants Ge801/7-1 and 7-2).	Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; BAYER ME, 1979, VIROLOGY, V94, P95, DOI 10.1016/0042-6822(79)90441-0; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; DECHER G, 1990, BIOCHIM BIOPHYS ACTA, V1023, P357, DOI 10.1016/0005-2736(90)90127-A; FROSCH M, 1987, MICROB PATHOGENESIS, V2, P319, DOI 10.1016/0882-4010(87)90074-X; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; GERARDYSCHAHN R, 1995, MOL MICROBIOL, V16, P441, DOI 10.1111/j.1365-2958.1995.tb02409.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; HILDEBRANDT H, 2008, NEUROCHEM RES, DOI DOI 10.1007/S11064-008-9724-7; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Lindberg AA, 1977, SURFACE CARBOHYDRATE, P289; LONG GS, 1995, BIOCHEM J, V309, P543, DOI 10.1042/bj3090543; Machida Y, 2000, J BIOSCI BIOENG, V90, P62, DOI 10.1016/S1389-1723(00)80035-3; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; ROBBINS JB, 1974, NEW ENGL J MED, V290, P1216, DOI 10.1056/NEJM197405302902202; Rode B, 2008, J BIOTECHNOL, V135, P202, DOI 10.1016/j.jbiotec.2008.03.012; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SARFF LD, 1975, LANCET, V1, P1099; SCHNAITMAN CA, 2001, MOL MED MICROBIOLOGY, V1, P93; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; SKOZA L, 1976, BIOCHEM J, V159, P457, DOI 10.1042/bj1590457; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sutherland IW, 1977, SURFACE CARBOHYDRATE, P209; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Weigele PR, 2003, J BACTERIOL, V185, P4022, DOI 10.1128/JB.185.14.4022-4030.2003; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	44	23	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9465	9474		10.1074/jbc.M808475200	http://dx.doi.org/10.1074/jbc.M808475200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189967	Green Published, hybrid			2022-12-25	WOS:000264669100053
J	Xie, BB; Bian, F; Chen, XL; He, HL; Guo, J; Gao, X; Zeng, YX; Chen, B; Zhou, BC; Zhang, YZ				Xie, Bin-Bin; Bian, Fei; Chen, Xiu-Lan; He, Hai-Lun; Guo, Jun; Gao, Xiang; Zeng, Yin-Xin; Chen, Bo; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Cold Adaptation of Zinc Metalloproteases in the Thermolysin Family from Deep Sea and Arctic Sea Ice Bacteria Revealed by Catalytic and Structural Properties and Molecular Dynamics NEW INSIGHTS INTO RELATIONSHIP BETWEEN CONFORMATIONAL FLEXIBILITY AND HYDROGEN BONDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; PSYCHROPHILIC ENZYMES; ACTIVE ENZYME; SEQUENCE; TEMPERATURES; STABILITY; STRATEGY; PROTEASE; STRAIN	Increased conformational flexibility is the prevailing explanation for the high catalytic efficiency of cold-adapted enzymes at low temperatures. However, less is known about the structural determinants of flexibility. We reported two novel cold-adapted zinc metalloproteases in the thermolysin family, vibriolysin MCP-02 from a deep sea bacterium and vibriolysin E495 from an Arctic sea ice bacterium, and compared them with their mesophilic homolog, pseudolysin from a terrestrial bacterium. Their catalytic efficiencies, k(cat)/K-m (10-40 degrees C), followed the order pseudolysin < MCP-02 < E495 with a ratio of similar to 1:2:4. MCP-02 and E495 have the same optimal temperature (T-opt, 57 degrees C, 5 degrees C lower than pseudolysin) and apparent melting temperature (T-m = 64 degrees C, similar to 10 degrees C lower than pseudolysin). Structural analysis showed that the slightly lower stabilities resulted from a decrease in the number of salt bridges. Fluorescence quenching experiments and molecular dynamics simulations showed that the flexibilities of the proteins were pseudolysin < MCP-02 < E495, suggesting that optimization of flexibility is a strategy for cold adaptation. Molecular dynamics results showed that the ordinal increase in flexibility from pseudolysin to MCP-02 and E495, especially the increase from MCP-02 to E495, mainly resulted from the decrease of hydrogen-bond stability in the dynamic structure, which was due to the increase in asparagine, serine, and threonine residues. Finally, a model for the cold adaptation of MCP-02 and E495 was proposed. This is the first report of the optimization of hydrogen-bonding dynamics as a strategy for cold adaptation and provides new insights into the structural basis underlying conformational flexibility.	[Xie, Bin-Bin; Bian, Fei; Chen, Xiu-Lan; He, Hai-Lun; Guo, Jun; Gao, Xiang; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zeng, Yin-Xin; Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai 200136, Peoples R China	Shandong University; Polar Research Institute of China	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn						Adekoya OA, 2006, PROTEINS, V62, P435, DOI 10.1002/prot.20773; Aghajari N, 2003, PROTEINS, V50, P636, DOI 10.1002/prot.10264; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; BARRETT AJ, 2004, HDB PROTEOLYTIC ENZY, P374; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brandsdal BO, 2001, FEBS LETT, V499, P171, DOI 10.1016/S0014-5793(01)02552-2; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Chessa JP, 2000, BBA-PROTEIN STRUCT M, V1479, P265, DOI 10.1016/S0167-4838(00)00018-2; Collins T, 2003, J MOL BIOL, V328, P419, DOI 10.1016/S0022-2836(03)00287-0; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEDER J, 1968, BIOCHEM BIOPH RES CO, V32, P326, DOI 10.1016/0006-291X(68)90389-6; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Moe E, 2004, J MOL BIOL, V343, P1221, DOI 10.1016/j.jmb.2004.09.004; Olufsen M, 2005, J BIOL CHEM, V280, P18042, DOI 10.1074/jbc.M500948200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Svingor A, 2001, J BIOL CHEM, V276, P28121, DOI 10.1074/jbc.M104432200; THAYER MM, 1991, J BIOL CHEM, V266, P2864; TRONRUD DE, 1986, EUR J BIOCHEM, V157, P261, DOI 10.1111/j.1432-1033.1986.tb09664.x; Wintrode PL, 2000, J BIOL CHEM, V275, P31635, DOI 10.1074/jbc.M004503200; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003	44	57	61	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9257	9269		10.1074/jbc.M808421200	http://dx.doi.org/10.1074/jbc.M808421200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181663	hybrid, Green Published			2022-12-25	WOS:000264669100032
J	Agne, B; Infanger, S; Wang, F; Hofstetter, V; Rahim, G; Martin, M; Lee, DW; Hwang, I; Schnell, D; Kessler, F				Agne, Birgit; Infanger, Sibylle; Wang, Fei; Hofstetter, Valere; Rahim, Gwendoline; Martin, Meryll; Lee, Dong Wook; Hwang, Inhwan; Schnell, Danny; Kessler, Felix			A Toc159 Import Receptor Mutant, Defective in Hydrolysis of GTP, Supports Preprotein Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; ARABIDOPSIS CHLOROPLASTS; OUTER-MEMBRANE; ATTOC159; TRANSLOCON; PLASTIDS; FAMILY; DOMAIN; DIMERIZATION; BIOGENESIS	The heterotrimeric Toc core complex of the chloroplast protein import apparatus contains two GTPases, Toc159 and Toc34, together with the protein-conducting channel Toc75. Toc159 and Toc34 are exposed at the chloroplast surface and function in preprotein recognition. Together, they have been shown to facilitate the import of photosynthetic proteins into chloroplasts in Arabidopsis. Consequently, the ppi2 mutant lacking at Toc159 has a non-photosynthetic albino phenotype. Previous mutations in the conserved G1 and G3 GTPase motifs abolished the function of Toc159 in vivo by disrupting targeting of the receptor to chloroplasts. Here, we demonstrate that a mutant in a conserved G1 lysine (atToc159 K868R) defective in GTP binding and hydrolysis can target and assemble into Toc complexes. We show that atToc159 K868R can support protein import into isolated chloroplasts, albeit at lower preprotein binding and import efficiencies compared with the wild-type receptor. Considering the absence of measurable GTPase activity in the K868R mutant, we conclude that GTP hydrolysis at atToc159 is not strictly required for preprotein translocation. The data also indicate that preprotein import requires at least one additional GTPase other than Toc159.	[Kessler, Felix] Univ Neuchatel, Lab Physiol Vegetale, CH-2007 Neuchatel, Switzerland; [Wang, Fei; Schnell, Danny] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wang, Fei; Schnell, Danny] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Lee, Dong Wook; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	University of Neuchatel; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Pohang University of Science & Technology (POSTECH)	Kessler, F (corresponding author), Univ Neuchatel, Lab Physiol Vegetale, Rue Emile Argand 11, CH-2009 Neuchatel, Switzerland.	felix.kessler@unine.ch		Kessler, Felix/0000-0001-6409-5043	National Institutes of Health [GM61893]; Grant Crop Functional Genomics Research Center [M107KG010003-07K0701-00330]; Ministry of Education, Science, and Technology, Korea; Swiss National Science Foundation [3100A0-109667]; University of Neuchatel; National Centre of Competence in Research (NCCR) Plant Survival; research program of the Swiss National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Crop Functional Genomics Research Center; Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Neuchatel; National Centre of Competence in Research (NCCR) Plant Survival(Swiss National Science Foundation (SNSF)); research program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61893 (to D.J.S.). This work was also supported by Grant Crop Functional Genomics Research Center (M107KG010003-07K0701-00330), Ministry of Education, Science, and Technology, Korea (to I. H.), the Swiss National Science Foundation (3100A0-109667), the University of Neuchatel, and the National Centre of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S. C. Section 1734 solely to indicate this fact.	Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Hiltbrunner A, 2001, BIOCHEM CELL BIOL, V79, P629, DOI 10.1139/bcb-79-5-629; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200	35	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8661	8670		10.1074/jbc.M804235200	http://dx.doi.org/10.1074/jbc.M804235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19188370	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000264397800051
J	Ahn, S; Kim, J; Hara, MR; Ren, XR; Lefkowitz, RJ				Ahn, Seungkirl; Kim, Jihee; Hara, Makoto R.; Ren, Xiu-Rong; Lefkowitz, Robert J.			beta-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RIBOSOMAL S6 KINASE; BETA-ARRESTIN; ANGIOTENSIN-II; CELL-SURVIVAL; AKT PHOSPHORYLATION; ERK1/2 ACTIVATION; DEATH; MITOCHONDRIA; TRANSCRIPTION	beta-Arrestins, originally discovered as terminators of G protein-coupled receptor signaling, have more recently been appreciated to also function as signal transducers in their own right, although the consequences for cellular physiology have not been well understood. Here we demonstrate that beta-arrestin-2 mediates anti-apoptotic cytoprotective signaling stimulated by a typical 7-transmembrane receptor the angiotensin ATII 1A receptor, expressed endogenously in rat vascular smooth muscle cells or by transfection in HEK-293 cells. Receptor stimulation leads to concerted activation of two pathways, ERK/p90RSK and PI3K/AKT, which converge to phosphorylate and inactivate the pro-apoptotic protein BAD. Anti-apoptotic effects as well as pathway activities can be stimulated by an angiotensin analog (SII), which has been previously shown to activate beta-arrestin but not G protein-dependent signaling, and are abrogated by beta-arrestin-2 small interfering RNA. These findings establish a key role for beta-arrestin-2 in mediating cellular cytoprotective functions by a 7-transmembrane receptor and define the biochemical pathways involved.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R37HL016037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Archacki SR, 2003, PHYSIOL GENOMICS, V15, P65, DOI 10.1152/physiolgenomics.00181.2002; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DEL PL, 1997, SCIENCE, V278, P687; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Korshunov VA, 2008, CURR OPIN HEMATOL, V15, P250, DOI 10.1097/MOH.0b013e3282f97d71; Lee KW, 2008, CANCER RES, V68, P1916, DOI 10.1158/0008-5472.CAN-07-3195; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XP, 2005, CANCER RES, V65, P7338, DOI 10.1158/0008-5472.CAN-04-2263; Zhao M, 2004, J BIOL CHEM, V279, P49259, DOI 10.1074/jbc.M405118200	50	122	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8846	8856		10.1074/jbc.M808463200	http://dx.doi.org/10.1074/jbc.M808463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171933	hybrid, Green Published			2022-12-25	WOS:000264397800068
J	Bafna, PA; Jha, A; Auerbach, A				Bafna, Pallavi A.; Jha, Archana; Auerbach, Anthony			Aromatic Residues epsilon Trp-55 and delta Trp-57 and the Activation of Acetylcholine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN INTERFACE; LIGAND-BINDING DOMAIN; GATED ION-CHANNEL; X-RAY-STRUCTURE; AGONIST BINDING; CYS-LOOP; EXTRACELLULAR DOMAIN; GAMMA-SUBUNIT; AFFINITY; SITE	The two transmitter binding sites of the neuromuscular acetylcholine (ACh) receptor channel contain several aromatic residues, including a tryptophan located on the complementary, negative face of each binding pocket. These two residues, Trp-55 in the epsilon subunit and Trp-57 in the delta subunit, were mutated (AEFHILRVY), and for most constructs the rate constants for acetylcholine binding and channel gating were estimated by using single channel kinetic analyses. The rate constants for unliganded channel opening and closing were also estimated for some mutants. From these measurements we calculated all of the equilibrium constants of the "allosteric" cycle as follows: diliganded gating, unliganded gating, dissociation from the C(losed) conformation, and dissociation from the O(pen) conformation. The results indicate the following. (i) These aromatic side chains play a relatively minor role in ACh receptor channel activation. (ii) The main consequence of mutations is to reduce the affinity of the O conformation of the binding site for ACh, with the effect being greater at the epsilon subunit. (iii) In epsilon (but not delta) the aromatic nature of the side chain is important in determining affinity, to a slightly greater degree in the O conformation. Phi value analyses (of both tryptophan residues) show Phi similar to 1 for both the ACh binding and diliganded gating reactions. (iv) This suggests that the structural boundaries of the dynamic elements of the gating conformational change may not be subunit-delimited, and (v) the mutated tryptophan residues experience energy changes that occur relatively early in both the ligand-binding and channel-gating reactions.	[Bafna, Pallavi A.; Jha, Archana; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu	jha, archana/AAQ-2120-2020		National Institutes of Health [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-23513. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chiara DC, 1998, FEBS LETT, V423, P223, DOI 10.1016/S0014-5793(98)00093-3; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 1977, Methods Enzymol, V46, P582; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li LT, 2001, CHEM BIOL, V8, P47, DOI 10.1016/S1074-5521(00)00055-7; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Stewart DS, 2006, BIOCHEMISTRY-US, V45, P10641, DOI 10.1021/bi060686t; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Yan D, 1999, J BIOL CHEM, V274, P5537, DOI 10.1074/jbc.274.9.5537; ZHANG YN, 1995, J PHYSIOL-LONDON, V486, P189, DOI 10.1113/jphysiol.1995.sp020802; ZHOU M, 1999, THESIS STATE U NEW Y; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	39	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8582	8588		10.1074/jbc.M807152200	http://dx.doi.org/10.1074/jbc.M807152200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171937	hybrid, Green Published			2022-12-25	WOS:000264397800042
J	Liu, J; Fujisawa, M; Hicks, DB; Krulwich, TA				Liu, Jun; Fujisawa, Makoto; Hicks, David B.; Krulwich, Terry A.			Characterization of the Functionally Critical AXAXAXA and PXXEXXP Motifs of the ATP Synthase c-Subunit from an Alkaliphilic Bacillus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL ENERGY-CONVERSION; SP STRAIN TA2.A1; ESCHERICHIA-COLI; FIRMUS OF4; F1F0-ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; MOLECULAR ARCHITECTURE; ADENOSINE-TRIPHOSPHATE; PROTON TRANSLOCATION; NA+/H+ ANTIPORTER	The membrane-embedded rotor in the F-0 sector of proton-translocating ATP synthases is formed from hairpin-like c-subunits that are protonated and deprotonated during energization of ATP synthesis. This study focuses on two c-subunit motifs that are unique to synthases of extremely alkaliphilic Bacillus species. One motif is the AXAXAXA sequence found in the N-terminal helix-1 instead of the GXGXGXG of non-alkaliphiles. Quadruple A -> G chromosomal mutants of alkaliphilic Bacillus pseudofirmus OF4 retain 50% of the wild-type hydrolytic activity (ATPase) but <18% of the ATP synthase capacity at high pH. Consistent with a structural impact of the four alanine replacements, the mutant ATPase activity showed enhanced inhibition by dicyclohexylcarbodiimide, which blocks the helix-2 carboxylate. Single, double, or triple A -> G mutants exhibited more modest defects, as monitored by malate growth. The key carboxylate is in the second motif, which is (PXXEXXP)-X-51-X-54 in extreme alkaliphiles instead of the (A/G) XX(E/D) XXP found elsewhere. Mutation of Pro(51) to alanine had been shown to severely reduce malate growth and ATP synthesis at high pH. Here, two Pro51 to glycine mutants of different severities retained ATP synthase capacity but exhibited growth deficits and proton leakiness. A Glu(54) to Asp(54) change increased proton leakiness and reduced malate growth 79-90%. The Pro(51) and the Glu(54) mutants were both more dicyclohexylcarbodiimide-sensitive than wild type. The results highlight the requirement for c-subunit adaptations to achieve alkaliphile ATP synthesis with minimal cytoplasmic proton loss and suggest partial suppression of some mutations by changes outside the atp operon.	[Liu, Jun; Fujisawa, Makoto; Hicks, David B.; Krulwich, Terry A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Krulwich, TA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl, New York, NY 10029 USA.	terry.krulwich@mssm.edu			National Institutes of Health [GM28454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 (to T. A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Arechaga I, 2001, FEBS LETT, V494, P1, DOI 10.1016/S0014-5793(01)02300-6; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; GUFFANTI AA, 1994, J BIOL CHEM, V269, P21576; GUFFANTI AA, 1991, J GEN MICROBIOL, V137, P2375, DOI 10.1099/00221287-137-10-2375; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; HICKS DB, 1990, J BIOL CHEM, V265, P20547; HOPPE J, 1980, EUR J BIOCHEM, V112, P17, DOI 10.1111/j.1432-1033.1980.tb04981.x; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; IVEY DM, 1991, MOL GEN GENET, V229, P292, DOI 10.1007/BF00272169; IVEY DM, 1992, RES MICROBIOL, V143, P467, DOI 10.1016/0923-2508(92)90092-3; Kosono S, 2004, FEMS MICROBIOL LETT, V232, P93, DOI 10.1016/S0378-1097(04)00037-0; Krulwich TA, 1997, EXTREMOPHILES, V1, P163, DOI 10.1007/s007920050030; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; KRULWICH TA, 1985, J BIOL CHEM, V260, P4055; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; Liu XY, 2007, BIOCHEMISTRY-US, V46, P306, DOI 10.1021/bi0619167; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P913, DOI 10.1016/j.bbabio.2006.02.015; Mulkidjanian AY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P251, DOI 10.1007/s10541-005-0108-1; Olsson K, 2003, J BACTERIOL, V185, P461, DOI 10.1128/JB.185.2.461-465.2003; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Rivera-Torres IO, 2004, FEBS LETT, V575, P131, DOI 10.1016/j.febslet.2004.08.049; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; Valiyaveetil F, 2002, BBA-BIOENERGETICS, V1553, P296, DOI 10.1016/S0005-2728(01)00251-1; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	54	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8714	8725		10.1074/jbc.M808738200	http://dx.doi.org/10.1074/jbc.M808738200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176524	Green Published, hybrid			2022-12-25	WOS:000264397800055
J	Galvez, BG; San Martin, N; Rodriguez, C				Galvez, Beatriz G.; San Martin, Nuria; Rodriguez, Carlos			TNF-alpha Is Required for the Attraction of Mesenchymal Precursors to White Adipose Tissue in Ob/ob Mice	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; INFLAMMATION; DELIVERY; OBESITY; LUNG	Most adult tissues harbour a stem cell subpopulation (Mesenchymal Precursors or MPs) that represent a small proportion of the total cell number and have the potential to differentiate into several cell types within the mesenchymal lineage. In adipose tissue, adipocytes account for two-thirds of the total cell number. The remaining cells include blood and endothelial cells, along with adipocyte precursors (adipose MPs). Obesity is defined as an excess of body fat that frequently results in a significant impairment of health. The ob/ob mice bear a mutation in the ob gene that causes a deficiency in the hormone leptin and hence obesity. Here, we present evidence that ob/ob mice have a dramatic decrease in the resident MP pool of several tissues, including squeletal muscle, heart, lung and adipose tissue. Moreover, we show that that there is a migration of MP cells from distant organs, as well as homing of these cells to the adipose tissue mass of the ob/ob mice. We call this process adipotaxis. Once in the adipose tissue, migrant MPs undergoe adipose differentiation, giving rise to new differentiated adipocytes within the adipose mass. Finally, we provide evidence that adipotaxis is largely explained by the production of high levels of Tumor Necrosis Factor-alpha (TNF-alpha) within the ob/ob adipose tissue. The therapeutic implications for human obesity as well as for regenerative medicine are further discussed in this paper.	[Galvez, Beatriz G.; San Martin, Nuria; Rodriguez, Carlos] Projech Sci Technol, Madrid, Spain		Galvez, BG (corresponding author), Projech Sci Technol, Madrid, Spain.	carlosr@projech.com	Gálvez, Beatriz G./H-1644-2015	Gálvez, Beatriz G./0000-0002-8082-9323; rodriguez, carlos/0000-0001-9593-8680	Spanish Ministry of Education [CIT-090100-2007-05, CEI-010000-2007-11]	Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Education (Profit: CIT-090100-2007-05 and CEIPAR: CEI-010000-2007-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Dundas SR, 2001, J HISTOCHEM CYTOCHEM, V49, P1321, DOI 10.1177/002215540104901015; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Kathryn E., 2003, J CLIN INVEST, V112, P1785; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KIMBER I, 1992, J INVEST DERMATOL, V99, pS48, DOI 10.1111/1523-1747.ep12668986; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu XF, 2008, MOL REPROD DEV, V75, P1426, DOI 10.1002/mrd.20867; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	21	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4444	10.1371/journal.pone.0004444	http://dx.doi.org/10.1371/journal.pone.0004444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214223	Green Submitted, gold, Green Published			2022-12-25	WOS:000265484300003
J	Ducros, M; Moreaux, L; Bradley, J; Tiret, P; Griesbeck, O; Charpak, S				Ducros, Mathieu; Moreaux, Laurent; Bradley, Jonathan; Tiret, Pascale; Griesbeck, Oliver; Charpak, Serge			Spectral Unmixing: Analysis of Performance in the Olfactory Bulb In Vivo	PLOS ONE			English	Article							EXCITATION CROSS-SECTIONS; FLUORESCENT PROTEINS; MICROSCOPY; ABSORPTION; EXPRESSION; VARIANTS; CFP; PH	Background: The generation of transgenic mice expressing combinations of fluorescent proteins has greatly aided the reporting of activity and identification of specific neuronal populations. Methods capable of separating multiple overlapping fluorescence emission spectra, deep in the living brain, with high sensitivity and temporal resolution are therefore required. Here, we investigate to what extent spectral unmixing addresses these issues. Methodology/Principal Findings: Using fluorescence resonance energy transfer (FRET)-based reporters, and two-photon laser scanning microscopy with synchronous multichannel detection, we report that spectral unmixing consistently improved FRET signal amplitude, both in vitro and in vivo. Our approach allows us to detect odor-evoked FRET transients 180-250 mm deep in the brain, the first demonstration of in vivo spectral imaging and unmixing of FRET signals at depths greater than a few tens of micrometer. Furthermore, we determine the reporter efficiency threshold for which FRET detection is improved by spectral unmixing. Conclusions/Significance: Our method allows the detection of small spectral variations in depth in the living brain, which is essential for imaging efficiently transgenic animals expressing combination of multiple fluorescent proteins.	[Ducros, Mathieu; Moreaux, Laurent; Tiret, Pascale; Charpak, Serge] INSERM, U603, Paris, France; [Ducros, Mathieu; Moreaux, Laurent; Tiret, Pascale; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Ducros, Mathieu; Moreaux, Laurent; Bradley, Jonathan; Tiret, Pascale; Charpak, Serge] Univ Paris 05, Paris, France; [Bradley, Jonathan] CNRS, UMR 8118, Paris, France; [Griesbeck, Oliver] Max Planck Inst Neurobiol, Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	Ducros, M (corresponding author), INSERM, U603, Paris, France.	serge.charpak@univ-paris5.fr	Charpak, Serge/M-9412-2017; Ducros, Mathieu/Q-6663-2017	Ducros, Mathieu/0000-0002-7625-036X; Bradley, Jonathan/0000-0002-6933-1153; Griesbeck, Oliver/0000-0001-5883-5594	Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT) [ACI NIC0025, ACI IBPC:DRAB 042492]; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM) [ICP20001222128, ACE20071110945]; Region Ile de France (Sesame program); Fondation Bettancourt Schueller; Human frontier science program organisation (HSFPO); Ecole des Neurosciences Paris Ile-de-France (ENP); Association Francaise contre les Myopathies [12411]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Ile de France (Sesame program)(Region Ile-de-France); Fondation Bettancourt Schueller; Human frontier science program organisation (HSFPO)(Human Frontier Science Program); Ecole des Neurosciences Paris Ile-de-France (ENP); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	Financial support was provided by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT, ACI NIC0025 and ACI IBPC:DRAB 042492), the Centre National de la Recherche Scientifique (CNRS), the Fondation pour la Recherche Medicale (FRM; ICP20001222128, ACE20071110945), the Region Ile de France (Sesame program), the Fondation Bettancourt Schueller, the Human frontier science program organisation (HSFPO), Ecole des Neurosciences Paris Ile-de-France (ENP). Pascale Tiret was supported by a fellowship from the Association Francaise contre les Myopathies (12411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Buehler C, 2005, J FLUORESC, V15, P41, DOI 10.1007/s10895-005-0212-z; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; CHEONG WF, 1995, OPTICAL THERMAL RESP, P8; DAVIES LM, 2007, P SPIE, V6443; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Ecker RC, 2004, CYTOM PART A, V59A, P172, DOI 10.1002/cyto.a.20053; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Green RO, 1998, REMOTE SENS ENVIRON, V65, P227, DOI 10.1016/S0034-4257(98)00064-9; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Haraguchi T, 2002, GENES CELLS, V7, P881, DOI 10.1046/j.1365-2443.2002.00575.x; Harris AT, 2006, CYTOM PART A, V69A, P872, DOI 10.1002/cyto.a.20309; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Hiraoka Y, 1991, Semin Cell Biol, V2, P153; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Kasparov S, 2002, EXP PHYSIOL, V87, P715, DOI 10.1113/eph8702480; Lansford R, 2001, J BIOMED OPT, V6, P311, DOI 10.1117/1.1383780; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; MANK M, 2008, NAT METHODS; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nadrigny F, 2006, EUR BIOPHYS J BIOPHY, V35, P533, DOI 10.1007/s00249-005-0040-8; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shimozono S, 2008, METHOD CELL BIOL, V85, P381, DOI 10.1016/S0091-679X(08)85016-9; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Tay LH, 2007, BIOPHYS J, V93, P4031, DOI 10.1529/biophysj.107.109629; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2006, CYTOM PART A, V69A, P904, DOI 10.1002/cyto.a.20267; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wachman ES, 1997, BIOPHYS J, V73, P1215, DOI 10.1016/S0006-3495(97)78154-2; WALLACE DJ, 2008, NAT METHODS; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zimmermann A, 2002, PHOTOCHEM PHOTOBIOL, V75, P335, DOI 10.1562/0031-8655(2002)075<0335:IVIOTP>2.0.CO;2; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zucker RM, 2007, CYTOM PART A, V71A, P174, DOI 10.1002/cyto.a.20371	48	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4418	10.1371/journal.pone.0004418	http://dx.doi.org/10.1371/journal.pone.0004418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198655	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483900015
J	Olmstead, MC; Ouagazzal, AM; Kieffer, BL				Olmstead, Mary C.; Ouagazzal, Abdel-Mouttalib; Kieffer, Brigitte L.			Mu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; COCAINE; HEROIN; ETHANOL; MICE; PERFORMANCE; WITHDRAWAL; DEPENDENCE; ALCOHOL; NEURONS	Impulsivity is a primary feature of many psychiatric disorders, most notably attention deficit hyperactivity disorder and drug addiction. Impulsivity includes a number of processes such as the inability to delay gratification, the inability to withhold a motor response, or acting before all of the relevant information is available. These processes are mediated by neural systems that include dopamine, serotonin, norepinephrine, glutamate and cannabinoids. We examine, for the first time, the role of opioid systems in impulsivity by testing whether inactivation of the mu- (Oprm1) or delta- (Oprd1) opioid receptor gene alters motor impulsivity in mice. Wild-type and knockout mice were examined on either a pure C57BL6/J (BL6) or a hybrid 50% C57Bl/6J-50% 129Sv/pas (HYB) background. Mice were trained to respond for sucrose in a signaled nose poke task that provides independent measures of associative learning ( responses to the reward-paired cue) and motor impulsivity (premature responses). Oprm1 knockout mice displayed a remarkable decrease in motor impulsivity. This was observed on the two genetic backgrounds and did not result from impaired associative learning, as responses to the cue signaling reward did not differ across genotypes. Furthermore, mutant mice were insensitive to the effects of ethanol, which increased disinhibition and decreased conditioned responding in wild-type mice. In sharp contrast, mice lacking the Oprd1 gene were more impulsive than controls. Again, mutant animals showed no deficit in associative learning. Ethanol completely disrupted performance in these animals. Together, our results suggest that mu- opioid receptors enhance, whereas delta- opioid receptors inhibit, motor impulsivity. This reveals an unanticipated contribution of endogenous opioid receptor activity to disinhibition. In a broader context, these data suggest that alterations in mu- or delta- opioid receptor function may contribute to impulse control disorders.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Ouagazzal, Abdel-Mouttalib; Kieffer, Brigitte L.] Inst Genet Biol Mol Cellulaire, Dept Neurobiol, Illkirch Graffenstaden, France	Queens University - Canada; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Olmstead, MC (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	olmstead@queensu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); the Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Louis Pasteur (ULP); National Institute of Drug Abuse (NIH-NIDA) [DA 05010]; European Consortium GENADDICT [LSHM-CT-2004-005166]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Louis Pasteur (ULP); National Institute of Drug Abuse (NIH-NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); European Consortium GENADDICT	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Louis Pasteur (ULP), the National Institute of Drug Abuse (NIH-NIDA #DA 05010) and the European Consortium GENADDICT # LSHM-CT-2004-005166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Bowers BJ, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-21-j0004.2001; Chefer VI, 2003, EUR J NEUROSCI, V18, P1915, DOI 10.1046/j.1460-9568.2003.02912.x; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Contet C, 2004, CURR OPIN NEUROBIOL, V14, P370, DOI 10.1016/j.conb.2004.05.005; CRITCHLOW B, 1986, AM PSYCHOL, V41, P751, DOI 10.1037/0003-066X.41.7.751; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Ghozland S, 2002, J NEUROSCI, V22, P1146, DOI 10.1523/JNEUROSCI.22-03-01146.2002; Isles AR, 2004, J NEUROSCI, V24, P6733, DOI 10.1523/JNEUROSCI.1650-04.2004; JOB MO, 2007, BIOL PSYCHI IN PRESS; Keller JJ, 2005, BEHAV BRAIN RES, V162, P143, DOI 10.1016/j.bbr.2005.03.004; Kim SW, 1998, J CLIN PSYCHIAT, V59, P159; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Lee TM, 2002, BRAIN INJURY, V16, P885, DOI 10.1080/02699050210128915; LINNOILA M, 1993, INT CLIN PSYCHOPHARM, V8, P53, DOI 10.1097/00004850-199309001-00008; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mitchell JM, 2007, NEUROPSYCHOPHARMACOL, V32, P439, DOI 10.1038/sj.npp.1301226; Moeller FG, 2002, DRUG ALCOHOL DEPEN, V68, P105; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Papaleo F, 2007, EUR J NEUROSCI, V25, P3398, DOI 10.1111/j.1460-9568.2007.05595.x; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; PATTIJ T, 2008, TRENDS PHAR IN PRESS; Pau CWH, 2002, ARCH CLIN NEUROPSYCH, V17, P663, DOI 10.1016/S0887-6177(01)00169-X; PLIAKAS AM, 2005, BIOL PSYCHIAT, V57, P1385; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SANCHISSEGURA C, 2006, ADDICT BIOL, V11, P38; Schmidt P, 2001, FORENSIC SCI INT, V115, P219, DOI 10.1016/S0379-0738(00)00333-9; Sharpe LG, 2000, SYNAPSE, V37, P292, DOI 10.1002/1098-2396(20000915)37:4<292::AID-SYN6>3.0.CO;2-V; Shen KZ, 2002, J PHYSIOL-LONDON, V541, P219, DOI 10.1113/jphysiol.2001.013404; Tien LT, 2003, BRAIN RES BULL, V61, P109, DOI 10.1016/S0361-9230(03)00077-7; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Witkowski G, 2006, BRAIN RES, V1094, P92, DOI 10.1016/j.brainres.2006.03.119	43	74	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4410	10.1371/journal.pone.0004410	http://dx.doi.org/10.1371/journal.pone.0004410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JN	19198656	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483900011
J	Thompson, D; Batterham, AM; Markovitch, D; Dixon, NC; Lund, AJS; Walhin, JP				Thompson, Dylan; Batterham, Alan M.; Markovitch, Daniella; Dixon, Natalie C.; Lund, Adam J. S.; Walhin, Jean-Philippe			Confusion and Conflict in Assessing the Physical Activity Status of Middle-Aged	PLOS ONE			English	Article							OF-SPORTS-MEDICINE; POSTPRANDIAL LIPEMIA; SEDENTARY ADULTS; PUBLIC-HEALTH; UNITED-STATES; HEART-RATE; ENERGY-EXPENDITURE; ACTIVITY PATTERNS; EXERCISE; RECOMMENDATION	Background: Physical activity (including exercise) is prescribed for health and there are various recommendations that can be used to gauge physical activity status. The objective of the current study was to determine whether twelve commonly-used physical activity recommendations similarly classified middle-aged men as sufficiently active for general health. Methods and Findings: We examined the commonality in the classification of physical activity status between twelve variations of physical activity recommendations for general health in ninety men aged 45-64 years. Physical activity was assessed using synchronised accelerometry and heart rate. Using different guidelines but the same raw data, the proportion of men defined as active ranged from to 11% to 98% for individual recommendations (median 73%, IQR 30% to 87%). There was very poor absolute agreement between the recommendations, with an intraclass correlation coefficient (A, 1) of 0.24 (95% CI, 0.15 to 0.34). Only 8% of men met all 12 recommendations and would therefore be unanimously classified as active and only one man failed to meet every recommendation and would therefore be unanimously classified as not sufficiently active. The wide variability in physical activity classification was explained by ostensibly subtle differences between the 12 recommendations for thresholds related to activity volume (time or energy), distribution (e. g., number of days of the week), moderate intensity cut-point (e. g., 3 vs. 4 metabolic equivalents or METs), and duration (including bout length). Conclusions: Physical activity status varies enormously depending on the physical activity recommendation that is applied and even ostensibly small differences have a major impact. Approximately nine out of every ten men in the present study could be variably described as either active or not sufficiently active. Either the effective dose or prescription that underlies each physical activity recommendation is different or each recommendation is seeking the same prescriptive outcome but with variable success.	[Thompson, Dylan; Markovitch, Daniella; Dixon, Natalie C.; Lund, Adam J. S.; Walhin, Jean-Philippe] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Batterham, Alan M.] Univ Teesside, Hlth & Social Care Inst, Middlesbrough TS1 3BA, Cleveland, England	University of Bath; University of Teesside	Thompson, D (corresponding author), Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England.	d.thompson@bath.ac.uk	thompson, dylan/C-2478-2009	BATTERHAM, ALAN/0000-0002-7865-7227; Thompson, Dylan/0000-0002-6312-1518	ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		*AM COLL SPORTS ME, 2008, EX MED CALL EV PHYS; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; *BRIT HEART FDN, 2007, BEAT HEART DIS TOG G; Brooks GA, 2004, AM J CLIN NUTR, V79, P921; Centers for Disease Control and Prevention, 2008, PHYS ACT EV REC; Coleman KJ, 1999, PREV MED, V28, P510, DOI 10.1006/pmed.1998.0471; COOKSEY D, 2006, HM TREASURY; CROUTER SE, 2007, EUROPEAN J CLIN NUTR; DALEY AJ, 2008, DOCT MUCH PHYS ACT S; Department of Health, 2004, LEAST 5 WEEK EV IMP; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Healy GN, 2006, DIABETES CARE, V29, P2598, DOI 10.2337/dc06-0313; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Institute of Medicine, 2005, DIET REF INT EN CARB; KING DS, 1995, J APPL PHYSIOL, V78, P17, DOI 10.1152/jappl.1995.78.1.17; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P1209; Kruger J, 2008, JAMA-J AM MED ASSOC, V299, P30; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; Lynch BM, 2007, ANN BEHAV MED, V34, P135, DOI 10.1007/BF02872668; Macfarlane DJ, 2006, PREV MED, V43, P332, DOI 10.1016/j.ypmed.2006.06.002; MAYOR S, 2008, BRIT MED J, V336, P576; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Miyashita M, 2006, AM J CLIN NUTR, V83, P24; National Centre for Social Research, 2004, HLTH SURV ENGL 2003; National Health Service, 2006, GEN PRACT PHYS ACT Q; National Institute for Health and Clinical Excellence, 2006, NICE PUBL HLTH INT G; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Phongsavan P, 2007, PSYCHOL SPORT EXERC, V8, P939, DOI 10.1016/j.psychsport.2006.11.004; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Ramirez-Zea M, 2005, PUBLIC HEALTH NUTR, V8, P1213, DOI 10.1079/PHN2005807; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tully MA, 2007, J EPIDEMIOL COMMUN H, V61, P778, DOI 10.1136/jech.2006.053058; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; *WHO, 2007, GLOB STRAT DIET PHYS	47	40	41	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4337	10.1371/journal.pone.0004337	http://dx.doi.org/10.1371/journal.pone.0004337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JI	19183812	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483200011
J	Bartolomucci, A; Cabassi, A; Govoni, P; Ceresini, G; Cero, C; Berra, D; Dadomo, H; Franceschini, P; Dell'Omo, G; Parmigiani, S; Palanza, P				Bartolomucci, Alessandro; Cabassi, Aderville; Govoni, Paolo; Ceresini, Graziano; Cero, Cheryl; Berra, Daniela; Dadomo, Harold; Franceschini, Paolo; Dell'Omo, Giacomo; Parmigiani, Stefano; Palanza, Paola			Metabolic Consequences and Vulnerability to Diet-Induced Obesity in Male Mice under Chronic Social Stress	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BODY-MASS; PSYCHOSOCIAL STRESS; FOOD-INTAKE; TYROSINE-HYDROXYLASE; CORTISOL SECRETION; ABDOMINAL OBESITY; GENE-EXPRESSION; NEUROPEPTIDE-Y; ANIMAL-MODELS	Social and psychological factors interact with genetic predisposition and dietary habit in determining obesity. However, relatively few pre-clinical studies address the role of psychosocial factors in metabolic disorders. Previous studies from our laboratory demonstrated in male mice: 1) opposite status-dependent effect on body weight gain under chronic psychosocial stress; 2) a reduction in body weight in individually housed (Ind) male mice. In the present study these observations were extended to provide a comprehensive characterization of the metabolic consequences of chronic psychosocial stress and individual housing in adult CD-1 male mice. Results confirmed that in mice fed standard diet, dominant (Dom) and Ind had a negative energy balance while subordinate (Sub) had a positive energy balance. Locomotor activity was depressed in Sub and enhanced in Dom. Hyperphagia emerged for Dom and Sub and hypophagia for Ind. Dom also showed a consistent decrease of visceral fat pads weight as well as increased norepinephrine concentration and smaller adipocytes diameter in the perigonadal fat pad. On the contrary, under high fat diet Sub and, surprisingly, Ind showed higher while Dom showed lower vulnerability to obesity associated with hyperphagia. In conclusion, we demonstrated that social status under chronic stress and individual housing deeply affect mice metabolic functions in different, sometime opposite, directions. Food intake, the hedonic response to palatable food as well as the locomotor activity and the sympathetic activation within the adipose fat pads all represent causal factors explaining the different metabolic alterations observed. Overall this study demonstrates that pre-clinical animal models offer a suitable tool for the investigation of the metabolic consequences of chronic stress exposure and associated psychopathologies.	[Bartolomucci, Alessandro; Cero, Cheryl; Berra, Daniela; Dadomo, Harold; Franceschini, Paolo; Parmigiani, Stefano; Palanza, Paola] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Cabassi, Aderville] Univ Parma, Dept Internal Med Nephrol & Hlth Sci, I-43100 Parma, Italy; [Govoni, Paolo] Univ Parma, Dept Expt Med, I-43100 Parma, Italy; [Ceresini, Graziano] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy	University of Parma; University of Parma; University of Parma; University of Parma	Bartolomucci, A (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy.	alessandro.bartolomucci@unipr.it	dadomo, harold/GQP-4815-2022	Cero, Cheryl/0000-0003-0513-8669; Dell'Omo, Giacomo/0000-0002-9601-9675; PARMIGIANI, STEFANO/0000-0002-6658-2029	University of Parma	University of Parma	Supported by The University of Parma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baran SE, 2005, NEUROREPORT, V16, P39, DOI 10.1097/00001756-200501190-00010; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; BARTNESS TJ, 1989, AM J PHYSIOL, V257, pR1533, DOI 10.1152/ajpregu.1989.257.6.R1533; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; Bartolomucci A, 2005, MED SCI MONITOR, V11, pRA147; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A, 2003, PHYSIOL BEHAV, V80, P57, DOI 10.1016/S0031-9384(03)00209-9; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bartolomucci A, 2002, ETHOL ECOL EVOL, V14, P341; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Cabassi A, 2005, J CLIN ENDOCR METAB, V90, P2888, DOI 10.1210/jc.2004-1995; Cabassi A, 1998, LIFE SCI, V62, P1111, DOI 10.1016/S0024-3205(98)00034-4; Cabassi A, 2002, HYPERTENSION, V39, P656, DOI 10.1161/hy0202.103471; Camm AJ, 1996, CIRCULATION, V93, P1043; Cichon M, 2002, P ROY SOC B-BIOL SCI, V269, P1493, DOI 10.1098/rspb.2002.2054; Cinti S, 1999, ADIPOSE ORGAN; COCCURELLO R, 2008, NEUROSCI BI IN PRESS; Cross-Mellor SK, 1999, AM J PHYSIOL-REG I, V277, pR705, DOI 10.1152/ajpregu.1999.277.3.R705; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Epel ES, 2000, PSYCHOSOM MED, V62, P623, DOI 10.1097/00006842-200009000-00005; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; Flatmark T, 2000, ACTA PHYSIOL SCAND, V168, P1; Foster MT, 2006, AM J PHYSIOL-REG I, V290, pR1284, DOI 10.1152/ajpregu.00437.2005; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kaplan JR, 1999, ANN NY ACAD SCI, V896, P145, DOI 10.1111/j.1749-6632.1999.tb08112.x; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P231, DOI 10.1016/0149-7634(81)90004-X; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Marniemi J, 2002, J INTERN MED, V251, P35, DOI 10.1046/j.1365-2796.2002.00921.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Meerlo, 1996, Stress, V1, P21; MEISEL RL, 1990, PHYSIOL BEHAV, V47, P815, DOI 10.1016/0031-9384(90)90002-L; MELHORN SJ, 2007, APPETITE, V49, P313; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Monteiro R, 2006, OBES SURG, V16, P804, DOI 10.1381/096089206777346600; NAOI M, 1988, J CHROMATOGR-BIOMED, V427, P229, DOI 10.1016/0378-4347(88)80125-7; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nonogaki K, 2007, ENDOCRINOLOGY, V148, P4658, DOI 10.1210/en.2007-0296; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; SAHAKIAN BJ, 1982, PHYSIOL BEHAV, V28, P117, DOI 10.1016/0031-9384(82)90112-3; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shi HF, 2005, AM J PHYSIOL-REG I, V288, pR1028, DOI 10.1152/ajpregu.00648.2004; Smith AW, 2005, INT J OBESITY, V29, P244, DOI 10.1038/sj.ijo.0802835; Solomon MB, 2007, AM J PHYSIOL-REG I, V292, pR283, DOI 10.1152/ajpregu.00330.2006; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Tamashiro KLK, 2007, PHYSIOL BEHAV, V91, P440, DOI 10.1016/j.physbeh.2007.04.004; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; Tamashiro KLK, 2006, PHYSIOL BEHAV, V89, P536, DOI 10.1016/j.physbeh.2006.05.026; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; van Dijk G, 2008, EUR J PHARMACOL, V585, P137, DOI 10.1016/j.ejphar.2007.11.079; van Kampen Marja, 2002, Stress, V5, P37; vanLeeuwen SD, 1997, PHYSIOL BEHAV, V62, P77, DOI 10.1016/S0031-9384(97)00144-3; VANSTRIEN T, 1986, INT J OBESITY, V10, P29; Veenema AH, 2003, J NEUROENDOCRINOL, V15, P256, DOI 10.1046/j.1365-2826.2003.00986.x; Wardle J, 2007, OBES REV, V8, P73, DOI 10.1111/j.1467-789X.2007.00322.x; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; Wilson ME, 2008, PHYSIOL BEHAV, V94, P586, DOI 10.1016/j.physbeh.2008.03.019; Yamada K, 2000, PHYSIOL BEHAV, V68, P555, DOI 10.1016/S0031-9384(99)00214-0	83	114	114	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4331	10.1371/journal.pone.0004331	http://dx.doi.org/10.1371/journal.pone.0004331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180229	gold, Green Published, Green Submitted			2022-12-25	WOS:000274089700014
J	Watanabe, T; Suzuki, T; Ishikawa, A; Yokota, Y; Ueda, HR; Yamada, RG; Tei, H; Imai, S; Tomida, S; Kobayashi, J; Naito, E; Yasuo, S; Nakao, N; Namikawa, T; Yoshimura, T; Ebihara, S				Watanabe, Tsuyoshi; Suzuki, Tohru; Ishikawa, Akira; Yokota, Yuki; Ueda, Hiroki R.; Yamada, Rikuhiro G.; Tei, Hajime; Imai, Saki; Tomida, Shigeru; Kobayashi, Junya; Naito, Emiko; Yasuo, Shinobu; Nakao, Nobuhiro; Namikawa, Takao; Yoshimura, Takashi; Ebihara, Shizufumi			Genetic and Molecular Analysis of Wild-Derived Arrhythmic Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LOCOMOTOR-ACTIVITY; CIRCADIAN PERIOD; BEHAVIORAL RHYTHMS; NEUROPEPTIDE-Y; MOUSE; CLOCK; EXPRESSION; QTL; TRANSCRIPTION	A new circadian variant was isolated by screening the intercross offspring of wild-caught mice (Mus musculus castaneus). This variant was characterized by an initial maintenance of damped oscillations and subsequent loss of rhythmicity after being transferred from light-dark (LD) cycles to constant darkness (DD). To map the genes responsible for the persistence of rhythmicity (circadian ratio) and the length of free-running period (tau), quantitative trait locus (QTL) analysis was performed using F-2 mice obtained from an F-1 cross between the circadian variant and C57BL/6J mice. As a result, a significant QTL with a main effect for circadian ratio (Arrhythmicity; Arrh-1) was mapped on Chromosome (Chr) 8. For tau, four significant QTLs, Short free-running period (Sfp-1) (Chr 1), Sfp-2 (Chr 6), Sfp-3 (Chr 8), Sfp-4 (Chr 11) were determined. An epistatic interaction was detected between Chr 3 (Arrh-2) and Chr 5 (Arrh-3). An in situ hybridization study of clock genes and mouse Period1::luciferase (mPer1::luc) real-time monitoring analysis in the suprachiasmatic nucleus (SCN) suggested that arrhythmicity in this variant might not be attributed to core circadian mechanisms in the SCN neurons. Our strategy using wild-derived variant mice may provide a novel opportunity to evaluate circadian and its related disorders in human that arise from the interaction between multiple variant genes.	[Watanabe, Tsuyoshi; Suzuki, Tohru; Yokota, Yuki; Imai, Saki; Tomida, Shigeru; Kobayashi, Junya; Naito, Emiko; Yasuo, Shinobu; Nakao, Nobuhiro; Yoshimura, Takashi; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan; [Suzuki, Tohru] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka, Japan; [Ishikawa, Akira; Namikawa, Takao] Nagoya Univ, Grad Sch Bioagricult Sci, Div Applied Genet & Physiol, Nagoya, Aichi, Japan; [Ueda, Hiroki R.; Yamada, Rikuhiro G.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Hyogo, Japan; [Ueda, Hiroki R.] RIKEN, Ctr Developmental Biol, Funct Genom Subunit, Hyogo, Japan; [Tei, Hajime] Mitsubishi Kagaku Inst Life Sci, Res Grp Chronogenom, Tokyo, Japan	Nagoya University; Hamamatsu University School of Medicine; Nagoya University; RIKEN; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Watanabe, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014; Yoshimura, Takashi/C-8306-2012; Ueda, Hiroki R/C-5037-2014	Ishikawa, Akira/0000-0002-8275-4230; Yoshimura, Takashi/0000-0001-7018-9652; Ueda, Hiroki R/0000-0001-8342-9176	Grant-in-Aid for Scientific Research	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid for Scientific Research to S.E.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHURCHILL GA, 1994, GENETICS, V138, P963; DIETRICH W, 1992, GENETICS, V131, P423; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; HOFSTETTER JR, 1995, BEHAV GENET, V25, P545, DOI 10.1007/BF02327578; Hofstetter JR, 2003, J BIOL RHYTHM, V18, P450, DOI 10.1177/0748730403259468; Hofstetter JR, 1999, CHRONOBIOL INT, V16, P269, DOI 10.3109/07420529909116857; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Knott SA, 1998, GENETICS, V149, P1069; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Lall GS, 2003, NEUROSCIENCE, V119, P611, DOI 10.1016/S0306-4522(02)00811-4; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Soscia SJ, 2004, BRAIN RES, V1023, P148, DOI 10.1016/j.brainres.2004.07.037; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suzuki T, 2000, BEHAV GENET, V30, P447, DOI 10.1023/A:1010298701251; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vadasz C, 2000, NAT GENET, V26, P395, DOI 10.1038/82506; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Watanabe T, 2007, J BIOL RHYTHM, V22, P58, DOI 10.1177/0748730406295435; Wei WH, 2007, ANIM GENET, V38, P222, DOI 10.1111/j.1365-2052.2007.01591.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2002, J BIOL RHYTHM, V17, P512, DOI 10.1177/0748730402238233; Zhao WD, 2002, MAMM GENOME, V13, P345, DOI 10.1007/s00335-001-2154-3; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4301	10.1371/journal.pone.0004301	http://dx.doi.org/10.1371/journal.pone.0004301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173005	Green Published, gold			2022-12-25	WOS:000265483000010
J	Kitagaki, H; Cowart, LA; Matmati, N; Montefusco, D; Gandy, J; de Avalos, SV; Novgorodo, SA; Zheng, J; Obeid, LM; Hannun, YA				Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Novgorodo, Sergei A.; Zheng, Jim; Obeid, Lina M.; Hannun, Yusuf A.			ISC1-dependent Metabolic Adaptation Reveals an Indispensable Role for Mitochondria in Induction of Nuclear Genes during the Diauxic Shift in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; SPHINGOLIPID BIOSYNTHESIS; RETROGRADE RESPONSE; LINKS METABOLISM; GENOME STABILITY; YEAST LONGEVITY; RTG2 PROTEIN; EXPRESSION; ACTIVATION; KINASE	Growth of Saccharomyces cerevisiae following glucose depletion ( the diauxic shift) depends on a profound metabolic adaptation accompanied by a global reprogramming of gene expression. In this study, we provide evidence for a heretofore unsuspected role for Isc1p in mediating this reprogramming. Initial studies revealed that yeast cells deleted in ISC1, the gene encoding inositol sphingolipid phospholipase C, which resides in mitochondria in the post-diauxic phase, showed defective aerobic respiration in the post-diauxic phase but retained normal intrinsic mitochondrial functions, including intact mitochondrial DNA, normal oxygen consumption, and normal mitochondrial polarization. Microarray analysis revealed that the Delta isc1 strain failed to up-regulate genes required for nonfermentable carbon source metabolism during the diauxic shift, thus suggesting a mechanism for the defective supply of respiratory substrates into mitochondria in the post-diauxic phase. This defect in regulating nuclear gene induction in response to a defect in a mitochondrial enzyme raised the possibility that mitochondria may initiate diauxic shift-associated regulation of nucleus-encoded genes. This was established by demonstrating that in respiratory-deficient petite cells these genes failed to be upregulated across the diauxic shift in a manner similar to the Delta isc1 strain. Isc1p- and mitochondrial function-dependent genes significantly overlapped with Adr1p-, Snf1p-, and Cat8p-dependent genes, suggesting some functional link among these factors. However, the retrograde response was not activated in Delta isc1, suggesting that the response of Delta isc1 cannot be simply attributed to mitochondrial dysfunction. These results suggest a novel role for Isc1p in allowing the reprogramming of gene expression during the transition from anaerobic to aerobic metabolism.	[Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Zheng, Jim; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Zheng, Jim; Hannun, Yusuf A.] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Novgorodo, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Cowart, L. Ashley; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Kitagaki, Hiroshi] Saga Univ, Fac Agr, Saga 8408502, Japan	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Saga University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Kitagaki, Hiroshi/N-1666-2019	obeid, lina/0000-0002-0734-0847	National Institutes of Health [GM43825, R01 AG016583]; Veterans Affairs Merit Award; Merit Review Entry Program Award; Department of Veterans Affairs, Office of Research and Development; Noda Institute for Scientific Research; NATIONAL CANCER INSTITUTE [R24CA095841] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696, P20RR016434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Merit Review Entry Program Award; Department of Veterans Affairs, Office of Research and Development(US Department of Veterans Affairs); Noda Institute for Scientific Research(Noda Institute for Scientific Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM43825 ( to Y. A. H.) and Grant R01 AG016583 ( to L. M. O.). This work was also supported by a Veterans Affairs Merit Award ( to L. M. O.), a Merit Review Entry Program Award ( to L. A. C.) from the Department of Veterans Affairs, Office of Research and Development, and in part by an NISR research grant from the Noda Institute for Scientific Research ( to H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Borghouts C, 2004, GENETICS, V166, P765, DOI 10.1534/genetics.166.2.765; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Butow RA, 2002, CELL DEATH DIFFER, V9, P1043, DOI 10.1038/sj.cdd.4401083; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; Cowart LA, 2003, J BIOL CHEM, V278, P30328, DOI 10.1074/jbc.M300656200; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040; Jazwinski SM, 2005, FEMS YEAST RES, V5, P1253, DOI 10.1016/j.femsyr.2005.07.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Machida K, 1998, J BACTERIOL, V180, P4460, DOI 10.1128/JB.180.17.4460-4465.1998; Nishizawa M, 2004, YEAST, V21, P903, DOI 10.1002/yea.1138; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P201, DOI 10.1016/S0005-2760(97)00117-3; Schneider-Berlin KR, 2005, MUTAT RES-FUND MOL M, V572, P84, DOI 10.1016/j.mrfmmm.2004.12.010; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trotter PJ, 2005, ARCH BIOCHEM BIOPHYS, V442, P21, DOI 10.1016/j.abb.2005.07.016; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10818	10830		10.1074/jbc.M805029200	http://dx.doi.org/10.1074/jbc.M805029200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19179331	hybrid, Green Published			2022-12-25	WOS:000265104600056
J	Padmanabhan, U; Dollins, DE; Fridy, PC; York, JD; Downes, CP				Padmanabhan, Usha; Dollins, D. Eric; Fridy, Peter C.; York, John D.; Downes, C. Peter			Characterization of a Selective Inhibitor of Inositol Hexakisphosphate Kinases USE IN DEFINING BIOLOGICAL ROLES AND METABOLIC RELATIONSHIPS OF INOSITOL PYROPHOSPHATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; 1,4,5-TRISPHOSPHATE 3-KINASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; PHOSPHATE MULTIKINASE; HYPEROSMOTIC STRESS; CRYSTAL-STRUCTURE; PROTEIN; FAMILY; PENTAKISPHOSPHATE; IDENTIFICATION	Inositol hexakisphosphate kinases (IP6Ks) phosphorylate inositol hexakisphosphate (InsP(6)) to yield 5-diphosphoinositol pentakisphosphate (5-[PP]-InsP(5) or InsP(7)). In this study, we report the characterization of a selective inhibitor, N-2-(m-(trifluoromethy)lbenzyl) N-6-(p-nitrobenzyl) purine (TNP), for these enzymes. TNP dose-dependently and selectively inhibited the activity of IP6K in vitro and inhibited InsP(7) and InsP(8) synthesis in vivo without affecting levels of other inositol phosphates. TNP did not inhibit either human or yeast Vip/PPIP5K, a newly described InsP(6)/InsP(7) 1/3-kinase. Overexpression of IP6K1, -2, or -3 in cells rescued TNP inhibition of InsP(7) synthesis. TNP had no effect on the activity of a large number of protein kinases, suggesting that it is selective for IP6Ks. TNP reversibly reduced InsP(7)/InsP(8) levels. TNP in combination with genetic studies was used to implicate the involvement of two pathways for synthesis of InsP(8) in yeast. TNP induced a fragmented vacuole phenotype in yeast, consistent with inhibition of Kcs1, a Saccharomyces cerevisiae IP6K. In addition, it also inhibited insulin release from Min6 cells in a dose-dependent manner further implicating InsP(7) in this process. TNP thus provides a means of selectively and rapidly modulating cellular InsP(7) levels, providing a new and versatile tool to study the biological function and metabolic relationships of inositol pyrophosphates.	[Padmanabhan, Usha; Downes, C. Peter] Univ Dundee, Div Mol Physiol, James Black Ctr, Dundee DD1 5EH, Scotland; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Durham, NC 27710 USA; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Canc Biol, Howard Hughes Med Inst, Durham, NC 27710 USA; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA	University of Dundee; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Downes, CP (corresponding author), Univ Dundee, Div Mol Physiol, James Black Ctr, Dundee DD1 5EH, Scotland.	c.p.downes@dundee.ac.uk		Fridy, Peter/0000-0002-8208-9154	Division of Signal Transduction Therapy consortium (University of Dundee); MRC [G9403619] Funding Source: UKRI; Medical Research Council [G9403619] Funding Source: researchfish	Division of Signal Transduction Therapy consortium (University of Dundee); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Division of Signal Transduction Therapy consortium (University of Dundee).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Chang SC, 2002, J BIOL CHEM, V277, P43836, DOI 10.1074/jbc.M206134200; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; DASILVA CP, 1994, J BIOL CHEM, V269, P12521; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; HUANG KN, 1995, GENETICS, V141, P1275; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Poinas A, 2005, CHEMBIOCHEM, V6, P1449, DOI 10.1002/cbic.200400443; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Saiardi A, 2001, P NATL ACAD SCI USA, V98, P2306, DOI 10.1073/pnas.041614598; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	36	78	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10571	10582		10.1074/jbc.M900752200	http://dx.doi.org/10.1074/jbc.M900752200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208622	Green Published, hybrid			2022-12-25	WOS:000265104600031
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			Transmembrane Domain 8 of the gamma-Aminobutyric Acid Transporter GAT-1 Lines a Cytoplasmic Accessibility Pathway into Its Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; CL-COTRANSPORT FUNCTION; GABA TRANSPORTER; RAT-BRAIN; SEROTONIN TRANSPORTER; ALTERNATING ACCESS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; XENOPUS OOCYTES	GAT-1 is a sodium- and chloride-coupled gamma-aminobutyric acid (GABA) transporter, which fulfills an essential role in the synaptic transmission by this neurotransmitter. Cysteine-399 is the major site of inhibition of GAT-1 by membrane-permeant sulfhydryl reagents. This cysteine residue was previously thought to reside on a cytoplasmic loop connecting transmembrane domains (TMs) 8 and 9. However, the crystal structure of LeuT, a bacterial homologue of the mammalian neurotransmitter: sodium symporters, revealed that the residue corresponding to Cys-399 is in fact located in the middle of TM 8. This residue is located to the cytoplasmic side of Asp-395 and Ser-396, whose side chains are thought to ligand one of the two cotransported sodium ions. To determine how the sulfhydryl reagents approach cysteine-399, a cysteine scan of all 35 residues of TM 8 was performed. Sulfhydryl reagents inhibited transport when a cysteine residue was present at either of the positions 399, 402, 406, and 410. SKF-89976A and other non-transportable analogues, which are expected to lock the transporter in a conformation facing the extracellular medium, protected against the sulfhydryl modification at positions 399, 402, and 406. Such a protection was not seen by GABA itself, which actually modestly potentiated the modification at positions 399 and 402. Our results point to an alpha-helical stripe on TM8 lining an aqueous access pathway from the cytoplasm into the binding pocket, which gets occluded in the conformation of the transporter where the binding pocket is exposed to the extracellular medium.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters.	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters.(European Commission)	This work was supported by the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	33	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9727	9732		10.1074/jbc.M809423200	http://dx.doi.org/10.1074/jbc.M809423200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19201752	hybrid, Green Published			2022-12-25	WOS:000264892900012
J	Zhang, L; Bharadwaj, AG; Casper, A; Barkley, J; Barycki, JJ; Simpson, MA				Zhang, Ling; Bharadwaj, Alamelu G.; Casper, Andrew; Barkley, Joel; Barycki, Joseph J.; Simpson, Melanie A.			Hyaluronidase Activity of Human Hyal1 Requires Active Site Acidic and Tyrosine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; PROSTATE-CANCER; ESCHERICHIA-COLI; ANGIOGENESIS; EXPRESSION; GROWTH; GLYCOSYLATION; HYDROLYSIS; MECHANISMS; ENZYMES	Hyaluronidases are a family of endolytic glycoside hydrolases that cleave the beta 1-4 linkage between N-acetylglucosamine and glucuronic acid in hyaluronan polymers via a substrate-assisted mechanism. In humans, turnover of hyaluronan by this enzyme family is critical for normal extracellular matrix remodeling. However, elevated expression of the Hyal1 isozyme accelerates tumor growth and metastatic progression. In this study, we used structural information, site-directed mutagenesis, and steady state enzyme kinetics to probe molecular determinants of human Hyal1 function. Mutagenesis of active site residues Glu(131) and Tyr(247) to Gln and Phe, respectively, eliminated activity at all hyaluronan concentrations (to 125 mu M or 2.5 mg/ml). Conservative mutagenesis of Asp(129) and Tyr(202) significantly impaired catalysis by increases of 5- and 10-fold in apparent Km and reductions in V-max of 95 and 50%, respectively. Tyr(247) and Asp(129) are required for stabilization of the catalytic nucleophile, which arises as a resonance intermediate of N-acetylglucosamine on the substrate. Glu(131) is a likely proton donor for the hydroxyl leaving group. Tyr(202) is a substrate binding determinant. General disulfide reduction had no effect on activity in solution, but enzymatic deglycosylation reduced Hyal1 activity in a time-dependent fashion. Mutagenesis identified Asn(350) glycosylation as the requisite modification. Deletion of the C-terminal epidermal growth factor-like domain, in which Asn(350) is located, also eliminated activity, irrespective of glycosylation. Collectively, these studies define key components of Hyal1 active site catalysis, and structural factors critical for stability. Such detailed understanding will allow rational design of enzyme modulators.	[Zhang, Ling; Bharadwaj, Alamelu G.; Casper, Andrew; Barkley, Joel; Barycki, Joseph J.; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Simpson, MA (corresponding author), N246 Beadle Ctr, Lincoln, NE 68588 USA.	msimpson2@unl.edu			National Institutes of Health [R01 CA106584]; NCRR [P20 RR018759]; NATIONAL CANCER INSTITUTE [R01CA106584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106584 and NCRR P20 RR018759 ( to M. A. S.).	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Coutinho PM, 1999, ROY SOC CH, P3; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Hofinger ESA, 2008, GLYCOCONJUGATE J, V25, P101, DOI 10.1007/s10719-007-9058-8; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P963, DOI 10.1093/glycob/cwm070; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jedrzejas MJ, 2005, PROTEINS, V61, P227, DOI 10.1002/prot.20592; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Li MW, 2002, J ANDROL, V23, P211; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 1996, CANCER RES, V56, P651; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PISZKIEWICZ D, 1968, J AM CHEM SOC, V90, P2156, DOI 10.1021/ja01010a038; PRASAD ARS, 1983, BIOCHEMISTRY-US, V22, P4272, DOI 10.1021/bi00287a017; Rao V, 1999, PROTEIN SCI, V8, P2338; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Shiftan L, 2005, CANCER RES, V65, P10316, DOI 10.1158/0008-5472.CAN-04-3947; Shiftan L, 2006, CONTRAST MEDIA MOL I, V1, P106, DOI 10.1002/cmmi.96; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; West D. C., 1989, CIBA F SYMP, V143, P201; West D. C., 1989, CIBA F SYMP, V143, P281; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1989, CIBA F SYMP, V143, P187; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	41	37	41	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9433	9442		10.1074/jbc.M900210200	http://dx.doi.org/10.1074/jbc.M900210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201751	Green Published, hybrid			2022-12-25	WOS:000264669100050
J	Laner-Plamberger, S; Kaser, A; Paulischta, M; Hauser-Kronberger, C; Eichberger, T; Frischauf, AM				Laner-Plamberger, S.; Kaser, A.; Paulischta, M.; Hauser-Kronberger, C.; Eichberger, T.; Frischauf, A. M.			Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes	ONCOGENE			English	Article						GLI1; GLI2; Hedgehog signaling; activated JUN; basal cell carcinoma; keratinocytes	BASAL-CELL CARCINOMAS; HEDGEHOG SIGNALING PATHWAY; SKIN TUMOR-DEVELOPMENT; HUMAN EPIDERMAL-CELLS; C-JUN; TERMINAL PHOSPHORYLATION; HUMAN KERATINOCYTES; PROTEIN-KINASE; AP-1 PROTEINS; HUMAN HOMOLOG	Sustained Hedgehog (HH) signaling is implicated in basal cell carcinoma of the skin and other types of cancer. Here we show that GLI1 and GLI2, the main transcriptional activators of the HH pathway, directly regulate expression of the activator protein 1 (AP-1) family member JUN, a transcription factor controlling keratinocyte proliferation and skin homeostasis. Activation of the JUN promoter by GLI is dependent on a GLI-binding site and the AP-1 sites known to be involved in self-activation of JUN. Transcription of JUN is greatly enhanced in the presence of GLI and requires activated JUN protein. GLI2act is a more potent activator than GLI1 in these experiments and physical interaction with phosphorylated JUN was only detected for GLI2act. The synergistic effect of GLI and JUN extends to the activation of further GLI target genes as shown by shRNA-mediated knockdown of JUN in human keratinocytes. Some of these cooperatively activated genes are involved in cell-cycle progression, which is consistent with a significant reduction of the proliferative potential of GLI in the absence of JUN. These results suggest a novel connection between HH/GLI pathway activity and JUN, which may contribute to the oncogenic activity of HH/GLI signaling in skin.	[Laner-Plamberger, S.; Kaser, A.; Paulischta, M.; Eichberger, T.; Frischauf, A. M.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Hauser-Kronberger, C.] Paracelsus Med Univ Salzburg, St Johanns Hosp, Dept Pathol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University	Frischauf, AM (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	annemarie.frischauf@sbg.ac.at	Laner-Plamberger, Sandra/AFP-1191-2022	Laner-Plamberger, Sandra/0000-0002-1416-6023; Kaser-Eichberger, Alexandra/0000-0002-6115-5036	Austrian Genome Project GENAU Ultrasensitive Proteomics; Genomics II; University of Salzburg priority program Biosciences and Health	Austrian Genome Project GENAU Ultrasensitive Proteomics; Genomics II; University of Salzburg priority program Biosciences and Health	We thank Dr Fritz Aberger for stimulating discussions and critical reading of the paper, Mag. Stefan Klingler for advice on propagation ofhuman primary foreskin keratinocytes and Dr Martina Winklmayr for help with co- immunoprecipitations and cloning. We are particularly grateful to Dr Michael J Birrer for providing the JUN expression plasmid and Dr Rune Toftgard for a SUFU expression construct. This work was supported by the Austrian Genome Project GENAU Ultrasensitive Proteomics and Genomics II and the University ofSalzburg priority program Biosciences and Health.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Bannister AJ, 1995, ONCOGENE, V11, P2509; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eichberger T, 2008, J BIOL CHEM, V283, P12426, DOI 10.1074/jbc.M707117200; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Giesecke AV, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100053; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Gramigni C, 1998, FEBS LETT, V440, P119, DOI 10.1016/S0014-5793(98)01443-4; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; HERBER B, 1994, ONCOGENE, V9, P1295; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kasper Maria, 2007, V397, P67; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Sheng H, 2002, CANCER RES, V62, P5308; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Speek M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-13; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca Barbara, 2002, J Biol, V1, P9, DOI 10.1186/1475-4924-1-9; STEIN B, 1992, PHOTOCHEM PHOTOBIOL, V55, P409, DOI 10.1111/j.1751-1097.1992.tb04255.x; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Vezina Chad M, 2007, Curr Urol Rep, V8, P275, DOI 10.1007/s11934-007-0073-x; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yates S, 2002, WOUND REPAIR REGEN, V10, P5, DOI 10.1046/j.1524-475X.2002.10902.x; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang G, 2006, ONCOGENE, V25, P7260, DOI 10.1038/sj.onc.1209726; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	83	44	47	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1639	1651		10.1038/onc.2009.10	http://dx.doi.org/10.1038/onc.2009.10			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19219074				2022-12-25	WOS:000264780500008
J	Kuhnen, CM; Chiao, JY				Kuhnen, Camelia M.; Chiao, Joan Y.			Genetic Determinants of Financial Risk Taking	PLOS ONE			English	Article							PERSONALITY-TRAIT; POLYMORPHISM; ASSOCIATION; SEROTONIN; DOPAMINE; REWARD	Individuals vary in their willingness to take financial risks. Here we show that variants of two genes that regulate dopamine and serotonin neurotransmission and have been previously linked to emotional behavior, anxiety and addiction (5-HTTLPR and DRD4) are significant determinants of risk taking in investment decisions. We find that the 5-HTTLPR s/s allele carriers take 28% less risk than those carrying the s/l or l/l alleles of the gene. DRD4 7-repeat allele carriers take 25% more risk than individuals without the 7-repeat allele. These findings contribute to the emerging literature on the genetic determinants of economic behavior.	Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Chiao, Joan Y.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Chiao, Joan Y.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Kuhnen, CM (corresponding author), Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA.	c-kuhnen@kellogg.northwestern.edu; jchiao@northwestern.edu			Zell Center for Risk Research at the Kellogg School of Management; NSF [BCS-0720312, BCS-0722326]	Zell Center for Risk Research at the Kellogg School of Management; NSF(National Science Foundation (NSF))	Kuhnen acknowledges generous financial support for this work from the Zell Center for Risk Research at the Kellogg School of Management. This work is also supported by NSF BCS-0720312 and NSF BCS-0722326 grants to J.Y.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldu X, 2007, ANN NY ACAD SCI, V1118, P43, DOI 10.1196/annals.1412.007; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CESARINI D, 2009, Q J EC, V124; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DREBER A, EVOLUTION H IN PRESS; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eisen SA, 1998, ADDICTION, V93, P1375; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Eisenberg DTA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-173; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; KIM SJ, 2006, J NEURAL TRANSMISSIO; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; MARKOWITZ H, 1952, J FINANCE, V0007; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; SCHULTZ W, 2007, TRENDS NEUROSCIENCE, V30; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	25	163	167	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4362	10.1371/journal.pone.0004362	http://dx.doi.org/10.1371/journal.pone.0004362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JP	19209222	Green Submitted, gold, Green Published			2022-12-25	WOS:000265484100001
J	Warter, L; Cohen, L; Benureau, Y; Chavez, D; Yang, Y; Bodola, F; Lemon, SM; Traboni, C; Lanford, RE; Martin, A				Warter, Lucile; Cohen, Lisette; Benureau, Yann; Chavez, Deborah; Yang, Yan; Bodola, Francis; Lemon, Stanley M.; Traboni, Cinzia; Lanford, Robert E.; Martin, Annette			A Cooperative Interaction between Nontranslated RNA Sequences and NS5A Protein Promotes In Vivo Fitness of a Chimeric Hepatitis C/GB Virus B	PLOS ONE			English	Article								GB virus B (GBV-B) is closely related to hepatitis C virus (HCV), infects small non-human primates, and is thus a valuable surrogate for studying HCV. Despite significant differences, the 59 nontranslated RNAs (NTRs) of these viruses fold into four similar structured domains (I-IV), with domains II-III-IV comprising the viral internal ribosomal entry site (IRES). We previously reported the in vivo rescue of a chimeric GBV-B (vGB/III(HC)) containing HCV sequence in domain III, an essential segment of the IRES. We show here that three mutations identified within the vGB/III(HC) genome (within the 3'NTR, upstream of the poly(U) tract, and NS5A coding sequence) are necessary and sufficient for production of this chimeric virus following intrahepatic inoculation of synthetic RNA in tamarins, and thus apparently compensate for the presence of HCV sequence in domain III. To assess the mechanism(s) underlying these compensatory mutations, and to determine whether 5'NTR subdomains participating in genome replication do so in a virus-specific fashion, we constructed and evaluated a series of chimeric subgenomic GBV-B replicons in which various 5'NTR subdomains were substituted with their HCV homologs. Domains I and II of the GBV-B 5'NTR could not be replaced with HCV sequence, indicating that they contain essential, virus-specific RNA replication elements. In contrast, domain III could be swapped with minimal loss of genome replication capacity in cell culture. The 3'NTR and NS5A mutations required for rescue of the related chimeric virus in vivo had no effect on replication of the subgenomic GBneoD/III(HC) RNA in vitro. The data suggest that in vivo fitness of the domain III chimeric virus is dependent on a cooperative interaction between the 5'NTR, 3'NTR and NS5A at a step in the viral life cycle subsequent to genome replication, most likely during particle assembly. Such a mechanism may be common to all hepaciviruses.	[Warter, Lucile; Cohen, Lisette; Benureau, Yann; Martin, Annette] Univ Paris 07, Inst Pasteur, CNRS, Unite Genet Mol Virus ARN, URA 3015, F-75221 Paris, France; [Chavez, Deborah; Lanford, Robert E.] SW Natl Primate Res Ctr, SW Fdn Biomed Res, San Antonio, TX USA; [Yang, Yan; Bodola, Francis; Lemon, Stanley M.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Hepatitis Res, Galveston, TX USA; [Traboni, Cinzia] Ist Ricerche Biol Molecolare P Angeletti, Pomezia, Italy	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Texas Biomedical Research Institute; University of Texas System; University of Texas Medical Branch Galveston	Warter, L (corresponding author), Singapore Immunol Network, Singapore, Singapore.	annette.martin@pasteur.fr	Martin, Annette/A-2425-2016	Martin, Annette/0000-0002-3054-3925	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [R24-RR015081, U19-AI40035, RO1 AI49574, P51 RR13986]; National Institutes of Health; French National Center for Scientific Research (CNRS) [BDI fellowship]; French National Research Agency (ANR) [fellowship]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015081, P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035, R01AI049574] Funding Source: NIH RePORTER	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency (ANR)(French National Research Agency (ANR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), and grants R24-RR015081, U19-AI40035, RO1 AI49574, and P51 RR13986 from the National Institutes of Health. L.W. was supported by a BDI fellowship from the French National Center for Scientific Research (CNRS) and Y.B. by a fellowship from the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Becher P, 2000, J VIROL, V74, P7884, DOI 10.1128/JVI.74.17.7884-7894.2000; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bukh J, 2001, J MED VIROL, V65, P694, DOI 10.1002/jmv.2092; Butkiewicz N, 2000, J VIROL, V74, P4291, DOI 10.1128/JVI.74.9.4291-4301.2000; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevalier C, 2007, MOL THER, V15, P1452, DOI 10.1038/sj.mt.6300186; Cristofari G, 2004, NUCLEIC ACIDS RES, V32, P2623, DOI 10.1093/nar/gkh579; De Tomassi A, 2002, J VIROL, V76, P7736, DOI 10.1128/JVI.76.15.7736-7746.2002; Fang JWS, 2000, J HEPATOL, V33, P632, DOI 10.1034/j.1600-0641.2000.033004632.x; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Frolov I, 1998, RNA, V4, P1418, DOI 10.1017/S1355838298981031; Ghibaudo D, 2004, J BIOL CHEM, V279, P24965, DOI 10.1074/jbc.M401148200; Grace K, 1999, J GEN VIROL, V80, P2337, DOI 10.1099/0022-1317-80-9-2337; Honda M, 1996, RNA, V2, P955; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051; Ivanyi-Nagy R, 2006, NUCLEIC ACIDS RES, V34, P2618, DOI 10.1093/nar/gkl240; Kim YK, 2002, BIOCHEM BIOPH RES CO, V290, P105, DOI 10.1006/bbrc.2001.6167; Kong LK, 2002, J VIROL, V76, P12457, DOI 10.1128/JVI.76.24.12457-12462.2002; Lanford RE, 2003, VIROLOGY, V311, P72, DOI 10.1016/S0042-6822(03)00193-4; Lemon SM, 1997, SEMIN VIROL, V8, P274, DOI 10.1006/smvy.1997.0129; Luo GX, 2003, J VIROL, V77, P3312, DOI 10.1128/JVI.77.5.3312-3318.2003; Mankouri J, 2008, J GEN VIROL, V89, P1911, DOI 10.1099/vir.0.2008/001131-0; Martin A, 2003, P NATL ACAD SCI USA, V100, P9962, DOI 10.1073/pnas.1731505100; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murakami K, 2001, ARCH VIROL, V146, P729, DOI 10.1007/s007050170142; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nam JH, 2004, J VIROL, V78, P9389, DOI 10.1128/JVI.78.17.9389-9399.2004; Ohba K, 1996, FEBS LETT, V378, P232, DOI 10.1016/0014-5793(95)01441-1; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pizzuti M, 2003, J VIROL, V77, P7502, DOI 10.1128/JVI.77.13.7502-7509.2003; Reusken CBEM, 2003, J GEN VIROL, V84, P1761, DOI 10.1099/vir.0.19063-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Rijnbrand R, 2005, HEPATOLOGY, V41, P986, DOI 10.1002/hep.20656; RIJNBRAND R, 1995, FEBS LETT, V365, P115, DOI 10.1016/0014-5793(95)00458-L; Rijnbrand R, 2000, J VIROL, V74, P773, DOI 10.1128/JVI.74.2.773-783.2000; Rijnbrand R, 2001, RNA, V7, P585, DOI 10.1017/S1355838201000589; Sbardellati A, 2001, J GEN VIROL, V82, P2437, DOI 10.1099/0022-1317-82-10-2437; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Svitkin YV, 2005, J VIROL, V79, P6868, DOI 10.1128/JVI.79.11.6868-6881.2005; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Thiel H.J., 2005, VIRUS TAXONOMY, P993; Woollard DJ, 2008, J VIROL, V82, P3054, DOI 10.1128/JVI.01153-07; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003; Yu HY, 2000, J VIROL, V74, P5825, DOI 10.1128/JVI.74.13.5825-5835.2000	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4419	10.1371/journal.pone.0004419	http://dx.doi.org/10.1371/journal.pone.0004419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204793	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484000008
J	Hagan, JP; O'Neill, BL; Stewart, CL; Kozlov, SV; Croce, CM				Hagan, John P.; O'Neill, Brittany L.; Stewart, Colin L.; Kozlov, Serguei V.; Croce, Carlo M.			At Least Ten Genes Define the Imprinted Dlk1-Dio3 Cluster on Mouse Chromosome 12qF1	PLOS ONE			English	Article								Background: Genomic imprinting is an exception to Mendelian genetics in that imprinted genes are expressed monoallelically, dependent on parental origin. In mammals, imprinted genes are critical in numerous developmental and physiological processes. Aberrant imprinted gene expression is implicated in several diseases including Prader-Willi/Angelman syndromes and cancer. Methodology/Principal Findings: To identify novel imprinted genes, transcription profiling was performed on two uniparentally derived cell lines, androgenetic and parthenogenetic primary mouse embryonic fibroblasts. A maternally expressed transcript termed Imprinted (R) under bar NA near (M) under bar eg3/ Gtl2 (Irm) was identified and its expression studied by Northern blotting and whole mounts in situ hybridization. The imprinted region that contains Irm has a parent of origin effect in three mammalian species, including the sheep callipyge locus. In mice and humans, both maternal and paternal uniparental disomies (UPD) cause embryonic growth and musculoskeletal abnormalities, indicating that both alleles likely express essential genes. To catalog all imprinted genes in this chromosomal region, twenty-five mouse mRNAs in a 1.96Mb span were investigated for allele specific expression. Conclusions/Significance: Ten imprinted genes were elucidated. The imprinting of three paternally expressed protein coding genes (Dlk1, Peg11, and Dio3) was confirmed. Seven noncoding RNAs (Meg3/Gtl2, Anti-Peg11, Meg8, Irm/"Rian", AK050713, AK053394, and Meg9/Mirg) are characterized by exclusive maternal expression. Intriguingly, the majority of these noncoding RNA genes contain microRNAs and/or snoRNAs within their introns, as do their human orthologs. Of the 52 identified microRNAs that map to this region, six are predicted to regulate negatively Dlk1, suggesting an additional mechanism for interactions between allelic gene products. Since several previous studies relied heavily on in silico analysis and RT-PCR, our findings from Northerns and cDNA cloning clarify the genomic organization of this region. Our results expand the number of maternally expressed noncoding RNAs whose loss may be responsible for the phenotypes associated with mouse pUPD12 and human pUPD14 syndromes.	[Hagan, John P.; O'Neill, Brittany L.; Croce, Carlo M.] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Stewart, Colin L.] NCI, NIH, Ctr Canc Res, Canc & Dev Biol Lab, Frederick, MD USA; [Kozlov, Serguei V.] NCI, NIH, SAIC Frederick Inc, Ctr Advanced Preclin Res Mouse Canc Genet Program, Frederick, MD USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hagan, JP (corresponding author), Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	microrna@gmail.com	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Hagan, John/0000-0003-0295-4898	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; and with Federal funds from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEECHEY C, 2003, MOUSE IMPRINTING DAT; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cotter PD, 1997, AM J MED GENET, V70, P74, DOI 10.1002/(SICI)1096-8628(19970502)70:1<74::AID-AJMG14>3.0.CO;2-U; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fan T, 2005, DEVELOPMENT, V132, P635, DOI 10.1242/dev.01612; Fokstuen S, 1999, J PEDIATR-US, V134, P689, DOI 10.1016/S0022-3476(99)70282-9; Genter MB, 2003, PHYSIOL GENOMICS, V16, P67, DOI 10.1152/physiolgenomics.00117.2003; Georgiades P, 2000, DEVELOPMENT, V127, P4719; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Hagan JP, 2004, GENOMICS, V84, P836, DOI 10.1016/j.ygeno.2004.07.007; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NUCLEIC ACIDS RES, V23, P36, DOI 10.1093/nar/23.1.36; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Hiura H, 2007, FEBS LETT, V581, P1255, DOI 10.1016/j.febslet.2007.02.034; Hogan B, 1994, MANIPULATING MOUSE E; Joyce JA, 1998, J CLIN PATHOL-MOL PA, V51, P185, DOI 10.1136/mp.51.4.185; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kato MV, 1998, GENOMICS, V47, P146, DOI 10.1006/geno.1997.5089; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; LABIALLE S, 2008, EPIGENETICS, V3; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; LINSLEY PS, 2007, MOL CELL BIOL; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morison IM, 1998, HUM MOL GENET, V7, P1599, DOI 10.1093/hmg/7.10.1599; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Palferman S, 2001, HUM MOL GENET, V10, P973; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; PENTAO L, 1992, AM J HUM GENET, V50, P690; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Schmidt JV, 2000, GENE DEV, V14, P1997; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; SchusterGossler K, 1996, MAMM GENOME, V7, P20, DOI 10.1007/s003359900006; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shimoda M, 2002, GENOMICS, V79, P483, DOI 10.1006/geno.2002.6727; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutton VR, 2000, AM J MED GENET, V93, P381, DOI 10.1002/1096-8628(20000828)93:5<381::AID-AJMG7>3.0.CO;2-9; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wassink T H, 2000, Curr Psychiatry Rep, V2, P170, DOI 10.1007/s11920-000-0063-x; Weidman JR, 2006, MAMM GENOME, V17, P157, DOI 10.1007/s00335-005-0116-x; Williamson CM, 1998, CYTOGENET CELL GENET, V81, P73, DOI 10.1159/000014992; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xiao Y, 2006, BIOCHEM BIOPH RES CO, V340, P1217, DOI 10.1016/j.bbrc.2005.12.128; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	86	108	122	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4352	10.1371/journal.pone.0004352	http://dx.doi.org/10.1371/journal.pone.0004352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194500	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483600004
J	Beduneau, A; Ma, ZY; Grotepas, CB; Kabanov, A; Rabinow, BE; Gong, N; Mosley, RL; Dou, HY; Boska, MD; Gendelman, HE				Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Kabanov, Alexander; Rabinow, Barrett E.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.			Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles	PLOS ONE			English	Article								Background: We posit that the same mononuclear phagocytes (MP) that serve as target cells and vehicles for a host of microbial infections can be used to improve diagnostics and drug delivery. We also theorize that physical and biological processes such as particle shape, size, coating and opsonization that affect MP clearance of debris and microbes can be harnessed to facilitate uptake of nanoparticles (NP) and tissue delivery. Methods: Monocytes and monocyte-derived macrophages (MDM) were used as vehicles of superparamagnetic iron oxide (SPIO) NP and immunoglobulin (IgG) or albumin coated SPIO for studies of uptake and distribution. IgG coated SPIO was synthesized by covalent linkage and uptake into monocytes and MDM investigated related to size, time, temperature, concentration, and coatings. SPIO and IgG SPIO were infused intravenously into naive mice. T-2 measures using magnetic resonance imaging (MRI) were used to monitor tissue distribution in animals. Results: Oxidation of dextran on the SPIO surface generated reactive aldehyde groups and permitted covalent linkage to amino groups of murine and human IgG and F(ab')(2) fragments and for Alexa Fluor (R) 488 hydroxylamine to form a Schiff base. This labile intermediate was immediately reduced with sodium cyanoborohydride in order to stabilize the NP conjugate. Optical density measurements of the oxidized IgG, F(ab')(2), and/or Alexa Fluor (R) 488 SPIO demonstrated similar to 50% coupling yield. IgG-SPIO was found stable at 4 degrees C for a period of 1 month during which size and polydispersity index varied little from 175 nm and 200 nm, respectively. In vitro, NP accumulated readily within monocyte and MDM cytoplasm after IgG-SPIO exposure; whereas, the uptake of native SPIO in monocytes and MDM was 10-fold less. No changes in cell viability were noted for the SPIO-containing monocytes and MDM. Cell morphology was not changed as observed by transmission electron microscopy. Compared to unconjugated SPIO, intravenous injection of IgG-SPIO afforded enhanced and sustained lymphoid tissue distribution over 24 hours as demonstrated by MRI. Conclusions: Facilitated uptake of coated SPIO in monocytes and MDM was achieved. Uptake was linked to particle size and was time and concentration dependent. The ability of SPIO to be rapidly taken up and distributed into lymphoid tissues also demonstrates feasibility of macrophage-targeted nanoformulations for diagnostic and drug therapy.	[Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Kabanov, Alexander] Univ Nebraska, Med Ctr, Dept Pharm Sci, Lincoln, NE 68583 USA; [Boska, Michael D.] Univ Nebraska, Med Ctr, Dept Radiol, Lincoln, NE 68583 USA; [Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Lincoln, NE 68583 USA; [Kabanov, Alexander; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Drug Delivery & Nanomed, Lincoln, NE 68583 USA; [Rabinow, Barrett E.] Baxter Healthcare Corp, Round Lake, IL USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Baxter International Inc	Beduneau, A (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	mboska@unmc.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012; Kabanov, Alexander V/N-3356-2013; Kabanov, Alexander/AAY-5751-2020	Kabanov, Alexander V/0000-0002-3665-946X; Kabanov, Alexander/0000-0002-3665-946X; Beduneau, Arnaud/0000-0001-7577-0374	National Institutes of Health [2R37 NS36126, PO1 NS31492, 2R01 NS034239, P20RR15635, P30 AI42845, U54NS43011-01, P01MH64570, 1T32 NS07488, P01 NS43985]; Baxter Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034239, P01NS043985, P01NS031492, T32NS007488, R37NS036126, U54NS043011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for the research was provided by National Institutes of Health Grants 2R37 NS36126, PO1 NS31492, 2R01 NS034239, P20RR15635, P20RR15635, P30 AI42845, U54NS43011-01, P01MH64570, 1T32 NS07488, P01 NS43985 and from Baxter Healthcare (to H.E.G.). Dr. Barrett Rabinow is an employee of Baxter Healthcare who played a role in study design and supplied reagents used in data acquisition.	AUDRAN R, 1995, NUCL MED BIOL, V22, P817, DOI 10.1016/0969-8051(95)00013-N; BETAGERI GV, 1993, J PHARM PHARMACOL, V45, P48, DOI 10.1111/j.2042-7158.1993.tb03678.x; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; Ciborowski P, 2006, CURR HIV RES, V4, P279, DOI 10.2174/157016206777709474; CONNOR RI, 1991, P NATL ACAD SCI USA, V88, P9593, DOI 10.1073/pnas.88.21.9593; DALEKE DL, 1990, BIOCHIM BIOPHYS ACTA, V1024, P352, DOI 10.1016/0005-2736(90)90365-U; DOBROVOLSKAIA MA, 2008, MOL PHARM; Dou HY, 2007, VIROLOGY, V358, P148, DOI 10.1016/j.virol.2006.08.012; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dutta T, 2007, J DRUG TARGET, V15, P89, DOI 10.1080/10611860600965914; Engberink RDO, 2008, J CEREBR BLOOD F MET, V28, P841, DOI 10.1038/sj.jcbfm.9600580; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Fujiwara H, 1996, Kekkaku, V71, P43; Gorantla S, 2006, J LEUKOCYTE BIOL, V80, P1165, DOI 10.1189/jlb.0206110; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2; Kadiu I, 2005, NEUROTOX RES, V8, P25, DOI 10.1007/BF03033818; Khan MA, 2005, J ANTIMICROB CHEMOTH, V55, P223, DOI 10.1093/jac/dkh522; Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4; Kuwata T, 2007, AIDS RES HUM RETROV, V23, P372, DOI 10.1089/aid.2006.0208; Manjunath K, 2006, J DRUG TARGET, V14, P632, DOI 10.1080/10611860600888850; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; Moghimi SM, 2001, CRIT REV THER DRUG, V18, P527; Nelson JA, 2005, J NEUROSCI RES, V80, P562, DOI 10.1002/jnr.20466; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Paul M, 1998, J DRUG TARGET, V5, P481, DOI 10.3109/10611869808997874; Pereboeva L, 2004, BIODRUGS, V18, P361, DOI 10.2165/00063030-200418060-00003; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Pietruska M, 2006, Adv Med Sci, V51 Suppl 1, P166; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Zelivyanskaya ML, 2003, J NEUROSCI RES, V73, P284, DOI 10.1002/jnr.10693; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	39	114	119	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4343	10.1371/journal.pone.0004343	http://dx.doi.org/10.1371/journal.pone.0004343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183814	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483200013
J	Collins, A; Hill, LE; Chandramohan, Y; Whitcomb, D; Droste, SK; Reul, JMHM				Collins, Andrew; Hill, Louise E.; Chandramohan, Yalini; Whitcomb, Daniel; Droste, Susanne K.; Reul, Johannes M. H. M.			Exercise Improves Cognitive Responses to Psychological Stress through Enhancement of Epigenetic Mechanisms and Gene Expression in the Dentate Gyrus	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; HISTONE H3 PHOSPHORYLATION; REGULAR VOLUNTARY EXERCISE; GLUCOCORTICOID-RECEPTOR; GRANULE NEURONS; C-FOS; STEREOTYPIC BEHAVIOR; SYNAPTIC PLASTICITY; PHOSPHO-ACETYLATION; BANK VOLES	Background: We have shown previously that exercise benefits stress resistance and stress coping capabilities. Furthermore, we reported recently that epigenetic changes related to gene transcription are involved in memory formation of stressful events. In view of the enhanced coping capabilities in exercised subjects we investigated epigenetic, gene expression and behavioral changes in 4-weeks voluntarily exercised rats. Methodology/Principal Findings: Exercised and control rats coped differently when exposed to a novel environment. Whereas the control rats explored the new cage for the complete 30-min period, exercised animals only did so during the first 15 min after which they returned to sleeping or resting behavior. Both groups of animals showed similar behavioral responses in the initial forced swim session. When re-tested 24 h later however the exercised rats showed significantly more immobility behavior and less struggling and swimming. If rats were killed at 2 h after novelty or the initial swim test, i.e. at the peak of histone H3 phospho-acetylation and c-Fos induction, then the exercised rats showed a significantly higher number of dentate granule neurons expressing the histone modifications and immediate-early gene induction. Conclusions/Significance: Thus, irrespective of the behavioral response in the novel cage or initial forced swim session, the impact of the event at the dentate gyrus level was greater in exercised rats than in control animals. Furthermore, in view of our concept that the neuronal response in the dentate gyrus after forced swimming is involved in memory formation of the stressful event, the observations in exercised rats of enhanced neuronal responses as well as higher immobility responses in the re-test are consistent with the reportedly improved cognitive performance in these animals. Thus, improved stress coping in exercised subjects seems to involve enhanced cognitive capabilities possibly resulting from distinct epigenetic mechanisms in dentate gyrus neurons.	[Collins, Andrew; Hill, Louise E.; Chandramohan, Yalini; Whitcomb, Daniel; Droste, Susanne K.; Reul, Johannes M. H. M.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of Bristol	Collins, A (corresponding author), Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	Hans.Reul@bristol.ac.uk	Reul, Johannes/B-4132-2019	Reul, Johannes/0000-0002-8787-4012; Whitcomb, Daniel/0000-0003-2703-1643	Medical Research Council; Neuroendocrinology Charitable Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neuroendocrinology Charitable Trust	This work was supported by the Medical Research Council and the Neuroendocrinology Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda L, 2006, BEHAV BRAIN RES, V167, P156, DOI 10.1016/j.bbr.2005.09.002; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; BYRNE A, 1993, J PSYCHOSOM RES, V37, P565, DOI 10.1016/0022-3999(93)90050-P; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cooper JJ, 1996, ANIM WELFARE, V5, P245; COOPER JJ, 1991, ANIM BEHAV, V41, P971, DOI 10.1016/S0003-3472(05)80635-9; DEPABLO JM, 1989, PHYSIOL BEHAV, V46, P229, DOI 10.1016/0031-9384(89)90261-8; Dietrich MO, 2005, BRAIN RES, V1065, P20, DOI 10.1016/j.brainres.2005.09.038; Dijkstra I, 1998, J NEUROSCI, V18, P3909; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; Droste SK, 2006, J NEUROENDOCRINOL, V18, P915, DOI 10.1111/j.1365-2826.2006.01489.x; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Friedman JE, 1997, HORM METAB RES, V29, P214, DOI 10.1055/s-2007-979024; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gielen S, 2001, CIRCULATION, V103, pE1; Harri M, 1999, LAB ANIM SCI, V49, P401; HILL LE, 2008, J PSYCHOPHA IN PRESS; Jonsdottir IH, 2000, IMMUNOL CELL BIOL, V78, P562, DOI 10.1046/j.1440-1711.2000.00961.x; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Korte SM, 1996, EUR J PHARMACOL, V301, P19, DOI 10.1016/0014-2999(96)00064-7; Kramer KM, 2000, BRAIN RES BULL, V53, P77; Lambert GW, 1998, J APPL PHYSIOL, V85, P962, DOI 10.1152/jappl.1998.85.3.962; Lancel M, 2003, EUR J NEUROSCI, V17, P2171, DOI 10.1046/j.1460-9568.2003.02658.x; Linthorst ACE, 1995, EUR J NEUROSCI, V7, P2418, DOI 10.1111/j.1460-9568.1995.tb01040.x; Linthorst ACE, 2002, EUR J NEUROSCI, V16, P2441, DOI 10.1046/j.1460-9568.2002.02400.x; Linthorst ACE, 1998, ANN NY ACAD SCI, V840, P139, DOI 10.1111/j.1749-6632.1998.tb09558.x; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reul JMHM, 2008, J PSYCHOPHARMACOL, V22, P469, DOI 10.1177/0269881108094617; REUL JMH, 2006, P 6 INT C NEUR JUN 1; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Reul JMHM, 2007, PSYCHONEUROENDOCRINO, V32, pS21, DOI 10.1016/j.psyneuen.2007.03.016; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Steckler T., 2005, TEC BEHAV N 1, P95; STECKLER T, 1999, BAILLIERES BEST PRAC, P597; STEPTOE A, 1989, J PSYCHOSOM RES, V33, P537, DOI 10.1016/0022-3999(89)90061-5; Swanson L W, 1977, Ciba Found Symp, P25; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vasuta C, 2007, HIPPOCAMPUS, V17, P1201, DOI 10.1002/hipo.20349; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; WYSS JM, 1979, NEUROSCIENCE, V4, P463, DOI 10.1016/0306-4522(79)90124-6	52	108	109	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4330	10.1371/journal.pone.0004330	http://dx.doi.org/10.1371/journal.pone.0004330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180197	Green Published, Green Submitted, gold			2022-12-25	WOS:000274089700013
J	Zheng, L; Nikolaev, A; Wardill, TJ; O'Kane, CJ; de Polavieja, GG; Juusola, M				Zheng, Lei; Nikolaev, Anton; Wardill, Trevor J.; O'Kane, Cahir J.; de Polavieja, Gonzalo G.; Juusola, Mikko			Network Adaptation Improves Temporal Representation of Naturalistic Stimuli in Drosophila Eye: I Dynamics	PLOS ONE			English	Article							ADAPTED BLOWFLY PHOTORECEPTORS; LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; FLY COMPOUND EYE; LIGHT ADAPTATION; VISUAL-SYSTEM; INFORMATION-TRANSMISSION; GRADED POTENTIALS; PATTERN-RECOGNITION; MUSCA-DOMESTICA	Because of the limited processing capacity of eyes, retinal networks must adapt constantly to best present the ever changing visual world to the brain. However, we still know little about how adaptation in retinal networks shapes neural encoding of changing information. To study this question, we recorded voltage responses from photoreceptors (R1-R6) and their output neurons (LMCs) in the Drosophila eye to repeated patterns of contrast values, collected from natural scenes. By analyzing the continuous photoreceptor-to-LMC transformations of these graded-potential neurons, we show that the efficiency of coding is dynamically improved by adaptation. In particular, adaptation enhances both the frequency and amplitude distribution of LMC output by improving sensitivity to under-represented signals within seconds. Moreover, the signal-to-noise ratio of LMC output increases in the same time scale. We suggest that these coding properties can be used to study network adaptation using the genetic tools in Drosophila, as shown in a companion paper (Part II).	[Zheng, Lei; Nikolaev, Anton; Wardill, Trevor J.; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain; [Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China	University of Sheffield; University of Cambridge; Autonomous University of Madrid; Autonomous University of Madrid; Beijing Normal University	Zheng, L (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	O'Kane, Cahir/Q-6681-2019; O'Kane, Cahir J/C-4413-2011; Juusola, Mikko/E-6948-2011	O'Kane, Cahir/0000-0002-3488-2078; Juusola, Mikko/0000-0002-4428-5330; de Polavieja, Gonzalo/0000-0001-5359-3426; Wardill, Trevor/0000-0002-2049-113X	Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Royal Society; MEC; Biociencia program; CAM-UAM; Biotechnology and Biological Sciences Research Council [BB/D001900/1, BB/F012071/1] Funding Source: researchfish; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Royal Society(Royal Society of London); MEC(European Commission); Biociencia program; CAM-UAM; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Biotechnology and Biological Sciences Research Council (MJ, CJO'K), the Gatsby Charitable Foundation (MJ), the Royal Society (MJ, GGdP), MEC (GGdP), Biociencia program (GGdP) and CAM-UAM (GGdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; ARMITAGE JD, 1965, APPL OPTICS, V4, P445, DOI 10.1364/AO.4.000445; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brinkworth RSA, 2008, J VISION, V8, DOI 10.1167/8.11.8; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Burton BG, 2003, J EXP BIOL, V206, P3963, DOI 10.1242/jeb.00600; Burton BG, 2002, J COMP PHYSIOL A, V188, P527, DOI 10.1007/s00359-002-0327-5; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; Cover TM, 1991, ELEMENTS INFORM THEO; Dan Y, 1996, J NEUROSCI, V16, P3351; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; de Polavieja GG, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061910; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; De Polavieja GG, 2002, J THEOR BIOL, V214, P657, DOI 10.1006/jtbi.2001.2498; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Heisenberg M., 1984, VISION DROSOPHILA GE; HEISENBERG M, 1977, J COMP PHYSIOL A, V117, P163; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; HUMMEL R, 1977, COMPUT VISION GRAPH, V6, P184, DOI 10.1016/S0146-664X(77)80011-7; JARVILEHTO M, 1971, Z VERGL PHYSIOL, V75, P422, DOI 10.1007/BF00630561; JUUSOLA M, 1993, J COMP PHYSIOL A, V172, P511, DOI 10.1007/BF00213533; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Juusola M, 1995, J NEUROPHYSIOL, V74, P2538, DOI 10.1152/jn.1995.74.6.2538; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; Juusola M, 2007, BIOESSAYS, V29, P178, DOI 10.1002/bies.20532; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Linsker R., 1989, ADV NEURAL INFORMATI, P186; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Mah EL, 2008, BIOL CYBERN, V98, P357, DOI 10.1007/s00422-008-0222-4; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schwartz G, 2008, J NEUROPHYSIOL, V99, P1787, DOI 10.1152/jn.01025.2007; Segev R, 2007, J NEUROPHYSIOL, V98, P1380, DOI 10.1152/jn.00395.2007; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SHAW SR, 1984, J EXP BIOL, V112, P225; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Straw AD, 2008, J VISION, V8, DOI 10.1167/8.3.32; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; UUSITALO RO, 1995, J NEUROPHYSIOL, V73, P1782, DOI 10.1152/jn.1995.73.5.1782; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.3.3; van Hateren JH, 2006, J COMP PHYSIOL A, V192, P187, DOI 10.1007/s00359-005-0060-y; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Wolfram V, 2004, J NEUROPHYSIOL, V92, P1918, DOI 10.1152/jn.00201.2004; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	93	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4307	10.1371/journal.pone.0004307	http://dx.doi.org/10.1371/journal.pone.0004307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180196	Green Published, gold, Green Accepted			2022-12-25	WOS:000274089700006
J	Sapin, E; Lapray, D; Berod, A; Goutagny, R; Leger, L; Ravassard, P; Clement, O; Hanriot, L; Fort, P; Luppi, PH				Sapin, Emilie; Lapray, Damien; Berod, Anne; Goutagny, Romain; Leger, Lucienne; Ravassard, Pascal; Clement, Olivier; Hanriot, Lucie; Fort, Patrice; Luppi, Pierre-Herve			Localization of the Brainstem GABAergic Neurons Controlling Paradoxical (REM) Sleep	PLOS ONE			English	Article								Paradoxical sleep (PS) is a state characterized by cortical activation, rapid eye movements and muscle atonia. Fifty years after its discovery, the neuronal network responsible for the genesis of PS has been only partially identified. We recently proposed that GABAergic neurons would have a pivotal role in that network. To localize these GABAergic neurons, we combined immunohistochemical detection of Fos with non-radioactive in situ hybridization of GAD67 mRNA (GABA synthesis enzyme) in control rats, rats deprived of PS for 72 h and rats allowed to recover after such deprivation. Here we show that GABAergic neurons gating PS (PS-off neurons) are principally located in the ventrolateral periaqueductal gray (vlPAG) and the dorsal part of the deep mesencephalic reticular nucleus immediately ventral to it (dDpMe). Furthermore, iontophoretic application of muscimol for 20 min in this area in head-restrained rats induced a strong and significant increase in PS quantities compared to saline. In addition, we found a large number of GABAergic PS-on neurons in the vlPAG/dDPMe region and the medullary reticular nuclei known to generate muscle atonia during PS. Finally, we showed that PS-on neurons triggering PS localized in the SLD are not GABAergic. Altogether, our results indicate that multiple populations of PS-on GABAergic neurons are distributed in the brainstem while only one population of PS-off GABAergic neurons localized in the vlPAG/dDpMe region exist. From these results, we propose a revised model for PS control in which GABAergic PS-on and PS-off neurons localized in the vlPAG/dDPMe region play leading roles.	[Sapin, Emilie; Lapray, Damien; Goutagny, Romain; Leger, Lucienne; Ravassard, Pascal; Clement, Olivier; Hanriot, Lucie; Fort, Patrice; Luppi, Pierre-Herve] CNRS, UMR5167, Lyon, France; [Berod, Anne] Univ Lyon 1, CNRS, FRE3006, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sapin, E (corresponding author), CNRS, UMR5167, Lyon, France.	luppi@sommeil.univ-lyon1.fr	FORT, Patrice/G-6851-2017; goutagny, romain/C-1461-2018; Luppi, Pierre-Hervé/C-4333-2014	FORT, Patrice/0000-0003-1211-8631; goutagny, romain/0000-0002-1268-533X; Luppi, Pierre-Hervé/0000-0002-0503-423X; Clement, Olivier/0000-0002-7193-8931; Ravassard, Pascal/0000-0002-7500-3623	Universite Claude Bernard Lyon1; CNRS; Universite de Lyon; Universite Lyon 1; Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC)	Universite Claude Bernard Lyon1; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; Universite Lyon 1; Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC)	Our sponsors are Universite Claude Bernard Lyon1, CNRS and CNRS, Universite de Lyon, Universite Lyon 1 and the Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; CHASE MH, 1989, J NEUROSCI, V9, P743; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Greco MA, 2001, MOL BRAIN RES, V88, P176, DOI 10.1016/S0169-328X(01)00039-0; GUILLEMINAULT C, 2000, PRINCIPLES PRACTICE; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P33; Peyron C, 1998, J NEUROSCI, V18, P9996; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; RAVASSARD P, SLEEP IN PRESS; Sakai K, 1981, BRAIN MECH PERCEPTUA, P405; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Swanson LW, 1998, BRAIN MAPS STRUCTURE, p[vii, 267]; Vanini G, 2007, NEUROSCIENCE, V145, P1157, DOI 10.1016/j.neuroscience.2006.12.051; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19	35	166	167	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4272	10.1371/journal.pone.0004272	http://dx.doi.org/10.1371/journal.pone.0004272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169414	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482800002
J	Gomis-Ruth, FX				Xavier Gomis-Rueth, F.			Catalytic Domain Architecture of Metzincin Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MATRIX METALLOPROTEINASES; CRYSTAL-STRUCTURE; CYSTEINE SWITCH; SNAKE-VENOM; STRUCTURAL BASIS; ACTIVE-SITE; ASTACIN; FAMILY; ACTIVATION; PROTEASE	Metalloproteases cleave proteins and peptides, and deregulation of their function leads to pathology. An understanding of their structure and mechanisms of action is necessary to the development of strategies for their regulation. Among metallopeptidases are the metzincins, which are mostly multidomain proteins with similar to 130-260-residue globular catalytic domains showing a common core architecture characterized by a long zinc-binding consensus motif, HEXXHXXGXX(H/D), and a methionine-containing Met-turn. Metzincins participate in unspecific protein degradation such as digestion of intake proteins and tissue development, maintenance, and remodeling, but they are also involved in highly specific cleavage events to activate or inactivate themselves or other (pro)enzymes and bioactive peptides. Metzincins are subdivided into families, and seven such families have been analyzed at the structural level: the astacins, ADAMs/adamalysins/reprolysins, serralysins, matrix metalloproteinases, snapalysins, leishmanolysins, and pappalysins. These families are reviewed from a structural point of view.	CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gomis-Ruth, FX (corresponding author), CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es		Gomis-Ruth, F. Xavier/0000-0002-6848-6874	Spanish Public Agencies; European Union [LSHG-2006-018830]; European Union [223101]; National Catalan Government [2005SGR00280];  [BIO2006-02668];  [BIO2009-10334]	Spanish Public Agencies; European Union; European Union(European Commission); National Catalan Government; ; 	This work was supported by Grants BIO2006-02668 and BIO2009-10334 and the CONSOLIDER-INGENIO 2010 Project "La Factoria de Cristalizacion" (CSD2006-00015) from Spanish Public Agencies; European Union FP6 Strep Project LSHG-2006-018830 "CAMP"; European Union FP7 Collaborative Project 223101 "AntiPathoGN"; and Grant 2005SGR00280 from the National Catalan Government.	BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; Baumann U., 2004, HDB PROTEOLYTIC ENZY, V1, P579; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Domingues FS, 2000, J MOL BIOL, V297, P1003, DOI 10.1006/jmbi.2000.3615; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Garcia-Castellanos R, 2007, ARCH BIOCHEM BIOPHYS, V457, P57, DOI 10.1016/j.abb.2006.10.004; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; Hege T, 2001, J MOL BIOL, V314, P181, DOI 10.1006/jmbi.2001.5125; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Kurisu G, 1997, J BIOCHEM, V121, P304; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 2008, CONNECT TISSUE RES, V49, P169, DOI 10.1080/03008200802151698; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schlagenhauf E, 1998, STRUCTURE, V6, P1035, DOI 10.1016/S0969-2126(98)00104-X; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKEDA S, 2009, SEMIN CELL IN PRESS; TALLANT C, 2009, BIOCH BIOPH IN PRESS; Tallant C, 2007, BIOL CHEM, V388, P1243, DOI 10.1515/BC.2007.143; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3	45	154	162	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15353	15357		10.1074/jbc.R800069200	http://dx.doi.org/10.1074/jbc.R800069200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19201757	Green Published, hybrid			2022-12-25	WOS:000266501000002
J	Abdul-Hafez, A; Shu, RJ; Uhal, BD				Abdul-Hafez, Amal; Shu, Ruijie; Uhal, Bruce D.			JunD and HIF-1 alpha mediate transcriptional activation of angiotensinogen by TGF-beta 1 in human lung fibroblasts	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; local angiotensin system; angiotensinogen promoter; activation protein-1	IDIOPATHIC PULMONARY-FIBROSIS; ALVEOLAR EPITHELIAL-CELLS; TRANSFORMING GROWTH FACTOR-BETA(1); BLEOMYCIN-INDUCED APOPTOSIS; DISEASE PROGRESSION; MESANGIAL CELLS; LIVER FIBROSIS; STELLATE CELLS; IN-VITRO; EXPRESSION	Earlier work showed that TGF-beta 1 potently increases angiotensinogen (AGT) gene mRNA in primary human lung fibroblasts. Here the mechanism of TGF-beta 1-induced AGT expression was studied in the IMR90 human lung fibroblast cell line. The increase in AGT mRNA induced by TGF-beta 1 was completely blocked by actinomycin-D. TGF-beta 1 increased the activity of a full-length human AGT promoter-luciferase reporter (AGT-LUC) but did not alter AGT mRNA half-life. Serial deletion analyses revealed that 67% of TGF-beta-inducible AGT-LUC activity resides in a small domain of the AGT core promoter; this domain contains binding sites for hypoxia-inducible factor (HIF)-1 and activation protein-1 (AP-1) transcription factors. TGF-beta 1 increased HIF-1 alpha protein abundance and the activity of a hypoxia-responsive element reporter; overexpression of HIF-1 increased basal AGT-LUC activity. Both oligonucleotide pulldown and chromatin immunoprecipitation assays revealed increased binding of JunD and HIF-1 alpha to the AGT core promoter in response to TGF-beta 1. TGF-beta 1-inducible AGT-LUC was reduced by an AP-1 dominant negative or by mutation of the AP-1 site. Knockdown of either JunD or HIF-1 alpha individually by siRNA partially reduced AGT-LUC. In contrast, simultaneous knockdown of both JunD and HIF-1 alpha completely eliminated TGF-beta 1-inducible AGT-LUC activity. These data suggest that TGF-beta 1 up-regulates AGT transcription in human lung fibroblasts through a mechanism that requires both JunD and HIF-1 alpha binding to the AGT core promoter. They also suggest a molecular mechanism linking hypoxia signaling and fibrogenic stimuli in the lungs.-Abdul-Hafez, A., Shu, R., Uhal, B. D. JunD and HIF-1 alpha mediate transcriptional activation of angiotensinogen by TGF-beta 1 in human lung fibroblasts. FASEB J. 23, 1655-1662 (2009)	[Abdul-Hafez, Amal; Shu, Ruijie; Uhal, Bruce D.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University	Uhal, BD (corresponding author), Michigan State Univ, Dept Physiol, 3197 Biomed & Phys Sci Bldg, E Lansing, MI 48824 USA.	uhal@msu.edu	Abdul-Hafez, Amal/HCH-3743-2022	Abdul-Hafez, Amal/0000-0002-2895-7862	Public Health Service [HL-45136]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045136, R29HL045136] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service grant HL-45136 to B.D.U. and by an American Heart Association predoctoral fellowship to A.A.-H.	Campbell SE, 1997, J MOL CELL CARDIOL, V29, P1947, DOI 10.1006/jmcc.1997.0435; Dixon JB, 2003, J HEPATOL, V39, P967, DOI 10.1016/S0168-8278(03)00459-8; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Jeunemaitre X, 2004, HANDB EXP PHARM, V163/1, P173; Jiang YL, 2007, ACTA BIOCH BIOPH SIN, V39, P73, DOI 10.1111/j.1745-7270.2007.00249.x; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Li XP, 2006, AM J PHYSIOL-LUNG C, V291, pL887, DOI 10.1152/ajplung.00432.2005; Li XP, 2004, AM J PHYSIOL-LUNG C, V287, pL46, DOI 10.1152/ajplung.00442.2003; Li XP, 2003, AM J PHYSIOL-LUNG C, V284, pL501, DOI 10.1152/ajplung.00273.2002; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Marshall RP, 2000, AM J RESP CRIT CARE, V161, P1999, DOI 10.1164/ajrccm.161.6.9907004; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Molina-Molina M, 2008, EUR RESPIR J, V32, P1004, DOI 10.1183/09031936.00015808; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pfafflin A, 2006, CELL PHYSIOL BIOCHEM, V18, P199, DOI 10.1159/000097667; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Shi YF, 2007, FEBS LETT, V581, P203, DOI 10.1016/j.febslet.2006.12.010; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Uhal BD, 1998, AM J PHYSIOL-LUNG C, V275, pL1192, DOI 10.1152/ajplung.1998.275.6.L1192; Uhal BD, 1995, AM J PHYSIOL-LUNG C, V269, pL819, DOI 10.1152/ajplung.1995.269.6.L819; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; Wang RG, 1999, AM J PHYSIOL-LUNG C, V277, pL1158, DOI 10.1152/ajplung.1999.277.6.L1158; Wang RQ, 2000, AM J PHYSIOL-LUNG C, V279, pL143, DOI 10.1152/ajplung.2000.279.1.L143; Weber K T, 2000, J Renin Angiotensin Aldosterone Syst, V1, P295, DOI 10.3317/jraas.2000.058; Xaubet A, 2003, AM J RESP CRIT CARE, V168, P431, DOI 10.1164/rccm.200210-1165OC; Xiao F, 2006, J GASTROEN HEPATOL, V21, P1488, DOI 10.1111/j.1440-1746.2006.04527.x; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231; [No title captured]	36	33	34	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1655	1662		10.1096/fj.08-114611	http://dx.doi.org/10.1096/fj.08-114611			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19211927	Green Published			2022-12-25	WOS:000266652400005
J	Hayes, MJ; Moss, SE				Hayes, Matthew J.; Moss, Stephen E.			Annexin 2 Has a Dual Role as Regulator and Effector of v-Src in Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; ENDOCYTIC VESICLES; ACTIN; CALPACTIN; BINDING; COMPLEX; PROTEIN; P36; IDENTIFICATION	Cell transformation by v-Src involves rearrangement of the actin cytoskeleton, disassembly of focal adhesions, and the development of anchorage-independent growth. Here, we report that this is dependent on annexin 2, a v-Src substrate and calcium-dependent regulator of actin dynamics. Using a thermoactivatable mutant of v-Src, we show that at the permissive temperature, annexin 2 becomes phosphorylated and colocalizes with activated v-Src and focal adhesion kinase both at the plasma membrane and in a Rab11-positive compartment of the endosomal pathway. In cells depleted of annexin 2 by small interfering RNA, v-Src becomes activated at the permissive temperature but does not target to the plasma membrane or to perinuclear vesicles, and cell transformation does not occur. Our findings reveal a dual role for annexin 2, first as a regulator of v-Src trafficking and targeting and second as a v-Src effector in the reorganization of actin.	[Hayes, Matthew J.; Moss, Stephen E.] UCL, Univ Coll London Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England	University of London; University College London	Moss, SE (corresponding author), UCL, Univ Coll London Inst Ophthalmol, Div Cell Biol, 11-43 Bath St, London EC1V 9EL, England.	s.moss@ucl.ac.uk			Wellcome Trust Program [GR072694MF]	Wellcome Trust Program(Wellcome Trust)	This work was supported by Wellcome Trust Program Grant GR072694MF.	Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; de Diesbach P, 2008, EXP CELL RES, V314, P1465, DOI 10.1016/j.yexcr.2008.01.015; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; GARBER EA, 1983, VIROLOGY, V126, P73, DOI 10.1016/0042-6822(83)90462-2; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; HAYES MJ, 2008, BIOCH BIOPH IN PRESS; Hilbig A., 2008, V177, P179; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; MARTIN F, 1988, BIOCHEM J, V251, P777, DOI 10.1042/bj2510777; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Meijne AML, 1997, EXP CELL RES, V234, P477, DOI 10.1006/excr.1997.3637; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SARIS CJM, 1986, CELL, V46, P201, DOI 10.1016/0092-8674(86)90737-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Trischler M, 1999, J CELL SCI, V112, P4773; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamada A, 2005, J BIOL CHEM, V280, P6016, DOI 10.1074/jbc.M408215200; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; YAO H, 2008, LUNG CANC IN PRESS; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	52	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10202	10210		10.1074/jbc.M807043200	http://dx.doi.org/10.1074/jbc.M807043200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193640	Green Published, hybrid			2022-12-25	WOS:000264892900062
J	Poulsen, BE; Rath, A; Deber, CM				Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.			The Assembly Motif of a Bacterial Small Multidrug Resistance Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; TRANSPORTER EMRE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEIN; OLIGOMERIC STATE; TOPOLOGY; SEQUENCE; PARALLEL; REVEALS	Multidrug transporters such as the small multidrug resistance (SMR) family of bacterial integral membrane proteins are capable of conferring clinically significant resistance to a variety of common therapeutics. As antiporter proteins of similar to 100 amino acids, SMRs must self-assemble into homo-oligomeric structures for efflux of drug molecules. Oligomerization centered at transmembrane helix four (TM4) has been implicated in SMR assembly, but the full complement of residues required to mediate its self-interaction remains to be characterized. Here, we use Hsmr, the 110-residue SMR family member of the archaebacterium Halobacterium salinarum, to determine the TM4 residue motif required to mediate drug resistance and SMR self-association. Twelve single point mutants that scan the central portion of the TM4 helix (residues 85-104) were constructed and were tested for their ability to confer resistance to the cytotoxic compound ethidium bromide. Six residues were found to be individually essential for drug resistance activity (Gly(90), Leu(91), Leu(93), Ile(94), Gly(97), and Val(98)), defining a minimum activity motif of (90)GLXLIXXGV(98) within TM4. When the propensity of these mutants to dimerize on SDS-PAGE was examined, replacements of all but Ile resulted in similar to 2-fold reduction of dimerization versus the wild-type antiporter. Our work defines a minimum activity motif of 90GLXLIXXGV98 within TM4 and suggests that this sequence mediates TM4-based SMR dimerization along a single helix surface, stabilized by a small residue heptad repeat sequence. These TM4-TM4 interactions likely constitute the highest affinity locus for disruption of SMR function by directly targeting its self-assembly mechanism.	[Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca	Poulsen, Bradley/AAW-9750-2020		Canadian Institutes of Health Research (CIHR) [CIHR FRN-5810]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR) ( Grant CIHR FRN-5810) ( to C. M. D.).	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Heir E, 1999, INT J FOOD MICROBIOL, V48, P211, DOI 10.1016/S0168-1605(99)00044-6; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LITTLEJOHN TG, 1992, FEMS MICROBIOL LETT, V95, P259; Liu Y, 2002, GENOME BIOL, V3; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Rath A, 2007, FEBS LETT, V581, P1335, DOI 10.1016/j.febslet.2007.02.050; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SMITH SO, 1995, P NATL ACAD SCI USA, V92, P488, DOI 10.1073/pnas.92.2.488; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044	41	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9870	9875		10.1074/jbc.M900182200	http://dx.doi.org/10.1074/jbc.M900182200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224913	hybrid, Green Published			2022-12-25	WOS:000264892900028
J	Avval, FZ; Holmgren, A				Avval, Farnaz Zahedi; Holmgren, Arne			Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEOSIDE TRIPHOSPHATE POOLS; ESCHERICHIA-COLI; DNA-DAMAGE; DIPHOSPHATE REDUCTASE; CALF THYMUS; ALLOSTERIC REGULATION; TISSUE DISTRIBUTION; RECOMBINANT MOUSE; MIXED DISULFIDE; RESTING CELLS	Ribonucleotide reductase (RNR) catalyzes the rate-limiting step in deoxyribonucleotide synthesis essential for DNA replication and repair. RNR in S phase mammalian cells comprises a weak cytosolic complex of the catalytic R1 protein containing redox active cysteine residues and the R2 protein harboring the tyrosine free radical. Each enzyme turnover generates a disulfide in the active site of R1, which is reduced by C-terminally located shuttle dithiols leaving a disulfide to be reduced. Electrons for reduction come ultimately from NADPH via thioredoxin reductase and thioredoxin (Trx) or glutathione reductase, glutathione, and glutaredoxin (Grx), but the mechanism has not been clarified for mammalian RNR. Using recombinant mouse RNR, we found that Trx1 and Grx1 had similar catalytic efficiency (kcat/Km). With 4mM GSH, Grx1 showed a higher affinity (apparent Km value, 0.18 mu M) compared with Trx1 which displayed a higher apparent k(cat), suggesting its major role in S phase DNA replication. Surprisingly, Grx activity was strongly dependent on GSH concentrations (apparent Km value, 3 mM) and a Grx2 C40S mutant was active despite only one cysteine residue in the active site. This demonstrates a GSH-mixed disulfide mechanism for glutaredoxin catalysis in contrast to the dithiol mechanism for thioredoxin. This may be an advantage with the low levels of RNR for DNA repair or in tumor cells with high RNR and no or low Trx expression. Our results demonstrate mechanistic differences between the mammalian and canonical Escherichia coli RNR enzymes, which may offer an explanation for the nonconserved shuttle dithiol sequences in the C terminus of the R1.	[Avval, Farnaz Zahedi; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se		Zahedi Avval, Farnaz/0000-0001-8915-3596	Swedish Research Council Medicine [3529]; Swedish Cancer Society [961]; K. A. Wallenberg Foundation; Ministry of Health and Medical Education of Iran	Swedish Research Council Medicine(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ministry of Health and Medical Education of Iran	This work was supported in part by Swedish Research Council Medicine Grant 3529, Swedish Cancer Society Grant 961, and funds from the K. A. Wallenberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a scholarship from the Ministry of Health and Medical Education of Iran.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Berardi MJ, 1998, BIOCHEMISTRY-US, V37, P5849, DOI 10.1021/bi972924d; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Camier S, 2007, FREE RADICAL BIO MED, V42, P1008, DOI 10.1016/j.freeradbiomed.2006.12.027; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; DAVIS R, 1994, J BIOL CHEM, V269, P23171; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; ERIKSSON S, 1975, EUR J BIOCHEM, V56, P289, DOI 10.1111/j.1432-1033.1975.tb02232.x; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HANSSON HA, 1986, EXP CELL RES, V163, P363, DOI 10.1016/0014-4827(86)90067-4; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOPPER S, 1983, J BIOL CHEM, V258, P3453; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Koc A, 2006, J BIOL CHEM, V281, P15058, DOI 10.1074/jbc.M601968200; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; KUCERA R, 1982, ARCH BIOCHEM BIOPHYS, V214, P102, DOI 10.1016/0003-9861(82)90012-1; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; REDDY GPV, 1982, J BIOL CHEM, V257, P2526; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; ROZELL B, 1993, EUR J CELL BIOL, V62, P314; Sjoberg BM, 2002, METHOD ENZYMOL, V348, P1; SLABAUGH MB, 1984, J VIROL, V52, P501, DOI 10.1128/JVI.52.2.501-506.1984; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xue LJ, 2003, CANCER RES, V63, P980; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112	62	110	114	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8233	8240		10.1074/jbc.M809338200	http://dx.doi.org/10.1074/jbc.M809338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176520	Green Published, hybrid			2022-12-25	WOS:000264397800006
J	Wang, ZP; Zhang, SC; Tong, Z; Li, L; Wang, GF				Wang, Zhiping; Zhang, Shicui; Tong, Zhou; Li, Lei; Wang, Guangfeng			Maternal Transfer and Protective Role of the Alternative Complement Components in Zebrafish Danio rerio	PLOS ONE			English	Article								Embryos of most fish develop externally and are exposed to an aquatic environment full of potential pathogens, whereas they have little or only limited ability to mount an efficient and protective response. How fish embryos survive pathogenic attacks remains poorly defined. Here we demonstrate that the maternal immunization of female zebrafish with formalin-killed Aeromonas hydrophila causes a significant increase in C3 and Bf contents in the mother, a corresponding rise in the offspring, and induces a remarkable increase in the hemolytic activities in both the mother and offspring. In addition, the embryos derived from the immunized mother are significantly more tolerant to A. hydrophila challenge than those from the unimmunized fish, and blocking C3 and Bf activities by injection of the antibodies against C3 and Bf into the embryos render them more susceptible to A. hydrophila. These results clearly show that the protection of zebrafish embryos against A. hydrophila can be achieved by the maternally-transferred immunity of the complement system operating via the alternative pathway. This appears to be the first report providing in vivo evidences for the protective role of the alternative complement components in the early embryos of zebrafish, paving the way for insights into the in vivo function of other maternally-transferred factors in fish.	[Wang, Zhiping; Zhang, Shicui; Tong, Zhou; Li, Lei; Wang, Guangfeng] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China	Ocean University of China	Wang, ZP (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn			Natural Science Foundation of China (NSFC) [30730072]; Ministry of Science and Technology (MOST) of China [2006CB101805]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China)	This work was supported by grants (30730072) of Natural Science Foundation of China (NSFC) and grants (2006CB101805) of Ministry of Science and Technology (MOST) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILDFELL R J, 1992, Journal of Aquatic Animal Health, V4, P97, DOI 10.1577/1548-8667(1992)004&lt;0097:PAPCOA&gt;2.3.CO;2; BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; Brown LL, 1997, DIS AQUAT ORGAN, V31, P95, DOI 10.3354/dao031095; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Choi JH, 2002, FISHERIES SCI, V68, P1367, DOI 10.1046/j.1444-2906.2002.00576.x; Ekdahl KN, 2007, CLIN VACCINE IMMUNOL, V14, P549, DOI 10.1128/CVI.00486-06; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Ellis A. E., 1988, Fish vaccination., P20; Hanif A, 2004, FISH SHELLFISH IMMUN, V17, P411, DOI 10.1016/j.fsi.2004.04.013; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Holbech H, 2001, COMP BIOCHEM PHYS C, V130, P119, DOI 10.1016/S1532-0456(01)00229-0; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; Jung WK, 2003, INT J BIOCHEM CELL B, V35, P255, DOI 10.1016/S1357-2725(02)00176-0; KANLIS G, 1995, FISHERIES SCI, V61, P791, DOI 10.2331/fishsci.61.791; Li Jun-Feng, 2005, Yichuan, V27, P797; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Oshima S, 1996, J GEN VIROL, V77, P2441, DOI 10.1099/0022-1317-77-10-2441; Picchietti S, 2006, FISH SHELLFISH IMMUN, V20, P398, DOI 10.1016/j.fsi.2005.06.001; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; PLOUG M, 1985, ANAL BIOCHEM, V146, P411, DOI 10.1016/0003-2697(85)90560-3; SIN YM, 1994, AQUACULTURE, V120, P229, DOI 10.1016/0044-8486(94)90081-7; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Swain P, 2006, FISH SHELLFISH IMMUN, V20, P519, DOI 10.1016/j.fsi.2005.06.011; Takemura A, 1997, FISH SHELLFISH IMMUN, V7, P355, DOI 10.1006/fsim.1997.0090; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; van Loon J. J. A, 1981, ASPECTS DEV COMP IMM, P469; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; YOUSIF AN, 1991, DIS AQUAT ORGAN, V10, P45, DOI 10.3354/dao010045; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207	39	49	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4498	10.1371/journal.pone.0004498	http://dx.doi.org/10.1371/journal.pone.0004498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223977	Green Published, Green Submitted, gold			2022-12-25	WOS:000265485800007
J	Abdullah, NM; Rosania, GR; Shedden, K				Abdullah, Newaj M.; Rosania, Gus R.; Shedden, Kerby			Selective Targeting of Tumorigenic Cancer Cell Lines by Microtubule Inhibitors	PLOS ONE			English	Article								For anticancer drug therapy, it is critical to kill those cells with highest tumorigenic potential, even when they comprise a relatively small fraction of the overall tumor cell population. We have used the established NCI/DTP 60 cell line growth inhibition assay as a platform for exploring the relationship between chemical structure and growth inhibition in both tumorigenic and non-tumorigenic cancer cell lines. Using experimental measurements of "take rate'' in ectopic implants as a proxy for tumorigenic potential, we identified eight chemical agents that appear to strongly and selectively inhibit the growth of the most tumorigenic cell lines. Biochemical assay data and structure-activity relationships indicate that these compounds act by inhibiting tubulin polymerization. Yet, their activity against tumorigenic cell lines is more selective than that of the other microtubule inhibitors in clinical use. Biochemical differences in the tubulin subunits that make up microtubules, or differences in the function of microtubules in mitotic spindle assembly or cell division may be associated with the selectivity of these compounds.	[Rosania, Gus R.] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Shedden, Kerby] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Rosania, Gus R.; Shedden, Kerby] MACE, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Abdullah, NM (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	grosania@umich.edu; kshedden@umich.edu		Shedden, Kerby/0000-0001-7222-6664	United States National Institutes of Health [P20HG003890]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078200] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	United States National Institutes of Health grant P20HG003890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; Chen K, 1997, J MED CHEM, V40, P3049, DOI 10.1021/jm970146h; Chen K, 1997, J MED CHEM, V40, P2266, DOI 10.1021/jm960858s; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; KOU SC, 1993, J MED CHEM, V36, P1146; LI L, 1994, J MED CHEM, V37, P1126, DOI 10.1021/jm00034a010; LI LP, 1994, J MED CHEM, V37, P3400, DOI 10.1021/jm00046a025; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; PETTIT GR, 1995, J MED CHEM, V38, P1666, DOI 10.1021/jm00010a011; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SCHATTEN G, 1986, DEV BIOL, V130, P74; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TEICHER BA, 1997, ANTICANCER DRUG DEV, P104; VANOSDOL WW, 1994, J NATL CANCER I, V86, P1855; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WARN RM, 1990, CELL MOTIL CYTOSKEL, V17, P34, DOI 10.1002/cm.970170106; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wilson PG, 1997, DEV BIOL, V184, P207, DOI 10.1006/dbio.1997.8545; Xia Y, 1998, J MED CHEM, V41, P1155, DOI 10.1021/jm9707479; Xia Y, 2001, J MED CHEM, V44, P3932, DOI 10.1021/jm0101085	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4470	10.1371/journal.pone.0004470	http://dx.doi.org/10.1371/journal.pone.0004470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214225	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484300009
J	Hu, M; Qin, ZHS				Hu, Ming; Qin, Zhaohui S.			Query Large Scale Microarray Compendium Datasets Using a Model-Based Bayesian Approach with Variable Selection	PLOS ONE			English	Article							GENE-EXPRESSION DATA; GENOME; IDENTIFICATION; ALGORITHM; NETWORKS; PATTERNS; FAMILY; GUILT	In microarray gene expression data analysis, it is often of interest to identify genes that share similar expression profiles with a particular gene such as a key regulatory protein. Multiple studies have been conducted using various correlation measures to identify co-expressed genes. While working well for small datasets, the heterogeneity introduced from increased sample size inevitably reduces the sensitivity and specificity of these approaches. This is because most co-expression relationships do not extend to all experimental conditions. With the rapid increase in the size of microarray datasets, identifying functionally related genes from large and diverse microarray gene expression datasets is a key challenge. We develop a model-based gene expression query algorithm built under the Bayesian model selection framework. It is capable of detecting co-expression profiles under a subset of samples/experimental conditions. In addition, it allows linearly transformed expression patterns to be recognized and is robust against sporadic outliers in the data. Both features are critically important for increasing the power of identifying co-expressed genes in large scale gene expression datasets. Our simulation studies suggest that this method outperforms existing correlation coefficients or mutual information-based query tools. When we apply this new method to the Escherichia coli microarray compendium data, it identifies a majority of known regulons as well as novel potential target genes of numerous key transcription factors.	[Hu, Ming; Qin, Zhaohui S.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hu, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	qin@umich.edu	Qin, Zhaohui S/E-8196-2011; Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui S/0000-0002-1583-146X; Qin, Zhaohui/0000-0002-1583-146X; Hu, Ming/0000-0002-6062-8794	University of Michigan [CCMB pilot grant]; University of Michigan Rackham Graduate School; Department of Biostatistics at the University of Michigan [Richard G. Cornell Fellowship]	University of Michigan(University of Michigan System); University of Michigan Rackham Graduate School(University of Michigan System); Department of Biostatistics at the University of Michigan	This work is partially supported by a University of Michigan CCMB pilot grant, a spring/summer research grant from the University of Michigan Rackham Graduate School and the Richard G. Cornell Fellowship from the Department of Biostatistics at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Butte A J, 2000, Pac Symp Biocomput, P418; Chen R, 1996, J ROY STAT SOC B MET, V58, P397; Cheng Y., 2000, P 8 INT C INT SYST M, P93; DHOLLANDER T, 2007, BIOINFORMATICS; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GELMAN A, 1995, BAYESIAN DATA ANAL, pR19; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Ghosh D, 2002, BIOINFORMATICS, V18, P275, DOI 10.1093/bioinformatics/18.2.275; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kim S, 2006, BIOMETRIKA, V93, P877, DOI 10.1093/biomet/93.4.877; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; LIU JS, 2001, MONTE CARLO STRATEGI; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; Medvedovic M, 2002, BIOINFORMATICS, V18, P1194, DOI 10.1093/bioinformatics/18.9.1194; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Owen AB, 2003, GENOME RES, V13, P1828, DOI 10.1101/gr.1125403; Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sheng QZ, 2003, BIOINFORMATICS, V19, pII196, DOI 10.1093/bioinformatics/btg1078; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4495	10.1371/journal.pone.0004495	http://dx.doi.org/10.1371/journal.pone.0004495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214232	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484300018
J	Dahlberg, C; Auger, H; Dupont, S; Sasakura, Y; Thorndyke, M; Joly, JS				Dahlberg, Carl; Auger, Helene; Dupont, Sam; Sasakura, Yasunori; Thorndyke, Mike; Joly, Jean-Stephane			Refining the Ciona intestinalis Model of Central Nervous System Regeneration	PLOS ONE			English	Article								Background: New, practical models of central nervous system regeneration are required and should provide molecular tools and resources. We focus here on the tunicate Ciona intestinalis, which has the capacity to regenerate nerves and a complete adult central nervous system, a capacity unusual in the chordate phylum. We investigated the timing and sequence of events during nervous system regeneration in this organism. Methodology/Principal Findings: We developed techniques for reproducible ablations and for imaging live cellular events in tissue explants. Based on live observations of more than 100 regenerating animals, we subdivided the regeneration process into four stages. Regeneration was functional, as shown by the sequential recovery of reflexes that established new criteria for defining regeneration rates. We used transgenic animals and labeled nucleotide analogs to describe in detail the early cellular events at the tip of the regenerating nerves and the first appearance of the new adult ganglion anlage. Conclusions/Significance: The rate of regeneration was found to be negatively correlated with adult size. New neural structures were derived from the anterior and posterior nerve endings. A blastemal structure was implicated in the formation of new neural cells. This work demonstrates that Ciona intestinalis is as a useful system for studies on regeneration of the brain, brain-associated organs and nerves.			Dahlberg, C (corresponding author), Univ Gothenburg, Dept Marine Ecol, Fiskebacksill, Sweden.	carl.dahlberg@marecol.gu.se; auger@inaf.cnrs-gif.fr	Dupont, Sam T/F-5527-2013	Dahlberg, Carl Martin Olof/0000-0002-9384-2666	INRA; CNRS; French GIS Institut de la Genomique Marine; Plurigenes STREP project [LSHG-CT-2005-018673]; Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; MRT [PhD fellowship]; ARC [PhD fellowship]; Marine Genomics Network for Women in Science Gender Action Plan [fellowship]; MEXT [17018018]; NIG Cooperative Research Program [2008-B02]; National Bioresource Project [07128019, 07128021]	INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); French GIS Institut de la Genomique Marine; Plurigenes STREP project; Marine Genomics Network of Excellence; MRT; ARC(Australian Research Council); Marine Genomics Network for Women in Science Gender Action Plan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIG Cooperative Research Program; National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work carried out at Gif was supported by INRA, CNRS, the French GIS Institut de la Genomique Marine, the Plurigenes STREP project LSHG-CT-2005-018673, the Marine Genomics Network of Excellence (EU-FP6 contract no. GOCE-CT-2004-505403). H. Auger held a PhD fellowship from MRT and ARC and a fellowship from the Marine Genomics Network for Women in Science Gender Action Plan. Y. Sasakura was supported by Grants-in-Aid for Scientific Research for a Priority Area from MEXT (17018018) and the NIG Cooperative Research Program (2008-B02). The E15 transgenic line was provided by the National Bioresource Project (07128019 and 07128021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Awazu S, 2007, GENESIS, V45, P307, DOI 10.1002/dvg.20290; BOLLNER T, 1993, CELL TISSUE RES, V272, P553, DOI 10.1007/BF00318562; BOLLNER T, 1992, J COMP NEUROL, V325, P572, DOI 10.1002/cne.903250409; Bollner T, 1997, P ROY SOC B-BIOL SCI, V264, P1117, DOI 10.1098/rspb.1997.0154; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bullock T., 1965, STRUCTURE FUNCTION N; Carnevali MDC, 2001, MAR ECOL PROG SER, V215, P155, DOI 10.3354/meps215155; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; CHAMBOST D, 1966, CR ACAD SCI D NAT, P969; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deyts C, 2006, EUR J NEUROSCI, V24, P2299, DOI 10.1111/j.1460-9568.2006.05073.x; Dupont S, 2006, J EXP BIOL, V209, P3873, DOI 10.1242/jeb.02445; Gould RM, 2005, BIOL BULL-US, V209, P49, DOI 10.2307/3593141; Gunnarsson JS, 1999, ENVIRON TOXICOL CHEM, V18, P1534, DOI 10.1002/etc.5620180728; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; JOLY JS, 2007, SEMINARS CELL DEV BI; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kawamura K, 2008, DEV DYNAM, V237, P1812, DOI 10.1002/dvdy.21592; Koster RW, 2006, J NEUROSCI, V26, P7293, DOI 10.1523/JNEUROSCI.0095-06.2006; KOYAMA H, 1993, J COMP NEUROL, V338, P549, DOI 10.1002/cne.903380405; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lender T., 1964, Bulletin de la Societe Zoologique de France, V89, P546; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Mackie GO, 2006, CAN J ZOOL, V84, P1146, DOI 10.1139/Z06-106; MACKIE GO, 1995, J MAR BIOL ASSOC UK, V75, P141, DOI 10.1017/S0025315400015253; Mackie GO, 2000, CAN J ZOOL, V78, P1626, DOI 10.1139/cjz-78-9-1626; MILLAR R, 1953, CIONA LIVERPOOL; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Petersen JK, 1997, J EXP MAR BIOL ECOL, V218, P1; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rinkevich Y, 2007, DEV BIOL, V312, P131, DOI 10.1016/j.ydbio.2007.09.005; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y	39	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4458	10.1371/journal.pone.0004458	http://dx.doi.org/10.1371/journal.pone.0004458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212465	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484200013
J	Rosu, V; Ahmed, N; Paccagnini, D; Gerlach, G; Fadda, G; Hasnain, SE; Zanetti, S; Sechi, LA				Rosu, Valentina; Ahmed, Niyaz; Paccagnini, Daniela; Gerlach, Gerald; Fadda, Giovanni; Hasnain, Seyed E.; Zanetti, Stefania; Sechi, Leonardo A.			Specific Immunoassays Confirm Association of Mycobacterium avium Subsp paratuberculosis with Type-1 but Not Type-2 Diabetes Mellitus	PLOS ONE			English	Article								Background: Mycobacterium avium subspecies paratuberculosis ( MAP) is a versatile pathogen with a broad host range. Its association with type-1 diabetes mellitus (T1DM) has been recently proposed. Rapid identification of infectious agents such as MAP in diabetic patients at the level of clinics might be helpful in deciphering the role of chronic bacterial infection in the development of autoimmune diseases such as T1DM. Methodology/Principal Findings: We describe use of an ELISA method to identify live circulating MAP through the detection of a cell envelope protein, MptD by a specific M13 phage - fMptD. We also used another ELISA format to detect immune response to MptD peptide. Both the methods were tested with blood plasma obtained from T1DM, type-2 diabetes (T2DM) patients and non-diabetic controls. Our results demonstrate MptD and fMptD ELISA assays to be accurate and sensitive to detect MAP bacilli in a large fraction (47.3%) of T1DM patients as compared to non-diabetic controls (12.6%) and those with confirmed T2DM (7.7%). Comparative analysis of ELISA assays performed here with 3 other MAP antigen preparations, namely HbHA, Gsd and whole cell MAP lysates confirmed comparable sensitivity of the MptD peptide and the fMptD based ELISA assays. Moreover, we were successful in demonstrating positive bacterial culture in two of the clinical specimen derived from T1DM patients. Conclusions and Significance: The MptD peptide/fMptD based ELISA or similar tests could be suggested as rapid and specific field level diagnostic tests for the identification of MAP in diabetic patients and for finding the explanations towards the occurrence of type-1 or type-2 diabetes in the light of an active infectious trigger.	[Rosu, Valentina; Paccagnini, Daniela; Zanetti, Stefania; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol, I-07100 Sassari, Italy; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Lab Pathogen Biol, Hyderabad 500134, Andhra Pradesh, India; [Gerlach, Gerald] Univ Vet Med, Hannover, Germany; [Fadda, Giovanni] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	University of Sassari; University of Hyderabad; University of Veterinary Medicine Hannover, Foundation; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Rosu, V (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol, I-07100 Sassari, Italy.	sechila@uniss.it	Sechi, Leonardo Antonio/Y-3109-2018; Fadda, Giovanni/K-6224-2012; Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583; sechi, leonardo antonio/0000-0003-0566-2049; Hasnain, Seyed/0000-0002-2967-0791	MIUR; University of Sassari; Italian Government/University of Sassari [visiting scientist]; Department of Biotechnology of the Indian Government, Mycobacterium-w program; University of Hyderabad [Bose National Fellow]	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Sassari; Italian Government/University of Sassari; Department of Biotechnology of the Indian Government, Mycobacterium-w program; University of Hyderabad(University of Hyderabad)	LAS would like to acknowledge support from the MIUR and the University of Sassari. NA was supported through a visiting scientist scheme of the Italian Government/University of Sassari and also would like to acknowledge the Department of Biotechnology of the Indian Government for funding support through a grant under Mycobacterium-w program. SEH is a JC Bose National Fellow at the University of Hyderabad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannantine JP, 2008, INFECT IMMUN, V76, P739, DOI 10.1128/IAI.00915-07; Bromeyer L, 2005, MED HYPOTHESES, V65, P433, DOI 10.1016/j.mehy.2005.04.017; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; CHILD DF, 1995, DIABETIC MED, V12, P595, DOI 10.1111/j.1464-5491.1995.tb00548.x; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Davies JM, 1997, IMMUNOL CELL BIOL, V75, P113, DOI 10.1038/icb.1997.16; Dow CT, 2006, MED HYPOTHESES, V67, P782, DOI 10.1016/j.mehy.2006.04.029; Feige U, 1996, EXS, V77, P359; Frongia O, 2001, DIABETES CARE, V24, P1846, DOI 10.2337/diacare.24.10.1846; HEINZMANN J, 2008, VET MICROBI IN PRESS; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; MARTIN LALANDE J, 1964, Rev Tuberc Pneumol (Paris), V28, P342; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Rosu Valentina, 2008, Ann Clin Microbiol Antimicrob, V7, P9, DOI 10.1186/1476-0711-7-9; Rowe MT, 2006, LETT APPL MICROBIOL, V42, P305, DOI 10.1111/j.1472-765X.2006.01873.x; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Sechi LA, 2006, VACCINE, V24, P236, DOI 10.1016/j.vaccine.2005.11.030; Sechi LA, 2005, J CLIN MICROBIOL, V43, P5275, DOI 10.1128/JCM.43.10.5275-5277.2005; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Sechi LA, 2006, WORLD J GASTROENTERO, V12, P7161, DOI 10.3748/wjg.v12.i44.7161; Stratmann J, 2004, INFECT IMMUN, V72, P1265, DOI 10.1128/IAI.72.3.1265-1274.2004; Stratmann J, 2006, APPL ENVIRON MICROB, V72, P5150, DOI 10.1128/AEM.00590-06; TOBA M, 1954, Kekkaku, V29, P86; van Halteren AGS, 2002, J AUTOIMMUN, V18, P139, DOI 10.1006/jaut.2001.0578	30	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4386	10.1371/journal.pone.0004386	http://dx.doi.org/10.1371/journal.pone.0004386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204799	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484000003
J	Wee, KB; Surana, U; Aguda, BD				Wee, Keng Boon; Surana, Uttam; Aguda, Baltazar D.			Oscillations of the p53-Akt Network: Implications on Cell Survival and Death	PLOS ONE			English	Article								Intracellular protein levels of p53 and MDM2 have been shown to oscillate in response to ionizing radiation (IR), but the physiological significance of these oscillations remains unclear. The p53-MDM2 negative feedback loop - the putative cause of the oscillations - is embedded in a network involving a mutual antagonism (or positive feedback loop) between p53 and AKT. We have shown earlier that this p53-AKT network predicts an all-or-none switching behavior between a pro-survival cellular state (low p53 and high AKT levels) and a pro-apoptotic state (high p53 and low AKT levels). Here, we show that upon exposure to IR, the p53-AKT network can also reproduce the experimentally observed p53 and MDM2 oscillations. The present work is based on the hypothesis that the physiological significance of the experimentally observed oscillations could be found in their role in regulating the switching behavior of the p53-AKT network between pro-survival and proapoptotic states. It is shown here that these oscillations are associated with a significant decrease in the threshold level of IR at which switching from a pro-survival to a pro-apoptotic state occurs. Moreover, oscillations in p53 protein levels induce higher levels of expression of p53-target genes compared to non-oscillatory p53, and thus influence cell-fate decisions between cell cycle arrest/DNA damage repair versus apoptosis.	[Surana, Uttam] ASTAR, Inst Mol & Cell Biol, Proteos, Singapore; [Aguda, Baltazar D.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Aguda, Baltazar D.] Ohio State Univ, OSU Med Ctr, Ctr Critical Care, Columbus, OH 43210 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wee, KB (corresponding author), ASTAR, Inst Mol & Cell Biol, Proteos, Singapore.	bdaguda@mbi.osu.edu	Surana, Uttam/H-1142-2011	Surana, Uttam/0000-0002-4785-6514	A*STAR [Graduate Scholarship]; Mathematical Biosciences Institute; Center for Critical Care, Medical Center, at The Ohio State University	A*STAR(Agency for Science Technology & Research (A*STAR)); Mathematical Biosciences Institute; Center for Critical Care, Medical Center, at The Ohio State University	K. B. Wee is a recipient of an A*STAR Graduate Scholarship. B. D. Aguda is supported by the Mathematical Biosciences Institute, and the Center for Critical Care, Medical Center, at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Collister M, 1998, CARCINOGENESIS, V19, P2115, DOI 10.1093/carcin/19.12.2115; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Grill CJ, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290153; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Jiang P, 2007, CELL RES, V17, P283, DOI 10.1038/cr.2007.19; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Maier D, 1998, ONCOGENE, V16, P3331, DOI 10.1038/sj.onc.1201832; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohnishi T, 1999, RADIAT RES, V151, P368, DOI 10.2307/3579950; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Tyson JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100060; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wee KB, 2006, BIOPHYS J, V91, P857, DOI 10.1529/biophysj.105.077693; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhao RB, 2000, GENE DEV, V14, P981; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	83	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4407	10.1371/journal.pone.0004407	http://dx.doi.org/10.1371/journal.pone.0004407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197384	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483700014
J	Turakainen, H; Saarimaki-Vire, J; Sinjushina, N; Partanen, J; Savilahti, H				Turakainen, Hilkka; Saarimaeki-Vire, Jonna; Sinjushina, Natalia; Partanen, Juha; Savilahti, Harri			Transposition-Based Method for the Rapid Generation of Gene-Targeting Vectors to Produce Cre/Flp-Modifiable Conditional Knock-Out Mice	PLOS ONE			English	Article							VITRO DNA TRANSPOSITION; SITE-SPECIFIC RECOMBINATION; IN-VITRO; ESCHERICHIA-COLI; BACTERIOPHAGE MU; MAMMALIAN-CELLS; CRE RECOMBINASE; TRANSGENIC MICE; MOUSE; ACTIVATION	Conditional gene targeting strategies are progressively used to study gene function tissue-specifically and/or at a defined time period. Instrumental to all of these strategies is the generation of targeting vectors, and any methodology that would streamline the procedure would be highly beneficial. We describe a comprehensive transposition-based strategy to produce gene-targeting vectors for the generation of mouse conditional alleles. The system employs a universal cloning vector and two custom-designed mini-Mu transposons. It produces targeting constructions directly from BAC clones, and the alleles generated are modifiable by Cre and Flp recombinases. We demonstrate the applicability of the methodology by modifying two mouse genes, Chd22 and Drapc1. This straightforward strategy should be readily suitable for high-throughput targeting vector production.	[Savilahti, Harri] Univ Helsinki, Inst Biotechnol, Program Cellular Biotechnol, Viikki Bioctr, Helsinki, Finland; [Saarimaeki-Vire, Jonna; Sinjushina, Natalia; Partanen, Juha] Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Program Dev Biol, FIN-00014 Helsinki, Finland; [Savilahti, Harri] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Helsinki; University of Helsinki; University of Turku	Turakainen, H (corresponding author), Univ Helsinki, Inst Biotechnol, Program Cellular Biotechnol, Viikki Bioctr, Helsinki, Finland.	harri.savilahti@utu.fi		Partanen, Juha/0000-0001-8850-4825; Saarimaki-Vire, Jonna/0000-0002-8865-7060; Savilahti, Harri/0000-0002-6246-2572	Academy of Finland; National Technology Agency of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology; Viikki Graduate School of Biosciences	Academy of Finland(Academy of Finland); National Technology Agency of Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki Graduate School in Biotechnology and Molecular Biology; Viikki Graduate School of Biosciences	This study was supported by the Academy of Finland and the National Technology Agency of Finland (TEKES). Additional financial support was provided by the Sigrid Juselius Foundation and the Finnish Cultural Foundation as well as the Helsinki Graduate School in Biotechnology and Molecular Biology (J.S.-V.) and the Viikki Graduate School of Biosciences (N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin A, 1996, MOL CELL BIOL, V16, P1851; Aoyama M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni055; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Chaconas George, 2002, P384; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Haapa S, 1999, GENOME RES, V9, P308; Haapa-Paananen S, 2002, J BIOL CHEM, V277, P2843, DOI 10.1074/jbc.M108044200; HOGAN B, 1994, MANIPULATING MOUSE G; Jukkola T, 2005, GENESIS, V43, P148, DOI 10.1002/gene.20163; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kekarainen T, 2002, GENOME RES, V12, P584, DOI 10.1101/gr.220702; KOES R, 1995, P NATL ACAD SCI USA, V92, P8149, DOI 10.1073/pnas.92.18.8149; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Laurent LC, 2000, J VIROL, V74, P2760, DOI 10.1128/JVI.74.6.2760-2769.2000; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;200::AID-BIES3&gt;3.0.CO;2-V; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Orsini L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm070; Pajunen M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm563; Poussu E, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni102; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sambrook J, 2001, MOL CLONING LAB MANU; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; Taira S, 1999, MOL MICROBIOL, V34, P736, DOI 10.1046/j.1365-2958.1999.01635.x; Vilen H, 2003, J VIROL, V77, P123, DOI 10.1128/JVI.77.1.123-134.2003; Vilen H, 2001, TRANSGENIC RES, V10, P69, DOI 10.1023/A:1008959231644; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7; Zhang CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni014; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; ZON LI, 1989, BIOTECHNIQUES, V7, P696; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	41	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4341	10.1371/journal.pone.0004341	http://dx.doi.org/10.1371/journal.pone.0004341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194496	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483600002
J	Meyer-Hoffert, U; Wu, ZH; Schroder, JM				Meyer-Hoffert, Ulf; Wu, Zhihong; Schroeder, Jens-Michael			Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor	PLOS ONE			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; STRATUM-CORNEUM; LAMELLAR GRANULES; SERINE PROTEASES; HUMAN EPIDERMIS; LEKTI; EXPRESSION; BLAST; PROLIFERATION; DESQUAMATION	Kallikreins-related peptidases (KLKs) are serine proteases and have been implicated in the desquamation process of the skin. Their activity is tightly controlled by epidermal protease inhibitors like the lympho-epithelial Kazal-type inhibitor ( LEKTI). Defects of the LEKTI-encoding gene serine protease inhibitor Kazal type (Spink) 5 lead to the absence of LEKTI and result in the genodermatose Netherton syndrome, which mimics the common skin disease atopic dermatitis. Since many KLKs are expressed in human skin with KLK5 being considered as one of the most important KLKs in skin desquamation, we proposed that more inhibitors are present in human skin. Herein, we purified from human stratum corneum by HPLC techniques a new KLK5-inhibiting peptide encoded by a member of the Spink family, designated as Spink9 located on chromosome 5p33.1. This peptide is highly homologous to LEKTI and was termed LEKTI-2. Recombinant LEKTI-2 inhibited KLK5 but not KLK7, 14 or other serine proteases tested including trypsin, plasmin and thrombin. Spink9 mRNA expression was detected in human skin samples and in cultured keratinocytes. LEKTI-2 immune-expression was focally localized at the stratum granulosum and stratum corneum at palmar and plantar sites in close localization to KLK5. At sites of plantar hyperkeratosis, LEKTI-2 expression was increased. We suggest that LEKTI-2 contributes to the regulation of the desquamation process in human skin by specifically inhibiting KLK5.	[Meyer-Hoffert, Ulf; Wu, Zhihong; Schroeder, Jens-Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Meyer-Hoffert, U (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Campus Kiel, Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Wu, Zhihong/G-3569-2011; Wu, Zhihong/AAK-3433-2020; Schroeder, Jens M/B-3994-2009	Meyer-Hoffert, Ulf/0000-0003-2305-1428; 	Deutsche Forschungsgemeinschaft [SFB 617, SCHR305/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SFB 617 and SCHR305/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; GRIFFITHS WA, 1998, TXB DERMATOLOGY, P1486; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knies Y, 2006, EXP DERMATOL, V15, P347, DOI 10.1111/j.0906-6705.2006.00422.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer-Hoffert U, 2004, J INVEST DERMATOL, V123, P338, DOI 10.1111/j.0022-202X.2004.23202.x; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; Schroder JM, 1997, METHOD ENZYMOL, V288, P266; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SONDELL B, 1995, J INVEST DERMATOL, V104, P819, DOI 10.1111/1523-1747.ep12607007; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yano S, 2006, EXP DERMATOL, V15, P356, DOI 10.1111/j.0906-6705.2006.00425.x; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	40	52	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4372	10.1371/journal.pone.0004372	http://dx.doi.org/10.1371/journal.pone.0004372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190773	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483300011
J	Slominski, AT; Zmijewski, MA; Semak, I; Sweatman, T; Janjetovic, Z; Li, W; Zjawiony, JK; Tuckey, RC				Slominski, Andrzej T.; Zmijewski, Michal A.; Semak, Igor; Sweatman, Trevor; Janjetovic, Zorica; Li, Wei; Zjawiony, Jordan K.; Tuckey, Robert C.			Sequential Metabolism of 7-Dehydrocholesterol to Steroidal 5,7-Dienes in Adrenal Glands and Its Biological Implication in the Skin	PLOS ONE			English	Article							LEMLI-OPITZ-SYNDROME; SIDE-CHAIN CLEAVAGE; CYTOCHROME P450SCC; STEROIDOGENIC ENZYMES; CELL-LINE; VITAMIN-D; HPA AXIS; CHOLESTEROL; PATHWAY; MITOCHONDRIA	Since P450scc transforms 7-dehydrocholesterol (7DHC) to 7-dehydropregnenolone (7DHP) in vitro, we investigated sequential 7DHC metabolism by adrenal glands ex vivo. There was a rapid, time- and dose-dependent metabolism of 7DHC by adrenals from rats, pigs, rabbits and dogs with production of more polar 5,7-dienes as detected by RP-HPLC. Based on retention time (RT), UV spectra and mass spectrometry, we identified the major products common to all tested species as 7DHP, 22-hydroxy-7DHC and 20,22-dihydroxy-7DHC. The involvement of P450scc in adrenal metabolic transformation was confirmed by the inhibition of this process by DL-aminoglutethimide. The metabolism of 7DHC with subsequent production of 7DHP was stimulated by forscolin indicating involvement of cAMP dependent pathways. Additional minor products of 7DHC metabolism that were more polar than 7DHP were identified as 17-hydroxy-7DHP ( in pig adrenals but not those of rats) and as pregna-4,7-diene-3,20-dione (7-dehydroprogesterone). Both products represented the major identifiable products of 7DHP metabolism in adrenal glands. Studies with purified enzymes show that StAR protein likely transports 7DHC to the inner mitochondrial membrane, that 7DHC can compete effectively with cholesterol for the substrate binding site on P450scc and that the catalytic efficiency of 3bHSD for 7DHP (V-m/K-m) is 40% of that for pregnenolone. Skin mitochondria are capable of transforming 7DHC to 7DHP and the 7DHP is metabolized further by skin extracts. Finally, 7DHP, its photoderivative 20-oxopregnacalciferol, and pregnenolone exhibited biological activity in skin cells including inhibition of proliferation of epidermal keratinocytes and melanocytes, and melanoma cells. These findings define a novel steroidogenic pathway: 7DHC -> 22(OH)7DH-C -> 20,22(OH)(2)7DHC -> 7DHP, with potential further metabolism of 7DHP mediated by 3 beta HSD or CYP17, depending on mammalian species. The 5-7 dienal intermediates of the pathway can be a source of biologically active vitamin D3 derivatives after delivery to or production in the skin, an organ intermittently exposed to solar radiation.	[Zmijewski, Michal A.; Janjetovic, Zorica] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA; [Sweatman, Trevor] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN USA; [Semak, Igor] Belarusian State Univ, Dept Biochem, Minsk 220050, BELARUS; [Li, Wei] Univ Tennessee, Hlth Sci Ctr, Dept Pharm Sci, Memphis, TN USA; [Zjawiony, Jordan K.] Univ Mississippi, Dept Pharmacognosy, Oxford, MS USA; [Tuckey, Robert C.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Belarusian State University; University of Tennessee System; University of Tennessee Health Science Center; University of Mississippi; University of Western Australia	Slominski, AT (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA.	aslominski@utmem.edu	Tuckey, Robert/H-5983-2014; Ding, Cheng-Qiang/B-6287-2011; Semak, Igor/AAT-9273-2020	Semak, Igor/0000-0001-9430-8492; Li, Wei/0000-0002-9522-4474; Zjawiony, Jordan/0000-0001-5242-2799; Tuckey, Robert/0000-0002-5022-4729; Slominski, Andrzej/0000-0001-8963-3995; Zmijewski, Michal/0000-0003-2206-3531	NIH [R01AR052190, 1R15CA125623]; University of Western Australia; Belarus State University; NATIONAL CANCER INSTITUTE [R15CA125623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Western Australia; Belarus State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant R01AR052190, grant #1R15CA125623, University of Western Australia and Belarus State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR JR, 1974, EUR J BIOCHEM, V49, P117, DOI 10.1111/j.1432-1033.1974.tb03817.x; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; BURSTEIN S, 1976, STEROIDS, V28, P115, DOI 10.1016/0039-128X(76)90131-8; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cooke GM, 1996, J STEROID BIOCHEM, V58, P95, DOI 10.1016/0960-0760(96)00002-7; Dalla Valle L, 2004, J STEROID BIOCHEM, V88, P79, DOI 10.1016/j.jsbmb.2003.11.001; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; GURYEV O, 2003, P NATL ACAD SCI US; Hauet T, 2002, ENDOCR RES, V28, P395, DOI 10.1081/ERC-120016814; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1975, J BIOL CHEM, V250, P226; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; HUME R, 1984, EUR J BIOCHEM, V140, P583, DOI 10.1111/j.1432-1033.1984.tb08142.x; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; LAMBETH JD, 1982, MOL CELL BIOCHEM, V45, P13, DOI 10.1007/BF01283159; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Marcos J, 2004, STEROIDS, V69, P51, DOI 10.1016/j.steroids.2003.09.013; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; MURARI MP, 1982, J STEROID BIOCHEM, V17, P615, DOI 10.1016/0022-4731(82)90562-3; NAKAJIN S, 1984, J BIOL CHEM, V259, P3971; Nowaczyk MJM, 1998, AM J MED GENET, V78, P419, DOI 10.1002/(SICI)1096-8628(19980806)78:5<419::AID-AJMG5>3.0.CO;2-G; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pignatelli D, 2006, J ENDOCRINOL, V191, P301, DOI 10.1677/joe.1.06972; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Semak I, 2005, BIOCHEMISTRY-US, V44, P9300, DOI 10.1021/bi050202d; Semak I, 2004, ARCH BIOCHEM BIOPHYS, V421, P61, DOI 10.1016/j.abb.2003.08.036; SEMAK I, 2008, J PINEAL RES; Shackleton C, 2002, J STEROID BIOCHEM, V82, P225, DOI 10.1016/S0960-0760(02)00155-3; Shackleton CHL, 1999, STEROIDS, V64, P481, DOI 10.1016/S0039-128X(99)00022-7; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; SLOMINSKI A, 1993, EXP CELL RES, V206, P189, DOI 10.1006/excr.1993.1137; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; TAIT AD, 1985, FEBS LETT, V182, P107, DOI 10.1016/0014-5793(85)81164-9; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Tian XQ, 1999, J BIOL CHEM, V274, P4174, DOI 10.1074/jbc.274.7.4174; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; TOAFF ME, 1982, ENDOCRINOLOGY, V111, P1785, DOI 10.1210/endo-111-6-1785; TUCKEY RC, 1992, J STEROID BIOCHEM, V42, P883, DOI 10.1016/0960-0760(92)90097-3; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; Tuckey RC, 1999, EUR J BIOCHEM, V263, P319, DOI 10.1046/j.1432-1327.1999.00483.x; TUCKEY RC, 1984, INT J BIOCHEM, V16, P497, DOI 10.1016/0020-711X(84)90166-6; Tuckey RC, 2008, INT J BIOCHEM CELL B, V40, P2619, DOI 10.1016/j.biocel.2008.05.006; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Zbytek B, 2006, PEPTIDES, V27, P3276, DOI 10.1016/j.peptides.2006.07.017; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zmijewski MA, 2009, STEROIDS, V74, P218, DOI 10.1016/j.steroids.2008.10.017; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	59	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4309	10.1371/journal.pone.0004309	http://dx.doi.org/10.1371/journal.pone.0004309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190754	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483300001
J	Balasubramanian, S; Schwartz, C; Singh, A; Warthmann, N; Kim, MC; Maloof, JN; Loudet, O; Trainer, GT; Dabi, T; Borevitz, JO; Chory, J; Weigel, D				Balasubramanian, Sureshkumar; Schwartz, Christopher; Singh, Anandita; Warthmann, Norman; Kim, Min Chul; Maloof, Julin N.; Loudet, Olivier; Trainer, Gabriel T.; Dabi, Tsegaye; Borevitz, Justin O.; Chory, Joanne; Weigel, Detlef			QTL Mapping in New Arabidopsis thaliana Advanced Intercross-Recombinant Inbred Lines	PLOS ONE			English	Article								Background: Even when phenotypic differences are large between natural or domesticated strains, the underlying genetic basis is often complex, and causal genomic regions need to be identified by quantitative trait locus (QTL) mapping. Unfortunately, QTL positions typically have large confidence intervals, which can, for example, lead to one QTL being masked by another, when two closely linked loci are detected as a single QTL. One strategy to increase the power of precisely localizing small effect QTL, is the use of an intercross approach before inbreeding to produce Advanced Intercross RILs (AI-RILs). Methodology/Principal Findings: We present two new AI-RIL populations of Arabidopsis thaliana genotyped with an average intermarker distance of 600 kb. The advanced intercrossing design led to expansion of the genetic map in the two populations, which contain recombination events corresponding to 50 kb/cM in an F-2 population. We used the AI-RILs to map QTL for light response and flowering time, and to identify segregation distortion in one of the AI-RIL populations due to a negative epistatic interaction between two genomic regions. Conclusions/Significance: The two new AI-RIL populations, EstC and KendC, derived from crosses of Columbia (Col) to Estland (Est-1) and Kendallville (Kend-L) provide an excellent resource for high precision QTL mapping. Moreover, because they have been genotyped with over 100 common markers, they are also excellent material for comparative QTL mapping.	[Singh, Anandita; Warthmann, Norman; Kim, Min Chul; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Schwartz, Christopher; Warthmann, Norman; Maloof, Julin N.; Loudet, Olivier; Trainer, Gabriel T.; Dabi, Tsegaye; Borevitz, Justin O.; Chory, Joanne; Weigel, Detlef] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA USA; [Maloof, Julin N.] Univ Calif Davis, Sect Plant Biol, Davis, CA USA; [Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Loudet, Olivier] INRA, SGAP, Versailles, France; [Balasubramanian, Sureshkumar] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4067, Australia; [Schwartz, Christopher] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, San Diego, CA 92138 USA	Max Planck Society; Salk Institute; University of California System; University of California Davis; University of Chicago; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Salk Institute	Balasubramanian, S (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Warthmann, Norman/E-1069-2011; Weigel, Detlef/C-1418-2008; Loudet, Olivier/CAF-7559-2022; Balasubramanian, Sureshkumar/AAS-6919-2020; Loudet, Olivier/K-8266-2012; Borevitz, Justin/B-5423-2012	Weigel, Detlef/0000-0002-2114-7963; Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Loudet, Olivier/0000-0003-3717-0137; Borevitz, Justin/0000-0001-8408-3699; Singh, Anandita/0000-0002-4568-7331; Maloof, Julin/0000-0002-9623-2599	NIH NRSA [F23-GM65032-1]; EMBO Long-Term Fellowship [ALTF-473]; NIH [GM62932]; ERA-PG [ARABRAS]; DFG [Gottfried Wilhelm Leibniz Award]; Howard Hughes Medical Institute; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932, F32GM065032] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-PG; DFG(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NRSA Grant F23-GM65032-1 (CS), an EMBO Long-Term Fellowship ALTF-473 (SB), NIH grant GM62932 (JC & DW), ERA-PG (BMBF) Grant ARABRAS, and a Gottfried Wilhelm Leibniz Award from the DFG (DW), the Howard Hughes Medical Institute, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1998, GENETICS, V149, P749; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Borevitz JO, 2002, GENETICS, V160, P683; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BURR B, 1991, TRENDS GENET, V7, P55, DOI 10.1016/0168-9525(91)90232-F; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Darvasi A, 2005, TRENDS GENET, V21, P373, DOI 10.1016/j.tig.2005.05.003; DARVASI A, 1995, GENETICS, V141, P1199; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Jurinke C, 2001, Methods Mol Biol, V170, P103; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Magliano TMA, 2005, PLANT PHYSIOL, V138, P1126, DOI 10.1104/pp.104.059071; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Rikke BA, 1998, MAMM GENOME, V9, P963, DOI 10.1007/s003359900907; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wilson IW, 2001, GENETICS, V158, P1301; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	49	77	77	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4318	10.1371/journal.pone.0004318	http://dx.doi.org/10.1371/journal.pone.0004318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183806	gold, Green Published			2022-12-25	WOS:000265483200005
J	Reeves, PA; Richards, CM				Reeves, Patrick A.; Richards, Christopher M.			Accurate Inference of Subtle Population Structure (and Other Genetic Discontinuities) Using Principal Coordinates	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; PHYLOGENETIC INFERENCE; EVOLUTIONARY HISTORY; AFLP; DIFFERENTIATION; IDENTIFICATION; DIVERSITY; TAXA; STRATIFICATION; PERFORMANCE	Background: Accurate inference of genetic discontinuities between populations is an essential component of intraspecific biodiversity and evolution studies, as well as associative genetics. The most widely-used methods to infer population structure are model-based, Bayesian MCMC procedures that minimize Hardy-Weinberg and linkage disequilibrium within subpopulations. These methods are useful, but suffer from large computational requirements and a dependence on modeling assumptions that may not be met in real data sets. Here we describe the development of a new approach, PCO-MC, which couples principal coordinate analysis to a clustering procedure for the inference of population structure from multilocus genotype data. Methodology/Principal Findings: PCO-MC uses data from all principal coordinate axes simultaneously to calculate a multidimensional "density landscape'', from which the number of subpopulations, and the membership within subpopulations, is determined using a valley-seeking algorithm. Using extensive simulations, we show that this approach outperforms a Bayesian MCMC procedure when many loci (e. g. 100) are sampled, but that the Bayesian procedure is marginally superior with few loci (e. g. 10). When presented with sufficient data, PCO-MC accurately delineated subpopulations with population F-st values as low as 0.03 (G(st)'>0.2), whereas the limit of resolution of the Bayesian approach was F-st = 0.05 (G(st)'>0.35). Conclusions/Significance: We draw a distinction between population structure inference for describing biodiversity as opposed to Type I error control in associative genetics. We suggest that discrete assignments, like those produced by PCO-MC, are appropriate for circumscribing units of biodiversity whereas expression of population structure as a continuous variable is more useful for case-control correction in structured association studies.	[Reeves, Patrick A.; Richards, Christopher M.] ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO USA	United States Department of Agriculture (USDA)	Reeves, PA (corresponding author), ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO USA.	crichard@lamar.colostate.edu	Richards, Christopher/A-8328-2013	Richards, Christopher/0000-0002-9978-6079; Reeves, Patrick/0000-0001-9991-1397	USDA-ARS; CRIS [5402-21000-012-00]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); CRIS	This research was funded by USDA-ARS, CRIS project 5402-21000-012-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2004, TAXON, V53, P429, DOI 10.2307/4135620; Albach DC, 2004, PLANT SYST EVOL, V246, P177, DOI 10.1007/s00606-004-0148-9; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; Badr A, 2002, CAN J BOT, V80, P962, DOI [10.1139/b02-084, 10.1139/B02-084]; Bakkeren G, 2000, MYCOLOGIA, V92, P510, DOI 10.2307/3761510; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; Brysting AK, 2004, TAXON, V53, P365, DOI 10.2307/4135615; Corander J, 2003, GENETICS, V163, P367; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; de Knijff P, 2001, J MOL EVOL, V52, P85, DOI 10.1007/s002390010137; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; EXCOFFIER L, 1992, GENETICS, V131, P479; Goldman DH, 2004, AM J BOT, V91, P707, DOI 10.3732/ajb.91.5.707; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grunig CR, 2002, CAN J BOT, V80, P1239, DOI [10.1139/b02-115, 10.1139/B02-115]; Gusfield D, 2002, INFORM PROCESS LETT, V82, P159, DOI 10.1016/S0020-0190(01)00263-0; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hipp Andrew L., 2007, Aliso, V23, P193; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Krauss SL, 2001, AUST J BOT, V49, P611, DOI 10.1071/BT00072; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Landry PA, 1996, ZOOL SCR, V25, P283, DOI 10.1111/j.1463-6409.1996.tb00167.x; Larson SR, 2003, CAN J BOT, V81, P789, DOI [10.1139/B03-077, 10.1139/b03-077]; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LEFKOVITCH LP, 1976, MATH BIOSCI, V31, P157, DOI 10.1016/0025-5564(76)90047-X; LEWIS PO, 2002, GDA GENETIC DATA ANA; Liu Nianjun, 2006, Human Genomics, V2, P353; LOCKWOOD DR, 2007, PLANT BREEDING REV, V29, P285; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Marhold K, 2004, ANN BOT-LONDON, V93, P507, DOI 10.1093/aob/mch073; Martinez-Ortega MM, 2004, SYST BOT, V29, P965, DOI 10.1600/0363644042451071; MARTINEZORTEGA MM, 1999, THESIS U SALAMANCA S; Mock KE, 2004, MOL ECOL, V13, P1085, DOI 10.1111/j.1365-294X.2004.02143.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Pella J, 2006, CAN J FISH AQUAT SCI, V63, P576, DOI 10.1139/f05-224; Perrie LR, 2003, J BIOGEOGR, V30, P1729, DOI 10.1046/j.1365-2699.2003.00938.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Quagliaro J, 2001, J HERED, V92, P38, DOI 10.1093/jhered/92.1.38; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Reeves PA, 2007, SYST BIOL, V56, P302, DOI 10.1080/10635150701324225; RICHARDS CM, TREE GENETI IN PRESS; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruas PM, 2003, GENET MOL BIOL, V26, P319, DOI 10.1590/S1415-47572003000300017; Silverman BW, 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sudupak MA, 2004, EUPHYTICA, V135, P229, DOI 10.1023/B:EUPH.0000014938.02019.f3; Sullivan JP, 2004, EVOLUTION, V58, P825; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Torpdahl M, 2004, J APPL MICROBIOL, V97, P566, DOI 10.1111/j.1365-2672.2004.02337.x; Vandemark G, 2000, MYCOLOGIA, V92, P656, DOI 10.2307/3761423; VICKERY RK, 1987, SYST BOT, V12, P339, DOI 10.2307/2419258; Wang ZY, 2004, BIOCHEM SYST ECOL, V32, P399, DOI 10.1016/j.bse.2003.10.006; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x	76	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4269	10.1371/journal.pone.0004269	http://dx.doi.org/10.1371/journal.pone.0004269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172174	Green Published, gold			2022-12-25	WOS:000265482900002
J	Yuan, ZQ; Lehtinen, MK; Merlo, P; Villen, J; Gygi, S; Bonni, A				Yuan, Zengqiang; Lehtinen, Maria K.; Merlo, Paola; Villen, Judit; Gygi, Steven; Bonni, Azad			Regulation of Neuronal Cell Death by MST1-FOXO1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; CEREBELLAR GRANULE CELLS; POSTMITOTIC NEURONS; NERVOUS-SYSTEM; APOPTOSIS; CYCLE; ACTIVATION; SURVIVAL; PATHWAY; PHOSPHORYLATION	The protein kinase mammalian Sterile 20-like kinase 1 (MST1) plays a critical role in the regulation of cell death. Recent studies suggest that MST1 mediates oxidative stress-induced neuronal cell death by phosphorylating the transcription factor FOXO3 at serine 207, a site that is conserved in other FOXO family members. Here, we show that MST1-induced phosphorylation of FOXO1 at serine 212, corresponding to serine 207 in FOXO3, disrupts the association of FOXO1 with 14-3-3 proteins. Accordingly, MST1 mediates the nuclear translocation of FOXO1 in primary rat cerebellar granule neurons that are deprived of neuronal activity. We also find a requirement for MST1 in cell death of granule neurons upon withdrawal of growth factors and neuronal activity, and MST1 induces cell death in a FOXO1-dependent manner. Finally, we show that the MST1-regulatory, scaffold protein Nore1 is required for survival factor deprivation induced neuronal death. Collectively, these findings define MST1-FOXO1 signaling as an important link survival factor deprivation-induced neuronal cell death with implications for our understanding of brain development and neurological diseases.	[Yuan, Zengqiang; Lehtinen, Maria K.; Merlo, Paola; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Villen, Judit; Gygi, Steven] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017; Merlo, Paola/K-5330-2014	Merlo, Paola/0000-0003-0105-7044; Yuan, Zengqiang/0000-0001-5739-2867; Villen, Judit/0000-0002-1005-1739	National Institutes of Health [NS047188, NS41021]; Paul Glenn laboratories; Lefler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188, R01NS041021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn laboratories; Lefler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047188 and NS41021 (to A.B.). This work was also supported by a pilot grant from the Paul Glenn laboratories (to A.B.) and a grant from the Lefler Foundation (to Z.Y.).	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim AH, 2008, CELL CYCLE, V7, P3819, DOI 10.4161/cc.7.24.7215; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lehtinen MK, 2008, CURR MOL MED, V8, P313, DOI 10.2174/156652408784533805; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Miller TM, 1996, J NEUROSCI, V16, P7487; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shalizi A, 2003, J NEUROSCI, V23, P7326; Suh YS, 2002, NEUROSCI LETT, V325, P1, DOI 10.1016/S0304-3940(02)00216-1; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	37	140	148	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11285	11292		10.1074/jbc.M900461200	http://dx.doi.org/10.1074/jbc.M900461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221179	Green Published, hybrid			2022-12-25	WOS:000265494500032
J	Menze, MA; Boswell, L; Toner, M; Hand, SC				Menze, Michael A.; Boswell, Leaf; Toner, Mehmet; Hand, Steven C.			Occurrence of Mitochondria-targeted Late Embryogenesis Abundant (LEA) Gene in Animals Increases Organelle Resistance to Water Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMIA-FRANCISCANA EMBRYOS; SHOCK/ALPHA-CRYSTALLIN PROTEIN; MAMMALIAN-CELLS; INTRACELLULAR TREHALOSE; DESICCATION TOLERANCE; ENHANCED PROTECTION; MEMBRANE INTEGRITY; DIVALENT-CATIONS; IMPORT MACHINERY; IN-VITRO	Anhydrobiotic animals survive virtually complete loss of cellular water. The mechanisms that explain this phenomenon are not fully understood but often include the accumulation of low molecular weight solutes such as trehalose and macromolecules like Late Embryogenesis Abundant (LEA) proteins. Here we report for the first time the occurrence of a mitochondria-targeted LEA gene (Afrlea3m) product in an animal species. The deduced molecular mass of the 307-amino acid polypeptide from the brine shrimp Artemia franciscana is 34 kDa. Bioinformatic analyses reveal features typical of a Group 3 LEA protein, and subcellular localization programs predict targeting of the mature peptide to the mitochondrial matrix, based on an N-terminal, amphipathic presequence. Real-time quantitative PCR shows that Afralea3m mRNA is expressed manyfold higher in desiccation-tolerant embryonic stages when compared with intolerant nauplius larvae. Mitochondrial localization of the protein was confirmed by transfection of human hepatoma cells (HepG2/C3A) with a nucleotide construct encoding the first 70 N-terminal amino acids of AfrLEA3m in-frame with the nucleotide sequence for green fluorescence protein. The chimeric protein was readily incorporated into mitochondria of these cells. Successful targeting of a protein to human mitochondria by use of an arthropod signaling sequence clearly reveals the highly conserved nature of such presequences, as well as of the import machinery. Finally, mitochondria isolated from A. franciscana embryos, which naturally contain AfrLEA3m and trehalose, exhibit resistance to water stress (freezing) as evidenced by an unchanged capacity for oxidative phosphorylation on succinate + rotenone, a resistance that is absent in mammalian mitochondria lacking AfrLEA3m.	[Menze, Michael A.; Boswell, Leaf; Hand, Steven C.] Louisiana State Univ, Dept Biol Sci, Div Cellular Dev & Integrat Biol, Baton Rouge, LA 70803 USA; [Toner, Mehmet] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, Charlestown, MA 02129 USA	Louisiana State University System; Louisiana State University; Harvard University; Massachusetts General Hospital	Menze, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Cellular Dev & Integrat Biol, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	menze@lsu.edu	Menze, Michael/AAP-8165-2020	Menze, Michael/0000-0003-1072-5462	National Institutes of Health [2 RO1 DK046270-14A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 RO1 DK046270-14A1.	Acker JP, 2002, CELL PRESERV TECHNOL, V1, P129; Bolen D W, 2001, Methods Mol Biol, V168, P17; BROWN AD, 1972, J GEN MICROBIOL, V72, P589, DOI 10.1099/00221287-72-3-589; Buchanan S. S., 2005, CELL PRESERV TECHNOL, V3, P212, DOI DOI 10.1089/CPT.2005.3.212; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1; CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4; CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; CLARK ME, 1977, BIOL BULL, V153, P468, DOI 10.2307/1540601; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Covi JA, 2005, J EXP BIOL, V208, P2783, DOI 10.1242/jeb.01680; Crowe J.H., 1973, ANHYDROBIOSIS; Crowe JH, 2004, INTEGR COMP BIOL, V44, P542; Crowe JH, 2002, INTEGR COMP BIOL, V42, P497, DOI 10.1093/icb/42.3.497; Cuming AC, 1999, SEED PROTEINS, P753; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; FOLKERT A, 2005, INTEGR COMP BIOL, V45, P725; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; HAND SC, 2008, OCEANS HUMAN HLTH RI, P611; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Liu XH, 2005, BBA-BIOMEMBRANES, V1717, P21, DOI 10.1016/j.bbamem.2005.09.012; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Reynolds JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P366, DOI 10.1086/420950; Rosgen J, 2007, PROTEIN SCI, V16, P733, DOI 10.1110/ps.062671607; Somero G. N., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level. Tenth international conference on comparative physiology, Grans-sur-Serre, Switzerland, 15-17 Sep 1990., P3; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; VANLEEUWENHOEK A, 1807, SELECTED WORK A VANL, V2, P207; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Willsie JK, 2001, J EXP BIOL, V204, P2339; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zheng Y, 1998, BBA-GENE STRUCT EXPR, V1442, P419, DOI 10.1016/S0167-4781(98)00192-4	59	55	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10714	10719		10.1074/jbc.C900001200	http://dx.doi.org/10.1074/jbc.C900001200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228698	Green Published, hybrid			2022-12-25	WOS:000265104600045
J	Matzner, U; Breiden, B; Schwarzmann, G; Yaghootfam, A; Fluharty, AL; Hasilik, A; Sandhoff, K; Gieselmann, V				Matzner, Ulrich; Breiden, Bernadette; Schwarzmann, Guenter; Yaghootfam, Afshin; Fluharty, Arvan L.; Hasilik, Andrej; Sandhoff, Konrad; Gieselmann, Volkmar			Saposin B-dependent Reconstitution of Arylsulfatase A Activity in Vitro and in Cell Culture Models of Metachromatic Leukodystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBROSIDE SULFATE ACTIVATOR; LIPID-EXTRACTION CAPACITY; MOBILIZES LIPIDS; KIDNEY-CELLS; PROTEIN; ENZYME; PATIENT; STORAGE; PURIFICATION; DEGRADATION	Arylsulfatase A (ASA) catalyzes the intralysosomal desulfation of 3-O-sulfogalactosylceramide (sulfatide) to galactosylceramide. The reaction requires saposin B (Sap B), a non-enzymatic protein-aceous cofactor which presents sulfatide to the catalytic site of ASA. The lack of either ASA or Sap B results in a block of sulfatide degradation, progressive intralysosomal accumulation of sulfatide, and the fatal lysosomal storage disease metachromatic leukodystrophy. We studied the coupled Sap B-ASA reaction in vitro using detergent-free micellar and liposomal assay systems and in vivo using cell culture models of metachromatic leukodystrophy. Under in vitro conditions, the reaction had a narrowpHoptimum around pH 4.3 and was inhibited by mono- and divalent cations, phosphate and sulfite. Bis(monoacylglycero) phosphate and phosphatidic acid were activators of the reaction, underscoring a significant role of acidic phosphoglycerolipids in sphingolipid degradation. Desulfation was negligible when Sap B was substituted by Sap A, C, or D. Up to a molar ratio between Sap B and sulfatide of 1: 5, an elevation of Sap B concentrations caused a sharp increase of sulfatide hydrolysis, indicating the requirement of unexpected high Sap B levels for maximum turnover. Feeding of ASA-deficient, sulfatide-storing primary mouse kidney cells with ASA caused partial clearance of sulfatide. Co-feeding of Sap B or its precursor prosaposin resulted in the lysosomal uptake of the cofactor but did not promote ASA-catalyzed sulfatide hydrolysis. This suggests that Sap B is not a limiting factor of the coupled Sap B-ASA reaction in mouse kidney cells even if sulfatide has accumulated to unphysiologically high levels.	[Matzner, Ulrich; Yaghootfam, Afshin; Gieselmann, Volkmar] Univ Bonn, Inst Physiol Chem, D-53115 Bonn, Germany; [Breiden, Bernadette; Schwarzmann, Guenter; Sandhoff, Konrad] Univ Bonn, LIMES, Membrane Biol & Lipid Biochem Unit, Kekule Inst Organ Chem & Biochem, D-53115 Bonn, Germany; [Fluharty, Arvan L.] Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; [Hasilik, Andrej] Univ Marburg, Inst Physiol Chem, D-35032 Marburg, Germany	University of Bonn; University of Bonn; University of California System; University of California Los Angeles; Philipps University Marburg	Matzner, U (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	matzner@institut.physiochem.uni-bonn.de	Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109	European Leukodystrophy Association; Bundesministerium fur Bildung und Forschung (Leukonet); Deutsche Forschungsgemeinschaft [Sa 257/21, SFB 645, 202272]	European Leukodystrophy Association; Bundesministerium fur Bildung und Forschung (Leukonet)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research grants from the European Leukodystrophy Association, the Bundesministerium fur Bildung und Forschung (Leukonet), Deutsche Forschungsgemeinschaft Grants Sa 257/21 and SFB 645, and the seventh framework program of the EU-funded "Lipidomic-Net" (proposal 202272).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CESTARO B, 1984, ITAL J BIOCHEM, V33, P381; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; DOLLY JO, 1981, BIOCHEM J, V193, P919, DOI 10.1042/bj1930919; FLUHARTY AL, 1992, BIOCHEM MED METAB B, V47, P66, DOI 10.1016/0885-4505(92)90009-N; Fluharty CB, 2001, J NEUROSCI RES, V63, P82, DOI 10.1002/1097-4547(20010101)63:1<82::AID-JNR10>3.0.CO;2-D; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Gopalakrishnan MM, 2004, BIOCHEM J, V383, P507, DOI 10.1042/BJ20040175; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Henseler M, 1996, J BIOL CHEM, V271, P8416, DOI 10.1074/jbc.271.14.8416; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; JEFFREY HJ, 1977, AUST J EXP BIOL MED, V55, P339, DOI 10.1038/icb.1977.28; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; Klein D, 2009, BIOL CHEM, V390, P41, DOI 10.1515/BC.2009.009; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KOSHY KM, 1982, LIPIDS, V17, P998, DOI 10.1007/BF02534598; LAPIDOT Y, 1967, J LIPID RES, V8, P142; Locatelli-Hoops S, 2006, J BIOL CHEM, V281, P32451, DOI 10.1074/jbc.M607281200; Matzner U, 2005, HUM MOL GENET, V14, P1139, DOI 10.1093/hmg/ddi126; Matzner U, 2008, J MOL MED, V86, P433, DOI 10.1007/s00109-008-0309-3; Norris AJ, 2005, J LIPID RES, V46, P2254, DOI 10.1194/jlr.M500188-JLR200; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; Remmel N, 2007, FEBS J, V274, P3405, DOI 10.1111/j.1742-4658.2007.05873.x; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Sandhoff K., 2001, METABOLIC ANDMOLECUL, P3371; Schierau A, 1999, J BIOL CHEM, V274, P3651, DOI 10.1074/jbc.274.6.3651; SCHWARZMANN G, 1987, METHOD ENZYMOL, V138, P319; SOMMERLADE HJ, 1994, BIOCHEM J, V297, P123, DOI 10.1042/bj2970123; STINSHOFF K, 1975, BIOCHIM BIOPHYS ACTA, V377, P126, DOI 10.1016/0005-2744(75)90293-4; Sun Y, 2002, MOL GENET METAB, V76, P271, DOI 10.1016/S1096-7192(02)00114-2; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6	41	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9372	9381		10.1074/jbc.M809457200	http://dx.doi.org/10.1074/jbc.M809457200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19224915	Green Published, hybrid			2022-12-25	WOS:000264669100043
J	Chen, Q; Zhang, H; Li, QM; An, Y; Herkenham, M; Lai, WM; Popovich, P; Agarwal, S; Quan, N				Chen, Qun; Zhang, Hao; Li, Qiming; An, Ying; Herkenham, Miles; Lai, Wenmin; Popovich, Phillip; Agarwal, Sudha; Quan, Ning			Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; IL-1 RECEPTOR; MOUSE-BRAIN; INFLAMMATION; INDUCTION; GENE; LIPOPOLYSACCHARIDE; GLUCOCORTICOIDS; POLYMORPHISMS; TRANSCRIPTION	The type 1 interleukin-1 receptor (IL-1R1) mediates diverse functions of interleukin-1 (IL-1) in the nervous, immune, and neuroendocrine systems. It has been suggested previously that the versatile functions of IL-1 may in part be conferred by the multiple promoters of IL-1R1 that have been identified for the human IL-1R1 gene. Promoters for murine IL-1R1 (mIL-1R1) gene have not been studied in detail. We performed 5'-rapid amplification of cDNA ends to determine the transcription start sites (TSS) in mIL-1R1, using mRNAs derived from 24 different tissues. The results revealed three putative TSSs of mIL-1R1. Three full-length cDNAs containing these distinct TSSs were recovered in screens of cloned cDNA libraries. Translation of these cDNAs produced IL-1R1 proteins that were verified by Western blot analysis. IL-1 stimulation of the individual IL-1R1 proteins resulted in the activation of NF-kappa B. Promoter-reporter assay for genomic DNA sequences immediately upstream of the three TSSs validated that the sequences possess promoter activity in a cell type-specific manner. These promoters are termed P1, P2, and P3 of the mIL-1R1, in 5' to 3' order. Quantitative PCR analysis of P1-, P2-, and P3-specific mIL-1R1 mRNAs showed that there is tissue-specific distribution of these mRNAs in vivo, and there are distinct patterns of P1, P2, and P3 mRNA expression in different cell lines. In the brain, P3 mRNA is expressed preferentially in the dentate gyrus. Further, glucocorticoids differentially regulate these promoters in a cell type-specific manner. Together, these results suggest that the different IL-1R1 promoters contribute to the discrete and diverse actions of IL-1.	[Quan, Ning] Ohio State Univ, Dept Oral Biol, Columbus, OH 43210 USA; [Herkenham, Miles] NIMH, Funct Neuroanat Sect, Bethesda, MD 20892 USA; [Lai, Wenmin; Popovich, Phillip] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Ohio; Ohio State University	Quan, N (corresponding author), 4179 Postle Hall,305 W 12th Ave, Columbus, OH 43210 USA.	quan.14@osu.edu	Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395; Herkenham, Miles/0000-0003-2228-4238	National Institutes of Health [R01 AI076926]; Intramural Research Program of the National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI076926 (to N.Q.). This work was also supported by the Intramural Research Program of the National Institute of Mental Health.	AKAHOSHI T, 1988, J EXP MED, V167, P924, DOI 10.1084/jem.167.3.924; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; BAN E, 1993, NEUROENDOCRINOLOGY, V58, P581, DOI 10.1159/000126594; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BERGHOLDT R, 1995, CYTOKINE, V7, P727, DOI 10.1006/cyto.1995.0086; BOMSZTYK K, 1989, P NATL ACAD SCI USA, V86, P8034, DOI 10.1073/pnas.86.20.8034; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; D'Amora P, 2006, AM J REPROD IMMUNOL, V56, P178, DOI 10.1111/j.1600-0897.2006.00415.x; DUBOIS CM, 1993, EXP HEMATOL, V21, P303; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Ito A, 1997, J INTERF CYTOK RES, V17, P413, DOI 10.1089/jir.1997.17.413; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Lynch MA, 2002, VITAM HORM, V64, P185, DOI 10.1016/S0083-6729(02)64006-3; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Quan N, 2002, HISTOL HISTOPATHOL, V17, P273, DOI 10.14670/HH-17.273; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; SHIEH JH, 1993, BLOOD, V81, P1745; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; SIMS JE, 1994, EUR CYTOKINE NETW, V5, P539; SIMS JE, 1995, CYTOKINE, V7, P483, DOI 10.1006/cyto.1995.0066; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SPRIGGS MK, 1990, J BIOL CHEM, V265, P22499; Wu H, 2007, FEBS J, V274, P3218, DOI 10.1111/j.1742-4658.2007.05891.x; Ye K, 1996, CYTOKINE, V8, P421, DOI 10.1006/cyto.1996.0058; YE K, 1993, P NATL ACAD SCI USA, V90, P2295, DOI 10.1073/pnas.90.6.2295; Zhang H, 2008, NEUROSCIENCE, V157, P895, DOI 10.1016/j.neuroscience.2008.09.038; ZHANG H, 2008, BRAIN BEHAV IMMUN, V22, P31	31	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8694	8704		10.1074/jbc.M808261200	http://dx.doi.org/10.1074/jbc.M808261200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19196714	Green Published, hybrid			2022-12-25	WOS:000264397800054
J	Wilson, CL; Schmidt, AP; Pirila, E; Valore, EV; Ferri, N; Sorsa, T; Ganz, T; Parks, WC				Wilson, Carole L.; Schmidt, Amy P.; Pirilae, Emma; Valore, Erika V.; Ferri, Nicola; Sorsa, Timo; Ganz, Tomas; Parks, William C.			Differential Processing of alpha- and beta-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN NK CELLS; EPITHELIAL-CELLS; HUMAN-NEUTROPHILS; ANTIMICROBIAL PEPTIDE; HUMAN BETA-DEFENSIN-1; MATRILYSIN EXPRESSION; INDUCIBLE PEPTIDE; GENE-EXPRESSION; INNATE IMMUNITY	Proteolytic processing of defensins is a critical mode of post-translational regulation of peptide activity. Because mouse alpha-defensin precursors are cleaved and activated by matrix metalloproteinase-7 (MMP-7), we determined if additional defensin molecules, namely human neutrophil defensin pro-HNP-1 and beta-defensins, are targets for MMP-7. We found that MMP-7 cleaves within the pro-domain of the HNP-1 precursor, a reaction that does not generate the mature peptide but produces a 59-amino acid intermediate. This intermediate, which retains the carboxyl-terminal end of the pro-domain, had antimicrobial activity, indicating that the residues important for masking defensin activity reside in the amino terminus of this domain. Mature HNP-1 was resistant to processing by MMP-7 unless the peptide was reduced and alkylated, demonstrating that only the pro-domain of alpha-defensins is normally accessible for cleavage by this enzyme. From the 47-residue HBD-1 precursor, MMP-7 catalyzed removal of 6 amino acids from the amino terminus. Neither a 39-residue intermediate form of HBD-1 nor the mature 36-residue form of HBD-1 was cleaved by MMP-7. In addition, both pro-HBD-2, with its shorter amino-terminal extension, and pro-HBD-3 were resistant to MMP-7. However, human and mouse beta-defensin precursors that lack disulfide bonding contain a cryptic MMP-7-sensitive site within the mature peptide moiety. These findings support and extend accumulating evidence that the native three-dimensional structure of both alpha- and beta-defensins protects the mature peptides against proteolytic processing by MMP-7. We also conclude that sites for MMP-7 cleavage are more common at the amino termini of beta-defensin rather than beta-defensin precursors, and that catalysis at these sites in beta-defensin pro-domains results in acquisition of defensin activity.	[Wilson, Carole L.] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Parks, William C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98104 USA; [Schmidt, Amy P.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Pirilae, Emma; Sorsa, Timo] Univ Helsinki, Inst Dent, Dept Periodontol, FIN-00014 Helsinki, Finland; [Valore, Erika V.; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ferri, Nicola] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Helsinki; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Milan	Wilson, CL (corresponding author), Univ Washington, Dept Pathol, 325 9th Ave,Box 359675, Seattle, WA 98104 USA.	carolew2@u.washington.edu	ferri, nicola/K-7085-2019; Ganz, Tomas/AAN-3308-2020; Ferri, Nicola/F-4879-2013; Parks, William C./AAH-6786-2021; Ganz, Tomas/D-4567-2009	ferri, nicola/0000-0001-8898-7441; Ferri, Nicola/0000-0001-8898-7441; Ganz, Tomas/0000-0002-2830-5469	National Institutes of Health [DE14040, HL29594]; Academy of Finland and Helsinki University Central Hospital Research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland and Helsinki University Central Hospital Research grant(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14040 (to C. L. W.) and HL29594 (to W. C. P.). This work was also supported by an Academy of Finland and Helsinki University Central Hospital Research grant (to T. S. and E. P.).	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Cha JH, 1996, BIOCHEMISTRY-US, V35, P15831, DOI 10.1021/bi962085f; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Cunliffe RN, 2002, J CLIN PATHOL, V55, P298, DOI 10.1136/jcp.55.4.298; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Frye M, 2000, J CLIN PATHOL, V53, P770, DOI 10.1136/jcp.53.10.770; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; HARWIG SSL, 1992, BLOOD, V79, P1532; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Krishnakumari V, 2003, BIOCHEMISTRY-US, V42, P9307, DOI 10.1021/bi034403y; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; Kuula H, 2008, ARCH ORAL BIOL, V53, P175, DOI 10.1016/j.archoralbio.2007.09.010; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; Lopez-Boado YS, 2001, J BIOL CHEM, V276, P41417, DOI 10.1074/jbc.M107121200; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Ogle CK, 2002, CRIT CARE MED, V30, P428, DOI 10.1097/00003246-200202000-00027; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 1998, AM J PATHOL, V152, P1247; RICE WG, 1987, BLOOD, V70, P757; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V105, P190, DOI 10.1111/1523-1747.ep12317104; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Svinarich DM, 1997, AM J OBSTET GYNECOL, V176, P470, DOI 10.1016/S0002-9378(97)70517-9; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wehkamp J, 2002, DIGEST DIS SCI, V47, P1349, DOI 10.1023/A:1015334917273; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamaguchi Y, 2001, J BIOL CHEM, V276, P31510, DOI 10.1074/jbc.M104149200; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zucht H D, 1998, Eur J Med Res, V3, P315	62	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8301	8311		10.1074/jbc.M809744200	http://dx.doi.org/10.1074/jbc.M809744200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181662	Green Published, hybrid			2022-12-25	WOS:000264397800014
J	Vu, I; Smelick, G; Harris, S; Lee, SC; Weil, E; Whitehead, RF; Bruno, JF				Vu, Ivana; Smelick, Gillian; Harris, Sam; Lee, Sarah C.; Weil, Ernesto; Whitehead, Robert F.; Bruno, John F.			Macroalgae Has No Effect on the Severity and Dynamics of Caribbean Yellow Band Disease	PLOS ONE			English	Article								By removing herbivores and promoting increases in macroalgae, overfishing is thought to indirectly cause coral disease and mortality. We performed three field manipulations to test the general hypothesis that overfishing and the subsequent alteration of coral reef trophic dynamics are a cause of coral epizootics. Specifically, we asked whether the presence of macroalgae can influence within- and among-colony spread rates of Caribbean Yellow Band Disease in Montastraea faveolata. Macroalgae were placed next to infected and healthy, adult and small coral colonies to measure effects on disease spread rate, coral growth and coral survival. Surprisingly, the addition of macroalgae did not affect disease severity or coral fitness. Our results indicate that macroalgae have no effect on the severity and dynamics of Caribbean Yellow Band Disease and that fisheries management alone will not mitigate the effects of this important epizootic.	[Vu, Ivana; Smelick, Gillian; Harris, Sam; Lee, Sarah C.; Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, San Juan, PR 00936 USA; [Whitehead, Robert F.] Univ N Carolina Wilmington, Ctr Marine Sci, Wilmington, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Puerto Rico; University of North Carolina; University of North Carolina Wilmington	Vu, I (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	jbruno@unc.edu	Weil, Ernesto/AAI-3591-2020; Lee, Sarah/Q-3372-2017; Weil, Ernesto/ABF-1290-2020	Weil, Ernesto/0000-0001-5275-1584	National Science Foundation [OCE-0326705]; University of North Carolina at Chapel Hill; GEF-World Bank CRTR program; NOAA-CRES [NA170P2919]; University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development	National Science Foundation(National Science Foundation (NSF)); University of North Carolina at Chapel Hill; GEF-World Bank CRTR program; NOAA-CRES(National Oceanic Atmospheric Admin (NOAA) - USA); University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development	This research was funded in part the National Science Foundation (OCE-0326705 to JFB), The University of North Carolina at Chapel Hill, the GEF-World Bank CRTR program through the disease working group and a NOAA-CRES grant (NA170P2919) to EW. The University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES NG, 1995, MAR ECOL PROG SER, V118, P305, DOI 10.3354/meps118305; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; BENNER R, 1993, MAR CHEM, V41, P153, DOI 10.1016/0304-4203(93)90113-3; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruckner AW, 2006, DIS AQUAT ORGAN, V69, P67, DOI 10.3354/dao069067; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Budd A.F., 1991, Bulletins of American Paleontology, V101, P1; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, SYMBIOSIS, V37, P63; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; DAVIES PS, 1989, MAR BIOL, V101, P389; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HARVELL CD, 2008, ECOLOGY IN PRESS; Hayes ML, 2001, HYDROBIOLOGIA, V460, P213, DOI 10.1023/A:1013121503937; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Precht WF, 2005, SCIENCE, V308, P1741; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Santavy DL, 1999, CORAL REEFS, V18, P97, DOI 10.1007/s003380050162; Selig ER., 2006, ANALYZING RELATIONSH, P111; Sharp JH, 2002, MAR CHEM, V77, P239, DOI 10.1016/S0304-4203(02)00002-6; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E., 2000, PROC 9 INT CORAL REE, V2, P1231	48	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4514	10.1371/journal.pone.0004514	http://dx.doi.org/10.1371/journal.pone.0004514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223986	Green Submitted, gold, Green Published			2022-12-25	WOS:000265485800014
J	Atkinson, HJ; Morris, JH; Ferrin, TE; Babbitt, PC				Atkinson, Holly J.; Morris, John H.; Ferrin, Thomas E.; Babbitt, Patricia C.			Using Sequence Similarity Networks for Visualization of Relationships Across Diverse Protein Superfamilies	PLOS ONE			English	Article								The dramatic increase in heterogeneous types of biological data-in particular, the abundance of new protein sequences requires fast and user-friendly methods for organizing this information in a way that enables functional inference. The most widely used strategy to link sequence or structure to function, homology-based function prediction, relies on the fundamental assumption that sequence or structural similarity implies functional similarity. New tools that extend this approach are still urgently needed to associate sequence data with biological information in ways that accommodate the real complexity of the problem, while being accessible to experimental as well as computational biologists. To address this, we have examined the application of sequence similarity networks for visualizing functional trends across protein superfamilies from the context of sequence similarity. Using three large groups of homologous proteins of varying types of structural and functional diversity-GPCRs and kinases from humans, and the crotonase superfamily of enzymes-we show that overlaying networks with orthogonal information is a powerful approach for observing functional themes and revealing outliers. In comparison to other primary methods, networks provide both a good representation of group-wise sequence similarity relationships and a strong visual and quantitative correlation with phylogenetic trees, while enabling analysis and visualization of much larger sets of sequences than trees or multiple sequence alignments can easily accommodate. We also define important limitations and caveats in the application of these networks. As a broadly accessible and effective tool for the exploration of protein superfamilies, sequence similarity networks show great potential for generating testable hypotheses about protein structure-function relationships.	Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA; [Atkinson, Holly J.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Inst Quantitative Biosci, San Francisco, CA 94143 USA; [Morris, John H.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharm Chem, San Francisco, CA 94143 USA; [Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Biopharm Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Atkinson, HJ (corresponding author), Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA.	babbitt@cgl.ucsf.edu	Ferrin, Thomas E./W-8842-2019	Ferrin, Thomas E./0000-0001-6227-0637; Morris, John "Scooter"/0000-0003-0290-7979	NIH [GM60595, T32 GM067547]; NSF [DBI 0640476, P41 RR01081];  [P01 GM071790]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, R01GM060595, P01GM071790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM60595 and NSF grant DBI 0640476 to P.C.B. and P41 RR01081 to T.E.F.. H.J.A. received support from NIH grant T32 GM067547. Initial exploration of sequence similarity networks used the enolases and amidohydrolases superfamilies as example data sets, and was supported by P01 GM071790 to P.C.B.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Huang CL, 2007, EXP MOL MED, V39, P565, DOI 10.1038/emm.2007.62; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; MORRIS JH, VISUALIZATION ANAL B; Morris JH, 2007, BIOINFORMATICS, V23, P2345, DOI 10.1093/bioinformatics/btm329; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nguyen TT, 2008, BIOCHEMISTRY-US, V47, P1194, DOI 10.1021/bi7017738; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; WIESE R, YFILES ORGANIC LAYOU; WIESE R, 2001, P 9 INT S GRAPH DRAW, P453; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535	49	288	290	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4345	10.1371/journal.pone.0004345	http://dx.doi.org/10.1371/journal.pone.0004345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190775	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483300004
J	Liang, S; Yang, N; Pan, Y; Deng, S; Lin, XJ; Yang, XJ; Katsaros, D; Roby, KF; Hamilton, TC; Connolly, DC; Coukos, G; Zhang, L				Liang, Shun; Yang, Nuo; Pan, Yue; Deng, Shan; Lin, Xiaojuan; Yang, Xiaojun; Katsaros, Dionyssios; Roby, Katherine F.; Hamilton, Thomas C.; Connolly, Denise C.; Coukos, George; Zhang, Lin			Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation	PLOS ONE			English	Article								Background: The Phosphatidylinositol 3'-kinase is a key regulator in various cancer-associated signal transduction pathways. Genetic alterations of its catalytic subunit alpha, PIK3CA, have been identified in ovarian cancer. Our in vivo data suggests that PIK3CA activation is one of the early genetic events in ovarian cancer. However, its role in malignant transformation of ovarian surface epithelium (OSE) is largely unclear. Methodology/Principal Findings: Using the Mullerian inhibiting substance type II receptor (MISIIR) promoter, we generated transgenic mice that expressed activated PIK3CA in the Mullerian epithelium. Overexpression of PIK3CA in OSE induced remarkable hyperplasia, but was not able to malignantly transform OSE in vivo. The consistent result was also observed in primary cultured OSEs. Although enforced expression of PIK3CA could not induce OSE anchorage-independent growth, it significantly increased anchorage-independent growth of OSE transformed by mutant K-ras. Conclusions/Significance: While PIK3CA activation may not be able to initiate OSE transformation, we conclude that activation of PIK3CA may be an important molecular event contributing to the maintenance of OSE transformation initiated by oncogenes such as K-ras.	[Liang, Shun; Yang, Nuo; Pan, Yue; Deng, Shan; Lin, Xiaojuan; Yang, Xiaojun; Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, I-10124 Turin, Italy; [Roby, Katherine F.] Univ Kansas, Med Ctr, Ctr Reproductive Sci, Kansas City, KS USA; [Hamilton, Thomas C.; Connolly, Denise C.] Fox Chase Canc Ctr, Ovarian Canc Program, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Turin; University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center	Liang, S (corresponding author), Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Coukos, George/0000-0001-8813-7367	Ovarian Cancer Research Fund; NCI [P50-CA83638]; American Cancer Society [IRG-78-002-30]; Mary Kay Ash Charitable Foundation; Italian Association for Cancer Research (AIRC); NATIONAL CANCER INSTITUTE [P50CA083638, R01CA142776] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Kay Ash Charitable Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ovarian Cancer Research Found (LZ), NCI Ovarian Cancer SPORE P50-CA83638 (Career Development Award, LZ), American Cancer Society IRG-78-002-30 (LZ), and Mary Kay Ash Charitable Foundation (LZ). DK was partly supported by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chodankar R, 2005, CURR BIOL, V15, P561, DOI 10.1016/j.cub.2005.01.052; Connolly DC, 2003, CANCER RES, V63, P1389; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu LM, 2005, CLIN CANCER RES, V11, P8208, DOI 10.1158/1078-0432.CCR-05-0206; Hu LM, 2002, CANCER RES, V62, P1087; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JIA S, 2008, NATURE; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Parsons R, 2005, CLIN CANCER RES, V11, P7965, DOI 10.1158/1078-0432.CCR-05-1681; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; Suzuki S, 2000, CANCER RES, V60, P5382; Teixeira J, 2001, ENDOCR REV, V22, P657, DOI 10.1210/er.22.5.657; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2003, CANCER RES, V63, P4225; Zhang L, 2003, CANCER RES, V63, P3403; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4295	10.1371/journal.pone.0004295	http://dx.doi.org/10.1371/journal.pone.0004295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172191	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482900010
J	Kesimer, M; Scull, M; Brighton, B; DeMaria, G; Burns, K; O'Neal, W; Pickles, RJ; Sheehan, JK				Kesimer, Mehmet; Scull, Margaret; Brighton, Brian; DeMaria, Genevieve; Burns, Kimberlie; O'Neal, Wanda; Pickles, Raymond J.; Sheehan, John K.			Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense	FASEB JOURNAL			English	Article						mucins; influenza virus; mucus; glycocalyx; sialic acid	TUMOR-DERIVED EXOSOMES; PROTEOMIC ANALYSIS; CELL EXOSOMES; SIALIC-ACID; MUC1 MUCIN; IN-VITRO; CANCER; MICROVESICLES; EXPRESSION; BIOGENESIS	Airway mucus forms the structural basis of the local innate immune defense mechanism. It is an integrated, active, viscoelastic gel matrix evolved to protect the exposed lung from physical, chemical, and pathological erosion. Exosomes are biologically active vesicles secreted by different cell types including epithelial, hematopoietic, and some tumor cells. They are also present in some biological fluids such as serum, urine, breast milk, and bronchoalveolar lavage fluid. In this study, we demonstrate for the first time that exosome-like vesicles with antiviral properties are present in human tracheobronchial epithelial (HTBE) cell culture secretions. These vesicles have been isolated by differential centrifugation and are characterized further by mass spectrometry, flow cytometry, immunoblotting, electron microscopy, and light-scattering methods. HTBE vesicles exhibited characteristic exosomal size (30-100 nm) and morphology (cup-shaped) with a buoyant density in sucrose of 1.12-1.18 g/ml. Biochemical characterization further revealed typical surface, cytoskeletal, and cytoplasmic proteins characteristic of exosomes, including the multivesicular and late endosomal membrane markers Tsg101 and CD63. The presence of RNA was also observed. The epithelial mucins MUC1, MUC4, and MUC16 also contributed to the vesicles' structure. Notably, alpha-2,6-linked sialic acid was associated with these mucin molecules and subsequent functional analysis showed that these vesicles have a neutralizing effect on human influenza virus, which is known to bind sialic acid. Taken together, these findings suggest that airway epithelial cells release exosome-like vesicles and that these structures may be involved in diverse physiological processes in airway biology, including innate mucosal defense.-Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., Pickles, R. J., Sheehan, J. K. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23, 1858-1868 (2009)	[Kesimer, Mehmet; DeMaria, Genevieve; Sheehan, John K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Scull, Margaret; Pickles, Raymond J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Brighton, Brian; Burns, Kimberlie; O'Neal, Wanda] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sheehan, JK (corresponding author), 4021 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	kesimer@med.unc.edu	Scull, Margaret/K-9963-2019; , Mehmet Kesimer/AHB-9223-2022	Scull, Margaret/0000-0002-6860-2468	National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH) [HL084934, HL HL77844-1]; NIH Molecular Biology of Viral Diseases [5-T32-AI007419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934, R01HL077844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Molecular Biology of Viral Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the UNC Cystic Fibrosis Center Tissue Procurement and Culture Core. This work was supported by a gift from an anonymous donor for research targeted to proteomics of cystic fibrosis lung disease (J.K.S.) and National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH) grants HL084934 and HL HL77844-1. M. S. is a recipient of the George H. Hitchings Fund for Health Research and Science Education of the Triangle Community Foundation. This work was also supported by NIH Molecular Biology of Viral Diseases training grant 5-T32-AI007419.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Agrawal B, 2005, INT IMMUNOL, V17, P391, DOI 10.1093/intimm/dxh219; Aupeix K, 1997, J CLIN INVEST, V99, P1546, DOI 10.1172/JCI119317; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Buschow SI, 2005, BLOOD CELL MOL DIS, V35, P398, DOI 10.1016/j.bcmd.2005.08.005; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Cho JA, 2005, INT J CANCER, V114, P613, DOI 10.1002/ijc.20757; Clayton A, 2003, EUR J IMMUNOL, V33, P522, DOI 10.1002/immu.200310028; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HEARN PR, 1981, J CELL SCI, V47, P227; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; RAMPHAL R, 1983, INFECT IMMUN, V41, P339, DOI 10.1128/IAI.41.1.339-344.1983; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Rieu S, 2000, EUR J BIOCHEM, V267, P583, DOI 10.1046/j.1432-1327.2000.01036.x; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Sheehan John K, 2006, Novartis Found Symp, V279, P155; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Whiteside TL, 2005, BRIT J CANCER, V92, P209, DOI 10.1038/sj.bjc.6602360; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	55	253	264	2	68	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1858	1868		10.1096/fj.08-119131	http://dx.doi.org/10.1096/fj.08-119131			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19190083	Green Published			2022-12-25	WOS:000266652400026
J	Penaloza, C; Estevez, B; Orlanski, S; Sikorska, M; Walker, R; Smith, C; Smith, B; Lockshin, RA; Zakeri, Z				Penaloza, Carlos; Estevez, Brian; Orlanski, Shari; Sikorska, Marianna; Walker, Roy; Smith, Catherine; Smith, Brandon; Lockshin, Richard A.; Zakeri, Zahra			Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells	FASEB JOURNAL			English	Article						apoptosis; estrogen; ethanol; gender; testosterone	GENDER-DIFFERENCES; AUTOIMMUNE-DISEASES; MOUSE-BRAIN; ESTROGENS; MICE; DIMORPHISM; CYP7B; MEN	Sexual dimorphisms are typically attributed to the hormonal differences arising once sex differentiation has occurred. However, in some sexually dimorphic diseases that differ in frequency but not severity, the differences cannot be logically connected to the sex hormones. Therefore, we asked whether any aspect of sexual dimorphism could be attributed to chromosomal rather than hormonal differences. Cells taken from mice at d 10.5 postconception ( PC) before sexual differentiation, at d 17.5 PC after the first embryonic assertion of sexual hormones, and at postnatal day 17 ( puberty) were cultured and exposed to 400 mu M ethanol or 20 mu M camptothecin or to infection with influenza A virus ( multiplicity of infection of 5). The results showed that untreated male and female cells of the same age grew at similar rates and manifested similar morphology. However, they responded differently to the applied stressors, even before the production of fetal sex hormones. Furthermore, microarray and qPCR analyses of the whole 10.5 PC embryos also revealed differences in gene expression between male and female tissues. Likewise, the exposure of cells isolated from fetuses and adolescent mice to the stressors and/or sex hormones yielded expression patterns that reflected chromosomal sex, with ethanol feminizing male cells and masculinizing female cells. We conclude that cells differ innately according to sex irrespective of their history of exposure to sex hormones. These differences may have consequences in the course of sexually dimorphic diseases and their therapy.-Penaloza, C., Estevez, B., Orlanski, S., Sikorska, M., Walker, R., Smith, C., Smith, B., Lockshin R. A., Zakeri, Z. Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells. FASEB J. 23, 1869-1879 (2009)	[Penaloza, Carlos; Estevez, Brian; Orlanski, Shari; Zakeri, Zahra] CUNY Queens Coll, Flushing, NY 11367 USA; [Penaloza, Carlos; Estevez, Brian; Orlanski, Shari; Zakeri, Zahra] CUNY, Grad Ctr, Flushing, NY 11367 USA; [Sikorska, Marianna; Walker, Roy; Smith, Catherine; Smith, Brandon] CNR, Inst Biol Sci, Ottawa, ON, Canada; [Lockshin, Richard A.] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; National Research Council Canada; Saint John's University	Zakeri, Z (corresponding author), CUNY Queens Coll, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	zahra_zakeri@hotmail.com		Estevez, Brian/0000-0002-1863-7224	National Institutes of Health [RO3]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from National Institutes of Health Grant RO3 to Z. Z.; Minority Access to Research Careers Undergraduate Student Training for Academic Research (MARC U-STAR) to Z. Z.; and the National Science Foundation New York City Louis Stokes Alliance for Minority Participation (LSAMP) and the City University of New York Alliance for Graduate Education and the Professoriate (CUNY AGEP). We thank Ms. Nikezic-Ardolic for technical impact on the original idea and methodologies for this manuscript. We also thank Dr. Tahereh Entezari- Zaher, Dr. Mohammad Javdan, and Tamjeed Sikder for technical and intellectual assistance.	Ahuja HS, 1997, DEV DYNAM, V208, P466; Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063; Angele MK, 2003, AM J PHYSIOL-ENDOC M, V285, pE189, DOI 10.1152/ajpendo.00035.2003; Bain C, 2004, JNCI-J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Ceribelli A, 2007, J THORAC ONCOL, V2, pS15, DOI 10.1097/01.JTO.0000268635.25579.7e; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Dulos J, 2005, ARTHRITIS RHEUM-US, V52, P770, DOI 10.1002/art.20950; Gompel A, 2007, Menopause Int, V13, P65, DOI 10.1258/175404507780796433; Heyer A, 2005, J CEREBR BLOOD F MET, V25, P427, DOI 10.1038/sj.jcbfm.9600056; Higashi E, 2007, DRUG METAB DISPOS, V35, P1935, DOI 10.1124/dmd.107.016568; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Karafolas N., 1996, Optical Fiber Technology: Materials, Devices and Systems, V2, P149, DOI 10.1006/ofte.1996.0017; Lockshin MD, 2001, J APPL PHYSIOL, V91, P2366, DOI 10.1152/jappl.2001.91.5.2366; Lockshin MD, 2007, ARTHRITIS RHEUM, V56, P1048, DOI 10.1002/art.22631; Lockshin MD, 2006, ORTHOP CLIN N AM, V37, P629, DOI 10.1016/j.ocl.2006.08.002; Mollerup S, 1999, CANCER RES, V59, P3317; Nickerson M, 2006, J APPL PHYSIOL, V101, P566, DOI 10.1152/japplphysiol.00259.2006; Nikezic-Ardolic M, 1999, LUPUS, V8, P375, DOI 10.1177/096120339900800509; Peippo JP, 2002, MOL HUM REPROD, V8, P923, DOI 10.1093/molehr/8.10.923; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Shulman Lisa M, 2006, Expert Rev Neurother, V6, P407; Tang WJ, 2006, BIOCHEM BIOPH RES CO, V344, P540, DOI 10.1016/j.bbrc.2006.03.175; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Walker PR, 2004, ARTIF INTELL MED, V31, P137, DOI 10.1016/j.artmed.2004.01.008; WORKMAN C, 2002, GENOME BIOL, V0003; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Zorgdrager A, 2002, EUR NEUROL, V48, P204, DOI 10.1159/000066166	32	81	85	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1869	1879		10.1096/fj.08-119388	http://dx.doi.org/10.1096/fj.08-119388			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19190082	Green Published			2022-12-25	WOS:000266652400027
J	Yip, L; Woehrle, T; Corriden, R; Hirsh, M; Chen, Y; Inoue, Y; Ferrari, V; Insel, PA; Junger, WG				Yip, Linda; Woehrle, Tobias; Corriden, Ross; Hirsh, Mark; Chen, Yu; Inoue, Yoshiaki; Ferrari, Vhe; Insel, Paul A.; Junger, Wolfgang G.			Autocrine regulation of T-cell activation by ATP release and P2X(7) receptors	FASEB JOURNAL			English	Article						interleukin-2; NFAT; calcium signaling; real-time PCR; siRNA silencing	EXTRACELLULAR ADENOSINE-TRIPHOSPHATE; OF-FUNCTION; L-SELECTIN; CALCIUM; POLYMORPHISM; EXPRESSION; KINASE; LYMPHOCYTES; CHANNEL; IMPAIRS	T-cell activation requires the influx of extracellular calcium, although mechanistic details regarding such activation are not fully defined. Here, we show that P2X(7) receptors play a key role in calcium influx and downstream signaling events associated with the activation of T cells. By real-time PCR and immunohistochemistry, we find that Jurkat T cells and human CD4(+) T cells express abundant P2X(7) receptors. We show, using a novel fluorescent microscopy technique, that T-cell receptor (TCR) stimulation triggers the rapid release of ATP (<100 mu M). This release of ATP is required for TCR- mediated calcium influx, NFAT activation, and interleukin-2 (IL-2) production. TCR activation up-regulates P2X(7) receptor gene expression. Removal of extracellular ATP by apyrase or alkaline phosphatase treatment, inhibition of ATP release with the maxi-anion channel blocker gadolinium chloride, or siRNA silencing of P2X(7) receptors blocks calcium entry and inhibits T-cell activation. Moreover, lymphocyte activation is impaired in C57BL/6 mice that express poorly functional P2X(7) receptors, compared to control BALB/c mice, which express fully functional P2X(7) receptors. We conclude that ATP release and autocrine, positive feedback through P2X(7) receptors is required for the effective activation of T cells.-Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P. A., Junger, W. G. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J. 23, 1685-1693 (2009)	[Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Yip, Linda; Corriden, Ross; Hirsh, Mark; Chen, Yu; Inoue, Yoshiaki; Ferrari, Vhe; Junger, Wolfgang G.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Corriden, Ross; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Yip, Linda] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University	Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave,E-ST-8M10C, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452	National Institute of General Medical Sciences [R01 GM-51477, GM-60475, GM-66232]; Lymphoma and Leukemia Society; DOD/CDMRP [PR043034]; NIH GCRC [5MO1-RR-00827-25]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, T32GM007752, R01GM051477, R01GM060475] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); DOD/CDMRP(United States Department of Defense); NIH GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Amnon Altman for his advice and Dr. Marion Schneider for the helpful discussions of our results. This study was supported in part by National Institute of General Medical Sciences grants R01 GM-51477, GM-60475 (W.G.J.), and GM-66232; a grant from the Lymphoma and Leukemia Society (P.A.I.); DOD/CDMRP grant PR043034 (W.G.J.); and NIH GCRC grant 5MO1-RR-00827-25.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Aswad F, 2006, CELL IMMUNOL, V243, P58, DOI 10.1016/j.cellimm.2006.12.003; BALASUBRAMANYAM M, 1995, CELL CALCIUM, V18, P526, DOI 10.1016/0143-4160(95)90015-2; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; BLANCHARD DK, 1995, BLOOD, V85, P3173, DOI 10.1182/blood.V85.11.3173.bloodjournal85113173; Boudreault F, 2002, AM J PHYSIOL-CELL PH, V282, pC219, DOI 10.1152/ajpcell.00317.2001; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Corriden R, 2007, AM J PHYSIOL-CELL PH, V293, pC1420, DOI 10.1152/ajpcell.00271.2007; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dubyak GR, 2000, J AUTONOM NERV SYST, V81, P64, DOI 10.1016/S0165-1838(00)00155-7; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Glass R, 2000, CELL TISSUE RES, V300, P295, DOI 10.1007/s004410000206; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Hirsh MI, 2008, CRIT CARE MED, V36, P3220, DOI 10.1097/CCM.0b013e31818f238e; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jamieson GP, 1996, J CELL PHYSIOL, V166, P637, DOI 10.1002/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MURGIA M, 1993, J BIOL CHEM, V268, P8199; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2000, J BIOL CHEM, V275, P11735, DOI 10.1074/jbc.275.16.11735; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Ralevic V, 1998, PHARMACOL REV, V50, P413; REDEGELD F, 1991, J IMMUNOL, V147, P3638; Rothermel Annette L., 2004, BMC Immunology, V5, P1; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; SHIVNAN E, 1995, J IMMUNOL, V154, P1146; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Soto F, 1999, NEUROPHARMACOLOGY, V38, P141, DOI 10.1016/S0028-3908(98)00158-0; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2006, MOL BIOL CELL, V17, P3378, DOI 10.1091/mbc.E05-10-0993; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Yip L, 2007, SHOCK, V27, P242, DOI 10.1097/01.shk.0000245014.96419.3a; Yoon MJ, 2007, BIOL PHARM BULL, V30, P671, DOI 10.1248/bpb.30.671; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002	55	214	221	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1685	1693		10.1096/fj.08-126458	http://dx.doi.org/10.1096/fj.08-126458			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19211924	Green Published			2022-12-25	WOS:000266652400008
J	Feng, DJ; Witkowski, A; Smith, S				Feng, Dejiang; Witkowski, Andrzej; Smith, Stuart			Down-regulation of Mitochondrial Acyl Carrier Protein in Mammalian Cells Compromises Protein Lipoylation and Respiratory Complex I and Results in Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; ALPHA-LIPOIC ACID; PYRUVATE-DEHYDROGENASE COMPLEX; BOVINE HEART-MITOCHONDRIA; NEUROSPORA-CRASSA MITOCHONDRIA; NUCLEAR-ENCODED SUBUNITS; SACCHAROMYCES-CEREVISIAE; KETOGLUTARATE DEHYDROGENASE; SPECTROPHOTOMETRIC ASSAY; ESCHERICHIA-COLI	The objective of this study was to evaluate the physiological importance of the mitochondrial fatty acid synthesis pathway in mammalian cells using the RNA interference strategy. Transfection of HEK293T cells with small interfering RNAs targeting the acyl carrier protein (ACP) component reduced ACP mRNA and protein levels by >85% within 24 h. The earliest phenotypic changes observed were a marked decrease in the proportion of post-translationally lipoylated mitochondrial proteins recognized by anti-lipoate antibodies and a reduction in their catalytic activity, and a slowing of the cell growth rate. Later effects observed included a reduction in the specific activity of respiratory complex I, lowered mitochondrial membrane potential, the development of cytoplasmic membrane blebs containing high levels of reactive oxygen species and ultimately, cell death. Supplementation of the culture medium with lipoic acid offered some protection against oxidative damage but did not reverse the protein lipoylation defect. These observations are consistent with a dual role for ACP in mammalian mitochondrial function. First, as a key component of the mitochondrial fatty acid biosynthetic pathway, ACP plays an essential role in providing the octanoyl-ACP precursor required for the protein lipoylation pathway. Second, as one of the subunits of complex I, ACP is required for the efficient functioning of the electron transport chain and maintenance of normal mitochondrial membrane potential.	[Feng, Dejiang; Witkowski, Andrzej; Smith, Stuart] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Smith, S (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	ssmith@chori.org		Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [GM069717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069717.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Casciari JJ, 2001, BRIT J CANCER, V84, P1544, DOI 10.1054/bjoc.2001.1814; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Ewald R, 2007, PLANT PHYSIOL, V145, P41, DOI 10.1104/pp.107.104000; Finucane DM, 1999, EXP CELL RES, V251, P166, DOI 10.1006/excr.1999.4527; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1997, J BIOL CHEM, V272, P31974, DOI 10.1074/jbc.272.51.31974; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; Hinttala R, 2005, J MOL MED, V83, P786, DOI 10.1007/s00109-005-0712-y; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Huang HM, 2003, J NEUROSCI RES, V74, P309, DOI 10.1002/jnr.10756; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MIKOLAJCZYK S, 1990, EUR J BIOCHEM, V187, P431, DOI 10.1111/j.1432-1033.1990.tb15322.x; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Moungjaroen J, 2006, J PHARMACOL EXP THER, V319, P1062, DOI 10.1124/jpet.106.110965; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pack RA, 2002, MOL IMMUNOL, V38, P733, DOI 10.1016/S0161-5890(01)00110-9; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; RAHMATULLAH M, 1990, J BIOL CHEM, V265, P14512; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Sen CK, 1999, CELL DEATH DIFFER, V6, P481, DOI 10.1038/sj.cdd.4400514; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triepels R, 1999, J INHERIT METAB DIS, V22, P163, DOI 10.1023/A:1005402020569; Trinkaus J P, 1973, Ciba Found Symp, V14, P233; TSUNODA JN, 1967, ARCH BIOCHEM BIOPHYS, V118, P395, DOI 10.1016/0003-9861(67)90366-9; Van de Mark K, 2003, J CELL PHYSIOL, V194, P325, DOI 10.1002/jcp.10205; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; WEINBERG MB, 1980, BIOCHEM J, V188, P601, DOI 10.1042/bj1880601; Wenzel U, 2005, APOPTOSIS, V10, P359, DOI 10.1007/s10495-005-0810-x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; ZENSEN R, 1992, FEBS LETT, V310, P179, DOI 10.1016/0014-5793(92)81324-F; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zheng JB, 1999, BIOCHEM BIOPH RES CO, V261, P499, DOI 10.1006/bbrc.1999.1063	73	63	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11436	11445		10.1074/jbc.M806991200	http://dx.doi.org/10.1074/jbc.M806991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221180	Green Published, hybrid			2022-12-25	WOS:000265494500048
J	Tsoi, BM; Beckhouse, AG; Gelling, CL; Raftery, MJ; Chiu, J; Tsoi, AM; Lauterbach, L; Rogers, PJ; Higgins, VJ; Dawes, IW				Tsoi, Bonny M.; Beckhouse, Anthony G.; Gelling, Cristy L.; Raftery, Mark J.; Chiu, Joyce; Tsoi, Abraham M.; Lauterbach, Lars; Rogers, Peter J.; Higgins, Vincent J.; Dawes, Ian W.			Essential Role of One-carbon Metabolism and Gcn4p and Bas1p Transcriptional Regulators during Adaptation to Anaerobic Growth of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; CHEMOSTAT CULTURES; MANNOPROTEIN GENES; YEAST; PROTEIN; IDENTIFICATION; EXPRESSION; GLYCINE	The transcriptional activator Gcn4p is considered the master regulator of amino acid metabolism in Saccharomyces cerevisiae and is required for the transcriptional response to amino acid starvation. Here it is shown that Gcn4p plays a previously undescribed role in regulating adaptation to anaerobic growth. A gcn4 mutant exhibited a highly extended lag phase after a shift to anaerobiosis that was the result of L-serine depletion. In addition, the one-carbon metabolism and purine biosynthesis transcriptional regulator Bas1p were strictly required for anaerobic growth on minimal medium, and this was similarly due to L-serine limitation in bas1 mutants. The induction of one-carbon metabolism during anaerobiosis is needed to increase the supply of L-serine from the glycine and threonine pathways. Using a number of experimental approaches, we demonstrate that these transcription regulators play vital roles in regulating L-serine biosynthesis in the face of increased demand during adaptation to anaerobiosis. This increased L-serine requirement is most likely due to anaerobic remodeling of the cell wall, involving de novo synthesis of a large number of very serine-rich mannoproteins and an increase in the total serine content of the cell wall. During anaerobic starvation for L-serine, this essential amino acid is preferentially directed to the cell wall, indicating the existence of a regulatory mechanism to balance competing cellular demands.	[Tsoi, Bonny M.; Beckhouse, Anthony G.; Gelling, Cristy L.; Chiu, Joyce; Tsoi, Abraham M.; Lauterbach, Lars; Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Tsoi, Bonny M.; Higgins, Vincent J.] Univ Western Sydney, Sch Biomed & Hlth Sci, Penrith, NSW 1791, Australia; [Rogers, Peter J.] Fosters Grp Ltd, Abbotsford 3067, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Western Sydney University	Dawes, IW (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Beckhouse, Anthony G/A-2601-2010; Lauterbach, Lars/L-6671-2014; Chiu, Joyce/H-7772-2017	Beckhouse, Anthony G/0000-0002-5141-8250; Lauterbach, Lars/0000-0002-6601-6473; Chiu, Joyce/0000-0001-8910-8664	Australian Research Council; Australian Research Council Postgraduate Awards	Australian Research Council(Australian Research Council); Australian Research Council Postgraduate Awards(Australian Research Council)	This work was supported by Linkage and Discovery Grants from the Australian Research Council (to I. W. D., V. J. H., and P. J. R.) and by Australian Research Council Postgraduate Awards (to B. M. T., C. L. G., A. M. T., and A. G. B.).	Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; Abramova NE, 2001, GENETICS, V157, P1169; Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; BECKHOUSE AG, 2006, THESIS U NEW S WALES; Beckhouse AG, 2008, FEMS YEAST RES, V8, P1214, DOI 10.1111/j.1567-1364.2008.00439.x; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; Cook RJ, 2000, AM J CLIN NUTR, V72, P1419; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; de Groot MJL, 2007, MICROBIOL-SGM, V153, P3864, DOI 10.1099/mic.0.2007/009969-0; Denis V, 1998, MOL GEN GENET, V259, P246, DOI 10.1007/s004380050810; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Gelling C. L., 2008, THESIS U NEW S WALES; Gelling CL, 2004, J BIOL CHEM, V279, P7072, DOI 10.1074/jbc.M309178200; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HERMANN H, 1992, GENE, V119, P137, DOI 10.1016/0378-1119(92)90079-5; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hong SP, 1999, J BIOL CHEM, V274, P10523, DOI 10.1074/jbc.274.15.10523; Horie T, 2001, YEAST, V18, P1493, DOI 10.1002/yea.790; Kitagaki H, 1997, EUR J BIOCHEM, V249, P343, DOI 10.1111/j.1432-1033.1997.t01-1-00343.x; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; KONDO K, 1991, J BIOL CHEM, V266, P17537; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lai LC, 2005, MOL CELL BIOL, V25, P4075, DOI 10.1128/MCB.25.10.4075-4091.2005; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Piper MDW, 2002, FEMS YEAST RES, V2, P59, DOI 10.1016/S1567-1356(01)00061-7; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Sood R, 2000, GENETICS, V154, P787; STOVER P, 1991, J BIOL CHEM, V266, P1543; Subramanian M, 2005, MOL MICROBIOL, V57, P53, DOI 10.1111/j.1365-2958.2005.04663.x; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; Wiebe MG, 2008, FEMS YEAST RES, V8, P140, DOI 10.1111/j.1567-1364.2007.00234.x; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11205	11215		10.1074/jbc.M809225200	http://dx.doi.org/10.1074/jbc.M809225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224916	hybrid, Green Published			2022-12-25	WOS:000265494500024
J	McNutt, MC; Kwon, HJ; Chen, CY; Chen, JR; Horton, JD; Lagace, TA				McNutt, Markey C.; Kwon, Hyock Joo; Chen, Chiyuan; Chen, Justin R.; Horton, Jay D.; Lagace, Thomas A.			Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; MOLECULAR-BASIS; GENE; MUTATIONS; BINDING; MUTANTS; IDENTIFICATION; DEGRADATION	PCSK9 is a secreted protein that degrades low density lipoprotein receptors (LDLRs) in liver by binding to the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR. It is not known whether PCSK9 causes degradation of LDLRs within the secretory pathway or following secretion and reuptake via endocytosis. Here we show that a mutation in the LDLR EGF-A domain associated with familial hypercholesterolemia, H306Y, results in increased sensitivity to exogenous PCSK9-mediated cellular degradation because of enhanced PCSK9 binding affinity. The crystal structure ofthePCSK9-EGF-A(H306Y) complex shows that Tyr-306 forms a hydrogen bond with Asp-374 in PCSK9 at neutral pH, which strengthens the interaction with PCSK9. To block secreted PCSK9 activity, LDLR (H306Y) subfragments were added to the medium of HepG2 cells stably overexpressing wild-type PCSK9 or gain-of-function PCSK9 mutants associated with hypercholesterolemia (D374Y or S127R). These subfragments blocked secreted PCSK9 binding to cell surface LDLRs and resulted in the recovery of LDLR levels to those of control cells. We conclude that PCSK9 acts primarily as a secreted factor to cause LDLR degradation. These studies support the concept that pharmacological inhibition of the PCSK9-LDLR interaction extracellularly will increase hepatic LDLR expression and lower plasma low density lipoprotein levels.	[McNutt, Markey C.; Chen, Chiyuan; Chen, Justin R.; Horton, Jay D.; Lagace, Thomas A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kwon, Hyock Joo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Horton, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jay.horton@utsouthwestern.edu			National Institutes of Health [HL-38049, HL-20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038049, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-38049 and HL-20948 (to J.D.H.). This work was also supported by The Perot Family Foundation.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1974, J BIOL CHEM, V249, P789; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day INM, 1997, HUM MUTAT, V10, P116; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	47	127	179	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10561	10570		10.1074/jbc.M808802200	http://dx.doi.org/10.1074/jbc.M808802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224862	hybrid, Green Published			2022-12-25	WOS:000265104600030
J	Quintero-Monzon, O; Jonasson, EM; Bertling, E; Talarico, L; Chaudhry, F; Sihvo, M; Lappalainen, P; Goode, BL				Quintero-Monzon, Omar; Jonasson, Erin M.; Bertling, Enni; Talarico, Lou; Chaudhry, Faisal; Sihvo, Maarit; Lappalainen, Pekka; Goode, Bruce L.			Reconstitution and Dissection of the 600-kDa Srv2/CAP Complex ROLES FOR OLIGOMERIZATION AND COFILIN-ACTIN BINDING IN DRIVING ACTIN TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ASSOCIATED PROTEIN; N-TERMINAL DOMAIN; CEREVISIAE ADENYLYL CYCLASE; DICTYOSTELIUM-DISCOIDEUM; FILAMENT TURNOVER; PORCINE BRAIN; ADP-ACTIN; CAP; YEAST; MECHANISM	Srv2/cyclase-associated protein is expressed in virtually all plant, animal, and fungal organisms and has a conserved role in promoting actin depolymerizing factor/cofilin-mediated actin turnover. This is achieved by the abilities of Srv2 to recycle cofilin from ADP-actin monomers and to promote nucleotide exchange (ATP for ADP) on actin monomers. Despite this important and universal role in facilitating actin turnover, the mechanism underlying Srv2 function has remained elusive. Previous studies have demonstrated a critical functional role for the G-actin-binding C-terminal half of Srv2. Here we describe an equally important role in vivo for the N-terminal half of Srv2 in driving actin turnover. We pinpoint this activity to a conserved patch of surface residues on the N-terminal dimeric helical folded domain of Srv2, and we show that this functional site interacts with cofilin-actin complexes. Furthermore, we show that this site is essential for Srv2 acceleration of cofilin-mediated actin turnover in vitro. A cognate Srv2-binding site is identified on a conserved surface of cofilin, suggesting that this function likely extends to other organisms. In addition, our analyses reveal that higher order oligomerization of Srv2 depends on its N-terminal predicted coiled coil domain and that oligomerization optimizes Srv2 function in vitro and in vivo. Based on these data, we present a revised model for the mechanism by which Srv2 promotes actin turnover, in which coordinated activities of its N- and C-terminal halves catalyze sequential steps in recycling cofilin and actin monomers.	[Quintero-Monzon, Omar; Jonasson, Erin M.; Talarico, Lou; Chaudhry, Faisal; Goode, Bruce L.] Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Bertling, Enni; Sihvo, Maarit; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland	Brandeis University; University of Helsinki	Goode, BL (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	goode@brandeis.edu		Lappalainen, Pekka/0000-0001-6227-0354	National Institutes of Health [GM63691]; Academy of Finland and Sigrid Juselius Foundation; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, T32GM007596, R01GM063691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland and Sigrid Juselius Foundation(Academy of Finland); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63691 (to B. G.). This work was also supported by grants from the Academy of Finland and Sigrid Juselius Foundation (to P. L.) and from the American Cancer Society.	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chaudhry F, 2007, MOL BIOL CELL, V18, P3002, DOI 10.1091/mbc.E06-11-1041; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harlow E., 1988, USING ANTIBODIES LAB; Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.0.CO;2-E; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Ksiazek D, 2003, STRUCTURE, V11, P1171, DOI 10.1016/S0969-2126(03)00180-1; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Mavoungou C, 2004, J BIOMOL NMR, V29, P73, DOI 10.1023/B:JNMR.0000019513.86120.98; Moriyama K, 2002, J CELL SCI, V115, P1591; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Nishida Y, 1998, J BIOL CHEM, V273, P28019, DOI 10.1074/jbc.273.43.28019; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Quintero-Monzon O, 2005, MOL BIOL CELL, V16, P3128, DOI 10.1091/mbc.E05-01-0059; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; WANG J, 1992, MOL CELL BIOL, V12, P4937, DOI 10.1128/MCB.12.11.4937; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; Yu J, 1999, J BIOL CHEM, V274, P19985, DOI 10.1074/jbc.274.28.19985; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243	44	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10923	10934		10.1074/jbc.M808760200	http://dx.doi.org/10.1074/jbc.M808760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19201756	Green Published, hybrid			2022-12-25	WOS:000265104600065
J	Ratovitski, T; Gucek, M; Jiang, HB; Chighladze, E; Waldron, E; D'Ambola, J; Hou, ZP; Liang, YD; Poirier, MA; Hirschhorn, RR; Graham, R; Hayden, MR; Cole, RN; Ross, CA				Ratovitski, Tamara; Gucek, Marjan; Jiang, Haibing; Chighladze, Ekaterine; Waldron, Elaine; D'Ambola, James; Hou, Zhipeng; Liang, Yideng; Poirier, Michelle A.; Hirschhorn, Ricky R.; Graham, Rona; Hayden, Michael R.; Cole, Robert N.; Ross, Christopher A.			Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE CLEAVAGE; TRANSGENIC MICE; INTRANUCLEAR INCLUSIONS; PALLIDOLUYSIAN ATROPHY; DEPENDENT PROTEOLYSIS; REDUCES TOXICITY; REPEAT LENGTH; MU-CALPAIN; WILD-TYPE; IN-VIVO	Huntingtin proteolysis is implicated in Huntington disease pathogenesis, yet, the nature of huntingtin toxic fragments remains unclear. Huntingtin undergoes proteolysis by calpains and caspases within an N-terminal region between amino acids 460 and 600. We have focused on proteolytic steps producing shorter N-terminal fragments, which we term cp-1 and cp-2 (distinct from previously described cp-A/cp-B). We used HEK293 cells to express the first 511 residues of huntingtin and further define the cp-1 and cp-2 cleavage sites. Based on epitope mapping with huntingtin-specific antibodies, we found that cp-1 cleavage occurs between residues 81 and 129 of huntingtin. Affinity and size exclusion chromatography were used to further purify huntingtin cleavage products and enrich for the cp-1/cp-2 fragments. Using mass spectrometry, we found that the cp-2 fragment is generated by cleavage of huntingtin at position Arg(167). This site was confirmed by deletion analysis and specific detection with a custom-generated cp-2 site neo-epitope antibody. Furthermore, alterations of this cleavage site resulted in a decrease in toxicity and an increase in aggregation of huntingtin in neuronal cells. These data suggest that cleavage of huntingtin at residue Arg(167) may mediate mutant huntingtin toxicity in Huntington disease.	[Ratovitski, Tamara; Jiang, Haibing; Chighladze, Ekaterine; Waldron, Elaine; D'Ambola, James; Hou, Zhipeng; Liang, Yideng; Poirier, Michelle A.; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA; [Gucek, Marjan; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Cellular & Mol Med, Baltimore, MD 21287 USA; [Hirschhorn, Ricky R.] Hood Coll, Dept Biol, Frederick, MD 21701 USA; [Graham, Rona; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Child & Family Research Institute; University of British Columbia	Ratovitski, T (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA.	tratovi1@jhmi.edu; caross@jhu.edu	Graham, Rona K/R-7358-2018; Ross, Christopher A/H-8395-2013; Hayden, Michael R/D-8581-2011	Graham, Rona K/0000-0003-3722-6241; Hayden, Michael R/0000-0001-5159-1419	National Institutes of Health [16375]; NINDS [NS038144-08]; Huntington Disease Society of America Coalition for the Cure,; High Q Foundation; Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Huntington Disease Society of America Coalition for the Cure,; High Q Foundation; Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 16375 from the NINDS and NS038144-08. This work was also supported by the Huntington Disease Society of America Coalition for the Cure, High Q Foundation, Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada).	Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bizat N, 2003, J NEUROSCI, V23, P5020; Coombe DR, 1998, J IMMUNOL METHODS, V215, P145, DOI 10.1016/S0022-1759(98)00081-7; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wen Y, 2000, CANCER RES, V60, P6841; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	43	103	104	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10855	10867		10.1074/jbc.M804813200	http://dx.doi.org/10.1074/jbc.M804813200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204007	hybrid, Green Published			2022-12-25	WOS:000265104600059
J	Andersen, J; Taboureau, O; Hansen, KB; Olsen, L; Egebjerg, J; Stromgaard, K; Kristensen, AS				Andersen, Jacob; Taboureau, Olivier; Hansen, Kasper B.; Olsen, Lars; Egebjerg, Jan; Stromgaard, Kristian; Kristensen, Anders S.			Location of the Antidepressant Binding Site in the Serotonin Transporter IMPORTANCE OF SER-438 IN RECOGNITION OF CITALOPRAM AND TRICYCLIC ANTIDEPRESSANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIES-SCANNING MUTAGENESIS; HIGH-AFFINITY RECOGNITION; TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; 5-HYDROXYTRYPTAMINE UPTAKE; SUBSTRATE RECOGNITION; IMIPRAMINE-BINDING; BACTERIAL HOMOLOG; ACCURATE DOCKING; AMINO-ACID	The serotonin transporter (SERT) regulates extracellular levels of serotonin (5-hydroxytryptamine, 5HT) in the brain by transporting 5HT into neurons and glial cells. The human SERT (hSERT) is the primary target for drugs used in the treatment of emotional disorders, including depression. hSERT belongs to the solute carrier 6 family that includes a bacterial leucine transporter (LeuT), for which a high resolution crystal structure has become available. LeuT has proved to be an excellent model for human transporters and has advanced the understanding of solute carrier 6 transporter structure-function relationships. However, the precise structural mechanism by which antidepressants inhibit hSERT and the location of their binding pockets are still elusive. We have identified a residue (Ser-438) located within the 5HT-binding pocket in hSERT to be a critical determinant for the potency of several antidepressants, including the selective serotonin reuptake inhibitor citalopram and the tricyclic antidepressants imipramine, clomipramine, and amitriptyline. A conservative mutation of Ser-438 to threonine (S438T) selectively increased the K-i values for these antidepressants up to 175-fold. The effects of introducing a protein methyl group into the 5HT-binding pocket by S438T were absent or reduced for analogs of these antidepressants lacking a single methyl group. This suggests that these antidepressants interact directly with Ser-438 during binding to hSERT, implying an overlapping localization of substrate- and inhibitor-binding sites in hSERT suggesting that antidepressants function by a mechanism that involves direct occlusion of the 5HT-binding site.	[Andersen, Jacob; Taboureau, Olivier; Olsen, Lars; Stromgaard, Kristian; Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Taboureau, Olivier] Tech Univ Denmark, BioCentrum DTU, DK-2800 Lyngby, Denmark; [Hansen, Kasper B.; Egebjerg, Jan] H Lundbeck & Co AS, Lundbeck Res Denmark, DK-2500 Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Lundbeck Corporation	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Med Chem, Univ Parken 2, DK-2100 Copenhagen, Denmark.	krst@farma.ku.dk; ask@farma.ku.dk	Andersen, Jacob/B-7768-2016; Olsen, Lars/AAY-8278-2020; Hansen, Kasper B/C-4062-2008; Olsen, Lars/C-9706-2010; Stromgaard, Kristian/E-3380-2010; Kristensen, Anders Skov/B-4414-2009	Andersen, Jacob/0000-0002-8067-3074; Hansen, Kasper B/0000-0002-3303-4819; Kristensen, Anders Skov/0000-0001-8955-6790; Olsen, Lars/0000-0002-7607-7130; Stromgaard, Kristian/0000-0003-2206-4737	Carlsberg Foundation; Danish Medical Research Council; Lundbeck Foundation; Danish Council for Strategic Research NABIIT Programme; Drug Research Academy	Carlsberg Foundation(Carlsberg Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research NABIIT Programme(Danske Strategiske Forskningsrad (DSF)); Drug Research Academy	This work was supported by the Carlsberg Foundation and the Danish Medical Research Council (to L. O.), the Lundbeck Foundation (to K. B. H.), the Danish Council for Strategic Research NABIIT Programme (to O. T.), and the Drug Research Academy (to J. A.).	Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; ANDERSEN J, 2007, SOC NEUR ABSTR, V248, P15; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1996, MOL PHARMACOL, V50, P957; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HUMPHREYS CJ, 1988, MOL PHARMACOL, V33, P657; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; Larsen MB, 2004, J BIOL CHEM, V279, P42147, DOI 10.1074/jbc.M405579200; MARCUSSON JO, 1986, MOL PHARMACOL, V30, P121; Mortensen OV, 2001, J NEUROCHEM, V79, P237, DOI 10.1046/j.1471-4159.2001.00587.x; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Rudnick G, 2007, ACS CHEM BIOL, V2, P606, DOI 10.1021/cb7001818; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sur C, 1997, P NATL ACAD SCI USA, V94, P7639, DOI 10.1073/pnas.94.14.7639; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; WENNOGLE LP, 1982, EUR J PHARMACOL, V86, P303, DOI 10.1016/0014-2999(82)90333-8; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	43	93	93	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10276	10284		10.1074/jbc.M806907200	http://dx.doi.org/10.1074/jbc.M806907200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213730	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000264892900069
J	Chang, KY; Shen, MR; Lee, MY; Wang, WL; Su, WC; Chang, WC; Chen, BK				Chang, Kwang-Yu; Shen, Meng-Ru; Lee, Mei-Yi; Wang, Wen-Lin; Su, Wu-Chou; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal Growth Factor-activated Aryl Hydrocarbon Receptor Nuclear Translocator/HIF-1 beta Signal Pathway Up-regulates Cyclooxygenase-2 Gene Expression Associated with Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; LUNG-CANCER; CERVICAL-CANCER; POOR SURVIVAL; VASCULAR ENDOTHELIUM; TUMOR ANGIOGENESIS; BINDING PROTEINS; A431 CELLS; PHASE-II; C-JUN	Hypoxia-inducible factor (HIF) accumulates when tumors grow under hypoxic conditions. The genesis of tumors, however, usually involves normoxic conditions. In this study, we were interested in examining the potential role of aryl hydrocarbon receptor nuclear translocator (ARNT)/HIF-1 beta in tumor growth under normoxic conditions, specifically when cells are treated with epidermal growth factor (EGF),which is known to affect the gene expression of tumor growth-related protein COX-2 (cyclooxygenase-2). The results showed that EGF receptor inhibitor, AG1478, abolished EGF-induced nuclear accumulation of ARNT as well as the expression of COX-2. ARNT small interfering RNA inhibited the promoter activity, mRNA level, and protein expression of COX-2 in cells treated with EGF. In contrast, CoCl2-induced HIF-1 beta exhibited no effect on COX-2 expression. EGF also stimulated the formation of the ARNT.c-Jun complex as well as the complex binding to the COX-2 promoter. ARNT small interfering RNAs blocked EGF-activated cell migration. Moreover, COX-2 and ARNT were cohorts present distinctively in clinical specimens of human cervical squamous cell carcinoma and were almost nondetectable in adjacent normal or noncancerous cervical tissues. Our results revealed that ARNT plays an important role in EGF-regulated COX-2 gene expression and may thus be related to either a cause or a consequence of tumorigenesis in cervical cancer.	[Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Shen, Meng-Ru] Natl Cheng Kung Univ, Dept Obstet & Gynecol, Tainan 701, Taiwan; [Shen, Meng-Ru; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biosignal Transduct, Tainan 701, Taiwan; [Chang, Kwang-Yu; Su, Wu-Chou] Natl Cheng Kung Univ, Dept Internal Med, Tainan 701, Taiwan; [Chang, Kwang-Yu] Natl Inst Canc Res, Natl Hlth Res Inst, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan	Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan.	bkchen58@mail.ncku.edu.tw	Chang, Kwang-Yu/G-9161-2011	Su, Wu-Chou/0000-0003-2953-4105	National Science Council of the Republic of China [NSC 95-2320-B-006-071-MY2]; National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers	This work was supported in part by National Science Council of the Republic of China Grant NSC 95-2320-B-006-071-MY2 and by the National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers.	Agarwala A, 2008, J THORAC ONCOL, V3, P374, DOI 10.1097/JTO.0b013e3181693869; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chang JHT, 2007, CLIN CANCER RES, V13, P38, DOI 10.1158/1078-0432.CCR-06-1166; Chen HHW, 2005, INT J RADIAT ONCOL, V63, P1093, DOI 10.1016/j.ijrobp.2005.03.062; Chen LC, 2005, MOL PHARMACOL, V67, P2057, DOI 10.1124/mol.104.010900; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Csiki I, 2006, CANCER RES, V66, P143, DOI 10.1158/0008-5472.CAN-05-1357; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Gadgeel SM, 2007, J THORAC ONCOL, V2, P299, DOI 10.1097/01.JTO.0000263712.61697.69; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Half E, 2002, CANCER RES, V62, P1676; Itoh S, 2003, ORAL ONCOL, V39, P829, DOI 10.1016/S1368-8375(03)00105-2; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim GE, 2004, CLIN CANCER RES, V10, P1366, DOI 10.1158/1078-0432.CCR-0497-03; Konturek SJ, 2005, J PHYSIOL PHARMACOL, V56, P507; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Reckamp KL, 2006, CLIN CANCER RES, V12, P3381, DOI 10.1158/1078-0432.CCR-06-0112; Richardson CM, 2005, LUNG CANCER, V48, P47, DOI 10.1016/j.lungcan.2004.09.007; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Subbaramaiah K, 2008, J BIOL CHEM, V283, P33955, DOI 10.1074/jbc.M805490200; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Wirth LJ, 2005, J CLIN ONCOL, V23, P6976, DOI 10.1200/JCO.2005.02.4182; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhong H, 2000, CANCER RES, V60, P1541; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	49	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9908	9916		10.1074/jbc.M806210200	http://dx.doi.org/10.1074/jbc.M806210200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203995	Green Published, hybrid			2022-12-25	WOS:000264892900033
J	Funke, T; Yang, Y; Han, H; Healy-Fried, M; Olesen, S; Becker, A; Schonbrunn, E				Funke, Todd; Yang, Yan; Han, Huijong; Healy-Fried, Martha; Olesen, Sanne; Becker, Andreas; Schoenbrunn, Ernst			Structural Basis of Glyphosate Resistance Resulting from the Double Mutation Thr(97) -> Ile and Pro(101) -> Ser in 5-Enolpyruvylshikimate-3-phosphate Synthase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHEDRAL REACTION INTERMEDIATE; KLEBSIELLA-PNEUMONIAE; HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; SHIKIMATE PATHWAY; SUBSTITUTION; INHIBITION; IDENTIFICATION; MECHANISMS	The shikimate pathway enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) is the target of the broad spectrum herbicide glyphosate. The genetic engineering of EPSPS led to the introduction of glyphosate-resistant crops worldwide. The genetically engineered corn lines NK603 and GA21 carry distinct EPSPS enzymes. CP4 EPSPS, expressed in NK603 corn and transgenic soybean, cotton, and canola, belongs to class II EPSPS, glyphosate-insensitive variants of this enzyme isolated from certain Gram-positive bacteria. GA21 corn, on the other hand, was created by point mutations of class I EPSPS, such as the enzymes from Zea mays or Escherichia coli, which are sensitive to low glyphosate concentrations. The structural basis of the glyphosate resistance resulting from these point mutations has remained obscure. We studied the kinetic and structural effects of the T97I/P101S double mutation, the molecular basis for GA21 corn, using EPSPS from E. coli. The T97I/P101S enzyme is essentially insensitive to glyphosate (K-i = 2.4 mM) but maintains high affinity for the substrate phosphoenolpyruvate (PEP) (K-m = 0.1 mM). The crystal structure at 1.7-angstrom resolution revealed that the dual mutation causes a shift of residue Gly(96) toward the glyphosate binding site, impairing efficient binding of glyphosate, while the side chain of Ile(97) points away from the substrate binding site, facilitating PEP utilization. The single site T97I mutation renders the enzyme sensitive to glyphosate and causes a substantial decrease in the affinity for PEP. Thus, only the concomitant mutations of Thr(97) and Pro(101) induce the conformational changes necessary to produce catalytically efficient, glyphosate-resistant class I EPSPS.	[Yang, Yan; Han, Huijong; Olesen, Sanne; Becker, Andreas; Schoenbrunn, Ernst] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Funke, Todd; Healy-Fried, Martha; Schoenbrunn, Ernst] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	H Lee Moffitt Cancer Center & Research Institute; University of Kansas	Schonbrunn, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org		Han, Huijong/0000-0002-1197-3014; Schonbrunn, Ernst/0000-0002-3589-3510	National Institutes of Health (NIH) [5R01GM070633]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545, R01GM070633] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant 5R01GM070633.	ALBERG DG, 1992, J AM CHEM SOC, V114, P3535, DOI 10.1021/ja00035a058; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; BOOCOCK MR, 1983, FEBS LETT, V154, P127, DOI 10.1016/0014-5793(83)80888-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Du WS, 2000, BIOCHEMISTRY-US, V39, P10140, DOI 10.1021/bi000890v; Eichholtz D.A., 2001, U.S. Patent, Patent No. 6225114; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Eschenburg S, 2003, J BIOL CHEM, V278, P49215, DOI 10.1074/jbc.M309741200; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANZ JE, 1997, GLYPHOSATE UNIQUE GL, P596; Funke T, 2007, BIOCHEMISTRY-US, V46, P13344, DOI 10.1021/bi701095u; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; HASLAM E, 1993, SHIKIMIC ACID METABO, P1; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lebrun M., 2003, Mutated 5-enolpyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene, Patent No. [US 6566587, 6566587]; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Padgette SR, 1995, HERBICIDE RESISTANT, P53; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Perez-Jones A, 2007, PLANTA, V226, P395, DOI 10.1007/s00425-007-0490-6; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Priestman MA, 2005, BIOCHEMISTRY-US, V44, P3241, DOI 10.1021/bi048198d; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; SMITH EA, 1992, VET HUM TOXICOL, V34, P531; SOST D, 1990, ARCH BIOCHEM BIOPHYS, V282, P433, DOI 10.1016/0003-9861(90)90140-T; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1984, EUR J BIOCHEM, V143, P351, DOI 10.1111/j.1432-1033.1984.tb08379.x; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Williams GM, 2000, REGUL TOXICOL PHARM, V31, P117, DOI 10.1006/rtph.1999.1371; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3; [No title captured], Patent No. 6040497	47	99	115	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9854	9860		10.1074/jbc.M809771200	http://dx.doi.org/10.1074/jbc.M809771200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211556	hybrid, Green Published			2022-12-25	WOS:000264892900026
J	Wang, GN; Matsuura, I; He, DM; Liu, F				Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang			Transforming Growth Factor-beta-inducible Phosphorylation of Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GLYCOGEN-SYNTHASE KINASE-3-BETA; FAMILY MEDIATOR SMAD1; TGF-BETA; MAP KINASE; SIGNALING PATHWAYS; CELL-CYCLE; IN-VIVO; ANTIPROLIFERATIVE FUNCTION; NEURAL INDUCTION	Smad proteins transduce the transforming growth factor-beta (TGF-beta) signal at the cell surface into gene regulation in the nucleus. Upon TGF-beta treatment, the highly homologous Smad2 and Smad3 are phosphorylated by the TGF-beta receptor at the SSXS motif in the C-terminal tail. Here we show that in addition to the C-tail, three (S/T)-P sites in the Smad3 linker region, Ser(208), Ser(204), and Thr(179) are phosphorylated in response to TGF-beta. The linker phosphorylation peaks at 1 h after TGF-beta treatment, behind the peak of the C-tail phosphorylation. We provide evidence suggesting that the C-tail phosphorylation by the TGF-beta receptor is necessary for the TGF-beta-induced linker phosphorylation. Although the TGF-beta receptor is necessary for the linker phosphorylation, the receptor itself does not phosphorylate these sites. We further show that ERK is not responsible for TGF-beta-dependent phosphorylation of these three sites. We show that GSK3 accounts for TGF-beta-inducible Ser(204) phosphorylation. Flavopiridol, a pan-CDK inhibitor, abolishes TGF-beta-induced phosphorylation of Thr(179) and Ser(208), suggesting that the CDK family is responsible for phosphorylation of Thr(179) and Ser(208) in response to TGF-beta. Mutation of the linker phosphorylation sites to nonphosphorylatable residues increases the ability of Smad3 to activate a TGF-beta/Smad-target gene as well as the growth-inhibitory function of Smad3. Thus, these observations suggest that TGF-beta-induced phosphorylation of Smad3 linker sites inhibits its antiproliferative activity.	[Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Wang, Guannan; Liu, Fang] Rutgers State Univ, Grad Program Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick	Liu, F (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	fangliu@cabm.rutgers.edu			National Institutes of Health [CA93771]; NATIONAL CANCER INSTITUTE [R01CA093771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA93771 (to F. L.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Carlson BA, 1996, CANCER RES, V56, P2973; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DE AWJ, 1996, P NATL ACAD SCI USA, V93, P2735; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Liu F, 2003, FRONT BIOSCI-LANDMRK, V8, pS1280, DOI 10.2741/1149; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; LOSIEWICZ MD, 1994, BIOCHEM BIOPH RES CO, V201, P589, DOI 10.1006/bbrc.1994.1742; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Meijer L, 1999, PHARMACOL THERAPEUT, V82, P279, DOI 10.1016/S0163-7258(98)00057-6; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pagano M, 2004, CELL, V118, P535, DOI 10.1016/j.cell.2004.08.013; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Prokova V, 2005, NUCLEIC ACIDS RES, V33, P3708, DOI 10.1093/nar/gki679; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sater AK, 2003, DIFFERENTIATION, V71, P434, DOI 10.1046/j.1432-0436.2003.7107006.x; Senderowicz AM, 2005, PROG DRUG RES, V63, P183; Shchemelinin I, 2006, FOLIA BIOL-PRAGUE, V52, P137; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ20041820; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Yamagata H, 2005, CANCER RES, V65, P157; Yonekura A, 1999, ENDOCR J, V46, P545, DOI 10.1507/endocrj.46.545; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	76	100	104	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9663	9673		10.1074/jbc.M809281200	http://dx.doi.org/10.1074/jbc.M809281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218245	hybrid, Green Published			2022-12-25	WOS:000264892900006
J	Yuan, C; Sidhu, RS; Kuklev, DV; Kado, Y; Wada, M; Song, I; Smith, WL				Yuan, Chong; Sidhu, Ranjinder S.; Kuklev, Dmitry V.; Kado, Yuji; Wada, Masayuki; Song, Inseok; Smith, William L.			Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ENDOPEROXIDE-H SYNTHASE-1; PROSTAGLANDIN PRODUCTION; PROTEIN; OXYGENATION; INHIBITION; PATHWAYS; EXPRESSION; GENERATION; MECHANISM	Prostaglandin endoperoxide H synthases (PGHSs) 1 and 2, also known as cyclooxygenases (COXs), catalyze the oxygenation of arachidonic acid ( AA) in the committed step in prostaglandin (PG) biosynthesis. PGHSs are homodimers that display half of sites COX activity with AA; thus, PGHSs function as conformational heterodimers. Here we show that, during catalysis, fatty acids (FAs) are bound at both COX sites of a PGHS-2 dimer. Initially, an FA binds with high affinity to one COX site of an unoccupied homodimer. This monomer becomes an allosteric monomer, and it causes the partner monomer to become the catalytic monomer that oxygenates AA. A variety of FAs can bind with high affinity to the COX site of the monomer that becomes the allosteric monomer. Importantly, the efficiency of AA oxygenation is determined by the nature of the FA bound to the allosteric monomer. When tested with low concentrations of saturated and monounsaturated FAs ( e. g. oleic acid), the rates of AA oxygenation are typically 1.5-2 times higher with PGHS-2 than with PGHS-1. These different kinetic behaviors of PGHSs may account for the ability of PGHS-2 but not PGHS-1 to efficiently oxygenate AA in intact cells when AA is a small fraction of the FA pool such as during "late phase" PG synthesis.	[Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kuklev, Dmitry V.] Cayman Chem Co, Ann Arbor, MI 48108 USA; [Song, Inseok] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Michigan System; University of Michigan; University of Seoul	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	smithww@umich.edu			National Institutes of Health [GM68848]; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68848 ( to W. L. S.). This work was also supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada ( to R. S. S.).	Bala M, 2008, BIOCHEM PHARMACOL, V75, P1472, DOI 10.1016/j.bcp.2007.12.005; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; KENNEDY TA, 1994, J BIOL CHEM, V269, P27357; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kuklev DV, 2006, CHEM PHYS LIPIDS, V144, P172, DOI 10.1016/j.chemphyslip.2006.09.002; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; Kuklev DV, 2003, J LIPID RES, V44, P1060, DOI 10.1194/jlr.D200046-JLR200; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kuwata H, 2000, J IMMUNOL, V165, P4024, DOI 10.4049/jimmunol.165.7.4024; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; PACEASCIAK C, 1968, BIOCHIM BIOPHYS ACTA, V152, P784, DOI 10.1016/0005-2760(68)90126-4; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; TOJO G, 2006, OXIDATION ALCOHOLS A, P50; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	40	91	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10046	10055		10.1074/jbc.M808634200	http://dx.doi.org/10.1074/jbc.M808634200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218248	hybrid, Green Published			2022-12-25	WOS:000264892900047
J	Zhou, J; Vos, CC; Gjyrezi, A; Yoshida, M; Khuri, FR; Tamanoi, F; Giannakakou, P				Zhou, Jun; Vos, Chantal Chanel; Gjyrezi, Ada; Yoshida, Minoru; Khuri, Fadlo R.; Tamanoi, Fuyuhiko; Giannakakou, Paraskevi			The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL TRANSFERASE INHIBITORS; HISTONE DEACETYLASE INHIBITORS; OVARIAN-CANCER CELLS; GLUCOCORTICOID-RECEPTOR; IN-VIVO; PACLITAXEL; ACETYLATION; EXPRESSION; CHAPERONE; TUBULIN	The cytoplasmic deacetylase HDAC6 is an important regulator of cellular pathways that include response to stress, protein folding, microtubule stability, and cell migration, thus representing an attractive target for cancer chemotherapy. However, little is known about its upstream regulation. Our previous work has implicated HDAC6 as a new protein target for the farnesyltransferase inhibitors (FTIs), although HDAC6 lacks a farnesylation motif. Here we show that the protein farnesyltransferase (FTase) and HDAC6 are present in a protein complex together with microtubules in vivo and in vitro. FTase binds microtubules directly via its alpha subunit, and this association requires the C terminus of tubulin. Treatment with an FTI removed FTase, but not HDAC6, from the protein complex, suggesting that the active form of FTase is bound to microtubules. Importantly, the removal of FTase from microtubules abrogated HDAC6 activity, as did a stable knockdown of the alpha subunit of FTase (FT alpha KD). Interestingly, the FT alpha KD cells showed increased sensitivity to the antiproliferative effects of Taxol and the FTI lonafarnib when used either as single agents or in combination as compared with parental cells. Altogether, these data suggest that FTase, via its tubulin-association, is a critical upstream regulator of HDAC6 activity and that FTase expression could help stratify cancer patients that would most benefit from this treatment.	[Vos, Chantal Chanel; Gjyrezi, Ada; Giannakakou, Paraskevi] Weill Cornell Med Coll, Div Hematol Clin Oncol, Dept Med, New York, NY 10065 USA; [Zhou, Jun; Khuri, Fadlo R.; Giannakakou, Paraskevi] Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA; [Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Grp, Wako, Saitama 3510198, Japan; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol, Los Angeles, CA 90095 USA; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Immunol, Los Angeles, CA 90095 USA; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Mol Genet, Los Angeles, CA 90095 USA	Cornell University; Emory University; RIKEN; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Giannakakou, P (corresponding author), Weill Cornell Med Coll, Div Hematol Clin Oncol, Dept Med, 1300 York Ave, New York, NY 10065 USA.	pag2015@med.cornell.edu	Khuri, Fadlo R./AAU-4942-2020; Yoshida, Minoru/C-8049-2014	Khuri, Fadlo R./0000-0002-8638-7618; Yoshida, Minoru/0000-0002-4376-5674	National Institutes of Health [CA100202, CA114335, 1F32CA134148-01, CA041996]; NATIONAL CANCER INSTITUTE [R01CA100202, R01CA041996, R01CA114335, F32CA134148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100202 and CA114335 ( to P. G.), 1F32CA134148-01 ( to C. C. V.), and CA041996 ( to F. T.).	Adjei AA, 2003, LUNG CANCER-J IASLC, V41, pS55, DOI 10.1016/S0169-5002(03)00143-0; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; Del Villar K, 1999, J BIOL CHEM, V274, P27010, DOI 10.1074/jbc.274.38.27010; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kamath K, 2003, CANCER RES, V63, P6026; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khan SG, 1996, BIOCHEM BIOPH RES CO, V220, P795, DOI 10.1006/bbrc.1996.0483; Kim ES, 2005, CANCER, V104, P561, DOI 10.1002/cncr.21188; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; Marcus AI, 2005, CANCER RES, V65, P3883, DOI 10.1158/0008-5472.CAN-04-3757; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Moasser MM, 1998, P NATL ACAD SCI USA, V95, P1369, DOI 10.1073/pnas.95.4.1369; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun JZ, 1999, CANCER RES, V59, P4919; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200	36	29	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9648	9655		10.1074/jbc.M808708200	http://dx.doi.org/10.1074/jbc.M808708200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228685	Green Published, hybrid			2022-12-25	WOS:000264892900004
J	Abdel-Hafiz, H; Dudevoir, ML; Horwitz, KB				Abdel-Hafiz, Hany; Dudevoir, Michelle L.; Horwitz, Kathryn B.			Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; ANDROGEN RECEPTOR; SUMO-1 MODIFICATION; B-RECEPTORS; KAPPA-B; BINDING PROTEINS; TERMINAL DOMAIN; HINGE REGION; A-RECEPTORS; DNA-BINDING	Posttranslational modification by small ubiquitin-like modifier ( SUMO) is a major regulator of transcription. We previously showed that progesterone receptors ( PR) have a single consensus psi KXE SUMO-conjugation motif centered at Lys-388 in the N-terminal domain of PR-B and a homologous site of PR-A. SUMOylation of the PR is hormone-dependent and has a suppressive effect on transcription of an exogenous promoter. Here we show that repression of PR activity by SUMOylation at Lys-388 is uncoupled from phosphorylation, involves synergy between tandem progesterone response elements, and is associated with lowered ligand sensitivity and slowed ligand-dependent down-regulation. However, paradoxically, cellular overexpression of SUMO-1 increases PR transcriptional activity even if Lys-388 is mutated, suggesting that the receptors are activated indirectly by other SUMOylated proteins. One of these is the coactivator SRC-1, whose binding to PR and enhancement of agonist-dependent N-/C-terminal interactions is augmented by the presence of SUMO-1. Increased transcription due to SRC-1 is independent of PR SUMOylation based on assays with the Lys-388 mutants and the pure antiprogestin ZK98299, which blocks N-/C-terminal interactions. In summary, SUMOylation tightly regulates the transcriptional activity of PR by repressing the receptors directly while activating them indirectly through augmented SRC-1 coactivation.	[Abdel-Hafiz, Hany; Dudevoir, Michelle L.; Horwitz, Kathryn B.] Univ Colorado Denver, Div Endocrinol, Dept Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Abdel-Hafiz, H (corresponding author), MS 8106,POB 6511, Aurora, CO 80045 USA.	hany.abdel-hafiz@ucdenver.edu		Horwitz, Kathryn/0000-0001-7402-6455	National Institutes of Health, NCI [CA26869-29]; National Foundation for Cancer Research; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE [R37CA026869, R01CA026869] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA26869-29. This work was also supported by the National Foundation for Cancer Research, the Breast Cancer Research Foundation, and the Avon Foundation.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Dong X, 2004, J MOL ENDOCRINOL, V32, P843, DOI 10.1677/jme.0.0320843; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heneghan AF, 2006, BIOCHEMISTRY-US, V45, P3285, DOI 10.1021/bi052046g; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Kalkhoven E, 1996, INT J CANCER, V65, P682, DOI 10.1002/(SICI)1097-0215(19960301)65:5<682::AID-IJC20>3.0.CO;2-8; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knotts TA, 2001, J BIOL CHEM, V276, P8475, DOI 10.1074/jbc.M009805200; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; LE DY, 2002, ENDOCRINOLOGY, V143, P3482; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; SARTORIUS CA, 1994, CANCER RES, V54, P3868; SARTORIUS CA, 1993, J BIOL CHEM, V268, P9262; Sathya G, 2002, MOL CELL ENDOCRINOL, V192, P171, DOI 10.1016/S0303-7207(01)00673-6; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; SHERIDAN PL, 1989, J BIOL CHEM, V264, P7054; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Takimoto GS, 1996, J BIOL CHEM, V271, P13308, DOI 10.1074/jbc.271.23.13308; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tirard M, 2007, MOL CELL ENDOCRINOL, V268, P20, DOI 10.1016/j.mce.2007.01.010; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; Tung L, 2001, J BIOL CHEM, V276, P39843, DOI 10.1074/jbc.M106843200; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; Tyulmenkov VV, 2000, MOL CELL ENDOCRINOL, V165, P151, DOI 10.1016/S0303-7207(00)00250-1; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WEI LL, 1990, MOL ENDOCRINOL, V4, P1833, DOI 10.1210/mend-4-12-1833; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	76	31	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9099	9108		10.1074/jbc.M805226200	http://dx.doi.org/10.1074/jbc.M805226200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211567	hybrid, Green Published			2022-12-25	WOS:000264669100013
J	Kizuka, Y; Tonoyama, Y; Oka, S				Kizuka, Yasuhiko; Tonoyama, Yasuhiro; Oka, Shogo			Distinct Transport and Intracellular Activities of Two GlcAT-P Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNK-1 CARBOHYDRATE EPITOPE; GOLGI LOCALIZATION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; EXPRESSION; GLYCOSYLATION; GLUCURONOSYLTRANSFERASES; GLYCOPROTEINS	A neural glycotope, human natural killer-1 carbohydrate, is involved in synaptic plasticity. The key biosynthetic enzyme is a glucuronyltransferase, GlcAT-P, a type II membrane protein comprising an N-terminal cytoplasmic tail, transmembrane domain, stem region, and C-terminal catalytic domain. Previously, we reported that GlcAT-P has two isoforms differing in only the presence or absence of the N-terminal 13 amino acids (P-N13) in the cytoplasmic tail, but the functional distinction of these two isoforms has not been reported. Herein, we show that when expressed in Neuro2A cells, short form GlcAT-P (sGlcAT-P) exhibited significantly higher glucuronylation activity than the longer form (1GlcAT-P), despite their comparable specific activities in vitro. In addition, sGlcAT-P was strictly localized in Golgi apparatus, whereas lGlcAT-P was mainly localized in Golgi but partly in the endoplasmic reticulum. We demonstrated that the small GTPase, Sar1, recognized a dibasic motif in the cytoplasmic tail near P-N13 that was important for exiting the endoplasmic reticulum, and Sar1 interacted with sGlcAT-P more strongly than 1GlcAT-P. Finally, the attachment of P-N13 to another glycosyltransferase, poly-sialyltransferase-I (ST8Sia-IV), had similar effects, such as reduced activity and entrapment within endoplasmic reticulum. These results suggest that P-N13 can control glycosyltransferase transport through Sar1 binding interference.	[Kizuka, Yasuhiko] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068507, Japan; [Tonoyama, Yasuhiro; Oka, Shogo] Kyoto Univ, Dept Biol Chem, Grad Sch Med, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Creative Scientific Research [16GS0313]; JSPS Fellows; Ministry of Education, Culture, Sports, Science, and Technology	Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Creative Scientific Research 16GS0313 (to S. O.) and a Grant-in-Aid for JSPS Fellows (to Y. K.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kojima N, 1997, J BIOCHEM-TOKYO, V122, P1265; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Ma JY, 1997, J BIOL CHEM, V272, P672; Mitsumoto Y, 2000, GENOMICS, V65, P166, DOI 10.1006/geno.2000.6152; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Stroud WJ, 2003, TRAFFIC, V4, P631, DOI 10.1034/j.1600-0854.2003.00122.x; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; VIRTANEN I, 1980, J CELL BIOL, V85, P429, DOI 10.1083/jcb.85.2.429; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamamoto S, 2002, J BIOCHEM, V131, P337, DOI 10.1093/oxfordjournals.jbchem.a003108	36	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9247	9256		10.1074/jbc.M807517200	http://dx.doi.org/10.1074/jbc.M807517200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181664	Green Published, hybrid			2022-12-25	WOS:000264669100031
J	Park, AYJ; Shen, TL; Chien, S; Guan, JL				Park, Ann Y. J.; Shen, Tang-Long; Chien, Shu; Guan, Jun-Lin			Role of Focal Adhesion Kinase Ser-732 Phosphorylation in Centrosome Function during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; FAK PHOSPHORYLATION; ENDOTHELIAL-CELLS; TYR-397 PHOSPHORYLATION; SERINE PHOSPHORYLATION; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; EPITHELIAL-CELLS; AURORA-A	Focal adhesion kinase (FAK) is the major cytoplasmic tyrosine kinase in focal adhesions and a critical mediator of integrin signaling in a variety of cells, including endothelial cells (ECs). Here we describe a new function for FAK in the regulation of centrosome functions in a Ser-732 phosphorylation-dependent manner during mitosis. Deletion of FAK in primary ECs causes increases in centrosome numbers, multipolar and disorganized spindles, and unaligned chromosomes during mitosis. Re-expression of wild-type FAK, but not S732A mutant, rescued these mitotic defects, suggesting a role for Ser-732 phosphorylation in the regulation of centrosomal functions. Consistent with this possibility, Ser-732-phosphorylated FAK was found to co-localize in centrosomes in mitotic cells. FAK also associated with cytoplasmic dynein in a Ser-732 phosphorylation-dependent manner. Further analysis in FAK-null primary ECs showed that S732A mutant could rescue EC migration but not proliferation or tubulogenesis in vitro. Last, we showed that deletion of FAK in ECs reduced tumor angiogenesis in vivo, which could be restored by re-expression of wild-type FAK but not S732A mutant. Together, these studies demonstrated a novel role for Ser-732 phosphorylation of FAK in the regulation of centrosome function during mitosis, which may contribute to EC proliferation and angiogenesis.	[Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.] Cornell Univ, Coll Vet Med, Grad Program Pharmacol, Ithaca, NY 14853 USA; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 106, Taiwan; [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; National Taiwan University; University of California System; University of California San Diego	Guan, JL (corresponding author), Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Shen, Tang-Long/C-7460-2011		National Institutes of Health [HL73394, HL64382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394, R01HL064382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73394 (to J.- L. G.) and HL64382 (to S. C.).	BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 1996, J CELL SCI, V109, P1787; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Haskell H, 2003, CLIN CANCER RES, V9, P2157; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jacamo R, 2007, J CELL PHYSIOL, V210, P436, DOI 10.1002/jcp.20870; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma A, 2001, MOL BIOL CELL, V12, P1; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; ORLY J, 1979, CELL, V17, P295, DOI 10.1016/0092-8674(79)90155-7; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2004, CARDIOVASC RES, V64, P421, DOI 10.1016/j.cardiores.2004.07.012; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Villa-Moruzzi E, 2007, BIOCHEM J, V408, P7, DOI 10.1042/BJ20070058; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; WINKLBAUER R, 1986, DEV BIOL, V118, P70, DOI 10.1016/0012-1606(86)90074-6; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Xie ZG, 2004, CELL CYCLE, V3, P108; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yamakita Y, 1999, J CELL BIOL, V144, P315, DOI 10.1083/jcb.144.2.315; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	51	42	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9418	9425		10.1074/jbc.M809040200	http://dx.doi.org/10.1074/jbc.M809040200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201755	Green Published, hybrid			2022-12-25	WOS:000264669100048
J	Sajish, M; Kalayil, S; Verma, SK; Nandicoori, VK; Prakash, B				Sajish, Mathew; Kalayil, Sissy; Verma, Sunil Kumar; Nandicoori, Vinay Kumar; Prakash, Balaji			The Significance of EXDD and RXKD Motif Conservation in Rel Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRINGENT RESPONSE; GUANOSINE 5'-DIPHOSPHATE-3'-MONOPHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; STRUCTURAL BASIS; (P)PPGPP; PPGPP; RIBOSOME; TETRAPHOSPHATE; 5-DIPHOSPHATE	Monofunctional and bifunctional classes of Rel proteins catalyze pyrophosphoryl transfer from ATP to 3'-OH of GTP/GDP to synthesize (p) ppGpp, which is essential for normal microbial physiology and survival. Bifunctional proteins additionally catalyze the hydrolysis of (p) ppGpp. We have earlier demonstrated that although both catalyze identical the (p) ppGpp synthesis reaction, they exhibit a differential response to Mg2+ due to a unique charge reversal in the synthesis domain; an RXKD motif in the synthesis domain of bifunctional protein is substituted by an EXDD motif in that of the monofunctional proteins. Here, we show that these motifs also determine substrate specificities (GTP/GDP), cooperativity, and regulation of catalytic activities at the N-terminal region through the C-terminal region. Most importantly, a mutant bifunctional Rel carrying an EXDD instigates a novel catalytic reaction, resulting in the synthesis of pGpp by an independent hydrolysis of the 5'P-alpha-O-P-beta bond of GTP/GDP or (p) ppGpp. Further experiments with RelA from Escherichia coli wherein EXDD is naturally present also revealed the presence of pGpp, albeit at low levels. This work brings out the biological significance of RXKD/EXDD motif conservation in Rel proteins and reveals an additional catalytic activity for the monofunctional proteins, prompting an extensive investigation for the possible existence and role of pGpp in the biological system.	[Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Sajish, Mathew; Kalayil, Sissy; Verma, Sunil Kumar; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in; bprakash@iitk.ac.in	Thekkel, Sajish Mathew/AAM-3548-2021; Verma, Sunil Kumar/J-8838-2019	Thekkel, Sajish Mathew/0000-0001-6715-5953; Verma, Sunil Kumar/0000-0001-9443-2493; Nandicoori, Vinay/0000-0002-5682-4178; Kalayil, Sissy/0000-0002-6731-2055	Wellcome Trust, United Kingdom International Senior Research Fellowship; Department of Biotechnology, New Delhi	Wellcome Trust, United Kingdom International Senior Research Fellowship(Wellcome Trust); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by a Wellcome Trust, United Kingdom International Senior Research Fellowship (to B. P.) and generous support provided by the Department of Biotechnology, New Delhi (to B. P. and V. K. N.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Avarbock D, 1999, GENE, V233, P261, DOI 10.1016/S0378-1119(99)00114-6; CASHEL M, 1970, J BIOL CHEM, V245, P2309; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; COCHRAN JW, 1974, J BIOL CHEM, V249, P353; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; NEGRE D, 1989, BIOCHEMISTRY-US, V28, P1814, DOI 10.1021/bi00430a058; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PAO CC, 1979, J BIOL CHEM, V254, P688; PAO CC, 1980, J BIOL CHEM, V255, P1830; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SY J, 1973, P NATL ACAD SCI USA, V70, P306, DOI 10.1073/pnas.70.2.306; SY J, 1975, BIOCHEMISTRY-US, V14, P970, DOI 10.1021/bi00676a015; WAGNER EGH, 1980, MOL GEN GENET, V180, P139, DOI 10.1007/BF00267363; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1	30	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9115	9123		10.1074/jbc.M807187200	http://dx.doi.org/10.1074/jbc.M807187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201753	hybrid, Green Published			2022-12-25	WOS:000264669100015
J	Gingras, AR; Ziegler, WH; Bobkov, AA; Joyce, MG; Fasci, D; Himmel, M; Rothemund, S; Ritter, A; Grossmann, JG; Patel, B; Bate, N; Goult, BT; Emsley, J; Barsukov, IL; Roberts, GCK; Liddington, RC; Ginsberg, MH; Critchley, DR				Gingras, Alexandre R.; Ziegler, Wolfgang H.; Bobkov, Andrey A.; Joyce, M. Gordon; Fasci, Domenico; Himmel, Mirko; Rothemund, Sven; Ritter, Anett; Grossmann, J. Guenter; Patel, Bipin; Bate, Neil; Goult, Benjamin T.; Emsley, Jonas; Barsukov, Igor L.; Roberts, Gordon C. K.; Liddington, Robert C.; Ginsberg, Mark H.; Critchley, David R.			Structural Determinants of Integrin Binding to the Talin Rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; ACTIN-BINDING; MOLECULAR-GRAPHICS; FERM DOMAIN; VINCULIN; SITE; ACTIVATION; CYTOSKELETON; INTERACTS; CONTAINS	The adaptor protein talin serves both to activate the integrin family of cell adhesion molecules and to couple integrins to the actin cytoskeleton. Integrin activation has been shown to involve binding of the talin FERM domain to membrane proximal sequences in the cytoplasmic domain of the integrin beta-subunit. However, a second integrin-binding site (IBS2) has been identified near the C-terminal end of the talin rod. Here we report the crystal structure of IBS2 (residues 1974-2293), which comprises two five-helix bundles, "IBS2-A" (1974-2139) and "IBS2-B" (2140-2293), connected by a continuous helix with a distinct kink at its center that is stabilized by side-chain H-bonding. Solution studies using small angle x-ray scattering and NMR point to a fairly flexible quaternary organization. Using pull-down and enzyme-linked immunosorbent assays, we demonstrate that integrin binding requires both IBS2 domains, as does binding to acidic phospholipids and robust targeting to focal adhesions. We have defined the membrane proximal region of the integrin cytoplasmic domain as the major binding region, although more membrane distal regions are also required for strong binding. Alanine-scanning mutagenesis points to an important electrostatic component to binding. Thermal unfolding experiments show that integrin binding induces conformational changes in the IBS2 module, which we speculate are linked to vinculin and membrane binding.	[Gingras, Alexandre R.; Joyce, M. Gordon; Patel, Bipin; Bate, Neil; Goult, Benjamin T.; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England; [Grossmann, J. Guenter; Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Ziegler, Wolfgang H.; Himmel, Mirko; Rothemund, Sven; Ritter, Anett] Univ Leipzig, Fac Med, Klin Forsch Leipzig, Interdisziplinares Zentrum, D-04103 Leipzig, Germany; [Bobkov, Andrey A.; Liddington, Robert C.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Fasci, Domenico; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Emsley, Jonas] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Leicester; University of Liverpool; Leipzig University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of Nottingham	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009; emsley, jonas/A-8509-2016	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807; emsley, jonas/0000-0002-8949-8030; Roberts, Gordon/0000-0001-6200-1373; Ziegler, Wolfgang H./0000-0003-4529-1916; Himmel, Mirko/0000-0001-7872-8016	National Institutes of Health Cell Migration Consortium from NIGMS [U54GM64346]; Wellcome Trust; Cancer Research UK; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cell Migration Consortium Grant U54GM64346 from NIGMS. This work was also supported by the Wellcome Trust and Cancer Research UK. The work in Leipzig was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GILMORE AP, 1993, J CELL BIOL, V122, P337, DOI 10.1083/jcb.122.2.337; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hemmings L, 1996, J CELL SCI, V109, P2715; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liddington RC, 2003, CURR BIOL, V13, pR94, DOI 10.1016/S0960-9822(03)00035-6; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; MCLACHLAN AD, 1994, J MOL BIOL, V235, P1278, DOI 10.1006/jmbi.1994.1081; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200; Xu WM, 1998, DEVELOPMENT, V125, P327; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	45	61	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8857	8867		10.1074/jbc.M805937200	http://dx.doi.org/10.1074/jbc.M805937200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176533	Green Published, hybrid			2022-12-25	WOS:000264397800069
J	Eagle, RA; Flack, G; Warford, A; Martinez-Borra, J; Jafferji, I; Traherne, JA; Ohashi, M; Boyle, LH; Barrow, AD; Caillat-Zucman, S; Young, NT; Trowsdale, J				Eagle, Robert A.; Flack, Gillian; Warford, Anthony; Martinez-Borra, Jesus; Jafferji, Insiya; Traherne, James A.; Ohashi, Maki; Boyle, Louise H.; Barrow, Alexander D.; Caillat-Zucman, Sophie; Young, Neil T.; Trowsdale, John			Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G	PLOS ONE			English	Article							I-RELATED CHAIN; DOWN-REGULATION; NKG2D RECEPTOR; NK CELLS; T-CELLS; NATURAL CYTOTOXICITY; KILLER-CELLS; MIC LIGANDS; TUMOR; GENE	Background: The activating immunoreceptor NKG2D is expressed on Natural Killer (NK) cells and subsets of T cells. NKG2D contributes to anti-tumour and anti-viral immune responses in vitro and in vivo. The ligands for NKG2D in humans are diverse proteins of the MIC and ULBP/RAET families that are upregulated on the surface of virally infected cells and tumours. Two splicing variants of ULBP5/RAET1G have been cloned previously, but not extensively characterised. Methodology/Principal Findings: We pursue a number of approaches to characterise the expression, trafficking, and function of the two isoforms of ULBP5/RAET1G. We show that both transcripts are frequently expressed in cell lines derived from epithelial cancers, and in primary breast cancers. The full- length transcript, RAET1G1, is predicted to encode a molecule with transmembrane and cytoplasmic domains that are unique amongst NKG2D ligands. Using specific anti- RAET1G1 antiserum to stain tissue microarrays we show that RAET1G1 expression is highly restricted in normal tissues. RAET1G1 was expressed at a low level in normal gastrointestinal epithelial cells in a similar pattern to MICA. Both RAET1G1 and MICA showed increased expression in the gut of patients with celiac disease. In contrast to healthy tissues the RAET1G1 antiserum stained a wide variety or different primary tumour sections. Both endogenously expressed and transfected RAET1G1 was mainly found inside the cell, with a minority of the protein reaching the cell surface. Conversely the truncated splicing variant of RAET1G2 was shown to encode a solublemolecule that could be secreted from cells. Secreted RAET1G2 was shown to downregulate NKG2D receptor expression on NK cells and hence may represent a novel tumour immune evasion strategy. Conclusions/Significance: We demonstrate that the expression patterns of ULBP5RAET1G are very similar to the well-characterised NKG2D ligand, MICA. However the two isoforms of ULBP5/RAET1G have very different cellular localisations that are likely to reflect unique functionality.	[Eagle, Robert A.; Martinez-Borra, Jesus; Jafferji, Insiya; Traherne, James A.; Ohashi, Maki; Boyle, Louise H.; Barrow, Alexander D.; Trowsdale, John] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Flack, Gillian; Warford, Anthony] Wellcome Trust Sanger Inst, Atlas Protein Express Grp, Hinxton, England; [Caillat-Zucman, Sophie] Hop St Vincent De Paul, INSERM, U561, AVENIR Team, Paris, France; [Young, Neil T.] Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England; [Eagle, Robert A.] CALTECH, MC170 25, Pasadena, CA 91125 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; California Institute of Technology	Eagle, RA (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge, England.	robeagle@caltech.edu	Boyle, Louise/AFU-1885-2022; Eagle, Robert/A-2679-2011	Barrow, Alexander/0000-0001-5833-0537; Eagle, Robert/0000-0003-0304-6111; Boyle, Louise/0000-0002-3105-6555; Caillat-Zucman, Sophie/0000-0002-4535-3550	Cancer Research UK; The Isaac Newton Trust; The Leukaemia Research Fund; The Wellcome Trust; Medical Research Council [G9800943] Funding Source: researchfish; MRC [G9800943] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); The Isaac Newton Trust; The Leukaemia Research Fund; The Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by grants from Cancer Research UK and The Isaac Newton Trust to RAE, The Leukaemia Research Fund to NTY, and The Wellcome Trust to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bahram S, 2005, CURR OPIN IMMUNOL, V17, P505, DOI 10.1016/j.coi.2005.07.016; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Boyle LH, 2007, J NEUROCHEM, V102, P1853, DOI 10.1111/j.1471-4159.2007.04687.x; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cao W, 2008, INT IMMUNOL, V20, P981, DOI 10.1093/intimm/dxn057; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Coudert JD, 2006, SEMIN CANCER BIOL, V16, P333, DOI 10.1016/j.semcancer.2006.07.008; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Fuertes MB, 2008, J IMMUNOL, V180, P4606, DOI 10.4049/jimmunol.180.7.4606; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; GUERRA N, 2008, IMMUNITY, V28, P492; HALE G, 1993, J REPROD IMMUNOL, V23, P189, DOI 10.1016/0165-0378(93)90007-5; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Pende D, 2002, CANCER RES, V62, P6178; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; STUART AE, 1983, J CLIN PATHOL, V36, P1176, DOI 10.1136/jcp.36.10.1176; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104	55	33	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4503	10.1371/journal.pone.0004503	http://dx.doi.org/10.1371/journal.pone.0004503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223974	Green Published, gold, Green Accepted			2022-12-25	WOS:000265485800009
J	Song, R; Qian, F; Li, YP; Sheng, X; Cao, SX; Xu, Q				Song, Ran; Qian, Feng; Li, Yu-Pei; Sheng, Xia; Cao, Shao-Xian; Xu, Qiang			Phosphatase of Regenerating Liver-3 Localizes to Cyto-Membrane and Is Required for B16F1 Melanoma Cell Metastasis In Vitro and In Vivo	PLOS ONE			English	Article								Background: Phosphatase of regenerating liver-3 (PRL-3) is a member of the novel phosphatases of regenerating liver family, characterized by one protein tyrosine phosphatase active domain and a C-terminal prenylation (CCVM) motif. Though widely proposed to facilitate metastasis in many cancer types, PRL-3's cellular localization and the function of its CCVM motif in metastatic process remain unknown. Methodology/Principal Findings: In the present study, a series of Myc tagged PRL-3 wild type or mutant plasmids were expressed in B16F1 melanoma cells to investigate the relationship between PRL-3's cellular localization and metastasis. With immuno-fluorescence microcopy and cell adhesion/migration assay in vitro, and an experimental passive metastasis model in vivo, we found that CCVM motif is critical for the localization of PRL-3 on cell plasma membrane and the lung metastasis of melanoma. In particular, Cystine 170 is the key site for prenylation in this process. Conclusions/Significance: These results suggest that cellular localization of PRL-3 is highly correlated with its function in tumor metastasis, and inhibition of PRL-3 prenylation might be a new approach to cancer therapy.	[Song, Ran; Qian, Feng; Li, Yu-Pei; Sheng, Xia; Cao, Shao-Xian; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Song, R (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	molpharm@163.com			National Natural Science Foundation of China [30500619]; Natural Science Foundation of Jiangsu Province, China [BK2007716, BK2008022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (No. 30500619) and the Natural Science Foundation of Jiangsu Province, China (No. BK2007716 and No. BK2008022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; BOS JL, 1989, CANCER RES, V49, P4682; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi JK, 2000, MOL VIS, V6, P222; de Bono JS, 2003, SEMIN ONCOL, V30, P79, DOI 10.1053/j.seminoncol.2003.08.010; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Heiskanen MA, 2000, CANCER RES, V60, P799; Kim KA, 2004, FEBS LETT, V565, P181, DOI 10.1016/j.febslet.2004.03.062; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Peng LR, 2006, BIOCHEM BIOPH RES CO, V342, P179, DOI 10.1016/j.bbrc.2006.01.102; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zhang XM, 2001, CLIN EXP METASTAS, V18, P415, DOI 10.1023/A:1010960615370	28	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4450	10.1371/journal.pone.0004450	http://dx.doi.org/10.1371/journal.pone.0004450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214221	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484300005
J	Flierl, MA; Rittirsch, D; Nadeau, BA; Sarma, JV; Day, DE; Lentsch, AB; Huber-Lang, MS; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Sarma, J. Vidya; Day, Danielle E.; Lentsch, Alex B.; Huber-Lang, Markus S.; Ward, Peter A.			Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response	PLOS ONE			English	Article								Following our recent report that phagocytic cells (neutrophils, PMNs, and macrophages) are newly discovered sources of catecholamines, we now show that both epinephrine and norepinephrine directly activate NF kappa B in macrophages, causing enhanced release of proinflammatory cytokines (TNF alpha, IL-1 beta, IL-6). Both adrenal-intact (AD+) and adrenalectomized (ADX) rodents were used, because ADX animals had greatly enhanced catecholamine release from phagocytes, facilitating our efforts to understand the role of catecholamines released from phagocytes. Phagocytes isolated from adrenalectomized rats displayed enhanced expression of tyrosine-hydroxylase and dopamine-beta-hydroxylase, two key enzymes for catecholamine production and exhibited higher baseline secretion of norepinephrine and epinephrine. The effects of upregulation of phagocyte-derived catecholamines were investigated in two models of acute lung injury (ALI). Increased levels of phagocyte-derived catecholamines were associated with intensification of the acute inflammatory response, as assessed by increased plasma leak of albumin, enhanced myeloperoxidase content in lungs, augmented levels of proinflammatory mediators in bronchoalveolar lavage fluids, and elevated expression of pulmonary ICAM-1 and VCAM-1. In adrenalectomized rats, development of ALI was enhanced and related to alpha(2)-adrenoceptors engagement but not to involvement of mineralocorticoid or glucocorticoid receptors. Collectively, these data demonstrate that catecholamines are potent inflammatory activators of macrophages, upregulating NF kappa B and further downstream cytokine production of these cells. In adrenalectomized animals, which have been used to further assess the role of catecholamines, there appears to be a compensatory increase in catecholamine generating enzymes and catecholamines in macrophages, resulting in amplification of the acute inflammatory response via engagement of alpha(2)-adrenoceptors.	[Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Sarma, J. Vidya; Day, Danielle E.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Lab Trauma, Sepsis & Inflammat Res, Cincinnati, OH 45221 USA; [Huber-Lang, Markus S.] Univ Ulm, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-89069 Ulm, Germany	University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; Ulm University	Flierl, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431	NIH [GM29507, GM61656, HL-31963, DK56029, AG025881]; Deutsche Forschungsgemeinschaft [HU 823/2-2, HU 823/2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH grants GM29507, GM61656 and HL-31963 (P.A.W.), NIH grants DK56029 and AG025881 (A.B.L.) and Deutsche Forschungsgemeinschaft grants HU 823/2-2 and HU 823/2-3 (M.H.-L.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN KD, 1991, BRAIN BEHAV IMMUN, V5, P235, DOI 10.1016/0889-1591(91)90021-2; BENSCHOP RJ, 1994, CIRCULATION, V89, P762, DOI 10.1161/01.CIR.89.2.762; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 1997, ELECTROPHORESIS, V18, P1760, DOI 10.1002/elps.1150181009; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; BUU NT, 1993, J NEUROCHEM, V61, P1557, DOI 10.1111/j.1471-4159.1993.tb13656.x; CHELMICKASCHORR E, 1988, J NEUROIMMUNOL, V17, P347, DOI 10.1016/0165-5728(88)90125-7; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; FARAJ BA, 1995, BIOCHEM PHARMACOL, V50, P1007, DOI 10.1016/0006-2952(95)00230-W; FARAJ BA, 1991, PHARMACOLOGY, V42, P135, DOI 10.1159/000138790; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Kradin R, 2001, EXP MOL PATHOL, V70, P1, DOI 10.1006/exmp.2000.2342; Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786; Lentsch AB, 2001, RESP PHYSIOL, V128, P17, DOI 10.1016/S0034-5687(01)00260-2; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; MADDEN K S, 1989, Brain Behavior and Immunity, V3, P72, DOI 10.1016/0889-1591(89)90007-X; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Maestroni GJM, 2003, J NEUROIMMUNOL, V144, P91, DOI 10.1016/j.jneuroim.2003.08.039; Marino F, 1999, EXP HEMATOL, V27, P489, DOI 10.1016/S0301-472X(98)00057-5; Morken JJ, 2002, SHOCK, V18, P46, DOI 10.1097/00024382-200207000-00009; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Ozturk H, 2007, INT UROL NEPHROL, V39, P267, DOI 10.1007/s11255-006-0074-6; Rudolph AE, 2000, MOL CELL ENDOCRINOL, V165, P221, DOI 10.1016/S0303-7207(00)00258-6; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; SPENGLER RN, 1994, J IMMUNOL, V152, P3024; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 1996, AM J PATHOL, V149, P1079; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791	42	114	120	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4414	10.1371/journal.pone.0004414	http://dx.doi.org/10.1371/journal.pone.0004414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212441	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200001
J	Koehncke, A; Telschow, A; Werren, JH; Hammerstein, P				Koehncke, Arnulf; Telschow, Arndt; Werren, John H.; Hammerstein, Peter			Life and Death of an Influential Passenger: Wolbachia and the Evolution of CI-Modifiers by Their Hosts	PLOS ONE			English	Article								Background: Wolbachia are intracellular bacteria widely distributed among arthropods and nematodes. In many insect species these bacteria induce a cytoplasmic incompatibility (CI) between sperm of infected males and eggs of uninfected females. From an evolutionary point of view, CI is puzzling: In order to induce this modification-rescue system, Wolbachia affect sperm of infected males even though Wolbachia are only transmitted maternally. Phylogenetic studies of Wolbachia and hosts show that the bacteria rarely cospeciate with their hosts, indicating that infections are lost in host species. However, the mechanisms leading to Wolbachia loss are not well understood. Results: Using a population genetic model, we investigate the spread of host mutants that enhance or repress Wolbachia action by affecting either bacterial transmission or the level of CI. We show that host mutants that decrease CI-levels in males (e.g. by reducing Wolbachia-density during spermatogenesis) spread, even at cost to mutant males. Increase of these mutants can lead to loss of Wolbachia infections, either as a direct consequence of their increase or in a step-wise manner, and we derive analytically a threshold penetrance above which a mutation's spread leads to extinction of Wolbachia. Selection on host modifiers is sexually antagonistic in that, conversely, host mutants that enhance Wolbachia in females are favoured whereas suppressors are not. Conclusions: Our results indicate that Wolbachia is likely to be lost from host populations on long evolutionary time scales due to reduction of CI levels in males. This can occur either by evolution of single host modifiers with large effects or through accumulation of several modifier alleles with small effects on Wolbachia action, even at cost to mutant males and even if infected hosts do not incur fecundity costs. This possibility is consistent with recent findings and may help to explain the apparent short evolutionary persistence times of Wolbachia in many host systems.	[Koehncke, Arnulf; Hammerstein, Peter] Humboldt Univ, Biol Therapy Inst, Berlin, Germany; [Telschow, Arndt] Kyoto Univ, Ctr Ecol Res, Kyoto, Japan; [Telschow, Arndt] Univ Munster, Inst Evolut & Biodivers, D-4400 Munster, Germany; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Humboldt University of Berlin; Kyoto University; University of Munster; University of Rochester	Koehncke, A (corresponding author), Humboldt Univ, Biol Therapy Inst, Berlin, Germany.	arnulf.koehncke@biologie.hu-berlin.de	Koehncke, Arnulf/A-2839-2011	Werren, John/0000-0001-9353-2070; Kohncke, Arnulf/0000-0002-4104-0477	U.S. NSF [EF0328363]; Japanese Society for the Promotion of Science (JSPS); Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 618]; German National Merit Foundation	U.S. NSF(National Science Foundation (NSF)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Merit Foundation	Contributions of JHW were supported by the U.S. NSF grant EF0328363, those of AT by the Japanese Society for the Promotion of Science (JSPS) and the Volkswagenstiftung, and those of PH and AK by the Deutsche Forschungsgemeinschaft (SFB 618). AK received additional support from the German National Merit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BREEUWER JAJ, 1993, GENETICS, V135, P565; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; CAVALCANTI AGL, 1957, NUCL GENES CYTOPLASM, V91, P327; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Charlat S, 2006, CURR BIOL, V16, P2453, DOI 10.1016/j.cub.2006.10.062; Charlat S, 2007, SCIENCE, V317, P214, DOI 10.1126/science.1143369; Clark ME, 2008, HEREDITY, V101, P420, DOI 10.1038/hdy.2008.71; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; Engelstadter J, 2004, J THEOR BIOL, V231, P345, DOI 10.1016/j.jtbi.2004.06.029; Engelstadter J, 2008, THEOR POPUL BIOL, V73, P125, DOI 10.1016/j.tpb.2007.08.004; Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Hammerstein P, 1996, J MATH BIOL, V34, P511; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1990, GENETICS, V126, P933; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P97, DOI 10.1098/rspb.1996.0016; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Maroja LS, 2008, HEREDITY, V101, P435, DOI 10.1038/hdy.2008.75; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Opijnen T, 2005, INSECT MOL BIOL, V14, P653, DOI 10.1111/j.1365-2583.2005.00595.x; RIGAUD T, 1992, HEREDITY, V68, P47, DOI 10.1038/hdy.1992.6; Serbus LR, 2007, PLOS PATHOG, V3, P1930, DOI 10.1371/journal.ppat.0030190; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Vala F, 2002, EVOLUTION, V56, P1331, DOI 10.1111/j.0014-3820.2002.tb01447.x; Vavre F, 2003, EVOLUTION, V57, P421; Vavre F, 2001, EVOLUTION, V55, P1710, DOI 10.1111/j.0014-3820.2001.tb00691.x; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	46	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4425	10.1371/journal.pone.0004425	http://dx.doi.org/10.1371/journal.pone.0004425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209229	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484100004
J	Hulth, A; Rydevik, G; Linde, A				Hulth, Anette; Rydevik, Gustaf; Linde, Annika			Web Queries as a Source for Syndromic Surveillance	PLOS ONE			English	Article							OUTBREAKS; SEARCHES	In the field of syndromic surveillance, various sources are exploited for outbreak detection, monitoring and prediction. This paper describes a study on queries submitted to a medical web site, with influenza as a case study. The hypothesis of the work was that queries on influenza and influenza-like illness would provide a basis for the estimation of the timing of the peak and the intensity of the yearly influenza outbreaks that would be as good as the existing laboratory and sentinel surveillance. We calculated the occurrence of various queries related to influenza from search logs submitted to a Swedish medical web site for two influenza seasons. These figures were subsequently used to generate two models, one to estimate the number of laboratory verified influenza cases and one to estimate the proportion of patients with influenza-like illness reported by selected General Practitioners in Sweden. We applied an approach designed for highly correlated data, partial least squares regression. In our work, we found that certain web queries on influenza follow the same pattern as that obtained by the two other surveillance systems for influenza epidemics, and that they have equal power for the estimation of the influenza burden in society. Web queries give a unique access to ill individuals who are not (yet) seeking care. This paper shows the potential of web queries as an accurate, cheap and labour extensive source for syndromic surveillance.	[Hulth, Anette; Rydevik, Gustaf; Linde, Annika] Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden	Swedish Institute for Infectious Disease Control	Hulth, A (corresponding author), Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden.	anette.hulth@smi.se	Rydevik, Gustaf/I-7510-2019; Hulth, Anette/E-2162-2017	Hulth, Anette/0000-0002-3132-808X; Rydevik, Gustaf/0000-0002-5066-6092	Swedish Emergency Management Agency (Krisberedskapsmyndigheten)	Swedish Emergency Management Agency (Krisberedskapsmyndigheten)	The Swedish Emergency Management Agency (Krisberedskapsmyndigheten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2008, SCAND J PUBLIC HEALT, V36, P475, DOI 10.1177/1403494808089566; ARMITAGE P, 2005, ENCY BIOSTATISTICS, V2, P1323; Bork K H, 2006, Euro Surveill, V11, P229; Chapman WW, 2005, ARTIF INTELL MED, V33, P31, DOI 10.1016/j.artmed.2004.04.001; Das Debjani, 2005, MMWR Suppl, V54, P41; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fienberg SE, 2005, STAT MED, V24, P513, DOI 10.1002/sim.2032; GINSBERG J, 2008, NATURE          1119; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; JOHNSON HA, 2004, MEDINFO, V11, P1202; Jormanainen V, 2001, EMERG INFECT DIS, V7, P474, DOI 10.3201/eid0703.017324; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; MOSTASHARI F, 2003, J URBAN HLTH S1, V80, P43; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; R Core Team, 2022, R LANG ENV STAT COMP; Rolland E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-10; *SMI NAT INFL REF, INFL ANN REP 2006 20; Smith G E, 2006, Euro Surveill, V11, P220; *VARDG LABS, 2008, VAD TYCK ANV VARDG; WEHRENS R, 2007, JSS, V18; Wehrens R., 2007, PLS PARTIAL LEAST SQ; Zeng XM, 2002, J AM MED INFORM ASSN, V9, pS17, DOI 10.1197/jamia.M1219	24	134	140	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4378	10.1371/journal.pone.0004378	http://dx.doi.org/10.1371/journal.pone.0004378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197389	gold, Green Submitted, Green Published			2022-12-25	WOS:000265483700004
J	Bui, T; Sequeira, J; Wen, TC; Sola, A; Higashi, Y; Kondoh, H; Genetta, T				Bui, Thai; Sequeira, Judith; Wen, Tong Chun; Sola, Augusto; Higashi, Yujiro; Kondoh, Hisato; Genetta, Tom			ZEB1 Links p63 and p73 in a Novel Neuronal Survival Pathway Rapidly Induced in Response to Cortical Ischemia	PLOS ONE			English	Article								Background: Acute hypoxic/ischemic insults to the forebrain, often resulting in significant cellular loss of the cortical parenchyma, are a major cause of debilitating injury in the industrialized world. A clearer understanding of the pro-death/pro-survival signaling pathways and their downstream targets is critical to the development of therapeutic interventions to mitigate permanent neurological damage. Methodology/Principal Findings: We demonstrate here that the transcriptional repressor ZEB1, thought to be involved in regulating the timing and spatial boundaries of basic-Helix-Loop-Helix transactivator-mediated neurogenic determination/differentiation programs, functions to link a pro-survival transcriptional cascade rapidly induced in cortical neurons in response to experimentally induced ischemia. Employing histological, tissue culture, and molecular biological read-outs, we show that this novel pro-survival response, initiated through the rapid induction of p63, is mediated ultimately by the transcriptional repression of a pro-apoptotic isoform of p73 by ZEB1. We show further that this phylogenetically conserved pathway is induced as well in the human cortex subjected to episodes of clinically relevant stroke. Conclusions/Significance: The data presented here provide the first evidence that ZEB1 induction is part of a protective response by neurons to ischemia. The stroke-induced increase in ZEB1 mRNA and protein levels in cortical neurons is both developmentally and phylogenetically conserved and may therefore be part of a fundamental cellular response to this insult. Beyond the context of stroke, the finding that ZEB1 is regulated by a member of the p53 family has implications for cell survival in other tissue and cellular environments subjected to ischemia, such as the myocardium and, in particular, tumor masses.	[Genetta, Tom] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Sequeira, Judith] Emory Univ, Sch Med, Dept Pathol, Lab Med, Atlanta, GA 30322 USA; [Wen, Tong Chun; Sola, Augusto] MidAtlantic Neonatol Assoc, Mooristown, NJ USA; [Higashi, Yujiro] Inst Dev Res, Aichi, Japan; [Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan	Emory University; Emory University; Osaka University	Bui, T (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.	tgenett@emory.edu			The Cerebral Palsy International Research Foundation, Inc; Emory-Egleston Research Center; Emory Goddard Scholar Fund	The Cerebral Palsy International Research Foundation, Inc; Emory-Egleston Research Center; Emory Goddard Scholar Fund	Funding for this work was provided by the following sources: The Cerebral Palsy International Research Foundation, Inc, the Emory-Egleston Research Center and the Emory Goddard Scholar Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, CURRENT PROTOCOLS MO; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; Dobbelstein M, 2005, BIOCHEM BIOPH RES CO, V331, P688, DOI 10.1016/j.bbrc.2005.03.155; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; Genetta T, 2007, J NEUROSCI RES, V85, P131, DOI 10.1002/jnr.21067; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Haupt Y, 2004, CELL CYCLE, V3, P884; Jacobs WB, 2006, J NEUROCHEM, V97, P1571, DOI 10.1111/j.1471-4159.2006.03980.x; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Janardhan Vallabh, 2004, Curr Cardiol Rep, V6, P117, DOI 10.1007/s11886-004-0009-8; Jefferson BK, 2005, CURR PROB CARDIOLOGY, V30, P333, DOI 10.1016/j.cpcardiol.2005.02.002; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; KUAN CH, 2000, TRENDS NEURO, V23, P454; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Nakamura T, 2008, ANTIOXID REDOX SIGN, V10, P87, DOI 10.1089/ars.2007.1858; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SCHUG J, 1997, CBILTR19971001V00; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Takagi T, 1998, DEVELOPMENT, V125, P21; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vinten-Johansen J, 2007, J APPL PHYSIOL, V103, P1441, DOI 10.1152/japplphysiol.00642.2007; Wen TC, 2004, BRAIN RES PROTOC, V13, P76, DOI 10.1016/j.brainresprot.2004.02.003; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang B, 1998, J Stroke Cerebrovasc Dis, V7, P1, DOI 10.1016/S1052-3057(98)80015-3; Zhang QH, 2002, SCIENCE, V295, P1895; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	53	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4373	10.1371/journal.pone.0004373	http://dx.doi.org/10.1371/journal.pone.0004373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194497	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483500012
J	Corlazzoli, F; Rossetti, S; Bistulfi, G; Ren, MQ; Sacchi, N				Corlazzoli, Francesca; Rossetti, Stefano; Bistulfi, Gaia; Ren, Mingqiang; Sacchi, Nicoletta			Derangement of a Factor Upstream of RAR alpha Triggers the Repression of a Pleiotropic Epigenetic Network	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; BINDING PROTEIN-II; PROMOTER; CYP26A1; SIGNAL	Background: Chromatin adapts and responds to extrinsic and intrinsic cues. We hypothesize that inheritable aberrant chromatin states in cancer and aging are caused by genetic/environmental factors. In previous studies we demonstrated that either genetic mutations, or loss, of retinoic acid receptor alpha (RAR alpha), can impair the integration of the retinoic acid (RA) signal at the chromatin of RA-responsive genes downstream of RAR alpha, and can lead to aberrant repressive chromatin states marked by epigenetic modifications. In this study we tested whether the mere interference with the availability of RA signal at RAR alpha, in cells with an otherwise functional RAR alpha, can also induce epigenetic repression at RA-responsive genes downstream of RAR alpha. Methodology/Principal Findings: To hamper the availability of RA at RAR alpha in untransformed human mammary epithelial cells, we targeted the cellular RA-binding protein 2 (CRABP2), which transports RA from the cytoplasm onto the nuclear RARs. Stable ectopic expression of a CRABP2 mutant unable to enter the nucleus, as well as stable knock down of endogenous CRABP2, led to the coordinated transcriptional repression of a few RA-responsive genes downstream of RAR alpha. The chromatin at these genes acquired an exacerbated repressed state, or state "of no return''. This aberrant state is unresponsive to RA, and therefore differs from the physiologically repressed, yet "poised'' state, which is responsive to RA. Consistent with development of homozygosis for epigenetically repressed loci, a significant proportion of cells with a defective CRABP2-mediated RA transport developed heritable phenotypes indicative of loss of function. Conclusion/Significance: Derangement/lack of a critical factor necessary for RARa function induces epigenetic repression of a RA-regulated gene network downstream of RARa, with major pleiotropic biological outcomes.	[Corlazzoli, Francesca; Rossetti, Stefano; Bistulfi, Gaia; Ren, Mingqiang; Sacchi, Nicoletta] Roswell Pk Canc Inst, Canc Genet Program, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Corlazzoli, F (corresponding author), Roswell Pk Canc Inst, Canc Genet Program, Buffalo, NY 14263 USA.	nicoletta.sacchi@roswellpark.org			NCI [R01-CA127614-01A2]; Predoctoral US Army Award [W81XWH0510222]; University of Milan Foreign Exchange Program; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA127614] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Predoctoral US Army Award; University of Milan Foreign Exchange Program; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI R01-CA127614-01A2 grant (NS). GB and FC were supported by the Predoctoral US Army Award W81XWH0510222 and the University of Milan Foreign Exchange Program, SR was supported by a postdoctoral Susan Komen Foundation award.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiba H, 1997, MOL CELL BIOL, V17, P3013, DOI 10.1128/MCB.17.6.3013; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jing YK, 1997, CANCER RES, V57, P1668; Kikuchi K, 2001, BIOORG MED CHEM LETT, V11, P1215, DOI 10.1016/S0960-894X(01)00177-9; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Pozzi S, 2006, ONCOGENE, V25, P1400, DOI 10.1038/sj.onc.1209173; Pozzi S, 2006, CANCER RES, V66; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456; Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381	21	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4305	10.1371/journal.pone.0004305	http://dx.doi.org/10.1371/journal.pone.0004305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19173001	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483500001
J	Wu, GQ; Arzeno, NM; Shen, LL; Tang, DK; Zheng, DA; Zhao, NQ; Eckberg, DL; Poon, CS				Wu, Guo-Qiang; Arzeno, Natalia M.; Shen, Lin-Lin; Tang, Da-Kan; Zheng, Da-An; Zhao, Nai-Qing; Eckberg, Dwain L.; Poon, Chi-Sang			Chaotic Signatures of Heart Rate Variability and Its Power Spectrum in Health, Aging and Heart Failure	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; SYMPATHOVAGAL INTERACTION; NONLINEAR DYNAMICS; VENTILATORY FLOW; HUMANS; MODULATION; COMPLEXITY; COMPONENTS; INDEXES; SYSTEM	A paradox regarding the classic power spectral analysis of heart rate variability (HRV) is whether the characteristic high-(HF) and low-frequency (LF) spectral peaks represent stochastic or chaotic phenomena. Resolution of this fundamental issue is key to unraveling the mechanisms of HRV, which is critical to its proper use as a noninvasive marker for cardiac mortality risk assessment and stratification in congestive heart failure (CHF) and other cardiac dysfunctions. However, conventional techniques of nonlinear time series analysis generally lack sufficient sensitivity, specificity and robustness to discriminate chaos from random noise, much less quantify the chaos level. Here, we apply a 'litmus test' for heartbeat chaos based on a novel noise titration assay which affords a robust, specific, time-resolved and quantitative measure of the relative chaos level. Noise titration of running short-segment Holter tachograms from healthy subjects revealed circadian-dependent (or sleep/wake-dependent) heartbeat chaos that was linked to the HF component (respiratory sinus arrhythmia). The relative 'HF chaos' levels were similar in young and elderly subjects despite proportional age-related decreases in HF and LF power. In contrast, the near-regular heartbeat in CHF patients was primarily nonchaotic except punctuated by undetected ectopic beats and other abnormal beats, causing transient chaos. Such profound circadian-, age- and CHF-dependent changes in the chaotic and spectral characteristics of HRV were accompanied by little changes in approximate entropy, a measure of signal irregularity. The salient chaotic signatures of HRV in these subject groups reveal distinct autonomic, cardiac, respiratory and circadian/sleep-wake mechanisms that distinguish health and aging from CHF.	Fudan Univ, Dept Engn Sci & Mech, Shanghai 200433, Peoples R China; [Arzeno, Natalia M.; Poon, Chi-Sang] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Arzeno, Natalia M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Shen, Lin-Lin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Tang, Da-Kan; Zheng, Da-An] Fudan Univ, Sch Informat Sci & Engn, Shanghai, Peoples R China; [Zhao, Nai-Qing] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Eckberg, Dwain L.] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23284 USA	Fudan University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Fudan University; Fudan University; Fudan University; Virginia Commonwealth University	Wu, GQ (corresponding author), Fudan Univ, Dept Engn Sci & Mech, Shanghai 200433, Peoples R China.	cpoon@mit.edu			NIH [HL079503-02S1, HL079503, HL075014, HL072849]; Shanghai Leading Academic Discipline Project [B112]; National Natural Science Foundation of China [30370353, 30370529]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079503, R21HL075014, R01HL072849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NMA was recipient of an NIH graduate research training award HL079503-02S1. This work was supported in part by Shanghai Leading Academic Discipline Project, No B112 (GQW), National Natural Science Foundation of China grant No. 30370353 (GQW) and, No. 30370529 (LLS), and U.S. National Institutes of Health grants HL079503, HL075014 and HL072849 (CSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bilan A, 2005, J ELECTROCARDIOL, V38, P239, DOI 10.1016/j.jelectrocard.2005.01.012; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 1999, J CARDIOVASC ELECTR, V10, P1350, DOI 10.1111/j.1540-8167.1999.tb00190.x; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Eckberg DL, 1995, REGULATION BREATHING, P669; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Glass L, 1999, J CARDIOVASC ELECTR, V10, P1358, DOI 10.1111/j.1540-8167.1999.tb00191.x; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HEDMAN AE, 1995, ACTA PHYSIOL SCAND, V155, P205, DOI 10.1111/j.1748-1716.1995.tb09965.x; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; Kamath M, 1995, HEART RATE VARIABILI, P75; KANTERS JK, 1994, J CARDIOVASC ELECTR, V5, P591, DOI 10.1111/j.1540-8167.1994.tb01300.x; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Li C, 2009, ACTA PHYS SIN-CH ED, V58, P1348, DOI 10.7498/aps.58.1348; MALIA M, 1995, HISTOIRE, P99; MANCIA G, 1993, NEW ENGL J MED, V328, P347, DOI 10.1056/NEJM199302043280511; OSAKA M, 1995, J CARDIOVASC ELECTR, V6, P441, DOI 10.1111/j.1540-8167.1995.tb00417.x; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1995, AM J PHYSIOL-HEART C, V268, pH1606, DOI 10.1152/ajpheart.1995.268.4.H1606; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Piepoli M, 1997, CIRCULATION, V95, P1813; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2000, J CARDIOVASC ELECTR, V11, P235, DOI 10.1111/j.1540-8167.2000.tb00329.x; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Pyetan E, 2003, IEEE T BIO-MED ENG, V50, P777, DOI 10.1109/TBME.2003.812158; Rachmuth G, 2008, HFSP J, V2, P156, DOI 10.2976/1.2905393; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Sugihara G, 1996, P NATL ACAD SCI USA, V93, P2608, DOI 10.1073/pnas.93.6.2608; Taylor J Andrew, 2006, J Appl Physiol (1985), V101, P678, DOI 10.1152/japplphysiol.00446.2006; Taylor JA, 2001, AM J PHYSIOL-HEART C, V280, pH2804, DOI 10.1152/ajpheart.2001.280.6.H2804; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; Turcott RG, 1996, ANN BIOMED ENG, V24, P269, DOI 10.1007/BF02667355; Wessel N, 2007, INT J BIFURCAT CHAOS, V17, P3325, DOI 10.1142/S0218127407019093; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105; WOO MA, 1994, J AM COLL CARDIOL, V23, P565, DOI 10.1016/0735-1097(94)90737-4; Wu GQ, 2005, P ANN INT IEEE EMBS, P764, DOI 10.1109/IEMBS.2005.1616527; Wysocki M, 2006, RESP PHYSIOL NEUROBI, V153, P54, DOI 10.1016/j.resp.2005.09.008; [No title captured], DOI DOI 10.1063/1.3141426	58	64	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4323	10.1371/journal.pone.0004323	http://dx.doi.org/10.1371/journal.pone.0004323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183809	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483200008
J	Singh, G; Popli, S; Hari, Y; Malhotra, P; Mukherjee, S; Bhatnagar, RK				Singh, Gatikrushna; Popli, Sonam; Hari, Yukti; Malhotra, Pawan; Mukherjee, Sunil; Bhatnagar, Raj K.			Suppression of RNA silencing by Flock house virus B2 protein is mediated through its interaction with the PAZ domain of Dicer	FASEB JOURNAL			English	Article						viral suppressors; RNAi sensor line	DOUBLE-STRANDED-RNA; SMALL INTERFERING RNA; STRUCTURAL BASIS; ANIMAL VIRUS; RECOGNITION; BINDING; CELLS; PLANT; BETANODAVIRUS; INDUCTION	RNA silencing is a conserved pathway that functions as an antiviral mechanism. The majority of viruses encode silencing suppressors that interfere with siRNA- and miRNA-guided silencing pathways. The insect flock house virus B2 protein (FHVB2) functions as an RNAi silencing suppressor that inhibits siRNA biogenesis. Here, we describe the generation of a GFP silent sensor line (Sf21) and a GFP sensor line expressing FHVB2 to study RNAi suppression mechanisms. Overexpression of FHVB2 resulted in suppression of GFP-RNAi and resumption of GFP expression. Protein fractionation studies with FHVB2-transfected cells showed that FHVB2 associates with a high-molecular-weight complex of Dicer and dsRNA/siRNAs. Yeast two-hybrid and pulldown assays revealed an interaction between FHVB2 and Drosophila Dicer proteins that appeared to involve PAZ domains. To map the FHVB2 domains interacting with Dicer, we used a 17-residue C-terminal deletion mutant. RNAi suppression was reversed in cells transfected with the FHVB2 mutant as revealed by loss of GFP. Additional yeast two-hybrid and in vitro pulldown assays confirmed that the C-terminal region of FHVB2 was involved in the interaction with the PAZ domains of Dicers. These results thus reveal a novel interaction between FHVB2 and Dicer that leads to suppression of siRNA biogenesis.-Singh, G., Popli, S., Hari, Y., Malhotra, P., Mukherjee, S., Bhatnagar, R. K. Suppression of RNA silencing by Flock house virus B2 protein is mediated through its interaction with the PAZ domain of Dicer. FASEB J. 23, 1845-1857 (2009)	[Singh, Gatikrushna; Popli, Sonam; Hari, Yukti; Malhotra, Pawan; Mukherjee, Sunil; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi 110067, India.	pawanm@icgeb.res.in; sunilm@icgeb.res.in; raj@icgeb.res.in	Popli, Sonam/AAR-1900-2021; Singh, Gatikrushna/H-9639-2017	Popli, Sonam/0000-0001-7450-6862; 				Agrawal N, 2004, BIOCHEM BIOPH RES CO, V320, P428, DOI 10.1016/j.bbrc.2004.05.184; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Fenner BJ, 2007, J VIROL, V81, P5449, DOI 10.1128/JVI.00009-07; Fenner BJ, 2006, J VIROL, V80, P6822, DOI 10.1128/JVI.00079-06; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Karjee Sumona, 2008, V442, P187, DOI 10.1007/978-1-59745-191-8_14; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Matzke MA, 2004, PLOS BIOL, V2, P582, DOI 10.1371/journal.pbio.0020133; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Silhavy D, 2004, TRENDS PLANT SCI, V9, P76, DOI 10.1016/j.tplants.2003.12.010; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	40	60	61	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1845	1857		10.1096/fj.08-125120	http://dx.doi.org/10.1096/fj.08-125120			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19193719				2022-12-25	WOS:000266652400025
J	Wawrzynow, B; Pettersson, S; Zylicz, A; Bramham, J; Worrall, E; Hupp, TR; Ball, KL				Wawrzynow, Bartosz; Pettersson, Susanne; Zylicz, Alicja; Bramham, Janice; Worrall, Erin; Hupp, Ted R.; Ball, Kathryn L.			A Function for the RING Finger Domain in the Allosteric Control of MDM2 Conformation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; SMALL-MOLECULE ANTAGONISTS; ONCOPROTEIN MDM2; IN-VIVO; LIGASE ACTIVITY; BINDING-SITE; PROTEIN; ACTIVATION; PATHWAY; UBIQUITINATION	The MDM2 oncoprotein plays multiple regulatory roles in the control of p53-dependent gene expression. A picture of MDM2 is emerging where structurally discrete but interdependent functional domains are linked through changes in conformation. The domain structure includes: (i) a hydrophobic pocket at the N terminus of MDM2 that is involved in both its transrepressor and E3-ubiqutin ligase functions, (ii) a central acid domain that recognizes a ubiquitination signal in the core DNA binding domain of p53, and (iii) a C-terminal C2H2C4 RING finger domain that is required for E2 enzyme-binding and ATP-dependent molecular chaperone activity. Here we show that the binding affinity of MDM2s hydrophobic pocket can be regulated through the RING finger domain and that increases in pocket affinity are reflected by a gain in MDM2 transrepressor activity. Thus, mutations within the RING domain that affect zinc coordination, but not one that inhibits ATP binding, produce MDM2 proteins that have a higher affinity for the BOX-I transactivation domain of p53 and a reduced I-0.5 for p53 transrepression. An allosteric model for regulation of the hydrophobic pocket is supported by differences in protein conformation and pocket accessibility between wild-type and the RING domain mutant MDM2 proteins. Additionally the data demonstrate that the complex relationship between different domains of MDM2 can impact on the efficacy of anticancer drugs directed toward its hydrophobic pocket.	[Wawrzynow, Bartosz; Pettersson, Susanne; Ball, Kathryn L.] Univ Edinburgh, Canc Res UK Interferon & Cell Signalling Grp, Edinburgh EH4 2SR, Midlothian, Scotland; [Worrall, Erin; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Signal Transduct Grp P53, Edinburgh EH4 2SR, Midlothian, Scotland; [Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, Warsaw, Poland; [Bramham, Janice] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Edinburgh	Ball, KL (corresponding author), Univ Edinburgh, Canc Res UK Interferon & Cell Signalling Grp, Edinburgh EH4 2SR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk		Zylicz, Alicja/0000-0003-4174-3073	Cancer Research UK; Polish Ministry of Science and Higher Education [NN301 032534]	Cancer Research UK(Cancer Research UK); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Cancer Research UK (to S. P. and B. W.).; Supported by the Polish Ministry of Science and Higher Education (Grant NN301 032534).	Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; BODDY MN, 1994, TRENDS BIOCHEM SCI, V19, P198, DOI 10.1016/0968-0004(94)90020-5; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Bottger V, 1996, ONCOGENE, V13, P2141; Bowman AL, 2007, J AM CHEM SOC, V129, P12809, DOI 10.1021/ja073687x; Brooks CL, 2004, CELL CYCLE, V3, P895; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Espinoza-Fonseca LM, 2006, BIOPOLYMERS, V83, P365, DOI 10.1002/bip.20566; Espinoza-Fonseca LM, 2008, BIOCHEM BIOPH RES CO, V370, P547, DOI 10.1016/j.bbrc.2008.03.053; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Ganguli G, 2003, MOL CANCER RES, V1, P1027; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Knights CD, 2003, J BIOL CHEM, V278, P52890, DOI 10.1074/jbc.M300279200; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Stoll R, 2001, BIOCHEMISTRY-US, V40, P336, DOI 10.1021/bi000930v; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	46	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11517	11530		10.1074/jbc.M809294200	http://dx.doi.org/10.1074/jbc.M809294200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19188367	Green Published, hybrid			2022-12-25	WOS:000265494500056
J	Kato-Takagaki, K; Mizukoshi, Y; Yoshizawa, Y; Akazawa, D; Torii, Y; Ono, K; Tanimura, R; Shimada, I; Takahashi, H				Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Torii, Yuichi; Ono, Katsuki; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo			Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; PLATELET-COLLAGEN; NMR-SPECTROSCOPY; IN-VIVO; RECEPTOR; PROTEINS; PROGRAM; CHAIN; IDENTIFICATION; AGGREGATION	Glycoprotein VI (GPVI) is a major collagen receptor on the platelet surface that recognizes the glycine-proline-hydroxyproline (GPO) sequence in the collagen molecule and plays a crucial role in thrombus formation. Inhibitors that block the interaction of GPVI with collagen have potential for use as antithrombotic drugs. For low molecular weight drug design for GPVI, it is essential to obtain precise structural and interaction information about GPVI-binding ligands. However, experimentally obtained structural and interaction information of small ligands, such as peptides, in the GPVI-bound state has not been reported. In this study, by screening a phage-displayed peptide library, we discovered a novel peptide ligand (pep-10L; YSDTDWLYFSTS) without any similarities to the sequence of collagen that inhibits GPVI-GPO binding. Systematic Ala scanning in surface plasmon resonance experiments and a saturation transfer difference NMR experiment revealed that Trp(6), Leu(7), Phe(9), and Ser(10) residues in the pep-10L peptide interacted with GPVI. Furthermore, the GPVI-bound conformation of the pep-10L peptide was determined using transferred nuclear Overhauser effect analysis. The obtained structure has revealed that the central part of pep-10L (Asp(5)-Phe(9)) has a helical conformation, the side chains of Trp(6), Leu(7), and Phe(9) form a hydrophobic side in the helix, and the Tyr(8) side chain faces the opposite direction from the hydrophobic side. Computational docking prediction has shown that the hydrophobic side of pep-10L sticks in the hydrophobic groove on the GPVI surface, which corresponds to the putative collagen-related peptide binding groove. These data could enable the structure-guided development of a small molecule GPVI antagonist.	[Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Ono, Katsuki; Shimada, Ichio; Takahashi, Hideo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Ono, Katsuki] JBIC, Tokyo 1350064, Japan; [Torii, Yuichi; Tanimura, Ryuji] JBIC, Toray Branch Off, Kanagawa 2488555, Japan; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Shimada, I (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Aomi 2-41-6, Tokyo 1350064, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp; hid.takahashi@aist.go.jp	Akazawa, Daisuke/S-5596-2019; Tanimura, Ryuji/GOH-0166-2022	Tanimura, Ryuji/0000-0002-7865-5686	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the New Energy and Industrial Technology Development Organization.	ARAI M, 1995, BRIT J HAEMATOL, V89, P124, DOI 10.1111/j.1365-2141.1995.tb08900.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Leduc AM, 2003, P NATL ACAD SCI USA, V100, P11273, DOI 10.1073/pnas.1934759100; Li HQ, 2007, ARTERIOSCL THROM VAS, V27, P1199, DOI 10.1161/ATVBAHA.107.140590; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Mizukoshi Y, 2006, J BIOMOL NMR, V34, P23, DOI 10.1007/s10858-005-5054-0; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RYO R, 1992, AM J HEMATOL, V39, P25, DOI 10.1002/ajh.2830390107; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tam EM, 2009, J MOL BIOL, V385, P79, DOI 10.1016/j.jmb.2008.09.091; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	26	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10720	10727		10.1074/jbc.M808563200	http://dx.doi.org/10.1074/jbc.M808563200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228693	Green Published, hybrid			2022-12-25	WOS:000265104600046
J	Sulka, B; Lortat-Jacob, H; Terreux, R; Letourneur, F; Rousselle, P				Sulka, Beatrice; Lortat-Jacob, Hugues; Terreux, Raphael; Letourneur, Francois; Rousselle, Patricia			Tyrosine Dephosphorylation of the Syndecan-1 PDZ Binding Domain Regulates Syntenin-1 Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; CRYSTAL-STRUCTURE; SHORT ARM; LAMININ; PHOSPHORYLATION; PROTEIN; INTEGRIN; IDENTIFICATION; RECOGNITION; MEMBRANE	Heparan sulfate proteoglycan receptor syndecan-1 interacts with the carboxyl-terminal LG4/5 domain in laminin 332 (alpha 3LG4/5) and participates in cell adhesion and spreading. To dissect the function of syndecan-1 in these processes, we made use of a cell adhesion model in which syndecan-1 exclusively interacts with a recombinantly expressed alpha 3LG4/5 fragment. Plating HT1080 cells on this fragment induces the formation of actin-containing protrusive structures in an integrin-independent manner. Here we show that syndecan-1-mediated formation of membrane protrusions requires dephosphorylation of tyrosine residues in syndecan-1. Accordingly, inhibition of phosphatases with orthovanadate decreases cell adhesion to the alpha 3LG4/5 fragment. We demonstrate that the PDZ-containing protein syntenin-1, known to connect cytoskeletal proteins, binds to syndecan-1 in cells plated on the alpha 3LG4/5 fragment and participates in the formation of membrane protrusions. We further show that syntenin-1 recruitment depends on the dephosphorylation of Tyr-309 located within syndecan-1 PDZ binding domain EFYA. We propose that tyrosine dephosphorylation of syndecan-1 may regulate its association with cytoskeleton components.	[Sulka, Beatrice; Terreux, Raphael; Letourneur, Francois; Rousselle, Patricia] Univ Lyon 1, IFR Biosci Gerland Lyon Sud 128, IBCP, CNRS,UMR 5086, F-69367 Lyon 07, France; [Lortat-Jacob, Hugues] UJF, CNRS, UMR Commissariat Energie Atom 5075, Inst Biol Struct, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Rousselle, P (corresponding author), Univ Lyon 1, IFR Biosci Gerland Lyon Sud 128, IBCP, CNRS,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	patricia.rousselle@ibcp.fr		terreux, raphael/0000-0003-1243-7413; Letourneur, Francois/0000-0003-2232-6127	European Economic Community [NMP2-CT-2003-504017]; Association pour la Recherche sur le Cancer [1128, 3985]; Ligue Nationale contre le Cancer; Rhone-Alpes region; Agence Nationale de la Recherche Chemispike program	European Economic Community; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche Chemispike program(French National Research Agency (ANR))	This work was supported by grants from European Economic Community Contract NMP2-CT-2003-504017, the Association pour la Recherche sur le Cancer (Grants 1128 (to P. R.) and 3985 (to F. L.), the Ligue Nationale contre le Cancer (Loire, Drome, Savoie), a "Program Cible" Grant from the Rhone-Alpes region, and the Agence Nationale de la Recherche Chemispike program.	Asundi VK, 1997, BIOCHEM BIOPH RES CO, V240, P502, DOI 10.1006/bbrc.1997.7684; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Belin V, 2006, PROTEIN EXPRES PURIF, V48, P43, DOI 10.1016/j.pep.2006.02.014; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; CARTER BZ, 1991, LAB INVEST, V65, P610; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Helmke BM, 2004, ONCOL REP, V12, P221; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; SONNENBERG A, 1993, J CELL SCI, V106, P1083; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Yokoyama F, 2005, BIOCHEMISTRY-US, V44, P9581, DOI 10.1021/bi050598t; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	58	42	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10659	10671		10.1074/jbc.M807643200	http://dx.doi.org/10.1074/jbc.M807643200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228696	Green Published, hybrid			2022-12-25	WOS:000265104600040
J	van Dijk, TH; Grefhorst, A; Oosterveer, MH; Bloks, VW; Staels, B; Reijngoud, DJ; Kuipers, F				van Dijk, Theo H.; Grefhorst, Aldo; Oosterveer, Maaike H.; Bloks, Vincent W.; Staels, Bart; Reijngoud, Dirk-Jan; Kuipers, Folkert			An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr(-/-) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; PERIPHERAL INSULIN SENSITIVITY; BILE-ACID; GENE-EXPRESSION; ENTEROHEPATIC CIRCULATION; NONSTEADY STATE; DEFICIENT MICE; OB/OB MICE; FXR; HOMEOSTASIS	The farnesoid X receptor (FXR) is involved in regulation of bile acid and lipid metabolism. Recently, a role for FXR in control of glucose metabolism became evident. Because FXR is expressed along the length of the small intestine, we evaluated the potential role of FXR in glucose absorption and processing. During intravenous infusion of a trace amount of D-[6,6-H-2(2)] glucose, a D-[U-C-13] glucose-enriched oral glucose bolus was given, and glucose kinetics were determined in wild-type and Fxr(-/-) mice. Compared with wild-type mice, Fxr(-/-) mice showed a delayed plasma appearance of orally administered glucose. Multicompartmental kinetic modeling revealed that this delay was caused by an increased flux through the glucose 6-phosphate pool in enterocytes. Thus, our results show involvement of FXR in intestinal glucose absorption, representing a novel physiological function for this nuclear receptor.	[van Dijk, Theo H.; Reijngoud, Dirk-Jan; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Grefhorst, Aldo; Oosterveer, Maaike H.; Bloks, Vincent W.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, NL-9700 RB Groningen, Netherlands; [Staels, Bart] Univ Lille 2, Inst Pasteur Lille, INSERM, U545, F-59019 Lille, France	University of Groningen; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Grefhorst, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, POB 30-001, NL-9700 RB Groningen, Netherlands.	A.Grefhorst@med.umcg.nl	Staels, Bart/N-9497-2016; Bloks, Vincent/A-7609-2012; oosterveer, maaike h/C-3374-2013	Staels, Bart/0000-0002-3784-1503; Bloks, Vincent/0000-0001-6493-7482; Kuipers, Folkert/0000-0003-2518-737X; Reijngoud, Dirk-Jan/0000-0003-1157-4491	European Union [018734]; Dutch Diabetes Foundation [2002.00.041]; Daiichi Sankyo, Inc.; Agence Nationale de la Recherche [A05056GS, PPV06217NSA, ANR-06-PHYSIO-027-01]	European Union(European Commission); Dutch Diabetes Foundation; Daiichi Sankyo, Inc.(Daiichi Sankyo Company Limited); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by European Union Hepadip Grant 018734, Dutch Diabetes Foundation Grant 2002.00.041, an unrestricted research grant from Daiichi Sankyo, Inc. (Parsippany, NJ), and Agence Nationale de la Recherche Grants A05056GS, PPV06217NSA, and ANR-06-PHYSIO-027-01 (Project R06510NS).	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Claudel T, 2002, J CLIN INVEST, V109, P961; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; COBELLI C, 1987, AM J PHYSIOL, V252, pE679, DOI 10.1152/ajpendo.1987.252.5.E679; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Higashiyama H, 2008, ACTA HISTOCHEM, V110, P86, DOI 10.1016/j.acthis.2007.08.001; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; KEPPLER D, 1970, METHODEN ENZYMATISCH, P1089; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; MARI A, 1992, AM J PHYSIOL, V263, pE400, DOI 10.1152/ajpendo.1992.263.2.E400; PROIETTO J, 1987, AM J PHYSIOL, V252, pE77, DOI 10.1152/ajpendo.1987.252.1.E77; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; TISSOT S, 1990, DIABETOLOGIA, V33, P449, DOI 10.1007/BF00405104; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; van der Leij FR, 2007, GENOMICS, V90, P680, DOI 10.1016/j.ygeno.2007.08.004; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200	29	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10315	10323		10.1074/jbc.M807317200	http://dx.doi.org/10.1074/jbc.M807317200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204003	Green Published, hybrid			2022-12-25	WOS:000265104600005
J	Zhang, Y; Kozlov, G; Pocanschi, CL; Brockmeier, U; Ireland, BS; Maattanen, P; Howe, C; Elliott, T; Gehring, K; Williams, DB				Zhang, Yinan; Kozlov, Guennadi; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Maattanen, Pekka; Howe, Chris; Elliott, Tim; Gehring, Kalle; Williams, David B.			ERp57 Does Not Require Interactions with Calnexin and Calreticulin to Promote Assembly of Class I Histocompatibility Molecules, and It Enhances Peptide Loading Independently of Its Redox Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PROTEIN-DISULFIDE-ISOMERASE; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; CHAPERONE CALRETICULIN; FUNCTIONAL-PROPERTIES; PROLYL 4-HYDROXYLASE; OXIDOREDUCTASE ERP57; CRYSTAL-STRUCTURE	ERp57 is a thiol oxidoreductase that catalyzes disulfide formation in heavy chains of class I histocompatibility molecules. It also forms a mixed disulfide with tapasin within the class I peptide loading complex, stabilizing the complex and promoting efficient binding of peptides to class I molecules. Since ERp57 associates with the lectin chaperones calnexin and calreticulin, it is thought that ERp57 requires these chaperones to gain access to its substrates. To test this idea, we examined class I biogenesis in cells lacking calnexin or calreticulin or that express an ERp57 mutant that fails to bind to these chaperones. Remarkably, heavy chain disulfides formed at the same rate in these cells as in wild type cells. Moreover, ERp57 formed a mixed disulfide with tapasin and promoted efficient peptide loading in the absence of interactions with calnexin and calreticulin. These findings suggest that ERp57 has the capacity to recognize its substrates directly in addition to being recruited through lectin chaperones. We also found that calreticulin could be recruited into the peptide loading complex in the absence of interactions with both ERp57 and substrate oligosaccharides, demonstrating the importance of its polypeptide binding site in substrate recognition. Finally, by inactivating the redox-active sites of ERp57, we demonstrate that its enzymatic activity is dispensable in stabilizing the peptide loading complex and in supporting efficient peptide loading. Thus, ERp57 appears to play a structural rather than catalytic role within the peptide loading complex.	[Zhang, Yinan; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhang, Yinan; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi; Maattanen, Pekka; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Howe, Chris; Elliott, Tim] Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Toronto; University of Toronto; McGill University; University of Southampton	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,Rm 5316, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca	Gehring, Kalle/I-4403-2013; Zhang, Yinan/N-6432-2014; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Zhang, Yinan/0000-0002-3471-6598; Gehring, Kalle/0000-0001-6500-1184; Elliott, Tim/0000-0003-1097-0222	Canadian Institutes of Health Research [MOP-53310, MOP-74567]; Canadian Cancer Society; MRC [G0400767] Funding Source: UKRI; Cancer Research UK [10601] Funding Source: researchfish; Medical Research Council [G0400767] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Canadian Institutes of Health Research Grants MOP-53310 and MOP-74567 (to D.B.W. and K.G.) and a grant from the Canadian Cancer Society (to D.B.W.).	Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DEVIRGILIO C, 1993, YEAST, V9, P185, DOI 10.1002/yea.320090209; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Harris MR, 1998, J IMMUNOL, V160, P5404; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; Suh WK, 1999, J IMMUNOL, V162, P1530; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tolstrup AB, 2001, GENE, V263, P77; Walker KW, 1997, J BIOL CHEM, V272, P8845; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	57	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10160	10173		10.1074/jbc.M808356200	http://dx.doi.org/10.1074/jbc.M808356200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196713	hybrid, Green Published			2022-12-25	WOS:000264892900058
J	Meshki, J; Douglas, SD; Lai, JP; Schwartz, L; Kilpatrick, LE; Tuluc, F				Meshki, John; Douglas, Steven D.; Lai, Jian-Ping; Schwartz, Lynnae; Kilpatrick, Laurie E.; Tuluc, Florin			Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; RHO-ASSOCIATED KINASE; SUBSTANCE-P RECEPTOR; SMOOTH-MUSCLE; ROCK-I; SIGNAL-TRANSDUCTION; HUMAN-MONOCYTES; PHOSPHORYLATION; ACTIVATION; PHOSPHATASE	We have investigated the effect of neurokinin 1 receptor (NK1R) agonists on HEK293 cells transfected with the NK1R receptor. The NK1R receptor mediates dramatic shape changes that include contractions of the membrane cortex resulting in membrane bleb formation. We have found that the cell shape changes correlate with changes in electrical impedance measured in cellular monolayers. The shape and impedance changes were prevented after preincubation with NK1R antagonists aprepitant and L-73060. Although bleb formation usually heralds apoptotic cell death, we have found that NK1R-mediated cellular blebbing does not associate with apoptosis. Preincubation with a cell-permeable derivative of C3 transferase that blocks Rho or with the Rho-associated coiled-coil kinase inhibitor Y27632 completely prevented NK1R-induced shape and impedance changes. Blebbing was also completely inhibited by ML-9, a myosin light chain kinase inhibitor. Furthermore, the phospholipase C inhibitor U73,122 did not interfere with the effect of Substance P(SP) on cellular morphology and cellular impedance but completely blocked SP-induced intracellular calcium increase, indicating that the blebbing is a process independent of intracellular calcium elevations. Blebbing is a protein kinase C-independent process, since the nonselective protein kinase C inhibitor GF109203X did not interfere with SP-induced effects. Based on these results, we provide the first evidence that NK1R receptor-ligand interaction can cause apoptosis-independent cellular blebbing and that this process is mediated by the Rho/Rho-associated coiled-coil kinase pathway.	[Meshki, John; Douglas, Steven D.; Lai, Jian-Ping; Kilpatrick, Laurie E.; Tuluc, Florin] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Schwartz, Lynnae] Childrens Hosp Philadelphia, Div Anesthesiol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Kilpatrick, Laurie E.; Tuluc, Florin] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Tuluc, F (corresponding author), 3615 Civ Ctr Blvd,Abramson Res Bldg,Rm 1208C, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu	Lai, Jianping/E-3583-2015; Tuluc, Petronel/C-2527-2011	Lai, Jianping/0000-0002-3217-692X; Douglas, Steven/0000-0002-3748-3603	National Institutes of Health [P01-MH076388, R01-MH049981]; Joseph Stokes Jr. Research Institute Foerderer-Murray; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049981, P01MH076388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph Stokes Jr. Research Institute Foerderer-Murray; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-MH076388 and R01-MH049981 (to S. D. D.). This work was also supported by the Joseph Stokes Jr. Research Institute Foerderer-Murray research award (to F. T.).	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amantini C, 2008, J PHARMACOL EXP THER, V327, P215, DOI 10.1124/jpet.108.138719; Barr AJ, 1997, J BIOL CHEM, V272, P2223; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chernova I, 2009, J LEUKOCYTE BIOL, V85, P154, DOI 10.1189/jlb.0408260; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; Esteban F, 2006, CANCER METAST REV, V25, P137, DOI 10.1007/s10555-006-8161-9; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Feistritzer C, 2003, REGUL PEPTIDES, V116, P119, DOI 10.1016/S0167-0115(03)00193-9; FONG TM, 1992, MOL PHARMACOL, V41, P24; Gao SY, 2004, NEPHRON EXP NEPHROL, V97, pE49, DOI 10.1159/000078406; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudima S, 2007, J VIROL, V81, P3608, DOI 10.1128/JVI.02277-06; Guo CJ, 2002, J NEUROIMMUNOL, V131, P160, DOI 10.1016/S0165-5728(02)00277-1; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Ho WZ, 2002, FASEB J, V16, P616, DOI 10.1096/fj.01-0655fje; Ho WZ, 1997, J IMMUNOL, V159, P5654; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; Koyama S, 1998, J APPL PHYSIOL, V84, P1528, DOI 10.1152/jappl.1998.84.5.1528; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; Lai JP, 2006, P NATL ACAD SCI USA, V103, P7771, DOI 10.1073/pnas.0602563103; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; LANIYONU A, 1988, FEBS LETT, V240, P186, DOI 10.1016/0014-5793(88)80365-X; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL523, DOI 10.1152/ajplung.00328.2007; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Reed KL, 2004, P NATL ACAD SCI USA, V101, P9115, DOI 10.1073/pnas.0403210101; Riddick N, 2008, J CELL BIOCHEM, V103, P1158, DOI 10.1002/jcb.21488; Rittner HL, 2007, ANESTHESIOLOGY, V107, P1009, DOI 10.1097/01.anes.0000291454.90754.de; RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schratzberger P, 1997, J IMMUNOL, V158, P3895; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Velmuri GS, 1996, BIOCHEM J, V314, P805, DOI 10.1042/bj3140805; Weinstock JV, 2003, J IMMUNOL, V171, P3762, DOI 10.4049/jimmunol.171.7.3762; Weisman Gary A, 2006, Biotechnol Genet Eng Rev, V22, P171; WILLIAMS M, 1987, ANNU REV PHARMACOL, V27, P315; Yang YL, 2003, BRAIN RES, V991, P18, DOI 10.1016/S0006-8993(03)03451-6; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	60	66	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9280	9289		10.1074/jbc.M808825200	http://dx.doi.org/10.1074/jbc.M808825200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179340	hybrid, Green Published			2022-12-25	WOS:000264669100034
J	Chen, K; Kurgan, L				Chen, Ke; Kurgan, Lukasz			Investigation of Atomic Level Patterns in Protein-Small Ligand Interactions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INTERACTION SITES; BINDING-SITES; RESOLUTION; RESIDUES	Background: Shape complementarity and non-covalent interactions are believed to drive protein-ligand interaction. To date protein-protein, protein-DNA, and protein-RNA interactions were systematically investigated, which is in contrast to interactions with small ligands. We investigate the role of covalent and non-covalent bonds in protein-small ligand interactions using a comprehensive dataset of 2,320 complexes. Methodology and Principal Findings: We show that protein-ligand interactions are governed by different forces for different ligand types, i.e., protein-organic compound interactions are governed by hydrogen bonds, van der Waals contacts, and covalent bonds; protein-metal ion interactions are dominated by electrostatic force and coordination bonds; protein-anion interactions are established with electrostatic force, hydrogen bonds, and van der Waals contacts; and protein-inorganic cluster interactions are driven by coordination bonds. We extracted several frequently occurring atomic-level patterns concerning these interactions. For instance, 73% of investigated covalent bonds were summarized with just three patterns in which bonds are formed between thiol of Cys and carbon or sulfur atoms of ligands, and nitrogen of Lys and carbon of ligands. Similar patterns were found for the coordination bonds. Hydrogen bonds occur in 67% of protein-organic compound complexes and 66% of them are formed between NH- group of protein residues and oxygen atom of ligands. We quantify relative abundance of specific interaction types and discuss their characteristic features. The extracted protein-organic compound patterns are shown to complement and improve a geometric approach for prediction of binding sites. Conclusions and Significance: We show that for a given type (group) of ligands and type of the interaction force, majority of protein-ligand interactions are repetitive and could be summarized with several simple atomic-level patterns. We summarize and analyze 10 frequently occurring interaction patterns that cover 56% of all considered complexes and we show a practical application for the patterns that concerns interactions with organic compounds.	[Chen, Ke; Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	University of Alberta	Chen, K (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.	lkurgan@ece.ualberta.ca	Kurgan, Lukasz/B-5721-2009	Kurgan, Lukasz/0000-0002-7749-0314; Chen, Ke/0000-0002-6962-1724	Informatics Circle of Research Excellence (iCORE) [scholarship]; Alberta Ingenuity Fund (AIF); Natural Sciences and Engineering Research Council (NSERC) [Discovery grant]	Informatics Circle of Research Excellence (iCORE); Alberta Ingenuity Fund (AIF); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a scholarship awarded by Informatics Circle of Research Excellence (iCORE) and Alberta Ingenuity Fund (AIF) to K.C. and by Discovery grant awarded by the Natural Sciences and Engineering Research Council (NSERC) of Canada to L.K.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Ansari S, 2005, PROTEINS, V61, P344, DOI 10.1002/prot.20593; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; Davis AM, 2003, ANGEW CHEM INT EDIT, V42, P2718, DOI 10.1002/anie.200200539; Declercq JP, 1999, PROTEIN SCI, V8, P2194, DOI 10.1110/ps.8.10.2194; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Liu DL, 2007, BIOCHEMISTRY-US, V46, P11789, DOI 10.1021/bi7012849; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Scapin G, 2006, CURR PHARM DESIGN, V12, P2087, DOI 10.2174/138161206777585201; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zauhar RJ, 2003, J MED CHEM, V46, P5674, DOI 10.1021/jm030242k; Zhu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001926; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	45	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4473	10.1371/journal.pone.0004473	http://dx.doi.org/10.1371/journal.pone.0004473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221587	Green Submitted, Green Published, gold			2022-12-25	WOS:000265485700006
J	Tang, S; Le, PK; Tse, S; Wallace, DC; Huang, TS				Tang, Sha; Le, Phung Khanh; Tse, Stephanie; Wallace, Douglas C.; Huang, Taosheng			Heterozygous Mutation of Opa1 in Drosophila Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MITOCHONDRIAL MORPHOLOGY; OXIDATIVE STRESS; CYTOCHROME-C; IN-VIVO; EXTENSION; APOPTOSIS; FISSION; GENE; SEX	Optic atrophy 1 (OPA1) is a dynamin-like GTPase located in the inner mitochondrial membrane and mutations in OPA1 are associated with autosomal dominant optic atrophy (DOA). OPA1 plays important roles in mitochondrial fusion, cristae remodeling and apoptosis. Our previous study showed that dOpa1 mutation caused elevated reactive oxygen species (ROS) production and resulted in damage and death of the cone and pigment cells in Drosophila eyes. Since ROS-induced oxidative damage to the cells is one of the primary causes of aging, in this study, we examined the effects of heterozygous dOpa1 mutation on the lifespan. We found that heterozygous dOpa1 mutation caused shortened lifespan, increased susceptibility to oxidative stress and elevated production of ROS in the whole Drosophila. Antioxidant treatment partially restored lifespan in the male dOpa1 mutants, but had no effects in the females. Heterozygous dOpa1 mutation caused an impairment of respiratory chain complex activities, especially complexes II and III, and reversible decreased aconitase activity. Heterozygous dOpa1 mutation is also associated with irregular and dysmorphic mitochondria in the muscle. Our results, for the first time, demonstrate the important role of OPA1 in aging and lifespan, which is most likely mediated through augmented ROS production.	[Tang, Sha; Le, Phung Khanh; Tse, Stephanie; Huang, Taosheng] Univ Calif Irvine, Dept Pediat, Div Human Genet, Irvine, CA 92717 USA; [Wallace, Douglas C.; Huang, Taosheng] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Huang, Taosheng] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Huang, Taosheng] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tang, S (corresponding author), Univ Calif Irvine, Dept Pediat, Div Human Genet, Irvine, CA 92717 USA.	huangts@uci.edu		Huang, Taosheng/0000-0001-6601-6687	Helen & Larry Hoag Foundation; NIH [Clinical Associate Physician Award, NS21328, AG24373, DK73691, AG13154]; Howard Hughes Biomedical Science Program; UCI [Junior Physician-Scientists Award]; NEI [1R01EY018876]; Cystinosis Research Foundation; NATIONAL EYE INSTITUTE [R01EY018876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, R01AG013154] Funding Source: NIH RePORTER	Helen & Larry Hoag Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Biomedical Science Program; UCI; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cystinosis Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was partially supported by the Helen & Larry Hoag Foundation, an NIH Clinical Associate Physician Award, the Howard Hughes Biomedical Science Program, a UCI Junior Physician-Scientists Award and NEI 1R01EY018876 to TH. ST is supported by the Cystinosis Research Foundation. DCW is supported by the following NIH research grant NS21328, AG24373, DK73691, AG13154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballard JWO, 2007, AGING CELL, V6, P699, DOI 10.1111/j.1474-9726.2007.00331.x; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartman P, 2004, MECH AGEING DEV, V125, P417, DOI 10.1016/j.mad.2004.02.007; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; SPINAZZI M, 2008, HUM MOL GENET; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; AM J HUM GENET, V65, P1428	49	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4492	10.1371/journal.pone.0004492	http://dx.doi.org/10.1371/journal.pone.0004492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221591	Green Published, gold			2022-12-25	WOS:000265485700016
J	Porwal, S; Lal, S; Cheema, S; Kalia, VC				Porwal, Shalini; Lal, Sadhana; Cheema, Simrita; Kalia, Vipin Chandra			Phylogeny in Aid of the Present and Novel Microbial Lineages: Diversity in Bacillus	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; 16S RIBOSOMAL-RNA; MULTIPLE SEQUENCE ALIGNMENT; RESTRICTION ANALYSIS ARDRA; COMPLETE GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; THURINGIENSIS STRAINS; SPHAERICUS STRAINS; GENETIC DIVERSITY; CEREUS GROUP	Bacillus represents microbes of high economic, medical and biodefense importance. Bacillus strain identification based on 16S rRNA sequence analyses is invariably limited to species level. Secondly, certain discrepancies exist in the segregation of Bacillus subtilis strains. In the RDP/NCBI databases, out of a total of 2611 individual 16S rDNA sequences belonging to the 175 different species of the genus Bacillus, only 1586 have been identified up to species level. 16S rRNA sequences of Bacillus anthracis (153 strains), B. cereus (211 strains), B. thuringiensis (108 strains), B. subtilis (271 strains), B. licheniformis (131 strains), B. pumilus (83 strains), B. megaterium (47 strains), B. sphaericus (42 strains), B. clausii (39 strains) and B. halodurans (36 strains) were considered for generating species-specific framework and probes as tools for their rapid identification. Phylogenetic segregation of 1121, 16S rDNA sequences of 10 different Bacillus species in to 89 clusters enabled us to develop a phylogenetic frame work of 34 representative sequences. Using this phylogenetic framework, 305 out of 1025, 16S rDNA sequences presently classified as Bacillus sp. could be identified up to species level. This identification was supported by 20 to 30 nucleotides long signature sequences and in silico restriction enzyme analysis specific to the 10 Bacillus species. This integrated approach resulted in identifying around 30% of Bacillus sp. up to species level and revealed that B. subtilis strains can be segregated into two phylogenetically distinct groups, such that one of them may be renamed.	[Porwal, Shalini; Lal, Sadhana; Cheema, Simrita; Kalia, Vipin Chandra] CSIR, IGIB, Delhi, India; [Porwal, Shalini] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Porwal, S (corresponding author), CSIR, IGIB, Delhi Univ Campus, Delhi, India.	vckalia@igib.res.in		Porwal, Shalini/0000-0003-3862-4671	Task Force project, Council of Scientific and Industrial Research	Task Force project, Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by the Task Force project, Council of Scientific and Industrial Research and granted permission to publish. The funders had a role in decision to publish. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Al-Ajlani MM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-17; ALEXANDER B, 1990, J GEN MICROBIOL, V136, P367, DOI 10.1099/00221287-136-2-367; ARBER W, 1979, SCIENCE, V205, P361, DOI 10.1126/science.377489; Arcuri EF, 2000, MICROBIOL-SGM, V146, P1593, DOI 10.1099/00221287-146-7-1593; ASH C, 1991, LETT APPL MICROBIOL, V13, P202, DOI 10.1111/j.1472-765X.1991.tb00608.x; ASH C, 1992, FEMS MICROBIOL LETT, V94, P75; ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BAILEY TL, 2006, MEME DISCOVERING ANA, pW369; Baldauf SL, 2003, TRENDS GENET, V19, P345, DOI 10.1016/S0168-9525(03)00112-4; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Bavykin SG, 2004, J CLIN MICROBIOL, V42, P3711, DOI 10.1128/jcm.42.8.3711-3730.2004; BERGEY D.H, 1939, BERGEYS MANUAL DETER; Bjorkroth J, 1999, INT J SYST BACTERIOL, V49, P983, DOI 10.1099/00207713-49-3-983; BLANC DS, 1993, J CLIN MICROBIOL, V31, P71, DOI 10.1128/JCM.31.1.71-77.1993; Blanc M, 1997, INT J SYST BACTERIOL, V47, P1246, DOI 10.1099/00207713-47-4-1246; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; Borin S, 1997, FEMS MICROBIOL LETT, V157, P87, DOI 10.1016/S0378-1097(97)00458-8; BOURQUE SN, 1995, APPL ENVIRON MICROB, V61, P1623, DOI 10.1128/AEM.61.4.1623-1626.1995; BOUVET A, 1991, INT J SYST BACTERIOL, V41, P483, DOI 10.1099/00207713-41-4-483; BRADBURY JM, 2001, INT J SYST EVOL MICR, V51, P2227; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Buchanan R.E, 1974, BERGEYS MANUAL DETER, V8th ed., DOI 10.1007/bergeysoutline200405; Bujnicki JM, 2003, CURR PROTEIN PEPT SC, V4, P327, DOI 10.2174/1389203033487072; Carlson CR, 1996, FEMS MICROBIOL LETT, V141, P163, DOI 10.1016/0378-1097(96)00216-9; CARLSON CR, 1994, MOL MICROBIOL, V13, P161, DOI 10.1111/j.1365-2958.1994.tb00411.x; CARLSON CR, 1993, J BACTERIOL, V175, P1053, DOI 10.1128/JB.175.4.1053-1060.1993; CARLSON CR, 1994, APPL ENVIRON MICROB, V60, P1719, DOI 10.1128/AEM.60.6.1719-1725.1994; Cheney G., 2002, MANAGE COMMUN Q, V16, P92, DOI DOI 10.1177/0893318902161006; Chun J, 2000, ANTON LEEUW INT J G, V78, P123, DOI 10.1023/A:1026555830014; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; da Silva KRA, 1999, RES MICROBIOL, V150, P153, DOI 10.1016/S0923-2508(99)80032-1; Daffonchio D, 2006, APPL ENVIRON MICROB, V72, P1295, DOI 10.1128/AEM.72.2.1295-1301.2006; Daffonchio D, 1998, INT J SYST BACTERIOL, V48, P107, DOI 10.1099/00207713-48-1-107; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; DAVIDSON EW, 1995, MEM I OSWALDO CRUZ, V90, P81, DOI 10.1590/S0074-02761995000100018; de Barjac H, 1980, Ann Microbiol (Paris), V131B, P191; De Clerck E, 2004, FEMS MICROBIOL LETT, V231, P91, DOI 10.1016/S0378-1097(03)00935-2; De Clerck E, 2002, SYST APPL MICROBIOL, V25, P611, DOI 10.1078/07232020260517751; De Gheldre Y, 1999, INT J SYST BACTERIOL, V49, P1591, DOI 10.1099/00207713-49-4-1591; DEBARJAC H, 1985, APPL MICROBIOL BIOT, V21, P85, DOI 10.1007/BF00252367; Djordjevic SP, 2000, APPL ENVIRON MICROB, V66, P1098, DOI 10.1128/AEM.66.3.1098-1106.2000; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; DUNCAN KE, 1994, EVOLUTION, V48, P2002, DOI 10.1111/j.1558-5646.1994.tb02229.x; Ehrenstein B, 1996, J CLIN MICROBIOL, V34, P2414, DOI 10.1128/JCM.34.10.2414-2420.1996; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FRACHON E, 1991, APPL ENVIRON MICROB, V57, P3394, DOI 10.1128/AEM.57.11.3394-3398.1991; Fritze D, 2004, PHYTOPATHOLOGY, V94, P1245, DOI 10.1094/PHYTO.2004.94.11.1245; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; FUKUNAGA M, 1993, J GEN MICROBIOL, V139, P1141, DOI 10.1099/00221287-139-6-1141; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Green DH, 1999, APPL ENVIRON MICROB, V65, P4288; GUERINEAU M, 1991, J INVERTEBR PATHOL, V57, P325, DOI 10.1016/0022-2011(91)90136-E; Guinebretiere MH, 2001, APPL ENVIRON MICROB, V67, P4520, DOI 10.1128/AEM.67.10.4520-4530.2001; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Han B, 2007, APPL ENVIRON MICROB, V73, P3581, DOI 10.1128/AEM.02863-06; Hansen BM, 2001, FEMS MICROBIOL LETT, V202, P209, DOI 10.1016/S0378-1097(01)00309-3; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Helgason E, 1998, CURR MICROBIOL, V37, P80, DOI 10.1007/s002849900343; Herman L, 2000, RES MICROBIOL, V151, P255, DOI 10.1016/S0923-2508(00)00146-7; Heyndrickx M, 1999, INT J SYST BACTERIOL, V49, P1083, DOI 10.1099/00207713-49-3-1083; Heyndrickx M, 1996, J MICROBIOL METH, V26, P247, DOI 10.1016/0167-7012(96)00916-5; HEYNDRICKX M, 2002, APPL SYSTEMATICS BAC; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; HOFTE H, 1989, MICROBIOL REV, V53, P242; ISHIHARA H, 1968, BIOCHIM BIOPHYS ACTA, V166, P496, DOI 10.1016/0005-2787(68)90237-2; Ishihara H, 2002, CURR MICROBIOL, V45, P18, DOI 10.1007/s00284-001-0041-5; JACKSON SG, 1995, LETT APPL MICROBIOL, V21, P103, DOI 10.1111/j.1472-765X.1995.tb01017.x; Jalava K, 1999, LETT APPL MICROBIOL, V28, P269, DOI 10.1046/j.1365-2672.1999.00527.x; Jensen GB, 1996, CURR MICROBIOL, V33, P228, DOI 10.1007/s002849900105; Joung KB, 2002, J APPL MICROBIOL, V93, P1075, DOI 10.1046/j.1365-2672.2002.01788.x; KALIA VC, 1994, WORLD J MICROB BIOT, V10, P224, DOI 10.1007/BF00360893; Kasai H, 2000, J CLIN MICROBIOL, V38, P301; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lal S, 2008, INDIAN J MICROBIOL, V48, P228, DOI 10.1007/s12088-008-0034-1; Lapidus A, 2002, FEMS MICROBIOL LETT, V209, P23, DOI 10.1111/j.1574-6968.2002.tb11104.x; Lee H, 2000, J CLIN MICROBIOL, V38, P2966, DOI 10.1128/JCM.38.8.2966-2971.2000; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; LOWE T, 1990, NUCLEIC ACIDS RES, V18, P1757, DOI 10.1093/nar/18.7.1757; Maes N, 1997, J CLIN MICROBIOL, V35, P2477, DOI 10.1128/JCM.35.10.2477-2481.1997; Manachini PL, 1998, SYST APPL MICROBIOL, V21, P520, DOI 10.1016/S0723-2020(98)80064-7; Martirani L, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-1; MITSUHASHI M, 1994, NATURE, V367, P759, DOI 10.1038/367759a0; Nakamura LK, 1999, INT J SYST BACTERIOL, V49, P1211, DOI 10.1099/00207713-49-3-1211; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; Ning W, 1997, SYST APPL MICROBIOL, V20, P423, DOI 10.1016/S0723-2020(97)80011-2; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmisano MM, 2001, INT J SYST EVOL MICR, V51, P1671, DOI 10.1099/00207713-51-5-1671; Perez C, 2007, CELL MICROBIOL, V9, P2931, DOI 10.1111/j.1462-5822.2007.01007.x; Persson A, 1999, J CLIN MICROBIOL, V37, P3815, DOI 10.1128/JCM.37.12.3815-3821.1999; PETERSEN DJ, 1995, FEMS MICROBIOL LETT, V133, P71, DOI 10.1111/j.1574-6968.1995.tb07863.x; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Porwal S, 2008, BIORESOURCE TECHNOL, V99, P5444, DOI 10.1016/j.biortech.2007.11.011; PRICE C, 1986, MICROBIOL SCI, V3, P296; Priest F, 1981, AEROBIC ENDOSPORE FO, P35; Priest Fergus G., 1993, P3; Pruss BM, 1999, J BACTERIOL, V181, P2624; Purohit HJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-19; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rippere KE, 1997, INT J SYST BACTERIOL, V47, P214, DOI 10.1099/00207713-47-1-214; Rowan NJ, 2001, APPL ENVIRON MICROB, V67, P3873, DOI 10.1128/AEM.67.9.3873-3881.2001; SCHENKEL RGM, 1993, REV MICROBIOL, V24, P166; Senesi S, 2001, APPL ENVIRON MICROB, V67, P834, DOI 10.1128/AEM.67.2.834-839.2001; Skerman V. B. D., 1980, APPROVED LISTS BACTE; Sonakya V, 2001, BIOTECHNOL LETT, V23, P1463, DOI 10.1023/A:1011664912970; Sorokulova IB, 2003, LETT APPL MICROBIOL, V37, P169, DOI 10.1046/j.1472-765X.2003.01372.x; STACKEBRANDT E, 2002, APPL SYSTEMATICS BAC; Stakenborg T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-46; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Suihko ML, 2003, J APPL MICROBIOL, V94, P25, DOI 10.1046/j.1365-2672.2003.01803.x; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 1999, BIOSCI BIOTECH BIOCH, V63, P943, DOI 10.1271/bbb.63.943; teGiffel MC, 1997, FEMS MICROBIOL LETT, V146, P47, DOI 10.1111/j.1574-6968.1997.tb10169.x; Tena D, 2007, CLIN INFECT DIS, V44, pE40, DOI 10.1086/511077; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Ticknor LO, 2001, APPL ENVIRON MICROB, V67, P4863, DOI 10.1128/AEM.67.10.4863-4873.2001; Vaerewijck MJM, 2001, J APPL MICROBIOL, V91, P1074, DOI 10.1046/j.1365-2672.2001.01477.x; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vary PS, 2007, APPL MICROBIOL BIOT, V76, P957, DOI 10.1007/s00253-007-1089-3; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; VOLD BS, 1985, MICROBIOL REV, V49, P71, DOI 10.1128/MMBR.49.1.71-80.1985; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wattiau P, 2001, APPL MICROBIOL BIOT, V56, P816, DOI 10.1007/s002530100691; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu XY, 2006, J MICROBIOL METH, V64, P107, DOI 10.1016/j.mimet.2005.04.021; Xu D, 2003, INT J SYST EVOL MICR, V53, P695, DOI 10.1099/ijs.0.02346-0; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Yamada Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1244, DOI 10.1271/bbb.61.1244; Yamamoto S, 1998, INT J SYST BACTERIOL, V48, P813, DOI 10.1099/00207713-48-3-813; Yamamoto S, 1999, INT J SYST BACTERIOL, V49, P87, DOI 10.1099/00207713-49-1-87; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P1079, DOI 10.1099/00207713-51-3-1079; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P2087, DOI 10.1099/00207713-51-6-2087; YOUSTEN AA, 1980, ANN INST PASTEUR MIC, VB131, P297; ZAHNER V, 1994, J APPL BACTERIOL, V76, P327, DOI 10.1111/j.1365-2672.1994.tb01636.x; ZEIGLER DR, 2001, GENUS GEOBACILLUS, V3; 2007, NEW ENGLAND BIOLABS	152	83	89	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4438	10.1371/journal.pone.0004438	http://dx.doi.org/10.1371/journal.pone.0004438			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212464	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200005
J	Hager, JH; Ulanet, DB; Hennighausen, L; Hanahan, D				Hager, Jeffrey H.; Ulanet, Danielle B.; Hennighausen, Lothar; Hanahan, Douglas			Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer	PLOS ONE			English	Article								Tumor cell death is modulated by an intrinsic cell death pathway controlled by the pro-and anti-apoptotic members of the Bcl-2 family. Up-regulation of anti-apoptotic Bcl-2 family members has been shown to suppress cell death in pre-clinical models of human cancer and is implicated in human tumor progression. Previous gain-of-function studies in the RIP1-Tag2 model of pancreatic islet carcinogenesis, involving uniform or focal/temporal over-expression of Bcl-x(L), demonstrated accelerated tumor formation and growth. To specifically assess the role of endogenous Bcl-x in regulating apoptosis and tumor progression in this model, we engineered a pancreatic beta-cell-specific knockout of both alleles of Bcl-x using the Cre-LoxP system of homologous recombination. Surprisingly, there was no appreciable effect on tumor cell apoptosis rates or on tumor growth in the Bcl-x knockout mice. Other anti-apoptotic Bcl-2 family members were expressed but not substantively altered at the mRNA level in the Bcl-x-null tumors, suggestive of redundancy without compensatory transcriptional up-regulation. Interestingly, the incidence of invasive carcinomas was reduced, and tumor cells lacking Bcl-x were impaired in invasion in a two-chamber trans-well assay under conditions mimicking hypoxia. Thus, while the function of Bcl-x in suppressing apoptosis and thereby promoting tumor growth is evidently redundant, genetic ablation implicates Bcl-x in selectively facilitating invasion, consistent with a recent report documenting a pro-invasive capability of Bcl-x(L) upon exogenous over-expression.	[Hager, Jeffrey H.; Ulanet, Danielle B.; Hanahan, Douglas] Univ Calif San Francisco, Diabetes & Hellen Diller Family Comprehens Canc, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Hennighausen, Lothar] NIDDK, NIH, Lab Genet & Physiol, Bethesda, MD USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hager, JH (corresponding author), Apoptos Inc, San Diego, CA USA.	dh@biochem.ucsf.edu		Hennighausen, Lothar/0000-0001-8319-9841	A.P. Giannini Foundation for Medical Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Cancer Institute [R01CA45234]; NATIONAL CANCER INSTITUTE [R01CA045234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061000] Funding Source: NIH RePORTER	A.P. Giannini Foundation for Medical Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the A.P. Giannini Foundation for Medical Research (D.B.U), The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (L.H.), and grants from the National Cancer Institute (D.H.; R01CA45234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Ban J, 1998, BIOCHEM BIOPH RES CO, V248, P147, DOI 10.1006/bbrc.1998.8907; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choi J, 2005, CANCER RES, V65, P5554, DOI 10.1158/0008-5472.CAN-04-4570; CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; EFRAT S, 1987, EMBO J, V6, P2699, DOI 10.1002/j.1460-2075.1987.tb02562.x; Elson DA, 2000, CANCER RES, V60, P6189; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gort EH, 2008, CURR MOL MED, V8, P60; Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hickman JA, 2002, CURR OPIN GENET DEV, V12, P67, DOI 10.1016/S0959-437X(01)00266-0; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; NAIK P, 1994, COLD SPRING HARB SYM, V59, P459, DOI 10.1101/SQB.1994.059.01.051; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PARANGI S, 1995, CANCER RES, V55, P6071; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Spandidos DA, 2002, INT J ONCOL, V21, P237; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Thomadaki H, 2006, CRIT REV CL LAB SCI, V43, P1, DOI 10.1080/10408360500295626; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Wagner KU, 2000, DEVELOPMENT, V127, P4949; WANG GL, 1993, BLOOD, V82, P3610; Weiler M, 2006, CELL DEATH DIFFER, V13, P1156, DOI 10.1038/sj.cdd.4401786; Wick W, 2004, J NEUROCHEM, V91, P1275, DOI 10.1111/j.1471-4159.2004.02806.x	49	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4455	10.1371/journal.pone.0004455	http://dx.doi.org/10.1371/journal.pone.0004455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209227	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484100013
J	Lehnert, S; Van Loo, P; Thilakarathne, PJ; Marynen, P; Verbeke, G; Schuit, FC				Lehnert, Stefan; Van Loo, Peter; Thilakarathne, Pushpike J.; Marynen, Peter; Verbeke, Geert; Schuit, Frans C.			Evidence for Co-Evolution between Human MicroRNAs and Alu-Repeats	PLOS ONE			English	Article							MESSENGER-RNA; GENOME EVOLUTION; MOBILE ELEMENTS; CLEAVAGE; TARGETS; BIOGENESIS; INSIGHTS; DISEASE; DOMAIN; GENES	This paper connects Alu repeats, the most abundant repetitive elements in the human genome and microRNAs, small RNAs that alter gene expression at the post-transcriptional level. Base-pair complementarity could be demonstrated between the seed sequence of a subset of human microRNAs and Alu repeats that are integrated parallel (sense) in mRNAs. The most common target site coincides with the evolutionary most conserved part of Alu. A primate-specific gene cluster on chromosome 19 encodes the majority of miRNAs that target the most conserved sense Alu site. The individual miRNA genes within this cluster are flanked by an Alu-LINE signature, which has been duplicated with the clustered miRNA genes. Gene duplication events in this locus are supported by comparing repeat length variations of the LINE elements within the cluster with those in the rest of the chromosome. Thus, a dual relationship exists between an evolutionary young miRNA cluster and their Alu targets that may have evolved in the same time window. One hypothesis for this dual relationship is that these miRNAs could protect against too high rates of duplicative transposition, which would destroy the genome.	[Schuit, Frans C.] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium; [Van Loo, Peter; Marynen, Peter] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Van Loo, Peter; Marynen, Peter] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Elect Engn, Bioinformatics Grp, Louvain, Belgium; [Thilakarathne, Pushpike J.; Verbeke, Geert] Katholieke Univ Leuven, UZ Sint Rafael, Biostat Ctr, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Lehnert, S (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium.	frans.schuit@med.kuleuven.be	Van Loo, Peter/A-3287-2012; Verbeke, Geert/I-5587-2015	Verbeke, Geert/0000-0001-8430-7576; Van Loo, Peter/0000-0003-0292-1949	FS laboratory [GOA 2004/11]; SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology	FS laboratory; SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology	This work was financially supported by a research grant to the FS laboratory (GOA 2004/11) and by SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; BORCHERT GM, 2006, NAT STRUCT MOL BIOL; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEBEDEV YB, 2006, GENE; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Ray DA, 2007, MOL ECOL, V16, P19, DOI 10.1111/j.1365-294X.2006.03104.x; Royo H, 2006, CYTOGENET GENOME RES, V113, P99, DOI 10.1159/000090820; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; ZHANG R, 2008, MOL BIOL EVOL	33	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4456	10.1371/journal.pone.0004456	http://dx.doi.org/10.1371/journal.pone.0004456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209240	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484100014
J	Konduru, NV; Tyurina, YY; Feng, WH; Basova, LV; Belikova, NA; Bayir, H; Clark, K; Rubin, M; Stolz, D; Vallhov, H; Scheynius, A; Witasp, E; Fadeel, B; Kichambare, PD; Star, A; Kisin, ER; Murray, AR; Shvedova, AA; Kagan, VE				Konduru, Nagarjun V.; Tyurina, Yulia Y.; Feng, Weihong; Basova, Liana V.; Belikova, Natalia A.; Bayir, Huelya; Clark, Katherine; Rubin, Marc; Stolz, Donna; Vallhov, Helen; Scheynius, Annika; Witasp, Erika; Fadeel, Bengt; Kichambare, Padmakar D.; Star, Alexander; Kisin, Elena R.; Murray, Ashley R.; Shvedova, Anna A.; Kagan, Valerian E.			Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes In Vitro and In Vivo	PLOS ONE			English	Article							APOPTOTIC CELLS; CYTOCHROME-C; MACROPHAGES; LUNG; RELEASE; NANOPARTICLES; BIODISTRIBUTION; IDENTIFICATION; TRANSLOCATION; TRANSPORTERS	Broad applications of single-walled carbon nanotubes (SWCNT) dictate the necessity to better understand their health effects. Poor recognition of non-functionalized SWCNT by phagocytes is prohibitive towards controlling their biological action. We report that SWCNT coating with a phospholipid "eat-me'' signal, phosphatidylserine (PS), makes them recognizable in vitro by different phagocytic cells-murine RAW264.7 macrophages, primary monocyte-derived human macrophages, dendritic cells, and rat brain microglia. Macrophage uptake of PS-coated nanotubes was suppressed by the PS-binding protein, Annexin V, and endocytosis inhibitors, and changed the pattern of pro- and anti-inflammatory cytokine secretion. Loading of PS-coated SWCNT with pro-apoptotic cargo (cytochrome c) allowed for the targeted killing of RAW264.7 macrophages. In vivo aspiration of PS-coated SWCNT stimulated their uptake by lung alveolar macrophages in mice. Thus, PS-coating can be utilized for targeted delivery of SWCNT with specified cargoes into professional phagocytes, hence for therapeutic regulation of specific populations of immune-competent cells.	[Konduru, Nagarjun V.; Tyurina, Yulia Y.; Feng, Weihong; Basova, Liana V.; Belikova, Natalia A.; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA; [Clark, Katherine; Rubin, Marc; Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Kichambare, Padmakar D.; Star, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kisin, Elena R.; Murray, Ashley R.; Shvedova, Anna A.] NIOSH, HELD, Pathol Physiol Res Branch, Morgantown, WV USA; [Vallhov, Helen; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, S-10401 Stockholm, Sweden; [Witasp, Erika; Fadeel, Bengt; Kagan, Valerian E.] Karolinska Inst, Inst Environm Med, Div Biochem Toxicol, S-10401 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Karolinska Institutet; Karolinska Institutet	Konduru, NV (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA.	kagan@pitt.edu	Star, Alexander/C-3399-2013	Star, Alexander/0000-0001-7863-5987; Kagan, Valerian E./0000-0002-7245-1885; Tyurina, Yulia/0000-0003-0287-2091	NIOSH [OH008282]; NORA [92700Y]; Swedish Research Council; Swedish Council for Working Life and Social Research; Human Frontier Science Program (HFSP); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER	NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NORA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by NIOSH OH008282, NORA 92700Y, the Swedish Research Council, the Swedish Council for Working Life and Social Research, and the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arepalli S, 2004, CARBON, V42, P1783, DOI 10.1016/j.carbon.2004.03.038; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; BIRCH ME, 2003, MONITORING DIESEL PA, P229; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Borm PJA, 2004, J NANOSCI NANOTECHNO, V4, P521, DOI 10.1166/jnn.2004.081; Buentke E, 2001, CLIN EXP ALLERGY, V31, P1583, DOI 10.1046/j.1365-2222.2001.01199.x; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044; Chen X, 2004, ANGEW CHEM INT EDIT, V43, P6111, DOI 10.1002/anie.200460620; Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Elder Alison, 2006, Clin Occup Environ Med, V5, P785; Fadeel B, 2007, NANOTOXICOLOGY, V1, P73, DOI 10.1080/17435390701565578; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gonzalez-Flecha Beatriz, 2004, Molecular Aspects of Medicine, V25, P169, DOI 10.1016/j.mam.2004.02.017; Gorelik O, 2000, PURIFICATION PROCEDU; Gotovac S, 2007, J COLLOID INTERF SCI, V314, P18, DOI 10.1016/j.jcis.2007.04.080; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jiang JF, 2003, FREE RADICAL BIO MED, V35, P814, DOI 10.1016/S0891-5849(03)00429-5; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; KISIN E, 2005, TOXICOLOGIST, V84, pA1041; Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Larroche C, 2004, AUTOIMMUN REV, V3, P159, DOI 10.1016/S1568-9972(03)00091-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lecaroz C, 2006, J NANOSCI NANOTECHNO, V6, P3296, DOI 10.1166/jnn.2006.478; LEU D, 1984, J PHARM SCI, V73, P1433, DOI 10.1002/jps.2600731028; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Longhi C, 2005, INT J IMMUNOPATH PH, V18, P317, DOI 10.1177/039463200501800214; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mohanty B, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445102; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Scott CD, 2003, J NANOSCI NANOTECHNO, V3, P63, DOI 10.1166/jnn.2003.164; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Service RF, 2004, SCIENCE, V304, P1732, DOI 10.1126/science.304.5678.1732; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Twigg HL, 2004, SEMIN RESP CRIT CARE, V25, P21, DOI 10.1055/s-2004-822302; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Vadiveloo PK, 1999, J LEUKOCYTE BIOL, V66, P579, DOI 10.1002/jlb.66.4.579; Vallhov H, 2006, NANO LETT, V6, P1682, DOI 10.1021/nl060860z; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Wang SR, 2006, NANOTECHNOLOGY, V17, P634, DOI 10.1088/0957-4484/17/3/003; White B, 2007, J PHYS CHEM C, V111, P13684, DOI 10.1021/jp070853e; Yang H, 2006, CHEM COMMUN, P1425, DOI 10.1039/b515896f	82	99	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4398	10.1371/journal.pone.0004398	http://dx.doi.org/10.1371/journal.pone.0004398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198650	Green Accepted, gold, Green Published			2022-12-25	WOS:000265483900007
J	Desguerre, I; Christov, C; Mayer, M; Zeller, R; Becane, HM; Bastuji-Garin, S; Leturcq, F; Chiron, C; Chelly, J; Gherardi, RK				Desguerre, Isabelle; Christov, Christo; Mayer, Michele; Zeller, Reinhard; Becane, Henri-Marc; Bastuji-Garin, Sylvie; Leturcq, France; Chiron, Catherine; Chelly, Jamel; Gherardi, Romain K.			Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up	PLOS ONE			English	Article							PROGRESSION; PREVALENCE; MUTATIONS; CHILDREN	Background: To explore clinical heterogeneity of Duchenne muscular dystrophy (DMD), viewed as a major obstacle to the interpretation of therapeutic trials Methodology/Principal Findings: A retrospective single institution long-term follow-up study was carried out in DMD patients with both complete lack of muscle dystrophin and genotyping. An exploratory series (series 1) was used to assess phenotypic heterogeneity and to identify early criteria predicting future outcome; it included 75 consecutive steroid-free patients, longitudinally evaluated for motor, respiratory, cardiac and cognitive functions (median follow-up: 10.5 yrs). A validation series (series 2) was used to test robustness of the selected predictive criteria; it included 34 more routinely evaluated patients (age>12 yrs). Multivariate analysis of series 1 classified 70/75 patients into 4 clusters with distinctive intellectual and motor outcomes: A (early infantile DMD, 20%): severe intellectual and motor outcomes; B (classical DMD, 28%): intermediate intellectual and poor motor outcome; C ( moderate pure motor DMD, 22%): normal intelligence and delayed motor impairment; and D (severe pure motor DMD, 30%): normal intelligence and poor motor outcome. Group A patients had the most severe respiratory and cardiac involvement. Frequency of mutations upstream to exon 30 increased from group A to D, but genotype/phenotype correlations were restricted to cognition (IQ>71: OR 7.7, 95%CI 1.6-20.4, p<0.003). Diagnostic accuracy tests showed that combination of "clinical onset <2 yrs" with "mental retardation" reliably assigned patients to group A (sensitivity 0.93, specificity 0.98). Combination of "lower limb MMT score>6 at 8 yrs" with "normal or borderline mental status" reliably assigned patients to group C (sensitivity: 1, specificity: 0.94). These criteria were also predictive of "early infantile DMD" and "moderate pure motor DMD" in series 2. Conclusions/Significance: DMD can be divided into 4 sub-phenotypes differing by severity of muscle and brain dysfunction. Simple early criteria can be used to include patients with similar outcomes in future therapeutic trials.	[Desguerre, Isabelle; Gherardi, Romain K.] Hop Necker Enfants Malad, Dept Neuropediat, Neuromuscular Dis Reference Ctr Garches Necker Mo, Paris, France; [Desguerre, Isabelle; Christov, Christo; Gherardi, Romain K.] Univ Paris 12, Mondor Biomed Res Inst, INSERM U841, Dept Neurosci, F-94010 Creteil, France; [Christov, Christo] Mondor Biomed Res Inst, INSERM U841, Creteil, France; [Mayer, Michele] Trousseau Hosp, Dept Neuropediat, Paris, France; [Zeller, Reinhard; Leturcq, France; Chelly, Jamel] Cochin St Vincent de Paul Hosp Grp, Dept Biochem & Genet, Paris, France; [Becane, Henri-Marc; Leturcq, France; Chelly, Jamel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Bastuji-Garin, Sylvie] Henri Mondor Hospital, Dept Publ Hlth & Stat Dept, Creteil, France; [Chiron, Catherine] Univ Paris 05, INSERM, U663, F-75270 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Desguerre, I (corresponding author), Hop Necker Enfants Malad, Dept Neuropediat, Neuromuscular Dis Reference Ctr Garches Necker Mo, Paris, France.	romain.gherardi@hmn.aphp.fr	Bastuji-Garin, Sylvie/R-3479-2018; Chelly, Jamel/J-7528-2015; Chiron, Catherine/E-8506-2016; Zeller, Reinhard/AAZ-7583-2020	Bastuji-Garin, Sylvie/0000-0001-9855-5183; Chelly, Jamel/0000-0002-0939-8719; Chiron, Catherine/0000-0002-9096-1694; Zeller, Reinhard/0000-0002-9504-5521	Association Francaise contre les Myopathies (AFM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOP KG, 1981, ARCH NEUROL-CHICAGO, V38, P406, DOI 10.1001/archneur.1981.00510070040004; Bouvier P, 1999, CHILD ABUSE NEGLECT, V23, P779, DOI 10.1016/S0145-2134(99)00050-2; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; BUSHBY KMD, 1995, DEV MED CHILD NEUROL, V37, P260; BUSHBY KMD, 1992, J INHERIT METAB DIS, V15, P551, DOI 10.1007/BF01799614; Chung BHY, 2004, PEDIATRICS, V114, pE548, DOI 10.1542/peds.2004-0668; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Escolar DM, 2005, ANN NEUROL, V58, P151, DOI 10.1002/ana.20523; Jeppesen J, 2003, NEUROMUSCULAR DISORD, V13, P804, DOI 10.1016/S0960-8966(03)00162-7; Kaminska A, 1999, EPILEPSY RES, V36, P15, DOI 10.1016/S0920-1211(99)00021-2; Kapsa R, 2003, LANCET NEUROL, V2, P299, DOI 10.1016/S1474-4422(03)00382-X; KILMER DD, 1993, ARCH PHYS MED REHAB, V74, P1168; Knottnerus JA, 2002, BMJ-BRIT MED J, V324, P477, DOI 10.1136/bmj.324.7335.477; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; MENDELL JR, 1987, ARCH NEUROL-CHICAGO, V44, P808, DOI 10.1001/archneur.1987.00520200012009; Mok E, 2006, AM J CLIN NUTR, V83, P65; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NICHOLSON LVB, 1993, J MED GENET, V30, P728, DOI 10.1136/jmg.30.9.728; PRELLE A, 1992, J NEUROL, V239, P76, DOI 10.1007/BF00862976; Sifringer M, 2004, HUM GENET, V114, P149, DOI 10.1007/s00439-003-1041-2; SUTHERS GK, 1992, AM J HUM GENET, V50, P887; UITENBROEK DG, 1997, SISA DIAGNOSTIC ACCU; Van der Kooij A. J., 2004, SAGE HDB QUANTITATIV, P49; Van Essen AJ, 2004, NATURAL HIST DUCHENN; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Wilcox MA, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S15; WILCOX MA, 2005, ARTHRITIS RHEUM, V53, P263	31	110	114	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4347	10.1371/journal.pone.0004347	http://dx.doi.org/10.1371/journal.pone.0004347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194511	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483600003
J	Kenny, JG; Ward, D; Josefsson, E; Jonsson, IM; Hinds, J; Rees, HH; Lindsay, JA; Tarkowski, A; Horsburgh, MJ				Kenny, John G.; Ward, Deborah; Josefsson, Elisabet; Jonsson, Ing-Marie; Hinds, Jason; Rees, Huw H.; Lindsay, Jodi A.; Tarkowski, Andrej; Horsburgh, Malcolm J.			The Staphylococcus aureus Response to Unsaturated Long Chain Free Fatty Acids: Survival Mechanisms and Virulence Implications	PLOS ONE			English	Article								Staphylococcus aureus is an important human commensal and opportunistic pathogen responsible for a wide range of infections. Long chain unsaturated free fatty acids represent a barrier to colonisation and infection by S. aureus and act as an antimicrobial component of the innate immune system where they are found on epithelial surfaces and in abscesses. Despite many contradictory reports, the precise anti-staphylococcal mode of action of free fatty acids remains undetermined. In this study, transcriptional (microarrays and qRT-PCR) and translational (proteomics) analyses were applied to ascertain the response of S. aureus to a range of free fatty acids. An increase in expression of the sigma(B) and CtsR stress response regulons was observed. This included increased expression of genes associated with staphyloxanthin synthesis, which has been linked to membrane stabilisation. Similarly, up-regulation of genes involved in capsule formation was recorded as were significant changes in the expression of genes associated with peptidoglycan synthesis and regulation. Overall, alterations were recorded predominantly in pathways involved in cellular energetics. In addition, sensitivity to linoleic acid of a range of defined (sigB, arcA, sasF, sarA, agr, crtM) and transposon-derived mutants (vraE, SAR2632) was determined. Taken together, these data indicate a common mode of action for long chain unsaturated fatty acids that involves disruption of the cell membrane, leading to interference with energy production within the bacterial cell. Contrary to data reported for other strains, the clinically important EMRSA-16 strain MRSA252 used in this study showed an increase in expression of the important virulence regulator RNAIII following all of the treatment conditions tested. An adaptive response by S. aureus of reducing cell surface hydrophobicity was also observed. Two fatty acid sensitive mutants created during this study were also shown to diplay altered pathogenesis as assessed by a murine arthritis model. Differences in the prevalence and clinical importance of S. aureus strains might partly be explained by their responses to antimicrobial fatty acids.	[Kenny, John G.; Ward, Deborah; Rees, Huw H.; Horsburgh, Malcolm J.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Josefsson, Elisabet; Jonsson, Ing-Marie; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Hinds, Jason; Lindsay, Jodi A.] Univ London, Div Cellular & Molecular Med, London WC1E 7HU, England	University of Liverpool; University of Gothenburg; University of London	Kenny, JG (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	M.J.Horsburgh@Liverpool.ac.uk	Kenny, John/HCI-1952-2022; Lindsay, Jodi/ABH-8205-2020; Lindsay, Jodi/B-9565-2008; Horsburgh, Malcolm J/H-9657-2013; Arora, Rajesh/AAE-4596-2021	Kenny, John/0000-0003-2994-6169; Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Arora, Rajesh/0000-0001-7307-9221; Hinds, Jason/0000-0002-2739-1908	BBSRC [BB/D003563/1]; LUA/ALF; Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; Swedish Research Council; Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; Family Tholens and Kristlers Foundation; Biotechnology and Biological Sciences Research Council [BB/D003563/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LUA/ALF; Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; Family Tholens and Kristlers Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was enabled by the BBSRC grant BB/D003563/1 awarded to MJH. EJ, IMJ and AT were supported by LUA/ALF, Goteborg Medical Society, Goteborg Rheumatism Association, King Gustaf V's 80 Years Foundation, Swedish Research Council, Swedish Rheumatism Association, The Sigurd and Elsa Golje Memorial Foundation and the Family Tholens and Kristlers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MNA, 1970, LIPIDS, V5, P838, DOI 10.1007/BF02531977; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; CAMILLI A, 1990, J BACTERIOL, V172, P3738, DOI 10.1128/jb.172.7.3738-3744.1990; CAMPBELL IM, 1983, J CLIN MICROBIOL, V18, P408, DOI 10.1128/JCM.18.2.408-415.1983; Chamberlain NR, 1997, J MED MICROBIOL, V46, P693, DOI 10.1099/00222615-46-8-693; Chamberlain NR, 1996, J MED MICROBIOL, V44, P125, DOI 10.1099/00222615-44-2-125; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332, DOI 10.1128/IAI.59.12.4332-4337.1991; Chan PF, 1998, J BACTERIOL, V180, P6082; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Dufour M, 2007, APPL ENVIRON MICROB, V73, P5507, DOI 10.1128/AEM.01013-07; DYE ES, 1981, INFECT IMMUN, V32, P98, DOI 10.1128/IAI.32.1.98-104.1981; ENGLER HD, 1992, J MED MICROBIOL, V37, P238, DOI 10.1099/00222615-37-4-238; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Freiberg C, 2005, ANTIMICROB AGENTS CH, V49, P749, DOI 10.1128/AAC.49.2.749-759.2005; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; GRINSTED J, 1973, J GEN MICROBIOL, V75, P259, DOI 10.1099/00221287-75-2-259; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HECZKO PB, 1979, J CLIN MICROBIOL, V9, P333; Hilmarsson H, 2007, ARCH VIROL, V152, P2225, DOI 10.1007/s00705-007-1063-5; Hilmarsson H, 2006, ARCH VIROL, V151, P1217, DOI 10.1007/s00705-005-0699-2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2004, INFECT IMMUN, V72, P3073, DOI 10.1128/IAI.72.5.3073-3076.2004; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Johnson AP, 2005, J ANTIMICROB CHEMOTH, V56, P455, DOI 10.1093/jac/dki266; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Josefsson E, 2008, MICROB PATHOGENESIS, V44, P103, DOI 10.1016/j.micpath.2007.08.010; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; KAPRAL FA, 1992, J MED MICROBIOL, V37, P235, DOI 10.1099/00222615-37-4-235; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; LONG JP, 1992, J MED MICROBIOL, V37, P232, DOI 10.1099/00222615-37-4-232; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; MORTENSEN JE, 1992, J MED MICROBIOL, V36, P293, DOI 10.1099/00222615-36-4-293; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NIEMAN C, 1954, BACTERIOL REV, V18, P147, DOI 10.1128/MMBR.18.2.147-163.1954; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Qoronfleh MW, 1998, FEMS MICROBIOL LETT, V166, P103, DOI 10.1016/S0378-1097(98)00317-6; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Riordan JT, 2006, INT J ANTIMICROB AG, V28, P54, DOI 10.1016/j.ijantimicag.2006.01.013; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Ruzin A, 1998, J BACTERIOL, V180, P182, DOI 10.1128/JB.180.1.182-185.1998; Ruzin A, 2000, J BACTERIOL, V182, P2668, DOI 10.1128/JB.182.9.2668-2671.2000; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; SCHAFER L, 1991, J INVEST DERMATOL, V96, P10, DOI 10.1111/1523-1747.ep12514648; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; SHRYOCK TR, 1992, J MED MICROBIOL, V36, P288, DOI 10.1099/00222615-36-4-288; SPEERT DP, 1979, INFECT IMMUN, V26, P1202, DOI 10.1128/IAI.26.3.1202-1210.1979; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Won SR, 2007, FEBS LETT, V581, P4999, DOI 10.1016/j.febslet.2007.09.045; Wydro P, 2007, BIOMACROMOLECULES, V8, P2611, DOI 10.1021/bm700453x; XIONG Z, 1992, J MED MICROBIOL, V37, P192, DOI 10.1099/00222615-37-3-192; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	92	119	121	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4344	10.1371/journal.pone.0004344	http://dx.doi.org/10.1371/journal.pone.0004344			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183815	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000265483200014
J	Cameron, HL; Foster, WG				Cameron, Heather L.; Foster, Warren G.			Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic Mice	PLOS ONE			English	Article								Breast cancer is the most common cancer in Western women and while its precise etiology is unknown, environmental factors are thought to play a role. The organochlorine pesticide dieldrin is a persistent environmental toxicant thought to increase the risk of breast cancer and reduce survival in the human population. The objective of this study was to define the effect of developmental exposure to environmentally relevant concentrations of dieldrin, on mammary tumor development in the offspring. Sexually mature FVB-MMTV/neu female mice were treated with vehicle (corn oil), or dieldrin (0.45, 2.25, and 4.5 mu g/g body weight) daily by gavage for 5 days prior to mating and then once weekly throughout gestation and lactation until weaning. Dieldrin concentrations were selected to produce serum levels representative of human background body burdens, occupational exposure, and overt toxicity. Treatment had no effect on litter size, birth weight or the number of pups surviving to weaning. The highest dose of dieldrin significantly increased the total tumor burden and the volume and number of tumors found in the thoracic mammary glands. Increased mRNA and protein expression of the neurotrophin BDNF and its receptor TrkB was increased in tumors from the offspring of dieldrin treated dams. This study indicates that developmental exposure to the environmental contaminant dieldrin causes increased tumor burden in genetically predisposed mice. Dieldrin exposure also altered the expression of BNDF and TrkB, novel modulators of cancer pathogenesis.	[Cameron, Heather L.; Foster, Warren G.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada	McMaster University	Cameron, HL (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.	fosterw@mcmaster.ca		Cameron, Heather/0000-0002-3886-8257	American Chemistry Council; Natural Sciences and Engineering Research Council [WG 261905-03]	American Chemistry Council; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this project was provided by an unrestricted research grant from the American Chemistry Council and a grant in aid from the Natural Sciences and Engineering Research Council (WG 261905-03). Sponsors of this project did not participate in any phase of the study design, data collection and analysis, decision to publish or preparation of the manuscript. Salary support for Drs. Foster and Cameron from the Canadian Institutes of Health Research and the Ontario Women's Health Council is gratefully acknowledged.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Bachowski S, 1998, TOXICOL APPL PHARM, V150, P301, DOI 10.1006/taap.1998.8372; Birgo B B, 1975, Environ Physiol Biochem, V5, P440; Blasco-Gutierrez MJ, 2007, CANCER INVEST, V25, P405, DOI 10.1080/07357900701206349; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; BUELL P, 1973, J NATL CANCER I, V51, P1479, DOI 10.1093/jnci/51.5.1479; Cameron HL, 2008, REPROD TOXICOL, V25, P256, DOI 10.1016/j.reprotox.2007.11.013; *CAN CANC SOC NAT, 2008, CAN CAN STAT 2008; Cantor KP, 2003, ENVIRON HEALTH PERSP, V111, P179, DOI 10.1289/ehp.4347; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; DAVIES K, 1988, CHEMOSPHERE, V17, P263, DOI 10.1016/0045-6535(88)90219-6; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Engel LS, 2005, AM J EPIDEMIOL, V161, P121, DOI 10.1093/aje/kwi022; Entschladen F, 2006, MED HYPOTHESES, V67, P33, DOI 10.1016/j.mehy.2006.01.015; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Foster WG, 2008, ENVIRON RES, V108, P21, DOI 10.1016/j.envres.2008.05.001; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P686; Hoyer AP, 2000, J CLIN EPIDEMIOL, V53, P323, DOI 10.1016/S0895-4356(99)00165-1; Hoyer AP, 1998, LANCET, V352, P1816, DOI 10.1016/S0140-6736(98)04504-8; Jaboin J, 2002, CANCER RES, V62, P6756; Kang KS, 1996, ENVIRON HEALTH PERSP, V104, P192, DOI 10.2307/3432789; Kannan K, 1997, Rev Environ Contam Toxicol, V152, P1; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacIntosh DL, 1996, ENVIRON HEALTH PERSP, V104, P202, DOI 10.2307/3432790; Mathur V, 2002, ENVIRON INT, V28, P331, DOI 10.1016/S0160-4120(02)00031-4; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEWSOME WH, 1995, CHEMOSPHERE, V30, P2143, DOI 10.1016/0045-6535(95)00086-N; Popnikolov NK, 2005, MODERN PATHOL, V18, P1535, DOI 10.1038/modpathol.3800487; Ramamoorthy K, 1997, ENDOCRINOLOGY, V138, P1520, DOI 10.1210/en.138.4.1520; Reis JS, 2006, MODERN PATHOL, V19, P307, DOI 10.1038/modpathol.3800542; Ricci A, 2005, GROWTH FACTORS, V23, P303, DOI 10.1080/08977190500233813; Ries LAG, 2008, SEER CANC STAT REV; ROGAN WJ, 1994, ENVIRON HEALTH PERSP, V102, P89, DOI 10.1289/ehp.94102s1189; SHEN H, 2007, HUM REPROD DEM199; Shibayama E, 1996, AM J PATHOL, V148, P1807; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Tarraf C, 2003, FOOD ADDIT CONTAM A, V20, P819, DOI 10.1080/0265203031000138231; Verkasalo PK, 1999, INT J CANCER, V83, P743, DOI 10.1002/(SICI)1097-0215(19991210)83:6<743::AID-IJC8>3.0.CO;2-Q; WASSERMANN M, 1976, B ENVIRON CONTAM TOX, V15, P478, DOI 10.1007/BF01685076; Zhang Y, 2008, ONCOLOGY-BASEL, V75, P17, DOI 10.1159/000151615; Zhu ZW, 2002, MOL CARCINOGEN, V35, P138, DOI 10.1002/mc.10083; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	50	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4303	10.1371/journal.pone.0004303	http://dx.doi.org/10.1371/journal.pone.0004303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173004	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483000012
J	Chou, CY; Yu, LPC; Tong, L				Chou, Chi-Yuan; Yu, Linda P. C.; Tong, Liang			Crystal Structure of Biotin Carboxylase in Complex with Substrates and Implications for Its Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; ACETYL-COA CARBOXYLASE; PYRUVATE-CARBOXYLASE; PROPIONIC ACIDEMIA; INDUCED SYNERGISM; DOMAIN; MUTATIONS; EXPRESSION; RESIDUES; ANGSTROM	Biotin-dependent carboxylases are widely distributed in nature and have important functions in many cellular processes. These enzymes share a conserved biotin carboxylase (BC) component, which catalyzes the ATP-dependent carboxylation of biotin using bicarbonate as the donor. Despite the availability of a large amount of biochemical and structural information on BC, the molecular basis for its catalysis is currently still poorly understood. We report here the crystal structure at 2.0 angstrom resolution of wild-type Escherichia coli BC in complex with its substrates biotin, bicarbonate, and Mg-ADP. The structure suggests that Glu(296) is the general base that extracts the proton from bicarbonate, and Arg(338) is the residue that stabilizes the enolate biotin intermediate in the carboxylation reaction. The B domain of BC is positioned closer to the active site, leading to a 2-angstrom shift in the bound position of the adenine nucleotide and bringing it near the bicarbonate for catalysis. One of the oxygen atoms of bicarbonate is located in the correct position to initiate the nucleophilic attack on ATP to form the carboxyphosphate intermediate. This oxygen is also located close to the N1' atom of biotin, providing strong evidence that the phosphate group, derived from decomposition of carboxyphosphate, is the general base that extracts the proton on this N1' atom. The structural observations are supported by mutagenesis and kinetic studies. Overall, this first structure of BC in complex with substrates offers unprecedented insights into the molecular mechanism for the catalysis by this family of enzymes.	[Chou, Chi-Yuan; Yu, Linda P. C.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Columbia University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Chou, Chi-Yuan/0000-0002-3400-171X; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [DK067238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067238 (to L. T.).	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Artymiuk PJ, 1996, NAT STRUCT BIOL, V3, P128, DOI 10.1038/nsb0296-128; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng D, 2007, PROTEIN EXPRES PURIF, V51, P11, DOI 10.1016/j.pep.2006.06.005; Cho YS, 2008, PROTEINS, V70, P268, DOI 10.1002/prot.21611; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; DeLano W.L., 2002, PYMOL MANUAL; Desviat LR, 2003, MOL GENET METAB, V80, P315, DOI 10.1016/S1096-7192(03)00130-6; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; FRY DC, 1985, J AM CHEM SOC, V107, P7659, DOI 10.1021/ja00311a072; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khayat R, 2001, BIOCHEMISTRY-US, V40, P6344, DOI 10.1021/bi010158b; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kondo S, 2004, ACTA CRYSTALLOGR D, V60, P486, DOI 10.1107/S0907444904000423; Kondo S, 2007, ACTA CRYSTALLOGR D, V63, P885, DOI 10.1107/S0907444907029423; Levert KL, 2000, BIOCHEMISTRY-US, V39, P4122, DOI 10.1021/bi992662a; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; Sloane V, 2001, J BIOL CHEM, V276, P24991, DOI 10.1074/jbc.M101472200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	44	48	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11690	11697		10.1074/jbc.M805783200	http://dx.doi.org/10.1074/jbc.M805783200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213731	Green Published, hybrid			2022-12-25	WOS:000265494500071
J	Radziszewska, A; Schroer, SA; Choi, D; Tajmir, P; Radulovich, N; Ho, JC; Wang, LY; Liadis, N; Hakem, R; Tsao, MS; Penn, LZ; Evan, GI; Woo, M				Radziszewska, Anna; Schroer, Stephanie A.; Choi, Diana; Tajmir, Panteha; Radulovich, Nikolina; Ho, James C.; Wang, Linyuan; Liadis, Nicole; Hakem, Razqallah; Tsao, Ming-Sound; Penn, Linda Z.; Evan, Gerard I.; Woo, Minna			Absence of Caspase-3 Protects Pancreatic beta-Cells from c-Myc-induced Apoptosis without Leading to Tumor Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-EXPRESSION; DOWN-REGULATION; CULTURE; MICE; REQUIREMENT; ACTIVATION; RECEPTOR; CYCLE; FAS	c-Myc is a powerful trigger of beta-cell apoptosis, proliferation, and dedifferentiation in rodent islets in vivo. In a transgenic mouse model, c-Myc induction causes rapid beta-cell apoptosis and overt diabetes. When suppression of apoptosis is achieved by overexpression of Bcl-xL in an inducible model of c-Myc activation, a full spectrum of tumor development, including distant metastasis, occurs. Caspase-3 is a key pro-apoptotic protein involved in the execution phase of multiple apoptotic pathways. To test whether caspase-3 is an essential mediator of apoptosis in this model of tumorigenesis, we generated caspase-3 knock-out mice containing the inducible c-myc transgene (c-Myc(+) Casp3(-/-)). In contrast to Bcl-x(L)-overexpressing c-Myc(+) mice, c-Myc(+) Casp3(-/-) mice remained euglycemic for up to 30 days of c-Myc activation, and there was no evidence of tumor formation. Interestingly, caspase-3 deletion also led to the suppression of proliferation, perhaps through regulation of the cell cycle inhibitory protein p27, suggesting a possible mechanism for maintaining a balance between suppression of apoptosis and excessive proliferation in the context of c-Myc activation. Additionally, c-Myc-activated Casp3(-/-) mice were protected from streptozotocin-induced diabetes. Our studies demonstrate that caspase-3 deletion confers protection from c-Myc-induced apoptosis and diabetes development without unwanted tumorigenic effects. These results may lead to further elucidation of the mechanisms of c-Myc biology relevant to beta-cells, which may result in novel therapeutic strategies for diabetes.	[Radziszewska, Anna; Schroer, Stephanie A.; Tajmir, Panteha; Radulovich, Nikolina; Ho, James C.; Wang, Linyuan; Liadis, Nicole; Hakem, Razqallah; Tsao, Ming-Sound; Penn, Linda Z.; Woo, Minna] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Choi, Diana; Woo, Minna] Univ Toronto, Ontario Canc Inst, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Pharmacol, San Francisco, CA 94143 USA; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), Univ Toronto, Ontario Canc Inst, Dept Med Biophys, 610 Univ Ave,Rm 8-113, Toronto, ON M5G 2M9, Canada.	mwoo@uhnres.utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; Radziszewska, Ania/0000-0002-3885-3477; Penn, Linda/0000-0001-8133-5459; Hakem, Razqallah/0000-0001-5948-7931	Canadian Institutes for Health Research; Canadian Diabetes Association	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by grants from the Canadian Institutes for Health Research and the Canadian Diabetes Association (to M. W.).	Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Klefstrom J, 2002, J BIOL CHEM, V277, P43224, DOI 10.1074/jbc.M206967200; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li J, 2007, CARCINOGENESIS, V28, P1163, DOI 10.1093/carcin/bgm025; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Woo M, 1999, J IMMUNOL, V163, P4909; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Woo M, 2000, CELL RES, V10, P267, DOI 10.1038/sj.cr.7290054; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamada K, 1999, DIABETES, V48, P478, DOI 10.2337/diabetes.48.3.478; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245	50	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10947	10956		10.1074/jbc.M806960200	http://dx.doi.org/10.1074/jbc.M806960200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19213729	Green Published, hybrid			2022-12-25	WOS:000265104600067
J	Wang, J; Rajput, A; Kan, JLC; Rose, R; Liu, XQ; Kuropatwinski, K; Hauser, J; Beko, A; Dominquez, I; Sharratt, EA; Brattain, L; Levea, C; Sun, FL; Keane, DM; Gibson, NW; Brattain, MG				Wang, Jing; Rajput, Ashwani; Kan, Julie L. C.; Rose, Rebecca; Liu, Xiao-Qiong; Kuropatwinski, Karen; Hauser, Jennie; Beko, Alexander; Dominquez, Ivan; Sharratt, Elizabeth A.; Brattain, Lisa; LeVea, Charles; Sun, Feng-Lei; Keane, David M.; Gibson, Neil W.; Brattain, Michael G.			Knockdown of Ron Kinase Inhibits Mutant Phosphatidylinositol 3-Kinase and Reduces Metastasis in Human Colon Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MACROPHAGE-STIMULATING PROTEIN; GROWTH-FACTOR; COLORECTAL-CANCER; SCATTER-FACTOR; BREAST-CANCER; PIK3CA GENE; CELL-LINES; TIGHT JUNCTIONS; HIGH-FREQUENCY	Abnormal accumulation and activation of receptor tyrosine kinase Ron (recepteur d'origine nantais) has been demonstrated in a variety of primary human cancers. We show that RNA interference-mediated knockdown of Ron kinase in a highly tumorigenic colon cancer cell line led to reduced proliferation as compared with the control cells. Decreased Ron expression sensitized HCT116 cells to growth factor deprivation stress-induced apoptosis as reflected by increased DNA fragmentation and caspase 3 activation. In addition, cell motility was decreased in Ron knockdown cells as measured by wound healing assays and transwell assays. HCT116 cells are heterozygous for gain of function mutant PIK3CA H1047R. Analysis of signaling proteins that are affected by Ron knockdown revealed that phosphatidylinositol 3-kinase (PI3K) activity of the mutant PI3K as well as AKT phosphorylation was substantially reduced in the Ron knockdown cells compared with the control cells. Moreover, we demonstrated in vivo that knockdown of Ron expression significantly reduced lung metastasis as compared with the control cells in the orthotopic models. In summary, our results demonstrate that Ron plays an essential role in maintaining malignant phenotypes of colon cancer cells through regulating mutant PI3K activity. Therefore, targeting Ron kinase could be a potential strategy for colon cancer treatment, especially in patients bearing gain of function mutant PI3K activity.	[Wang, Jing; Liu, Xiao-Qiong; Brattain, Lisa; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Rajput, Ashwani] Univ New Mexico, Div Surg Oncol, Dept Surg, Albuquerque, NM 87131 USA; [Rose, Rebecca; Kuropatwinski, Karen; Hauser, Jennie; Beko, Alexander; Dominquez, Ivan; Sharratt, Elizabeth A.] Roswell Pk Canc Inst, Dept Pharm & Therapeut, Buffalo, NY 14263 USA; [LeVea, Charles] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Kan, Julie L. C.; Sun, Feng-Lei; Keane, David M.; Gibson, Neil W.] OSI Pharmaceut, Farmingdale, NY 11735 USA	University of Nebraska System; University of Nebraska Medical Center; University of New Mexico; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Astellas Pharmaceuticals; OSI Pharmaceuticals	Wang, J (corresponding author), 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu			National Institutes of Health [CA34432, CA54807]; Eppley Cancer Institute; Ralph Wilson Foundation; Buswell Research Foundation; NATIONAL CANCER INSTITUTE [R01CA034432, R01CA054807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eppley Cancer Institute; Ralph Wilson Foundation; Buswell Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA34432 and CA54807 (to M. G. B.) from the NCI. This work was also supported by a pilot project grant from Eppley Cancer Institute (to J. W.) and by grants from the Ralph Wilson Foundation and the Buswell Research Foundation (to A. R.).	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; BOYD DD, 1988, CANCER RES, V48, P2469; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cereijido M, 2000, AM J PHYSIOL-GASTR L, V279, pG477, DOI 10.1152/ajpgi.2000.279.3.G477; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Danilkovitch-Miagkova A, 2001, HISTOL HISTOPATHOL, V16, P623, DOI 10.14670/HH-16.623; DelBufalo D, 1997, FASEB J, V11, P947, DOI 10.1096/fasebj.11.12.9337147; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Greene F, 2002, CANC STAGING HDB, P127; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; LI BQ, 1995, BIOCHEM BIOPH RES CO, V216, P110, DOI 10.1006/bbrc.1995.2598; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu QP, 1999, J IMMUNOL, V163, P6606; Lowney JK, 1998, SURGERY, V124, P1043, DOI 10.1067/msy.1998.92561; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Morrow CJ, 2005, FEBS LETT, V579, P5123, DOI 10.1016/j.febslet.2005.07.096; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NAKANE PK, 1975, ANN NY ACAD SCI, V254, P203, DOI 10.1111/j.1749-6632.1975.tb29170.x; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Portera CA, 1998, SURG ONCOL, V7, P183, DOI 10.1016/S0960-7404(99)00020-1; RONSIN C, 1993, ONCOGENE, V8, P1195; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santoro MM, 2000, ONCOGENE, V19, P5208, DOI 10.1038/sj.onc.1203819; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang D, 2004, ONCOGENE, V23, P1668, DOI 10.1038/sj.onc.1207282; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang MH, 1996, ONCOGENE, V13, P2167; Wang MH, 1996, EXP CELL RES, V226, P39, DOI 10.1006/excr.1996.0200; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WOLMARK N, 1983, CANCER, V51, P1315, DOI 10.1002/1097-0142(19830401)51:7<1315::AID-CNCR2820510723>3.0.CO;2-0; Xiao ZQ, 2000, BIOCHEM BIOPH RES CO, V267, P669, DOI 10.1006/bbrc.1999.2011; Xu XM, 2004, ONCOGENE, V23, P8464, DOI 10.1038/sj.onc.1207907; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; ZARNEGAR R, 1989, CANCER RES, V49, P3314; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhou YQ, 2002, J BIOL CHEM, V277, P38104, DOI 10.1074/jbc.M206167200; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	65	69	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10912	10922		10.1074/jbc.M809551200	http://dx.doi.org/10.1074/jbc.M809551200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224914	Green Published, hybrid			2022-12-25	WOS:000265104600064
J	Kragh, CL; Lund, LB; Febbraro, F; Hansen, HD; Gai, WP; El-Agnaf, O; Richter-Landsberg, C; Jensen, PH				Kragh, Christine L.; Lund, Louise B.; Febbraro, Fabia; Hansen, Hanne D.; Gai, Wei-Ping; El-Agnaf, Omar; Richter-Landsberg, Christiane; Jensen, Poul Henning			alpha-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; UNFOLDED PROTEIN RESPONSE; PARKINSONS-DISEASE; INCLUSION FORMATION; RAT-BRAIN; CYTOPLASMIC INCLUSIONS; NEURONAL DEGENERATION; TYROSINE KINASE; SH-SY5Y CELLS; LEWY BODIES	Multiple system atrophy is a neurodegenerative disorder characterized by accumulation of aggregated Ser-129-phosphorylated alpha-synuclein in oligodendrocytes. p25 alpha is an oligodendroglial protein that potently stimulates alpha-synuclein aggregation in vitro. To model multiple system atrophy, we coexpressed human p25 alpha and alpha-synuclein in the rat oligodendroglial cell line OLN-93 and observed a cellular response characterized by a fast retraction of microtubules from the cellular processes to the perinuclear region followed by a protracted development of apoptosis. This response was dependent on phosphorylation at Ser-129 in alpha-synuclein as demonstrated by site-directed mutagenesis. Treatment of the cells with the kinase inhibitor 2-dimethylamino-4,5,6,7-tetrabromo-1H benzimidazole that targets kinases like casein kinase 2, and polo-like kinases abrogated the toxicity. The polo-like kinase inhibitor BI 2536 caused apoptosis in the model. Ser-129 phosphorylation was linked to the formation of phosphorylated oligomers detectable by immunoblotting, and their formation was inhibited by 2-dimethylamino-4,5,6,7-tetrabromo-1H benzimidazole. The process of microtubule retraction was also dependent on aggregation as demonstrated by the protective effect of treating the cells with the specific peptide inhibitor of alpha-synuclein aggregation ASI1D and the non-selective inhibitors Congo Red and baicalein. The fast microtubule retraction was followed by the development of the apoptotic markers: activated caspase-3, phosphatidylserine externalization, nuclear condensation, and fragmentation. These markers could all be blocked by the inhibitors of phosphorylation, aggregation, and caspase-3. Hence, the model predicts that both Ser-129 phosphorylation and aggregation control the toxic alpha-syn pathway in oligodendroglial cells and may represent therapeutic intervention points in multiple system atrophy.	[Kragh, Christine L.; Lund, Louise B.; Febbraro, Fabia; Hansen, Hanne D.; Jensen, Poul Henning] Univ Aarhus, Dept Biochem Med, DK-8000 Aarhus, Denmark; [Lund, Louise B.] Lundbeck AS, DK-2500 Copenhagen, Denmark; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Adelaide, SA 5042, Australia; [El-Agnaf, Omar] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany	Aarhus University; Lundbeck Corporation; Flinders University South Australia; United Arab Emirates University; Carl von Ossietzky Universitat Oldenburg	Jensen, PH (corresponding author), Univ Aarhus, Dept Biochem Med, Ole Worms 1170, DK-8000 Aarhus, Denmark.	phj@biokemi.au.dk	Febbraro, Fabia/AAO-9454-2020; Gai, Wei-Ping/A-3700-2008; Hansen, Hanne Demant/C-9029-2013; Febbraro, Fabia/G-9097-2016	Hansen, Hanne Demant/0000-0001-5564-7627; Jensen, Poul Henning/0000-0002-4439-9020; Febbraro, Fabia/0000-0001-8336-2776	Lundbeck Foundation, Danish Research Council for Health and Disease [271-05-0166]; Aarhus University Research Foundation; Danish Parkinson's Disease Foundation; Wacherhausen Foundation; National Health and Medical Research Council [275528]; Nordic Center of Excellence for Neurodegenerative Disorders; Foundation of 2/7-1984; innovation consortium CureND	Lundbeck Foundation, Danish Research Council for Health and Disease(Lundbeckfonden); Aarhus University Research Foundation; Danish Parkinson's Disease Foundation; Wacherhausen Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nordic Center of Excellence for Neurodegenerative Disorders; Foundation of 2/7-1984; innovation consortium CureND	This work was supported by the Lundbeck Foundation, Danish Research Council for Health and Disease Grant 271-05-0166, the Aarhus University Research Foundation, The Danish Parkinson's Disease Foundation, Wacherhausen Foundation, National Health and Medical Research Council Grant 275528, Nordic Center of Excellence for Neurodegenerative Disorders, the Foundation of 2/7-1984 to Treatment of Parkinson's Disease, and the innovation consortium CureND.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feldman JD, 1998, J NEUROSCI RES, V53, P502, DOI 10.1002/(SICI)1097-4547(19980815)53:4<502::AID-JNR13>3.0.CO;2-3; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gai WP, 1999, J NEUROCHEM, V73, P2093; Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066; Goldbaum O, 2003, J NEUROSCI, V23, P8872; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hirsch C, 2006, TRENDS CELL BIOL, V16, P657, DOI 10.1016/j.tcb.2006.10.006; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; JAYASURIYA H, 1992, J NAT PROD, V55, P696, DOI 10.1021/np50083a026; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Oda T, 2008, NEUROSCI RES, V60, P29, DOI 10.1016/j.neures.2007.09.005; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Omri B, 1998, ONCOGENE, V16, P2351, DOI 10.1038/sj.onc.1201761; Omri B, 1996, J NEUROCHEM, V67, P1360; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Troy CM, 2002, J NEUROSCI RES, V69, P145, DOI 10.1002/jnr.10294; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wakabayashi K, 2006, NEUROPATHOLOGY, V26, P338, DOI 10.1111/j.1440-1789.2006.00713.x; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200; Zhu XW, 2000, NEUROBIOL AGING, V21, P807, DOI 10.1016/S0197-4580(00)00217-7	77	105	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10211	10222		10.1074/jbc.M809671200	http://dx.doi.org/10.1074/jbc.M809671200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203998	Green Published, hybrid			2022-12-25	WOS:000264892900063
J	Covian, R; Trumpower, BL				Covian, Raul; Trumpower, Bernard L.			Ilicicolin Inhibition and Binding at Center N of the Dimeric Cytochrome bc(1) Complex Reveal Electron Transfer and Regulatory Interactions between Monomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION; SACCHAROMYCES-CEREVISIAE; MECHANISM; PURIFICATION; ANTIMYCIN; MUTANTS; SITES; HEMES	We have determined the kinetics of ilicicolin binding and dissociation at center N of the yeast bc(1) complex and its effect on the reduction of cytochrome b with center P blocked. The addition of ilicicolin to the oxidized complex resulted in a non-linear inhibition of the extent of cytochrome b reduction by quinol together with a shift of the reduced b(H) heme spectrum, indicating electron transfer between monomers. The possibility of a fast exchange of ilicicolin between center N sites was excluded in two ways. First, kinetic modeling showed that fast movement of an inhibitor between monomers would result in a linear inhibition of the extent of cytochrome b reduction through center N. Second, we determined a very slow dissociation rate for ilicicolin (k = 1.2 x 10(-3) s(-1)) as calculated from its displacement by antimycin. Ilicicolin binding to the reduced bc1 complex occurred in a single phase (k(on) = 1.5-1.7 x 10(5) M-1 s(-1)) except in the presence of stigmatellin, where a second slower binding phase comprising similar to 50% of the spectral change was observed. This second kinetic event was weakly dependent on ilicicolin concentration, which suggests that binding of ilicicolin to one center N in the dimer transmits a slow (k = 2-3 s(-1)) conformational change that allows binding of the inhibitor in the other monomer. These results, together with the evidence for inter-monomeric electron transfer, provide further support for a dimeric model of regulatory interactions between center P and center N sites in the bc1 complex.	[Covian, Raul; Trumpower, Bernard L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020379, R37GM020379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 20379. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BECHMANN G, 1992, EUR J BIOCHEM, V208, P315, DOI 10.1111/j.1432-1033.1992.tb17189.x; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Covian R, 2005, J BIOL CHEM, V280, P22732, DOI 10.1074/jbc.M413592200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1044, DOI 10.1016/j.bbabio.2008.04.008; Covian R, 2007, J BIOL CHEM, V282, P24198, DOI 10.1074/jbc.M700662200; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Ding MG, 2006, J BIOL CHEM, V281, P36036, DOI 10.1074/jbc.M608026200; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; KAMENSKY Y, 1985, FEBS LETT, V181, P95, DOI 10.1016/0014-5793(85)81120-0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LENEFSKY EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; RICH PR, 1990, BIOCHIM BIOPHYS ACTA, V1018, P29, DOI 10.1016/0005-2728(90)90106-E; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; Shinkarev VP, 2007, FEBS LETT, V581, P1535, DOI 10.1016/j.febslet.2007.03.037; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	29	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8605	8611		10.1074/jbc.M808914200	http://dx.doi.org/10.1074/jbc.M808914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176478	Green Published, hybrid			2022-12-25	WOS:000264397800045
J	Sussman, M; Mieog, JC; Doyle, J; Victor, S; Willis, BL; Bourne, DG				Sussman, Meir; Mieog, Jos C.; Doyle, Jason; Victor, Steven; Willis, Bette L.; Bourne, David G.			Vibrio Zinc-Metalloprotease Causes Photoinactivation of Coral Endosymbionts and Coral Tissue Lesions	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OUTER ENVELOPE MEMBRANE; POCILLOPORA-DAMICORNIS; HEMAGGLUTININ PROTEASE; PHOTOSYSTEM-II; CLIMATE-CHANGE; SP-NOV.; VULNIFICUS METALLOPROTEASE; ELEVATED-TEMPERATURES; YELLOW BLOTCH/BAND	Background: Coral diseases are emerging as a serious threat to coral reefs worldwide. Of nine coral infectious diseases, whose pathogens have been characterized, six are caused by agents from the family Vibrionacae, raising questions as to their origin and role in coral disease aetiology. Methodology/Principal Findings: Here we report on a Vibrio zinc-metalloprotease causing rapid photoinactivation of susceptible Symbiodinium endosymbionts followed by lesions in coral tissue. Symbiodinium photosystem II inactivation was diagnosed by an imaging pulse amplitude modulation fluorometer in two bioassays, performed by exposing Symbiodinium cells and coral juveniles to non-inhibited and EDTA-inhibited supernatants derived from coral white syndrome pathogens. Conclusion/Significance: These findings demonstrate a common virulence factor from four phylogenetically related coral pathogens, suggesting that zinc-metalloproteases may play an important role in Vibrio pathogenicity in scleractinian corals.	[Sussman, Meir; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Sussman, Meir; Mieog, Jos C.; Doyle, Jason; Bourne, David G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Mieog, Jos C.] AIMS, Townsville, Qld, Australia; [Victor, Steven] Univ Groningen, Biol Ctr, Dept Marine Bent Ecol & Evolut, Haren, Netherlands; PICRC, Koror, Palau	James Cook University; James Cook University; Australian Institute of Marine Science; University of Groningen	Sussman, M (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	dsmb007@jcu.edu.au	Bourne, David G/B-5073-2008; Mieog, Jos/N-6522-2014; Mieog, Jos/AAV-3371-2021	Bourne, David G/0000-0002-1492-8710; Mieog, Jos/0000-0002-2153-8956; Mieog, Jos/0000-0002-2153-8956	ARC [Discovery grant]; James Cook University CRIG; NWO-WOTRO [W84-576]; Australian Institute of Marine Science	ARC(Australian Research Council); James Cook University CRIG; NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Australian Institute of Marine Science	This study was funded by an ARC Discovery grant and a James Cook University CRIG grant to BL Willis. JC Mieog was supported by a NWO-WOTRO grant (the Netherlands, project nr. W84-576). Work at the Cape Ferguson laboratories was supported by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguirre-Guzman G, 2004, AQUAC RES, V35, P1395, DOI 10.1111/j.1365-2109.2004.01165.x; Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony SL, 2008, DIS AQUAT ORGAN, V81, P255, DOI 10.3354/dao01962; Asada K, 1996, PHOTOSYNTHESIS ENV, P123, DOI DOI 10.1007/0-306-48135-9_5; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barash Y, 2005, AQUAT MICROB ECOL, V40, P183, DOI 10.3354/ame040183; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BOOTH BA, 1983, INFECT IMMUN, V42, P639, DOI 10.1128/IAI.42.2.639-644.1983; BOOTH BA, 1986, J INFECT DIS, V154, P183, DOI 10.1093/infdis/154.1.183; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Breitbart M, 2005, FEMS MICROBIOL LETT, V243, P431, DOI 10.1016/j.femsle.2005.01.004; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cervino JM, 2004, SYMBIOSIS, V37, P63; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; CROWTHER RS, 1987, BIOCHIM BIOPHYS ACTA, V924, P393, DOI 10.1016/0304-4165(87)90153-X; Denkin SM, 1999, APPL ENVIRON MICROB, V65, P3555; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; EGIDIUS E, 1987, AQUACULTURE, V67, P15, DOI 10.1016/0044-8486(87)90004-4; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOW S, 1988, REV INFECT DIS, V10, pS274; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P3432, DOI 10.1021/bi00228a012; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Foulongne V, 2004, PATHOL BIOL, V52, P104, DOI 10.1016/j.patbio.2003.06.001; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; Goarant C, 1998, AQUACULTURE, V169, P291, DOI 10.1016/S0044-8486(98)00380-9; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Havaux M, 2003, PLANT PHYSIOL, V132, P300, DOI 10.1104/pp.102.017178; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; JOYARD J, 1983, J BIOL CHEM, V258, P1; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kimura MA, 1985, NEUTRAL THEORY MOL E; KOCH R, 1891, BAKT FORSCH VERH 10; KOTHARY MH, 1985, INFECT IMMUN, V50, P534, DOI 10.1128/IAI.50.2.534-540.1985; KUOKAU L, 1997, CURR MICROBIOL, V34, P110; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LARSEN KS, 1991, BIOCHEMISTRY-US, V30, P2613, DOI 10.1021/bi00224a007; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Miyoshi S, 2001, TOXICON, V39, P1883, DOI 10.1016/S0041-0101(01)00171-4; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Murray AG, 2009, PREV VET MED, V88, P167, DOI 10.1016/j.prevetmed.2008.09.006; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; OLIVER JD, 1986, DIAGN MICR INFEC DIS, V5, P99, DOI 10.1016/0732-8893(86)90112-4; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Piskorska M, 2007, AFRICAN J ENV SCI TE, V1, P93; Pochon X, 2001, MAR BIOL, V139, P1069; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Retief J D, 2000, Methods Mol Biol, V132, P243; Roff G, 2008, J PHYCOL, V44, P526, DOI 10.1111/j.1529-8817.2008.00480.x; Rosenberg E, 2004, ANNU REV MICROBIOL, V58, P143, DOI 10.1146/annurev.micro.58.030603.123610; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosenberg E, 2009, ISME J, V3, P139, DOI 10.1038/ismej.2008.104; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santiago-Vazquez LZ, 2007, MAR BIOL, V152, P549, DOI 10.1007/s00227-007-0704-2; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; SCHREIBER E., 1927, WISS MEERESUNTERSUCH ABT HELGOLAND, V16, P1; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; Schroda M, 1999, PLANT CELL, V11, P1165, DOI 10.1105/tpc.11.6.1165; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2006, DIS AQUAT ORGAN, V69, P111, DOI 10.3354/dao069111; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; UTZ JP, 1962, LAB INVEST, V11, P1018; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P2617, DOI 10.1098/rspb.2001.2007; VANOPPEN MJ, 2001, P BIOL SCI, V1478, P1759; Varina M, 2008, J BACTERIOL, V190, P6589, DOI 10.1128/JB.00535-08; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; WOO PTK, 1999, FISH DIS DISORDERS, V3; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yoshida Takashi, 2003, Microbes and Environments, V18, P216, DOI 10.1264/jsme2.18.216; [No title captured]	136	73	74	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4511	10.1371/journal.pone.0004511	http://dx.doi.org/10.1371/journal.pone.0004511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225559	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000265486000003
J	Hnasko, R; Bruederle, CE				Hnasko, Robert; Bruederle, Cathrin E.			Inoculation of Scrapie with the Self-Assembling RADA-Peptide Disrupts Prion Accumulation and Extends Hamster Survival	PLOS ONE			English	Article							NANOFIBER SCAFFOLD; LAMININ RECEPTOR; TRANSGENIC MICE; BETA-SHEET; CONGO RED; PROTEIN; PRP; INHIBITION; PROPAGATION; CONVERSION	Intracerebral inoculation of 263K Scrapie brain homogenate (PrPsc) with a self-assembling RADA-peptide (RADA) significantly delayed disease onset and increased hamster survival. Time of survival was dependent on the dose of RADA and pre-incubation with PrPsc prior to inoculation. RADA treatment resulted in the absence of detectable PrPsc at 40 d followed by an increased rate of PrPsc accumulation at 75 d up to sacrifice. In all PrPsc inoculated animals, clinical symptoms were observed similar to 10 d prior to sacrifice and brains showed spongiform degeneration with Congo red positive plaques. A time-dependent increase in reactive gliosis was observed in both groups with more GFAP detected in RADA treated animals at all time points. The PrP protein showed dose-dependent binding to RADA and this binding was competitively inhibited by Congo Red. We conclude that RADA disrupts the efficacy of prion transmission by altering the rate of PrPsc accumulation. This is the first demonstration that a self-assembling biomolecular peptide can interact with PrPsc, disrupt the course of Scrapie disease process, and extend survival.	[Hnasko, Robert; Bruederle, Cathrin E.] USDA ARS, PWA, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA	United States Department of Agriculture (USDA)	Hnasko, R (corresponding author), USDA ARS, PWA, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA.	Robert.Hnasko@ars.usda.gov			USDA-ARS National Program in AnimalHealth [5325-32000-008-00D]	USDA-ARS National Program in AnimalHealth	This work was supported and administered under the USDA-ARS National Program in AnimalHealth (CRIS # 5325-32000-008-00D). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funding agency has approved the publication of this manuscript.	BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Caspi S, 1998, J BIOL CHEM, V273, P3484, DOI 10.1074/jbc.273.6.3484; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DE GL, 1994, J BIOL CHEM, V269, P7859; DEARMOND SJ, 1994, PHILOS T R SOC B, V343, P415, DOI 10.1098/rstb.1994.0038; DeArmond SJ, 2003, CLIN LAB MED, V23, P1, DOI 10.1016/S0272-2712(02)00041-0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Demaimay R, 1998, J NEUROCHEM, V71, P2534; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Lu X, 2006, CURR PHARM DESIGN, V12, P2749, DOI 10.2174/138161206777947713; Ludewigs H, 2007, EXPERT REV ANTI-INFE, V5, P613, DOI 10.1586/14787210.5.4.613; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roterman I, 2001, Med Sci Monit, V7, P771; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Scott MR, 2000, ARCH VIROL, P113; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23; Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a	41	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4440	10.1371/journal.pone.0004440	http://dx.doi.org/10.1371/journal.pone.0004440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212437	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484200006
J	Singh, A; Mohan, ML; Isaac, AO; Luo, X; Petrak, J; Vyoral, D; Singh, N				Singh, Ajay; Mohan, Maradumane L.; Isaac, Alfred Orina; Luo, Xiu; Petrak, Jiri; Vyoral, Daniel; Singh, Neena			Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NEURONAL PRP; COPPER; TRAFFICKING; MECHANISMS; BRAIN; REPLICATION; TRANSFERRIN; ENDOCYTOSIS; INSIGHTS	Converging evidence leaves little doubt that a change in the conformation of prion protein (PrPC) from a mainly alpha-helical to a beta-sheet rich PrP-scrapie (PrPSc) form is the main event responsible for prion disease associated neurotoxicity. However, neither the mechanism of toxicity by PrPSc, nor the normal function of PrPC is entirely clear. Recent reports suggest that imbalance of iron homeostasis is a common feature of prion infected cells and mouse models, implicating redox-iron in prion disease pathogenesis. In this report, we provide evidence that PrPC mediates cellular iron uptake and transport, and mutant PrP forms alter cellular iron levels differentially. Using human neuroblastoma cells as models, we demonstrate that over-expression of PrPC increases intra-cellular iron relative to non-transfected controls as indicated by an increase in total cellular iron, the cellular labile iron pool (LIP), and iron content of ferritin. As a result, the levels of iron uptake proteins transferrin (Tf) and transferrin receptor (TfR) are decreased, and expression of iron storage protein ferritin is increased. The positive effect of PrPC on ferritin iron content is enhanced by stimulating PrPC endocytosis, and reversed by cross-linking PrPC on the plasma membrane. Expression of mutant PrP forms lacking the octapeptide-repeats, the membrane anchor, or carrying the pathogenic mutation PrP102L decreases ferritin iron content significantly relative to PrPC expressing cells, but the effect on cellular LIP and levels of Tf, TfR, and ferritin is complex, varying with the mutation. Neither PrPC nor the mutant PrP forms influence the rate or amount of iron released into the medium, suggesting a functional role for PrPC in cellular iron uptake and transport to ferritin, and dysfunction of PrPC as a significant contributing factor of brain iron imbalance in prion disorders.	[Singh, Ajay; Mohan, Maradumane L.; Isaac, Alfred Orina; Luo, Xiu; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Petrak, Jiri; Vyoral, Daniel] Charles Univ Prague, Fac Med 1, Dept Pathol Physiol, CR-11636 Prague, Czech Republic	Case Western Reserve University; Charles University Prague	Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Petrak, Jiri/I-8950-2017; Isaac, Alfred Orina/AEO-1445-2022; Mohan, Maradumane L/F-4700-2013	Petrak, Jiri/0000-0002-8695-4803; Isaac, Alfred Orina/0000-0003-3338-2239; 	NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039089, R29NS035962, R01NS035962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding source, NIH. Sponsor had no role at all in the study.	Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Choi CJ, 2007, TOXICOL SCI, V98, P495, DOI 10.1093/toxsci/kfm099; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Erel O, 1998, CLIN CHEM, V44, P2313; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hur K, 2002, MECH AGEING DEV, V123, P1637, DOI 10.1016/S0047-6374(02)00099-4; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim NH, 2000, BRAIN RES, V884, P98, DOI 10.1016/S0006-8993(00)02907-3; Liu XF, 2005, ANN NY ACAD SCI, V1054, P136, DOI 10.1196/annals.1345.016; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Petrak JF, 2001, J INORG BIOCHEM, V86, P669, DOI 10.1016/S0162-0134(01)00232-X; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; SINGH A, 2009, PLOS PATHOG IN PRESS; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Tenopoulou M, 2007, BIOCHEM J, V403, P261, DOI 10.1042/BJ20061840; Vyoral D, 1998, BIOL TRACE ELEM RES, V61, P263, DOI 10.1007/BF02789087; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zivny JH, 2008, BLOOD CELL MOL DIS, V40, P302, DOI 10.1016/j.bcmd.2007.09.009	45	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4468	10.1371/journal.pone.0004468	http://dx.doi.org/10.1371/journal.pone.0004468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212444	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484200016
J	Miao, W; Xiong, J; Bowen, J; Wang, W; Liu, YF; Braguinets, O; Grigull, J; Pearlman, RE; Orias, E; Gorovsky, MA				Miao, Wei; Xiong, Jie; Bowen, Josephine; Wang, Wei; Liu, Yifan; Braguinets, Olga; Grigull, Jorg; Pearlman, Ronald E.; Orias, Eduardo; Gorovsky, Martin A.			Microarray Analyses of Gene Expression during the Tetrahymena thermophila Life Cycle	PLOS ONE			English	Article								Background: The model eukaryote, Tetrahymena thermophila, is the first ciliated protozoan whose genome has been sequenced, enabling genome-wide analysis of gene expression. Methodology/Principal Findings: A genome-wide microarray platform containing the predicted coding sequences (putative genes) for T. thermophila is described, validated and used to study gene expression during the three major stages of the organism's life cycle: growth, starvation and conjugation. Conclusions/Significance: Of the,27,000 predicted open reading frames, transcripts homologous to only,5900 are not detectable in any of these life cycle stages, indicating that this single-celled organism does indeed contain a large number of functional genes. Transcripts from over 5000 predicted genes are expressed at levels >5x corrected background and 95 genes are expressed at >250x corrected background in all stages. Transcripts homologous to 91 predicted genes are specifically expressed and 155 more are highly up-regulated in growing cells, while 90 are specifically expressed and 616 are up-regulated during starvation. Strikingly, transcripts homologous to 1068 predicted genes are specifically expressed and 1753 are significantly up-regulated during conjugation. The patterns of gene expression during conjugation correlate well with the developmental stages of meiosis, nuclear differentiation and DNA elimination. The relationship between gene expression and chromosome fragmentation is analyzed. Genes encoding proteins known to interact or to function in complexes show similar expression patterns, indicating that co-ordinate expression with putative genes of known function can identify genes with related functions. New candidate genes associated with the RNAi-like process of DNA elimination and with meiosis are identified and the late stages of conjugation are shown to be characterized by specific expression of an unexpectedly large and diverse number of genes not involved in nuclear functions.	[Miao, Wei; Bowen, Josephine; Wang, Wei; Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Miao, Wei; Xiong, Jie] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Wang, Wei] Shanxi Univ, Inst Biotechnol, Taiyuan, Peoples R China; [Liu, Yifan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Braguinets, Olga; Pearlman, Ronald E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, N York, ON M3J 1P3, Canada; [Orias, Eduardo] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA USA	University of Rochester; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Shanxi University; University of Michigan System; University of Michigan; York University - Canada; York University - Canada; University of California System; University of California Santa Barbara	Miao, W (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	miaowei530@yeah.net; goro@mail.rochester.edu		Xiong, Jie/0000-0001-8923-0424; miao, wei/0000-0003-3440-8322; Liu, Yifan/0000-0002-3896-0002	National Institutes of Health [GM021793, GM072752]; Projects of International Cooperation from the Ministry of Science and Technology of China [2006DFA31960]; Natural Sciences Foundation of China [30670298]; NCRR (NIH) [RR009231]; University of California Toxic Substance Research and Teaching Program [SB060007]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072752, R01GM021793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Projects of International Cooperation from the Ministry of Science and Technology of China; Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NCRR (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of California Toxic Substance Research and Teaching Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM021793 and GM072752 to M.G., and Projects of International Cooperation from the Ministry of Science and Technology of China (No.2006DFA31960) and Natural Sciences Foundation of China (No.30670298) to W. M. E.O. was supported by NCRR (NIH) grant RR009231 and a University of California Toxic Substance Research and Teaching Program grant, SB060007. R.E.P. was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng035; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Asai DJ, 2000, METHODS CELL BIOL; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borst P, 1998, MOL BIOCHEM PARASIT, V91, P67, DOI 10.1016/S0166-6851(97)00184-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BRUNS PJ, 1974, J EXP ZOOL, V188, P337, DOI 10.1002/jez.1401880309; BRUNS PJ, 1975, DEV BIOL, V42, P75, DOI 10.1016/0012-1606(75)90315-2; CALZONE FJ, 1983, J BIOL CHEM, V258, P6887; CassidyHanley D, 1997, GENETICS, V146, P135; Cole ES, 1997, DEV BIOL, V189, P215, DOI 10.1006/dbio.1997.8648; Coyne RS, 1996, GENETICS, V144, P1479; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fan QC, 2000, METHOD CELL BIOL, V62, P533; Feng LF, 2007, AQUAT TOXICOL, V81, P99, DOI 10.1016/j.aquatox.2006.11.005; FINLEY MJ, 1980, DEV BIOL, V79, P81, DOI 10.1016/0012-1606(80)90074-3; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Frankel J, 2000, METHOD CELL BIOL, V62, P27; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; GAERTIG J, 1993, CELL MOTIL CYTOSKEL, V25, P243, DOI 10.1002/cm.970250305; GIBBONS IR, 1963, P NATL ACAD SCI USA, V50, P1002, DOI 10.1073/pnas.50.5.1002; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guerra RF, 2007, BIOPHYS J, V93, P176, DOI 10.1529/biophysj.106.099929; Hamilton EP, 2006, GENOMICS, V88, P443, DOI 10.1016/j.ygeno.2006.05.002; Hamilton EP, 2006, EUKARYOT CELL, V5, P771, DOI 10.1128/EC.5.4.771-780.2006; HOROWITZ S, 1985, P NATL ACAD SCI USA, V82, P2452, DOI 10.1073/pnas.82.8.2452; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenuwein H, 2002, SCIENCE, V297, P2215, DOI 10.1126/science.1077903; KAPLER GM, 1994, GENETICS, V137, P455; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Li SQ, 2006, DEV BIOL, V295, P633, DOI 10.1016/j.ydbio.2006.03.048; Liu YF, 2005, EUKARYOT CELL, V4, P421, DOI 10.1128/EC.4.2.421-431.2005; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; MARTINDALE DW, 1982, EXP CELL RES, V140, P227, DOI 10.1016/0014-4827(82)90172-0; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Miao W, 2006, ENVIRON MICROBIOL, V8, P1122, DOI 10.1111/j.1462-2920.2006.00988.x; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, EUKARYOT CELL, V3, P1233, DOI 10.1128/EC.3.5.1233-1240.2004; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2008, J CELL SCI, V121, P2148, DOI 10.1242/jcs.031799; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; NELSEN EM, 1978, J PROTOZOOL, V25, P113, DOI 10.1111/j.1550-7408.1978.tb03880.x; NELSEN EM, 1978, DEV BIOL, V66, P17, DOI 10.1016/0012-1606(78)90270-1; Nikiforov MA, 1999, GENE DEV, V13, P2852, DOI 10.1101/gad.13.21.2852; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Orias E, 2000, J EUKARYOT MICROBIOL, V47, P328, DOI 10.1111/j.1550-7408.2000.tb00057.x; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Shrimali RK, 2005, BIOCHEM BIOPH RES CO, V329, P147, DOI 10.1016/j.bbrc.2005.01.120; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smothers JF, 1997, DEVELOPMENT, V124, P4537; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P180, DOI 10.1093/nar/22.2.180; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Udani RA, 2002, MECH DEVELOP, V118, P215, DOI 10.1016/S0925-4773(02)00259-9; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Wei Z, 2006, DEV BIOL, V300, P476, DOI 10.1016/j.ydbio.2006.08.034; Weinstein JN, 2008, SCIENCE, V319, P1772, DOI 10.1126/science.1151888; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; YAO MC, 1987, CELL, V48, P779, DOI 10.1016/0092-8674(87)90075-4; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	82	137	160	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4429	10.1371/journal.pone.0004429	http://dx.doi.org/10.1371/journal.pone.0004429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204800	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484000015
J	Xiang, J; Yang, HB; Che, C; Zou, HX; Yang, HS; Wei, YQ; Quan, JM; Zhang, H; Yang, Z; Lin, S				Xiang, Jing; Yang, Hongbo; Che, Chao; Zou, Haixia; Yang, Hanshuo; Wei, Yuquan; Quan, Junmin; Zhang, Hui; Yang, Zhen; Lin, Shuo			Identifying Tumor Cell Growth Inhibitors by Combinatorial Chemistry and Zebrafish Assays	PLOS ONE			English	Article								Cyclin-dependent kinases (CDKs) play important roles in regulating cell cycle progression, and altered cell cycles resulting from over-expression or abnormal activation of CDKs observed in many human cancers. As a result, CDKs have become extensive studied targets for developing chemical inhibitors for cancer therapies; however, protein kinases share a highly conserved ATP binding pocket at which most chemical inhibitors bind, therefore, a major challenge in developing kinase inhibitors is achieving target selectivity. To identify cell growth inhibitors with potential applications in cancer therapy, we used an integrated approach that combines one-pot chemical synthesis in a combinatorial manner to generate diversified small molecules with new chemical scaffolds coupled with growth inhibition assay using developing zebrafish embryos. We report the successful identification of a novel lead compound that displays selective inhibitory effects on CDK2 activity, cancer cell proliferation, and tumor progression in vivo. Our approaches should have general applications in developing cell proliferation inhibitors using an efficient combinatorial chemical genetic method and integrated biological assays. The novel cell growth inhibitor we identified should have potential as a cancer therapeutic agent.	[Zou, Haixia; Yang, Zhen] Peking Univ, Coll Chem, Key Lab Bioorgan Chem & Mol Engn, Minist Educ, Beijing 100871, Peoples R China; [Xiang, Jing; Che, Chao; Zou, Haixia; Quan, Junmin; Zhang, Hui; Yang, Zhen; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen, Peoples R China; [Yang, Hongbo; Lin, Shuo] Peking Univ, Minist Educ, Coll Life Sci, Ctr Dev Biol & Genet, Beijing, Peoples R China; [Yang, Hanshuo; Wei, Yuquan] Sichuan Univ, W China Med Sch, W China Hosp, Biotherapy & Canc Ctr, State Key Lab, Chengdu, Peoples R China; [Zhang, Hui] Nevada Canc Inst, Las Vegas, NV USA; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol, Cell, & Dev Biol, Los Angeles, CA 90024 USA	Peking University; Peking University; University Town of Shenzhen; Peking University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Xiang, J (corresponding author), Peking Univ, Coll Chem, Key Lab Bioorgan Chem & Mol Engn, Minist Educ, Beijing 100871, Peoples R China.	zyang@pku.edu.cn; shuolin@ucla.edu	Yang, Zhen/J-6306-2015	Yang, Zhen/0000-0001-8036-934X; Che, Chao/0000-0001-7773-0907	National Science Foundation of China [20325208, 20225318, 20521202, 20672004]; Ministry of Education of China (985 program); Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China (985 program)(Ministry of Education, China); Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University	National Science Foundation of China (Grants 20325208, 20225318, 20521202, and 20672004), the Ministry of Education of China (985 program), Shenzhen Science and Technology Key Laboratory Promotion Fund, and the Instrumental Analysis Fund of Peking University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; Armstrong RW, 1996, ACCOUNTS CHEM RES, V29, P123, DOI 10.1021/ar9502083; Balme G, 2003, EUR J ORG CHEM, V2003, P4101, DOI 10.1002/ejoc.200300378; Bienayme H, 1998, ANGEW CHEM INT EDIT, V37, P2234, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R; Bienayme H, 2000, CHEM-EUR J, V6, P3321, DOI 10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO;2-A; Byth KF, 2004, BIOORG MED CHEM LETT, V14, P2249, DOI 10.1016/j.bmcl.2004.02.008; Cantrell CL, 1999, NAT PROD LETT, V14, P39, DOI 10.1080/10575639908045433; CHE C, 2007, J COMB CHEM; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FANTL V, 1993, CANCER SURV, V18, P77; Fischer PM, 2000, CURR MED CHEM, V7, P1213, DOI 10.2174/0929867003374048; Hardcastle IR, 2004, J MED CHEM, V47, P3710, DOI 10.1021/jm0311442; Hirai H, 2005, CURR TOP MED CHEM, V5, P167, DOI 10.2174/1568026053507688; Huwe A, 2003, ANGEW CHEM INT EDIT, V42, P2122, DOI 10.1002/anie.200200540; Kato N, 2003, J CANCER RES CLIN, V129, P222, DOI 10.1007/s00432-003-0426-x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lemeer S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000581; Lonardo F, 1999, CANCER RES, V59, P2470; Luk KC, 2004, BIOORG MED CHEM LETT, V14, P913, DOI 10.1016/j.bmcl.2003.12.009; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McMahon G, 1998, Curr Opin Drug Discov Devel, V1, P131; Meijer L, 1999, PHARMACOL THERAPEUT, V82, P279, DOI 10.1016/S0163-7258(98)00057-6; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nicolaou KC, 2003, CHEM COMMUN, P551, DOI 10.1039/b209440c; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pevarello P, 2004, J MED CHEM, V47, P3367, DOI 10.1021/jm031145u; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sharma V, 2004, J MED CHEM, V47, P3700, DOI 10.1021/jm040013d; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sielecki TM, 2000, J MED CHEM, V43, P1, DOI 10.1021/jm990256j; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; SUMANAS S, 2004, TARGET; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tang J, 2003, BIOORG MED CHEM LETT, V13, P2985, DOI 10.1016/S0960-894X(03)00630-9; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WOLOWIEC D, 1995, LEUKEMIA, V9, P1382; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129; Zhu JP, 2003, EUR J ORG CHEM, V2003, P1133, DOI 10.1002/ejoc.200390167	49	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4361	10.1371/journal.pone.0004361	http://dx.doi.org/10.1371/journal.pone.0004361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194508	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483600006
J	Battaglia, S; Benzoubir, N; Nobilet, S; Charneau, P; Samuel, D; Zignego, AL; Atfi, A; Brechot, C; Bourgeade, MF				Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Charneau, Pierre; Samuel, Didier; Zignego, Anna Linda; Atfi, Azeddine; Brechot, Christian; Bourgeade, Marie-Francoise			Liver Cancer-Derived Hepatitis C Virus Core Proteins Shift TGF-Beta Responses from Tumor Suppression to Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Background: Chronic hepatitis C virus (HCV) infection and associated liver cirrhosis represent a major risk factor for hepatocellular carcinoma (HCC) development. TGF-beta is an important driver of liver fibrogenesis and cancer; however, its actual impact in human cancer progression is still poorly known. The aim of this study was to investigate the role of HCC-derived HCV core natural variants on cancer progression through their impact on TGF-beta signaling. Principal Findings: We provide evidence that HCC-derived core protein expression in primary human or mouse hepatocyte alleviates TGF-beta responses in terms or growth inhibition or apoptosis. Instead, in these hepatocytes TGF-beta was still able to induce an epithelial to mesenchymal transition (EMT), a process that contributes to the promotion of cell invasion and metastasis. Moreover, we demonstrate that different thresholds of Smad3 activation dictate the TGF-beta responses in hepatic cells and that HCV core protein, by decreasing Smad3 activation, may switch TGF-beta growth inhibitory effects to tumor promoting responses. Conclusion/Significance: Our data illustrate the capacity of hepatocytes to develop EMT and plasticity under TGF-beta, emphasize the role of HCV core protein in the dynamic of these effects and provide evidence for a paradigm whereby a viral protein implicated in oncogenesis is capable to shift TGF-beta responses from cytostatic effects to EMT development.	[Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Samuel, Didier; Brechot, Christian; Bourgeade, Marie-Francoise] INSERM, U 785, Villejuif, France; [Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Samuel, Didier; Bourgeade, Marie-Francoise] Univ Paris Sud, UMR S 785, Villejuif, France; [Charneau, Pierre] Inst Pasteur, Grp Vectorol, Paris, France; [Samuel, Didier; Bourgeade, Marie-Francoise] AP HP, Hop Paul Brousse, Ctr Hepato Biliaire, Villejuif, France; [Zignego, Anna Linda] Univ Florence, Dept Internal Med, I-50121 Florence, Italy; [Atfi, Azeddine] INSERM, U 673, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm)	Battaglia, S (corresponding author), INSERM, U 785, Villejuif, France.	marion.bourgeade@inserm.fr	CHARNEAU, Pierre/M-1565-2017; Ibrahim, Essam Hassan/G-1960-2018; Zignego, Anna Linda/AAL-8205-2021	CHARNEAU, Pierre/0000-0003-1184-5773; Ibrahim, Essam Hassan/0000-0003-0130-2257; BENZOUBIR, Nassima/0000-0001-7502-7441	INSERM; Association pour la Recherche sur le Cancer (ARC); Agence Nationale de Recherche sur le SIDA (ANRS); European Community (VIRGIL)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); European Community (VIRGIL)(European Commission)	This work was supported by INSERM, Association pour la Recherche sur le Cancer (ARC), Agence Nationale de Recherche sur le SIDA (ANRS) and European Community (VIRGIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; BAUM B, 2008, SEMIN CELL DEV BIOL; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Delhem N, 2001, ONCOGENE, V20, P5836, DOI 10.1038/sj.onc.1204744; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Giannini C, 2003, HEPATOLOGY, V38, P114, DOI 10.1053/jhep.2003.50265; GRESSNER OA, 2008, J GASTROENTEROL HEPA; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368; Lai MMC, 2000, CURR TOP MICROBIOL, V242, P117; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McIntyre M, 1999, ONCOGENE, V18, P4577, DOI 10.1038/sj.onc.1202815; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Pawlotsky Jean-Michel, 2003, Clin Liver Dis, V7, P45, DOI 10.1016/S1089-3261(02)00065-X; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3; Rullier A, 2001, MODERN PATHOL, V14, P496, DOI 10.1038/modpathol.3880338; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schrantz N, 2001, MOL BIOL CELL, V12, P3139, DOI 10.1091/mbc.12.10.3139; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Serra R, 2005, ENDOCR-RELAT CANCER, V12, P749, DOI 10.1677/erc.1.00936; Sobesky R, 2007, HEPATOLOGY, V46, P1704, DOI 10.1002/hep.21898; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	47	100	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4355	10.1371/journal.pone.0004355	http://dx.doi.org/10.1371/journal.pone.0004355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190755	gold, Green Published			2022-12-25	WOS:000265483300005
J	Hammond, KL; Loynes, HE; Mowbray, C; Runke, G; Hammerschmidt, M; Mullins, MC; Hildreth, V; Chaudhry, B; Whitfield, TT				Hammond, Katherine L.; Loynes, Helen E.; Mowbray, Catriona; Runke, Greg; Hammerschmidt, Matthias; Mullins, Mary C.; Hildreth, Victoria; Chaudhry, Bill; Whitfield, Tanya T.			A Late Role for bmp2b in the Morphogenesis of Semicircular Canal Ducts in the Zebrafish Inner Ear	PLOS ONE			English	Article								Background: The Bone Morphogenetic Protein (BMP) genes bmp2 and bmp4 are expressed in highly conserved patterns in the developing vertebrate inner ear. It has, however, proved difficult to elucidate the function of BMPs during ear development as mutations in these genes cause early embryonic lethality. Previous studies using conditional approaches in mouse and chicken have shown that Bmp4 has a role in semicircular canal and crista development, but there is currently no direct evidence for the role of Bmp2 in the developing inner ear. Methodology/Principal Findings: We have used an RNA rescue strategy to test the role of bmp2b in the zebrafish inner ear directly. Injection of bmp2b or smad5 mRNA into homozygous mutant swirl (bmp2b(-/-)) embryos rescues the early patterning defects in these mutants and the fish survive to adulthood. As injected RNA will only last, at most, for the first few days of embryogenesis, all later development occurs in the absence of bmp2b function. Although rescued swirl adult fish are viable, they have balance defects suggestive of vestibular dysfunction. Analysis of the inner ears of these fish reveals a total absence of semicircular canal ducts, structures involved in the detection of angular motion. All other regions of the ear, including the ampullae and cristae, are present and appear normal. Early stages of otic development in rescued swirl embryos are also normal. Conclusions/Significance: Our findings demonstrate a critical late role for bmp2b in the morphogenesis of semicircular canals in the zebrafish inner ear. This is the first demonstration of a developmental role for any gene during post-embryonic stages of otic morphogenesis in the zebrafish. Despite differences in the early stages of semicircular canal formation between zebrafish and amniotes, the role of Bmp2 in semicircular canal duct outgrowth is likely to be conserved between different vertebrate species.	[Hammond, Katherine L.; Loynes, Helen E.; Mowbray, Catriona; Whitfield, Tanya T.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Hammerschmidt, Matthias] Max Planck Inst Immunobiol, Freiburg, Germany; [Runke, Greg; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Hildreth, Victoria; Chaudhry, Bill] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England	University of Sheffield; Max Planck Society; University of Pennsylvania; Newcastle University - UK	Hammond, KL (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	t.whitfield@sheffield.ac.uk	Whitfield, Tanya/E-6203-2010	Whitfield, Tanya/0000-0003-1575-1504	Wellcome Trust [057101]; MRC [G78/5898, G0400100, G0700091]; NIH [R01-GM56326]; British Heart Foundation; Yorkshire Cancer Research; Medical Research Council [G0700091B, G0400100, G0400100B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056326] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Yorkshire Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Wellcome Trust (057101) and the MRC (G78/5898) to TW, from the NIH (R01-GM56326) to MCM, and from the British Heart Foundation to BC. Funding for the confocal imaging in Fig. 3 was provided by Yorkshire Cancer Research. The CDBG zebrafish aquaria were supported by the MRC (G0400100, G0700091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer H, 2001, DEVELOPMENT, V128, P849; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Cecconi F, 2004, DEVELOPMENT, V131, P2125, DOI 10.1242/dev.01082; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Dick A, 2000, DEVELOPMENT, V127, P343; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Fekete DM, 1997, DEVELOPMENT, V124, P2451; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Gerlach-Bank LM, 2004, DEV DYNAM, V229, P219, DOI 10.1002/dvdy.10414; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Hild M, 1999, DEVELOPMENT, V126, P2149; Kappler JA, 2004, P NATL ACAD SCI USA, V101, P13056, DOI 10.1073/pnas.0405224101; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kobayashi Y, 2008, TOHOKU J EXP MED, V215, P207, DOI 10.1620/tjem.215.207; Kramer C, 2002, DEV BIOL, V250, P263, DOI 10.1006/dbio.2002.0805; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lambert FM, 2008, J NEUROSCI, V28, P8086, DOI 10.1523/JNEUROSCI.1288-08.2008; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Morsli H, 1998, J NEUROSCI, V18, P3327; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; MOWBRAY C, 2002, THESIS U SHEFFIELD; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Oh SH, 1996, J NEUROSCI, V16, P6463; Orlovsky G N, 1991, Curr Opin Neurobiol, V1, P621, DOI 10.1016/S0959-4388(05)80039-X; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Robledo RF, 2006, GENESIS, V44, P425, DOI 10.1002/dvg.20233; Salminen M, 2000, DEVELOPMENT, V127, P13; Schmid B, 2000, DEVELOPMENT, V127, P957; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Shawi M, 2008, GENE EXPR PATTERNS, V8, P369, DOI 10.1016/j.gep.2008.05.004; Sidi S, 2004, J NEUROSCI, V24, P4213, DOI 10.1523/JNEUROSCI.0223-04.2004; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; WATERMAN RE, 1984, ANAT REC, V210, P101, DOI 10.1002/ar.1092100113; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu DK, 1996, J NEUROSCI, V16, P6454	55	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4368	10.1371/journal.pone.0004368	http://dx.doi.org/10.1371/journal.pone.0004368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190757	Green Published, gold, Green Accepted			2022-12-25	WOS:000265483300007
J	Weber, P; Kula-Eversole, E; Pyza, E				Weber, Pawel; Kula-Eversole, Elzbieta; Pyza, Elzbieta			Circadian Control of Dendrite Morphology in the Visual System of Drosophila melanogaster	PLOS ONE			English	Article							PERIOD GENE-PRODUCT; 1ST OPTIC NEUROPIL; MUSCA-DOMESTICA L; RHYTHMIC CHANGES; SIZE CHANGES; CRYPTOCHROME; CLOCK; FLUCTUATIONS; EXPRESSION; PIGMENT	Background: In the first optic neuropil (lamina) of the fly's visual system, monopolar cells L1 and L2 and glia show circadian rhythms in morphological plasticity. They change their size and shape during the day and night. The most pronounced changes have been detected in circadian size of the L2 axons. Looking for a functional significance of the circadian plasticity observed in axons, we examined the morphological plasticity of the L2 dendrites. They extend from axons and harbor postsynaptic sites of tetrad synaptic contacts from the photoreceptor terminals. Methodology/Principal Findings: The plasticity of L2 dendrites was evaluated by measuring an outline of the L2 dendritic trees. These were from confocal images of cross sections of L2 cells labeled with GFP. They were in wild-type and clock mutant flies held under different light conditions and sacrified at different time points. We found that the L2 dendrites are longest at the beginning of the day in both males and females. This rhythm observed under a day/night regime (LD) was maintained in constant darkness (DD) but not in continuous light (LL). This rhythm was not present in the arrhythmic per(01) mutant in LD or in DD. In the clock photoreceptor cry(b) mutant the rhythm was maintained but its pattern was different than that observed in wild-type flies. Conclusions/Significance: The results obtained showed that the L2 dendrites exhibit circadian structural plasticity. Their morphology is controlled by the per gene-dependent circadian clock. The L2 dendrites are longest at the beginning of the day when the daytime tetrad presynaptic sites are most numerous and L2 axons are swollen. The presence of the rhythm, but with a different pattern in cry(b) mutants in LD and DD indicates a new role of cry in the visual system. The new role is in maintaining the circadian pattern of changes of the L2 dendrite length and shape.	[Weber, Pawel; Kula-Eversole, Elzbieta; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cytol & Histol, PL-30060 Krakow, Poland; [Kula-Eversole, Elzbieta] Howard Hughes Med Inst, Dept Biol, Waltham, MA USA; [Kula-Eversole, Elzbieta] Brandeis Univ, Natl Ctr Behavioral Genom, Waltham, MA 02254 USA	Jagiellonian University; Howard Hughes Medical Institute; Brandeis University	Weber, P (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cytol & Histol, PL-30060 Krakow, Poland.	elzbieta.pyza@uj.edu.pl			Polish Ministry of Science and High Education [N303 040 32/1400]; Jagiellonian University; NIH [NS44232, P30 NS45713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland); Jagiellonian University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by Polish Ministry of Science and High Education grant no N303 040 32/1400 and Jagiellonian University grant DS ZCH 2007/2008 to Elzbieta Pyza, and in part by NIH grants NS44232 and P30 NS45713 to Michael Rosbash. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balys M, 2001, J EXP BIOL, V204, P3303; BRAND AH, 1993, DEVELOPMENT, V118, P401; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CHEN DM, 1992, VISUAL NEUROSCI, V9, P125, DOI 10.1017/S0952523800009585; Cheng YZ, 1998, J NEUROSCI, V18, P741; COLLINS B, 2006, CELL, V95, P669; EWER J, 1992, J NEUROSCI, V12, P3321; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; GORSKAANDRZEJAK J, 2003, J INSECT PH IN PRESS; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Miskiewicz K, 2008, J COMP NEUROL, V509, P422, DOI 10.1002/cne.21765; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; PYZA E, 1993, P ROY SOC B-BIOL SCI, V254, P97, DOI 10.1098/rspb.1993.0133; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 1997, J NEUROBIOL, V32, P517, DOI 10.1002/(SICI)1097-4695(199705)32:5<517::AID-NEU6>3.0.CO;2-8; Shafer OT, 2002, J NEUROSCI, V22, P5946; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; ZERR DM, 1990, J NEUROSCI, V10, P2749	31	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4290	10.1371/journal.pone.0004290	http://dx.doi.org/10.1371/journal.pone.0004290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173003	gold, Green Published			2022-12-25	WOS:000265483000005
J	Zeng, FH; Xu, J; Harris, RC				Zeng, Fenghua; Xu, Jie; Harris, Raymond C.			Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells	FASEB JOURNAL			English	Article						E3 ubiquitin ligase; PY motif mutation; PI3 kinase; nuclear translocation	ENDOCYTIC DOWN-REGULATION; GROWTH-FACTOR RECEPTOR; WW DOMAIN; TRANSCRIPTIONAL COACTIVATOR; NUCLEAR-LOCALIZATION; CONTAINING PROTEINS; LIDDLES-SYNDROME; LIGAND; CANCER; YAP	ErbB4, a type I transmembrane receptor tyrosine kinase, is a member of the epidermal growth factor receptor family. Its cleavage releases an intracellular C-terminal domain (ICD), which can be either degraded following ubiqitination or translocated to the nucleus and regulate gene expression. There are 2 ErbB4 ICD isoforms: CYT-1 and CYT-2. We and others have previously reported that following cleavage, CYT-2 selectively translocates to the nucleus. In the current study we found that following cleavage, the intracellular levels of CYT-1 ICD decreased rapidly, while levels of CYT-2 ICD remained relatively stable. CYT-1 ICD degradation could be prevented by administration of either the proteasome inhibitor lactacystin or the lysosome inhibitor chloroquine, indicating both proteasomal and lysosomal degradation. Further studies implicated Nedd4, an E3 ubiquitin ligase, as a mediator of CYT-1 ubiquitination and degradation. The interaction of Nedd4 with CYT-1 was shown by coimmnunoprecipitation, an in vitro direct binding assay, and an in vitro ubiquitination assay. Three PPxY or PY motifs present in the CYT-1 C terminus are necessary for binding by Nedd4 WW domains, because impaired interactions are seen in mutation of any of the PY motifs. Nedd4-CYT-1 binding was associated with increased CYT-1 ubiquitination following proteasome inhibitor treatment. Impaired Nedd4 binding to CYT-1 by PY motif mutations led to increased CYT-1 ICD stability, whereas only one of the PY motif mutations (Y1056A), which disrupts the binding sites for both a WW domain and an SH2 domain of PI3 kinase, demonstrated enhanced nuclear translocation following HB-EGF treatment. These studies indicate that Nedd4 mediates ErbB4 CYT-1 ICD ubiquitination and degradation, and the prevention of both WW binding and PI3 kinase activity are required for ErbB4 nuclear translocation.-Zeng, F., Xu, J., Harris, R. C. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells. FASEB J. 23, 1935-1945 (2009)	[Harris, Raymond C.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Harris, Raymond C.] Nashville Vet Affairs Hosp, Nashville, TN USA	Vanderbilt University	Harris, RC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, C-3121 Med Ctr N, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu			Department of Veterans Affairs (R.H.); National Institutes of Health [DK51265]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265] Funding Source: NIH RePORTER	Department of Veterans Affairs (R.H.)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Department of Veterans Affairs (R.H.) and National Institutes of Health grant DK51265 (R.H.).	Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Baulida J, 1996, J BIOL CHEM, V271, P5251; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Furuhashi M, 2005, J CLIN ENDOCR METAB, V90, P340, DOI 10.1210/jc.2004-1027; Gallo RM, 2006, BIOCHEM BIOPH RES CO, V349, P372, DOI 10.1016/j.bbrc.2006.08.055; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Hamburger AW, 1997, ANTICANCER RES, V17, P2197; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jones FE, 2008, J MAMMARY GLAND BIOL, V13, P247, DOI 10.1007/s10911-008-9076-6; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223	33	37	39	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1935	1945		10.1096/fj.08-121947	http://dx.doi.org/10.1096/fj.08-121947			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19193720	Green Published			2022-12-25	WOS:000266652400032
J	Hamdane, D; Xia, CW; Im, SC; Zhang, HM; Kim, JJP; Waskell, L				Hamdane, Djemel; Xia, Chuanwu; Im, Sang-Choul; Zhang, Haoming; Kim, Jung-Ja P.; Waskell, Lucy			Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SYNTHASE REDUCTASE; ELECTRON-TRANSFER; BINDING-SITE; NADPH-CYTOCHROME-P-450 REDUCTASE; MACROMOLECULAR MOTIONS; P-450; KINETICS; FMN; MECHANISM; FAD	NADPH-cytochrome P450 oxidoreductase (CYPOR) catalyzes the transfer of electrons to all known microsomal cytochromes P450. A CYPOR variant, with a 4-amino acid deletion in the hinge connecting the FMN domain to the rest of the protein, has been crystallized in three remarkably extended conformations. The variant donates an electron to cytochrome P450 at the same rate as the wild-type, when provided with sufficient electrons. Nevertheless, it is defective in its ability to transfer electrons intramolecularly from FAD to FMN. The three extended CYPOR structures demonstrate that, by pivoting on the C terminus of the hinge, the FMN domain of the enzyme undergoes a structural rearrangement that separates it from FAD and exposes the FMN, allowing it to interact with its redox partners. A similar movement most likely occurs in the wild-type enzyme in the course of transferring electrons from FAD to its physiological partner, cytochrome P450. A model of the complex between an open conformation of CYPOR and cytochrome P450 is presented that satisfies mutagenesis constraints. Neither lengthening the linker nor mutating its sequence influenced the activity of CYPOR. It is likely that the analogous linker in other members of the diflavin family functions in a similar manner.	[Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Hamdane, Djemel; Im, Sang-Choul; Zhang, Haoming; Waskell, Lucy] Univ Michigan, Sch Med, Ann Arbor, MI 48105 USA; [Hamdane, Djemel; Im, Sang-Choul; Zhang, Haoming; Waskell, Lucy] Vet Affairs Med Res Ctr, Ann Arbor, MI 48105 USA	Medical College of Wisconsin; University of Michigan System; University of Michigan	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjkim@mcw.edu; waskell@umich.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [GM35533, GM52682]; Veterans Affairs Merit Review; U.S. Dept. of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533, R01GM052682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); U.S. Dept. of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM35533 (to L. W.) and GM52682 (to J. J. K.). This work was also supported by a Veterans Affairs Merit Review Grant (to L. W.). Use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38 and Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHATTACHARYYA AK, 1991, BIOCHEMISTRY-US, V30, P759, DOI 10.1021/bi00217a027; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRAY RD, 1982, J BIOL CHEM, V257, P1086; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; LANGE R, 1994, BIOPHYS J, V66, P89, DOI 10.1016/S0006-3495(94)80772-6; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; MASTERS BSS, 1980, PHARMACOL THERAPEUT, V9, P227; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; OPRIAN DD, 1979, J BIOL CHEM, V254, P8895; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VERMILION JL, 1981, J BIOL CHEM, V256, P266; VERMILION JL, 1978, J BIOL CHEM, V253, P8812; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wiehe Kevin, 2008, V413, P283; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u	49	162	164	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11374	11384		10.1074/jbc.M807868200	http://dx.doi.org/10.1074/jbc.M807868200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19171935	hybrid, Green Published			2022-12-25	WOS:000265494500042
J	Lee, BL; Li, XJ; Liu, YS; Sykes, BD; Fliegel, L				Lee, Brian L.; Li, Xiuju; Liu, Yongsheng; Sykes, Brian D.; Fliegel, Larry			Structural and Functional Analysis of Transmembrane XI of the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN STRUCTURE; AMINO-ACIDS; SEGMENT-IV; ANTIPORTER; EXPRESSION; MODEL; INHIBITION; MUTATIONS; MECHANISM; PEPTIDES	The Na+/H+ exchanger isoform 1 is a ubiquitously expressed integral membrane protein that regulates intracellular pH in mammals by extruding an intracellular H+ in exchange for one extracellular Na+. We characterized structural and functional aspects of the critical transmembrane (TM) segment XI (residues 449-470) by using cysteine scanning mutagenesis and high resolution NMR. Each residue of TM XI was mutated to cysteine in the background of the cysteine-less protein and the sensitivity to water-soluble sulfhydryl reactive compounds MTSET ((2-(trimethylammonium) ethyl) methanethiosulfonate) and MTSES ((2-sulfonatoethyl) methanethiosulfonate) was determined for those residues with at least moderate activity remaining. Of the residues tested, only proteins with mutations L457C, I461C, and L465C were inhibited by MTSET. The activity of the L465C mutant was almost completely eliminated, whereas that of the L457C and I461C mutants was partially affected. The structure of a peptide representing TM XI (residues Lys(447)-Lys(472)) was determined using high resolution NMR spectroscopy in dodecylphosphocholine micelles. The structure consisted of helical regions between Asp(447)-Tyr(454) and Phe(460)-Lys(471) at the N and C termini of the peptide, respectively, connected by a region with poorly defined, irregular structure consisting of residues Gly(455)-Gly(459). TM XI of NHE1 had a structural similarity to TM XI of the Escherichia coli Na+/H+ exchanger NhaA. The results suggest that TM XI is a discontinuous helix, with residue Leu(465) contributing to the pore.	[Lee, Brian L.; Li, Xiuju; Liu, Yongsheng; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			NANUC; Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; University of Alberta	NANUC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta(University of Alberta)	This work was supported in part by NANUC, Canadian Institutes of Health Research, Natural Science and Engineering Research Council of Canada, the University of Alberta, and a grant from the Canadian Institutes of Health Research (to L. F. and B. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wakabayashi S, 2000, FEBS LETT, V487, P257, DOI 10.1016/S0014-5793(00)02348-6; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f; [No title captured]	46	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11546	11556		10.1074/jbc.M809201200	http://dx.doi.org/10.1074/jbc.M809201200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19176522	Green Published, hybrid			2022-12-25	WOS:000265494500058
J	Tousseyn, T; Thathiah, A; Jorissen, E; Raemaekers, T; Konietzko, U; Reiss, K; Maes, E; Snellinx, A; Serneels, L; Nyabi, O; Annaert, W; Saftig, P; Hartmann, D; De Strooper, B				Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Konietzko, Uwe; Reiss, Karina; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Saftig, Paul; Hartmann, Dieter; De Strooper, Bart			ADAM10, the Rate-limiting Protease of Regulated Intramembrane Proteolysis of Notch and Other Proteins, Is Processed by ADAMS-9, ADAMS-15, and the gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; METALLOPROTEASE-DISINTEGRIN PROTEIN; CELL-CELL ADHESION; ALPHA-SECRETASE; INTRACELLULAR DOMAIN; MEMBRANE-PROTEINS; CONVERTING-ENZYME; PROSTATE-CANCER; GROWTH-FACTOR; MICE LACKING	ADAM10 is involved in the proteolytic processing and shedding of proteins such as the amyloid precursor protein (APP), cadherins, and the Notch receptors, thereby initiating the regulated intramembrane proteolysis (RIP) of these proteins. Here, we demonstrate that the sheddase ADAM10 is also subject to RIP. We identify ADAM9 and -15 as the proteases responsible for releasing the ADAM10 ectodomain, and Presenilin/gamma-Secretase as the protease responsible for the release of the ADAM10 intracellular domain (ICD). This domain then translocates to the nucleus and localizes to nuclear speckles, thought to be involved in gene regulation. Thus, ADAM10 performs a dual role in cells, as a metalloprotease when it is membrane-bound, and as a potential signaling protein once cleaved by ADAM9/15 and the gamma-Secretase.	[Hartmann, Dieter] Univ Bonn, Inst Anat, D-53115 Bonn, Germany; [Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Hartmann, Dieter; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Hartmann, Dieter; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Dev & Mol Genet, B-3000 Louvain, Belgium; [Raemaekers, Tim; Annaert, Wim] Katholieke Univ Leuven VIB, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reiss, Karina; Saftig, Paul] Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; [Konietzko, Uwe] Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland	University of Bonn; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Kiel; University of Zurich	Hartmann, D (corresponding author), Univ Bonn, Inst Anat, Nussallee 10, D-53115 Bonn, Germany.	dhartman@uni-bonn.de; Bart.destrooper@med.kuleuven.be	Saftig, Paul/A-7966-2010; Reiss, Karina/B-3175-2010; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Serneels, Lutgarde/0000-0002-5463-4231; Tousseyn, Thomas/0000-0002-0397-1086	Alzheimer's Association; Fonds voor Wetenschappelijik Onderzoek; Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006; Deutsche Forschungsgemeinschaft [SFB415-TPB9]; Bristol Myers Squib; Flemish Government; Federal Office for Scientific Affairs [IUAP P6/43/]	Alzheimer's Association(Alzheimer's Association); Fonds voor Wetenschappelijik Onderzoek; Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bristol Myers Squib; Flemish Government(European Commission); Federal Office for Scientific Affairs	This work was supported in part by grants from the Alzheimer's Association and the Fonds voor Wetenschappelijik Onderzoek (F.W.O.) (to D.H.), a Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006 grant (to W.A.), the Deutsche Forschungsgemeinschaft SFB415-TPB9 (to P.S. and K.R.), and a Freedom to Discover grant from Bristol Myers Squib, a Methusalem grant of the Flemish Government(to B.D.S.), and grants from the F.W.O., K.U. Leuven (to G.O.A.), VIB, and Federal Office for Scientific Affairs (IUAP P6/43/), Belgium (to W.A. and B.D.S.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Arima T, 2007, CANCER SCI, V98, P1720, DOI 10.1111/j.1349-7006.2007.00601.x; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Fleischer S, 1974, Methods Enzymol, V31, P6; Gaultier A, 2002, J BIOL CHEM, V277, P23336, DOI 10.1074/jbc.M201792200; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kang TB, 2002, J BIOL CHEM, V277, P48514, DOI 10.1074/jbc.M208961200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; KONIETZKO U, 2008, NEUROBIOL A IN PRESS; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Mancia F, 2005, CELL, V123, P185, DOI 10.1016/j.cell.2005.10.004; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Martin J, 2002, J BIOL CHEM, V277, P33683, DOI 10.1074/jbc.M200988200; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Moss ML, 2002, ESSAYS BIOCHEM, V38, P141, DOI 10.1042/bse0380141; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	70	138	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11738	11747		10.1074/jbc.M805894200	http://dx.doi.org/10.1074/jbc.M805894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213735	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000265494500076
J	Li, ZY; Chen, LH; Kabra, NH; Wang, CG; Fang, J; Chen, JD				Li, Zhenyu; Chen, Lihong; Kabra, Neha; Wang, Chuangui; Fang, Jia; Chen, Jiandong			Inhibition of SUV39H1 Methyltransferase Activity by DBC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; PANCREATIC BETA-CELLS; CALORIE RESTRICTION; INSULIN-SECRETION; SIRT1 DEACETYLASE; LIFE-SPAN; HETEROCHROMATIN; SURVIVAL; PROTEIN; PGC-1-ALPHA	SUV39H1 is a histone H3K9-specific methyltransferase important for heterochromatin formation, regulation of gene expression, and induction of senescence in premalignant cells. SUV39H1 forms a complex with SirT1, and its activity is stimulated by SirT1 binding. Here we present evidence that the product of the DBC1 (deleted in breast cancer 1) gene disrupts the SUV39H1-SirT1 complex. Furthermore, DBC1 binds to the SUV39H1 catalytic domain and inhibits its ability to methylate histone H3 in vitro and in vivo. Knockdown of endogenous DBC1 increased the level of cellular H3K9 methylation. As expected, DBC1 also binds to SirT1 and inhibits the deacetylase activity of SirT1. These results identify DBC1 as a novel cellular inhibitor of SUV39H1 activity. DBC1 may be an important regulator of heterochromatin formation and genomic stability by disrupting the SUV39H1-SirT1 complex and inactivating both enzymes.	[Li, Zhenyu; Chen, Lihong; Kabra, Neha; Fang, Jia; Chen, Jiandong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; East China Normal University	Chen, JD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org		Fang, Jia/0000-0001-8583-1652	National Institutes of Health [CA121291]; NATIONAL CANCER INSTITUTE [R01CA121291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA121291 (to J.C.).	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	30	63	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10361	10366		10.1074/jbc.M900956200	http://dx.doi.org/10.1074/jbc.M900956200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218236	hybrid, Green Published			2022-12-25	WOS:000265104600010
J	Huff, J; Pavlenok, M; Sukumaran, S; Niederweis, M				Huff, Jason; Pavlenok, Mikhail; Sukumaran, Suja; Niederweis, Michael			Functions of the Periplasmic Loop of the Porin MspA from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; OMPF PORIN; CHARGED RESIDUES; CELL-WALL; CHANNEL; VOLTAGE; PROTEIN; GROWTH; PERMEABILITY	MspA is the major porin of Mycobacterium smegmatis and mediates diffusion of small and hydrophilic solutes across the outer membrane. The octameric structure of MspA, its sharply defined constriction zone, and a large periplasmic loop L6 represent novel structural features. L6 consists of 13 amino acids and is directly adjacent to the constriction zone. Deletion of 3, 5, 7, 9, and 11 amino acids of the L6 loop resulted in functional pores that restored glucose uptake and growth of a porin mutant of M. smegmatis. Lipid bilayer experiments revealed that all mutant channels were noisier than wild type (wt) MspA, indicating that L6 is required for pore stability in vitro. Voltage gating of the Escherichia coli porin OmpF was attributed to loops that collapse into the channel in response to a strong electrical field. Here, we show that deletion mutants Delta 7, Delta 9, and Delta 11 had critical voltages similar to wt MspA. This demonstrated that the L6 loop is not the primary voltage-dependent gating mechanism of MspA. Surprisingly, large deletions in L6 resulted in 3-6-fold less extractable pores, whereas small deletions did not alter expression levels of MspA. Pores with large deletions in L6 were more permissive for glucose than smaller deletion mutants, whereas their single channel conductance was similar to that of wt MspA. These results indicate that translocation of ions through the MspA pore is governed by different mechanisms than that of neutral solutes. This is the first study identifying a molecular determinant of solute translocation in a mycobacterial porin.	[Huff, Jason; Pavlenok, Mikhail; Sukumaran, Suja; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Niederweis, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 609 Bevill Biomed Res Bldg,845 19th St S, Birmingham, AL 35294 USA.	mnieder@uab.edu		Niederweis, Michael/0000-0003-4068-8092	National Institutes of Health [HG004145, T32 HL07553]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HG004145 (to M. N.).; Supported by a fellowship from the National Institutes of Health "Basic Mechanisms of Lung Diseases" Training Grant T32 HL07553.	Bainbridge G, 1998, FEBS LETT, V431, P305, DOI 10.1016/S0014-5793(98)00761-3; Basle A, 2004, PROTEIN ENG DES SEL, V17, P665, DOI 10.1093/protein/gzh078; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Heinz C, 2003, J BIOL CHEM, V278, P8678, DOI 10.1074/jbc.M212280200; HOENGER A, 1993, J MOL BIOL, V233, P400, DOI 10.1006/jmbi.1993.1520; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; KORCHEV YE, 1995, J MEMBRANE BIOL, V143, P143; Korkmaz F, 2008, BIOCHEMISTRY-US, V47, P12126, DOI 10.1021/bi801224y; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2008, MYCOBACTERIAL CELL ENVELOPE, P153; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Robertson KM, 2002, BIOCHEM CELL BIOL, V80, P517, DOI 10.1139/O02-145; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SEN K, 1988, J BIOL CHEM, V263, P1182; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stahl C, 2005, MOL MICROBIOL, V57, P1509, DOI 10.1111/j.1365-2958.2005.04766.x; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; VanGelder P, 1997, J MOL BIOL, V269, P468, DOI 10.1006/jmbi.1997.1063; VanGelder P, 1997, PROTEIN ENG, V10, P699, DOI 10.1093/protein/10.6.699; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Worner M, 2007, SMALL, V3, P1084, DOI 10.1002/smll.200600559	42	8	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10223	10231		10.1074/jbc.M808599200	http://dx.doi.org/10.1074/jbc.M808599200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208627	Green Published, hybrid			2022-12-25	WOS:000264892900064
J	Lawton, TJ; Sayavedra-Soto, LA; Arp, DJ; Rosenzweig, AC				Lawton, Thomas J.; Sayavedra-Soto, Luis A.; Arp, Daniel J.; Rosenzweig, Amy C.			Crystal Structure of a Two-domain Multicopper Oxidase IMPLICATIONS FOR THE EVOLUTION OF MULTICOPPER BLUE PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING NITRITE REDUCTASE; ALCALIGENES-FAECALIS; STREPTOMYCES-COELICOLOR; STRUCTURE ALIGNMENT; COPPER OXIDASES; SMALL LACCASE; WEB SERVER; SITE; SEQUENCE; REVEALS	The two-domain multicopper oxidases are proposed to be key intermediates in the evolution of three-domain multicopper oxidases. A number of two-domain multicopper oxidases have been identified from genome sequences and are classified as type A, type B, or type C on the basis of the predicted location of the type 1 copper center. The crystal structure of blue copper oxidase, a type C two-domain multicopper oxidase from Nitrosomonas europaea, has been determined to 1.9 angstrom resolution. Blue copper oxidase is a trimer, of which each subunit comprises two cupredoxin domains. Each subunit houses a type 1 copper site in domain 1 and a type 2/type 3 trinuclear copper cluster at the subunit-subunit interface. The coordination geometry at the trinuclear copper site is consistent with reduction of the copper ions. Although the overall architecture of blue copper oxidase is similar to nitrite reductases, detailed structural alignments show that the fold and domain orientation more closely resemble the three-domain multicopper oxidases. These observations have important implications for the evolution of nitrite reductases and multicopper oxidases.	[Lawton, Thomas J.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Lawton, Thomas J.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Sayavedra-Soto, Luis A.; Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Northwestern University; Northwestern University; Oregon State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu			National Institutes of Health [GM070473]; Oregon Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070473 (to A. C. R.). This work was also supported by a grant from the Oregon Agricultural Experimental Station (to O. S. U.).	ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bento I, 2005, DALTON T, P3507, DOI 10.1039/b504806k; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; BOURBONNAIS R, 1995, APPL ENVIRON MICROB, V61, P1876, DOI 10.1128/AEM.61.5.1876-1880.1995; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V827, P320, DOI 10.1016/0167-4838(85)90217-1; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Ellis MJ, 2007, J BIOL INORG CHEM, V12, P1119, DOI 10.1007/s00775-007-0282-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Ferraroni M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-60; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; HYMAN MR, 1992, J BIOL CHEM, V267, P1534; Inoue T, 1998, J BIOCHEM, V124, P876, DOI 10.1093/oxfordjournals.jbchem.a022201; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kukimoto M, 1996, J BIOL CHEM, V271, P13680, DOI 10.1074/jbc.271.23.13680; KUKIMOTO M, 1995, PROTEIN ENG, V8, P153, DOI 10.1093/protein/8.2.153; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; Lyashenko AV, 2006, J BIOL INORG CHEM, V11, P963, DOI 10.1007/s00775-006-0158-x; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; MESSERSCHMIDT A, 1993, J MOL BIOL, V230, P997, DOI 10.1006/jmbi.1993.1215; Messerschmidt A., 2006, HDB METALLOPROTEINS; Messerschmidt A., 1997, MULTICOPPER OXIDASES; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; MURPHY MEP, 1995, BIOCHEMISTRY-US, V34, P12107, DOI 10.1021/bi00038a003; Murphy MEP, 1997, PROTEIN SCI, V6, P761; Murphy MEP, 1997, J BIOL CHEM, V272, P28455, DOI 10.1074/jbc.272.45.28455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stein LY, 1998, APPL ENVIRON MICROB, V64, P1514; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zhukhlistova NE, 2008, CRYSTALLOGR REP+, V53, P92, DOI 10.1134/S1063774508010124; Zhukova YN, 2007, CRYSTALLOGR REP+, V52, P826, DOI 10.1134/S1063774507050124	58	55	57	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10174	10180		10.1074/jbc.M900179200	http://dx.doi.org/10.1074/jbc.M900179200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224923	hybrid, Green Published			2022-12-25	WOS:000264892900059
J	Kahle, J; Piaia, E; Neimanis, S; Meisterernst, M; Doenecke, D				Kahle, Joerg; Piaia, Elisa; Neimanis, Sonja; Meisterernst, Michael; Doenecke, Detlef			Regulation of Nuclear Import and Export of Negative Cofactor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; TRANSCRIPTION IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; GLUCOCORTICOID-RECEPTOR; SEQUENCE REQUIREMENTS; LOCALIZATION SIGNALS; GENE-TRANSCRIPTION; MULTIPLE PATHWAYS; PORE COMPLEX	The negative cofactor 2 (NC2) is a protein complex composed of two subunits, NC2 alpha and NC2 beta, and plays a key role in transcription regulation. Here we investigate whether each subunit contains a nuclear localization signal (NLS) that permits individual crossing of the nuclear membrane or whether nuclear import of NC2 alpha and NC2 beta depends on heterodimerization. Our results from in vitro binding studies and transfection experiments in cultured cells show that each subunit contains a classical NLS (cNLS) that is recognized by the importin alpha/beta heterodimer. Regardless of the individual cNLSs the two NC2 subunits are translocated as a preassembled complex as co-transfection experiments with wild-type and cNLS- deficient NC2 subunits demonstrate. Ran-dependent binding of the nuclear export receptor Crm1/exportin 1 confirmed the presence of a leucine-rich nuclear export signal (NES) in NC2 beta. In contrast, NC2 alpha does not exhibit a NES. Our results from interspecies heterokaryon assays suggest that heterodimerization with NC2 alpha masks the NES in NC2 beta, which prevents nuclear export of the NC2 complex. A mutation in either one of the two cNLSs decreases the extent of importin alpha/beta-mediated nuclear import of the NC2 complex. In addition, the NC2 complex can enter the nucleus via a second pathway, facilitated by importin 13. Because importin 13 binds exclusively to the NC2 complex but not to the individual subunits this alternative import pathway depends on sequence elements distributed among the two subunits.	[Kahle, Joerg; Neimanis, Sonja; Doenecke, Detlef] Univ Gottingen, Dept Mol Biol, Inst Biochem & Mol Cell Biol, D-37073 Gottingen, Germany; [Piaia, Elisa; Meisterernst, Michael] GSF, Natl Res Ctr Environm & Hlth, Dept Gene Express, D-81377 Munich, Germany; [Meisterernst, Michael] Univ Munster, Dept Med, Inst Cell & Tumor Biol, D-48149 Munster, Germany; [Piaia, Elisa] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munster; University of Lausanne	Doenecke, D (corresponding author), Univ Gottingen, Dept Mol Biol, Inst Biochem & Mol Cell Biol, Humboldtalle 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de			Deutsche Forschungsgemeinschaft Sonderforschungsbereich [523]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 523: Protein und Membrantransport zwischen zellularen Kompartimenten.	Albert TK, 2007, P NATL ACAD SCI USA, V104, P10000, DOI 10.1073/pnas.0703490104; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti Elena, 2002, Results Probl Cell Differ, V35, P93; Creton S, 2002, GENE DEV, V16, P3265, DOI 10.1101/gad.234002; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; INOSTROZA JA, 1992, CELL, V70, P477; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; MICHAEL WM, 1995, CELL, V83, P415; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tao T, 2006, AM J RESP CELL MOL, V35, P668, DOI 10.1165/rcmb.2006-0073OC; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; WHITE RJ, 1994, SCIENCE, V266, P448, DOI 10.1126/science.7939686; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	71	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9382	9393		10.1074/jbc.M805694200	http://dx.doi.org/10.1074/jbc.M805694200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19204005	Green Published, hybrid			2022-12-25	WOS:000264669100044
J	Estrada, DF; Boudreaux, DM; Zhong, DL; Jeor, SCS; De Guzman, RN				Estrada, D. Fernando; Boudreaux, Daniel M.; Zhong, Dalian; Jeor, Stephen C. St.; De Guzman, Roberto N.			The Hantavirus Glycoprotein G1 Tail Contains Dual CCHC-type Classical Zinc Fingers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IIIA; CYTOPLASMIC TAIL; NUCLEOCAPSID PROTEIN; INTERFERON RESPONSES; UUKUNIEMI-VIRUS; NMR; RECOGNITION; DOMAIN; COMPLEX; SPECTROSCOPY	Hantaviruses are distributed worldwide and can cause a hemorrhagic fever or a cardiopulmonary syndrome in humans. Mature virions consist of RNA genome, nucleocapsid protein, RNA polymerase, and two transmembrane glycoproteins, G1 and G2. The ectodomain of G1 is surface-exposed; however, it has a 142-residue C-terminal cytoplasmic tail that plays important roles in viral assembly and host-pathogen interaction. Here we show by NMR, circular dichroism spectroscopy, and mutagenesis that a highly conserved cysteine/histidine-rich region in the G1 tail of hantaviruses forms two CCHC-type classical zinc fingers. Unlike classical zinc fingers, however, the two G1 zinc fingers are intimately joined together, forming a compact domain with a unique fold. We discuss the implication of the hantaviral G1 zinc fingers in viral assembly and host-pathogen interaction.	[De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Boudreaux, Daniel M.; Jeor, Stephen C. St.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA	University of Kansas; Nevada System of Higher Education (NSHE); University of Nevada Reno	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	Pacific-Southwest, RCE/B-6155-2009		National Institutes of Health [AI065359, AI057160]; American Heart Association [0755724Z]; National Science Foundation [0326999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065359 ( to S. C. S. J.) and AI057160 ( to R. N. D.). This work was also supported by American Heart Association Grant 0755724Z ( to R. N. D.), National Science Foundation Grant 0326999 ( to S. C. S.), the Madison and Lila Self Graduate Fellowship ( to D. F. E.), and the Reno Cancer Foundation ( to D. M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elliot R.M., 2000, VIRUS TAXONOMY, P599; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; FLINT SJ, 2000, PRINCIPLES VIROLOGY, P92; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Geimonen E, 2003, J VIROL, V77, P10760, DOI 10.1128/JVI.77.20.10760-10768.2003; Geimonen E, 2003, J VIROL, V77, P1638, DOI 10.1128/JVI.77.2.1638-1643.2003; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOFFMAN RC, 1993, J MAGN RESON SER B, V102, P61, DOI 10.1006/jmrb.1993.1062; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huth JR, 1997, PROTEIN SCI, V6, P2359; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; PELTON JG, 1993, PROTEIN SCI, V2, P543; Sen N, 2007, J VIROL, V81, P4323, DOI 10.1128/JVI.02279-06; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; VONBONSDORFF CH, 1975, J VIROL, V16, P1296, DOI 10.1128/JVI.16.5.1296-1307.1975; Wang Y, 2008, J BIOL CHEM, V283, P28297, DOI 10.1074/jbc.M804869200; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Westman BJ, 2004, BIOCHEMISTRY-US, V43, P13318, DOI 10.1021/bi049506a; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	50	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8645	8651		10.1074/jbc.M808081200	http://dx.doi.org/10.1074/jbc.M808081200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179334	Green Published, hybrid			2022-12-25	WOS:000264397800049
J	Gallagher, DT; Smith, N; Kim, SK; Robinson, H; Reddy, PT				Gallagher, D. Travis; Smith, Natasha; Kim, Sook-Kyung; Robinson, Howard; Reddy, Prasad T.			Profound Asymmetry in the Structure of the cAMP-free cAMP Receptor Protein (CRP) from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; FAMILY	The cyclic AMP receptor protein (CRP, also called catabolite gene activator protein or CAP) plays a key role in metabolic regulation in bacteria and has become a widely studied model allosteric transcription factor. On binding its effector cAMP in the N-terminal domain, CRP undergoes a structural transition to a conformation capable of specific DNA binding in the C-terminal domain and transcription initiation. The crystal structures of Escherichia coli CRP (EcCRP) in the cAMP-bound state, both with and without DNA, are known, although its structure in the off state (cAMP-free, apoCRP) remains unknown. We describe the crystal structure at 2.0 angstrom resolution of the cAMP-free CRP homodimer from Mycobacterium tuberculosis H37Rv (MtbCRP), whose sequence is 30% identical with EcCRP, as the first reported structure of an off-state CRP. The overall structure is similar to that seen for the cAMP- bound EcCRP, but the apo MtbCRP homodimer displays a unique level of asymmetry, with a root mean square deviation of 3.5 angstrom between all C alpha positions in the two subunits. Unlike structures of on-state EcCRP and other homologs in which the C-domains are asymmetrically positioned but possess the same internal conformation, the two C-domains of apo MtbCRP differ both in hinge structure and in internal arrangement, with numerous residues that have completely different local environments and hydrogen bond interactions, especially in the hinge and DNA-binding regions. Comparison of the structures of apo MtbCRP and DNA-bound EcCRP shows how DNA binding would be inhibited in the absence of cAMP and supports a mechanism involving functional asymmetry in apoCRP.	[Gallagher, D. Travis; Smith, Natasha; Reddy, Prasad T.] Natl Inst Stand & Technol, Div Biol Sci, Gaithersburg, MD 20899 USA; [Kim, Sook-Kyung] Korea Res Inst Stand & Sci, Div Metrol Qual Life, Ctr Bioanal, Taejon 305340, South Korea; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	National Institute of Standards & Technology (NIST) - USA; Korea Research Institute of Standards & Science (KRISS); United States Department of Energy (DOE); Brookhaven National Laboratory	Gallagher, DT (corresponding author), Natl Inst Stand & Technol, Div Biol Sci, 100 Bur Rd,NIST Mailstop 8310, Gaithersburg, MD 20899 USA.	gallaghe@umbi.umd.edu			U. S. Department of Energy; National Institutes of Health; Northeast Collaborative Access Team (NECAT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Collaborative Access Team (NECAT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge the gift of M. tuberculosis H<INF>37</INF>R<INF>v</INF> chromosomal DNA from Drs. John Belisle and Patrick Brennan, Colorado State University, the technical and logistical support of Darwin Diaz and Dawn Rode, the support of the U. S. Department of Energy (Biological and Environmental Research) and the National Institutes of Health (National Center for Research Resources) for data collected at NSLS beamline X29, and the support of the Northeast Collaborative Access Team (NECAT) at Argonne National Laboratories Advanced Photon Source.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; DeLano W.L., 2002, PYMOL MOL VISUALIZAT; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Joyce MG, 2006, J BIOL CHEM, V281, P28318, DOI 10.1074/jbc.M602654200; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leu SF, 1999, BIOCHEMISTRY-US, V38, P6222, DOI 10.1021/bi982938z; MASURE HR, 1987, MICROBIOL REV, V51, P60, DOI 10.1128/MMBR.51.1.60-65.1987; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napoli AA, 2006, J MOL BIOL, V357, P173, DOI 10.1016/j.jmb.2005.12.051; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200	27	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8228	8232		10.1074/jbc.C800215200	http://dx.doi.org/10.1074/jbc.C800215200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19193643	Green Published, hybrid			2022-12-25	WOS:000264397800005
J	Torres, MP; Lee, MJ; Ding, F; Purbeck, C; Kuhlman, B; Dokholyan, NV; Dohlman, HG				Torres, Matthew P.; Lee, Michael J.; Ding, Feng; Purbeck, Carrie; Kuhlman, Brian; Dokholyan, Nikolay V.; Dohlman, Henrik G.			G Protein Mono-ubiquitination by the Rsp5 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED UBIQUITINATION; YEAST SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNIT; DOWN-REGULATION; SIGNAL-TRANSDUCTION; PHEROMONE RESPONSE; N-MYRISTOYLATION; PLASMA-MEMBRANE; ESSENTIAL GENE; A-FACTOR	Emerging evidence suggests that ubiquitination serves as a protein trafficking signal in addition to its well characterized role in promoting protein degradation. The yeast G protein alpha subunit Gpa1 represents a rare example of a protein that undergoes both mono- and poly-ubiquitination. Whereas mono-ubiquitinated Gpa1 is targeted to the vacuole, poly-ubiquitinated Gpa1 is directed instead to the proteasome. Here we investigate the structural requirements for mono- and poly-ubiquitination of Gpa1. We find that variants of Gpa1 engineered to be unstable are more likely to be poly-ubiquitinated and less likely to be mono-ubiquitinated. In addition, mutants that cannot be myristoylated are no longer mono-ubiquitinated but are still poly-ubiquitinated. Finally, we show that the ubiquitin ligase Rsp5 is necessary for Gpa1 mono-ubiquitination in vivo and that the purified enzyme is sufficient to catalyze Gpa1 mono-ubiquitination in vitro. Taken together, these data indicate that mono-and poly-ubiquitination have distinct enzyme and substrate recognition requirements; whereas poly-ubiquitination targets misfolded protein for degradation, a distinct ubiquitination apparatus targets the fully mature, fully myristoylated G protein for mono-ubiquitination and delivery to the vacuole.	[Torres, Matthew P.; Lee, Michael J.; Ding, Feng; Purbeck, Carrie; Kuhlman, Brian; Dokholyan, Nikolay V.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Genet Med Bldg,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Ding, Feng/G-6029-2011; Dokholyan, Nikolay/B-2238-2009; Dokholyan, Nikolay/D-8081-2018	Ding, Feng/0000-0003-1850-6336; Dokholyan, Nikolay/0000-0002-8225-4025; Dokholyan, Nikolay/0000-0002-8225-4025; Lee, Michael/0000-0003-3378-6196; Dohlman, Henrik/0000-0003-2443-0729; Torres, Matthew/0000-0001-7296-4536	NIGMS NIH HHS [R01 GM080739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Naviglio S, 2004, CELL SIGNAL, V16, P1229, DOI 10.1016/j.cellsig.2004.03.012; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Song JP, 1996, BIOCHEMISTRY-US, V35, P14806, DOI 10.1021/bi961846b; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466	63	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8931	8941		10.1074/jbc.M809058200	http://dx.doi.org/10.1074/jbc.M809058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176477	Green Published, hybrid			2022-12-25	WOS:000264397800076
J	Young, JD; Martel, J; Young, L; Wu, CY; Young, A; Young, D				Young, John D.; Martel, Jan; Young, Lena; Wu, Cheng-Yeu; Young, Andrew; Young, David			Putative Nanobacteria Represent Physiological Remnants and Culture By-Products of Normal Calcium Homeostasis	PLOS ONE			English	Article							FETUIN-A; CALCIFYING NANOPARTICLES; GLYCOPROTEIN/FETUIN-A; RANDALLS PLAQUE; SERUM; CARBONATE; PHOSPHATE; CALCIFICATION; PROTEIN; HYDROXYAPATITE	Putative living entities called nanobacteria (NB) are unusual for their small sizes (50-500 nm), pleomorphic nature, and accumulation of hydroxyapatite (HAP), and have been implicated in numerous diseases involving extraskeletal calcification. By adding precipitating ions to cell culture medium containing serum, mineral nanoparticles are generated that are morphologically and chemically identical to the so-called NB. These nanoparticles are shown here to be formed of amorphous mineral complexes containing calcium as well as other ions like carbonate, which then rapidly acquire phosphate, forming HAP. The main constituent proteins of serum-derived NB are albumin, fetuin-A, and apolipoprotein A1, but their involvement appears circumstantial since so-called NB from different body fluids harbor other proteins. Accordingly, by passage through various culture media, the protein composition of these particles can be modulated. Immunoblotting experiments reveal that antibodies deemed specific for NB react in fact with either albumin, fetuin-A, or both, indicating that previous studies using these reagents may have detected these serum proteins from the same as well as different species, with human tissue nanoparticles presumably absorbing bovine serum antigens from the culture medium. Both fetal bovine serum and human serum, used earlier by other investigators as sources of NB, paradoxically inhibit the formation of these entities, and this inhibition is trypsin-sensitive, indicating a role for proteins in this inhibitory process. Fetuin-A, and to a lesser degree albumin, inhibit nanoparticle formation, an inhibition that is overcome with time, ending with formation of the so-called NB. Together, these data demonstrate that NB are most likely formed by calcium or apatite crystallization inhibitors that are somehow overwhelmed by excess calcium or calcium phosphate found in culture medium or in body fluids, thereby becoming seeds for calcification. The structures described earlier as NB may thus represent remnants and by-products of physiological mechanisms used for calcium homeostasis, a concept which explains the vast body of NB literature as well as explains the true origin of NB as lifeless protein-mineralo entities with questionable role in pathogenesis.	[Young, John D.; Martel, Jan; Young, Lena; Wu, Cheng-Yeu; Young, Andrew; Young, David] Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan; [Martel, Jan] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacter Pathogenesis, Tao Yuan, Taiwan; [Young, John D.] Rockefeller Univ, Adjunct Fac, Lab Cellular Physiol & Immunol, New York, NY USA; [Young, Lena] Harvard Univ, Cambridge, MA 02138 USA	Chang Gung University; Chang Gung University; Chang Gung University; Rockefeller University; Harvard University	Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [FMRPD2T02]	Primordia Institute of New Sciences and Medicine; Chang Gung University	This study was supported by Primordia Institute of New Sciences and Medicine and by a grant from Chang Gung University (FMRPD2T02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Barr SC, 2003, AM J VET RES, V64, P176, DOI 10.2460/ajvr.2003.64.176; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; CLARK JS, 1955, CAN J CHEM, V33, P665, DOI 10.1139/v55-078; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frank PG, 2000, J LIPID RES, V41, P853; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; GARNETT J, 1990, BIOCHEM J, V266, P863; GEER DE, 1972, J WATER POLLUT CON F, V44, P2342; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; HOUSE WA, 1986, J COLLOID INTERF SCI, V112, P309, DOI 10.1016/0021-9797(86)90101-3; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; JONES JA, 2008, UROL IN PRESS; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MATHEW G, INT J NANOMEDICINE, V3, P265; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9; POSNER AS, 1969, PHYSIOL REV, V49, P760, DOI 10.1152/physrev.1969.49.4.760; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.0.CO;2-6; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; RUOSLAHTI E, 1976, P NATL ACAD SCI USA, V73, P4641, DOI 10.1073/pnas.73.12.4641; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Simonetti AB, 2007, BRAZ J MICROBIOL, V38, P153, DOI 10.1590/S1517-83822007000100032; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vuckovic M, 2005, J SERB CHEM SOC, V70, P1255, DOI 10.2298/JSC0511255V; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	77	84	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4417	10.1371/journal.pone.0004417	http://dx.doi.org/10.1371/journal.pone.0004417			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198665	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483900014
J	Kerr, KCR; Lijtmaer, DA; Barreira, AS; Hebert, PDN; Tubaro, PL				Kerr, Kevin C. R.; Lijtmaer, Dario A.; Barreira, Ana S.; Hebert, Paul D. N.; Tubaro, Pablo L.			Probing Evolutionary Patterns in Neotropical Birds through DNA Barcodes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; GENUS; SPECIATION; DIVERSIFICATION; DIFFERENTIATION; CONSERVATION; BIOGEOGRAPHY; GENETICS; RATES	Background: The Neotropical avifauna is more diverse than that of any other biogeographic region, but our understanding of patterns of regional divergence is limited. Critical examination of this issue is currently constrained by the limited genetic information available. This study begins to address this gap by assembling a library of mitochondrial COI sequences, or DNA barcodes, for Argentinian birds and comparing their patterns of genetic diversity to those of North American birds. Methodology and Principal Findings: Five hundred Argentinian species were examined, making this the first major examination of DNA barcodes for South American birds. Our results indicate that most southern Neotropical bird species show deep sequence divergence from their nearest-neighbour, corroborating that the high diversity of this fauna is not based on an elevated incidence of young species radiations. Although species ages appear similar in temperate North and South American avifaunas, patterns of regional divergence are more complex in the Neotropics, suggesting that the high diversity of the Neotropical avifauna has been fueled by greater opportunities for regional divergence. Deep genetic splits were observed in at least 21 species, though distribution patterns of these lineages were variable. The lack of shared polymorphisms in species, even in species with less than 0.5M years Conclusions: These findings confirm the efficacy of species delimitation in birds via DNA barcodes, even when tested on a global scale. Further, they demonstrate how large libraries of a standardized gene region provide insight into evolutionary processes.	[Kerr, Kevin C. R.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Lijtmaer, Dario A.; Barreira, Ana S.; Tubaro, Pablo L.] Museo Argentino Cienc Nat Bernardino Rivadavia, Div Ornitol, Buenos Aires, DF, Argentina	University of Guelph; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Kerr, KCR (corresponding author), Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	kkerr@uoguelph.ca	Kerr, Kevin/B-8510-2013; Hebert, Paul DN/C-4161-2013	Kerr, Kevin/0000-0002-6784-3884; Hebert, Paul DN/0000-0002-3081-6700; Barreira, Ana S./0000-0001-7568-488X	CONICET; Lounsbery Foundation; NSERC; Genome Canada through the Ontario Genomics Institute	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Lounsbery Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This research program was funded by grants from CONICET and from the Lounsbery Foundation to PLT and by grants from NSERC and from Genome Canada through the Ontario Genomics Institute to PDNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Arnaiz-Villena A, 1998, CELL MOL LIFE SCI, V54, P1031, DOI 10.1007/s000180050230; Bates JM, 1999, AUK, V116, P1093, DOI 10.2307/4089688; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Brumfield RT, 2005, AUK, V122, P414, DOI 10.1642/0004-8038(2005)122[0414:MVIBPO]2.0.CO;2; Brumfield RT, 1996, CONDOR, V98, P547, DOI 10.2307/1369567; Chesser RT, 2000, MOL PHYLOGENET EVOL, V15, P369, DOI 10.1006/mpev.1999.0774; Cicero C, 1998, MOL ECOL, V7, P1359, DOI 10.1046/j.1365-294x.1998.00483.x; Clements JF, 2007, CLEMENTS CHECKLIST B; Edelaar Pim, 2003, Vogelwarte, V42, P113; Fjeldsa J, 2007, ZOOL SCR, V36, P133, DOI 10.1111/j.1463-6409.2006.00270.x; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Friesen VL, 1997, COLON WATERBIRD, V20, P353, DOI 10.2307/1521703; Garcia-Moreno J, 1999, MOL PHYLOGENET EVOL, V12, P273, DOI 10.1006/mpev.1999.0617; Garcia-Moreno J, 1998, CONDOR, V100, P629, DOI 10.2307/1369744; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lijtmaer DA, 2004, MOL PHYLOGENET EVOL, V33, P562, DOI 10.1016/j.ympev.2004.07.011; Lovette IJ, 2001, AUK, V118, P211, DOI 10.1642/0004-8038(2001)118[0211:MPOTPR]2.0.CO;2; Mata JRR, 2006, FIELD GUIDE BIRDS S; Mazar Barnett J., 2001, ANNOTATED CHECKLIST; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Moore WS, 2006, BIOL J LINN SOC, V87, P611, DOI 10.1111/j.1095-8312.2006.00586.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; NAROSKY T, 2003, BIRDS ARGENTINA URUG; NEWTON I, 2000, SPECIATION BIOGEOGRA; NORES M, 1992, AUK, V109, P346, DOI 10.2307/4088203; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; PRUM RO, 1994, CONDOR, V96, P692, DOI 10.2307/1369472; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Snow D.W., 2004, HDB BIRDS WORLD, V9, P110; Straneck R. J., 1993, R MUS ARG CIENC NAT, V16, P51; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; TEAM RDC, 2007, R LANGUAGE ENV STAT; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; TRAYLOR M A JR, 1988, Fieldiana Zoology, P1; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Yoo HS, 2006, MOL CELLS, V22, P323; ZINK RM, 1995, CONDOR, V97, P639, DOI 10.2307/1369173	54	138	153	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4379	10.1371/journal.pone.0004379	http://dx.doi.org/10.1371/journal.pone.0004379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194495	Green Published, gold			2022-12-25	WOS:000265483600010
J	Cooper, B; Fuchs, E; Flugge, G				Cooper, Ben; Fuchs, Eberhard; Fluegge, Gabriele			Expression of the Axonal Membrane Glycoprotein M6a Is Regulated by Chronic Stress	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ALTERS DENDRITIC MORPHOLOGY; CHRONIC PSYCHOSOCIAL STRESS; PYRAMIDAL NEURONS; GENE-EXPRESSION; HIPPOCAMPAL-FORMATION; APICAL DENDRITES; RAT; REORGANIZATION; IDENTIFICATION	It has been repeatedly shown that chronic stress changes dendrites, spines and modulates expression of synaptic molecules. These effects all may impair information transfer between neurons. The present study shows that chronic stress also regulates expression of M6a, a glycoprotein which is localised in axonal membranes. We have previously demonstrated that M6a is a component of glutamatergic axons. The present data reveal that it is the splice variant M6a-Ib, not M6a-Ia, which is strongly expressed in the brain. Chronic stress in male rats (3 weeks daily restraint) has regional effects: quantitative in situ hybridization demonstrated that M6a-Ib mRNA in dentate gyrus granule neurons and in CA3 pyramidal neurons is downregulated, whereas M6a-Ib mRNA in the medial prefrontal cortex is upregulated by chronic stress. This is the first study showing that expression of an axonal membrane molecule is differentially affected by stress in a region-dependent manner. Therefore, one may speculate that diminished expression of the glycoprotein in the hippocampus leads to altered output in the corresponding cortical projection areas. Enhanced M6a-Ib expression in the medial prefrontal cortex (in areas prelimbic and infralimbic cortex) might be interpreted as a compensatory mechanism in response to changes in axonal projections from the hippocampus. Our findings provide evidence that in addition to alterations in dendrites and spines chronic stress also changes the integrity of axons and may thus impair information transfer even between distant brain regions.	[Cooper, Ben; Fuchs, Eberhard; Fluegge, Gabriele] Leibniz Inst Primate Res, German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany; [Fuchs, Eberhard] Univ Gottingen, Sch Med, Dept Neurol, D-37075 Gottingen, Germany; [Fuchs, Eberhard; Fluegge, Gabriele] Univ Gottingen, CMPB, DFG, D-37075 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; German Research Foundation (DFG); University of Gottingen	Cooper, B (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	efuchs@gwdg.de		Cooper, Benjamin/0000-0003-2374-9922	DFG (German Science Foundation); Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen	DFG (German Science Foundation)(German Research Foundation (DFG)); Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen	This work was in part funded by the DFG (German Science Foundation) Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen. DFG and CMPB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, J NEUROSCI RES, V78, P702, DOI 10.1002/jnr.20328; Alfonso J, 2004, EUR J NEUROSCI, V19, P659, DOI 10.1111/j.1460-9568.2004.03178.x; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cooper B, 2008, BRAIN RES, V1197, P1, DOI 10.1016/j.brainres.2007.11.066; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; DIORIO D, 1993, J NEUROSCI, V13, P3839; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Huminiecki L, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-31; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; Meijer OC, 2002, J NEUROENDOCRINOL, V14, P499, DOI 10.1046/j.1365-2826.2002.00795.x; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Perez-Cruz Claudia, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/46276; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCHEIBEL ME, 1970, INT REV NEUROBIOL, V13, P1; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Sullivan RM, 2004, STRESS, V7, P131, DOI 10.1080/102538900410001679310; Sullivan RM, 1999, J NEUROSCI, V19, P2834; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TERREBERRY RR, 1987, BRAIN RES BULL, V19, P639, DOI 10.1016/0361-9230(87)90050-5; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2	46	23	24	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e3659	10.1371/journal.pone.0003659	http://dx.doi.org/10.1371/journal.pone.0003659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19180239	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483100001
J	Cunningham, D; Fonager, J; Jarra, W; Carret, C; Preiser, P; Langhorne, J				Cunningham, Deirdre; Fonager, Jannik; Jarra, William; Carret, Celine; Preiser, Peter; Langhorne, Jean			Rapid Changes in Transcription Profiles of the Plasmodium yoelii yir Multigene Family in Clonal Populations: Lack of Epigenetic Memory?	PLOS ONE			English	Article								The pir multigene family, found in the genomes of Plasmodium vivax, P. knowlesi and the rodent malaria species, encode variant antigens that could be targets of the immune response. Individual parasites of the rodent malaria Plasmodium yoelii, selected by micromanipulation, transcribe only 1 to 3 different pir (yir) suggesting tight transcriptional control at the level of individual cells. Using microarray and quantitative RT-PCR, we show that despite this very restricted transcription in a single cell, many yir genes are transcribed throughout the intra-erythrocytic asexual cycle. The timing and level of transcription differs between genes, with some being more highly transcribed in ring and trophozoite stages, whereas others are more highly transcribed in schizonts. Infection of immunodeficient mice with single infected erythrocytes results in populations of parasites each with transcriptional profiles different from that of the parent parasite population and from each other. This drift away from the original 'set' of transcribed genes does not appear to follow a preset pattern and "epigenetic memory'' of the yir transcribed in the parent parasite can be rapidly lost. Thus, regulation of pir gene transcription may be different from that of the well-characterised multigene family, var, of Plasmodium falciparum.	[Cunningham, Deirdre; Fonager, Jannik; Jarra, William; Langhorne, Jean] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Carret, Celine] Wellcome Trust Sanger Inst, Pathogen Microarrays Grp, Cambridge, England; [Preiser, Peter] Nanyang Technol Univ, Biosci Res Ctr, Singapore, Singapore	MRC National Institute for Medical Research; Wellcome Trust Sanger Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cunningham, D (corresponding author), Natl Inst Med Res, Div Parasitol, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Preiser, Peter R/A-2201-2011; Fonager, Jannik/AAJ-8292-2020	Langhorne, Jean/0000-0002-2257-9733; , Peter/0000-0003-4331-7000; Fonager, Jannik/0000-0003-1688-1482	MRC, UK; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme [LSHP-CT-2004-503578]; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC, UK and is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARNWELL JW, 1982, J IMMUNOL, V128, P224; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CHOOKAJORN T, 2007, P NATL ACAD SCI US; Corredor V, 2004, MOL BIOCHEM PARASIT, V138, P37, DOI 10.1016/j.molbiopara.2004.05.017; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cunningham DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/j.1365-2958.2005.04840.x; Daily JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; del Portillo HA, 2004, INT J PARASITOL, V34, P1547, DOI 10.1016/j.ijpara.2004.10.012; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, MOL MICROBIOL, V59, P364, DOI 10.1111/j.1365-2958.2005.05007.x; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Fernandez-Becerra C, 2005, MOL MICROBIOL, V58, P648, DOI 10.1111/j.1365-2958.2005.04850.x; Fischer K, 2003, MOL MICROBIOL, V48, P1209, DOI 10.1046/j.1365-2958.2003.03491.x; Fonager J, 2007, MOL BIOCHEM PARASIT, V156, P1, DOI 10.1016/j.molbiopara.2007.06.006; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; JARRA W, 1989, PARASITE IMMUNOL, V11, P1, DOI 10.1111/j.1365-3024.1989.tb00644.x; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kaviratne Mallika, 2003, P291, DOI 10.1016/B978-012194851-1/50039-1; Korir CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/j.meegid.2005.01.003; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; MCLEAN SA, 1982, EXP PARASITOL, V54, P296, DOI 10.1016/0014-4894(82)90038-8; MENDIS KN, 1988, AM J TROP MED HYG, V38, P42, DOI 10.4269/ajtmh.1988.38.42; Merino EF, 2006, MOL BIOCHEM PARASIT, V149, P10, DOI 10.1016/j.molbiopara.2006.04.002; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; VOSS TS, 2005, NATURE; WALLIKER D, 1983, TROPICAL MED SERIES	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4285	10.1371/journal.pone.0004285	http://dx.doi.org/10.1371/journal.pone.0004285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173007	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483000003
J	Forsee, WT; Cartee, RT; Yother, J				Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet			Characterization of the Lipid Linkage Region and Chain Length of the Cellubiuronic Acid Capsule of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN SYNTHASES; POLYSACCHARIDE BIOSYNTHESIS; TYPE-3 POLYSACCHARIDE; ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; MECHANISM; OLIGOSACCHARIDE; MODULATION; STRAINS	The processive reaction mechanisms of beta-glycosyl-polymerases are poorly understood. The cellubiuronan synthase of Streptococcus pneumoniae catalyzes the synthesis of the type 3 capsular polysaccharide through the alternate additions of beta-1,3-Glc and beta-1,4-GlcUA. The processive multistep reaction involves the sequential binding of two nucleotide sugar donors in coordination with the extension of a polysaccharide chain associated with the carbohydrate acceptor recognition site. Degradation analysis using cellubiuronan-specific depolymerase demonstrated that the oligosaccharide-lipid and polysaccharide-lipid products synthesized in vitro with recombinant cellubiuronan synthase had a similar oligosaccharyl-lipid at their reducing termini, providing definitive evidence for a precursor-product relationship and also confirming that growth occurred at the nonreducing end following initiation on phosphatidylglycerol. The presence of a lipid marker at the reducing end allowed the quantitative determination of cellubiuronic acid polysaccharide chain lengths. As the UDP-GlcUA concentration was increased from 1 to 11.5 mu M, the level of synthase in the transitory processive state decreased, with the predominant oligosaccharide-lipid product containing 3 uronic acid residues, whereas the proportion of synthase in the fully processive state increased and the polysaccharide chain length increased from 320 to 6700 monosaccharide units. In conjunction with other kinetic data, these results suggest that the formation of a complex between a tetrauronosyl oligomer and the carbohydrate acceptor recognition site plays a central role in coordinating the repetitive interaction of the synthase with the nucleotide sugar donors and modulating the chain length of cellubiuronan polysaccharide.	[Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yother, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 661-12, Birmingham, AL 35294 USA.	jyother@uab.edu			National Institutes of Health [R01 GM 53017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01 GM 53017.	Arrecubieta C, 1996, J EXP MED, V184, P449, DOI 10.1084/jem.184.2.449; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Bodevin-Authelet S, 2005, J BIOL CHEM, V280, P8813, DOI 10.1074/jbc.M412803200; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; CABIB E, 1983, P NATL ACAD SCI-BIOL, V80, P3318, DOI 10.1073/pnas.80.11.3318; CAMPBELL JH, 1966, IMMUNOCHEMISTRY, V3, P195, DOI 10.1016/0019-2791(66)90184-4; Cartee RT, 2005, J BACTERIOL, V187, P4470, DOI 10.1128/JB.187.13.4470-4479.2005; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Cartee RT, 2001, J BIOL CHEM, V276, P48831, DOI 10.1074/jbc.M106481200; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Davies GJ, 2001, TRENDS GLYCOSCI GLYC, V13, P105, DOI 10.4052/tigg.13.105; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; FernandezLopez M, 1996, MOL MICROBIOL, V20, P993, DOI 10.1111/j.1365-2958.1996.tb02540.x; Forsee WT, 2009, J BIOL CHEM, V284, P11836, DOI 10.1074/jbc.M900379200; Forsee WT, 2000, J BIOL CHEM, V275, P25972, DOI 10.1074/jbc.M002613200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Hoshi H, 2004, J BIOL CHEM, V279, P2341, DOI 10.1074/jbc.M305723200; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; Reeves RE, 1941, J BIOL CHEM, V139, P511; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; SMITH EEB, 1960, J GEN MICROBIOL, V22, P265, DOI 10.1099/00221287-22-1-265; STOOLMILLER AC, 1969, J BIOL CHEM, V244, P236; SUGAHARA K, 1979, J BIOL CHEM, V254, P6252; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; TORRIANI A, 1962, J BIOL CHEM, V237, P3; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WRIGHT A, 1965, BIOCHIM BIOPHYS ACTA, V104, P594, DOI 10.1016/0304-4165(65)90366-1	38	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11826	11835		10.1074/jbc.M900386200	http://dx.doi.org/10.1074/jbc.M900386200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19228688	Green Published, hybrid			2022-12-25	WOS:000265494600014
J	Baillif, V; Robins, RJ; Le Feunteun, S; Lesot, P; Billault, I				Baillif, Vincent; Robins, Richard J.; Le Feunteun, Steven; Lesot, Philippe; Billault, Isabelle			Investigation of Fatty Acid Elongation and Desaturation Steps in Fusarium lateritium by Quantitative Two-dimensional Deuterium NMR Spectroscopy in Chiral Oriented Media	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE LIQUID-CRYSTALS; NATURAL-ABUNDANCE; H-2 NMR; CLADOSPORIUM-CLADOSPORIOIDES; GLUCOSE FERMENTATION; HYDROGEN-TRANSFER; OLEIC-ACID; BIOSYNTHESIS; REDUCTASE; STEREOCHEMISTRY	The origin of hydrogen atoms during fatty acid biosynthesis in Fusarium lateritium has been quantified by isotope tracking close to natural abundance. Methyl linoleate was isolated from F. lateritium grown in natural abundance medium or in medium slightly enriched with labeled water, glucose, or acetate, and the H-2 incorporation was determined by quantitative H-2-{H-1} NMR in isotropic and chiral oriented solvents. Thus, the individual (H-2/H-1)(i) ratio at each pro-R and pro-S hydrogen position of the CH2 groups along the chain can be analyzed. These values allow the isotope redistribution coefficients (a(ij)) that characterize the specific source of each hydrogen atom to be related to the nonexchangeable hydrogen atoms in glucose and to the medium water. In turn, these can be related to the stereoselectivity that operates during the introduction or removal of hydrogens along the fatty acid chain. First, at even CH2 the pro-S hydrogen comes only from water by protonation, whereas the pro-R hydrogen is introduced partly via acetate but principally from water. Second, the nonexchangeable hydrogens of glucose ( positions H-6,6 and H-1) are shown to be introduced to the odd CH2 via the NAD(P) H pool used by both reductases involved in the elongation steps of the fatty acid chain. Third, it is proved that hydrogens removed at sites 9,10 and 12,13 during desaturation by Delta(9)- and Delta(12)-desaturases are pro-R, and that during these desaturation steps alpha-secondary kinetic isotope effects occur at the 9 and 12 positions and not at the 10 and 13 positions.	[Billault, Isabelle] Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, UMR 6230, CEISAM,UFR Sci & Tech,CNRS, F-44322 Nantes 3, France; [Lesot, Philippe] Univ Paris 11, CNRS, Lab Struct Organ, RMN Milieu Oriente,ICMMO,UMR 8182, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Billault, I (corresponding author), Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, UMR 6230, CEISAM,UFR Sci & Tech,CNRS, Bat 9,2 Rue Houssiniere,BP 92208, F-44322 Nantes 3, France.	isabelle.billault@univ-nantes.fr	Lesot, Philippe/M-3390-2017; Le Feunteun, Steven/AAA-9521-2021	Lesot, Philippe/0000-0002-5811-7530; Le Feunteun, Steven/0000-0002-4476-2811; Robins, Richard/0000-0002-5325-8983				Aroulanda C, 2001, J AM CHEM SOC, V123, P12059, DOI 10.1021/ja011685l; Baillif V, 2006, J AM CHEM SOC, V128, P11180, DOI 10.1021/ja0617892; Behrouzian B, 2001, CHEM COMMUN, P401, DOI 10.1039/b008972i; Billault I, 2005, J BIOL CHEM, V280, P17645, DOI 10.1074/jbc.M500909200; Billault I, 2004, J AM CHEM SOC, V126, P3250, DOI 10.1021/ja038814d; Buist PH, 1996, J AM CHEM SOC, V118, P6295, DOI 10.1021/ja953262n; Buist PH, 1998, J AM CHEM SOC, V120, P871, DOI 10.1021/ja971362i; Duan JR, 2002, CHEMBIOCHEM, V3, P752, DOI 10.1002/1439-7633(20020802)3:8<752::AID-CBIC752>3.0.CO;2-G; DUAN JR, 2002, THESIS U NANTES NANT; GORBIK L T, 1980, Mikrobiologicheskii Zhurnal (Kiev), V42, P191; Guiet S, 2003, PHYTOCHEMISTRY, V64, P227, DOI 10.1016/S0031-9422(03)00278-4; Kawaguchi A., 1999, COMPR NAT PROD CHEM, P23, DOI [10.1016/B978-0-08-091283-7.00001-1, DOI 10.1016/B978-0-08-091283-7.00001-1]; Lafon O, 2004, J MAGN RESON, V171, P135, DOI 10.1016/j.jmr.2004.08.010; Lesot P, 2004, ANAL CHEM, V76, P2827, DOI 10.1021/ac030385e; Lesot P, 2003, CHEM-EUR J, V9, P1724, DOI 10.1002/chem.200390199; Lesot P, 2008, ANAL CHEM, V80, P2963, DOI 10.1021/ac702443b; Marcinkeviciene J, 2001, ARCH BIOCHEM BIOPHYS, V390, P101, DOI 10.1006/abbi.2001.2349; Martin M, 1990, NMR BASIC PRINCIPLES, P1; MCINNES AG, 1983, TETRAHEDRON, V39, P3515, DOI 10.1016/S0040-4020(01)88661-0; MIZUGAKI M, 1984, J BIOCHEM-TOKYO, V95, P311, DOI 10.1093/oxfordjournals.jbchem.a134610; MORRIS LJ, 1970, BIOCHEM J, V118, P681, DOI 10.1042/bj1180681g; OHAGAN D, 1992, POLYKETIDE METABOLIT, P19; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pionnier S, 2003, J AGR FOOD CHEM, V51, P2076, DOI 10.1021/jf0259617; Rawlings BJ, 1998, NAT PROD REP, V15, P275; RAWLINGS BJ, 1989, J AM CHEM SOC, V111, P3382, DOI 10.1021/ja00191a041; REESE PB, 1988, J AM CHEM SOC, V110, P316, DOI 10.1021/ja00209a065; Robins RJ, 2008, J BIOL CHEM, V283, P9704, DOI 10.1074/jbc.M710272200; Robins Richard J., 2003, Phytochemistry Reviews, V2, P87, DOI 10.1023/B:PHYT.0000004301.52646.a8; Roger O, 2004, J BIOL CHEM, V279, P24923, DOI 10.1074/jbc.M401232200; SAITO K, 1982, BIOCHEM BIOPH RES CO, V108, P995, DOI 10.1016/0006-291X(82)92098-8; SAITO K, 1981, J BIOCHEM-TOKYO, V90, P1697, DOI 10.1093/oxfordjournals.jbchem.a133646; Sarfati M, 2000, CHEM COMMUN, P2069, DOI 10.1039/b006244h; Schmidt Hanns-Ludwig, 2003, Phytochemistry Reviews, V2, P61, DOI 10.1023/B:PHYT.0000004185.92648.ae; SCHROEPF.GJ, 1965, J BIOL CHEM, V240, P54; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P465, DOI 10.1111/j.1432-1033.1977.tb11549.x; SEDGWICK B, 1980, J CHEM SOC CHEM COMM, P96, DOI 10.1039/c39800000096; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P481, DOI 10.1111/j.1432-1033.1977.tb11550.x; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; TOWNSEND CA, 1988, J AM CHEM SOC, V110, P318, DOI 10.1021/ja00209a066; Zhang BL, 2006, EUR J LIPID SCI TECH, V108, P125, DOI 10.1002/ejlt.200500294; Zhang BL, 2003, CHEM-EUR J, V9, P3604, DOI 10.1002/chem.200304761; Zhang BL, 2002, J AGR FOOD CHEM, V50, P1574, DOI 10.1021/jf010776z; ZHANG HL, 1995, J BIOL CHEM, V270, P16023, DOI 10.1074/jbc.270.27.16023	44	34	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10783	10792		10.1074/jbc.M807826200	http://dx.doi.org/10.1074/jbc.M807826200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19213728	Green Published, hybrid			2022-12-25	WOS:000265104600053
J	Barylko, B; Mao, YS; Wlodarski, P; Jung, G; Binns, DD; Sun, HQ; Yin, HL; Albanesi, JP				Barylko, Barbara; Mao, Yuntao S.; Wlodarski, Pawel; Jung, Gwanghyun; Binns, Derk D.; Sun, Hui-Qiao; Yin, Helen L.; Albanesi, Joseph P.			Palmitoylation Controls the Catalytic Activity and Subcellular Distribution of Phosphatidylinositol 4-Kinase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; LOCALIZATION; DOMAIN; PHOSPHOINOSITIDES; SUPERFAMILY; ACTIVATION; COMPLEXES; REVEALS; ENZYMES	Phosphatidylinositol 4-kinases play essential roles in cell signaling and membrane trafficking. They are divided into type II and III families, which have distinct structural and enzymatic properties and are essentially unrelated in sequence. Mammalian cells express two type II isoforms, phosphatidylinositol 4-kinase II alpha (PI4KII alpha) and II beta (PI4KII beta). Nearly all of PI4KII alpha, and about half of PI4KII beta, associates integrally with membranes, requiring detergent for solubilization. This tight membrane association is because of palmitoylation of a cysteine-rich motif, CCPCC, located within the catalytic domains of both type II isoforms. Deletion of this motif from PI4KII alpha converts the kinase from an integral to a tightly bound peripheral membrane protein and abrogates its catalytic activity (Barylko, B., Gerber, S. H., Binns, D. D., Grichine, N., Khvotchev, M., Sudhof, T. C., and Albanesi, J. P. ( 2001) J. Biol. Chem. 276, 7705-7708). Here we identify the first two cysteines in the CCPCC motif as the principal sites of palmitoylation under basal conditions, and we demonstrate the importance of the central proline for enzymatic activity, although not for membrane binding. We further show that palmitoylation is critical for targeting PI4KII alpha to the trans-Golgi network and for enhancement of its association with low buoyant density membrane fractions, commonly termed lipid rafts. Replacement of the four cysteines in CCPCC with a hydrophobic residue, phenylalanine, substantially restores catalytic activity of PI4KII alpha in vitro and in cells without restoring integral membrane binding. Although this FFPFF mutant displays a perinuclear distribution, it does not strongly co-localize with wild-type PI4KII alpha and associates more weakly with lipid rafts.	[Mao, Yuntao S.; Sun, Hui-Qiao; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Barylko, Barbara; Wlodarski, Pawel; Jung, Gwanghyun; Binns, Derk D.; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wlodarski, Pawel] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, Warsaw, Poland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Warsaw	Yin, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Helen.Yin@UTSouthwestern.edu; Joseph.Albanesi@UTSouthwestern.edu	Mao, Yuntao/E-9168-2012	Wlodarski, Pawel/0000-0002-0683-1791	National Institutes of Health [RO1 GM75401, R01 GM66110]; American Heart Association Texas Affiliate [0455005Y]; National Science Foundation [9982061]; Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075401, R01GM066110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Texas Affiliate(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM75401 ( to J. P. A.) and R01 GM66110 ( to H. L. Y.). This work was also supported by American Heart Association Texas Affiliate Grant 0455005Y ( to J. P. A. in recognition of HCA Hospitals, North Richland Hills, TX), National Science Foundation Grant 9982061 ( to B. B.), and the Welch Foundation Grant I-1200 ( to H. L. Y.).	Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Bijlmakers MJ, 2009, MOL MEMBR BIOL, V26, P93, DOI 10.1080/09687680802650481; BLIGH EG, 1959, CAN J MED SCI, V37, P911, DOI DOI 10.1139/O59-099; Chang FS, 2005, J CELL BIOL, V171, P133, DOI 10.1083/jcb.200501086; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; de Matteis MA, 2007, BIOCHEM SOC SYMP, V74, P107, DOI 10.1042/BSS2007c10; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Jung G, 2008, BIOCHEM J, V409, P501, DOI 10.1042/BJ20070821; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LINDER ME, 1995, METHOD ENZYMOL, V250, P314; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Waugh MG, 2003, BIOCHEM J, V373, P57, DOI 10.1042/BJ20030089; Waugh MG, 2001, BIOCHEM SOC T, V29, P509, DOI 10.1042/BST0290509; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	43	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9994	10003		10.1074/jbc.M900724200	http://dx.doi.org/10.1074/jbc.M900724200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211550	hybrid, Green Published			2022-12-25	WOS:000264892900042
J	Zaas, DW; Swan, ZD; Brown, BJ; Li, G; Randell, SH; Degan, S; Sunday, ME; Wright, JR; Abraham, SN				Zaas, David W.; Swan, Zachary D.; Brown, Bethany J.; Li, Guojie; Randell, Scott H.; Degan, Simone; Sunday, Mary E.; Wright, Jo Rae; Abraham, Soman N.			Counteracting Signaling Activities in Lipid Rafts Associated with the Invasion of Lung Epithelial Cells by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; PLASMA-MEMBRANE; GOLGI-COMPLEX; SHOW EVIDENCE; IN-VIVO; CAVEOLIN-1; PHOSPHORYLATION; EXPRESSION; PROTEIN; MICE	Pseudomonas aeruginosa has the capacity to invade lung epithelial cells by co-opting the intrinsic endocytic properties of lipid rafts, which are rich in cholesterol, sphingolipids, and proteins, such as caveolin-1 and -2. We compared intratracheal Pseudomonas infection in wild type and caveolin-deficient mice to investigate the role of caveolin proteins in the pathogenesis of Pseudomonas pneumonia. Unlike wild type mice, which succumb to pneumonia, caveolin-deficient mice are resistant to Pseudomonas. We observed that Pseudomonas invasion of lung epithelial cells is dependent on caveolin-2 but not caveolin-1. Phosphorylation of caveolin-2 by Src family kinases is an essential event for Pseudomonas invasion. Our studies also reveal the existence of a distinct signaling mechanism in lung epithelial cells mediated by COOH-terminal Src kinase (Csk) that negatively regulates Pseudomonas invasion. Csk migrates to lipid raft domains, where it decreases phosphorylation of caveolin-2 by inactivating c-Src. Whereas Pseudomonas co-opts the endocytic properties of caveolin-2 for invasion, there also exists in these cells an intrinsic Csk-dependent cellular defense mechanism aimed at impairing this activity. The success of Pseudomonas in co-opting lipid raft-mediated endocytosis to invade lung epithelial cells may depend on the relative strengths of these counteracting signaling activities.	[Zaas, David W.; Swan, Zachary D.] Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Brown, Bethany J.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Li, Guojie; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Degan, Simone; Sunday, Mary E.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Randell, Scott H.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zaas, DW (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, DUMC Box 3501,Bell Bldg,Rm 350, Durham, NC 27710 USA.	david.zaas@duke.edu		Sunday, Mary E./0000-0002-6788-1469; Degan, Simone/0000-0001-5417-1196	National Institutes of Health [HL083092, HL084917, HL-30923, DK050814-28, DK065988]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084917, K08HL083092, R01HL030923, R23HL030923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050814, P30DK065988, R37DK050814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083092 ( to D. W. Z.), HL084917 ( to M. S.), HL-30923 ( to J. R. W.), DK050814-28 ( to S. N. A.), and DK065988 ( for mouse tracheal epithelial cell culture) ( to S. H. R.). This research was also supported by the Parker B. Francis Foundation.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Davidson Donald J, 2004, J Cyst Fibros, V3 Suppl 2, P59, DOI 10.1016/j.jcf.2004.05.013; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; DUNN M, 1995, CLIN CHEST MED, V16, P95; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P3863; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; MERCER AA, 1979, J BACTERIOL, V140, P37, DOI 10.1128/JB.140.1.37-42.1979; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Vang T, 2003, J BIOL CHEM, V278, P17597, DOI 10.1074/jbc.C300077200; Wang XB, 2004, BIOCHEMISTRY-US, V43, P13694, DOI 10.1021/bi049295+; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200	35	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9955	9964		10.1074/jbc.M808629200	http://dx.doi.org/10.1074/jbc.M808629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211560	Green Published, hybrid			2022-12-25	WOS:000264892900038
J	Blot, N; Wu, XJ; Thomas, JC; Zhang, J; Garczarek, L; Bohm, S; Tu, JM; Zhou, M; Ploscher, M; Eichacker, L; Partensky, F; Scheer, H; Zhao, KH				Blot, Nicolas; Wu, Xian-Jun; Thomas, Jean-Claude; Zhang, Juan; Garczarek, Laurence; Boehm, Stephan; Tu, Jun-Ming; Zhou, Ming; Ploescher, Matthias; Eichacker, Lutz; Partensky, Frederic; Scheer, Hugo; Zhao, Kai-Hong			Phycourobilin in Trichromatic Phycocyanin from Oceanic Cyanobacteria Is Formed Post-translationally by a Phycoerythrobilin Lyase-Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOBILIPROTEIN BETA-SUBUNITS; MARINE UNICELLULAR CYANOBACTERIA; ANABAENA SP PCC-7120; CHROMOPHORE ATTACHMENT; ENERGY-TRANSFER; ALPHA-SUBUNIT; R-PHYCOCYANIN; BILIN LYASE; CPCS-I; SYNECHOCOCCUS	Most cyanobacteria harvest light with large antenna complexes called phycobilisomes. The diversity of their constituting phycobiliproteins contributes to optimize the photosynthetic capacity of these microorganisms. Phycobiliprotein biosynthesis, which involves several post-translational modifications including covalent attachment of the linear tetrapyrrole chromophores (phycobilins) to apoproteins, begins to be well understood. However, the biosynthetic pathway to the blue-green-absorbing phycourobilin (lambda(max) similar to 495 nm) remained unknown, although it is the major phycobilin of cyanobacteria living in oceanic areas where blue light penetrates deeply into the water column. We describe a unique trichromatic phycocyanin, R-PC V, extracted from phycobilisomes of Synechococcus sp. strain WH8102. It is evolutionarily remarkable as the only chromoprotein known so far that absorbs the whole wavelength range between 450 and 650 nm. R-PC V carries a phycourobilin chromophore on its alpha-subunit, and this can be considered an extreme case of adaptation to blue-green light. We also discovered the enzyme, RpcG, responsible for its biosynthesis. This monomeric enzyme catalyzes binding of the green-absorbing phycoerythrobilin at cysteine 84 with concomitant isomerization to phycourobilin. This reaction is analogous to formation of the orange-absorbing phycoviolobilin from the red-absorbing phycocyanobilin that is catalyzed by the lyase-isomerase PecE/F in some freshwater cyanobacteria. The fusion protein, RpcG, and the heterodimeric PecE/F are mutually interchangeable in a heterologous expression system in Escherichia coli. The novel R-PC V likely optimizes rod-core energy transfer in phycobilisomes and thereby adaptation of a major phytoplankton group to the blue-green light prevailing in oceanic waters.	[Wu, Xian-Jun; Zhang, Juan; Tu, Jun-Ming; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Blot, Nicolas; Garczarek, Laurence; Partensky, Frederic] Univ Paris 06, Biol Stn, F-29682 Roscoff, France; [Blot, Nicolas; Garczarek, Laurence; Partensky, Frederic] CNRS, UMR7144, Grp Plancton Ocean, F-29682 Roscoff, France; [Wu, Xian-Jun; Zhang, Juan; Tu, Jun-Ming; Zhou, Ming; Zhao, Kai-Hong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Thomas, Jean-Claude] CNRS, F-75230 Paris, France; [Thomas, Jean-Claude] Ecole Normale Super, UMR 8186, Dept Biol Mol Organismes Photosynthet, F-75230 Paris, France; [Boehm, Stephan; Tu, Jun-Ming; Ploescher, Matthias; Eichacker, Lutz; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Eichacker, Lutz] Univ Stavanger, CORE, N-4036 Stavanger, Norway	Huazhong Agricultural University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Huazhong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Munich; Universitetet i Stavanger	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com	Partensky, Frédéric/AAH-1170-2021; Partensky, Frédéric/B-9194-2018	Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Garczarek, Laurence/0000-0002-8191-8395	Volkswagen Foundation [I/77900]; National Natural Science Foundation of China [30670489, 30870519]; French Agence Nationale de la Recherche (ANR) [ANR-05-BLAN-0122-01]; Deutsche Forschungsgemeinschaft [SFB 533]	Volkswagen Foundation(Volkswagen); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a partnership grant of the Volkswagen Foundation (Grant I/77900) (to H. S. and K. H. Z.), Grants 30670489 and 30870519 from the National Natural Science Foundation of China (to K. H. Z. and M. Z.), Grant ANR-05-BLAN-0122-01 from the French Agence Nationale de la Recherche (ANR) program PhycoSyn (to J. C. T., N. B., L. G., and F. P.), and Grant SFB 533, TPA1 from the Deutsche Forschungsgemeinschaft (to H. S.).	BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; BISHOP JE, 1987, J AM CHEM SOC, V109, P875, DOI 10.1021/ja00237a039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANAANI O, 1980, FEBS LETT, V115, P225, DOI 10.1016/0014-5793(80)81174-4; Dammeyer T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1121, DOI 10.1039/b807209b; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; GANTT E, 1986, PHOTOSYNTHESIS, V3, P260; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; GLAZER AN, 1977, J BIOL CHEM, V252, P32; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; GLAZER AN, 1973, J BIOL CHEM, V248, P659; Green B. R., 2003, LIGHT HARVESTING ANT; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LIPSCHULTZ CA, 1981, BIOCHEMISTRY-US, V20, P3371, DOI 10.1021/bi00515a010; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; MacColl R, 1996, J BIOL CHEM, V271, P17157, DOI 10.1074/jbc.271.29.17157; Miller CA, 2008, J BIOL CHEM, V283, P19293, DOI 10.1074/jbc.M802734200; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; ONG LJ, 1984, SCIENCE, V224, P80, DOI 10.1126/science.224.4644.80; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; Partensky F., 1999, MARINE CYANOBACTERIA, V19, P457; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter W.M., 2002, HEME CHLOROPHYLL BIL, P311, DOI DOI 10.1385/1-59259-243-0:311; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Shen GZ, 2008, J BACTERIOL, V190, P4808, DOI 10.1128/JB.00436-08; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Six C, 2005, J BACTERIOL, V187, P1685, DOI 10.1128/JB.187.5.1685-1694.2005; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; THOMAS BA, 1993, BIOCHIM BIOPHYS ACTA, V1143, P104, DOI 10.1016/0005-2728(93)90222-2; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; YU MH, 1981, PLANT PHYSIOL, V68, P482, DOI 10.1104/pp.68.2.482; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4	54	65	73	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9290	9298		10.1074/jbc.M809784200	http://dx.doi.org/10.1074/jbc.M809784200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19182270	Green Published, hybrid			2022-12-25	WOS:000264669100035
J	Huertas, P; Jackson, SP				Huertas, Pablo; Jackson, Stephen P.			Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; HOMOLOGOUS RECOMBINATION; CHECKPOINT CONTROL; DAMAGE RESPONSE; SAE2; PHOSPHORYLATION; COMPLEX; HYPERPHOSPHORYLATION; PATHWAY; GENE	In G(0) and G(1), DNA double strand breaks are repaired by non-homologous end joining, whereas in S and G(2), they are also repaired by homologous recombination. The human CtIP protein controls double strand break (DSB) resection, an event that occurs effectively only in S/G(2) and that promotes homologous recombination but not non-homologous end joining. Here, we mutate a highly conserved cyclin-dependent kinase (CDK) target motif in CtIP and reveal that mutating Thr-847 to Ala impairs resection, whereas mutating it to Glu to mimic constitutive phosphorylation does not. Moreover, we show that unlike cells expressing wild-type CtIP, cells expressing the Thr-to-Glu mutant resect DSBs even after CDK inhibition. Finally, we establish that Thr-847 mutations to either Ala or Glu affect DSB repair efficiency, cause hypersensitivity toward DSB-generating agents, and affect the frequency and nature of radiation-induced chromosomal rearrangements. These results suggest that CDK-mediated control of resection in human cells operates by mechanisms similar to those recently established in yeast.	[Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Huertas, Pablo/N-2245-2016; Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Huertas, Pablo/0000-0002-1756-4449; Jackson, Stephen Philip/0000-0001-9317-7937; 	Cancer Research UK; European Community [LSHG-CT-2005512113]; Genomic Instability in Cancer and Precancer [HEALTH-F22007-201630]; Biotechnology and Biological Sciences Research Council Research [BBF0016651]; Biotechnology and Biological Sciences Research Council [BB/F001665/1] Funding Source: researchfish; BBSRC [BB/F001665/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Community(European Commission); Genomic Instability in Cancer and Precancer; Biotechnology and Biological Sciences Research Council Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Cancer Research UK and the European Community (Integrated Project DNA repair, Grant LSHG-CT-2005512113, and Genomic Instability in Cancer and Precancer, Grant HEALTH-F22007-201630) (to S. P. J.) and Biotechnology and Biological Sciences Research Council Research Grant BBF0016651 (to P. H.).	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; HARRINGTON J, 1992, MOL CELL BIOL, V12, P4758, DOI 10.1128/MCB.12.10.4758; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Vilkki S, 2002, J MED GENET, V39, P785, DOI 10.1136/jmg.39.11.785; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu GK, 2006, CELL CYCLE, V5, P1592, DOI 10.4161/cc.5.15.3127; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	35	345	352	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9558	9565		10.1074/jbc.M808906200	http://dx.doi.org/10.1074/jbc.M808906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19202191	Green Published, hybrid			2022-12-25	WOS:000264669100062
J	Algar, EM; Muscat, A; Dagar, V; Rickert, C; Chow, CW; Biegel, JA; Ekert, PG; Saffery, R; Craig, J; Johnstone, RW; Ashley, DM				Algar, Elizabeth M.; Muscat, Andrea; Dagar, Vinod; Rickert, Christian; Chow, C. W.; Biegel, Jaclyn A.; Ekert, Paul G.; Saffery, Richard; Craig, Jeff; Johnstone, Ricky W.; Ashley, David M.			Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors	PLOS ONE			English	Article								SMARCB1 is deleted in rhabdoid tumor, an aggressive paediatric malignancy affecting the kidney and CNS. We hypothesized that the oncogenic pathway in rhabdoid tumors involved epigenetic silencing of key cell cycle regulators as a consequence of altered chromatin-remodelling, attributable to loss of SMARCB1, and that this hypothesis if proven could provide a biological rationale for testing epigenetic therapies in this disease. We used an inducible expression system to show that the imprinted cell cycle inhibitor CDKN1C is a downstream target for SMARCB1 and is transcriptionally activated by increased histone H3 and H4 acetylation at the promoter. We also show that CDKN1C expression induces cell cycle arrest, CDKN1C knockdown with siRNA is associated with increased proliferation, and is able to compete against the anti-proliferative effect of restored SMARCB1 expression. The histone deacetylase inhibitor (HDACi), Romidepsin, specifically restored CDKN1C expression in rhabdoid tumor cells through promoter histone H3 and H4 acetylation, recapitulating the effect of SMARCB1 on CDKNIC allelic expression, and induced cell cycle arrest in G401 and STM91-01 rhabdoid tumor cell lines. CDKN1C expression was also shown to be generally absent in clinical specimens of rhabdoid tumor, however CDKN1A and CDKN1B expression persisted. Our observations suggest that maintenance of CDKN1C expression plays a critical role in preventing rhabdoid tumor growth. Significantly, we report for the first time, parallels between the molecular pathways of SMARCB1 restoration and Romidepsin treatment, and demonstrate a biological basis for the further exploration of histone deacetylase inhibitors as relevant therapeutic reagents in the treatment of rhabdoid tumor.			Algar, EM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Res Lab, Childrens Canc Ctr, Flemington Rd, Parkville, Vic 3052, Australia.	elizabeth.algar@rch.org.au	Johnstone, Ricky w/H-3748-2014; Saffery, Richard/GLS-1976-2022; Craig, Jeffrey M/B-3484-2012; Algar, Elizabeth/B-3770-2012; Ekert, Paul/Q-1842-2015; Ekert, Paul G/C-7247-2013	Johnstone, Ricky w/0000-0001-7053-9237; Saffery, Richard/0000-0002-9510-4181; Craig, Jeffrey M/0000-0003-3979-7849; Ekert, Paul/0000-0002-2976-8617; Ekert, Paul G/0000-0002-2976-8617	NATIONAL CANCER INSTITUTE [R01CA046274] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA046274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algar E, 2000, HUM MUTAT, V15, P497, DOI 10.1002/1098-1004(200006)15:6<497::AID-HUMU2>3.0.CO;2-F; Algar EM, 1999, J MED GENET, V36, P524; Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Biegel JA, 2002, CLIN CANCER RES, V8, P3461; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jackson EM, 2007, AM J MED GENET A, V143A, P1767, DOI 10.1002/ajmg.a.31843; Jordan CT, 1996, EXP HEMATOL, V24, P1347; Judkins AR, 2004, AM J SURG PATHOL, V28, P644, DOI 10.1097/00000478-200405000-00013; Kikuchi T, 2002, ONCOGENE, V21, P2741, DOI 10.1038/sj.onc.1205376; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kobatake T, 2004, ONCOL REP, V12, P1087; Kuang SQ, 2007, ONCOGENE, V26, P1439, DOI 10.1038/sj.onc.1209907; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Lindemann RK, 2004, CELL CYCLE, V3, P779; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Merchant SH, 2005, HUM PATHOL, V36, P180, DOI 10.1016/j.humpath.2004.12.007; Merlo P, 2005, J BIOL CHEM, V280, P30354, DOI 10.1074/jbc.M500635200; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; OTA S, 1993, CANCER-AM CANCER SOC, V71, P2862, DOI 10.1002/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D; Pan XF, 2005, BIOCHEM BIOPH RES CO, V337, P1052, DOI 10.1016/j.bbrc.2005.09.155; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Reincke BS, 2003, J CELL PHYSIOL, V194, P303, DOI 10.1002/jcp.10201; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Savla J, 2000, JNCI-J NATL CANCER I, V92, P648, DOI 10.1093/jnci/92.8.648; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Shen LL, 2003, BLOOD, V101, P4131, DOI 10.1182/blood-2002-08-2466; Shin JY, 2000, CANCER RES, V60, P262; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Tsugu A, 2000, AM J PATHOL, V157, P919, DOI 10.1016/S0002-9440(10)64605-6; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	52	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4482	10.1371/journal.pone.0004482	http://dx.doi.org/10.1371/journal.pone.0004482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221586	Green Published, gold			2022-12-25	WOS:000265485700009
J	Cheng, L; Chen, H; Yao, XS; Qi, GQ; Liu, HW; Lee, K; Lee, K; Zhang, JT; Chen, SH; Lin, XL; Zhao, WC; Li, JK; Li, M				Cheng, Lei; Chen, Hao; Yao, Xinsheng; Qi, Guoqing; Liu, Hongwei; Lee, Kwongman; Lee, Kaho; Zhang, Jieting; Chen, Shihui; Lin, Xiaoli; Zhao, Wenchao; Li, Jiankuan; Li, Ming			A Plant-Derived Remedy for Repair of Infarcted Heart	PLOS ONE			English	Article								Background: Myocardial infarction (MI) due to coronary artery disease remains one of the leading causes of premature death. Replacement of infarcted heart tissue with regenerating myocardium from endogenous progenitor pools or exogenously introduced stem cells remains a therapeutic ideal. Their impracticality mainly lies in their low efficiency in cardiogenic differentiation (CD). Our recent studies with an acute MI animal model have already demonstrated the therapeutic effect of the MeOH extract of Geum japonicum (EGJ), providing clear evidence of myocardial regeneration. Methods and Findings: The present study further isolated the active component contained in EGJ using bioassay-guided isolation and investigated its efficacy in the treatment of infarcted heart in animal MI models. We demonstrated that substantial repair of infarcted heart in animal MI models by EGJ can be mimicked by the isolated candidate compound (cardiogenin) in MI animal models. Clear evidence of newly regenerated endogenous mesenchymal stem cells (MSCs) derived cardiomyocytes was observed throughout the infarct zone, accompanied by significantly improved functional performance of the heart. Transplantation of MSCs pretreated with EGJ or cardiogenin into a MI animal model also resulted in substantial regeneration of functional myocardium, implying that the activated MSCs carry all the necessary blueprints for myocardial regeneration. Signaling pathways specific to cell survival, CD identified in embryonic heart induction and angiogenesis were activated in both cardiogenin-treated MSCs and cardiogenin-induced regenerating myocardium. Conclusions: This study has demonstrated the therapeutic effects of cardiogenin in infarcted heart repair, and identified the associated signalling pathways for effective cardiogenic differentiation of MSCs, cell survival and angiogenesis. These findings should enable new treatment strategies for MI to be developed immediately.	[Cheng, Lei; Chen, Hao; Zhang, Jieting; Chen, Shihui; Lin, Xiaoli; Zhao, Wenchao; Li, Jiankuan; Li, Ming] Chinese Univ Hong Kong, Minist Educ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Cheng, Lei; Chen, Hao; Lee, Kwongman; Zhang, Jieting; Chen, Shihui; Li, Ming] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Lee, Kaho] Chinese Univ Hong Kong, Fac Med, Dept Anat, Hong Kong, Peoples R China; [Qi, Guoqing] Hebei Med Univ, Affiliated Hosp 1, Dept Cardiol, Shijiazhuang, Peoples R China; [Yao, Xinsheng] Jian Univ, Dept Pharmacol, Guangzhou, Peoples R China; [Liu, Hongwei] Chinese Acad Sci, Inst Microbiol, Key Lab Systemat Mycol & Lichenol, Beijing, Peoples R China	Chinese University of Hong Kong; Ministry of Education, China; Chinese University of Hong Kong; Chinese University of Hong Kong; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Cheng, L (corresponding author), Chinese Univ Hong Kong, Minist Educ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	li-ming@cuhk.edu.hk	Lee, Kenneth Ka Ho/H-6698-2013; Chen, Hao/D-3425-2012; Chen, Hao/AAH-4124-2020	Lee, Kenneth Ka Ho/0000-0002-6520-304X; Chen, Hao/0000-0001-8319-8101; Chen, Hao/0000-0001-8319-8101	CUHK [6901985]; VC of the Chinese University of Hong Kong [2140569]; CRF; NSFC [20502016];  [7103270]	CUHK(Chinese University of Hong Kong); VC of the Chinese University of Hong Kong; CRF; NSFC(National Natural Science Foundation of China (NSFC)); 	The work was supported by a CUHK Stem Cell grant (6901985), a private donation (7103270), an equipment grant from the VC of the Chinese University of Hong Kong, a RGC grant (2140569), a CRF grant and a NSFC grant (20502016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; CHEN U, 1993, DEV DYNAM, V197, P217, DOI 10.1002/aja.1001970306; Damjanov I, 1974, Curr Top Pathol, V59, P69; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Foley A, 2004, TRENDS CARDIOVAS MED, V14, P121, DOI 10.1016/j.tcm.2004.01.003; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Li M, 2006, CLIN CHEM, V52, P1460, DOI 10.1373/clinchem.2006.068247; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Menasche P, 2004, NAT BIOTECHNOL, V22, P1237, DOI 10.1038/nbt1004-1237; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Perry Lily M., 1980, MED PLANTS E SE ASIA; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; Yoo KJ, 2000, CIRCULATION, V102, P204	28	23	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2009	4	2							e4461	10.1371/journal.pone.0004461	http://dx.doi.org/10.1371/journal.pone.0004461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JS	19221596	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484400001
J	Gomes, JE; Corado, M; Schweisguth, F				Gomes, Jose-Eduardo; Corado, Maria; Schweisguth, Francois			Van Gogh and Frizzled Act Redundantly in the Drosophila Sensory Organ Precursor Cell to Orient Its Asymmetric Division	PLOS ONE			English	Article								Drosophila sensory organ precursor cells (SOPs) divide asymmetrically along the anterior-posterior (a-p) body axis to generate two different daughter cells. Planar Cell Polarity (PCP) regulates the a-p orientation of the SOP division. The localization of the PCP proteins Van Gogh (Vang) and Frizzled (Fz) define anterior and posterior apical membrane domains prior to SOP division. Here, we investigate the relative contributions of Vang, Fz and Dishevelled (Dsh), a membrane-associated protein acting downstream of Fz, in orienting SOP polarity. Genetic and live imaging analyses suggest that Dsh restricts the localization of a centrosome-attracting activity to the anterior cortex and that Vang is a target of Dsh in this process. Using a clone border assay, we provide evidence that the Vang and fz genes act redundantly in SOPs to orient its polarity axis in response to extrinsic local PCP cues. Additionally, we find that the activity of Vang is dispensable for the non-autonomous polarizing activity of fz. These observations indicate that both Vang and Fz act as cues for downstream effectors orienting the planar polarity axis of dividing SOPs.	[Gomes, Jose-Eduardo; Corado, Maria; Schweisguth, Francois] Inst Jacques Monod, F-75251 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Gomes, JE (corresponding author), Inst Jacques Monod, 2 Pl Jussieu, F-75251 Paris, France.	fschweis@pasteur.fr		Gomes, Jose Eduardo/0000-0001-7264-9448	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure (ENS); Fundacao para a Ciencia e a Tecnologia (FCT); National Science Foundation (NSF)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure (ENS); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by: Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure (ENS), Fundacao para a Ciencia e a Tecnologia (FCT), National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bastock R, 2007, DEVELOPMENT, V134, P3055, DOI 10.1242/dev.010447; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; KLEIN TJ, 2005, ANN REV CELL DEV BIO; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lee H, 2002, GENETICS, V160, P1535; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Zecca M, 2002, DEVELOPMENT, V129, P1357	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4485	10.1371/journal.pone.0004485	http://dx.doi.org/10.1371/journal.pone.0004485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214234	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484300015
J	Zimmermann, E; Kring, SII; Berentzen, TL; Holst, C; Pers, TH; Hansen, T; Pedersen, O; Sorensen, TIA; Jess, T				Zimmermann, Esther; Kring, Sofia I. I.; Berentzen, Tina L.; Holst, Claus; Pers, Tune H.; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.; Jess, Tine			Fatness-Associated FTO Gene Variant Increases Mortality Independent of Fatness - in Cohorts of Danish Men	PLOS ONE			English	Article							BODY-MASS INDEX; ADULT OBESITY; YOUNG MEN; RS9939609; FAT; OVERWEIGHT; CHILDHOOD; SMOKING	Background: The A-allele of the single nucleotide polymorphism (SNP), rs9939609, in the FTO gene is associated with increased fatness. We hypothesized that the SNP is associated with morbidity and mortality through the effect on fatness. Methodology/Principal Findings: In a population of 362,200 Danish young men, examined for military service between 1943 and 1977, all obese (BMI >= 31.0 kg/m(2)) and a random 1% sample of the others were identified. In 1992-94, at an average age of 46 years, 752 of the obese and 876 of the others were re-examined, including measurements of weight, fat mass, height, and waist circumference, and DNA sampling. Hospitalization and death occurring during the following median 13.5 years were ascertained by linkage to national registers. Cox regression analyses were performed using a dominant effect model (TT vs. TA or AA). In total 205 men died. Mortality was 42% lower (p = 0.001) with the TT genotype than in A-allele carriers. This phenomenon was observed in both the obese and the randomly sampled cohort when analysed separately. Adjustment for fatness covariates attenuated the association only slightly. Exploratory analyses of cause-specific mortality and morbidity prior to death suggested a general protective effect of the TT genotype, whereas there were only weak associations with disease incidence, except for diseases of the nervous system. Conclusion: Independent of fatness, the A-allele of the FTO SNP appears to increase mortality of a magnitude similar to smoking, but without a particular underlying disease pattern barring an increase in the risk of diseases of the nervous system.	[Zimmermann, Esther; Kring, Sofia I. I.; Berentzen, Tina L.; Holst, Claus; Sorensen, Thorkild I. A.; Jess, Tine] Univ Copenhagen Hosp, Inst Prevent Med, Ctr Hlth & Soc, DK-2100 Copenhagen, Denmark; [Pers, Tune H.] Tech Univ Denmark, Ctr Biol Sequence Analysis, Lyngby, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Steno Diabetes Center	Zimmermann, E (corresponding author), Univ Copenhagen Hosp, Inst Prevent Med, Ctr Hlth & Soc, DK-2100 Copenhagen, Denmark.	tj@ipm.regionh.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Huicho, Luis/0000-0002-5272-5885; Zimmermann, Esther/0000-0001-5854-0542; Hansen, Torben/0000-0001-8748-3831; Pers, Tune/0000-0003-0207-4831	Cluster for Endocrinology and Metabolism, University of Copenhagen; Danish Council for Strategic Research [2101-06-0005]	Cluster for Endocrinology and Metabolism, University of Copenhagen; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen. Further, it is a part of the research program of the Danish Obesity Research Centre (DanORC, see www.danorc.dk). DanORC is supported by the Danish Council for Strategic Research (Grant 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; *DAN NAT BOARD HLT, 2006, NEW FIG NAT BOARD HL; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HEITMANN BL, 1994, EUR J CLIN NUTR, V48, P228; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Juel K, 1999, DAN MED BULL, V46, P354; Pedersen CB, 2006, DAN MED BULL, V53, P441; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; SCHNOHR P, 2001, J EUROPEAN SOC CARDI, V3; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200	26	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4428	10.1371/journal.pone.0004428	http://dx.doi.org/10.1371/journal.pone.0004428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214238	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484300001
J	Lind, M; Oden, A; Fahlen, M; Eliasson, B				Lind, Marcus; Oden, Anders; Fahlen, Martin; Eliasson, Bjorn			The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE BURDEN; MICROVASCULAR COMPLICATIONS; INSULIN-TREATMENT; HEMOGLOBIN; MODELS; RISK	Aim: The updated mean HbA1c has been used in risk estimates of diabetic complications, but it does not take into account the temporal relationship between HbA1c and diabetic complications. We studied whether the updated mean HbA1c underestimated the risk of diabetic complications. Method: Continuous HbA1c curves for 10,000 hypothetical diabetes patients were simulated over an average of 7 years. Simulations were based on HbA1c values encountered in clinical practice. We assumed that each short time interval of the continuous HbA1c curves had a long-lasting effect on diabetic complications, as evidenced by earlier studies. We tested several different HbA1c variables including various profiles, e.g. different duration, of such a long-lasting effect. The predictive power of these variables was compared with that of the updated mean HbA1c. Results: The predictive power of the constructed HbA1c variables differed considerably compared to that of the updated mean HbA1c. The risk increase per standard deviation could be almost 100% higher for a constructed predictor than the updated mean HbA1c. Conclusions: The importance of good glycemic control in preventing diabetic complications could have been underestimated in earlier hallmark studies by not taking the time-dependent effect of HbA1c into account.	Uddevalla Cent Hosp, Dept Med, Uddevalla, Sweden; [Oden, Anders] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Fahlen, Martin] Kungalv Hospital, Dept Med, Kungalv, Sweden; [Eliasson, Bjorn] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden	Voestalpine AG; Chalmers University of Technology; Sahlgrenska University Hospital	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022; Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 1995, DIABETES, V44, P968; Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Bagust A, 2001, DIABETOLOGIA, V44, P2140, DOI 10.1007/s001250100023; *CONTR CARD RISK D, 2008, NEW ENGL J MED, V358, P2545; COX DR, 1972, J R STAT SOC B, V34, P187; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Eeg-Olofsson K, 2007, DIABETES CARE, V30, P496, DOI 10.2337/dc06-1406; Fahlen M, 2005, DIABETIC MED, V22, P382, DOI 10.1111/j.1464-5491.2004.01444.x; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; HOLMAN RR, 2008, N ENGL J MED    0910; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Lawes CMM, 2004, STROKE, V35, P1024, DOI 10.1161/01.STR.0000126208.14181.DD; LIND M, 2008, SYSTEMATIC REV HBA1C, P2282; LIND M, 2008, DIABET IN PRESS 0312; LIPTSER B, 2001, STAT RANDOM PROCESSE; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Nardi A, 2003, STAT MED, V22, P3597, DOI 10.1002/sim.1592; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Osterbrand M, 2007, EUR J EPIDEMIOL, V22, P151, DOI 10.1007/s10654-007-9107-4; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	28	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4412	10.1371/journal.pone.0004412	http://dx.doi.org/10.1371/journal.pone.0004412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209233	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484100003
J	Rutishauser, D; Mertz, KD; Moos, R; Brunner, E; Rulicke, T; Calella, AM; Aguzzi, A				Rutishauser, Dorothea; Mertz, Kirsten D.; Moos, Rita; Brunner, Erich; Ruelicke, Thomas; Calella, Anna Maria; Aguzzi, Adriano			The Comprehensive Native Interactome of a Fully Functional Tagged Prion Protein	PLOS ONE			English	Article							SCRAPIE; MICE; PRP; RESISTANT; INFECTIVITY; PROPAGATION; EXPRESSION; ISOFORMS; ABSENCE; DISEASE	The enumeration of the interaction partners of the cellular prion protein, PrPC, may help clarifying its elusive molecular function. Here we added a carboxy proximal myc epitope tag to PrPC. When expressed in transgenic mice, PrPmyc carried a GPI anchor, was targeted to lipid rafts, and was glycosylated similarly to PrPC. PrPmyc antagonized the toxicity of truncated PrP, restored prion infectibility of PrPC-deficient mice, and was physically incorporated into PrPSc aggregates, indicating that it possessed all functional characteristics of genuine PrPC. We then immunopurified myc epitope-containing protein complexes from PrPmyc transgenic mouse brains. Gentle differential elution with epitope-mimetic decapeptides, or a scrambled version thereof, yielded 96 specifically released proteins. Quantitative mass spectrometry with isotope-coded tags identified seven proteins which co-eluted equimolarly with PrPC and may represent component of a multiprotein complex. Selected PrPC interactors were validated using independent methods. Several of these proteins appear to exert functions in axomyelinic maintenance.	[Rutishauser, Dorothea; Mertz, Kirsten D.; Moos, Rita; Brunner, Erich; Calella, Anna Maria; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Rutishauser, Dorothea] Funct Genom Ctr Zurich, Zurich, Switzerland; [Brunner, Erich] Univ Zurich, Ctr Model Organism Proteomes, CH-8006 Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Res Ctr Biomodels Austria, Vienna, Austria	University of Zurich; University Zurich Hospital; University of Zurich; University of Veterinary Medicine Vienna	Rutishauser, D (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Mertz, Kirsten/AAY-1660-2020; Aguzzi, Adriano/A-3351-2008	Mertz, Kirsten/0000-0002-3074-6925; Rutishauser, Dorothea/0000-0003-2303-103X; Aguzzi, Adriano/0000-0002-0344-6708	National Prion Research Program [DAMD17-03-1-0456]; European Union; Swiss National Foundation; National Competence Center on Neural Plasticity and Repair; Stammbach foundation; DEFRA; Roche Research Foundation	National Prion Research Program; European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Competence Center on Neural Plasticity and Repair; Stammbach foundation; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Roche Research Foundation	AA is supported by the National Prion Research Program (DoD, DAMD17-03-1-0456), European Union contracts (TSEUR, Immunoprion), the Swiss National Foundation, the National Competence Center on Neural Plasticity and Repair, the Stammbach foundation, DEFRA and the Roche Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2005, IMMUNITY, V22, P145, DOI 10.1016/j.immuni.2004.12.007; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; AGUZZI A, 2007, MOL MECH PRION PATHO; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bian JF, 2006, BIOCHEM BIOPH RES CO, V340, P894, DOI 10.1016/j.bbrc.2005.12.085; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Ledesma MD, 2003, EMBO REP, V4, P1190, DOI 10.1038/sj.embor.7400021; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lipart C, 2002, J VIROL METHODS, V101, P1, DOI 10.1016/S0166-0934(01)00413-X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nishida N, 1999, LAB INVEST, V79, P689; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; PATTISON IH, 1965, VET REC, V77, P1388, DOI 10.1136/vr.77.47.1388; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmalfeldt M, 2000, J CELL SCI, V113, P807; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; von Haller PD, 2001, PROTEOMICS, V1, P1010; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; 2004, J BIOL CHEM, P36497	57	64	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4446	10.1371/journal.pone.0004446	http://dx.doi.org/10.1371/journal.pone.0004446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209230	Green Published, gold, Green Accepted			2022-12-25	WOS:000265484100010
J	Asrar, S; Zhou, ZK; Ren, W; Jia, ZP				Asrar, Suhail; Zhou, Zikai; Ren, Wei; Jia, Zhengping			Ca2+ Permeable AMPA Receptor Induced Long-Term Potentiation Requires PI3/MAP Kinases but Not Ca/CaM-Dependent Kinase II	PLOS ONE			English	Article								Ca2+ influx via GluR2-lacking Ca2+-permeable AMPA glutamate receptors (CP-AMPARs) can trigger changes in synaptic efficacy in both interneurons and principle neurons, but the underlying mechanisms remain unknown. We took advantage of genetically altered mice with no or reduced GluR2, thus allowing the expression of synaptic CP-AMPARs, to investigate the molecular signaling process during CP-AMPAR-induced synaptic plasticity at CA1 synapses in the hippocampus. Utilizing electrophysiological techniques, we demonstrated that these receptors were capable of inducing numerous forms of long-term potentiation (referred to as CP-AMPAR dependent LTP) through a number of different induction protocols, including high-frequency stimulation (HFS) and theta-burst stimulation (TBS). This included a previously undemonstrated form of protein-synthesis dependent late-LTP (L-LTP) at CA1 synapses that is NMDA-receptor independent. This form of plasticity was completely blocked by the selective CP-AMPAR inhibitor IEM-1460, and found to be dependent on postsynaptic Ca2+ ions through calcium chelator (BAPTA) studies. Surprisingly, Ca/CaM-dependent kinase II ( CaMKII), the key protein kinase that is indispensable for NMDA-receptor dependent LTP at CA1 synapses appeared to be not required for the induction of CP-AMPAR dependent LTP due to the lack of effect of two separate pharmacological inhibitors (KN-62 and staurosporine) on this form of potentiation. Both KN-62 and staurosporine strongly inhibited NMDA-receptor dependent LTP in control studies. In contrast, inhibitors for PI3-kinase (LY294002 and wortmannin) or the MAPK cascade (PD98059 and U0126) significantly attenuated this CP-AMPAR-dependent LTP. Similarly, postsynaptic infusion of tetanus toxin (TeTx) light chain, an inhibitor of exocytosis, also had a significant inhibitory effect on this form of LTP. These results suggest that distinct synaptic signaling underlies GluR2-lacking CP-AMPAR-dependent LTP, and reinforces the recent notions that CP-AMPARs are important facilitators of synaptic plasticity in the brain.	[Asrar, Suhail; Zhou, Zikai; Jia, Zhengping] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Asrar, Suhail; Zhou, Zikai; Jia, Zhengping] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ren, Wei] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Shaanxi Normal University	Asrar, S (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	zpjia@hotmail.com	Jia, zhengping/AAZ-4190-2021	Zhou, Zikai/0000-0002-4577-9826	Canadian Institutes of Health Research (CIHR) [MOP-42396]; Ontario Mental Health Foundation; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR MOP-42396) and Ontario Mental Health Foundation. Suhail Asrar was supported by the Ontario Graduate Scholarship (OGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Buldakova SL, 2007, NEUROSCIENCE, V144, P88, DOI 10.1016/j.neuroscience.2006.09.005; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Opazo P, 2003, J NEUROSCI, V23, P3679; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sanchez-Martinez C, 2003, BIOORG MED CHEM LETT, V13, P3835, DOI 10.1016/S0960-894X(03)00791-1; Sanna PP, 2002, J NEUROSCI, V22, P3359; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Wang S, 2002, J NEUROPHYSIOL, V88, P29, DOI 10.1152/jn.2002.88.1.29	49	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4339	10.1371/journal.pone.0004339	http://dx.doi.org/10.1371/journal.pone.0004339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190753	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483300003
J	Ishida, T; Fushinobu, S; Kawai, R; Kitaoka, M; Igarashi, K; Samejima, M				Ishida, Takuya; Fushinobu, Shinya; Kawai, Rie; Kitaoka, Motomitsu; Igarashi, Kiyohiko; Samejima, Masahiro			Crystal Structure of Glycoside Hydrolase Family 55 beta-1,3-Glucanase from the Basidiomycete Phanerochaete chrysosporium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; PARALLEL BETA-HELICES; CLOSTRIDIUM-CELLULOLYTICUM; INULIN FRUCTOTRANSFERASE; TRICHODERMA-HARZIANUM; PROCESSIVE ACTION; CELLULASE CE148F; ACTIVE-SITE; CLONING; GLUCAN	Glycoside hydrolase family 55 consists of beta-1,3-glucanases mainly from filamentous fungi. A beta-1,3-glucanase (Lam55A) from the Basidiomycete Phanerochaete chrysosporium hydrolyzes beta-1,3-glucans in the exo-mode with inversion of anomeric configuration and produces gentiobiose in addition to glucose from beta-1,3/1,6-glucans. Here we report the crystal structure of Lam55A, establishing the three-dimensional structure of a member of glycoside hydrolase 55 for the first time. Lam55A has two beta-helical domains in a single polypeptide chain. These two domains are separated by a long linker region but are positioned side by side, and the overall structure resembles a rib cage. In the complex, a gluconolactone molecule is bound at the bottom of a pocket between the two beta-helical domains. Based on the position of the gluconolactone molecule, Glu-633 appears to be the catalytic acid, whereas the catalytic base residue could not be identified. The substrate binding pocket appears to be able to accept a gentiobiose unit near the cleavage site, and a long cleft runs from the pocket, in accordance with the activity of this enzyme toward various beta-1,3-glucan oligosaccharides. In conclusion, we provide important features of the substrate-binding site at the interface of the two beta-helical domains, demonstrating an unexpected variety of carbohydrate binding modes.	[Ishida, Takuya; Kawai, Rie; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Fushinobu, Shinya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Samejima, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amsam@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Igarashi, Kiyohiko/E-6799-2016; Kitaoka, Motomitsu/R-1536-2019	Fushinobu, Shinya/0000-0003-1346-6435; Igarashi, Kiyohiko/0000-0001-5152-7177; Kitaoka, Motomitsu/0000-0002-0083-1838	Japanese Ministry of Education, Culture, Sports, and Technology [17380102]; Graduate School of Agricultural and Life Sciences; University of Tokyo	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Graduate School of Agricultural and Life Sciences; University of Tokyo	This work was supported by Grant-in-Aid for Scientific Research 17380102 (to M. S.) from the Japanese Ministry of Education, Culture, Sports, and Technology and by a Grant for the Research Collaboration of Assistant Professors (to K. I. and S. F.) from Graduate School of Agricultural and Life Sciences, the University of Tokyo.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; BIELECKI S, 1991, CRIT REV BIOTECHNOL, V10, P275, DOI 10.3109/07388559109038212; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P59, DOI 10.1016/S0968-0004(01)02046-1; Cohen-Kupiec R, 1999, GENE, V226, P147, DOI 10.1016/S0378-1119(98)00583-6; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giczey G, 2001, APPL ENVIRON MICROB, V67, P865, DOI 10.1128/AEM.67.2.865-871.2001; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; KASAHARA S, 1992, J FERMENT BIOENG, V74, P238, DOI 10.1016/0922-338X(92)90118-E; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Kawai R, 2006, APPL MICROBIOL BIOT, V71, P898, DOI 10.1007/s00253-005-0214-4; Kim CS, 2007, J MICROBIOL BIOTECHN, V17, P37; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Larsson AM, 2003, STRUCTURE, V11, P1111, DOI 10.1016/S0969-2126(03)00147-3; Martin K, 2007, FEMS MICROBIOL REV, V31, P168, DOI 10.1111/j.1574-6976.2006.00055.x; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nobe R, 2004, BIOSCI BIOTECH BIOCH, V68, P2111, DOI 10.1271/bbb.68.2111; Nobe R, 2003, BIOSCI BIOTECH BIOCH, V67, P1349, DOI 10.1271/bbb.67.1349; OHNO N, 1986, CARBOHYD RES, V158, P217, DOI 10.1016/0008-6215(86)84019-8; OHNO N, 1989, CARBOHYD RES, V194, P261, DOI 10.1016/0008-6215(89)85024-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITSON SM, 1995, BIOCHEM J, V308, P733, DOI 10.1042/bj3080733; PITSON SM, 1993, ENZYME MICROB TECH, V15, P178, DOI 10.1016/0141-0229(93)90136-P; Rigden DJ, 2002, FEBS LETT, V530, P225, DOI 10.1016/S0014-5793(02)03490-7; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; RUEL K, 1991, APPL ENVIRON MICROB, V57, P374, DOI 10.1128/AEM.57.2.374-384.1991; SCHAEFFER HJ, 1994, APPL ENVIRON MICROB, V60, P594, DOI 10.1128/AEM.60.2.594-598.1994; STONE BA, 1992, CHEM BIOL 1 ARROW 3, P283; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSUJISAKA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1201, DOI 10.1080/00021369.1981.10864682; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; YAMAMOTO R, 1983, CARBOHYD RES, V122, P217, DOI 10.1016/0008-6215(83)88333-5; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Yoshida M, 2001, BIOSCI BIOTECH BIOCH, V65, P2050, DOI 10.1271/bbb.65.2050; ZEVENHUI.LP, 1970, J GEN MICROBIOL, V61, P183, DOI 10.1099/00221287-61-2-183	59	41	42	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10100	10109		10.1074/jbc.M808122200	http://dx.doi.org/10.1074/jbc.M808122200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193645	hybrid, Green Published			2022-12-25	WOS:000264892900052
J	Baba, A; Akagi, K; Takayanagi, M; Flanagan, JG; Kobayashi, T; Hattori, M				Baba, Atsushi; Akagi, Koshiro; Takayanagi, Mai; Flanagan, John G.; Kobayashi, Toshihide; Hattori, Mitsuharu			Fyn Tyrosine Kinase Regulates the Surface Expression of Glycosylphosphatidylinositol-linked Ephrin via the Modulation of Sphingomyelin Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; GROWTH-FACTOR RECEPTOR; LIPID RAFTS; INTRACELLULAR TRAFFICKING; NEUTRAL SPHINGOMYELINASES; ACID SPHINGOMYELINASE; FAMILY; HETEROGENEITY; CELLS; SRC	Glycosylphosphatidylinositol-linked ephrin-As play important roles in various biological events, such as neuronal development and immune responses. Because the surface amount of ephrin-As is critical in these events, the trafficking of ephrin-As must be regulated by intracellular machinery. In particular, Src family protein-tyrosine kinases regulate the intracellular trafficking of several membrane molecules and act downstream of ephrin-As; whether they affect the trafficking of ephrin-As, however, has remained unexplored. Here, we report that the activity of Src family protein-tyrosine kinases, particularly Fyn, negatively regulates the cell-surface amount of ephrin-As. The expression of constitutively active Fyn decreases the surface amount of ephrin-As. Conversely, the expression of dominant-negative Fyn or the application of a Src-family inhibitor increases the surface amount of ephrin-A2. The total cellular amount of ephrin-A is inversely correlated with its amount on the surface, suggesting that ephrin-As are more stable in the intracellular compartment. The expression of constitutively active Fyn increases the amount of sphingomyelin clusters on the plasma membrane, whereas inhibiting Fyn decreases it. Moreover, the inhibition of sphingomyelin synthesis greatly increases the surface amount of ephrin-As. Altogether, these results suggest that Fyn regulates the surface amount of ephrin-As by modulating the metabolism of sphingomyelin, which presumably inhibits the trafficking of ephrin-As from endosomes to the plasma membrane. The signaling cascade described here may function as part of the negative feedback loop of ephrin-A function.	[Baba, Atsushi; Akagi, Koshiro; Takayanagi, Mai; Hattori, Mitsuharu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, Aichi 4678603, Japan; [Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kobayashi, Toshihide] RIKEN Frontier Res Syst, Suprabiomol Syst Res Grp, Wako, Saitama 3510198, Japan	Nagoya City University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; RIKEN	Baba, A (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, 3-1 Tanabe Dori, Aichi 4678603, Japan.	atbaba@phar.nagoya-cu.ac.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Hattori, Mitsuharu/F-3859-2010	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Hattori, Mitsuharu/0000-0002-0503-4969; Baba, Atsushi/0000-0002-6871-7249	Ministry of Education, Science, Sports, and Culture	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Science, Sports, and Culture (to A. B. and M. H.).	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cheng H, 2008, CURR BIOL, V18, P705, DOI 10.1016/j.cub.2008.04.043; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DITTMER JC, 1964, J LIPID RES, V5, P126; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FUSAKI N, 1994, INT IMMUNOL, V6, P1245, DOI 10.1093/intimm/6.8.1245; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ishitsuka R, 2005, J BIOCHEM, V137, P249, DOI 10.1093/jb/mvi041; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mishra S, 2007, J NEUROCHEM, V103, P135, DOI 10.1111/j.1471-4159.2007.04720.x; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Rijnboutt S, 1996, J CELL BIOL, V132, P35, DOI 10.1083/jcb.132.1.35; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; TAKEUCHI M, 1993, J BIOL CHEM, V268, P27413; WANG E, 1991, J BIOL CHEM, V266, P14486; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185	46	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9206	9214		10.1074/jbc.M809401200	http://dx.doi.org/10.1074/jbc.M809401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181669	hybrid, Green Published			2022-12-25	WOS:000264669100027
J	Park, CY; Jun, HJ; Wakita, T; Cheong, JH; Hwang, SB				Park, Chul-Yong; Jun, Hyun-Jeong; Wakita, Takaji; Cheong, Jae Hun; Hwang, Soon B.			Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; LIVER-X-RECEPTOR; HEPATOCELLULAR-CARCINOMA; RNA REPLICATION; TRANSCRIPTION FACTOR; LIPID-ACCUMULATION; SYNTHASE GENE; PPAR-GAMMA; STEATOSIS; INFECTION	Hepatitis C virus (HCV) infection is often associated with hepatic steatosis and yet the molecular mechanisms of HCV-associated steatosis are poorly understood. Because sterol regulatory element-binding proteins (SREBPs) are the major transcriptional factors in lipogenic gene expression including fatty acid synthase (FAS), we examined the effects of HCV nonstructural proteins on the signaling pathways of SREBP. In this study, we demonstrated that HCV nonstructural 4B (NS4B) protein increased the transcriptional activities of SREBPs. We also showed that HCV NS4B enhanced the protein expression levels of SREBPs and FAS. This was further confirmed in the context of viral RNA replication and HCV infection. The up-regulation of both SREBP and FAS by NS4B protein required phosphatidylinositol 3-kinase activity. We also demonstrated that NS4B protein induced a lipid accumulation in hepatoma cells. In addition, NS4B protein synergistically elevated the transcriptional activity of HCV core-mediated SREBP-1. These results strongly suggest that NS4B may play an important role in HCV-associated liver pathogenesis by modulating the SREBP signaling pathway.	[Park, Chul-Yong; Jun, Hyun-Jeong; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang 431060, South Korea; [Park, Chul-Yong; Jun, Hyun-Jeong; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, South Korea; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Cheong, Jae Hun] Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea	Hallym University; Hallym University; National Institute of Infectious Diseases (NIID); Pusan National University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr			Cancer Control, Ministry of Health and Welfare [0620100]; New Drug Target Discovery [M10601000044-06N0100-04410]; Ministry of Education, Science and Technology, Korea [ROA-2007-000-20051-0]	Cancer Control, Ministry of Health and Welfare; New Drug Target Discovery; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National R&D Program for Cancer Control, Ministry of Health and Welfare Grant 0620100, Korea, the Research Program for New Drug Target Discovery (M10601000044-06N0100-04410) and Biotechnology Development (2008-04100), and National Research Laboratory Grant ROA-2007-000-20051-0 from the Ministry of Education, Science and Technology, Korea.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHO YG, 1993, MOL CELLS, V3, P195; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Choi SH, 2007, GASTROENTEROLOGY, V132, P343, DOI 10.1053/j.gastro.2006.10.038; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Fartoux L, 2005, HEPATOLOGY, V41, P82, DOI 10.1002/hep.20519; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim SS, 2007, GASTROENTEROLOGY, V132, P311, DOI 10.1053/j.gastro.2006.10.032; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lundin M, 2006, J GEN VIROL, V87, P3263, DOI 10.1099/vir.0.82211-0; Mihm S, 1997, HEPATOLOGY, V25, P735, DOI 10.1002/hep.510250340; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Ramalho F, 2003, ANTIVIR RES, V60, P125, DOI 10.1016/j.antiviral.2003.08.007; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	50	110	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9237	9246		10.1074/jbc.M808773200	http://dx.doi.org/10.1074/jbc.M808773200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19204002	Green Published, hybrid			2022-12-25	WOS:000264669100030
J	Telford, JE; Kilbride, SM; Davey, GP				Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.			Complex I Is Rate-limiting for Oxygen Consumption in the Nerve Terminal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ELECTRON-TRANSPORT CHAIN; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE; BRAIN MITOCHONDRIA; SYNAPTOSOMES; RESPIRATION; INHIBITION; DEFICIENCY; MUTATIONS	Metabolic control analysis was used to determine the spread of control exerted by the electron transport chain complexes over oxygen consumption rates in the nerve terminal. Oxygen consumption rates and electron transport chain complex activities were titrated with appropriate inhibitors to determine the flux control coefficients and the inhibition thresholds in rat brain synaptosomes. The flux control coefficients for complex I, complex II/III, complex III, and complex IV were found to be 0.30 +/- 0.07, 0.20 +/- 0.03, 0.20 +/- 0.05, and 0.08 +/- 0.05, respectively. Inhibition thresholds for complex I, complex II/III, complex III, and complex IV activities were determined to be similar to 10, similar to 30, similar to 35, and 50-65%, respectively, before major changes in oxygen consumption rates were observed. These results indicate that, of the electron transport chain components, complex I exerts a high level of control over synaptosomal bioenergetics, suggesting that complex I deficiencies that are present in neurodegenerative disorders, such as Parkinson disease, are sufficient to compromise oxygen consumption in the synaptosomal model of the nerve terminal.	[Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trin Coll Dublin, Trin Coll Inst Neurosci, Dublin 2, Ireland; [Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trin Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Davey, GP (corresponding author), Trin Coll Dublin, Trin Coll Inst Neurosci, Dublin 2, Ireland.	gdavey@tcd.ie	Davey, Gavin/HGB-4233-2022		Programme for Research in Third-Level Institutions, Science Foundation Ireland; Marie Curie Transfer of Knowledge [MTKD-CT-2005-030005]	Programme for Research in Third-Level Institutions, Science Foundation Ireland(Science Foundation Ireland); Marie Curie Transfer of Knowledge(European Commission)	This work was supported in part by the Programme for Research in Third-Level Institutions, Science Foundation Ireland, and Marie Curie Transfer of Knowledge Grant MTKD-CT-2005-030005.	ALMEIDA A, 1995, DEV NEUROSCI-BASEL, V17, P212, DOI 10.1159/000111289; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davey GP, 1996, J NEUROCHEM, V66, P1617; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Joyce OJP, 2003, J NEUROCHEM, V86, P1032, DOI 10.1046/j.1471-4159.2003.01915.x; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; King T., 1967, METHOD ENZYMOL, V10, P217; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093; PAUWELS PJ, 1985, J NEUROCHEM, V44, P143, DOI 10.1111/j.1471-4159.1985.tb07123.x; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Sipos I, 2003, J NEUROCHEM, V84, P112, DOI 10.1046/j.1471-4159.2003.01513.x; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wharton DC., 1967, METHOD ENZYMOL, P245	28	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9109	9114		10.1074/jbc.M809101200	http://dx.doi.org/10.1074/jbc.M809101200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193637	Green Published, hybrid			2022-12-25	WOS:000264669100014
J	Lu, HY; Zhang, JP; Wu, NQ; Liu, KB; Xu, D; Li, Q				Lu, Houyuan; Zhang, Jianping; Wu, Naiqin; Liu, Kam-Biu; Xu, Deke; Li, Quan			Phytoliths Analysis for the Discrimination of Foxtail Millet (Setaria italica) and Common Millet (Panicum miliaceum)	PLOS ONE			English	Article							WHEAT TRITICUM-MONOCOCCUM; ORYZA-SATIVA POACEAE; INFLORESCENCE BRACTS; SILICA BODIES; RICE; GRASSES; CHINA; WILD; AESTIVUM; CARCINOGENESIS	Foxtail millet (Setaria italica) and Common millet (Panicum miliaceum) are the oldest domesticated dry farming crops in Eurasia. Identifying these two millets in the archaeobotanical remains are still problematic, especially because the millet grains preserve only when charred. Phytoliths analysis provides a viable method for identifying this important crop. However, to date, the identification of millet phytoliths has been questionable, because very little study has been done on their morphometry and taxonomy. Particularly, no clear diagnostic feature has been used to distinguish between Foxtail millet and Common millet. Here we examined the anatomy and silicon structure patterns in the glumes, lemmas, and paleas from the inflorescence bracts in 27 modern plants of Foxtail millet, Common millet, and closely related grasses, using light microscopy with phase-contrast and microscopic interferometer. Our research shows that five key diagnostic characteristics in phytolith morphology can be used to distinguish Foxtail millet from Common millet based on the presence of cross-shaped type, regularly arranged papillae, V-undulated type, endings structures of epidermal long cell, and surface ridgy line sculpture in the former species. We have established identification criteria that, when used together, give the only reliable way of distinguishing between Foxtail millet and Common millet species based on their phytoliths characteristics, thus making a methodological contribution to phytolith research. Our findings also have important implications in the fields of plant taxonomy, agricultural archaeology, and the culture history of ancient civilizations.	[Lu, Houyuan; Zhang, Jianping; Wu, Naiqin; Xu, Deke; Li, Quan] Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China; [Liu, Kam-Biu] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Louisiana State University System; Louisiana State University	Lu, HY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China.	houyuanlu@mail.iggcas.ac.cn	Lu, houyuan/L-8661-2019; Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014	Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X	Chinese Academy of Sciences [kzcx2-yw-117]; NSFC [40771216, 40325002]; Chinese Civilization Origin projects [2006BAK21B02]; U.S. NSF [BCS-0623514, ATM-0402475]	Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); Chinese Civilization Origin projects; U.S. NSF(National Science Foundation (NSF))	This work was supported by the Chinese Academy of Sciences (100 Talents Programme, kzcx2-yw-117), NSFC (40771216; 40325002), Chinese Civilization Origin projects (2006BAK21B02), and the U.S. NSF(BCS-0623514, ATM-0402475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo C, 2001, ANN BOT FENN, V38, P1; Ball T, 1996, J ARCHAEOL SCI, V23, P619, DOI 10.1006/jasc.1996.0058; BALL TB, 1993, CAN J BOT, V71, P1182, DOI 10.1139/b93-139; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Berlin AM, 2003, J ARCHAEOL SCI, V30, P115, DOI 10.1006/jasc.2002.0812; Costea Mihai, 2002, SIDA Contributions to Botany, V20, P525; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; CRAWFORD GW, 1992, ORIGINS AGR; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Harvey EL, 2005, J ARCHAEOL SCI, V32, P739, DOI 10.1016/j.jas.2004.12.010; HODSON MJ, 1985, ANN BOT-LONDON, V55, P649, DOI 10.1093/oxfordjournals.aob.a086944; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jacobs S. W. L., 2001, Telopea, V9, P439; Krishnan S, 2000, BOT J LINN SOC, V132, P241, DOI 10.1111/j.1095-8339.2000.tb01529.x; LIU CJ, 2004, KAOGU, P748; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 1998, THESIS CHINESE ACAD; Lu TLD, 1998, ANTIQUITY, V72, P902, DOI 10.1017/S0003598X00087548; Madella M., 2003, INDUS ETHNOBIOLOGY N, P199; MULHOLLAND SC, 1990, CAN J BOT, V68, P1638, DOI 10.1139/b90-210; MULHOLLAND SC, 1988, CAN J BOT, V66, P2001, DOI 10.1139/b88-273; MUSIL AF, 1963, AGR HDB USDA, V219; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; Nesbitt M.G., 2005, CULTURAL HIST PLANTS, P45; PAHRRY DW, 1966, ANN BOT, V30, P525; PARRY DW, 1982, ANN BOT-LONDON, V49, P531, DOI 10.1093/oxfordjournals.aob.a086278; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D. R., 2006, PHYTOLITHS COMPREHEN, P238; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1984, AM ANTIQUITY, V49, P361, DOI 10.2307/280024; Portillo M, 2006, ECON BOT, V60, P121, DOI 10.1663/0013-0001(2006)60[121:MAOIPP]2.0.CO;2; Renfrew J. M., 1973, Palaeoethnobotany. The prehistoric food plants of the Near East and Europe.; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P132; SANGSTER AG, 1983, NEW PHYTOL, V93, P105, DOI 10.1111/j.1469-8137.1983.tb02696.x; TAKEOKA Y, 1984, JPN J CROP SCI, V53, P197, DOI 10.1626/jcs.53.197; TERRELL EE, 1981, AM J BOT, V68, P697, DOI 10.2307/2442797; TUBB HJ, 1993, ANN BOT-LONDON, V72, P537, DOI 10.1006/anbo.1993.1142; Wang Y., 1993, STUDY PHYTOLITH ITS, P228; Whang SS, 1998, AM J BOT, V85, P461, DOI 10.2307/2446428; You XL., 1993, AGR HIST CHINA, V12, P1; Zhao Z, 2006, I ARCHAEOLOGY CHINES, P97; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zheng D.S, 2005, J PLANT GENETIC RESO, V6, P354	46	145	186	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4448	10.1371/journal.pone.0004448	http://dx.doi.org/10.1371/journal.pone.0004448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212442	gold, Green Submitted, Green Published			2022-12-25	WOS:000265484200009
J	Yamakawa, Y; Kanai, R; Matsumura, M; Naito, E				Yamakawa, Yoshinori; Kanai, Ryota; Matsumura, Michikazu; Naito, Eiichi			Social Distance Evaluation in Human Parietal Cortex	PLOS ONE			English	Article							ASSOCIATION CORTEX; PERCEPTION; SPACE; REPRESENTATIONS; MAGNITUDE; DICTATOR; NUMBER; WINDOW; COMMON; TARGET	Across cultures, social relationships are often thought of, described, and acted out in terms of physical space (e.g. "close friends'' "high lord''). Does this cognitive mapping of social concepts arise from shared brain resources for processing social and physical relationships? Using fMRI, we found that the tasks of evaluating social compatibility and of evaluating physical distances engage a common brain substrate in the parietal cortex. The present study shows the possibility of an analytic brain mechanism to process and represent complex networks of social relationships. Given parietal cortex's known role in constructing egocentric maps of physical space, our present findings may help to explain the linguistic, psychological and behavioural links between social and physical space.	[Yamakawa, Yoshinori] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Yamakawa, Yoshinori] Japan Soc Promot Sci, Tokyo, Japan; [Yamakawa, Yoshinori; Naito, Eiichi] ATR Comput Neurosci Lab, Kyoto, Japan; [Yamakawa, Yoshinori] NEC Corp Ltd, Corp Corp Planning Div, Tokyo, Japan; [Kanai, Ryota] UCL, Inst Cognit Neurosci, London WC1E 6BT, England; [Matsumura, Michikazu] Kyoto Univ, Grad Sch Human & Environm Stud, Kyoto, Japan; [Naito, Eiichi] Kobe Advanced ICT Res Ctr, Natl Inst Informat & Communication Technol, Dept Res 1, Biophys ICT Grp, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; NEC Corporation; University of London; University College London; Kyoto University	Yamakawa, Y (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	enaito@atr.jp		Kanai, Ryota/0000-0002-0186-2687; yamakawa, yoshinori/0000-0002-7995-1794	Kyoto University COE Program "Center of Excellence for Psychological Studies"; Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan [19500290]; Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory; Human Frontier Science Foundation	Kyoto University COE Program "Center of Excellence for Psychological Studies"; Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan; Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Foundation(Human Frontier Science Program)	This study was supported by Kyoto University COE Program "Center of Excellence for Psychological Studies" and Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan and by the Grant-in-Aid for Scientific Research (C), 19500290, MEXT, Japan. Y.Y. is supported by the Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory. R.K. is supported by Human Frontier Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlof GA, 1997, ECONOMETRICA, V65, P1005, DOI 10.2307/2171877; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bogardus Emory S., 1959, SOCIAL DISTANCE; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Bottero W, 2003, BRIT J SOCIOL, V54, P177, DOI 10.1080/0007131032000080195; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; CHIAO JY, 2008, NEUROPSYCHOLOGIA; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith C., 2004, NEUROSCIENCE SOCIAL; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Goleman D., 2006, SOCIAL INTELLIGENCE; Hagura N, 2007, J NEUROSCI, V27, P7047, DOI 10.1523/JNEUROSCI.0970-07.2007; Hall E.T., 1966, HIDDEN DIMENSION, V609; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hoffman E, 1996, AM ECON REV, V86, P653; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Milner A. D., 1995, VISUAL BRAIN ACTION; Naito E, 2008, J NEUROPHYSIOL, V99, P695, DOI 10.1152/jn.00529.2007; Neggers SFW, 2006, NEUROIMAGE, V31, P320, DOI 10.1016/j.neuroimage.2005.12.028; OSSOWSKI S, 1963, CLASS STRUCTURE SOCI; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RAPCSAK SZ, 1995, BRAIN COGNITION, V27, P213, DOI 10.1006/brcg.1995.1018; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P118, DOI 10.1152/jn.1980.43.1.118; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zebrowitz L. A., 1997, READING FACES WINDOW; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	42	39	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4360	10.1371/journal.pone.0004360	http://dx.doi.org/10.1371/journal.pone.0004360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JO	19204791	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000265484000001
J	Hormannsperger, G; Clavel, T; Hoffmann, M; Reiff, C; Kelly, D; Loh, G; Blaut, M; Holzlwimmer, G; Laschinger, M; Haller, D				Hoermannsperger, Gabriele; Clavel, Thomas; Hoffmann, Micha; Reiff, Caroline; Kelly, Denise; Loh, Gunnar; Blaut, Michael; Hoelzlwimmer, Gabriele; Laschinger, Melanie; Haller, Dirk			Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation	PLOS ONE			English	Article								Background: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). Methodology/Principal Findings: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF Delta ARE and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. Conclusions/Significance: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.	[Hoermannsperger, Gabriele; Clavel, Thomas; Hoffmann, Micha; Haller, Dirk] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Chair Biofunct, D-8050 Freising Weihenstephan, Germany; [Reiff, Caroline; Kelly, Denise] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB9 1FX, Scotland; [Loh, Gunnar; Blaut, Michael] Deutsches Inst Ernahrungsforsch, Potsdam, Germany; [Hoelzlwimmer, Gabriele] Helmholz Zent Munchen, Inst Pathol, Munich, Germany; [Laschinger, Melanie] Tech Univ Munich, Dept Surg, Munich, Germany	Technical University of Munich; University of Aberdeen; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hormannsperger, G (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Chair Biofunct, D-8050 Freising Weihenstephan, Germany.	haller@wzw.tum.de		Meharg, Caroline/0000-0003-0573-9528; Haller, Dirk/0000-0002-6977-4085; Blaut, Michael/0000-0002-6628-2907	European Nutrigenomics Organisation [FP6-506360]; Bundesministerium fur Bildung und Forschung [AZ0313814]	European Nutrigenomics Organisation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Financial support for this study was obtained from the European Nutrigenomics Organisation, contract nr. FP6-506360 and the Bundesministerium fur Bildung und Forschung, AZ0313814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chapman TM, 2006, DRUGS, V66, P1371, DOI 10.2165/00003495-200666100-00006; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clovel T, 2007, INFLAMM BOWEL DIS, V13, P1153, DOI 10.1002/ibd.20174; Dardalhon V, 2002, CELL BIOL INT, V26, P669, DOI 10.1006/cbir.2002.0917; Giacinto CD, 2005, J IMMUNOL, V174, P3237; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Gionchetti P, 2007, DIS COLON RECTUM, V50, P2075, DOI 10.1007/s10350-007-9068-4; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hensbergen PJ, 2004, J BIOL CHEM, V279, P13402, DOI 10.1074/jbc.M312814200; HEO J, 2006, TOXICOL SCI, V96, P92; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Inatomi O, 2005, J GASTROENTEROL, V40, P483, DOI 10.1007/s00535-005-1573-4; Isaacs K, 2008, INFLAMM BOWEL DIS, V14, P1597, DOI 10.1002/ibd.20465; Isowa N, 2000, AM J PHYSIOL-LUNG C, V279, pL1075, DOI 10.1152/ajplung.2000.279.6.L1075; Kamada N, 2008, INFECT IMMUN, V76, P214, DOI 10.1128/IAI.01193-07; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; LAHAT N, 2008, AM J PHYSL IN PRESS; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Marinari Umberto Maria, 2003, Molecular Aspects of Medicine, V24, P205, DOI 10.1016/S0098-2997(03)00015-3; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Proost P, 2006, BIOCHEM SOC T, V34, P997, DOI 10.1042/BST0340997; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ruiz PA, 2005, J IMMUNOL, V174, P2990, DOI 10.4049/jimmunol.174.5.2990; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; SCHAHS P, 2008, EXP CELL RE IN PRESS; Shanmugam N, 2006, J BIOL CHEM, V281, P31212, DOI 10.1074/jbc.M602445200; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; Tebo JM, 1998, BLOOD, V92, P4742, DOI 10.1182/blood.V92.12.4742.424k26_4742_4749; Tien MT, 2006, J IMMUNOL, V176, P3841, DOI 10.4049/jimmunol.176.6.3841-b; TilsalaTimisjarvi A, 1997, INT J FOOD MICROBIOL, V35, P49, DOI 10.1016/S0168-1605(97)88066-X; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002	52	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4365	10.1371/journal.pone.0004365	http://dx.doi.org/10.1371/journal.pone.0004365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197385	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483700003
J	Siliceo, M; Merida, I				Siliceo, Maria; Merida, Isabel			T Cell Receptor-dependent Tyrosine Phosphorylation of beta 2-Chimaerin Modulates Its Rac-GAP Function in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; GROWTH-CONE COLLAPSE; SRC-FAMILY KINASES; ACTIN CYTOSKELETON; ADAPTER PROTEIN; NEUROBLASTOMA-CELLS; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; RHO-FAMILY; C1 DOMAINS	The actin cytoskeleton has an important role in the organization and function of the immune synapse during antigen recognition. Dynamic rearrangement of the actin cytoskeleton in response to T cell receptor (TCR) triggering requires the coordinated activation of Rho family GTPases that cycle between active and inactive conformations. This is controlled by GTPase-activating proteins (GAP), which regulate inactivation of Rho GTPases, and guanine exchange factors, which mediate their activation. Whereas much attention has centered on guanine exchange factors for Rho GTPases in T cell activation, the identity and functional roles of the GAP in this process are largely unknown. We previously reported beta 2-chimaerin as a diacylglycerol-regulated Rac-GAP that is expressed in T cells. We now demonstrate Lck-dependent phosphorylation of beta 2-chimaerin in response to TCR triggering. We identify Tyr-153 as the Lck-dependent phosphorylation residue and show that its phosphorylation negatively regulates membrane stabilization of beta 2-chimaerin, decreasing its GAP activity to Rac. This study establishes the existence of TCR-dependent regulation of beta 2-chimaerin and identifies a novel mechanism for its inactivation.	[Siliceo, Maria; Merida, Isabel] Consejo Super Invest Cient, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Merida, I (corresponding author), Consejo Super Invest Cient, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,UAM Campus Cantoblanco, E-28049 Madrid, Spain.	imerida@cnb.csic.es	Merida, Isabel/A-9713-2014	Merida, Isabel/0000-0003-2762-6241	Carlos III Institute (Spanish Ministry of Health) [RD067002071035]; Spanish Ministry of Education [BFU2007-62639]; Comunidad de Madrid [S-SAL-0311]	Carlos III Institute (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Education(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported in part by Grants RD067002071035 from the Carlos III Institute (Spanish Ministry of Health), BFU2007-62639 (Spanish Ministry of Education), and S-SAL-0311 from Comunidad de Madrid.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Hall C, 2005, TRENDS BIOCHEM SCI, V30, P169, DOI 10.1016/j.tibs.2005.02.003; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Penninger JM, 1999, EUR J IMMUNOL, V29, P1709, DOI 10.1002/(SICI)1521-4141(199905)29:05<1709::AID-IMMU1709>3.3.CO;2-F; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Salojin KV, 1999, J IMMUNOL, V163, P844; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang H, 2006, BIOCHEM SOC T, V34, P855, DOI 10.1042/BST0340855; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; YUAN SX, 1995, CANCER RES, V55, P3456; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	58	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11354	11363		10.1074/jbc.M806098200	http://dx.doi.org/10.1074/jbc.M806098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19201754	hybrid, Green Published			2022-12-25	WOS:000265494500040
J	Kiefer, H; Mizutani, A; Iemura, SI; Natsume, T; Ando, H; Kuroda, Y; Mikoshiba, K				Kiefer, Helene; Mizutani, Akihiro; Iemura, Shun-Ichiro; Natsume, Tohru; Ando, Hideaki; Kuroda, Yukiko; Mikoshiba, Katsuhiko			Inositol 1,4,5-Triphosphate Receptor-binding Protein Released with Inositol 1,4,5-Triphosphate (IRBIT) Associates with Components of the mRNA 3 ' Processing Machinery in a Phosphorylation-dependent Manner and Inhibits Polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) POLYMERASE; SPECIFICITY FACTOR; 1,4,5-TRISPHOSPHATE RECEPTOR; 3'-END FORMATION; MULTIPLE FORMS; 160-KD SUBUNIT; FACTOR CPSF-73; IP3 RECEPTOR; CLEAVAGE; SIGNAL	IRBIT is a recently identified protein that modulates the activities of both inositol 1,4,5-triphosphate receptor and pancreas-type Na+/HCO3- cotransporter 1, and the multi-site phosphorylation of IRBIT is required for achieving this modulatory action. Here, we report the identification of the cleavage and polyadenylation specificity factor (CPSF), which is a multi-protein complex involved in 3' processing of mRNA precursors, as an additional binding partner for IRBIT. We found that IRBIT interacted with CPSF and was recruited to an exogenous polyadenylation signal-containing RNA. The main target for IRBIT in CPSF was Fip1 subunit, and the phosphorylation of the serine-rich region of IRBIT was required both for direct association with Fip1 in vitro and for redistribution of Fip1 into the cytoplasm of intact cells. Furthermore, tert-butylhydroquinone (tBHQ), an agent that induces oxidative stress, increased the phosphorylation level of IRBIT in vivo and in parallel enhanced the interaction between IRBIT and CPSF and promoted the cytoplasmic distribution of endogenous Fip1. In addition to CPSF, IRBIT interacted in vitro with poly(A) polymerase (PAP), which is the enzyme recruited by CPSF to elongate the poly(A) tail, and inhibited PAP activity in a phosphorylation-dependent manner. These findings raise the possibility that IRBIT modulates the polyadenylation state of specific mRNAs, both by controlling the cytoplasmic/nuclear partitioning of Fip1 and by inhibiting PAP activity, in response to a stimulus that alters its phosphorylation state.	[Kiefer, Helene; Mizutani, Akihiro; Ando, Hideaki; Kuroda, Yukiko; Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Iemura, Shun-Ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Syst Control Team, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Kawaguchi, Saitama 3320012, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Dev Neurobiol Lab, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Kiefer, Hélène/Q-2752-2018; Mizutani, Akihiro/GPS-4809-2022; Ando, Hideaki/D-3876-2017; Mikoshiba, Katsuhiko/N-7943-2015; Kiefer, Helene/AAY-9185-2020; Natsume, Tohru/M-7627-2018; Kuroda, Yukiko/L-6332-2013; Kuroda, Yukiko/L-6332-2013	Kiefer, Hélène/0000-0002-6631-741X; Mizutani, Akihiro/0000-0003-4155-802X; Natsume, Tohru/0000-0002-1510-2582; Kuroda, Yukiko/0000-0002-5335-4238; Kuroda, Yukiko/0000-0001-7713-9471	Ministry of Education, Science, and Culture of Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Inoue Foundation for Science; Moritani Scholarship Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inoue Foundation for Science(Inoue Foundation for Science); Moritani Scholarship Foundation	This work was supported by the Ministry of Education, Science, and Culture of Japan, the Japan Science and Technology Agency, the Japan Society for the Promotion of Science, the Inoue Foundation for Science, and the Moritani Scholarship Foundation.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2009, J NEUROCHEM, V109, P539, DOI 10.1111/j.1471-4159.2009.05979.x; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kim H, 2003, EMBO J, V22, P5208, DOI 10.1093/emboj/cdg486; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; RYNER LC, 1989, MOL CELL BIOL, V9, P4229, DOI 10.1128/MCB.9.10.4229; SCHEK N, 1992, MOL CELL BIOL, V12, P5386, DOI 10.1128/MCB.12.12.5386; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; THURESSON AC, 1994, P NATL ACAD SCI USA, V91, P979, DOI 10.1073/pnas.91.3.979; WAHLE E, 1991, J BIOL CHEM, V266, P3131; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Xing HY, 2004, J BIOL CHEM, V279, P10551, DOI 10.1074/jbc.M311719200; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002410; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	44	23	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10694	10705		10.1074/jbc.M807136200	http://dx.doi.org/10.1074/jbc.M807136200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224921	Green Published, hybrid			2022-12-25	WOS:000265104600043
J	Amarneh, B; Matthews, KA; Rawson, RB				Amarneh, Bilal; Matthews, Krista A.; Rawson, Robert B.			Activation of Sterol Regulatory Element-binding Protein by the Caspase Drice in Drosophila Larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; BIOCHEMICAL-ANALYSIS; CYSTEINE PROTEASE; DRONC; DIAP1; PURIFICATION; MELANOGASTER; APOPTOSIS; CLEAVES; GENOME	During larval development in Drosophila melanogaster, transcriptional activation of target genes by sterol regulatory element-binding protein (dSREBP) is essential for survival. In all cases studied to date, activation of SREBPs requires sequential proteolysis of the membrane-bound precursor by site-1 protease (S1P) and site-2 protease (S2P). Cleavage by S2P, within the first membrane-spanning helix of SREBP, releases the transcription factor. In contrast to flies lacking dSREBP, flies lacking dS2P are viable. The Drosophila effector caspase Drice cleaves dSREBP, and cleavage requires an Asp residue at position 386, in the cytoplasmic juxtamembrane stalk. The initiator caspase Dronc does not cleave dSREBP, but animals lacking dS2P require both drice and dronc to complete development. They do not require Dcp1, although this effector caspase also can cleave dSREBP in vitro. Cleavage of dSREBP by Drice releases the amino-terminal transcription factor domain of dSREBP to travel to the nucleus where it mediates the increased transcription of target genes needed for lipid synthesis and uptake. Drice-dependent activation of dSREBP explains why flies lacking dS2P are viable, and flies lacking dSREBP itself are not.	[Amarneh, Bilal; Matthews, Krista A.; Rawson, Robert B.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rawson, RB (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Rob.Rawson@UTSouthwestern.Edu			National Institutes of Health [R01 GM07145701A1]; The Perot Family Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Perot Family Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM07145701A1. This work was also supported by The Perot Family Foundation.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; CHURCH RB, 1966, GENET RES, V7, P383, DOI 10.1017/S0016672300009836; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dorstyn L, 2008, CELL DEATH DIFFER, V15, P461, DOI 10.1038/sj.cdd.4402288; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Higgins ME, 2001, J LIPID RES, V42, P1939; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Laundrie B, 2003, GENETICS, V165, P1881; Matthews KA, 2009, GENETICS, V181, P119, DOI 10.1534/genetics.108.093450; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; SANG JH, 1956, J EXP BIOL, V33, P45; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Theopold U, 1996, P NATL ACAD SCI USA, V93, P1195, DOI 10.1073/pnas.93.3.1195; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044	33	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9674	9682		10.1074/jbc.M900346200	http://dx.doi.org/10.1074/jbc.M900346200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224859	hybrid, Green Published			2022-12-25	WOS:000264892900007
J	Ding, MG; di Rago, JP; Trumpower, BL				Ding, Martina G.; di Rago, Jean-Paul; Trumpower, Bernard L.			Combining Inhibitor Resistance-conferring Mutations in Cytochrome b Creates Conditional Synthetic Lethality in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BC(1) COMPLEX; MOLECULAR-BASIS; ILICICOLIN-H; REGULATORY INTERACTIONS; ATOVAQUONE RESISTANCE; UBIQUINOL OXIDATION; MUTANTS RESISTANT; C REDUCTASE; Q(O) SITE	The mitochondrial cytochrome bc(1) complex is an essential respiratory enzyme in oxygen-utilizing eukaryotic cells. Its core subunit, cytochrome b, contains two sites, center P and center N, that participate in the electron transfer activity of the bc(1) complex and that can be blocked by specific inhibitors. In yeast, there are various point mutations that confer inhibitor resistance at center P or center N. However, there are no yeast strains in which the bc(1) complex is resistant to both center P and center N inhibitors. We attempted to create such strains by crossing yeast strains with inhibitor-resistant mutations at center P with yeast strains with inhibitor-resistant mutations at center N. Characterization of yeast colonies emerging from the cross revealed that there were multiple colonies resistant against either inhibitor alone but that the mutational changes were ineffective when combined and when the yeast were grown in the presence of both inhibitors. Inhibitor titrations of bc(1) complex activities in mitochondrial membranes from the various yeast mutants showed that a mutation that confers resistance to an inhibitor at center P, when combined with a mutation that confers resistance to an inhibitor at center N, eliminates or markedly decreases the resistance conferred by the center N mutation. These results indicate that there is a pathway for structural communication between the two active sites of cytochrome b and open new possibilities for the utilization of center N as a potential drug target.	[Ding, Martina G.; Trumpower, Bernard L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [di Rago, Jean-Paul] Univ Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France	Dartmouth College; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Trumpower, BL (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 20379. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baggish AL, 2002, ANTIMICROB AGENTS CH, V46, P1163, DOI 10.1128/AAC.46.5.1163-1173.2002; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Ding MG, 2006, J BIOL CHEM, V281, P36036, DOI 10.1074/jbc.M608026200; DIRAGO JP, 1990, FEBS LETT, V263, P93, DOI 10.1016/0014-5793(90)80713-S; DIRAGO JP, 1989, J BIOL CHEM, V264, P14543; ENDO T, 1970, J ANTIBIOT, V23, P91, DOI 10.7164/antibiotics.23.91; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; GERTH K, 1980, J ANTIBIOT, V33, P1474, DOI 10.7164/antibiotics.33.1474; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; Kessl JJ, 2004, J BIOL CHEM, V279, P2817, DOI 10.1074/jbc.M309984200; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; RAPER KB, 1949, AMANUAL PENICILLIA, P616; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; SCHMITT ME, 1991, J BIOL CHEM, V266, P14958; THIERBACH G, 1982, MOL GEN GENET, V186, P501, DOI 10.1007/BF00337956; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P102; TRUMPOWER BL, 2004, ENCY BIOL CHEM, V1, P528; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g; YANG XH, 1988, J BIOL CHEM, V263, P11962; YU CA, 1972, J BIOL CHEM, V247, P1012	34	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8478	8485		10.1074/jbc.M809278200	http://dx.doi.org/10.1074/jbc.M809278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179332	Green Published, hybrid			2022-12-25	WOS:000264397800032
J	Vernia, S; Solaz-Fuster, MC; Gimeno-Alcaniz, JV; Rubio, T; Garcia-Haro, L; Foretz, M; de Cordoba, SR; Sanz, P				Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Foretz, Marc; Rodriguez de Cordoba, Santiago; Sanz, Pascual			AMP-activated Protein Kinase Phosphorylates R5/PTG, the Glycogen Targeting Subunit of the R5/PTG-Protein Phosphatase 1 Holoenzyme, and Accelerates Its Down-regulation by the Laforin-Malin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; AMINO-ACID-SEQUENCE; SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; CELLULAR-ENERGY; PTG; ACCUMULATION; METABOLISM; DISEASE; SYSTEM	R5/PTG is one of the glycogen targeting subunits of type 1 protein phosphatase, a master regulator of glycogen synthesis. R5/PTG recruits the phosphatase to the places where glycogen synthesis occurs, allowing the activation of glycogen synthase and the inactivation of glycogen phosphorylase, thus increasing glycogen synthesis and decreasing its degradation. In this report, we show that the activity of R5/PTG is regulated by AMP-activated protein kinase (AMPK). We demonstrate that AMPK interacts physically with R5/PTG and modifies its basal phosphorylation status. We have also mapped the major phosphorylation sites of R5/PTG by mass spectrometry analysis, observing that phosphorylation of Ser-8 and Ser-268 increased upon activation of AMPK. We have recently described that the activity of R5/PTG is down- regulated by the laforin-malin complex, composed of a dual specificity phosphatase (laforin) and an E3-ubiquitin ligase (malin). We now demonstrate that phosphorylation of R5/PTG at Ser-8 by AMPK accelerates its laforin/malin-dependent ubiquitination and subsequent proteasomal degradation, which results in a decrease of its glycogenic activity. Thus, our results define a novel role of AMPK in glycogen homeostasis.	[Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Sanz, Pascual] CSIC, Inst Biomed, Valencia 46010, Spain; [Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Sanz, Pascual] CIBERER, Valencia 46010, Spain; [Foretz, Marc] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Foretz, Marc] INSERM, U567, F-75014 Paris, France; [Rodriguez de Cordoba, Santiago] CIBERER, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sanz, P (corresponding author), CSIC, Inst Biomed, Jaime Roig 11, Valencia 46010, Spain.	sanz@ibv.csic.es	Sanz, Pascual/K-2751-2014; Rubio, Teresa/ABC-6384-2020; Vernia, Santiago/Q-7038-2017; FORETZ, Marc/O-7334-2017; de Cordoba, Santiago Rodriguez/K-6727-2014	Sanz, Pascual/0000-0002-2399-4103; Rubio, Teresa/0000-0003-0843-528X; Vernia, Santiago/0000-0001-6728-5555; FORETZ, Marc/0000-0001-7017-9032; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; , Luisa/0000-0003-0519-9322	Fundacio'n Marato TV3; Spanish Ministry of Education and Science [SAF2005-00852]; European Commission [LSHM-CT-2004-005272]	Fundacio'n Marato TV3; Spanish Ministry of Education and Science(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Fundacio'n Marato TV3, the Spanish Ministry of Education and Science ( Grant SAF2005-00852), and the European Commission ( Grant LSHM-CT-2004-005272).	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CHEN YH, 1994, DIABETES, V43, P1234, DOI 10.2337/diabetes.43.10.1234; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cohen PTW, 2002, J CELL SCI, V115, P241; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Doherty MJ, 1996, FEBS LETT, V399, P339, DOI 10.1016/S0014-5793(96)01357-9; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1111/j.1574-6976.2001.tb00574.x; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; LEGRAIN P, 1994, NUCLEIC ACIDS RES, V22, P3241, DOI 10.1093/nar/22.15.3241; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Solaz-Fuster MC, 2006, CELL SIGNAL, V18, P1702, DOI 10.1016/j.cellsig.2006.01.021; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	35	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8247	8255		10.1074/jbc.M808492200	http://dx.doi.org/10.1074/jbc.M808492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171932	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000264397800008
J	Middelbos, IS; Vester, BM; Karr-Lilienthal, LK; Schook, LB; Swanson, KS				Middelbos, Ingmar S.; Vester, Brittany M.; Karr-Lilienthal, Lisa K.; Schook, Lawrence B.; Swanson, Kelly S.			Age and Diet Affect Gene Expression Profile in Canine Skeletal Muscle	PLOS ONE			English	Article							MONOAMINE-OXIDASE; PROTEIN; DNA; IDENTIFICATION; METABOLISM; RECEPTOR; BINDING; GROWTH; TRANSCRIPTION; LOCALIZATION	We evaluated gene transcription in canine skeletal muscle (biceps femoris) using microarray analysis to identify effects of age and diet on gene expression. Twelve female beagles were used (six 1-year olds and six 12-year olds) and they were fed one of two experimental diets for 12 months. One diet contained primarily plant-based protein sources (PPB), whereas the second diet contained primarily animal-based protein sources (APB). Affymetrix GeneChip Canine Genome Arrays were used to hybridize extracted RNA. Age had the greatest effect on gene transcription (262 differentially expressed genes), whereas the effect of diet was relatively small (22 differentially expressed genes). Effects of age (regardless of diet) were most notable on genes related to metabolism, cell cycle and cell development, and transcription function. All these genes were predominantly down-regulated in geriatric dogs. Age-affected genes that were differentially expressed on only one of two diets were primarily noted in the PPB diet group (144/165 genes). Again, genes related to cell cycle (22/35) and metabolism (15/19) had predominantly decreased transcription in geriatric dogs, but 6/8 genes related to muscle development had increased expression. Effects of diet on muscle gene expression were mostly noted in geriatric dogs, but no consistent patterns in transcription were observed. The insight these data provide into gene expression profiles of canine skeletal muscle as affected by age, could serve as a foundation for future research pertaining to age-related muscle diseases.	[Middelbos, Ingmar S.; Vester, Brittany M.; Karr-Lilienthal, Lisa K.; Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Middelbos, IS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Schook, Lawrence/0000-0002-6580-8364; Swanson, Kelly/0000-0001-5518-3076	National Center for Supercomputing Applications; University of Illinois; NCSA/UIUC Faculty Fellows Program; Pyxis Genomics, Inc., Chicago, IL	National Center for Supercomputing Applications; University of Illinois; NCSA/UIUC Faculty Fellows Program; Pyxis Genomics, Inc., Chicago, IL	This work was funded in part by the National Center for Supercomputing Applications and the University of Illinois, under auspices of the NCSA/UIUC Faculty Fellows Program, and in part by Pyxis Genomics, Inc., Chicago, IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAFCO, 2007, OFF PUBL AAFCO; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; Basso D, 2004, GUT, V53, P1159, DOI 10.1136/gut.2003.024471; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bolstad BM, 2004, THESIS U CALIFORNIA; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Del Rio M, 2007, J CLIN ONCOL, V25, P773, DOI 10.1200/JCO.2006.07.4187; Demarchi F, 2007, CELL CYCLE, V6, P136; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; *GENECHIP, 2002, EXPR AN DAT AN FUND; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Helman EE, 2003, J ANIM SCI, V81, P2199; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kami K, 1999, MUSCLE NERVE, V22, P1576, DOI 10.1002/(SICI)1097-4598(199911)22:11<1576::AID-MUS14>3.0.CO;2-T; Knight BC, 1998, BIOCHEM J, V331, P161, DOI 10.1042/bj3310161; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEVY R, 1997, INT PSYCHOGERIATR, V6, P63; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; LIOU J, CURRENT BIOL, V15, P1235; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Mellick GD, 1999, MOVEMENT DISORD, V14, P219, DOI 10.1002/1531-8257(199903)14:2<219::AID-MDS1003>3.3.CO;2-0; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Naguib M, 2002, ANESTHESIOLOGY, V96, P202, DOI 10.1097/00000542-200201000-00035; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Ohinata Y, 2003, FEBS LETT, V537, P1, DOI 10.1016/S0014-5793(03)00036-X; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Ploner A., 2006, HEATPLUS HEAT MAP DI; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Slizhikova DK, 2005, RUSS J BIOORG CHEM+, V31, P178, DOI 10.1007/s11171-005-0024-6; Swanson KS, 2004, J ANIM SCI, V82, P1713; SWANSON KS, 2007, NEUROBIOL AGING, P10017; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wakshlag JJ, 2003, J ANIM PHYSIOL AN N, V87, P408, DOI 10.1046/j.0931-2439.2003.00452.x; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zeng J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1117	77	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4481	10.1371/journal.pone.0004481	http://dx.doi.org/10.1371/journal.pone.0004481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221602	Green Published, gold			2022-12-25	WOS:000265485700008
J	Coulon, M; Deputte, BL; Heyman, Y; Baudoin, C				Coulon, Marjorie; Deputte, Bertrand L.; Heyman, Yvan; Baudoin, Claude			Individual Recognition in Domestic Cattle (Bos taurus): Evidence from 2D-Images of Heads from Different Breeds	PLOS ONE			English	Article							RIGHT-HEMISPHERE ADVANTAGE; FACE RECOGNITION; TEMPORAL CORTEX; SHEEP; DISCRIMINATION; ANIMALS; REPRESENTATIONS; CHIMPANZEES; BEHAVIOR; FAMILIARITY	Background: In order to maintain cohesion of groups, social animals need to process social information efficiently. Visual individual recognition, which is distinguished from mere visual discrimination, has been studied in only few mammalian species. In addition, most previous studies used either a small number of subjects or a few various views as test stimuli. Dairy cattle, as a domestic species allow the testing of a good sample size and provide a large variety of test stimuli due to the morphological diversity of breeds. Hence cattle are a suitable model for studying individual visual recognition. This study demonstrates that cattle display visual individual recognition and shows the effect of both familiarity and coat diversity in discrimination. Methodology/Principal Findings: We tested whether 8 Prim'Holstein heifers could recognize 2D-images of heads of one cow (face, profiles, 3/4 views) from those of other cows. Experiments were based on a simultaneous discrimination paradigm through instrumental conditioning using food rewards. In Experiment 1, all images represented familiar cows (belonging to the same social group) from the Prim'Holstein breed. In Experiments 2, 3 and 4, images were from unfamiliar (unknown) individuals either from the same breed or other breeds. All heifers displayed individual recognition of familiar and unfamiliar individuals from their own breed. Subjects reached criterion sooner when recognizing a familiar individual than when recognizing an unfamiliar one (Exp 1: 3.1+/-0.7 vs. Exp 2: 5.2+/-1.2 sessions; Z = 1.99, N = 8, P = 0.046). In addition almost all subjects recognized unknown individuals from different breeds, however with greater difficulty. Conclusions/Significance: Our results demonstrated that cattle have efficient individual recognition based on categorization capacities. Social familiarity improved their performance. The recognition of individuals with very different coat characteristics from the subjects was the most difficult task. These results call for studies exploring the mechanisms involved in face recognition allowing interspecies comparisons, including humans.	[Coulon, Marjorie; Deputte, Bertrand L.; Baudoin, Claude] Univ Paris 13, CNRS, UMR 7153, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France; [Deputte, Bertrand L.] ENVA, Dept Ethol, Maisons Alfort, France; [Heyman, Yvan] INRA, UMR 1198 Biol Dev Reproduct, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); Universite Paris 13; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Coulon, M (corresponding author), Univ Paris 13, CNRS, UMR 7153, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	marjorie.coulon@leec.univ-paris13.fr			Ministere de l'Enseignement et de la Recherche	Ministere de l'Enseignement et de la Recherche	This work was supported by a grant from the Ministere de l'Enseignement et de la Recherche to Marjorie Coulon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; BOUISSOU MF, 1965, ANN BIOL ANIM BIOCH, V5, P327, DOI 10.1051/rnd:19650301; BOUISSOU MF, 1972, ANIM BEHAV, V20, P474, DOI 10.1016/S0003-3472(72)80011-3; Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; BRUCE V, 1987, APPL COGNITIVE PSYCH, V1, P109, DOI 10.1002/acp.2350010204; Coulon M, 2007, J COMP PSYCHOL, V121, P198, DOI 10.1037/0735-7036.121.2.198; CUMMINS K A, 1991, Journal of Dairy Science, V74, P301; DASSER V, 1987, ETHOLOGY, V76, P65; Ferreira G, 2004, BEHAV PROCESS, V67, P491, DOI 10.1016/j.beproc.2004.08.005; Fox M. W., 1975, WILD CANIDS THEIR SY; Hagen K, 2003, APPL ANIM BEHAV SCI, V82, P13, DOI 10.1016/S0168-1591(03)00053-4; HALE E. B., 1956, BEHAVIOUR, V10, P240, DOI 10.1163/156853956X00174; HALPIN ZT, 1980, BIOL BEHAV, V5, P233; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; Houpt K., 2005, DOMESTIC ANIMAL BEHA; Johnston RE, 2001, ANIM BEHAV, V61, P545, DOI 10.1006/anbe.2000.1637; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; KENDRICK KM, 1991, J ANIM SCI, V69, P5008, DOI 10.2527/1991.69125008x; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Lambrechts Marcel M., 1995, V12, P115; Moe RO, 2006, APPL ANIM BEHAV SCI, V101, P362, DOI 10.1016/j.applanim.2006.02.004; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P249, DOI 10.1007/s002650050095; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Parr L., 1998, EVOL COMMUN, V2, P1, DOI [10.1075/eoc.2.1.02par, DOI 10.1075/EOC.2.1.02PAR]; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 2008, EMOTION, V8, P216, DOI 10.1037/1528-3542.8.2.216; Parr LA, 2006, BRAIN COGNITION, V62, P30, DOI 10.1016/j.bandc.2006.03.006; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; Peirce JW, 2002, NEUROREPORT, V13, P2395, DOI 10.1097/00001756-200212200-00004; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; RUIZ M, 1993, APP ANIM BEHAV SCI, V36, P317; RYAN CME, 1994, BEHAV PROCESS, V33, P155, DOI 10.1016/0376-6357(94)90064-7; RYAN CME, 1982, BEHAV ANAL LETT, V2, P213; Sato Shusuke, 1996, Animal Science and Technology, V67, P36; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Van der Velden J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001695; Waring G.H., 2003, HORSE BEHAV, V2; WATANABE S, 1991, BIRD BEHAV, V9, P20, DOI 10.3727/015613890791749136; ZAYAN R, 1994, BEHAV PROCESS, V33, P233, DOI 10.1016/0376-6357(94)90068-X; Zayan R, 1998, BEHAV PROCESS, V42, P87, DOI 10.1016/S0376-6357(97)00064-8	45	44	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4441	10.1371/journal.pone.0004441	http://dx.doi.org/10.1371/journal.pone.0004441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212439	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200007
J	Casalbore, P; Budoni, M; Ricci-Vitiani, L; Cenciarelli, C; Petrucci, G; Milazzo, L; Montano, N; Tabolacci, E; Maira, G; Larocca, LM; Pallini, R				Casalbore, Patrizia; Budoni, Manuela; Ricci-Vitiani, Lucia; Cenciarelli, Carlo; Petrucci, Giovanna; Milazzo, Luisa; Montano, Nicola; Tabolacci, Elisabetta; Maira, Giulio; Larocca, Luigi M.; Pallini, Roberto			Tumorigenic Potential of Olfactory Bulb-Derived Human Adult Neural Stem Cells Associates with Activation of TERT and NOTCH1	PLOS ONE			English	Article								Background: Multipotent neural stem cells (NSCs) have been isolated from neurogenic regions of the adult brain. Reportedly, these cells can be expanded in vitro under prolonged mitogen stimulation without propensity to transform. However, the constitutive activation of the cellular machinery required to bypass apoptosis and senescence places these cells at risk for malignant transformation. Methodology/Principal Findings: Using serum-free medium supplemented with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), we established clonally derived NS/ progenitor cell (NS/PC) cultures from the olfactory bulb (OB) of five adult patients. The NS/ PC cultures obtained from one OB specimen lost growth factor dependence and neuronal differentiation at early passage. These cells developed glioblastoma tumors upon xenografting in immunosuppressed mice. The remaining NS/ PC cultures were propagated either as floating neurospheres or as adherent monolayers with mainteinance of growth factor dependence and multipotentiality at late passage. These cells were engrafted onto the CNS of immunosuppressed rodents. Overall, the grafted NS/PCs homed in the host parenchyma showing ramified morphology and neuronal marker expression. However, a group of animals transplanted with NS/PCs obtained from an adherent culture developed fast growing tumors histologically resembling neuroesthesioblastoma. Cytogenetic and molecular analyses showed that the NS/ PC undergo chromosomal changes with repeated in vitro passages under mitogen stimulation, and that up-regulation of hTERT and NOTCH1 associates with in vivo tumorigenicity. Conclusions/Significance: Using culturing techniques described in current literature, NS/PCs arise from the OB of adult patients which in vivo either integrate in the CNS parenchyma showing neuron-like features or initiate tumor formation. Extensive xenografting studies on each human derived NS cell line appear mandatory before any use of these cells in the clinical setting.	[Casalbore, Patrizia; Budoni, Manuela; Cenciarelli, Carlo] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Ricci-Vitiani, Lucia; Milazzo, Luisa] Ist Superiore Sanita, Dept Hematol Oncolo & Mol Med, Rome, Italy; [Petrucci, Giovanna; Larocca, Luigi M.] Catholic Univ, Sch Med, Inst Pathol, Rome, Italy; [Budoni, Manuela; Cenciarelli, Carlo; Montano, Nicola; Maira, Giulio; Pallini, Roberto] Catholic Univ, Sch Med, Inst Neurosurg, Rome, Italy; [Tabolacci, Elisabetta] Catholic Univ, Sch Med, Inst Genet, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Casalbore, P (corresponding author), CNR, Inst Neurobiol & Mol Med, Rome, Italy.	pallini@rm.unicatt.it	Larocca, Luigi M/A-1577-2008; Montano, Nicola/M-4565-2016; Larocca, Luigi Maria/M-9590-2019; PALLINI, Roberto/AAA-3747-2019; TABOLACCI, Elisabetta/AAR-6538-2020; Petrucci, Giovanna/AAB-9192-2022; Ricci Vitiani, Lucia/J-8320-2016; Pallini, Roberto/AAA-3760-2019; CENCIARELLI, CARLO/AAC-1603-2019	Larocca, Luigi M/0000-0003-1739-4758; Montano, Nicola/0000-0002-4965-1950; Larocca, Luigi Maria/0000-0003-1739-4758; PALLINI, Roberto/0000-0002-4611-8827; TABOLACCI, Elisabetta/0000-0002-4707-2242; Petrucci, Giovanna/0000-0002-9280-3673; Ricci Vitiani, Lucia/0000-0001-7336-5615; CENCIARELLI, CARLO/0000-0001-7480-4608	Fondi dAteneo (Progetti D1); ATENA Onlus; Nando Peretti Foundations	Fondi dAteneo (Progetti D1); ATENA Onlus; Nando Peretti Foundations	This work was supported by grants from Fondi dAteneo (Progetti D1), from ATENA Onlus, and Nando Peretti Foundations, and from Mrs. Paola Krajnik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DAVIS GA, 1995, NEUROSURGERY, V36, P599, DOI 10.1227/00006123-199503000-00023; Falchetti ML, 2003, CANCER RES, V63, P3750; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Siebzehnrubl FA, 2009, BRAIN PATHOL, V19, P399, DOI 10.1111/j.1750-3639.2008.00189.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022	25	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4434	10.1371/journal.pone.0004434	http://dx.doi.org/10.1371/journal.pone.0004434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209236	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484100006
J	Petit, AC; Nicolas, JF				Petit, Anne-Cecile; Nicolas, Jean-Francois			Large-Scale Clonal Analysis Reveals Unexpected Complexity in Surface Ectoderm Morphogenesis	PLOS ONE			English	Article								Background: Understanding the series of morphogenetic processes that underlie the making of embryo structures is a highly topical issue in developmental biology, essential for interpreting the massive molecular data currently available. In mouse embryo, long-term in vivo analysis of cell behaviours and movements is difficult because of the development in utero and the impossibility of long-term culture. Methodology/Principal Findings: We improved and combined two genetic methods of clonal analysis that together make practicable large-scale production of labelled clones. Using these methods we performed a clonal analysis of surface ectoderm (SE), a poorly understood structure, for a period that includes gastrulation and the establishment of the body plan. We show that SE formation starts with the definition at early gastrulation of a pool of founder cells that is already dorso-ventrally organized. This pool is then regionalized antero-posteriorly into three pools giving rise to head, trunk and tail. Each pool uses its own combination of cell rearrangements and mode of proliferation for elongation, despite a common clonal strategy that consists in disposing along the antero-posterior axis precursors of dorso-ventrally-oriented stripes of cells. Conclusions/Significance: We propose that these series of morphogenetic processes are organized temporally and spatially in a posterior zone of the embryo crucial for elongation. The variety of cell behaviours used by SE precursor cells indicates that these precursors are not equivalent, regardless of a common clonal origin and a common clonal strategy. Another major result is the finding that there are founder cells that contribute only to the head and tail. This surprising observation together with others can be integrated with ideas about the origin of axial tissues in bilaterians.	[Petit, Anne-Cecile; Nicolas, Jean-Francois] Inst Pasteur, Unite Biol Mol Dev, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Petit, AC (corresponding author), Inst Pasteur, Unite Biol Mol Dev, Paris, France.	jfnicola@pasteur.fr	Nicolas, Jean-François/AAW-9289-2020; Petit, Anne-Cecile/AAH-2658-2020	PETIT, Anne-Cecile/0000-0003-4143-9848	Cells into Organs; EuroStemCell; Association Francaise contre les Myopathies; Institut National de la Recherche Medicale; Universite Pierre et Marie Curie	Cells into Organs; EuroStemCell(European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut National de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie	This work was supported by grants from Cells into Organs (European Network of excellence), EuroStemCell (European consortium for stem cell research) and the Association Francaise contre les Myopathies. J.F.N. is from the Institut National de la Recherche Medicale, and A.C.P. from Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D., 2004, P679; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BONNEROT C, 1993, CR ACAD SCI III-VIE, V316, P1207; Bruce AEE, 1998, DEV BIOL, V201, P101, DOI 10.1006/dbio.1998.8968; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eloy-Trinquet S, 2000, CURR TOP DEV BIOL, V47, P33; Eloy-Trinquet S, 2002, DEVELOPMENT, V129, P3609; Eloy-Trinquet S, 2002, DEVELOPMENT, V129, P111; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Garcia-Bellido AC, 1998, INT J DEV BIOL, V42, P353; Gardner R.L., 1985, Philosophical Transactions of the Royal Society of London B Biological Sciences, V312, P1; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JAEGERSTEN G, 1955, ZOOL BIDR UPPS, V30, P321; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Luria SE, 1943, GENETICS, V28, P491; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mathis L, 2002, TRENDS GENET, V18, P627, DOI 10.1016/S0168-9525(02)02806-8; Mathis L, 1997, DEVELOPMENT, V124, P4089; MATHIS L, 1998, MICROINJECTIONS TRAN, P439; MATHIS L, 1997, ANN I PASTEUR ACTUAL, V8, P3; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; Nielsen C., 1995, ANIMAL EVOLUTION INT; Petit AC, 2005, REPROD NUTR DEV, V45, P321, DOI 10.1051/rnd:2005024; PETIT AC, 2008, THESIS U PIERRE MARI; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Raff RA, 2000, EVOL DEV, V2, P102, DOI 10.1046/j.1525-142x.2000.00035.x; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Rolland-Lagan AG, 2005, J THEOR BIOL, V232, P157, DOI 10.1016/j.jtbi.2004.04.045; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schlosser G., 2004, MODULARITY DEV EVOLU; SELLECK MAJ, 1992, NATO ADV SCI I A-LIF, V231, P23; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steinmetz PRH, 2007, P NATL ACAD SCI USA, V104, P2727, DOI 10.1073/pnas.0606589104; Stern C.D., 2004, GASTRULATION CELLS E; Stern CD, 2001, NAT CELL BIOL, V3, pE216, DOI 10.1038/ncb0901-e216; TZOUANACOU E, 2009, REDEFINING PRO UNPUB; VALENTINE JW, 2004, ORIGIN PHYLA; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; WILSON V, 1995, DEVELOPMENT, V121, P877; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	68	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4353	10.1371/journal.pone.0004353	http://dx.doi.org/10.1371/journal.pone.0004353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197371	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483700002
J	Swenson, NG				Swenson, Nathan G.			Phylogenetic Resolution and Quantifying the Phylogenetic Diversity and Dispersion of Communities	PLOS ONE			English	Article								Conservation biologists and community ecologists have increasingly begun to quantify the phylogenetic diversity and phylogenetic dispersion in species assemblages. In some instances, the phylogenetic trees used for such analyses are fully bifurcating, but in many cases the phylogenies being used contain unresolved nodes (i.e. polytomies). The lack of phylogenetic resolution in such studies, while certainly not preferred, is likely to continue particularly for those analyzing diverse communities and datasets with hundreds to thousands of taxa. Thus it is imperative that we quantify potential biases and losses of statistical power in studies that use phylogenetic trees that are not completely resolved. The present study is designed to meet both of these goals by quantifying the phylogenetic diversity and dispersion of simulated communities using resolved and gradually 'unresolved' phylogenies. The results show that: (i) measures of community phylogenetic diversity and dispersion are generally more sensitive to loss of resolution basally in the phylogeny and less sensitive to loss of resolution terminally; and (ii) the loss of phylogenetic resolution generally causes false negative results rather than false positives.	Harvard Univ, Ctr Trop Forest Sci, Asia Program, Cambridge, MA 02138 USA	Harvard University	Swenson, NG (corresponding author), Harvard Univ, Ctr Trop Forest Sci, Asia Program, Cambridge, MA 02138 USA.	nswenson@oeb.harvard.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	Institute for the Study of Planet Earth at University of Arizona [Dissertation Improvement Grant]	Institute for the Study of Planet Earth at University of Arizona	Dissertation Improvement Grant from the Institute for the Study of Planet Earth at University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Faith DP, 2002, CONSERV BIOL, V16, P248, DOI 10.1046/j.1523-1739.2002.00503.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 2006, EVOL BIOINFORM ONLIN, V2, P70; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRAFEN A, 1992, J THEOR BIOL, V156, P405, DOI 10.1016/S0022-5193(05)80635-6; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; MARTINS EP, 1991, EVOLUTION, V45, P534, DOI [10.2307/2409910, 10.1111/j.1558-5646.1991.tb04328.x]; Minh BQ, 2006, SYST BIOL, V55, P769, DOI 10.1080/10635150600981604; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378	27	159	161	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4390	10.1371/journal.pone.0004390	http://dx.doi.org/10.1371/journal.pone.0004390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194509	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483600015
J	Vernis, L; Facca, C; Delagoutte, E; Soler, N; Chanet, R; Guiard, B; Faye, G; Baldacci, G				Vernis, Laurence; Facca, Celine; Delagoutte, Emmanuelle; Soler, Nicolas; Chanet, Roland; Guiard, Bernard; Faye, Gerard; Baldacci, Giuseppe			A Newly Identified Essential Complex, Dre2-Tah18, Controls Mitochondria Integrity and Cell Death after Oxidative Stress in Yeast	PLOS ONE			English	Article								A mutated allele of the essential gene TAH18 was previously identified in our laboratory in a genetic screen for new proteins interacting with the DNA polymerase delta in yeast [1]. The present work shows that Tah18 plays a role in response to oxidative stress. After exposure to lethal doses of H(2)O(2), GFP-Tah18 relocalizes to the mitochondria and controls mitochondria integrity and cell death. Dre2, an essential Fe/S cluster protein and homologue of human anti-apoptotic Ciapin1, was identified as a molecular partner of Tah18 in the absence of stress. Moreover, Ciapin1 is able to replace yeast Dre2 in vivo and physically interacts with Tah18. Our results are in favour of an oxidative stress-induced cell death in yeast that involves mitochondria and is controlled by the newly identified Dre2-Tah18 complex.	[Vernis, Laurence; Facca, Celine; Delagoutte, Emmanuelle; Soler, Nicolas; Chanet, Roland; Baldacci, Giuseppe] Univ Paris 11, INSERM, Regulat Replicat ADN Eucaryotes, UMR2027,CNRS,Inst Curie, F-91405 Orsay, France; [Guiard, Bernard] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Faye, Gerard] Inst Curie, CNRS, UMR2027, Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Vernis, L (corresponding author), Univ Paris 11, INSERM, Regulat Replicat ADN Eucaryotes, UMR2027,CNRS,Inst Curie, F-91405 Orsay, France.	laurence.vernis-beringue@curie.u-psud.fr	Vernis, Laurence/B-7414-2019; Soler, Nicolas/B-7720-2016; /L-1666-2018	Soler, Nicolas/0000-0002-4292-4020; /0000-0001-7878-0877	french CNRS [post-doctoral fellowship]; INSERM; Institut Curie	french CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	This work was supported financially by french CNRS, INSERM and Institut Curie. NS is a recipient of French CNRS post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Burkart W, 1999, CR ACAD SCI III-VIE, V322, P89, DOI 10.1016/S0764-4469(99)80029-8; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; Del Carratore R, 2002, MUTAT RES-GEN TOX EN, V513, P183, DOI 10.1016/S1383-5718(01)00310-2; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Feng YM, 2005, BIOCHEM J, V392, P65, DOI 10.1042/BJ20050195; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Fiorani P, 2000, ANN NY ACAD SCI, V922, P65; FLINT DH, 1993, J BIOL CHEM, V268, P25547; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ivanovska I, 2005, J CELL BIOL, V170, P391, DOI 10.1083/jcb.200503069; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludovico P, 2003, FEMS YEAST RES, V3, P91, DOI 10.1016/S1567-1356(02)00166-6; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MACIERZYNSKA E, 2007, CELL MOL BIOL LETT; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Maris AF, 2000, CURR GENET, V37, P175, DOI 10.1007/s002940050516; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Reid RJD, 1999, P NATL ACAD SCI USA, V96, P11440, DOI 10.1073/pnas.96.20.11440; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1993, GENE, V127, P139, DOI 10.1016/0378-1119(93)90629-H; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang H, 2008, MOL BIOL CELL, V19, P2127, DOI 10.1091/mbc.E07-11-1113; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	57	62	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4376	10.1371/journal.pone.0004376	http://dx.doi.org/10.1371/journal.pone.0004376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194512	Green Published, gold			2022-12-25	WOS:000265483600009
J	Gondois-Rey, F; Dental, C; Halfon, P; Baumert, TF; Olive, D; Hirsch, I				Gondois-Rey, Francoise; Dental, Clelia; Halfon, Philippe; Baumert, Thomas F.; Olive, Daniel; Hirsch, Ivan			Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1	PLOS ONE			English	Article								Plasmacytoid dendritic cells (pDCs) are responsible for the production of type I IFN during viral infection. Viral elimination by IFN-alpha-based therapy in more than 50% of patients chronically infected with hepatitis C virus (HCV) suggests a possible impairment of production of endogenous IFN-alpha by pDCs in infected individuals. In this study, we investigated the impact of HCV on pDC function. We show that exposure of pDCs to patient serum- and cell culture-derived HCV resulted in production of IFN-alpha by pDCs isolated from some donors, although this production was significantly lower than that induced by influenza and human herpesvirus type 1 (HHV-1). Using specific inhibitors we demonstrate that endocytosis and endosomal acidification were required for IFN-alpha production by pDCs in response to cell culture-derived HCV. HCV and noninfectious HCV-like particles inhibited pDC-associated production of IFN-alpha stimulated with Toll-like receptor 9 (TLR9) agonists (CpG-A or HHV-1) but not that of IFN-alpha stimulated with TLR7 agonists (resiquimod or influenza virus). The blockade of TLR9-mediated production of IFN-alpha, effective only when pDCs were exposed to virus prior to or shortly after CpG-A stimulation, was already detectable at the IFN-alpha transcription level 2 h after stimulation with CpG-A and correlated with down-regulation of the transcription factor IRF7 expression and of TLR9 expression. In conclusion, rapidly and early occurring particle-host cell protein interaction during particle internalization and endocytosis followed by blockade of TLR9 function could result in less efficient sensing of HCV RNA by TLR7, with impaired production of IFN-alpha. This finding is important for our understanding of HCV-DC interaction and immunopathogenesis of HCV infection.	[Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Ctr Rech Cancerol Marseille, INSERM, UMR891, Marseille, France; [Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Inst Paoli Calmettes, Marseille, France; [Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Univ Aix Marseille 2, Marseille, France; [Halfon, Philippe] Alphabio Lab, Dept Virol, Marseille, France; [Baumert, Thomas F.] Univ Louis Pasteur, INSERM, U748, F-67070 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gondois-Rey, F (corresponding author), Ctr Rech Cancerol Marseille, INSERM, UMR891, Marseille, France.	ivan.hirsch@inserm.fr	Baumert, Thomas/ABF-4718-2020; Hirsch, Ivan/J-7726-2015	Baumert, Thomas/0000-0002-8864-2168; Hirsch, Ivan/0000-0003-1701-1438	ANRS; INSERM; Institut Paoli-Calmettes; Plateform Cancer Immuno-Monitoring IBiSA; EU; ANR	ANRS(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Plateform Cancer Immuno-Monitoring IBiSA; EU(European Commission); ANR(French National Research Agency (ANR))	This work was financially supported by ANRS, INSERM, Institut Paoli-Calmettes, and by Plateform Cancer Immuno-Monitoring IBiSA, and by funds (to TFB) from the EU (FP5) and ANR (chair of excellence).	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Amjad M, 2008, MICROBIOL IMMUNOL, V52, P499, DOI 10.1111/j.1348-0421.2008.00067.x; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Bai X, 1997, CLIN CHEM, V43, P1843; Barth H, 2005, BLOOD, V105, P3605, DOI 10.1182/blood-2004-05-1952; Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Decalf J, 2007, J EXP MED, V204, P2423, DOI 10.1084/jem.20070814; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gondois-Rey F, 2001, AIDS, V15, P1931, DOI 10.1097/00002030-200110190-00004; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; LAMBERT AA, 2008, BLOOD; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Schroeder JT, 2008, J ALLERGY CLIN IMMUN, V121, P486, DOI 10.1016/j.jaci.2007.09.049; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Ulsenheimer A, 2005, HEPATOLOGY, V41, P643, DOI 10.1002/hep.20592; VINCENT IE, 2007, HEPATITIS B VIRUS IN; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200; Wellnitz S, 2002, J VIROL, V76, P1181, DOI 10.1128/JVI.76.3.1181-1193.2002; Wertheimer AM, 2004, HEPATOLOGY, V40, P335, DOI 10.1002/hep.20306; Yi AK, 1998, J IMMUNOL, V160, P4755; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	73	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4319	10.1371/journal.pone.0004319	http://dx.doi.org/10.1371/journal.pone.0004319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183807	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483200006
J	Seidman, MA; Chew, TW; Schenkel, AR; Muller, WA				Seidman, Michael A.; Chew, Tina W.; Schenkel, Alan R.; Muller, William A.			PECAM-Independent Thioglycollate Peritonitis Is Associated With a Locus on Murine Chromosome 2	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; QUANTITATIVE TRAIT LOCI; PERIVASCULAR BASEMENT-MEMBRANE; COMPLEMENT COMPONENT C5; IN-VIVO; LEUKOCYTE MIGRATION; BACILLUS-ANTHRACIS; INBRED MICE; INFLAMMATION; CD31	Background: Previous studies have demonstrated that knockout or inhibition of Platelet/Endothelial Cell Adhesion Molecule (PECAM, CD31) in a number of murine strains results in impaired inflammatory responses, but that no such phenotype is seen in the C57BL/6 (B6) murine background. Methodology/Principal Findings: We have undertaken a quantitative trait locus (QTL) mapping effort between FVB/n (FVB) and B6 mice deficient for PECAM to identify the gene or genes responsible for this unique feature of B6 mice. We have identified a locus on murine chromosome 2 at approximately 35.8 Mb that is strongly associated (LOD score = 9.0) with inflammatory responses in the absence of PECAM. Conclusions/Significance: These data potentiate further study of the diapedesis machinery, as well as potential identification of new components of this machinery. As such, this study is an important step to better understanding the processes of inflammation.	[Seidman, Michael A.; Chew, Tina W.; Muller, William A.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Schenkel, Alan R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biol Sci, Ft Collins, CO 80523 USA	Cornell University; Colorado State University	Seidman, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol, New York, NY USA.	wamuller@northwestern.edu	Seidman, Michael/J-4731-2019; Schenkel, Alan/G-1880-2017	Seidman, Michael/0000-0002-9594-827X; Schenkel, Alan/0000-0002-1603-5713	NIH [GM07739, R01 HL046849, R01 HL064774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064774, R01HL064774, R01HL046849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for M.A.S. comes from the Tri-Institutional M.D./Ph.D. Program, NIH MSTP grant GM07739. Support for this W. A. M. comes from NIH R01 grants HL046849 and HL064774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer K, 2004, ARTHRITIS RHEUM-US, V50, P3721, DOI 10.1002/art.20624; Biswas P, 2003, BIOCHEM BIOPH RES CO, V303, P212, DOI 10.1016/S0006-291X(03)00313-9; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; BOGEN SA, 1992, AM J PATHOL, V141, P843; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BROWNSTEIN DG, 1991, J VIROL, V65, P1946, DOI 10.1128/JVI.65.4.1946-1951.1991; CINADER B, 1964, J EXP MED, V120, P897, DOI 10.1084/jem.120.5.897; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Duncan GS, 1999, J IMMUNOL, V162, P3022; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liao F, 1999, J IMMUNOL, V163, P5640; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Mahooti S, 2000, AM J PATHOL, V157, P75, DOI 10.1016/S0002-9440(10)64519-1; McIndoe RA, 1999, P NATL ACAD SCI USA, V96, P2210, DOI 10.1073/pnas.96.5.2210; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 2007, ADHESION MOL FUNCTIO, P201; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; NILSSON UR, 1967, J EXP MED, V125, P1, DOI 10.1084/jem.125.1.1; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Schenkel AR, 2004, J IMMUNOL, V173, P6403, DOI 10.4049/jimmunol.173.10.6403; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wilkinson R, 2002, BLOOD, V100, P184, DOI 10.1182/blood-2002-01-0027; Wong MX, 2002, J IMMUNOL, V168, P6455, DOI 10.4049/jimmunol.168.12.6455	46	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4316	10.1371/journal.pone.0004316	http://dx.doi.org/10.1371/journal.pone.0004316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180231	Green Published, Green Submitted, gold			2022-12-25	WOS:000274089700008
J	Malekzadeh, F; Alberti, C; Nouraei, M; Vahedi, H; Zaccaria, I; Meinzer, U; Nasseri-Moghaddam, S; Sotoudehmanesh, R; Momenzadeh, S; Khaleghnejad, R; Rashtak, S; Olfati, G; Malekzadeh, R; Hugot, JP				Malekzadeh, Fatemeh; Alberti, Corinne; Nouraei, Mehdi; Vahedi, Homayoon; Zaccaria, Isabelle; Meinzer, Ulrich; Nasseri-Moghaddam, Siavosh; Sotoudehmanesh, Rasoul; Momenzadeh, Sara; Khaleghnejad, Reza; Rashtak, Shahrooz; Olfati, Golrokh; Malekzadeh, Reza; Hugot, Jean-Pierre			Crohn's Disease and Early Exposure to Domestic Refrigeration	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; OLMSTED COUNTY; PREVALENCE; POPULATION; SUSCEPTIBILITY; ASSOCIATION; EPIDEMIOLOGY; MINNESOTA; VARIANTS	Background: Environmental risk factors playing a causative role in Crohn's Disease (CD) remain largely unknown. Recently, it has been suggested that refrigerated food could be involved in disease development. We thus conducted a pilot case control study to explore the association of CD with the exposure to domestic refrigeration in childhood. Methodology/Principal Findings: Using a standard questionnaire we interviewed 199 CD cases and 207 age-matched patients with irritable bowel syndrome (IBS) as controls. Cases and controls were followed by the same gastroenterologists of tertiary referral clinics in Tehran, Iran. The questionnaire focused on the date of the first acquisition of home refrigerator and freezer. Data were analysed by a multivariate logistic model. The current age was in average 34 years in CD cases and the percentage of females in the case and control groups were respectively 48.3% and 63.7%. Patients were exposed earlier than controls to the refrigerator (X2 = 9.9, df = 3, P = 0.04) and refrigerator exposure at birth was found to be a risk factor for CD (OR = 2.08 (95% CI: 1.01-4.29), P = 0.05). Comparable results were obtained looking for the exposure to freezer at home. Finally, among the other recorded items reflecting the hygiene and comfort at home, we also found personal television, car and washing machine associated with CD. Conclusion: This study supports the opinion that CD is associated with exposure to domestic refrigeration, among other household factors, during childhood.	[Malekzadeh, Fatemeh; Nouraei, Mehdi; Vahedi, Homayoon; Nasseri-Moghaddam, Siavosh; Sotoudehmanesh, Rasoul; Momenzadeh, Sara; Khaleghnejad, Reza; Rashtak, Shahrooz; Olfati, Golrokh; Malekzadeh, Reza] Univ Tehran, Digest Dis Res Ctr, Tehran, Iran; [Alberti, Corinne; Zaccaria, Isabelle] Hop Robert Debre, Unite Epidemiol Clin, APHP, Paris, France; [Alberti, Corinne; Zaccaria, Isabelle] INSERM, CIE5, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Hop Robert Debre, Serv Gastroenterol Pediat, AP HP, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Univ Paris Diderot, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] INSERM, U843, Paris, France	University of Tehran; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Malekzadeh, F (corresponding author), Univ Tehran, Digest Dis Res Ctr, Tehran, Iran.	jean-pierre.hugot@rdb.aphp.fr	Malekzadeh, Reza/U-1382-2017; Hugot, Jean-Pierre/F-6594-2012; Meinzer, Ulrich/N-4282-2019	Malekzadeh, Reza/0000-0002-9820-6335; Malekzadeh, Reza/0000-0003-1043-3814; Hugot, Jean-Pierre/0000-0002-8446-6056	INSERM, France; faculty of medicine Paris Diderot, Freance; mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); faculty of medicine Paris Diderot, Freance; mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran(Tehran University of Medical Sciences)	This work was supported by the INSERM, France; the faculty of medicine Paris Diderot, Freance; the mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh R, 2005, J GASTROEN HEPATOL, V20, P1691, DOI 10.1111/j.1440-1746.2005.03905.x; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; BRAHME F, 1975, GASTROENTEROLOGY, V69, P342; CHITKARA DK, 2007, AM J GASTROENTEROL, V102, P1; EASON RJ, 1982, AUST NZ J MED, V12, P125, DOI 10.1111/j.1445-5994.1982.tb02443.x; EVANS JG, 1965, GUT, V6, P311, DOI 10.1136/gut.6.4.311; FELLOWS IW, 1990, GUT, V31, P1262, DOI 10.1136/gut.31.11.1262; Forbes A, 2006, INT J COLORECTAL DIS, V21, P399, DOI 10.1007/s00384-005-0003-7; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; GHAVAMI A, 1969, DIS COLON RECTUM, V12, P462, DOI 10.1007/BF02617735; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hellers G, 1979, Acta Chir Scand Suppl, V490, P1; Heresbach D, 2005, GUT, V54, P215, DOI 10.1136/gut.2004.041715; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2003, EUR J HUM GENET, V11, P179, DOI 10.1038/sj.ejhg.5200932; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; IBBOTSON JP, 1992, CLIN EXP IMMUNOL, V87, P224, DOI 10.1111/j.1365-2249.1992.tb02979.x; Jacobsen BA, 2006, EUR J GASTROEN HEPAT, V18, P601, DOI 10.1097/00042737-200606000-00005; Kallinowski F, 1998, HEPATO-GASTROENTEROL, V45, P1552; Karlinger K, 2000, EUR J RADIOL, V35, P154, DOI 10.1016/S0720-048X(00)00238-2; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; KYLE J, 1971, GASTROENTEROLOGY, V61, P826; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P75, DOI 10.3748/wjg.v12.i1.75; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Malekzadeh R, 2000, GASTROENTEROLOGY, V118, pA1356, DOI 10.1016/S0016-5085(00)81293-7; MALEKZADEH R, 1986, IRANIAN J MED, V13, P54; MALEKZADEH R, 2000, IRN J MED SCI, V25, P138; MAYBERRY JF, 1984, GUT, V25, P886, DOI 10.1136/gut.25.8.886; McCormick P, 2001, Ir Med J, V94, P203; MIRMADJLESSI SH, 1985, AM J GASTROENTEROL, V80, P862; Molinie F, 2004, GUT, V53, P843, DOI 10.1136/gut.2003.025346; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Saebo Arve, 2005, Eur J Intern Med, V16, P176, DOI 10.1016/j.ejim.2004.11.008; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Timmer A, 1999, INFLAMM BOWEL DIS, V5, P79, DOI 10.1097/00054725-199905000-00002; WRIGHT JP, 1986, S AFR MED J, V70, P10	46	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4288	10.1371/journal.pone.0004288	http://dx.doi.org/10.1371/journal.pone.0004288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177167	gold, Green Submitted, Green Published			2022-12-25	WOS:000265483100003
J	Teng, ACT; Adamo, K; Tesson, F; Stewart, AFR				Teng, Allen C. T.; Adamo, Kristi; Tesson, Frederique; Stewart, Alexandre F. R.			Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss	FASEB JOURNAL			English	Article						fatty acid; genetics; MyoD; obesity	TRANSCRIPTION FACTORS; FTO GENE; OBESITY; MYOGENESIS; COFACTOR; MYOD	Diet-induced weight loss is affected by a wide range of factors, including genetic variation. Identifying functional polymorphisms will help to elucidate mechanisms that account for variation in dietary metabolism. Previously, we reported a strong association between a common single nucleotide polymorphism (SNP) rs2419621 (C>T) in the promoter of acyl-CoA synthetase long chain 5 (ACSL5), rapid weight loss in obese Caucasian females, and elevated ACSL5 mRNA levels in skeletal muscle biopsies. Here, we showed by electrophoretic mobility shift assay (EMSA) that the T allele creates a functional cis-regulatory E-box element (CANNTG) that is recognized by the myogenic regulatory factor MyoD. The T allele promoted MyoD-dependent activation of a 1089-base pair ACSL5 promoter fragment in nonmuscle CV1 cells. Differentiation of skeletal myoblasts significantly elevated expression of the ACSL5 promoter. The T allele sustained promoter activity 48 h after differentiation, whereas the C allele showed a significant decline. These results reveal a mechanism for elevated transcription of ACSL5 in skeletal muscle of carriers of the rs2419621(T) allele, associated with more rapid diet-induced weight loss. Natural selection favoring promoter polymorphisms that reduced expression of catabolic genes in skeletal muscle likely accounts for the resistance of obese individuals to dietary intervention.-Teng, A. C., Adamo, K., Tesson, F., Stewart, A. F. R. Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss. FASEB J. 23, 1705-1709 (2009)	[Adamo, Kristi; Tesson, Frederique] Univ Ottawa, Inst Heart, Lab Genet Cardiac Dis, Ottawa, ON K1Y 4W7, Canada; [Teng, Allen C. T.; Tesson, Frederique; Stewart, Alexandre F. R.] Univ Ottawa, Fac Med, Program Human & Mol Genet, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4W7, Canada; [Teng, Allen C. T.; Adamo, Kristi; Tesson, Frederique; Stewart, Alexandre F. R.] John & Jennifer Ruddy Canadian Cardiovasc Genet C, Ottawa, ON, Canada; [Adamo, Kristi] Childrens Hosp Eastern Ontario, Res Inst, Healthy Act Living & Obes Res Grp, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Tesson, F (corresponding author), Univ Ottawa, Inst Heart, Lab Genet Cardiac Dis, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	ftesson@ottawaheart.ca; astewart@ottawaheart.ca	Stewart, Alexandre F.R./A-5677-2011; Tesson, Frederique/A-3218-2013	Stewart, Alexandre/0000-0003-2673-9164; Adamo, Kristi/0000-0001-7925-1889	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank N. Mikhael and M. Belanger for plasmid construction. A.F.R.S. and F.T. are funded by the Canadian Institutes of Health Research (CIHR). We also thank Dr. S. Dandona for reviewing the manuscript.	Adamo KB, 2007, OBESITY, V15, P1068, DOI 10.1038/oby.2007.630; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Haupt A, 2008, OBESITY, V16, P1969, DOI 10.1038/oby.2008.283; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Muller TD, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-85; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SKERJANC IS, 1994, DEV BIOL, V163, P125, DOI 10.1006/dbio.1994.1128; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WILLIG TN, 1993, DEV MED CHILD NEUROL, V35, P1074, DOI 10.1111/j.1469-8749.1993.tb07925.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429; ZHUANG Y, 1992, P NATL ACAD SCI USA, V89, P12132, DOI 10.1073/pnas.89.24.12132	22	19	21	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1705	1709		10.1096/fj.08-120998	http://dx.doi.org/10.1096/fj.08-120998			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19218499	Green Accepted			2022-12-25	WOS:000266652400010
J	Bardwell, AJ; Frankson, E; Bardwell, L				Bardwell, A. Jane; Frankson, Erlynn; Bardwell, Lee			Selectivity of Docking Sites in MAPK Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-AFFINITY INTERACTION; C-JUN; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; BINDING; PHOSPHORYLATION; INHIBITION; ERK2	Protein kinases often recognize their substrates and regulators through docking interactions that occur outside of the active site; these interactions can help us to understand kinase networks, and to target kinases with drugs. During mitogen-activated protein kinase (MAPK) signaling, the ability of MAPK kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The extent to which docking contributes to the specificity of MAPK transactions is incompletely understood. Here we characterize the selectivity of the interaction between MKK-derived D-sites and MAPKs by measuring the ability of D-site peptides to inhibit MAPK-mediated phosphorylation of D-site-containing substrates. We find that all MKK D-sites bind better to their cognate MAPKs than they do to non-cognate MAPKs. For instance, the MKK3 D-site peptide, which is a remarkably potent inhibitor of p38 alpha (IC50 < 10 nM), does not inhibit JNK1 or JNK2. Likewise, MAPKs generally bind as well or better to cognate D-sites than to non-cognate D-sites. For instance, JNK1 and JNK2 do not appreciably bind to any D-sites other than their cognate D-sites from MKK4 and MKK7. In general, cognate, within-pathway interactions are preferred about an order of magnitude over non-cognate interactions. However, the selectivity of MAPKs and their cognate MKK-derived D-sites for each other is limited in some cases; in particular, ERK2 is not very selective. We conclude that MAPK-docking sites in MAPK kinases bind selectively to their cognate MAPKs.	[Bardwell, A. Jane; Frankson, Erlynn; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	NIGMS [GM60366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060366, P50GM076516] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60366 from the NIGMS.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Force T, 2004, CIRCULATION, V109, P1196, DOI 10.1161/01.CIR.0000118538.21306.A9; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Jiang Y, 1997, J BIOL CHEM, V272, P11096; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Johnson L, 2007, BIOCHEM SOC T, V35, P7, DOI 10.1042/BST0350007; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Molina DM, 2005, J BIOL CHEM, V280, P42051, DOI 10.1074/jbc.M510590200; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Parang K, 2004, CURR OPIN DRUG DISC, V7, P617; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Senawong T, 2008, HUM MOL GENET, V17, P419, DOI 10.1093/hmg/ddm319; Seyfried J, 2005, MOL CELL BIOL, V25, P9820, DOI 10.1128/MCB.25.22.9820-9828.2005; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	69	94	95	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13165	13173		10.1074/jbc.M900080200	http://dx.doi.org/10.1074/jbc.M900080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19196711	hybrid, Green Published			2022-12-25	WOS:000265688300063
J	Tian, P; Bernstein, HD				Tian, Pu; Bernstein, Harris D.			Identification of a Post-targeting Step Required for Efficient Cotranslational Translocation of Proteins across the Escherichia coli Inner Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MALTOSE-BINDING PROTEIN; CYTOPLASMIC MEMBRANE; SEQUENCE RECOGNITION; MATURE SEQUENCE; SECY COMPLEX; EXPORT; PEPTIDE; SECRETION; PATHWAY	Recent studies have shown that cytoplasmic proteins are exported efficiently in Escherichia coli only if they are attached to signal peptides that are recognized by the signal recognition particle and are thereby targeted to the SecYEG complex cotranslationally. The evidence suggests that the entry of these proteins into the secretory pathway at an early stage of translation is necessary to prevent them from folding into a translocation-incompetent conformation. We found, however, that several glycolytic enzymes attached to signal peptides that are recognized by the signal recognition particle were exported inefficiently. Based on previous studies of post-translational export, we hypothesized that the export block was due to the presence of basic residues at the extreme N terminus of each enzyme. Consistent with our hypothesis, we found that the introduction of negatively charged residues into this segment increased the efficiency of export. Export efficiency was sensitive to the number, position, and sequence context of charged residues. The importance of charge for efficient export was underscored by an in silico analysis that revealed a conserved negative charge bias at the N terminus of the mature region of bacterial presecretory proteins. Our results demonstrate that cotranslational targeting of a protein to the E. coli SecYEG complex does not ensure its export but that export also depends on a subsequent event (most likely the initiation of translocation) that involves sequences both within and just beyond the signal peptide.	[Tian, Pu; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov	TIAN, PU/F-5739-2012		National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052022, ZIADK052022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health.	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; BELIN D, 1996, EMBO J, V15, P469; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; CAMMACK KA, 1965, BIOCHEM J, V96, P671, DOI 10.1042/bj0960671; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Frate MC, 2000, EUR J BIOCHEM, V267, P3836, DOI 10.1046/j.1432-1327.2000.01422.x; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kajava AV, 2000, J BACTERIOL, V182, P2163, DOI 10.1128/JB.182.8.2163-2169.2000; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; Mallik I, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-32; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORENO F, 1980, NATURE, V286, P356, DOI 10.1038/286356a0; Moser Michael, 2007, V390, P63; Nesmeyanova MA, 1997, FEBS LETT, V403, P203, DOI 10.1016/S0014-5793(97)00052-5; Newitt JA, 1998, J BIOL CHEM, V273, P12451, DOI 10.1074/jbc.273.20.12451; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PUZISS JW, 1992, J BACTERIOL, V174, P92, DOI 10.1128/jb.174.1.92-101.1992; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; SUMMERS RG, 1989, J BIOL CHEM, V264, P20074; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; YAMANE K, 1988, J BIOL CHEM, V263, P19690	44	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11396	11404		10.1074/jbc.M900375200	http://dx.doi.org/10.1074/jbc.M900375200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19211555	Green Published, hybrid			2022-12-25	WOS:000265494500044
J	Lee, J; Sperandio, V; Frantz, DE; Longgood, J; Camilli, A; Phillips, MA; Michael, AJ				Lee, Jeongmi; Sperandio, Vanessa; Frantz, Doug E.; Longgood, Jamie; Camilli, Andrew; Phillips, Margaret A.; Michael, Anthony J.			An Alternative Polyamine Biosynthetic Pathway Is Widespread in Bacteria and Essential for Biofilm Formation in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; ESCHERICHIA-COLI; ORNITHINE-DECARBOXYLASE; SIDEROPHORE BIOSYNTHESIS; PETROBACTIN BIOSYNTHESIS; ACINETOBACTER-BAUMANNII; SPERMIDINE SYNTHASE; BACILLUS-SUBTILIS; GENE; NORSPERMIDINE	Polyamines are small organic cations found in all cells, and the biosynthetic pathway is well described in eukaryotes and Escherichia coli. The characterized pathway uses decarboxylated S-adenosylmethionine as the aminopropyl group donor to form spermidine from putrescine by the key enzymes S-adenosylmethionine decarboxylase and spermidine synthase. We report here the in vivo characterization of an alternative polyamine biosynthetic pathway from Vibrio cholerae, the causative agent of human cholera. The pathway uses aspartate beta-semialdehyde as the aminopropyl group donor and consists of a fused protein containing L-2,4-diaminobutyrate aminotransferase and L-2,4-diaminobutyrate decarboxylase, a carboxynorspermidine dehydrogenase (CANSDH), and a carboxynorspermidine decarboxylase (CANSDC). We show that in V. cholerae, this pathway is required for synthesis of both sym-norspermidine and spermidine. Heterologous expression of the V. cholerae pathway in E. coli results in accumulation of the nonnative polyamines diaminopropane and sym-norspermidine. Genetic deletion of the V. cholerae CANSDC led to accumulation of carboxynorspermidine, whereas deletion of either CANSDC or the putative CANSDH led to loss of sym-norspermidine and spermidine. These results allowed unambiguous identification of the gene encoding CANSDH. Furthermore, deletion of either CANSDH or CANSDC led to a 50-60% reduction in growth rate of planktonic cells and severely reduced biofilm formation, which could be rescued by exogenously supplied sym-norspermidine but not spermidine. The pathway was not required for infectivity in a mouse model of V. cholerae infection. Notably, the alternative polyamine biosynthetic pathway is widespread in bacteria and is likely to play a previously unrecognized role in the biology of these organisms.	[Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lee, Jeongmi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Frantz, Doug E.; Longgood, Jamie] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Tufts University; Tufts University	Michael, AJ (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	tony.michael@bbsrc.ac.uk	Lee, Jeongmi/AAJ-7720-2020	Lee, Jeongmi/0000-0002-9948-7554	National Institutes of Health [R01 AI34432, RO1 AI55058]; Biotechnology and Biological Sciences Research Council, United Kingdom; Institute Development Fellowship [BB/E024467/1]; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055058, R01AI034432, R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Development Fellowship; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI34432 ( to M. A. P.) and RO1 AI55058 ( to A. C.). This work was also supported by Biotechnology and Biological Sciences Research Council, United Kingdom, Institute Development Fellowship BB/E024467/1 ( to A. J. M.) and Welch Foundation Grant I-1257 ( to M. A. P.)	ANTON DL, 1987, J BIOL CHEM, V262, P2817; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; Brickman TJ, 1996, J BACTERIOL, V178, P54, DOI 10.1128/jb.178.1.54-60.1996; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; HIGASHI K, 2008, J BIOL CHEM; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ikai H, 1997, J BACTERIOL, V179, P5118, DOI 10.1128/jb.179.16.5118-5125.1997; IKAI H, 1994, FEMS MICROBIOL LETT, V124, P225, DOI 10.1111/j.1574-6968.1994.tb07288.x; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kim AD, 2000, J BACTERIOL, V182, P6667, DOI 10.1128/JB.182.23.6667-6672.2000; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; Oves-Costales D, 2008, CHEM COMMUN, P4034, DOI 10.1039/b809353a; PARK MH, 1984, J BIOL CHEM, V259, P2123; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; SRIVENUGOPAL KS, 1980, FEBS LETT, V112, P260, DOI 10.1016/0014-5793(80)80193-1; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Vandenende CS, 2004, J BACTERIOL, V186, P5596, DOI 10.1128/JB.186.17.5596-5602.2004; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021	43	128	133	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9899	9907		10.1074/jbc.M900110200	http://dx.doi.org/10.1074/jbc.M900110200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196710	hybrid, Green Published			2022-12-25	WOS:000264892900032
J	Waschbusch, D; Born, S; Niediek, V; Kirchgessner, N; Tamboli, IY; Walter, J; Merkel, R; Hoffmann, B				Waschbuesch, Dieter; Born, Simone; Niediek, Verena; Kirchgessner, Norbert; Tamboli, Irfan Y.; Walter, Jochen; Merkel, Rudolf; Hoffmann, Bernd			Presenilin 1 Affects Focal Adhesion Site Formation and Cell Force Generation via c-Src Transcriptional and Posttranslational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EPHRIN-B LIGANDS; TYROSINE PHOSPHORYLATION; BETA-CATENIN; INTRAMEMBRANE PROTEOLYSIS; GENE-EXPRESSION; KINASE-ACTIVITY; ENDOCYTOSIS; PAXILLIN; NOTCH	Presenilin 1 and 2 (PS) are critical components of the gamma-secretase complex that cleaves type I transmembrane proteins within their transmembrane domains. This process leads to release of proteolytically processed products from cellular membranes and plays an essential role in signal transduction or vital functions as cell adhesion. Here we studied the function of presenilins in cell-matrix interaction of wild-type and PS knock-out mouse embryonic fibroblasts. We found for PS1(-/-) cells an altered morphology with significantly reduced sizes of focal adhesion sites compared with wild type. Cell force analyses on micropatterned elastomer films revealed PS1(-/-) cell forces to be reduced by 50%. Pharmacological inhibition confirmed this function of gamma-secretase in adhesion site and cell force formation. On the regulatory level, PS1 deficiency was associated with strongly decreased phosphotyrosine levels of focal adhesion site-specific proteins. The reduced tyrosine phosphorylation was caused by a down-regulation of c-Src kinase activity primarily at the level of c-Src transcription. The direct regulatory connection between PS1 and c-Src could be identified with ephrinB2 as PS1 target protein. Overexpression of ephrinB2 cytoplasmic domain resulted in its nuclear translocation with increased levels of c-Src and a full complementation of the PS1(-/-) adhesion and phosphorylation phenotype. Cleavage of full-length EB2 and subsequent intracellular domain translocation depended on PS1 as these processes were only found in WT cells. Therefore, we conclude that gamma-secretase is vital for controlling cell adhesion and force formation by transcriptional regulation of c-Src via ephrinB2 cleavage.	[Waschbuesch, Dieter; Born, Simone; Niediek, Verena; Kirchgessner, Norbert; Hoffmann, Bernd] Res Ctr Julich GmbH, Inst Bio & Nanosyst Biomech 4, D-52425 Julich, Germany; [Tamboli, Irfan Y.; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn	Merkel, R (corresponding author), Res Ctr Julich, Inst Bio & Nanosyst, IBN 4, D-52425 Julich, Germany.	b.hoffmann@fz-juelich.de	Hoffmann, Bernd/I-7237-2013; Wang, Caihong/T-5837-2019; Merkel, Rudolf/G-3647-2013; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Merkel, Rudolf/0000-0003-3178-3282; Hoffmann, Bernd/0000-0002-3803-8835; Waschbusch, Dieter/0000-0002-8953-2585; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BADLEY RA, 1980, J CELL SCI, V43, P379; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Battaglia AA, 2003, NAT NEUROSCI, V6, P339, DOI 10.1038/nn1034; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Cesa CM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712870; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dehm SM, 2004, BIOCHEM CELL BIOL, V82, P263, DOI 10.1139/o03-077; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fortini ME, 2001, CURR OPIN CELL BIOL, V13, P627, DOI 10.1016/S0955-0674(00)00261-1; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ingley E., 2007, BIOCHIM BIOPHYS ACTA, V1784, P56; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Parker M, 2004, BIOCHEM BIOPH RES CO, V323, P17, DOI 10.1016/j.bbrc.2004.07.209; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Prager K, 2007, J BIOL CHEM, V282, P14083, DOI 10.1074/jbc.M608437200; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Singh N, 2001, EXP CELL RES, V263, P1, DOI 10.1006/excr.2000.5098; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Volberg T, 2001, J CELL SCI, V114, P2279; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	64	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10138	10149		10.1074/jbc.M806825200	http://dx.doi.org/10.1074/jbc.M806825200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176482	hybrid, Green Published			2022-12-25	WOS:000264892900056
J	Welinder, KG; Jorgensen, M				Welinder, Karen G.; Jorgensen, Malene			Covalent Structures of Potato Tuber Lipases (Patatins) and Implications for Vacuolar Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC TOBACCO; STORAGE PROTEIN; CV KURAS; GLYCOSYLATION; GLYCOPROTEIN; PEROXIDASE; EXPRESSION; STABILITY; GENE	Proteome data of potato (Solanum tuberosum) tuber juice and of purified potato tuber vacuoles indicated that mature patatins may perhaps lack a C-terminal propeptide. We have confirmed this by complete mass spectrometric sequencing of a number of patatin variants as well as their N-linked complex-type glycans from the starch-rich cultivar Kuras. For this cultivar full-length patatin cDNAs have also been sequenced, as the patatin locus is highly polymorphous. It is well known that patatins are located in the vacuoles of potato tubers. Furthermore, the complex glycan structures show that the path is via the Golgi apparatus. However, the vacuolar targeting signal has never been identified for this storage and defense protein, which amounts to 25-40% of tuber protein. We propose that a six-residue C-terminal propeptide, -ANKASY-COO- comprises this signal. The crystallographic structure of a recombinant patatin (Rydel, T. J., Williams, J. M., Krieger, E., Moshiri, F., Stallings, W. C., Brown, S. M., Pershing, J. C., Prucell, J. P., and Alibhai, M. F. (2003) Biochemistry 42, 6696-6708), which included this propeptide thus, for the first time, shows the structure of a putative ligand of the vacuolar sorting receptor and processing enzyme responsible for patatin import.	[Welinder, Karen G.; Jorgensen, Malene] Aalborg Univ, Sect Biotechnol, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark	Aalborg University	Welinder, KG (corresponding author), Aalborg Univ, Sect Biotechnol, Dept Biotechnol Chem & Environm Engn, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	kgw@bio.aau.dk; mj@bio.aau.dk	Joergensen, Malene/AFS-0738-2022	Welinder, Karen Gjesing/0000-0002-5409-0131; Jorgensen, Malene Moller/0000-0003-1381-3863	Danish Research Council for Technology and Production [274-06-0331]; Danish Research Agency [2052-03-0022]	Danish Research Council for Technology and Production; Danish Research Agency	The work was supported by Grant 274-06-0331 ( to M. J.) from the Danish Research Council for Technology and Production, and Grant 2052-03-0022 from the Danish Research Agency.	Bauw G, 2006, FEBS J, V273, P3569, DOI 10.1111/j.1742-4658.2006.05364.x; Crookshanks M, 2001, FEBS LETT, V506, P123, DOI 10.1016/S0014-5793(01)02888-5; Emmersen Jeppe, 2007, Methods Mol Biol, V367, P77; GANAL MW, 1991, MOL GEN GENET, V225, P501, DOI 10.1007/BF00261693; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Jekel PA, 2003, PHYTOCHEMISTRY, V63, P517, DOI 10.1016/S0031-9422(03)00224-3; Jorgensen M, 2006, J AGR FOOD CHEM, V54, P9389, DOI 10.1021/jf0623945; Kim YS, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-36; Knudsen SK, 2008, BIOCHEM J, V412, P563, DOI 10.1042/BJ20071497; Matthiesen R, 2004, PROTEOMICS, V4, P2583, DOI 10.1002/pmic.200300792; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pots AM, 1999, J AGR FOOD CHEM, V47, P4587, DOI 10.1021/jf981180n; ROSAHL S, 1987, EMBO J, V6, P1155, DOI 10.1002/j.1460-2075.1987.tb02348.x; ROSAHL S, 1986, MOL GEN GENET, V203, P214, DOI 10.1007/BF00333957; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; SONNEWALD U, 1989, PLANTA, V179, P171, DOI 10.1007/BF00393687; SONNEWALD U, 1989, PLANTA, V178, P176, DOI 10.1007/BF00393192; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; Tams JW, 1998, FEBS LETT, V421, P234, DOI 10.1016/S0014-5793(97)01573-1; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261	26	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9764	9769		10.1074/jbc.M809674200	http://dx.doi.org/10.1074/jbc.M809674200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211558	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000264892900016
J	Mckee, KK; Capizzi, S; Yurchenco, PD				McKee, Karen K.; Capizzi, Stephanie; Yurchenco, Peter D.			Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; GAMMA-1 CHAIN; GLOBULAR DOMAINS; SCHWANN-CELLS; ALPHA-CHAIN; LG MODULES; AGRIN; DYSTROGLYCAN; SITES; MICE	Laminins that possess three short arms contribute to basement membrane assembly by anchoring to cell surfaces, polymerizing, and binding to nidogen and collagen IV. Although laminins containing the alpha 4 and alpha 5 subunits are expressed in alpha 2-deficient congenital muscular dystrophy, they may be ineffective substitutes because they bind weakly to cell surfaces and/or because they lack the third arm needed for polymerization. We asked whether linker proteins engineered to bind to deficient laminins that provide such missing activities would promote basement membrane assembly in a Schwann cell model. A chimeric fusion protein (alpha LNNd) that adds a short arm terminus to laminin through the nidogen binding locus was generated and compared with the dystrophy-ameliorating protein miniagrin (mAgrin) that binds to the laminin coiled-coil dystroglycan and sulfatides. alpha LNNd was found to mediate laminin binding to collagen IV, to bind to galactosyl sulfatide, and to selectively convert alpha-short arm deletion-mutant laminins Lm Delta alpha LN and Lm Delta alpha LN-L4b into polymerizing laminins. This protein enabled polymerization-deficient laminin but not an adhesion-deficient laminin lacking LG domains (Lm Delta LG) to assemble an extracellular matrix on Schwann cell surfaces. mAgrin, on the other hand, enabled Lm Delta LG to form an extracellular matrix on cell surfaces without increasing accumulation of non-polymerizing laminins. These gain-of-function studies reveal distinct polymerization and anchorage contributions to basement membrane assembly in which the three different LN domains mediate the former, and the LG domains provide primary anchorage with secondary contributions from the alpha LN domain. These findings may be relevant for an understanding of the pathogenesis and treatment of laminin deficiency states.	[McKee, Karen K.; Capizzi, Stephanie; Yurchenco, Peter D.] Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Yurchenco, PD (corresponding author), Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, 675 Hoes Lane, Piscataway, NJ 08854 USA.	yurchenc@umdnj.edu		Yurchenco, Peter/0000-0003-0387-2317	National Institutes of Health [R01-NS38469, R37-DK36425]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS38469 and R37-DK36425. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, HUM MOL GENET, V15, P2690, DOI 10.1093/hmg/ddl201; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; KALB E, 1991, J BIOL CHEM, V266, P19047; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Smirnov SP, 2005, J BIOL CHEM, V280, P41449, DOI 10.1074/jbc.M508939200; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Tsiper MV, 2002, J CELL SCI, V115, P1005; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Willem M, 2002, DEVELOPMENT, V129, P2711; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500; YURCHENCO P, 2009, CURR PHARM IN PRESS; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636	45	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8984	8994		10.1074/jbc.M809719200	http://dx.doi.org/10.1074/jbc.M809719200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189961	Green Published, hybrid			2022-12-25	WOS:000264397800081
J	Bultema, R; Longnecker, R; Swanson-Mungerson, M				Bultema, R.; Longnecker, R.; Swanson-Mungerson, M.			Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis	ONCOGENE			English	Article						Epstein-Barr virus; LMP2A; Burkitt's lymphoma; Bcl; Myc; transgenic models	MEMBRANE-PROTEIN 2A; ENDEMIC BURKITTS-LYMPHOMA; BCL-X-L; B-CELL; C-MYC; GENE-EXPRESSION; IN-VIVO; CONSTITUTIVE ACTIVATION; EBV; PATHWAY	Despite the identification of Epstein-Barr virus (EBV) in tumors of Burkitt's lymphoma (BL) over 40 years ago, the exact contribution of EBV to BL is undefined. EBV encodes for multiple proteins in latent B cells that affect B cell survival and activation. One such protein, latent membrane protein 2A (LMP2A), protects B cells from numerous pro-apoptotic stimuli. Therefore, we tested whether LMP2A protects B cells from apoptosis induced by aberrant c-MYC expression that precedes and dominates BL. We crossed LMP2A-transgenic mice (LMP2A-Tg), in which all B cells express LMP2A, to a transgenic mouse that expresses a BL translocation of myc (lambda-MYC-Tg mice). LMP2A promotes proliferation and protects B cells from MYC-induced apoptosis in lambda-MYC-Tg mice. LMP2A also accelerates the development of lymphoma in LMP2A/lambda-MYC-Tg mice. Finally, LMP2A increases the expression of Bcl-X-L in both pretumor B cells and tumor cells, suggesting a mechanism for LMP2A-mediated B cell survival in the presence of MYC. These results support a hypothesis that EBV LMP2A promotes tumor development by protecting pre-tumor B cells that would normally apoptose after the c-myc translocation.	[Bultema, R.; Longnecker, R.; Swanson-Mungerson, M.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Longnecker, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Ward 6-231,303 E Chicago Ave, Chicago, IL 60611 USA.	r-longnecker@northwestern.edu			Public Health Service [CA62234, CA73507]; NATIONAL CANCER INSTITUTE [R01CA133063, R01CA062234, R01CA073507] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RL is a John Edward Porter Professor in Biomedical Research and supported by the Public Health Service Grants CA62234 and CA73507 from the NCI. The authors thank Dr Herbert C Morse III, the NIAID, and the NCI for the lambda-MYC transgenic mice.	Anderson LJ, 2008, J GEN VIROL, V89, P1563, DOI 10.1099/vir.0.2008/001461-0; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Bell AI, 2006, J GEN VIROL, V87, P2885, DOI 10.1099/vir.0.81906-0; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Chen SY, 2002, J VIROL, V76, P9556, DOI 10.1128/JVI.76.18.9556-9561.2002; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Fukuda M, 2004, J VIROL, V78, P1697, DOI 10.1128/JVI.78.4.1697-1705.2004; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gerbitz A, 1999, ONCOGENE, V18, P1745, DOI 10.1038/sj.onc.1202468; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Ikeda A, 2004, J IMMUNOL, V172, P5329, DOI 10.4049/jimmunol.172.9.5329; Kim JS, 2006, J PATHOL, V209, P44, DOI 10.1002/path.1940; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Linden M, 2004, BLOOD, V103, P2779, DOI 10.1182/blood-2003-10-3399; Mancao C, 2005, BLOOD, V106, P4339, DOI 10.1182/blood-2005-06-2341; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Newman SC., 2003, BIOSTATISTICAL METHO; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pan YR, 2008, CELL MICROBIOL, V10, P2447, DOI 10.1111/j.1462-5822.2008.01221.x; Panousis CG, 1997, J VIROL, V71, P4752, DOI 10.1128/JVI.71.6.4752-4760.1997; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; RICKINSON AB, 2007, EPSTEINBARR VIRUS; Swanson PJ, 2004, J IMMUNOL, V172, P6684, DOI 10.4049/jimmunol.172.11.6684; Swanson-Mungerson MA, 2005, J VIROL, V79, P7355, DOI 10.1128/JVI.79.12.7355-7362.2005; Swanson-Mungerson M, 2006, J VIROL, V80, P6764, DOI 10.1128/JVI.00433-06; Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang H, 2006, J IMMUNOL, V177, P2793, DOI 10.4049/jimmunol.177.5.2793; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu D, 2005, BLOOD, V105, P2135, DOI 10.1182/blood-2004-07-2573	39	40	42	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1471	1476		10.1038/onc.2008.492	http://dx.doi.org/10.1038/onc.2008.492			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19182823	Green Accepted			2022-12-25	WOS:000264354400008
J	Shawkey, MD; Firestone, MK; Brodie, EL; Beissinger, SR				Shawkey, Matthew D.; Firestone, Mary K.; Brodie, Eoin L.; Beissinger, Steven R.			Avian Incubation Inhibits Growth and Diversification of Bacterial Assemblages on Eggs	PLOS ONE			English	Article								Microbial infection is a critical source of mortality for early life stages of oviparous vertebrates, but parental defenses against infection are less well known. Avian incubation has been hypothesized to reduce the risk of trans-shell infection by limiting microbial growth of pathogenic bacteria on eggshells, while enhancing growth of commensal or beneficial bacteria that inhibit or competitively exclude pathogens. We tested this hypothesis by comparing bacterial assemblages on naturally incubated and experimentally unincubated eggs at laying and late incubation using a universal 16S rRNA microarray containing probes for over 8000 bacterial taxa. Before treatment, bacterial assemblages on individual eggs from both treatment groups were dissimilar to one another, as measured by clustering in non-metric dimensional scaling (NMDS) ordination space. After treatment, assemblages of unincubated eggs were similar to one another, but those of incubated eggs were not. Furthermore, assemblages of unincubated eggs were characterized by high abundance of six indicator species while incubated eggs had no indicator species. Bacterial taxon richness remained static on incubated eggs, but increased significantly on unincubated eggs, especially in several families of Gram-negative bacteria. The relative abundance of individual bacterial taxa did not change on incubated eggs, but that of 82 bacterial taxa, including some known to infect the interior of eggs, increased on unincubated eggs. Thus, incubation inhibits all of the relatively few bacteria that grow on eggshells, and does not appear to promote growth of any bacteria.	[Shawkey, Matthew D.; Firestone, Mary K.; Beissinger, Steven R.] Univ Calif, Dept Environm Sci Policy & Management, Div Ecosyst Sci Div, Berkeley, CA USA; [Firestone, Mary K.; Brodie, Eoin L.] Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Shawkey, MD (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	beis@nature.berkeley.edu	Brodie, Eoin L/A-7853-2008; Beissinger, Steven R/F-3809-2012	Brodie, Eoin L/0000-0002-8453-8435; Shawkey, Matthew/0000-0002-5131-8209	NSF [IOB-0517549]; U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02- 05CH11231]	NSF(National Science Foundation (NSF)); U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	This work was supported by NSF grant IOB-0517549 to S. R. Beissinger and M. K. Firestone. Additional work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under Contract DE-AC02- 05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2007, LABDSV ORDINATION MU; ARENDT WJ, 1993, PEARY EYED THRASHER; Bandyopadhyay Anuradha, 1996, Indian Journal of Experimental Biology, V34, P48; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; Board RG, 1994, MICROBIOLOGY AVIAN E; Borg I, 2010, MODERN MULTIDIMENSIO; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; BRUCE J, 1991, POULT SCI S, V22, P257; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557; Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Giacomello E, 2006, BIOL LETTERS, V2, P330, DOI 10.1098/rsbl.2006.0492; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Han XY, 2005, J ANTIMICROB CHEMOTH, V55, P853, DOI 10.1093/jac/dki139; Houston CS, 1997, J WILDLIFE DIS, V33, P328, DOI 10.7589/0090-3558-33.2.328; Knouft JH, 2003, P ROY SOC B-BIOL SCI, V270, P2405, DOI 10.1098/rspb.2003.2501; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; KOZLOWSKI S, 1989, INTECOL SLUPSK, P121; Law-Brown J, 2003, INT J SYST EVOL MICR, V53, P683, DOI 10.1099/ijs.0.02334-0; LIU WT, 2002, MANUAL ENV MICROBIOL, P114; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Mielke P. W., 2001, PERMUTATION METHODS; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Raffaele H.A., 1998, GUIDE BIRDS W INDIES; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; *TEAM TDC, 2008, R LANG ENV STAT COMP; Zar J. H., 1996, BIOSTATISTICAL ANAL	40	69	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4522	10.1371/journal.pone.0004522	http://dx.doi.org/10.1371/journal.pone.0004522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225566	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486000004
J	Brown, AE; Baumbach, J; Cook, PE; Ligoxygakis, P				Brown, Anthony E.; Baumbach, Janina; Cook, Peter E.; Ligoxygakis, Petros			Short-Term Starvation of Immune Deficient Drosophila Improves Survival to Gram-Negative Bacterial Infections	PLOS ONE			English	Article							NITRIC-OXIDE; DIETARY RESTRICTION; MITOCHONDRIAL BIOGENESIS; PATHOGEN RECOGNITION	Background: Primary immunodeficiencies are inborn errors of immunity that lead to life threatening conditions. These predispositions describe human immunity in natura and highlight the important function of components of the Toll-IL-1-receptor-nuclear factor kappa B (TIR-NF-kappa B) pathway. Since the TIR-NF-kappa B circuit is a conserved component of the host defence in higher animals, genetically tractable models may contribute ideas for clinical interventions. Methodology/Principal Findings: We used immunodeficient fruit flies (Drosophila melanogaster) to address questions pertaining to survival following bacterial infection. We describe here that flies lacking the NF-kappa B protein Relish, indispensable for countering Gram-negative bacteria, had a greatly improved survival to such infections when subject to dietary short-term starvation (STS) prior to immune challenge. STS induced the release of Nitric Oxide (NO), a potent molecule against pathogens in flies, mice and humans. Administering the NO Synthase-inhibitory arginine analog N-Nitro-L-Arginine-Methyl-Ester (L-NAME) but not its inactive enantiomer D-NAME increased once again sensitivity to infection to levels expected for relish mutants. Surprisingly, NO signalling required the NF-kappa B protein Dif, usually needed for responses against Gram-positive bacteria. Conclusions/Significance: Our results show that NO release through STS may reflect an evolutionary conserved process. Moreover, STS could be explored to address immune phenotypes related to infection and may offer ways to boost natural immunity.	[Brown, Anthony E.; Baumbach, Janina; Ligoxygakis, Petros] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; [Brown, Anthony E.; Cook, Peter E.] Univ Oxford, Peter Medawar Building Pathogen Res, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Brown, AE (corresponding author), Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England.	petros.ligoxygakis@bioch.ox.ac.uk		Brown, Anthony/0000-0002-1271-310X	Medical Research Council UK [G0300170]; EPA Cephalosporin Trust Fund [CF 115]; Studienstiftung des Deutschen Volkes [scholarship]; EMBO [long-term fellowship]; MRC [G0300170] Funding Source: UKRI; Medical Research Council [G0300170] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPA Cephalosporin Trust Fund; Studienstiftung des Deutschen Volkes; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This investigation was supported by the Medical Research Council UK (career establishment grant G0300170 to PL) and the EPA Cephalosporin Trust Fund (pump-priming grant CF 115 to PL). JB was the recipient of a Studienstiftung des Deutschen Volkes scholarship. PEC was supported by an EMBO long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; CHER DJ, 1987, J IMMUNOL, V138, P3688; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Huang FP, 1998, EUR J IMMUNOL, V28, P4062, DOI 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mojena M, 2001, FASEB J, V15, P583; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; van den Brink GR, 2002, CLIN DIAGN LAB IMMUN, V9, P182, DOI 10.1128/CDLI.9.1.182-183.2002; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wu JL, 2007, CELL MICROBIOL, V9, P1073, DOI 10.1111/j.1462-5822.2006.00853.x; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	25	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4490	10.1371/journal.pone.0004490	http://dx.doi.org/10.1371/journal.pone.0004490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221590	Green Published, Green Submitted, gold			2022-12-25	WOS:000265485700015
J	Grigoryan, A; Hall, HI; Durant, T; Wei, XM				Grigoryan, Anna; Hall, H. Irene; Durant, Tonji; Wei, Xiangming			Late HIV Diagnosis and Determinants of Progression to AIDS or Death after HIV Diagnosis among Injection Drug Users, 33 US States, 1996-2004	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; DISEASE PROGRESSION; SURVIVAL; ERA; INFECTION; ADHERENCE; MORTALITY	Background: The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinants of survival for HIV-infected people. Injection drug users (IDUs) are less likely than persons in other transmission categories to seek early HIV counseling, testing, and treatment. Our objective was to estimate the proportion of IDUs with a late HIV diagnosis (AIDS diagnosis within 12 months of HIV diagnosis) and determine the factors associated with disease progression after HIV diagnosis. Methodology/Principal Findings: Using data from 33 states with confidential name-based HIV reporting, we determined the proportion of IDUs aged >= 13 years who received a late HIV diagnosis during 1996-2004. We used standardized Kaplan-Meier survival methods to determine differences in time of progression from HIV to AIDS and death, by race/ethnicity, sex, age group, CD4(+) T-cell count, metropolitan residence, and diagnosis year. We compared the survival of IDUs with the survival of persons in other transmission categories. During 1996-2004, 42.2% (11,635) of 27,572 IDUs were diagnosed late. For IDUs, the risk for progression from HIV to AIDS 3 years after HIV diagnosis was greater for nonwhites, males and older persons. Three-year survival after HIV diagnosis was lower for IDU males (87.3%, 95% confidence interval (CI), 87.1-87.4) compared with males exposed through male-to-male sexual contact (91.6%, 95% CI, 91.6-91.7) and males exposed through high-risk heterosexual contact (HRHC) (91.9%, 95% CI, 91.8-91.9). Survival was also lower for IDU females (89.5%, 95% CI, 89.4-89.6) compared to HRHC females (93.3%, 95% CI, 93.3-93.4). Conclusions/Significance: A substantial proportion of IDUs living with HIV received their HIV diagnosis late. To improve survival of IDUs, HIV prevention efforts must ensure early access to HIV testing and care, as well as encourage adherence to antiretroviral treatment to slow disease progression.	[Grigoryan, Anna; Hall, H. Irene; Durant, Tonji] Ctr Dis Control & Prevent, Div HIV AIDS, Atlanta, GA 30333 USA; [Wei, Xiangming] McKing Consult Corp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Grigoryan, A (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS, Atlanta, GA 30333 USA.	ffg7@cdc.gov						Amato D., 1988, COMMUN STAT-THEOR M, V17, P143; Andersen R, 2000, HEALTH SERV RES, V35, P389; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2007, HIV AIDS SURV REP 20, V17; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Couturier E, 1998, AIDS, V12, P795, DOI 10.1097/00002030-199807000-00016; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jarlais DCD, 2004, JAIDS-J ACQ IMM DEF, V35, P158, DOI 10.1097/00126334-200402010-00010; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Manfredi R, 2002, DRUG AGING, V19, P647, DOI 10.2165/00002512-200219090-00003; Mitty JA, 2002, CLIN INFECT DIS, V34, P984, DOI 10.1086/339447; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; Muga R, 2004, J EPIDEMIOL COMMUN H, V58, P286, DOI 10.1136/jech.2003.010066; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Porter D, 2003, MOL CANCER RES, V1, P362; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; *US DEP HHS, 2008, GUID US ANT AG HIV 1; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wood E, 2003, CAN MED ASSOC J, V169, P656	29	54	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4445	10.1371/journal.pone.0004445	http://dx.doi.org/10.1371/journal.pone.0004445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JR	19214229	gold, Green Published			2022-12-25	WOS:000265484300004
J	Hildebrand, PW; Scheerer, P; Park, JH; Choe, HW; Piechnick, R; Ernst, OP; Hofmann, KP; Heck, M				Hildebrand, Peter W.; Scheerer, Patrick; Park, Jung Hee; Choe, Hui-Woog; Piechnick, Ronny; Ernst, Oliver P.; Hofmann, Klaus Peter; Heck, Martin			A Ligand Channel through the G Protein Coupled Receptor Opsin	PLOS ONE			English	Article								The G protein coupled receptor rhodopsin contains a pocket within its seven-transmembrane helix (TM) structure, which bears the inactivating 11-cis-retinal bound by a protonated Schiff-base to Lys296 in TM7. Light-induced 11-cis-/all-trans-isomerization leads to the Schiff-base deprotonated active Meta II intermediate. With Meta II decay, the Schiff-base bond is hydrolyzed, all-trans-retinal is released from the pocket, and the apoprotein opsin reloaded with new 11-cis-retinal. The crystal structure of opsin in its active Ops* conformation provides the basis for computational modeling of retinal release and uptake. The ligand-free 7TM bundle of opsin opens into the hydrophobic membrane layer through openings A (between TM1 and 7), and B (between TM5 and 6), respectively. Using skeleton search and molecular docking, we find a continuous channel through the protein that connects these two openings and comprises in its central part the retinal binding pocket. The channel traverses the receptor over a distance of ca. 70 angstrom and is between 11.6 and 3.2 angstrom wide. Both openings are lined with aromatic residues, while the central part is highly polar. Four constrictions within the channel are so narrow that they must stretch to allow passage of the retinal beta-ionone-ring. Constrictions are at openings A and B, respectively, and at Trp265 and Lys296 within the retinal pocket. The lysine enforces a 90 degrees elbow-like kink in the channel which limits retinal passage. With a favorable Lys side chain conformation, 11-cis-retinal can take the turn, whereas passage of the all-trans isomer would require more global conformational changes. We discuss possible scenarios for the uptake of 11-cis- and release of all-trans-retinal. If the uptake gate of 11-cis-retinal is assigned to opening B, all-trans is likely to leave through the same gate. The unidirectional passage proposed previously requires uptake of 11-cis-retinal through A and release of photolyzed all-trans-retinal through B.	[Hildebrand, Peter W.; Scheerer, Patrick; Park, Jung Hee; Piechnick, Ronny; Ernst, Oliver P.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University	Hildebrand, PW (corresponding author), Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany.	peter.hildebrand@charite.de		Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft [SFB 449, SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 449 and SFB 740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Hildebrand PW, 2004, FEBS LETT, V559, P145, DOI 10.1016/S0014-5793(04)00061-4; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MATSUMOTO H, 1978, VISION RES, V18, P607, DOI 10.1016/0042-6989(78)90212-2; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977	22	93	93	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4382	10.1371/journal.pone.0004382	http://dx.doi.org/10.1371/journal.pone.0004382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194506	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483600011
J	Doxiadis, GGM; Heijmans, CMC; Bonhomme, M; Otting, N; Crouau-Roy, B; Bontrop, RE				Doxiadis, Gaby G. M.; Heijmans, Corrine M. C.; Bonhomme, Maxime; Otting, Nel; Crouau-Roy, Brigitte; Bontrop, Ronald E.			Compound Evolutionary History of the Rhesus Macaque Mhc Class I B Region Revealed by Microsatellite Analysis and Localization of Retroviral Sequences	PLOS ONE			English	Article								In humans, the single polymorphic B locus of the major histocompatibility complex is linked to the microsatellite MIB. In rhesus macaques, however, haplotypes are characterized by the presence of unique combinations of multiple B genes, which may display different levels of polymorphism. The aim of the study was to shed light on the evolutionary history of this highly complex region. First, the robustness of the microsatellite MIB-linked to almost half of the B genes in rhesus macaques (Mamu-B)-for accurate B haplotyping was studied. Based on the physical map of an established haplotype comprising 7 MIB loci, each located next to a certain Mamu-B gene, two MIB loci, MIB1 and MIB6, were investigated in a panel of MHC homozygous monkeys. MIB1 revealed a complex genotyping pattern, whereas MIB6 analysis resulted in the detection of one or no amplicon. Both patterns are specific for a given B haplotype, show Mendelian segregation, and even allow a more precise haplotype definition than do traditional typing methods. Second, a search was performed for retroelements that may have played a role in duplication processes as observed in the macaque B region. This resulted in the description of two types of duplicons. One basic unit comprises an expressed Mamu-B gene, adjacent to an HERV16 copy closely linked to MIB. The second type of duplicon comprises a Mamu-B (pseudo) gene, linked to a truncated HERV16 structure lacking its MIB segment. Such truncation seems to coincide with the loss of B gene transcription. Subsequent to the duplication processes, recombination between MIB and Mamu-B loci appears to have occurred, resulting in a hyperplastic B region. Thus, analysis of MIB in addition to B loci allows deciphering of the compound evolutionary history of the class I B region in Old World monkeys.	[Doxiadis, Gaby G. M.; Heijmans, Corrine M. C.; Otting, Nel; Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, Rijswijk, Netherlands; [Bonhomme, Maxime; Crouau-Roy, Brigitte] Univ Paul Sabatier, Dept Evolut & Divers Biol, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Doxiadis, GGM (corresponding author), Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, Rijswijk, Netherlands.	doxiadis@bprc.nl	Bontrop, Ronald E/J-3628-2012; Bonhomme, Maxime/AAK-3263-2020; Bonhomme, Maxime/F-2962-2014; Bontrop, Ronald E./D-4844-2011	Bontrop, Ronald E/0000-0003-0874-6467; Bonhomme, Maxime/0000-0002-1210-4777; 	NIH/NIAID [HHSN266200400088C, 5R24RR016038-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by NIH/NIAID contract number HHSN266200400088C and 5R24RR016038-05. The funding organization played no active role in the study or preparation of the manuscript.	Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Bonhomme M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-514; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Bontrop RE, 2005, TRENDS IMMUNOL, V26, P227, DOI 10.1016/j.it.2005.02.003; Bontrop RE, 1999, IMMUNOL REV, V167, P339, DOI 10.1111/j.1600-065X.1999.tb01403.x; BONTROP RE, 1995, IMMUNOL REV, V143, P33, DOI 10.1111/j.1600-065X.1995.tb00669.x; BOYSON JE, 1995, IMMUNOGENETICS, V41, P59; Boyson JE, 1996, J IMMUNOL, V157, P5428; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; Clisson I, 2000, AM J PRIMATOL, V50, P205, DOI 10.1002/(SICI)1098-2345(200003)50:3<205::AID-AJP3>3.0.CO;2-Y; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; Doxiadis GGM, 2008, J VIROL, V82, P6667, DOI 10.1128/JVI.00097-08; Doxiadis GGM, 2006, P NATL ACAD SCI USA, V103, P5864, DOI 10.1073/pnas.0600643103; Grimaldi MC, 1996, HUM IMMUNOL, V51, P89, DOI 10.1016/S0198-8859(96)00228-5; Grimaldi MC, 1997, J MOL EVOL, V44, P336, DOI 10.1007/PL00006151; Karl JA, 2008, IMMUNOGENETICS, V60, P37, DOI 10.1007/s00251-007-0267-x; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kulski JK, 1999, J MOL EVOL, V48, P675, DOI 10.1007/PL00006511; Kulski JK, 2005, CYTOGENET GENOME RES, V110, P181, DOI 10.1159/000084951; Kulski JK, 2004, MOL BIOL EVOL, V21, P2079, DOI 10.1093/molbev/msh216; Kulski JK, 1999, J MOL EVOL, V49, P84, DOI 10.1007/PL00006537; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; OTTING N, 1993, IMMUNOGENETICS, V38, P141; Otting N, 2008, IMMUNOGENETICS, V60, P507, DOI 10.1007/s00251-008-0311-5; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Shiina T, 2006, GENETICS, V173, P1555, DOI 10.1534/genetics.106.057034; SLIERENDREGT BL, 1995, INT IMMUNOL, V7, P1671, DOI 10.1093/intimm/7.10.1671; Urvater JA, 2000, J IMMUNOL, V164, P1386, DOI 10.4049/jimmunol.164.3.1386; Vierboom MPM, 2005, ARTHRITIS RES THER, V7, P145, DOI 10.1186/ar1773; Vogel TU, 1999, IMMUNOL REV, V167, P327, DOI 10.1111/j.1600-065X.1999.tb01402.x	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4287	10.1371/journal.pone.0004287	http://dx.doi.org/10.1371/journal.pone.0004287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172173	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482900007
J	Diaz-Hernandez, M; Diez-Zaera, M; Sanchez-Nogueiro, J; Gomez-Villafuertes, R; Canals, JM; Alberch, J; Miras-Portugal, MT; Lucas, JJ				Diaz-Hernandez, Miguel; Diez-Zaera, Maria; Sanchez-Nogueiro, Jesus; Gomez-Villafuertes, Rosa; Canals, Josep M.; Alberch, Jordi; Teresa Miras-Portugal, Maria; Lucas, Jose J.			Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration	FASEB JOURNAL			English	Article						ATP; calcium; apoptosis; polyglutamine; BBG	BRILLIANT BLUE-G; CELL-DEATH; EXTRACELLULAR ATP; SYNAPTIC TERMINALS; MUTANT HUNTINGTIN; MOTOR DYSFUNCTION; P2X(7) RECEPTORS; MINOCYCLINE; NEURONS; PATHOGENESIS	The precise mechanism by which mutant huntingtin elicits its toxicity remains unknown. However, synaptic alterations and increased susceptibility to neuronal death are known contributors to Huntington's disease (HD) symptomatology. While decreased metabolism has long been associated with HD, recent findings have surprisingly demonstrated reduced neuronal apoptosis in Caenorhabditis elegans and Drosophila models of HD by drugs that diminish ATP production. Interestingly, extracellular ATP has been recently reported to elicit neuronal death through stimulation of P2X7 receptors. These are ATP-gated cation channels known to modulate neurotransmitter release from neuronal presynaptic terminals and to regulate cytokine production and release from microglia. We hypothesized that alteration in P2X7-mediated calcium permeability may contribute to HD synaptic dysfunction and increased neuronal apoptosis. Using mouse and cellular models of HD, we demonstrate increased P2X7- receptor level and altered P2X7- mediated calcium permeability in somata and terminals of HD neurons. Furthermore, cultured neurons expressing mutant huntingtin showed increased susceptibility to apoptosis triggered by P2X7receptor stimulation. Finally, in vivo administration of the P2X7-antagonist Brilliant Blue-G (BBG) to HD mice prevented neuronal apoptosis and attenuated body weight loss and motor-coordination deficits. These in vivo data strongly suggest that altered P2X7- receptor level and function contribute to HD pathogenesis and highlight the therapeutic potential of P2X7 receptor antagonists.-Diaz-Hernandez, M., Diez-Zaera, M., Sanchez-Nogueiro, J., Gomez-Villafuertes, R., Canals, J. M., Alberch, J., Miras-Portugal, M. T., Lucas, J. J. Altered P2X7- receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J. 23, 1893-1906 (2009)	[Diaz-Hernandez, Miguel; Sanchez-Nogueiro, Jesus; Lucas, Jose J.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Diaz-Hernandez, Miguel; Canals, Josep M.; Alberch, Jordi; Lucas, Jose J.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Diaz-Hernandez, Miguel; Diez-Zaera, Maria; Sanchez-Nogueiro, Jesus; Gomez-Villafuertes, Rosa; Teresa Miras-Portugal, Maria] Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol 4, Madrid, Spain; [Canals, Josep M.; Alberch, Jordi] Univ Barcelona, Fac Med, Dept Biol Cellular & Anat Patol, Inst Invest Biomed August Pi & Sunyer, Barcelona 7, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Instituto de Salud Carlos III; Complutense University of Madrid; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Lucas, JJ (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus UAM Cantoblanco, Madrid 28049, Spain.	jjlucas@cbm.uam.es	Alberch, Jordi/K-5702-2014; Miras-Portugal, Maria Teresa/L-7137-2014; Canals, Josep M/M-3846-2014; Lucas, Jose J./U-6543-2019; Gomez-Villafuertes, Rosa/L-7181-2014	Alberch, Jordi/0000-0002-8684-2721; Canals, Josep M/0000-0001-6829-7670; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Lucas, Jose J./0000-0003-1597-3916; Diez Zaera, Maria/0000-0001-7062-7579; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed); Ministerio de Educacion y Ciencia, Comunidad Autonoma de Madrid, Fundacion "La Caixa," Fundacion Marcelino Botin	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed); Ministerio de Educacion y Ciencia, Comunidad Autonoma de Madrid, Fundacion "La Caixa," Fundacion Marcelino Botin(Spanish Government)	The authors thank Drs. M. R. Fernandez and C. Tomas for helpful discussion and comments; Dr. O. Howard for comments and style correction; and Drs. S. Finkbeiner and M. Arrasate (Gladstone Institute, San Francisco, CA, USA) for kindly providing plasmids expressing exon 1 htt fused to GFP with 17 or 72 Q repeats. The authors are also grateful to Javier Palac n, Desiree Ruiz, and Alicia Tomico for technical assistance. This work was supported by Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed) and by grants from Ministerio de Educacion y Ciencia, Comunidad Autonoma de Madrid, Fundacion "La Caixa," Fundacion Marcelino Botin, and by an institutional grant from Fundacion Ramon Areces. M.D.II. was a recipient of a "Juan de la Cierva" contract from Ministerio de Educacion y Ciencia and is currently a recipient of a "Ramon y Cajal" contract.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Diaz-Hernandez M, 2005, J NEUROSCI, V25, P9773, DOI 10.1523/JNEUROSCI.3183-05.2005; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; DUBINSKY JM, 1989, J NEUROSCI, V9, P3955; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Ferrari D, 1996, J IMMUNOL, V156, P1531; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; GROSS E, 1961, Z Krebsforsch, V64, P287, DOI 10.1007/BF00525218; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P514, DOI 10.1001/archopht.124.4.514; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Li CM, 2002, FEBS LETT, V531, P127, DOI 10.1016/S0014-5793(02)03424-5; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marin-Garcia P, 2008, NEUROSCIENCE, V151, P361, DOI 10.1016/j.neuroscience.2007.10.038; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Reynolds N, 2007, MOVEMENT DISORD, V22, P292, DOI 10.1002/mds.21199; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sanchez-Nogueiro J, 2005, FEBS LETT, V579, P3783, DOI 10.1016/j.febslet.2005.05.073; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yu Y, 2008, BRAIN RES, V1194, P45, DOI 10.1016/j.brainres.2007.11.064	59	179	197	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1893	1906		10.1096/fj.08-122275	http://dx.doi.org/10.1096/fj.08-122275			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19171786				2022-12-25	WOS:000266652400029
J	Nayak, A; Glockner-Pagel, J; Vaeth, M; Schumann, JE; Buttmann, M; Bopp, T; Schmitt, E; Serfling, E; Berberich-Siebelt, F				Nayak, Arnab; Gloeckner-Pagel, Judith; Vaeth, Martin; Schumann, Julia E.; Buttmann, Mathias; Bopp, Tobias; Schmitt, Edgar; Serfling, Edgar; Berberich-Siebelt, Friederike			Sumoylation of the Transcription Factor NFATc1 Leads to Its Subnuclear Relocalization and Interleukin-2 Repression by Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; EFFECTOR T-CELLS; NF-ATC; ACTIVATION; SUMO; EXPRESSION; DIFFERENTIATION; PROTEINS; BINDING; IL-2	The family of NFAT (nuclear factor of activated T-cells) transcription factors plays an important role in cytokine gene regulation. In peripheral T-cells NFATc1 and -c2 are predominantly expressed. Because of different promoter and poly(A) site usage as well as alternative splicing events, NFATc1 is synthesized in multiple isoforms. The highly inducible NFATc1/A contains a relatively short C terminus, whereas the longer, constitutively expressed isoform NFATc1/C spans an extra C-terminal peptide of 246 amino acids. Interestingly, this NFATc1/C-specific terminus can be highly sumoylated. Upon sumoylation, NFATc1/C, but not the unsumoylated NFATc1/A, translocates to promyelocytic leukemia nuclear bodies. This leads to interaction with histone deacetylases followed by deacetylation of histones, which in turn induces transcriptionally inactive chromatin. As a consequence, expression of the NFATc1 target gene interleukin-2 is suppressed. These findings demonstrate that the modification by SUMO (small ubiquitin-like modifier) converts NFATc1 from an activator to a site-specific transcriptional repressor, revealing a novel regulatory mechanism for NFATc1 function.	[Berberich-Siebelt, Friederike] Univ Wurzburg, Dept Mol Pathol, Inst Pathol, D-97080 Wurzburg, Germany; [Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Bopp, Tobias; Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany	University of Wurzburg; University of Wurzburg; Johannes Gutenberg University of Mainz	Berberich-Siebelt, F (corresponding author), Univ Wurzburg, Dept Mol Pathol, Inst Pathol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	path230@mail.uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Serfling, Edgar/X-7212-2019; Buttmann, Mathias/AAD-7488-2021; Bopp, Tobias/A-4328-2018	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685; Bopp, Tobias/0000-0002-3232-8065; Vaeth, Martin/0000-0001-8974-7052	Deutsche Forschungsgemeinschaft [SFB 466/B3, BE 2309/2-1, SPP1365]; Wilhelm-Sander-Foundation; Mildred-Scheel-Foundation for Cancer Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander-Foundation; Mildred-Scheel-Foundation for Cancer Research(Deutsche Krebshilfe)	This work was further by supported by Deutsche Forschungsgemeinschaft Grants SFB 466/B3, BE 2309/2-1, and SPP1365, by the Wilhelm-Sander-Foundation, and the Mildred-Scheel-Foundation for Cancer Research.	Altschmied J, 1997, BIOTECHNIQUES, V23, P436, DOI 10.2144/97233bm19; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Gall JG, 2001, FEBS LETT, V498, P164, DOI 10.1016/S0014-5793(01)02461-9; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kuss AW, 1999, EUR J IMMUNOL, V29, P3077, DOI 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	41	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10935	10946		10.1074/jbc.M900465200	http://dx.doi.org/10.1074/jbc.M900465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218564	Green Published, hybrid			2022-12-25	WOS:000265104600066
J	Zarelli, VEP; Ruete, MC; Roggero, CM; Mayorga, LS; Tomes, CN				Zarelli, Valeria E. P.; Ruete, Maria C.; Roggero, Carlos M.; Mayorga, Luis S.; Tomes, Claudia N.			PTP1B Dephosphorylates N-Ethylmaleimide-sensitive Factor and Elicits SNARE Complex Disassembly during Human Sperm Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACROSOMAL EXOCYTOSIS; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; HUMAN SPERMATOZOA; S-NITROSYLATION; PHOSPHORYLATION; NEUROTOXINS; RAB3A; SYNAPTOBREVIN	The reversible phosphorylation of tyrosyl residues in proteins is a cornerstone of the signaling pathways that regulate numerous cellular responses. Protein tyrosine phosphorylation is controlled through the concerted actions of protein-tyrosine kinases and phosphatases. The goal of the present study was to unveil the mechanisms by which protein tyrosine dephosphorylation modulates secretion. The acrosome reaction, a specialized type of regulated exocytosis undergone by sperm, is initiated by calcium and carried out by a number of players, including tyrosine kinases and phosphatases, and fusion-related proteins such as Rab3A, alpha-SNAP, N-ethylmaleimide-sensitive factor (NSF), SNAREs, complexin, and synaptotagmin VI. We report here that inducers were unable to elicit the acrosome reaction when permeabilized human sperm were loaded with anti-PTP1B antibodies or with the dominant-negative mutant PTP1B D181A; subsequent introduction of wild type PTP1B or NSF rescued exocytosis. Wild type PTP1B, but not PTP1B D181A, caused cis SNARE complex dissociation during the acrosome reaction through a mechanism involving NSF. Unlike its non-phosphorylated counterpart, recombinant phospho-NSF failed to dissociate SNARE complexes from rat brain membranes. These results strengthen our previous observation that NSF activity is regulated rather than constitutive during sperm exocytosis and indicate that NSF must be dephosphorylated by PTP1B to disassemble SNARE complexes. Interestingly, phospho-NSF served as a substrate for PTP1B in an in vitro assay. Our findings demonstrate that phosphorylation of NSF on tyrosine residues prevents its SNARE complex dissociation activity and establish for the first time a role for PTP1B in the modulation of the membrane fusion machinery.	[Zarelli, Valeria E. P.; Ruete, Maria C.; Roggero, Carlos M.; Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol IHEM CONICET, Lab Biol Celular & Mol, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Tomes, CN (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol IHEM CONICET, Lab Biol Celular & Mol, CC 56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar	Roggero, Carlos/AAX-4354-2020	Mayorga, Luis S/0000-0002-5995-0671; Ruete, Maria Celeste/0000-0002-8183-5637	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina).	AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; MAYORGA L, 2007, IUBMB LIFE, V59, P1; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; SCHULTE RJ, 1994, J IMMUNOL, V153, P5465; Seligman J, 2004, BIOL REPROD, V71, P1009, DOI 10.1095/biolreprod.104.028035; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOMES C, 2006, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Valdez SR, 2007, SYNAPSE, V61, P124, DOI 10.1002/syn.20353; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; YAMASAKI S, 1994, P NATL ACAD SCI USA, V91, P4688, DOI 10.1073/pnas.91.11.4688; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Yunes R, 2002, FEBS LETT, V525, P126, DOI 10.1016/S0014-5793(02)03102-2; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	46	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10491	10503		10.1074/jbc.M807614200	http://dx.doi.org/10.1074/jbc.M807614200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208619	Green Published, hybrid			2022-12-25	WOS:000265104600023
J	Baniulis, D; Yamashita, E; Whitelegge, JP; Zatsman, AI; Hendrich, MP; Hasan, SS; Ryan, CM; Cramer, WA				Baniulis, Danas; Yamashita, Eiki; Whitelegge, Julian P.; Zatsman, Anna I.; Hendrich, Michael P.; Hasan, S. Saif; Ryan, Christopher M.; Cramer, William A.			Structure-Function, Stability, and Chemical Modification of the Cyanobacterial Cytochrome b(6)f Complex from Nostoc sp PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; OXIDOREDUCTASE ACTIVITY; SPINACH-CHLOROPLASTS; ANGSTROM RESOLUTION; ELECTRON-TRANSFER; PHOTOSYSTEM-II; ACETYLATION; ANABAENA; HEME; PHOTOSYNTHESIS	The crystal structure of the cyanobacterial cytochrome b(6)f complex has previously been solved to 3.0-angstrom resolution using the thermophilic Mastigocladus laminosus whose genome has not been sequenced. Several unicellular cyanobacteria, whose genomes have been sequenced and are tractable for mutagenesis, do not yield b(6)f complex in an intact dimeric state with significant electron transport activity. The genome of Nostoc sp. PCC 7120 has been sequenced and is closer phylogenetically to M. laminosus than are unicellular cyanobacteria. The amino acid sequences of the large core subunits and four small peripheral subunits of Nostoc are 88 and 80% identical to those in the M. laminosus b(6)f complex. Purified b6f complex from Nostoc has a stable dimeric structure, eight subunits with masses similar to those of M. laminosus, and comparable electron transport activity. The crystal structure of the native b6f complex, determined to a resolution of 3.0 angstrom (PDB id: 2ZT9), is almost identical to that of M. laminosus. Two unique aspects of the Nostoc complex are: (i) a dominant conformation of heme b(p) that is rotated 180 about the alpha- and gamma-meso carbon axis relative to the orientation in the M. laminosus complex and (ii) acetylation of the Rieske iron-sulfur protein (PetC) at the N terminus, a post-translational modification unprecedented in cyanobacterial membrane and electron transport proteins, and in polypeptides of cytochrome bc complexes from any source. The high spin electronic character of the unique heme c(n) is similar to that previously found in the b(6)f complex from other sources.	[Baniulis, Danas; Hasan, S. Saif; Cramer, William A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Yamashita, Eiki] Osaka Univ, Inst Prot Res, Osaka 5600043, Japan; [Zatsman, Anna I.; Hendrich, Michael P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Whitelegge, Julian P.; Ryan, Christopher M.] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Osaka University; Carnegie Mellon University; University of California System; University of California Los Angeles	Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	waclab@purdue.edu	Baniulis, Danas/AAA-9458-2021; Hasan, Syed Saif/A-3400-2015; Yamashita, Eiki/V-6758-2019	Baniulis, Danas/0000-0002-2693-2020; Hasan, Syed Saif/0000-0002-0759-7511; Yamashita, Eiki/0000-0002-4278-0039	National Institutes of Health Grants [GM-38323, GM-077387]; NIH/NCRR [R21RR021913-01A2]; U. S. DOE [W31-109-ENG-389]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077387, R01GM038323, R56GM038323] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U. S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-38323 ( to W. A. C.) and GM-077387 ( to M. P. H.) and by NIH/NCRR Grant R21RR021913-01A2 ( to J.P.W.). The x-ray structure analysis was carried out at the Advanced Photon Source, Argonne National Laboratory was supported by U. S. DOE Grant W31-109-ENG-389.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barak R, 2004, J MOL BIOL, V342, P383, DOI 10.1016/j.jmb.2004.07.020; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Boronowsky U, 2001, BBA-BIOENERGETICS, V1506, P55, DOI 10.1016/S0005-2728(01)00184-0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cramer W, 2008, PHOTOSYNTHETIC PROTE, P155, DOI [10.1002/9783527623464.ch7, DOI 10.1002/9783527623464.CH7]; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELLEFSON WL, 1980, METHOD ENZYMOL, V69, P223; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Gomez SM, 2003, MOL CELL PROTEOMICS, V2, P1068, DOI 10.1074/mcp.M300062-MCP200; Hurley JK, 2002, BBA-BIOENERGETICS, V1554, P5, DOI 10.1016/S0005-2728(02)00188-3; HURT E, 1981, EUR J BIOCHEM, V117, P591; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KRINNER M, 1982, BIOCHIM BIOPHYS ACTA, V681, P110, DOI 10.1016/0005-2728(82)90284-5; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Mackay DT, 2007, MOL MICROBIOL, V64, P1540, DOI 10.1111/j.1365-2958.2007.05752.x; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; MICHEL H, 1988, J BIOL CHEM, V263, P1123; MICHEL H, 1991, J BIOL CHEM, V266, P17584; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson ME, 2005, J BIOL CHEM, V280, P10395, DOI 10.1074/jbc.M410948200; PECK HD, 1965, BIOCHIM BIOPHYS ACTA, V96, P429, DOI 10.1016/0005-2787(65)90561-7; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Porra RJ., 1991, CHLOROPHYLLS, P31; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schneider D, 2002, J BIOL CHEM, V277, P10949, DOI 10.1074/jbc.M104076200; Schneider D, 2007, RES MICROBIOL, V158, P45, DOI 10.1016/j.resmic.2006.10.002; Shalev-Malul G, 2008, ENVIRON MICROBIOL, V10, P988, DOI 10.1111/j.1462-2920.2007.01519.x; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; TAKEMURA R, 1992, J CELL SCI, V103, P953; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMITANI A, 2006, FRONT RES EARTH EVOL, V2, P1; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; WALKER FA, 1988, J AM CHEM SOC, V110, P6234, DOI 10.1021/ja00226a045; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Zatsman AI, 2006, J AM CHEM SOC, V128, P14246, DOI 10.1021/ja065798m; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang Huamin, 2005, Journal of Structural and Functional Genomics, V6, P219, DOI 10.1007/s10969-005-1912-y; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	56	79	81	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9861	9869		10.1074/jbc.M809196200	http://dx.doi.org/10.1074/jbc.M809196200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189962	hybrid, Green Published			2022-12-25	WOS:000264892900027
J	Doern, A; Cao, XJ; Sereno, A; Reyes, CL; Altshuler, A; Huang, F; Hession, C; Flavier, A; Favis, M; Tran, H; Ailor, E; Levesque, M; Murphy, T; Berquist, L; Tamraz, S; Snipas, T; Garber, E; Shestowsky, WS; Rennard, R; Graff, CP; Wu, XF; Snyder, W; Cole, L; Gregson, D; Shields, M; Ho, SN; Reff, ME; Glaser, SM; Dong, JY; Demarest, SJ; Hariharan, K				Doern, Adam; Cao, Xianjun; Sereno, Arlene; Reyes, Christopher L.; Altshuler, Angelina; Huang, Flora; Hession, Cathy; Flavier, Albert; Favis, Michael; Tran, Hon; Ailor, Eric; Levesque, Melissa; Murphy, Tracey; Berquist, Lisa; Tamraz, Susan; Snipas, Tracey; Garber, Ellen; Shestowsky, William S.; Rennard, Rachel; Graff, Christilyn P.; Wu, Xiufeng; Snyder, William; Cole, Lindsay; Gregson, David; Shields, Michael; Ho, Steffan N.; Reff, Mitchell E.; Glaser, Scott M.; Dong, Jianying; Demarest, Stephen J.; Hariharan, Kandasamy			Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE SCANNING MUTAGENESIS; MONOCLONAL-ANTIBODIES; DOWN-REGULATION; IGF-1 RECEPTOR; EWINGS-SARCOMA; SOMATOMEDIN-C; BINDING-SITE; TUMOR-GROWTH; CANCER; PROTEIN	Therapeutic antibodies directed against the type 1 insulin-like growth factor receptor (IGF-1R) have recently gained significant momentum in the clinic because of preliminary data generated in human patients with cancer. These antibodies inhibit ligand-mediated activation of IGF-1R and the resulting downstream signaling cascade. Here we generated a panel of antibodies against IGF-1R and screened them for their ability to block the binding of both IGF-1 and IGF-2 at escalating ligand concentrations (> 1 mu M) to investigate allosteric versus competitive blocking mechanisms. Four distinct inhibitory classes were found as follows: 1) allosteric IGF-1 blockers, 2) allosteric IGF-2 blockers, 3) allosteric IGF-1 and IGF-2 blockers, and 4) competitive IGF-1 and IGF-2 blockers. The epitopes of representative antibodies from each of these classes were mapped using a purified IGF-1R library containing 64 mutations. Most of these antibodies bound overlapping surfaces on the cysteine-rich repeat and L2 domains. One class of allosteric IGF-1 and IGF-2 blocker was identified that bound a separate epitope on the outer surface of the FnIII-1 domain. Using various biophysical techniques, we show that the dual IGF blockers inhibit ligand binding using a spectrum of mechanisms ranging from highly allosteric to purely competitive. Binding of IGF-1 or the inhibitory antibodies was associated with conformational changes in IGF-1R, linked to the ordering of dynamic or unstructured regions of the receptor. These results suggest IGF-1R uses disorder/order within its polypeptide sequence to regulate its activity. Interestingly, the activity of representative allosteric and competitive inhibitors on H322M tumor cell growth in vitro was reflective of their individual ligand-blocking properties. Many of the antibodies in the clinic likely adopt one of the inhibitory mechanisms described here, and the outcome of future clinical studies may reveal whether a particular inhibitory mechanism leads to optimal clinical efficacy.	[Doern, Adam; Cao, Xianjun; Sereno, Arlene; Reyes, Christopher L.; Altshuler, Angelina; Huang, Flora; Hession, Cathy; Flavier, Albert; Favis, Michael; Tran, Hon; Ailor, Eric; Levesque, Melissa; Murphy, Tracey; Berquist, Lisa; Tamraz, Susan; Snipas, Tracey; Garber, Ellen; Shestowsky, William S.; Rennard, Rachel; Graff, Christilyn P.; Wu, Xiufeng; Snyder, William; Shields, Michael; Ho, Steffan N.; Reff, Mitchell E.; Glaser, Scott M.; Dong, Jianying; Demarest, Stephen J.; Hariharan, Kandasamy] Biogen Idec, San Diego, CA 92130 USA; [Cole, Lindsay; Gregson, David] Appl Photophys Ltd, Leatherhead KT22 7PB, Surrey, England	Biogen	Demarest, SJ (corresponding author), Biogen Idec, Dept Prot Chem, 5200 Res Pl, San Diego, CA 92122 USA.	stephen.demarest@biogenidec.com	Altshuler, Angelina/I-8023-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105373] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams TE, 2004, GROWTH FACTORS, V22, P89, DOI 10.1080/08977190410001700998; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Burtrum D, 2003, CANCER RES, V63, P8912; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Demarest SJ, 2006, J BIOL CHEM, V281, P30755, DOI 10.1074/jbc.M605190200; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; HARIHARAN K, 2007, Patent No. 20070243194; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hudson P.J., 2001, CURRENT PROTOCOLS IM; JACOBS S, 1986, ENDOCRINOLOGY, V118, P223, DOI 10.1210/endo-118-1-223; JANNSON M, 1997, J BIOL CHEM, V272, P8189; Karnieli E, 1996, J BIOL CHEM, V271, P19304, DOI 10.1074/jbc.271.32.19304; KULL FC, 1983, J BIOL CHEM, V258, P6561; KULL FC, 1982, BIOCHEM BIOPH RES CO, V106, P1019, DOI 10.1016/0006-291X(82)91813-7; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Leavey PJ, 2008, EXPERT REV ANTICANC, V8, P617, DOI 10.1586/14737140.8.4.617; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McKern NM, 1997, PROTEIN SCI, V6, P2663; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; ROTH RA, 1983, ENDOCRINOLOGY, V112, P1865, DOI 10.1210/endo-112-5-1865; ROTH RA, 1982, P NATL ACAD SCI-BIOL, V79, P7312, DOI 10.1073/pnas.79.23.7312; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Zhan SL, 1995, ONCOGENE, V11, P2503	42	21	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10254	10267		10.1074/jbc.M809709200	http://dx.doi.org/10.1074/jbc.M809709200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211557	Green Published, hybrid			2022-12-25	WOS:000264892900067
J	Natalizio, BJ; Robson-Dixon, ND; Garcia-Blanco, MA				Natalizio, Barbara J.; Robson-Dixon, Nicole D.; Garcia-Blanco, Mariano A.			The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROCESSING FACTORS; EXON DEFINITION; RPB7 SUBUNIT; TRANSCRIPTION; PHOSPHORYLATION; RECRUITMENT; ENZYME; CTD; ELONGATION	Eukaryotic messenger RNA precursors (pre-mRNAs) synthesized by RNA polymerase II (RNAP II) are processed co-transcriptionally. The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II is thought to mediate the coupling of transcription with pre-mRNA processing by coordinating the recruitment of processing factors during synthesis of nascent transcripts. Previous studies have demonstrated that the phosphorylated CTD is required for efficient co-transcriptional processing. In the study presented here we investigated whether the CTD is sufficient to coordinate transcription with pre-mRNA capping and splicing in the context of two other DNA-dependent RNA polymerases, mammalian RNAP III and bacteriophage T7 RNAP. Our results indicate that the CTD fused to the largest subunit of RNAP III (POLR3A) is not sufficient to enhance co-transcriptional pre-mRNA splicing or capping in vivo. Additionally, we analyzed a T7 RNAP-CTD fusion protein and examined its ability to enhance pre-mRNA splicing and capping of both constitutively and alternatively spliced substrates. We observed that the CTD in the context of T7 RNAP was not sufficient to enhance pre-mRNA splicing or capping either in vitro or in vivo. We propose that the efficient coupling of transcription to pre-mRNA processing requires not only the phosphorylated CTD but also other RNAP II specific subunits or associated factors.	[Natalizio, Barbara J.; Robson-Dixon, Nicole D.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Natalizio, Barbara J.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Garcia-Blanco, MA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3053 424 CARL, Durham, NC 27710 USA.	garci001@mc.duke.edu			National Institutes of Health [R01 GM071037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM071037 (to M. A. G.-B). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Borodulina OR, 2008, RNA, V14, P1865, DOI 10.1261/rna.1006608; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; EDERY I, 1995, MOL CELL BIOL, V15, P3363; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Ghosh S, 2000, RNA, V6, P1325, DOI 10.1017/S1355838200992537; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Hirose Y, 2000, GENE DEV, V14, P1415; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McCracken S, 1998, COLD SPRING HARB SYM, V63, P301, DOI 10.1101/sqb.1998.63.301; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Mitsuzawa H, 2003, NUCLEIC ACIDS RES, V31, P4696, DOI 10.1093/nar/gkg688; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; Natalizio BJ, 2005, METHODS, V37, P314, DOI 10.1016/j.ymeth.2005.07.013; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Sepehri S, 1997, GENOME RES, V7, P1006, DOI 10.1101/gr.7.10.1006; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Wagner EJ, 2003, RNA, V9, P1552, DOI 10.1261/rna.5840803; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Zeng CQ, 2000, MOL CELL BIOL, V20, P8290, DOI 10.1128/MCB.20.21.8290-8301.2000	51	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8683	8693		10.1074/jbc.M806919200	http://dx.doi.org/10.1074/jbc.M806919200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176527	Green Published, hybrid			2022-12-25	WOS:000264397800053
J	Stewart, JA; Campbell, JL; Bambara, RA				Stewart, Jason A.; Campbell, Judith L.; Bambara, Robert A.			Significance of the Dissociation of Dna2 by Flap Endonuclease 1 to Okazaki Fragment Processing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; POLYMERASE-DELTA; YEAST DNA2; ENZYMATIC-PROPERTIES; PRIMER REMOVAL; STRANDED DNA; HELICASE/NUCLEASE; HELICASE; CLEAVAGE; METABOLISM	Okazaki fragments are initiated by short RNA/DNA primers, which are displaced into flap intermediates for processing. Flap endonuclease 1 (FEN1) and Dna2 are responsible for flap cleavage. Replication protein A (RPA)-bound flaps inhibit cleavage by FEN1 but stimulate Dna2, requiring that Dna2 cleaves prior to FEN1. Upon cleavage, Dna2 leaves a short flap, which is then cut by FEN1 forming a nick for ligation. Both enzymes require a flap with a free 5'- end for tracking to the cleavage sites. Previously, we demonstrated that FEN1 disengages the tracking mechanism of Dna2 to remove it from the flap. To determine why the disengagement mechanism evolved, we measured FEN1 dissociation of Dna2 on short RNA and DNA flaps, which occur during flap processing. Dna2 tracked onto these flaps but could not cleave, presenting a block to FEN1 entry. However, FEN1 disengaged these nonproductively bound Dna2 molecules, proceeding on to conduct proper cleavage. These results clarify the importance of disengagement. Additional results showed that flap substrate recognition and tracking by FEN1, as occur during fragment processing, are required for effective displacement of the flap-bound Dna2. Dna2 was recently shown to dissociate flap-bound RPA, independent of cleavage. Using a nuclease-defective Dna2 mutant, we reconstituted the sequential dissociation reactions in the proposed RPA/Dna2/FEN1 pathway showing that, even without cutting, Dna2 enables FEN1 to cleave RPA-coated flaps. In summary, RPA, Dna2, and FEN1 have evolved highly coordinated binding properties enabling one protein to succeed the next for proper and efficient Okazaki flap processing.	[Stewart, Jason A.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441, T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 to R. A. B.), with additional support from Grant GM087666 ( to J. L. C.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	40	22	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8283	8291		10.1074/jbc.M809189200	http://dx.doi.org/10.1074/jbc.M809189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179330	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-25	WOS:000264397800012
J	Ren, H; Yu, DY; Ge, BS; Cook, B; Xu, ZN; Zhang, SG				Ren, Hui; Yu, Daoyong; Ge, Baosheng; Cook, Brian; Xu, Zhinan; Zhang, Shuguang			High-Level Production, Solubilization and Purification of Synthetic Human GPCR Chemokine Receptors CCR5, CCR3, CXCR4 and CX3CR1	PLOS ONE			English	Article								Chemokine receptors belong to a class of integral membrane G-protein coupled receptors (GPCRs) and are responsible for transmitting signals from the extracellular environment. However, the structural changes in the receptor, connecting ligand binding to G-protein activation, remain elusive for most GPCRs due to the difficulty to produce them for structural and functional studies. We here report high-level production in E. coli of 4 human GPCRs, namely chemokine receptors (hCRs) CCR5, CCR3, CXCR4 and CX3CR1 that are directly involved in HIV-1 infection, asthma and cancer metastasis. The synthetic genes of CCR5, CCR3, CXCR4 and CX3CR1 were synthesized using a two-step assembly/amplification PCR method and inserted into two different kinds of expression systems. After systematic screening of growth conditions and host strains, TB medium was selected for expression of pEXP-hCRs. The low copy number pBAD-DEST49 plasmid, with a moderately strong promoter tightly regulated by L-arabinose, proved helpful for reducing toxicity of expressed membrane proteins. The synthetic Trx-hCR fusion genes in the pBAD-DEST49 vector were expressed at high levels in the Top10 strain. After a systematic screen of 96 detergents, the zwitterionic detergents of the Fos-choline series (FC9-FC16) emerged as the most effective for isolation of the hCRs. The FC14 was selected both for solubilization from bacterial lysates and for stabilization of the Trx-hCRs during purification. Thus, the FC-14 solubilized Trx-hCRs could be purified using size exclusion chromatography as monomers and dimers with the correct apparent MW and their alpha-helical content determined by circular dichroism. The identity of two of the expressed hCRs (CCR3 and CCR5) was confirmed using immunoblots using specific monoclonal antibodies. After optimization of expression systems and detergent-mediated purification procedures, we achieved large-scale, high-level production of 4 human GPCR chemokine receptor in a two-step purification, yielding milligram quantities of CCR5, CCR3, CXCR4 and CX3CR1 for biochemical, biophysical and structural analysis.	[Ren, Hui; Yu, Daoyong; Ge, Baosheng; Cook, Brian; Xu, Zhinan; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Yu, Daoyong; Ge, Baosheng] China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China	Massachusetts Institute of Technology (MIT); China University of Petroleum	Ren, H (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu	Yu, Daoyong/E-5269-2013; Ge, Baosheng/AAT-4788-2020	Yu, Daoyong/0000-0002-3380-1897; Ge, Baosheng/0000-0001-9906-2081; Zhang, Shuguang/0000-0002-3856-3752	John Simon Guggenheim Fellowship; NIH	John Simon Guggenheim Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SZ gratefully acknowledges a John Simon Guggenheim Fellowship to provide freedom to pursue frontiers of studying membrane protein structures. This work is supported in part by NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Baedeker M, 1999, FEBS LETT, V457, P57, DOI 10.1016/S0014-5793(99)01000-5; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bane SE, 2007, PROTEIN EXPRES PURIF, V52, P348, DOI 10.1016/j.pep.2006.10.017; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Elsner J, 2004, ALLERGY, V59, P1243, DOI 10.1111/j.1398-9995.2004.00710.x; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANNINEN AL, 1994, BIOL CHEM H-S, V375, P833; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HJELMELAND LM, 1990, METHOD ENZYMOL, V182, P253; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; KAISER L, 2008, P NATL ACAD SCI, V105; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Lu ZJ, 1996, J BIOL CHEM, V271, P5059; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Luster AD, 2001, CURR OPIN ALLERGY CL, V1, P561, DOI 10.1097/00130832-200112000-00012; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Morokata T, 2006, J PHARMACOL EXP THER, V317, P244, DOI 10.1124/jpet.105.097048; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; NASSAL M, 1987, J BIOL CHEM, V262, P9264; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sambrook J, 2001, MOL CLONING LAB MANU; SARDET C, 1976, J MOL BIOL, V105, P383, DOI 10.1016/0022-2836(76)90100-5; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shaw Alison Z, 2003, Methods Mol Biol, V228, P23, DOI 10.1385/1-59259-400-X:23; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Suzuki K, 2006, BIOCHEM BIOPH RES CO, V339, P1217, DOI 10.1016/j.bbrc.2005.11.141; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; VANRENSWOUDE J, 1984, METHOD ENZYMOL, V104, P329; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; [No title captured]	78	70	73	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4509	10.1371/journal.pone.0004509	http://dx.doi.org/10.1371/journal.pone.0004509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223978	Green Published, gold			2022-12-25	WOS:000265485800012
J	Tavabi, K; Elling, L; Dobel, C; Pantev, C; Zwitserlood, P				Tavabi, Kambiz; Elling, Ludger; Dobel, Christian; Pantev, Christo; Zwitserlood, Pienie			Effects of Place of Articulation Changes on Auditory Neural Activity: A Magnetoencephalography Study	PLOS ONE			English	Article							PHONOLOGICAL VARIATION; MISMATCH NEGATIVITY; LEXICAL ACCESS; ASSIMILATION; PERCEPTION; REGULARITIES; RECOGNITION; INFERENCE; LANGUAGE; GERMAN	In casual speech, phonemic segments often assimilate such that they adopt features from adjacent segments, a typical feature being their place of articulation within the vocal tract (e.g., labial, coronal, velar). Place assimilation (e.g., from coronal /n/ to labial /m/: rainbow ->*raimbow) alters the surface form of words. Listeners' ability to perceptually compensate for such changes seems to depend on the phonemic context, on whether the adjacent segment (e.g., the /b/ in "rainbow'') invites the particular change. Also, some assimilations occur frequently (e.g., /n/->/m/), others are rare (e.g., /m/->/n/). We investigated the effects of place assimilation, its contextual dependency, and its frequency on the strength of auditory evoked mismatch negativity (MMN) responses, using pseudowords. Results from magnetoencephalography (MEG) revealed that the MMN was modulated both by the frequency and contextual appropriateness of assimilations.	[Tavabi, Kambiz; Elling, Ludger; Dobel, Christian; Pantev, Christo] Inst Biomagnetism & Biosignalanal, Munster, Germany; [Tavabi, Kambiz] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA USA; [Zwitserlood, Pienie] Univ Munster, Dept Psychol, D-4400 Munster, Germany	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Munster	Tavabi, K (corresponding author), Inst Biomagnetism & Biosignalanal, Munster, Germany.	zwitser@psy.uni-muenster.de		Tavabi, Kambiz/0000-0003-1881-892X	Deutsche Forschungsgemeinschaft [ZW-65-65/5-1]; German Volkswagen Foundation [I/80709]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Volkswagen Foundation(Volkswagen)	The Deutsche Forschungsgemeinschaft as part of SPP 1234: Phonological and phonetic competence: between grammar, signal processing, and neural activity (Project ZW-65-65/5-1 Neural and psychological correlates of phonological categories). For his involvement in this project C.D. was supported by the German Volkswagen Foundation (Volkswagen Stiftung, I/80709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma P, 2001, GLOT INT, V5, P341; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Coenen E, 2001, LANG COGNITIVE PROC, V16, P535, DOI 10.1080/01690960143000155; DARCY I, VARIATION G IN PRESS; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Frauenfelder U., 1999, LANGUAGE COMPREHENSI, P1; Friedrich Claudia K, 2006, Behav Brain Funct, V2, P36, DOI 10.1186/1744-9081-2-36; Gaskell MG, 2008, J EXP PSYCHOL HUMAN, V34, P1632, DOI 10.1037/a0011977; Gaskell MG, 2003, J PHONETICS, V31, P447, DOI 10.1016/S0095-4470(03)00012-3; Gaskell MG, 1998, J EXP PSYCHOL HUMAN, V24, P380, DOI 10.1037/0096-1523.24.2.380; Gow DW, 2003, PERCEPT PSYCHOPHYS, V65, P575, DOI 10.3758/BF03194584; Gow DW, 2001, J MEM LANG, V45, P133, DOI 10.1006/jmla.2000.2764; Gumnior H, 2005, LANG COGNITIVE PROC, V20, P465, DOI 10.1080/01690960444002174; Jun J, 2004, PHONETICALLY BASED P, P58, DOI DOI 10.1017/CBO9780511486401.003; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; MARSLENWILSON W, 1995, LANG COGNITIVE PROC, V10, P285, DOI 10.1080/01690969508407097; Mitterer H, 2003, PERCEPT PSYCHOPHYS, V65, P956, DOI 10.3758/BF03194826; Mitterer H, 2006, Q J EXP PSYCHOL, V59, P1395, DOI 10.1080/17470210500198726; Mitterer H, 2006, COGNITIVE SCI, V30, P451, DOI 10.1207/s15516709cog0000_57; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pulvermuller F, 2006, NEUROIMAGE, V31, P1297, DOI 10.1016/j.neuroimage.2006.01.030; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Ranbom LJ, 2007, J MEM LANG, V57, P273, DOI 10.1016/j.jml.2007.04.001; Takegata R, 2001, PSYCHOPHYSIOLOGY, V38, P92, DOI 10.1017/S0048577201991243; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Wheeldon L., 2000, STUDIES COGNITION SE, P165	29	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4452	10.1371/journal.pone.0004452	http://dx.doi.org/10.1371/journal.pone.0004452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209225	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484100011
J	Trape, S				Trape, Sebastien			Impact of Climate Change on the Relict Tropical Fish Fauna of Central Sahara: Threat for the Survival of Adrar Mountains Fishes, Mauritania	PLOS ONE			English	Article							AFRICA	Background: Four central Sahara mountainous massifs provide habitats for relict populations of fish. In the Adrar of Mauritania all available data on the presence and distribution of fish come from pre-1960 surveys where five fish species were reported: Barbus pobeguini, Barbus macrops, Barbus mirei, Sarotherodon galilaeus, and Clarias anguillaris. Since 1970, drought has had a severe impact in the Adrar where rainfall decreased by 35%. To investigate whether the relict populations of fish have survived the continuing drought, a study was carried out from 2004 to 2008. Methodology/Principal Findings: An inventory of perennial bodies of water was drawn up using a literature review and analysis of topographical and hydrological maps. Field surveys were carried out in order to locate the bodies of water described in the literature, identify the presence of fish, determine which species were present and estimate their abundance. The thirteen sites where the presence of fish was observed in the 1950s -Ksar Torchane, Ilij, Molomhar, Agueni, Tachot, Hamdoun, Terjit, Toungad, El Berbera, Timagazine, Dayet el Mbarek, Dayet et-Tefla, Nkedei-were located and surveyed. The Ksar Torchane spring -type locality and the only known locality of B. mirei- has dried up at the height of the drought in 1984, and any fish populations have since become extinct there. The Timagazine, Dayet el Mbarek and Dayet et-Tefla pools have become ephemeral. The Hamdoun guelta appears to be highly endangered. The fish populations at the other sites remain unchanged. Four perennial pools which are home to populations of B. pobeguini are newly recorded. Conclusion/Significance: The tropical relict fish populations of the Adrar mountains of Mauritania appear to be highly endangered. Of thirteen previously recorded populations, four have become extinct since the beginning of the drought period. New fish population extinctions may occur should low levels of annual rainfall be repeated.	[Trape, Sebastien] IRD, Unite Rech 070, Dakar, Senegal; [Trape, Sebastien] Univ Montpellier 2, Lab ECOLAG, Unite Mixte Rech 5119, F-34095 Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Trape, S (corresponding author), IRD, Unite Rech 070, Dakar, Senegal.	sebastien_trape@yahoo.fr			IRD special programme Evolution Climatique et Sante	IRD special programme Evolution Climatique et Sante	This work was supported in part by the IRD special programme Evolution Climatique et Sante. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAGET J, 1959, NOTE POISSONS BORKOU, P173; Dekeyser P. L., 1955, Notes Africaines, VNo. 65, P28; DEKEYSER PL, 1956, MEMOIRE IFAN, V54; DRUYAN LM, 1989, INT J CLIMATOL, V9, P77, DOI 10.1002/joc.3370090107; Dumont H.J., 1982, Palaeoecology of Africa and the Surrounding Islands, V14, P1; DUMONT HJ, 1994, HYDROBIOLOGIA, V272, P1, DOI 10.1007/BF00006508; DUMONT HJ, 1987, AFRICAN WETLANDS SHA, P79; ESTEVE ROLANDE, 1952, BULL MUS NATL HIST NAT, V24, P176; Gasse F, 2006, CR PALEVOL, V5, P35, DOI 10.1016/j.crpv.2005.09.012; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; HULME M, 1992, INT J CLIMATOL, V12, P685, DOI 10.1002/joc.3370120703; L'Hote Y, 2002, HYDROLOG SCI J, V47, P563, DOI 10.1080/02626660209492960; LEBERRE C, 1989, FAUNE SAHARA, V1; Leveque C., 1990, Ichthyological Exploration of Freshwaters, V1, P39; Leveque C., 1989, Cybium, V13, P165; LEVEQUE C, 2003, POISSONS EAUX DOUCES, V1, P322; LHOTE H, 1942, B SOC CENTR AGR PECH, V49, P19; Monod T., 1951, Bull Inst franc Afr noire, V13, P802; Monod T., 1955, Bull Inst franY Afr noire, V17A, P590; Monod T., 1954, Bull Inst franY Afr noire, V16A, P295; PELLEGRIN J, 1921, MEM SOC SC NAT MAROC, V1; PELLEGRIN J, 1937, POISSONS SAHARA OCCI, P337; PELLEGRIN J, 1913, C R ASS FR AVANC SCI, V42, P346; RISER J, 1986, REV GEOL DYN GEOGR, V27, P205; *STAT MET AT, REL PLUV ANN 1921 20; TALBOT MR, 1980, SAHARA NILE, P37; Teugels G., 2003, POISSONS EAUX DOUCES, V40, P144; Vernet R., 1995, CLIMATS ANCIENS NORD; VILLIERS A, 1953, B IFAN, V15, P631	29	41	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4400	10.1371/journal.pone.0004400	http://dx.doi.org/10.1371/journal.pone.0004400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204792	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484000004
J	Barbour, JD; Ndhlovu, LC; Tan, QX; Ho, T; Epling, L; Bredt, BM; Levy, JA; Hecht, FM; Sinclair, E				Barbour, Jason D.; Ndhlovu, Lishomwa C.; Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Levy, Jay A.; Hecht, Frederick M.; Sinclair, Elizabeth			High CD8+T Cell Activation Marks a Less Differentiated HIV-1 Specific CD8+T Cell Response that Is Not Altered by Suppression of Viral Replication	PLOS ONE			English	Article								Background: The relationship of elevated T cell activation to altered T cell differentiation profiles, each defining features of HIV-1 infection, has not been extensively explored. We hypothesized that anti-retroviral suppression of T cell activation levels would lead to alterations in the T cell differentiation of total and HIV-1 specific CD8+ T cell responses among recently HIV-1 infected adults. Methodology/Principal Findings: We performed a longitudinal study simultaneously measuring T cell activation and maturation markers on both total and antigen-specific T cells in recently infected adults: prior to treatment; after the initiation of HAART; and after treatment was halted. Prior to treatment, HIV-1 Gag-specific CD8+ T cells were predominantly of a highly activated, intermediate memory (CD27+CD28-) phenotype, while CMV pp65-specific CD8+ T cells showed a late memory (CD27-CD28-), low activation phenotype. Participants with the highest fraction of late memory (CD27-CD28-) HIV-1-specific CD8+ T cells had higher CD4+ T cell counts (rho = +0.74, p = 0.004). In turn, those with the highest fraction of intermediate memory (CD27+CD28-) HIV-1 specific CD8+ T cells had high total CD8+ T cell activation (rho = +0.68, p = 0.01), indicating poorer long-term clinical outcomes. The HIV-1 specific T cell differentiation profile was not readily altered by suppression of T cell activation following HAART treatment. Conclusions/Significance: A more differentiated, less activated HIV-1 specific CD8+ T cell response may be clinically protective. Anti-retroviral treatment initiated two to four months after infection lowered T cell activation but had no effect on the differentiation profile of the HIV-1-specific response. Intervention during the first month of acute infection may be required to shift the differentiation phenotype of HIV-1 specific responses to a more clinically favorable profile.	[Barbour, Jason D.; Levy, Jay A.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Ndhlovu, Lishomwa C.; Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA; [Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Core Immunol Lab, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Barbour, JD (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	jbarbour@php.ucsf.edu	n, l/AAX-3992-2020	Hecht, Frederick/0000-0002-5782-1171; Ndhlovu, Lishomwa/0000-0001-5427-4187	NIH/NIAID [AI066917, AI41531, AI47062, AI68498]; Irvington Institute Fellowship Program of the Cancer Research Institute; University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research [P30 AI27763]; NIH/NCRR UCSF-CTSI [UL1 RR024131-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068498, K01AI066917, R01AI047062, P30AI027763, U01AI041531] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Irvington Institute Fellowship Program of the Cancer Research Institute; University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.D.B. is supported by AI066917 (NIH/NIAID) and L.C.N. by the Irvington Institute Fellowship Program of the Cancer Research Institute. This project was supported by grants from the National Institutes of Health AI41531 (Levy/Hecht NIAID), AI47062 (Jacobson), AI68498 (Nixon) National Institutes of Health, and pilot awards to J.D.B. and L.C.N. from the University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research, P30 AI27763. This publication was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131-01. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Peptide pools were the generous gift of BD Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; APPAY V, 2008, CYTOMETRY A; Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Lubaki NM, 1999, J ACQ IMMUN DEF SYND, V22, P19, DOI 10.1097/00042560-199909010-00003; Lucas M, 2004, J IMMUNOL, V172, P1744, DOI 10.4049/jimmunol.172.3.1744; Muthumani K, 2008, J VIROL; Nomura Laurel E, 2006, AIDS Res Ther, V3, P18, DOI 10.1186/1742-6405-3-18; NORTHFIELD JW, 2007, J VIROL; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8	26	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4408	10.1371/journal.pone.0004408	http://dx.doi.org/10.1371/journal.pone.0004408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198651	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483900010
J	Schulthess, FT; Katz, S; Ardestani, A; Kawahira, H; Georgia, S; Bosco, D; Bhushan, A; Maedler, K				Schulthess, Fabienne T.; Katz, Sophie; Ardestani, Amin; Kawahira, Hiroshi; Georgia, Senta; Bosco, Domenico; Bhushan, Anil; Maedler, Kathrin			Deletion of the Mitochondrial Flavoprotein Apoptosis Inducing Factor (AIF) Induces beta-Cell Apoptosis and Impairs beta-Cell Mass	PLOS ONE			English	Article								Background: Apoptosis is a hallmark of beta-cell death in both type 1 and type 2 diabetes mellitus. Understanding how apoptosis contributes to beta-cell turnover may lead to strategies to prevent progression of diabetes. A key mediator of apoptosis, mitochondrial function, and cell survival is apoptosis inducing factor (AIF). In the present study, we investigated the role of AIF on beta-cell mass and survival using the Harlequin (Hq) mutant mice, which are hypomorphic for AIF. Methodology/Principal Findings: Immunohistochemical evaluation of pancreata from Hq mutant mice displayed much smaller islets compared to wild-type mice (WT). Analysis of beta-cell mass in these mice revealed a greater than 4-fold reduction in beta-cell mass together with an 8-fold increase in beta-cell apoptosis. Analysis of cell cycle dynamics, using BrdU pulse as a marker for cells in S-phase, did not detect significant differences in the frequency of beta-cells in S-phase. In contrast, double staining for phosphorylated Histone H3 and insulin showed a 3-fold increase in beta-cells in the G2 phase in Hq mutant mice, but no differences in M-phase compared to WT mice. This suggests that the beta-cells from Hq mutant mice are arrested in the G2 phase and are unlikely to complete the cell cycle. beta-cells from Hq mutant mice display increased sensitivity to hydrogen peroxide-induced apoptosis, which was confirmed in human islets in which AIF was depleted by siRNA. AIF deficiency had no effect on glucose stimulated insulin secretion, but the impaired effect of hydrogen peroxide on beta-cell function was potentiated. Conclusions/Significance: Our results indicate that AIF is essential for maintaining beta-cell mass and for oxidative stress response. A decrease in the oxidative phosphorylation capacity may counteract the development of diabetes, despite its deleterious effects on beta-cell survival.	[Schulthess, Fabienne T.; Ardestani, Amin; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, Bremen, Germany; [Schulthess, Fabienne T.; Katz, Sophie; Kawahira, Hiroshi; Georgia, Senta; Bhushan, Anil; Maedler, Kathrin] Univ Calif Los Angeles, Dept Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA; [Bosco, Domenico] Univ Geneva, Sch Med, Dept Surg, Cell Isolat & Transplant Ctr, CH-1211 Geneva, Switzerland	University of Bremen; University of California System; University of California Los Angeles; University of Geneva	Schulthess, FT (corresponding author), Univ Bremen, Ctr Biomol Interact, Bremen, Germany.	kmaedler@uni-bremen.de	Maedler, Kathrin/ABE-3022-2021; Georgia, Senta/AAP-1971-2020	Maedler, Kathrin/0000-0002-7436-1197; Georgia, Senta/0000-0002-2016-7866; Ardestani, Amin/0000-0002-0685-8564; Bosco, Domenico/0000-0003-3453-9613	Larry Hillblom Research Foundation; German Research Foundation; European Foundation for the Study of Diabetes (EFSD); Swiss National Foundation Fellowship award; NCRR; NIDDK; JDRF [NA 31-2008-416]	Larry Hillblom Research Foundation; German Research Foundation(German Research Foundation (DFG)); European Foundation for the Study of Diabetes (EFSD); Swiss National Foundation Fellowship award; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation)	This work was supported by the Larry Hillblom Research Foundation, the German Research Foundation (DFG, Emmy Noether Program) and the European Foundation for the Study of Diabetes (EFSD). Fabienne Schulthess is recipient of the Swiss National Foundation Fellowship award. Human islets were provided through the Islet Cell Resource Consortium, administered by the ABCC and supported by NCRR, NIDDK and JDRF and through the European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program, supported by JDRF grant NA 31-2008-416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Sakurai K, 2001, BIOL PHARM BULL, V24, P876, DOI 10.1248/bpb.24.876; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WIEDERKEHR A, 2008, CELL CALCIUM; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Zhong LW, 2007, J CLIN INVEST, V117, P2869, DOI 10.1172/JCI32198	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4394	10.1371/journal.pone.0004394	http://dx.doi.org/10.1371/journal.pone.0004394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197367	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483700009
J	Martuszewska, D; Ljungberg, B; Johansson, M; Landberg, G; Oslakovic, C; Dahlback, B; Hafizi, S				Martuszewska, Danuta; Ljungberg, Borje; Johansson, Martin; Landberg, Goran; Oslakovic, Cecilia; Dahlback, Bjorn; Hafizi, Sassan			Tensin3 Is a Negative Regulator of Cell Migration and All Four Tensin Family Members Are Downregulated in Human Kidney Cancer	PLOS ONE			English	Article								Background: The Tensin family of intracellular proteins (Tensin1, -2, -3 and -) are thought to act as links between the extracellular matrix and the cytoskeleton, and thereby mediate signaling for cell shape and motility. Dysregulation of Tensin expression has previously been implicated in human cancer. Here, we have for the first time evaluated the significance of all four Tensins in a study of human renal cell carcinoma (RCC), as well as probed the biological function of Tensin3. Principal Findings: Expression of Tensin2 and Tensin3 at mRNA and protein levels was largely absent in a panel of diverse human cancer cell lines. Quantitative RT-PCR analysis revealed mRNA expression of all four Tensin genes to be significantly downregulated in human kidney tumors (50 - 100% reduction versus normal kidney cortex; P < 0.001). Furthermore, the mRNA expressions of Tensins mostly correlated positively with each other and negatively with tumor grade, but not tumor size. Immunohistochemical analysis revealed Tensin3 to be present in the cytoplasm of tubular epithelium in normal human kidney sections, whilst expression was weaker or absent in 41% of kidney tumors. A subset of tumor sections showed a preferential plasma membrane expression of Tensin3, which in clear cell RCC patients was correlated with longer survival. Stable expression of Tensin3 in HEK 293 cells markedly inhibited both cell migration and matrix invasion, a function independent of putative phosphatase activity in Tensin3. Conversely, siRNA knockdown of endogenous Tensin3 in human cancer cells significantly increased their migration. Conclusions: Our findings indicate that the Tensins may represent a novel group of metastasis suppressors in the kidney, the loss of which leads to greater tumor cell motility and consequent metastasis. Moreover, tumorigenesis in the human kidney may be facilitated by a general downregulation of Tensins. Therefore, anti-metastatic therapies may benefit from restoring or preserving Tensin expression in primary tumors.	[Martuszewska, Danuta; Oslakovic, Cecilia; Dahlback, Bjorn; Hafizi, Sassan] Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioper Sci, S-90187 Umea, Sweden; [Johansson, Martin; Landberg, Goran] Lund Univ, Univ Hosp Malmo, Dept Lab Med, Sect Pathol, S-22100 Lund, Sweden	Lund University; Skane University Hospital; Umea University; Lund University; Skane University Hospital	Martuszewska, D (corresponding author), Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden.	Sassan.Hafizi@med.lu.se	Hafizi, Sassan/W-4424-2019	Hafizi, Sassan/0000-0002-4539-0888; Ljungberg, Borje/0000-0002-4121-3753; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council (Vetenskapsradet); Malmo University Hospital Trust; Malmo University Hospital Cancer Trust; Greta and Johan Kock Trust; Crafoord Trust; Royal Physiographic Society in Lund; Anna-Greta Crafoord Trust [fellowship]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Malmo University Hospital Trust; Malmo University Hospital Cancer Trust; Greta and Johan Kock Trust; Crafoord Trust; Royal Physiographic Society in Lund; Anna-Greta Crafoord Trust	Swedish Research Council (Vetenskapsradet), the Cancer Foundation, Alfred Osterlund Trust, Malmo University Hospital Trust, Malmo University Hospital Cancer Trust, Greta and Johan Kock Trust, Crafoord Trust, and the Royal Physiographic Society in Lund. D.M. was supported by a fellowship from the Anna-Greta Crafoord Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Chiang MK, 2005, DEV BIOL, V279, P368, DOI 10.1016/j.ydbio.2004.12.027; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Cui YM, 2004, MOL CANCER RES, V2, P225; Escudier B, 2008, CANCER J, V14, P325, DOI 10.1097/PPO.0b013e3181867605; Gitlitz BJ, 2003, UROL CLIN N AM, V30, P589, DOI 10.1016/S0094-0143(03)00027-2; Glazer AA, 1996, J UROLOGY, V155, P448, DOI 10.1016/S0022-5347(01)66415-2; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hedberg Y, 2003, BRIT J CANCER, V88, P1417, DOI 10.1038/sj.bjc.6600922; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lidgren A, 2008, BJU INT, V101, P480, DOI 10.1111/j.1464-410X.2007.07238.x; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 1997, J CELL BIOL, V136, P1349, DOI 10.1083/jcb.136.6.1349; Maeda I, 2006, J MOL ENDOCRINOL, V36, pR1, DOI 10.1677/jme.1.01913; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Ries L MD, 2008, SEER CANC STAT REV 1; Rodrigue CM, 2005, ONCOGENE, V24, P3274, DOI 10.1038/sj.onc.1208485; Ryschich E, 2006, CANCER RES, V66, P198, DOI 10.1158/0008-5472.CAN-05-1636; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; SKINNER DG, 1971, CANCER-AM CANCER SOC, V28, P1165, DOI 10.1002/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850	32	49	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4350	10.1371/journal.pone.0004350	http://dx.doi.org/10.1371/journal.pone.0004350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194507	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483500006
J	Arking, DE; Khera, A; Xing, C; Kao, WHL; Post, W; Boerwinkle, E; Chakravarti, A				Arking, Dan E.; Khera, Amit; Xing, Chao; Kao, W. H. Linda; Post, Wendy; Boerwinkle, Eric; Chakravarti, Aravinda			Multiple Independent Genetic Factors at NOS1AP Modulate the QT Interval in a Multi-Ethnic Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIAC REPOLARIZATION; CARDIOVASCULAR MORTALITY; REGULATOR NOS1AP; HAPLOTYPE MAP; ELDERLY-MEN; PROLONGATION; ASSOCIATION; VARIANTS	Extremes of electrocardiographic QT interval are associated with increased risk for sudden cardiac death (SCD); thus, identification and characterization of genetic variants that modulate QT interval may elucidate the underlying etiology of SCD. Previous studies have revealed an association between a common genetic variant in NOS1AP and QT interval in populations of European ancestry, but this finding has not been extended to other ethnic populations. We sought to characterize the effects of NOS1AP genetic variants on QT interval in the multi-ethnic population-based Dallas Heart Study (DHS, n = 3,072). The SNP most strongly associated with QT interval in previous samples of European ancestry, rs16847548, was the most strongly associated in White (P = 0.005) and Black (P = 3.6 x 10(-5)) participants, with the same direction of effect in Hispanics (P = 0.17), and further showed a significant SNP x sex-interaction (P = 0.03). A second SNP, rs16856785, uncorrelated with rs16847548, was also associated with QT interval in Blacks (P = 0.01), with qualitatively similar results in Whites and Hispanics. In a previously genotyped cohort of 14,107 White individuals drawn from the combined Atherosclerotic Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) cohorts, we validated both the second locus at rs16856785 (P = 7.63 x 10(-8)), as well as the sex-interaction with rs16847548 (P = 8.68 x 10(-6)). These data extend the association of genetic variants in NOS1AP with QT interval to a Black population, with similar trends, though not statistically significant at P < 0.05, in Hispanics. In addition, we identify a strong sex-interaction and the presence of a second independent site within NOS1AP associated with the QT interval. These results highlight the consistent and complex role of NOS1AP genetic variants in modulating QT interval.	[Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Khera, Amit] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Khera, Amit] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Div Epidemiol, Houston, TX USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	arking@jhmi.edu		Xing, Chao/0000-0002-1838-0502; Ballantyne, Christie/0000-0002-6432-1730	Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore; UT Southwestern at Dallas; NIH/NCRR-CR [M01-RR00633]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, N01-HC-85086, N01 HC-15103, N01 HC-55222, U01 HL080295]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC045133, N01HC055222, N01HC085086, N01HC055015, N01HC055021, N01HC055016, N01HC055022, N01HC085079, N01HC075150, N01HC015103, N01HC055019, N01HC055018, N01HC055020] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R41HL055019, R42HL055018, R41HL055018] Funding Source: NIH RePORTER	Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore; UT Southwestern at Dallas; NIH/NCRR-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore (DEA, WHLK, WP, AC) and UT Southwestern at Dallas (AK, CX). The Dallas Heart Study was funded by the Donald W. Reynolds Foundation (Las Vegas, NE) and was partially supported by USPHS GCRC grant # M01-RR00633 from NIH/NCRR-CR. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The Cardiovascular Heart Study is supported by contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01 HC-15103, N01 HC-55222, and U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; EIJGELSHEIM M, 2008, HUM MOL GENET; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; KAO WHL, 2009, CIRCULATION IN PRESS; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; RAITAKARI OT, 2008, ANN MED         0910, P1; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sharp DS, 1998, ANN EPIDEMIOL, V8, P99, DOI 10.1016/S1047-2797(97)00121-X; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	27	26	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4333	10.1371/journal.pone.0004333	http://dx.doi.org/10.1371/journal.pone.0004333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180230	Green Submitted, Green Published, gold			2022-12-25	WOS:000274089700015
J	Wagner, MV; Smolka, MB; de Bruin, RAM; Zhou, HL; Wittenberg, C; Dowdy, SF				Wagner, Michelle V.; Smolka, Marcus B.; de Bruin, Rob A. M.; Zhou, Huilin; Wittenberg, Curt; Dowdy, Steven F.			Whi5 Regulation by Site Specific CDK-Phosphorylation in Saccharomyces cerevisiae	PLOS ONE			English	Article								The Whi5 transcriptional repressor is a negative regulator of G1 cell cycle progression in Saccharomyces cerevisiae and is functionally equivalent to the Retinoblastoma (Rb) tumor suppressor protein in mammals. In early G1, Whi5 binds to and inhibits SBF (Swi4/Swi6) transcriptional complexes. At Start, Cln:Cdc28 kinases phosphorylate and inactivate Whi5, causing its dissociation from SBF promoters and nuclear export, allowing activation of SBF transcription and entry into late G1. In an analysis of Whi5 phosphorylation, we found that 10 of the 12 putative CDK phosphorylation sites on Whi5 were occupied in vivo in asynchronously growing cells. In addition, we identified 6 non-CDK Whi5 phosphorylation sites. Whi5 CDK and non-CDK phosphorylation mutants were functional and able to rescue the small cell size of whi5 Delta cells. However, the Whi5 CDK mutant with all 12 putative CDK sites changed to alanine causes a dramatic cell cycle phenotype when expressed with a Swi6 CDK phosphorylation mutant. Mutational analysis of Whi5 determined that only four C-terminal CDK sites were necessary and sufficient for Whi5 inactivation when Swi6 CDK sites were also mutated. Although these four Whi5 CDK sites do not wholly determine Whi5 nuclear export, they do impact regulation of cell size. Taken together, these observations begin to dissect the regulatory role of specific phosphorylation sites on Whi5.	[Dowdy, Steven F.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Wagner, Michelle V.; Smolka, Marcus B.; Zhou, Huilin; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Molecular Med, La Jolla, CA 92093 USA; [Wagner, Michelle V.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smolka, Marcus B.; Zhou, Huilin] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [de Bruin, Rob A. M.; Wittenberg, Curt] Scripps Res Inst, Dept Molecular Biol, La Jolla, CA USA; [Wittenberg, Curt] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute	Wagner, MV (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu		Zhou, Huilin/0000-0002-1350-4430	NIH [CA067754, GM008666]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.V.W. was funded by the NIH Cancer Cell Biology Training grant (CA067754) and the NIH Basic Clinical Genetics Training grant (GM008666). This work was supported by the Howard Hughes Medical Institute (S.F.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Brachmann CB, 1998, YEAST, V14, P115; Breeden L, 1996, CURR TOP MICROBIOL, V208, P95; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MITTNACHT S, 1994, EMBO J, V13, P118, DOI 10.1002/j.1460-2075.1994.tb06241.x; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Wijnen H, 1999, GENETICS, V153, P1131; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4300	10.1371/journal.pone.0004300	http://dx.doi.org/10.1371/journal.pone.0004300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172996	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483000009
J	Bilokapic, S; Ivic, N; Godinic-Mikulcic, V; Piantanida, I; Ban, N; Weygand-Durasevic, I				Bilokapic, Silvija; Ivic, Nives; Godinic-Mikulcic, Vlatka; Piantanida, Ivo; Ban, Nenad; Weygand-Durasevic, Ivana			Idiosyncratic Helix-Turn-Helix Motif in Methanosarcina barkeri Seryl-tRNA Synthetase Has a Critical Architectural Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; TERNARY COMPLEX; ACTIVE-SITE; YEAST; AMINOACYLATION; TRNA(SER); BINDING	All seryl-tRNA synthetases (SerRSs) are functional homodimers with a C-terminal active site domain typical for class II aminoacyl-tRNA synthetases and an N-terminal domain involved in tRNA binding. The recently solved three-dimensional structure of Methanosarcina barkeri SerRS revealed the idiosyncratic features of methanogenic-type SerRSs; that is, an active site zinc ion, a unique tRNA binding domain, and an insertion of similar to 30 residues in the catalytic domain, which adopt a helix-turn-helix (HTH) fold. Here, we present biochemical evidence for multiple roles of the HTH motif; it is important for dimerization of the enzyme, contributes to the overall stability, and is critical for the proper positioning of the tRNA binding domain relative to the catalytic domain. The changes in intrinsic fluorescence during denaturation of the wild-type M. barkeri SerRS and of the mutated variant lacking the HTH motif combined with cross-linking and gel analysis of protein subunits during various stages of the unfolding process revealed significantly reduced stability of the mutant dimers. In vitro kinetic analysis of enzymes, mutated in one of the N-terminal helices and the HTH motif, shows impaired tRNA binding and aminoacylation and emphasizes the importance of this domain for the overall architecture of the enzyme. The role of the idiosyncratic HTH motif in dimer stabilization and association between the catalytic and tRNA binding domain has been additionally confirmed by a yeast two-hybrid approach. Furthermore, we provide experimental evidence that tRNA binds across the dimer.	[Bilokapic, Silvija; Godinic-Mikulcic, Vlatka; Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 41000, Croatia; [Ivic, Nives] Rudjer Boskovic Inst, Div Phys Chem, HR-10000 Zagreb, Croatia; [Piantanida, Ivo] Rudjer Boskovic Inst, Div Organ Chem & Biochem, HR-10000 Zagreb, Croatia; [Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	University of Zagreb; Rudjer Boskovic Institute; Rudjer Boskovic Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 41000, Croatia.	weygand@chem.pmf.hr	Piantanida, Ivo/J-3868-2012; Piantanida, Ivo/L-9230-2019; Bilokapic, Silvija/H-5108-2018	Piantanida, Ivo/0000-0002-9933-446X; Piantanida, Ivo/0000-0002-9933-446X; Godinic Mikulcic, Vlatka/0000-0003-0319-8035	Ministry of Science, Education, and Sports of the Republic of Croatia [119-0982913-1358]; Swiss National Science Foundation (SNSF); SNSF; Unity through Knowledge Fund [10/07]	Ministry of Science, Education, and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); Unity through Knowledge Fund	This work was supported by grants from the Ministry of Science, Education, and Sports of the Republic of Croatia (Project 119-0982913-1358), the Swiss National Science Foundation (SNSF), and the Scientific Co-operation between the Eastern Europe and Switzerland (SCOPES) program of the SNSF and the Unity through Knowledge Fund (UKF Project 10/07).	Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Bilokapic S, 2008, FEBS J, V275, P2831, DOI 10.1111/j.1742-4658.2008.06423.x; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; BUECHTER DD, 1995, BIOCHEMISTRY-US, V34, P6014, DOI 10.1021/bi00018a002; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DOCKBREGEON AC, 1990, EUR J BIOCHEM, V188, P283, DOI 10.1111/j.1432-1033.1990.tb15401.x; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; FRUGIER M, 1992, P NATL ACAD SCI USA, V89, P3990, DOI 10.1073/pnas.89.9.3990; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Gruic-Sovulj I, 2006, J MOL BIOL, V361, P128, DOI 10.1016/j.jmb.2006.06.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Mandal AK, 1998, PROTEIN SCI, V7, P1046; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Rees B, 2000, J MOL BIOL, V299, P1157, DOI 10.1006/jmbi.2000.3792; Rocak S, 2002, FEMS MICROBIOL LETT, V214, P101, DOI 10.1111/j.1574-6968.2002.tb11331.x; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; SENGER B, 1995, J MOL BIOL, V249, P45, DOI 10.1006/jmbi.1995.0279; Sherman JM, 1996, BIOCHEMISTRY-US, V35, P601, DOI 10.1021/bi951602b; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Tang SN, 2005, FEBS LETT, V579, P1441, DOI 10.1016/j.febslet.2005.01.045; Tumbula D, 1999, GENETICS, V152, P1269; Tworowski D, 2005, J MOL BIOL, V350, P866, DOI 10.1016/j.jmb.2005.05.051; Tworowski D, 2003, PROTEIN SCI, V12, P1247, DOI 10.1110/ps.0301203; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; YAN W, 1994, J BIOL CHEM, V269, P10022; Zhang CM, 2005, BIOCHEMISTRY-US, V44, P7240, DOI 10.1021/bi050285y	37	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10706	10713		10.1074/jbc.M808501200	http://dx.doi.org/10.1074/jbc.M808501200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228694	Green Published, hybrid			2022-12-25	WOS:000265104600044
J	Redig, AJ; Sassano, A; Majchrzak-Kita, B; Katsoulidis, E; Liu, H; Altman, JK; Fish, EN; Wickrema, A; Platanias, LC				Redig, Amanda J.; Sassano, Antonella; Majchrzak-Kita, Beata; Katsoulidis, Efstratios; Liu, Hui; Altman, Jessica K.; Fish, Eleanor N.; Wickrema, Amittha; Platanias, Leonidas C.			Activation of Protein Kinase C eta by Type I Interferons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MESSENGER-RNA TRANSLATION; HUMAN HEMATOPOIETIC PROGENITORS; IMATINIB MESYLATE STI571; P70 S6 KINASE; PKC-ETA; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; MAMMALIAN TARGET; CELLS RESPOND; ALPHA	Type I interferons (IFNs) are cytokines with diverse biological properties, including antiviral, growth inhibitory, and immunomodulatory effects. Although several signaling pathways are activated during engagement of the type I IFN receptor and participate in the induction of IFN responses, the mechanisms of generation of specific signals for distinct biological effects remain to be elucidated. Weprovide evidence that a novel member of the protein kinase C (PKC) family of proteins is rapidly phosphorylated and activated during engagement of the type I IFN receptor. In contrast to other members of the PKC family that are also regulated by IFN receptors, PKC eta does not regulate IFN-inducible transcription of interferon-stimulated genes or generation of antiviral responses. However, its function promotes cell cycle arrest and is essential for the generation of the suppressive effects of IFN alpha on normal and leukemic human myeloid (colony-forming unit-granulocyte macrophage) bone marrow progenitors. Altogether, our studies establish PKC eta as a unique element in IFN signaling that plays a key and essential role in the generation of the regulatory effects of type I IFNs on normal and leukemic hematopoiesis.	[Liu, Hui; Wickrema, Amittha] Univ Chicago, Canc Res Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Toronto Res Inst, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	University of Chicago; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			NCI NIH HHS [CA77816, CA121192, CA098550, CA100579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA098550, R01CA100579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Ghanem S, 2007, CANCER BIOL THER, V6, P1375; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Barragan M, 2003, LEUKEMIA LYMPHOMA, V44, P1865, DOI 10.1080/1042819031000110964; Bassini A, 1999, BLOOD, V93, P1178, DOI 10.1182/blood.V93.4.1178.404k28_1178_1188; Beck J, 1998, BRIT J CANCER, V77, P87, DOI 10.1038/bjc.1998.13; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; BROXMEYER HE, 1985, J IMMUNOL, V135, P2502; Chen YB, 2008, EXPERT OPIN INV DRUG, V17, P939, DOI 10.1517/13543784.17.6.939 ; Chida K, 2003, CANCER RES, V63, P2404; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Di Baldassarre A, 2007, J CELL BIOCHEM, V101, P411, DOI 10.1002/jcb.21189; Fahrmann M, 2008, CURR MED CHEM, V15, P1175, DOI 10.2174/092986708784310413; Fields AP, 2007, BIOCHEM SOC T, V35, P996, DOI 10.1042/BST0350996; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Grander D, 1997, EUR J HAEMATOL, V59, P129; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hanauske AR, 2004, CURR PHARM DESIGN, V10, P1923, DOI 10.2174/1381612043384376; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kashiwagi M, 2002, J BIOCHEM, V132, P853, DOI 10.1093/oxfordjournals.jbchem.a003297; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, CELL CYCLE, V7, P2112, DOI 10.4161/cc.7.14.6258; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Livneh E, 1996, ONCOGENE, V12, P1545; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Martin PM, 2005, EXPERT OPIN THER TAR, V9, P299, DOI 10.1517/14728222.9.2.299; MEANS RT, 1993, J CLIN INVEST, V91, P416, DOI 10.1172/JCI116216; Moschos S, 2005, CANC TREAT, V126, P207, DOI 10.1007/0-387-24361-5_9; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Oshevski S, 1999, BIOCHEM BIOPH RES CO, V263, P603, DOI 10.1006/bbrc.1999.1425; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; RAEFSKY EL, 1985, J IMMUNOL, V135, P2507; Redig AJ, 2008, LEUKEMIA LYMPHOMA, V49, P1255, DOI 10.1080/10428190802007726; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 1997, BLOOD, V90, P2574; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; VANTHULL E, 1978, CANCER RES, V38, P911; Venkatesan BA, 2006, CELL SIGNAL, V18, P508, DOI 10.1016/j.cellsig.2005.05.022; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Vitale M, 2006, EUR J HISTOCHEM, V50, P15; Weekx SFA, 1998, EXP HEMATOL, V26, P1034; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200	83	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10301	10314		10.1074/jbc.M807254200	http://dx.doi.org/10.1074/jbc.M807254200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19211565	hybrid, Green Published			2022-12-25	WOS:000265104600004
J	Sinha, PK; Torres-Bacete, J; Nakamaru-Ogiso, E; Castro-Guerrero, N; Matsuno-Yagi, A; Yagi, T				Sinha, Prem Kumar; Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao			Critical Roles of Subunit NuoH (ND1) in the Assembly of Peripheral Subunits with the Membrane Domain of Escherichia coli NDH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; MITOCHONDRIAL COMPLEX-I; HEREDITARY OPTIC NEUROPATHY; UBIQUINONE REDUCTION KINETICS; CONSERVED CHARGED RESIDUES; PARACOCCUS-DENITRIFICANS; BINDING SUBUNIT; STRUCTURAL ORGANIZATION; GLUCOSE-DEHYDROGENASE; STRUCTURE PREDICTION	The bacterial proton-translocating NADH: quinone oxidoreductase (NDH-1) consists of two domains, a peripheral arm and a membrane arm. NuoH is a counterpart of ND1, which is one of seven mitochondrially encoded hydrophobic subunits, and is considered to be involved in quinone/inhibitor binding. Sequence comparison in a wide range of species showed that NuoH is comprehensively conserved, particularly with charged residues in the cytoplasmic side loops. We have constructed 40 mutants of 27 conserved residues predicted to be in the cytoplasmic side loops of Escherichia coli NuoH by utilizing the chromosomal DNA manipulation technique and investigated roles of these residues. Mutants of Arg(37), Arg(46), Asp(63), Gly(134), Gly(145), Arg(148), Glu(220), and Glu(228) showed low deamino-NADH-K3Fe(CN)(6) reductase activity, undetectable NDH-1 in Blue Native gels, low contents of peripheral subunits ( especially NuoB and NuoCD) bound to the membranes, and a significant loss of the membrane potential and proton-pumping function coupled to deamino-NADH oxidation. The results indicated that these conserved residues located in the cytoplasmic side loops are essential for the assembly of the peripheral subunits with the membrane arm. Implications for the involvement of NuoH (ND1) in maintaining the structure and function of NDH-1 are discussed.	[Sinha, Prem Kumar; Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, MEM-256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930; Castro Guerrero, Norma/0000-0002-8645-2694	National Institutes of Health [R01GM033712]; The Scripps Research Institute, La Jolla, CA [19803-MEM]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Scripps Research Institute, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 ( to T. Y. and A. M.- Y.). This is Publication 19803-MEM from The Scripps Research Institute, La Jolla, CA.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2001, FEBS LETT, V508, P385, DOI 10.1016/S0014-5793(01)03111-8; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Horvath R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kervinen M, 2006, HUM MOL GENET, V15, P2543, DOI 10.1093/hmg/ddl176; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Kurki S, 2000, BIOCHEMISTRY-US, V39, P13496, DOI 10.1021/bi001134s; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Miyoshi H, 2001, J BIOENERG BIOMEMBR, V33, P223, DOI 10.1023/A:1010735019982; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; MURPHY E, 1985, EMBO J, V4, P3357, DOI 10.1002/j.1460-2075.1985.tb04089.x; Ohnishi T, 2005, FEBS LETT, V579, P4555, DOI 10.1016/j.febslet.2005.06.086; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Roth R, 2001, BBA-BIOENERGETICS, V1504, P352, DOI 10.1016/S0005-2728(00)00265-6; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schuler F, 2001, BBA-BIOENERGETICS, V1506, P79, DOI 10.1016/S0005-2728(01)00183-9; Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; Vgenopoulou I, 2006, J BACTERIOL, V188, P3264, DOI 10.1128/JB.188.9.3264-3272.2006; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555	71	52	53	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9814	9823		10.1074/jbc.M809468200	http://dx.doi.org/10.1074/jbc.M809468200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189973	Green Published, hybrid			2022-12-25	WOS:000264892900022
J	Ferreras, C; Hernandez, ED; Martinez-Costa, OH; Aragon, JJ				Ferreras, Cristina; Hernandez, Eloy D.; Martinez-Costa, Oscar H.; Aragon, Juan J.			Subunit Interactions and Composition of the Fructose 6-Phosphate Catalytic Site and the Fructose 2,6-Bisphosphate Allosteric Site of Mammalian Phosphofructokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; ASCITES TUMOR-CELLS; DICTYOSTELIUM-DISCOIDEUM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP; INHIBITION; ENZYME; YEAST; FRUCTOSE-1,6-BISPHOSPHATASE	Mammalian phosphofructokinase originated by duplication, fusion, and divergence of a primitive prokaryotic gene, with the duplicated fructose 6-phosphate catalytic site in the C-terminal half becoming an allosteric site for the activator fructose 2,6-bisphosphate. It has been suggested that both sites are shared across the interface between subunits aligned in an antiparallel orientation, the N-terminal half of one subunit facing the C-terminal half of the other. The composition of these binding sites and the way in which subunits interact to form the dimer within the tetrameric enzyme have been reexamined by systematic point mutations to alanine of key amino acid residues of human muscle phosphofructokinase. We found that residues His-199, His-298, Arg-201, and Arg-292 contribute to the catalytic site and not to the allosteric site, because their mutation decreased the affinity for fructose 6-phosphate without affecting the activation by fructose 2,6-bisphosphate or its binding affinity. In contrast, residues Arg-566, Arg-655, and His-661 were critical components of the fructose bisphosphate allosteric site, because their mutation strongly reduced the action and affinity of the activator, with no alteration of substrate binding to the active site. Our results suggest that mammalian phosphofructokinase subunits associate with the N-terminal halves facing each other to form the two catalytic sites/dimer and the C-terminal halves forming the allosteric sites. Additionally, mutation of certain residues eliminated activation by fructose 1,6-bisphosphate, but not its binding, with little effect on activation by fructose 2,6-bisphosphate, indicating a divergence in the signal transduction route despite their binding to the same site.	[Martinez-Costa, Oscar H.] Univ Autonoma Madrid, Fac Med, Dept Bioquim, E-28029 Madrid, Spain; Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cienti, Fac Med, E-28029 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Martinez-Costa, OH (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	oscar.martinez@uam.es; juanjose.aragon@uam.es	Martinez-Costa, Oscar/B-7275-2014	Martinez-Costa, Oscar/0000-0003-4893-2205	Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia [BMC2002-00769, BFU2005-09071]	Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BMC2002-00769 and BFU2005-09071 from the Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia.	ARAGON JJ, 1986, EUR J BIOCHEM, V161, P757, DOI 10.1111/j.1432-1033.1986.tb10504.x; Barcena M, 2007, J STRUCT BIOL, V159, P135, DOI 10.1016/j.jsb.2007.03.004; Benjamin S, 2007, J STRUCT BIOL, V159, P498, DOI 10.1016/j.jsb.2007.06.001; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang SH, 2002, BIOCHEM BIOPH RES CO, V290, P670, DOI 10.1006/bbrc.2001.6262; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; ESTEVEZ AM, 1995, FEBS LETT, V374, P100, DOI 10.1016/0014-5793(95)01085-S; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FOE LG, 1985, J BIOL CHEM, V260, P726; GONZALEZMATEOS F, 1993, J BIOL CHEM, V268, P7809; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KITAJIMA S, 1983, J BIOL CHEM, V258, P7352; KUNDROT CE, 1991, BIOCHEMISTRY-US, V30, P1478, DOI 10.1021/bi00220a005; LAD PM, 1973, BIOCHEMISTRY-US, V12, P4303, DOI 10.1021/bi00746a001; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Martinez-Costa OH, 2004, BIOCHEM J, V377, P77, DOI 10.1042/BJ20031032; Martinez-Costa OH, 2007, FEBS LETT, V581, P3033, DOI 10.1016/j.febslet.2007.05.059; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; MARTINEZCOSTA OH, 1994, EUR J BIOCHEM, V226, P1007, DOI 10.1111/j.1432-1033.1994.01007.x; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1995, AM J HUM GENET, V56, P131; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; Santamaria B, 2002, J BIOL CHEM, V277, P1210, DOI 10.1074/jbc.M109480200; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; SOLS A, 1981, CURR TOP CELL REGUL, V19, P77; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; TORNHEIM K, 1985, J BIOL CHEM, V260, P7985; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315	35	17	17	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9124	9131		10.1074/jbc.M807737200	http://dx.doi.org/10.1074/jbc.M807737200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218242	hybrid, Green Published			2022-12-25	WOS:000264669100016
J	Yamasaki, T; Takahashi, A; Pan, JZ; Yamaguchi, N; Yokoyama, KK				Yamasaki, Takahito; Takahashi, Akinori; Pan, Jianzhi; Yamaguchi, Naoto; Yokoyama, Kazunari K.			Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-INDUCED DIFFERENTIATION; RETINOIC ACID; F9 CELLS; INTRAMOLECULAR INHIBITION; HEMATOPOIETIC-CELLS; MAMMARY-TUMORS; ATF-2; AP-1; DOMAIN; ALPHA	Activation transcription factor-2 (ATF-2) is phosphorylated by various protein kinases, such as JNK/p38/ERK, calmodulin kinase IV, protein kinase A, and protein kinase C (PKC), in response to a variety of stimuli. However, the role of the phosphorylation of ATF-2 by PKC in vivo in the transcriptional control of genes that include the activation protein-1 (AP-1)/cyclic AMP-response element remains to be defined. Using antibodies against the phosphorylated serine residue (Ser(P)) at position 121 of ATF-2, we have demonstrated that PKC phosphorylates ATF-2 at Ser-121 and that phosphorylation of Ser-121 (to yield ATF-2pS121) becomes detectable at the late stage of the response of HeLa cells to 12-O-tetradecanoylphorbol-13-acetate (TPA) and is maintained for more than 2 h. By contrast, phosphorylation of ATF-2 at threonine residues 69 and 71 (Thr69/71, to yield ATF-2pT69/71) and at Ser-340 and Ser-367 (to yield ATF-2pS340 and ATF-2pS367) is detectable as an immediate early response. Unlike levels of ATF-2pT69/71 and ATF2pS340, the level of ATF-2pS121 increases in the nuclei of HeLa cells in response to TPA. A serine-to-alanine mutation at position 121 of ATF-2 represses the c-Jun-dependent transcription of AP-1/cyclic AMP-response element reporter genes and also the p300-mediated activation of a Gal4-reporter gene in response to TPA. Our results suggest that the phosphorylation of ATF-2 at Ser-121 plays a key role in the c-Jun-mediated activation of transcription that occurs in response to TPA.	[Yamasaki, Takahito; Pan, Jianzhi; Yokoyama, Kazunari K.] RIKEN, BioResource Ctr, Gene Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Takahashi, Akinori; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Chiba 2608675, Japan	RIKEN; Chiba University	Yokoyama, KK (corresponding author), RIKEN, BioResource Ctr, Gene Engn Div, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	kazu@brc.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19041069]; Naito Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Memorial Foundation(Naito Memorial Foundation)	This work was supported by Grant 19041069 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Naito Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bocco JL, 1996, ONCOGENE, V12, P1971; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHATTON B, 1994, ONCOGENE, V9, P375; Cho YH, 1998, CELL GROWTH DIFFER, V9, P147; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Khuri FR, 1996, CELL GROWTH DIFFER, V7, P595; KINDREGAN HC, 1994, J BIOL CHEM, V269, P27756; KITABAYASHI I, 1995, EMBO J, V14, P3496, DOI 10.1002/j.1460-2075.1995.tb07356.x; KITABAYASHI I, 1992, EMBO J, V11, P167, DOI 10.1002/j.1460-2075.1992.tb05039.x; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; SAKURAI A, 1991, BIOCHEM BIOPH RES CO, V181, P629, DOI 10.1016/0006-291X(91)91237-7; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Schmalz D, 1998, J CELL SCI, V111, P1823; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Szczepanowska J, 1998, P NATL ACAD SCI USA, V95, P4146, DOI 10.1073/pnas.95.8.4146; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; TSENG CP, 1994, CARCINOGENESIS, V15, P707, DOI 10.1093/carcin/15.4.707; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170	44	38	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8567	8581		10.1074/jbc.M808719200	http://dx.doi.org/10.1074/jbc.M808719200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176525	Green Published, hybrid			2022-12-25	WOS:000264397800041
J	Gong, Y; Sun, Y; McNutt, MA; Sun, Q; Hou, L; Liu, H; Shen, Q; Ling, Y; Chi, Y; Zhang, B				Gong, Y.; Sun, Y.; McNutt, M. A.; Sun, Q.; Hou, L.; Liu, H.; Shen, Q.; Ling, Y.; Chi, Y.; Zhang, B.			Localization of TEIF in the centrosome and its functional association with centrosome amplification in DNA damage, telomere dysfunction and human cancers	ONCOGENE			English	Article						centrosome; DNA damage; telomere dysfunction; cancer	CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; TUMOR-VIRUSES; I TAX; PROTEINS; 11Q13; CELLS; MICROTUBULE; ONCOGENE; KINASE	Centrosome amplification and telomere shortening, which are commonly detected in human cancers, have been implicated in the induction of chromosome instability in tumorigenesis. The functions of these two structures are closely related to DNA damage repair machinery, and some factors that operate in the maintenance of telomeres also take part in the regulation of centrosome status, suggesting they are functionally linked. We report that TEIF (telomerase transcriptional elements-interacting factor), a transactivator of the hTERT (human telomerase reverse transcriptase subunit) gene, is distributed in the centrosome throughout the cell cycle, but its transport into the centrosome is increased under some conditions, and its distribution is dependent on its C-terminal domain. Experimental modulation of TEIF expression through overexpression, polypeptide expression or depletion affected centrosome status and increased abnormalities of cell mitosis. Localization of TEIF to the centrosome was also stimulated by treatment with genotoxic agents and experimental telomere dysfunction, accompanying centrosome amplification. Moreover, we demonstrated that the expression level of TEIF is not only closely correlated with centrosome amplification in soft tissue sarcomas but it is also significantly related to tumor histologic grade. Our data confirmed TEIF functions as a centrosome regulator. Its participation in DNA damage response, including telomere dysfunction and tumorigenesis, indicates TEIF is likely to be a factor involved in linking centrosome amplification and telomere dysfunction in cancer development.	[Gong, Y.; Sun, Y.; McNutt, M. A.; Sun, Q.; Hou, L.; Liu, H.; Shen, Q.; Ling, Y.; Chi, Y.; Zhang, B.] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University	Zhang, B (corresponding author), Peking Univ, Dept Pathol, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhangbo@bjmu.edu.cn			National Natural Science Foundation of China [30570691]; Doctors Program Foundations of Ministry Education [20040001147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctors Program Foundations of Ministry Education	This research was supported by National Natural Science Foundation of China (no. 30570691), and Doctors Program Foundations of Ministry Education (Grant 20040001147).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Churikov D, 2006, MOL CELL BIOL, V26, P6971, DOI 10.1128/MCB.01011-06; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Doxsey SJ, 2001, NAT CELL BIOL, V3, pE105, DOI 10.1038/35074618; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fletcher L, 2006, CANCER LETT, V243, P1, DOI 10.1016/j.canlet.2006.01.006; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Gillingham AK, 2000, EMBO REP, V1, P524; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Gisselsson D, 2005, GENE CHROMOSOME CANC, V42, P22, DOI 10.1002/gcc.20094; Gisselsson D, 2004, BRIT J CANCER, V91, P327, DOI 10.1038/sj.bjc.6601803; Gisselsson D, 2003, ADV CANCER RES, V87, P1; Gisselsson D, 2002, BRIT J CANCER, V87, P202, DOI 10.1038/sj.bjc.6600438; GISSELSSON D, 2001, ATLAS GENETICS CYTOG; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hara T, 2008, CANCER SCI, V99, P1155, DOI 10.1111/j.1349-7006.2008.00798.x; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Lou Y, 2004, BIOCHEM BIOPH RES CO, V321, P495, DOI 10.1016/j.bbrc.2004.06.171; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Pihan GA, 1999, SEMIN CANCER BIOL, V9, P289, DOI 10.1006/scbi.1999.0131; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; Pumfery A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-50; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Slijepcevic P, 2006, DNA REPAIR, V5, P1299, DOI 10.1016/j.dnarep.2006.05.038; Smith S, 1999, J CELL SCI, V112, P3649; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tang Zhiwei, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P402; Tang ZW, 2004, BIOCHEM BIOPH RES CO, V324, P1324, DOI 10.1016/j.bbrc.2004.09.201; van Asseldonk M, 2000, GENOMICS, V66, P35, DOI 10.1006/geno.2000.6194; Wang X, 2007, CELL DEATH DIFFER, V14, P924, DOI 10.1038/sj.cdd.4402105; Wong KF, 1999, CANCER GENET CYTOGEN, V113, P93, DOI 10.1016/S0165-4608(98)00285-4; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481; Zhao YJ, 2005, BIOCHEM BIOPH RES CO, V333, P908, DOI 10.1016/j.bbrc.2005.05.172	48	11	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1549	1560		10.1038/onc.2008.503	http://dx.doi.org/10.1038/onc.2008.503			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19198626				2022-12-25	WOS:000264537400007
J	Prasad, A; Park, IW; Allen, H; Zhang, X; Reddy, MVR; Boominathan, R; Reddy, EP; Groopman, JE				Prasad, A.; Park, I-W; Allen, H.; Zhang, X.; Reddy, M. V. R.; Boominathan, R.; Reddy, E. P.; Groopman, J. E.			Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells	ONCOGENE			English	Article						mantle cell lymphoma; cell cycle; cytotoxicity; apoptosis; sulfonyl compounds	INITIATION-FACTOR 4E; C-MYC; CASPASE-3 ACTIVATION; HUMAN CANCER; EXPRESSION; APOPTOSIS; PROTEIN; SURVIVAL; PATHWAY; DEATH	Mantle cell lymphoma (MCL) is characterized by the uncontrolled overexpression of cyclin D1. Styryl sulfonyl compounds have shown potent antitumor activity against MCL by inducing cell-cycle arrest and apoptosis. However, the exact molecular mechanism by which these compounds function is yet to be elucidated. Here, we show that the prototypical styryl sulfonyl compound ON 01910.Na decreased cyclin D1 and c-Myc protein levels in MCL cells, whereas mRNA levels of cyclin D1 were minimally affected. Notably, ON 01910.Na suppressed eukaryotic translation initiation factor 4E (eIF4E)-mediated cyclin D1 mRNA translation, decreased levels of phosphorylated Akt, mammalian target of Rapamycin (mTOR) and eIF4E-binding protein (eIF4E-BP), lowered the cap site binding activity of eIF4E and directly inhibited activity of phosphatidylinositol-3 kinase (PI-3K). Analysis of apoptotic signaling pathways revealed that ON 01910.Na induced the release of cytochrome c from mitochondria, altered expression of Bcl-2 family of proteins and stimulated activation of caspases. Taken together, styryl sulfonyls can cause a rapid decrease of cyclin D1 by blocking cyclin D1 mRNA translation through inhibition of the PI-3K/Akt/mTOR/eIF4E-BP signaling pathway and triggering a cytochrome c-dependent apoptotic pathway in MCL cells.	[Groopman, J. E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Dept Med, Boston, MA 02215 USA; [Reddy, M. V. R.; Boominathan, R.; Reddy, E. P.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Dept Biochem, Philadelphia, PA 19122 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Groopman, JE (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	jgroopma@bidmc.harvard.edu	Reddy, E. Premkumar/F-6233-2011		SBIR [1 R43 CA134108-01A1];  [CA109820]; NATIONAL CANCER INSTITUTE [R01CA109820, R43CA134108] Funding Source: NIH RePORTER	SBIR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a charitable contribution from Mr and Mrs Henryk and Rochelle Schwarz and SBIR grant # 1 R43 CA134108-01A1. E Premkumar Reddy was supported by grant CA109820. Disclosure: Dr Groopman is a consultant to Onconova Therapeutics, Inc.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Bertoni F, 2006, HEMATOL ONCOL, V24, P22, DOI 10.1002/hon.767; Bertoni F, 2007, INT J BIOCHEM CELL B, V39, P1747, DOI 10.1016/j.biocel.2007.04.026; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Brauns SC, 2005, ANTICANCER RES, V25, P4197; Campo E, 1999, SEMIN HEMATOL, V36, P115; de Leeuw RJ, 2004, HUM MOL GENET, V13, P1827, DOI 10.1093/hmg/ddh195; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; LEROUX D, 1991, BRIT J HAEMATOL, V77, P346, DOI 10.1111/j.1365-2141.1991.tb08582.x; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martin SA, 2005, CANCER RES, V65, P10657, DOI 10.1158/0008-5472.CAN-05-2087; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Park IW, 2007, ONCOGENE, V26, P5635, DOI 10.1038/sj.onc.1210350; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Reddy MVR, 2008, J MED CHEM, V51, P86, DOI 10.1021/jm701077b; Rizzatti EG, 2005, BRIT J HAEMATOL, V130, P516, DOI 10.1111/j.1365-2141.2005.05630.x; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Witzig TE, 2005, J CLIN ONCOL, V23, P6409, DOI 10.1200/JCO.2005.55.017; YODERHILL J, 1993, J BIOL CHEM, V268, P5566; ZUCCA E, 1995, ANN ONCOL, V6, P257, DOI 10.1093/oxfordjournals.annonc.a059155	41	62	64	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1518	1528		10.1038/onc.2008.502	http://dx.doi.org/10.1038/onc.2008.502			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19198627				2022-12-25	WOS:000264537400004
J	Keriel, A; Mahuteau-Betzer, F; Jacquet, C; Plays, M; Grierson, D; Sitbon, M; Tazi, J				Keriel, Anne; Mahuteau-Betzer, Florence; Jacquet, Chantal; Plays, Marc; Grierson, David; Sitbon, Marc; Tazi, Jamal			Protection against Retrovirus Pathogenesis by SR Protein Inhibitors	PLOS ONE			English	Article								Indole derivatives compounds (IDC) are a new class of splicing inhibitors that have a selective action on exonic splicing enhancers (ESE)-dependent activity of individual serine-arginine-rich (SR) proteins. Some of these molecules have been shown to compromise assembly of HIV infectious particles in cell cultures by interfering with the activity of the SR protein SF2/ASF and by subsequently suppressing production of splicing-dependent retroviral accessory proteins. For all replication-competent retroviruses, a limiting requirement for infection and pathogenesis is the expression of the envelope glycoprotein which strictly depends on the host splicing machinery. Here, we have evaluated the efficiency of IDC on an animal model of retroviral pathogenesis using a fully replication-competent retrovirus. In this model, all newborn mice infected with a fully replicative murine leukemia virus (MLV) develop erythroleukemia within 6 to 8 weeks of age. We tested several IDC for their ability to interfere ex vivo with MLV splicing and virus spreading as well as for their protective effect in vivo. We show here that two of these IDC, IDC13 and IDC78, selectively altered splicing-dependent production of the retroviral envelope gene, thus inhibiting early viral replication in vivo, sufficiently to protect mice from MLV-induced pathogenesis. The apparent specificity and clinical safety observed here for both IDC13 and IDC78 strongly support further assessment of inhibitors of SR protein splicing factors as a new class of antiretroviral therapeutic agents.			Keriel, A (corresponding author), Univ Montpellier 1, Univ Montpellier 2, IFR122, CNRS,IGMM,UMR5535, Montpellier, France.	marc.sitbon@igmm.cnrs.fr; jamal.tazi@igmm.cnrs.fr	Keriel, Anne/N-3753-2017; Sitbon, Marc/A-6771-2010	Keriel, Anne/0000-0003-3340-299X; Sitbon, Marc/0000-0003-3616-2338; Mahuteau-Betzer, Florence/0000-0002-3009-252X; Tazi, Jamal/0000-0002-1949-8748				Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Anderson Jenny L, 2004, Curr HIV/AIDS Rep, V1, P47, DOI 10.1007/s11904-004-0007-x; Audit M, 1999, J VIROL, V73, P10472, DOI 10.1128/JVI.73.12.10472-10479.1999; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; CHATIS PA, 1984, J VIROL, V52, P248, DOI 10.1128/JVI.52.1.248-254.1984; CHESEBRO B, 1983, VIROLOGY, V128, P221, DOI 10.1016/0042-6822(83)90332-X; CHESEBRO B, 1981, VIROLOGY, V112, P131, DOI 10.1016/0042-6822(81)90619-X; Dejardin J, 2000, J VIROL, V74, P3709, DOI 10.1128/JVI.74.8.3709-3714.2000; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Peterson KE, 2006, CURR TOP MICROBIOL, V303, P67, DOI 10.1007/978-3-540-33397-5_4; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SITBON M, 1986, CELL, V47, P851, DOI 10.1016/0092-8674(86)90800-7; SITBON M, 1991, P NATL ACAD SCI USA, V88, P5932, DOI 10.1073/pnas.88.13.5932; SITBON M, 1985, VIROLOGY, V141, P110, DOI 10.1016/0042-6822(85)90187-4; SITBON M, 1986, J VIROL, V57, P389, DOI 10.1128/JVI.57.1.389-393.1986; Sorensen AB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-46; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Soret J, 2003, Prog Mol Subcell Biol, V31, P89; Soret J, 2006, PROG MOLEC, V44, P65; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; Wolff L, 1996, CURR TOP MICROBIOL, V211, P191; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07	32	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4533	10.1371/journal.pone.0004533	http://dx.doi.org/10.1371/journal.pone.0004533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225570	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486000010
J	Miracle, A; Denslow, ND; Kroll, KJ; Liu, MC; Wang, KKW				Miracle, Ann; Denslow, Nancy D.; Kroll, Kevin J.; Liu, Ming Cheng; Wang, Kevin K. W.			Spillway-Induced Salmon Head Injury Triggers the Generation of Brain alpha II-Spectrin Breakdown Product Biomarkers Similar to Mammalian Traumatic Brain Injury	PLOS ONE			English	Article								Recent advances in biomedical research have resulted in the development of specific biomarkers for diagnostic testing of disease condition or physiological risk. Of specific interest are alpha II-spectrin breakdown products (SBDPs), which are produced by proteolytic events in traumatic brain injury and have been used as biomarkers to predict the severity of injury in humans and other mammalian brain injury models. This study describes and demonstrates the successful use of antibody-based mammalian SBDP biomarkers to detect head injury in migrating juvenile Chinook salmon (Oncorhynchus tshawytscha) that have been injured during passage through high-energy hydraulic environments present in spillways under different operational configurations. Mortality and injury assessment techniques currently measure only near-term direct mortality and easily observable acute injury. Injury-based biomarkers may serve as a quantitative indicator of subacute physical injury and recovery, and aid hydropower operators in evaluation of safest passage configuration and operation actions for migrating juvenile salmonids. We describe a novel application of SBDP biomarkers for head injury for migrating salmon. To our knowledge, this is the first documented cross-over use of a human molecular biomarker in a wildlife and operational risk management scenario.	Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA; [Liu, Ming Cheng; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovative Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Ctr Neuroproteom & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Banyan Biomarkers Inc.; State University System of Florida; University of Florida	Miracle, A (corresponding author), Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA.	ann.miracle@pnl.gov		Wang, Kevin/0000-0002-9343-6473; kroll, kevin j/0000-0002-5374-6733	Pacific Northwest National Laboratory	Pacific Northwest National Laboratory(United States Department of Energy (DOE))	This work was supported by directed funds from Pacific Northwest National Laboratory to ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Bergman PJ, 2003, CLIN TECH SMALL AN P, V18, P88, DOI 10.1053/svms.2003.36621; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Burger J, 2007, ENVIRON RES, V104, P135, DOI 10.1016/j.envres.2006.08.002; Cianci CD, 1999, BIOCHEMISTRY-US, V38, P15721, DOI 10.1021/bi991458k; de Boer JG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-422; Eason C, 2002, TOXICOLOGY, V181, P517, DOI 10.1016/S0300-483X(02)00472-9; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Gastaldi L, 2007, COMP BIOCHEM PHYS C, V146, P398, DOI 10.1016/j.cbpc.2007.04.014; Johnson GE, 2003, N AM J FISH MANAGE, V23, P441, DOI 10.1577/1548-8675(2003)023<0441:EOJEAH>2.0.CO;2; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; LIVINGSTONE DR, 1993, J CHEM TECHNOL BIOT, V57, P195; Miracle AL, 2005, REPROD TOXICOL, V19, P321, DOI 10.1016/j.reprotox.2004.06.007; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Neitzel DA, 2004, T AM FISH SOC, V133, P447, DOI 10.1577/02-021; *NOAA, 2008, ISS SUMM FED COL RIV; PERKINS EJ, 2008, TOXICOGENOMICS REGUL, P87; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Plummer PJ, 2007, VET CLIN N AM-FOOD A, V23, P481, DOI 10.1016/j.cvfa.2007.07.005; Robbens J, 2007, TRENDS BIOTECHNOL, V25, P460, DOI 10.1016/j.tibtech.2007.08.005; SKALSKI JR, 2003, SURVIVAL CONDITION C; Soutschek J, 1996, DEV BRAIN RES, V97, P279, DOI 10.1016/S0165-3806(96)00145-9; Soutschek J, 1995, NEUROSCI LETT, V202, P133, DOI 10.1016/0304-3940(95)12231-1; Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zupanc GKH, 1999, J EXP BIOL, V202, P1435	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4491	10.1371/journal.pone.0004491	http://dx.doi.org/10.1371/journal.pone.0004491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214235	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484300016
J	Fan, ZM; Yuan, L; Chatterjee, R				Fan, Zhanmin; Yuan, Ling; Chatterjee, Ranjini			Increased Hydrogen Production by Genetic Engineering of Escherichia coli	PLOS ONE			English	Article							FORMATE HYDROGENLYASE; TRANSCRIPTIONAL ACTIVATOR; OPERON; EXPRESSION; GLUCOSE; FHLA; FNR; IMPROVEMENT; PROTEIN; NITRITE	Escherichia coli is capable of producing hydrogen under anaerobic growth conditions. Formate is converted to hydrogen in the fermenting cell by the formate hydrogenlyase enzyme system. The specific hydrogen yield from glucose was improved by the modification of transcriptional regulators and metabolic enzymes involved in the dissimilation of pyruvate and formate. The engineered E. coli strains ZF1 (Delta focA; disrupted in a formate transporter gene) and ZF3 (Delta narL; disrupted in a global transcriptional regulator gene) produced 14.9, and 14.4 mu mols of hydrogen/mg of dry cell weight, respectively, compared to 9.8 mu mols of hydrogen/mg of dry cell weight generated by wild-type E. coli strain W3110. The molar yield of hydrogen for strain ZF3 was 0.96 mols of hydrogen/mol of glucose, compared to 0.54 mols of hydrogen/mol of glucose for the wild-type E. coli strain. The expression of the global transcriptional regulator protein FNR at levels above natural abundance had a synergistic effect on increasing the hydrogen yield in the Delta focA genetic background. The modification of global transcriptional regulators to modulate the expression of multiple operons required for the biosynthesis of formate hydrogenlyase represents a practical approach to improve hydrogen production.	[Fan, Zhanmin; Yuan, Ling] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Fan, Zhanmin; Yuan, Ling] Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY 40506 USA; [Chatterjee, Ranjini] Farasis Energy Inc, Hayward, CA USA	University of Kentucky; University of Kentucky	Fan, ZM (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	rjic@novozymes.com			U.S. Department of Energy [DE-FG02-03ER83868]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Small Business Innovative Research grant DE-FG02-03ER83868 from the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Buckley M, 2006, MICROBIAL ENERGY CON; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gokarn RR, 2000, APPL ENVIRON MICROB, V66, P1844, DOI 10.1128/AEM.66.5.1844-1850.2000; HOPPER S, 1994, J BIOL CHEM, V269, P19597; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, P262; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Khanal SK, 2004, INT J HYDROGEN ENERG, V29, P1123, DOI 10.1016/j.ijhydene.2003.11.002; Maeda T, 2007, APPL MICROBIOL BIOT, V77, P879, DOI 10.1007/s00253-007-1217-0; MAUPIN JA, 1990, J BACTERIOL, V172, P4798, DOI 10.1128/jb.172.9.4798-4806.1990; Miller J.H., 1972, EXPT MOL GENETICS CO; Nath K, 2004, APPL MICROBIOL BIOT, V65, P520, DOI 10.1007/s00253-004-1644-0; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; PAULETTE M, 2006, FEMS MICROBIOLOGY RE, V25, P455; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Petri R, 2004, CURR OPIN BIOTECH, V15, P298, DOI 10.1016/j.copbio.2004.05.005; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; SCHLENSOG V, 1994, J BIOL CHEM, V269, P19590; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; Self WT, 1999, MICROBIOL-UK, V145, P41, DOI 10.1099/13500872-145-1-41; Self WT, 2001, MICROBIOL-SGM, V147, P3093, DOI 10.1099/00221287-147-11-3093; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Yoshida A, 2006, APPL MICROBIOL BIOT, V73, P67, DOI 10.1007/s00253-006-0456-9	30	39	41	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4432	10.1371/journal.pone.0004432	http://dx.doi.org/10.1371/journal.pone.0004432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212440	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484200003
J	Kredel, S; Oswald, F; Nienhaus, K; Deuschle, K; Rocker, C; Wolff, M; Heilker, R; Nienhaus, GU; Wiedenmann, J				Kredel, Simone; Oswald, Franz; Nienhaus, Karin; Deuschle, Karen; Roecker, Carlheinz; Wolff, Michael; Heilker, Ralf; Nienhaus, G. Ulrich; Wiedenmann, Joerg			mRuby, a Bright Monomeric Red Fluorescent Protein for Labeling of Subcellular Structures	PLOS ONE			English	Article							ENTACMAEA-QUADRICOLOR; PEROXISOMES; VARIANTS; ORANGE; PHOTOCONVERSION; ISOMERIZATION; ASSOCIATION; INHERITANCE; EVOLUTION; ANTHOZOA	A monomeric variant of the red fluorescent protein eqFP611, mRuby, is described. With excitation and emission maxima at 558 nm and 605 nm, respectively, and a large Stokes shift of 47 nm, mRuby appears particularly useful for imaging applications. The protein shows an exceptional resistance to denaturation at pH extremes. Moreover, mRuby is about tenfold brighter compared to EGFP when being targeted to the endoplasmic reticulum. The engineering process of eqFP611 revealed that the C-terminal tail of the protein acts as a natural peroxisomal targeting signal (PTS). Using an mRuby variant carrying the eqFP611-PTS, we discovered that ordered inheritance of peroxisomes is widespread during mitosis of different mammalian cell types. The ordered partitioning is realized by the formation of peroxisome clusters around the poles of the mitotic spindle and ensures that equal numbers of the organelle are inherited by the daughter cells. The unique spectral properties make mRuby the marker of choice for a multitude of cell biological applications. Moreover, the use of mRuby has allowed novel insights in the biology of organelles responsible for severe human diseases.	[Kredel, Simone; Wolff, Michael; Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med I, D-89069 Ulm, Germany; [Nienhaus, Karin; Deuschle, Karen; Roecker, Carlheinz; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Wolff, Michael; Heilker, Ralf] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanog Ctr, Southampton SO9 5NH, Hants, England	Ulm University; Ulm University; Ulm University; Boehringer Ingelheim; University of Illinois System; University of Illinois Urbana-Champaign; NERC National Oceanography Centre; University of Southampton	Kredel, S (corresponding author), Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany.	joerg.wiedenmann@noc.soton.ac.uk	Oswald, Franz/AAO-9584-2020; Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192	Deutsche Forschungsgemeinschaft [Ni291/4, SFB 569/A4, SFB 497/D2, Wi1990/2-1, SFB 497/B9, SFB 518/A18]; Fonds der Chemischen Industrie; Landesstiftung Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Landesstiftung Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany(Boehringer Ingelheim)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, grants DFG Ni291/4, SFB 569/A4 and SFB 497/D2 to G.U.N., Wi1990/2-1 to J.W., and SFB 497/B9 and SFB 518/A18 to F.O.), Fonds der Chemischen Industrie (to G.U.N.), Landesstiftung Baden-Wurttemberg (Elite Postdoc Program to J.W.) and a collaborative grant of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany to J.W. and G.U.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Collings DA, 2003, PLANTA, V218, P204, DOI 10.1007/s00425-003-1096-2; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu M, 2006, BBA-MOL CELL RES, V1763, P1669, DOI 10.1016/j.bbamcr.2006.08.015; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hendrix J, 2008, BIOPHYS J, V94, P4103, DOI 10.1529/biophysj.107.123596; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Ivanchenko S, 2007, BIOPHYS J, V92, P4451, DOI [10.1529/biophysj.106.103408, 10.1529/biophysj. 106.103408]; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Loos DC, 2006, J AM CHEM SOC, V128, P6270, DOI 10.1021/ja0545113; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nienhaus K, 2008, J AM CHEM SOC, V130, P12578, DOI 10.1021/ja8046443; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Wanders RJA, 2004, AM J MED GENET A, V126A, P355, DOI 10.1002/ajmg.a.20661; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Wiedenmann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854680; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J., 1997, (sulcata) Pennant, (Cnidaria, Anthozoa, Actinaria) in Gentechnologie und Molekularbiologie, Offenlegungsschrift DE, Patent No. [197 18 640 A1, 19718640]; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	42	141	150	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4391	10.1371/journal.pone.0004391	http://dx.doi.org/10.1371/journal.pone.0004391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194514	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000265483600016
J	Guzman-Ayala, M; Lee, KL; Mavrakis, KJ; Goggolidou, P; Norris, DP; Episkopou, V				Guzman-Ayala, Marcela; Lee, Kian Leong; Mavrakis, Konstantinos J.; Goggolidou, Paraskevi; Norris, Dominic P.; Episkopou, Vasso			Graded Smad2/3 Activation Is Converted Directly into Levels of Target Gene Expression in Embryonic Stem Cells	PLOS ONE			English	Article								The Transforming Growth Factor (TGF) beta signalling family includes morphogens, such as Nodal and Activin, with important functions in vertebrate development. The concentration of the morphogen is critical for fate decisions in the responding cells. Smad2 and Smad3 are effectors of the Nodal/Activin branch of TGF beta signalling: they are activated by receptors, enter the nucleus and directly transcribe target genes. However, there have been no studies correlating levels of Smad2/3 activation with expression patterns of endogenous target genes in a developmental context over time. We used mouse Embryonic Stem (ES) cells to create a system whereby levels of activated Smad2/3 can be manipulated by an inducible constitutively active receptor (Alk4*) and an inhibitor (SB-431542) that blocks specifically Smad2/3 activation. The transcriptional responses were analysed by microarrays at different time points during activation and repression. We identified several genes that follow faithfully and reproducibly the Smad2/3 activation profile. Twenty-seven of these were novel and expressed in the early embryo downstream of Smad2/3 signalling. As they responded to Smad2/3 activation in the absence of protein synthesis, they were considered direct. These immediate responsive genes included negative intracellular feedback factors, like SnoN and I-Smad7, which inhibit the transcriptional activity of Smad2/3. However, their activation did not lead to subsequent repression of target genes over time, suggesting that this type of feedback is inefficient in ES cells or it is counteracted by mechanisms such as ubiquitin-mediated degradation by Arkadia. Here we present an ES cell system along with a database containing the expression profile of thousands of genes downstream of Smad2/3 activation patterns, in the presence or absence of protein synthesis. Furthermore, we identify primary target genes that follow proportionately and with high sensitivity changes in Smad2/3 levels over 15-30 hours. The above system and resource provide tools to study morphogen function in development.	[Guzman-Ayala, Marcela; Lee, Kian Leong; Mavrakis, Konstantinos J.; Episkopou, Vasso] Imperial Coll Sch Med, Hammersmith Hosp, Ctr Clin Sci, MRC, London, England; [Goggolidou, Paraskevi; Norris, Dominic P.] MRC, Mammalian Genet Unit, Harwell, Berks, England	Imperial College London	Guzman-Ayala, M (corresponding author), Imperial Coll Sch Med, Hammersmith Hosp, Ctr Clin Sci, MRC, London, England.	vepiskop@csc.mrc.ac.uk	LEE, Kian Leong/E-3584-2013; Episkopou, Vasso/E-2952-2010	LEE, Kian Leong/0000-0002-0443-2746; 	Medical Research Council, United Kingdom; Medical Research Council [MC_EX_G0501680, MC_U120074332] Funding Source: researchfish; MRC [MC_EX_G0501680, MC_U120074332] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, United Kingdom.	Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Ang SL, 2004, SEMIN CELL DEV BIOL, V15, P555, DOI 10.1016/j.semcdb.2004.04.009; Armes NA, 1997, DEVELOPMENT, V124, P3797; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dickmeis T, 2001, DEV DYNAM, V222, P571, DOI 10.1002/dvdy.1220; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; JONES CM, 1995, DEVELOPMENT, V121, P3651; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LEVY L, 2007, MOL CELL BIOL; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; NAGANO Y, 2007, J BIOL CHEM; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Norris DP, 2002, DEVELOPMENT, V129, P3455; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	72	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4268	10.1371/journal.pone.0004268	http://dx.doi.org/10.1371/journal.pone.0004268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172185	Green Published, gold, Green Accepted			2022-12-25	WOS:000265482900001
J	Hirrlinger, J; Scheller, A; Hirrlinger, PG; Kellert, B; Tang, WN; Wehr, MC; Goebbels, S; Reichenbach, A; Sprengel, R; Rossner, MJ; Kirchhoff, F				Hirrlinger, Johannes; Scheller, Anja; Hirrlinger, Petra G.; Kellert, Beate; Tang, Wannan; Wehr, Michael C.; Goebbels, Sandra; Reichenbach, Andreas; Sprengel, Rolf; Rossner, Moritz J.; Kirchhoff, Frank			Split-Cre Complementation Indicates Coincident Activity of Different Genes In Vivo	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; TRANSGENIC MICE; STEM-CELLS; NG2 CELLS; EXPRESSION; MOUSE; RECOMBINASE; OLIGODENDROCYTES; ASTROCYTES	Cre/LoxP recombination is the gold standard for conditional gene regulation in mice in vivo. However, promoters driving the expression of Cre recombinase are often active in a wide range of cell types and therefore unsuited to target more specific subsets of cells. To overcome this limitation, we designed inactive "split-Cre'' fragments that regain Cre activity when overlapping co-expression is controlled by two different promoters. Using transgenic mice and virus-mediated expression of split-Cre, we show that efficient reporter gene activation is achieved in vivo. In the brain of transgenic mice, we genetically defined a subgroup of glial progenitor cells in which the Plp1- and the Gfap-promoter are simultaneously active, giving rise to both astrocytes and NG2-positive glia. Similarly, a subset of interneurons was labelled after viral transfection using Gad67- and Cck1 promoters to express split-Cre. Thus, split-Cre mediated genomic recombination constitutes a powerful spatial and temporal coincidence detector for in vivo targeting.	[Hirrlinger, Johannes] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany; [Hirrlinger, Johannes; Scheller, Anja; Hirrlinger, Petra G.; Kellert, Beate; Wehr, Michael C.; Goebbels, Sandra; Rossner, Moritz J.; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Hirrlinger, Johannes; Kirchhoff, Frank] DFG, Research Ctr Molecular Physiol Brain, Gottingen, Germany; [Scheller, Anja] Free Univ Berlin, Sect Biol Chem & Pharm, D-1000 Berlin, Germany; [Hirrlinger, Petra G.; Reichenbach, Andreas] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Tang, Wannan; Sprengel, Rolf] Max Planck Inst Med Res, Dept Molecular Neurobiol, Heidelberg, Germany	Leipzig University; Max Planck Society; German Research Foundation (DFG); Free University of Berlin; Leipzig University; Max Planck Society	Hirrlinger, J (corresponding author), Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany.	johannes.hirrlinger@medizin.uni-leipzig.de; kirchhoff@em.mpg.de	Kirchhoff, Frank/B-9335-2008; Hirrlinger, Johannes/F-5984-2010; Reichenbach, Andreas/B-2510-2017; Scheller, Anja/B-8577-2018; Wehr, Michael/J-7989-2019	Kirchhoff, Frank/0000-0002-2324-2761; Scheller, Anja/0000-0001-8955-2634; Wehr, Michael/0000-0003-1770-8323; Tang, Wannan/0000-0002-2263-6435; Rossner, Moritz/0000-0002-0667-3420	Max Planck Society; Deutsche Forschungsgemeinschaft; DFG Research Center for Molecular Physiology of the Brain [SPP 1172, SFB636/A4]; INSERM/Max-Planck Society [AMIGO]; VW Stiftung [AZ-1/80 704]; Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); INSERM/Max-Planck Society(Institut National de la Sante et de la Recherche Medicale (Inserm)Max Planck Society); VW Stiftung; Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig	This work was supported by the Max Planck Society (FK), by the Deutsche Forschungsgemeinschaft through the DFG Research Center for Molecular Physiology of the Brain (FK), SPP 1172 (FK, AR, JH), SFB636/A4 (RS), a joint INSERM/Max-Planck Society AMIGO grant (FK), the VW Stiftung (AZ-1/80 704; RS) and by the Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; During Matthew J, 2003, Methods Mol Med, V76, P221; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nolte C, 2001, GLIA, V33, P72; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; Xu YW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm559; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	51	98	101	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4286	10.1371/journal.pone.0004286	http://dx.doi.org/10.1371/journal.pone.0004286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172189	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482900006
J	Tian, L; Gu, LY; Li, GM				Tian, Lei; Gu, Liya; Li, Guo-Min			Distinct Nucleotide Binding/Hydrolysis Properties and Molar Ratio of MutS alpha and MutS beta Determine Their Differential Mismatch Binding Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; REPAIR PROTEIN MUTS; ATPASE ACTIVITY; DNA MISMATCH; HMUTS-ALPHA; RECOGNITION COMPLEX; MOLECULAR SWITCH; HUMAN-CELLS; HYDROLYSIS; SUBUNIT	MutS alpha (MSH2/MSH6) and MutS beta (MSH2/MSH3) are eukaryotic mismatch recognition proteins that preferentially process base-base and small insertion/deletion (ID) mispairs, respectively, despite the fact that cells contain a MutS alpha:MutS beta ratio of 10:1. To explore the mechanism underlying the differential mismatch recognition by these two proteins, purified human alpha MutS and MutS beta were analyzed individually and competitively for their abilities to interact with a T-G and an ID substrate. We show that MutS alpha has K-D values of 26.5 and 38.2 nM for the G-T and ID substrates, respectively, and that MutS beta has K-D values of 76.5 and 23.5 nM for G-T and ID, respectively. Consistent with these results, competitive binding assays revealed the following relative binding affinities: MutS beta-ID > MutS alpha-T-G > MutS alpha-ID >> MutS beta-T-G. Interestingly, binding of MutS beta to ID heteroduplexes is greatly stimulated when the MutS alpha:MutS beta ratio is >= 10. Distinct ATP/ADP binding and ATPase activities of MutS alpha and MutS beta were also observed. In the absence of DNA, ADP binding and ATPase activities of MutS beta are significantly higher than those of MutS alpha. However, interaction with DNA significantly stimulates the MutS alpha ATPase activity and reduces the MutS beta ATPase activity, the consequence being that both proteins exhibit the same level of hydrolytic activity. We conclude that the preferential processing of base-base and ID heteroduplexes by MutS alpha and MutS beta is determined by their significant differences in ATPase activity, ADP binding activity, and high cellular MutS alpha:MutS beta ratio.	[Li, Guo-Min] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [GM072756, CA115942, CA104333]; NATIONAL CANCER INSTITUTE [R01CA104333, R01CA115942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072756 and CA115942 (to G.-M. L.) and CA104333 (to L. G.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Biswas I, 1996, J BIOL CHEM, V271, P5040; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gu LY, 2006, METHOD ENZYMOL, V408, P303, DOI 10.1016/S0076-6879(06)08019-0; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; McCulloch SD, 2003, J BIOL CHEM, V278, P3891, DOI 10.1074/jbc.M210687200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	32	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11557	11562		10.1074/jbc.M900908200	http://dx.doi.org/10.1074/jbc.M900908200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19228687	Green Published, hybrid			2022-12-25	WOS:000265494500059
J	Katzenberger, RJ; Marengo, MS; Wassarman, DA				Katzenberger, Rebeccah J.; Marengo, Matthew S.; Wassarman, David A.			Control of Alternative Splicing by Signal-dependent Degradation of Splicing-regulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CELL-CYCLE PROGRESSION; DNA-DAMAGE; TOPOISOMERASE-I; RADIOSENSITIZING AGENT; TRANSDUCTION PATHWAYS; PROTEOMIC ANALYSIS; RECOGNITION MOTIF; GENE-EXPRESSION; HUMAN GENOME	Alternative pre-mRNA splicing is a major gene expression regulatory mechanism in metazoan organisms. Proteins that bind pre-mRNA elements and control assembly of splicing complexes regulate utilization of pre-mRNA alternative splice sites. To understand how signaling pathways impact this mechanism, an RNA interference screen in Drosophila S2 cells was used to identify proteins that regulate TAF1 (TBP-associated factor 1) alternative splicing in response to activation of the ATR (ATMRAD3-related) signaling pathway by the chemotherapeutic drug camptothecin (CPT). The screen identified 15 proteins that, when knocked down, caused the same change in TAF1 alternative splicing as CPT treatment. However, combined RNA interference and CPT treatment experiments indicated that only a subset of the identified proteins are targets of the CPT-induced signal, suggesting that multiple independent pathways regulate TAF1 alternative splicing. To understand how signals modulate the function of splicing factors, we characterized one of the CPT targets, Tra2 (Transformer-2). CPT was found to down-regulate Tra2 protein levels. CPT-induced Tra2 down-regulation was ATR-dependent and temporally paralleled the change in TAF1 alternative splicing, supporting the conclusion that Tra2 directly regulates TAF1 alternative splicing. Additionally, CPT-induced Tra2 down-regulation occurred independently of new protein synthesis, suggesting a post-translational mechanism. The proteasome inhibitor MG132 reduced CPT-induced Tra2 degradation and TAF1 alternative splicing, and mutation of evolutionarily conserved Tra2 lysine 81, a potential ubiquitin conjugation site, to arginine inhibited CPT-induced Tra2 degradation, supporting a proteasome-dependent alternative splicing mechanism. We conclude that CPT-induced TAF1 alternative splicing occurs through ATR-signaled degradation of a subset of splicing-regulatory proteins.	[Katzenberger, Rebeccah J.; Marengo, Matthew S.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; [Marengo, Matthew S.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	dawassarman@wisc.edu			National Institutes of Health [T32 GM08688]; National Science Foundation [MCB-0614059, MCB-0743403]; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM08688 (to M. S. M.). This work was also supported by National Science Foundation Grants MCB-0614059 and MCB-0743403 (to D. A. W.) and by a predoctoral fellowship from the PhRMA Foundation (to M. S. M.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRAND SF, 1995, GENE, V154, P187, DOI 10.1016/0378-1119(94)00840-O; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chandler DS, 2003, MOL CELL BIOL, V23, P5174, DOI 10.1128/MCB.23.15.5174-5185.2003; Chen BS, 2002, CURR BIOL, V12, pR620, DOI 10.1016/S0960-9822(02)01134-X; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dembla-Rajpal N, 2004, BBA-GENE STRUCT EXPR, V1680, P34, DOI 10.1016/j.bbaexp.2004.08.008; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lai MC, 2003, BIOCHEM J, V371, P937, DOI 10.1042/BJ20021827; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lynch KW, 2007, ADV EXP MED BIOL, V623, P161, DOI 10.1007/978-0-387-77374-2_10; Marengo MS, 2008, RNA, V14, P1681, DOI 10.1261/rna.1048808; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mollet I, 2006, FEBS J, V273, P4807, DOI 10.1111/j.1742-4658.2006.05502.x; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Qi JL, 2006, NUCLEIC ACIDS RES, V34, P6256, DOI 10.1093/nar/gkl755; Saeki K, 2005, AM J PHYSIOL-ENDOC M, V289, pE419, DOI 10.1152/ajpendo.00512.2004; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sciabica KS, 2006, NUCLEIC ACIDS RES, V34, P6612, DOI 10.1093/nar/gkl984; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Solier S, 2004, MOL CANCER RES, V2, P53; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Venables JP, 2004, HUM MOL GENET, V13, P1525, DOI 10.1093/hmg/ddh165; Venables JP, 2005, HUM MOL GENET, V14, P2289, DOI 10.1093/hmg/ddi233; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I	67	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10737	10746		10.1074/jbc.M809506200	http://dx.doi.org/10.1074/jbc.M809506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218244	Green Published, hybrid			2022-12-25	WOS:000265104600048
J	Horak, M; Wenthold, RJ				Horak, Martin; Wenthold, Robert J.			Different Roles of C-terminal Cassettes in the Trafficking of Full-length NR1 Subunits to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; NMDA RECEPTOR SUBUNITS; D-ASPARTATE RECEPTORS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; SPLICE VARIANTS; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; MOTIF	N-Methyl-D-aspartate (NMDA) receptors are glutamategated ion channels composed of NR1 and NR2 subunits. When expressed alone, the most prevalent NR1 splice variant and all NR2 subunits are retained in the endoplasmic reticulum (ER), whereas other NR1 splice variants reach the cell surface to varying degrees. Because similar trafficking patterns have been seen for single transmembrane domain chimeric proteins with appended C termini of NMDA receptor subunits, these chimeric proteins have been used as a model for studying the mechanisms underlying the ER retention and surface trafficking of NMDA receptors. Using this approach, an RRR motif in the C1 cassette has been identified as a major ER retention signal present in NR1 subunits, and the surface localization of other NR1 splice variants has been explained by the absence of the C1 cassette or by the presence of a PDZ/coatomer protein complex II-binding domain in the C2' cassette. However, when we tested these conclusions using full-length NR1 constructs, a more complex role of the C-terminal cassettes in the trafficking of NR1 subunits emerged. Our experiments showed that two independent ER retention motifs in the C1 cassette, KKK and RRR, are the signals mediating ER retention of the full-length NR1 subunits and that the C2 cassette has an additional inhibitory effect on the forward trafficking of NR1 subunits. On the other hand, C0 and C2' cassettes had an enhancing effect on the trafficking of NR1 subunits to the cell surface. Our observations identify the unique roles of C-terminal cassettes in the trafficking of full-length NR1 subunits.	[Horak, Martin; Wenthold, Robert J.] NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Horak, M (corresponding author), NIDCD, Neurochem Lab, NIH, Rm 4146,50 S Dr, Bethesda, MD 20892 USA.	horakm@nidcd.nih.gov	Horak, Martin/A-7297-2010; Horak, Martin/F-9819-2010	Horak, Martin/0000-0002-4359-051X	National Institutes of Health NIDCD Intramural Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	National Institutes of Health NIDCD Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health NIDCD Intramural Program.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Davey F, 2005, J NEUROCHEM, V94, P1243, DOI 10.1111/j.1471-4159.2005.03271.x; Ehlers MD, 1998, J NEUROSCI, V18, P720; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; ISHII T, 1993, J BIOL CHEM, V268, P2836; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin JW, 1998, J NEUROSCI, V18, P2017; Matsuda I, 2000, BIOCHEM BIOPH RES CO, V275, P565, DOI 10.1006/bbrc.2000.3351; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Okabe S, 1999, J NEUROSCI, V19, P7781; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4	29	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9683	9691		10.1074/jbc.M807050200	http://dx.doi.org/10.1074/jbc.M807050200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188369	Green Published, hybrid			2022-12-25	WOS:000264892900008
J	Imtiyaz, HXZ; Zhou, XH; Zhang, HB; Chen, DH; Hu, TS; Zhang, JK				Imtiyaz, Hongxia Z.; Zhou, Xiaohui; Zhang, Haibing; Chen, Dehua; Hu, Taishan; Zhang, Jianke			The Death Domain of FADD Is Essential for Embryogenesis, Lymphocyte Development, and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; HEMATOPOIETIC STEM-CELLS; TNF RECEPTOR; INDUCED APOPTOSIS; MICE LACKING; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; DEFICIENT MICE; CD95 FAS/APO-1; CUTTING EDGE	The Fas-associated death domain-containing protein ( FADD) is an adaptor for relaying apoptotic signals initiated by death receptors such as Fas. Whereas a lack of death receptors has no effect on mouse development, FADD deficiency results in early embryonic lethality, indicating that FADD has additional functions independent of death receptors. We have previously shown that conditional deletion of FADD not only impairs apoptosis but also leads to defective lymphocyte proliferation. The non-apoptotic signaling mediated by FADD remains poorly understood. Earlier studies have suggested that FADD carboxyl terminal serine phosphorylation likely plays a role in FADD-mediated proliferation signaling in T cells. The FADD death domain is presumably only required for apoptotic signaling, as it interacts with death receptors which are dispensable during embryonic development and lymphocyte proliferation. To test this hypothesis, we have performed mutational analyses of the FADD death domain and identified a mutant, R117Q, which lacks binding to Fas and, thus, is incapable of apoptotic signaling in cell lines. Unexpectedly, this death domain point mutation disrupted mouse embryonic development as shown by in vivo functional reconstitution analyses. Interestingly, a second FADD death domain mutant, V121N, retained normal Fas binding and apoptotic signaling ability but also failed to support mouse development. Furthermore, lymphocyte proliferation responses were impaired by V121N. This reverse genetic study has revealed a previously unappreciated role of the FADD death domain, which likely functions as a molecular switch regulating two distinct signals leading to apoptosis and cell proliferation and is critical for embryogenesis, lymphocyte development, and proliferation.	[Imtiyaz, Hongxia Z.; Zhou, Xiaohui; Zhang, Haibing; Chen, Dehua; Hu, Taishan; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, JK (corresponding author), 233 S 10th St,731 BLSB, Philadelphia, PA 19107 USA.	jzhang@mail.jci.tju.edu	Lin, Zongli/L-6084-2019	Zhang, Jianke/0000-0002-5822-2226	National Institutes of Health [RO1 CA95454]; W. W. Smith Charitable Trust; CORNCERN Foundation; Thomas Jefferson University Grants [920011, 910580]; NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; CORNCERN Foundation; Thomas Jefferson University Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA95454 ( NCI). This work was also supported by the W. W. Smith Charitable Trust, CORNCERN Foundation, and Thomas Jefferson University Grants 920011 and 910580 ( to J. Z.).	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CHINNAIYAN AM, 1995, CELL, V81, P512; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; ITOH N, 1993, J BIOL CHEM, V268, P10932; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Peng SL, 1996, J EXP MED, V184, P1149, DOI 10.1084/jem.184.3.1149; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RATHMELL JC, 2002, CELL S, V109, P97; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033; Zhou T, 1996, J IMMUNOL, V156, P2661; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	58	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9917	9926		10.1074/jbc.M900249200	http://dx.doi.org/10.1074/jbc.M900249200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203997	Green Published, hybrid			2022-12-25	WOS:000264892900034
J	Mayerhofer, PU; Cook, JP; Wahlman, J; Pinheiro, TTJ; Moore, KAH; Lord, JM; Johnson, AE; Roberts, LM				Mayerhofer, Peter U.; Cook, Jonathan P.; Wahlman, Judit; Pinheiro, Teresa T. J.; Moore, Katherine A. H.; Lord, J. Michael; Johnson, Arthur E.; Roberts, Lynne M.			Ricin A Chain Insertion into Endoplasmic Reticulum Membranes Is Triggered by a Temperature Increase to 37 degrees C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; TOXIN A1 POLYPEPTIDE; CHOLERA-TOXIN; RETROGRADE TRANSPORT; MISFOLDED GLYCOPROTEINS; PSEUDOMONAS EXOTOXIN; STRUCTURAL-CHANGES; PERTUSSIS TOXIN; TRANSFER-RNA; SHIGA TOXIN	After endocytic uptake by mammalian cells, the heterodimeric plant toxin ricin is transported to the endoplasmic reticulum (ER), where the ricin A chain (RTA) must cross the ER membrane to reach its ribosomal substrates. Here, using gel filtration chromatography, sedimentation, fluorescence, fluorescence resonance energy transfer, and circular dichroism, we show that both fluorescently labeled and unlabeled RTA bind both to ER microsomal membranes and to negatively charged liposomes. The binding of RTA to the membrane at 0-30 degrees C exposes certain RTA residues to the nonpolar lipid core of the bilayer with little change in the secondary structure of the protein. However, major structural rearrangements in RTA occur when the temperature is increased. At 37 degrees C, membrane-bound toxin loses some of its helical content, and its C terminus moves closer to the membrane surface where it inserts into the bilayer. RTA is then stably bound to the membrane because it is nonextractable with carbonate. The sharp temperature dependence of the structural changes does not coincide with a lipid phase change because little change in fluorescence-detected membrane mobility occurred between 30 and 37 degrees C. Instead, the structural rearrangements may precede or initiate toxin retrotranslocation through the ER membrane to the cytosol. The sharp temperature dependence of these changes in RTA further suggests that they occur optimally in mammalian targets of the plant toxin.	[Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Cook, Jonathan P.; Pinheiro, Teresa T. J.; Moore, Katherine A. H.; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Warwick; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, 116 Reynolds Med Bldg, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu; Lynne.Roberts@warwick.ac.uk	Johnson, Arthur E/G-3457-2012; Cook, Jonathan/D-5704-2011	Cook, Jonathan/0000-0003-3690-555X	National Institutes of Health [GM26494]; Wellcome Trust Program [080566Z/06/Z]; Robert A. Welch Foundation Chair [BE-0017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Program(Wellcome Trust); Robert A. Welch Foundation Chair(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26494 (to A. E. J.). This work was also supported by Wellcome Trust Program Grant 080566Z/06/Z (to J. M. L. and L. M. R.) and by Robert A. Welch Foundation Chair Grant BE-0017 (to A. E. J.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; ARGENT RH, 1994, J BIOL CHEM, V269, P26705; Beaumelle B, 1997, J BIOL CHEM, V272, P22097, DOI 10.1074/jbc.272.35.22097; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Carbonetti NH, 1999, INFECT IMMUN, V67, P602, DOI 10.1128/IAI.67.2.602-607.1999; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; Day PJ, 2001, J BIOL CHEM, V276, P7202, DOI 10.1074/jbc.M009499200; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; DEJONGH HHJ, 1992, BIOCHEMISTRY-US, V31, P1636, DOI 10.1021/bi00121a008; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Haugland R.P., 2002, HDB FLUORESCENT PROB; HIGGINS JA, 1977, BIOCHIM BIOPHYS ACTA, V470, P342, DOI 10.1016/0005-2736(77)90126-2; Jackson ME, 1999, J CELL SCI, V112, P467; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; KREITMAN RJ, 1995, BIOCHEM J, V307, P29, DOI 10.1042/bj3070029; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; SIMPSON JC, 1995, EUR J BIOCHEM, V232, P458; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; YE J, 1991, J BIOL CHEM, V266, P23016; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	48	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10232	10242		10.1074/jbc.M808387200	http://dx.doi.org/10.1074/jbc.M808387200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211561	Green Published, hybrid			2022-12-25	WOS:000264892900065
J	Paulusma, CC; de Waart, DR; Kunne, C; Mok, KS; Elferink, RPJO				Paulusma, Coen C.; de Waart, D. Rudi; Kunne, Cindy; Mok, Kam S.; Elferink, Ronald P. J. Oude			Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; LIPID-COMPOSITION; PLASMA-MEMBRANES; ATP8B1 MUTATIONS; INSECT CELLS; HUMAN ABCG2; RAT-LIVER; MICE; EXPRESSION; SECRETION	Mutations in ATP8B1 cause severe inherited liver disease. The disease is characterized by impaired biliary bile salt excretion (cholestasis), but the mechanism whereby impaired ATP8B1 function results in cholestasis is poorly understood. ATP8B1 is a type 4 P-type ATPase and is a flippase for phosphatidylserine. Atp8b1-deficient mice display a dramatic increase in the biliary extraction of cholesterol from the canalicular ( apical) membrane of the hepatocyte. Here we studied the hypothesis that disproportionate cholesterol extraction from the canalicular membrane impairs the activity of the bile salt transporter, ABCB11, and as a consequence causes cholestasis. Using single pass liver perfusions, we show that not only ABCB11-mediated transport but also Abcc2-mediated transport were reduced at least 4-fold in Atp8b1 deficiency. Weshow that canalicular membranes of cholestatic Atp8b1-deficient mice have a dramatically reduced cholesterol to phospholipid ratio, i.e. 0.75 +/- 0.24 versus 2.03 +/- 0.71 for wild type. In vitro depletion of cholesterol from mouse liver plasma membranes using methyl-beta-cyclodextrin demonstrated a near linear relation between cholesterol content of the membranes and ATP-dependent taurocholate transport. Abcc2-mediated transport activity was not affected up to 30% of membrane cholesterol depletion but declined to negligible levels at 70% of membrane cholesterol depletion. These effects were reversible as cholesterol repletion of the liver membranes completely restored Abcb11- and Abcc2-mediated transport. Our data demonstrate that membrane cholesterol content is a critical determinant of ABCB11/ABCC2 transport activity, provide an explanation for the etiology of ATP8B1 disease, and suggest a novel mechanism protecting the canalicular membrane against luminal bile salt overload.	[Paulusma, Coen C.; de Waart, D. Rudi; Kunne, Cindy; Mok, Kam S.; Elferink, Ronald P. J. Oude] Acad Med Ctr, AMC Liver Ctr, NL-1105 BK Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Paulusma, CC (corresponding author), Acad Med Ctr, AMC Liver Ctr, S 1-168,Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	c.c.paulusma@amc.uva.nl	Paulusma, Coen/AAR-7943-2021	Paulusma, Coen/0000-0001-7284-1974				Amigo L, 1999, J LIPID RES, V40, P533; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Waart DR, 2006, LIVER INT, V26, P362, DOI 10.1111/j.1478-3231.2005.01234.x; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Elferink RPJO, 2000, SEMIN LIVER DIS, V20, P293, DOI 10.1055/s-2000-9385; GIMPL G, 1995, BIOCHEMISTRY-US, V34, P13794, DOI 10.1021/bi00042a010; Groen A, 2008, GASTROENTEROLOGY, V134, P2091, DOI 10.1053/j.gastro.2008.02.097; Groen A, 2007, J HEPATOL, V47, P114, DOI 10.1016/j.jhep.2007.02.011; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Kosters A, 2006, J LIPID RES, V47, P1959, DOI 10.1194/jlr.M500511-JLR200; Kurbegov AC, 2003, GASTROENTEROLOGY, V125, P1227, DOI 10.1016/S0016-5085(03)01199-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mazzone A, 2006, HEPATOLOGY, V43, P287, DOI 10.1002/hep.21039; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Nibbering CP, 1999, J MEMBRANE BIOL, V167, P165, DOI 10.1007/s002329900480; Painter JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/sj.ejhg.5201355; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Stapelbroek JM, 2006, HEPATOLOGY, V43, P51, DOI 10.1002/hep.20998; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; van Mil SWC, 2005, J MED GENET, V42, P449, DOI 10.1136/jmg.2004.026187; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1	31	88	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9947	9954		10.1074/jbc.M808667200	http://dx.doi.org/10.1074/jbc.M808667200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228692	hybrid, Green Published			2022-12-25	WOS:000264892900037
J	Ling, F; Yoshida, M; Shibata, T				Ling, Feng; Yoshida, Minoru; Shibata, Takehiko			Heteroduplex Joint Formation Free of Net Topological Change by Mhr1, a Mitochondrial Recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED FRAGMENTS; HUMAN RAD52 PROTEIN; HOMOLOGOUS GENETIC-RECOMBINATION; COLI RECT PROTEIN; ESCHERICHIA-COLI; SUPERHELICAL DNA; CRYSTAL-STRUCTURE; REVERSE GYRASE; YEAST; EXCHANGE	Homologous pairing, an essential process for homologous recombination, is the formation of a heteroduplex joint by an invading single-stranded DNA tail and a complementary sequence within double-strandedDNA(dsDNA). The base rotation of the parental dsDNA, to switch from parental base pairs to heteroduplex ones with the invading single-stranded DNA, sterically requires vertical extension between adjacent base pairs, which inevitably induces untwisting of the dsDNA. RecA is a prototype of the RecA/Rad51/Dmc1 family proteins, which promote ATP-dependent homologous pairing in homologous DNA recombination in vivo, except in mitochondria. As predicted by the requirement for the untwisting, dsDNA bound to RecA is extended and untwisted, and homologous pairing by RecA in vitro is extensively stimulated by the negative supercoils of dsDNA substrates. D-loop formation in negatively super-coiled dsDNA, which serves as an assay for homologous pairing, is also catalyzed in an ATP-independent manner by proteins structurally unrelated to RecA, such as Mhr1. Mhr1 is required for yeast mitochondrial DNA recombination instead of RecA family proteins. Inconsistent with the topological requirements, tests for the effects of negative supercoils revealed that Mhr1 catalyzes homologous pairing with relaxed closed circular dsDNA much more efficiently than with negatively supercoiled dsDNA. Topological analyses indicated that neither the process nor the products of homologous pairing by Mhr1 involve a net topological change of closed circular dsDNA. This would be favorable for homologous recombination in mitochondria, where dsDNA is unlikely to be under topological stress toward unwinding. We propose a novel topological mechanism wherein Mhr1 induces untwisting without net topological change.	[Ling, Feng; Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Shibata, Takehiko] RIKEN, Adv Sci Inst, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Ling, F (corresponding author), RIKEN, Adv Sci Inst, Chem Genet Lab, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	ling@postman.riken.go.jp; tshibata@postman.riken.go.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	Bioarchitect Research Program of RIKEN; Life Science Foundation of Japan; Japan Society for the Promotion of Science [18570168, 20570171, 19370004]	Bioarchitect Research Program of RIKEN; Life Science Foundation of Japan(Life Science Foundation of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Bioarchitect Research Program of RIKEN (to F.L. and M.Y.), a grant from the Life Science Foundation of Japan (to F.L.), Grants-in-Aid for Scientific Research (C) 18570168 and 20570171 from the Japan Society for the Promotion of Science (to F.L.), Grant-in-Aid (B) 19370004 from the Japan Society for the Promotion of Science (to T.S.), and a grant from the RIKEN Strategic Research Program (to F.L.).	BEATTIE KL, 1977, J MOL BIOL, V116, P783, DOI 10.1016/0022-2836(77)90271-6; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; HALL SD, 1993, J BACTERIOL, V175, P277, DOI 10.1128/JB.175.1.277-287.1993; HOLLOMAN WK, 1975, P NATL ACAD SCI USA, V72, P2394, DOI 10.1073/pnas.72.6.2394; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KOCHOYAN M, 1987, J MOL BIOL, V196, P599, DOI 10.1016/0022-2836(87)90036-2; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2004, MOL BIOL CELL, V15, P310, DOI 10.1091/mbc.E03-07-0508; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MUNIYAPPA K, 1986, J BIOL CHEM, V261, P7472; NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1982, J BIOL CHEM, V257, P3981; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vlieghe D, 1996, SCIENCE, V273, P1702, DOI 10.1126/science.273.5282.1702; WU AM, 1982, CELL, V30, P37, DOI 10.1016/0092-8674(82)90009-5; Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9341	9353		10.1074/jbc.M900023200	http://dx.doi.org/10.1074/jbc.M900023200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193646	Green Published, hybrid			2022-12-25	WOS:000264669100040
J	Perera, F; Tang, WY; Herbstman, J; Tang, DL; Levin, L; Miller, R; Ho, SM				Perera, Frederica; Tang, Wan-yee; Herbstman, Julie; Tang, Deliang; Levin, Linda; Miller, Rachel; Ho, Shuk-mei			Relation of DNA Methylation of 5 '-CpG Island of ACSL3 to Transplacental Exposure to Airborne Polycyclic Aromatic Hydrocarbons and Childhood Asthma	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; PROSTATE CARCINOGENESIS; RESPIRATORY SYMPTOMS; BREAST-MILK; FATTY-ACIDS; HIGH-RISK; GENE; BIRTH; IDENTIFICATION; TRANSCRIPTION	In a longitudinal cohort of similar to 700 children in New York City, the prevalence of asthma (>25%) is among the highest in the US. This high risk may in part be caused by transplacental exposure to traffic-related polycyclic aromatic hydrocarbons (PAHs) but biomarkers informative of PAH-asthma relationships is lacking. We here hypothesized that epigenetic marks associated with transplacental PAH exposure and/or childhood asthma risk could be identified in fetal tissues. Mothers completed personal prenatal air monitoring for PAH exposure determination. Methylation sensitive restriction fingerprinting was used to analyze umbilical cord white blood cell (UCWBC) DNA of 20 cohort children. Over 30 DNA sequences were identified whose methylation status was dependent on the level of maternal PAH exposure. Six sequences were found to be homologous to known genes having one or more 5'-CpG island(s) (5'-CGI). Of these, acyl-CoA synthetase long-chain family member 3 (ACSL3) exhibited the highest concordance between the extent of methylation of its 5'-CGI in UCWBCs and the level of gene expression in matched fetal placental tissues in the initial 20 cohort children. ACSL3 was therefore chosen for further investigation in a larger sample of 56 cohort children. Methylation of the ACSL3 5'-CGI was found to be significantly associated with maternal airborne PAH exposure exceeding 2.41 ng/m(3) (OR = 13.8; p<0.001; sensitivity = 75%; specificity = 82%) and with a parental report of asthma symptoms in children prior to age 5 (OR = 3.9; p<0.05). Thus, if validated, methylated ACSL3 5'CGI in UCWBC DNA may be a surrogate endpoint for transplacental PAH exposure and/or a potential biomarker for environmentally-related asthma. This exploratory report provides a new blueprint for the discovery of epigenetic biomarkers relevant to other exposure assessments and/or investigations of exposure-disease relationships in birth cohorts. The results support the emerging theory of early origins of later life disease development.	[Perera, Frederica; Herbstman, Julie; Tang, Deliang; Miller, Rachel] Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10027 USA; [Tang, Wan-yee; Levin, Linda; Ho, Shuk-mei] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ho, Shuk-mei] Univ Cincinnati, Ctr Environm Genet, Cincinnati, OH 45221 USA; [Ho, Shuk-mei] Univ Cincinnati, Coll Med, Canc Ctr, Cincinnati, OH 45221 USA; [Miller, Rachel] Columbia Univ, Coll Phys & Surgeons, Div Pulmonary Allergy & Critical Care Med, New York, NY 10027 USA	Columbia University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Columbia University	Perera, F (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10027 USA.	shuk-mei.ho@uc.edu		Tang, Wan-Yee/0000-0002-0663-9820	National Institutes of Health [ES009600, ES008977, ES015905, ES013071, ES015584, ES006096, ES016817]; Department of Defense [DAMD W81XWH-06-1-0373]; U.S. Environmental Protection Agency [RD-832141]; New York Community Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015905, K99ES016817, R21ES013071, P30ES006096, R01ES015584, R01ES013163, P50ES009600, P01ES009600, R01ES008977, R00ES016817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); U.S. Environmental Protection Agency(United States Environmental Protection Agency); New York Community Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is in part supported by National Institutes of Health grants: ES009600 (FP), ES008977 (FP), ES015905 (FP, SMH, RM, DT), ES013071 (SMH), ES015584 (SMH), and ES006096 (SMH), ES016817 (WYT), the Department of Defense award DAMD W81XWH-06-1-0373 (WYT), the U.S. Environmental Protection Agency award RD-832141(FP), and the New York Community Trust (FP,RM, DT, JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Beck M, 2000, ACTA PAEDIATR, V89, P279, DOI 10.1080/080352500750028401; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAS DK, 1982, LUNG, V160, P207, DOI 10.1007/BF02719294; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Gyorffy E, 2008, MUTAGENESIS, V23, P1, DOI 10.1093/mutage/gem043; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilakivi-Clarke L, 2006, TRENDS ENDOCRIN MET, V17, P340, DOI 10.1016/j.tem.2006.09.002; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Huang THM, 1997, CANCER RES, V57, P1030; Jedrychowski W, 2005, EUR J EPIDEMIOL, V20, P775, DOI 10.1007/s10654-005-1048-1; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Kuzmin A, 2008, GENE EXPR PATTERNS, V8, P107, DOI 10.1016/j.modgep.2007.09.005; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Li SF, 2003, ANN NY ACAD SCI, V983, P161, DOI 10.1111/j.1749-6632.2003.tb05971.x; Liu J, 2008, TOXICOL SCI, V102, P76, DOI 10.1093/toxsci/kfm290; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Miller RL, 2008, AM J RESP CRIT CARE, V177, P567, DOI 10.1164/rccm.200710-1511PP; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Minekura H, 2001, GENE, V278, P185, DOI 10.1016/S0378-1119(01)00714-4; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Nicholas SW, 2005, AM J PUBLIC HEALTH, V95, P245, DOI 10.2105/AJPH.2004.042705; Oddy WH, 2006, PEDIAT ALLERG IMM-UK, V17, P4, DOI 10.1111/j.1399-3038.2005.00340.x; Padmanabhan V, 2007, REV ENDOCR METAB DIS, V8, P67, DOI 10.1007/s11154-007-9051-3; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Selgrade MK, 2006, ENVIRON HEALTH PERSP, V114, P615, DOI 10.1289/ehp.8376; Stock W, 2000, LANCET, V355, P1351, DOI 10.1016/S0140-6736(00)02125-5; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; TANG WY, 2008, ENDOCRINOLOGY   0731; Tomita Michiyo, 2004, Lipids Health Dis, V3, P1, DOI 10.1186/1476-511X-3-1; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Weber P, 2001, BRIT J NUTR, V86, pS93, DOI 10.1079/BJN2001344; Wijga A, 2003, PEDIAT ALLERG IMM-UK, V14, P156, DOI 10.1034/j.1399-3038.2003.00022.x; Woods RK, 2004, THORAX, V59, P105, DOI 10.1136/thorax.2003.009498; Wu MC, 2004, ONCOGENE, V23, P250, DOI 10.1038/sj.onc.1207076	51	308	320	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4488	10.1371/journal.pone.0004488	http://dx.doi.org/10.1371/journal.pone.0004488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221603	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485700013
J	Vidarsson, H; Westergren, R; Heglind, M; Blomqvist, SR; Breton, S; Enerback, S				Vidarsson, Hilmar; Westergren, Rickard; Heglind, Mikael; Blomqvist, Sandra Rodrigo; Breton, Sylvie; Enerback, Sven			The Forkhead Transcription Factor Foxi1 Is a Master Regulator of Vacuolar H+-ATPase Proton Pump Subunits in the Inner Ear, Kidney and Epididymis	PLOS ONE			English	Article								The vacuolar H+-ATPase dependent transport of protons across cytoplasmic membranes in FORE (forkhead related) cells ofendolymphatic epithelium in the inner ear, intercalated cells of collecting ducts in the kidney and in narrow and clear cells of epididymis require expression of several subunits that assemble into a functional multimeric proton pump. We demonstrate that expression of four such subunits A1, B1, E2 and a4 all co-localize with the forkhead transcription factor Foxi1 in a subset of epithelial cells at these three locations. In cells, of such epithelia, that lack Foxi1 we fail to identify any expression of A1, B1, E2 and a4 demonstrating an important role for the transcription factor Foxi1 in regulating subunit availability. Promoter reporter experiments, electrophoretic mobility shift assays (EMSA) and site directed mutagenesis demonstrate that a Foxi1 expression vector can trans-activate an a4-promoter reporter construct in a dose dependent manner. Furthermore, we demonstrate using chromatin immunoprecipitation (ChIP) assays that Foxi1-dependent activation to a large extent depends on cis-elements at position -561/-547 in the a4 promoter. Thus, we provide evidence that Foxi1 is necessary for expression of at least four subunits in three different epithelia and most likely is a major determinant for proper assembly of a functional vacuolar H+-ATPase complex at these locations.	[Vidarsson, Hilmar; Westergren, Rickard; Heglind, Mikael; Blomqvist, Sandra Rodrigo; Enerback, Sven] Univ Gothenburg, Ctr Med Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Breton, Sylvie] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nephrol Div, Ctr Syst Biol, Program Membrane Biol, Boston, MA USA	University of Gothenburg; Harvard University; Harvard Medical School; Massachusetts General Hospital	Vidarsson, H (corresponding author), Univ Gothenburg, Ctr Med Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	sven.enerback@medgen.gu.se			Swedish Research Council [K2005-32BI-15324-01A]; EU [QLK3-CT-2002-02149, LSHM-CT-2003-503041]; The Arne and IngaBritt Foundation; The Soderberg Foundation; NIH [HD040793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); The Arne and IngaBritt Foundation; The Soderberg Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SE's laboratory is supported from the Swedish Research Council (grant K2005-32BI-15324-01A), EU grants (QLK3-CT-2002-02149) and (LSHM-CT-2003-503041), The Arne and IngaBritt Foundation and The Soderberg Foundation. SB's laboratory is supported by NIH grant HD040793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314	20	91	93	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4471	10.1371/journal.pone.0004471	http://dx.doi.org/10.1371/journal.pone.0004471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214237	Green Submitted, gold, Green Published			2022-12-25	WOS:000265484300010
J	Komarova, NL; Katouli, AA; Wodarz, D				Komarova, Natalia L.; Katouli, Allen A.; Wodarz, Dominik			Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia	PLOS ONE			English	Article								Chronic myeloid leukemia (CML) is a cancer of the hematopoietic system and has been treated with the drug Imatinib relatively successfully. Drug resistance, acquired by mutations, is an obstacle to success. Two additional drugs are now considered and could be combined with Imatinib to prevent resistance, Dasatinib and Nilotinib. While most mutations conferring resistance to one drug do not confer resistance to the other drugs, there is one mutation (T315I) that induces resistance against all three drugs. Using computational methods, the combination of two drugs is found to increase the probability of treatment success despite this cross-resistance. Combining more than two drugs, however, does not provide further advantages. We also explore possible combination therapies using drugs currently under development. We conclude that among the targeted drugs currently available for the treamtent of CML, only the two most effective ones should be used in combination for the prevention of drug resistance.	[Komarova, Natalia L.; Katouli, Allen A.; Wodarz, Dominik] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [R01 CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded in part by NIH grant R01 CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Burley SK, 2005, BLOOD, V106, p206A, DOI 10.1182/blood.V106.11.698.698; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; COLDMAN AJ, 1983, MATH BIOSCI, V65, P291, DOI 10.1016/0025-5564(83)90066-4; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Daley GQ, 2003, SEMIN HEMATOL, V40, P11, DOI 10.1053/shem.2003.50035; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Duncan EA, 2008, MOL CANCER THER, V7, P391, DOI 10.1158/1535-7163.MCT-07-0305; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; GOLDIE JH, 1998, DRUG RESISTANCE CANC; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; O'Dwyer ME, 2002, ANNU REV MED, V53, P369, DOI 10.1146/annurev.med.53.082901.103853; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788	34	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4423	10.1371/journal.pone.0004423	http://dx.doi.org/10.1371/journal.pone.0004423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204794	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484000012
J	Morse, AM; Peterson, DG; Islam-Faridi, MN; Smith, KE; Magbanua, Z; Garcia, SA; Kubisiak, TL; Amerson, HV; Carlson, JE; Nelson, CD; Davis, JM				Morse, Alison M.; Peterson, Daniel G.; Islam-Faridi, M. Nurul; Smith, Katherine E.; Magbanua, Zenaida; Garcia, Saul A.; Kubisiak, Thomas L.; Amerson, Henry V.; Carlson, John E.; Nelson, C. Dana; Davis, John M.			Evolution of Genome Size and Complexity in Pinus	PLOS ONE			English	Article							GYPSY-LIKE RETROTRANSPOSON; LOBLOLLY-PINE; CENTROMERIC REGION; DNA CONTENT; GENE; MAIZE; ARABIDOPSIS; SEQUENCES; ORGANIZATION; POPULATIONS	Background: Genome evolution in the gymnosperm lineage of seed plants has given rise to many of the most complex and largest plant genomes, however the elements involved are poorly understood. Methodology/Principal Findings: Gymny is a previously undescribed retrotransposon family in Pinus that is related to Athila elements in Arabidopsis. Gymny elements are dispersed throughout the modern Pinus genome and occupy a physical space at least the size of the Arabidopsis thaliana genome. In contrast to previously described retroelements in Pinus, the Gymny family was amplified or introduced after the divergence of pine and spruce ( Picea). If retrotransposon expansions are responsible for genome size differences within the Pinaceae, as they are in angiosperms, then they have yet to be identified. In contrast, molecular divergence of Gymny retrotransposons together with other families of retrotransposons can account for the large genome complexity of pines along with protein-coding genic DNA, as revealed by massively parallel DNA sequence analysis of Cot fractionated genomic DNA. Conclusions/Significance: Most of the enormous genome complexity of pines can be explained by divergence of retrotransposons, however the elements responsible for genome size variation are yet to be identified. Genomic resources for Pinus including those reported here should assist in further defining whether and how the roles of retrotransposons differ in the evolution of angiosperm and gymnosperm genomes.	[Morse, Alison M.; Davis, John M.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Peterson, Daniel G.; Magbanua, Zenaida] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS USA; [Islam-Faridi, M. Nurul; Smith, Katherine E.; Kubisiak, Thomas L.; Nelson, C. Dana] USDA Forest Serv So Res Stn, Saucier, MS USA; [Garcia, Saul A.; Amerson, Henry V.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA; [Carlson, John E.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA	State University System of Florida; University of Florida; Mississippi State University; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Morse, AM (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	jmdavis@ufl.edu		Davis, John/0000-0002-8522-5406; Peterson, Daniel/0000-0002-0274-5968	USDA Forest Service-Southern Research Station [SRS 00-CA-11330126-016]; NSF [DBI-0421717]; USDA-CSREES [2006-34506-17290]	USDA Forest Service-Southern Research Station(United States Department of Agriculture (USDA)United States Forest Service); NSF(National Science Foundation (NSF)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the USDA Forest Service-Southern Research Station (Agreement SRS 00-CA-11330126-016 to JMD and AMM), NSF DBI-0421717 (to DGP, CDN and MNI-F) and USDA-CSREES 2006-34506-17290 (to DGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1998, GENES GENET SYST, V73, P243, DOI 10.1266/ggs.73.243; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Auckland LD, 2001, CAN J BOT, V79, P1375, DOI 10.1139/cjb-79-11-1375; Belyayev A, 2005, CYTOGENET GENOME RES, V109, P43, DOI 10.1159/000082380; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bennett MD, 2004, PLANT DNA C VALUES D; Bennetzen JL, 1998, CURR OPIN PLANT BIOL, V1, P103, DOI 10.1016/S1369-5266(98)80010-1; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Cai Q, 2006, ANN BOT-LONDON, V97, P715, DOI 10.1093/aob/mcl030; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dvorak WS, 2000, NEW FOREST, V20, P163, DOI 10.1023/A:1006763120982; Elsik CG, 2000, MOL GEN GENET, V264, P47, DOI 10.1007/s004380000279; Friesen N, 2001, MOL BIOL EVOL, V18, P1176, DOI 10.1093/oxfordjournals.molbev.a003905; Fuchs J, 2008, CHROMOSOME RES, V16, P891, DOI 10.1007/s10577-008-1252-4; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2008, PLANT SCI, V174, P557, DOI 10.1016/j.plantsci.2008.03.015; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; Islam-Faridi MN, 2007, GENOME, V50, P241, DOI 10.1139/G06-153; Jewell David C., 1994, P484; Joyner KL, 2001, CAN J BOT, V79, P192, DOI 10.1139/cjb-79-2-192; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kamm A, 1996, P NATL ACAD SCI USA, V93, P2708, DOI 10.1073/pnas.93.7.2708; Kinlaw CS, 1997, TRENDS PLANT SCI, V2, P356, DOI 10.1016/S1360-1385(97)84624-9; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kumekawa N, 2000, DNA RES, V7, P315, DOI 10.1093/dnares/7.6.315; Liu RY, 2007, P NATL ACAD SCI USA, V104, P11844, DOI 10.1073/pnas.0704258104; Lorenz WW, 2002, TREE PHYSIOL, V22, P301, DOI 10.1093/treephys/22.5.301; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McKeand S, 2003, J FOREST, V101, P32; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Millar Constance L., 1998, P69; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; MURRAY MG, 1981, J MOL EVOL, V17, P31, DOI 10.1007/BF01792422; OHRI D, 1986, PLANT SYST EVOL, V153, P119, DOI 10.1007/BF00989421; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Paterson AH, 2006, NAT REV GENET, V7, P174, DOI 10.1038/nrg1806; Pereira V, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r79; Peterson DG, 2002, TRENDS GENET, V18, P547, DOI 10.1016/S0168-9525(02)02764-6; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; PRICE RA, 1989, ECOLOGY BIOGEOGRAPHY, P49; RAKE AV, 1980, CAN J GENET CYTOL, V22, P69, DOI 10.1139/g80-010; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Santini S, 2002, CHROMOSOMA, V111, P192, DOI 10.1007/s00412-002-0196-2; Schmidt A, 2000, THEOR APPL GENET, V101, P7, DOI 10.1007/s001220051442; Shibata F, 2004, J CELL SCI, V117, P2963, DOI 10.1242/jcs.01144; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VARMUS H, 1989, MOBILE DNA, P53; VOYTAS DF, 1988, NATURE, V336, P242, DOI 10.1038/336242a0; Voytas DF, 1996, SCIENCE, V274, P737, DOI 10.1126/science.274.5288.737; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Walbot V, 2001, P NATL ACAD SCI USA, V98, P8163, DOI 10.1073/pnas.161278798; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wilcox PL, 1996, P NATL ACAD SCI USA, V93, P3859, DOI 10.1073/pnas.93.9.3859; Williams CG, 2002, BIOL J LINN SOC, V75, P503, DOI 10.1046/j.1095-8312.2002.00038.x; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yuan YN, 2003, PLANT J, V34, P249, DOI 10.1046/j.1365-313X.2003.01716.x; YUE X, 1988, MOL BIOL EVOL, V5, P675; ZIMMER EA, 1988, GENETICS, V120, P1125; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	74	118	122	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4332	10.1371/journal.pone.0004332	http://dx.doi.org/10.1371/journal.pone.0004332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194510	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483600001
J	Touma, C; Fenzl, T; Ruschel, J; Palme, R; Holsboer, F; Kimura, M; Landgraf, R				Touma, Chadi; Fenzl, Thomas; Ruschel, Joerg; Palme, Rupert; Holsboer, Florian; Kimura, Mayumi; Landgraf, Rainer			Rhythmicity in Mice Selected for Extremes in Stress Reactivity: Behavioural, Endocrine and Sleep Changes Resembling Endophenotypes of Major Depression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL SYSTEM; SLOW-WAVE ACTIVITY; ATYPICAL DEPRESSION; GROWTH-HORMONE; HPA AXIS; CORTICOSTERONE; CORTISOL; BRAIN; CRH	Background: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, including hyper- or hypo-activity of the stress hormone system, plays a critical role in the pathophysiology of mood disorders such as major depression (MD). Further biological hallmarks of MD are disturbances in circadian rhythms and sleep architecture. Applying a translational approach, an animal model has recently been developed, focusing on the deviation in sensitivity to stressful encounters. This so-called 'stress reactivity' (SR) mouse model consists of three separate breeding lines selected for either high (HR), intermediate (IR), or low (LR) corticosterone increase in response to stressors. Methodology/Principle Findings: In order to contribute to the validation of the SR mouse model, our study combined the analysis of behavioural and HPA axis rhythmicity with sleep-EEG recordings in the HR/IR/LR mouse lines. We found that hyper-responsiveness to stressors was associated with psychomotor alterations (increased locomotor activity and exploration towards the end of the resting period), resembling symptoms like restlessness, sleep continuity disturbances and early awakenings that are commonly observed in melancholic depression. Additionally, HR mice also showed neuroendocrine abnormalities similar to symptoms of MD patients such as reduced amplitude of the circadian glucocorticoid rhythm and elevated trough levels. The sleep-EEG analyses, furthermore, revealed changes in rapid eye movement (REM) and non-REM sleep as well as slow wave activity, indicative of reduced sleep efficacy and REM sleep disinhibition in HR mice. Conclusion/Significance: Thus, we could show that by selectively breeding mice for extremes in stress reactivity, clinically relevant endophenotypes of MD can be modelled. Given the importance of rhythmicity and sleep disturbances as biomarkers of MD, both animal and clinical studies on the interaction of behavioural, neuroendocrine and sleep parameters may reveal molecular pathways that ultimately lead to the discovery of new targets for antidepressant drugs tailored to match specific pathologies within MD.	[Touma, Chadi; Fenzl, Thomas; Ruschel, Joerg; Holsboer, Florian; Kimura, Mayumi; Landgraf, Rainer] Max Planck Inst Psychiat, Munich, Germany; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria	Max Planck Society; University of Veterinary Medicine Vienna	Touma, C (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	touma@mpipsykl.mpg.de	Touma, Chadi/G-4677-2011; Yan, Shuo/B-8381-2009; Palme, Rupert/A-3499-2008	Palme, Rupert/0000-0001-9466-3662	Max Planck Society (MPS)	Max Planck Society (MPS)(Max Planck Society)	Funding for this study was provided by the Max Planck Society (MPS). The MPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2002, J AFFECT DISORDERS, V72, P125, DOI 10.1016/S0165-0327(02)00169-6; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Antonijevic I, 2008, STRESS, V11, P15, DOI 10.1080/10253890701378967; Armitage R, 2000, PSYCHIAT RES, V95, P201, DOI 10.1016/S0165-1781(00)00178-5; Armitage R., 1997, CURRENT REV MOOD ANX, V1, P139; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buysse DJ, 1997, BIOL PSYCHIAT, V41, P406, DOI 10.1016/S0006-3223(96)00041-8; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chang FC, 1998, AM J PHYSIOL-REG I, V275, pR793, DOI 10.1152/ajpregu.1998.275.3.R793; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Fenzl T, 2007, J NEUROSCI METH, V166, P229, DOI 10.1016/j.jneumeth.2007.07.007; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gonzalez MMD, 1998, BEHAV PHARMACOL, V9, P655, DOI 10.1097/00008877-199812000-00001; Gonzalez MMD, 1997, J SLEEP RES, V6, P164; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hartmann A, 1997, NEUROBIOL AGING, V18, P285, DOI 10.1016/S0197-4580(97)80309-0; Hasler G, 2004, PSYCHOL MED, V34, P1047, DOI 10.1017/S0033291703001697; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 2008, NAT REV NEUROSCI, V9, P638, DOI 10.1038/nrn2453; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kimura M, 2006, J SLEEP RES, V15, P101; Kleitman N., 1963, SLEEP WAKEFULNESS; Kriegsfeld LJ, 2006, HORM BEHAV, V49, P557, DOI 10.1016/j.yhbeh.2005.12.011; KUPFER DJ, 1995, BIOL PSYCHIAT, V38, P391, DOI 10.1016/0006-3223(94)00295-E; KUPFER DJ, 1976, BIOL PSYCHIAT, V11, P159; Lepschy M, 2007, LAB ANIM-UK, V41, P372, DOI 10.1258/002367707781282730; Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Modell Sieglinde, 2007, Curr Psychiatry Rep, V9, P480, DOI 10.1007/s11920-007-0065-z; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; QUITKIN FM, 1985, J AFFECT DISORDERS, V8, P61, DOI 10.1016/0165-0327(85)90073-4; Rechtschaffen A., 1968, MANUAL STANDARDIZED; REYNOLDS CF, 1987, SLEEP, V10, P199, DOI 10.1093/sleep/10.3.199; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V16, P461; SACHAR EJ, 1973, ARCH GEN PSYCHIAT, V28, P19; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V17, P554; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shaffery J, 2003, NEUROSCIENTIST, V9, P82, DOI 10.1177/1073858402239594; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Steiger A, 2002, SLEEP MED REV, V6, P125, DOI 10.1053/smrv.2001.0159; STEIGER A, 1994, J PSYCHIAT RES, V28, P225, DOI 10.1016/0022-3956(94)90008-6; Steiger A, 2007, J PSYCHIATR RES, V41, P537, DOI 10.1016/j.jpsychires.2006.04.007; Stone EA, 2008, NEUROSCI BIOBEHAV R, V32, P508, DOI 10.1016/j.neubiorev.2007.08.007; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Thomson F, 2008, NEUROCHEM RES, V33, P691, DOI 10.1007/s11064-007-9518-3; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Voigtlander T, 2006, EUR J NEUROSCI, V23, P2723, DOI 10.1111/j.1460-9568.2006.04801.x; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Yassouridis A, 1999, J SLEEP RES, V8, P25, DOI 10.1046/j.1365-2869.1999.00133.x; [No title captured]; [No title captured]; [No title captured]	78	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4325	10.1371/journal.pone.0004325	http://dx.doi.org/10.1371/journal.pone.0004325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JH	19177162	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483100008
J	Kravchenko-Balasha, N; Mizrachy-Schwartz, S; Klein, S; Levitzki, A				Kravchenko-Balasha, Nataly; Mizrachy-Schwartz, Sarit; Klein, Shoshana; Levitzki, Alexander			Shift from Apoptotic to Necrotic Cell Death during Human Papillomavirus-induced Transformation of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CISPLATIN-INDUCED APOPTOSIS; GENE-EXPRESSION; CERVICAL-CANCER; ERK ACTIVATION; DNA-DAMAGE; NECROSIS; TYPE-16; DIFFERENTIATION; FORM	Oncogenic transformation is a complex, multistep process, which goes through several stages before complete malignant transformation occurs. To identify early processes in carcinogenesis, we used an in vitro model, based on the initiating event in cervical cancer, papillomavirus transformation of keratinocytes. We compared gene expression in primary keratinocytes (K) and papillomavirus-transformed keratinocytes from early (E) and late (L) passages and from benzo[a] pyrene-treated L cells (BP). The transformed cells exhibit similar transcriptional changes to clinical cervical carcinoma. The number of transcripts expressed progressively decreased during the evolution from K to BP cells. Bioinformatic analysis, validated by detailed biochemical analysis, revealed substantial contraction of both pro-and antiapoptotic networks during transformation. Nonetheless, L and BP cells were not resistant to apoptotic stimuli. At doses of cisplatin that led to 30-60% apoptosis of K and E cells, transformed L and BP cells underwent 80% necrotic cell death, which became the default response to genotoxic stress. Moreover, appreciable necrotic fractions were observed in the cervical carcinoma cell line, HeLa, in response to comparable doses of cisplatin. The shrinkage of biochemical networks, including the apoptotic network, may allow a cancer cell to economize on energy usage to facilitate enhanced proliferation but leaves it vulnerable to stress. This study supports the hypothesis that the process of cancer transformation may be accompanied by a shift from apoptosis to necrosis.	[Kravchenko-Balasha, Nataly; Mizrachy-Schwartz, Sarit; Klein, Shoshana; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Safra Campus, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Israel's Ministry of Science and Technology (MOST)	This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science and Technology (MOST).	Ahn WS, 2004, INT J GYNECOL CANCER, V14, P475, DOI 10.1111/j.1048-891x.2004.14308.x; Arechaga-Ocampo E, 2008, GYNECOL ONCOL, V108, P10, DOI 10.1016/j.ygyno.2007.08.070; Bae Su Mi, 2003, Cancer Res Treat, V35, P549, DOI 10.4143/crt.2003.35.6.549; Baldus SE, 2005, ONCOGENE, V24, P810, DOI 10.1038/sj.onc.1208235; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; BARBOSA MS, 1989, ONCOGENE, V4, P1529; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; DURST M, 1987, ONCOGENE, V1, P251; DURST M, 1991, J VIROL, V65, P796; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Geiger T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000605; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; MITRANIROSENBAUM S, 1992, INTERVIROLOGY, V33, P76, DOI 10.1159/000150234; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; MONTGOMERY KD, 1995, GENE CHROMOSOME CANC, V14, P97, DOI 10.1002/gcc.2870140203; Okada M, 2004, BLOOD, V103, P2299, DOI 10.1182/blood-2003-05-1605; PIRISI L, 1988, CARCINOGENESIS, V9, P1573, DOI 10.1093/carcin/9.9.1573; POLAKOWSKA RR, 1994, DEV DYNAM, V199, P176, DOI 10.1002/aja.1001990303; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Sanchez-Perez I, 2002, MOL BIOL CELL, V13, P2933, DOI 10.1091/mbc.E02-01-0022; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheridan MT, 2001, INT J RADIAT ONCOL, V50, P503, DOI 10.1016/S0360-3016(01)01496-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Szabo C, 2005, CRIT CARE MED, V33, pS530, DOI 10.1097/01.CCM.0000187002.88999.CF; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WOODWORTH CD, 1988, CANCER RES, V48, P4620; Yeh PY, 2002, BIOCHEM PHARMACOL, V63, P1423, DOI 10.1016/S0006-2952(02)00908-5; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	52	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11717	11727		10.1074/jbc.M900217200	http://dx.doi.org/10.1074/jbc.M900217200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221178	Green Published, hybrid			2022-12-25	WOS:000265494500074
J	Lai, J; Bernhard, OK; Turville, SG; Harman, AN; Wilkinson, J; Cunningham, AL				Lai, Joey; Bernhard, Oliver K.; Turville, Stuart G.; Harman, Andrew N.; Wilkinson, John; Cunningham, Anthony L.			Oligomerization of the Macrophage Mannose Receptor Enhances gp120-mediated Binding of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CARBOHYDRATE-RECOGNITION DOMAINS; HUMAN DENDRITIC CELLS; CYSTEINE-RICH DOMAIN; C-TYPE LECTIN; DC-SIGN; MASS-SPECTROMETRY; LIGAND-BINDING; IN-VITRO; INFECTION	C-type lectin receptors expressed on the surface of dendritic cells and macrophages are able to bind glycoproteins of microbial pathogens via mannose, fucose, and N-acetylglucosamine. Langerin on Langerhans cells, dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin on dendritic cells, and mannose receptor (MR) on dendritic cells and macrophages bind the human immunodeficiency virus (HIV) envelope protein gp120 principally via high mannose oligosaccharides. These C-type lectin receptors can also oligomerize to facilitate enhanced ligand binding. This study examined the effect of oligomerization of MR on its ability to bind to mannan, monomeric gp120, native trimeric gp140, and HIV type 1 BaL. Mass spectrometry analysis of crosslinked MR showed homodimerization on the surface of primary monocyte-derived dendritic cells and macrophages. Both monomeric and dimeric MR were precipitated by mannan, but only the dimeric form was co-immunoprecipitated by gp120. These results were confirmed independently by flow cytometry analysis of soluble monomeric and trimeric HIV envelope and a cellular HIV virion capture assay. As expected, mannan bound to the carbohydrate recognition domains of MR dimers mostly in a calcium-dependent fashion. Unexpectedly, gp120-mediated binding of HIV to dimers on MR-transfected Rat-6 cells and macrophages was not calcium-dependent, was only partially blocked by mannan, and was also partially inhibited by N-acetylgalactosamine 4-sulfate. Thus gp120-mediated HIV binding occurs via the calcium-dependent, non-calcium-dependent carbohydrate recognition domains and the cysteine-rich domain at the C terminus of MR dimers, presenting a much broader target for potential inhibitors of gp120-MR binding.	[Lai, Joey; Turville, Stuart G.; Harman, Andrew N.; Wilkinson, John; Cunningham, Anthony L.] Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia; [Bernhard, Oliver K.] Ludwig Inst Canc Res, Joint Prote Lab, Melbourne, Vic 3050, Australia	University of Sydney; Westmead Institute for Medical Research; Ludwig Institute for Cancer Research	Cunningham, AL (corresponding author), Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia.	tony_cunningham@wmi.usyd.edu.au	Cunningham, Tony L/B-7011-2013; Harman, Andrew N/K-5256-2012	Cunningham, Tony L/0000-0002-6744-5667; Harman, Andrew N/0000-0003-1535-1279; Turville, Stuart/0000-0003-1918-5343; wilkinson, john/0000-0001-8728-4146				BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Bernhard OK, 2004, BIOCHEMISTRY-US, V43, P256, DOI 10.1021/bi034847u; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chang J, 1996, J VIROL, V70, P7792, DOI 10.1128/JVI.70.11.7792-7803.1996; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; GEYER H, 1988, J BIOL CHEM, V263, P11760; Grandjean C, 2001, CHEMBIOCHEM, V2, P747, DOI 10.1002/1439-7633(20011001)2:10<747::AID-CBIC747>3.0.CO;2-O; Kapp EA, 2003, ANAL CHEM, V75, P6251, DOI 10.1021/ac034616t; KOUP RA, 2001, CURRENT PROTOCOLS IM; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LARGENT BL, 1984, J BIOL CHEM, V259, P1764; LEE RT, 1984, BIOCHEMISTRY-US, V23, P4255, DOI 10.1021/bi00313a037; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MERKLE RK, 1991, ARCH BIOCHEM BIOPHYS, V290, P248, DOI 10.1016/0003-9861(91)90616-Q; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; SHEPHERD VL, 1981, P NATL ACAD SCI-BIOL, V78, P1019, DOI 10.1073/pnas.78.2.1019; Soilleux EJ, 2002, J PATHOL, V198, P511, DOI 10.1002/path.1205; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	48	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11027	11038		10.1074/jbc.M809698200	http://dx.doi.org/10.1074/jbc.M809698200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224860	hybrid, Green Published			2022-12-25	WOS:000265494500007
J	Yamazaki, Y; Matsunaga, Y; Tokunaga, Y; Obayashi, S; Saito, M; Morita, T				Yamazaki, Yasuo; Matsunaga, Yukiko; Tokunaga, Yuko; Obayashi, Shinya; Saito, Mai; Morita, Takashi			Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCELERATED EVOLUTION; ORF-VIRUS; PHOSPHOLIPASE-A2 ISOZYMES; CRYSTAL-STRUCTURE; FLT-1 RECEPTOR; BINDING; PERMEABILITY; NEUROPILIN-1; HEPARIN; DOMAIN	Vascular endothelial growth factor (VEGF-A) and its family proteins are crucial regulators of blood vessel formation and vascular permeability. Snake venom has recently been shown to be an exogenous source of unique VEGF (known as VEGF-F), and now, two types of VEGF-F with distinct biochemical properties have been reported. Here, we show that VEGF-Fs (venomtype VEGFs) are highly variable in structure and function among species, in contrast to endogenous tissue-type VEGFs (VEGFAs) of snakes. Although the structures of tissue-type VEGFs are highly conserved among venomous snake species and even among all vertebrates, including humans, those of venom-type VEGFs are extensively variegated, especially in the regions around receptor-binding loops and C-terminal putative coreceptor-binding regions, indicating that highly frequent variations are located around functionally key regions of the proteins. Genetic analyses suggest that venom-type VEGF gene may have developed from a tissue-type gene and that the unique sequence of its C-terminal region was generated by an alteration in the translation frame in the corresponding exons. We further verified that a novel venom-type VEGF from Bitis arietans displays unique properties distinct from already known VEGFs. Our results may provide evidence of a novel mechanism causing the generation of multiple snake toxins and also of a new model of molecular evolution.	[Yamazaki, Yasuo; Matsunaga, Yukiko; Tokunaga, Yuko; Obayashi, Shinya; Saito, Mai; Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan	Meiji Pharmaceutical University	Morita, T (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, 2-522-1 Noshio, Tokyo 2048588, Japan.	tmorita@my-pharm.ac.jp		Yamazaki, Yasuo/0000-0001-5297-9837; Matsunaga, Yukiko/0000-0002-1392-5681	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to T. M.). The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number( s) FJ554642, FJ554643, FJ554635, FJ554636, FJ554637, FJ554638, FJ554639, FJ554640, FJ554641.	Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Chen YL, 2005, THROMB HAEMOSTASIS, V93, P331, DOI 10.1160/TH04-09-0568; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gasmi A, 2000, BIOCHEM BIOPH RES CO, V268, P69, DOI 10.1006/bbrc.2000.2078; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kiba A, 2003, J BIOL CHEM, V278, P13453, DOI 10.1074/jbc.M210931200; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komori Y, 1999, BIOCHEMISTRY-US, V38, P11796, DOI 10.1021/bi990562z; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mercer AA, 2002, J GEN VIROL, V83, P2845, DOI 10.1099/0022-1317-83-11-2845; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; OGAWA T, 1992, P NATL ACAD SCI USA, V89, P8557, DOI 10.1073/pnas.89.18.8557; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074/jbc.M411395200; Takahashi H, 2004, J BIOL CHEM, V279, P46304, DOI 10.1074/jbc.M403687200; Tokunaga Y, 2006, BIOCHEM BIOPH RES CO, V348, P957, DOI 10.1016/j.bbrc.2006.07.117; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Yamazaki Y, 2005, BIOCHEMISTRY-US, V44, P8858, DOI 10.1021/bi050197d; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200; Yamazaki Y, 2007, CURR PHARM DESIGN, V13, P2872, DOI 10.2174/138161207782023775; Yamazaki Y, 2007, BIOCHEM BIOPH RES CO, V355, P693, DOI 10.1016/j.bbrc.2007.02.038; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3	31	56	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9885	9891		10.1074/jbc.M809071200	http://dx.doi.org/10.1074/jbc.M809071200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208624	Green Published, hybrid			2022-12-25	WOS:000264892900030
J	Yang, SH; Sarkar, SN; Liu, R; Perez, EJ; Wang, XF; Wen, Y; Yan, LJ; Simpkins, JW				Yang, Shao-Hua; Sarkar, Saumyendra N.; Liu, Ran; Perez, Evelyn J.; Wang, Xiaofei; Wen, Yi; Yan, Liang-Jun; Simpkins, James W.			Estrogen Receptor beta as a Mitochondrial Vulnerability Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-BETA; SUBCELLULAR-DISTRIBUTION; GENE-EXPRESSION; ALPHA; LOCALIZATION; CELLS; PROLIFERATION; EXTRANUCLEAR; GENERATION; PROSTATE	We recently demonstrated mitochondrial localization of estrogen receptor beta ( ER beta). We herein confirm the mitochondrial localization of ER beta by the loss of mitochondrial ER beta immunoreactivity in ER beta knockdown cells. Aphenotype change characterized as an increase in resistance to oxidative stressors is associated with ER beta knockdown. ER beta knockdown results in a lower resting mitochondrial membrane potential (Delta psi m) and increase in resistance to hydrogen peroxide-induced Delta psi m depolarization in both immortal hippocampal cells and primary hippocampal neurons. ER beta knockdown cells maintained ATP concentrations despite insults that compromise ATP production and produce less mitochondrial superoxide under oxidative stress. Furthermore, similar mitochondrial phenotype changes were identified in primary hippocampal neurons derived from ER beta knock-out mice. These data demonstrate that ER beta is expressed in mitochondria and function as a mitochondrial vulnerability factor involved in Delta psi m maintenance, potentially through a mitochondrial transcription dependent mechanism.	[Yang, Shao-Hua; Sarkar, Saumyendra N.; Liu, Ran; Perez, Evelyn J.; Wang, Xiaofei; Wen, Yi; Yan, Liang-Jun; Simpkins, James W.] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Yang, SH (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76017 USA.	syang@hsc.unt.edu	Yang, Shaohua/D-1738-2013; Wen, Yi/C-6013-2009	Yan, Liang-Jun/0000-0002-5815-5430; Liu, Ran/0000-0002-3882-0616	National Institutes of Health; NINDS [NS054651, NS054687, AG10485, AG22550, AG27956]; American Heart Association, Inc., Texas Affiliate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054687, R01NS054651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027956, P01AG010485, P01AG022550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association, Inc., Texas Affiliate(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants NS054651 (to S. Y.), NS054687 (to S. Y.), AG10485 (to J. W. S.), AG22550 (to J. W. S.), and AG27956 (to J. W. S.). This work was also supported by a grant from the American Heart Association, Inc., Texas Affiliate (to S. Y.).	Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Batistatou A, 2004, J CANCER RES CLIN, V130, P405, DOI 10.1007/s00432-004-0548-9; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Cammarata PR, 2004, EXP EYE RES, V78, P861, DOI 10.1016/j.exer.2003.09.027; Cammarata PR, 2005, EXP EYE RES, V81, P165, DOI 10.1016/j.exer.2005.01.019; Chen JQ, 2005, BBA-MOL CELL RES, V1746, P1, DOI 10.1016/j.bbamcr.2005.08.001; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Felty Quentin, 2005, J Carcinog, V4, P1, DOI 10.1186/1477-3163-4-1; Fried G, 2004, EUR J NEUROSCI, V20, P2345, DOI 10.1111/j.1460-9568.2004.03693.x; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Klein RL, 2002, METHODS, V28, P286, DOI 10.1016/S1046-2023(02)00234-7; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lazennec G, 2006, CANCER LETT, V231, P151, DOI 10.1016/j.canlet.2005.01.021; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; McEwen B, 2001, P NATL ACAD SCI USA, V98, P7093, DOI 10.1073/pnas.121146898; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Milner TA, 2001, J COMP NEUROL, V429, P355; Moats RK, 1998, BIOL REPROD, V58, P531, DOI 10.1095/biolreprod58.2.531; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2004, CNS NEUROL DISORD-DR, V3, P297, DOI 10.2174/1568007043337193; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Sarkar SN, 2003, J NEUROCHEM, V87, P333, DOI 10.1046/j.1471-4159.2003.02006.x; Sherwin BB, 1999, J PSYCHIATR NEUROSCI, V24, P315; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Solakidi S, 2005, BBA-MOL CELL RES, V1745, P382, DOI 10.1016/j.bbamcr.2005.05.010; Stevenson JC, 2000, J STEROID BIOCHEM, V74, P387, DOI 10.1016/S0960-0760(00)00117-5; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Treeck O, 2007, MOL CELL ENDOCRINOL, V264, P50, DOI 10.1016/j.mce.2006.10.003; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wang XF, 2003, INVEST OPHTH VIS SCI, V44, P2067, DOI 10.1167/iovs.02-0841; Wise PM, 2006, NEUROSCIENCE, V138, P831, DOI 10.1016/j.neuroscience.2005.08.046; Wise PM, 2002, RECENT PROG HORM RES, V57, P235, DOI 10.1210/rp.57.1.235; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SH, 2005, CNS NEUROL DISORD-DR, V4, P169, DOI 10.2174/1568007053544174; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	60	60	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9540	9548		10.1074/jbc.M808246200	http://dx.doi.org/10.1074/jbc.M808246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189968	Green Published, hybrid			2022-12-25	WOS:000264669100060
J	Green, S; Squire, CJ; Nieuwenhuizen, NJ; Baker, EN; Laing, W				Green, Sol; Squire, Christopher J.; Nieuwenhuizen, Niels J.; Baker, Edward N.; Laing, William			Defining the Potassium Binding Region in an Apple Terpene Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-FARNESENE; ARISTOLOCHENE SYNTHASE; GERANYL PYROPHOSPHATE; TRICHODIENE SYNTHASE; PARTIAL-PURIFICATION; ASPERGILLUS-TERREUS; LIMONENE SYNTHASE; PEEL TISSUE; BIOSYNTHESIS	Terpene synthases are a family of enzymes largely responsible for synthesizing the vast array of terpenoid compounds known to exist in nature. Formation of terpenoids from their respective 10-, 15-, or 20- carbon atom prenyl diphosphate precursors is initiated by divalent (M2+) metal ion-assisted electrophilic attack. In addition to M2+, monovalent cations (M+) have also been shown to be essential for the activity of certain terpene synthases most likely by facilitating substrate binding or catalysis. An apple alpha-farnesene synthase (MdAFS1), which has a dependence upon potassium (K+), was used to identify active site regions that may be important for M+ binding. Protein homology modeling revealed a surface-exposed loop (H-alpha l loop) in MdAFS1 that fulfilled the necessary requirements for a K+ binding region. Site-directed mutagenesis analysis of specific residues within this loop then revealed their crucial importance to this K+ response and strongly implicated specific residues in direct K+ binding. The role of the H-alpha l loop in terpene synthase K+ coordination was confirmed in a Conifer pinene synthase also using site-directed mutagenesis. These findings provide the first direct evidence for a specific M+ binding region in two functionally and phylogenetically divergent terpene synthases. They also provide a basis for understanding K+ activation in other terpene synthases and establish a new role for the H-alpha l loop region in terpene synthase catalysis.	New Zealand Inst Plant & Food Res, Auckland, New Zealand; [Green, Sol; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Green, Sol; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; University of Auckland	Green, S (corresponding author), DSIR, Mt Albert Res Ctr, Plant & Food Res, 120 Mt Albert Rd,Private Bag 92169, Auckland, New Zealand.	sol.green@hortresearch.co.nz	Laing, William A/E-3636-2010; Green, Sol A/D-1949-2011	Laing, William A/0000-0003-0458-6590; Nieuwenhuizen, Niels/0000-0003-2514-7570; Baker, Edward/0000-0003-2456-7661; Squire, Christopher/0000-0001-9212-0461	NewZealand Foundation for Research, Science, and Technology [C06X0403]	NewZealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology)	This work was supported by NewZealand Foundation for Research, Science, and Technology Grant C06X0403 and Plant & Food Internal Investment funding. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANET EFLJ, 1970, AUST J CHEM, V23, P2101, DOI 10.1071/CH9702101; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; BEILBY MJ, 1986, PLANT PHYSIOL, V82, P417, DOI 10.1104/pp.82.2.417; Boyer Paul D., 1942, JOUR BIOL CHEM, V146, P673; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; CROTEAU R, 1989, J BIOL CHEM, V264, P15309; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROTEAU R, 1989, J BIOL CHEM, V264, P2075; CROTEAU R, 1988, J BIOL CHEM, V263, P10063; CROTEAU R, 1990, ARCH BIOCHEM BIOPHYS, V277, P374, DOI 10.1016/0003-9861(90)90593-N; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; DUEBER MT, 1978, PLANT PHYSIOL, V62, P598, DOI 10.1104/pp.62.4.598; EVANS HJ, 1966, ANN REV PLANT PHYSIO, V17, P47, DOI 10.1146/annurev.pp.17.060166.000403; FROST RG, 1977, PLANT PHYSIOL, V59, P22, DOI 10.1104/pp.59.1.22; Gapper NE, 2006, POSTHARVEST BIOL TEC, V41, P225, DOI 10.1016/j.postharvbio.2006.04.014; Green S, 2007, PHYTOCHEMISTRY, V68, P176, DOI 10.1016/j.phytochem.2006.10.017; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McKay SAB, 2003, PLANT PHYSIOL, V133, P368, DOI 10.1104/pp.103.022723; MUDD SH, 1958, J BIOL CHEM, V231, P481; MURRAY KE, 1969, AUST J CHEM, V22, P197, DOI 10.1071/CH9690197; OBRIEN MC, 1995, J BIOL CHEM, V270, P2247, DOI 10.1074/jbc.270.5.2247; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pechous SW, 2005, POSTHARVEST BIOL TEC, V35, P125, DOI 10.1016/j.postharvbio.2004.08.005; Pechous SW, 2004, PLANTA, V219, P84, DOI 10.1007/s00425-003-1191-4; ROBINSON DR, 1970, BIOCHEMISTRY-US, V9, P80, DOI 10.1021/bi00803a011; Rynkiewicz MJ, 2002, BIOCHEMISTRY-US, V41, P1732, DOI 10.1021/bi011960g; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAVAGE TJ, 1994, J BIOL CHEM, V269, P4012; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Zuckerkandl E, 1965, EVOLUTIONARY DIVERGE	54	35	42	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8652	8660		10.1074/jbc.M807140200	http://dx.doi.org/10.1074/jbc.M807140200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181671	hybrid, Green Published			2022-12-25	WOS:000264397800050
J	Campos, SK; Ozbun, MA				Campos, Samuel K.; Ozbun, Michelle A.			Two Highly Conserved Cysteine Residues in HPV16 L2 Form an Intramolecular Disulfide Bond and Are Critical for Infectivity in Human Keratinocytes	PLOS ONE			English	Article								Background: Minor capsid protein L2 performs an indispensable but uncharacterized role in human papillomavirus infections. A neutralizing B cell epitope has recently been mapped to the N-terminus of HPV16 L2, residues 17-36, and exposure of this region of L2 has been implicated in translocation of incoming virions from the endo/lysosomal compartment to the cellular cytoplasm. Here we examine the redox state of Cys22 and Cys28 two highly conserved cysteines located within this epitope. We also investigate the infectivity of virions containing L2 single and double cysteine point mutants. Methodology and Principal Findings: Denaturing/non-reducing gel analysis and thiol labeling experiments of wild type and cysteine mutant HPV16 virion particles strongly support the existence of a buried intramolecular C22-C28 disulfide bond. The disulfide was confirmed by tandem mass spectrometry of L2 protein from non-reduced virions. Single C22S and C28S and the double C22/28S mutants were non-infectious but had no apparent defects in cell binding, endocytosis, or trafficking to lysosomes by 8 h post infection. During infection with L2 mutant particles, there was a marked decrease in L2 levels compared to wild type L2-containing virions, suggesting a failure of mutant L2/genome complexes to exit the endo/lysosomal compartment. Conclusions and Significance: L2 residues C22 and C28 are bound as an intramolecular disulfide bond in HPV16 virions and are necessary for infectivity. Previous work has suggested that the furin-dependent exposure of the 17-36 epitope and subsequent interaction of this region with an unknown receptor is necessary for egress from the endo/lysosomal compartment and infection. Identification of the C22-C28 disulfide suggests that reduction of this disufide bond may be necessary for exposure of 17-36 and HPV16 infection.	Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Campos, Samuel K.; Ozbun, Michelle A.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Arizona; University of New Mexico	Campos, SK (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.	mozbun@salud.unm.edu	Campos, Samuel K/H-8998-2019; Ozbun, Michelle Adair/Q-4158-2017; Ozbun, Michelle/AAN-2922-2021	Campos, Samuel K/0000-0003-1540-9821; Ozbun, Michelle Adair/0000-0001-8551-4606; Ozbun, Michelle/0000-0001-8551-4606	NIH [CA085747, CA132136, T32 AI07538]; NRSA postdoctoral fellowship [F32 CA123842];  [1 CO6 RR012511]; NATIONAL CANCER INSTITUTE [R01CA132136, R01CA085747, F32CA123842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants CA085747 and CA132136 (MAO), NIH Training Grant T32 AI07538 (SKC) and NRSA postdoctoral fellowship F32 CA123842 (SKC). We acknowledge 1 CO6 RR012511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Culp TD, 2006, J VIROL, V80, P11381, DOI 10.1128/JVI.01328-06; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2007, J VIROL, V81, P8784, DOI 10.1128/JVI.00552-07; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 1998, J VIROL, V72, P142, DOI 10.1128/JVI.72.1.142-150.1998; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DUNKER AK, 1969, J BIOL CHEM, V244, P5074; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fenouillet E, 2008, J BIOL CHEM, V283, P26340, DOI 10.1074/jbc.M805221200; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Florin L, 2006, J VIROL, V80, P6691, DOI 10.1128/JVI.00057-06; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Heino P, 2000, VIROLOGY, V276, P304, DOI 10.1006/viro.2000.0342; Holmgren SC, 2005, J VIROL, V79, P3938, DOI 10.1128/JVI.79.7.3938-3948.2005; INOCENCIO NM, 1994, J BIOL CHEM, V269, P31831; Ishii Y, 2005, VIRUS GENES, V31, P321, DOI 10.1007/s11262-005-3250-3; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Kawana Y, 2001, J VIROL, V75, P2331, DOI 10.1128/JVI.75.5.2331-2336.2001; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Langenbach KJ, 1999, J BIOL CHEM, V274, P7032, DOI 10.1074/jbc.274.11.7032; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; McKee ML, 1999, BIOCHEMISTRY-US, V38, P16507, DOI 10.1021/bi991308+; Mere J, 2005, J BIOL CHEM, V280, P21194, DOI 10.1074/jbc.M412656200; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Okoye A, 2005, VIRUS RES, V108, P1, DOI 10.1016/j.virusres.2004.07.004; Okun MM, 2001, J VIROL, V75, P4332, DOI 10.1128/JVI.75.9.4332-4342.2001; Ozbun MA, 2002, J GEN VIROL, V83, P2753, DOI 10.1099/0022-1317-83-11-2753; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Schelhaas M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000148; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Sen J, 2007, PROTEIN SCI, V16, P1236, DOI 10.1110/ps.072771407; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Smith S, 2008, ECONTENT, V31, P21; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	63	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4463	10.1371/journal.pone.0004463	http://dx.doi.org/10.1371/journal.pone.0004463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214230	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484300007
J	Alghisi, GC; Ponsonnet, L; Ruegg, C				Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio			The Integrin Antagonist Cilengitide Activates alpha V beta 3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells	PLOS ONE			English	Article								Cilengitide is a high-affinity cyclic pentapeptdic alpha V integrin antagonist previously reported to suppress angiogenesis by inducing anoikis of endothelial cells adhering through alpha V beta 3/alpha V beta 5 integrins. Angiogenic endothelial cells express multiple integrins, in particular those of the beta 1 family, and little is known on the effect of cilengitide on endothelial cells expressing alpha V beta 3 but adhering through beta 1 integrins. Through morphological, biochemical, pharmacological and functional approaches we investigated the effect of cilengitide on alpha V beta 3-expressing human umbilical vein endothelial cells (HUVEC) cultured on the beta 1 ligands fibronectin and collagen I. We show that cilengitide activated cell surface alpha V beta 3, stimulated phosphorylation of FAK (Y(397) and Y(576/577)), Src (S(418)) and VE-cadherin (Y(658) and Y(731)), redistributed alpha V beta 3 at the cell periphery, caused disappearance of VE-cadherin from cellular junctions, increased the permeability of HUVEC monolayers and detached HUVEC adhering on low-density beta 1 integrin ligands. Pharmacological inhibition of Src kinase activity fully prevented cilengitide-induced phosphorylation of Src, FAK and VE-cadherin, and redistribution of aV beta 3 and VE-cadherin and partially prevented increased permeability, but did not prevent HUVEC detachment from low-density matrices. Taken together, these observations reveal a previously unreported effect of cilengitide on endothelial cells namely its ability to elicit signaling events disrupting VE-cadherin localization at cellular contacts and to increase endothelial monolayer permeability. These effects are potentially relevant to the clinical use of cilengitide as anticancer agent.	[Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio] Univ Lausanne, Div Expt Oncol, CePO, Fac Biol & Med, CH-1066 Epalinges, Switzerland; [Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio] NCCR Mol Oncol, ISREC, Epalinges, Switzerland	University of Lausanne; Swiss Institute Experimental Cancer Research	Alghisi, GC (corresponding author), Univ Lausanne, Div Expt Oncol, CePO, Fac Biol & Med, CH-1066 Epalinges, Switzerland.	curzio.ruegg@unil.ch			Oncosuisse [0181212-12-2005, 02020.02.2007]; National Center for Competence in Research; Medic Foundation	Oncosuisse; National Center for Competence in Research; Medic Foundation	This work was supported by grants from Oncosuisse (OCS 0181212-12-2005 and 02020.02.2007), the National Center for Competence in Research (NCCR, molecular Oncology, a research instrument of the SNF), and the Medic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, INT J RADIAT ONCOL, V65, P1536, DOI 10.1016/j.ijrobp.2006.04.036; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bezzi M, 2003, J BIOL CHEM, V278, P43603, DOI 10.1074/jbc.M308114200; Bieler G, 2007, ONCOGENE, V26, P5722, DOI 10.1038/sj.onc.1210354; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Buerkle MA, 2002, BRIT J CANCER, V86, P788, DOI 10.1038/sj.bjc.6600141; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Khaspekova S G, 1996, Biokhimiia, V61, P412; Kumar CC, 2003, CURR DRUG TARGETS, V4, P123, DOI 10.2174/1389450033346830; Loges S, 2007, BIOCHEM BIOPH RES CO, V357, P1016, DOI 10.1016/j.bbrc.2007.04.060; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; MITJANS F, 1995, J CELL SCI, V108, P2825; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; QIAO RL, 1995, AM J PHYSIOL-CELL PH, V269, pC110, DOI 10.1152/ajpcell.1995.269.1.C110; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Smith Jeffrey W, 2003, Curr Opin Investig Drugs, V4, P741; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tatone C, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-48; Tentori L, 2008, ONCOL REP, V19, P1039; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Watson PMD, 2007, MOL CELL NEUROSCI, V34, P147, DOI 10.1016/j.mcn.2006.10.007; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Xiong JP, 2007, METHOD ENZYMOL, V426, P307, DOI 10.1016/S0076-6879(07)26014-8; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamada S, 2006, NEUROSURGERY, V59, P1304, DOI 10.1227/01.NEU.0000245622.70344.BE; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200	53	112	117	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4449	10.1371/journal.pone.0004449	http://dx.doi.org/10.1371/journal.pone.0004449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212436	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484200010
J	Dupierrix, E; Gresty, M; Ohlmann, T; Chokron, S				Dupierrix, Eve; Gresty, Michael; Ohlmann, Theophile; Chokron, Sylvie			Long Lasting Egocentric Disorientation Induced by Normal Sensori-Motor Spatial Interaction	PLOS ONE			English	Article							PRISM ADAPTATION; UNILATERAL NEGLECT; PERCEIVING DISTANCE; BODY ORIENTATION; PERCEPTION; REPRESENTATION; STIMULATION; SLEEP; SPACE; REHABILITATION	Background: Perception of the cardinal directions of the body, right-left, up-down, ahead-behind, which appears so absolute and fundamental to the organisation of behaviour can in fact, be modified. Perhaps unsurprisingly, it has been shown that prolonged distorted perception of the orientation of body axes can be a consequence of disordered sensorimotor signals, including long-term prismatic adaptation and lesions of the central nervous system. We report the novel and surprising finding that a long-lasting distortion of perception of personal space can also be induced by an ecological pointing task without the artifice of distorting normal sensori-motor relationships. Methodology/Principal Findings: Twelve right-handed healthy adults performed the task of pointing with their arms, without vision, to indicate their subjective 'straight ahead', a task often used to assess the Egocentric Reference. This was performed before, immediately, and one day after a second task intended to 'modulate' perception of spatial direction. The 'modulating' task lasted 5 minutes and consisted of asking participants to point with the right finger to targets that appeared only in one (right or left) half of a computer screen. Estimates of the 'straight-ahead' during pre-test were accurate (inferior to 0.3 degrees deviation). Significantly, up to one day after performing the modulating task, the subjective 'straight-ahead' was deviated (by approximately 3.2 degrees) to the same side to which subjects had pointed to targets. Conclusion/Significance: These results reveal that the perception of directional axes for behaviour is readily influenced by interactions with the environment that involve no artificial distortion of normal sensori-motor-spatial relationships and does not necessarily conform to the cardinal directions as defined by the anatomy of orthostatic posture. We thus suggest that perceived space is a dynamic construction directly dependent upon our past experience about the direction and/or the localisation of our sensori-motor spatial interaction with environment.	Coll France, LPPA, CNRS, UMR 7152, F-75231 Paris, France; [Dupierrix, Eve; Ohlmann, Theophile; Chokron, Sylvie] CNRS, LPNC, UMR 5105, Grenoble, France; [Dupierrix, Eve; Ohlmann, Theophile; Chokron, Sylvie] Fdn Adolphe De Rothschild, Serv Neurol, ERT TREAT Vision, Paris, France; [Gresty, Michael] Imperial Coll London, MRC, Div Neurosci & Mental Hlth, Sect Neuro Otol, London, England	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Imperial College London	Dupierrix, E (corresponding author), Coll France, LPPA, CNRS, UMR 7152, F-75231 Paris, France.	eve.dupierrix@college-de-france.fr			University Pierre Mendes France of Grenoble; Centre National de la Recherche Scientifique; Edmond and Benjamin de Rothschild Foundations (New York, Geneva); Medical Research Council [MC_U950770497, G0600183] Funding Source: researchfish; MRC [MC_U950770497, G0600183] Funding Source: UKRI	University Pierre Mendes France of Grenoble; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Edmond and Benjamin de Rothschild Foundations (New York, Geneva); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the University Pierre Mendes France of Grenoble and the Centre National de la Recherche Scientifique. We thank also the Edmond and Benjamin de Rothschild Foundations (New York, Geneva) for supporting the research of the TREAT vision team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 2006, EXP BRAIN RES, V170, P30, DOI 10.1007/s00221-005-0174-z; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; BIGUER B, 1988, BRAIN, V111, P1405, DOI 10.1093/brain/111.6.1405; CHAIN F, 1979, REV NEUROL, V135, P105; Chokron S, 1997, CORTEX, V33, P47, DOI 10.1016/S0010-9452(97)80004-4; Chokron S, 1997, NEUROPSYCHOLOGIA, V35, P1503, DOI 10.1016/S0028-3932(97)00079-1; Chokron S, 2003, NEUROIMAGE, V20, pS75, DOI 10.1016/j.neuroimage.2003.09.002; CHOKRON S, 1995, NEUROPSYCHOLOGIA, V33, P703, DOI 10.1016/0028-3932(95)00007-P; Chokron S, 2007, NEUROPSYCHOLOGIA, V45, P3127, DOI 10.1016/j.neuropsychologia.2007.08.001; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; Coello Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002862; Colent C, 2000, NEUROREPORT, V11, P1899, DOI 10.1097/00001756-200006260-00019; DELLATOLAS G, 1988, REV PSYCHOL APPL, V38, P117; Duclos C, 2004, EXP BRAIN RES, V158, P58, DOI 10.1007/s00221-004-1871-8; Dupierrix E, 2008, BRAIN RES, V1214, P127, DOI 10.1016/j.brainres.2008.01.021; Fadiga L, 2000, INT J PSYCHOPHYSIOL, V35, P165, DOI 10.1016/S0167-8760(99)00051-3; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Gibson JJ, 1979, ECOLOGICAL APPROACH; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Humphreys GW, 2006, COGN NEUROPSYCHOL, V23, P463, DOI 10.1080/02643290500202755; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karnath HO, 1996, J NEUROL NEUROSUR PS, V60, P217, DOI 10.1136/jnnp.60.2.217; Karnath HO, 2002, EXP BRAIN RES, V143, P350, DOI 10.1007/s00221-001-0996-2; KAZANDJIAN S, 2008, BRAIN RES; Kazandjian S, 2008, NAT REV NEUROSCI, V9, P965, DOI 10.1038/nrn2456-c1; Kerkhoff G, 2006, RESTOR NEUROL NEUROS, V24, P201; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Laureys S, 2001, NEUROSCIENCE, V105, P521, DOI 10.1016/S0306-4522(01)00269-X; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Michel C, 2006, RESTOR NEUROL NEUROS, V24, P419; OXBURY JM, 1974, BRAIN, V97, P551, DOI 10.1093/brain/97.1.551; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 2001, PSYCHOL SCI, V12, P418, DOI 10.1111/1467-9280.00377; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Redding GA, 2006, NEUROPSYCHOLOGIA, V44, P1, DOI 10.1016/j.neuropsychologia.2005.04.009; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1990, REV NEUROL, V146, P626; ROBERTSON IH, 1992, NEUROPSYCHOLOGIA, V30, P553, DOI 10.1016/0028-3932(92)90058-T; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Witt JK, 2004, PERCEPTION, V33, P577, DOI 10.1068/p5090; ZUCKERMAN M, 1993, PSYCHOL SCI, V4, P49, DOI 10.1111/j.1467-9280.1993.tb00556.x	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4465	10.1371/journal.pone.0004465	http://dx.doi.org/10.1371/journal.pone.0004465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212433	Green Published, gold			2022-12-25	WOS:000265484200015
J	Mani, P; Yadav, VK; Das, SK; Chowdhury, S				Mani, Prithvi; Yadav, Vinod Kumar; Das, Swapan Kumar; Chowdhury, Shantanu			Genome-Wide Analyses of Recombination Prone Regions Predict Role of DNA Structural Motif in Recombination	PLOS ONE			English	Article								HapMap findings reveal surprisingly asymmetric distribution of recombinogenic regions. Short recombinogenic regions (hotspots) are interspersed between large relatively non-recombinogenic regions. This raises the interesting possibility of DNA sequence and/or other cis-elements as determinants of recombination. We hypothesized the involvement of non-canonical sequences that can result in local non-B DNA structures and tested this using the G-quadruplex DNA as a model. G-quadruplex or G4 DNA is a unique form of four-stranded non-B DNA structure that engages certain G-rich sequences, presence of such motifs has been noted within telomeres. In support of this hypothesis, genome-wide computational analyses presented here reveal enrichment of potential G4 (PG4) DNA forming sequences within 25618 human hotspots relative to 9290 coldspots (p < 0.0001). Furthermore, co- occurrence of PG4 DNA within several short sequence elements that are associated with recombinogenic regions was found to be significantly more than randomly expected. Interestingly, analyses of more than 50 DNA binding factors revealed that co- occurrence of PG4 DNA with target DNA binding sites of transcription factors c-Rel, NF-kappa B (p50 and p65) and Evi-1 was significantly enriched in recombination-prone regions. These observations support involvement of G4 DNA in recombination, predicting a functional model that is consistent with duplex-strand separation induced by formation of G4 motifs in supercoiled DNA and/or when assisted by other cellular factors.	[Mani, Prithvi; Yadav, Vinod Kumar; Chowdhury, Shantanu] CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, Delhi, India; [Chowdhury, Shantanu] CSIR, Inst Genom & Integrat Biol, Proteom & Struct Biol Unit, Delhi, India; [Das, Swapan Kumar] CSIR, Inst Genom & Integrat Biol, Funct Genom Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Mani, P (corresponding author), CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, Delhi, India.	shantanuc@igib.res.in	Yadav, Vinod k/J-9279-2014	Yadav, Vinod k/0000-0001-6450-7036; Das, Swapan/0000-0002-2197-8855	CSIR Task Force Project [CMM 0017]	CSIR Task Force Project(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR Task Force Project (CMM 0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Du Z, 2007, BIOCHEM BIOPH RES CO, V354, P1067, DOI 10.1016/j.bbrc.2007.01.093; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Fojtik P, 2004, NUCLEIC ACIDS RES, V32, P298, DOI 10.1093/nar/gkh179; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; Ghosal G, 2007, J MOL BIOL, V372, P864, DOI 10.1016/j.jmb.2007.07.013; Gilbert DE, 1999, CURR OPIN STRUC BIOL, V9, P305, DOI 10.1016/S0959-440X(99)80041-4; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kirkpatrick DT, 1999, GENETICS, V152, P101; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; LEITH IR, 1993, BIOCHEM BIOPH RES CO, V196, P601, DOI 10.1006/bbrc.1993.2292; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; McManus SA, 2008, J MOL BIOL, V375, P960, DOI 10.1016/j.jmb.2007.10.080; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Myers S, 2006, BIOCHEM SOC T, V34, P526, DOI 10.1042/BST0340526; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qiu P, 2002, MAMM GENOME, V13, P327, DOI 10.1007/s00335-001-2141-8; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sandovici I, 2006, PLOS GENET, V2, P944, DOI 10.1371/journal.pgen.0020101; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Sinden RR, 2005, NATURE, V437, P1097, DOI 10.1038/4371097a; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wyman C, 2008, MOL CELL, V30, P5, DOI 10.1016/j.molcel.2008.03.007; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhang J, 2004, HUM MOL GENET, V13, P2823, DOI 10.1093/hmg/ddh310; Zhao YQ, 2007, FEBS LETT, V581, P1951, DOI 10.1016/j.febslet.2007.04.017	63	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4399	10.1371/journal.pone.0004399	http://dx.doi.org/10.1371/journal.pone.0004399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198658	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483900008
J	Piganeau, G; Eyre-Walker, A				Piganeau, Gwenael; Eyre-Walker, Adam			Evidence for Variation in the Effective Population Size of Animal Mitochondrial DNA	PLOS ONE			English	Article							GENETIC DIVERSITY; CODON USAGE; POLYMORPHISM; EVOLUTION; MUTATION; RATES	Background: It has recently been shown that levels of diversity in mitochondrial DNA are remarkably constant across animals of diverse census population sizes and ecologies, which has led to the suggestion that the effective population of mitochondrial DNA may be relatively constant. Results: Here we present several lines of evidence that suggest, to the contrary, that the effective population size of mtDNA does vary, and that the variation can be substantial. First, we show that levels of mitochondrial and nuclear diversity are correlated within all groups of animals we surveyed. Second, we show that the effectiveness of selection on non-synonymous mutations, as measured by the ratio of the numbers of non-synonymous and synonymous polymorphisms, is negatively correlated to levels of mitochondrial diversity. Finally, we estimate the effective population size of mitochondrial DNA in selected mammalian groups and show that it varies by at least an order of magnitude. Conclusions: We conclude that there is variation in the effective population size of mitochondria. Furthermore we suggest that the relative constancy of DNA diversity may be due to a negative correlation between the effective population size and the mutation rate per generation.	[Piganeau, Gwenael] Univ Paris 06, MBCE, Observ Oceanol, UMR 7628, Banyuls Sur Mer, France; [Piganeau, Gwenael] CNRS, MBCE, Observ Oceanol, UMR 7628, Banyuls sur Mer, France; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9RH, E Sussex, England	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Sussex	Piganeau, G (corresponding author), Univ Paris 06, MBCE, Observ Oceanol, UMR 7628, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr; a.c.eyre-walker@sussex.ac.uk	Piganeau, Gwenael V/C-7600-2011; Eyre-Walker, Adam/G-6216-2011	Piganeau, Gwenael V/0000-0002-9992-4187; Eyre-Walker, Adam/0000-0001-5527-8729	CNRS; GAP Marine Genomics fellowship; BBSRC	CNRS(Centre National de la Recherche Scientifique (CNRS)); GAP Marine Genomics fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	G.P. was funded by the CNRS and a GAP Marine Genomics fellowship. AEW was funded by the BBSRC. The funding agencies took no part in the design and conduct of the analysis.	Albu M, 2008, MOL BIOL EVOL, V25, P2521, DOI 10.1093/molbev/msn224; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bazin E, 2005, NUCLEIC ACIDS RES, V33, pD481, DOI 10.1093/nar/gki076; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bierne N, 2003, GENETICS, V165, P1587; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; CHAO L, 1993, EVOLUTION, V47, P688, DOI 10.1111/j.1558-5646.1993.tb02124.x; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; EyreWalker A, 1997, MOL BIOL EVOL, V14, P455, DOI 10.1093/oxfordjournals.molbev.a025781; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gillespie JH, 2000, GENETICS, V155, P909; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Mulligan CJ, 2006, SCIENCE, V314, DOI 10.1126/science.1132585; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; NEVO E, 1984, EVOLUTIONARY DYNAMIC, P13; Popadin K, 2007, P NATL ACAD SCI USA, V104, P13390, DOI 10.1073/pnas.0701256104; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Welch JJ, 2008, J MOL EVOL, V67, P418, DOI 10.1007/s00239-008-9146-9; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	26	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4396	10.1371/journal.pone.0004396	http://dx.doi.org/10.1371/journal.pone.0004396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198657	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000265483900006
J	Kroner, A; Schwab, N; Ip, CW; Leder, C; Nave, KA; Maurer, M; Wiendl, H; Martini, R				Kroner, Antje; Schwab, Nicholas; Ip, Chi Wang; Leder, Christoph; Nave, Klaus-Armin; Maeurer, Mathias; Wiendl, Heinz; Martini, Rudolf			PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; MYELIN DEGENERATION; PROTEOLIPID PROTEIN; AXONOPATHIC CHANGES; CLONAL EXPANSIONS; IMMUNE-DEFICIENCY; MICE; CELLS; CNS; AUTOIMMUNITY	We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T- lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype of the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T- lymphocytes in PLPtg/PD-1-/- double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T- cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.	[Kroner, Antje; Schwab, Nicholas; Ip, Chi Wang; Leder, Christoph; Maeurer, Mathias; Wiendl, Heinz; Martini, Rudolf] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Kroner, Antje; Ip, Chi Wang; Maeurer, Mathias; Martini, Rudolf] Univ Wurzburg, Sect Dev Neurobiol, D-97070 Wurzburg, Germany; [Schwab, Nicholas; Leder, Christoph; Wiendl, Heinz] Univ Wurzburg, Clin Res Grp MS & Neuroimmunol, D-97070 Wurzburg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Max Planck Society	Kroner, A (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	heinz.wiendl@klinik.uni-wuerzburg.de; rudolf.martini@mail.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021; Nave, Klaus-Armin/C-8883-2011; Ip, Chi Wang/HCH-3822-2022; Schwab, Nicholas/H-4516-2019	Ip, Chi Wang/0000-0003-0484-385X; Martini, Rudolf/0000-0002-5463-5592; Schwab, Nicholas/0000-0001-5494-9885; Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [SFB 581]; Gemeinnutzige Hertie-Stiftung [1.01.1/05/10]; Thyssen foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; Thyssen foundation	The project was funded by the Deutsche Forschungsgemeinschaft (SFB 581; to RM and HW), by the Gemeinnutzige Hertie-Stiftung (1.01.1/05/10 to RM) and the Thyssen foundation (to R. M. and H. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Gorman MP, 2007, NEUROLOGY, V68, P1305, DOI 10.1212/01.wnl.0000259522.49388.53; Grundtner R, 2007, NEUROBIOL DIS, V28, P261, DOI 10.1016/j.nbd.2007.05.006; Hafler DA, 2005, NAT REV IMMUNOL, V5, P83, DOI 10.1038/nri1532; Ip CW, 2008, MOL CELL NEUROSCI, V38, P489, DOI 10.1016/j.mcn.2008.04.009; Ip CW, 2007, NEUROBIOL DIS, V25, P105, DOI 10.1016/j.nbd.2006.08.023; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Ip CW, 2006, NEUROMOL MED, V8, P175, DOI 10.1385/NMM:8:1-2:175; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kobsar I, 2003, BRAIN, V126, P804, DOI 10.1093/brain/awg072; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; KRONER A, 2008, NEUROBIOL D IN PRESS; Leder C, 2007, MOL CELL NEUROSCI, V36, P416, DOI 10.1016/j.mcn.2007.08.002; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Martin-Orozco N, 2006, J EXP MED, V203, P817, DOI 10.1084/jem.20060219; Maurer M, 2001, MOL CELL NEUROSCI, V17, P1094, DOI 10.1006/mcne.2001.0990; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schmid CD, 2000, J NEUROSCI, V20, P729, DOI 10.1523/JNEUROSCI.20-02-00729.2000; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Warshawsky I, 2005, ANN NEUROL, V58, P470, DOI 10.1002/ana.20601	35	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4405	10.1371/journal.pone.0004405	http://dx.doi.org/10.1371/journal.pone.0004405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197390	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483700012
J	Ilin, Y; Richter-Levin, G				Ilin, Yana; Richter-Levin, Gal			Enriched Environment Experience Overcomes Learning Deficits and Depressive-Like Behavior Induced by Juvenile Stress	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; CORTICOTROPIN-RELEASING HORMONE; NEURAL RECOGNITION MOLECULES; MESSENGER-RNA EXPRESSION; OPEN-FIELD ACTIVITY; EARLY-LIFE STRESS; MEMORY CONSOLIDATION; MAJOR DEPRESSION; ANIMAL-MODEL; HIPPOCAMPAL PLASTICITY	Mood disorders affect the lives and functioning of millions each year. Epidemiological studies indicate that childhood trauma is predominantly associated with higher rates of both mood and anxiety disorders. Exposure of rats to stress during juvenility (JS) (27-29 days of age) has comparable effects and was suggested as a model of induced predisposition for these disorders. The importance of the environment in the regulation of brain, behavior and physiology has long been recognized in biological, social and medical sciences. Here, we studied the effects of JS on emotional and cognitive aspects of depressive-like behavior in adulthood, on Hypothalamic-Pituitary-Adrenal (HPA) axis reactivity and on the expression of cell adhesion molecule L1 (L1-CAM). Furthermore, we combined it with the examination of potential reversibility by enriched environment (EE) of JS - induced disturbances of emotional and cognitive aspects of behavior in adulthood. Three groups were tested: Juvenile Stress -subjected to Juvenile stress; Enriched Environment -subjected to Juvenile stress and then, from day 30 on to EE; and Naives. In adulthood, coping and stress responses were examined using the elevated plus-maze, open field, novel setting exploration and two way shuttle avoidance learning. We found that, JS rats showed anxiety-and depressive-like behaviors in adulthood, altered HPA axis activity and altered L1-CAM expression. Increased expression of L1-CAM was evident among JS rats in the basolateral amygdala (BLA) and Thalamus (TL). Furthermore, we found that EE could reverse most of the effects of Juvenile stress, both at the behavioral, endocrine and at the biochemical levels. The interaction between JS and EE resulted in an increased expression of L1-CAM in dorsal cornu ammonis (CA) area 1 (dCA1).	[Ilin, Yana; Richter-Levin, Gal] Univ Haifa, Dept Psychol, ISAN, IL-31999 Haifa, Israel	University of Haifa	Ilin, Y (corresponding author), Univ Haifa, Dept Psychol, ISAN, IL-31999 Haifa, Israel.	galrichterlevin@gmail.com	Richter Levin, Gal/GVT-4050-2022	Richter Levin, Gal/0000-0001-7980-5212	EU [512012]; Institute for the Study of Affective Neuroscience (ISAN)	EU(European Commission); Institute for the Study of Affective Neuroscience (ISAN)	This study was supported by the EU's PROMEMORIA grant # 512012 to GRL, and by a grant from The Institute for the Study of Affective Neuroscience (ISAN) (2007) to GRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 1999, J NEUROSCI, V19, P10530; Armstrong KR, 1998, CONTEMP TOP LAB ANIM, V37, P64; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Avital A, 2001, NEUROPSYCHOPHARMACOL, V25, P669, DOI 10.1016/S0893-133X(01)00286-X; Bardo MT, 2004, NEBR SYM MOTIV, V50, P127; Becker K, 2007, DEV NEUROBIOL, V67, P617, DOI 10.1002/dneu.20372; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bevins RA, 1999, BEHAV BRAIN RES, V99, P53, DOI 10.1016/S0166-4328(98)00069-2; Brook GA, 2000, EUR J NEUROSCI, V12, P3224, DOI 10.1046/j.1460-9568.2000.00228.x; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; CHAMOVE AS, 1989, LAB ANIM, V23, P215, DOI 10.1258/002367789780810608; Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; ENGELLENNER WJ, 1982, PHYSIOL BEHAV, V29, P885, DOI 10.1016/0031-9384(82)90339-0; ESCORIHUELA RM, 1994, BEHAV BRAIN RES, V61, P169, DOI 10.1016/0166-4328(94)90157-0; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; Gutman David A, 2002, Semin Clin Neuropsychiatry, V7, P89, DOI 10.1053/scnp.2002.31781; Hansen LT, 2000, APPL ANIM BEHAV SCI, V68, P163, DOI 10.1016/S0168-1591(00)00093-9; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Huang-Brown KM, 2002, LAB ANIMAL, V31, P34; Ichise M, 2006, J NEUROSCI, V26, P4638, DOI 10.1523/JNEUROSCI.5199-05.2006; Jaferi A, 2006, ENDOCRINOLOGY, V147, P4917, DOI 10.1210/en.2005-1393; Jucker M, 1996, NEUROSCIENCE, V75, P703, DOI 10.1016/0306-4522(96)00276-X; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knafo S, 2005, EUR J NEUROSCI, V21, P581, DOI 10.1111/j.1460-9568.2005.03862.x; Laifenfeld D, 2005, NEUROBIOL DIS, V20, P432, DOI 10.1016/j.nbd.2005.03.023; Laifenfeld D, 2005, BIOL PSYCHIAT, V57, P716, DOI 10.1016/j.biopsych.2004.12.016; Laifenfeld D, 2002, J NEUROCHEM, V83, P1054, DOI 10.1046/j.1471-4159.2002.01215.x; Law JWS, 2003, J NEUROSCI, V23, P10419; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maroun M, 2003, J NEUROSCI, V23, P4406; Matsumoto M, 2008, PHARMACOL BIOCHEM BE, V89, P247, DOI 10.1016/j.pbb.2007.12.017; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2002, METABOLISM, V51, P2, DOI 10.1053/meta.2002.33183; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mello DMD, 2007, BEHAV BRAIN RES, V181, P232, DOI 10.1016/j.bbr.2007.04.010; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; MOHAMMED AH, 1993, BEHAV BRAIN RES, V57, P183, DOI 10.1016/0166-4328(93)90134-C; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Patterson-Kane E G, 1999, J Appl Anim Welf Sci, V2, P97, DOI 10.1207/s15327604jaws0202_2; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Price JL, 1996, PROG BRAIN RES, V107, P523; Pryce C, 2002, PHARMACOL BIOCHEM BE, V73, P1, DOI 10.1016/S0091-3057(02)00861-4; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; RICE CJ, 2008, ENDOCRINOLOGY; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Sandi C, 2001, NEUROSCIENCE, V102, P329, DOI 10.1016/S0306-4522(00)00484-X; Sandi C, 2007, NEUROENDOCRINOLOGY, V85, P158, DOI 10.1159/000101535; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P9; SHARP PE, 1987, BEHAV NEUROSCI, V101, P170, DOI 10.1037/0735-7044.101.2.170; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; STYREN SD, 1995, EXP NEUROL, V131, P165, DOI 10.1016/0014-4886(95)90038-1; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Tsoory M, 2006, INT J NEUROPSYCHOPH, V9, P713, DOI 10.1017/S1461145705006255; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Venero C, 2004, J NEUROSCI RES, V75, P172, DOI 10.1002/jnr.10857; Venero C, 2002, NEUROSCIENCE, V115, P1211, DOI 10.1016/S0306-4522(02)00543-2; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wilner Warren, 2005, Psychoanal Rev, V92, P759, DOI 10.1521/prev.2005.92.5.759; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; WOOD PM, 1990, J NEUROSCI, V10, P3635	92	79	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4329	10.1371/journal.pone.0004329	http://dx.doi.org/10.1371/journal.pone.0004329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549YF	19180243	Green Submitted, Green Published, gold			2022-12-25	WOS:000274089700012
J	Farke, AA; Wolff, EDS; Tanke, DH				Farke, Andrew A.; Wolff, Ewan D. S.; Tanke, Darren H.			Evidence of Combat in Triceratops	PLOS ONE			English	Article								Background: The horns and frill of Triceratops and other ceratopsids (horned dinosaurs) are interpreted variously as display structures or as weapons against conspecifics and predators. Lesions (in the form of periosteal reactive bone, healing fractures, and alleged punctures) on Triceratops skulls have been used as anecdotal support of intraspecific combat similar to that in modern horned and antlered animals. If ceratopsids with different cranial morphologies used their horns in such combat, this should be reflected in the rates of lesion occurrence across the skull. Methodology/Principal Findings: We used a G-test of independence to compare incidence rates of lesions in Triceratops (which possesses two large brow horns and a smaller nasal horn) and the related ceratopsid Centrosaurus (with a large nasal horn and small brow horns), for the nasal, jugal, squamosal, and parietal bones of the skull. The two taxa differ significantly in the occurrence of lesions on the squamosal bone of the frill (P = 0.002), but not in other cranial bones (P>0.20). Conclusions/Significance: This pattern is consistent with Triceratops using its horns in combat and the frill being adapted as a protective structure for this taxon. Lower pathology rates in Centrosaurus may indicate visual rather than physical use of cranial ornamentation in this genus, or a form of combat focused on the body rather than the head.	Raymond M Alf Museum Paleontol, Claremont, CA USA; [Wolff, Ewan D. S.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Tanke, Darren H.] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada	University of Wisconsin System; University of Wisconsin Madison	Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA USA.	afarke@webb.org		Wolff, Ewan/0000-0002-5726-4766; Farke, Andrew/0000-0002-6930-2002	National Science Foundation [Graduate Research Fellowship, EAR-0819953]; Division Of Earth Sciences [0819953] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded in part by a National Science Foundation Graduate Research Fellowship and a National Science Foundation grant (EAR-0819953) to AAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro TM, 2003, BEHAV ECOL SOCIOBIOL, V55, P32, DOI 10.1007/s00265-003-0672-6; FARK AA, 2004, PALAEONTOL ELECT, V7; Farke AA, 2007, J VERTEBR PALEONTOL, V27, P724, DOI 10.1671/0272-4634(2007)27[724:ROPIPA]2.0.CO;2; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FROSTER CA, 1996, J VERTEBRATE PALEONT, V16, P246; Happ John, 2008, P354; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Kumar V., 2004, ROBBINS COTRAN PATHO; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Lull RS, 1908, AM J SCI, V25, P387; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; McGavin M.D., 2006, PATHOLOGIC BASIS VET; MOLNAR R E, 1977, Evolutionary Theory, V3, P165; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Sokal RR, 1995, BIOMETRY; Tanke D.H., 2006, HORNS BEAKS CERATOPS, P319; TANKE DH, NEW PERSPEC IN PRESS	17	45	46	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4252	10.1371/journal.pone.0004252	http://dx.doi.org/10.1371/journal.pone.0004252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172995	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483000001
J	Murphy, TM; Belmonte, M; Shu, S; Britt, AB; Hatteroth, J				Murphy, Terence M.; Belmonte, Mark; Shu, Stephanie; Britt, Anne B.; Hatteroth, James			Requirement for Abasic Endonuclease Gene Homologues in Arabidopsis Seed Development	PLOS ONE			English	Article							DNA GLYCOSYLASE DOMAIN; REPAIR; METHYLATION; DEMETER; ENDOSPERM; PROTEIN; APN1	Arabidopsis thaliana has three genes, Ape1L, Ape2, and Arp, that show homology to abasic (apurinic/apyrimidinic) endonuclease genes of bacterial, yeast, or animal cells. In bacteria, yeast, and animals, abasic endonucleases function in base excision repair of oxidized and other modified DNA bases. Here we report that plants with knock-out mutations in any one of Ape1L, Ape2, or Arp show no apparent differences from wild type in growth rate, growth habit, and fertility. However, coincident knock-out mutations in Ape1L and Ape2 are lethal and lead to abortion of developing embryos. Mutations of Arp are not deleterious, even in combination with one of the other two mutations. The results are consistent with the interpretation that the process of base excision repair, involving at least one intact copy of Ape1L or Ape2, is required in the process of embryogenesis.	[Murphy, Terence M.; Belmonte, Mark; Shu, Stephanie; Britt, Anne B.; Hatteroth, James] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Murphy, TM (corresponding author), Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA.	tmmurphy@ucdavis.edu			Natural Sciences and Engineering Research Council of Canada postdoctoral [fellowship]	Natural Sciences and Engineering Research Council of Canada postdoctoral(Natural Sciences and Engineering Research Council of Canada (NSERC))	MB was supported by a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, DEVELOPMENT, V127, P2493; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Britt A. B., 2002, ARABIDOPSIS BOOK; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Choi Y, 2004, P NATL ACAD SCI USA, V101, P7481, DOI 10.1073/pnas.0402328101; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Kimura S, 2006, CHEM REV, V106, P753, DOI 10.1021/cr040482n; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; KUNZ BA, 1994, P NATL ACAD SCI USA, V91, P8165, DOI 10.1073/pnas.91.17.8165; Liedl B. E., 1993, Plant Molecular Biology Reporter, V11, P194, DOI 10.1007/BF02669844; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murphy TM, 2005, PHYSIOL PLANTARUM, V123, P227, DOI 10.1111/j.1399-3054.2005.00453.x; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Ramotar D, 1997, BIOCHEM CELL BIOL, V75, P327, DOI 10.1139/bcb-75-4-327; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sorensen MB, 1996, MOL GEN GENET, V250, P750, DOI 10.1007/BF02172987; SORENSEN MB, 1992, P NATL ACAD SCI USA, V89, P4119, DOI 10.1073/pnas.89.9.4119; Wang D, 2004, MOL CANCER THER, V3, P679; Wang Y, 2006, MOL CELL BIOL, V26, P9083, DOI 10.1128/MCB.01216-06; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836	23	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4297	10.1371/journal.pone.0004297	http://dx.doi.org/10.1371/journal.pone.0004297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172180	Green Published, gold			2022-12-25	WOS:000265482900012
J	Ingram, RJ; Isaacs, JD; Kaur, G; Lowther, DE; Reynolds, CJ; Boyton, RJ; Collinge, J; Jackson, GS; Altmann, DM				Ingram, Rebecca J.; Isaacs, Jeremy D.; Kaur, Gurman; Lowther, Daniel E.; Reynolds, Catherine J.; Boyton, Rosemary J.; Collinge, John; Jackson, Graham S.; Altmann, Daniel M.			A role of cellular prion protein in programming T-cell cytokine responses in disease	FASEB JOURNAL			English	Article						T lymphocyte; knockout mouse; Th17	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOCYTE-ACTIVATION; SIGNAL-TRANSDUCTION; PROTEOLIPID PROTEIN; DENDRITIC CELLS; PRP GENE; MICE; EXPRESSION; SCRAPIE; INDUCTION	The cellular prion protein (PrPC) is widely expressed in neural and non-neural tissues, but its function is unknown. Elucidation of the part played by PrPC in adaptive immunity has been a particular conundrum: increased expression of cell surface PrPC has been documented during T-cell activation, yet the functional significance of this activation remains unclear, with conflicting data on the effects of Prnp gene knockout on various parameters of T-cell immunity. We show here that Prnp mRNA is highly inducible within 8-24 h of T-cell activation, with surface protein levels rising from 24 h. When measured in parallel with CD69 and CD25, PrPC is a late activation antigen. Consistent with its up-regulation being a late activation event, PrP deletion did not alter T-cell-antigen presenting cell conjugate formation. Most important, activated PrP0/0 T cells demonstrated much reduced induction of several T helper (Th) 1, Th2, and Th17 cytokines, whereas others, such as TNF-alpha and IL-9, were unaffected. These changes were investigated in the context of an autoimmune model and a bacterial challenge model. In experimental autoimmune encephalomyelitis, PrP-knockout mice showed enhanced disease in the face of reduced IL-17 responses. In a streptococcal sepsis model, this constrained cytokine program was associated with poorer local control of infection, although with reduced bacteremia. The findings indicate that PrPC is a potentially important molecule influencing T-cell activation and effector function-Ingram, R. J., Isaacs, J. D., Kaur, G., Lowther, D. E., Reynolds, C. J., Boyton, R. J., Collinge, J., Jackson, G. S., Altmann, D. M. A role of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J. 23, 1672-1684 (2009)	[Ingram, Rebecca J.; Isaacs, Jeremy D.; Kaur, Gurman; Lowther, Daniel E.; Altmann, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Infect Dis & Immun, Human Dis Immunogenet Grp, London W12 0NN, England; [Isaacs, Jeremy D.; Collinge, John; Jackson, Graham S.] UCL, Dept Neurodegenerat Dis, Inst Neurol, MRC Pr Unit, London, England; [Reynolds, Catherine J.; Boyton, Rosemary J.] Univ London Imperial Coll Sci Technol & Med, Lung Immunol Grp, Immunol & Infect NHLI, London W12 0NN, England	Imperial College London; University of London; University College London; Imperial College London	Altmann, DM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Infect Dis & Immun, Human Dis Immunogenet Grp, Du Cane Rd, London W12 0NN, England.	d.altmann@imperial.ac.uk	Ingram, Rebecca J/F-9711-2013	Ingram, Rebecca J/0000-0003-1832-2457; Kaur, Gurman/0000-0001-7722-3956; Jackson, Graham/0000-0002-3125-2011; Altmann, Daniel/0000-0002-2436-6192	UK Medical Research Council (MRC) Clinical Research Training Fellowship; Medical Research Council [G108/495, G0700153, MC_U123170362, G0400503B, MC_U123192748] Funding Source: researchfish; MRC [MC_U123192748, G108/495, MC_U123170362, G0700153] Funding Source: UKRI	UK Medical Research Council (MRC) Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK Medical Research Council (MRC) Clinical Research Training Fellowship awarded to J.D.I. The authors thank Professor S. Sriskandan for access to the streptococcal model and Ray Young of the MRC Prion Unit for assistance with artwork. John Collinge and Graham S. Jackson are shareholders and John Collinge is a Director of D-Gen Ltd., an MRC spinoff company that manufactures ICSM18, an anti-PrP monoclonal antibody used in this study.	Antoine N, 2000, HAEMATOLOGICA, V85, P475; Bainbridge J, 2005, IMMUNOL LETT, V96, P147, DOI 10.1016/j.imlet.2004.08.006; Ballerini C, 2006, J IMMUNOL, V176, P7254, DOI 10.4049/jimmunol.176.12.7254; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Ellmerich S, 2005, J IMMUNOL, V174, P1938, DOI 10.4049/jimmunol.174.4.1938; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 2000, MICROSC RES TECHNIQ, V50, P76, DOI 10.1002/1097-0029(20000701)50:1<76::AID-JEMT11>3.0.CO;2-#; Genoud N, 2004, P NATL ACAD SCI USA, V101, P4198, DOI 10.1073/pnas.0400131101; Hofstetter HH, 2007, J IMMUNOL, V178, P1372, DOI 10.4049/jimmunol.178.3.1372; Holada K, 1998, BRIT J HAEMATOL, V103, P276, DOI 10.1046/j.1365-2141.1998.01032.x; Hugel B, 2004, CELL MOL LIFE SCI, V61, P2998, DOI 10.1007/s00018-004-4318-2; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Isaacs JD, 2008, IMMUNOLOGY, V125, P313, DOI 10.1111/j.1365-2567.2008.02853.x; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kubosaki A, 2001, BIOCHEM BIOPH RES CO, V282, P103, DOI 10.1006/bbrc.2001.4538; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Lin T, 2001, J IMMUNOL, V166, P3733; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mabbott NA, 1997, IMMUNOLOGY, V92, P161, DOI 10.1046/j.1365-2567.1997.00331.x; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Mazzoni IE, 2005, BIOCHEM CELL BIOL, V83, P644, DOI 10.1139/o05-058; McBride SM, 2005, MED HYPOTHESES, V65, P570, DOI 10.1016/j.mehy.2005.02.038; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Paar C, 2007, EUR J CELL BIOL, V86, P253, DOI 10.1016/j.ejcb.2007.03.001; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Premzl M, 2005, GENE, V349, P121, DOI 10.1016/j.gene.2004.11.049; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Sriskandan S, 2001, J INFECT DIS, V184, P166, DOI 10.1086/322018; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; TUOHY VK, 1992, J NEUROIMMUNOL, V39, P67, DOI 10.1016/0165-5728(92)90175-K; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	53	21	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1672	1684		10.1096/fj.08-116087	http://dx.doi.org/10.1096/fj.08-116087			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19204074	Green Submitted			2022-12-25	WOS:000266652400007
J	Cho, IT; Kim, DH; Kang, YH; Lee, CH; Amangyelid, T; Nguyen, TA; Hurwitz, J; Seo, YS				Cho, Il-taeg; Kim, Do-hyung; Kang, Young-Hoon; Lee, Chul-Hwan; Amangyelid, Tamir; Nguyen, Tuan Anh; Hurwitz, Jerard; Seo, Yeon-Soo			Human Replication Factor C Stimulates Flap Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-DELTA; ATP UTILIZATION; SACCHAROMYCES-CEREVISIAE; OKAZAKI FRAGMENTS; COMPLEX-FORMATION; GENOME STABILITY; SYNDROME PROTEIN; EXCISION-REPAIR; HUMAN FEN1	Flap endonuclease 1 (FEN1) is the enzyme responsible for specifically removing the flap structure produced during DNA replication, repair, and recombination. Here we report that the human replication factor C(RFC) complex stimulates the nuclease activity of human FEN1 in an ATP-independent manner. Although proliferating cell nuclear antigen is also known to stimulate FEN1, less RFC was required for comparable FEN1 stimulation. Kinetic analyses indicate that the mechanism by which RFC stimulates FEN1 is distinct from that by proliferating cell nuclear antigen. Heat-denatured RFC or its subunit retained, fully or partially, the ability to stimulate FEN1. Via systematic deletion analyses, we have defined three specific regions of RFC4 capable of stimulating FEN1. The region of RFC4 with the highest activity spans amino acids 170-194 and contains RFC box VII. Four amino acid residues (i.e. Tyr-182, Glu-188, Pro-189, and Ser-192) are especially important for FEN1 stimulatory activity. Thus, RFC, via several stimulatory motifs per molecule, potently activates FEN1. This function makes RFC a critical partner with FEN1 for the processing of eukaryotic Okazaki fragments.	[Cho, Il-taeg; Kim, Do-hyung; Kang, Young-Hoon; Lee, Chul-Hwan; Amangyelid, Tamir; Nguyen, Tuan Anh; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea; [Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Korea Advanced Institute of Science & Technology (KAIST); Memorial Sloan Kettering Cancer Center	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100; Nguyen, Tuan Anh/0000-0001-7793-2699	Ministry of Education, Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation grants funded by the Ministry of Education, Science and Technology.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Greene AL, 1999, HUM MOL GENET, V8, P2263, DOI 10.1093/hmg/8.12.2263; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kang YH, 2009, J BIOL CHEM, V284, P10376, DOI 10.1074/jbc.M808894200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Miyata T, 2004, NAT STRUCT MOL BIOL, V11, P632, DOI 10.1038/nsmb788; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Sharma S, 2004, HUM MOL GENET, V13, P2247, DOI 10.1093/hmg/ddh234; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wu XH, 1999, NUCLEIC ACIDS RES, V27, P956, DOI 10.1093/nar/27.4.956; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	62	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10387	10399		10.1074/jbc.M808893200	http://dx.doi.org/10.1074/jbc.M808893200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208620	hybrid, Green Published			2022-12-25	WOS:000265104600013
J	Grou, CP; Carvalho, AF; Pinto, MP; Huybrechts, SJ; Sa-Miranda, C; Fransen, M; Azevedo, JE				Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Huybrechts, Sofie J.; Sa-Miranda, Clara; Fransen, Marc; Azevedo, Jorge E.			Properties of the Ubiquitin-Pex5p Thiol Ester Conjugate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL CYCLING RECEPTOR; HUMAN PTS1 RECEPTOR; IMPORT RECEPTOR; PROTEIN IMPORT; CONSERVED CYSTEINE; ZELLWEGER-SYNDROME; PEX5P; UBIQUITINATION; MEMBRANE; IDENTIFICATION	Pex5p, the peroxisomal protein cycling receptor, binds newly synthesized peroxisomal matrix proteins in the cytosol and promotes their translocation across the organelle membrane. During its transient passage through the membrane, Pex5p is monoubiquitinated at a conserved cysteine residue, a requisite for its subsequent ATP-dependent export back into the cytosol. Here we describe the properties of the soluble and membrane-bound monoubiquitinated Pex5p species (Ub-Pex5p). Our data suggest that 1) Ub-Pex5p is deubiquitinated by a combination of context-dependent enzymatic and nonenzymatic mechanisms; 2) soluble Ub-Pex5p retains the capacity to interact with the peroxisomal import machinery in a cargo-dependent manner; and 3) substitution of the conserved cysteine residue of Pex5p by a lysine results in a quite functional protein both in vitro and in vivo. Additionally, we show that MG132, a proteasome inhibitor, blocks the import of a peroxisomal reporter protein in vivo.	[Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Azevedo, Jorge E.] Inst Ciencias Biomed Abel Salazar ICBAS, P-4009003 Oporto, Portugal; [Huybrechts, Sofie J.; Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, Fac Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Azevedo, Jorge E/A-4113-2008; Fransen, Marc/C-6262-2008; Fransen, Marc/ADL-0723-2022; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013; Carvalho, Andreia/J-9013-2015; sá Miranda, Maria Clara/K-3920-2013	Azevedo, Jorge E/0000-0001-7714-5302; Fransen, Marc/0000-0001-9284-1197; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Carvalho, Andreia/0000-0001-8781-5680; sá Miranda, Maria Clara/0000-0003-0123-5525	Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union [LSHG-CT-2004-512018]; Flemish Government Geconcerteerde Onderzoeksacties [GOA2004/08]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject [G.0237.04]	Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union(European Commission); Flemish Government Geconcerteerde Onderzoeksacties; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject(FWO)	The work done in Porto was supported by grants from Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos) and Fundo Europeu de Desenvolvimento Regional, Portugal, and by the European Union VI Framework program Grant LSHG-CT-2004-512018, Peroxisomes in Health and Disease. The work done in Leuven was supported by Flemish Government Geconcerteerde Onderzoeksacties Grant GOA2004/08 and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject Grant G.0237.04.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Esteban-Pretel G, 2006, FREE RADICAL BIO MED, V41, P610, DOI 10.1016/j.freeradbiomed.2006.05.004; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Haas AL, 1997, FASEB J, V11, P1257; Haddad JJE, 2000, AM J PHYSIOL-LUNG C, V278, pL492, DOI 10.1152/ajplung.2000.278.3.L492; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Huybrechts SJ, 2008, J MED GENET, V45, P376, DOI 10.1136/jmg.2007.056697; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lindorff-Larsen K, 2000, ANAL BIOCHEM, V286, P308, DOI 10.1006/abio.2000.4807; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROSE IA, 1983, BIOCHEMISTRY-US, V22, P4234, DOI 10.1021/bi00287a012; Strajbl M, 2000, INT J QUANTUM CHEM, V77, P44, DOI 10.1002/(SICI)1097-461X(2000)77:1<44::AID-QUA6>3.0.CO;2-A; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	56	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10504	10513		10.1074/jbc.M808978200	http://dx.doi.org/10.1074/jbc.M808978200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208625	Green Published, hybrid			2022-12-25	WOS:000265104600024
J	Mikkelsen, SS; Jensen, SB; Chiliveru, S; Melchjorsen, J; Julkunen, I; Gaestel, M; Arthur, JSC; Flavell, RA; Ghosh, S; Paludan, SR				Mikkelsen, Susie S.; Jensen, Sren B.; Chiliveru, Srikanth; Melchjorsen, Jesper; Julkunen, Ilkka; Gaestel, Matthias; Arthur, J. Simon C.; Flavell, Richard A.; Ghosh, Sankar; Paludan, Sren R.			RIG-I-mediated Activation of p38 MAPK Is Essential for Viral Induction of Interferon and Activation of Dendritic Cells DEPENDENCE ON TRAF2 AND TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HELICASE ANTIVIRAL PATHWAY; NF-KAPPA-B; IMMUNE-RESPONSES; ADAPTER PROTEIN; TNF-ALPHA; SIGNALING PATHWAYS; GENE-EXPRESSION; INNATE; KINASE	The innate immune system provides an initial defense system against microbial infections and contributes to the development of adaptive immune response. Type I interferons play a pivotal role for the first line of defense against virus infections, and dendritic cells (DCs) are important sensors of pathogens responsible for priming of adaptive immune responses in lymphoid organs. Here we have investigated the role and mechanisms of activation of the MAPK pathway in innate immune responses induced by Sendai virus, a negative sense single-stranded RNA virus. Both p38 and JNK were activated in fibroblasts and DCs after infection with Sendai virus in a manner dependent on virus replication and RIG-I. Virus replication was also required for stimulation of interferon production in both cell types and interleukin-12 production in DCs. Blocking of p38 MAPK activation by the specific inhibitor SB202190 abolished the expression of these cytokines. p38 MAPK exerted its function independent of the MAPK-activated protein kinases MK2, MNK, and MSK1/2. We also observed that TRAF2 and TAK1 were essential for RIG-I-mediated activation of p38 MAPK. Interestingly, the kinase activity of p38 MAPK was required for its own phosphorylation, which was kinetically associated with TAB1 interaction. By contrast, the canonical p38 upstream kinase MKK3 was not involved in the p38-dependent response. Thus, activation of p38 MAPK by RIG-I proceeds via a TRAF2-TAK1-dependent pathway, where the enzymatic activity of the kinase plays an essential role. The p38 MAPK in turn stimulates important processes in the innate antiviral response.	[Mikkelsen, Susie S.; Jensen, Sren B.; Chiliveru, Srikanth; Melchjorsen, Jesper; Paludan, Sren R.] Univ Aarhus, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Melchjorsen, Jesper] Skejby Hosp, Dept Infect Dis, DK-8200 Aarhus, Denmark; [Julkunen, Ilkka] Natl Publ Hlth Inst, Dept Virus Dis & Immunol, FI-00300 Helsinki, Finland; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Arthur, J. Simon C.] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Flavell, Richard A.; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Aarhus University; Aarhus University; Finland National Institute for Health & Welfare; Hannover Medical School; University of Dundee; Yale University; Howard Hughes Medical Institute; Yale University	Paludan, SR (corresponding author), Univ Aarhus, Inst Med Microbiol & Immunol, Bartholin Bldg, DK-8000 Aarhus C, Denmark.	srp@microbiology.au.dk	Arthur, J. Simon/B-8058-2010; Gaestel, Matthias/A-6560-2013	Arthur, J. Simon/0000-0002-8135-1958; Gaestel, Matthias/0000-0002-4944-4652; Mikkelsen, Susie Sommer/0000-0003-1744-9106	Danish Medical Research Council [27106-0438]; Danish Natural Science Research Council [272-05-0222]; Lundbeck Foundation [116/06, R17-A1526]; Kathrine og Vigo Skovgards Fond; Aarhus University Research Foundation; Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University; Lundbeck Foundation [R17-2007-1526] Funding Source: researchfish; Medical Research Council [MC_U127081014] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; MRC [MC_U127081014] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Kathrine og Vigo Skovgards Fond; Aarhus University Research Foundation; Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Danish Medical Research Council Grant 27106-0438), Danish Natural Science Research Council Grant 272-05-0222, Lundbeck Foundation Grants 116/06 and R17-A1526, the Kathrine og Vigo Skovgards Fond, the Aarhus University Research Foundation, and the Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Mogensen TH, 2005, J MOL MED, V83, P180, DOI 10.1007/s00109-004-0620-6; OGANESYAN G, 2005, NATURE, V439, P211; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Petersen MS, 2000, SCAND J IMMUNOL, V51, P586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; SATO S, 2005, NAT IMMUNOL, V6, P2668; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yanagawa Y, 2002, J LEUKOCYTE BIOL, V71, P125; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	51	85	88	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10774	10782		10.1074/jbc.M807272200	http://dx.doi.org/10.1074/jbc.M807272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224920	Green Published, hybrid			2022-12-25	WOS:000265104600052
J	Wan, YZ; Xiao, H; Affolter, J; Kim, TW; Bulek, K; Chaudhuri, S; Carlson, D; Hamilton, T; Mazumder, B; Stark, GR; Thomas, J; Li, XX				Wan, Youzhong; Xiao, Hui; Affolter, Jeremy; Kim, Tae Whan; Bulek, Katarzyna; Chaudhuri, Sujan; Carlson, Deborah; Hamilton, Thomas; Mazumder, Barsanjit; Stark, George R.; Thomas, James; Li, Xiaoxia			Interleukin-1 Receptor-associated Kinase 2 Is Critical for Lipopolysaccharide-mediated Post-transcriptional Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INITIATION-FACTOR 4E; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; INNATE; PHOSPHORYLATION; MACROPHAGES; EXPRESSION; RESPONSIVENESS	IRAK2, a member of the interleukin-1 receptor-associated kinase (IRAK) family, has been implicated in Toll-like receptor (TLR)-mediated signaling. We generated IRAK2-deficient mice to examine its function in detail. These mice are resistant to lipopolysaccharide-induced septic shock, because of impaired TLR4-mediated induction of pro-inflammatory cytokines and chemokines. Although IRAK2 deficiency did not affect TLR4-mediated NF kappa B activation, a reduction of lipopolysaccharide (LPS)-mediated mRNA stabilization contributed to the reduced cytokine and chemokine production observed in bone marrow-derived macrophages from IRAK2-deficient mice. Furthermore, the ratios of LPS-induced cytokine and chemokine mRNAs in translation-active (polysomal) versus translation-inactive (free ribosomes) pools were reduced in IRAK2-deficient macrophages compared with wild type macrophages. Importantly, LPS-induced phosphorylation of MKK3/6, MNK1, and eIF4E was significantly reduced in IRAK2-deficient macrophages compared with wild type macrophages. Moreover, LPS stimulation induced an interaction of IRAK2 with TRAF6, MKK3/6, and MK2, implicating a critical role for mitogen-activated protein kinase signaling in LPS-induced IRAK2-mediated post-transcriptional control. These results reveal that IRAK2 is required for LPS-mediated post-transcriptional control of cytokine and chemokine expression, which plays an essential role in TLR4-induced septic shock.	[Xiao, Hui; Kim, Tae Whan; Bulek, Katarzyna; Hamilton, Thomas; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Wan, Youzhong; Stark, George R.] Cleveland Clin Fdn, Dept Mol Genet, Cleveland, OH 44195 USA; [Affolter, Jeremy; Carlson, Deborah; Thomas, James] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Affolter, Jeremy; Carlson, Deborah; Thomas, James] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chaudhuri, Sujan; Mazumder, Barsanjit] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Wan, Youzhong; Stark, George R.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Kim, Tae Whan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Cleveland State University; Case Western Reserve University; Case Western Reserve University	Thomas, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	james.thomas@utsouthwestern.edu; lix@ccf.org	Bulek, Katarzyna/L-7517-2015	Mazumder, Barsanjit/0000-0003-3069-7833; Hamilton, Thomas/0000-0002-9817-242X	National Institutes of Health [GM060020, RO1 AI50019, P50 GM021681, RO1 HL 79164]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020, P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060020 (to X.L.), RO1 AI50019 (to J.T.), P50 GM021681 (to J.T.), and RO1 HL 79164 (to B.M.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; MEDZHITOV R, 1997, NATURE, V388, P397; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	35	65	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10367	10375		10.1074/jbc.M807822200	http://dx.doi.org/10.1074/jbc.M807822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224918	Green Published, hybrid			2022-12-25	WOS:000265104600011
J	Dong, YM; Dimopoulos, G				Dong, Yuemei; Dimopoulos, George			Anopheles Fibrinogen-related Proteins Provide Expanded Pattern Recognition Capacity against Bacteria and Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNAIL BIOMPHALARIA-GLABRATA; INNATE IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; PLASMODIUM-FALCIPARUM; ANTIMICROBIAL PEPTIDE; GENE-EXPRESSION; LIFE-CYCLE; IN-VIVO; GAMBIAE; MOSQUITO	The fibrinogen-related protein family (FREP, also known as FBN) is an evolutionarily conserved immune gene family found in mammals and invertebrates. It is the largest pattern recognition receptor gene family in Anopheles gambiae, with as many as 59 putative members, while the Drosophila melanogaster genome has only 14 known FREP members. Our sequence and phylogenetic analysis suggest that this remarkable gene expansion in the mosquito is the result of tandem duplication of the fibrinogen domain. We found that the majority of the FREP genes displayed immune-responsive transcription after challenge with bacteria, fungi, or Plasmodium, and these expression patterns correlated strongly with gene phylogeny and chromosomal location. Using RNAi-mediated gene-silencing assays, we further demonstrated that some FREP members are essential factors of the mosquito innate immune system that are required for maintaining immune homeostasis, and members of this family have complementary and synergistic functions. One of the most potent anti-Plasmodium FREP proteins, FBN9, was found to interact with both Gram-negative and Gram-positive bacteria and strongly co-localized with both rodent and human malaria parasites in the mosquito midgut epithelium, suggesting that its defensive activity involves direct interaction with the pathogen. Interestingly, FBN9 formed dimers that bound to the bacterial surfaces with different affinities. Our findings indicate that the A. gambiae FREP gene family plays a central role in the mosquito innate immune system and provides an expanded pattern recognition and anti-microbial defense repertoire.	[Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), 615 N Wolfe Str Rm E4209, Baltimore, MD 21205 USA.	gdimopou@jhsph.edu		Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	NIAID [1R01AI061576-01A1]; Ellison Medical Foundation; World Health Organization/TDR; Johns Hopkins School of Public Health Faculty Innovation; Johns Hopkins Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); World Health Organization/TDR(World Health Organization); Johns Hopkins School of Public Health Faculty Innovation; Johns Hopkins Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI061576-01A1 from NIAID. This work was also supported by the Ellison Medical Foundation, the World Health Organization/TDR, a Johns Hopkins School of Public Health Faculty Innovation Grant, and the Johns Hopkins Malaria Research Institute.	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Benedict M. Q., 1997, The molecular biology of insect disease vectors: a methods manual., P3; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, CURR OPIN IMMUNOL, V16, P16, DOI 10.1016/j.coi.2003.11.010; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Carter R, 1993, Methods Mol Biol, V21, P67; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gorkun OV, 1997, BLOOD, V89, P4407, DOI 10.1182/blood.V89.12.4407; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; KOBAYASHI R, 1994, BIOCHEM BIOPH RES CO, V198, P1262, DOI 10.1006/bbrc.1994.1178; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Kurtz J, 2006, TRENDS IMMUNOL, V27, P493, DOI 10.1016/j.it.2006.09.001; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Perovic-Ottstadt S, 2004, EUR J BIOCHEM, V271, P1924, DOI 10.1111/j.1432-1033.2004.04102.x; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang X, 2004, INSECT MOL BIOL, V13, P273, DOI 10.1111/j.0962-1075.2004.00484.x; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang SM, 2008, INNATE IMMUN-LONDON, V14, P175, DOI 10.1177/1753425908093800; Zhang SM, 2008, DEV COMP IMMUNOL, V32, P1119, DOI 10.1016/j.dci.2008.03.001; Zhang SM, 2004, GENE, V341, P255, DOI 10.1016/j.gene.2004.07.003; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang SM, 2003, DEV COMP IMMUNOL, V27, P175, DOI 10.1016/S0145-305X(02)00091-5	65	149	156	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9835	9844		10.1074/jbc.M807084200	http://dx.doi.org/10.1074/jbc.M807084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193639	hybrid, Green Published			2022-12-25	WOS:000264892900024
J	Koksal, AC; Nardozzi, JD; Cingolani, G				Koksal, Adem C.; Nardozzi, Jonathan D.; Cingolani, Gino			Dimeric Quaternary Structure of the Prototypical Dual Specificity Phosphatase VH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS; TYROSINE PHOSPHORYLATION; PROTEIN PHOSPHATASES; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; H1 PHOSPHATASE; DNA-BINDING; IN-VITRO; STAT1; DEPHOSPHORYLATION	The Vaccinia virus H1 gene product, VH1, is a dual specificity phosphatase that down-regulates the cellular antiviral response by dephosphorylating STAT1. The crystal structure of VH1, determined at 1.32 angstrom resolution, reveals a novel dimeric quaternary structure, which exposes two active sites spaced similar to 39 angstrom away from each other. VH1forms a stable dimer via an extensive domain swap of the N-terminal helix ( residues 1-20). In vitro, VH1 can dephosphorylate activated STAT1, in a reaction that is competed by the nuclear transport adapter importin alpha 5. Interestingly, VH1 is inactive with respect to STAT1 bound to DNA, suggesting that the viral phosphatase acts predominantly on the cytoplasmic pool of activated STAT1. We propose that the dimeric quaternary structure of VH1 is essential for specific recognition of activated STAT1, which prevents its nuclear translocation, thus blocking interferon-gamma signal transduction and antiviral response.	[Koksal, Adem C.; Nardozzi, Jonathan D.; Cingolani, Gino] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cingolani, G (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cingolag@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765; Koksal, Adem/0000-0002-3163-7421	National Institutes of Health [GM074846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846.	Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Becker S, 1998, FEBS LETT, V441, P141, DOI 10.1016/S0014-5793(98)01543-9; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W, 2002, PYMOL 0 99; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Krause CD, 2007, CYTOKINE GROWTH F R, V18, P473, DOI 10.1016/j.cytogfr.2007.06.009; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phan J, 2007, ACTA CRYSTALLOGR D, V63, P698, DOI 10.1107/S0907444907014904; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; VERLINDE CLMJ, 1991, EUR J BIOCHEM, V198, P53, DOI 10.1111/j.1432-1033.1991.tb15985.x; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	34	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10129	10137		10.1074/jbc.M808362200	http://dx.doi.org/10.1074/jbc.M808362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211553	Green Published, hybrid			2022-12-25	WOS:000264892900055
J	Furlow, PW; Percy, MJ; Sutherland, S; Bierl, C; McMullin, MF; Master, SR; Lappin, TRJ; Lee, FS				Furlow, Paul W.; Percy, Melanie J.; Sutherland, Scott; Bierl, Charlene; McMullin, Mary Frances; Master, Stephen R.; Lappin, Terence R. J.; Lee, Frank S.			Erythrocytosis-associated HIF-2 alpha Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUMOR-SUPPRESSOR GENE; FAMILIAL ERYTHROCYTOSIS; CONGENITAL POLYCYTHEMIA; OXYGEN HOMEOSTASIS; DOMAIN PROTEIN-2; HIF2A GENE; HYDROXYLATION; HIF-1-ALPHA; PHD2	A classic physiologic response to hypoxia in humans is the up-regulation of the ERYTHROPOIETIN (EPO) gene, which is the central regulator of red blood cell mass. The EPO gene, in turn, is activated by hypoxia inducible factor (HIF). HIF is a transcription factor consisting of an alpha subunit (HIF-alpha) and a beta subunit (HIF-beta). Under normoxic conditions, prolyl hydroxylase domain protein (PHD, also known as HIF prolyl hydroxylase and egg laying-defective nine protein) site specifically hydroxylates HIF-alpha in a conserved LXXLAP motif (where underlining indicates the hydroxylacceptor proline). This provides a recognition motif for the von Hippel Lindau protein, a component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha for degradation. Under hypoxic conditions, this inherently oxygen-dependent modification is arrested, thereby stabilizing HIF-alpha and allowing it to activate the EPO gene. We previously identified and characterized an erythrocytosis-associated HIF2A mutation, G537W. More recently, we reported two additional erythrocytosis-associated HIF2A mutations, G537R and M535V. Here, we describe the functional characterization of these two mutants as well as a third novel erythrocytosis-associated mutation, P534L. These mutations affect residues C-terminal to the LXXLAP motif. We find that all result in impaired degradation and thus aberrant stabilization of HIF-2 alpha. However, each exhibits a distinct profile with respect to their effects on PHD2 binding and von Hippel Lindau interaction. These findings reinforce the importance of HIF-2 alpha in human EPO regulation, demonstrate heterogeneity of functional defects arising from these mutations, and point to a critical role for residues C-terminal to the LXXLAP motif in HIF-alpha.	[Furlow, Paul W.; Sutherland, Scott; Bierl, Charlene; Master, Stephen R.; Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Percy, Melanie J.; McMullin, Mary Frances] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [McMullin, Mary Frances; Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7AB, Antrim, North Ireland	University of Pennsylvania; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	McMullin, Mary F/AAF-6472-2020; McMullin, Mary Frances/AAG-6078-2021	McMullin, Mary Frances/0000-0002-0773-0204; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X; Furlow, Paul/0000-0002-0754-4962	National Institutes of Health [R01-CA090261]; University of Pennsylvania Research Foundation; NATIONAL CANCER INSTITUTE [R01CA090261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01-CA090261 (to F.S.L.). This work was also supported by a University of Pennsylvania Research Foundation grant (to F.S.L.).	Al-Sheikh M, 2008, BLOOD CELL MOL DIS, V40, P160, DOI 10.1016/j.bcmd.2007.07.017; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Cario H, 2005, HAEMATOLOGICA, V90, P19; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gordeuk VR, 2005, HAEMATOLOGICA, V90, P109; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Lee FS, 2008, BLOOD REV, V22, P321, DOI 10.1016/j.blre.2008.04.003; Lee FS, 2006, CELL CYCLE, V5, P941, DOI 10.4161/cc.5.9.2723; Linke S, 2007, METHOD ENZYMOL, V435, P61, DOI 10.1016/S0076-6879(07)35004-0; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Percy MJ, 2008, HAEMATOL-HEMATOL J, V93, P963, DOI 10.3324/haematol.13250; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Percy MJ, 2003, BLOOD, V102, P1097, DOI 10.1182/blood-2002-10-3246; PERCY MJ, 2008, BLOOD, V112, P481; Perrotta S, 2006, BLOOD, V107, P514, DOI 10.1182/blood-2005-06-2422; Perrotta S, 2008, NEW ENGL J MED, V358, P1966; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	37	43	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9050	9058		10.1074/jbc.M808737200	http://dx.doi.org/10.1074/jbc.M808737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208626	Green Published, hybrid			2022-12-25	WOS:000264669100007
J	Gyamfi, MA; Wan, YJY				Gyamfi, Maxwell Afari; Wan, Yu-Jui Yvonne			Mechanisms of Resistance of Hepatocyte Retinoid X Receptor alpha-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; PPAR-ALPHA; PEROXISOME PROLIFERATORS; DEFICIENT MICE; BILE-ACIDS; RXR-ALPHA; LIPOPROTEIN METABOLISM; MEDIATED PATHWAYS; GENE-EXPRESSION; LIVER-INJURY	Peroxisome proliferators, such as the lipid-lowering fibrates that function as agonists for peroxisome proliferator-activated receptor alpha (PPAR alpha), induce liver tumors in rodents and may produce cholestasis in humans. Considerable attention has focused on peroxisome proliferator-induced hepatocellular carcinoma, a phenomenon not noted in man, whereas limited studies examine fibrates and other therapeutic drugs that induce cholestasis, a common finding in humans. Moreover, the mechanisms by which fibrates induce hepatocyte proliferation and cholestasis are still not fully understood. We have examined the role of hepatocyte retinoid X receptor alpha (RXR alpha), an essential partner of PPAR alpha, in modulating WY-14,643-induced hepatocyte proliferation and cholestasis. WY-14,643 treatment induced hepatomegaly in wild type (WT) mice that was also accompanied by induction of the expression of cyclins D1, D3, A2, and B1 and Cdc2 as well as inhibition of Wee 1. Such changes were either absent or greatly reduced in hepatocyte RXR alpha-null mice. Furthermore, neither WY-14,643 treatment nor RXR alpha deficiency affected apoptosis, indicating the importance of PPAR alpha/RXR alpha in regulating Wee 1-mediated Cdc2/cyclin B1 expression for cells to enter into mitosis. WY-14,643 treatment also induced cholestasis and liver injury, which is evidenced by induction of alanine aminotransferase, alkaline phosphatase, and hepatic bile acid levels in WT mice. Hepatocyte RXR alpha deficiency protected the mice from WY-14,643-induced liver injury. WY-14,643-mediated induction of the small heterodimer partner, Mrp3, and Cyp3a11 levels was greater in hepatocyte RXR alpha-null than in WT mouse livers suggesting enhanced repression of bile acid synthesis and increased efflux of bile acids into blood for renal excretion as well as hydroxylation of bile acids because of hepatocyte RXR alpha deficiency. These data establish a crucial role of hepatocyte RXR alpha in regulating WY-14,643-mediated cell cycle progression as well as bile acid homeostasis.	[Gyamfi, Maxwell Afari; Wan, Yu-Jui Yvonne] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Wan, YJY (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	ywan@kumc.edu			National Institutes of Health [AA14147, CA53596, AA12081, P20RR021940]; NATIONAL CANCER INSTITUTE [R29CA053596, R01CA053596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012081, R01AA014147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA14147, CA53596, AA12081, and P20RR021940. The costs of publication of this article were defrayed in part by the payment of page charges.	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai Y, 2002, EUR J PHARM SCI, V15, P89, DOI 10.1016/S0928-0987(01)00211-1; Cattley Russell C, 2004, Toxicol Pathol, V32 Suppl 2, P6, DOI 10.1080/01926230490451680; Cherrington NJ, 2003, DRUG METAB DISPOS, V31, P1315, DOI 10.1124/dmd.31.11.1315; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chung JG, 2001, CARCINOGENESIS, V22, P1213, DOI 10.1093/carcin/22.8.1213; Dohmen K, 2005, WORLD J GASTROENTERO, V11, P7702, DOI 10.3748/wjg.v11.i48.7702; GARIOT P, 1983, ARCH TOXICOL, V53, P151; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; INESTROSA NC, 1979, BIOCHEM J, V182, P779, DOI 10.1042/bj1820779; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lucena MI, 2006, WORLD J GASTROENTERO, V12, P5244; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; MARSMAN DS, 1988, CANCER RES, V48, P6739; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Phillips A, 2005, DRUG METAB DISPOS, V33, P233, DOI 10.1124/dmd.104.001461; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Roberts RA, 2000, TOXICOL LETT, V112, P49, DOI 10.1016/S0378-4274(99)00243-X; Roberts RA, 2001, TOXICOL LETT, V120, P301, DOI 10.1016/S0378-4274(01)00282-X; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Schoonjans K, 1996, J LIPID RES, V37, P907; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; TSUDA H, 1984, GANN, V75, P871; URA H, 1987, JPN J CANCER RES, V78, P216; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wan YJY, 2003, ENDOCRINOLOGY, V144, P605, DOI 10.1210/en.2002-221003; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; West DA, 1999, HEPATOLOGY, V30, P1417, DOI 10.1002/hep.510300612; WOLOWIEC D, 1995, INT J CANCER, V61, P381; Wu Y, 2004, EXP MOL PATHOL, V76, P24, DOI 10.1016/j.yexmp.2003.10.009; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005	46	12	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9321	9330		10.1074/jbc.M808861200	http://dx.doi.org/10.1074/jbc.M808861200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176532	Green Published, hybrid			2022-12-25	WOS:000264669100038
J	Noh, YH; Baek, JY; Jeong, W; Rhee, SG; Chang, TS				Noh, You Hyun; Baek, Jin Young; Jeong, Woojin; Rhee, Sue Goo; Chang, Tong-Shin			Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; DEPENDENT PEROXIDE REDUCTASE; OXIDATIVE STRESS; LIFE-SPAN; MAMMALIAN PEROXIREDOXIN; SITE CYSTEINE; GENE PROTECTS; ACTIVE-SITE; ANTIOXIDANT; EXPRESSION	The mitochondria are the major intracellular source of reactive oxygen species (ROS), which are generated during cellular respiration. The role of peroxiredoxin (Prx) III, a 2-Cys Prx family member, in the scavenging of mitochondrial H2O2 has recently been emphasized. While eliminating H2O2, Prx can become overoxidized and inactivated by modifying the active cysteine into cysteine sulfinic acid (Cys-SO2H). When 2-Cys Prxs are inactivated in vitro, sulfiredoxin (Srx) reduces the cysteine sulfinic acid to cysteines. However, whereas Srx is localized in the cytoplasm, Prx III is present exclusively in the mitochondria. Although Srx reduces sulfinic Prx III in vitro, it remains unclear whether the reduction of Prx III in cells is actually mediated by Srx. Our gain- and loss-of-function experiments show that Srx is responsible for reducing not only sulfinic cytosolic Prxs (I and II) but also sulfinic mitochondrial Prx III. We further demonstrate that Srx translocates from the cytosol to mitochondria in response to oxidative stress. Overexpression of mitochondrion-targeted Srx promotes the regeneration of sulfinic Prx III and results in cellular resistance to apoptosis, with enhanced elimination of mitochondrial H2O2 and decreased rates of mitochondrial membrane potential collapse. These results indicate that Srx plays a crucial role in the reactivation of sulfinic mitochondrial Prx III and that its mitochondrial translocation is critical in maintaining the balance between mitochondrial H2O2 production and elimination.	[Noh, You Hyun; Baek, Jin Young; Jeong, Woojin; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Chang, TS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Sci Bldg C,11-1 Daehyun Dong, Seoul 120750, South Korea.	changts@ewha.ac.kr			Korea Research Foundation funded by the Korean government [KRF-2006-331-C00195]; Korea Science and Engineering Foundation; Bio R& D Program funded by the Korean government [M10642040002-07N4204- 00210]; National Core Research Center program of the MEST, KOSEF [R15-2006-020]	Korea Research Foundation funded by the Korean government(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Bio R& D Program funded by the Korean government; National Core Research Center program of the MEST, KOSEF(Korea Science and Engineering Foundation)	This work was supported by the Korea Research Foundation funded by the Korean government ( the Ministry of Education and Human Resources Development, Grant KRF-2006-331-C00195 to T. S. C.), an Ewha Womans University Research Grant for 2005 ( to T. S. C.), the Korea Science and Engineering Foundation ( KOSEF) Bio R& D Program funded by the Korean government ( MEST, Grant M10642040002-07N4204- 00210 to T. S. C.), Grant R15-2006-020 from the National Core Research Center program of the MEST, KOSEF through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University, the SeoulR& BDProgram ( Grant 10527 to T. S. C.), and the second stage of the Brain Korea 21 Project ( to Y. H. N. and J. Y. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Halliwell B., 2007, FREE RADICAL BIO MED, P488; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Li LQ, 2008, FEBS LETT, V582, P2431, DOI 10.1016/j.febslet.2008.05.050; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nonn L, 2003, MOL CANCER RES, V1, P682; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	54	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8470	8477		10.1074/jbc.M808981200	http://dx.doi.org/10.1074/jbc.M808981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176523	Green Published, hybrid			2022-12-25	WOS:000264397800031
J	Scholl, FA; Dumesic, PA; Barragan, DI; Charron, J; Khavari, PA				Scholl, F. A.; Dumesic, P. A.; Barragan, D. I.; Charron, J.; Khavari, P. A.			Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin	ONCOGENE			English	Article						MAP kinase; Mek; Ras; cancer; apoptosis	EPIDERMAL HYPERPLASIA; TRANSGENIC MICE; MAP KINASE; MOUSE SKIN; ACTIVATION; PATHWAY; MUTATION; GROWTH; CANCER; DIFFERENTIATION	Ras genes are commonly mutated in human cancers of the skin and other tissues. Oncogenic Ras signals through multiple effector pathways, including the Erk1/2 mitogen-activated protein kinase (MAPK), phosphatidylinositol-3 kinase (PI3K) and the Ral guanine nucleotide exchange factor (RalGEF) cascades. In epidermis, the activation of oncogenic Ras induces hyperplasia and inhibits differentiation, features characteristic of squamous cell carcinoma. The downstream effector pathways required for oncogenic Ras effects in epidermis, however, are undefined. In this study, we investigated the direct contribution of Mek1 and Mek2 MAPKKs to oncogenic Ras signaling. The response of murine epidermis to conditionally active oncogenic Ras was unimpaired by deletion of either Mek1 or Mek2 MAPKKs individually. In contrast, Ras effects were entirely abolished by combined deletion of all Mek1/2 alleles, whereas epidermis retaining only one allele of either Mek1 or Mek2 showed intermediate responsiveness. Thus, the effects of oncogenic Ras on proliferation and differentiation in skin show a gene dosage-dependent requirement for the Erk1/2 MAPK cascade at the level of Mek1/2 MAPKKs.	[Scholl, F. A.; Dumesic, P. A.; Barragan, D. I.; Khavari, P. A.] Stanford Univ, Dept Dermatol, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Charron, J.] Univ Laval, Ctr Rech Cancerol, Hotel Dieu Quebec, CHUQ, Quebec City, PQ, Canada; [Khavari, P. A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Laval University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Dept Dermatol, Sch Med, Program Epithelial Biol, CCSR Bldg,Room 2145,269 Campus Dr, Stanford, CA 94305 USA.	khavari@stanford.edu	Charron, Jean/A-9792-2013	Charron, Jean/0000-0002-5133-0056	US VA Office of Research and Development; NIAMS/NIH [AR49737]; Swiss cancer foundation [BIL SKL-01236-02-2002]; CIHR [MOP-67208]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737] Funding Source: NIH RePORTER	US VA Office of Research and Development; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swiss cancer foundation; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A Truong and K Jameson for critical reading of the manuscript, E Fuchs for K14-Cre mice, P Chambon for K14-CreER mice, C Enrile for histological work, H Bernstein, P Bernstein and N Griffiths for support. This study was supported by the US VA Office of Research and Development and by AR49737 from NIAMS/NIH to PAK, the Swiss cancer foundation Grant BIL SKL-01236-02-2002 to FAS and MOP-67208 from CIHR to JC.	[Anonymous], 2007, NATURE, V449, P378; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; Denley A, 2008, METHOD ENZYMOL, V438, P291, DOI 10.1016/S0076-6879(07)38020-8; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; GREENHALGH DA, 1993, MOL CARCINOGEN, V7, P99, DOI 10.1002/mc.2940070208; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Kratz CP, 2007, J MOL MED-JMM, V85, P223, DOI 10.1007/s00109-006-0135-4; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; McCubrey JA, 2008, CURR OPIN INVEST DR, V9, P614; Murayama K, 2007, ONCOGENE, V26, P4882, DOI 10.1038/sj.onc.1210274; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Oh WJ, 2007, CARCINOGENESIS, V28, P2244, DOI 10.1093/carcin/bgm127; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sturgill TW, 2008, BIOCHEM BIOPH RES CO, V371, P1, DOI 10.1016/j.bbrc.2008.04.002; Sun BC, 2008, CELL CYCLE, V7, P934, DOI 10.4161/cc.7.7.5622; Tarutani M, 2003, CANCER RES, V63, P319; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wallace EM, 2005, CURR TOP MED CHEM, V5, P215, DOI 10.2174/1568026053507723; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	39	20	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1485	1495		10.1038/onc.2008.459	http://dx.doi.org/10.1038/onc.2008.459			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19198628	Green Accepted			2022-12-25	WOS:000264537400001
J	Varghese, RM; Sreenivas, V; Puliyel, JM; Varughese, S				Varghese, Raji Mathew; Sreenivas, Vishnubhatla; Puliyel, Jacob Mammen; Varughese, Sara			Refractive Status at Birth: Its Relation to Newborn Physical Parameters at Birth and Gestational Age	PLOS ONE			English	Article								Background: Refractive status at birth is related to gestational age. Preterm babies have myopia which decreases as gestational age increases and term babies are known to be hypermetropic. This study looked at the correlation of refractive status with birth weight in term and preterm babies, and with physical indicators of intra-uterine growth such as the head circumference and length of the baby at birth. Methods: All babies delivered at St. Stephens Hospital and admitted in the nursery were eligible for the study. Refraction was performed within the first week of life. 0.8% tropicamide with 0.5% phenylephrine was used to achieve cycloplegia and paralysis of accommodation. 599 newborn babies participated in the study. Data pertaining to the right eye is utilized for all the analyses except that for anisometropia where the two eyes were compared. Growth parameters were measured soon after birth. Simple linear regression analysis was performed to see the association of refractive status, ( mean spherical equivalent (MSE), astigmatism and anisometropia) with each of the study variables, namely gestation, length, weight and head circumference. Subsequently, multiple linear regression was carried out to identify the independent predictors for each of the outcome parameters. Results: Simple linear regression showed a significant relation between all 4 study variables and refractive error but in multiple regression only gestational age and weight were related to refractive error. The partial correlation of weight with MSE adjusted for gestation was 0.28 and that of gestation with MSE adjusted for weight was 0.10. Birth weight had a higher correlation to MSE than gestational age. Conclusion: This is the first study to look at refractive error against all these growth parameters, in preterm and term babies at birth. It would appear from this study that birth weight rather than gestation should be used as criteria for screening for refractive error, especially in developing countries where the incidence of intrauterine malnutrition is higher.	[Varghese, Raji Mathew; Puliyel, Jacob Mammen] St Stephens Hosp, Dept Neonatol, Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India; [Varughese, Sara] Christoffel Blindenmiss S Asia Region Office, Delhi, India	St. Stephen's Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Varghese, RM (corresponding author), St Stephens Hosp, Dept Neonatol, Delhi, India.	sara.varughese@gmail.com						BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Choi MY, 2000, BRIT J OPHTHALMOL, V84, P138, DOI 10.1136/bjo.84.2.138; Cook A, 2003, INVEST OPHTH VIS SCI, V44, P953, DOI 10.1167/iovs.02-0124; GRAHAM MV, 1963, BRIT MED J, V343, P1452; Holmstrom G, 1998, BRIT J OPHTHALMOL, V82, P1265, DOI 10.1136/bjo.82.11.1265; Khanna Rajesh, 2002, Indian Journal of Pediatrics, V69, P957, DOI 10.1007/BF02726013; Kuo A, 2003, J AAPOS, V7, P174, DOI 10.1016/S1091-8531(03)00017-X; MEHRA KS, 1965, BR J OPHTHALMOL, V49, P76; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; NISSENKORN I, 1983, BRIT J OPHTHALMOL, V67, P170, DOI 10.1136/bjo.67.3.170; Patel A R, 1970, J All India Ophthalmol Soc, V18, P59; Quinn GE, 1998, OPHTHALMOLOGY, V105, P1292, DOI 10.1016/S0161-6420(98)97036-1; Saunders KJ, 2002, BRIT J OPHTHALMOL, V86, P1035, DOI 10.1136/bjo.86.9.1035; SCHARF J, 1978, J PEDIAT OPHTH STRAB, V15, P48; SCHARF J, 1975, Journal of Pediatric Ophthalmology, V12, P193; Snir M, 2004, BRIT J OPHTHALMOL, V88, P900, DOI 10.1136/bjo.2003.037499; Ton Y, 2004, J AAPOS, V8, P534, DOI 10.1016/j.jaapos.2004.09.002; Varughese S, 2005, CURR EYE RES, V30, P423, DOI 10.1080/02713680590959295; Verma M, 1994, Indian Pediatr, V31, P1183	19	24	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4469	10.1371/journal.pone.0004469	http://dx.doi.org/10.1371/journal.pone.0004469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214228	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484300008
J	Sone, M; Uchida, A; Komatsu, A; Suzuki, E; Ibuki, I; Asada, M; Shiwaku, H; Tamura, T; Hoshino, M; Okazawa, H; Nabeshima, Y				Sone, Masaki; Uchida, Atsuko; Komatsu, Ayumi; Suzuki, Emiko; Ibuki, Ikue; Asada, Megumi; Shiwaku, Hiroki; Tamura, Takuya; Hoshino, Mikio; Okazawa, Hitoshi; Nabeshima, Yo-ichi			Loss of yata, a Novel Gene Regulating the Subcellular Localization of APPL, Induces Deterioration of Neural Tissues and Lifespan Shortening	PLOS ONE			English	Article								Background: The subcellular localization of membrane and secreted proteins is finely and dynamically regulated through intracellular vesicular trafficking for permitting various biological processes. Drosophila Amyloid precursor protein like (APPL) and Hikaru genki (HIG) are examples of proteins that show differential subcellular localization among several developmental stages. Methodology/Principal Findings: During the study of the localization mechanisms of APPL and HIG, we isolated a novel mutant of the gene, CG1973, which we named yata. This molecule interacted genetically with Appl and is structurally similar to mouse NTKL/SCYL1, whose mutation was reported to cause neurodegeneration. yata null mutants showed phenotypes that included developmental abnormalities, progressive eye vacuolization, brain volume reduction, and lifespan shortening. Exogenous expression of Appl or hig in neurons partially rescued the mutant phenotypes of yata. Conversely, the phenotypes were exacerbated in double null mutants for yata and Appl. We also examined the subcellular localization of endogenous APPL and exogenously pulse-induced APPL tagged with FLAG by immunostaining the pupal brain and larval motor neurons in yata mutants. Our data revealed that yata mutants showed impaired subcellular localization of APPL. Finally, yata mutant pupal brains occasionally showed aberrant accumulation of Sec23p, a component of the COPII coat of secretory vesicles traveling from the endoplasmic reticulum (ER) to the Golgi. Conclusion/Significance: We identified a novel gene, yata, which is essential for the normal development and survival of tissues. Loss of yata resulted in the progressive deterioration of the nervous system and premature lethality. Our genetic data showed a functional relationship between yata and Appl. As a candidate mechanism of the abnormalities, we found that yata regulates the subcellular localization of APPL and possibly other proteins.	[Sone, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan; [Sone, Masaki; Shiwaku, Hiroki; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Sone, Masaki; Uchida, Atsuko; Komatsu, Ayumi; Ibuki, Ikue; Asada, Megumi; Hoshino, Mikio; Nabeshima, Yo-ichi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Sone, Masaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Japan; [Suzuki, Emiko] Natl Inst Genet, Mishima, Shizuoka, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sone, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan.	sone.mtt@mri.tmd.ac.jp	Uchida, Atsuko/E-3081-2010; Sone, Masaki/Q-9058-2019; Ibuki, Yuko/AAY-8199-2020	Uchida, Atsuko/0000-0002-4658-1504; Ibuki, Yuko/0000-0001-6702-526X; Suzuki, Emiko/0000-0002-4005-0542; Shiwaku, Hiroki/0000-0001-7503-8044	center-of-excellence grant; Ministry of Education, Culture, Sports, Science and Technology of Japan [grants-in-aid for scientific research]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders	center-of-excellence grant; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders	This work was supported by center-of-excellence grant, program for improvement of research environment for young researchers from special coordination funds for promoting science and technology and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Mochida Memorial Foundation for Medical and Pharmaceutical Research and Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hoshino M, 1999, DEV GENES EVOL, V209, P1, DOI 10.1007/s004270050221; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kato M, 2002, GENOMICS, V79, P760, DOI 10.1006/geno.2002.6774; Knust E, 2007, CURR OPIN NEUROBIOL, V17, P541, DOI 10.1016/j.conb.2007.08.001; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Y, 2004, J NEUROBIOL, V61, P343, DOI 10.1002/neu.20048; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; McGuire AT, 2007, EMBO J, V26, P288, DOI 10.1038/sj.emboj.7601493; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Sone M, 2000, DEVELOPMENT, V127, P4157; Torroja L, 1996, J NEUROSCI, V16, P4638; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Torroja L, 1999, J NEUROSCI, V19, P7793; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; XU T, 1993, DEVELOPMENT, V117, P1223	38	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4466	10.1371/journal.pone.0004466	http://dx.doi.org/10.1371/journal.pone.0004466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209226	gold, Green Submitted, Green Published			2022-12-25	WOS:000265484100016
J	Wang, D; Lu, M; Miao, J; Li, TT; Wang, E; Cui, QH				Wang, Dong; Lu, Ming; Miao, Jing; Li, Tingting; Wang, Edwin; Cui, Qinghua			Cepred: Predicting the Co-Expression Patterns of the Human Intronic microRNAs with Their Host Genes	PLOS ONE			English	Article							IDENTIFICATION; GENOMICS; ATLAS	Identifying the tissues in which a microRNA is expressed could enhance the understanding of the functions, the biological processes, and the diseases associated with that microRNA. However, the mechanisms of microRNA biogenesis and expression remain largely unclear and the identification of the tissues in which a microRNA is expressed is limited. Here, we present a machine learning based approach to predict whether an intronic microRNA show high co-expression with its host gene, by doing so, we could infer the tissues in which a microRNA is high expressed through the expression profile of its host gene. Our approach is able to achieve an accuracy of 79% in the leave-one-out cross validation and 95% on an independent testing dataset. We further estimated our method through comparing the predicted tissue specific microRNAs and the tissue specific microRNAs identified by biological experiments. This study presented a valuable tool to predict the co-expression patterns between human intronic microRNAs and their host genes, which would also help to understand the microRNA expression and regulation mechanisms. Finally, this framework can be easily extended to other species.	[Wang, Dong; Lu, Ming; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China; [Wang, Dong; Lu, Ming; Cui, Qinghua] Peking Univ, MOE Key Lab Mol Cardiol, Beijing, Peoples R China; [Miao, Jing] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Li, Tingting] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Wang, Edwin] Natl Res Council Canada, Biotechnol Res Inst, Comp Chem & Biol Grp, Montreal, PQ, Canada	Peking University; Peking University; Peking University; Tsinghua University; National Research Council Canada	Wang, D (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China.	cuiqinghua@bjmu.edu.cn	Wang, Edwin/Y-1553-2019	Miao, Jing/0000-0003-0642-9740	National Basic Research program of China [2007CB512100]; 985 project of Peking University [985-2-108-121]	National Basic Research program of China(National Basic Research Program of China); 985 project of Peking University(Peking University)	This research was supported by the National Basic Research program of China (2007CB512100) and the 985 project of Peking University (No. 985-2-108-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vapnik V. N., 1998, NATURE STAT LEARNING; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou HJ, 2008, BIOCHEM BIOPH RES CO, V368, P709, DOI 10.1016/j.bbrc.2008.01.117	29	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4421	10.1371/journal.pone.0004421	http://dx.doi.org/10.1371/journal.pone.0004421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204784	Green Published, gold			2022-12-25	WOS:000265484000010
J	Foley, JE; Yeh, JRJ; Maeder, ML; Reyon, D; Sander, JD; Peterson, RT; Joung, JK				Foley, Jonathan E.; yeh, Jing-Ruey J.; Maeder, Morgan L.; Reyon, Deepak; Sander, Jeffry D.; Peterson, Randall T.; Joung, J. Keith			Rapid Mutation of Endogenous Zebrafish Genes Using Zinc Finger Nucleases Made by Oligomerized Pool ENgineering (OPEN)	PLOS ONE			English	Article								Background: Customized zinc finger nucleases (ZFNs) form the basis of a broadly applicable tool for highly efficient genome modification. ZFNs are artificial restriction endonucleases consisting of a non-specific nuclease domain fused to a zinc finger array which can be engineered to recognize specific DNA sequences of interest. Recent proof-of-principle experiments have shown that targeted knockout mutations can be efficiently generated in endogenous zebrafish genes via non-homologous end-joining-mediated repair of ZFN-induced DNA double-stranded breaks. The Zinc Finger Consortium, a group of academic laboratories committed to the development of engineered zinc finger technology, recently described the first rapid, highly effective, and publicly available method for engineering zinc finger arrays. The Consortium has previously used this new method (known as OPEN for Oligomerized Pool ENgineering) to generate high quality ZFN pairs that function in human and plant cells. Methodology/Principal Findings: Here we show that OPEN can also be used to generate ZFNs that function efficiently in zebrafish. Using OPEN, we successfully engineered ZFN pairs for five endogenous zebrafish genes: tfr2, dopamine transporter, telomerase, hif1aa, and gridlock. Each of these ZFN pairs induces targeted insertions and deletions with high efficiency at its endogenous gene target in somatic zebrafish cells. In addition, these mutations are transmitted through the germline with sufficiently high frequency such that only a small number of fish need to be screened to identify founders. Finally, in silico analysis demonstrates that one or more potential OPEN ZFN sites can be found within the first three coding exons of more than 25,000 different endogenous zebrafish gene transcripts. Conclusions and Significance: In summary, our study nearly triples the total number of endogenous zebrafish genes successfully modified using ZFNs (from three to eight) and suggests that OPEN provides a reliable method for introducing targeted mutations in nearly any zebrafish gene of interest.	[Foley, Jonathan E.; Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA; [Foley, Jonathan E.; Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Comput & Integrat Biol, Charlestown, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] MIT, Broad Inst, Cambridge, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] Harvard Univ, Cambridge, MA USA; [Reyon, Deepak; Sander, Jeffry D.] Iowa State Univ, Dept Genet Dev & Cell Biol, Interdept Grad Program Bioinformat & Comp Biol, Ames, IA 50011 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Iowa State University; Harvard University; Harvard Medical School	Foley, JE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA.	jjoung@partners.org	Reyon, Deepak/HCH-3183-2022	Peterson, Randall/0000-0003-0727-3469; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901	NIH [R01 GM069906, R21 HL091808, R01 HL79267, R33-GM066387]; MGH Department of Pathology; National Institute of Aging [K01 AG031300]; Claflin Distinguished Scholar Award; Pioneer-Hi-Bred International, Inc [2008 Graduate Fellowship]; ISU CIAG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091808, R01HL079267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387, R01GM069906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Department of Pathology; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Claflin Distinguished Scholar Award; Pioneer-Hi-Bred International, Inc; ISU CIAG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.E.F., M.L.M., and J.K.J. are supported by the NIH (R01 GM069906 and R21 HL091808) and the MGH Department of Pathology. J.-R.J.Y. is supported by the National Institute of Aging (K01 AG031300) and by a Claflin Distinguished Scholar Award. J.-R.J.Y. and R.T.P. are supported by the NIH (R01 HL79267). J.D.S is supported by Pioneer-Hi-Bred International, Inc 2008 Graduate Fellowship, NIH R33-GM066387, and ISU CIAG. D.R is supported by ISU CIAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Camenisch TD, 2008, MINI-REV MED CHEM, V8, P669, DOI 10.2174/138955708784567458; CARROLL D, 2008, GENE THER; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Isalan M, 1998, BIOCHEMISTRY-US, V37, P12026, DOI 10.1021/bi981358z; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Kiermer V, 2008, NAT METHODS, V5, P579, DOI 10.1038/nmeth0708-579; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kim YG, 1997, GENE, V203, P43, DOI 10.1016/S0378-1119(97)00489-7; Lee DK, 2003, CURR TOP MED CHEM, V3, P645, DOI 10.2174/1568026033452384; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pearson H, 2008, NATURE, V455, P160, DOI [10.1038/455160a, 10.1038/453150a]; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Segal DJ, 2001, CURR OPIN BIOTECH, V12, P632, DOI 10.1016/S0958-1669(01)00272-5; Thibodeau-Beganny Stacey, 2007, V408, P317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Woods IG, 2008, NAT BIOTECHNOL, V26, P650, DOI 10.1038/nbt0608-650; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8	47	185	215	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4348	10.1371/journal.pone.0004348	http://dx.doi.org/10.1371/journal.pone.0004348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198653	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483900001
J	Belin, S; Kaya, F; Duisit, G; Giacometti, S; Ciccolini, J; Fontes, M				Belin, Sophie; Kaya, Ferdinand; Duisit, Ghislaine; Giacometti, Sarah; Ciccolini, Joseph; Fontes, Michel			Antiproliferative Effect of Ascorbic Acid Is Associated with the Inhibition of Genes Necessary to Cell Cycle Progression	PLOS ONE			English	Article								Background: Ascorbic acid (AA), or Vitamin C, is most well known as a nutritional supplement with antioxidant properties. Recently, we demonstrated that high concentrations of AA act on PMP22 gene expression and partially correct the Charcot-Marie-Tooth disease phenotype in a mouse model. This is due to the capacity of AA, but not other antioxidants, to down-modulate cAMP intracellular concentration by a competitive inhibition of the adenylate cyclase enzymatic activity. Because of the critical role of cAMP in intracellular signalling, we decided to explore the possibility that ascorbic acid could modulate the expression of other genes. Methods and Findings: Using human pangenomic microarrays, we found that AA inhibited the expression of two categories of genes necessary for cell cycle progression, tRNA synthetases and translation initiation factor subunits. In in vitro assays, we demonstrated that AA induced the S-phase arrest of proliferative normal and tumor cells. Highest concentrations of AA leaded to necrotic cell death. However, quiescent cells were not susceptible to AA toxicity, suggesting the blockage of protein synthesis was mainly detrimental in metabolically-active cells. Using animal models, we found that high concentrations of AA inhibited tumor progression in nude mice grafted with HT29 cells (derived from human colon carcinoma). Consistently, expression of tRNA synthetases and ieF2 appeared to be specifically decreased in tumors upon AA treatment. Conclusions: AA has an antiproliferative activity, at elevated concentration that could be obtained using IV injection. This activity has been observed in vitro as well in vivo and likely results from the inhibition of expression of genes involved in protein synthesis. Implications for a clinical use in anticancer therapies will be discussed.	[Belin, Sophie; Kaya, Ferdinand; Duisit, Ghislaine; Fontes, Michel] Fac Med Timone, EA 4263, Marseille, France; [Giacometti, Sarah; Ciccolini, Joseph] Fac Pharm Marseille, Lab Pharmacokinet & Toxicokinet, UPRES, EA 3286, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Belin, S (corresponding author), Fac Med Timone, EA 4263, Marseille, France.	michel.fontes@univmed.fr	Ciccolini, Joseph/AAP-7193-2021; Belin, Sophie/AAJ-7962-2020	Ciccolini, Joseph/0000-0003-1733-3410	French ANR maladies rares program; INSERM; PACA	French ANR maladies rares program(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PACA(Region Provence-Alpes-Cote d'Azur)	This work has been funded by French ANR maladies rares program. S.Belin is supported by INSERM and PACA region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline S, 2006, CAN MED ASSOC J, V174, P956, DOI 10.1503/cmaj.060228; CAMERON E, 1974, CHEM-BIOL INTERACT, V9, P285, DOI 10.1016/0009-2797(74)90019-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; ENGER MD, 1978, BIOCHEMISTRY-US, V17, P2435, DOI 10.1021/bi00605a029; Heckelen A, 2004, ACTA OPHTHALMOL SCAN, V82, P564, DOI 10.1111/j.1600-0420.2004.00317.x; HOFFER L, 2008, ANN ONCOL; HOHMANN S, 1992, GENE, V120, P43, DOI 10.1016/0378-1119(92)90007-C; KAYA F, 2008, FEBS LETT; Kaya F, 2008, MUSCLE NERVE, V38, P1052, DOI 10.1002/mus.21071; Kaya F, 2007, NEUROMUSCULAR DISORD, V17, P248, DOI 10.1016/j.nmd.2006.12.008; Kuwai T, 2008, CLIN EXP METASTAS, V25, P477, DOI 10.1007/s10585-008-9153-7; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Motomura S, 1996, GENES CELLS, V1, P1101, DOI 10.1046/j.1365-2443.1996.d01-227.x; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; PAULING L, 1985, P NATL ACAD SCI USA, V82, P5185, DOI 10.1073/pnas.82.15.5185; PAULING L, 1986, NUTR REV, V44, P28; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SUSS J, 1972, Z ALLG MIKROBIOL, V12, P161, DOI 10.1002/jobm.3630120211; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; ZIRVI KA, 1989, CLIN EXP METASTAS, V7, P591, DOI 10.1007/BF01753670	25	56	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4409	10.1371/journal.pone.0004409	http://dx.doi.org/10.1371/journal.pone.0004409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197388	gold, Green Published			2022-12-25	WOS:000265483700015
J	Li, Y; Agarwal, P				Li, Yong; Agarwal, Pankaj			A Pathway-Based View of Human Diseases and Disease Relationships	PLOS ONE			English	Article								It is increasingly evident that human diseases are not isolated from each other. Understanding how different diseases are related to each other based on the underlying biology could provide new insights into disease etiology, classification, and shared biological mechanisms. We have taken a computational approach to studying disease relationships through 1) systematic identification of disease associated genes by literature mining, 2) associating diseases to biological pathways where disease genes are enriched, and 3) linking diseases together based on shared pathways. We identified 4,195 candidate disease associated genes for 1028 diseases. On average, about 50% of disease associated genes of a disease are statistically mapped to pathways. We generated a disease network which consists of 591 diseases and 6,931 disease relationships. We examined properties of this network and provided examples of novel disease relationships which cannot be readily captured through simple literature search or gene overlap analysis. Our results could potentially provide insights into the design of novel, pathway-guided therapeutic interventions for diseases.	[Li, Yong; Agarwal, Pankaj] GlaxoSmithKline R&D, Computat Biol, King Of Prussia, PA USA	GlaxoSmithKline	Li, Y (corresponding author), GlaxoSmithKline R&D, Computat Biol, King Of Prussia, PA USA.	yong.2.li@gsk.com	Agarwal, Pankaj/N-2147-2019; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Agarwal, Pankaj/0000-0002-4165-9990				Agarwal P, 2008, BRIEF BIOINFORM, V9, P479, DOI 10.1093/bib/bbn035; Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Childs B, 2000, ANNU REV GENOM HUM G, V1, P1, DOI 10.1146/annurev.genom.1.1.1; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Moseley FL, 2007, J PHARM PHARMACOL, V59, P609, DOI 10.1211/jpp.59.5.0001; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047	19	138	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4346	10.1371/journal.pone.0004346	http://dx.doi.org/10.1371/journal.pone.0004346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194489	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483500004
J	Oberto, J; Nabti, S; Jooste, V; Mignot, H; Rouviere-Yaniv, J				Oberto, Jacques; Nabti, Sabrina; Jooste, Valerie; Mignot, Herve; Rouviere-Yaniv, Josette			The HU Regulon Is Composed of Genes Responding to Anaerobiosis, Acid Stress, High Osmolarity and SOS Induction	PLOS ONE			English	Article								Background: The Escherichia coli heterodimeric HU protein is a small DNA-bending protein associated with the bacterial nucleoid. It can introduce negative supercoils into closed circular DNA in the presence of topoisomerase I. Cells lacking HU grow very poorly and display many phenotypes. Methodology/Principal Findings: We analyzed the transcription profile of every Escherichia coli gene in the absence of one or both HU subunits. This genome-wide in silico transcriptomic approach, performed in parallel with in vivo genetic experimentation, defined the HU regulon. This large regulon, which comprises 8% of the genome, is composed of four biologically relevant gene classes whose regulation responds to anaerobiosis, acid stress, high osmolarity, and SOS induction. Conclusions/Significance: The regulation a large number of genes encoding enzymes involved in energy metabolism and catabolism pathways by HU explains the highly pleiotropic phenotype of HU-deficient cells. The uniform chromosomal distribution of the many operons regulated by HU strongly suggests that the transcriptional and nucleoid architectural functions of HU constitute two aspects of a unique protein-DNA interaction mechanism.	[Oberto, Jacques; Nabti, Sabrina; Rouviere-Yaniv, Josette] CNRS, Inst Biolo Physico chim, Lab Physiol Bacterienne, UPR 9073, Paris, France; [Jooste, Valerie] Univ Dijon, INSERM, Epidemiol & Biostat Grp, UMR 866, Dijon, France; [Mignot, Herve] SPSS, Courbevoie, France	Centre National de la Recherche Scientifique (CNRS); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; International Business Machines (IBM)	Oberto, J (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.	jacques.oberto@igmors.u-psud.fr; josette.rouviere-yaniv@ibpc.fr	Jooste, Valerie/AFW-1362-2022	Jooste, Valerie/0000-0002-9902-0700	French "Ministere de la Recherche"; Centre National pour la Recherche Scientifique	French "Ministere de la Recherche"(Ministry of Research, France); Centre National pour la Recherche Scientifique	The French "Ministere de la Recherche" for microarray financing and the "Centre National pour la Recherche Scientifique" for general financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Bensaid A, 1996, J MOL BIOL, V256, P292, DOI 10.1006/jmbi.1996.0086; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Conter A, 1997, J MOL BIOL, V273, P75, DOI 10.1006/jmbi.1997.1308; CORTASSA S, 1993, MOL CELL BIOCHEM, V126, P115, DOI 10.1007/BF00925689; Davison A. C., 1997, BOOSTRAP METHODS THE; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DORMAN CJ, 2008, REGULATION TRANSCRIP, P151; DRI AM, 1991, J BACTERIOL, V173, P2852, DOI 10.1128/JB.173.9.2852-2863.1991; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; ELLEDGE SJ, 1983, J MOL BIOL, V164, P175, DOI 10.1016/0022-2836(83)90074-8; Fernandez S, 1997, MOL MICROBIOL, V23, P1169, DOI 10.1046/j.1365-2958.1997.3061670.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Giangrossi M, 2002, MOL MICROBIOL, V44, P205, DOI 10.1046/j.1365-2958.2002.02868.x; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Green J, 1997, MICROBIOL-SGM, V143, P2865, DOI 10.1099/00221287-143-9-2865; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Hartigan J., 1975, CLUSTERING ALGORITHM; HASELKORN R, 1976, P NATL ACAD SCI USA, V73, P1917, DOI 10.1073/pnas.73.6.1917; Hobman JL, 2007, J BACTERIOL, V189, P8786, DOI 10.1128/JB.00977-07; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; HSIEH LS, 1991, J MOL BIOL, V219, P443, DOI 10.1016/0022-2836(91)90185-9; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; Kovacs AT, 2005, BIOCHEM SOC T, V33, P36, DOI 10.1042/BST0330061; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Li C., 2003, ANAL GENE EXPRESSION, P120; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luke K, 2002, VIROLOGY, V299, P182, DOI 10.1006/viro.2002.1409; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; LUTKENHAUS JF, 1983, J BACTERIOL, V154, P1339, DOI 10.1128/JB.154.3.1339-1346.1983; Malik M, 1996, J MOL BIOL, V256, P66, DOI 10.1006/jmbi.1996.0068; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; MANNA D, 1994, J BACTERIOL, V176, P5378, DOI 10.1128/JB.176.17.5378-5384.1994; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Miller J.H., 1972, EXPT MOL GENETICS; Miyabe I, 2000, INT J RADIAT BIOL, V76, P43; Morales P, 2002, J BACTERIOL, V184, P1565, DOI 10.1128/JB.184.6.1565-1570.2002; Oberto J, 1996, J BACTERIOL, V178, P293, DOI 10.1128/jb.178.1.293-297.1996; OBERTO J, 1994, BIOCHIMIE, V76, P901, DOI 10.1016/0300-9084(94)90014-0; Oberto J, 2008, BIOINFORMATICS, V24, P424, DOI 10.1093/bioinformatics/btm600; PAINBENI E, 1993, J MOL BIOL, V234, P1021, DOI 10.1006/jmbi.1993.1656; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PREOBRAJENSKAYA O, 1994, MOL MICROBIOL, V13, P459, DOI 10.1111/j.1365-2958.1994.tb00440.x; Ramstein J, 2003, J MOL BIOL, V331, P101, DOI 10.1016/S0022-2836(03)00725-3; Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07; Rouviere-Yaniv J, 1978, Cold Spring Harb Symp Quant Biol, V42 Pt 1, P439; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sagi D, 2004, J MOL BIOL, V341, P419, DOI 10.1016/j.jmb.2004.06.023; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Semsey S, 2006, J MOL BIOL, V358, P355, DOI 10.1016/j.jmb.2006.02.022; Shanado Y, 1998, GENES CELLS, V3, P511, DOI 10.1046/j.1365-2443.1998.00208.x; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P111; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SINDEN RR, 1981, P NATL ACAD SCI-BIOL, V78, P224, DOI 10.1073/pnas.78.1.224; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; StataCorp, 2005, STAT STAT SOFTW REL; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tucker DL, 2003, J BACTERIOL, V185, P3190, DOI 10.1128/JB.185.10.3190-3201.2003; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	92	124	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4367	10.1371/journal.pone.0004367	http://dx.doi.org/10.1371/journal.pone.0004367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194530	Green Published, gold, Green Submitted			2022-12-25	WOS:000265483500011
J	Zhao, M; Li, X; Xu, P; Shen, X; Gui, XH; Wang, LL; DeRiemer, K; Mei, J; Gao, Q				Zhao, Ming; Li, Xia; Xu, Peng; Shen, Xin; Gui, Xiaohong; Wang, Lili; DeRiemer, Kathryn; Mei, Jian; Gao, Qian			Transmission of MDR and XDR Tuberculosis in Shanghai, China	PLOS ONE			English	Article								Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are global health problems. We sought to determine the characteristics, prevalence, and relative frequency of transmission of MDR and XDR TB in Shanghai, one of the largest cities in Asia. Methods: TB is diagnosed in district TB hospitals in Shanghai, China. Drug susceptibility testing for first-line drugs was performed for all culture positive TB cases, and tests for second-line drugs were performed for MDR cases. VNTR-7 and VNTR-16 were used to genotype the strains, and prior treatment history and treatment outcomes were determined for each patient. Results: There were 4,379 culture positive TB cases diagnosed with drug susceptibility test results available during March 2004 through November 2007. 247 (5.6%) were infected with a MDR strain of M. tuberculosis and 11 (6.3%) of the 175 MDR patients whose isolate was tested for susceptibility to second-line drugs, were XDR. More than half of the patients with MDR and XDR were newly diagnosed and had no prior history of TB treatment. Nearly 57% of the patients with MDR were successfully treated. Discussion: Transmission of MDR and XDR strains is a serious problem in Shanghai. While a history of prior anti-TB treatment indicates which individuals may have acquired MDR or XDR TB, it does not accurately predict which TB patients have disease caused by transmission of MDR and XDR strains. Therefore, universal drug susceptibility testing is recommended for new and retreatment TB cases.	[Zhao, Ming; Xu, Peng; Shen, Xin; Gui, Xiaohong; Wang, Lili; Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [Zhao, Ming; Li, Xia; Xu, Peng; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Molecular Virol, Shanghai, Peoples R China; [Zhao, Ming; Li, Xia; Xu, Peng; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China; [DeRiemer, Kathryn] Univ Calif Davis, Sch Med, Davis, CA USA	Shanghai Center for Disease Control & Prevention; Fudan University; Fudan University; University of California System; University of California Davis	Zhao, M (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China.	meijiansh@yahoo.com.cn; qgao99@yahoo.com	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Key Project of Chinese National Programs [2008ZX100/03-010, 2005CB523102, 2006AA02Z423]; NIH [D43 TW007887]; FOGARTY INTERNATIONAL CENTER [D43TW007887] Funding Source: NIH RePORTER	Key Project of Chinese National Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Key Project of Chinese National Programs (2008ZX100/03-010), the Key Project of Chinese National Programs for Fundamental Research and Development (973 program 2005CB523102), the Chinese National Programs 863 (2006AA02Z423), and NIH grant D43 TW007887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582; CANETTI GFW, 1969, B WORLD HEALTH ORGAN, P21; Chen J, 2007, TUBERCULOSIS, V87, P446, DOI 10.1016/j.tube.2007.05.014; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; WHO, 2001, COMM DIS CLUST GUID; *WHO, 2007, XDR TB FACTS NOV 200; *WHO, 2008, WHOHTMTB2008394; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 2007, MMWR MORB MORTAL WKL, V56, P250; 2006, MMWR MORB MORTAL WKL, V55, P301; 1998, INT J TUBERC LUNG DI, V2, P72	27	86	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4370	10.1371/journal.pone.0004370	http://dx.doi.org/10.1371/journal.pone.0004370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190774	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483300009
J	Lapidus, N; Minetti, A; Djibo, A; Guerin, PJ; Hustache, S; Gaboulaud, V; Grais, RF				Lapidus, Nael; Minetti, Andrea; Djibo, Ali; Guerin, Philippe J.; Hustache, Sarah; Gaboulaud, Valerie; Grais, Rebecca F.			Mortality Risk among Children Admitted in a Large-Scale Nutritional Program in Niger, 2006	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; ORGANIZATION GROWTH STANDARDS; MALNUTRITION	Background: In 2006, the Medecins sans Frontieres nutritional program in the region of Maradi (Niger) included 68,001 children 6-59 months of age with either moderate or severe malnutrition, according to the NCHS reference (weight-for-height, 80% of the NCHS median, and/or mid-upper arm circumference, 110 mm for children taller than 65 cm and/or presence of bipedal edema). Our objective was to identify baseline risk factors for death among children diagnosed with severe malnutrition using the newly introduced WHO growth standards. As the release of WHO growth standards changed the definition of severe malnutrition, which now includes many children formerly identified as moderately malnourished with the NCHS reference, studying this new category of children is crucial. Methodology: Program monitoring data were collected from the medical records of all children admitted in the program. Data included age, sex, height, weight, MUAC, clinical signs on admission including edema, and type of discharge (recovery, death, and default/loss to follow up). Additional data included results of a malaria rapid diagnostic test due to Plasmodium falciparum (Paracheck (R)) and whether the child was a resident of the region of Maradi or came from bordering Nigeria to seek treatment. Multivariate logistic regression was performed on a subset of 27,687 children meeting the new WHO growth standards criteria for severe malnutrition (weight-for-height< -3 Z score, mid-upper arm circumference< 110 mm for children taller than 65 cm or presence of bipedal edema). We explored two different models: one with only basic anthropometric data and a second model that included perfunctory clinical signs. Principal Findings: In the first model including only weight, height, sex and presence of edema, the risk factors retained were the weight/height(1.84) ratio (OR: 5,774; 95% CI: [2,284; 14,594]) and presence of edema (7.51 [5.12; 11.0]). A second model, taking into account supplementary data from perfunctory clinical examination, identified other risk factors for death: apathy (9.71 [6.92; 13.6]), pallor (2.25 [1.25; 4.05]), anorexia (1.89 [1.35; 2.66]), fever>38.5 degrees C (1.83 [1.25; 2.69]), and age below 1 year (1.42 [1.01; 1.99]). Conclusions: Although clinicians will continue to perform screening using clinical signs and anthropometry, these risk indicators may provide additional criteria for the assessment of absolute and relative risk of death. Better appraisal of the child's risk of death may help orientate the child towards either hospitalization or ambulatory care. As the transition from the NCHS growth reference to the WHO standards will increase the number of children classified as severely malnourished, further studies should explore means to identify children at highest risk of death within this group using simple and standardized indicators.	[Lapidus, Nael; Minetti, Andrea; Guerin, Philippe J.; Hustache, Sarah; Gaboulaud, Valerie; Grais, Rebecca F.] Epictr, Paris, France; [Djibo, Ali] Minist Hlth, Niamey, Niger		Lapidus, N (corresponding author), Epictr, Paris, France.	rebecca.grais@epicentre.msf.org	Lapidus, N./AAT-4479-2020; Guerin, Philippe/AAH-8873-2021	Lapidus, N./0000-0002-4837-1068; Freeman Grais, Rebecca/0000-0002-5037-8218; Guerin, Philippe/0000-0002-6008-2963	Medecins sans Frontieres-France; UN Standing Committee on Nutrition	Medecins sans Frontieres-France; UN Standing Committee on Nutrition	This research was funded entirely by Medecins sans Frontieres-France and the UN Standing Committee on Nutrition. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The MSF-France nutrition representative and Niger program officer provided their comments on the manuscript and are appropriately acknowledged.	Aguayo V., 2006, Morbidity and Mortality Weekly Report, V55, P1172; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 2003, LANCET, V362, P249, DOI 10.1016/S0140-6736(03)13926-8; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; ERINOSO HO, 1993, TROP GEOGR MED, V45, P290; Fawzi WW, 1997, AM J CLIN NUTR, V65, P1062, DOI 10.1093/ajcn/65.4.1062; Gernaat HBPE, 1998, J TROP PEDIATRICS, V44, P211, DOI 10.1093/tropej/44.4.211; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; *INS, 2007, SURV MORT NUTR CHILD; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Manary MJ, 1998, J PEDIATR-US, V133, P789, DOI 10.1016/S0022-3476(98)70153-2; Manary MJ, 1997, J PEDIATR GASTR NUTR, V24, P194, DOI 10.1097/00005176-199702000-00014; *NIS NIG MACR INC, 2007, DEM HLTH SURV MULT I; Prudhon C, 1997, EUR J CLIN NUTR, V51, P771, DOI 10.1038/sj.ejcn.1600483; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 1999, MAN SEV MALN MAN PHY; YIP R, 1994, J NUTR, V124, pS2043	20	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4313	10.1371/journal.pone.0004313	http://dx.doi.org/10.1371/journal.pone.0004313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177169	gold, Green Submitted, Green Published			2022-12-25	WOS:000265483100004
J	Barry, EF; Felquer, FA; Powell, JA; Biggs, L; Stomski, FC; Urbani, A; Ramshaw, H; Hoffmann, P; Wilce, MC; Grimbaldeston, MA; Lopez, AF; Guthridge, MA				Barry, Emma F.; Felquer, Fernando A.; Powell, Jason A.; Biggs, Lisa; Stomski, Frank C.; Urbani, Andrea; Ramshaw, Hayley; Hoffmann, Peter; Wilce, Matthew C.; Grimbaldeston, Michele A.; Lopez, Angel F.; Guthridge, Mark A.			14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM-CSF; PHOSPHORYLATION; PROTEINS; RECEPTOR; 14-3-3-PROTEINS; SPECIFICITY; IL-3; APOPTOSIS; SHC	Integrated cascades of protein tyrosine and serine/threonine phosphorylation play essential roles in transducing signals in response to growth factors and cytokines. How adaptor or scaffold proteins assemble signaling complexes through both phosphotyrosine and phosphoserine/threonine residues to regulate specific signaling pathways and biological responses is unclear. We show in multiple cell types that endogenous 14-3-3 zeta is phosphorylated on Tyr(179) in response to granulocyte macrophage colony-stimulating factor. Importantly, 14-3-3 zeta can function as an intermolecular bridge that couples to phosphoserine residues and also directly binds the SH2 domain of Shc via Tyr(179). The assembly of these 14-3-3:Shc scaffolds is specifically required for the recruitment of a phosphatidylinositol 3-kinase signaling complex and the regulation of CTL-EN cell survival in response to cytokine. The biological significance of these findings was further demonstrated using primary bone marrow-derived mast cells from 14-3-3 zeta(-/-) mice. We show that cytokine was able to promote Akt phosphorylation and viability of primary mast cells derived from 14-3-3 zeta(-/-) mice when reconstituted with wild type 14-3-3 zeta, but the Akt phosphorylation and survival response was reduced in cells reconstituted with the Y179F mutant. Together, these results show that 14-3-3:Shc scaffolds can act as multivalent signaling nodes for the integration of both phosphoserine/threonine and phosphotyrosine pathways to regulate specific cellular responses.	[Barry, Emma F.; Felquer, Fernando A.; Powell, Jason A.; Guthridge, Mark A.] Inst Med & Vet Sci, Div Human Immunol, Cell Growth & Differentiat Lab, Hanson Inst, Adelaide, SA 5000, Australia; [Felquer, Fernando A.; Stomski, Frank C.; Ramshaw, Hayley; Lopez, Angel F.] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Cytokine Receptor Lab, Adelaide, SA 5000, Australia; [Biggs, Lisa; Grimbaldeston, Michele A.] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Mast Cell Lab, Adelaide, SA 5000, Australia; [Lopez, Angel F.; Guthridge, Mark A.] Univ Adelaide, Dept Med, Adelaide, SA 5000, Australia; [Hoffmann, Peter] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia; [Urbani, Andrea] Univ Roma Tor Vergata, Dept Internal Med, Fdn S Lucia Ist Ricovero & Cura Carattere Sci, I-00133 Rome, Italy; [Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide; University of Rome Tor Vergata; Monash University	Guthridge, MA (corresponding author), Inst Med & Vet Sci, Div Human Immunol, Cell Growth & Differentiat Lab, Hanson Inst, Frome Rd, Adelaide, SA 5000, Australia.	mark.guthridge@imvs.sa.gov.au	Urbani, Andrea/AAD-1675-2022; Ramshaw, Hayley/F-3828-2013; Hoffmann, Peter/U-5996-2017; Urbani, Andrea/B-2953-2012; Lopez, Angel F/E-2260-2011; guthridge, mark a/I-1889-2014	Hoffmann, Peter/0000-0001-8493-2208; guthridge, mark a/0000-0002-0536-3471; Lopez, Angel F/0000-0001-7430-0135; Barry, Emma/0000-0003-2742-5650; Ramshaw, Hayley/0000-0001-9909-282X; Powell, jason/0000-0001-8493-9178	National Health and Medical Research Council of Australia; Peter Nelson Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter Nelson Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia and the Peter Nelson Foundation.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Giacometti S, 2004, PLANT BIOLOGY, V6, P422, DOI 10.1055/s-2004-820933; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 1997, MOL CELL BIOL, V17, P5485, DOI 10.1128/MCB.17.9.5485; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stomski FC, 1999, BLOOD, V94, P1933; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	33	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12080	12090		10.1074/jbc.M807637200	http://dx.doi.org/10.1074/jbc.M807637200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19218246	Green Published, hybrid			2022-12-25	WOS:000265494600040
J	Veverka, V; Henry, AJ; Slocombe, PM; Ventom, A; Mulloy, B; Muskett, FW; Muzylak, M; Greenslade, K; Moore, A; Zhang, L; Gong, JH; Qian, XM; Paszty, C; Taylor, RJ; Robinson, MK; Carr, MD				Veverka, Vaclav; Henry, Alistair J.; Slocombe, Patrick M.; Ventom, Andrew; Mulloy, Barbara; Muskett, Frederick W.; Muzylak, Mariusz; Greenslade, Kevin; Moore, Adrian; Zhang, Li; Gong, Jianhua; Qian, Xueming; Paszty, Chris; Taylor, Richard J.; Robinson, Martyn K.; Carr, Mark D.			Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; HEPARIN-BINDING SITES; TERMINAL MA-3 DOMAIN; CRYSTAL-STRUCTURE; GROWTH-FACTOR; NEUROTROPHIC FACTOR; TISSUE INHIBITOR; NMR ASSIGNMENT; PROTEIN; RESOLUTION	The secreted glycoprotein sclerostin has recently emerged as a key negative regulator of Wnt signaling in bone and has stimulated considerable interest as a potential target for therapeutics designed to treat conditions associated with low bone mass, such as osteoporosis. We have determined the structure of sclerostin, which resulted in the identification of a previously unknown binding site for heparin, suggestive of a functional role in localizing sclerostin to the surface of target cells. We have also mapped the interaction site for an antibody that blocks the inhibition of Wnt signaling by sclerostin. This shows minimal overlap with the heparin binding site and highlights a key role for this region of sclerostin in protein interactions associated with the inhibition of Wnt signaling. The conserved N- and C-terminal arms of sclerostin were found to be unstructured, highly flexible, and unaffected by heparin binding, which suggests a role in stabilizing interactions with target proteins.	[Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Henry, Alistair J.; Slocombe, Patrick M.; Ventom, Andrew; Muzylak, Mariusz; Greenslade, Kevin; Moore, Adrian; Taylor, Richard J.; Robinson, Martyn K.] UCB Celltech, Slough SL1 4EN, Berks, England; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Zhang, Li; Gong, Jianhua; Qian, Xueming; Paszty, Chris] Amgen Inc, Thousand Oaks, CA 91320 USA	University of Leicester; Celltech Group Ltd; National Institute for Biological Standards & Control; Amgen	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	UCB-Celltech Ltd; Wellcome Trust	UCB-Celltech Ltd(UCB Pharma SA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by UCB-Celltech Ltd and the Wellcome Trust.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Babcook JS, 1996, P NATL ACAD SCI USA, V93, P7843, DOI 10.1073/pnas.93.15.7843; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; Cattaruzza S, 2006, MACROMOL BIOSCI, V6, P667, DOI 10.1002/mabi.200600100; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Forster M, 2006, BIOCHEM SOC T, V34, P431, DOI 10.1042/BST0340431; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Mulloy B, 1997, THROMB HAEMOSTASIS, V77, P668; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; Ominsky MS, 2006, J BONE MINER RES, V21, pS44; Padhi D, 2007, J BONE MINER RES, V22, pS37; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Zhang L, 2006, J BONE MINER RES, V21, pS259	64	177	222	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10890	10900		10.1074/jbc.M807994200	http://dx.doi.org/10.1074/jbc.M807994200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208630	hybrid, Green Published			2022-12-25	WOS:000265104600062
J	Giliberto, L; Borghi, R; Piccini, A; Mangerini, R; Sorbi, S; Cirmena, G; Garuti, A; Ghetti, B; Tagliavini, F; Mughal, MR; Mattson, MP; Zhu, XW; Wang, XL; Guglielmotto, M; Tamagno, E; Tabatona, M				Giliberto, Luca; Borghi, Roberta; Piccini, Alessandra; Mangerini, Rosa; Sorbi, Sandro; Cirmena, Gabriella; Garuti, Anna; Ghetti, Bernardino; Tagliavini, Fabrizio; Mughal, Mohamed R.; Mattson, Mark P.; Zhu, Xiongwei; Wang, Xinglong; Guglielmotto, Michela; Tamagno, Elena; Tabatona, Massimo			Mutant Presenilin 1 Increases the Expression and Activity of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE PATHOGENESIS; NF-KAPPA-B; BETA-SECRETASE; OXIDATIVE STRESS; A-BETA; TRANSCRIPTIONAL REGULATION; INTRACELLULAR DOMAINS; TERMINAL FRAGMENT	Mutations of the presenilin 1 (PS1) gene are the most common cause of early onset familial Alzheimer disease (FAD). PS1 mutations alter the activity of the gamma-secretase on the beta-amyloid precursor protein (APP), leading to selective overproduction of beta-amyloid (A beta) 42 peptides, the species that forms oligomers that may exert toxic effects on neurons. Here we show that PS1 mutations, expressed both transiently and stably, in non-neuronal and neuronal cell lines increase the expression and the activity of the beta-secretase (BACE1), the rate-limiting step of A beta production. Also, BACE1 expression and activity are elevated in brains of PS1 mutant knock-in mice compared with wild type littermates as well as in cerebral cortex of FAD cases bearing various PS1 mutations compared with in sporadic AD cases and controls. The up-regulation of BACE1 by PS1 mutations requires the gamma-secretase cleavage of APP and is proportional to the amount of secreted A beta 42. A beta 42, and not AICD (APP intracellular domain), is indeed the APP derivative that mediates the overexpression of BACE1. The effect of PS1 mutations on BACE1 may contribute to determine the wide clinical and pathological phenotype of early onset FAD.	[Giliberto, Luca; Borghi, Roberta; Tabatona, Massimo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Cirmena, Gabriella; Garuti, Anna] Univ Genoa, Dept Internal Med & Med Specialties, I-16132 Genoa, Italy; [Piccini, Alessandra] Natl Inst Canc Res, Dept Cell Biol, I-16132 Genoa, Italy; [Mangerini, Rosa] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Mangerini, Rosa] Natl Canc Inst, I-16132 Genoa, Italy; [Sorbi, Sandro] Univ Florence, Dept Neurol & Psychiat Sci, I-50134 Florence, Italy; [Ghetti, Bernardino] Indiana Univ, Sch Med, Indiana Alzheimer Dis Ctr, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Tagliavini, Fabrizio] Ist Nazl Neurol Carlo Besta, Div Neuropathol & Neurol, I-20133 Milan, Italy; [Mughal, Mohamed R.; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Zhu, Xiongwei; Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Guglielmotto, Michela; Tamagno, Elena] Univ Turin, Dept Expt Med & Oncol, I-10125 Turin, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Florence; Indiana University System; Indiana University-Purdue University Indianapolis; IRCCS Istituto Neurologico Besta; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; University of Turin	Tabatona, M (corresponding author), Univ Genoa, Dept Neurosci Ophthalmol & Genet, Via De Toni 5, I-16132 Genoa, Italy.	mtabaton@neurologia.unige.it	/C-1310-2010; Zhu, Xiongwei/A-9629-2009; Mattson, Mark P/F-6038-2012; GUGLIELMOTTO, MICHELA/AAC-4843-2022; Tagliavini, Fabrizio/AAO-7891-2021	Zhu, Xiongwei/0000-0003-2092-6508; Tagliavini, Fabrizio/0000-0003-1039-7315; Wang, Xinglong/0000-0001-8657-0159; sorbi, sandro/0000-0002-0380-6670; Cirmena, Gabriella/0000-0002-5794-2766	Minister of Health, Italy; Telethon Foundation [GGP06009]; CARISA Foundation; Intramural Research Program of the NIA, National Institutes of Health; National Institutes of Health Public Health Service [AG10133]; National Institutes of Health [AG024028]; NATIONAL INSTITUTE ON AGING [ZIAAG000314, ZIAAG000312, P30AG010133, R01AG024028] Funding Source: NIH RePORTER	Minister of Health, Italy; Telethon Foundation(Fondazione Telethon); CARISA Foundation; Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Minister of Health (to M. T.), Italy and Telethon Foundation Grant GGP06009 (to M. T.), CARISA Foundation (to M. T.), by the Intramural Research Program of the NIA, National Institutes of Health (to M. P. M.), National Institutes of Health Public Health Service Grant AG10133(to B. G.), and National Institutes of Health Grant AG024028 (to X. Z.).	Assini A, 2003, NEUROLOGY, V60, P150, DOI 10.1212/01.WNL.0000040252.43269.83; Borghi R, 2007, NEUROBIOL AGING, V28, P1009, DOI 10.1016/j.neurobiolaging.2006.05.004; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; CLARK RF, 1995, HUM MOL GENET, V4, P1347, DOI 10.1093/hmg/4.8.1347; DE SB, 1999, NATURE, V398, P518; DU Y.S., 1997, P NATL ACAD SCI USA, V94, P5296; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; HAASS C, 1992, NATURE, V359, P325; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Lee HG, 2006, FREE RADICAL BIO MED, V41, P188, DOI 10.1016/j.freeradbiomed.2006.03.014; Lee PH, 2006, NEUROCHEM RES, V31, P821, DOI 10.1007/s11064-006-9086-y; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Mowrer KR, 2008, J BIOL CHEM, V283, P18694, DOI 10.1074/jbc.M801322200; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tabaton M, 2006, J ALZHEIMERS DIS, V9, P127; Tagami S, 2008, NEURODEGENER DIS, V5, P160, DOI 10.1159/000113690; Takao M, 2001, J NEUROPATH EXP NEUR, V60, P1137, DOI 10.1093/jnen/60.12.1137; TAMAGNO E, 2008, NEUROBIOL A IN PRESS; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xue SF, 2006, NEUROSCI LETT, V405, P231, DOI 10.1016/j.neulet.2006.07.013; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	65	40	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9027	9038		10.1074/jbc.M805685200	http://dx.doi.org/10.1074/jbc.M805685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19196715	hybrid, Green Published			2022-12-25	WOS:000264669100005
J	Lian, XJ; Gallouzi, IE				Lian, Xian Jin; Gallouzi, Imed-Eddine			Oxidative Stress Increases the Number of Stress Granules in Senescent Cells and Triggers a Rapid Decrease in p21(waf1/cip1) Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; HUMAN-DIPLOID FIBROBLASTS; CELLULAR SENESCENCE; PROCESSING BODIES; PROTEIN OXIDATION; BINDING PROTEINS; HEAT-SHOCK; IN-VIVO; CANCER; HUR	Very little is known as to how the accumulation of senescent cells during aging may affect our ability to cope with various stresses. Here we show that the assembly of stress granules (SGs) is part of the early events used by senescent cells to respond to certain stresses. Although SGs can form in response to stress during senescence activation, their number significantly increases once the cells are fully senescent. This increase correlates with a rapid decrease in the expression levels of the cyclin kinase inhibitor p21, an important activator of senescence. Throughout stress, p21 mRNA is stabilized and localizes to SGs, but only during late senescence does this localization interferes with its translation. Additionally, we observed that when the stress is relieved, senescent cells produce lower levels of p21 protein, which correlates with a small delay in SG disassembly. Therefore, our data suggest that SG formation and the reduction in p21 protein levels represent two main events by which senescent cells respond to stress.	[Lian, Xian Jin; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 904,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			Fonds de Recherche Scientifique de Quebec Master of Science fellowship; Canadian Institutes of Health Research Operating Grant [MOP-67026]	Fonds de Recherche Scientifique de Quebec Master of Science fellowship; Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a Fonds de Recherche Scientifique de Quebec Master of Science fellowship (to X. L.) and Canadian Institutes of Health Research Operating Grant MOP-67026 (to I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bruunsgaard H, 2000, IMMUNOL CELL BIOL, V78, P523, DOI 10.1046/j.1440-1711.2000.00965.x; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CAMPISI J, 2002, SCI AGING KNOWLEDGE, pPE1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; EFFROS RB, 1994, J GERONTOL, V49, pB65, DOI 10.1093/geronj/49.2.B65; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; Hayflick L, 1985, Clin Geriatr Med, V1, P15; Helenius M, 1999, EXP CELL RES, V248, P194, DOI 10.1006/excr.1999.4393; HONDA S, 1987, MECH AGEING DEV, V40, P81, DOI 10.1016/0047-6374(87)90036-4; Hsieh JK, 2000, ARTERIOSCL THROM VAS, V20, P973, DOI 10.1161/01.ATV.20.4.973; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673; Krtolica A, 2003, Adv Gerontol, V11, P109; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LUCE MC, 1992, EXP CELL RES, V202, P9, DOI 10.1016/0014-4827(92)90398-R; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Merker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P50, DOI 10.1006/abbi.1999.1657; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rosenfeldt F, 2004, ANN NY ACAD SCI, V1019, P78, DOI 10.1196/annals.1297.016; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Servais S, 2005, FREE RADICAL RES, V39, P305, DOI 10.1080/10715760400011098; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zarzhevsky N, 2001, ANN NY ACAD SCI, V928, P212	63	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8868	8878		10.1074/jbc.M806372200	http://dx.doi.org/10.1074/jbc.M806372200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176530	Green Published, hybrid			2022-12-25	WOS:000264397800070
J	Klimentidis, YC; Shriver, MD				Klimentidis, Yann C.; Shriver, Mark D.			Estimating Genetic Ancestry Proportions from Faces	PLOS ONE			English	Article							FACIAL RESEMBLANCE; UNITED-STATES; BIOGEOGRAPHICAL ANCESTRY; INFORMATIVE MARKERS; BIOMEDICAL-RESEARCH; ANTHROPOMETRIC DATA; GENOMIC ANCESTRY; KIN RECOGNITION; SKIN COLOR; OWN-RACE	Ethnicity can be a means by which people identify themselves and others. This type of identification mediates many kinds of social interactions and may reflect adaptations to a long history of group living in humans. Recent admixture in the US between groups from different continents, and the historically strong emphasis on phenotypic differences between members of these groups, presents an opportunity to examine the degree of concordance between estimates of group membership based on genetic markers and on visually-based estimates of facial features. We first measured the degree of Native American, European, African and East Asian genetic admixture in a sample of 14 self-identified Hispanic individuals, chosen to cover a broad range of Native American and European genetic admixture proportions. We showed frontal and side-view photographs of the 14 individuals to 241 subjects living in New Mexico, and asked them to estimate the degree of NA admixture for each individual. We assess the overall concordance for each observer based on an aggregated measure of the difference between the observer and the genetic estimates. We find that observers reach a significantly higher degree of concordance than expected by chance, and that the degree of concordance as well as the direction of the discrepancy in estimates differs based on the ethnicity of the observer, but not on the observers' age or sex. This study highlights the potentially high degree of discordance between physical appearance and genetic measures of ethnicity, as well as how perceptions of ethnic affiliation are context-specific. We compare our findings to those of previous studies and discuss their implications.	Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Klimentidis, YC (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	yann@unm.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044; Shriver, Mark/0000-0003-0006-0479	NIH NHGRI;  [HG02154]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH NHGRI HG02154 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Boehmer U, 2002, AM J PUBLIC HEALTH, V92, P1471, DOI 10.2105/AJPH.92.9.1471; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Condit CM, 2004, PUBLIC UNDERST SCI, V13, P249, DOI 10.1177/0963662504045573; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Gil-White F. J., 2002, FIELD METHOD, V14, P161, DOI [10.1177/1525822X02014002003, DOI 10.1177/1525822X02014002003]; Gil-White FJ, 2001, CURR ANTHROPOL, V42, P515, DOI 10.1086/321802; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; Gomez SL, 2005, ANN EPIDEMIOL, V15, P71, DOI 10.1016/j.annepidem.2004.03.002; HABYARIMANA J, 2004, ETHNIC IDENTIFIABILI; HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P259, DOI 10.1001/jama.267.2.259; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Harris David R., 2000, 00452 POP STUD CTR; Harris David R., 2002, 02522 POP STUD CTR; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HOLGUIN S, 2000, W PSYCH ASS ANN M PO; Johnson Gary R., 1987, SOCIOBIOLOGY ETHNOCE; Jones D, 2000, CURR ANTHROPOL, V41, P779, DOI 10.1086/317406; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KLIMENTIDIS YC, AM J PHYS ANTH UNPUB; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Luizon MR, 2008, AM J HUM BIOL, V20, P86, DOI 10.1002/ajhb.20681; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Montalvo FrankF., 2001, ETHNICITIES, V1, P321, DOI DOI 10.1177/146879680100100303; NESSE RM, 1990, ETHOL SOCIOBIOL, V11, P11, DOI 10.1016/0162-3095(90)90003-O; Ohman A, 2005, SCIENCE, V309, P711, DOI 10.1126/science.1116710; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Palmer C. T., 1997, J SOC EVOL SYST, V20, P39, DOI [DOI 10.1016/S1061-7361(97)90028-X, 10.1016/S1061-7361(97)90028-X]; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PFENNIG DW, 1995, SCI AM, V272, P98, DOI 10.1038/scientificamerican0695-98; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sinha M, 2006, NEW ENGL J MED, V354, P421, DOI 10.1056/NEJMc052515; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WEST CN, 2005, J NATL CANC I MONOGR, V35, P72, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI041; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809	53	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4460	10.1371/journal.pone.0004460	http://dx.doi.org/10.1371/journal.pone.0004460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KG	19223962	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485800001
J	Lutgendorff, F; Nijmeijer, RM; Sandstrom, PA; Trulsson, LM; Magnusson, KE; Timmerman, HM; van Minnen, LP; Rijkers, GT; Gooszen, HG; Akkermans, LMA; Soderholm, JD				Lutgendorff, Femke; Nijmeijer, Rian M.; Sandstrom, Per A.; Trulsson, Lena M.; Magnusson, Karl-Eric; Timmerman, Harro M.; van Minnen, L. Paul; Rijkers, Ger T.; Gooszen, Hein G.; Akkermans, Louis M. A.; Soderholm, Johan D.			Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis	PLOS ONE			English	Article							DOUBLE-BLIND; INFECTIOUS COMPLICATIONS; LACTOBACILLUS-FERMENTUM; ULCERATIVE-COLITIS; TIGHT JUNCTIONS; NITRIC-OXIDE; APOPTOSIS; MODEL; DISRUPTION; CYSTEINE	Background: During acute pancreatitis (AP), oxidative stress contributes to intestinal barrier failure. We studied actions of multispecies probiotics on barrier dysfunction and oxidative stress in experimental AP. Methodology/Principal Findings: Fifty-three male Spraque-Dawley rats were randomly allocated into five groups: 1) controls, non-operated, 2) sham-operated, 3) AP, 4) AP and probiotics and 5) AP and placebo. AP was induced by intraductal glycodeoxycholate infusion and intravenous cerulein (6 h). Daily probiotics or placebo were administered intragastrically, starting five days prior to AP. After cerulein infusion, ileal mucosa was collected for measurements of E. coli K12 and Cr-51-EDTA passage in Ussing chambers. Tight junction proteins were investigated by confocal immunofluorescence imaging. Ileal mucosal apoptosis, lipid peroxidation, and glutathione levels were determined and glutamate-cysteine-ligase activity and expression were quantified. AP-induced barrier dysfunction was characterized by epithelial cell apoptosis and alterations of tight junction proteins (i.e. disruption of occludin and claudin-1 and up-regulation of claudin-2) and correlated with lipid peroxidation (r>0.8). Probiotic pre-treatment diminished the AP-induced increase in E. coli passage (probiotics 57.4 +/- 33.5 vs. placebo 223.7 +/- 93.7 a.u.; P<0.001), Cr-51-EDTA flux (16.7 +/- 10.1 vs. 32.1 +/- 10.0 cm/s10(-6); P<0.005), apoptosis, lipid peroxidation (0.42 +/- 0.13 vs. 1.62 +/- 0.53 pmol MDA/mg protein; P<0.001), and prevented tight junction protein disruption. AP-induced decline in glutathione was not only prevented (14.33 +/- 1.47 vs. 8.82 +/- 1.30 nmol/mg protein, P<0.001), but probiotics even increased mucosal glutathione compared with sham rats (14.33 +/- 1.47 vs. 10.70 +/- 1.74 nmol/ mg protein, P<0.001). Glutamate-cysteine-ligase activity, which is rate- limiting in glutathione biosynthesis, was enhanced in probiotic pre-treated animals (probiotics 2.88 +/- 1.21 vs. placebo 1.94 +/- 0.55 nmol/min/mg protein; P<0.05) coinciding with an increase in mRNA expression of glutamate-cysteine-ligase catalytic (GCLc) and modifier (GCLm) subunits. Conclusions: Probiotic pre-treatment diminished AP-induced intestinal barrier dysfunction and prevented oxidative stress via mechanisms mainly involving mucosal glutathione biosynthesis.	[Lutgendorff, Femke; Sandstrom, Per A.; Trulsson, Lena M.; Soderholm, Johan D.] Linkoping Univ, Div Surg, Dept Clin & Expt Med, Linkoping, Sweden; [Lutgendorff, Femke; Nijmeijer, Rian M.; Timmerman, Harro M.; van Minnen, L. Paul; Rijkers, Ger T.; Gooszen, Hein G.; Akkermans, Louis M. A.] Univ Med Ctr, Dept Surg, Gastrointestinal Res Unit, Utrecht, Netherlands; [Magnusson, Karl-Eric] Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, S-58183 Linkoping, Sweden	Linkoping University; Utrecht University; Utrecht University Medical Center; Linkoping University	Lutgendorff, F (corresponding author), Linkoping Univ, Div Surg, Dept Clin & Expt Med, Linkoping, Sweden.	johan.d.soderholm@liu.se	SandstrÃm, Per/AAF-1841-2019; Rijkers, Ger/AAW-6143-2020; Rijkers, Ger/R-7236-2019; Gooszen, H.G./H-8036-2014	Rijkers, Ger/0000-0001-6948-6123; Magnusson, Karl-Eric/0000-0002-7809-8437	Swedish Research Council: Medicine; Senter, an agency of the Dutch Ministry of Economic Affairs [TSGE3109]	Swedish Research Council: Medicine(Swedish Research Council); Senter, an agency of the Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	Johan D. Soderholm and Karl-Eric Magnusson received financial support from the Swedish Research Council: Medicine. Part of this study was supported by Senter, an agency of the Dutch Ministry of Economic Affairs (grant number: TSGE3109). Funding sources were not involved in study design; collection, analysis and interpretation of data; writing of the paper; and the decision to submit it for publication.	Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Deitch EA, 2006, CRIT CARE MED, V34, P2294, DOI 10.1097/01.CCM.0000233857.94604.73; Ding Y, 2008, AM J PATHOL, V172, P1529, DOI 10.2353/ajpath.2008.070429; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; GRASS GM, 1988, PHARMACEUT RES, V5, P372, DOI 10.1023/A:1015911712079; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HAGEN TM, 1990, AM J PHYSIOL, V259, pG530, DOI 10.1152/ajpgi.1990.259.4.G530; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Katsube T, 2007, BBA-MOL CELL RES, V1773, P794, DOI 10.1016/j.bbamcr.2007.03.002; Kohler JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1048, DOI 10.1152/ajpgi.00241.2004; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; LU SC, 2008, MOL ASPECTS MED; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Musenga A, 2007, ANAL BIOANAL CHEM, V387, P917, DOI 10.1007/s00216-006-0980-6; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Peran L, 2006, INT J COLORECTAL DIS, V21, P737, DOI 10.1007/s00384-005-0773-y; Rau B, 2000, ANN SURG, V231, P352, DOI 10.1097/00000658-200003000-00008; Resta-Lenert S, 2002, GASTROENTEROLOGY, V122, P1070, DOI 10.1053/gast.2002.32372; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Siriwardena AK, 2007, GUT, V56, P1439, DOI 10.1136/gut.2006.115873; Solis WA, 2002, BIOCHEM PHARMACOL, V63, P1739, DOI 10.1016/S0006-2952(02)00897-3; SPORMANN H, 1989, PATHOL RES PRACT, V184, P507, DOI 10.1016/S0344-0338(89)80143-8; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; Tomson FL, 2004, GASTROENTEROLOGY, V127, P859, DOI 10.1053/j.gastro.2004.06.014; Trulsson LM, 2002, REGUL PEPTIDES, V106, P97, DOI 10.1016/S0167-0115(02)00056-3; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007; Velin AK, 2004, GUT, V53, P494, DOI 10.1136/gut.2003.028506; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; YASUDA T, 2007, J SURG RES; Yasuda T, 2006, J SURG RES, V135, P18, DOI 10.1016/j.jss.2006.02.050; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	47	90	103	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4512	10.1371/journal.pone.0004512	http://dx.doi.org/10.1371/journal.pone.0004512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223985	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485800013
J	Mi, J; Dziegielewski, J; Bolesta, E; Brautigan, DL; Larner, JM				Mi, Jun; Dziegielewski, Jaroslaw; Bolesta, Elzbieta; Brautigan, David L.; Larner, James M.			Activation of DNA-PK by Ionizing Radiation Is Mediated by Protein Phosphatase 6	PLOS ONE			English	Article								DNA-dependent protein kinase (DNA-PK) plays a critical role in DNA damage repair, especially in non-homologous end-joining repair of double-strand breaks such as those formed by ionizing radiation (IR) in the course of radiation therapy. Regulation of DNA-PK involves multisite phosphorylation but this is incompletely understood and little is known about protein phosphatases relative to DNA-PK. Mass spectrometry analysis revealed that DNA-PK interacts with the protein phosphatase-6 (PP6) SAPS subunit PP6R1. PP6 is a heterotrimeric enzyme that consists of a catalytic subunit, plus one of three PP6 SAPS regulatory subunits and one of three ankyrin repeat subunits. Endogenous PP6R1 co-immunoprecipitated DNA-PK, and IR enhanced the amount of complex and promoted its import into the nucleus. In addition, siRNA knockdown of either PP6R1 or PP6 significantly decreased IR activation of DNA-PK, suggesting that PP6 activates DNA-PK by association and dephosphorylation. Knockdown of other phosphatases PP5 or PP1c1 and subunits PP6R3 or ARS-A did not reduce IR activation of DNA-PK, demonstrating specificity for PP6R1. Finally, siRNA knockdown of PP6R1 or PP6 but not other phosphatases increased the sensitivity of glioblastoma cells to radiation-induced cell death to a level similar to DNA-PK deficient cells. Our data demonstrate that PP6 associates with and activates DNA-PK in response to ionizing radiation. Therefore, the PP6/PP6R1 phosphatase is a potential molecular target for radiation sensitization by chemical inhibition.	[Mi, Jun; Dziegielewski, Jaroslaw; Bolesta, Elzbieta; Larner, James M.] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Mi, J (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA USA.	jml2p@virginia.edu			NIH [ES011975, GM-56362]; Charles R. Burnett, Jr. and W. Griffin Burnett Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles R. Burnett, Jr. and W. Griffin Burnett Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants ES011975 (to J. M. L) and GM-56362 (to D. L. B.), as well as the Charles R. Burnett, Jr. and W. Griffin Burnett Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Povirk LF, 2007, NUCLEIC ACIDS RES, V35, P3869, DOI 10.1093/nar/gkm339; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106	35	76	80	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4395	10.1371/journal.pone.0004395	http://dx.doi.org/10.1371/journal.pone.0004395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198648	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483900005
J	Salvi, R; Arsenijevic, Y; Giacomini, M; Rey, JP; Voirol, MJ; Gaillard, RC; Risold, PY; Pralong, F				Salvi, Roberto; Arsenijevic, Yvan; Giacomini, Marco; Rey, Jean-Pierre; Voirol, Marie-Jeanne; Gaillard, Rolf Christian; Risold, Pierre-Yves; Pralong, Francois			The Fetal Hypothalamus Has the Potential to Generate Cells with a Gonadotropin Releasing Hormone (GnRH) Phenotype	PLOS ONE			English	Article							NEURAL STEM-CELL; FIBROBLAST GROWTH FACTOR-2; ADULT; NEURONS; BRAIN; NEUROGENESIS; PROGENITORS; POPULATIONS; LINEAGES; REGIONS	Background: Neurospheres (NS) are colonies of neural stem and precursor cells capable of differentiating into the central nervous system (CNS) cell lineages upon appropriate culture conditions: neurons, and glial cells. NS were originally derived from the embryonic and adult mouse striatum subventricular zone. More recently, experimental evidence substantiated the isolation of NS from almost any region of the CNS, including the hypothalamus. Methodology/Findings: Here we report a protocol that enables to generate large quantities of NS from both fetal and adult rat hypothalami. We found that either FGF-2 or EGF were capable of inducing NS formation from fetal hypothalamic cultures, but that only FGF-2 is effective in the adult cultures. The hypothalamic-derived NS are capable of differentiating into neurons and glial cells and most notably, as demonstrated by immunocytochemical detection with a specific anti-GnRH antibody, the fetal cultures contain cells that exhibit a GnRH phenotype upon differentiation. Conclusions/Significance: This in vitro model should be useful to study the molecular mechanisms involved in GnRH neuronal differentiation.	[Salvi, Roberto; Giacomini, Marco; Rey, Jean-Pierre; Voirol, Marie-Jeanne; Gaillard, Rolf Christian; Pralong, Francois] Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland; [Arsenijevic, Yvan] Univ Lausanne Hosp, Jules Gonin Eye Hosp, Lausanne, Switzerland; [Pralong, Francois] Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metabol, Geneva, Switzerland; [Risold, Pierre-Yves] Fac Med Pharm, EA 3922, Lab Histol, Besancon, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Salvi, R (corresponding author), Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland.	Francois.Pralong@chuv.ch	Messier, Claude/A-2322-2008; Risold, Pierre-Yves/AAJ-9535-2021; Risold, Pierre-Yves/M-7730-2018	Messier, Claude/0000-0002-4791-1763; Risold, Pierre-Yves/0000-0001-6801-591X; Arsenijevic, Yvan/0000-0001-6960-1291	Swiss National Science Foundation [320000-112075]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation grant #320000-112075 to FPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Arsenijevic Y, 2003, MOL NEUROBIOL, V27, P73, DOI 10.1385/MN:27:1:73; Chipperfield H, 2005, BRAIN RES PROTOC, V14, P146, DOI 10.1016/j.brainresprot.2004.12.003; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Ciofi P, 2000, NEUROSCIENCE, V99, P133, DOI 10.1016/S0306-4522(00)00186-X; Craig CG, 1996, J NEUROSCI, V16, P2649; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kruger GM, 2002, CELL, V110, P399, DOI 10.1016/S0092-8674(02)00899-1; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lillien L, 1998, CURR BIOL, V8, pR872, DOI 10.1016/S0960-9822(07)00548-9; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mastronardi C, 2006, J NEUROSCI, V26, P13167, DOI 10.1523/JNEUROSCI.4238-06.2006; Morshead CM, 2001, CURR OPIN NEUROBIOL, V11, P59, DOI 10.1016/S0959-4388(00)00174-4; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Salvi R, 2006, ENDOCRINOLOGY, V147, P816, DOI 10.1210/en.2005-0728; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Tobet SA, 2002, EUR J NEUROSCI, V16, P373, DOI 10.1046/j.1460-9568.2002.02105.x; Treier M, 1996, CURR OPIN CELL BIOL, V8, P833, DOI 10.1016/S0955-0674(96)80085-8; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Whitlock KE, 2006, MOL CELL ENDOCRINOL, V254, P39, DOI 10.1016/j.mce.2006.04.038; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4392	10.1371/journal.pone.0004392	http://dx.doi.org/10.1371/journal.pone.0004392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197372	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483700007
J	Qin, JY; Zhao, B; Wang, XW; Wang, LM; Yu, B; Ma, YH; Ma, CQ; Tang, HZ; Sun, JB; Xu, P				Qin, Jiayang; Zhao, Bo; Wang, Xiuwen; Wang, Limin; Yu, Bo; Ma, Yanhe; Ma, Cuiqing; Tang, Hongzhi; Sun, Jibin; Xu, Ping			Non-Sterilized Fermentative Production of Polymer-Grade L-Lactic Acid by a Newly Isolated Thermophilic Strain Bacillus sp 2-6	PLOS ONE			English	Article							LACTOBACILLUS-CASEI FERMENTATION; D-LACTATE DEHYDROGENASE; L(+)-LACTIC ACID; STATISTICAL OPTIMIZATION; RHIZOPUS-ORYZAE; COAGULANS; BATCH; HYDROLYSATE; GLUCOSE; BIOMASS	Background: The demand for lactic acid has been increasing considerably because of its use as a monomer for the synthesis of polylactic acid (PLA), which is a promising and environment-friendly alternative to plastics derived from petrochemicals. Optically pure L-lactic acid is essential for polymerization of PLA. The high fermentation cost of L-lactic acid is another limitation for PLA polymers to compete with conventional plastics. Methodology/Principal Findings: A Bacillus sp. strain 2-6 for production of L-lactic acid was isolated at 55 degrees C from soil samples. Its thermophilic characteristic made it a good lactic acid producer because optically pure L-lactic acid could be produced by this strain under open condition without sterilization. In 5-liter batch fermentation of Bacillus sp. 2-6, 118.0 g/liter of L-lactic acid with an optical purity of 99.4% was obtained from 121.3 g/liter of glucose. The yield was 97.3% and the average productivity was 4.37 g/liter/ h. The maximum L-lactic acid concentration of 182.0 g/liter was obtained from 30-liter fed-batch fermentation with an average productivity of 3.03 g/liter/ h and product optical purity of 99.4%. Conclusions/Significance: With the newly isolated Bacillus sp. strain 2-6, high concentration of optically pure L-lactic acid could be produced efficiently in open fermentation without sterilization, which would lead to a new cost-effective method for polymer-grade L-lactic acid production from renewable resources.	[Qin, Jiayang; Wang, Xiuwen; Wang, Limin; Ma, Yanhe; Sun, Jibin; Xu, Ping] Chinese Acad Sci, Tianjin Ind Biotechnol R&D Ctr, Tianjin, Peoples R China; [Zhao, Bo; Wang, Limin; Yu, Bo; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Beijing 100864, Peoples R China; [Qin, Jiayang; Wang, Xiuwen; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microb Technol, Jinan, Peoples R China; [Tang, Hongzhi; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Minist Educat, Key Lab Microb Metabolism, Shanghai, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong University; Shanghai Jiao Tong University	Qin, JY (corresponding author), Chinese Acad Sci, Tianjin Ind Biotechnol R&D Ctr, Tianjin, Peoples R China.	pingxu@sjtu.edu.cn	MA, YAN/HHN-2912-2022; yu, bo/A-9467-2008	yu, bo/0000-0003-3148-0986; Ma, Cuiqing/0000-0002-7468-1027; Sun, Jibin/0000-0002-0208-504X	National Basic Research Program of China [2007CB707803]; Chinese National Program for High Technology Research and Development [2006AA020102, 2007AA10Z360]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2007CB707803) and Chinese National Program for High Technology Research and Development (2006AA020102 and 2007AA10Z360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DM, 2003, BIOTECHNOL LETT, V25, P1833, DOI 10.1023/A:1026276925649; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SF, 2003, FORTUNE, V148, P92; CAMPBELL LL, 1959, J BACTERIOL, V78, P267, DOI 10.1128/JB.78.2.267-271.1959; CLEVERDON RC, 1949, J BACTERIOL, V58, P113, DOI 10.1128/JB.58.1.113-114.1949; CLEVERDON RC, 1949, J BACTERIOL, V58, P523, DOI 10.1128/JB.58.4.523-526.1949; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Datta R, 2006, J CHEM TECHNOL BIOT, V81, P1119, DOI 10.1002/jctb.1486; Ding SF, 2006, PROCESS BIOCHEM, V41, P1451, DOI 10.1016/j.procbio.2006.01.014; EINARSSON H, 1983, J AGR FOOD CHEM, V31, P1043, DOI 10.1021/jf00119a031; FERAIN T, 1994, J BACTERIOL, V176, P596, DOI 10.1128/jb.176.3.596-601.1994; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hofvendahl K, 2000, ENZYME MICROB TECH, V26, P87, DOI 10.1016/S0141-0229(99)00155-6; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; Kyla-Nikkila K, 2000, APPL ENVIRON MICROB, V66, P3835, DOI 10.1128/AEM.66.9.3835-3841.2000; Li Zheng, 2006, Biotechnology Journal, V1, P1453, DOI 10.1002/biot.200600099; Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; Manome A, 1998, J GEN APPL MICROBIOL, V44, P371, DOI 10.2323/jgam.44.371; Michelson T, 2006, ENZYME MICROB TECH, V39, P861, DOI 10.1016/j.enzmictec.2006.01.015; Pan CM, 2008, BIORESOURCE TECHNOL, V99, P3146, DOI 10.1016/j.biortech.2007.05.055; Park EY, 1998, BIOTECHNOL PROGR, V14, P699, DOI 10.1021/bp9800642; Patel M, 2004, BIOTECHNOL LETT, V26, P865, DOI 10.1023/B:bile.0000025893.27700.5c; Payot T, 1999, ENZYME MICROB TECH, V24, P191, DOI 10.1016/S0141-0229(98)00098-2; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Rosenberg M, 2005, BIOTECHNOL LETT, V27, P1943, DOI 10.1007/s10529-005-3907-y; Sakai K, 2006, J BIOSCI BIOENG, V101, P457, DOI 10.1263/jbb.101.457; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/s0079-6700(02)00012-6; TAGUCHI H, 1991, J BIOL CHEM, V266, P12588; Tay A, 2002, BIOTECHNOL BIOENG, V80, P1, DOI 10.1002/bit.10340; Tsuji F, 2002, POLYMER, V43, P1789; Viana R, 2005, RES MICROBIOL, V156, P641, DOI 10.1016/j.resmic.2005.02.011; Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5	35	78	89	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4359	10.1371/journal.pone.0004359	http://dx.doi.org/10.1371/journal.pone.0004359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194504	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483500009
J	Louie, SH; Yang, XY; Conrad, WH; Muster, J; Angers, S; Moon, RT; Cheyette, BNR				Louie, Sarah H.; Yang, Xiao Yong; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.; Cheyette, Benjamin N. R.			Modulation of the beta-Catenin Signaling Pathway by the Dishevelled-Associated Protein Hipk1	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; PLANAR CELL-POLARITY; NEURAL-TUBE CLOSURE; N-TERMINAL KINASE; XENOPUS-EMBRYOS; WNT/BETA-CATENIN; C-JUN; DIX DOMAIN; VERTEBRATE EMBRYOS; AXIS FORMATION	Background: Wnts are evolutionarily conserved ligands that signal through beta-catenin-dependent and beta-catenin-independent pathways to regulate cell fate, proliferation, polarity, and movements during vertebrate development. Dishevelled (Dsh/Dvl) is a multi-domain scaffold protein required for virtually all known Wnt signaling activities, raising interest in the identification and functions of Dsh-associated proteins. Methodology: We conducted a yeast-2-hybrid screen using an N-terminal fragment of Dsh, resulting in isolation of the Xenopus laevis ortholog of Hipk1. Interaction between the Dsh and Hipk1 proteins was confirmed by co-immunoprecipitation assays and mass spectrometry, and further experiments suggest that Hipk1 also complexes with the transcription factor Tcf3. Supporting a nuclear function during X. laevis development, Myc-tagged Hipk1 localizes primarily to the nucleus in animal cap explants, and the endogenous transcript is strongly expressed during gastrula and neurula stages. Experimental manipulations of Hipk1 levels indicate that Hipk1 can repress Wnt/beta-catenin target gene activation, as demonstrated by beta-catenin reporter assays in human embryonic kidney cells and by indicators of dorsal specification in X. laevis embryos at the late blastula stage. In addition, a subset of Wnt-responsive genes subsequently requires Hipk1 for activation in the involuting mesoderm during gastrulation. Moreover, either over-expression or knock-down of Hipk1 leads to perturbed convergent extension cell movements involved in both gastrulation and neural tube closure. Conclusions: These results suggest that Hipk1 contributes in a complex fashion to Dsh-dependent signaling activities during early vertebrate development. This includes regulating the transcription of Wnt/beta-catenin target genes in the nucleus, possibly in both repressive and activating ways under changing developmental contexts. This regulation is required to modulate gene expression and cell movements that are essential for gastrulation.	[Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Program Biol Sci, Grad Program Dev Biol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Louie, SH (corresponding author), Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA.	benjamin.cheyette@ucsf.edu	Moon, Randall T/B-1743-2014; Cheyette, Benjamin/K-5535-2014; Angers, Stephane/E-1432-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Cheyette, Benjamin/0000-0001-9934-7941; Angers, Stephane/0000-0001-7241-9044; Moon, Randall/0000-0002-9352-1408; Muster, Jeanot/0000-0002-1972-6851	NIH [R01, MH01750 K08]; HHMI [fellow]; NARSAD/Browning Foundation Young Investigator Award;  [1R01HD055300]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NARSAD/Browning Foundation Young Investigator Award(NARSAD); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an NIH R01. RTM is an investigator, and SA was a fellow of the HHMI. BNRC was supported by NIH MH01750 K08 and a NARSAD/Browning Foundation Young Investigator Award, and he and XYY are currently supported by 1R01HD055300 to BNRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHEYETTE BN, 2004, SCI STKE, pPE54; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1; CUI YZ, 1995, DEVELOPMENT, V121, P2177; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Djiane A, 2000, DEVELOPMENT, V127, P3091; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; HUANG HHEX, 2008, CURR OPIN CELL BIOL; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER R, 1991, METHOD CELL BIOL, V36, P61; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Makita R, 1998, MECH DEVELOP, V71, P165, DOI 10.1016/S0925-4773(98)00013-6; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; MCGREW LL, 1992, DEVELOPMENT, V115, P463; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; ROTHBACHER U, 1995, DEV BIOL, V170, P717, DOI 10.1006/dbio.1995.1249; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; RUI Y, 2004, EMBO J; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SOKOL SY, 1995, DEVELOPMENT, V121, P3487; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Tada M, 2000, DEVELOPMENT, V127, P2227; Tahinci E, 2007, DEVELOPMENT, V134, P4095, DOI 10.1242/dev.010272; THEISEN H, 1994, DEVELOPMENT, V120, P347; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yokota C, 2003, DEVELOPMENT, V130, P2199, DOI 10.1242/dev.00434; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	116	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4310	10.1371/journal.pone.0004310	http://dx.doi.org/10.1371/journal.pone.0004310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183803	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483200002
J	Nikolaev, A; Zheng, L; Wardill, TJ; O'Kane, CJ; de Polavieja, GG; Juusola, M				Nikolaev, Anton; Zheng, Lei; Wardill, Trevor J.; O'Kane, Cahir J.; de Polavieja, Gonzalo G.; Juusola, Mikko			Network Adaptation Improves Temporal Representation of Naturalistic Stimuli in Drosophila Eye: II Mechanisms	PLOS ONE			English	Article							LIGHT ADAPTATION; VISUAL-SYSTEM; HISTAMINE; PHOTORECEPTORS; CHANNEL; LAMINA; TRANSMISSION; PREFERENCE; TERMINALS; RESPONSES	Retinal networks must adapt constantly to best present the ever changing visual world to the brain. Here we test the hypothesis that adaptation is a result of different mechanisms at several synaptic connections within the network. In a companion paper (Part I), we showed that adaptation in the photoreceptors (R1-R6) and large monopolar cells (LMC) of the Drosophila eye improves sensitivity to under-represented signals in seconds by enhancing both the amplitude and frequency distribution of LMCs' voltage responses to repeated naturalistic contrast series. In this paper, we show that such adaptation needs both the light-mediated conductance and feedback-mediated synaptic conductance. A faulty feedforward pathway in histamine receptor mutant flies speeds up the LMC output, mimicking extreme light adaptation. A faulty feedback pathway from L2 LMCs to photoreceptors slows down the LMC output, mimicking dark adaptation. These results underline the importance of network adaptation for efficient coding, and as a mechanism for selectively regulating the size and speed of signals in neurons. We suggest that concert action of many different mechanisms and neural connections are responsible for adaptation to visual stimuli. Further, our results demonstrate the need for detailed circuit reconstructions like that of the Drosophila lamina, to understand how networks process information.	[Nikolaev, Anton; Zheng, Lei; Wardill, Trevor J.; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain; [Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China	University of Sheffield; University of Cambridge; Autonomous University of Madrid; Autonomous University of Madrid; Beijing Normal University	Nikolaev, A (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Juusola, Mikko/E-6948-2011	O'Kane, Cahir/0000-0002-3488-2078; de Polavieja, Gonzalo/0000-0001-5359-3426; Wardill, Trevor/0000-0002-2049-113X; Juusola, Mikko/0000-0002-4428-5330	Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Royal Society; MEC; Biociencia program; CAM-UAM; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001900/1, BB/F012071/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Royal Society(Royal Society of London); MEC(European Commission); Biociencia program; CAM-UAM; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Biotechnology and Biological Sciences Research Council (MJ, CJO'K), the Gatsby Charitable Foundation (MJ), the Royal Society (MJ, GGdP), MEC (GGdP), Biociencia program (GGdP) and CAM-UAM (GGdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 1990, J COMP PHYSIOL A, V167, P723, DOI 10.1007/BF00189763; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Pak W.L., 1979, P67; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; SHAW SR, 1984, J EXP BIOL, V112, P225; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; STRAUSFE.NJ, 1970, Z VERGL PHYSIOL, V70, P95, DOI 10.1007/BF00297712; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; UUSITALO RO, 1995, J NEUROPHYSIOL, V73, P1782, DOI 10.1152/jn.1995.73.5.1782; UUSITALO RO, 1995, J NEUROPHYSIOL, V74, P470, DOI 10.1152/jn.1995.74.1.470; Vahasoyrinki M, 2006, J NEUROSCI, V26, P2652, DOI 10.1523/JNEUROSCI.3316-05.2006; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Wolfram V, 2004, J NEUROPHYSIOL, V92, P1918, DOI 10.1152/jn.00201.2004; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4306	10.1371/journal.pone.0004306	http://dx.doi.org/10.1371/journal.pone.0004306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180195	Green Published, gold, Green Accepted			2022-12-25	WOS:000274089700005
J	Yonehara, K; Ishikane, H; Sakuta, H; Shintani, T; Nakamura-Yonehara, K; Kamiji, NL; Usui, S; Noda, M				Yonehara, Keisuke; Ishikane, Hiroshi; Sakuta, Hiraki; Shintani, Takafumi; Nakamura-Yonehara, Kayo; Kamiji, Nilton L.; Usui, Shiro; Noda, Masaharu			Identification of Retinal Ganglion Cells and Their Projections Involved in Central Transmission of Information about Upward and Downward Image Motion	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; MEDIAL TERMINAL NUCLEUS; VERTICAL OPTOKINETIC NYSTAGMUS; STARBURST AMACRINE CELLS; EYE-MOVEMENTS; DIRECTION SELECTIVITY; VISUAL EXPERIENCE; RABBIT RETINA; DYNAMIC CHARACTERISTICS; SPATIAL-ORGANIZATION	The direction of image motion is coded by direction-selective (DS) ganglion cells in the retina. Particularly, the ON DS ganglion cells project their axons specifically to terminal nuclei of the accessory optic system (AOS) responsible for optokinetic reflex (OKR). We recently generated a knock-in mouse in which SPIG1 (SPARC-related protein containing immunoglobulin domains 1)-expressing cells are visualized with GFP, and found that retinal ganglion cells projecting to the medial terminal nucleus (MTN), the principal nucleus of the AOS, are comprised of SPIG1(+) and SPIG1(-) ganglion cells distributed in distinct mosaic patterns in the retina. Here we examined light responses of these two subtypes of MTN-projecting cells by targeted electrophysiological recordings. SPIG1(+) and SPIG1(-) ganglion cells respond preferentially to upward motion and downward motion, respectively, in the visual field. The direction selectivity of SPIG1(+) ganglion cells develops normally in dark-reared mice. The MTN neurons are activated by optokinetic stimuli only of the vertical motion as shown by Fos expression analysis. Combination of genetic labeling and conventional retrograde labeling revealed that axons of SPIG1(+) and SPIG1(-) ganglion cells project to the MTN via different pathways. The axon terminals of the two subtypes are organized into discrete clusters in the MTN. These results suggest that information about upward and downward image motion transmitted by distinct ON DS cells is separately processed in the MTN, if not independently. Our findings provide insights into the neural mechanisms of OKR, how information about the direction of image motion is deciphered by the AOS.	[Yonehara, Keisuke; Sakuta, Hiraki; Shintani, Takafumi; Nakamura-Yonehara, Kayo; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Yonehara, Keisuke; Sakuta, Hiraki; Shintani, Takafumi; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Ishikane, Hiroshi; Kamiji, Nilton L.; Usui, Shiro] RIKEN, Brain Sci Inst, Lab Neuroinformat, Wako, Saitama, Japan; [Ishikane, Hiroshi] Senshu Univ, Grad Sch Humanities, Dept Psychol, Kawasaki, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; RIKEN	Yonehara, K (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Kamiji, Nilton/N-8420-2015; Noda, Masaharu/D-7146-2016; Kamiji, Nilton Liuji/AAF-3860-2020	Noda, Masaharu/0000-0002-3796-524X; Kamiji, Nilton Liuji/0000-0001-5006-6612; Shintani, Takafumi/0000-0002-6165-2307; Sakuta, Hiraki/0000-0003-2375-0528; Ishikane, Hiroshi/0000-0003-1316-2255; Yonehara, Keisuke/0000-0001-9541-6671	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. N. and H. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BENASSI C, 1989, VISUAL NEUROSCI, V2, P377, DOI 10.1017/S0952523800002182; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; COLLEWIJN H, 1977, EXP BRAIN RES, V27, P287; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; DAW NW, 1974, J PHYSIOL-LONDON, V240, P309, DOI 10.1113/jphysiol.1974.sp010612; De Zeeuw CI, 1998, OTOLARYNG HEAD NECK, V119, P193, DOI 10.1016/S0194-5998(98)70054-3; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; ERICKSON RG, 1980, EXP BRAIN RES, V40, P448; EVINGER C, 1978, J PHYSIOL-LONDON, V285, P209, DOI 10.1113/jphysiol.1978.sp012568; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; GIOLLI RA, 1984, J COMP NEUROL, V227, P228, DOI 10.1002/cne.902270208; GIOLLI RA, 1968, J COMP NEUROL, V133, P309, DOI 10.1002/cne.901330303; GRASSE KL, 1982, J NEUROPHYSIOL, V48, P490, DOI 10.1152/jn.1982.48.2.490; HAYHOW WR, 1960, J COMP NEUROL, V115, P187, DOI 10.1002/cne.901150207; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; HOFFMANN KP, 1995, J NEUROPHYSIOL, V73, P727, DOI 10.1152/jn.1995.73.2.727; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; IWAHORI N, 1981, NEUROSCI LETT, V23, P229, DOI 10.1016/0304-3940(81)90002-1; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Kao YH, 2003, J NEUROCYTOL, V32, P245, DOI 10.1023/B:NEUR.0000010083.03446.78; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LUI F, 1990, EXP BRAIN RES, V81, P77; MANGINI NJ, 1985, J COMP NEUROL, V241, P191, DOI 10.1002/cne.902410207; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MATSUO V, 1984, EXP BRAIN RES, V53, P197; MITCHINER JC, 1976, VISION RES, V16, P1169, DOI 10.1016/0042-6989(76)90258-3; MURASUGI CM, 1989, EXP BRAIN RES, V77, P183; NAKAYAMA K, 1981, VISION RES, V21, P1475, DOI 10.1016/0042-6989(81)90218-2; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; PAK MW, 1987, J COMP NEUROL, V258, P435, DOI 10.1002/cne.902580311; Peters MA, 2002, CURR OPIN NEUROBIOL, V12, P43, DOI 10.1016/S0959-4388(02)00288-X; Rodieck R.W., 1998, 1 STEPS SEEING; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sakatani T, 2007, NEUROSCI RES, V58, P324, DOI 10.1016/j.neures.2007.04.003; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sakuta H, 2006, J NEUROSCI, V26, P10868, DOI 10.1523/JNEUROSCI.3027-06.2006; SATAKANI T, 2004, NEUROSCI RES, V49, P123; Schmidt M, 1998, EUR J NEUROSCI, V10, P1533, DOI 10.1046/j.1460-9568.1998.00161.x; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Simpson J I, 1979, Prog Brain Res, V50, P715; SIMPSON JI, 1988, J NEUROPHYSIOL, V60, P2055, DOI 10.1152/jn.1988.60.6.2055; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; SINEX DG, 1979, VISION RES, V19, P853, DOI 10.1016/0042-6989(79)90018-X; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; STEWART DL, 1971, J NEUROPHYSIOL, V34, P139, DOI 10.1152/jn.1971.34.1.139; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; TERUBAYASHI H, 1984, J COMP NEUROL, V227, P285, DOI 10.1002/cne.902270211; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; VANDERTOGT C, 1993, J COMP NEUROL, V338, P175, DOI 10.1002/cne.903380204; VANEY DI, 1981, BRAIN RES, V212, P447, DOI 10.1016/0006-8993(81)90476-5; Vaney DI, 2001, MOTION VISION, P13; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANEY DI, 1994, J NEUROSCI, V14, P6301; WALLMAN J, 1985, J NEUROSCI, V5, P317; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847; Yamada H, 1974, Z Mikrosk Anat Forsch, V88, P997; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	81	119	124	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4320	10.1371/journal.pone.0004320	http://dx.doi.org/10.1371/journal.pone.0004320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177171	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483100007
J	Gonzalez-Periz, A; Horrillo, R; Ferre, N; Gronert, K; Dong, B; Moran-Salvador, E; Titos, E; Martinez-Clemente, M; Lopez-Parra, M; Arroyo, V; Claria, J				Gonzalez-Periz, Ana; Horrillo, Raquel; Ferre, Natalia; Gronert, Karsten; Dong, Baiyan; Moran-Salvador, Eva; Titos, Esther; Martinez-Clemente, Marcos; Lopez-Parra, Marta; Arroyo, Vicente; Claria, Joan			Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins	FASEB JOURNAL			English	Article						adiponectin; fatty liver disease; adipose tissue; lipid mediators	FATTY LIVER; DOCOSAHEXAENOIC ACID; ADIPOSE-TISSUE; LIPID MEDIATORS; PPAR-GAMMA; TNF-ALPHA; INFLAMMATION; RESOLUTION; MICE; E1	Omega-3-polyunsaturated fatty acids (omega 3-PUFAs) have well-documented protective effects that are attributed not only to eicosanoid inhibition but also to the formation of novel biologically active lipid mediators (i.e., resolvins and protectins). In this study, we examined their effects on ob/ob mice, an obesity model of insulin resistance and fatty liver disease. Dietary intake of omega-3-PUFAs had insulin-sensitizing actions in adipose tissue and liver and improved insulin tolerance in obese mice. Genes involved in insulin sensitivity (PPAR gamma), glucose transport (GLUT-2/GLUT-4), and insulin receptor signaling (IRS-1/IRS-2) were up-regulated by omega-3-PUFAs. Moreover, omega-3-PUFAs increased adiponectin, an anti-inflammatory and insulin-sensitizing adipokine, and induced AMPK phosphorylation, a fuel-sensing enzyme and a gatekeeper of the energy balance. Concomitantly, hepatic steatosis was alleviated by omega-3-PUFAs. A lipidomic analysis with liquid chromatography/mass spectrometry/mass spectrometry revealed that omega-3-PUFAs inhibited the formation of omega-6-PUFA-derived eicosanoids, while triggering the formation of omega-3-PUFA-derived resolvins and protectins. Moreover, representative members of these lipid mediators, namely resolvin E1 and protectin D1, mimicked the insulin-sensitizing and antisteatotic effects of omega-3-PUFAs and induced adiponectin expression to a similar extent that of rosiglitazone, a member of the thiazolidinedione family of antidiabetic drugs. Taken together, these findings uncover beneficial actions of omega-3-PUFAs and their bioactive lipid autacoids in preventing obesity-induced insulin resistance and hepatic steatosis.-Gonzalez-Periz, A., Horrillo, R., Ferre, N., Gronert, K., Dong, B., Moran-Salvador, E., Titos, E., Martinez-Clemente, M., Lopez-Parra, M., Arroyo, V., Claria, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946-1957 (2009)	[Gonzalez-Periz, Ana; Horrillo, Raquel; Ferre, Natalia; Moran-Salvador, Eva; Titos, Esther; Martinez-Clemente, Marcos; Lopez-Parra, Marta; Claria, Joan] Univ Barcelona, Dept Biochem & Mol Genet, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; [Arroyo, Vicente] Univ Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; [Gronert, Karsten; Dong, Baiyan] Univ Calif Berkeley, Sch Optometry, Ctr Eye Dis & Dev, Berkeley, CA 94720 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of California System; University of California Berkeley	Claria, J (corresponding author), Univ Barcelona, Dept Biochem & Mol Genet, Inst Invest Biomed August Pi & Sunyer, Villarroel 170, Barcelona 08036, Spain.	jclaria@clinic.ub.es	Ferré, Natalia/ABE-5700-2020; Arroyo, Vicente/F-9189-2015; Horrillo, Raquel/B-4348-2009; Titos, Esther/AAA-5394-2019; Claria, Joan/M-7772-2019	Ferré, Natalia/0000-0002-2838-1525; Arroyo, Vicente/0000-0002-2728-1848; Titos, Esther/0000-0002-2543-2243; Claria, Joan/0000-0003-4333-7749	Ministerio de Educacion y Ciencia [SAF 06/03191]; National Eye Institute [EY01613604]; CIBERehd is funded by the Instituto de Salud Carlos III [BES-2004-5054]; Generalitat de Catalunya-European Social Funds [2006FI-00091]	Ministerio de Educacion y Ciencia(Spanish Government); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CIBERehd is funded by the Instituto de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya-European Social Funds(Generalitat de Catalunya)	This work was supported by a grant from the Ministerio de Educacion y Ciencia (MEC; SAF 06/03191) to J.C. and by a grant from the National Eye Institute (EY01613604) to K.G. CIBERehd is funded by the Instituto de Salud Carlos III. A.G.-P. (BES-2004-5054) was supported by MEC. M. L.- P., E.T., and N.F. had contracts with Instituto de Salud Carlos III, CIBERehd, and MEC Juan de la Cierva, respectively. M.M.-C. (BES- 2007- 16147) and E.M.-S. (AP2007-02004) received fellowships from MEC. R. H. is supported by Generalitat de Catalunya-European Social Funds (2006FI-00091).	Alwayn IPJ, 2005, TRANSPLANTATION, V79, P606, DOI 10.1097/01.TP.0000150023.86487.44; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; CULP BR, 1979, PROSTAG LEUKOTR ESS, V3, P269, DOI 10.1016/0161-4630(79)90068-5; El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Ginsberg HN, 2006, CELL METAB, V4, P179, DOI 10.1016/j.cmet.2006.08.010; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gronert K, 1999, METH MOL B, V120, P119; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kielar ML, 2003, J AM SOC NEPHROL, V14, P389, DOI 10.1097/01.ASN.0000045047.44107.0B; Levy JR, 2004, HEPATOLOGY, V39, P608, DOI 10.1002/hep.20093; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lopez-Parra M, 2008, J LIPID RES, V49, P2513, DOI 10.1194/jlr.M800101-JLR200; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rousseau D, 2003, AM J PHYSIOL-HEART C, V285, pH1294, DOI 10.1152/ajpheart.00651.2002; Rousseau D, 2001, MOL CELL BIOCHEM, V225, P109, DOI 10.1023/A:1012266005428; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, METHOD ENZYMOL, V432, P275, DOI 10.1016/S0076-6879(07)32012-0; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Song BJ, 2008, J HEPATOL, V49, P262, DOI 10.1016/j.jhep.2008.04.023; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Werner A, 2005, AM J PHYSIOL-GASTR L, V288, pG1150, DOI 10.1152/ajpgi.00456.2004; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38	55	431	448	3	78	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1946	1957		10.1096/fj.08-125674	http://dx.doi.org/10.1096/fj.08-125674			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19211925	Green Published			2022-12-25	WOS:000266652400033
J	Lee, J; Kannagi, M; Ferrante, RJ; Kowall, NW; Ryu, H				Lee, Junghee; Kannagi, Mari; Ferrante, Robert J.; Kowall, Neil W.; Ryu, Hoon			Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis	FASEB JOURNAL			English	Article						transcription; mitochondria; astrocytes; neurodegeneration; motor neurons	SUPEROXIDE-DISMUTASE GENE; BCL-X(L) EXPRESSION; KAPPA-B; ASTROCYTES; APOPTOSIS; DEATH; MICE; ALS; OVEREXPRESSION; NEURONS	Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by selective degeneration of motor neurons and glial activation. Cell-specific transcriptional regulation induced by oxidative stress may contribute to the survival and activation of astrocytes in the face of motor neuron death. In the present study, we demonstrate an age-dependent increase in Bcl-xL and Ets-2 immunoreactivity that correlates with an increase of glial fibrillary acidic protein (GFAP)-positive cells in the ventral horn of the spinal cord in both ALS transgenic mice [mutant SOD1 (G93A)] and affected humans. Chromatin immunoprecipitation (ChIP) analysis verified that Ets-2 preferentially occupies the Ets-2 binding element in the promoter of Bcl-xL in primary astrocytes under oxidative stress conditions as well as in G93A spinal cords. Ets-2 small-interfering RNA down-regulated the transcriptional activity of Bcl-xL. In primary glial cultures, Bcl-xL overexpression and mutant SOD1 (G93A) both conferred resistance to oxidative stress-induced cell death. Our findings suggest that Ets-2 transcription factor activation of Bcl-xL gene may protect glia from constitutive oxidative stress that is thought to be a key mechanism contributing to the pathogenesis of ALS. This survival pathway may contribute to the glial survival and activation seen in the spinal cord of ALS patients.-Lee, J., Kannagi, M., Ferrante, R. J., Kowall, N. W., Ryu, H. Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis. FASEB J. 23, 1739-1749 (2009)	[Lee, Junghee; Ferrante, Robert J.; Kowall, Neil W.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ferrante, Robert J.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Ferrante, Robert J.] Boston Univ, Sch Med, Dept Psychol, Boston, MA 02118 USA; [Lee, Junghee; Kowall, Neil W.; Ryu, Hoon] Vet Affairs Boston Hlth Care Syst, Boston, MA USA; [Kannagi, Mari] Tokyo Med & Dent Univ, Dept Immunotherapeut, Tokyo, Japan; [Ferrante, Robert J.] Bedford Vet Affairs Med Ctr, Bedford, MA USA	Boston University; Boston University; Boston University; Tokyo Medical & Dental University (TMDU)	Lee, J (corresponding author), 150 S Huntington Ave, Boston, MA 02130 USA.	junghee@bu.edu; hoonryu@bu.edu	Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Lee, Junghee/0000-0002-9530-9806; Ryu, Hoon/0000-0001-6544-3732	National Institutes of Health (NIH) [NS-52724, P30 AG-13846, NS045242, NS045806]; Department of Veterans Affairs; World Class University; Korea Science and Engineering Foundation (KOSEF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045242, R01NS052724, U01NS045806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); World Class University; Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Cyd Khayter and Oh Kyu Kwon for technical assistance and the preparation of manuscript. J. L. is an awardee of a Les Turner ALS Foundation Grant. This work was supported by National Institutes of Health (NIH) NS-52724 (to H. R.), NIH P30 AG-13846 (to J. L.), NIH NS045242 and NS045806 (to R.J.F.), and a Department of Veterans Affairs (VA) merit grant (to J.L. and N.W.K.). This work was supported in part by a World Class University (WCU) grant from the Korea Science and Engineering Foundation (KOSEF)(to H.R.).	Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Grillot DAM, 1997, J IMMUNOL, V158, P4750; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Langley B, 2004, J NEUROSCI RES, V77, P621, DOI 10.1002/jnr.20210; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lee J, 2008, HUM MOL GENET, V17, P1774, DOI 10.1093/hmg/ddn067; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Niebroj-Dobosz I, 2004, FOLIA NEUROPATHOL, V42, P151; Ouyang YB, 2003, J CEREBR BLOOD F MET, V23, P275, DOI 10.1097/01.WCB.0000055774.06337.F6; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Phelka AD, 2006, NEUROTOXICOLOGY, V27, P192, DOI 10.1016/j.neuro.2005.09.006; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sanij E, 2001, BIOCHEM BIOPH RES CO, V287, P1003, DOI 10.1006/bbrc.2001.5680; Sevilla L, 2001, J BIOL CHEM, V276, P17800, DOI 10.1074/jbc.M008270200; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Warita H, 2001, MOL BRAIN RES, V89, P147, DOI 10.1016/S0169-328X(01)00029-8; Xu LJ, 1999, ANESTHESIOLOGY, V91, P1036, DOI 10.1097/00000542-199910000-00024; Xu LJ, 1999, NEUROSCI LETT, V277, P193, DOI 10.1016/S0304-3940(99)00882-4; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x	31	36	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1739	1749		10.1096/fj.08-121046	http://dx.doi.org/10.1096/fj.08-121046			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19179380	Green Published			2022-12-25	WOS:000266652400014
J	Cattaneo, M; Lotti, LV; Martino, S; Cardano, M; Orlandi, R; Mariani-Costantini, R; Biunno, I				Cattaneo, Monica; Lotti, Lavinia Vittoria; Martino, Simone; Cardano, Marina; Orlandi, Rosaria; Mariani-Costantini, Renato; Biunno, Ida			Functional Characterization of Two Secreted SEL1L Isoforms Capable of Exporting Unassembled Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HEPATOCELLULAR-CARCINOMA; EXPRESSION; PROTEINS; PROTEASOME; ANTIBODY; REGION; HRD1	SEL1L-A, a transmembrane glycoprotein residing in the endoplasmic reticulum (ER), is a component of the ER-associated degradation (ERAD) pathway. Alternative splicing generates two smaller SEL1L isoforms, -B and -C, that lack the SEL1L-A membrane-spanning region but retain some sel-1-like repeats, known to be involved in multi-protein interactions and signal transduction. In this study the functional characteristics of SEL1L-B and -C were investigated in human cell models. We show that these two isoforms are induced upon ER stress and activation of the unfolded protein response, together with SEL1L-A. Using transient transfection experiments (based on wild-type and mutant SEL1L constructs) combined with several biochemical tests we show that SEL1L-B and, more prominently, SEL1L-C are secreted glycoproteins. Although SEL1L-C is in monomeric form, SEL1L-B is engaged in intramolecular/intermolecular disulfide bonds. Both isoforms localize in secretory and degradative cellular compartments and in areas of cell-cell contact. However, whereas SEL1L-B is mainly associated with membranes, SEL1L-C shows the typical intralumenal localization of soluble proteins and is present in intercellular spaces. Furthermore, because of its peroxisomal domain, SEL1L-C localizes to peroxisomes. Both SEL1L-B and -C are involved in sorting and exporting unassembled Ig-mu(s) but do not affect two other ERAD substrates, the null Hong Kong variant of alpha(1)-antitrypsin, and mutant alpha(1)-AT Z. Overall these findings suggest that SEL1L-B and -C participate to novel molecular pathways that, in parallel with ERAD, contribute to the disposure of misfolded/unfolded or orphan proteins through degradation or secretion.	[Cattaneo, Monica; Biunno, Ida] CNR, Inst Biomed Technol, I-20090 Milan, Italy; [Lotti, Lavinia Vittoria; Martino, Simone] Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; [Cardano, Marina; Biunno, Ida] Integrated Syst Engn, I-20138 Milan, Italy; [Orlandi, Rosaria] Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy; [Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Oncol & Neurosci, I-66100 Chieti, Italy; [Mariani-Costantini, Renato] Univ G dAnnunzio, Ctr Excellence Aging CeSI, I-66100 Chieti, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Biunno, I (corresponding author), ITB CNR, Via Flli Cervi 93, I-20090 Milan, Italy.	ida.biunno@itb.cnr.it	Orlandi, Rosaria/C-1182-2017; Mariani-Costantini, Renato/B-6637-2012	Orlandi, Rosaria/0000-0002-0533-9041; Mariani-Costantini, Renato/0000-0002-4440-1848; , IDA_2/0000-0002-1068-4763; /0000-0002-1866-5866	MUR-FIRB nRBIP064CRT; MAP-LOMBARDIA [CO1/00692/00/X01]; Faculty of Medicine, G. d'Annunzio University; Faculty of Medicine, La Sapienza University	MUR-FIRB nRBIP064CRT; MAP-LOMBARDIA; Faculty of Medicine, G. d'Annunzio University; Faculty of Medicine, La Sapienza University	This work was supported by grants from MUR-FIRB nRBIP064CRT, MAP-LOMBARDIA, Grant CO1/00692/00/X01, 2007/2008 MUR 60% funds from the Faculty of Medicine, G. d'Annunzio University (to R. M.-C.), and 2007/2008 MUR 60% funds from the Faculty of Medicine, La Sapienza University (to L. V. L.).	Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Cattaneo M, 2004, GENE, V326, P149, DOI 10.1016/j.gene.2003.10.021; Cattaneo M, 2001, DNA CELL BIOL, V20, P1, DOI 10.1089/10445490150504648; Cattaneo M, 2000, INT J BIOL MARKER, V15, P26, DOI 10.1177/172460080001500105; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lainez B, 2004, INT IMMUNOL, V16, P169, DOI 10.1093/intimm/dxh014; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Lomas DA, 2004, THORAX, V59, P529, DOI 10.1136/thx.2003.006528; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731	29	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11405	11415		10.1074/jbc.M805408200	http://dx.doi.org/10.1074/jbc.M805408200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19204006	hybrid, Green Published			2022-12-25	WOS:000265494500045
J	Walker, P; Doenecke, D; Kahle, J				Walker, Patrick; Doenecke, Detlef; Kahle, Joerg			Importin 13 Mediates Nuclear Import of Histone Fold-containing Chromatin Accessibility Complex Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE PATHWAYS; CRYSTAL-STRUCTURE; PROTEIN; ISWI; TRANSCRIPTION; SUBUNITS; CLONING; BINDING; EXPORT; BETA	The histone fold is a structural element that facilitates heterodimerization, and histone fold heterodimers play crucial roles in gene regulation. Here, we investigated the nuclear import of two human histone fold pairs, which belong to the H2A/H2B family: CHRAC-15/CHRAC-17 and p12/CHRAC-17. Our results from in vitro nuclear import assays with permeabilized cells and in vivo cotransfection experiments reveal that importin 13 facilitates nuclear import of both histone fold heterodimers. Using glutathione S-transferase pulldown experiments, we provide evidence that heterodimers are required for efficient binding of importin 13 because the monomers alone do not significantly interact. Mutational analysis shows that stepwise substitution of basic amino acid residues conserved among the histone fold subunits leads to a progressive loss of importin 13 binding and nuclear accumulation of CHRAC-15/CHRAC-17 and p12/CHRAC-17. The distribution of basic amino acid residues among the histone fold subunits essential for nuclear uptake suggests that heterodimerization of the histone fold motif-containing proteins forms an importin 13-specific binding platform.	[Walker, Patrick; Doenecke, Detlef; Kahle, Joerg] Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Doenecke, D (corresponding author), Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, Humboldtallee 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de			Deutsche Forschungsgemeinschaft [523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 523: Protein und Membrantransport zwischen zellularen Kompartimenten).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Langst G, 2001, J CELL SCI, V114, P2561; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Neves-Costa A, 2006, RES PRO CEL, V41, P91, DOI 10.1007/007; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHI K, 1994, J BIOL CHEM, V269, P6320; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Sondermann H, 2003, STRUCTURE, V11, P1583, DOI 10.1016/j.str.2003.10.015; Spiga MG, 2004, NUCLEIC ACIDS RES, V32, P4945, DOI 10.1093/nar/gkh811; Strom AC, 2001, GENOME BIOL, V2; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	56	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11652	11662		10.1074/jbc.M806820200	http://dx.doi.org/10.1074/jbc.M806820200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19218565	Green Published, hybrid			2022-12-25	WOS:000265494500068
J	Montani, L; Gerrits, B; Gehrig, P; Kempf, A; Dimou, L; Wollscheid, B; Schwab, ME				Montani, Laura; Gerrits, Bertran; Gehrig, Peter; Kempf, Anissa; Dimou, Leda; Wollscheid, Bernd; Schwab, Martin E.			Neuronal Nogo-A Modulates Growth Cone Motility via Rho-GTP/LIMK1/Cofilin in the Unlesioned Adult Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; AXON REGENERATION; LIM KINASE; SLINGSHOT PHOSPHATASE; FUNCTIONAL RECOVERY; PROTEOMIC ANALYSIS; NEURITE OUTGROWTH; RAT CEREBELLUM; DEFICIENT MICE; MESSENGER-RNA	Nogo-A has been extensively studied as a myelin-associated neurite outgrowth inhibitor in the lesioned adult central nervous system. However, its role in the intact central nervous system has not yet been clarified. Analysis of the intact adult nervous system of C57BL/6 Nogo-A knock-out (KO) versus wild-type (WT) mice by a combined two-dimensional gel electrophoresis and isotope-coded affinity tagging approach revealed regulation of cytoskeleton-, transport-, and signaling growth-related proteins, pointing to regulation of the actin cytoskeleton, the neuronal growth machinery, and in particular the Rho-GTPase/LIMK1/cofilin pathway. Nogo-A KO adult neurons showed enlarged, more motile growth cones compared with WT neurons. The phenotype was reproduced by acute in vitro neutralization of neuronal Nogo-A. LIMK1 phosphorylation was increased in Nogo-A KO growth cones, and its reduction caused the decrease of KO growth cone motility to WT levels. Our study suggests that in the unlesioned adult nervous system, neuronal Nogo-A can restrict neuronal growth through negative modulation of growth cone motility.	[Montani, Laura; Kempf, Anissa; Dimou, Leda; Schwab, Martin E.] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Gerrits, Bertran; Gehrig, Peter] Univ Zurich, Funct Genom Ctr, CH-8057 Zurich, Switzerland; [Montani, Laura; Kempf, Anissa; Dimou, Leda; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland; [Wollscheid, Bernd] Swiss Fed Inst Technol, Mol Syst Biol Inst, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Montani, L (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	montani@hifo.uzh.ch	Dimou, Leda/E-7968-2012; Wollscheid, Bernd/E-8909-2010; Montani, Laura/M-9583-2017; Schwab, Martin E/B-6818-2016	Wollscheid, Bernd/0000-0002-3923-1610; Montani, Laura/0000-0002-8243-6734	Swiss National Science Foundation [31-63633.00]; National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation [2005(1)]; Transregio-Sonderforschungsbereich Konstanz-Zurich [34150609]; NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation(Swiss National Science Foundation (SNSF)); Transregio-Sonderforschungsbereich Konstanz-Zurich; NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme)(European Commission)	This work was supported by Swiss National Science Foundation Grant 31-63633.00, the National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation (Project MSC 2005(1)), the Transregio-Sonderforschungsbereich Konstanz-Zurich (Project 34150609), and the NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme).	Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Buffo A, 2000, J NEUROSCI, V20, P2275; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Gianola S, 2003, J NEUROSCI, V23, P4613; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Huber AB, 2002, J NEUROSCI, V22, P3553; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jin WL, 2003, J COMP NEUROL, V458, P1, DOI 10.1002/cne.10547; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liu YY, 2003, NEUROSCI LETT, V346, P153, DOI 10.1016/S0304-3940(03)00508-1; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Nyatia E, 2007, RES VET SCI, V83, P287, DOI 10.1016/j.rvsc.2007.01.011; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Trifunovski A, 2006, NEUROREPORT, V17, P913, DOI 10.1097/01.wnr.0000221831.95598.a3; Wang XX, 2002, J NEUROSCI, V22, P5505; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	44	87	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10793	10807		10.1074/jbc.M808297200	http://dx.doi.org/10.1074/jbc.M808297200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208621	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000265104600054
J	Jin, Y; Duan, L; Lee, SH; Kloosterboer, HJ; Blair, IA; Penning, TM				Jin, Yi; Duan, Ling; Lee, Seon Hwa; Kloosterboer, Helenius J.; Blair, Ian A.; Penning, Trevor M.			Human Cytosolic Hydroxysteroid Dehydrogenases of the Aldo-ketoreductase Superfamily Catalyze Reduction of Conjugated Steroids IMPLICATIONS FOR PHASE I AND PHASE II STEROID HORMONE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE ENZYMES; KETO REDUCTASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; TISSUE DISTRIBUTION; CRYSTAL-STRUCTURE; PHARMACOKINETIC PARAMETERS; POSTMENOPAUSAL WOMEN; RECEPTOR REGULATION; HUMAN PROSTATE; BINDING-SITE	Aldo-ketoreductase 1C (AKR1C) enzymes catalyze the NADPH-dependent reduction of ketosteroids to hydroxysteroids. They are Phase I metabolizing enzymes for natural and synthetic steroid hormones. They convert 5 alpha-dihydrotestosterone (Dht, potent androgen) to 3 alpha/beta-androstanediols ( inactive androgens) and the prodrug tibolone (Tib) to estrogenic 3 alpha/beta-hydroxytibolones. Herein we demonstrate for the first time that human AKR1C enzymes (AKR1C1-4) are able to reduce conjugated steroids such as Dht-17 beta-glucuronide (DhtG), Dht-17 beta-sulfate (DhtS), and Tib-17 beta-sulfate (TibS). Product identities were characterized by liquid chromatography-mass spectrometry, and kinetic parameters of the reactions were determined. The product profile of the reduction of each steroid conjugate by the individual AKR1C isoform was similar to that of the corresponding free steroid except for the reduction of DhtG catalyzed by AKR1C2, where a complete inversion in stereochemical preference to 3 beta-reduction (with DhtG) from 3 alpha-reduction (with Dht and DhtS) was observed. The catalytic efficiency of 3-keto reduction was modestly affected by the presence of a 17-sulfate group but severely impaired by the presence of a 17-glucuronide group for AKR1C1-3 isoforms. AKR1C4, however, showed superior catalytic efficiencies versus the other isoforms, and those were unaffected by steroid conjugation. Our findings provide evidence for alternative pathways of steroid metabolism where the phase I reaction (reduction) occurs after the phase II reaction (conjugation). Specifically, it is indicated that Dht is metabolized to its metabolite 3 alpha-andro-stanediol-17-glucuronide via the previously unrecognized "conjugation pathway" involving the sequential reactions of UGT2B17 and AKR1C4 in liver but via the conventional "reduction pathway" involving the sequential reactions of AKR1C2 and UGT2B15/17 in prostate.	[Jin, Yi; Duan, Ling; Lee, Seon Hwa; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Jin, Yi; Duan, Ling; Lee, Seon Hwa; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Kloosterboer, Helenius J.] NV Organon, Res & Dev Labs, NL-5340 BH Oss, Netherlands	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Merck & Company	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu	Blair, Ian A/B-3320-2010	Penning, Trevor/0000-0002-3937-1066; Lee, Seon Hwa/0000-0003-1095-5516	National Institutes of Health [R01-DK47015, R01-CA90744, P30 ES015857]; NIH Grant [P30 ES015857]; NATIONAL CANCER INSTITUTE [R01CA090744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015, R01-CA90744, and P30 ES015857 ( to T. M. P.). This work was also supported by a pilot project fund from NIH Grant P30 ES015857 ( to Y.J.).	Bauman DR, 2006, ENDOCRINOLOGY, V147, P5806, DOI 10.1210/en.2006-0627; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Belanger A, 2003, TRENDS ENDOCRIN MET, V14, P473, DOI 10.1016/j.tem.2003.10.005; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; Burczynski ME, 1999, BIOCHEMISTRY-US, V38, P10626, DOI 10.1021/bi995085z; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Chouinard S, 2008, J STEROID BIOCHEM, V109, P247, DOI 10.1016/j.jsbmb.2008.03.016; Cooper WC, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703414200; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; Falany JL, 2004, J STEROID BIOCHEM, V88, P383, DOI 10.1016/j.jsbmb.2004.01.005; Geese WJ, 2001, BIOCHEM BIOPH RES CO, V288, P280, DOI 10.1006/bbrc.2001.5746; Guillemette C, 1995, J STEROID BIOCHEM, V55, P355, DOI 10.1016/0960-0760(95)00183-2; Guillemette C, 1996, AM J PHYSIOL-ENDOC M, V271, pE348, DOI 10.1152/ajpendo.1996.271.2.E348; HOCHBERG RB, 1974, BIOCHEMISTRY-US, V13, P1938, DOI 10.1021/bi00706a025; JACOBSOHN GM, 1968, J BIOL CHEM, V243, P2985; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; MULDER GJ, 1992, ANNU REV PHARMACOL, V32, P25; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; RITTMASTER RS, 1993, ENDOCR REV, V14, P121, DOI 10.1210/er.14.1.121; RITTMASTER RS, 1988, J CLIN ENDOCR METAB, V66, P212, DOI 10.1210/jcem-66-1-212; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SHEN PD, 1994, BIOPHYS J, V67, P1414, DOI 10.1016/S0006-3495(94)80615-0; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, MOL PHARMACOL, V66, P1702, DOI 10.1124/mol.104.004515; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1112, DOI 10.1124/dmd.106.014159; Verheul HAM, 2007, CLIN PHARMACOL THER, V81, P573, DOI 10.1038/sj.clpt.6100094; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299	43	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10013	10022		10.1074/jbc.M809465200	http://dx.doi.org/10.1074/jbc.M809465200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218247	hybrid, Green Published			2022-12-25	WOS:000264892900044
J	Ochiai, A; Itoh, T; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Itoh, Takafumi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Structural Determinants Responsible for Substrate Recognition and Mode of Action in Family 11 Polysaccharide Lyases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL DEGRADATION; SP GL1 XANTHAN; PLANT-CELL; CRYSTAL-STRUCTURE; RHAMNOGALACTURONAN LYASE; PECTIC POLYSACCHARIDE; ERWINIA-CHRYSANTHEMI; ALGINATE LYASE; EXO-MODE; COMPLEX	A saprophytic Bacillus subtilis secretes two types of rhamnogalacturonan (RG) lyases, endotype YesW and exotype YesX, which are responsible for an initial cleavage of the RG type I (RG-I) region of plant cell wall pectin. Polysaccharide lyase family 11 YesW and YesX with a significant sequence identity (67.8%) cleave glycoside bonds between rhamnose and galacturonic acid residues in RG-I through a beta-elimination reaction. Here we show the structural determinants for substrate recognition and the mode of action in polysaccharide lyase family 11 lyases. The crystal structures of YesW in complex with rhamnose and ligand-free YesX were determined at 1.32 and 1.65 A resolution, respectively. The YesW amino acid residues such as Asn(152), Asp(172), Asn(532), Gly(533), Thr(534), and Tyr(595) in the active cleft bind to rhamnose molecules through hydrogen bonds and van der Waals contacts. Other rhamnose molecules are accommodated at the noncatalytic domain far from the active cleft, revealing that the domain possibly functions as a novel carbohydrate-binding module. A structural comparison between YesW and YesX indicates that a specific loop in YesX for recognizing the terminal saccharide molecule sterically inhibits penetration of the polymer over the active cleft. The loop-deficient YesX mutant exhibits YesW-like endotype activity, demonstrating that molecular conversion regarding the mode of action is achieved by the addition/removal of the loop for recognizing the terminal saccharide. This is the first report on a structural insight into RG-I recognition and molecular conversion of exotype to endotype in polysaccharide lyases.	[Ochiai, Akihito; Itoh, Takafumi; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Part of this work was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to A. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; COUTINHO PM, 1999, CARBOHYDRATE ACTIVE; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P438, DOI 10.1107/S1744309106011894; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yao YY, 2008, PROTEIN ENG DES SEL, V21, P561, DOI 10.1093/protein/gzn033; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; YODER MD, 1995, PLANT PHYSIOL, V107, P349, DOI 10.1104/pp.107.2.349; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011	44	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10181	10189		10.1074/jbc.M807799200	http://dx.doi.org/10.1074/jbc.M807799200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193638	Green Published, hybrid			2022-12-25	WOS:000264892900060
J	Zhou, QW; Kojic, M; Holloman, WK				Zhou, Qingwen; Kojic, Milorad; Holloman, William K.			DNA-binding Domain within the Brh2 N Terminus Is the Primary Interaction Site for Association with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRCA2; RECOMBINATIONAL REPAIR; GENOME STABILITY; PROTEIN; RAD51; MECHANISM; FILAMENTS; STABILIZATION; INTERPLAY; INSIGHTS	The C-terminal region of Brh2 (Brh2(CT)), the BRCA2 homolog in Ustilago maydis, is highly conserved and aligns with the DSS1/DNA-binding domain (DBD) of mammalian BRCA2, while the N-terminal region (Brh2(NT)) is poorly conserved and has no obvious functional domain except for the single Rad51-interacting BRC element. Paradoxically, Brh2(NT), but not Brh2(CT), complements the DNA repair and recombination deficiency of the brh2 mutant. We show here that Brh2(NT) exhibits an unexpected DNA binding activity with properties similar to that of the full-length protein. Deletion mapping localized the region responsible for the DNA binding activity to a stretch of residues between the BRC element and the canonical DBD. A heterologous DNA-binding domain from the large subunit of replication protein A substituted for the endogenous binding region within Brh2(NT) in supporting DNA repair. Rad51-promoted strand invasion was stimulated by Brh2(NT), but required the presence of the BRC element. The findings suggest a model in which Brh2(NT) serves as the principal site for association with DNA, while the Brh2(CT) provides a means for regulation.	[Zhou, Qingwen; Kojic, Milorad; Holloman, William K.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Holloman, WK (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10021 USA.	wkhollo@med.cornell.edu		Kojic, Milorad/0000-0002-0507-4231	National Institutes of Health [GM42482, GM79859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079859, R01GM042482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM42482 and GM79859.	Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedman LS, 1998, CANCER RES, V58, P1338; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Kojic M, 2005, MOL CELL BIOL, V25, P2547, DOI 10.1128/MCB.25.7.2547-2557.2005; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Kojic M, 2006, MOL CELL BIOL, V26, P678, DOI 10.1128/MCB.26.2.678-688.2006; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou QW, 2007, MOL CELL BIOL, V27, P2512, DOI 10.1128/MCB.01907-06	40	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8265	8273		10.1074/jbc.M809226200	http://dx.doi.org/10.1074/jbc.M809226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19182269	hybrid, Green Published			2022-12-25	WOS:000264397800010
J	Sato, I; Shimizu, M; Hoshino, T; Takaya, N				Sato, Ikuo; Shimizu, Motoyuki; Hoshino, Takayuki; Takaya, Naoki			The Glutathione System of Aspergillus nidulans Involves a Fungus-specific Glutathione S-Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; GENE; EXPRESSION; MECHANISM; REDUCTASE; PROTEINS; IDENTIFICATION; GROWTH; MITOCHONDRIAL; EVOLUTION	The tripeptide glutathione is involved in cellular defense mechanisms for xenobiotics and reactive oxygen species. This study investigated glutathione-dependent mechanisms in the model organism Aspergillus nidulans. A recombinant dimeric protein of A. nidulans glutathione reductase (GR) contained FAD and reduced oxidized glutathione (GSSG) using NADPH as an electron donor. A deletion strain of the GR gene (glrA) accumulated less intracellular reduced glutathione (GSH), indicating that the fungal GR contributes to GSSG reduction in vivo. Growth of the deletion strain of glrA was temperature-sensitive, and this phenotype was suppressed by adding GSH to the medium. The strain subsequently accumulated more intracellular superoxide, and cell-free respiration activity was partly defective. Growth of the strain decreased in the presence of oxidants, which induced glrA expression 1.5-6-fold. These results indicated that the fungal glutathione system functions as an antioxidant mechanism in A. nidulans. Our findings further revealed an initial proteomic differential display on GR-depleted and wild type strains. Up-regulation of thioredoxin reductase, peroxiredoxins, catalases, and cytochrome c peroxidase in the glrA-deletion strain revealed interplay between the glutathione system and both the thioredoxin system and hydrogen peroxide defense mechanisms. We also identified a hypothetical, up-regulated protein in the GR-depleted strains as glutathione S-transferase, which is unique among Ascomycetes fungi.	[Sato, Ikuo; Shimizu, Motoyuki; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	SATO, Ikuo/F-8365-2012		Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Bio-oriented Technology Research Advancement Institution and a grant-in-aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports, Japan.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BARRATT RW, 1965, GENETICS, V52, P233; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BEERS RF, 1952, J BIOL CHEM, V195, P133; Burns C, 2005, FUNGAL GENET BIOL, V42, P319, DOI 10.1016/j.fgb.2005.01.001; Cann JH, 2000, QUATERNARY RES, V54, P439, DOI 10.1006/qres.2000.2184; Carberry S, 2006, BIOCHEM BIOPH RES CO, V341, P1096, DOI 10.1016/j.bbrc.2006.01.078; Cha CJ, 2002, BIOCHEM J, V368, P589, DOI 10.1042/BJ20020400; Cho YW, 2002, BBA-GENE STRUCT EXPR, V1574, P399, DOI 10.1016/S0167-4781(01)00363-3; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GOODHEW CF, 1990, BIOCHEM J, V271, P707, DOI 10.1042/bj2710707; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HANKINSON O, 1974, J BIOL CHEM, V249, P2344; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang HH, 2008, BIOCHEMISTRY-US, V47, P1721, DOI 10.1021/bi702040u; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kim HG, 2001, BBA-GENE STRUCT EXPR, V1520, P179, DOI 10.1016/S0167-4781(01)00265-2; Klein M, 2002, FEBS LETT, V520, P63, DOI 10.1016/S0014-5793(02)02767-9; Lee J, 1997, J BIOL CHEM, V272, P23042, DOI 10.1074/jbc.272.37.23042; MASSEY V, 1965, J BIOL CHEM, V240, P4470; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Navarro RE, 1996, CURR GENET, V29, P352, DOI 10.1007/s002940050056; Oberegger H, 2000, FEBS LETT, V485, P113, DOI 10.1016/S0014-5793(00)02206-7; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; SAHLMAN L, 1989, J BIOL CHEM, V264, P8033; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Scherer M, 2002, EUKARYOT CELL, V1, P725, DOI 10.1128/EC.1.5.725-735.2002; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; Song JY, 2006, EUKARYOT CELL, V5, P1857, DOI 10.1128/EC.00244-06; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Tamaki H, 1999, J BACTERIOL, V181, P2958, DOI 10.1128/JB.181.9.2958-2962.1999; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985	49	46	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8042	8053		10.1074/jbc.M807771200	http://dx.doi.org/10.1074/jbc.M807771200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19171936	hybrid, Green Published			2022-12-25	WOS:000264195600067
J	Koslowski, MJ; Kubler, I; Chamaillard, M; Schaeffeler, E; Reinisch, W; Wang, GX; Beisner, J; Teml, A; Peyrin-Biroulet, L; Winter, S; Herrlinger, KR; Rutgeerts, P; Vermeire, S; Cooney, R; Fellermann, K; Jewell, D; Bevins, CL; Schwab, M; Stange, EF; Wehkamp, J				Koslowski, Maureen J.; Kuebler, Irmgard; Chamaillard, Mathias; Schaeffeler, Elke; Reinisch, Walter; Wang, Guoxing; Beisner, Julia; Teml, Alexander; Peyrin-Biroulet, Laurent; Winter, Stefan; Herrlinger, Klaus R.; Rutgeerts, Paul; Vermeire, Severine; Cooney, Rachel; Fellermann, Klaus; Jewell, Derek; Bevins, Charles L.; Schwab, Matthias; Stange, Eduard F.; Wehkamp, Jan			Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease	PLOS ONE			English	Article								Reduced expression of Paneth cell antimicrobial alpha-defensins, human defensin (HD)-5 and -6, characterizes Crohn's disease (CD) of the ileum. TCF-4 (also named TCF7L2), a Wnt signalling pathway transcription factor, orchestrates Paneth cell differentiation, directly regulates the expression of HD-5 and -6, and was previously associated with the decrease of these antimicrobial peptides in a subset of ileal CD. To investigate a potential genetic association of TCF-4 with ileal CD, we sequenced 2.1 kb of the 5' flanking region of TCF-4 in a small group of ileal CD patients and controls (n = 10 each). We identified eight single nucleotide polymorphisms (SNPs), of which three (rs3814570, rs10885394, rs10885395) were in linkage disequilibrium and found more frequently in patients; one (rs3814570) was thereby located in a predicted regulatory region. We carried out high-throughput analysis of this SNP in three cohorts of inflammatory bowel disease (IBD) patients and controls. Overall 1399 healthy individuals, 785 ulcerative colitis (UC) patients, 225 CD patients with colonic disease only and 784 CD patients with ileal involvement were used to determine frequency distributions. We found an association of rs3814570 with ileal CD but neither with colonic CD or UC, in a combined analysis (allele positivity: OR 1.27, 95% CI 1.07 to 1.52, p = 0.00737), which was the strongest in ileal CD patients with stricturing behaviour (allele frequency: OR 1.32, 95% CI 1.08 to 1.62, p = 0.00686) or an additional involvement of the upper GIT (allele frequency: OR 1.38, 95% CI 1.03 to1.84, p = 0.02882). The newly identified genetic association of TCF-4 with ileal CD provides evidence that the decrease in Paneth cell alpha-defensins is a primary factor in disease pathogenesis.			Koslowski, MJ (corresponding author), Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.	jan.wehkamp@ikp-stuttgart.de	Wang, Guoxing/G-6586-2013; Chamaillard, Mathias/L-6542-2013; Schwab, Matthias/ABH-7449-2020; Bevins, Charles L/P-4438-2015; Wehkamp, Jan/B-7319-2011	Chamaillard, Mathias/0000-0002-0243-9717; Bevins, Charles L/0000-0003-2725-2622; Cooney, Rachel/0000-0003-3710-157X; peyrin-biroulet, laurent/0000-0003-2536-6618; Wehkamp, Jan/0000-0001-6788-841X; Vermeire, Severine/0000-0001-9942-3019	NIAID NIH HHS [R01 AI050843-01, R01 AI050843, AI32738, AI50843, R01 AI032738, R01 AI032738-11, R37 AI032738] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI050843, R01AI032738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Duval A, 1999, CANCER RES, V59, P4213; Elphick D, 2008, AM J PATHOL, V172, P702, DOI 10.2353/ajpath.2008.070755; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gasche C, 2005, GUT, V54, P162, DOI 10.1136/gut.2003.035600; George MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-209; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kiehne K, 2006, WORLD J GASTROENTERO, V12, P1056, DOI 10.3748/wjg.v12.i7.1056; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Medici V, 2006, EUR J HUM GENET, V14, P459, DOI 10.1038/sj.ejhg.5201576; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Strober W, 2006, SCIENCE, V313, P1052, DOI 10.1126/science.1131997; Tenesa A, 2006, EUR J HUM GENET, V14, P259, DOI 10.1038/sj.ejhg.5201516; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083	32	94	99	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4496	10.1371/journal.pone.0004496	http://dx.doi.org/10.1371/journal.pone.0004496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221600	gold, Green Submitted, Green Published			2022-12-25	WOS:000265485700017
J	Martinez, RN; Alcober, OA				Martinez, Ricardo N.; Alcober, Oscar A.			A Basal Sauropodomorph (Dinosauria: Saurischia) from the Ischigualasto Formation (Triassic, Carnian) and the Early Evolution of Sauropodomorpha	PLOS ONE			English	Article							ARGENTINA; NOMENCLATURE; ASSEMBLAGE	Background: The earliest dinosaurs are from the early Late Triassic (Carnian) of South America. By the Carnian the main clades Saurischia and Ornithischia were already established, and the presence of the most primitive known sauropodomorph Saturnalia suggests also that Saurischia had already diverged into Theropoda and Sauropodomorpha. Knowledge of Carnian sauropodomorphs has been restricted to this single species. Methodology/Principal Findings: We describe a new small sauropodomorph dinosaur from the Ischigualsto Formation (Carnian) in northwest Argentina, Panphagia protos gen. et sp. nov., on the basis of a partial skeleton. The genus and species are characterized by an anteroposteriorly elongated fossa on the base of the anteroventral process of the nasal; wide lateral flange on the quadrate with a large foramen; deep groove on the lateral surface of the lower jaw surrounded by prominent dorsal and ventral ridges; bifurcated posteroventral process of the dentary; long retroarticular process transversally wider than the articular area for the quadrate; oval scars on the lateral surface of the posterior border of the centra of cervical vertebrae; distinct prominences on the neural arc of the anterior cervical vertebra; distal end of the scapular blade nearly three times wider than the neck; scapular blade with an expanded posterodistal corner; and medial lamina of brevis fossa twice as wide as the iliac spine. Conclusions/Significance: We regard Panphagia as the most basal sauropodomorph, which shares the following apomorphies with Saturnalia and more derived sauropodomorphs: basally constricted crowns; lanceolate crowns; teeth of the anterior quarter of the dentary higher than the others; and short posterolateral flange of distal tibia. The presence of Panphagia at the base of the early Carnian Ischigualasto Formation suggests an earlier origin of Sauropodomorpha during the Middle Triassic.	[Martinez, Ricardo N.; Alcober, Oscar A.] Museo Ciencias Nat, San Juan, Argentina		Martinez, RN (corresponding author), Museo Ciencias Nat, San Juan, Argentina.	martinez@unsj.edu.ar			Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; TV Tokio	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; TV Tokio	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan, research funders. TV Tokio, Fieldwork funders. The funders didn't have any role in the study or in the decision to publish or preperation of the manuscript.	ARCUCCI A, 1987, Ameghiniana, V24, P89; Barberena M.C., 1977, PESQUISAS, V7, P111; BARBERENA MC, 1985, NATL GEOGR RES, V1, P5; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 2007, Historical Biology, V19, P73, DOI 10.1080/08912960600866862; BONAPARTE JF, 1999, BRAZIL NATL SCI MUS, V15, P89; CASAMIQUELA RM, 1967, AMEGHINIANA, V4, P47; CHATTERJEE S, 1994, J VERTEBR PALEONTOL, V14, P142, DOI 10.1080/02724634.1994.10011546; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Colbert E. H., 1970, Am. Mus. Novit., VNo. 2405, P1; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; EZCURRA MD, 2008, LIBR RES 3 C LAT PAL; Galton P.M., 1985, Geologica et Palaeontologica, V19, P119; Galton P.M., 1984, Geologica et Palaeontologica, V18, P139; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2007, Revue de Paleobiologie, V26, P505; Galton PM, 1985, STUTTGARTER BEITRAGE, V118, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; MARTINEZ RN, 2008, LIBR RES 3 C LAT PAL; MARTINEZ RN, 2007, AMEGHINIANA S4, V44, pR28; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; Novaco R., 1986, ADV STUDY AGGRESSION, VII, P1; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; RAATH MA, 1977, THESIS RHODES U SALI; Reig O. A., 1963, Ameghiniana, V3, P3; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A. S., 1971, Breviora, VNo. 378, P1; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Tykoski RS, 2005, THESIS U TEXAS AUSTI; von Huene F., 1926, GEOL PALAEONTOL ABHA, V15, P139; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x	54	122	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4397	10.1371/journal.pone.0004397	http://dx.doi.org/10.1371/journal.pone.0004397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19209223	Green Published, gold			2022-12-25	WOS:000265485700001
J	Tsuruta, H; Paddon, CJ; Eng, D; Lenihan, JR; Horning, T; Anthony, LC; Regentin, R; Keasling, JD; Renninger, NS; Newman, JD				Tsuruta, Hiroko; Paddon, Christopher J.; Eng, Diana; Lenihan, Jacob R.; Horning, Tizita; Anthony, Larry C.; Regentin, Rika; Keasling, Jay D.; Renninger, Neil S.; Newman, Jack D.			High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli	PLOS ONE			English	Article							CELL-DENSITY CULTIVATION; MEVALONATE PATHWAY; BIOSYNTHESIS; EXPRESSION; REDUCTASE; SYNTHASE; PROTEIN; ACID	Background: Artemisinin derivatives are the key active ingredients in Artemisinin combination therapies (ACTs), the most effective therapies available for treatment of malaria. Because the raw material is extracted from plants with long growing seasons, artemisinin is often in short supply, and fermentation would be an attractive alternative production method to supplement the plant source. Previous work showed that high levels of amorpha-4,11-diene, an artemisinin precursor, can be made in Escherichia coli using a heterologous mevalonate pathway derived from yeast (Saccharomyces cerevisiae), though the reconstructed mevalonate pathway was limited at a particular enzymatic step. Methodology/Principal Findings: By combining improvements in the heterologous mevalonate pathway with a superior fermentation process, commercially relevant titers were achieved in fed-batch fermentations. Yeast genes for HMG-CoA synthase and HMG-CoA reductase (the second and third enzymes in the pathway) were replaced with equivalent genes from Staphylococcus aureus, more than doubling production. Amorpha-4,11-diene titers were further increased by optimizing nitrogen delivery in the fermentation process. Successful cultivation of the improved strain under carbon and nitrogen restriction consistently yielded 90 g/L dry cell weight and an average titer of 27.4 g/L amorpha-4,11-diene. Conclusions/Significance: Production of >25 g/L amorpha-4,11-diene by fermentation followed by chemical conversion to artemisinin may allow for development of a process to provide an alternative source of artemisinin to be incorporated into ACTs.	[Tsuruta, Hiroko; Paddon, Christopher J.; Eng, Diana; Lenihan, Jacob R.; Horning, Tizita; Anthony, Larry C.; Regentin, Rika; Renninger, Neil S.; Newman, Jack D.] Amyris Biotechnol, Emeryville, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn & Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Lawrence Berkeley Natl Lab, Div Phys Biosci, Berkeley, CA USA; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Tsuruta, H (corresponding author), Amyris Biotechnol, Emeryville, CA USA.	Paddon@amyris.com	Williams, Katherine/I-7881-2012; Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Paddon, Christopher/0000-0003-4182-2855	Institute for OneWorld Health; Bill & Melinda Gates Foundation	Institute for OneWorld Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was conducted under the sponsorship of the Institute for OneWorld Health through generous support of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Bloland PB., 2001, DRUG RESISTANCE MALA; Campobasso N, 2004, J BIOL CHEM, V279, P44883, DOI 10.1074/jbc.M407882200; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hedl M, 2004, J BACTERIOL, V186, P1927, DOI 10.1128/JB.186.7.1927-1932.2004; Hedl M, 2002, J BACTERIOL, V184, P2116, DOI 10.1128/JB.184.8.2116-2122.2002; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Korenromp E, 2005, WORLD MALARIA REPORT; KORZ DJ, 1995, J BIOTECHNOL, V39, P59, DOI 10.1016/0168-1656(94)00143-Z; Lau J, 2004, J BIOTECHNOL, V110, P95, DOI 10.1016/j.jbiotec.2004.02.001; Lenihan JR, 2008, BIOTECHNOL PROGR, V24, P1026, DOI 10.1002/btpr.27; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Olumese P, 2006, GUIDELINES TREATMENT; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Regentin R, 2003, APPL MICROBIOL BIOT, V61, P451, DOI 10.1007/s00253-003-1263-1; RIESENBERG D, 1991, CURR OPIN BIOTECH, V2, P380, DOI 10.1016/S0958-1669(05)80142-9; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rozkov A, 2004, BIOTECHNOL BIOENG, V88, P909, DOI 10.1002/bit.20327; Shang F, 2006, J BIOTECHNOL, V122, P285, DOI 10.1016/j.jbiotec.2005.11.020; Shapiro H.S., 1989, REG SEC MET ACT, P149; Sutherlin A, 2002, J BACTERIOL, V184, P4065, DOI 10.1128/JB.184.15.4065-4070.2002; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Wong A., 2006, [No title captured], Patent No. [WO2006128126 A1 (74), 2006128126]; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550	34	252	293	9	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4489	10.1371/journal.pone.0004489	http://dx.doi.org/10.1371/journal.pone.0004489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221601	Green Published, Green Submitted, gold			2022-12-25	WOS:000265485700014
J	Krstic, D; Boll, W; Noll, M				Krstic, Dimitrije; Boll, Werner; Noll, Markus			Sensory Integration Regulating Male Courtship Behavior in Drosophila	PLOS ONE			English	Article								The courtship behavior of Drosophila melanogaster serves as an excellent model system to study how complex innate behaviors are controlled by the nervous system. To understand how the underlying neural network controls this behavior, it is not sufficient to unravel its architecture, but also crucial to decipher its logic. By systematic analysis of how variations in sensory inputs alter the courtship behavior of a naive male in the single-choice courtship paradigm, we derive a model describing the logic of the network that integrates the various sensory stimuli and elicits this complex innate behavior. This approach and the model derived from it distinguish (i) between initiation and maintenance of courtship, (ii) between courtship in daylight and in the dark, where the male uses a scanning strategy to retrieve the decamping female, and (iii) between courtship towards receptive virgin females and mature males. The last distinction demonstrates that sexual orientation of the courting male, in the absence of discriminatory visual cues, depends on the integration of gustatory and behavioral feedback inputs, but not on olfactory signals from the courted animal. The model will complement studies on the connectivity and intrinsic properties of the neurons forming the circuitry that regulates male courtship behavior.	[Krstic, Dimitrije; Boll, Werner; Noll, Markus] Univ Zurich, Inst Mol Biol, Zurich, Switzerland; [Krstic, Dimitrije] PhD Program Mol Life Sci, Zurich, Switzerland	University of Zurich	Krstic, D (corresponding author), Univ Zurich, Inst Mol Biol, Zurich, Switzerland.	markus.noll@molbio.uzh.ch			Swiss National Science Foundation [3100A0-105823]; Kanton Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Zurich	This work was supported by grant 3100A0-105823 from the Swiss National Science Foundation (to M.N.) and the Kanton Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Benzer S., 1968, ENG SCI, V32, P50; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; BURNET B, 1973, EXPERIENTIA, V29, P488, DOI 10.1007/BF01926800; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; CONNOLLY K, 1969, EVOLUTION, V23, P548, DOI 10.1111/j.1558-5646.1969.tb03540.x; CROSSLEY S, 1970, NATURE, V225, P1064, DOI 10.1038/2251064a0; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Egan ES, 1999, J NEUROSCI, V19, P3665; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hall JC, 2002, J NEUROGENET, V16, P135, DOI 10.1080/01677060215307; HARDELAND R, 1971, AM NAT, V105, P198, DOI 10.1086/282717; Heisenberg M, 1997, BIOESSAYS, V19, P1065, DOI 10.1002/bies.950191205; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VENARD R, 1980, EXPERIENTIA, V36, P211, DOI 10.1007/BF01953737; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Villella A, 1997, GENETICS, V147, P1107; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; WELBERGEN P, 1987, BEHAVIOUR, V101, P253, DOI 10.1163/156853987X00017; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551	68	86	85	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4457	10.1371/journal.pone.0004457	http://dx.doi.org/10.1371/journal.pone.0004457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214231	Green Submitted, Green Published, gold			2022-12-25	WOS:000265484300006
J	Cheng, X; Eisenbraun, M; Xu, Q; Zhou, HL; Kulkarni, D; Subbarao, K; Kemble, G; Jin, H				Cheng, Xing; Eisenbraun, Michael; Xu, Qi; Zhou, Helen; Kulkarni, Deepali; Subbarao, Kanta; Kemble, George; Jin, Hong			H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; VIRUS-INFECTION; A VIRUS; TEMPERATURE SENSITIVITY; AVIAN INFLUENZA; MICE; ORIGIN; IMMUNIZATION; TRIVALENT; ANTIBODY	Background: Live attenuated influenza H5N1 vaccines have been produced and evaluated in mice and ferrets that were never exposed to influenza A virus infection (Suguitan et al., Plos Medicine, e360: 1541, 2006). However, the preexisting influenza heterosubtypic immunity on live attenuated H5N1 vaccine induced immune response has not been evaluated. Methodology and Principal Findings: Primary and recall B cell responses to live attenuated H5N1 vaccine viruses were examined using a sensitive antigen-specific B cell ELISpot assay to investigate the effect of preexisting heterosubtypic influenza immunity on the development of H5N1-specific B cell immune responses in ferrets. Live attenuated H5N1 A/Hong Kong/213/03 and A/Vietnam/1203/04 vaccine viruses induced measurable H5-specific IgM and IgG secreting B cells after intranasal vaccination. However, H5-specific IgG secreting cells were detected significantly earlier and at a greater frequency after H5N1 inoculation in ferrets previously primed with trivalent live attenuated influenza (H1N1, H3N2 and B) vaccine. Priming studies further revealed that the more rapid B cell responses to H5 resulted from cross-reactive B cell immunity to the hemagglutinin H1 protein. Moreover, vaccination with the H1N1 vaccine virus was able to induce protective responses capable of limiting replication of the H5N1 vaccine virus to a level comparable with prior vaccination with the H5N1 vaccine virus without affecting H5N1 vaccine virus induced antibody response. Conclusion: The findings indicate that previous vaccination with seasonal influenza vaccine may accelerate onset of immunity by an H5N1 ca vaccine and the heterosubtypic immunity may be beneficial for pandemic preparedness.	[Cheng, Xing; Eisenbraun, Michael; Xu, Qi; Zhou, Helen; Kulkarni, Deepali; Kemble, George; Jin, Hong] MedImmune, Mountain View, CA USA; [Subbarao, Kanta] NIAID, NIH, Lab Infect Dis, Bethesda, MD USA	AstraZeneca; Medimmune; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cheng, X (corresponding author), MedImmune, Mountain View, CA USA.	jinh@medimmune.com		Subbarao, Kanta/0000-0003-1713-3056	Intramural Research Program of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000933, ZIAAI000933] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding was provided by MedImmune. This research was supported in part by the Intramural Research Program of NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Brokstad KA, 2001, SCAND J IMMUNOL, V54, P243, DOI 10.1046/j.1365-3083.2001.00947.x; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Cox RJ, 2006, VACCINE, V24, P6577, DOI 10.1016/j.vaccine.2006.05.041; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; HAYNES JR, 2008, VACCINE IN PRESS; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2005, J VIROL, V79, P11014, DOI 10.1128/JVI.79.17.11014-11021.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lindemann M, 2006, CLIN IMMUNOL, V120, P342, DOI 10.1016/j.clim.2006.03.002; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Smirnov YA, 1999, ACTA VIROL, V43, P237; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Takahashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2358, DOI 10.1271/bbb.70142; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	36	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4436	10.1371/journal.pone.0004436	http://dx.doi.org/10.1371/journal.pone.0004436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209231	gold, Green Submitted, Green Published			2022-12-25	WOS:000265484100008
J	Rizzoli, A; Hauffe, HC; Tagliapietra, V; Neteler, M; Rosa, R				Rizzoli, Annapaola; Hauffe, Heidi C.; Tagliapietra, Valentina; Neteler, Markus; Rosa, Roberto			Forest Structure and Roe Deer Abundance Predict Tick-Borne Encephalitis Risk in Italy	PLOS ONE			English	Article								Background: The Western Tick-borne encephalitis (TBE) virus often causes devastating or lethal disease. In Europe, the number of human TBE cases has increased dramatically over the last decade, risk areas are expanding and new foci are being discovered every year. The early localisation of new TBE foci and the identification of the main risk factors associated with disease emergence represent a priority for the public health community. Although a number of socio-economic parameters have been suggested to explain TBE upsurges in eastern Europe, the principal driving factors in relatively stable western European countries have not been identified. Methodology/Principal Findings: In this paper, we analyse the correlation between the upsurge of TBE in 17 alpine provinces in northern Italy from 1992 to 2006 with climatic variables, forest structure (as a proxy for small mammal reservoir host abundance), and abundance of the principal large vertebrate tick host (roe deer), using datasets available for the last 40 years. No significant differences between the pattern of changes in climatic variables in provinces where TBE has emerged compared to provinces were no clinical TBE cases have been observed to date. Instead, the best model for explaining the increase in TBE incidence in humans in this area include changes in forest structure, in particular the ratio of coppice to high stand forest, and the density of roe deer. Conclusion/Significance: Substantial changes in vegetation structure that improve habitat suitability for the main TBE reservoir hosts (small mammals), as well as an increase in roe deer abundance due to changes in land and wildlife management practices, are likely to be among the most crucial factors affecting the circulation potential of Western TBE virus and, consequently, the risk of TBE emergence in humans in western Europe. We believe our approach will be useful in predicting TBE risk on a wider scale.	[Rizzoli, Annapaola; Hauffe, Heidi C.; Tagliapietra, Valentina; Neteler, Markus; Rosa, Roberto] Fdn Edmund Mach, Ctr Ric & Innovaz, Michele Alladige, Italy	Fondazione Edmund Mach	Rizzoli, A (corresponding author), Fdn Edmund Mach, Ctr Ric & Innovaz, Michele Alladige, Italy.	rizzoli@cealp.it	Tagliapietra, Valentina/P-8733-2015; Rizzoli, Annapaola/J-2439-2012; Hauffe, Heidi Christine/AAU-1684-2021; Rosa, Roberto/B-8562-2011; Hauffe, Heidi Christine C/B-9105-2011; Neteler, Markus/C-6328-2008; Rizzoli, Annapaola/B-8583-2011; Rosà, Roberto/AAB-4479-2021	Tagliapietra, Valentina/0000-0001-9535-2823; Rizzoli, Annapaola/0000-0003-3997-6783; Hauffe, Heidi Christine/0000-0003-3098-8964; Rosa, Roberto/0000-0002-8655-2230; Hauffe, Heidi Christine C/0000-0003-3098-8964; Neteler, Markus/0000-0003-1916-1966; Rosà, Roberto/0000-0002-8655-2230	EU [GOCE-2003-010284]	EU(European Commission)	This publication was partially funded by EU grant GOCE-2003-010284 EDEN and is catalogued by the EDEN Steering Committee as EDEN0130 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.	Amaducci L, 1976, Riv Patol Nerv Ment, V97, P77; [Anonymous], 2005, EC HUM WELL BEING SY; *APAT, 2006, GLI IND CLIM IT NEL; *APAT, 2007, GLI IND CLIM IT NEL; Auer I, 2007, INT J CLIMATOL, V27, P17, DOI 10.1002/joc.1377; Carpi G, 2008, EPIDEMIOL INFECT, V136, P1416, DOI 10.1017/S0950268807000039; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2006, INT J MED MICROBIOL, V296, P41, DOI 10.1016/j.ijmm.2006.02.008; Danielova V, 2006, INT J MED MICROBIOL, V296, P48, DOI 10.1016/j.ijmm.2006.02.007; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Floris R, 2006, NEW MICROBIOL, V29, P147; GASHWILER JS, 1979, AM MIDL NAT, V102, P95, DOI 10.2307/2425070; Gern L, 2008, INT J MED MICROBIOL, V298, P55, DOI 10.1016/j.ijmm.2008.01.005; Gilot B., 1975, Acta Tropica, V32, P340; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Gurnell J., 1985, Symposia of the Zoological Society of London, P377; Hansmann Y, 2006, SCAND J INFECT DIS, V38, P520, DOI 10.1080/00365540600585073; Hubalek Z, 2006, MED VET ENTOMOL, V20, P166, DOI 10.1111/j.1365-2915.2006.00615.x; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; Huss A, 2007, TICK BORNE DIS SWITZ; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; Kaiser R, 2000, INFECTION, V28, P78, DOI 10.1007/s150100050051; KAISER R, 2007, MONOGRAPH TICK BORNE, P21; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kriz B, 2004, INT J MED MICROBIOL, V293, P63, DOI 10.1016/S1433-1128(04)80010-X; KUNZ C, 2007, MONOGRAPH TICK BORNE, P4; Kunz Christian, 2002, IJMM International Journal of Medical Microbiology, V291, P56; KUNZE M, 2006, ISW TBE RESUME ISW T; Kunze U, 2007, WIEN MED WOCHENSCHR, V157, P228, DOI 10.1007/s10354-007-0424-8; Kunze Ursula, 2004, Wien Med Wochenschr, V154, P242, DOI 10.1007/s10354-004-0061-4; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lesnicar G, 2003, PEDIATR INFECT DIS J, V22, P612, DOI 10.1097/00006454-200307000-00009; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Materna J., 2005, Central European Journal of Public Health, V13, P24; MAZURKIEWICZ M, 1986, ACTA THERIOL, V31, P55, DOI 10.4098/AT.arch.86-4; MAZURKIEWICZ M, 1991, ACTA THERIOL, V36, P207, DOI 10.4098/AT.arch.91-21; Michalik J, 2003, J MED ENTOMOL, V40, P690, DOI 10.1603/0022-2585-40.5.690; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Niethammer J., 1978, HDB SAUGETIERE EUROP, P325; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Pedrotti L., 2001, BANCA DATI UNGULATI; Perkins SE, 2006, ECOLOGY, V87, P1981, DOI 10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2; Piccolin G, 2006, VECTOR-BORNE ZOONOT, V6, P24, DOI 10.1089/vbz.2006.6.24; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; Pugliese A, 2008, PARASITOLOGY, V135, P1531, DOI 10.1017/S003118200800036X; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; RANDOLPH SE, 2007, OIE SCI TEC IN PRESS, V27; RATCLIFFE PR, 1992, ECOLOGY MANAGEMENT C, P213; Rosa R, 2007, VECTOR-BORNE ZOONOT, V7, P285, DOI 10.1089/vbz.2006.0607; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stefanoff Pawel, 2006, Przegl Epidemiol, V60 Suppl 1, P151; Suess J, 2006, INT J MED MICROBIOL, V296, P63, DOI 10.1016/j.ijmm.2005.12.005; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Sumilo D, 2006, INT J MED MICROBIOL, V296, P76, DOI 10.1016/j.ijmm.2005.12.006; SUSS, 2007, MONOGRAPH TICK BORNE, P16; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Talleklint L, 1998, J MED ENTOMOL, V35, P521, DOI 10.1093/jmedent/35.4.521; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Verani P., 1995, Parassitologia (Rome), V37, P105; WATTS CHS, 1969, J ANIM ECOL, V38, P285, DOI 10.2307/2772; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zeman P, 1999, COMP IMMUNOL MICROB, V22, P247, DOI 10.1016/S0147-9571(99)00015-6	72	101	102	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4336	10.1371/journal.pone.0004336	http://dx.doi.org/10.1371/journal.pone.0004336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183811	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483200010
J	Lai, SK; Wang, YY; Cone, R; Wirtz, D; Hanes, J				Lai, Samuel K.; Wang, Ying-Ying; Cone, Richard; Wirtz, Denis; Hanes, Justin			Altering Mucus Rheology to "Solidify'' Human Mucus at the Nanoscale	PLOS ONE			English	Article								The ability of mucus to function as a protective barrier at mucosal surfaces rests on its viscous and elastic properties, which are not well understood at length scales relevant to pathogens and ultrafine environmental particles. Here we report that fresh, undiluted human cervicovaginal mucus (CVM) transitions from an impermeable elastic barrier to non-adhesive objects sized 1 mu m and larger to a highly permeable viscoelastic liquid to non-adhesive objects smaller than 500 nm in diameter. Addition of a nonionic detergent, present in vaginal gels, lubricants and condoms, caused CVM to behave as an impermeable elastic barrier to 200 and 500 nm particles, suggesting that the dissociation of hydrophobically-bundled mucin fibers created a finer elastic mucin mesh. Surprisingly, the macroscopic viscoelasticity, which is critical to proper mucus function, was unchanged. These findings provide important insight into the nanoscale structural and barrier properties of mucus, and how the penetration of foreign particles across mucus might be inhibited.	[Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Wang, Ying-Ying; Hanes, Justin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Dept Biomed Engn, Baltimore, MD 21218 USA; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Cone, Richard; Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Dept Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lai, SK (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	hanes@jhu.edu	wang, yingying/GRS-3058-2022; Wirtz, Denis/A-3257-2010	Lai, Samuel/0000-0003-4721-528X	NIH [5U01AI066726, R01GM075305, R21HL089816]; NSF [graduate research fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the NIH 5U01AI066726 (R.C.), NIH R01GM075305 (D.W.), NIH R21HL089816 (J.H.), and NSF graduate research fellowship (Y-Y.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Carlstedt I, 1989, Symp Soc Exp Biol, V43, P289; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; GALABERT C, 1987, CLIN CHIM ACTA, V164, P139, DOI 10.1016/0009-8981(87)90065-9; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GIROD S, 1992, EUR RESPIR J, V5, P477; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Goodman A, 2002, J MOL BIOL, V323, P199, DOI 10.1016/S0022-2836(02)00893-8; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; King M, 2006, PAEDIATR RESPIR REV, V7, pS212, DOI 10.1016/j.prrv.2006.04.199; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lech MM, 2002, EUR J CONTRACEP REPR, V7, P173, DOI 10.1080/713604342; Liu J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118104; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; PARKHURST MR, 1994, CELL IMMUNOL, V156, P77, DOI 10.1006/cimm.1994.1154; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; SAROSIEK J, 1984, ANN NY ACAD SCI, V435, P575, DOI 10.1111/j.1749-6632.1984.tb13888.x; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; SLOMIANY BL, 1986, BIOCHEM BIOPH RES CO, V141, P387, DOI 10.1016/S0006-291X(86)80381-3; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; WIRTZ D, 2008, ANN REV BIO IN PRESS	39	100	102	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4294	10.1371/journal.pone.0004294	http://dx.doi.org/10.1371/journal.pone.0004294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173002	gold, Green Published, Green Submitted			2022-12-25	WOS:000265483000007
J	Gillespie, JJ; Williams, K; Shukla, M; Snyder, EE; Nordberg, EK; Ceraul, SM; Dharmanolla, C; Rainey, D; Soneja, J; Shallom, JM; Vishnubhat, ND; Wattam, R; Purkayastha, A; Czar, M; Crasta, O; Setubal, JC; Azad, AF; Sobral, BS				Gillespie, Joseph J.; Williams, Kelly; Shukla, Maulik; Snyder, Eric E.; Nordberg, Eric K.; Ceraul, Shane M.; Dharmanolla, Chitti; Rainey, Daphne; Soneja, Jeetendra; Shallom, Joshua M.; Vishnubhat, Nataraj Dongre; Wattam, Rebecca; Purkayastha, Anjan; Czar, Michael; Crasta, Oswald; Setubal, Joao C.; Azad, Abdu F.; Sobral, Bruno S.			Rickettsia Phylogenomics: Unwinding the Intricacies of Obligate Intracellular Life	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; PROGRAMMED CELL-DEATH; OPEN READING FRAMES; MEMBRANE PROTEIN-A; MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE EXCHANGE FACTOR; APHID ACYRTHOSIPHON-PISUM; COMPLETE GENOME SEQUENCE; SPOTTED-FEVER; PHYLOGENETIC ANALYSIS	Background: Completed genome sequences are rapidly increasing for Rickettsia, obligate intracellular alpha-proteobacteria responsible for various human diseases, including epidemic typhus and Rocky Mountain spotted fever. In light of phylogeny, the establishment of orthologous groups (OGs) of open reading frames (ORFs) will distinguish the core rickettsial genes and other group specific genes (class 1 OGs or C1OGs) from those distributed indiscriminately throughout the rickettsial tree (class 2 OG or C2OGs). Methodology/Principal Findings: We present 1823 representative (no gene duplications) and 259 non-representative (at least one gene duplication) rickettsial OGs. While the highly reductive (similar to 1.2 MB) Rickettsia genomes range in predicted ORFs from 872 to 1512, a core of 752 OGs was identified, depicting the essential Rickettsia genes. Unsurprisingly, this core lacks many metabolic genes, reflecting the dependence on host resources for growth and survival. Additionally, we bolster our recent reclassification of Rickettsia by identifying OGs that define the AG (ancestral group), TG (typhus group), TRG (transitional group), and SFG (spotted fever group) rickettsiae. OGs for insect-associated species, tick-associated species and species that harbor plasmids were also predicted. Through superimposition of all OGs over robust phylogeny estimation, we discern between C1OGs and C2OGs, the latter depicting genes either decaying from the conserved C1OGs or acquired laterally. Finally, scrutiny of non-representative OGs revealed high levels of split genes versus gene duplications, with both phenomena confounding gene orthology assignment. Interestingly, non-representative OGs, as well as OGs comprised of several gene families typically involved in microbial pathogenicity and/or the acquisition of virulence factors, fall predominantly within C2OG distributions. Conclusion/Significance: Collectively, we determined the relative conservation and distribution of 14354 predicted ORFs from 10 rickettsial genomes across robust phylogeny estimation. The data, available at PATRIC (PathoSystems Resource Integration Center), provide novel information for unwinding the intricacies associated with Rickettsia pathogenesis, expanding the range of potential diagnostic, vaccine and therapeutic targets.	[Gillespie, Joseph J.; Williams, Kelly; Shukla, Maulik; Snyder, Eric E.; Nordberg, Eric K.; Dharmanolla, Chitti; Rainey, Daphne; Soneja, Jeetendra; Shallom, Joshua M.; Vishnubhat, Nataraj Dongre; Wattam, Rebecca; Purkayastha, Anjan; Czar, Michael; Crasta, Oswald; Setubal, Joao C.; Sobral, Bruno S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Gillespie, Joseph J.; Ceraul, Shane M.; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA	Virginia Polytechnic Institute & State University; University System of Maryland; University of Maryland Baltimore	Gillespie, JJ (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	pvittata@hotmail.com	Setubal, Joao Carlos/C-7305-2012; Sobral, Bruno/GVU-7637-2022	Setubal, Joao Carlos/0000-0001-9174-2816; Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264	NIAID [HHSN266200400035C]; NIH [AI59118, AI17828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017828, R37AI017828, R01AI059118] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded through NIAID contract HHSN266200400035C to BSS and NIH grants AI59118 and AI17828 to AFA.	ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; ALLIGNET J, 1993, GENE, V130, P91, DOI 10.1016/0378-1119(93)90350-C; Allignet J, 1998, ANTIMICROB AGENTS CH, V42, P1794, DOI 10.1128/AAC.42.7.1794; ALLIGNET J, 1995, ANTIMICROB AGENTS CH, V39, P2027, DOI 10.1128/AAC.39.9.2027; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson S G, 1996, Microb Comp Genomics, V1, P293; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bergey DH., 2001, BERGEYS MANUAL SYSTE; BININDAEMONDS O, 2006, SEQCONVERTER PL VERS; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; BRINTON LP, 1971, J BACTERIOL, V105, P1149, DOI 10.1128/JB.105.3.1149-1159.1971; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; BURGDORFER W, 1968, J HYG EPID MICROB IM, V12, P26; Campbell CL, 2004, J MED ENTOMOL, V41, P340, DOI 10.1603/0022-2585-41.3.340; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen M, 1998, ACTA VIROL, V42, P91; Chen M, 1998, ACTA VIROL, V42, P196; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHING WM, 1990, ANN NY ACAD SCI, V590, P334, DOI 10.1111/j.1749-6632.1990.tb42241.x; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cooper TF, 2000, P NATL ACAD SCI USA, V97, P12643, DOI 10.1073/pnas.220077897; Cooper TF, 2005, P ROY SOC B-BIOL SCI, V272, P403, DOI 10.1098/rspb.2004.2921; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DASCH GA, 1981, RICKETTSIAE RICKETTS, P61; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Deng Z, 2005, J VIROL, V79, P4640, DOI 10.1128/JVI.79.8.4640-4650.2005; Diaz-Montero CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/ajtmh.2001.65.371; Donigian JR, 2007, J BIOL CHEM, V282, P22662, DOI 10.1074/jbc.M702620200; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; EREMEEVA M, 1995, J CLIN MICROBIOL, V33, P3022, DOI 10.1128/JCM.33.11.3022-3024.1995; Eremeeva ME, 2005, ANN NY ACAD SCI, V1063, P47, DOI 10.1196/annals.1355.006; EREMEEVA ME, 2006, 20 M AM SOC RICK CON; EREMEEVA ME, 2007, 21 M AM SOC RICK SEP; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIETZ MJ, 1993, J CELL BIOL, V121, P855, DOI 10.1083/jcb.121.4.855; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Fukatsu T, 1999, APPL ENTOMOL ZOOL, V34, P391, DOI 10.1303/aez.34.391; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; GILMORE RD, 1993, GENE, V125, P97, DOI 10.1016/0378-1119(93)90752-O; GILMORE RD, 1991, MOL MICROBIOL, V5, P3089; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Grimaldi David, 2005, pi; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; HAMILTON EH, 1991, J INVEST DERMATOL, V96, P666, DOI 10.1111/1523-1747.ep12470590; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Houhamdi L, 2006, AM J TROP MED HYG, V74, P521, DOI 10.4269/ajtmh.2006.74.521; Houhamdi L, 2002, J INFECT DIS, V186, P1639, DOI 10.1086/345373; HUEBNER RJ, 1946, PUBLIC HEALTH REP, V61, P1677, DOI 10.2307/4585913; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jado I, 2007, EMERG INFECT DIS, V13, P1405, DOI 10.3201/eid1309.060186; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jiggins FM, 2006, J MOL EVOL, V62, P99, DOI 10.1007/s00239-005-0080-9; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kamen B, 1997, SEMIN ONCOL, V24, P30; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lawson ET, 2001, HEREDITY, V86, P497, DOI 10.1046/j.1365-2540.2001.00848.x; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1273, DOI 10.1128/AAC.35.7.1273; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindow JC, 2002, J BACTERIOL, V184, P5317, DOI 10.1128/JB.184.19.5317-5322.2002; LUSHER M, 1989, J GEN MICROBIOL, V135, P1145; Malek JA, 2004, NUCLEIC ACIDS RES, V32, P1059, DOI 10.1093/nar/gkh254; MCCLENAGHAN M, 1988, J GEN MICROBIOL, V134, P559; MCKIEL JA, 1967, CAN J MICROBIOL, V13, P503, DOI 10.1139/m67-065; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Medina-Sancheza A, 2005, ANN NY ACAD SCI, V1063, P327, DOI 10.1196/annals.1355.052; METZGER S, 1989, J BIOL CHEM, V264, P9122; METZGER S, 1988, J BIOL CHEM, V263, P15699; Moron CG, 2000, AM J TROP MED HYG, V62, P598, DOI 10.4269/ajtmh.2000.62.598; Myers W. F., 1981, RICKETTSIAE RICKETTS, P313; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ngwamidiba M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-12; Ngwamidiba M, 2005, ANN NY ACAD SCI, V1063, P94, DOI 10.1196/annals.1355.015; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2002, GENOME RES, V12, P808, DOI 10.1101/gr.227602; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; OGUIN WM, 1991, ANN NY ACAD SCI, V642, P51; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARENT R, 1992, J BACTERIOL, V174, P2891, DOI 10.1128/JB.174.9.2891-2897.1992; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Reeves WK, 2007, EXP APPL ACAROL, V41, P101, DOI 10.1007/s10493-006-9040-3; REISSGUTFREUND RJ, 1966, AM J TROP MED HYG, V15, P943, DOI 10.4269/ajtmh.1966.15.943; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Renesto P, 2005, FEMS MICROBIOL REV, V29, P99, DOI 10.1016/j.femsre.2004.09.002; ROTHNAGEL JA, 1986, J CELL BIOL, V102, P1419, DOI 10.1083/jcb.102.4.1419; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; ROUX V, 1993, J BACTERIOL, V175, P4895, DOI 10.1128/JB.175.15.4895-4904.1993; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; SAVINELLI EA, 1990, ANN NY ACAD SCI, V590, P523, DOI 10.1111/j.1749-6632.1990.tb42262.x; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; Sekeyova Z, 2001, INT J SYST EVOL MICR, V51, P1353, DOI 10.1099/00207713-51-4-1353; Seoane A, 2000, ANTIMICROB AGENTS CH, V44, P905, DOI 10.1128/AAC.44.4.905-909.2000; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Sopko R, 2006, GENOME RES, V16, P314, DOI 10.1101/gr.4976706; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; SORVILLO FJ, 1993, AM J TROP MED HYG, V48, P269, DOI 10.4269/ajtmh.1993.48.269; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Stenos J, 2000, INT J SYST EVOL MICR, V50, P1775, DOI 10.1099/00207713-50-5-1775; STOTHARD DR, 1995, SYST APPL MICROBIOL, V18, P52, DOI 10.1016/S0723-2020(11)80448-0; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Uchiyama T., 1999, RICKETTSIAE RICKETTS, P182; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; Van Dongen SM, 2000, THESIS U UTRECHT NET; van Passel MWJ, 2006, INFECT IMMUN, V74, P4892, DOI 10.1128/IAI.02087-05; VERBIST L, 1992, J ANTIMICROB CHEMOTH, V30, P39, DOI 10.1093/jac/30.suppl_A.39; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Weiss E., 1984, Bergey's Manual of systematic bacteriology. Volume 1, P687; WEISS E, 1975, APPL MICROBIOL, V30, P456, DOI 10.1128/AEM.30.3.456-463.1975; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Willems H, 1997, J BACTERIOL, V179, P3293, DOI 10.1128/jb.179.10.3293-3297.1997; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Xu WB, 1997, CLIN DIAGN LAB IMMUN, V4, P753, DOI 10.1128/CDLI.4.6.753-763.1997; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Yusuf M, 2004, J STORED PROD RES, V40, P207, DOI 10.1016/S0022-474X(02)00098-X; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869; Zchori-Fein E, 2006, PHYSIOL ENTOMOL, V31, P164, DOI 10.1111/j.1365-3032.2006.00504.x; Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221	190	137	142	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2018	10.1371/journal.pone.0002018	http://dx.doi.org/10.1371/journal.pone.0002018			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	19194535	Green Published, Green Submitted, gold			2022-12-25	WOS:000260867300027
J	Uetani, T; Nakayama, H; Okayama, H; Okura, T; Higaki, J; Inoue, H; Higashiyama, S				Uetani, Teruyoshi; Nakayama, Hironao; Okayama, Hideki; Okura, Takafumi; Higaki, Jitsuo; Inoue, Hirofumi; Higashiyama, Shigeki			Insufficiency of Pro-heparin-binding Epidermal Growth Factor-like Growth Factor Shedding Enhances Hypoxic Cell Death in H9c2 Cardiomyoblasts via the Activation of Caspase-3 and c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; MITOCHONDRIAL COMPLEX-III; HB-EGF; MYOCARDIAL-INFARCTION; RECEPTOR LIGANDS; EPITHELIAL-CELLS; EXPRESSION; APOPTOSIS; BAG-1; MEMBRANE	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a cardiogenic and cardiohypertrophic growth factor. ProHB-EGF, a product of the Hb-egf gene and the precursor of HB-EGF, is anchored to the plasma membrane. Its ectodomain region is shed by a disintegrin and metalloproteases (ADAMs) when activated by various stimulations. It has been reported that an uncleavable mutant of Hb-egf, uc-Hb-egf, produces uc-proHB-EGF, which is not cleaved by ADAMs and causes dilation of the heart in knock-in mice. This suggests that the shedding of proHB-EGF is essential for the development and survival of cardiomyocytes: however, the molecular mechanism involved has remained unclear. In this study, we investigated the relationship between uc-proHB-EGF expression and cardiomyocyte survival. Human uc-proHB-EGF was adenovirally introduced into the rat cardiomyoblast cell line H9c2, and the cells were cultured under normoxic and hypoxic conditions. Uc-proHB-EGF-expressing H9c2 cells underwent apoptosis under normoxic conditions, which distinctly increased under hypoxic conditions. Furthermore, we observed an increased Caspase-3 activity, reactive oxygen species accumulation, and an increased c-Jun N-terminal kinase (JNK) activity in the ucproHB-EGF-expressing H9c2 cells. Treatment of the uc-proHB-EGF transfectants with inhibitors of Caspase-3, reactive oxygen species, and JNK, namely, Z-VAD-fmk, N-acetylcysteine, and SP600125, respectively, significantly reduced hypoxic cell death. These data indicate that insufficiency of proHB-EGF shedding under hypoxic stress leads to cardiomyocyte apoptosis via Caspase-3- and JNK-dependent pathways.	[Uetani, Teruyoshi; Nakayama, Hironao; Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Uetani, Teruyoshi; Okayama, Hideki; Okura, Takafumi; Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Integrated Med & Informat, Toon, Ehime 7910295, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Prot Network Lab, CEREM, Toon, Ehime 7910295, Japan	Ehime University; Ehime University; Ehime University	Inoue, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan.	hinoue66@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [17390081]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid 17390081 for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Takeda Science Foundation (to S. H.).	Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Feng JX, 2006, PEPTIDES, V27, P1589, DOI 10.1016/j.peptides.2005.11.013; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Horikawa M, 1999, FEBS LETT, V459, P100, DOI 10.1016/S0014-5793(99)01213-2; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2002, J NEUROSCI, V22, P5365; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; Krieg T, 2004, J MOL CELL CARDIOL, V36, P435, DOI 10.1016/j.yjmcc.2003.12.013; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; PERRELLA MA, 1994, J BIOL CHEM, V269, P27045; Pillai SB, 1998, J PEDIATR SURG, V33, P973, DOI 10.1016/S0022-3468(98)90517-6; Pillai SB, 1999, J SURG RES, V87, P225, DOI 10.1006/jsre.1999.5764; Sakai M, 2001, EXP NEPHROL, V9, P28; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Tanaka N, 1999, BRAIN RES, V827, P130, DOI 10.1016/S0006-8993(99)01319-0; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yucel D, 2002, SCAND J CLIN LAB INV, V62, P463, DOI 10.1080/00365510260390019	42	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12399	12409		10.1074/jbc.M900463200	http://dx.doi.org/10.1074/jbc.M900463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19193634	hybrid, Green Published			2022-12-25	WOS:000265494600070
J	Zoeller, JJ; Pimtong, W; Corby, H; Goldoni, S; Iozzo, AE; Owens, RT; Ho, SY; Iozzo, RV				Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Owens, Rick T.; Ho, Shiu-Ying; Iozzo, Renato V.			A Central Role for Decorin during Vertebrate Convergent Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LEUCINE-RICH PROTEOGLYCANS; IN-VIVO; ZEBRAFISH GASTRULATION; TARGETED DISRUPTION; MUSCULAR-DYSTROPHY; DOWN-REGULATION; CELL POLARITY; BREAST-CANCER; FACTOR-BETA	Decorin, an archetypal member of the small leucine-rich proteoglycan gene family, regulates collagen fibrillogenesis and cell growth. To further explore its biological function, we examined the role of Decorin during zebrafish development. Zebrafish Decorin is a chondroitin sulfate proteoglycan that exhibits a high degree of conservation with its mammalian counterpart and displays a unique spatiotemporal expression pattern. Morpholino-mediated knockdown of zebrafish decorin identified a developmental role during medial-lateral convergence and anterior-posterior extension of the body plan, as well as in craniofacial cartilage formation. decorin morphants displayed a pronounced shortening of the head-to-tail axis as well as compression, flattening, and extension of the jaw cartilages. The morphant phenotype was efficiently rescued by zebrafish decorin mRNA. Unexpectedly, microinjection of excess zebrafish decorin mRNA or proteoglycan/protein core into one-cell stage embryos caused cyclopia. The morphant and overexpression phenotype represent a convergent extension defect. Our results indicate a central function for Decorin during early embryogenesis.	[Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Ho, Shiu-Ying] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Pimtong, Wittaya/0000-0003-0138-2146	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975]; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R.V.I.).	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dugan TA, 2006, J BIOL CHEM, V281, P38208, DOI 10.1074/jbc.M607244200; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Ouyang M, 2008, GENE EXPR PATTERNS, V8, P171, DOI 10.1016/j.gep.2007.10.011; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wang H, 2007, J BIOL CHEM, V282, P14586, DOI 10.1074/jbc.M609193200; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	56	33	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11728	11737		10.1074/jbc.M808991200	http://dx.doi.org/10.1074/jbc.M808991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19211552	Green Published, hybrid			2022-12-25	WOS:000265494500075
J	Dimitrova, LN; Kuroha, K; Tatematsu, T; Inada, T				Dimitrova, Lyudmila N.; Kuroha, Kazushige; Tatematsu, Tsuyako; Inada, Toshifumi			Nascent Peptide-dependent Translation Arrest Leads to Not4p-mediated Protein Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTOP MESSENGER-RNA; RIBOSOMAL EXIT TUNNEL; CYSTATHIONINE GAMMA-SYNTHASE; SACCHAROMYCES-CEREVISIAE; CCR4-NOT COMPLEX; TERMINATION CODON; YEAST; PURIFICATION; ARABIDOPSIS; ELONGATION	The potentially deleterious effects of aberrant mRNA lacking a termination codon (nonstop mRNA) are ameliorated by translation arrest, proteasome-mediated protein destabilization, and rapid mRNA degradation. Because polylysine synthesis via translation of the poly(A) mRNA tail leads to translation arrest and protein degradation by the proteasome, we examined the effects of other amino acid sequences. Insertion of 12 consecutive basic amino acids between GFP and HIS3 reporter genes, but not a stem-loop structure, resulted in degradation of the truncated green fluorescent protein (GFP) products by the proteasome. Translation arrest products derived from GFP-R12-FLAG-HIS3 or GFP-K12-FLAG-HIS3 mRNA were detected in a not4 Delta mutant, and MG132 treatment did not affect the levels of the truncated arrest products. Deletion of other components of the Ccr4-Not complex did not increase the levels of the translation arrest products or reporter mRNAs. A L35A substitution in the Not4p RING finger domain, which disrupted its interaction with the Ubc4/Ubc5E2 enzyme and its activity as an ubiquitin-protein ligase, also abrogated the degradation of arrest products. These results suggest that Not4p, a component of the Ccr4-Not complex, may act as an E3 ubiquitin-protein ligase for translation arrest products. The results let us propose that the interaction between basic amino acid residues and the negatively charged exit tunnel of the ribosome leads to translation arrest followed by Not4p-mediated ubiquitination and protein degradation by the proteasome.	[Dimitrova, Lyudmila N.; Kuroha, Kazushige; Inada, Toshifumi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tatematsu, Tsuyako; Inada, Toshifumi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Inada, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	p47294a@nucc.cc.nagoya-u.ac.jp	Inada, Toshifumi/AAE-1517-2019	Dimitrova-Paternoga, Lyudmila/0000-0001-5673-6373	Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Naito Foundation (to T. I.).	Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; AMBERG DC, 2005, METHODS YEAST GENETI, P262; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Isono E, 2005, J BIOL CHEM, V280, P6537, DOI 10.1074/jbc.M409364200; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JL, 2007, J MOL BIOL, V371, P1378, DOI 10.1016/j.jmb.2007.06.038; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onouchi H, 2004, BIOCHEM SOC T, V32, P597, DOI 10.1042/BST0320597; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; Sambrook J, 2006, CONDENSED PROTOCOLS, P237; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	35	172	173	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10343	10352		10.1074/jbc.M808840200	http://dx.doi.org/10.1074/jbc.M808840200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204001	Green Published, hybrid			2022-12-25	WOS:000265104600008
J	Tonhosolo, R; D'Alexandri, FL; de Rosso, VV; Gazarini, ML; Matsumura, MY; Peres, VJ; Merino, EF; Carlton, JM; Wunderlich, G; Mercadante, AZ; Kimura, EA; Katzin, AM				Tonhosolo, Renata; D'Alexandri, Fabio L.; de Rosso, Veridiana V.; Gazarini, Marcos L.; Matsumura, Miriam Y.; Peres, Valnice J.; Merino, Emilio F.; Carlton, Jane M.; Wunderlich, Gerhard; Mercadante, Adriana Z.; Kimura, Emilia A.; Katzin, Alejandro M.			Carotenoid Biosynthesis in Intraerythrocytic Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOENE SYNTHASE; OXIDATIVE STRESS; INFECTED ERYTHROCYTES; BIFUNCTIONAL ENZYME; TOXOPLASMA-GONDII; MOLECULAR-CLONING; IDENTIFICATION; MITOCHONDRION; ANTIOXIDANT; CHLOROQUINE	Carotenoids are widespread lipophilic pigments synthesized by all photosynthetic organisms and some nonphotosynthetic fungi and bacteria. All carotenoids are derived from the C40 isoprenoid precursor geranylgeranyl pyrophosphate, and their chemical and physical properties are associated with light absorption, free radical scavenging, and antioxidant activity. Carotenoids are generally synthesized in well defined subcellular organelles, the plastids, which are also present in the phylum Apicomplexa, which comprises a number of important human parasites, such as Plasmodium and Toxoplasma. Recently, it was demonstrated that Toxoplasma gondii synthesizes abscisic acid. We therefore asked if Plasmodium falciparum is also capable of synthesizing carotenoids. Herein, biochemical findings demonstrated the presence of carotenoid biosynthesis in the intraerythrocytic stages of the apicomplexan parasite P. falciparum. Using metabolic labeling with radioisotopes, in vitro inhibition tests with norflurazon, a specific inhibitor of plant carotenoid biosynthesis, the results showed that intraerythrocytic stages of P. falciparum synthesize carotenoid compounds. A plasmodial enzyme that presented phytoene synthase activity was also identified and characterized. These findings not only contribute to the current understanding of P. falciparum evolution but shed light on a pathway that could serve as a chemotherapeutic target.	[Tonhosolo, Renata; D'Alexandri, Fabio L.; Matsumura, Miriam Y.; Peres, Valnice J.; Wunderlich, Gerhard; Kimura, Emilia A.; Katzin, Alejandro M.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508000 Sao Paulo, Brazil; [de Rosso, Veridiana V.; Mercadante, Adriana Z.] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Dept Food Sci, BR-13081970 Campinas, SP, Brazil; [Gazarini, Marcos L.] Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, Brazil; [Merino, Emilio F.; Carlton, Jane M.] NYU, Langone Med Ctr, Dept Med Parasitol, New York, NY 10010 USA	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); New York University; NYU Langone Medical Center	Katzin, AM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Lineu Prestes 1374, BR-05508000 Sao Paulo, Brazil.	amkatzin@icb.usp.br	Gazarini, Marcos L/D-6022-2012; Wunderlich, Gerhard/G-8245-2012; de Rosso, Veridiana/P-4675-2019; de Rosso, Veridiana/B-7956-2012; Gazarini, Marcos L./O-7413-2019; Gazarini, Marcos/AFR-3473-2022; Mercadante, Adriana Z/C-4445-2012; Katzin, Alejandro/E-9862-2013; Tonhosolo, Renata/S-3544-2019	Wunderlich, Gerhard/0000-0003-1724-0337; de Rosso, Veridiana/0000-0001-7327-7471; de Rosso, Veridiana/0000-0001-7327-7471; Gazarini, Marcos/0000-0002-3882-6831; Mercadante, Adriana Z/0000-0003-4547-6064; Katzin, Alejandro/0000-0002-4782-2162; 	FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from FAPESP and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; BENAMOTZ A, 1986, BRIT POULTRY SCI, V27, P613, DOI 10.1080/00071668608416920; BEYER P, 1994, PURE APPL CHEM, V66, P1047, DOI 10.1351/pac199466051047; Breitenbach J, 2001, J AGR FOOD CHEM, V49, P5270, DOI 10.1021/jf0106751; BRITTON G, 1998, CAROTENOIDS BIOSYNTH, P110; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Couto AS, 1999, BIOCHEM J, V341, P629, DOI 10.1042/0264-6021:3410629; CREMER G, 1995, EXP PARASITOL, V81, P1, DOI 10.1006/expr.1995.1086; D'Alexandri FL, 2006, FEBS LETT, V580, P6343, DOI 10.1016/j.febslet.2006.10.042; D'Alexandri FL, 2006, ANAL BIOCHEM, V355, P189, DOI 10.1016/j.ab.2006.06.014; Dame JB, 1996, MOL BIOCHEM PARASIT, V79, P1, DOI 10.1016/0166-6851(96)02641-2; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DOGBO O, 1988, P NATL ACAD SCI USA, V85, P7054, DOI 10.1073/pnas.85.19.7054; Famin O, 2003, PARASITE, V10, P39, DOI 10.1051/parasite/2003101p39; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; Ginsburg H, 1999, DRUG RESIST UPDATE, V2, P180, DOI 10.1054/drup.1999.0085; Goulart HR, 2004, ANTIMICROB AGENTS CH, V48, P2502, DOI 10.1128/AAC.48.7.2502-2509.2004; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gunther S, 2005, BIOCHEM SOC T, V33, P977, DOI 10.1042/BST20050977; HUNT NH, 1990, BLOOD CELLS, V16, P499; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; KLEINIG H, 1985, METHOD ENZYMOL, V110, P267; KOYAMA T, 1985, METHOD ENZYMOL, V110, P153; Lacker T, 1999, J CHROMATOGR A, V854, P37, DOI 10.1016/S0021-9673(99)00584-1; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; Lin CY, 2007, BRIT J NUTR, V98, P226, DOI 10.1017/S0007114507691752; Ling Y, 2007, J BIOL CHEM, V282, P30804, DOI 10.1074/jbc.M703178200; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Mijts BN, 2003, CURR OPIN BIOTECH, V14, P597, DOI 10.1016/j.copbio.2003.09.009; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Neudert U, 1998, BBA-LIPID LIPID MET, V1392, P51, DOI 10.1016/S0005-2760(98)00017-4; Obornik M, 2002, GENE, V285, P109, DOI 10.1016/S0378-1119(02)00427-4; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Roos DS, 2002, PHILOS T R SOC B, V357, P35, DOI 10.1098/rstb.2001.1047; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Schofield A, 2005, PLANT PHYSIOL BIOCH, V43, P1052, DOI 10.1016/j.plaphy.2005.10.006; Sharpless KE, 1996, J CHROMATOGR B, V678, P187, DOI 10.1016/0378-4347(95)00494-7; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SIMOES APCF, 1992, ARCH BIOCHEM BIOPHYS, V298, P651, DOI 10.1016/0003-9861(92)90462-6; Snow RW, 2006, AM J TROP MED HYG, V74, P189, DOI 10.4269/ajtmh.2006.74.189; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Sullivan M, 2000, MOL BIOCHEM PARASIT, V109, P17, DOI 10.1016/S0166-6851(00)00226-7; Tao NG, 2007, PLANT CELL REP, V26, P837, DOI 10.1007/s00299-006-0289-0; Tonhosolo R, 2005, BIOCHEM J, V392, P117, DOI 10.1042/BJ20050441; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VIAL HJ, 1984, MOL BIOCHEM PARASIT, V13, P53, DOI 10.1016/0166-6851(84)90101-4	58	60	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9974	9985		10.1074/jbc.M807464200	http://dx.doi.org/10.1074/jbc.M807464200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203994	hybrid, Green Published			2022-12-25	WOS:000264892900040
J	Weimer, KME; Shane, BL; Brunetto, M; Bhattacharyya, S; Hati, S				Weimer, Kristina Mary Ellen; Shane, Brianne Leigh; Brunetto, Michael; Bhattacharyya, Sudeep; Hati, Sanchita			Evolutionary Basis for the Coupled-domain Motions in Thermus thermophilus Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NORMAL-MODE ANALYSIS; ACYL-COA DEHYDROGENASE; VIBRATIONAL-MODES; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; ENZYME CATALYSIS; DRUG-RESISTANCE; HIV-1 INTEGRASE; NETWORK MODEL	Aminoacyl-tRNA synthetases are multidomain proteins that catalyze the covalent attachment of amino acids to their cognate transfer RNA. Various domains of an aminoacyl-tRNA synthetase perform their specific functions in a highly coordinated manner to maintain high accuracy in protein synthesis in cells. The coordination of their function, therefore, requires communication between domains. In this study we explored the relevance of enzyme motion in domain-domain communications. Specifically, we attempted to probe whether the communication between distantly located domains of a multidomain protein is accomplished through a coordinated movement of structural elements. We investigated the collective motion in Thermus thermophilus leucyl-tRNA synthetase by studying the low frequency normal modes. We identified the mode that best described the experimentally observed conformational changes of T. thermophilus leucyl-tRNA synthetase upon substrate binding and analyzed the correlated and anticorrelated motions between different domains. Furthermore, we used statistical coupling analysis to explore if the amino acid pairs and/or clusters whose motions are thermally coupled have also coevolved. Our study demonstrates that a small number of residues belong to the category whose coupled thermal motions correspond to evolutionary coupling as well. These residue clusters constitute a distinguished set of interacting networks that are sparsely distributed in the domain interface. Residues of these networking clusters are within van der Waals contact, and we suggest that they are critical in the propagation of long range mechanochemical motions in T. thermophilus leucyl-tRNA synthetase.	[Weimer, Kristina Mary Ellen; Shane, Brianne Leigh; Brunetto, Michael; Bhattacharyya, Sudeep; Hati, Sanchita] Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA	University of Wisconsin System	Hati, S (corresponding author), Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA.	hatis@uwec.edu	Bhattacharyay, Sudeep/AAW-4015-2021	Bhattacharyay, Sudeep/0000-0002-3960-1239; BRUNETTO, MAURIZIA ROSSANA/0000-0001-8364-9152	Cottrell College Science Award, Research Corp. (Tucson, AZ); Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI	Cottrell College Science Award, Research Corp. (Tucson, AZ); Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI	This work was supported by the Cottrell College Science Award, Research Corp. (Tucson, AZ) (to S. H.) and the Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI.	Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barreca ML, 2003, BIOPHYS J, V84, P1450, DOI 10.1016/S0006-3495(03)74958-3; Bartlett GJ, 2008, PROTEINS, V71, P950, DOI 10.1002/prot.21779; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2006, SCIENCE, V312, P208, DOI 10.1126/science.1127654; Bhattacharyya S, 2005, BIOCHEMISTRY-US, V44, P16549, DOI 10.1021/bi051630m; Bhattacharyya S, 2007, J PHYS CHEM A, V111, P5729, DOI 10.1021/jp07l526+; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Brigo A, 2005, PROTEINS, V59, P723, DOI 10.1002/prot.20447; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Budiman ME, 2007, PROTEINS, V68, P670, DOI 10.1002/prot.21426; Chen JF, 2001, BIOCHEMISTRY-US, V40, P1144, DOI 10.1021/bi0017226; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Du X, 2002, BIOCHEMISTRY-US, V41, P10623, DOI 10.1021/bi026000o; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; HARRISON RW, 1984, BIOPOLYMERS, V23, P2943, DOI 10.1002/bip.360231216; HARTE WE, 1990, P NATL ACAD SCI USA, V87, P8864, DOI 10.1073/pnas.87.22.8864; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hawkins RJ, 2006, BIOPHYS J, V91, P2055, DOI 10.1529/biophysj.106.082180; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Karplus M, 2002, ACCOUNTS CHEM RES, V35, P321, DOI 10.1021/ar020082r; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lue SW, 2007, BIOCHEMISTRY-US, V46, P4466, DOI 10.1021/bi0618215; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; MASCARENHAS A, 2009, PROTEIN ENG, P153; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mustata GI, 2003, BIOPOLYMERS, V70, P186, DOI 10.1002/bip.10425; Nascimento AS, 2008, J MOL BIOL, V382, P763, DOI 10.1016/j.jmb.2008.07.043; Nawaz MH, 2007, J MOL BIOL, V367, P384, DOI 10.1016/j.jmb.2006.12.051; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soares TA, 2002, BIOPOLYMERS, V65, P313, DOI 10.1002/bip.10252; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205; Truhlar DG, 2002, ACCOUNTS CHEM RES, V35, P341, DOI 10.1021/ar0100226; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Vu MT, 2007, BIOCHEMISTRY-US, V46, P5170, DOI 10.1021/bi062078j; Williams AM, 2006, P NATL ACAD SCI USA, V103, P3586, DOI 10.1073/pnas.0507362103; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Zhang CM, 2005, BIOCHEMISTRY-US, V44, P7240, DOI 10.1021/bi050285y; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103	71	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10088	10099		10.1074/jbc.M807361200	http://dx.doi.org/10.1074/jbc.M807361200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188368	hybrid, Green Published			2022-12-25	WOS:000264892900051
J	Yamada, L; Saito, T; Taniguchi, H; Sawada, H; Harada, Y				Yamada, Lixy; Saito, Takako; Taniguchi, Hisaaki; Sawada, Hitoshi; Harada, Yoshito			Comprehensive Egg Coat Proteome of the Ascidian Ciona intestinalis Reveals Gamete Recognition Molecules Involved in Self-sterility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA GENES; SELF/NONSELF RECOGNITION; SPERM RECEPTOR; LC-MS/MS; IDENTIFICATION; ALLORECOGNITION; DOMAIN; FERTILIZATION; MECHANISM; EVOLUTION	Despite central roles of egg coat proteins in gamete recognition, their functions and composition are poorly understood. Here, we report that the proteome of the egg coat in the solitary ascidian Ciona intestinalis, called vitelline coat (VC) fraction, contains more than 800 proteins identified by mass spectrometry-based analyses. Over 100 proteins were enriched in the VC fraction compared with the VC-free egg proteome. The most abundant component in the VC was an apolipoprotein-like protein. The VC contained multiple homologs of mammalian zona pellucida (ZP) proteins, the number of which was unexpectedly large and most of which possessed epidermal growth factor-like repeats. Furthermore, the present study revealed that two fibrinogen-like proteins, v-Themis-A and -B, both of which are expressed in the VC, are the molecules responsible for the two self-sterility loci that were identified by our previous genetic study in this species.	[Saito, Takako; Sawada, Hitoshi; Harada, Yoshito] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan; [Yamada, Lixy; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Div Dis Prote, Tokushima 7708503, Japan; [Taniguchi, Hisaaki] Japan Sci & Technol Agcy JST, Inst Bioinformat Res & Dev BIRD, Chiyoda Ku, Tokyo 1028666, Japan	Nagoya University; Tokushima University; Japan Science & Technology Agency (JST)	Sawada, H (corresponding author), Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan.	hsawada@bio.nagoya-u.ac.jp; yharada@bio.nagoya-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012	Saito, Takako/0000-0002-3969-9192	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19370041, 19659080, 16659021, 19659018, 18770198]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research fellowship of the Japan Society for the Promotion of Science (JSPS) for young scientists (to L. Y.), the 21st COE program "Disease Proteomics" and Grants-in-aid for Scientific Research 19370041 and 19659080 by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to H. T.), Grants-in-aid for Exploratory Research 16659021 and 19659018 from MEXT (to H. S.), and Grant-in-aid 18770198 for Young Scientists (B) from MEXT (to Y. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aagaard JE, 2006, P NATL ACAD SCI USA, V103, P17302, DOI 10.1073/pnas.0603125103; Allet N, 2004, PROTEOMICS, V4, P2333, DOI 10.1002/pmic.200300840; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; Ban S, 2005, DEV BIOL, V286, P440, DOI 10.1016/j.ydbio.2005.08.004; Colinge J, 2005, ANAL CHEM, V77, P596, DOI 10.1021/ac0488513; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Goudet G, 2008, BIOL REPROD, V78, P796, DOI 10.1095/biolreprod.107.064568; Harada Y, 2008, INT J DEV BIOL, V52, P637, DOI 10.1387/ijdb.072544yh; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; Harada Y, 2007, MOL REPROD DEV, V74, P1178, DOI 10.1002/mrd.20616; Heller M, 2007, MOL CELL PROTEOMICS, V6, P1059, DOI 10.1074/mcp.M600326-MCP200; Howes E, 2001, J CELL SCI, V114, P4127; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; KAWAMURA K, 1991, DEV GROWTH DIFFER, V33, P139; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kuern U, 2007, DEV COMP IMMUNOL, V31, P1242, DOI 10.1016/j.dci.2007.03.011; Kurn U, 2007, DEV COMP IMMUNOL, V31, P360, DOI 10.1016/j.dci.2006.06.008; Lee YH, 1999, DEVELOPMENT, V126, P3857; Marino R, 1998, DEVELOPMENT, V125, P899; MORGAN TH, 1910, ROUX ARCH ENTWICKLUN, V30, P206; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Urayama S, 2008, J BIOL CHEM, V283, P21725, DOI 10.1074/jbc.M802631200; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193	31	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9402	9410		10.1074/jbc.M809672200	http://dx.doi.org/10.1074/jbc.M809672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193647	hybrid, Green Published			2022-12-25	WOS:000264669100046
J	Gillet, L; Roger, S; Besson, P; Lecaille, F; Gore, J; Bougnoux, P; Lalmanach, G; Le Guennec, JY				Gillet, Ludovic; Roger, Sebastien; Besson, Pierre; Lecaille, Fabien; Gore, Jacques; Bougnoux, Philippe; Lalmanach, Gilles; Le Guennec, Jean-Yves			Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; PROTEASES; INHIBITORS; PH; REPRESSOR; TARGETS; MATRIX; ROLES	Voltage-gated sodium channels (Na-V) are functionally expressed in highly metastatic cancer cells derived from nonexcitable epithelial tissues (breast, prostate, lung, and cervix). MDA-MB-231 breast cancer cells express functional sodium channel complexes, consisting of Na(V)1.5 and associated auxiliary beta-subunits, that are responsible for a sustained inward sodium current at the membrane potential. Although these channels do not regulate cellular multiplication or migration, their inhibition by the specific blocker tetrodotoxin impairs both the extracellular gelatinolytic activity (monitored with DQ-gelatin) and cell invasiveness leading to the attenuation of colony growth and cell spreading in three-dimensional Matrigel (R)-composed matrices. MDA-MB-231 cells express functional cysteine cathepsins, which we found play a predominant role (similar to 65%) in cancer invasiveness. Matrigel (R) invasion is significantly decreased in the presence of specific inhibitors of cathepsins Band S (CA-074 and Z-FL-COCHO, respectively), and co-application of tetrodotoxin does not further reduce cell invasion. This suggests that cathepsins B and S are involved in invasiveness and that their proteolytic activity partly depends on NaV function. Inhibiting NaV has no consequence for cathepsins at the transcription, translation, and secretion levels. However, NaV activity leads to an intracellular alkalinization and a perimembrane acidification favorable for the extracellular activity of these acidic proteases. We propose that Na-v enhance the invasiveness of cancer cells by favoring the pH-dependent activity of cysteine cathepsins. This general mechanism could lead to the identification of new targets allowing the therapeutic prevention of metastases.	[Gillet, Ludovic; Roger, Sebastien; Besson, Pierre; Gore, Jacques; Bougnoux, Philippe; Le Guennec, Jean-Yves] Univ Tours, Fac Med, INSERM, U921, F-37032 Tours, France; [Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, Fac Med, INSERM, U618, F-37032 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Roger, S (corresponding author), Univ Tours, Fac Med, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, France.	sebastien.roger@univ-tours.fr	LE GUENNEC, Jean-Yves/P-1067-2016; Lecaille, Fabien/GRY-5313-2022	Bougnoux, Philippe/0000-0002-8717-055X; Gillet, Ludovic/0000-0002-4990-6212; Lalmanach, Gilles/0000-0001-8562-4821; Roger, Sebastien/0000-0002-9852-5248; Lecaille, Fabien/0000-0003-1060-4222	Ligue contre le Cancer - Region Centre; Association pour la Recherche contre le Cancer; IFR 135-Imagerie Fonctionnelle; Ministere de la Recherche et des Technologies; Institut National de la Sante et de la Recherche Medicale (INSERM)	Ligue contre le Cancer - Region Centre(Region Centre-Val de Loire); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); IFR 135-Imagerie Fonctionnelle; Ministere de la Recherche et des Technologies; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant from the Ligue contre le Cancer - Region Centre, the Association pour la Recherche contre le Cancer, the IFR 135-Imagerie Fonctionnelle, the Ministere de la Recherche et des Technologies, and the Institut National de la Sante et de la Recherche Medicale (INSERM). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adachi K, 2004, ONCOGENE, V23, P7791, DOI 10.1038/sj.onc.1208067; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; BROMME D, 1989, BIOCHEM J, V264, P475; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chowdhury SF, 2002, J MED CHEM, V45, P5321, DOI 10.1021/jm020238t; Coulson JM, 2000, CANCER RES, V60, P1840; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Izumi H, 2003, CANCER TREAT REV, V29, P541, DOI 10.1016/S0305-7372(03)00106-3; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Jude S, 2006, PROG BIOPHYS MOL BIO, V90, P299, DOI 10.1016/j.pbiomolbio.2005.05.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Roger S, 2003, BBA-BIOMEMBRANES, V1616, P107, DOI 10.1016/j.bbamem.2003.07.001; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; Roger S, 2006, CURR PHARM DESIGN, V12, P3681, DOI 10.2174/138161206778522047; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Walker B, 2000, BIOCHEM BIOPH RES CO, V275, P401, DOI 10.1006/bbrc.2000.3311; Wang D, 2002, BIOCHEMISTRY-US, V41, P8849, DOI 10.1021/bi0257080; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033	42	151	164	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8671	8682		10.1074/jbc.M806891200	http://dx.doi.org/10.1074/jbc.M806891200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176528	Green Published, hybrid			2022-12-25	WOS:000264397800052
J	Graziane, NM; Yuen, EY; Yan, Z				Graziane, Nicholas M.; Yuen, Eunice Y.; Yan, Zhen			Dopamine D-4 Receptors Regulate GABA(A) Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; DEFICIT HYPERACTIVITY DISORDER; PREFRONTAL CORTICAL-NEURONS; ACTIN DEPOLYMERIZING FACTOR; PROTEIN-KINASE-C; WORKING-MEMORY; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; AMPA RECEPTORS; A RECEPTORS	The GABAA receptor-mediated inhibitory transmission in prefrontal cortex (PFC) is implicated in cognitive processes such as working memory. Our previous study has found that GABA(A)R current is subject to the regulation of dopamine D-4 receptors, a PFC-enriched neuromodulator critically involved in various mental disorders associated with PFC dysfunction. In this study, we have investigated the cellular mechanism underlying D-4 modulation of GABA(A)Rs. We found that the density of surface clusters of GABA(A)R beta 2/3 subunits was reduced by D-4, suggesting that the D-4 reduction of GABA(A)R current is associated with a decrease in functional GABA(A)Rs at the plasma membrane. Moreover, the D-4 reduction of GABA(A)R current was blocked by the actin stabilizer phalloidin and was occluded by the actin destabilizer latrunculin, suggesting that D-4 regulates GABA(A)R trafficking via an actin-dependent mechanism. Cofilin, a major actin depolymerizing factor whose activity is strongly increased by dephosphorylation at Ser(3), provides the possible link between D-4 signaling and the actin dynamics. Because myosin motor proteins are important for the transport of vesicles along actin filaments, we also tested the potential involvement of myosin in D-4 regulation of GABA(A)R trafficking. We found that dialysis with a myosin peptide, which competes with endogenous myosin proteins for actin-binding sites, prevented the D-4 reduction of GABA(A)R current. These results suggest that D-4 receptor activation increases cofilin activity presumably via its dephosphorylation, resulting in actin depolymerization, thus causing a decrease in the myosin-based transport of GABA(A)R clusters to the surface.	[Graziane, Nicholas M.; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Graziane, Nicholas/0000-0002-7055-7029	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants ( to Z. Y.).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Cai XA, 2002, J BIOL CHEM, V277, P36553, DOI 10.1074/jbc.M203752200; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Glase SA, 1997, J MED CHEM, V40, P1771, DOI 10.1021/jm970021c; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LEWIS DA, 1986, HUM NEUROBIOL, V5, P181; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rowe DC, 1998, MOL PSYCHIATR, V3, P419, DOI 10.1038/sj.mp.4000432; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; Shen L, 2000, J NEUROSCI, V20, P7932; TEHRANI MHJ, 1993, J NEUROCHEM, V60, P1755; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Wang X, 2002, J NEUROSCI, V22, P9185; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	65	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8329	8336		10.1074/jbc.M807387200	http://dx.doi.org/10.1074/jbc.M807387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179335	Green Published, hybrid			2022-12-25	WOS:000264397800017
J	Daehler, CC				Daehler, Curtis C.			Short Lag Times for Invasive Tropical Plants: Evidence from Experimental Plantings in Hawai'i	PLOS ONE			English	Article								Background: The lag time of an invasion is the delay between arrival of an introduced species and its successful spread in a new area. To date, most estimates of lag times for plants have been indirect or anecdotal, and these estimates suggest that plant invasions are often characterized by lag times of 50 years or more. No general estimates are available of lag times for tropical plant invasions. Historical plantings and documentation were used to directly estimate lag times for tropical plant invasions in Hawai'i. Methodology/Principal Findings: Historical planting records for the Lyon Arboretum dating back to 1920 were examined to identify plants that have since become invasive pests in the Hawaiian Islands. Annual reports describing escape from plantings were then used to determine the lag times between initial plantings and earliest recorded spread of the successful invaders. Among 23 species that eventually became invasive pests, the average lag time between introduction and first evidence of spread was 14 years for woody plants and 5 years for herbaceous plants. onclusions/Significance: These direct estimates of lag times are as much as an order of magnitude shorter than previous, indirect estimates, which were mainly based on temperate plants. Tropical invaders may have much shorter lag times than temperate species. A lack of direct and deliberate observations may have also inflated many previous lag time estimates. Although there have been documented cases of long lag times due to delayed arrival of a mutualist or environmental changes over time, this study suggests that most successful invasions are likely to begin shortly after arrival of the plant in a suitable habitat, at least in tropical environments. Short lag times suggest that controlled field trials may be a practical element of risk assessment for plant introductions.	Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Daehler, CC (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	daehler@hawaii.edu						Barney JN, 2006, BIOL INVASIONS, V8, P703, DOI 10.1007/s10530-005-3174-9; Beauchamp VB, 2007, WETLANDS, V27, P381, DOI 10.1672/0277-5212(2007)27[381:FROTVR]2.0.CO;2; Broncano MJ, 2005, FOREST ECOL MANAG, V211, P257, DOI 10.1016/j.foreco.2005.02.055; BURDON JJ, 1977, OECOLOGIA, V31, P1, DOI 10.1007/BF00348703; Caley P, 2008, DIVERS DISTRIB, V14, P196, DOI 10.1111/j.1472-4642.2007.00440.x; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; DAEHLER CC, 2006, BISHOP MUSEUM OCCASI, V86, P3; Dawson W, 2008, BIODIVERS CONSERV, V17, P1979, DOI 10.1007/s10531-008-9345-0; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; HARTT CE, HAWAIIAN SUGAR BOT; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Huang H, 2007, ECOL ENG, V29, P164, DOI 10.1016/j.ecoleng.2006.06.005; Jefferson L, 2004, WEED TECHNOL, V18, P1434, DOI 10.1614/0890-037X(2004)018[1434:IISPTC]2.0.CO;2; KOWARIK I, 1995, PLANT INVASIONS, P15; Lockwood J, 2006, INVASION ECOLOGY; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; MCKEY D, 1989, EXPERIENTIA, V45, P661, DOI 10.1007/BF01975683; Memmott J, 2005, J ANIM ECOL, V74, P50, DOI 10.1111/j.1365-2656.2004.00896.x; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; PIERSON EA, 1990, OECOLOGIA, V84, P519, DOI 10.1007/BF00328169; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Smith CW, 1998, PEST PLANTS HAWAIIAN; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Virtue J. G., 2008, Plant Protection Quarterly, V23, P166; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wangen SR, 2006, J APPL ECOL, V43, P258, DOI 10.1111/j.1365-2664.2006.01138.x	31	66	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4462	10.1371/journal.pone.0004462	http://dx.doi.org/10.1371/journal.pone.0004462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223966	gold, Green Published, Green Submitted			2022-12-25	WOS:000265485800002
J	Huang, SK; Darfler, MM; Nicholl, MB; You, JS; Bemis, KG; Tegeler, TJ; Wang, M; Wery, JP; Chong, KK; Nguyen, L; Scolyer, RA; Hoon, DSB				Huang, Sharon K.; Darfler, Marlene M.; Nicholl, Michael B.; You, Jinsam; Bemis, Kerry G.; Tegeler, Tony J.; Wang, Mu; Wery, Jean-Pierre; Chong, Kelly K.; Nguyen, Linhda; Scolyer, Richard A.; Hoon, Dave S. B.			LC/MS-Based Quantitative Proteomic Analysis of Paraffin-Embedded Archival Melanomas Reveals Potential Proteomic Biomarkers Associated with Metastasis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PYRUVATE-KINASE; PLASTIN GENE; CANCER; QUANTIFICATION; IDENTIFICATION; PROTEINS; HSP90; DJ-1; OVEREXPRESSION	Background: Melanoma metastasis status is highly associated with the overall survival of patients; yet, little is known about proteomic changes during melanoma tumor progression. To better understand the changes in protein expression involved in melanoma progression and metastasis, and to identify potential biomarkers, we conducted a global quantitative proteomic analysis on archival metastatic and primary melanomas. Methodology and Findings: A total of 16 metastatic and 8 primary cutaneous melanomas were assessed. Proteins were extracted from laser captured microdissected formalin fixed paraffin-embedded archival tissues by liquefying tissue cells. These preparations were analyzed by a LC/MS-based label-free protein quantification method. More than 1500 proteins were identified in the tissue lysates with a peptide ID confidence level of >75%. This approach identified 120 significant changes in protein levels. These proteins were identified from multiple peptides with high confidence identification and were expressed at significantly different levels in metastases as compared with primary melanomas (q-Value<0.05). Conclusions and Significance: The differentially expressed proteins were classified by biological process or mapped into biological system networks, and several proteins were implicated by these analyses as cancer-or metastasis-related. These proteins represent potential biomarkers for tumor progression. The study successfully identified proteins that are differentially expressed in formalin fixed paraffin-embedded specimens of metastatic and primary melanoma.	[Huang, Sharon K.; Nicholl, Michael B.; Chong, Kelly K.; Nguyen, Linhda; Hoon, Dave S. B.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Darfler, Marlene M.] Expression Pathol Inc, Gaithersburg, MD USA; [You, Jinsam; Bemis, Kerry G.; Tegeler, Tony J.; Wang, Mu; Wery, Jean-Pierre] Monarch LifeSci LLC, Indianapolis, IN USA; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney Melanoma Unit, Camperdown, NSW, Australia	John Wayne Cancer Institute; Melanoma Institute Australia; University of Sydney	Huang, SK (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA.	hoon@jwci.org	Hoon, Dave SB/C-7146-2018; Scolyer, Richard/AAE-8511-2019	Hoon, Dave SB/0000-0003-1915-3683; Scolyer, Richard/0000-0002-8991-0013; Nicholl, Michael/0000-0002-8513-845X	NIH, National Cancer Institute [CA029605, CA012582]; Leslie and Susan Gonda (Goldschmied) Foundation; Martin H. Weil Research Foundation; NATIONAL CANCER INSTITUTE [P01CA012582, P01CA029605] Funding Source: NIH RePORTER	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leslie and Susan Gonda (Goldschmied) Foundation; Martin H. Weil Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH, National Cancer Institute P0 grants CA029605 and CA012582, the Leslie and Susan Gonda (Goldschmied) Foundation, and the Martin H. Weil Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Ekins S, 2007, METH MOL B, V356, P319; Ekins S, 2005, PHARM DEV, P123, DOI 10.1002/0471728780.ch4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fitzpatrick DPG, 2007, PROTEOM CLIN APPL, V1, P246, DOI 10.1002/prca.200600768; Goto Y, 2008, CLIN CANCER RES, V14, P3401, DOI 10.1158/1078-0432.CCR-07-1842; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Higgs RE, 2005, J PROTEOME RES, V4, P1442, DOI 10.1021/pr050109b; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Hood BL, 2006, PROTEOMICS, V6, P4106, DOI 10.1002/pmic.200600016; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Koyanagi K, 2006, CLIN CANCER RES, V12, P1137, DOI 10.1158/1078-0432.CCR-05-1847; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LIN CS, 1993, J BIOL CHEM, V268, P2781; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Martinez SR, 2006, FROM MELANOCYTES TO MELANOMA: THE PROGRESSION TO MALIGNANCY, P551, DOI 10.1007/978-1-59259-994-3_31; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; MEYERS ML, 1998, CUTANEOUS MELANOMA, P325; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Okamoto T, 1998, J INVEST DERMATOL, V111, P1034, DOI 10.1046/j.1523-1747.1998.00411.x; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Otsuka M, 2001, BIOCHEM BIOPH RES CO, V289, P876, DOI 10.1006/bbrc.2001.6047; Pardo M, 2007, J PROTEOME RES, V6, P2802, DOI 10.1021/pr070021t; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; PARK TS, 1994, CANCER RES, V54, P1775; Picard D, 2004, NAT CELL BIOL, V6, P479, DOI 10.1038/ncb0604-479; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takeuchi H, 2003, CANCER RES, V63, P441; Troke PJF, 2006, BIOCHEM SOC SYMP, V73, P23; Wachsberger PR, 2002, MELANOMA RES, V12, P35, DOI 10.1097/00008390-200202000-00006; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	54	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4430	10.1371/journal.pone.0004430	http://dx.doi.org/10.1371/journal.pone.0004430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221597	gold, Green Submitted, Green Published			2022-12-25	WOS:000265485700002
J	Kerneis, S; Guerin, PJ; von Seidlein, L; Legros, D; Grais, RF				Kerneis, Solen; Guerin, Philippe J.; von Seidlein, Lorenz; Legros, Dominique; Grais, Rebecca F.			A Look Back at an Ongoing Problem: Shigella dysenteriae Type 1 Epidemics in Refugee Settings in Central Africa (1993-1995)	PLOS ONE			English	Article								Background: Shigella dysenteriae type 1 (Sd1) is a cause of major dysentery outbreaks, particularly among children and displaced populations in tropical countries. Although outbreaks continue, the characteristics of such outbreaks have rarely been documented. Here, we describe the Sd1 outbreaks occurring between 1993 and 1995 in 11 refugee settlements in Rwanda, Tanzania and Democratic Republic of the Congo (DRC). We also explored the links between the different types of the camps and the magnitude of the outbreaks. Methodology/Principal Findings: Number of cases of bloody diarrhea and deaths were collected on a weekly basis in 11 refugee camps, and analyzed retrospectively. Between November 1993 and February 1995, 181,921 cases of bloody diarrhea were reported. Attack rates ranged from 6.3% to 39.1% and case fatality ratios (CFRs) from 1.5% to 9.0% (available for 5 camps). The CFRs were higher in children under age 5. In Tanzania where the response was rapidly deployed, the mean attack rate was lower than in camps in the region of Goma without an immediate response (13.3% versus 32.1% respectively). Conclusions/Significance: This description, and the areas where data is missing, highlight both the importance of collecting data in future epidemics, difficulties in documenting outbreaks occurring in complex emergencies and most importantly, the need to assure that minimal requirements are met.	[Kerneis, Solen; Guerin, Philippe J.; Grais, Rebecca F.] Epictr, Paris, France; [von Seidlein, Lorenz] Joint Malaria Programme, Tanga, Tanzania; [von Seidlein, Lorenz] London Sch Hyg & Trop Med, Wellcome Trust Unit, Bangkok, Thailand; [Legros, Dominique] WHO, Geneva, Switzerland	World Health Organization	Kerneis, S (corresponding author), Epictr, Paris, France.	philippe.guerin@ndm.ox.ac.uk	Guerin, Philippe/AAH-8873-2021	Freeman Grais, Rebecca/0000-0002-5037-8218; Guerin, Philippe/0000-0002-6008-2963	international humanitarian aid organisation Medecins sans Frontieres	international humanitarian aid organisation Medecins sans Frontieres	This research was funded by the international humanitarian aid organisation Medecins sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P94; BOGAERTS J, 1985, ANN SOC BELG MED TR, V65, P281; Brown V, 2008, PLOS MED, V5, P553, DOI 10.1371/journal.pmed.0050089; Cavallo J D, 1995, Med Trop (Mars), V55, P351; Checchi F, 2007, 61 HPN; GANGAROSA EJ, 1970, J INFECT DIS, V122, P181, DOI 10.1093/infdis/122.3.170; Guerin PJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-8; Guerin PJ, 2004, T ROY SOC TROP MED H, V98, P635, DOI 10.1016/j.trstmh.2004.01.005; Guerin PJ, 2003, LANCET, V362, P705, DOI 10.1016/S0140-6736(03)14227-4; Heyman SN, 1997, J CLIN GASTROENTEROL, V25, P595, DOI 10.1097/00004836-199712000-00009; Klugman KP, 1997, S AFR MED J, V87, P1145; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laureillard D, 1998, Sante, V8, P303; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; LEVINE MM, 1970, LANCET, V2, P607; LOW S, 1994, IMPACT MASSIVE POPUL; Milleliri JM, 1995, ANN SOC BELG MED TR, V75, P201; MOORE PS, 1993, LANCET, V341, P935, DOI 10.1016/0140-6736(93)91223-9; MURRAY JCS, 1994, EP INT SERV 43 ANN C; Paquet C, 1995, Sante, V5, P181; RAHAMAN MM, 1975, J INFECT DIS, V131, P700, DOI 10.1093/infdis/132.1.15; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; ROGERIE F, 1986, ANTIMICROB AGENTS CH, V29, P883, DOI 10.1128/AAC.29.5.883; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Soares J L, 1994, Med Trop (Mars), V54, P319; TAYLOR DN, 1989, AM J TROP MED HYG, V40, P77, DOI 10.4269/ajtmh.1989.40.77; The Sphere Project, 2004, HUM CHART MIN STAND; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; TUTTLE J, 1995, J INFECT DIS, V171, P371, DOI 10.1093/infdis/171.2.371; United Nations High Commissioner for Refugees, 2000, STAT WORLDS REF 2000; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; *WHO, 1993, WHOCDD9445; *WHO, 2004, WHOCDD9345; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587; 1994, REFUGEES MAGAZIN SEP, V97	35	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4494	10.1371/journal.pone.0004494	http://dx.doi.org/10.1371/journal.pone.0004494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214226	gold, Green Published, Green Submitted			2022-12-25	WOS:000265484300017
J	Lorincz, ML; Geall, F; Bao, Y; Crunelli, V; Hughes, SW				Lorincz, Magor L.; Geall, Freya; Bao, Ying; Crunelli, Vincenzo; Hughes, Stuart W.			ATP-Dependent Infra-Slow (< 0.1 Hz) Oscillations in Thalamic Networks	PLOS ONE			English	Article								An increasing number of EEG and resting state fMRI studies in both humans and animals indicate that spontaneous low frequency fluctuations in cerebral activity at <0.1 Hz (infra-slow oscillations, ISOs) represent a fundamental component of brain functioning, being known to correlate with faster neuronal ensemble oscillations, regulate behavioural performance and influence seizure susceptibility. Although these oscillations have been commonly indicated to involve the thalamus their basic cellular mechanisms remain poorly understood. Here we show that various nuclei in the dorsal thalamus in vitro can express a robust ISO at similar to 0.005-0.1 Hz that is greatly facilitated by activating metabotropic glutamate receptors (mGluRs) and/or Ach receptors (AchRs). This ISO is a neuronal population phenomenon which modulates faster gap junction (GJ)-dependent network oscillations, and can underlie epileptic activity when AchRs or mGluRs are stimulated excessively. In individual thalamocortical neurons the ISO is primarily shaped by rhythmic, long-lasting hyperpolarizing potentials which reflect the activation of A1 receptors, by ATP-derived adenosine, and subsequent opening of Ba2+-sensitive K+ channels. We argue that this ISO has a likely non-neuronal origin and may contribute to shaping ISOs in the intact brain.	[Lorincz, Magor L.; Geall, Freya; Bao, Ying; Crunelli, Vincenzo; Hughes, Stuart W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Lorincz, ML (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	HughesSW@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010; Lőrincz, Magor L/C-7746-2012	Lőrincz, Magor L/0000-0001-5240-1904; Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X	Wellcome Trust [71436, 78403, 78311]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grants 71436, 78403 awarded to VC and 78311 awarded to SWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Albrecht D, 1998, NEUROSCI RES, V32, P209, DOI 10.1016/S0168-0102(98)00087-X; ALBRECHT D, 1994, NEUROREPORT, V5, P1909, DOI 10.1097/00001756-199410000-00017; CHATILA M, 1992, ELECTROEN CLIN NEURO, V83, P217, DOI 10.1016/0013-4694(92)90147-A; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Eisensehr I, 2001, EPILEPSY RES, V46, P241, DOI 10.1016/S0920-1211(01)00280-7; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Filippov IV, 2007, BRAIN RES, V1133, P78, DOI 10.1016/j.brainres.2006.11.038; Filippov IV, 2005, BRAIN RES, V1066, P179, DOI 10.1016/j.brainres.2005.10.061; Filippov IV, 2005, NEUROSCI LETT, V373, P51, DOI 10.1016/j.neulet.2004.09.056; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; He JF, 2003, J NEUROSCI, V23, P8281; Hughes SW, 2007, INT J PSYCHOPHYSIOL, V64, P3, DOI 10.1016/j.ijpsycho.2006.08.004; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hughes SW, 2002, NEUROSCIENCE, V110, P395, DOI 10.1016/S0306-4522(01)00577-2; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LOPESDAS.FH, 1973, ELECTROEN CLIN NEURO, V35, P641, DOI 10.1016/0013-4694(73)90217-4; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Lorincz ML, 2008, J NEUROSCI, V28, P660, DOI 10.1523/JNEUROSCI.4468-07.2008; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Parrino L, 2000, CLIN NEUROPHYSIOL, V111, pS39, DOI 10.1016/S1388-2457(00)00400-4; Pirchio M, 1997, J NEUROSCI, V17, P5428; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Tennigkeit F, 1998, NEUROSCIENCE, V83, P1063, DOI 10.1016/S0306-4522(97)00458-2; Terzano MG, 2000, SLEEP MED REV, V4, P101, DOI 10.1053/smrv.1999.0083; Timofeev I, 1998, J NEUROPHYSIOL, V80, P1495, DOI 10.1152/jn.1998.80.3.1495; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhatalo S, 2005, CLIN NEUROPHYSIOL, V116, P1, DOI 10.1016/j.clinph.2004.09.015; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Yamada M, 1998, PHARMACOL REV, V50, P723; ZHANG D, 2008, J NEUROPHYSIOL  0813; Zhu L, 2006, NEUROSCIENCE, V141, P621, DOI 10.1016/j.neuroscience.2006.04.069	57	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4447	10.1371/journal.pone.0004447	http://dx.doi.org/10.1371/journal.pone.0004447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212445	gold, Green Published, Green Accepted			2022-12-25	WOS:000265484200008
J	Mainardi, M; Landi, S; Berardi, N; Maffei, L; Pizzorusso, T				Mainardi, Marco; Landi, Silvia; Berardi, Nicoletta; Maffei, Lamberto; Pizzorusso, Tommaso			Reduced Responsiveness to Long-Term Monocular Deprivation of Parvalbumin Neurons Assessed by c-Fos Staining in Rat Visual Cortex	PLOS ONE			English	Article								Background: It is generally assumed that visual cortical cells homogeneously shift their ocular dominance (OD) in response to monocular deprivation (MD), however little experimental evidence directly supports this notion. By using immunohistochemistry for the activity-dependent markers c-Fos and Arc, coupled with staining for markers of inhibitory cortical sub-populations, we studied whether long-term MD initiated at P21 differentially affects visual response of inhibitory neurons in rat binocular primary visual cortex. Methodology/Principal Findings: The inhibitory markers GAD67, parvalbumin (PV), calbindin (CB) and calretinin (CR) were used. Visually activated Arc did not colocalize with PV and was discarded from further studies. MD decreased visually induced c-Fos activation in GAD67 and CR positive neurons. The CB population responded to MD with a decrease of CB expression, while PV cells did not show any effect of MD on c-Fos expression. The persistence of c-Fos expression induced by deprived eye stimulation in PV cells is not likely to be due to a particularly low threshold for activity-dependent c-Fos induction. Indeed, c-Fos induction by increasing concentrations of the GABAA antagonist picrotoxin in visual cortical slices was similar between PV cells and the other cortical neurons. Conclusion: These data indicate that PV cells are particularly refractory to MD, suggesting that different cortical subpopulation may show different response to MD.	[Mainardi, Marco; Landi, Silvia; Maffei, Lamberto] Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy; [Berardi, Nicoletta; Pizzorusso, Tommaso] Univ Florence, Dept Psychol, I-50121 Florence, Italy; [Berardi, Nicoletta; Maffei, Lamberto; Pizzorusso, Tommaso] CNR, Inst Neurosci, Pisa, Italy	Scuola Normale Superiore di Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Mainardi, M (corresponding author), Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy.	tommaso@in.cnr.it	Mainardi, Marco/AAY-4025-2020; Landi, Silvia/P-9418-2018; Pizzorusso, Tommaso/D-1399-2013	Landi, Silvia/0000-0001-7999-3452; Pizzorusso, Tommaso/0000-0001-5614-0668	Italian Ministry for University and research; Telethon [GGP05236]	Italian Ministry for University and research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon)	Funded by Italian Ministry for University and research and Telethon grant GGP05236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chow A, 1999, J NEUROSCI, V19, P9332; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fields RD, 1997, J NEUROSCI, V17, P7252; GANDHI SP, 2008, DELAYED PLASTICITY I; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hada Y, 1999, INVEST OPHTH VIS SCI, V40, P2535; HARTIG W, 1992, NEUROREPORT, V3, P869; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Landi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000346; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MOWER GD, 1989, DEV BRAIN RES, V45, P211, DOI 10.1016/0165-3806(89)90040-0; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Sekirnjak C, 1997, BRAIN RES, V766, P173, DOI 10.1016/S0006-8993(97)00527-1; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; WEISER M, 1995, J NEUROSCI, V15, P4298; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	42	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4342	10.1371/journal.pone.0004342	http://dx.doi.org/10.1371/journal.pone.0004342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194492	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483500003
J	Youngsteadt, E; Baca, JA; Osborne, J; Schal, C				Youngsteadt, Elsa; Alvarez Baca, Jeniffer; Osborne, Jason; Schal, Coby			Species-Specific Seed Dispersal in an Obligate Ant-Plant Mutualism	PLOS ONE			English	Article							RAIN-FOREST; EVOLUTION; EPIPHYTES; SELECTION; CONFLICT; SURVIVAL; BEHAVIOR; REMOVAL; SIZE	Throughout lowland Amazonia, arboreal ants collect seeds of specific plants and cultivate them in nutrient-rich nests, forming diverse yet obligate and species-specific symbioses called Neotropical ant-gardens (AGs). The ants depend on their symbiotic plants for nest stability, and the plants depend on AGs for substrate and nutrients. Although the AGs are limited to specific participants, it is unknown at what stage specificity arises, and seed fate pathways in AG epiphytes are undocumented. Here we examine the specificity of the ant-seed interaction by comparing the ant community observed at general food baits to ants attracted to and removing seeds of the AG plant Peperomia macrostachya. We also compare seed removal rates under treatments that excluded vertebrates, arthropods, or both. In the bait study, only three of 70 ant species collected P. macrostachya seeds, and 84% of observed seed removal by ants was attributed to the AG ant Camponotus femoratus. In the exclusion experiment, arthropod exclusion significantly reduced seed removal rates, but vertebrate exclusion did not. We provide the most extensive empirical evidence of species specificity in the AG mutualism and begin to quantify factors that affect seed fate in order to understand conditions that favor its departure from the typical diffuse model of plant-animal mutualism.	[Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behavior Biol, Raleigh, NC USA; [Alvarez Baca, Jeniffer] Univ Nacl San Antonio Abad Cusco, Fac Cienc Biol, Cuzco, Peru; [Osborne, Jason] N Carolina State Univ, Dept Stat, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Universidad Nacional de San Antonio Abad del Cusco; University of North Carolina; North Carolina State University	Youngsteadt, E (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Alvarez-Baca, Jeniffer Katherine/0000-0003-1373-089X; Youngsteadt, Elsa/0000-0003-2032-9674	NSF [Predoctoral Fellowship]; United States Department of Education [GAANN Fellowship]; NCSU [Internationalization seed]; Blanton J. Whitmire endowment	NSF(National Science Foundation (NSF)); United States Department of Education(US Department of Education); NCSU; Blanton J. Whitmire endowment	This work was supported by an NSF Predoctoral Fellowship and a United States Department of Education GAANN Fellowship (E.Y.), by an NCSU Internationalization seed grant (C.S.), and the Blanton J. Whitmire endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2008, ECOL ENTOMOL, V33, P59, DOI 10.1111/j.1365-2311.2007.00938.x; Auld TD, 1999, PLANT ECOL, V144, P201, DOI 10.1023/A:1009817132378; Beattie Andrew J., 2002, P211; Bebawi FF, 2004, AUST J EXP AGR, V44, P1157, DOI 10.1071/EA03194; Benzing D.H., 1990, VASCULAR EPIPHYTES; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; BESTELMEYER BT, ANTS STANDARD METHOD; Bluthgen N, 2001, J TROP ECOL, V17, P887, DOI 10.1017/S0266467401001651; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Chapman Colin A., 2002, P275, DOI 10.1079/9780851995250.0275; Corbara B, 1996, NATURWISSENSCHAFTEN, V83, P227; Cox DR., 1970, ANAL BINARY DATA; Croat T.B., 1978, FLORA BARRO COLORADO; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; Dejean A, 2000, SOCIOBIOLOGY, V35, P425; FEINSINGER P, 1978, BIOTROPICA, V10, P238, DOI 10.2307/2387911; Fornara DA, 2005, J TROP ECOL, V21, P79, DOI 10.1017/S026646740400197X; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; Holldobler B., 1990, pi; HORVITZ CC, 1980, AM J BOT, V67, P321, DOI 10.2307/2442342; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Junker RR, 2008, EVOL ECOL RES, V10, P295; Kaspari M, 1996, OECOLOGIA, V105, P397, DOI 10.1007/BF00328743; KASPARI M, 1993, OECOLOGIA, V95, P81, DOI 10.1007/BF00649510; KJELLSSON G, 1991, OECOLOGIA, V88, P435, DOI 10.1007/BF00317590; Kleinfeldt S.E., 1986, P283; Leal IR, 1998, BIOTROPICA, V30, P170, DOI 10.1111/j.1744-7429.1998.tb00052.x; LEMAIRE M, 1990, J CHEM ECOL, V16, P2067, DOI 10.1007/BF01020517; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; Madison M., 1979, SELBYANA, V5, P107; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; Nieder J, 2000, BIOTROPICA, V32, P385, DOI 10.1111/j.1744-7429.2000.tb00485.x; Orivel J, 1999, ECOSCIENCE, V6, P51, DOI 10.1080/11956860.1999.11952205; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Passos L, 2002, J ECOL, V90, P517, DOI 10.1046/j.1365-2745.2002.00687.x; Pizo MA, 2001, PLANT ECOL, V157, P37, DOI 10.1023/A:1013735305100; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; ROBERTS JT, 1986, ECOLOGY, V67, P1046, DOI 10.2307/1939827; Satterthwaite FE, 1941, PSYCHOMETRIKA, V6, P309, DOI 10.1007/BF02288586; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; VANDUNNE HJF, 2001, EPIPHYTES SECONDARY; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1987, BIOTROPICA, V19, P245, DOI 10.2307/2388342; Winkler M, 2005, ANN BOT-LONDON, V95, P1039, DOI 10.1093/aob/mci115; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; YU DW, 1994, BIOTROPICA, V26, P222, DOI 10.2307/2388813; Zotz G, 1998, J TROP ECOL, V14, P725, DOI 10.1017/S0266467498000534	52	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4335	10.1371/journal.pone.0004335	http://dx.doi.org/10.1371/journal.pone.0004335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194502	Green Submitted, Green Published, gold			2022-12-25	WOS:000265483500002
J	Castle, JC; Hara, Y; Raymond, CK; Garrett-Engele, P; Ohwaki, K; Kan, ZY; Kusunoki, J; Johnson, JM				Castle, John C.; Hara, Yoshikazu; Raymond, Christopher K.; Garrett-Engele, Philip; Ohwaki, Kenji; Kan, Zhengyan; Kusunoki, Jun; Johnson, Jason M.			ACC2 Is Expressed at High Levels Human White Adipose and Has an Isoform with a Novel N-Terminus	PLOS ONE			English	Article								Acetyl-CoA carboxylases ACC1 and ACC2 catalyze the carboxylation of acetyl-CoA to malonyl-CoA, regulating fatty-acid synthesis and oxidation, and are potential targets for treatment of metabolic syndrome. Expression of ACC1 in rodent lipogenic tissues and ACC2 in rodent oxidative tissues, coupled with the predicted localization of ACC2 to the mitochondrial membrane, have suggested separate functional roles for ACC1 in lipogenesis and ACC2 in fatty acid oxidation. We find, however, that human adipose tissue, unlike rodent adipose, expresses more ACC2 mRNA relative to the oxidative tissues muscle and heart. Human adipose, along with human liver, expresses more ACC2 than ACC1. Using RT-PCR, real-time PCR, and immunoprecipitation we report a novel isoform of ACC2 (ACC2.v2) that is expressed at significant levels in human adipose. The protein generated by this isoform has enzymatic activity, is endogenously expressed in adipose, and lacks the N-terminal sequence. Both ACC2 isoforms are capable of de novo lipogenesis, suggesting that ACC2, in addition to ACC1, may play a role in lipogenesis. The results demonstrate a significant difference in ACC expression between human and rodents, which may introduce difficulties for the use of rodent models for development of ACC inhibitors.	[Castle, John C.; Raymond, Christopher K.; Garrett-Engele, Philip; Kan, Zhengyan; Johnson, Jason M.] Rosetta Inpharmat LLC, Seattle, WA USA; [Hara, Yoshikazu; Ohwaki, Kenji; Kusunoki, Jun] Banyu Pharm Co Ltd, Tsukuba Res Inst, Metabol Disorder Res, Ibaraki, Osaka, Japan	Merck & Company	Castle, JC (corresponding author), Rosetta Inpharmat LLC, Seattle, WA USA.	john_castle@merck.com; jason_johnson@merck.com						Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Applied Biosystems, ESS REAL TIM PCR ESS; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; COOK GA, 1984, BIOCHEM J, V219, P337, DOI 10.1042/bj2190337; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Dean D, 2000, DIABETES, V49, P1295, DOI 10.2337/diabetes.49.8.1295; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Harwood H James Jr, 2004, Curr Opin Investig Drugs, V5, P283; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; THAMPY KG, 1988, J BIOL CHEM, V263, P6454; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; WAKIL SJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P225, DOI 10.1016/0006-3002(58)90177-X; Widmer J, 1996, BIOCHEM J, V316, P915, DOI 10.1042/bj3160915; WINZ R, 1994, J BIOL CHEM, V269, P14438; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	37	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4369	10.1371/journal.pone.0004369	http://dx.doi.org/10.1371/journal.pone.0004369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190759	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483300008
J	Nunes, JPL; Silva, JC				Nunes, Jose Pedro L.; Silva, Joao Carlos			Systemic Correlates of Angiographic Coronary Artery Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HEART-DISEASE; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; RISK; PROGRESSION; CHOLESTEROL; OBESITY; EXTENT	Coronary angiography allows a direct evaluation of coronary anatomy. The aim of the present investigation was to search for correlations between the magnitude of coronary artery disease, as assessed by angiography, and a number of systemic parameters. A group of 116 patients (80 male, 36 female) with coronary heart disease diagnosed by angiography, aged 62.0+/-10.5 years, was the subject of an observational study. Correlation and linear regression analysis using coronary artery disease burden (CADB - sum of the percentage of the luminal stenosis encountered in all the lesions of the coronary arterial trees) as dependent variable, and age, sex, plasma calcium, phosphorus, magnesium, glucose, HDL cholesterol, LDL cholesterol, triglycerides, uric acid, estimated glomerular filtration rate and body mass index as independent variables, were carried out. Significant correlation values versus CADB were seen with age (r 0.19, p 0.04), uric acid (r 0.18, p 0.048) and fasting plasma glucose (r 0.33, p < 0.001). Linear regression analysis, yielding a global significance level of 0.002, showed a significant value for glucose (p 0.018) and for sex (0.008). In conclusion, among several systemic parameters studied, plasma glucose was found to be correlated to coronary artery atherosclerosis lesions.	[Nunes, Jose Pedro L.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Silva, Joao Carlos] Hosp Sao Joao, Oporto, Portugal	Universidade do Porto; Sao Joao Hospital	Nunes, JPL (corresponding author), Univ Porto, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jplnunes@med.up.pt	Nunes, José Pedro L/D-9546-2013	Nunes, José Pedro L/0000-0001-6739-0304				[Anonymous], 2002, AM J KIDNEY DIS, V39, pS76, DOI DOI 10.1053/ajkd.2002.30944; Bo S, 2008, CURR OPIN LIPIDOL, V19, P50, DOI 10.1097/MOL.0b013e3282f33ccc; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Drexel H, 2005, DIABETES CARE, V28, P101, DOI 10.2337/diacare.28.1.101; DREXEL H, 1992, AM J CARDIOL, V70, P436, DOI 10.1016/0002-9149(92)91186-8; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HOOPER J, 1975, Annals of Clinical Biochemistry, V12, P255; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVEY AS, 2000, J AM SOC NEPHROL, V11, P828; Lomashvili K, 2006, KIDNEY INT, V69, P1464, DOI 10.1038/sj.ki.5000297; MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Niraj A, 2007, CLIN CARDIOL, V30, P391, DOI 10.1002/clc.20113; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nunes JPL, 2007, CLIN CARDIOL, V30, P464, DOI 10.1002/clc.20145; Nunes JPL, 2007, MED HYPOTHESES, V68, P541, DOI 10.1016/j.mehy.2006.08.021; Saely CH, 2008, ATHEROSCLEROSIS, V199, P317, DOI 10.1016/j.atherosclerosis.2007.11.020; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Taubert G, 2003, AM HEART J, V145, P285, DOI 10.1067/mhj.2003.134; Wenger NK, 2003, PROG CARDIOVASC DIS, V46, P199, DOI 10.1016/j.pcad.2003.08.003; Xi XP, 1997, FEBS LETT, V417, P283, DOI 10.1016/S0014-5793(97)01303-3	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4322	10.1371/journal.pone.0004322	http://dx.doi.org/10.1371/journal.pone.0004322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180194	Green Submitted, Green Published, gold			2022-12-25	WOS:000274089700009
J	Sidell, N; Hao, LJ; Pasquali, M; McDonald, JD				Sidell, Neil; Hao, Lijuan; Pasquali, Marzia; McDonald, J. David			Carcinogenic Effects in a Phenylketonuria Mouse Model	PLOS ONE			English	Article								Phenylketonuria (PKU) is a metabolic disorder caused by impaired phenylalanine hydroxylase (PAH). This condition results in hyperphenylalaninemia and elevated levels of abnormal phenylalanine metabolites, among which is phenylacetic acid/phenylacetate (PA). In recent years, PA and its analogs were found to have anticancer activity against a variety of malignancies suggesting the possibility that PKU may offer protection against cancer through chronically elevated levels of PA. We tested this hypothesis in a genetic mouse model of PKU (PAH(enu2)) which has a biochemical profile that closely resembles that of human PKU. Plasma levels of phenylalanine in homozygous (HMZ) PAH(enu2) mice were >12-fold those of heterozygous (HTZ) littermates while tyrosine levels were reduced. Phenylketones, including PA, were also markedly elevated to the range seen in the human disease. Mice were subjected to 7,12 dimethylbenz[a] anthracene (DMBA) carcinogenesis, a model which is sensitive to the anticancer effects of the PA derivative 4-chlorophenylacetate (4-CPA). Tumor induction by DMBA was not significantly different between the HTZ and HMZ mice, either in total tumor development or in the type of cancers that arose. HMZ mice were then treated with 4-CPA as positive controls for the anticancer effects of PA and to evaluate its possible effects on phenylalanine metabolism in PKU mice. 4-CPA had no effect on the plasma concentrations of phenylalanine, phenylketones, or tyrosine. Surprisingly, the HMZ mice treated with 4-CPA developed an unexplained neuromuscular syndrome which precluded its use in these animals as an anticancer agent. Together, these studies support the use of PAH(enu2) mice as a model for studying human PKU. Chronically elevated levels of PA in the PAH(enu2) mice were not protective against cancer.	[Hao, Lijuan] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Pasquali, Marzia] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [McDonald, J. David] Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA	Emory University; Utah System of Higher Education; University of Utah; Wichita State University	Sidell, N (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.	nsidell@emory.edu		Huicho, Luis/0000-0002-5272-5885	National Institutes of Health [HD040932]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD040932] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA129424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Study funded by a grant from the National Institutes of Health (HD040932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; BATSHAW ML, 1987, ENZYME, V38, P242, DOI 10.1159/000469211; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; FELLMAN JH, 1972, BIOCHIM BIOPHYS ACTA, V284, P90, DOI 10.1016/0005-2744(72)90048-4; FISHER SM, 1992, CANCER RES, V52, P662; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI DOI 10.1515/BCHM2.1934.227.1-4.169; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GUTHRIE R, 1963, PEDIATRICS, V32, P338; HANIGAN MH, 1990, CARCINOGENESIS, V11, P589, DOI 10.1093/carcin/11.4.589; Horlings H, 2005, EXP LUNG RES, V31, P513, DOI 10.1080/01902140590918740; Huang MT, 1998, CARCINOGENESIS, V19, P1697, DOI 10.1093/carcin/19.9.1697; HUDGINS WR, 1995, BIOCHEM PHARMACOL, V50, P1273, DOI 10.1016/0006-2952(95)02013-3; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; KAUR H, 1994, ANAL BIOCHEM, V220, P11, DOI 10.1006/abio.1994.1291; Keshava N, 2001, CANCER LETT, V167, P125, DOI 10.1016/S0304-3835(01)00478-5; LINBLAD B, 1977, J BIOL CHEM, V252, P5073; Liu JB, 2007, CANCER CHEMOTH PHARM, V59, P217, DOI 10.1007/s00280-006-0260-3; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; MICHALS K, 1988, BIOCHEM MED METAB B, V39, P18, DOI 10.1016/0885-4505(88)90053-9; Qing WG, 1997, CARCINOGENESIS, V18, P553, DOI 10.1093/carcin/18.3.553; SAMID D, 1992, CANCER RES, V52, P1988; Sarkissian CN, 2000, MOL GENET METAB, V69, P188, DOI 10.1006/mgme.2000.2974; Sawatsri S, 2001, INT J CANCER, V93, P687, DOI 10.1002/ijc.1399; Scaglia F, 2004, MOL GENET METAB, V81, pS79, DOI 10.1016/j.ymgme.2003.11.017; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SIDELL N, 1995, INT J CANCER, V60, P507, DOI 10.1002/ijc.2910600414; Sidell N, 2005, J STEROID BIOCHEM, V96, P335, DOI 10.1016/j.jsbmb.2005.04.040; Sidell N, 2003, BRIT J CANCER, V89, P412, DOI 10.1038/sj.bjc.6601108; Sidell N, 2007, CANCER LETT, V251, P302, DOI 10.1016/j.canlet.2006.11.031; TUCHMAN M, 1985, BIOCHEM MED METAB B, V34, P203, DOI 10.1016/0006-2944(85)90112-7; Wurz GT, 2005, J STEROID BIOCHEM, V97, P230, DOI 10.1016/j.jsbmb.2005.06.027	33	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4292	10.1371/journal.pone.0004292	http://dx.doi.org/10.1371/journal.pone.0004292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172175	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482900009
J	Bur, IM; Cohen-Solal, AM; Carmignac, D; Abecassis, PY; Chauvet, N; Martin, AO; van der Horst, GTJ; Robinson, ICAF; Maurel, P; Mollard, P; Bonnefont, X				Bur, Isabelle M.; Cohen-Solal, Anne M.; Carmignac, Danielle; Abecassis, Pierre-Yves; Chauvet, Norbert; Martin, Agnes O.; van der Horst, Gijsbertus T. J.; Robinson, Iain C. A. F.; Maurel, Patrick; Mollard, Patrice; Bonnefont, Xavier			The Circadian Clock Components CRY1 and CRY2 Are Necessary to Sustain Sex Dimorphism in Mouse Liver Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE-SECRETION; HEPATIC GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; DEFICIENT MICE; PATTERNED INFUSIONS; ELECTRICAL-ACTIVITY; MICROARRAY ANALYSIS; ANTERIOR-PITUITARY; SIGNAL TRANSDUCER; TRANSCRIPTION 5B	In mammals, males and females exhibit anatomical, hormonal, and metabolic differences. A major example of such sex dimorphism in mouse involves hepatic drug metabolism, which is also a noticeable target of circadian timekeeping. However, whether the circadian clock itself contributes to sex-biased metabolism has remained unknown, although several daily output parameters differ between sexes in a number of species, including humans. Here we show that dimorphic liver metabolism is altered when the circadian regulators Cryptochromes, Cry1 and Cry2, are inactivated. Indeed, double mutant Cry1(-/-) Cry2(-/-) male mice that lack a functional circadian clock express a number of sex-specific liver products, including several cytochrome P450 enzymes, at levels close to those measured in females. In addition, body growth of Cry-deficient mice is impaired, also in a sex-biased manner, and this phenotype goes along with an altered pattern of circulating growth hormone (GH) in mutant males, specifically. It is noteworthy that hormonal injections able to mimic male GH pulses reversed the feminized gene expression profile in the liver of Cry1(-/-) Cry2(-/-) males. Altogether, our observations suggest that the 24-h clock paces the dimorphic ultradian pulsatility of GH that is responsible for sex-dependent liver activity. We thus conclude that circadian timing, sex dimorphism, and liver metabolism are finely interconnected.	[Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier 5, France; [Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] CNRS, INSERM, U661, F-34094 Montpellier, France; [Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] Univ Montpellier, F-34094 Montpellier, France; [Carmignac, Danielle; Robinson, Iain C. A. F.] Natl Inst Med Res, Div Mol Neuroendocrinol, London NW7 1AA, England; [Abecassis, Pierre-Yves] Sanofi Aventis, Discovery Metab & Pharmacokinet Safety DMPK S, F-94140 Alfortville, France; [van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Maurel, Patrick] INSERM, U632, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; MRC National Institute for Medical Research; Sanofi-Aventis; Sanofi France; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bonnefont, X (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, 141 Rue Cardonille, F-34094 Montpellier 5, France.	Xavier.Bonnefont@igf.cnrs.fr	Chauvet, Norbert/D-7333-2016; van der Horst, Gijsbertus TJ/E-3661-2015; BONNEFONT, Xavier/AAH-3882-2019	Chauvet, Norbert/0000-0003-4388-6422; van der Horst, Gijsbertus TJ/0000-0002-7773-6396; BONNEFONT, Xavier/0000-0003-4778-4060; Martin, Agnes/0000-0001-6680-7139	Netherlands Organization for Scientific Research [ZonMW Vici 918.36.619]; European Community; Region Languedoc-Roussillon; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; MRC [MC_U117531708] Funding Source: UKRI; Medical Research Council [MC_U117531708] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Netherlands Organization for Scientific Research Grant ZonMW Vici 918.36.619 to G.T.J.v.d.H., a Marie Curie European Reintegration Grant from the European Community (to X. B.), a grant from the Region Languedoc-Roussillon (to P. M.), a grant from the Institut National de la Sante et de la Recherche Medicale (to P. M. and X. B.), and a grant from the Centre National de la Recherche Scientifique (to P. M. and X. B.).	Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Bonnefont X, 2000, ENDOCRINOLOGY, V141, P868, DOI 10.1210/en.141.3.868; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Bonnefont X, 2003, FEBS LETT, V548, P49, DOI 10.1016/S0014-5793(03)00727-0; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; CLARK RG, 1988, ENDOCRINOLOGY, V122, P2675, DOI 10.1210/endo-122-6-2675; CLARK RG, 1985, J ENDOCRINOL, V104, P53, DOI 10.1677/joe.0.1040053; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; DAAN S, 1975, P NATL ACAD SCI USA, V72, P3744, DOI 10.1073/pnas.72.9.3744; Davies JS, 2004, ENDOCRINOLOGY, V145, P2950, DOI 10.1210/en.2003-1236; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100; Fauquier T, 2001, P NATL ACAD SCI USA, V98, P8891, DOI 10.1073/pnas.151339598; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Giacchetti S, 2006, J CLIN ONCOL, V24, P3562, DOI 10.1200/JCO.2006.06.1440; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; GUSTAFSSON JA, 1978, ENDOCRINOLOGY, V103, P141, DOI 10.1210/endo-103-1-141; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Isensee J, 2007, GENDER MED, V4, pS75, DOI 10.1016/S1550-8579(07)80049-0; Jarukamjorn K, 2006, TOXICOLOGY, V219, P97, DOI 10.1016/j.tox.2005.11.014; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuwahara S, 2004, BRAIN RES, V998, P164, DOI 10.1016/j.brainres.2003.10.060; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941; MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; REINERINK EJM, 1991, J CHROMATOGR, V553, P233, DOI 10.1016/S0021-9673(01)88493-4; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Schwartz JB, 2003, CLIN PHARMACOKINET, V42, P107, DOI 10.2165/00003088-200342020-00001; Sun YM, 2006, J BIOMED SCI, V13, P845, DOI 10.1007/s11373-006-9108-4; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vida B, 2008, J NEUROENDOCRINOL, V20, P1270, DOI 10.1111/j.1365-2826.2008.01787.x; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; WILLOUGHBY JO, 1978, BRAIN RES, V151, P413, DOI 10.1016/0006-8993(78)90899-5; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang GY, 2008, COMMUN STAT-SIMUL C, V37, P106, DOI 10.1080/03610910701723930	52	61	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9066	9073		10.1074/jbc.M808360200	http://dx.doi.org/10.1074/jbc.M808360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211562	Green Published, hybrid			2022-12-25	WOS:000264669100009
J	Grishko, V; Xu, M; Ho, R; Mates, A; Watson, S; Kim, JT; Wilson, GL; Pearsall, AW				Grishko, Valentina; Xu, Min; Ho, Renee; Mates, Aaron; Watson, Scott; Kim, Jong T.; Wilson, Glenn L.; Pearsall, Albert W.			Effects of Hyaluronic Acid on Mitochondrial Function and Mitochondria-driven Apoptosis following Oxidative Stress in Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GENE-EXPRESSION; REPAIR CAPACITY; DNA-DAMAGE; CELL-DEATH; OSTEOARTHRITIS; MECHANISMS; CYTOKINES; MATRIX	Hyaluronic acid is widely used in the treatment of osteoarthritis and exerts significant chondroprotective effects. The exact mechanisms of its chondroprotective action are not yet fully elucidated. Human articular chondrocytes actively produce reactive oxygen and nitrogen species capable of causing cellular dysfunction and death. A growing body of evidence indicates that mitochondrial dysfunction and mitochondrial DNA damage play a causal role in disorders linked to excessive generation of oxygen free radicals. We hypothesized that the chondroprotective effects of hyaluronic acid on oxidatively stressed chondrocytes are due to preservation of mitochondrial function and amelioration of mitochondria-driven apoptosis. When primary human chondrocyte cultures were exposed to reactive oxygen or nitrogen species generators, mitochondrial DNA damage along with mitochondrial dysfunction and mitochondria-driven apoptosis accumulated as a consequence. In addition, cytokine-treated primary human chondrocytes showed increased levels of mitochondrial DNA damage. Pretreatment of chondrocytes with hyaluronic acid caused a decrease of mitochondrial DNA damage, enhanced mitochondrial DNA repair capacity and cell viability, preservation of ATP levels, and amelioration of apoptosis. The results of these studies demonstrate that enhanced chondrocyte survival and improved mitochondrial function under conditions of oxidative injury are probably important therapeutic mechanisms for the actions of hyaluronic acid in osteoarthritis.	[Grishko, Valentina; Xu, Min; Ho, Renee; Mates, Aaron; Watson, Scott; Kim, Jong T.; Pearsall, Albert W.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Grishko, Valentina; Wilson, Glenn L.] Univ S Alabama, Dept Orthopaed Surg, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Grishko, V (corresponding author), 307 Univ Blvd,MSB 1201, Mobile, AL 36688 USA.	vgrishko@jaguar1.usouthal.edu						Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Brun P, 2003, OSTEOARTHR CARTILAGE, V11, P208, DOI 10.1016/S1063-4584(02)00352-7; Corrado E. M., 1995, European Journal of Rheumatology and Inflammation, V15, P47; Creamer P, 1994, Osteoarthritis Cartilage, V2, P133, DOI 10.1016/S1063-4584(05)80063-9; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Grishko VI, 2009, OSTEOARTHR CARTILAGE, V17, P107, DOI 10.1016/j.joca.2008.05.009; Grishko VI, 1997, MUTAT RES-DNA REPAIR, V384, P73, DOI 10.1016/S0921-8777(97)00017-7; HIRASAWA K, 1999, OSTEOARTHR CARTILAGE, V7, P182; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; Jansen EJP, 2008, J ORTHOP RES, V26, P624, DOI 10.1002/jor.20569; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Kirwan JR, 1997, BAILLIERE CLIN RHEUM, V11, P769, DOI 10.1016/S0950-3579(97)80009-X; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kuhn K, 2003, J CELL PHYSIOL, V197, P379, DOI 10.1002/jcp.10372; Lakshman M, 2004, EXP MOL PATHOL, V76, P196, DOI 10.1016/j.yexmp.2003.12.009; Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Martin G, 2004, ARTHRITIS RHEUM-US, V50, P3549, DOI 10.1002/art.20596; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409; Punzi L, 2001, CLIN EXP RHEUMATOL, V19, P242; Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200; SCHIAVINATO A, 1989, CLIN ORTHOP RELAT R, P286; SMITH MM, 1987, RHEUMATOL INT, V7, P113, DOI 10.1007/BF00270463; Takahashi K, 2000, J RHEUMATOL, V27, P1713; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Vieira HLA, 1999, CELL MOL LIFE SCI, V56, P971, DOI 10.1007/s000180050486; Wang CT, 2006, OSTEOARTHR CARTILAGE, V14, P1237, DOI 10.1016/j.joca.2006.05.009; Weber GF, 2002, CANCER RES, V62, P2281; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhao H, 2008, INT J ONCOL, V32, P1159	37	86	90	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9132	9139		10.1074/jbc.M804178200	http://dx.doi.org/10.1074/jbc.M804178200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193642	Green Published, hybrid			2022-12-25	WOS:000264669100017
J	Mulero, MC; Aubareda, A; Orzaez, M; Messeguer, J; Serrano-Candelas, E; Martinez-Hoyer, S; Messeguer, A; Perez-Paya, E; Perez-Riba, M				Mulero, M. Carme; Aubareda, Anna; Orzaez, Mar; Messeguer, Joaquim; Serrano-Candelas, Eva; Martinez-Hoyer, Sergio; Messeguer, Angel; Perez-Paya, Enrique; Perez-Riba, Merce			Inhibiting the Calcineurin-NFAT (Nuclear Factor of Activated T Cells) Signaling Pathway with a Regulator of Calcineurin-derived Peptide without Affecting General Calcineurin Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; SMALL ORGANIC-MOLECULES; DOWN-SYNDROME; COMBINATORIAL LIBRARY; SELECTIVE-INHIBITION; CYCLOSPORINE-A; BINDING-SITE; IN-VIVO; IDENTIFICATION; EXPRESSION	Calcineurin phosphatase plays a crucial role in T cell activation. Dephosphorylation of the nuclear factors of activated T cells (NFATs) by calcineurin is essential for activating cytokine gene expression and, consequently, the immune response. Current immunosuppressive protocols are based mainly on calcineurin inhibitors, cyclosporine A and FK506. Unfortunately, these drugs are associated with severe side effects. Therefore, immunosuppressive agents with higher selectivity and lower toxicity must be identified. The immunosuppressive role of the family of proteins regulators of calcineurin (RCAN, formerly known as DSCR1) which regulate the calcineurin-NFAT signaling pathway, has been described recently. Here, we identify and characterize the minimal RCAN sequence responsible for the inhibition of calcineurin-NFAT signaling in vivo. The RCAN-derived peptide spanning this sequence binds to calcineurin with high affinity. This interaction is competed by a peptide spanning the NFAT PXIXIT sequence, which binds to calcineurin and facilitates NFAT dephosphorylation and activation. Interestingly, the RCAN-derived peptide does not inhibit general calcineurin phosphatase activity, which suggests that it may have a specific immunosuppressive effect on the calcineurin-NFAT signaling pathway. As such, the RCAN-derived peptide could either be considered a highly selective immunosuppressive compound by itself or be used as a new tool for identifying innovative immunosuppressive agents. We developed a low throughput assay, based on the RCAN1-calcineurin interaction, which identifies dipyridamole as an efficient in vivo inhibitor of the calcineurin-NFAT pathway that does not affect calcineurin phosphatase activity.	[Mulero, M. Carme; Aubareda, Anna; Serrano-Candelas, Eva; Martinez-Hoyer, Sergio; Perez-Riba, Merce] Inst Invest Biomed & Bellvitge IDIBELL, Med & Mol Genet Ctr, Barcelona 08907, Spain; [Orzaez, Mar; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Valencia 46013, Spain; [Perez-Paya, Enrique] CSIC, Inst Biomed Valencia, Valencia 46010, Spain; [Messeguer, Joaquim; Messeguer, Angel] CSIC, IIQAB, Dept Biol Organ Chem, ES-08034 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC)	Perez-Riba, M (corresponding author), Inst Invest Biomed & Bellvitge IDIBELL, Med & Mol Genet Ctr, Gran Via S-N Km 2-7, Barcelona 08907, Spain.	mpr@idibell.org	Serrano Candelas, Eva/I-1892-2015; Perez-Riba, Merce/AAA-6880-2019; Orzaez, Mar/B-4992-2014	Serrano Candelas, Eva/0000-0002-8929-5364; Orzaez, Mar/0000-0003-3231-5835; Perez-Riba, Merce/0000-0003-1604-4617; Messeguer, Angel/0000-0002-8358-9425	Fundacio La Marato de TV3 [030830]; Generalitat de Catalunya [2006 BE 00051]; Spanish Ministry of Education and Science [SAF2006-04815, BIO2004-00998, BIO2007-60066, CTQ2005-00995/BQU]; Fundacion Mutua Madrilena 2007	Fundacio La Marato de TV3; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Fundacion Mutua Madrilena 2007	This work was supported by grants from the Fundacio La Marato de TV3 (Reference 030830), the Generalitat de Catalunya (Reference 2006 BE 00051), the Spanish Ministry of Education and Science (Grants SAF2006-04815, BIO2004-00998, BIO2007-60066, CTQ2005-00995/BQU), and the Fundacion Mutua Madrilena 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Canela N, 2006, J BIOL CHEM, V281, P35942, DOI 10.1074/jbc.M603511200; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; DESCHRYVER EL, 2003, COCHRANE DB SYST REV, V1; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Humet M, 2003, J COMB CHEM, V5, P597, DOI 10.1021/cc020075u; Kang SH, 2005, J BIOL CHEM, V280, P37698, DOI 10.1074/jbc.M502247200; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Mora P, 2005, J MED CHEM, V48, P1265, DOI 10.1021/jm040834i; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; PerezPaya E, 1997, BBA-BIOMEMBRANES, V1329, P223, DOI 10.1016/S0005-2736(97)00112-0; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Vilar M, 2001, J BIOL CHEM, V276, P18122, DOI 10.1074/jbc.M100706200; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5	40	49	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9394	9401		10.1074/jbc.M805889200	http://dx.doi.org/10.1074/jbc.M805889200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189965	Green Published, hybrid			2022-12-25	WOS:000264669100045
J	Webber, J; Meran, S; Steadman, R; Phillips, A				Webber, Jason; Meran, Soma; Steadman, Robert; Phillips, Aled			Hyaluronan Orchestrates Transforming Growth Factor-beta 1-dependent Maintenance of Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; MUSCLE ACTIN EXPRESSION; GRANULATION-TISSUE; PULMONARY-FIBROSIS; TGF-BETA; PROMOTES; DIFFERENTIATION; PROGRESSION; RECEPTOR; CD44	The differentiation of resident fibroblasts to myofibroblasts is central to wound healing. In the context of organ fibrosis, however, persistence of these myofibroblasts is associated with progressive disease. This study examines mechanisms controlling the maintenance of the myofibroblast phenotype. Myofibroblasts were induced by adding transforming growth factor-beta 1 (TGF-beta 1) (10 ng/ml) to fibroblasts for 72 h. The phenotype was maintained for up to 120 h following removal of TGF-beta 1. Western blot for pSmad2 and -3 demonstrated persistent phosphorylation despite removal of exogenous TGF-beta 1. This persistence was because of autocrine synthesis of TGF-beta 1, which was inhibited by both anti-TGF-beta 1 antibody and the ALK5 inhibitor SB431542. Persistence of phenotype was also associated with increased hyaluronan (HA) generation, synthesis of the hyaladherin TSG6, and HA pericellular coat formation. These were all inhibited by TGF-beta receptor blockade. To further investigate the importance of HA synthesis, 4-methylumbelliferone was used to deplete the cytoplasmic pool of UDP-glucuronic acid, essential for HA chain elongation. This prevented formation of the pericellular HA matrix and decreased expression of alpha-SMA. 4-Methylumbelliferone had no effect, however, on Smad2 and -3 phosphorylation. Similarly inhibition of HAS2 by short interfering RNA prevented phenotypic activation without altering TGF-beta 1-dependent Smad phosphorylation, thus suggesting that HA-dependent regulation of cell phenotype was independent of Smad activation. These data suggest that myofibroblasts in areas of fibrosis maintain their own phenotype through autocrine TGF-beta 1 action and that extracellular HA matrices are an essential mediator of this. We propose a model in which the formation of the pericellular HA matrix regulates the outcome of Smad-dependent autocrine TGF-beta 1-activated signaling, and therefore persistence of the myofibroblast phenotype.	[Webber, Jason; Meran, Soma; Steadman, Robert; Phillips, Aled] Cardiff Univ, Sch Med, Cardiff Inst Tissue Engn & Repair, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Phillips, A (corresponding author), Cardiff Univ, Sch Med, Cardiff Inst Tissue Engn & Repair, Inst Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	phillipsao@cf.ac.uk	Steadman, Robert/O-1614-2016; Webber, Jason P/O-1960-2017	Steadman, Robert/0000-0002-1303-2496; Webber, Jason P/0000-0003-4772-3014	Kidney Wales Foundation	Kidney Wales Foundation	This work was supported by the Kidney Wales Foundation.	Anttila MA, 2000, CANCER RES, V60, P150; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Desmouliere A, 1996, MOL CELLULAR BIOL WO, P391; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GOUMENOS DS, 1994, NEPHROL DIAL TRANSPL, V9, P1418; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x; Kosaki R, 1999, CANCER RES, V59, P1141; KUHN C, 1991, AM J PATHOL, V138, P1257; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; SAPPINO AP, 1990, LAB INVEST, V63, P144; SATO Y, 1993, J CELL BIOL, V123, P1249, DOI 10.1083/jcb.123.5.1249; Schmid P, 1998, AM J PATHOL, V152, P485; Schuppan D, 2000, ACTA GASTRO-ENT BELG, V63, P366; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Yu Q, 2000, GENE DEV, V14, P163; Zhang HY, 1996, AM J PATHOL, V148, P527; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	50	98	102	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9083	9092		10.1074/jbc.M806989200	http://dx.doi.org/10.1074/jbc.M806989200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193641	Green Published, hybrid			2022-12-25	WOS:000264669100011
J	Yang, KS; Ilagan, MXG; Piwnica-Worms, D; Pike, LJ				Yang, Katherine S.; Ilagan, Ma. Xenia G.; Piwnica-Worms, David; Pike, Linda J.			Luciferase Fragment Complementation Imaging of Conformational Changes in the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF RECEPTOR; PROTEIN INTERACTIONS; AUTOPHOSPHORYLATION SITES; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; DIMERIZATION	Crystal structures of the epidermal growth factor (EGF) receptor suggest that its activation is associated with extensive conformational changes in both the extracellular and intracellular domains. However, evidence of these structural dynamics in intact cells has been lacking. Here we use luciferase complementation imaging to follow EGF-induced conformational changes in its receptor in real time in live cells. When the luciferase fragments are fused to the C terminus of an EGF receptor lacking the cytoplasmic domain, EGF stimulates a rapid increase in luciferase activity, consistent with ligand-induced receptor dimerization. However, when the luciferase fragments are fused to the C terminus of the full-length receptor, EGF induces a rapid but transient decrease in luciferase activity. The decrease requires tyrosine kinase activity, whereas the subsequent recovery requires MAP kinase activity. Our data demonstrate the utility of the luciferase system for in vivo imaging changes in EGF receptor dimerization and conformation. They also identify two sequential ligand-induced conformational changes in the EGF receptor.	[Yang, Katherine S.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Yang, Katherine S.; Pike, Linda J.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		Ilagan, Ma Xenia/0000-0003-2888-4859	NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025973] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA94056] Funding Source: Medline; NIA NIH HHS [R01 AG025973] Funding Source: Medline; NIGMS NIH HHS [R01 GM064491, R01 GM064491-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Blakely BT, 2000, NAT BIOTECHNOL, V18, P218, DOI 10.1038/72686; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lee NY, 2005, PROTEIN SCI, V14, P2793, DOI 10.1110/ps.051630305; Li WR, 2008, CANCER RES, V68, P4990, DOI 10.1158/0008-5472.CAN-07-5984; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Lichtner RB, 2001, CANCER RES, V61, P5790; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	28	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7474	7482		10.1074/jbc.M808041200	http://dx.doi.org/10.1074/jbc.M808041200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19171934	Green Published, hybrid			2022-12-25	WOS:000264195600011
J	Secchiero, P; Corallini, F; Ceconi, C; Parrinello, G; Volpato, S; Ferrari, R; Zauli, G				Secchiero, Paola; Corallini, Federica; Ceconi, Claudio; Parrinello, Giovanni; Volpato, Stefano; Ferrari, Roberto; Zauli, Giorgio			Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; ENDOTHELIAL-CELLS; PROLIFERATION; EXPRESSION; INVOLVEMENT; ACTIVATION; SURVIVAL; OSTEOPROTEGERIN; NEUTROPHILS; PROMOTES	Background: Since soluble TRAIL exhibits anti-inflammatory and anti-atherosclerotic activities both in vitro and in animal models, this study was designed to assess the relationship between the serum levels of TRAIL and clinical outcomes in patients with acute myocardial infarction (AMI). Methodology/Principal Findings: Levels of TRAIL were measured by ELISA in serial serum samples obtained from 60 patients admitted for AMI, both during hospitalization and in a follow-up of 12 months, as well as in 60 healthy control subjects. Serum levels of TRAIL were significantly decreased in patients with AMI at baseline (within 24 hours from admission), compared with healthy controls, and showed a significant inverse correlation with a series of negative prognostic markers, such as CK, CK-MB and BNP. TRAIL serum levels progressively increased at discharge, but normalized only at 6-12 months after AMI. Of note, low TRAIL levels at the patient discharge were associated with increased incidence of cardiac death and heart failure in the 12-month follow-up, even after adjustment for demographic and clinical risk parameters (hazard ratio [HR] of 0.93 [95% CI, 0.89 to 0.97]; p = 0.001). Conclusions/Significance: Although the number of patients studied was limited, our findings indicate for the first time that circulating TRAIL might represent an important predictor of cardiovascular events, independent of conventional risk markers.	[Secchiero, Paola; Corallini, Federica; Zauli, Giorgio] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Ceconi, Claudio; Ferrari, Roberto] Azienda Ospedaliera Univ S Anna, Cardiovasc Inst, Ferrara, Italy; [Parrinello, Giovanni] Univ Brescia, Med Stat Unit, I-25121 Brescia, Italy; [Volpato, Stefano] Univ Ferrara, Dept Expt & Clin Med, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Brescia; University of Ferrara	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Zauli, Giorgio/ABE-8001-2020; VOLPATO, STEFANO/H-2977-2014; secchiero, paola/G-9689-2015; FERRARI, ROBERTO/ABD-5169-2020	VOLPATO, STEFANO/0000-0003-4335-6034; secchiero, paola/0000-0003-4101-7987; Ferrari, Roberto/0000-0003-2046-9175; Zauli, Giorgio/0000-0002-3750-8698; Ceconi, Claudio/0000-0002-6381-1404	Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna)	Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna)	This work was supported by a grant from "Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005; Cassatella MA, 2006, J LEUKOCYTE BIOL, V79, P123, DOI 10.1189/jlb.0805431; Chen PL, 2008, J VASC RES, V45, P111, DOI 10.1159/000109880; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Jeremias I, 2000, CIRCULATION, V102, P915; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Ladenson JH, 2007, CLIN CHIM ACTA, V381, P3, DOI 10.1016/j.cca.2007.02.039; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Liao XD, 2005, LIFE SCI, V77, P160, DOI 10.1016/j.lfs.2004.11.029; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Nakajima H, 2003, JPN HEART J, V44, P833, DOI 10.1536/jhj.44.833; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; Nyormoi O, 2003, CELL DEATH DIFFER, V10, P558, DOI 10.1038/sj.cdd.4401209; Pritzker LB, 2004, MOL BIOL CELL, V15, P2834, DOI 10.1091/mbc.E04-01-0059; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Takahashi T, 2007, AM J CARDIOL, V100, P35, DOI 10.1016/j.amjcard.2007.02.049; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Zauli G, 2003, CIRC RES, V92, P732, DOI 10.1161/01.RES.0000067928.83455.9C; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1	32	75	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4442	10.1371/journal.pone.0004442	http://dx.doi.org/10.1371/journal.pone.0004442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221598	Green Published, gold, Green Submitted			2022-12-25	WOS:000265485700004
J	Bryant, PA; Smyth, GK; Robins-Browne, R; Curtis, N				Bryant, Penelope A.; Smyth, Gordon K.; Robins-Browne, Roy; Curtis, Nigel			Detection of Gene Expression in an Individual Cell Type within a Cell Mixture Using Microarray Analysis	PLOS ONE			English	Article								Background: A central issue in the design of microarray-based analysis of global gene expression is the choice between using cells of single type and a mixture of cells. This study quantified the proportion of lipopolysaccharide (LPS) induced differentially expressed monocyte genes that could be measured in peripheral blood mononuclear cells (PBMC), and determined the extent to which gene expression in the non-monocyte cell fraction diluted or obscured fold changes that could be detected in the cell mixture. Methodology/Principal Findings: Human PBMC were stimulated with LPS, and monocytes were then isolated by positive (Mono+) or negative (Mono-) selection. The non-monocyte cell fraction (MonoD) remaining after positive selection of monocytes was used to determine the effect of non-monocyte cells on overall expression. RNA from LPS-stimulated PBMC, Mono+, Mono- and MonoD samples was co-hybridised with unstimulated RNA for each cell type on oligonucleotide microarrays. There was a positive correlation in gene expression between PBMC and both Mono+ (0.77) and Mono- (0.61-0.67) samples. Analysis of individual genes that were differentially expressed in Mono+ and Mono- samples showed that the ability to detect expression of some genes was similar when analysing PBMC, but for others, differential expression was either not detected or changed in the opposite direction. As a result of the dilutional or obscuring effect of gene expression in non-monocyte cells, overall about half of the statistically significant LPS-induced changes in gene expression in monocytes were not detected in PBMC. However, 97% of genes with a four fold or greater change in expression in monocytes after LPS stimulation, and almost all (96-100%) of the top 100 most differentially expressed monocyte genes were detected in PBMC. Conclusions/Significance: The effect of non-responding cells in a mixture dilutes or obscures the detection of subtle changes in gene expression in an individual cell type. However, for studies in which only the most highly differentially expressed genes are of interest, separating and analysing individual cell types may be unnecessary.	[Bryant, Penelope A.; Curtis, Nigel] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia; [Bryant, Penelope A.; Robins-Browne, Roy; Curtis, Nigel] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Microbiol & Infect Dis Res Grp, Parkville, Vic, Australia; [Bryant, Penelope A.; Curtis, Nigel] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia; [Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Bryant, PA (corresponding author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Smyth, Gordon/B-5276-2008; Robinsbrowne, Roy/ABF-8434-2020; Curtis, Nigel/B-3491-2012	Smyth, Gordon/0000-0001-9221-2892; Robinsbrowne, Roy/0000-0001-9179-7884; Curtis, Nigel/0000-0003-3446-4594	National Health and Medical Research Council; National Heart Foundation of Australia; European Society of Paediatric Infectious Diseases [Fellowship Award]; University of Melbourne [Research Scholarship]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); European Society of Paediatric Infectious Diseases; University of Melbourne(University of Melbourne)	This study was supported by a grant from the National Health and Medical Research Council and National Heart Foundation of Australia. Dr. Bryant was the recipient of a European Society of Paediatric Infectious Diseases Fellowship Award and a University of Melbourne Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO T, 1994, J PHARMACOL EXP THER, V268, P1032; Baqui AAMA, 2000, IMMUNOPHARM IMMUNOT, V22, P401, DOI 10.3109/08923970009026002; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolt G, 2002, J GEN VIROL, V83, P1157, DOI 10.1099/0022-1317-83-5-1157; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fessele S, 2001, FASEB J, V15, P577; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Holloway AJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-511; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Rus V, 2002, CLIN IMMUNOL, V102, P283, DOI 10.1006/clim.2001.5182; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Viemann D, 2005, BBA-MOL CELL RES, V1746, P73, DOI 10.1016/j.bbamcr.2005.09.005; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640	25	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4427	10.1371/journal.pone.0004427	http://dx.doi.org/10.1371/journal.pone.0004427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212463	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484200002
J	Milstein, J; Mormann, F; Fried, I; Koch, C				Milstein, Joshua; Mormann, Florian; Fried, Itzhak; Koch, Christof			Neuronal Shot Noise and Brownian 1/f(2) Behavior in the Local Field Potential	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; BRAIN; EEG; AWAKE	We demonstrate that human electrophysiological recordings of the local field potential (LFP) from intracranial electrodes, acquired from a variety of cerebral regions, show a ubiquitous 1/f(2) scaling within the power spectrum. We develop a quantitative model that treats the generation of these fields in an analogous way to that of electronic shot noise, and use this model to specifically address the cause of this 1/f(2) Brownian noise. The model gives way to two analytically tractable solutions, both displaying Brownian noise: 1) uncorrelated cells that display sharp initial activity, whose extracellular fields slowly decay in time and 2) rapidly firing, temporally correlated cells that generate UP-DOWN states.	[Milstein, Joshua; Mormann, Florian; Koch, Christof] CALTECH, Pasadena, CA 91125 USA; [Mormann, Florian; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90024 USA; [Mormann, Florian; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behavior, Los Angeles, CA 90024 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Milstein, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.	milstein@caltech.edu	Mormann, Florian/K-1582-2014	Mormann, Florian/0000-0003-1305-8028	Sloan-Swartz Foundation; European Commission; NINDS; DARPA; NSF; Mathers Foundation	Sloan-Swartz Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Mathers Foundation	Funding was provided by a fellowship from the Sloan-Swartz Foundation to J.N. Milstein, by a Marie Curie fellowship from the European Commission to F. Mormann, and by NINDS, DARPA, NSF and the Mathers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; BROWN J, 2000, SCALING BIOL SANTA I; Buzsaki G., 2006, RHYTHMS BRAIN; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gardiner C W, 2004, HDB STOCHASTIC METHO; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gutenberg B., 1942, B SEISMOL SOC AM, V32, P163; Gutenberg B., 1954, SEISMICITY EARTH ASS; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kandel E., 2000, PRINCIPLES NEURAL SC; Koch Christof, 1999, P1; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Milstein JN, 2008, NEURAL COMPUT, V20, P2070, DOI 10.1162/neco.2008.06-07-537; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; PARETO V, 1897, COURS EC POLITQUE, V2; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Schottky W, 1918, ANN PHYS-BERLIN, V57, P541; STERIADE M, 1993, J NEUROSCI, V13, P3266; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006	30	95	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4338	10.1371/journal.pone.0004338	http://dx.doi.org/10.1371/journal.pone.0004338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190760	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000265483300002
J	Meur, AML; Mohebiany, AN; O'Connor, TP				Meur, Ana Mingorance-Le; Mohebiany, Alma N.; O'Connor, Timothy P.			Varicones and Growth Cones: Two Neurite Terminals in PC12 Cells	PLOS ONE			English	Article								The rat adrenal pheochromocytoma PC12 cell line is one of the traditional models for the study of neurite outgrowth and growth cone behavior. To clarify to what extent PC12 neurite terminals can be compared to neuronal growth cones, we have analyzed their morphology and protein distribution in fixed PC12 cells by immunocytochemistry. Our results show that that PC12 cells display a special kind of neurite terminal that includes a varicosity in close association with a growth cone. This hybrid terminal, or "varicone'', is characterized by the expression of specific markers not typically present in neuronal growth cones. For example, we show that calpain-2 is a specific marker of varicones and can be detected even before the neurite develops. Our data also shows that a fraction of PC12 neurites end in regular growth cones, which we have compared to hippocampal neurites as a control. We also report the extraordinary incidence of varicones in the literature referred to as "growth cones''. In summary, we provide evidence of two different kinds of neurite terminals in PC12 cells, including a PC12-specific terminal, which implies that care must be taken when using them as a model for neuronal growth cones or neurite outgrowth.	[Meur, Ana Mingorance-Le; Mohebiany, Alma N.; O'Connor, Timothy P.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Meur, AML (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	alemeur@interchange.ubc.ca		Mingorance, Ana/0000-0002-6213-6160; Mohebiany, Alma/0000-0001-9818-6867	CIHR [MOP-13246]; EMBO [Long-Term Fellowship]; MSFHR [Postdoctoral Fellowship]	CIHR(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); MSFHR(Michael Smith Foundation for Health Research)	This work was supported by CIHR grant (MOP-13246) to TPO and by an EMBO Long-Term Fellowship and a MSFHR Postdoctoral Fellowship to AMLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 2006, SCI STKE, pTR9; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; Evans JS, 2007, J NEUROCHEM, V103, P849, DOI 10.1111/j.1471-4159.2007.04815.x; GISPEN WH, 1991, MOL NEUROBIOL, V5, P61, DOI 10.1007/BF02935540; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1977, BRAIN RES, V129, P247, DOI 10.1016/0006-8993(77)90005-1; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Lamoureux P, 1997, J CELL SCI, V110, P635; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Lochner JE, 1998, MOL BIOL CELL, V9, P2463, DOI 10.1091/mbc.9.9.2463; LUCKENBILLEDDS L, 1979, J NEUROCYTOL, V8, P493, DOI 10.1007/BF01214805; MANIVANNAN S, 1994, J NEUROSCI, V14, P5917; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; MINGORANCELEMEU.A, 2009, EMBO J          1218, DOI DOI 10.1038/EMBOJ.2008.1265; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; Nakanishi S, 1998, ARCH HISTOL CYTOL, V61, P221, DOI 10.1679/aohc.61.221; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Park SJ, 2005, EMBO J, V24, P1557, DOI 10.1038/sj.emboj.7600586; PINTER M, 1994, NEUROSCI LETT, V170, P91, DOI 10.1016/0304-3940(94)90246-1; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Smith CL, 2004, J NEUROBIOL, V61, P222, DOI 10.1002/neu.20038; TAOCHENG JH, 1995, J NEUROSCI RES, V42, P323, DOI 10.1002/jnr.490420306; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; To KCW, 2007, MOL CELL NEUROSCI, V36, P425, DOI 10.1016/j.mcn.2007.08.001; VARNUMFINNEY B, 1994, J CELL BIOL, V127, P1071, DOI 10.1083/jcb.127.4.1071; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Zhou T, 2006, ACTA NEUROBIOL EXP, V66, P105	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4334	10.1371/journal.pone.0004334	http://dx.doi.org/10.1371/journal.pone.0004334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183810	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483200009
J	West, NP; Chow, FME; Randall, EJ; Wu, J; Chen, J; Ribeiro, JMC; Britton, WJ				West, Nicholas P.; Chow, Frances M. E.; Randall, Elizabeth J.; Wu, Jing; Chen, Jian; Ribeiro, Jose M. C.; Britton, Warwick J.			Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification	FASEB JOURNAL			English	Article						secreted enzymes; activity	PATHOGENIC MYCOBACTERIA; EXTRACELLULAR LIPASE; SEQUENCE ALIGNMENT; LIPOLYTIC ENZYMES; CULTURE FILTRATE; BOVIS BCG; PURIFICATION; MACROPHAGES; ESTERASE; DATABASE	Discovery and characterization of novel secreted enzymes of Mycobacterium tuberculosis are important for understanding the pathogenesis of one of the most important human bacterial pathogens. The proteome of M. tuberculosis contains over 400 potentially secreted proteins, the majority of which are uncharacterized. A family of seven cutinase-like proteins (CULPs) was identified by bioinformatic analysis, expressed and purified from Escherichia coli, and characterized in terms of their enzymatic activities. These studies revealed a functional diversity of enzyme classes based on differential preferences for substrate chain length. One member, Culp1, exhibited strong esterase activity, 40-fold higher than that of Culp6, which had strong activity as a lipase. Another, Culp4, performed moderately as an esterase and weakly as a lipase. Culp6 lipase activity was optimal above pH 7.0, and fully maintained to pH 8.5. None of the CULP members exhibited cutinase activity. Site-directed mutagenesis of each residue of the putative catalytic triad in Culp6 confirmed that each was essential for activity toward all fatty acid chain lengths of nitrophenyl esters and lipolytic function. Culp1 and Culp2 were present only in culture supernatants of M. tuberculosis, while Culp6, which is putatively essential for mycobacterial growth, was retained in the cell wall, suggesting the proteins play distinct roles in mycobacterial biology.-West, N. P., Chow, F. M. E., Randall, E. J., Wu, J., Chen, J., Ribeiro, J. M. C., Britton, W. J. Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. FASEB J. 23, 1694-1704 (2009)	[West, Nicholas P.; Chow, Frances M. E.; Randall, Elizabeth J.; Britton, Warwick J.] Centenary Inst Canc Med & Cell Biol, Mycobacterial Res Program, Newtown, NSW 2042, Australia; [Wu, Jing; Chen, Jian] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Wu, Jing; Chen, Jian] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Wu, Jing; Chen, Jian] Jiangnan Univ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Britton, Warwick J.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; Jiangnan University; Jiangnan University; Jiangnan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney	West, NP (corresponding author), Centenary Inst Canc Med & Cell Biol, Mycobacterial Res Program, Locked Bag 6, Newtown, NSW 2042, Australia.	n.west@centenary.org.au	Wu, Jing/GZK-5063-2022; West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890; Ribeiro, Jose/0000-0002-9107-0818; Britton, Warwick/0000-0001-6721-9646	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [HHSN266200400091C] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; FETT WF, 1992, APPL ENVIRON MICROB, V58, P2123, DOI 10.1128/AEM.58.7.2123-2130.1992; Fett WF, 2000, LETT APPL MICROBIOL, V31, P25, DOI 10.1046/j.1472-765X.2000.00752.x; Gupta R, 2003, BIOTECHNOL APPL BIOC, V37, P63, DOI 10.1042/BA20020059; Hovav AH, 2005, INFECT IMMUN, V73, P250, DOI 10.1128/IAI.73.1.250-257.2005; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; KORDEL M, 1991, J BACTERIOL, V173, P4836, DOI 10.1128/jb.173.15.4836-4841.1991; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; LESUISSE E, 1993, EUR J BIOCHEM, V216, P155, DOI 10.1111/j.1432-1033.1993.tb18127.x; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; MARTINEZ C, 1994, BIOCHEMISTRY-US, V33, P83, DOI 10.1021/bi00167a011; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ohno S., 1970, EVOLUTION GENE DUPLI; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Pernas MA, 2001, FEBS LETT, V501, P87, DOI 10.1016/S0014-5793(01)02630-8; Pratt J, 2000, CURR MICROBIOL, V40, P306, DOI 10.1007/s002849910061; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2824, DOI 10.1021/bi00684a006; Quistad GB, 2000, J BIOCHEM MOL TOXIC, V14, P51, DOI 10.1002/(SICI)1099-0461(2000)14:1<51::AID-JBT7>3.0.CO;2-W; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaefer Wilhelm, 1993, Trends in Microbiology, V1, P69, DOI 10.1016/0966-842X(93)90037-R; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; VONTIGERSTROM RG, 1989, CAN J MICROBIOL, V35, P511, DOI 10.1139/m89-079; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; Walz I, 2007, EUR FOOD RES TECHNOL, V225, P593, DOI 10.1007/s00217-006-0435-5; Weldingh K, 1999, FEMS IMMUNOL MED MIC, V23, P159, DOI 10.1111/j.1574-695X.1999.tb01235.x; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; WHEELER PR, 1988, J GEN MICROBIOL, V134, P2111; WHEELER PR, 1990, J GEN MICROBIOL, V136, P211, DOI 10.1099/00221287-136-1-211; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979	52	57	61	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1694	1704		10.1096/fj.08-114421	http://dx.doi.org/10.1096/fj.08-114421			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19225166	Green Published			2022-12-25	WOS:000266652400009
J	Friedman, MS; Oyserman, SM; Hankenson, KD				Friedman, Michael S.; Oyserman, Sivan M.; Hankenson, Kurt D.			Wnt11 Promotes Osteoblast Maturation and Mineralization through R-spondin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; DENTIN MATRIX PROTEIN-1; APICAL ECTODERMAL RIDGE; BETA-CATENIN; BONE-FORMATION; IN-VIVO; DIFFERENTIATION; EXPRESSION; LRP6; GENE	Wnt11 signals through both canonical (beta-catenin) and non-canonical pathways and is up-regulated during osteoblast differentiation and fracture healing. In these studies, we evaluated the role of Wnt11 during osteoblastogenesis. Wnt11 overexpression in MC3T3E1 pre-osteoblasts increases beta-catenin accumulation and promotes bone morphogenetic protein (BMP)-induced expression of alkaline phosphatase and mineralization. Wnt11 dramatically increases expression of the osteoblast-associated genes Dmp1 (dentin matrix protein 1), Phex (phosphate-regulating endopeptidase homolog), and Bsp (bone sialoprotein). Wnt11 also increases expression of Rspo2 (R-spondin 2), a secreted factor known to enhance Wnt signaling. Overexpression of Rspo2 is sufficient for increasing Dmp1, Phex, and Bsp expression and promotes bone morphogenetic protein-induced mineralization. Knockdown of Rspo2 abrogates Wnt11-mediated osteoblast maturation. Antagonism of T-cell factor (Tcf)/beta-catenin signaling with dominant negative Tcf blocks Wnt11-mediated expression of Dmp1, Phex, and Rspo2 and decreases mineralization. However, dominant negative Tcf fails to block the osteogenic effects of Rspo2 overexpression. These studies show that Wnt11 signals through beta-catenin, activating Rspo2 expression, which is then required for Wnt11-mediated osteoblast maturation.	[Friedman, Michael S.; Oyserman, Sivan M.] ThermoGenesis Corp, Rancho Cordova, CA 95742 USA; [Hankenson, Kurt D.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19103 USA	University of Pennsylvania	Hankenson, KD (corresponding author), 311 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	kdhank@vet.upenn.edu	Hankenson, Kurt/ABI-1547-2020; Hankenson, Kurt/AFS-9417-2022	Hankenson, Kurt/0000-0001-6361-143X	National Institutes of Health [R01DE017471, R01AR028922]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE017471 and R01AR028922.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Fischer L, 2002, J BIOL CHEM, V277, P30870, DOI 10.1074/jbc.M109330200; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; WENYAN L, 2008, FEBS LETT, V582, P643; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702	38	79	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14117	14125		10.1074/jbc.M808337200	http://dx.doi.org/10.1074/jbc.M808337200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19213727	hybrid, Green Published			2022-12-25	WOS:000266286100018
J	Forsee, WT; Cartee, RT; Yother, J				Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet			A Kinetic Model for Chain Length Modulation of Streptococcus pneumoniae Cellubiuronan Capsular Polysaccharide by Nucleotide Sugar Donor Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHONDROITIN SULFATE; N-ACETYLGLUCOSAMINE; ALPHA-LACTALBUMIN; CRYSTAL-STRUCTURE; TYPE-3 SYNTHASE; BINDING-SITE; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; MECHANISM	The chain length of Streptococcus pneumoniae type 3 capsular polysaccharide (cellubiuronic acid) is tightly regulated by the cellubiuronic acid synthase through an assembly process involving a catalytic motif that is potentially conserved over a wide range of related processive beta-glucan synthases. Cellubiuronic acid is initiated on a lipid and is composed of alternating beta-1,3-Glc and beta-1,4-glucuronic acid (GlcUA) linkages. The entire assembly process is carried out by a polypeptide synthase thought to contain a single active site, suggesting that the donor specificity is controlled by the terminal nonreducing sugar in the acceptor subsite. Shortly after initiation, the synthase undergoes an allosteric transition accompanied by the tight binding of the nascent chain via its nonreducing oligosaccharide terminal segment to the carbohydrate acceptor recognition site. The chain length of polysaccharide assembled by recombinant synthase in Escherichia coli membranes was determined by an ejection mechanism that appeared to be a reversal of the allosteric transition of the synthase from the transitory to the fully processive state. The rates of both ejection and transition were shown to be highly sensitive to the concentration of UDP-GlcUA. As the concentration of UDP-GlcUA was increased, both the rate of synthesis and the processive turnover time increased. The product of the processive turnover time and the rate of synthesis predicted a marked increase in polysaccharide chain size (from 50 to 1150 kDa) over a relatively narrow concentration range of 1-11.5 mu M UDP-GlcUA. The kinetic model chain length predictions were in close agreement with chemically determined sizes of polysaccharides synthesized at the same UDP-sugar concentrations. The model indicates that translocation occurs following the addition of GlcUA to the chain terminus, whereas UDP-Glc drives chain termination when inadequate levels of UDP-GlcUA are present. In sum, type 3 synthase appears to modulate polysaccharide chain length by functioning as a concentration-dependent kinetic timing device.	[Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yother, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 661-12, Birmingham, AL 35294 USA.	jyother@uab.edu			National Institutes of Health [R01 GM53017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01 GM53017.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cartee RT, 2005, J BACTERIOL, V187, P4470, DOI 10.1128/JB.187.13.4470-4479.2005; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Cartee RT, 2001, J BIOL CHEM, V276, P48831, DOI 10.1074/jbc.M106481200; Carter JA, 2007, MICROBIOL-SGM, V153, P3499, DOI 10.1099/mic.0.2007/010066-0; Charnock SJ, 2001, PLANT PHYSIOL, V125, P527, DOI 10.1104/pp.125.2.527; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Forsee WT, 2009, J BIOL CHEM, V284, P11826, DOI 10.1074/jbc.M900386200; Forsee WT, 2000, J BIOL CHEM, V275, P25972, DOI 10.1074/jbc.M002613200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; KHARTA BS, 1974, EUR J BIOCHEM, V44, P537; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; MITCHELL D, 1982, BIOCHEM J, V202, P387, DOI 10.1042/bj2020387; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Rodeheffer C, 2002, BBA-GEN SUBJECTS, V1573, P258, DOI 10.1016/S0304-4165(02)00392-6; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; TELSER A, 1966, ARCH BIOCHEM BIOPHYS, V116, P458, DOI 10.1016/0003-9861(66)90053-1; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	35	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11836	11844		10.1074/jbc.M900379200	http://dx.doi.org/10.1074/jbc.M900379200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19228689	Green Published, hybrid			2022-12-25	WOS:000265494600015
J	Katschke, KJ; Stawicki, S; Yin, JP; Steffek, M; Xi, HK; Sturgeon, L; Hass, PE; Loyet, KM; DeForge, L; Wu, Y; Campagne, MV; Wiesmann, C				Katschke, Kenneth J., Jr.; Stawicki, Scott; Yin, Jianping; Steffek, Micah; Xi, Hongkang; Sturgeon, Lizette; Hass, Philip E.; Loyet, Kelly M.; DeForge, Laura; Wu, Yan; Campagne, Menno van Lookeren; Wiesmann, Christian			Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPONENT C3; FACTOR-H; ACTIVATION; CONVERTASE; INSIGHTS; CR-1; THIOESTER; PROTEASE; REVEALS; BINDING	Amplification of the complement cascade through the alternative pathway can lead to excessive inflammation. Targeting C3b, a component central to the alternative pathway of complement, provides a powerful approach to inhibit complement-mediated immune responses and tissue injury. In the present study, phage display technology was employed to generate an antibody that selectively recognizes C3b but not the non-activated molecule C3. The crystal structure of C3b in complex with a Fab fragment of this antibody (S77) illustrates the structural basis for this selectivity. Cleavage of C3 to C3b results in a plethora of structural changes within C3, including the rearrangement of macroglobulin domain 6 enabling binding of S77 to the adjacent macroglobulin domain 7 domain. S77 blocks binding of factor B to C3b inhibiting the first step in the formation of the alternative pathway C3 convertase. In addition, S77 inhibits C5 binding to C3b. This results in significantly reduced formations of anaphylatoxins and membrane-attack complexes. This study for the first time demonstrates the structural basis for complement inhibition by a C3b-selective antibody and provides insights into the molecular mechanisms of alternative pathway complement activation.	[Katschke, Kenneth J., Jr.; Xi, Hongkang; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Stawicki, Scott; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Yin, Jianping; Steffek, Micah; Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Sturgeon, Lizette; Loyet, Kelly M.; DeForge, Laura] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Hass, Philip E.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com; wiesmann.christian@gene.com	Loyet, Kelly/AAD-7544-2021	Wiesmann, Christian/0000-0002-4092-9880				BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; DiLillo DJ, 2006, MOL IMMUNOL, V43, P1010, DOI 10.1016/j.molimm.2005.05.003; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; HACK CE, 1988, J IMMUNOL, V141, P1602; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lambris JD, 1996, J IMMUNOL, V156, P4821; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Undar A, 2002, ANN THORAC SURG, V74, P355, DOI 10.1016/S0003-4975(02)03656-1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	31	49	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10473	10479		10.1074/jbc.M809106200	http://dx.doi.org/10.1074/jbc.M809106200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19196712	Green Published, hybrid			2022-12-25	WOS:000265104600021
J	Yue, L; Mazzone, T				Yue, Lili; Mazzone, Theodore			Peroxisome Proliferator-activated Receptor gamma Stimulation of Adipocyte ApoE Gene Transcription Mediated by the Liver Receptor X Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E GENE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; GLUCOSE-METABOLISM; EXPRESSION; MACROPHAGES; STORAGE; FAT	Peroxisome proliferator-activated receptor (PPAR gamma) agonists increase insulin sensitivity in humans and are useful for treating human diabetes. Treatment with these agonists leads to increased apoE expression and triglyceride accumulation in adipocytes. The importance of apoE for adipocyte triglyceride accumulation is demonstrated by observations that triglyceride accumulation is impaired in apoE knockout adipocytes treated with PPAR gamma agonists. The current studies investigate the molecular mechanism for PPAR gamma stimulation of the adipocyte apoE gene and demonstrate that the liver receptor X (LXR) response element within an apoE gene downstream enhancer is required for the apoE response to PPAR gamma agonists. The response of the apoE gene to treatment with PPAR gamma agonists was delayed beyond 12 h suggesting the involvement of an intermediary pathway. The combined addition of PPAR gamma and LXR agonists did not increase apoE response beyond that observed with addition of either alone. Deletion or mutation of the LXR response element completely eliminated the adipocyte apoE gene response to a PPAR gamma agonist. Chromatin immunoprecipitation analyses performed using isolated adipocytes, or adipose tissue from mice treated with PPAR gamma agonists, showed increased LXR binding to the apoE gene after PPAR gamma agonist treatment. Knockdown of LXR expression completely eliminated the increase in apoE message, protein, and triglyceride in response to PPAR gamma stimulation. The LXR response element has been previously shown to mediate sterol responsiveness of the apoE gene, and apoE expression plays an important role in adipocyte triglyceride balance. The current observations suggest that the PPAR gamma- LXR-apoE regulatory cascade could be an important molecular link for cross-talk between adipocyte triglyceride and cholesterol homeostasis.	[Mazzone, Theodore] Univ Illinois, Dept Human Nutr, Chicago, IL 60612 USA; [Mazzone, Theodore] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Yue, Lili; Mazzone, Theodore] Univ Illinois, Dept Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mazzone, T (corresponding author), Univ Illinois, Sect Endocrinol Diabet & Metab MC 797, 1819 W Polk St, Chicago, IL 60612 USA.	tmazzone@uic.edu			National Institutes of Health [DK71711]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071711, R56DK071711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK71711 (to T.M.).	Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Dugail I, 2003, HORM METAB RES, V35, P204, DOI 10.1055/s-2003-39475; Espiritu DJ, 2008, DIABETES, V57, P2992, DOI 10.2337/db08-0592; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Huang ZH, 2007, AM J PHYSIOL-ENDOC M, V293, pE203, DOI 10.1152/ajpendo.00118.2007; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KOVANEN PT, 1975, J LIPID RES, V16, P211; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Le Lay S, 2003, J LIPID RES, V44, P1499, DOI 10.1194/jlr.M200466-JLR200; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lin CY, 1999, J LIPID RES, V40, P1618; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; MAZZONE T, 1994, J LIPID RES, V35, P1345; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Rao P, 2007, J CLIN ENDOCR METAB, V92, P4366, DOI 10.1210/jc.2007-1592; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Yue L, 2008, ENDOCRINOLOGY, V149, P4051, DOI 10.1210/en.2008-0340; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200; ZECHNER R, 1991, J BIOL CHEM, V266, P10583	30	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10453	10461		10.1074/jbc.M808482200	http://dx.doi.org/10.1074/jbc.M808482200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218241	Green Published, hybrid			2022-12-25	WOS:000265104600019
J	Coddens, A; Diswall, M; Angstrom, J; Breimer, ME; Goddeeris, B; Cox, E; Teneberg, S				Coddens, Annelies; Diswall, Mette; Angstrom, Jonas; Breimer, Michael E.; Goddeeris, Bruno; Cox, Eric; Teneberg, Susann			Recognition of Blood Group ABH Type 1 Determinants by the FedF Adhesin of F18-fimbriated Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE MEMBRANES; EPITHELIAL-CELLS; SMALL-INTESTINE; HELICOBACTER-PYLORI; FIMBRIAL ADHESIN; GROUP ANTIGENS; EDEMA DISEASE; GROUP GLYCOSPHINGOLIPIDS; MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY	F18-fimbriated Escherichia coli are associated with porcine postweaning diarrhea and edema disease. Adhesion of F18-fimbriated bacteria to the small intestine of susceptible pigs is mediated by the minor fimbrial subunit FedF. However, the target cell receptor for FedF has remained unidentified. Here we report that F18-fimbriated E. coli selectively interact with glycosphingolipids having blood group ABH determinants on type 1 core, and blood group A type 4 heptaglycosylceramide. The minimal binding epitope was identified as the blood group H type 1 determinant (Fuc alpha 2Gal beta 3GlcNAc), while an optimal binding epitope was created by addition of the terminal alpha 3-linked galactose or N-acetylgalactosamine of the blood group B type 1 determinant (Gal alpha 3(Fuc alpha 2)Gal beta 3GlcNAc) and the blood group A type 1 determinant (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc). To assess the role of glycosphingolipid recognition by F18-fimbriated E. coli in target tissue adherence, F18-binding glycosphingolipids were isolated from the small intestinal epithelium of blood group O and A pigs and characterized by mass spectrometry and proton NMR. The only glycosphingolipid with F18-binding activity of the blood group O pig was an H type 1 pentaglycosylceramide (Fuc alpha 2Gal beta 3GlcNAc-beta 3Gal beta 4Glc beta 1Cer). In contrast, the blood group A pig had a number of F18-binding glycosphingolipids, characterized as A type 1 hexaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), A type 4 heptaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), A type 1 octaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc beta 3-Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), and repetitive A type 1 nonaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc alpha 3-(Fuc alpha 2)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer). No blood group antigen-carrying glycosphingolipids were recognized by a mutant E. coli strain with deletion of the FedF adhesin, demonstrating that FedF is the structural element mediating binding of F18-fimbriated bacteria to blood group ABH determinants.	[Coddens, Annelies; Goddeeris, Bruno; Cox, Eric] Univ Ghent, Lab Vet Immunol, Fac Vet Med, B-9820 Ghent, Belgium; [Diswall, Mette; Angstrom, Jonas; Breimer, Michael E.] Sahlgrens Univ Hosp, Dept Surg, SE-41345 Gothenburg, Sweden; [Goddeeris, Bruno] Katholieke Univ Leuven, Fac Biosci Engn, Div Gene Technol, Dept Biosyst, B-3001 Heverlee, Belgium; [Teneberg, Susann] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden	Ghent University; Sahlgrenska University Hospital; KU Leuven; University of Gothenburg	Cox, E (corresponding author), Univ Ghent, Lab Vet Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Ghent, Belgium.	eric.cox@UGent.be; Susann.Teneberg@medkem.gu.se	Goddeeris, Bruno Maria/L-2440-2015	Goddeeris, Bruno Maria/0000-0003-3729-7592; Cox, Eric/0000-0003-4281-2990	Swedish Research Council/Medicine [11612, 12628]; Swedish Cancer Foundation; Magnus Bergvalls Foundation; UGent and FWO-Flanders [G001305N, 3G038907]	Swedish Research Council/Medicine(Swedish Research Council); Swedish Cancer Foundation; Magnus Bergvalls Foundation; UGent and FWO-Flanders(FWO)	This work was supported in part by the Swedish Research Council/Medicine ( Grant 11612 to S. T. and Grant 12628 to M. E. B.), the Swedish Cancer Foundation ( to S. T.), and Magnus Bergvalls Foundation ( to S. T.). The UGent and FWO-Flanders ( Grants G001305N and 3G038907) are acknowledged for their financial support.	Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backer AE, 1997, GLYCOBIOLOGY, V7, P943, DOI 10.1093/glycob/7.7.943; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; Bertschinger H. U., 1994, P193; BERTSCHINGER HU, 1993, VET MICROBIOL, V35, P79, DOI 10.1016/0378-1135(93)90117-P; BERTSCHINGER HU, 1990, VET MICROBIOL, V25, P267, DOI 10.1016/0378-1135(90)90083-8; BOCK K, 1985, J BIOL CHEM, V260, P8545; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BOUHOURS D, 1991, J BIOL CHEM, V266, P18613; BREIMER ME, 1982, J BIOL CHEM, V257, P557; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1986, BIOCHEMISTRY-US, V25, P7075, DOI 10.1021/bi00370a048; CLAUSEN H, 1984, BIOCHEM BIOPH RES CO, V124, P523, DOI 10.1016/0006-291X(84)91585-7; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Cohney S, 1999, INT J MOL MED, V3, P199; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; De Kerpel M, 2006, ACTA CRYSTALLOGR F, V62, P1278, DOI 10.1107/S1744309106049281; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; HOLGERSSON J, 1990, J BIOL CHEM, V265, P20790; HULTGREN SJ, 1989, P NATL ACAD SCI USA, V86, P4357, DOI 10.1073/pnas.86.12.4357; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; IMBERECHTS H, 1992, INFECT IMMUN, V60, P1963, DOI 10.1128/IAI.60.5.1963-1971.1992; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; ITO M, 1989, J BIOL CHEM, V264, P9510; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KING TP, 1995, GLYCOBIOLOGY, V5, P525, DOI 10.1093/glycob/5.5.525; KOSCIELAK J, 1973, EUR J BIOCHEM, V37, P214, DOI 10.1111/j.1432-1033.1973.tb02978.x; KYOGASHIMA M, 1989, ARCH BIOCHEM BIOPHYS, V270, P391, DOI 10.1016/0003-9861(89)90042-8; KYPRIANOU P, 1990, GLYCOCONJUGATE J, V7, P573, DOI 10.1007/BF01189078; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Lindhorst TK, 1998, GLYCOCONJUGATE J, V15, P605, DOI 10.1023/A:1006920027641; Liu YH, 1998, J HISTOCHEM CYTOCHEM, V46, P69, DOI 10.1177/002215549804600109; Mathieu S, 2004, AM J PATHOL, V164, P371, DOI 10.1016/S0002-9440(10)63127-6; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Meijerink E, 1997, MAMM GENOME, V8, P736, DOI 10.1007/s003359900556; NAGY B, 1992, INFECT IMMUN, V60, P1285, DOI 10.1128/IAI.60.4.1285-1294.1992; NYHOLM PG, 1989, J MOL RECOGNIT, V3, P103; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Parente F, 2003, HELICOBACTER, V8, P252, DOI 10.1046/j.1523-5378.2003.00152.x; PRASADARAO NV, 1993, J BIOL CHEM, V268, P10356; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; SAKO F, 1990, ARCH BIOCHEM BIOPHYS, V278, P228, DOI 10.1016/0003-9861(90)90252-T; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Smeds A, 2001, INFECT IMMUN, V69, P7941, DOI 10.1128/IAI.69.12.7941-7945.2001; Snoeck V, 2004, VET MICROBIOL, V100, P241, DOI 10.1016/j.vetmic.2004.03.001; STELLNER K, 1973, BIOCHEMISTRY-US, V12, P656, DOI 10.1021/bi00728a014; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; TENEBERG S, 1994, J BIOCHEM, V116, P560, DOI 10.1093/oxfordjournals.jbchem.a124562; Ukkonen P, 2000, LANCET, V356, P1398, DOI 10.1016/S0140-6736(00)02843-9; Verdonck F, 2002, VACCINE, V20, P2995, DOI 10.1016/S0264-410X(02)00220-7; Vogeli P, 1996, ANIM GENET, V27, P321; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040	65	58	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9713	9726		10.1074/jbc.M807866200	http://dx.doi.org/10.1074/jbc.M807866200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208633	Green Published, hybrid			2022-12-25	WOS:000264892900011
J	Gill, J; Yogavel, M; Kumar, A; Belrhali, H; Jain, SK; Rug, M; Brown, M; Maier, AG; Sharma, A				Gill, Jasmita; Yogavel, Manickam; Kumar, Anuj; Belrhali, Hassan; Jain, S. K.; Rug, Melanie; Brown, Monica; Maier, Alexander G.; Sharma, Amit			Crystal Structure of Malaria Parasite Nucleosome Assembly Protein DISTINCT MODES OF PROTEIN LOCALIZATION AND HISTONE RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CORE; EXPRESSION; SOFTWARE; SYSTEM; VPS75	Nucleosome assembly proteins (NAPs) are histone chaperones that are essential for the transfer and incorporation of histones into nucleosomes. NAPs participate in assembly and disassembly of nucleosomes and in chromatin structure organization. Human malaria parasite Plasmodium falciparum contains two nucleosome assembly proteins termed PfNapL and PfNapS. To gain structural insights into the mechanism of NAPs, we have determined and analyzed the crystal structure of PfNapL at 2.3 angstrom resolution. PfNapL, an ortholog of eukaryotic NAPs, is dimeric in nature and adopts a characteristic fold seen previously for yeast NAP-1 and Vps75 and for human SET/TAF-1b (beta)/INHAT. The PfNapL monomer is comprised of domain I, containing a dimerization alpha-helix, and a domain II, composed of alpha-helices and a beta-subdomain. Structural comparisons reveal that the "accessory domain," which is inserted between the domain I and domain II in yeast NAP-1 and other eukaryotic NAPs, is surprisingly absent in PfNapL. Expression of green fluorescent protein-tagged PfNapL confirmed its exclusive localization to the parasite cytoplasm. Attempts to disrupt the PfNapL gene were not successful, indicating its essential role for the malaria parasite. A detailed analysis of PfNapL structure suggests unique histone binding properties. The crucial structural differences observed between parasite and yeast NAPs shed light on possible new modes of histone recognition by nucleosome assembly proteins.	[Gill, Jasmita; Yogavel, Manickam; Kumar, Anuj; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Belrhali, Hassan] European Mol Biol Lab, F-38042 Grenoble 9, France; [Jain, S. K.] Hamdard Univ, Dept Biotechnol, New Delhi 110062, India; [Rug, Melanie; Brown, Monica; Maier, Alexander G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; European Molecular Biology Laboratory (EMBL); Jamia Hamdard University; Walter & Eliza Hall Institute	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Rug, Melanie/B-5417-2015; Kumar, Anuj/M-9040-2013; Manickam, Yogavel/O-4570-2015; Rug, Melanie/A-9504-2011; Maier, Alex G/A-6499-2009	Kumar, Anuj/0000-0002-8814-3625; Manickam, Yogavel/0000-0002-2119-062X; Maier, Alex G/0000-0001-7369-1058; Gill, Jasmita/0000-0002-7004-2850	Department of Biotechnology, Govt. of India; Wellcome Trust	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a grant from the Department of Biotechnology, Govt. of India. The x-ray facility at the International Centre for Genetic Engineering and Biotechnology, New Delhi, is funded by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANNUNZIATO AT, 1983, MOL CELL BIOCHEM, V55, P99, DOI 10.1007/BF00673705; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Crabb BS, 2004, METH MOL B, V270, P263; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Lankenau S, 2003, GENETICS, V163, P611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Navadgi VM, 2006, J BIOL CHEM, V281, P16978, DOI 10.1074/jbc.M602243200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	37	26	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10076	10087		10.1074/jbc.M808633200	http://dx.doi.org/10.1074/jbc.M808633200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176479	Green Published, hybrid			2022-12-25	WOS:000264892900050
J	Cantini, F; Veggi, D; Dragonetti, S; Savino, S; Scarselli, M; Romagnoli, G; Pizza, M; Banci, L; Rappuoli, R				Cantini, Francesca; Veggi, Daniele; Dragonetti, Sara; Savino, Silvana; Scarselli, Maria; Romagnoli, Giacomo; Pizza, Mariagrazia; Banci, Lucia; Rappuoli, Rino			Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; VACCINE; COMPLEX; GNA1870; DOMAIN	Factor H-binding protein is a 27-kDa lipoprotein of Neisseria meningitidis discovered while screening the bacterial genome for vaccine candidates. In addition to being an important component of a vaccine against meningococcus in late stage of development, the protein is essential for pathogenesis because it allows the bacterium to survive and grow in human blood by binding the human complement factor H. We recently reported the solution structure of the C-terminal domain of factor H-binding protein, which contains the immunodominant epitopes. In the present study, we report the structure of the full-length molecule, determined by nuclear magnetic resonance spectroscopy. The protein is composed of two independent barrels connected by a short link. Mapping the residues recognized by monoclonal antibodies with bactericidal or factor H binding inhibition properties allowed us to predict the sites involved in the function of the protein. The structure therefore provides the basis for designing improved vaccine molecules.	[Cantini, Francesca; Dragonetti, Sara; Banci, Lucia] Magnet Resonance Ctr CERM, I-50019 Sesto Fiorentino, Italy; [Veggi, Daniele; Savino, Silvana; Scarselli, Maria; Romagnoli, Giacomo; Pizza, Mariagrazia; Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy	Novartis	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; rino.rappuoli@novartis.com	Cantini, Francesca/O-1220-2015	Cantini, Francesca/0000-0003-0526-6732; BANCI, LUCIA/0000-0003-0562-5774	Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) [RBLA032ZM7]	Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) Grant RBLA032ZM7.	Banci L, 1998, J AM CHEM SOC, V120, P12903, DOI 10.1021/ja981791w; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Girard MP, 2006, VACCINE, V24, P4692, DOI 10.1016/j.vaccine.2006.03.034; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Nabuurs SB, 2003, J AM CHEM SOC, V125, P12026, DOI 10.1021/ja035440f; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606	31	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9022	9026		10.1074/jbc.C800214200	http://dx.doi.org/10.1074/jbc.C800214200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19196709	hybrid, Green Published			2022-12-25	WOS:000264669100004
J	Tucker, DE; Ghosh, M; Ghomashchi, F; Loper, R; Suram, S; John, BS; Girotti, M; Bollinger, JG; Gelb, MH; Leslie, CC				Tucker, Dawn E.; Ghosh, Moumita; Ghomashchi, Farideh; Loper, Robyn; Suram, Saritha; John, Bonnie St.; Girotti, Milena; Bollinger, James G.; Gelb, Michael H.; Leslie, Christina C.			Role of Phosphorylation and Basic Residues in the Catalytic Domain of Cytosolic Phospholipase A(2)alpha in Regulating Interfacial Kinetics and Binding and Cellular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ACTIVATED PROTEIN-KINASE; PRODUCT-CONTAINING VESICLES; PHORBOL-MYRISTATE ACETATE; SMOOTH-MUSCLE-CELLS; C2 DOMAIN; HYDROLYZING PHOSPHOLIPASE-A2; ANIONIC PHOSPHOLIPIDS; CALCIUM REQUIREMENT; CRYSTAL-STRUCTURE	Group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) is regulated by phosphorylation and calcium-induced translocation to membranes. Immortalized mouse lung fibroblasts lacking endogenous cPLA(2)alpha(IMLF-/-) were reconstituted with wild type and cPLA(2)alpha mutants to investigate how calcium, phosphorylation, and the putative phosphatidylinositol 4,5-bisphosphate (PIP2) binding site regulate translocation and arachidonic acid (AA) release. Agonists that elicit distinct modes of calcium mobilization were used. Serum induced cPLA(2)alpha translocation to Golgi within seconds that temporally paralleled the initial calcium transient. However, the subsequent influx of extracellular calcium was essential for stable binding of cPLA(2)alpha to Golgi and AA release. In contrast, phorbol 12-myristate 13-acetate induced low amplitude calcium oscillations, slower translocation of cPLA(2)alpha to Golgi, and much less AA release, which were blocked by chelating extracellular calcium. AA release from IMLF-/- expressing phosphorylation site (S505A) and PIP2 binding site (K488N/K543N/K544N) mutants was partially reduced compared with cells expressing wild type cPLA(2)alpha, but calcium-induced translocation was not impaired. Consistent with these results, Ser-505 phosphorylation did not change the calcium requirement for interfacial binding and catalysis in vitro but increased activity by 2-fold. Mutations in basic residues in the catalytic domain of cPLA(2)alpha reduced activation by PIP2 but did not affect the concentration of calcium required for interfacial binding or phospholipid hydrolysis. The results demonstrate that Ser-505 phosphorylation and basic residues in the catalytic domain principally act to regulate cPLA(2)alpha hydrolytic activity.	[Ghomashchi, Farideh; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Ghomashchi, Farideh; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Tucker, Dawn E.; Ghosh, Moumita; Loper, Robyn; Suram, Saritha; John, Bonnie St.; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; [Girotti, Milena] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Jewish Health; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu; lesliec@njc.org		gelb, michael/0000-0001-7000-5219	National Institutes of Health [HL61378, HL34303, HL50040]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050040, P01HL034303, R01HL061378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL61378 (to C. C. L.), HL34303 (to C. C. L.), and HL50040 (to M. H. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADEREM AA, 1986, J EXP MED, V163, P139, DOI 10.1084/jem.163.1.139; ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Bayburt T, 1997, BIOCHEMISTRY-US, V36, P3216, DOI 10.1021/bi961659d; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; BITTERMAN PB, 1992, AM J MED, V92, pS39, DOI 10.1016/0002-9343(92)90606-C; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BONNEY RJ, 1980, BIOCHIM BIOPHYS ACTA, V633, P410, DOI 10.1016/0304-4165(80)90199-3; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; KRAMER RM, 1993, J BIOL CHEM, V268, P26796; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KURIMURA T, 1980, J GEN VIROL, V46, P237, DOI 10.1099/0022-1317-46-1-237; Leslie CC, 2004, PROSTAG LEUKOTR ESS, V70, P373, DOI 10.1016/j.plefa.2003.12.012; LESLIE CC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P261, DOI 10.1016/0005-2760(90)90129-L; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MCNEIL PL, 1985, J CELL BIOL, V101, P372, DOI 10.1083/jcb.101.2.372; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Muthalif MM, 1996, J BIOL CHEM, V271, P30149, DOI 10.1074/jbc.271.47.30149; Muthalif MM, 2001, J BIOL CHEM, V276, P39653, DOI 10.1074/jbc.M103136200; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Rzigalinski BA, 1996, BBA-LIPID LIPID MET, V1299, P342, DOI 10.1016/0005-2760(95)00224-3; Schalkwijk CG, 1996, BIOCHEM J, V313, P91, DOI 10.1042/bj3130091; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	66	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9596	9611		10.1074/jbc.M807299200	http://dx.doi.org/10.1074/jbc.M807299200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176526	Green Published, hybrid			2022-12-25	WOS:000264669100066
J	McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A				McCabe, N.; Cerone, M. A.; Ohishi, T.; Seimiya, H.; Lord, C. J.; Ashworth, A.			Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer	ONCOGENE			English	Article						BRCA1/2; Tankyrase 1; synthetic lethality; anticancer therapy	DNA-REPAIR DEFECT; POLY(ADP-RIBOSE) POLYMERASE; CENTROSOME AMPLIFICATION; HUMAN TELOMERES; MUTANT-CELLS; TRF1; PARP; INSTABILITY; PROGRESSION; SUBSTRATE	The BRCA1 and BRCA2 proteins are involved in the maintenance of genome stability and germ-line loss-of-function mutations in either BRCA1 or BRCA2 strongly predispose carriers to cancers of the breast and other organs. It has been demonstrated previously that inhibiting elements of the cellular DNA maintenance pathways represents a novel therapeutic approach to treating tumors in these individuals. Here, we show that inhibition of the telomere-associated protein, Tankyrase 1, is also selectively lethal with BRCA deficiency. We also demonstrate that the selectivity caused by inhibition of Tankyrase 1 is associated with an exacerbation of the centrosome amplification phenotype associated with BRCA deficiency. We propose that inhibition of Tankyrase 1 could be therapeutically exploited in BRCA-associated cancers.	[McCabe, N.; Cerone, M. A.; Lord, C. J.; Ashworth, A.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [McCabe, N.; Ashworth, A.] Inst Canc Res, Canc Res UK Gene Funct & Regulat Grp, London SW3 6JB, England; [Ohishi, T.; Seimiya, H.] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 170, Japan	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Japanese Foundation for Cancer Research	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	Alan.Ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Ohishi, Tomokazu/0000-0002-9039-4474; Seimiya, Hiroyuki/0000-0003-3314-9736	Breakthrough Breast Cancer; Cancer Research UK	Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	This work was funded by Breakthrough Breast Cancer and Cancer Research UK. We thank Jill Williamson and Dave Robertson for assistance with karyotyping and microscopy, respectively.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Seimiya H, 2006, BRIT J CANCER, V94, P341, DOI 10.1038/sj.bjc.6602951; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	26	60	66	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1465	1470		10.1038/onc.2008.483	http://dx.doi.org/10.1038/onc.2008.483			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19182824				2022-12-25	WOS:000264354400007
J	Tchougounova, E; Jiang, Y; Brasater, D; Lindberg, N; Kastemar, M; Asplund, A; Westermark, B; Uhrbom, L				Tchougounova, E.; Jiang, Y.; Brasater, D.; Lindberg, Nanna; Kastemar, M.; Asplund, A.; Westermark, B.; Uhrbom, L.			Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence	ONCOGENE			English	Article						Sox5; glioma; PDGF; p27(Kip1); senescence	NEURAL PROGENITORS; IN-VIVO; INHIBITOR P27(KIP1); CYCLE PROGRESSION; BRAIN-TUMORS; PROTEIN; EXPRESSION; CANCER; GENES; CELLS	SOX5 is a member of the high-mobility group superfamily of architectural non-histone proteins involved in gene regulation and maintenance of chromatin structure in a wide variety of developmental processes. Sox5 was identified as a brain tumor locus in a retroviral insertional mutagenesis screen of platelet-derived growth factor B (PDGFB)-induced mouse gliomas. Here we have investigated the role of Sox5 in PDGFB-induced gliomagenesis in mice. We show that Sox5 can suppress PDGFB-induced glioma development predominantly upon Ink4a-loss. In human glioma cell lines and tissues, we found very low levels of SOX5 compared with normal brain. Overexpression of Sox5 in human glioma cells led to a reduction in clone formation and inhibition of proliferation. Combined expression of Sox5 and PDGFB in primary brain cell cultures caused decreased proliferation and an increased number of senescent cells in the Ink4a(-/-) cells only. Protein analyses showed a reduction in the amount and activation of Akt and increased levels of p27(Kip1) upon Sox5 expression that was dominant to PDGFB signaling and specific to Ink4a(-/-) cells. Upon inhibition of p27(Kip1), the effects of Sox5 on proliferation and senescence could be reversed. Our data suggest a novel pathway, where Sox5 may suppress the oncogenic effects of PDGFB signaling during glioma development by regulating p27(Kip1) in a p19(Arf)-dependent manner, leading to acute cellular senescence.	[Tchougounova, E.; Jiang, Y.; Brasater, D.; Lindberg, Nanna; Kastemar, M.; Asplund, A.; Westermark, B.; Uhrbom, L.] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden	Uppsala University	Uhrbom, L (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden.	lene.uhrbom@genpat.uu.se		Westermark, Bengt/0000-0001-7153-5545	Swedish Cancer Society; Swedish Research Council; Association for International Cancer Research; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Association for International Cancer Research; Swedish Society for Medical Research	We thank Veronique Lefebvre for the Sox5 cDNA, Fredrik Ponten for supplying the normal and tumor tissue microarrays, and Umashankar Singh for advice on siRNA. This work has been supported by grants from the Swedish Cancer Society, the Swedish Research Council and Association for International Cancer Research, and by donations in the memory of Joacim Bonnevier. ET has been supported by postdoctoral grants from the Swedish Research Council, the Swedish Society for Medical Research and the Swedish Cancer Society.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Hagerstrand D, 2006, ONCOGENE, V25, P4913, DOI 10.1038/sj.onc.1209497; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; JEN J, 1994, CANCER RES, V54, P6353; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; KAMB A, 1994, SCIENCE, V264, P440; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Schlierf B, 2007, NEUROPATH APPL NEURO, V33, P621, DOI 10.1111/j.1365-2990.2007.00881.x; Schultz C, 2002, CANCER RES, V62, P6270; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; The WHO, 2020, CLASSIFICATION TUMOU; Ueda R, 2007, INT J CANCER, V120, P1704, DOI 10.1002/ijc.22472; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; Xia Y, 2000, CANCER RES, V60, P6303; Zafarana G, 2002, CANCER RES, V62, P1822	42	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1537	1548		10.1038/onc.2009.9	http://dx.doi.org/10.1038/onc.2009.9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19219070				2022-12-25	WOS:000264537400006
J	Zhang, D; Shooshtarizadeh, P; Laventie, BJ; Colin, DA; Chich, JF; Vidic, J; de Barry, J; Chasserot-Golaz, S; Delalande, F; Van Dorsselaer, A; Schneider, F; Helle, K; Aunis, D; Prevost, G; Metz-Boutigue, MH				Zhang, Dan; Shooshtarizadeh, Peiman; Laventie, Benoit-Joseph; Colin, Didier Andre; Chich, Jean-Francois; Vidic, Jasmina; de Barry, Jean; Chasserot-Golaz, Sylvette; Delalande, Francois; Van Dorsselaer, Alain; Schneider, Francis; Helle, Karen; Aunis, Dominique; Prevost, Gilles; Metz-Boutigue, Marie-Helene			Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A(2)	PLOS ONE			English	Article								Background: Antimicrobial peptides derived from the natural processing of chromogranin A (CgA) are co-secreted with catecholamines upon stimulation of chromaffin cells. Since PMNs play a central role in innate immunity, we examine responses by PMNs following stimulation by two antimicrobial CgA-derived peptides. Methodology/Principal Findings: PMNs were treated with different concentrations of CgA-derived peptides in presence of several drugs. Calcium mobilization was observed by using flow cytometry and calcium imaging experiments. Immunocytochemistry and confocal microscopy have shown the intracellular localization of the peptides. The calmodulin-binding and iPLA2 activating properties of the peptides were shown by Surface Plasmon Resonance and iPLA2 activity assays. Finally, a proteomic analysis of the material released after PMNs treatment with CgA-derived peptides was performed by using HPLC and Nano-LC MS-MS. By using flow cytometry we first observed that after 15 s, in presence of extracellular calcium, Chromofungin (CHR) or Catestatin (CAT) induce a concentration-dependent transient increase of intracellular calcium. In contrast, in absence of extra cellular calcium the peptides are unable to induce calcium depletion from the stores after 10 minutes exposure. Treatment with 2-APB (2-aminoethoxydiphenyl borate), a store operated channels (SOCs) blocker, inhibits completely the calcium entry, as shown by calcium imaging. We also showed that they activate iPLA2 as the two CaM-binding factors (W7 and CMZ) and that the two sequences can be aligned with the two CaM-binding domains reported for iPLA2. We finally analyzed by HPLC and Nano-LC MS-MS the material released by PMNs following stimulation by CHR and CAT. We characterized several factors important for inflammation and innate immunity. Conclusions/Significance: For the first time, we demonstrate that CHR and CAT, penetrate into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 pathway. Our study highlights the role of two CgA-derived peptides in the active communication between neuroendocrine and immune systems.	[Zhang, Dan; Shooshtarizadeh, Peiman; Chich, Jean-Francois; Delalande, Francois; Aunis, Dominique; Metz-Boutigue, Marie-Helene] INSERM, U575, Strasbourg, France; [Laventie, Benoit-Joseph; Colin, Didier Andre; Prevost, Gilles] Univ Louis Pasteur, Hop Univ Strasbourg, Inst Bacteriol,UPRES, Fac Med,EA 3432, F-67070 Strasbourg, France; [Chich, Jean-Francois; Vidic, Jasmina] INRA, Virol & Immunol Mol, Jouy En Josas, France; [de Barry, Jean; Chasserot-Golaz, Sylvette] Univ Louis Pasteur, CNRS, Inst Neurosci Cellulaires Integrat, UMR 7168, F-67070 Strasbourg, France; [Zhang, Dan; Schneider, Francis] Hop Hautepierre, Dept Reanimat Med, Strasbourg, France; [Van Dorsselaer, Alain] ULP, CNRS, IPHC DSA, Lab spectromet BioOrgan,UMR7178, Strasbourg, France; [Helle, Karen] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Zhang, Dan] Chongqing Univ Med Sci, Hosp 1, Chongqing, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Bergen; Chongqing Medical University	Zhang, D (corresponding author), INSERM, U575, Strasbourg, France.	metz@neurochem.u-strasbg.fr	Chasserot-Golaz, Sylvette/K-7625-2017; Dominique, Aunis/W-1419-2019; LAVENTIE, Benoît-Joseph/H-5260-2011; Vidic, Jasmina/AFP-6747-2022	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Vidic, Jasmina/0000-0002-8549-8199; Delalande, Francois/0000-0003-3590-9874; Chasserot-Golaz, Sylvette/0000-0002-7437-2558	Inserm; CNRS; Universite Louis Pasteur Strasbourg; The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg [3150]; Fondation Transplantation; French ministery de la recherche et de l'enseignement superieur; BRAHMS	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur Strasbourg; The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg; Fondation Transplantation; French ministery de la recherche et de l'enseignement superieur; BRAHMS	Inserm, CNRS, Universite Louis Pasteur Strasbourg, The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg (Grant 3150), Fondation Transplantation, French ministery de la recherche et de l'enseignement superieur, BRAHMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDAL S, 1992, REGUL PEPTIDES, V41, P9, DOI 10.1016/0167-0115(92)90509-S; Amato A, 2005, REGUL PEPTIDES, V130, P42, DOI 10.1016/j.regpep.2005.03.004; ANDERSSON KB, 1988, NATURE, V332, P688, DOI 10.1038/332688a0; ANGELETTI RH, 1994, ACTA PHYSIOL SCAND, V152, P11, DOI 10.1111/j.1748-1716.1994.tb09780.x; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Blois A, 2006, REGUL PEPTIDES, V135, P78, DOI 10.1016/j.regpep.2006.04.007; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; BOLOTINA VM, 2004, SCI STKE, pPE34; Brekke JF, 2002, REGUL PEPTIDES, V105, P93, DOI 10.1016/S0167-0115(02)00004-6; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cerra MC, 2008, FASEB J, V22, P3992, DOI 10.1096/fj.08-110239; CHEUNG NS, 1994, J NEUROCHEM, V62, P2246; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Corti A, 2004, GEN COMP ENDOCR, V136, P217, DOI 10.1016/j.ygcen.2003.12.012; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; EIDEN LE, 1987, NATURE, V325, P301, DOI 10.1038/325301a0; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Gasparri A, 1997, J BIOL CHEM, V272, P20835, DOI 10.1074/jbc.272.33.20835; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Goumon Y, 1996, EUR J BIOCHEM, V235, P516, DOI 10.1111/j.1432-1033.1996.t01-1-00516.x; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Jean-Eric G, 2005, REGUL PEPTIDES, V124, P27, DOI 10.1016/j.regpep.2004.06.022; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2007, EUR BIOPHYS J BIOPHY, V36, P1019, DOI 10.1007/s00249-007-0169-8; JEANFRANCOIS F, 2008, BIOPHYS J; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kang YL, 2008, BIOORG MED CHEM LETT, V18, P3749, DOI 10.1016/j.bmcl.2008.05.046; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Koeslag JH, 1999, J PHYSIOL-LONDON, V517, P643, DOI 10.1111/j.1469-7793.1999.0643s.x; Koike T, 1998, J BIOCHEM-TOKYO, V123, P1079; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Lasunskaia EB, 1997, APOPTOSIS, V2, P156, DOI 10.1023/A:1026460330596; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lohr C, 2006, GLIA, V54, P642, DOI 10.1002/glia.20368; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Metz-Boutigue MH, 1998, CELL MOL NEUROBIOL, V18, P249, DOI 10.1023/A:1022573004910; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Morita K, 2002, J PHARMACOL EXP THER, V302, P972, DOI 10.1124/jpet.102.033456; Moussa LB, 1999, FEBS LETT, V461, P280, DOI 10.1016/S0014-5793(99)01453-2; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; OSEAS R, 1981, BLOOD, V57, P939; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; RUSSELL J, 1994, ENDOCRINOLOGY, V135, P337, DOI 10.1210/en.135.1.337; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; STRUB JM, 1995, EUR J BIOCHEM, V229, P356, DOI 10.1111/j.1432-1033.1995.0356k.x; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tota B, 2003, REGUL PEPTIDES, V114, P123, DOI 10.1016/S0167-0115(03)00112-5; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wong SH, 2009, RHEUMATOLOGY, V48, P39, DOI 10.1093/rheumatology/ken412; YOO SH, 1992, BIOCHEMISTRY-US, V31, P6134, DOI 10.1021/bi00141a025; Zhang KX, 2006, DIABETES OBES METAB, V8, P621, DOI 10.1111/j.1463-1326.2006.00575.x	80	88	96	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4501	10.1371/journal.pone.0004501	http://dx.doi.org/10.1371/journal.pone.0004501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225567	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486000001
J	Mishra, BS; Singh, M; Aggrawal, P; Laxmi, A				Mishra, Bhuwaneshwar S.; Singh, Manjul; Aggrawal, Priyanka; Laxmi, Ashverya			Glucose and Auxin Signaling Interaction in Controlling Arabidopsis thaliana Seedlings Root Growth and Development	PLOS ONE			English	Article								Background: Plant root growth and development is highly plastic and can adapt to many environmental conditions. Sugar signaling has been shown to affect root growth and development by interacting with phytohormones such as gibberellins, cytokinin and abscisic acid. Auxin signaling and transport has been earlier shown to be controlling plant root length, number of lateral roots, root hair and root growth direction. Principal Findings: Increasing concentration of glucose not only controls root length, root hair and number of lateral roots but can also modulate root growth direction. Since root growth and development is also controlled by auxin, whole genome transcript profiling was done to find out the extent of interaction between glucose and auxin response pathways. Glucose alone could transcriptionally regulate 376 (62%) genes out of 604 genes affected by IAA. Presence of glucose could also modulate the extent of regulation 2 fold or more of almost 63% genes induced or repressed by IAA. Interestingly, glucose could affect induction or repression of IAA affected genes (35%) even if glucose alone had no significant effect on the transcription of these genes itself. Glucose could affect auxin biosynthetic YUCCA genes family members, auxin transporter PIN proteins, receptor TIR1 and members of a number of gene families including AUX/IAA, GH3 and SAUR involved in auxin signaling. Arabidopsis auxin receptor tir1 and response mutants, axr2, axr3 and slr1 not only display a defect in glucose induced change in root length, root hair elongation and lateral root production but also accentuate glucose induced increase in root growth randomization from vertical suggesting glucose effects on plant root growth and development are mediated by auxin signaling components. Conclusion: Our findings implicate an important role of the glucose interacting with auxin signaling and transport machinery to control seedling root growth and development in changing nutrient conditions.	[Mishra, Bhuwaneshwar S.; Singh, Manjul; Aggrawal, Priyanka; Laxmi, Ashverya] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Mishra, BS (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	ashverya_laxmi@nipgr.res.in	singh, manjul/L-3521-2019	singh, manjul/0000-0001-9547-269X	Department of Biotechnology, Government of India; University Grant Commission, India [Junior Research Fellowship]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India)	Project support from Department of Biotechnology, Government of India. Junior Research Fellowship to BSM from University Grant Commission, India	Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Dekkers BJW, 2008, PLANT MOL BIOL, V67, P151, DOI 10.1007/s11103-008-9308-6; FEIFEI S, 2007, PLANT PHYSIOL, V146, P178; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gonzali S, 2005, PLANT J, V44, P633, DOI 10.1111/j.1365-313X.2005.02555.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; JASON WR, 2001, TRENDS PLANT SCI, V6, P425; KARZ W, 1990, PHYSIOL PLANTARUM, V80, P257; Laxmi A, 2004, PLANT MOL BIOL, V56, P185, DOI 10.1007/s11103-004-2799-x; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Laxmi A, 2006, PLANT MOL BIOL, V62, P409, DOI 10.1007/s11103-006-9032-z; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Ohto MA, 2006, PLANT CELL PHYSIOL, V47, P1603, DOI 10.1093/pcp/pcl027; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; RADERMACHER E, 1993, J PLANT PHYSIOL, V141, P698, DOI 10.1016/S0176-1617(11)81577-4; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Shin H, 2005, PLANT J, V42, P188, DOI 10.1111/j.1365-313X.2005.02369.x; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yuan K, 2006, J EXP BOT, V57, P3359, DOI 10.1093/jxb/erl096	22	236	245	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4502	10.1371/journal.pone.0004502	http://dx.doi.org/10.1371/journal.pone.0004502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223973	Green Submitted, gold, Green Published			2022-12-25	WOS:000265485800008
J	Saxe, JP; Tomilin, A; Scholer, HR; Plath, K; Huang, J				Saxe, Jonathan P.; Tomilin, Alexey; Schoeler, Hans R.; Plath, Kathrin; Huang, Jing			Post-Translational Regulation of Oct4 Transcriptional Activity	PLOS ONE			English	Article								Oct4 is a key component of the molecular circuitry which regulates embryonic stem cell proliferation and differentiation. It is essential for maintenance of undifferentiated, pluripotent cell populations, and accomplishes these tasks by binding DNA in multiple heterodimer and homodimer configurations. Very little is known about how formation of these complexes is regulated, or the mechanisms through which Oct4 proteins respond to complex extracellular stimuli which regulate pluripotency. Here, we provide evidence for a phosphorylation-based mechanism which regulates specific Oct4 homodimer conformations. Point mutations of a putative phosphorylation site can specifically abrogate transcriptional activity of a specific homodimer assembly, with little effect on other configurations. Moreover, we performed bioinformatic predictions to identify a subset of Oct4 target genes which may be regulated by this specific assembly, and show that altering Oct4 protein levels affects transcription of Oct4 target genes which are regulated by this assembly but not others. Finally, we identified several signaling pathways which may mediate this phosphorylation and act in combination to regulate Oct4 transcriptional activity and protein stability. These results provide a mechanism for rapid and reversible alteration of Oct4 transactivation potential in response to extracellular signals.			Saxe, JP (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.	jonathan.saxe@yale.edu; jinghuang@mednet.ucla.edu	Tomilin, Alexey/AAK-3068-2021; Tomilin, Alexey N/C-3361-2014; Tomilin, Alexey/AAA-8774-2022; , HS/AAB-4434-2019	Tomilin, Alexey N/0000-0002-1137-7167; Tomilin, Alexey/0000-0002-1137-7167; , HS/0000-0003-2643-5136; Saxe, Jonathan/0000-0001-7301-6423; Plath, Kathrin/0000-0001-7796-3372	NCI NIH HHS [R01 CA124974-02, R01 CA124974-03, R01 CA124974, R01 CA124974-01] Funding Source: Medline; NHGRI NIH HHS [R21 HG003729, R21 HG003729-01A1, R21 HG003729-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124974] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003729] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUITT SC, 1994, DEVELOPMENT, V120, P37; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	43	95	98	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4467	10.1371/journal.pone.0004467	http://dx.doi.org/10.1371/journal.pone.0004467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221599	gold, Green Published			2022-12-25	WOS:000265485700005
J	Croteau, NJ; Furgason, MLM; Devos, D; Munson, M				Croteau, Nicole J.; Furgason, Melonnie L. M.; Devos, Damien; Munson, Mary			Conservation of Helical Bundle Structure between the Exocyst Subunits	PLOS ONE			English	Article								Background: The exocyst is a large hetero-octomeric protein complex required for regulating the targeting and fusion of secretory vesicles to the plasma membrane in eukaryotic cells. Although the sequence identity between the eight different exocyst subunits is less than 10%, structures of domains of four of the subunits revealed a similar helical bundle topology. Characterization of several of these subunits has been hindered by lack of soluble protein for biochemical and structural studies. Methodology/Principal Findings: Using advanced hidden Markov models combined with secondary structure predictions, we detect significant sequence similarity between each of the exocyst subunits, indicating that they all contain helical bundle structures. We corroborate these remote homology predictions by identifying and purifying a predicted domain of yeast Sec10p, a previously insoluble exocyst subunit. This domain is soluble and folded with approximately 60% alpha-helicity, in agreement with our predictions, and capable of interacting with several known Sec10p binding partners. Conclusions/Significance: Although all eight of the exocyst subunits had been suggested to be composed of similar helical bundles, this has now been validated by our hidden Markov model structure predictions. In addition, these predictions identified protein domains within the exocyst subunits, resulting in creation and characterization of a soluble, folded domain of Sec10p.	[Croteau, Nicole J.; Furgason, Melonnie L. M.; Munson, Mary] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Devos, Damien] EMBL, Heidelberg, Germany	University of Massachusetts System; University of Massachusetts Worcester; European Molecular Biology Laboratory (EMBL)	Croteau, NJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	mary.munson@umassmed.edu	devos, damien/ABH-5348-2020; Munson, Mary/A-9777-2009	Munson, Mary/0000-0003-2297-8053; Devos, Damien/0000-0002-9453-4753	EU [LSHG-CT-2005-5120828]; US National Institutes of Health [GM068803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068803] Funding Source: NIH RePORTER	EU(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the EU grant 3D-Repertoire (LSHG-CT-2005-5120828) to D.D., and by the US National Institutes of Health grant GM068803 to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cavanaugh LF, 2007, J BIOL CHEM, V282, P23418, DOI 10.1074/jbc.M703716200; Chen Y, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-45; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kuemmel D, 2008, CURR PROTEIN PEPT SC, V9, P197, DOI 10.2174/138920308783955252; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHOLTZ JM, 1995, P NATL ACAD SCI USA, V92, P185, DOI 10.1073/pnas.92.1.185; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoon J, 2005, PROTEIN EXPRES PURIF, V44, P1, DOI 10.1016/j.pep.2005.04.020	45	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4443	10.1371/journal.pone.0004443	http://dx.doi.org/10.1371/journal.pone.0004443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214222	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484300002
J	Kumar, KA; Baxter, P; Tarun, AS; Kappe, SHI; Nussenzweig, V				Kumar, Kota Arun; Baxter, Peter; Tarun, Alice S.; Kappe, Stefan H. I.; Nussenzweig, Victor			Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites	PLOS ONE			English	Article								Immunization with radiation attenuated Plasmodium sporozoites (RAS) elicits sterile protective immunity against sporozoite challenge in murine models and in humans. Similarly to RAS, the genetically attenuated sporozoites (GAPs) named uis3(-), uis4(-) and P36p(-) have arrested growth during the liver stage development, and generate a powerful protective immune response in mice. We compared the protective mechanisms in P. yoelii RAS, uis3(-) and uis4(-) in BALB/c mice. In RAS and GAPs, sterile immunity is only achieved after one or more booster injections. There were no differences in the immune responses to the circumsporozoite protein (CSP) generated by RAS and GAPs. To evaluate the role of non-CSP T-cell antigens we immunized antibody deficient, CSP-transgenic BALB/c mice, that are T cell tolerant to CSP, with P. yoelii RAS or with uis3(-) or uis4(-) GAPs, and challenged them with wild type sporozoites. In every instance the parasite liver stage burden was approximately 3 logs higher in antibody deficient CSP transgenic mice as compared to antibody deficient mice alone. We conclude that CSP is a powerful protective antigen in both RAS and GAPs viz., uis3(-) and uis4(-) and that the protective mechanisms are similar independently of the method of sporozoite attenuation.	[Kumar, Kota Arun; Baxter, Peter; Nussenzweig, Victor] NYU, Sch Med, Dept Pathol, Micheal Hidelberg Div Immunol, New York, NY 10003 USA; [Kumar, Kota Arun] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Tarun, Alice S.; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA USA	New York University; University of Hyderabad; Center for Infectious Disease Research	Kumar, KA (corresponding author), NYU, Sch Med, Dept Pathol, Micheal Hidelberg Div Immunol, New York, NY 10003 USA.	kaksl@uohyd.ernet.in		Tarun, Alice/0000-0002-0300-6657	Dana Foundation; Bill and Melinda Gates Foundation	Dana Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Dana Foundation (to Victor Nussenzweig) and the Bill and Melinda Gates Foundation (to Stefan H.I. Kappe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; KLOTZ FW, 1995, J IMMUNOL, V154, P3391; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VANDERBERG JP, 2005, PLOS BIOL, V34, P991; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	35	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4480	10.1371/journal.pone.0004480	http://dx.doi.org/10.1371/journal.pone.0004480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214236	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484300013
J	Johansson, A; Jonasson, I; Gyllensten, U				Johansson, Asa; Jonasson, Inger; Gyllensten, Ulf			Extended Haplotypes in the Growth Hormone Releasing Hormone Receptor Gene (GHRHR) Are Associated with Normal Variation in Height	PLOS ONE			English	Article								Mutations in the gene for growth hormone releasing hormone receptor (GHRHR) cause isolated growth hormone deficiency (IGHD) but this gene has not been found to affect normal variation in height. We performed a whole genome linkage analysis for height in a population from northern Sweden and identified a region on chromosome 7 with a lod-score of 4.7. The GHRHR gene is located in this region and typing of tagSNPs identified a haplotype that is associated with height (p=0.00077) in the original study population. Analysis of a sample from an independent population from the most northern part of Sweden also showed an association with height (p=0.0039) but with another haplotype in the GHRHR gene. Both haplotypes span the 39 part of the GHRHR gene, including the region in which most of the mutations in IGHD have been located. The effect size of these haplotypes are larger than that of any gene previously associated with height, which indicates that GHRHR might be one of the most important genes so far identified affecting normal variation in human height.	[Johansson, Asa; Jonasson, Inger; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden	Uppsala University	Johansson, A (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden.	ulf.gyllensten@genpat.uu.se	Johansson, Åsa/G-5270-2011; Johansson, Åsa/AAG-6799-2021	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498	Swedish Natural Sciences Research Council; European Commission /EUROSPAN; Foundation for Strategic Research; The Linneaus Centre for Bioinformatics	Swedish Natural Sciences Research Council; European Commission /EUROSPAN(European CommissionEuropean Commission Joint Research Centre); Foundation for Strategic Research; The Linneaus Centre for Bioinformatics	The study was supported by grants from The Swedish Natural Sciences Research Council, The European Commission /EUROSPAN, The Foundation for Strategic Research (SSF) and The Linneaus Centre for Bioinformatics (LCB). None of the sponsors or funders had any involvement in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aguiar-Oliveira MH, 1999, J CLIN ENDOCR METAB, V84, P4118, DOI 10.1210/jc.84.11.4118; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Cann HM, 2002, SCIENCE, V296, P261; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HASSLER S, 2004, BEFOLKNING BOSATTNIN, P107; Johansson A, 2005, HUM GENET, V116, P105, DOI 10.1007/s00439-004-1213-8; JOHANSSON A, 2003, HUM GENET; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lettre G, 2007, HUM GENET, V122, P129, DOI 10.1007/s00439-007-0385-4; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Liu YZ, 2004, ANN HUM GENET, V68, P472, DOI 10.1046/j.1529-8817.2003.00117.x; Norio R, 2003, HUM GENET, V112, P470, DOI 10.1007/s00439-002-0877-1; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salvatori R, 1999, J CLIN ENDOCR METAB, V84, P917, DOI 10.1210/jc.84.3.917; Salvatori R, 2002, MOL ENDOCRINOL, V16, P450, DOI 10.1210/me.16.3.450; Salvatori R, 2001, J CLIN ENDOCR METAB, V86, P273, DOI 10.1210/jc.86.1.273; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; Wajnrajch MP, 1996, NAT GENET, V12, P88, DOI 10.1038/ng0196-88; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4464	10.1371/journal.pone.0004464	http://dx.doi.org/10.1371/journal.pone.0004464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209235	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484100015
J	Pan, J; Wang, J; Zhou, ZF; Yan, YL; Zhang, W; Lu, W; Ping, S; Dai, QL; Yuan, ML; Feng, B; Hou, XG; Zhang, Y; Ma, R; Liu, T; Feng, L; Wang, L; Chen, M; Lin, M				Pan, Jie; Wang, Jin; Zhou, Zhengfu; Yan, Yongliang; Zhang, Wei; Lu, Wei; Ping, Shuzhen; Dai, Qilin; Yuan, Menglong; Feng, Bin; Hou, Xiaoguang; Zhang, Ying; Ma, Ruiqiang; Liu, Tingting; Feng, Lu; Wang, Lei; Chen, Ming; Lin, Min			IrrE, a Global Regulator of Extreme Radiation Resistance in Deinococcus radiodurans, Enhances Salt Tolerance in Escherichia coli and Brassica napus	PLOS ONE			English	Article								Background: Globally, about 20% of cultivated land is now affected by salinity. Salt tolerance is a trait of importance to all crops in saline soils. Previous efforts to improve salt tolerance in crop plants have met with only limited success. Bacteria of the genus Deinococcus are known for their ability to survive highly stressful conditions, and therefore possess a unique pool of genes conferring extreme resistance. In Deinococcus radiodurans, the irrE gene encodes a global regulator responsible for extreme radioresistance. Methodology/Principal Findings: Using plate assays, we showed that IrrE protected E. coli cells against salt shock and other abiotic stresses such as oxidative, osmotic and thermal shocks. Comparative proteomic analysis revealed that IrrE functions as a switch to regulate different sets of proteins such as stress responsive proteins, protein kinases, glycerol-degrading enzymes, detoxification proteins, and growth-related proteins in E. coli. We also used quantitative RT-PCR to investigate expression of nine selected stress-responsive genes in transgenic and wild-type Brassica napus plants. Transgenic B. napus plants expressing the IrrE protein can tolerate 350 mM NaCl, a concentration that inhibits the growth of almost all crop plants. Conclusions: Expression of IrrE, a global regulator for extreme radiation resistance in D. radiodurans, confers significantly enhanced salt tolerance in both E. coli and B. napus. We thus propose that the irrE gene might be used as a potentially promising transgene to improve abiotic stress tolerances in crop plants.	[Pan, Jie; Zhou, Zhengfu; Yan, Yongliang; Zhang, Wei; Lu, Wei; Yuan, Menglong; Hou, Xiaoguang; Zhang, Ying; Ma, Ruiqiang; Chen, Ming; Lin, Min] Chinese Acad Agr Sci, Key Lab Crop Biotechnol, Minist Agr, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Jin; Dai, Qilin; Feng, Bin; Liu, Tingting] SW Univ Sci & Technol, Commission Sci Technol & Industry Natl Defence, Key Lab Nuclear Waste Treatment & Environm Safety, Mianyang, Peoples R China; [Yan, Yongliang; Zhang, Wei; Ping, Shuzhen; Lin, Min] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Feng, Lu; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin Key Lab Microb Funct Genom, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Southwest University of Science & Technology - China; Chinese Academy of Sciences; Nankai University	Pan, J (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Biotechnol, Minist Agr, Biotechnol Res Inst, Beijing, Peoples R China.	chenmingbio@hotmail.com; linmin57@vip.163.com	feng, lu/M-5113-2015; Wang, Lei/C-5176-2009; min, lin/AAJ-7325-2020; Dai, Qilin/AAX-4057-2020	Wang, Lei/0000-0003-4427-0881; Dai, Qilin/0000-0001-8680-4306; yan, yongliang/0000-0002-4297-6648	National Basic Research (973) Program of China [2007CB707805]; National Natural Science Foundation of China [30670050]; National High-Tech (863) Program of China [2007AA021305]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Basic Research (973) Program of China (No.2007CB707805), the National Natural Science Foundation of China (No.30670050), and the National High-Tech (863) Program of China Grant 2007AA021305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; ANDRE L, 1988, J GEN MICROBIOL, V134, P669; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubunenko M, 2007, J BACTERIOL, V189, P2844, DOI 10.1128/JB.01713-06; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holmstrom KO, 2000, J EXP BOT, V51, P177, DOI 10.1093/jexbot/51.343.177; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; Ohba H, 2005, GENE, V363, P133, DOI 10.1016/j.gene.2005.07.035; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; RANDALL SK, 1986, J BIOL CHEM, V261, P1364; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Rus AM, 2001, PLANT CELL ENVIRON, V24, P875, DOI 10.1046/j.1365-3040.2001.00719.x; Sambrook J, 2001, MOL CLONING LAB MANU; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; TRUNIGER V, 1994, J BACTERIOL, V176, P1796, DOI 10.1128/jb.176.6.1796-1800.1994; Vijayakumar SRV, 2004, J BACTERIOL, V186, P8499, DOI 10.1128/JB.186.24.8499-8507.2004; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	55	61	78	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4422	10.1371/journal.pone.0004422	http://dx.doi.org/10.1371/journal.pone.0004422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204796	Green Published, gold, Green Submitted			2022-12-25	WOS:000265484000011
J	Hunter, RG; Bellani, R; Bloss, E; Costa, A; McCarthy, K; McEwen, BS				Hunter, Richard G.; Bellani, Rudy; Bloss, Erik; Costa, Ana; McCarthy, Katharine; McEwen, Bruce S.			Regulation of Kainate Receptor Subunit mRNA by Stress and Corticosteroids in the Rat Hippocampus	PLOS ONE			English	Article							MOSSY FIBER SYNAPSES; GLUCOCORTICOID-RECEPTOR; KAINIC ACID; MINERALOCORTICOID RECEPTOR; PYRAMIDAL NEURONS; ADULT-RAT; EXPRESSION; ADRENALECTOMY; BRAIN; CELLS	Kainate receptors are a class of ionotropic glutamate receptors that have a role in the modulation of glutamate release and synaptic plasticity in the hippocampal formation. Previous studies have implicated corticosteroids in the regulation of these receptors and recent clinical work has shown that polymorphisms in kainate receptor subunit genes are associated with susceptibility to major depression and response to anti-depressant treatment. In the present study we sought to examine the effects of chronic stress and corticosteroid treatments upon the expression of the mRNA of kainate receptor subunits GluR5-7 and KA1-2. Our results show that, after 7 days, adrenalectomy results in increased expression of hippocampal KA1, GluR6 and GluR7 mRNAs, an effect which is reversed by treatment with corticosterone in the case of KA1 and GluR7 and by aldosterone treatment in the case of GluR6. 21 days of chronic restraint stress (CRS) elevated the expression of the KA1 subunit, but had no effect on the expression of the other subunits. Similarly, 21 days of treatment with a moderate dose of corticosterone also increased KA1 mRNA in the dentate gyrus, whereas a high corticosterone dose has no effect. Our results suggest an interaction between hippocampal kainate receptor composition and the hypothalamic-pituitary-adrenal (HPA) axis and show a selective chronic stress induced modulation of the KA1 subunit in the dentate gyrus and CA3 that has implications for stress-induced adaptive structural plasticity.	[Hunter, Richard G.; Bellani, Rudy; Bloss, Erik; Costa, Ana; McCarthy, Katharine; McEwen, Bruce S.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Rockefeller University	Hunter, RG (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave, New York, NY 10021 USA.	rhunter@rockefeller.edu	Hunter, Richard/A-8043-2009; McEwen, Bruce/Z-1630-2019; Hunter, Richard G./F-1314-2014	Hunter, Richard G./0000-0002-3130-0941; Bloss, Erik/0000-0001-5031-4591	NIH [MH 15125, MH41256, MH065749]; Gary R. Helman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015125, R01MH041256, R37MH041256, F32MH065749] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gary R. Helman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH MH 15125, MH41256 and MH065749. RGH was supported by the Gary R. Helman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2006, NEUROENDOCRINOLOGY, V83, P371, DOI 10.1159/000096092; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Blackwood DHR, 2007, NEUROTOX RES, V11, P73, DOI 10.1007/BF03033484; Bortolotto ZA, 2005, NEUROTOXICOLOGY, V26, P769, DOI 10.1016/j.neuro.2005.02.004; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P249, DOI 10.1080/10408440801981957; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CLARK AS, 1992, BRAIN RES, V585, P161, DOI 10.1016/0006-8993(92)91202-P; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Darstein M, 2003, J NEUROSCI, V23, P8013; DEMONTIGNY C, 1987, EXP BRAIN RES, V65, P605, DOI 10.1007/BF00235983; Frye C A, 2000, Stress, V3, P185, DOI 10.3109/10253890009001122; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Han F, 2005, NEUROSCI RES, V51, P371, DOI 10.1016/j.neures.2004.12.013; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUNTER RG, 2006, NEUROPHARMACOLOGY; Hunter RG, 2007, BRAIN RES, V1152, P234, DOI 10.1016/j.brainres.2007.03.042; Joels M, 1996, MOL BRAIN RES, V37, P15, DOI 10.1016/0169-328X(95)00267-V; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Laje G, 2007, AM J PSYCHIAT, V164, P1530, DOI 10.1176/appi.ajp.2007.06122018; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; LUINE VN, 1993, BRAIN RES, V616, P65, DOI 10.1016/0006-8993(93)90193-Q; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Magarinos AM, 1998, BRAIN RES, V809, P314, DOI 10.1016/S0006-8993(98)00882-8; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; MUNCK A, 1994, ANN NY ACAD SCI, V746, P115, DOI 10.1111/j.1749-6632.1994.tb39221.x; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1980, BRAIN RES, V195, P47; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Raudensky J, 2007, BRAIN RES, V1135, P129, DOI 10.1016/j.brainres.2006.12.002; Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798; Schiffer HH, 2007, AM J MED GENET B, V144B, P20, DOI 10.1002/ajmg.b.30374; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P391, DOI 10.1113/jphysiol.2004.079624; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1995, BRAIN RES, V680, P217, DOI 10.1016/0006-8993(95)00235-I; WISDEN W, 1993, J NEUROSCI, V13, P3582; WOOLLEY CS, 1991, BRAIN RES, V554, P312, DOI 10.1016/0006-8993(91)90207-C; Wullner U, 1997, BRAIN RES, V768, P215, DOI 10.1016/S0006-8993(97)00645-8	44	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4328	10.1371/journal.pone.0004328	http://dx.doi.org/10.1371/journal.pone.0004328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180187	Green Published, gold, Green Submitted			2022-12-25	WOS:000274089700011
J	Wodarz, D; Komarova, N				Wodarz, Dominik; Komarova, Natalia			Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection	PLOS ONE			English	Article							VIRAL REPLICATION; TRANSMISSION; VIROTHERAPY; PATHOGEN; GROWTH	Oncolytic viruses are viruses that specifically infect cancer cells and kill them, while leaving healthy cells largely intact. Their ability to spread through the tumor makes them an attractive therapy approach. While promising results have been observed in clinical trials, solid success remains elusive since we lack understanding of the basic principles that govern the dynamical interactions between the virus and the cancer. In this respect, computational models can help experimental research at optimizing treatment regimes. Although preliminary mathematical work has been performed, this suffers from the fact that individual models are largely arbitrary and based on biologically uncertain assumptions. Here, we present a general framework to study the dynamics of oncolytic viruses that is independent of uncertain and arbitrary mathematical formulations. We find two categories of dynamics, depending on the assumptions about spatial constraints that govern that spread of the virus from cell to cell. If infected cells are mixed among uninfected cells, there exists a viral replication rate threshold beyond which tumor control is the only outcome. On the other hand, if infected cells are clustered together ( e. g. in a solid tumor), then we observe more complicated dynamics in which the outcome of therapy might go either way, depending on the initial number of cells and viruses. We fit our models to previously published experimental data and discuss aspects of model validation, selection, and experimental design. This framework can be used as a basis for model selection and validation in the context of future, more detailed experimental studies. It can further serve as the basis for future, more complex models that take into account other clinically relevant factors such as immune responses.	[Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA; [Komarova, Natalia] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [1R01AI058153-04]; Dr. Wodarz's university; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Wodarz's university; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant: 1R01AI058153-04 and Institutional funding from Dr. Wodarz's university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JA, 1997, SURVEY MODELS TUMOR; Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; ANDERSON R M, 1991; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; BARBOUR A, 1990, STOCHASTIC PROCESSES; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bell JC, 2007, CURR CANCER DRUG TAR, V7, P127, DOI 10.2174/156800907780058844; Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3; Chahlavi Ali, 1999, Neoplasia (New York), V1, P162, DOI 10.1038/sj.neo.7900016; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Davis JJ, 2005, J GENE MED, V7, P1380, DOI 10.1002/jgm.800; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Goodrum FD, 1997, J VIROL, V71, P548, DOI 10.1128/JVI.71.1.548-561.1997; Harrison D, 2001, HUM GENE THER, V12, P1323, DOI 10.1089/104303401750270977; Kaplan JM, 2005, CURR GENE THER, V5, P595, DOI 10.2174/156652305774964677; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Kirn DH, 1996, MOL MED TODAY, V2, P519, DOI 10.1016/S1357-4310(97)81456-6; Korn WM, 2006, CANCER GENE THER, V13, P792, DOI 10.1038/sj.cgt.7700947; Lorence RM, 2003, CURR OPIN MOL THER, V5, P618; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCormick F, 2005, ONCOGENE, V24, P7817, DOI 10.1038/sj.onc.1209064; McCormick F, 2003, CANCER BIOL THER, V2, pS157; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Novozhilov AS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-6; Nowak M. A., 2000, VIRUS DYNAMICS MATH; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Post Dawn E, 2005, Future Oncol, V1, P247, DOI 10.1517/14796694.1.2.247; Roberts MS, 2006, CURR OPIN MOL THER, V8, P314; SHIRLEY MD, 2005, ECOL COMPLEX, V2; Vaha-Koskela M. J., 2007, CANC LETT; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodarz D, 2003, HUM GENE THER, V14, P153, DOI 10.1089/104303403321070847; Wodarz D, 2001, CANCER RES, V61, P3501; Wodarz D., 2004, GENES THER MOL BIOL, V8, P137	38	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4271	10.1371/journal.pone.0004271	http://dx.doi.org/10.1371/journal.pone.0004271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180240	Green Published, gold, Green Submitted			2022-12-25	WOS:000274089700004
J	Storchi, R; Biella, GEM; Liberati, D; Baselli, G				Storchi, Riccardo; Biella, Gabriele E. M.; Liberati, Diego; Baselli, Giuseppe			Extraction and Characterization of Essential Discharge Patterns from Multisite Recordings of Spiking Ongoing Activity	PLOS ONE			English	Article								Background: Neural activation patterns proceed often by schemes or motifs distributed across the involved cortical networks. As neurons are correlated, the estimate of all possible dependencies quickly goes out of control. The complex nesting of different oscillation frequencies and their high non-stationariety further hamper any quantitative evaluation of spiking network activities. The problem is exacerbated by the intrinsic variability of neural patterns. Methodology/Principal Findings: Our technique introduces two important novelties and enables to insulate essential patterns on larger sets of spiking neurons and brain activity regimes. First, the sampling procedure over N units is based on a fixed spike number k in order to detect N-dimensional arrays (k-sequences), whose sum over all dimension is k. Then k-sequences variability is greatly reduced by a hierarchical separative clustering, that assigns large amounts of distinct k-sequences to few classes. Iterative separations are stopped when the dimension of each cluster comes to be smaller than a certain threshold. As threshold tuning critically impacts on the number of classes extracted, we developed an effective cost criterion to select the shortest possible description of our dataset. Finally we described three indexes (C, S, R) to evaluate the average pattern complexity, the structure of essential classes and their stability in time. Conclusions/Significance: We validated this algorithm with four kinds of surrogated activity, ranging from random to very regular patterned. Then we characterized a selection of ongoing activity recordings. By the S index we identified unstable, moderatly and strongly stable patterns while by the C and the R indices we evidenced their non-random structure. Our algorithm seems able to extract interesting and non-trivial spatial dynamics from multisource neuronal recordings of ongoing and potentially stimulated activity. Combined with time-frequency analysis of LFPs could provide a powerful multiscale approach linking population oscillations with multisite discharge patterns.	Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Storchi, Riccardo] Inst Molecular Bioimaging & Physiol, Milan, Italy; [Biella, Gabriele E. M.] Inst Molecular Bioimaging & Physiol, Natl Res Council, Milan, Italy; [Liberati, Diego] Politech Sch Milan, Natl Res Council, Dept Electron & Informat, Milan, Italy; [Baselli, Giuseppe] Politech Sch Milan, Dept Biomed Engn, Milan, Italy	Universita di Modena e Reggio Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Storchi, R (corresponding author), Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy.	riccardo.storchi@gmail.com	Liberati, Diego Ettore/AAE-2900-2020	Biella, Gabriele/0000-0001-8451-249X; Storchi, Riccardo/0000-0002-3656-7514	University of Modena; San Raffaele Hospital	University of Modena; San Raffaele Hospital	Support was provided by the University of Modena and by San Raffaele Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Boley D, 1998, DATA MIN KNOWL DISC, V2, P325, DOI 10.1023/A:1009740529316; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; HEKSTRA AP, 1989, IEEE T INFORM THEORY, V35, P44, DOI 10.1109/18.42175; HOCHBAUM DS, 1985, MATH OPER RES, V10, P180, DOI 10.1287/moor.10.2.180; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Johnson DH, 2001, J COMPUT NEUROSCI, V10, P47, DOI 10.1023/A:1008968010214; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; McKay DJC., 2003, INFORM THEORY INFERE; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; RIEKE F, BIALEK W SPIKES EXPL; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Savaresi S. M., 2004, Intelligent Data Analysis, V8, P345; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Smith AC, 2006, NEURAL COMPUT, V18, P1197, DOI 10.1162/neco.2006.18.5.1197; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steriade M, 1998, Sleep Res Online, V1, P1; Steriade M., 1990, THALAMIC OSCILLATION; Tetko IV, 2001, J NEUROSCI METH, V105, P15, DOI 10.1016/S0165-0270(00)00337-X; Tetko IV, 2001, J NEUROSCI METH, V105, P1, DOI 10.1016/S0165-0270(00)00336-8; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	43	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4299	10.1371/journal.pone.0004299	http://dx.doi.org/10.1371/journal.pone.0004299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173006	Green Submitted, gold, Green Published			2022-12-25	WOS:000265483000008
J	Ghani, AC; Sutherland, CJ; Riley, EM; Drakeley, CJ; Griffin, JT; Gosling, RD; Filipe, JAN				Ghani, Azra C.; Sutherland, Colin J.; Riley, Eleanor M.; Drakeley, Chris J.; Griffin, Jamie T.; Gosling, Roly D.; Filipe, Joao A. N.			Loss of Population Levels of Immunity to Malaria as a Result of Exposure-Reducing Interventions: Consequences for Interpretation of Disease Trends	PLOS ONE			English	Article								Background: The persistence of malaria as an endemic infection and one of the major causes of childhood death in most parts of Africa has lead to a radical new call for a global effort towards eradication. With the deployment of a highly effective vaccine still some years away, there has been an increased focus on interventions which reduce exposure to infection in the individual and -by reducing onward transmission-at the population level. The development of appropriate monitoring of these interventions requires an understanding of the timescales of their effect. Methods & Findings: Using a mathematical model for malaria transmission which incorporates the acquisition and loss of both clinical and parasite immunity, we explore the impact of the trade-off between reduction in exposure and decreased development of immunity on the dynamics of disease following a transmission-reducing intervention such as insecticide-treated nets. Our model predicts that initially rapid reductions in clinical disease incidence will be observed as transmission is reduced in a highly immune population. However, these benefits in the first 5-10 years after the intervention may be offset by a greater burden of disease decades later as immunity at the population level is gradually lost. The negative impact of having fewer immune individuals in the population can be counterbalanced either by the implementation of highly-effective transmission-reducing interventions (such as the combined use of insecticide-treated nets and insecticide residual sprays) for an indefinite period or the concurrent use of a pre-erythrocytic stage vaccine or prophylactic therapy in children to protect those at risk from disease as immunity is lost in the population. Conclusions: Effective interventions will result in rapid decreases in clinical disease across all transmission settings while population-level immunity is maintained but may subsequently result in increases in clinical disease many years later as population-level immunity is lost. A dynamic, evolving intervention programme will therefore be necessary to secure substantial, stable reductions in malaria transmission.	[Ghani, Azra C.; Griffin, Jamie T.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Ghani, Azra C.; Filipe, Joao A. N.] London Sch Hygiene & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Sutherland, Colin J.; Riley, Eleanor M.; Drakeley, Chris J.; Gosling, Roly D.] London Sch Hygiene & Trop Med, Dept Infect & Trop Dis, London, England; [Filipe, Joao A. N.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 1TN, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Ghani, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	a.ghani@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Riley, Eleanor/AAL-1382-2020; Ghani, Azra/B-8560-2009; Sutherland, Colin/AAN-3939-2020; Riley, Eleanor M/C-8960-2013; Ferguson, Neil/B-8578-2008	Fraser, Christophe/0000-0003-2399-9657; Riley, Eleanor/0000-0003-3447-3570; Sutherland, Colin/0000-0003-1592-6407; Riley, Eleanor M/0000-0003-3447-3570; Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; White, Michael/0000-0002-7472-4138; Ghani, Azra/0000-0002-0007-4910; Filipe, Joao/0000-0002-2353-7981; Flasche, Stefan/0000-0002-5808-2606	The Gates Foundation; MRC;  [38773];  [G9901439]; Medical Research Council [G0600719B] Funding Source: researchfish	The Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was in part funded by a grant from The Gates Foundation (Grant ID# 38773). Data used in the study were collected in an MRC-funded study (grant number: G9901439). The funders played no role in the design, analysis or drafting of the results.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; ANDERSON RM, 1985, NATURE, V315, P493, DOI 10.1038/315493a0; [Anonymous], 2004, COCHRANE DB SYST REV; Aron J.L., 1982, P139; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; GOSLING R, 2008, MALARIA J, V3, P7; GRAMICCIA G, 1988, PRINCIPLE PRACTICE M; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Wipasa J, 2007, EXPERT OPIN BIOL TH, V7, P1841, DOI 10.1517/14712598.7.12.1841; World Health Organization, 2008, INS TREAT MOSQ NETS	32	112	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4383	10.1371/journal.pone.0004383	http://dx.doi.org/10.1371/journal.pone.0004383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198649	Green Published, Green Submitted, gold			2022-12-25	WOS:000265483900004
J	Nickerson, EK; Wuthiekanun, V; Wongsuvan, G; Limmathurosakul, D; Srisamang, P; Mahavanakul, W; Thaipadungpanit, J; Shah, KR; Arayawichanont, A; Amornchai, P; Thanwisai, A; Day, NP; Peacock, SJ				Nickerson, Emma K.; Wuthiekanun, Vanaporn; Wongsuvan, Gumphol; Limmathurosakul, Direk; Srisamang, Pramot; Mahavanakul, Weera; Thaipadungpanit, Janjira; Shah, Krupal R.; Arayawichanont, Arkhom; Amornchai, Premjit; Thanwisai, Aunchalee; Day, Nicholas P.; Peacock, Sharon J.			Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; BACTEREMIA; GENES; COMMUNITY; IDENTIFICATION; DETERMINANTS; ASSOCIATION; INFECTIONS; EXPERIENCE	Background: Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world. The factors determining mortality in developing countries have not been identified. Methods: A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period. All-cause and S. aureus-attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL). Principal Findings: A total of 270 patients with invasive S. aureus infection were recruited. The range of clinical manifestations was broad and comparable to that described in developed countries. All-cause and S. aureus-attributable mortality rates were 26% and 20%, respectively. Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p < 0.001) on univariate analysis. Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p < 0.001). Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus-attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival. Conclusions: Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world. Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.			Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Afroz S, 2008, JPN J INFECT DIS, V61, P393; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Korownyk C, 2007, CAN FAM PHYSICIAN, V53, P1680; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; *NCCLS, 2004, M100S14  S, V24, P40; NEELA V, 2008, INT J INFECT DIS; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Renwick L, 2008, EUR J CLIN MICROBIOL, V27, P791, DOI 10.1007/s10096-008-0503-9; Tang YW, 2007, J CLIN MICROBIOL, V45, P1867, DOI 10.1128/JCM.02100-06; Topeli A, 2000, INT J ANTIMICROB AG, V14, P57, DOI 10.1016/S0924-8579(99)00147-8; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WILSON R, 1957, AM J MED, V22, P437, DOI 10.1016/0002-9343(57)90099-2; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004	32	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6512	10.1371/journal.pone.0006512	http://dx.doi.org/10.1371/journal.pone.0006512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652705	Green Submitted, Green Published, gold			2022-12-25	WOS:000268637800018
J	Nickerson, EK; Hongsuwan, M; Limmathurotsakul, D; Wuthiekanun, V; Shah, KR; Srisomang, P; Mahavanakul, W; Wacharaprechasgul, T; Fowler, VG; West, TE; Teerawatanasuk, N; Becher, H; White, NJ; Chierakul, W; Day, NP; Peacock, SJ				Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; Shah, Krupal R.; Srisomang, Pramot; Mahavanakul, Weera; Wacharaprechasgul, Therapon; Fowler, Vance G., Jr.; West, T. Eoin; Teerawatanasuk, Nitaya; Becher, Harald; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.			Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; MEDICAL PROGRESS; EPIDEMIOLOGY; POPULATION; MORTALITY; CHILDREN	Background: Most information on invasive Staphylococcus aureus infections comes from temperate countries. There considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. Methods: A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. Principal Findings: Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. Conclusions: S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.	[Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nickerson, Emma K.; White, Nicholas J.; Day, Nicholas P.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Shah, Krupal R.; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Wacharaprechasgul, Therapon] Sappasithiprasong Hosp, Dept Radiol, Ubon Ratchathani, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [Teerawatanasuk, Nitaya] Sappasithiprasong Hosp, Dept Microbiol, Ubon Ratchathani, Thailand; [Becher, Harald] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Duke University; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford	Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; National Institutes of Health [R01-AI068804, U54 AI057141]; Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust. EKN, MH, DL, VW, NJW, WC, NPD and SJP are funded by the Wellcome Trust. VGF is funded by National Institutes of Health award R01-AI068804. TEW is funded by National Institutes of Health award U54 AI057141 and by a Parker B. Francis Fellowship in Pulmonary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; DHAWAN A, 1993, ANN TROP PAEDIATR, V13, P189, DOI 10.1080/02724936.1993.11747644; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Karunakaran Rina, 2007, Journal of Microbiology Immunology and Infection, V40, P432; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; *NCCLS, 2004, M100S14  S, V24, P40; Nkomo VT, 2007, HEART, V93, P1510, DOI 10.1136/hrt.2007.118810; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Powell JP, 2008, EXPERT REV ANTI-INFE, V6, P299, DOI 10.1586/14787210.6.3.299; Singhi S, 2008, INDIAN J PEDIATR, V75, P25, DOI 10.1007/s12098-008-0002-0; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018	25	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4308	10.1371/journal.pone.0004308	http://dx.doi.org/10.1371/journal.pone.0004308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19652705	Green Published, gold			2022-12-25	WOS:000274089700007
